A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Use this spreadsheet as a guide to some of the literature that has been published regarding the potential risks of "COVID-19 vaccines". Certain keywords have been highlighted here encompassing around half of the database. These studies are of particular importance when considering the risks to the lives of young, healthy, college-age individuals from both Sars-CoV-2 and "COVID-19 vaccines". Known and documented risks from the "vaccines" include: myocarditis, heart attack, stroke, thrombosis, cancer increases, and death. Modern bioethics, international accords, and common decency agree on the requirement of informed consent, which includes the right to refuse any medical intervention without prejudice. Any product with such potential side effects cannot be mandated under any circumstances. | Titles with the following keywords are highlighted in the following colors | Number of titles with keywords | % of this database | ||||||||||||
2 | Death | 11 | 1.09% | |||||||||||||
3 | Children | 20 | 1.98% | |||||||||||||
4 | Young | 24 | 2.38% | |||||||||||||
5 | Thrombocytopenia | 191 | 18.95% | |||||||||||||
6 | Myocarditis | 212 | 21.05% | |||||||||||||
7 | Stroke | 12 | 1.19% | |||||||||||||
8 | Cancer | 10 | 1.00% | |||||||||||||
9 | Causation | 26 | 2.59% | |||||||||||||
10 | Meta-analyses | 4 | 0.40% | |||||||||||||
11 | Total | 510 | 50.90% | |||||||||||||
12 | Hyperlink | Title | link_part | Source | Unique_link | APA | es_APA | es_APA_A-Z | en_APA | en_APA_A-Z | UNIQUE_CHECK | CONCAT | FINAL_en_APA_A-Z | |||
13 | Cerebral venous thrombosis after COVID-19 vaccination in the UK: a multicentre cohort study: | https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)01608-1/ | https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)01608-1/ | Perry, R. J., Tamborska, A., Singh, B., Craven, B., Marigold, R., Arthur-Farraj, P., ... & Zambreanu, L. (2021). Cerebral venous thrombosis after vaccination against COVID-19 in the UK: a multicentre cohort study. The Lancet, 398(10306), 1147-1156. | Perry, R. J., Tamborska, A., Singh, B., Craven, B., Marigold, R., Arthur-Farraj, P., ... y Zambreanu, L. (2021). Trombosis venosa cerebral después de la vacunación contra COVID-19 en el Reino Unido: un estudio de cohorte multicéntrico. The Lancet, 398(10306), 1147-1156. https://www.sciencedirect.com/science/article/pii/S1052305721003414 | A, Q. J., Qin, D. A., & PEI, J. X. (2021). Artritis reactiva después de la vacunación de COVID-19. Vacunas humanas e inmunoterapiautica, 17 (9), 2954-2956. https://pubmed.ncbi.nlm.nih.gov/33858208/ | Perry, R. J., Tamborska, A., Singh, B., Craven, B., Marigold, R., Arthur-Farraj, P., ... & Zambreanu, L. (2021). Cerebral venous thrombosis after vaccination against COVID-19 in the UK: a multicentre cohort study. The Lancet, 398(10306), 1147-1156. https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)01608-1/ | Abbate, A., Gavin, J., Madanchi, N., Kim, C., Shah, P. R., Klein, K., ... & Danielides, S. (2021). Fulminant myocarditis and systemic hyperinflammation temporally associated with BNT162b2 mRNA COVID-19 vaccination in two patients. International Journal of Cardiology, 340, 119-121. https://pubmed.ncbi.nlm.nih.gov/34416319/. | Perry, R. J., Tamborska, A., Singh, B., Craven, B., Marigold, R., Arthur-Farraj, P., ... & Zambreanu, L. (2021). Cerebral venous thrombosis after vaccination against COVID-19 in the UK: a multicentre cohort study. The Lancet, 398(10306), 1147-1156. | https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)01608-1/ | Perry, R. J., Tamborska, A., Singh, B., Craven, B., Marigold, R., Arthur-Farraj, P., ... & Zambreanu, L. (2021). Cerebral venous thrombosis after vaccination against COVID-19 in the UK: a multicentre cohort study. The Lancet, 398(10306), 1147-1156. https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)01608-1/ | Abbate, A., Gavin, J., Madanchi, N., Kim, C., Shah, P. R., Klein, K., ... & Danielides, S. (2021). Fulminant myocarditis and systemic hyperinflammation temporally associated with BNT162b2 mRNA COVID-19 vaccination in two patients. International Journal of Cardiology, 340, 119-121. https://www.sciencedirect.com/science/article/pii/S0167527321012286. | 753 | |||
14 | Vaccine-induced immune thrombotic thrombocytopenia with disseminated intravascular coagulation and death after ChAdOx1 nCoV-19 vaccination: https://www.sciencedirect.com/science/article/pii/S1052305721003414 | Vaccine-induced immune thrombotic thrombocytopenia with disseminated intravascular coagulation and death after ChAdOx1 nCoV-19 vaccination: | https://www.sciencedirect.com/science/article/pii/S1052305721003414 | https://www.sciencedirect.com/science/article/pii/S1052305721003414 | Aladdin, Y., Algahtani, H., & Shirah, B. (2021). Vaccine-induced immune thrombotic thrombocytopenia with disseminated intravascular coagulation and death following the ChAdOx1 nCoV-19 vaccine. Journal of Stroke and Cerebrovascular Diseases, 30(9), 105938. | Aladdin, Y., Algahtani, H. y Shirah, B. (2021). Trombocitopenia trombótica inmune inducida por vacuna con coagulación intravascular diseminada y muerte después de la vacuna ChAdOx1 nCoV-19. Revista de accidentes cerebrovasculares y enfermedades cerebrovasculares, 30(9), 105938. https://pubmed.ncbi.nlm.nih.gov/33928772/ | Abbate, A., Gavin, J., Midanchi, N., Kim, C., Shah, P. R., Klein, K., ... & Danivelides, S. (2021). Miocarditis fulminante y hiperinflamación sistémica asociada temporalmente con la vacunación con BNT162B2 MRNA COVID-19 en dos pacientes. Diario Internacional de Cardiología, 340, 119-121. https://pubmed.ncbi.nlm.nih.gov/34092166/ | Aladdin, Y., Algahtani, H., & Shirah, B. (2021). Vaccine-induced immune thrombotic thrombocytopenia with disseminated intravascular coagulation and death following the ChAdOx1 nCoV-19 vaccine. Journal of Stroke and Cerebrovascular Diseases, 30(9), 105938. https://www.sciencedirect.com/science/article/pii/S1052305721003414 | Abbate, A., Gavin, J., Madanchi, N., Kim, C., Shah, P. R., Klein, K., ... & Danielides, S. (2021). Fulminant myocarditis and systemic hyperinflammation temporally associated with BNT162b2 mRNA COVID-19 vaccination in two patients. International Journal of Cardiology, 340, 119-121. https://www.ncbi.nlm.nih.gov/pubmed/34416319 | Aladdin, Y., Algahtani, H., & Shirah, B. (2021). Vaccine-induced immune thrombotic thrombocytopenia with disseminated intravascular coagulation and death following the ChAdOx1 nCoV-19 vaccine. Journal of Stroke and Cerebrovascular Diseases, 30(9), 105938. | https://www.sciencedirect.com/science/article/pii/S1052305721003414 | Aladdin, Y., Algahtani, H., & Shirah, B. (2021). Vaccine-induced immune thrombotic thrombocytopenia with disseminated intravascular coagulation and death following the ChAdOx1 nCoV-19 vaccine. Journal of Stroke and Cerebrovascular Diseases, 30(9), 105938. https://www.sciencedirect.com/science/article/pii/S1052305721003414 | Abbattista, M., Martinelli, I., & Peyvandi, F. (2021). Comparison of adverse drug reactions among four COVID‐19 vaccines in Europe using the EudraVigilance database: thrombosis at unusual sites. Journal of Thrombosis and Haemostasis, 19(10), 2554-2558. https://pubmed.ncbi.nlm.nih.gov/34375510/ | |||
15 | Fatal cerebral hemorrhage after COVID-19 vaccine: | https://pubmed.ncbi.nlm.nih.gov/33928772/ | https://pubmed.ncbi.nlm.nih.gov/33928772/ | Bjørnstad-Tuveng, T. H., Rudjord, A., & Anker, P. (2021). Fatal cerebral haemorrhage after COVID-19 vaccine. Tidsskrift for Den norske legeforening. | Bjørnstad-Tuveng, TH, Rudjord, A. y Anker, P. (2021). Hemorragia cerebral fatal después de la vacuna COVID-19. Tidsskrift para Den norske legeforening. https://www.sciencedirect.com/science/article/pii/S2666602221000409 | Abbate, A., Gavin, J., Midanchi, N., Kim, C., Shah, P. R., Klein, K., ... & Danivelides, S. (2021). Miocarditis fulminante y hiperinflamación sistémica asociada temporalmente con la vacunación con BNT162B2 MRNA COVID-19 en dos pacientes. Diario Internacional de Cardiología, 340, 119-121. https://www.ncbi.nlm.nih.gov/pubmed/34092429 | Bjørnstad-Tuveng, T. H., Rudjord, A., & Anker, P. (2021). Fatal cerebral haemorrhage after COVID-19 vaccine. Tidsskrift for Den norske legeforening. https://pubmed.ncbi.nlm.nih.gov/33928772/ | Abbate, A., Gavin, J., Madanchi, N., Kim, C., Shah, P. R., Klein, K., ... & Danielides, S. (2021). Fulminant myocarditis and systemic hyperinflammation temporally associated with BNT162b2 mRNA COVID-19 vaccination in two patients. International Journal of Cardiology, 340, 119-121. https://www.sciencedirect.com/science/article/pii/S0167527321012286. | Bjørnstad-Tuveng, T. H., Rudjord, A., & Anker, P. (2021). Fatal cerebral haemorrhage after COVID-19 vaccine. Tidsskrift for Den norske legeforening. | https://pubmed.ncbi.nlm.nih.gov/33928772/ | Bjørnstad-Tuveng, T. H., Rudjord, A., & Anker, P. (2021). Fatal cerebral haemorrhage after COVID-19 vaccine. Tidsskrift for Den norske legeforening. https://pubmed.ncbi.nlm.nih.gov/33928772/ | Abi Zeid Daou, C., Natout, M. A., & El Hadi, N. (2021). Biphasic anaphylaxis after exposure to the first dose of Pfizer‐BioNTech COVID‐19 mRNA vaccine. Journal of medical virology, 93(10), 6027-6029. https://pubmed.ncbi.nlm.nih.gov/34050949/ | ||||
16 | Myocarditis after mRNA vaccination against SARS-CoV-2, a case series: | https://www.sciencedirect.com/science/article/pii/S2666602221000409 | https://www.sciencedirect.com/science/article/pii/S2666602221000409 | King, W. W., Petersen, M. R., Matar, R. M., Budweg, J. B., Pardo, L. C., & Petersen, J. W. (2021). Myocarditis following mRNA vaccination against SARS-CoV-2, a case series. American Heart Journal Plus: Cardiology Research and Practice, 8, 100042. | King, W. W., Petersen, M. R., Matar, R. M., Budweg, J. B., Pardo, L. C. y Petersen, J. W. (2021). Miocarditis tras la vacunación con ARNm contra el SARS-CoV-2, una serie de casos. American Heart Journal Plus: Investigación y práctica de cardiología, 8, 100042. https://www.sciencedirect.com/science/article/pii/S2213333X21003929 | Abbate, A., Gavin, J., Midanchi, N., Kim, C., Shah, P. R., Klein, K., ... & Danivelides, S. (2021). Miocarditis fulminante y hiperinflamación sistémica asociada temporalmente con la vacunación con BNT162B2 MRNA COVID-19 en dos pacientes. Diario Internacional de Cardiología, 340, 119-121. https://www.sciencedirect.com/science/article/pii/S2214250921001530 | King, W. W., Petersen, M. R., Matar, R. M., Budweg, J. B., Pardo, L. C., & Petersen, J. W. (2021). Myocarditis following mRNA vaccination against SARS-CoV-2, a case series. American Heart Journal Plus: Cardiology Research and Practice, 8, 100042. https://www.sciencedirect.com/science/article/pii/S2666602221000409 | Abbattista, M., Martinelli, I., & Peyvandi, F. (2021). Comparison of adverse drug reactions among four COVID‐19 vaccines in Europe using the EudraVigilance database: thrombosis at unusual sites. Journal of Thrombosis and Haemostasis, 19(10), 2554-2558. https://pubmed.ncbi.nlm.nih.gov/34375510/ | King, W. W., Petersen, M. R., Matar, R. M., Budweg, J. B., Pardo, L. C., & Petersen, J. W. (2021). Myocarditis following mRNA vaccination against SARS-CoV-2, a case series. American Heart Journal Plus: Cardiology Research and Practice, 8, 100042. | https://www.sciencedirect.com/science/article/pii/S2666602221000409 | King, W. W., Petersen, M. R., Matar, R. M., Budweg, J. B., Pardo, L. C., & Petersen, J. W. (2021). Myocarditis following mRNA vaccination against SARS-CoV-2, a case series. American Heart Journal Plus: Cardiology Research and Practice, 8, 100042. https://www.sciencedirect.com/science/article/pii/S2666602221000409 | Abičić, A., Adamec, I., & Habek, M. (2022). Miller Fisher syndrome following Pfizer COVID-19 vaccine. Neurological Sciences, 43(3), 1495-1497. https://pubmed.ncbi.nlm.nih.gov/34817727/. | ||||
17 | Three cases of acute venous thromboembolism in women after vaccination against COVID-19: | https://www.sciencedirect.com/science/article/pii/S2213333X21003929 | https://www.sciencedirect.com/science/article/pii/S2213333X21003929 | Andraska, E. A., Kulkarni, R., Chaudhary, M., & Sachdev, U. (2022). Three cases of acute venous thromboembolism in females after vaccination for coronavirus disease 2019. Journal of Vascular Surgery: Venous and Lymphatic Disorders, 10(1), 14-17. | Andraska, EA, Kulkarni, R., Chaudhary, M. y Sachdev, U. (2022). Tres casos de tromboembolismo venoso agudo en mujeres después de la vacunación contra la enfermedad por coronavirus 2019. Journal of Vascular Surgery: Venous and Lymphatic Disorders, 10(1), 14-17. https://www.sciencedirect.com/science/article/abs/pii/S1936879821003988 | Abbattista, M., Martinelli, I., Peyvandi, F. (2021). Comparación de reacciones adversas de los medicamentos entre las cuatro vacunas COVID-19 en Europa utilizando la base de datos EudRAVAVIGILANCE: trombosis a sitios inusuales. Journal of Thrombosis y Haemostasis, 19 (10), 2554-2558. https://pubmed.ncbi.nlm.nih.gov/34107198/ | Andraska, E. A., Kulkarni, R., Chaudhary, M., & Sachdev, U. (2022). Three cases of acute venous thromboembolism in females after vaccination for coronavirus disease 2019. Journal of Vascular Surgery: Venous and Lymphatic Disorders, 10(1), 14-17. https://www.sciencedirect.com/science/article/pii/S2213333X21003929 | Abi Zeid Daou, C., Natout, M. A., & El Hadi, N. (2021). Biphasic anaphylaxis after exposure to the first dose of Pfizer‐BioNTech COVID‐19 mRNA vaccine. Journal of medical virology, 93(10), 6027-6029. https://pubmed.ncbi.nlm.nih.gov/34050949/ | Andraska, E. A., Kulkarni, R., Chaudhary, M., & Sachdev, U. (2022). Three cases of acute venous thromboembolism in females after vaccination for coronavirus disease 2019. Journal of Vascular Surgery: Venous and Lymphatic Disorders, 10(1), 14-17. | https://www.sciencedirect.com/science/article/pii/S2213333X21003929 | Andraska, E. A., Kulkarni, R., Chaudhary, M., & Sachdev, U. (2022). Three cases of acute venous thromboembolism in females after vaccination for coronavirus disease 2019. Journal of Vascular Surgery: Venous and Lymphatic Disorders, 10(1), 14-17. https://www.sciencedirect.com/science/article/pii/S2213333X21003929 | Abou-Foul, A. K., Ross, E., Abou-Foul, M., & George, A. P. (2021). Cervical lymphadenopathy following coronavirus disease 2019 vaccine: clinical characteristics and implications for head and neck cancer services. The Journal of Laryngology & Otology, 135(11), 1025-1030. https://pubmed.ncbi.nlm.nih.gov/34526175/ | ||||
18 | Acute thrombosis of the coronary tree after vaccination against COVID-19: | https://www.sciencedirect.com/science/article/abs/pii/S1936879821003988 | https://www.sciencedirect.com/science/article/abs/pii/S1936879821003988 | Tajstra, M., Jaroszewicz, J., & Gąsior, M. (2021). Acute coronary tree thrombosis after vaccination for COVID-19. Cardiovascular Interventions, 14(9), e103-e104. | Tajstra, M., Jaroszewicz, J. y Gąsior, M. (2021). Trombosis aguda del árbol coronario tras la vacunación contra COVID-19. Intervenciones cardiovasculares, 14(9), e103-e104. https://pubmed.ncbi.nlm.nih.gov/33929487/ | Abi Zeid Daou, C., Notaut, M. A., & El Hadi, N. (2021). Anafilaxia bifásica después de la exposición a la primera dosis de vacuna contra ARNm de Pfizer-Biontech Covid-19. Diario de virología médica, 93 (10), 6027-6029. https://pubmed.ncbi.nlm.nih.gov/33657648/ | Tajstra, M., Jaroszewicz, J., & Gąsior, M. (2021). Acute coronary tree thrombosis after vaccination for COVID-19. Cardiovascular Interventions, 14(9), e103-e104. https://www.sciencedirect.com/science/article/abs/pii/S1936879821003988 | Abičić, A., Adamec, I., & Habek, M. (2022). Miller Fisher syndrome following Pfizer COVID-19 vaccine. Neurological Sciences, 43(3), 1495-1497. https://pubmed.ncbi.nlm.nih.gov/34817727/. | Tajstra, M., Jaroszewicz, J., & Gąsior, M. (2021). Acute coronary tree thrombosis after vaccination for COVID-19. Cardiovascular Interventions, 14(9), e103-e104. | https://www.sciencedirect.com/science/article/abs/pii/S1936879821003988 | Tajstra, M., Jaroszewicz, J., & Gąsior, M. (2021). Acute coronary tree thrombosis after vaccination for COVID-19. Cardiovascular Interventions, 14(9), e103-e104. https://www.sciencedirect.com/science/article/abs/pii/S1936879821003988 | Abou‐Ismail, M. Y., Moser, K. A., Smock, K. J., & Lim, M. Y. (2021). Vaccine‐induced thrombotic thrombocytopenia following Ad26. COV2. S vaccine in a man presenting as acute venous thromboembolism. American Journal of Hematology. https://pubmed.ncbi.nlm.nih.gov/34096082/ | ||||
19 | US case reports of cerebral venous sinus thrombosis with thrombocytopenia after vaccination with Ad26.COV2.S (against covid-19), March 2 to April 21, 2020: | https://pubmed.ncbi.nlm.nih.gov/33929487/ | https://pubmed.ncbi.nlm.nih.gov/33929487/ | See, I., Su, J. R., Lale, A., Woo, E. J., Guh, A. Y., Shimabukuro, T. T., ... & Broder, K. R. (2021). US case reports of cerebral venous sinus thrombosis with thrombocytopenia after Ad26. COV2. S vaccination, March 2 to April 21, 2021. Jama, 325(24), 2448-2456. | Véase, I., Su, J. R., Lale, A., Woo, E. J., Guh, A. Y., Shimabukuro, T. T., ... y Broder, K. R. (2021). Informes de casos estadounidenses de trombosis del seno venoso cerebral con trombocitopenia después del Ad26. COV2. Vacunación S, 2 de marzo al 21 de abril de 2021. Jama, 325(24), 2448-2456. https://www.thelancet.com/journals/langas/article/PIIS2468-1253(21)00197-7/ | Abičić, A., Adamec, I., & Habek, M. (2022). Síndrome de Fisher Miller después de la vacuna Pfizer Covid-19. Ciencias neurológicas, 43 (3), 1495-1497. https://pubmed.ncbi.nlm.nih.gov/34789193/. | See, I., Su, J. R., Lale, A., Woo, E. J., Guh, A. Y., Shimabukuro, T. T., ... & Broder, K. R. (2021). US case reports of cerebral venous sinus thrombosis with thrombocytopenia after Ad26. COV2. S vaccination, March 2 to April 21, 2021. Jama, 325(24), 2448-2456. https://pubmed.ncbi.nlm.nih.gov/33929487/ | Abou-Foul, A. K., Ross, E., Abou-Foul, M., & George, A. P. (2021). Cervical lymphadenopathy following coronavirus disease 2019 vaccine: clinical characteristics and implications for head and neck cancer services. The Journal of Laryngology & Otology, 135(11), 1025-1030. https://pubmed.ncbi.nlm.nih.gov/34526175/ | See, I., Su, J. R., Lale, A., Woo, E. J., Guh, A. Y., Shimabukuro, T. T., ... & Broder, K. R. (2021). US case reports of cerebral venous sinus thrombosis with thrombocytopenia after Ad26. COV2. S vaccination, March 2 to April 21, 2021. Jama, 325(24), 2448-2456. | https://pubmed.ncbi.nlm.nih.gov/33929487/ | See, I., Su, J. R., Lale, A., Woo, E. J., Guh, A. Y., Shimabukuro, T. T., ... & Broder, K. R. (2021). US case reports of cerebral venous sinus thrombosis with thrombocytopenia after Ad26. COV2. S vaccination, March 2 to April 21, 2021. Jama, 325(24), 2448-2456. https://pubmed.ncbi.nlm.nih.gov/33929487/ | Ahmad, S. A., Salih, K. H., Ahmed, S. F., Kakamad, F. H., Salh, A. M., Hassan, M. N., ... & Hussein, D. A. (2021). Post COVID-19 transverse myelitis; a case report with review of literature. Annals of Medicine and Surgery, 69, 102749. https://pubmed.ncbi.nlm.nih.gov/34457267/. | ||||
20 | Portal vein thrombosis associated with ChAdOx1 nCov-19 vaccine: | https://www.thelancet.com/journals/langas/article/PIIS2468-1253(21)00197-7/ | https://www.thelancet.com/journals/langas/article/PIIS2468-1253(21)00197-7/ | Öcal, O., Stecher, S. S., & Wildgruber, M. (2021). Portal vein thrombosis associated with ChAdOx1 nCov-19 vaccination. The lancet Gastroenterology & hepatology, 6(8), 676. | Öcal, O., Stecher, SS y Wildgruber, M. (2021). Trombosis de la vena porta asociada con la vacunación ChAdOx1 nCov-19. The lancet Gastroenterología y hepatología, 6(8), 676. https://pubmed.ncbi.nlm.nih.gov/33871350/ | Abou-Foul, A. K., Ross, E., Abou-Foul, M., & George, A. P. (2021). Linfadenopatía cervical siguiendo la enfermedad de Coronavirus 2019 Vacuna: Características clínicas e implicaciones para los servicios de cáncer de cabeza y cuello. The Journal of Laringology & Otology, 135 (11), 1025-1030. https://pubmed.ncbi.nlm.nih.gov/33786231/ | Öcal, O., Stecher, S. S., & Wildgruber, M. (2021). Portal vein thrombosis associated with ChAdOx1 nCov-19 vaccination. The lancet Gastroenterology & hepatology, 6(8), 676. https://www.thelancet.com/journals/langas/article/PIIS2468-1253(21)00197-7/ | Abou‐Ismail, M. Y., Moser, K. A., Smock, K. J., & Lim, M. Y. (2021). Vaccine‐induced thrombotic thrombocytopenia following Ad26. COV2. S vaccine in a man presenting as acute venous thromboembolism. American Journal of Hematology. https://pubmed.ncbi.nlm.nih.gov/34096082/ | Öcal, O., Stecher, S. S., & Wildgruber, M. (2021). Portal vein thrombosis associated with ChAdOx1 nCov-19 vaccination. The lancet Gastroenterology & hepatology, 6(8), 676. | https://www.thelancet.com/journals/langas/article/PIIS2468-1253(21)00197-7/ | Öcal, O., Stecher, S. S., & Wildgruber, M. (2021). Portal vein thrombosis associated with ChAdOx1 nCov-19 vaccination. The lancet Gastroenterology & hepatology, 6(8), 676. https://www.thelancet.com/journals/langas/article/PIIS2468-1253(21)00197-7/ | Ai, S., Awford, A., & Roncolato, F. (2021). Hemophagocytic lymphohistiocytosis following ChAdOx1 nCov‐19 vaccination. Journal of Medical Virology. https://pubmed.ncbi.nlm.nih.gov/34406660/. | ||||
21 | Management of cerebral and splanchnic vein thrombosis associated with thrombocytopenia in subjects previously vaccinated with Vaxzevria (AstraZeneca): position statement of the Italian Society for the Study of Hemostasis and Thrombosis (SISET): | https://pubmed.ncbi.nlm.nih.gov/33871350/ | https://pubmed.ncbi.nlm.nih.gov/33871350/ | Gresele, P., Marietta, M., Ageno, W., Marcucci, R., Contino, L., Donadini, M. P., ... & De Stefano, V. (2021). Management of cerebral and splanchnic vein thrombosis associated with thrombocytopenia in subjects previously vaccinated with Vaxzevria (AstraZeneca): a position statement from the Italian Society for the Study of Haemostasis and Thrombosis (SISET). Blood Transfusion, 19(4), 281. | Gresele, P., Marietta, M., Ageno, W., Marcucci, R., Contino, L., Donadini, M. P., ... y De Stefano, V. (2021). Manejo de la trombosis de la vena cerebral y esplácnica asociada con trombocitopenia en sujetos previamente vacunados con Vaxzevria (AstraZeneca): declaración de posición de la Sociedad Italiana para el Estudio de la Hemostasia y la Trombosis (SISET). Transfusión de sangre, 19(4), 281. https://www.sciencedirect.com/science/article/pii/S0022510X21003014 | Abou-Ismail, M. Y., Moser, K. A., Smock, K. J., & Lim, M. Y. (2021). Trombocitopenia trombótica inducida por la vacuna después de AD26. COV2. La vacuna es en un hombre que se presenta como tromboembolismo venoso agudo. American Journal of Hematology. https://pubmed.ncbi.nlm.nih.gov/34851078/. | Gresele, P., Marietta, M., Ageno, W., Marcucci, R., Contino, L., Donadini, M. P., ... & De Stefano, V. (2021). Management of cerebral and splanchnic vein thrombosis associated with thrombocytopenia in subjects previously vaccinated with Vaxzevria (AstraZeneca): a position statement from the Italian Society for the Study of Haemostasis and Thrombosis (SISET). Blood Transfusion, 19(4), 281. https://pubmed.ncbi.nlm.nih.gov/33871350/ | Ahmad, S. A., Salih, K. H., Ahmed, S. F., Kakamad, F. H., Salh, A. M., Hassan, M. N., ... & Hussein, D. A. (2021). Post COVID-19 transverse myelitis; a case report with review of literature. Annals of Medicine and Surgery, 69, 102749. https://pubmed.ncbi.nlm.nih.gov/34457267/. | Gresele, P., Marietta, M., Ageno, W., Marcucci, R., Contino, L., Donadini, M. P., ... & De Stefano, V. (2021). Management of cerebral and splanchnic vein thrombosis associated with thrombocytopenia in subjects previously vaccinated with Vaxzevria (AstraZeneca): a position statement from the Italian Society for the Study of Haemostasis and Thrombosis (SISET). Blood Transfusion, 19(4), 281. | https://pubmed.ncbi.nlm.nih.gov/33871350/ | Gresele, P., Marietta, M., Ageno, W., Marcucci, R., Contino, L., Donadini, M. P., ... & De Stefano, V. (2021). Management of cerebral and splanchnic vein thrombosis associated with thrombocytopenia in subjects previously vaccinated with Vaxzevria (AstraZeneca): a position statement from the Italian Society for the Study of Haemostasis and Thrombosis (SISET). Blood Transfusion, 19(4), 281. https://pubmed.ncbi.nlm.nih.gov/33871350/ | Akiyama, H., Kakiuchi, S., Rikitake, J., Matsuba, H., Sekinada, D., Kozuki, Y., & Iwata, N. (2021). Immune thrombocytopenia associated with Pfizer-BioNTech’s BNT162b2 mRNA COVID-19 vaccine. IDCases, 25, e01245. https://www.sciencedirect.com/science/article/pii/S2214250921002018. | ||||
22 | Vaccine-induced immune immune thrombotic thrombocytopenia and cerebral venous sinus thrombosis after vaccination with COVID-19; a systematic review: | https://www.sciencedirect.com/science/article/pii/S0022510X21003014 | https://www.sciencedirect.com/science/article/pii/S0022510X21003014 | Sharifian-Dorche, M., Bahmanyar, M., Sharifian-Dorche, A., Mohammadi, P., Nomovi, M., & Mowla, A. (2021). Vaccine-induced immune thrombotic thrombocytopenia and cerebral venous sinus thrombosis post COVID-19 vaccination; a systematic review. Journal of the neurological sciences, 428, 117607. | Sharifian-Dorche, M., Bahmanyar, M., Sharifian-Dorche, A., Mohammadi, P., Nomovi, M. y Mowla, A. (2021). Trombocitopenia trombótica inmunitaria inducida por vacuna y trombosis del seno venoso cerebral después de la vacunación contra COVID-19; una revisión sistemática. Revista de ciencias neurológicas, 428, 117607. https://www.sciencedirect.com/science/article/abs/pii/S0735675721004381 | Ahmad, S. A., Salih, K. H., Ahmed, S. F., Kakamad, F. H., SALH, A. M., Hassan, M. N., ... & Hussein, D. A. (2021). Post Covid-19 Myelitis transversal; Un informe de caso con revisión de la literatura. Anales de medicina y cirugía, 69, 102749. https://pubmed.ncbi.nlm.nih.gov/34189662/ | Sharifian-Dorche, M., Bahmanyar, M., Sharifian-Dorche, A., Mohammadi, P., Nomovi, M., & Mowla, A. (2021). Vaccine-induced immune thrombotic thrombocytopenia and cerebral venous sinus thrombosis post COVID-19 vaccination; a systematic review. Journal of the neurological sciences, 428, 117607. https://www.sciencedirect.com/science/article/pii/S0022510X21003014 | Ai, S., Awford, A., & Roncolato, F. (2021). Hemophagocytic lymphohistiocytosis following ChAdOx1 nCov‐19 vaccination. Journal of Medical Virology. https://pubmed.ncbi.nlm.nih.gov/34406660/. | Sharifian-Dorche, M., Bahmanyar, M., Sharifian-Dorche, A., Mohammadi, P., Nomovi, M., & Mowla, A. (2021). Vaccine-induced immune thrombotic thrombocytopenia and cerebral venous sinus thrombosis post COVID-19 vaccination; a systematic review. Journal of the neurological sciences, 428, 117607. | https://www.sciencedirect.com/science/article/pii/S0022510X21003014 | Sharifian-Dorche, M., Bahmanyar, M., Sharifian-Dorche, A., Mohammadi, P., Nomovi, M., & Mowla, A. (2021). Vaccine-induced immune thrombotic thrombocytopenia and cerebral venous sinus thrombosis post COVID-19 vaccination; a systematic review. Journal of the neurological sciences, 428, 117607. https://www.sciencedirect.com/science/article/pii/S0022510X21003014 | Al-Maqbali, J. S., Al Rasbi, S., Kashoub, M. S., Al Hinaai, A. M., Farhan, H., Al Rawahi, B., & Al Alawi, A. M. (2021). A 59-year-old woman with extensive deep vein thrombosis and pulmonary thromboembolism 7 days following a first dose of the Pfizer-BioNTech BNT162b2 mRNA COVID-19 vaccine. The American journal of case reports, 22, e932946-1. https://pubmed.ncbi.nlm.nih.gov/34117206/ | ||||
23 | Thrombosis with thrombocytopenia syndrome associated with COVID-19 vaccines: | https://www.sciencedirect.com/science/article/abs/pii/S0735675721004381 | https://www.sciencedirect.com/science/article/abs/pii/S0735675721004381 | Long, B., Bridwell, R., & Gottlieb, M. (2021). Thrombosis with thrombocytopenia syndrome associated with COVID-19 vaccines. The American journal of emergency medicine, 49, 58-61. | Long, B., Bridwell, R. y Gottlieb, M. (2021). Síndrome de trombosis con trombocitopenia asociado a las vacunas COVID-19. La revista americana de medicina de emergencia, 49, 58-61. https://www.sciencedirect.com/science/article/abs/pii/S0033062021000505 | AI, S., AWFORD, A., & RONCOLATO, F. (2021). Linfohistiocitosis hemofagocítica después de la vacunación de Chadox1 NCOV-19. Diario de virología médica. https://pubmed.ncbi.nlm.nih.gov/34509658/ | Long, B., Bridwell, R., & Gottlieb, M. (2021). Thrombosis with thrombocytopenia syndrome associated with COVID-19 vaccines. The American journal of emergency medicine, 49, 58-61. https://www.sciencedirect.com/science/article/abs/pii/S0735675721004381 | Akiyama, H., Kakiuchi, S., Rikitake, J., Matsuba, H., Sekinada, D., Kozuki, Y., & Iwata, N. (2021). Immune thrombocytopenia associated with Pfizer-BioNTech’s BNT162b2 mRNA COVID-19 vaccine. IDCases, 25, e01245. https://www.sciencedirect.com/science/article/pii/S2214250921002018 | Long, B., Bridwell, R., & Gottlieb, M. (2021). Thrombosis with thrombocytopenia syndrome associated with COVID-19 vaccines. The American journal of emergency medicine, 49, 58-61. | https://www.sciencedirect.com/science/article/abs/pii/S0735675721004381 | Long, B., Bridwell, R., & Gottlieb, M. (2021). Thrombosis with thrombocytopenia syndrome associated with COVID-19 vaccines. The American journal of emergency medicine, 49, 58-61. https://www.sciencedirect.com/science/article/abs/pii/S0735675721004381 | Al-Mashdali, A. F., Ata, Y. M., & Sadik, N. (2021). Post-COVID-19 vaccine acute hyperactive encephalopathy with dramatic response to methylprednisolone: A case report. Annals of Medicine and Surgery, 69, 102803. https://www.sciencedirect.com/science/article/pii/S2049080121007536 | ||||
24 | Covid-19 vaccine-induced thrombosis and thrombocytopenia: a commentary on an important and practical clinical dilemma: | https://www.sciencedirect.com/science/article/abs/pii/S0033062021000505 | https://www.sciencedirect.com/science/article/abs/pii/S0033062021000505 | Gupta, A., Sardar, P., Cash, M. E., Milani, R. V., & Lavie, C. J. (2021). Covid-19 vaccine-induced thrombosis and thrombocytopenia-a commentary on an important and practical clinical dilemma. Progress in cardiovascular diseases. | Gupta, A., Sardar, P., Cash, M. E., Milani, R. V. y Lavie, C. J. (2021). Trombosis y trombocitopenia inducidas por la vacuna Covid-19: un comentario sobre un dilema clínico importante y práctico. Avances en enfermedades cardiovasculares. https://www.sciencedirect.com/science/article/abs/pii/S0953620521001904 | Akiyama, H., Kakiuchi, S., Rikitake, J., Matsuba, H., Sekinada, D., Kozuki, Y., & Iwata, N. (2021). Thrombocitopenia inmune asociada con la vacuna BNT162B2 MRNA COVID-19 de Pfizer-BionTech. Idrases, 25, E01245. https://casereports.bmj.com/content/14/5/e242220.abstract. | Gupta, A., Sardar, P., Cash, M. E., Milani, R. V., & Lavie, C. J. (2021). Covid-19 vaccine-induced thrombosis and thrombocytopenia-a commentary on an important and practical clinical dilemma. Progress in cardiovascular diseases. https://www.sciencedirect.com/science/article/abs/pii/S0033062021000505 | Akiyama, H., Kakiuchi, S., Rikitake, J., Matsuba, H., Sekinada, D., Kozuki, Y., & Iwata, N. (2021). Immune thrombocytopenia associated with Pfizer-BioNTech’s BNT162b2 mRNA COVID-19 vaccine. IDCases, 25, e01245. https://www.sciencedirect.com/science/article/pii/S2214250921002018. | Gupta, A., Sardar, P., Cash, M. E., Milani, R. V., & Lavie, C. J. (2021). Covid-19 vaccine-induced thrombosis and thrombocytopenia-a commentary on an important and practical clinical dilemma. Progress in cardiovascular diseases. | https://www.sciencedirect.com/science/article/abs/pii/S0033062021000505 | Gupta, A., Sardar, P., Cash, M. E., Milani, R. V., & Lavie, C. J. (2021). Covid-19 vaccine-induced thrombosis and thrombocytopenia-a commentary on an important and practical clinical dilemma. Progress in cardiovascular diseases. https://www.sciencedirect.com/science/article/abs/pii/S0033062021000505 | Al-Mayhani, T., Saber, S., Stubbs, M. J., Losseff, N. A., Perry, R. J., Simister, R. J., ... & Werring, D. J. (2021). Ischaemic stroke as a presenting feature of ChAdOx1 nCoV-19 vaccine-induced immune thrombotic thrombocytopenia. Journal of Neurology, Neurosurgery & Psychiatry, 92(11), 1247-1248. https://pubmed.ncbi.nlm.nih.gov/34035134/ | ||||
25 | Thrombosis with thrombocytopenia syndrome associated with COVID-19 viral vector vaccines: | https://www.sciencedirect.com/science/article/abs/pii/S0953620521001904 | https://www.sciencedirect.com/science/article/abs/pii/S0953620521001904 | Cattaneo, M. (2021). Thrombosis with Thrombocytopenia Syndrome associated with viral vector COVID-19 vaccines. European Journal of Internal Medicine, 89, 22-24. | Cattaneo, M. (2021). Síndrome de Trombosis con Trombocitopenia asociado a vacunas de vector viral COVID-19. Revista Europea de Medicina Interna, 89, 22-24. https://www.sciencedirect.com/science/article/pii/S1665268121000557 | Akiyama, H., Kakiuchi, S., Rikitake, J., Matsuba, H., Sekinada, D., Kozuki, Y., & Iwata, N. (2021). Thrombocitopenia inmune asociada con la vacuna BNT162B2 MRNA COVID-19 de Pfizer-BionTech. Idrases, 25, E01245. https://www.sciencedirect.com/science/article/pii/S1876034121001878. | Cattaneo, M. (2021). Thrombosis with Thrombocytopenia Syndrome associated with viral vector COVID-19 vaccines. European Journal of Internal Medicine, 89, 22-24. https://www.sciencedirect.com/science/article/abs/pii/S0953620521001904 | Al-Maqbali, J. S., Al Rasbi, S., Kashoub, M. S., Al Hinaai, A. M., Farhan, H., Al Rawahi, B., & Al Alawi, A. M. (2021). A 59-year-old woman with extensive deep vein thrombosis and pulmonary thromboembolism 7 days following a first dose of the Pfizer-BioNTech BNT162b2 mRNA COVID-19 vaccine. The American journal of case reports, 22, e932946-1. https://pubmed.ncbi.nlm.nih.gov/34117206/ | Cattaneo, M. (2021). Thrombosis with Thrombocytopenia Syndrome associated with viral vector COVID-19 vaccines. European Journal of Internal Medicine, 89, 22-24. | https://www.sciencedirect.com/science/article/abs/pii/S0953620521001904 | Cattaneo, M. (2021). Thrombosis with Thrombocytopenia Syndrome associated with viral vector COVID-19 vaccines. European Journal of Internal Medicine, 89, 22-24. https://www.sciencedirect.com/science/article/abs/pii/S0953620521001904 | Al-Samkari, H., Leaf, R. K., & Goodarzi, K. (2021). Transient Thrombocytopenia With Glycoprotein-Specific Platelet Autoantibodies After Ad26. COV2. S Vaccination: A Case Report. Annals of Internal Medicine, 174(11), 1632-1633. https://pubmed.ncbi.nlm.nih.gov/34516272/. | ||||
26 | COVID-19 vaccine-induced immune-immune thrombotic thrombocytopenia: an emerging cause of splanchnic vein thrombosis: | https://www.sciencedirect.com/science/article/pii/S1665268121000557 | https://www.sciencedirect.com/science/article/pii/S1665268121000557 | Porres-Aguilar, M., Lazo-Langner, A., Panduro, A., & Uribe, M. (2021). COVID-19 vaccine-induced immune thrombotic thrombocytopenia: an emerging cause of splanchnic vein thrombosis. Annals of Hepatology. | Porres-Aguilar, M., Lazo-Langner, A., Panduro, A. y Uribe, M. (2021). Trombocitopenia trombótica inmunitaria inducida por la vacuna COVID-19: una causa emergente de trombosis de la vena esplácnica. Anales de hepatología. https://www.sciencedirect.com/science/article/pii/S1050173821000967 | Al-Maqbali, J. S., al Rasbi, S., Kashoub, M. S., Al Hinaái, A. M., Farhan, H., Al Rrawahi, B., & Al Alawi, A. M. (2021). Una mujer de 59 años con trombosis venosa extensa y tromboembolismo pulmonar 7 días después de una primera dosis de la vacuna PFIZE-BIONTECH BNT162B2 ARNm COVID-19. El American Journal of Case informa, 22, E932946-1. https://pubmed.ncbi.nlm.nih.gov/34033927/ | Porres-Aguilar, M., Lazo-Langner, A., Panduro, A., & Uribe, M. (2021). COVID-19 vaccine-induced immune thrombotic thrombocytopenia: an emerging cause of splanchnic vein thrombosis. Annals of Hepatology. https://www.sciencedirect.com/science/article/pii/S1665268121000557 | Al-Mashdali, A. F., Ata, Y. M., & Sadik, N. (2021). Post-COVID-19 vaccine acute hyperactive encephalopathy with dramatic response to methylprednisolone: A case report. Annals of Medicine and Surgery, 69, 102803. https://pubmed.ncbi.nlm.nih.gov/34512961/ | Porres-Aguilar, M., Lazo-Langner, A., Panduro, A., & Uribe, M. (2021). COVID-19 vaccine-induced immune thrombotic thrombocytopenia: an emerging cause of splanchnic vein thrombosis. Annals of Hepatology. | https://www.sciencedirect.com/science/article/pii/S1665268121000557 | Porres-Aguilar, M., Lazo-Langner, A., Panduro, A., & Uribe, M. (2021). COVID-19 vaccine-induced immune thrombotic thrombocytopenia: an emerging cause of splanchnic vein thrombosis. Annals of Hepatology. https://www.sciencedirect.com/science/article/pii/S1665268121000557 | Aladdin, Y., & Shirah, B. (2021). New-onset refractory status epilepticus following the ChAdOx1 nCoV-19 vaccine. Journal of Neuroimmunology, 357, 577629. https://www.sciencedirect.com/science/article/pii/S0165572821001569 | ||||
27 | The roles of platelets in COVID-19-associated coagulopathy and vaccine-induced immune thrombotic immune thrombocytopenia (covid): | https://www.sciencedirect.com/science/article/pii/S1050173821000967 | https://www.sciencedirect.com/science/article/pii/S1050173821000967 | Iba, T., & Levy, J. H. (2021). The roles of platelets in COVID-19-associated coagulopathy and vaccine-induced immune thrombotic thrombocytopenia. Trends in cardiovascular medicine. | Iba, T. y Levy, JH (2021). El papel de las plaquetas en la coagulopatía asociada a COVID-19 y la trombocitopenia trombótica inmunitaria inducida por vacunas. Tendencias en medicina cardiovascular. https://www.sciencedirect.com/science/article/abs/pii/S1568997221002160 | Al-Mashdali, A. F., ATA, Y. M., & SADIK, N. (2021). Vacuna post-covid-19 Vacuna de encefalopatía hiperactiva aguda con respuesta dramática a la metilprednisolona: un informe de caso. Anales de medicina y cirugía, 69, 102803. https://pubmed.ncbi.nlm.nih.gov/34077949/ | Iba, T., & Levy, J. H. (2021). The roles of platelets in COVID-19-associated coagulopathy and vaccine-induced immune thrombotic thrombocytopenia. Trends in cardiovascular medicine. https://www.sciencedirect.com/science/article/pii/S1050173821000967 | Al-Mashdali, A. F., Ata, Y. M., & Sadik, N. (2021). Post-COVID-19 vaccine acute hyperactive encephalopathy with dramatic response to methylprednisolone: A case report. Annals of Medicine and Surgery, 69, 102803. https://www.sciencedirect.com/science/article/pii/S2049080121007536 | Iba, T., & Levy, J. H. (2021). The roles of platelets in COVID-19-associated coagulopathy and vaccine-induced immune thrombotic thrombocytopenia. Trends in cardiovascular medicine. | https://www.sciencedirect.com/science/article/pii/S1050173821000967 | Iba, T., & Levy, J. H. (2021). The roles of platelets in COVID-19-associated coagulopathy and vaccine-induced immune thrombotic thrombocytopenia. Trends in cardiovascular medicine. https://www.sciencedirect.com/science/article/pii/S1050173821000967 | Aladdin, Y., Algahtani, H., & Shirah, B. (2021). Vaccine-induced immune thrombotic thrombocytopenia with disseminated intravascular coagulation and death following the ChAdOx1 nCoV-19 vaccine. Journal of Stroke and Cerebrovascular Diseases, 30(9), 105938. https://www.sciencedirect.com/science/article/pii/S1052305721003414 | ||||
28 | Roots of autoimmunity of thrombotic events after COVID-19 vaccination: | https://www.sciencedirect.com/science/article/abs/pii/S1568997221002160 | https://www.sciencedirect.com/science/article/abs/pii/S1568997221002160 | Elrashdy, F., Tambuwala, M. M., Hassan, S. S., Adadi, P., Seyran, M., Abd El-Aziz, T. M., ... & Uversky, V. N. (2021). Autoimmunity roots of the thrombotic events after COVID-19 vaccination. Autoimmunity reviews, 20(11), 102941. | Elrashdy, F., Tambuwala, M. M., Hassan, S. S., Adadi, P., Seyran, M., Abd El-Aziz, T. M., ... y Uversky, V. N. (2021). Raíces de autoinmunidad de los eventos trombóticos después de la vacunación COVID-19. Revisiones de autoinmunidad, 20(11), 102941. https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)01788-8/fulltext | Al-Mashdali, A. F., ATA, Y. M., & SADIK, N. (2021). Vacuna post-covid-19 Vacuna de encefalopatía hiperactiva aguda con respuesta dramática a la metilprednisolona: un informe de caso. Anales de medicina y cirugía, 69, 102803. https://www.sciencedirect.com/science/article/pii/S1201971221007049 | Elrashdy, F., Tambuwala, M. M., Hassan, S. S., Adadi, P., Seyran, M., Abd El-Aziz, T. M., ... & Uversky, V. N. (2021). Autoimmunity roots of the thrombotic events after COVID-19 vaccination. Autoimmunity reviews, 20(11), 102941. https://www.sciencedirect.com/science/article/abs/pii/S1568997221002160 | Al-Mayhani, T., Saber, S., Stubbs, M. J., Losseff, N. A., Perry, R. J., Simister, R. J., ... & Werring, D. J. (2021). Ischaemic stroke as a presenting feature of ChAdOx1 nCoV-19 vaccine-induced immune thrombotic thrombocytopenia. Journal of Neurology, Neurosurgery & Psychiatry, 92(11), 1247-1248. https://pubmed.ncbi.nlm.nih.gov/34035134/ | Elrashdy, F., Tambuwala, M. M., Hassan, S. S., Adadi, P., Seyran, M., Abd El-Aziz, T. M., ... & Uversky, V. N. (2021). Autoimmunity roots of the thrombotic events after COVID-19 vaccination. Autoimmunity reviews, 20(11), 102941. | https://www.sciencedirect.com/science/article/abs/pii/S1568997221002160 | Elrashdy, F., Tambuwala, M. M., Hassan, S. S., Adadi, P., Seyran, M., Abd El-Aziz, T. M., ... & Uversky, V. N. (2021). Autoimmunity roots of the thrombotic events after COVID-19 vaccination. Autoimmunity reviews, 20(11), 102941. https://www.sciencedirect.com/science/article/abs/pii/S1568997221002160 | Alalwan, A. A., Abou Trabeh, A., Premchandran, D., & Razeem, M. (2021). COVID-19 Vaccine-Induced Thrombotic Thrombocytopenia: A Case Series. Cureus, 13(9). https://pubmed.ncbi.nlm.nih.gov/34527501/ | ||||
29 | Cerebral venous sinus thrombosis after vaccination: the United Kingdom experience: | https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)01788-8/fulltext | https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)01788-8/fulltext | Lee, E. J., & Lee, A. I. (2021). Cerebral venous sinus thrombosis after vaccination: the UK experience. The Lancet, 398(10306), 1107-1109. | Lee, EJ y Lee, AI (2021). Trombosis del seno venoso cerebral después de la vacunación: la experiencia del Reino Unido. The Lancet, 398(10306), 1107-1109. https://www.nejm.org/doi/full/10.1056/nejme2106315 | Al-Mayhani, T., Sabre, S., Stubbs, M. J., Losseff, N. A., Perry, R. J., Simister, R. J., ... & Werring, D. J. (2021). El accidente cerebrovascular isquémico como una característica de presentación de la trombocitopenia trombótica inmune inducida por la vacuna contra la vacuna. Diario de Neurología, Neurocirugía y Psiquiatría, 92 (11), 1247-1248. https://pubmed.ncbi.nlm.nih.gov/34688190/ | Lee, E. J., & Lee, A. I. (2021). Cerebral venous sinus thrombosis after vaccination: the UK experience. The Lancet, 398(10306), 1107-1109. https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)01788-8/fulltext | Al-Samkari, H., Leaf, R. K., & Goodarzi, K. (2021). Transient Thrombocytopenia With Glycoprotein-Specific Platelet Autoantibodies After Ad26. COV2. S Vaccination: A Case Report. Annals of Internal Medicine, 174(11), 1632-1633. https://pubmed.ncbi.nlm.nih.gov/34516272/. | Lee, E. J., & Lee, A. I. (2021). Cerebral venous sinus thrombosis after vaccination: the UK experience. The Lancet, 398(10306), 1107-1109. | https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)01788-8/fulltext | Lee, E. J., & Lee, A. I. (2021). Cerebral venous sinus thrombosis after vaccination: the UK experience. The Lancet, 398(10306), 1107-1109. https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)01788-8/fulltext | Alania-Torres, E., Morillas-Climent, H., García-Escrivá, A., Vinueza-Buitrón, P., Poquet-Catalá, I., Zorio, E., ... & Valle-Muñoz, A. (2021). Case Report: Probable Myocarditis After Covid-19 mRNA Vaccine in a Patient With Arrhythmogenic Left Ventricular Cardiomyopathy. Frontiers in Cardiovascular Medicine, 1351. https://pubmed.ncbi.nlm.nih.gov/34712717/. | ||||
30 | Thrombotic immune thrombocytopenia induced by SARS-CoV-2 vaccine: | https://www.nejm.org/doi/full/10.1056/nejme2106315 | https://www.nejm.org/doi/full/10.1056/nejme2106315 | Cines, D. B., & Bussel, J. B. (2021). SARS-CoV-2 vaccine–induced immune thrombotic thrombocytopenia. New England Journal of Medicine, 384(23), 2254-2256. | Cines, D. B. y Bussel, J. B. (2021). Trombocitopenia trombótica inmunitaria inducida por la vacuna SARS-CoV-2. Revista de Medicina de Nueva Inglaterra, 384(23), 2254-2256. https://jamanetwork.com/journals/jamacardiology/fullarticle/2781601 | Al-Samkari, H., Hoja, R. K., & Goodarzi, K. (2021). Trombocitopenia transitoria con autoanticuerpos de plaquetas específicos de glicoproteína después de AD26. COV2. S Vacunación: un informe de caso. Anales de medicina interna, 174 (11), 1632-1633. https://pubmed.ncbi.nlm.nih.gov/34512961/ | Cines, D. B., & Bussel, J. B. (2021). SARS-CoV-2 vaccine–induced immune thrombotic thrombocytopenia. New England Journal of Medicine, 384(23), 2254-2256. https://www.nejm.org/doi/full/10.1056/nejme2106315 | Aladdin, Y., & Shirah, B. (2021). New-onset refractory status epilepticus following the ChAdOx1 nCoV-19 vaccine. Journal of Neuroimmunology, 357, 577629. https://pubmed.ncbi.nlm.nih.gov/34153802/ | Cines, D. B., & Bussel, J. B. (2021). SARS-CoV-2 vaccine–induced immune thrombotic thrombocytopenia. New England Journal of Medicine, 384(23), 2254-2256. | https://www.nejm.org/doi/full/10.1056/nejme2106315 | Cines, D. B., & Bussel, J. B. (2021). SARS-CoV-2 vaccine–induced immune thrombotic thrombocytopenia. New England Journal of Medicine, 384(23), 2254-2256. https://www.nejm.org/doi/full/10.1056/nejme2106315 | Albert, E., Aurigemma, G., Saucedo, J., & Gerson, D. S. (2021). Myocarditis following COVID-19 vaccination. Radiology case reports, 16(8), 2142-2145. https://www.ncbi.nlm.nih.gov/pubmed/34025885 | ||||
31 | Myocarditis after immunization with COVID-19 mRNA vaccines in members of the US military. This article reports that in “23 male patients, including 22 previously healthy military members, myocarditis was identified within 4 days after receipt of the vaccine”: | https://jamanetwork.com/journals/jamacardiology/fullarticle/2781601 | https://jamanetwork.com/journals/jamacardiology/fullarticle/2781601 | Montgomery, J., Ryan, M., Engler, R., Hoffman, D., McClenathan, B., Collins, L., ... & Cooper, L. T. (2021). Myocarditis following immunization with mRNA COVID-19 vaccines in members of the US military. JAMA cardiology, 6(10), 1202-1206. | Montgomery, J., Ryan, M., Engler, R., Hoffman, D., McClenathan, B., Collins, L., ... y Cooper, LT (2021). Miocarditis tras la inmunización con vacunas de ARNm COVID-19 en miembros del ejército de EE. UU. Cardiología JAMA, 6(10), 1202-1206. https://www.nejm.org/doi/full/10.1056/NEJMoa2104882?query=recirc_curatedRelated_article | Aladdin, Y., & Shirah, B. (2021). Epiléptico refractario de nueva aparición después de la vacuna Chadox1 NCOV-19. Diario de Neuroimmunology, 357, 577629. https://pubmed.ncbi.nlm.nih.gov/34092488/ | Montgomery, J., Ryan, M., Engler, R., Hoffman, D., McClenathan, B., Collins, L., ... & Cooper, L. T. (2021). Myocarditis following immunization with mRNA COVID-19 vaccines in members of the US military. JAMA cardiology, 6(10), 1202-1206. https://jamanetwork.com/journals/jamacardiology/fullarticle/2781601 | Aladdin, Y., & Shirah, B. (2021). New-onset refractory status epilepticus following the ChAdOx1 nCoV-19 vaccine. Journal of Neuroimmunology, 357, 577629. https://www.sciencedirect.com/science/article/pii/S0165572821001569 | Montgomery, J., Ryan, M., Engler, R., Hoffman, D., McClenathan, B., Collins, L., ... & Cooper, L. T. (2021). Myocarditis following immunization with mRNA COVID-19 vaccines in members of the US military. JAMA cardiology, 6(10), 1202-1206. | https://jamanetwork.com/journals/jamacardiology/fullarticle/2781601 | Montgomery, J., Ryan, M., Engler, R., Hoffman, D., McClenathan, B., Collins, L., ... & Cooper, L. T. (2021). Myocarditis following immunization with mRNA COVID-19 vaccines in members of the US military. JAMA cardiology, 6(10), 1202-1206. https://jamanetwork.com/journals/jamacardiology/fullarticle/2781601 | Aleem, A., & Shah, H. (2021). Gastric Varices. StatPearls [Internet]. https://pubmed.ncbi.nlm.nih.gov/34033367/ | ||||
32 | Thrombosis and thrombocytopenia after vaccination with ChAdOx1 nCoV-19: | https://www.nejm.org/doi/full/10.1056/NEJMoa2104882?query=recirc_curatedRelated_article | https://www.nejm.org/doi/full/10.1056/NEJMoa2104882?query=recirc_curatedRelated_article | Schultz, N. H., Sørvoll, I. H., Michelsen, A. E., Munthe, L. A., Lund-Johansen, F., Ahlen, M. T., ... & Holme, P. A. (2021). Thrombosis and thrombocytopenia after ChAdOx1 nCoV-19 vaccination. New England journal of medicine, 384(22), 2124-2130. | Schultz, N. H., Sørvoll, I. H., Michelsen, A. E., Munthe, L. A., Lund-Johansen, F., Ahlen, M. T., ... y Holme, P. A. (2021). Trombosis y trombocitopenia tras la vacunación ChAdOx1 nCoV-19. Revista de medicina de Nueva Inglaterra, 384(22), 2124-2130. https://pubmed.ncbi.nlm.nih.gov/34374740/ | Aladdin, Y., & Shirah, B. (2021). Epiléptico refractario de nueva aparición después de la vacuna Chadox1 NCOV-19. Diario de Neuroimmunology, 357, 577629. https://www.sciencedirect.com/science/article/pii/S0165572821002137 | Schultz, N. H., Sørvoll, I. H., Michelsen, A. E., Munthe, L. A., Lund-Johansen, F., Ahlen, M. T., ... & Holme, P. A. (2021). Thrombosis and thrombocytopenia after ChAdOx1 nCoV-19 vaccination. New England journal of medicine, 384(22), 2124-2130. https://www.nejm.org/doi/full/10.1056/NEJMoa2104882?query=recirc_curatedRelated_article | Aladdin, Y., Algahtani, H., & Shirah, B. (2021). Vaccine-induced immune thrombotic thrombocytopenia with disseminated intravascular coagulation and death following the ChAdOx1 nCoV-19 vaccine. Journal of Stroke and Cerebrovascular Diseases, 30(9), 105938. https://www.sciencedirect.com/science/article/pii/S1052305721003414 | Schultz, N. H., Sørvoll, I. H., Michelsen, A. E., Munthe, L. A., Lund-Johansen, F., Ahlen, M. T., ... & Holme, P. A. (2021). Thrombosis and thrombocytopenia after ChAdOx1 nCoV-19 vaccination. New England journal of medicine, 384(22), 2124-2130. | https://www.nejm.org/doi/full/10.1056/NEJMoa2104882?query=recirc_curatedRelated_article | Schultz, N. H., Sørvoll, I. H., Michelsen, A. E., Munthe, L. A., Lund-Johansen, F., Ahlen, M. T., ... & Holme, P. A. (2021). Thrombosis and thrombocytopenia after ChAdOx1 nCoV-19 vaccination. New England journal of medicine, 384(22), 2124-2130. https://www.nejm.org/doi/full/10.1056/NEJMoa2104882?query=recirc_curatedRelated_article | Allen, C. M., Ramsamy, S., Tarr, A. W., Tighe, P. J., Irving, W. L., Tanasescu, R., & Evans, J. R. (2021). Guillain–Barré syndrome variant occurring after SARS‐CoV‐2 vaccination. Annals of neurology, 90(2), 315-318. https://pubmed.ncbi.nlm.nih.gov/34114269/. | ||||
33 | Association of myocarditis with the BNT162b2 messenger RNA COVID-19 vaccine in a case series of children: | https://pubmed.ncbi.nlm.nih.gov/34374740/ | https://pubmed.ncbi.nlm.nih.gov/34374740/ | Dionne, A., Sperotto, F., Chamberlain, S., Baker, A. L., Powell, A. J., Prakash, A., ... & Friedman, K. G. (2021). Association of myocarditis with BNT162b2 messenger RNA COVID-19 vaccine in a case series of children. JAMA cardiology, 6(12), 1446-1450. | Dionne, A., Sperotto, F., Chamberlain, S., Baker, A. L., Powell, A. J., Prakash, A., ... y Friedman, K. G. (2021). Asociación de miocarditis con la vacuna COVID-19 de ARN mensajero BNT162b2 en una serie de casos de niños. Cardiología JAMA, 6(12), 1446-1450. https://www.nejm.org/doi/full/10.1056/NEJMoa2104840?query=recirc_curatedRelated_article | Aladdin, Y., Algahtani, H., & Shirah, B. (2021). Trombocitopenia trombótica inmune inducida por la vacuna con la coagulación intravascular diseminada y la muerte siguiendo la vacuna Chadox1 NCOV-19. Diario de accidentes cerebrovasculares y enfermedades cerebrovasculares, 30 (9), 105938. https://pubmed.ncbi.nlm.nih.gov/33928772/ | Dionne, A., Sperotto, F., Chamberlain, S., Baker, A. L., Powell, A. J., Prakash, A., ... & Friedman, K. G. (2021). Association of myocarditis with BNT162b2 messenger RNA COVID-19 vaccine in a case series of children. JAMA cardiology, 6(12), 1446-1450. https://pubmed.ncbi.nlm.nih.gov/34374740/ | Alalwan, A. A., Abou Trabeh, A., Premchandran, D., & Razeem, M. (2021). COVID-19 Vaccine-Induced Thrombotic Thrombocytopenia: A Case Series. Cureus, 13(9). https://pubmed.ncbi.nlm.nih.gov/34527501/ | Dionne, A., Sperotto, F., Chamberlain, S., Baker, A. L., Powell, A. J., Prakash, A., ... & Friedman, K. G. (2021). Association of myocarditis with BNT162b2 messenger RNA COVID-19 vaccine in a case series of children. JAMA cardiology, 6(12), 1446-1450. | https://pubmed.ncbi.nlm.nih.gov/34374740/ | Dionne, A., Sperotto, F., Chamberlain, S., Baker, A. L., Powell, A. J., Prakash, A., ... & Friedman, K. G. (2021). Association of myocarditis with BNT162b2 messenger RNA COVID-19 vaccine in a case series of children. JAMA cardiology, 6(12), 1446-1450. https://pubmed.ncbi.nlm.nih.gov/34374740/ | Alnæs, M., Storaas, T., Sørensen, M., Stylianou, E., & Tøndell, A. (2021). Covid-19-vaksiner gir økt risiko for anafylaksi. Tidsskrift for Den norske legeforening. https://pubmed.ncbi.nlm.nih.gov/33685103/ | ||||
34 | Thrombotic thrombocytopenia after vaccination with ChAdOx1 nCov-19: | https://www.nejm.org/doi/full/10.1056/NEJMoa2104840?query=recirc_curatedRelated_article | https://www.nejm.org/doi/full/10.1056/NEJMoa2104840?query=recirc_curatedRelated_article | Schultz, N. H., Sørvoll, I. H., Michelsen, A. E., Munthe, L. A., Lund-Johansen, F., Ahlen, M. T., ... & Holme, P. A. (2021). Thrombosis and thrombocytopenia after ChAdOx1 nCoV-19 vaccination. New England journal of medicine, 384(22), 2124-2130. | Schultz, N. H., Sørvoll, I. H., Michelsen, A. E., Munthe, L. A., Lund-Johansen, F., Ahlen, M. T., ... y Holme, P. A. (2021). Trombosis y trombocitopenia tras la vacunación ChAdOx1 nCoV-19. Revista de medicina de Nueva Inglaterra, 384(22), 2124-2130. https://haematologica.org/article/view/haematol.2021.279075 | Alalwan, A. A. A., Abou Trabeh, A., Premchandran, D., & Raeem, M. (2021). COVID-19 Trombocitopenia trombótica inducida por la vacuna: una serie de casos. CUREUS, 13 (9). https://pubmed.ncbi.nlm.nih.gov/34756770/ | Schultz, N. H., Sørvoll, I. H., Michelsen, A. E., Munthe, L. A., Lund-Johansen, F., Ahlen, M. T., ... & Holme, P. A. (2021). Thrombosis and thrombocytopenia after ChAdOx1 nCoV-19 vaccination. New England journal of medicine, 384(22), 2124-2130. https://www.nejm.org/doi/full/10.1056/NEJMoa2104840?query=recirc_curatedRelated_article | Alania-Torres, E., Morillas-Climent, H., García-Escrivá, A., Vinueza-Buitrón, P., Poquet-Catalá, I., Zorio, E., ... & Valle-Muñoz, A. (2021). Case Report: Probable Myocarditis After Covid-19 mRNA Vaccine in a Patient With Arrhythmogenic Left Ventricular Cardiomyopathy. Frontiers in Cardiovascular Medicine, 1351. https://pubmed.ncbi.nlm.nih.gov/34712717/. | Pomara, C., Sessa, F., Ciaccio, M., Dieli, F., Esposito, M., Garozzo, S. F., ... & Mannucci, P. M. (2021). Post-mortem findings in vaccine-induced thrombotic thrombocytopenia. haematologica, 106(8), 2291. | https://haematologica.org/article/view/haematol.2021.279075 | Pomara, C., Sessa, F., Ciaccio, M., Dieli, F., Esposito, M., Garozzo, S. F., ... & Mannucci, P. M. (2021). Post-mortem findings in vaccine-induced thrombotic thrombocytopenia. haematologica, 106(8), 2291. https://haematologica.org/article/view/haematol.2021.279075 | Althaus, K., Möller, P., Uzun, G., Singh, A., Beck, A., Bettag, M., ... & Bakchoul, T. (2021). Antibody-mediated procoagulant platelets in SARS-CoV-2-vaccination associated immune thrombotic thrombocytopenia. Haematologica, 106(8), 2170. https://pubmed.ncbi.nlm.nih.gov/34011137/. | ||||
35 | Post-mortem findings in vaccine-induced thrombotic thrombocytopenia (covid-19): | https://haematologica.org/article/view/haematol.2021.279075 | https://haematologica.org/article/view/haematol.2021.279075 | Pomara, C., Sessa, F., Ciaccio, M., Dieli, F., Esposito, M., Garozzo, S. F., ... & Mannucci, P. M. (2021). Post-mortem findings in vaccine-induced thrombotic thrombocytopenia. haematologica, 106(8), 2291. | Pomara, C., Sessa, F., Ciaccio, M., Dieli, F., Esposito, M., Garozzo, S. F., ... & Mannucci, P. M. (2021). Hallazgos post mortem en trombocitopenia trombótica inducida por vacunas. hematológica, 106(8), 2291. https://www.sciencedirect.com/science/article/pii/S0264410X21005247 | Alania-Torres, E., Morillas-Climent, H., García-Escrivá, A., Vinueza-Buitró, P., Poquet-Catalá, I., Zorio, E., ... & Valle-Muñoz, A. (2021). Informe de caso: miocarditis probable después de la vacuna contra el ARNm de COVID-19 en un paciente con miocardiopatía ventricular arritmogénica de la izquierda. Fronteras en medicina cardiovascular, 1351. https://www.revespcardiol.org/en-linkresolver-acute-myocarditis-after-administration-bnt162b2-S188558572100133X. | Pomara, C., Sessa, F., Ciaccio, M., Dieli, F., Esposito, M., Garozzo, S. F., ... & Mannucci, P. M. (2021). Post-mortem findings in vaccine-induced thrombotic thrombocytopenia. haematologica, 106(8), 2291. https://haematologica.org/article/view/haematol.2021.279075 | Albert, E., Aurigemma, G., Saucedo, J., & Gerson, D. S. (2021). Myocarditis following COVID-19 vaccination. Radiology case reports, 16(8), 2142-2145. https://www.ncbi.nlm.nih.gov/pubmed/34025885 | Welsh, K. J., Baumblatt, J., Chege, W., Goud, R., & Nair, N. (2021). Thrombocytopenia including immune thrombocytopenia after receipt of mRNA COVID-19 vaccines reported to the Vaccine Adverse Event Reporting System (VAERS). Vaccine, 39(25), 3329-3332. | https://www.sciencedirect.com/science/article/pii/S0264410X21005247 | Welsh, K. J., Baumblatt, J., Chege, W., Goud, R., & Nair, N. (2021). Thrombocytopenia including immune thrombocytopenia after receipt of mRNA COVID-19 vaccines reported to the Vaccine Adverse Event Reporting System (VAERS). Vaccine, 39(25), 3329-3332. https://www.sciencedirect.com/science/article/pii/S0264410X21005247 | Ambati, S., Colon, M., Mihic, M., Sanchez, J., & Bakar, A. (2021). Acute myopericarditis after covid-19 vaccine in teenagers. Case reports in cardiology, 2021. https://pubmed.ncbi.nlm.nih.gov/34589238/. | ||||
36 | Thrombocytopenia, including immune thrombocytopenia after receiving COVID-19 mRNA vaccines reported to the Vaccine Adverse Event Reporting System (VAERS): | https://www.sciencedirect.com/science/article/pii/S0264410X21005247 | https://www.sciencedirect.com/science/article/pii/S0264410X21005247 | Welsh, K. J., Baumblatt, J., Chege, W., Goud, R., & Nair, N. (2021). Thrombocytopenia including immune thrombocytopenia after receipt of mRNA COVID-19 vaccines reported to the Vaccine Adverse Event Reporting System (VAERS). Vaccine, 39(25), 3329-3332. | Welsh, KJ, Baumblatt, J., Chege, W., Goud, R. y Nair, N. (2021). Trombocitopenia, incluida la trombocitopenia inmunitaria después de recibir vacunas de ARNm contra la COVID-19, notificada al Sistema de notificación de eventos adversos a las vacunas (VAERS). Vacuna, 39(25), 3329-3332. https://pediatrics.aappublications.org/content/early/2021/06/04/peds.2021-052478 | Albert, E., Aurigemma, G., Saucedo, J., & Gerson, D. S. (2021). Miocarditis después de la vacunación de COVID-19. Informes de casos de radiología, 16 (8), 2142-2145. https://www.ncbi.nlm.nih.gov/pubmed/34586408 | Welsh, K. J., Baumblatt, J., Chege, W., Goud, R., & Nair, N. (2021). Thrombocytopenia including immune thrombocytopenia after receipt of mRNA COVID-19 vaccines reported to the Vaccine Adverse Event Reporting System (VAERS). Vaccine, 39(25), 3329-3332. https://www.sciencedirect.com/science/article/pii/S0264410X21005247 | Aleem, A., & Shah, H. (2021). Gastric Varices. StatPearls [Internet]. https://pubmed.ncbi.nlm.nih.gov/34033367/ | Marshall, M., Ferguson, I. D., Lewis, P., Jaggi, P., Gagliardo, C., Collins, J. S., ... & Guzman-Cottrill, J. A. (2021). Symptomatic acute myocarditis in 7 adolescents after Pfizer-BioNTech COVID-19 vaccination. Pediatrics, 148(3). | https://pediatrics.aappublications.org/content/early/2021/06/04/peds.2021-052478 | Marshall, M., Ferguson, I. D., Lewis, P., Jaggi, P., Gagliardo, C., Collins, J. S., ... & Guzman-Cottrill, J. A. (2021). Symptomatic acute myocarditis in 7 adolescents after Pfizer-BioNTech COVID-19 vaccination. Pediatrics, 148(3). https://pediatrics.aappublications.org/content/early/2021/06/04/peds.2021-052478 | Ambrosetti, M., & Pontali, E. (2021). COVID-19 vaccine-induced thrombosis. The International Journal of Tuberculosis and Lung Disease, 25(9), 691-692. https://pubmed.ncbi.nlm.nih.gov/34802488/. | ||||
37 | Acute symptomatic myocarditis in seven adolescents after Pfizer-BioNTech COVID-19 vaccination: | https://pediatrics.aappublications.org/content/early/2021/06/04/peds.2021-052478 | https://pediatrics.aappublications.org/content/early/2021/06/04/peds.2021-052478 | Marshall, M., Ferguson, I. D., Lewis, P., Jaggi, P., Gagliardo, C., Collins, J. S., ... & Guzman-Cottrill, J. A. (2021). Symptomatic acute myocarditis in 7 adolescents after Pfizer-BioNTech COVID-19 vaccination. Pediatrics, 148(3). | Marshall, M., Ferguson, I. D., Lewis, P., Jaggi, P., Gagliardo, C., Collins, J. S., ... y Guzman-Cottrill, J. A. (2021). Miocarditis aguda sintomática en 7 adolescentes tras la vacunación contra el COVID-19 de Pfizer-BioNTech. Pediatría, 148(3). https://www.sciencedirect.com/science/article/pii/S2589238X21000292#f0005 | Aleem, A., & Shah, H. (2021). Varices gástricas. Statpearls [Internet]. https://pubmed.ncbi.nlm.nih.gov/34375510/ | Marshall, M., Ferguson, I. D., Lewis, P., Jaggi, P., Gagliardo, C., Collins, J. S., ... & Guzman-Cottrill, J. A. (2021). Symptomatic acute myocarditis in 7 adolescents after Pfizer-BioNTech COVID-19 vaccination. Pediatrics, 148(3). https://pediatrics.aappublications.org/content/early/2021/06/04/peds.2021-052478 | Allen, C. M., Ramsamy, S., Tarr, A. W., Tighe, P. J., Irving, W. L., Tanasescu, R., & Evans, J. R. (2021). Guillain–Barré syndrome variant occurring after SARS‐CoV‐2 vaccination. Annals of neurology, 90(2), 315-318. https://pubmed.ncbi.nlm.nih.gov/34114269/. | Finsterer, J., & Korn, M. (2021). Aphasia seven days after second dose of an mRNA-based SARS-CoV-2 vaccine. Brain Hemorrhages, 2(4), 165-167. | https://www.sciencedirect.com/science/article/pii/S2589238X21000292#f0005 | Finsterer, J., & Korn, M. (2021). Aphasia seven days after second dose of an mRNA-based SARS-CoV-2 vaccine. Brain Hemorrhages, 2(4), 165-167. https://www.sciencedirect.com/science/article/pii/S2589238X21000292#f0005 | Ammirati, E., Cavalotti, C., Milazzo, A., Pedrotti, P., Soriano, F., Schroeder, J. W., ... & Oliva, F. (2021). Temporal relation between second dose BNT162b2 mRNA Covid-19 vaccine and cardiac involvement in a patient with previous SARS-COV-2 infection. International journal of cardiology. Heart & vasculature. https://www.sciencedirect.com/science/article/pii/S2352906721000622 | ||||
38 | Aphasia seven days after the second dose of an mRNA-based SARS-CoV-2 vaccine. Brain MRI revealed an intracerebral hemorrhage (ICBH) in the left temporal lobe in a 52-year-old man. | https://www.sciencedirect.com/science/article/pii/S2589238X21000292#f0005 | https://www.sciencedirect.com/science/article/pii/S2589238X21000292#f0005 | Finsterer, J., & Korn, M. (2021). Aphasia seven days after second dose of an mRNA-based SARS-CoV-2 vaccine. Brain Hemorrhages, 2(4), 165-167. | Finsterer, J. y Korn, M. (2021). Afasia siete días después de la segunda dosis de una vacuna contra el SARS-CoV-2 basada en ARNm. Hemorragias cerebrales, 2(4), 165-167. https://www.sciencedirect.com/science/article/abs/pii/S0896841121000895 | Allen, C. M., Ramsamy, S., Tarr, A. W., Tighe, P. J., Irving, W. L., Tanaascu, R., & Evans, J. R. (2021). Variante del síndrome de Guillain-Barré ocurre después de la vacunación de SARS-COV-2. Anales de neurología, 90 (2), 315-318. https://pubmed.ncbi.nlm.nih.gov/34722067/ | Finsterer, J., & Korn, M. (2021). Aphasia seven days after second dose of an mRNA-based SARS-CoV-2 vaccine. Brain Hemorrhages, 2(4), 165-167. https://www.sciencedirect.com/science/article/pii/S2589238X21000292#f0005 | Alnæs, M., Storaas, T., Sørensen, M., Stylianou, E., & Tøndell, A. (2021). Covid-19-vaksiner gir økt risiko for anafylaksi. Tidsskrift for Den norske legeforening. https://pubmed.ncbi.nlm.nih.gov/33685103/ | Hwang, J., Lee, S., Lee, S., Lee, M., Koyanagi, A., Jacob, L., Tizaoui, K., Yon, D., Shin, J., & Smith, L. (2021). Comparison of vaccine-induced thrombotic events between ChAdOx1 nCoV-19 and Ad26. COV. 2. S vaccines. Journal of autoimmunity, 122, 102681. | https://www.sciencedirect.com/science/article/abs/pii/S0896841121000895 | Hwang, J., Lee, S., Lee, S., Lee, M., Koyanagi, A., Jacob, L., Tizaoui, K., Yon, D., Shin, J., & Smith, L. (2021). Comparison of vaccine-induced thrombotic events between ChAdOx1 nCoV-19 and Ad26. COV. 2. S vaccines. Journal of autoimmunity, 122, 102681. https://www.sciencedirect.com/science/article/abs/pii/S0896841121000895 | An, Q. J., Qin, D. A., & Pei, J. X. (2021). Reactive arthritis after COVID-19 vaccination. Human Vaccines & Immunotherapeutics, 17(9), 2954-2956. https://pubmed.ncbi.nlm.nih.gov/34033732/. | ||||
39 | Comparison of vaccine-induced thrombotic episodes between ChAdOx1 nCoV-19 and Ad26.COV.2.S vaccines: | https://www.sciencedirect.com/science/article/abs/pii/S0896841121000895 | https://www.sciencedirect.com/science/article/abs/pii/S0896841121000895 | Hwang, J., Lee, S., Lee, S., Lee, M., Koyanagi, A., Jacob, L., Tizaoui, K., Yon, D., Shin, J., & Smith, L. (2021). Comparison of vaccine-induced thrombotic events between ChAdOx1 nCoV-19 and Ad26. COV. 2. S vaccines. Journal of autoimmunity, 122, 102681. | Hwang, J., Lee, S., Lee, S., Lee, M., Koyanagi, A., Jacob, L., Tizaoui, K., Yon, D., Shin, J. y Smith, L. (2021). Comparación de eventos trombóticos inducidos por la vacuna entre ChAdOx1 nCoV-19 y Ad26. COV. 2. Vacunas S. Revista de autoinmunidad, 122, 102681. https://www.sciencedirect.com/science/article/abs/pii/S0049384821003315 | Alnæs, M., Storaas, T., Sørensen, M., Stylianou, E., & Tøndell, A. (2021). COVID-19-VAKSINER GIR ØKT RISIKO PARA ANAFYLAKSI. TIDSSSKRIFT PARA DEN NORSKE LEGEFORENDO. https://pubmed.ncbi.nlm.nih.gov/34050949/ | Hwang, J., Lee, S., Lee, S., Lee, M., Koyanagi, A., Jacob, L., Tizaoui, K., Yon, D., Shin, J., & Smith, L. (2021). Comparison of vaccine-induced thrombotic events between ChAdOx1 nCoV-19 and Ad26. COV. 2. S vaccines. Journal of autoimmunity, 122, 102681. https://www.sciencedirect.com/science/article/abs/pii/S0896841121000895 | Althaus, K., Möller, P., Uzun, G., Singh, A., Beck, A., Bettag, M., ... & Bakchoul, T. (2021). Antibody-mediated procoagulant platelets in SARS-CoV-2-vaccination associated immune thrombotic thrombocytopenia. Haematologica, 106(8), 2170. https://pubmed.ncbi.nlm.nih.gov/34011137/. | Douxfils, J., Favresse, J., Dogné, J. M., Lecompte, T., Susen, S., Cordonnier, C., ... & Mullier, F. (2021). Hypotheses behind the very rare cases of thrombosis with thrombocytopenia syndrome after SARS-CoV-2 vaccination. Thrombosis research, 203, 163-171. | https://www.sciencedirect.com/science/article/abs/pii/S0049384821003315 | Douxfils, J., Favresse, J., Dogné, J. M., Lecompte, T., Susen, S., Cordonnier, C., ... & Mullier, F. (2021). Hypotheses behind the very rare cases of thrombosis with thrombocytopenia syndrome after SARS-CoV-2 vaccination. Thrombosis research, 203, 163-171. https://www.sciencedirect.com/science/article/abs/pii/S0049384821003315 | Anderson, A., Seddon, M., Shahzad, K., & Lunevicius, R. (2021). Post-COVID-19 vaccination occurrence of splenic infarction due to arterial thrombosis. BMJ Case Reports CP, 14(12), e243846. https://pubmed.ncbi.nlm.nih.gov/34876440/ | ||||
40 | Hypothesis behind the very rare cases of thrombosis with thrombocytopenia syndrome after SARS-CoV-2 vaccination: | https://www.sciencedirect.com/science/article/abs/pii/S0049384821003315 | https://www.sciencedirect.com/science/article/abs/pii/S0049384821003315 | Douxfils, J., Favresse, J., Dogné, J. M., Lecompte, T., Susen, S., Cordonnier, C., ... & Mullier, F. (2021). Hypotheses behind the very rare cases of thrombosis with thrombocytopenia syndrome after SARS-CoV-2 vaccination. Thrombosis research, 203, 163-171. | Douxfils, J., Favresse, J., Dogné, JM, Lecompte, T., Susen, S., Cordonnier, C., ... y Mullier, F. (2021). Hipótesis detrás de los rarísimos casos de trombosis con síndrome de trombocitopenia tras la vacunación contra el SARS-CoV-2. Investigación de trombosis, 203, 163-171. https://www.sciencedirect.com/science/article/pii/S0896841121000937 | Althaus, K., Möller, P., Uzun, G., Singh, A., Beck, A., Bettag, M., ... & Bakchoul, T. (2021). Parrillas proCoagulantes mediadas por el anticuerpo en SARS-COV-2-vacunación asociada a la trombocitopenia trombótica inmune. Haematologica, 106 (8), 2170. https://pubmed.ncbi.nlm.nih.gov/34393988/. | Douxfils, J., Favresse, J., Dogné, J. M., Lecompte, T., Susen, S., Cordonnier, C., ... & Mullier, F. (2021). Hypotheses behind the very rare cases of thrombosis with thrombocytopenia syndrome after SARS-CoV-2 vaccination. Thrombosis research, 203, 163-171. https://www.sciencedirect.com/science/article/abs/pii/S0049384821003315 | Ambati, S., Colon, M., Mihic, M., Sanchez, J., & Bakar, A. (2021). Acute myopericarditis after covid-19 vaccine in teenagers. Case reports in cardiology, 2021. https://pubmed.ncbi.nlm.nih.gov/34589238/ | Cari, L., Fiore, P., Alhosseini, M. N., Sava, G., & Nocentini, G. (2021). Blood clots and bleeding events following BNT162b2 and ChAdOx1 nCoV-19 vaccine: An analysis of European data. Journal of autoimmunity, 122, 102685. | https://www.sciencedirect.com/science/article/pii/S0896841121000937 | Cari, L., Fiore, P., Alhosseini, M. N., Sava, G., & Nocentini, G. (2021). Blood clots and bleeding events following BNT162b2 and ChAdOx1 nCoV-19 vaccine: An analysis of European data. Journal of autoimmunity, 122, 102685. https://www.sciencedirect.com/science/article/pii/S0896841121000937 | Andraska, E. A., Kulkarni, R., Chaudhary, M., & Sachdev, U. (2022). Three cases of acute venous thromboembolism in females after vaccination for coronavirus disease 2019. Journal of Vascular Surgery: Venous and Lymphatic Disorders, 10(1), 14-17. https://www.sciencedirect.com/science/article/pii/S2213333X21003929 | ||||
41 | Blood clots and bleeding episodes after BNT162b2 and ChAdOx1 nCoV-19 vaccination: analysis of European data: | https://www.sciencedirect.com/science/article/pii/S0896841121000937 | https://www.sciencedirect.com/science/article/pii/S0896841121000937 | Cari, L., Fiore, P., Alhosseini, M. N., Sava, G., & Nocentini, G. (2021). Blood clots and bleeding events following BNT162b2 and ChAdOx1 nCoV-19 vaccine: An analysis of European data. Journal of autoimmunity, 122, 102685. | Cari, L., Fiore, P., Alhosseini, M. N., Sava, G. y Nocentini, G. (2021). Coágulos de sangre y eventos hemorrágicos después de la vacuna BNT162b2 y ChAdOx1 nCoV-19: un análisis de datos europeos. Revista de autoinmunidad, 122, 102685. https://www.sciencedirect.com/science/article/abs/pii/S1052305721003098 | Ambati, S., Colón, M., Mihic, M., Sánchez, J., & Bakar, A. (2021). Myopericarditis aguda después de la vacuna COVID-19 en adolescentes. Informes de casos en cardiología, 2021. https://academic.oup.com/jpids/article/10/10/962/6329543. | Cari, L., Fiore, P., Alhosseini, M. N., Sava, G., & Nocentini, G. (2021). Blood clots and bleeding events following BNT162b2 and ChAdOx1 nCoV-19 vaccine: An analysis of European data. Journal of autoimmunity, 122, 102685. https://www.sciencedirect.com/science/article/pii/S0896841121000937 | Ambati, S., Colon, M., Mihic, M., Sanchez, J., & Bakar, A. (2021). Acute myopericarditis after covid-19 vaccine in teenagers. Case reports in cardiology, 2021. https://pubmed.ncbi.nlm.nih.gov/34589238/. | Dias, L., Soares-dos-Reis, R., Meira, J., Ferrão, D., Soares, P. R., Pastor, A., ... & Carvalho, M. (2021). Cerebral venous thrombosis after BNT162b2 mRNA SARS-CoV-2 vaccine. Journal of Stroke and Cerebrovascular Diseases, 30(8), 105906. | https://www.sciencedirect.com/science/article/abs/pii/S1052305721003098 | Dias, L., Soares-dos-Reis, R., Meira, J., Ferrão, D., Soares, P. R., Pastor, A., ... & Carvalho, M. (2021). Cerebral venous thrombosis after BNT162b2 mRNA SARS-CoV-2 vaccine. Journal of Stroke and Cerebrovascular Diseases, 30(8), 105906. https://www.sciencedirect.com/science/article/abs/pii/S1052305721003098 | Angelo, G., Francesca, G., Elena, M., Sara, S., Michelle, Z., & Mauro, T. (2021). Severe immune thrombocytopenia after COVID-19 vaccination: Report of four cases and review of the literature. Blood cells, molecules & diseases. https://pubmed.ncbi.nlm.nih.gov/34653943/. | ||||
42 | Cerebral venous thrombosis after BNT162b2 mRNA SARS-CoV-2 vaccine: | https://www.sciencedirect.com/science/article/abs/pii/S1052305721003098 | https://www.sciencedirect.com/science/article/abs/pii/S1052305721003098 | Dias, L., Soares-dos-Reis, R., Meira, J., Ferrão, D., Soares, P. R., Pastor, A., ... & Carvalho, M. (2021). Cerebral venous thrombosis after BNT162b2 mRNA SARS-CoV-2 vaccine. Journal of Stroke and Cerebrovascular Diseases, 30(8), 105906. | Dias, L., Soares-dos-Reis, R., Meira, J., Ferrão, D., Soares, P. R., Pastor, A., ... & Carvalho, M. (2021). Trombosis venosa cerebral después de la vacuna BNT162b2 mRNA SARS-CoV-2. Revista de accidentes cerebrovasculares y enfermedades cerebrovasculares, 30(8), 105906. https://www.sciencedirect.com/science/article/pii/S0953620521002363 | Ambati, S., Colón, M., Mihic, M., Sánchez, J., & Bakar, A. (2021). Myopericarditis aguda después de la vacuna COVID-19 en adolescentes. Informes de casos en cardiología, 2021. https://pubmed.ncbi.nlm.nih.gov/34149145/ | Dias, L., Soares-dos-Reis, R., Meira, J., Ferrão, D., Soares, P. R., Pastor, A., ... & Carvalho, M. (2021). Cerebral venous thrombosis after BNT162b2 mRNA SARS-CoV-2 vaccine. Journal of Stroke and Cerebrovascular Diseases, 30(8), 105906. https://www.sciencedirect.com/science/article/abs/pii/S1052305721003098 | Ambrosetti, M., & Pontali, E. (2021). COVID-19 vaccine-induced thrombosis. The International Journal of Tuberculosis and Lung Disease, 25(9), 691-692. https://pubmed.ncbi.nlm.nih.gov/34802488/. | Varona, J. F., García-Isidro, M., Moeinvaziri, M., Ramos-López, M., & Fernández-Domínguez, M. (2021). Primary adrenal insufficiency associated with Oxford-AstraZeneca ChAdOx1 nCoV-19 vaccine-induced immune thrombotic thrombocytopenia (VITT). European Journal of Internal Medicine, 91, 90-92. | https://www.sciencedirect.com/science/article/pii/S0953620521002363 | Varona, J. F., García-Isidro, M., Moeinvaziri, M., Ramos-López, M., & Fernández-Domínguez, M. (2021). Primary adrenal insufficiency associated with Oxford-AstraZeneca ChAdOx1 nCoV-19 vaccine-induced immune thrombotic thrombocytopenia (VITT). European Journal of Internal Medicine, 91, 90-92. https://www.sciencedirect.com/science/article/pii/S0953620521002363 | Annabi, E., Dupin, N., Sohier, P., Garel, B., Franck, N., Aractingi, S., ... & Oulès, B. (2021). Rare cutaneous adverse effects of COVID‐19 vaccines: a case series and review of the literature. Journal of the European Academy of Dermatology and Venereology. https://pubmed.ncbi.nlm.nih.gov/34363637/ | ||||
43 | Primary adrenal insufficiency associated with thrombotic immune thrombocytopenia induced by the Oxford-AstraZeneca ChAdOx1 nCoV-19 vaccine (VITT): | https://www.sciencedirect.com/science/article/pii/S0953620521002363 | https://www.sciencedirect.com/science/article/pii/S0953620521002363 | Varona, J. F., García-Isidro, M., Moeinvaziri, M., Ramos-López, M., & Fernández-Domínguez, M. (2021). Primary adrenal insufficiency associated with Oxford-AstraZeneca ChAdOx1 nCoV-19 vaccine-induced immune thrombotic thrombocytopenia (VITT). European Journal of Internal Medicine, 91, 90-92. | Varona, J. F., García-Isidro, M., Moeinvaziri, M., Ramos-López, M., & Fernández-Domínguez, M. (2021). Insuficiencia suprarrenal primaria asociada con la trombocitopenia trombótica inmunitaria (VITT) inducida por la vacuna Oxford-AstraZeneca ChAdOx1 nCoV-19. Revista europea de medicina interna, 91, 90-92. https://www.sciencedirect.com/science/article/pii/S0828282X21006243 | Ambrosetti, M., & Pontali, E. (2021). COVID-19 trombosis inducida por la vacuna. El Diario Internacional de Tuberculosis y Enfermedad Pulmonar, 25 (9), 691-692. https://pubmed.ncbi.nlm.nih.gov/34887867/. | Varona, J. F., García-Isidro, M., Moeinvaziri, M., Ramos-López, M., & Fernández-Domínguez, M. (2021). Primary adrenal insufficiency associated with Oxford-AstraZeneca ChAdOx1 nCoV-19 vaccine-induced immune thrombotic thrombocytopenia (VITT). European Journal of Internal Medicine, 91, 90-92. https://www.sciencedirect.com/science/article/pii/S0953620521002363 | Ammirati, E., Cavalotti, C., Milazzo, A., Pedrotti, P., Soriano, F., Schroeder, J. W., ... & Oliva, F. (2021). Temporal relation between second dose BNT162b2 mRNA Covid-19 vaccine and cardiac involvement in a patient with previous SARS-COV-2 infection. International journal of cardiology. Heart & vasculature. https://www.sciencedirect.com/science/article/pii/S2352906721000622 | Luk, A., Clarke, B., Dahdah, N., Ducharme, A., Krahn, A., McCrindle, B., ... & McDonald, M. (2021). Myocarditis and pericarditis after Covid-19 mRNA vaccination: practical considerations for care providers. Canadian Journal of Cardiology, 37(10), 1629-1634. | https://www.sciencedirect.com/science/article/pii/S0828282X21006243 | Luk, A., Clarke, B., Dahdah, N., Ducharme, A., Krahn, A., McCrindle, B., ... & McDonald, M. (2021). Myocarditis and pericarditis after Covid-19 mRNA vaccination: practical considerations for care providers. Canadian Journal of Cardiology, 37(10), 1629-1634. https://www.sciencedirect.com/science/article/pii/S0828282X21006243 | Anupama, Y. J., Patel, R. G., & Vankalakunti, M. (2021). Nephrotic syndrome following ChAdOx1 nCoV-19 vaccine against SARScoV-2. Kidney International Reports, 6(8), 2248. https://pubmed.ncbi.nlm.nih.gov/34250318/. | ||||
44 | Myocarditis and pericarditis after vaccination with COVID-19 mRNA: practical considerations for care providers: | https://www.sciencedirect.com/science/article/pii/S0828282X21006243 | https://www.sciencedirect.com/science/article/pii/S0828282X21006243 | Luk, A., Clarke, B., Dahdah, N., Ducharme, A., Krahn, A., McCrindle, B., ... & McDonald, M. (2021). Myocarditis and pericarditis after Covid-19 mRNA vaccination: practical considerations for care providers. Canadian Journal of Cardiology, 37(10), 1629-1634. | Luk, A., Clarke, B., Dahdah, N., Ducharme, A., Krahn, A., McCrindle, B., ... y McDonald, M. (2021). Miocarditis y pericarditis después de la vacunación con ARNm de Covid-19: consideraciones prácticas para los proveedores de atención. Revista Canadiense de Cardiología, 37(10), 1629-1634. https://www.sciencedirect.com/science/article/pii/S2666572721000389 | Ammirati, E., Cavalotti, C., Milazzo, A., Pedrotti, P., Soriano, F., Schroeder, J. W., ... & Oliva, F. (2021). Relación temporal entre la segunda dosis BNT162B2 MRNA COVID-19 Vacuna y la participación cardíaca en un paciente con infección previa de SARS-COV-2. Diario Internacional de Cardiología. Corazón y vasculatura. https://www.sciencedirect.com/science/article/pii/S0022347621007368 | Luk, A., Clarke, B., Dahdah, N., Ducharme, A., Krahn, A., McCrindle, B., ... & McDonald, M. (2021). Myocarditis and pericarditis after Covid-19 mRNA vaccination: practical considerations for care providers. Canadian Journal of Cardiology, 37(10), 1629-1634. https://www.sciencedirect.com/science/article/pii/S0828282X21006243 | An, Q. J., Qin, D. A., & Pei, J. X. (2021). Reactive arthritis after COVID-19 vaccination. Human Vaccines & Immunotherapeutics, 17(9), 2954-2956. https://pubmed.ncbi.nlm.nih.gov/34033732/. | Melas, N. (2021). Portal vein thrombosis occurring after the first dose of mRNA SARS-CoV-2 vaccine in a patient with antiphospholipid syndrome. Thrombosis Update. | https://www.sciencedirect.com/science/article/pii/S2666572721000389 | Melas, N. (2021). Portal vein thrombosis occurring after the first dose of mRNA SARS-CoV-2 vaccine in a patient with antiphospholipid syndrome. Thrombosis Update. https://www.sciencedirect.com/science/article/pii/S2666572721000389 | Aomar-Millán, I. F., de Victoria-Carazo, J. M., Peregrina-Rivas, J. A., & Villegas-Rodríguez, I. (2021). COVID-19, Guillain-Barré syndrome, and the vaccine. A dangerous combination. Revista clinica espanola. https://pubmed.ncbi.nlm.nih.gov/34108736/. | ||||
45 | “Portal vein thrombosis occurring after the first dose of SARS-CoV-2 mRNA vaccine in a patient with antiphospholipid syndrome”: | https://www.sciencedirect.com/science/article/pii/S2666572721000389 | https://www.sciencedirect.com/science/article/pii/S2666572721000389 | Melas, N. (2021). Portal vein thrombosis occurring after the first dose of mRNA SARS-CoV-2 vaccine in a patient with antiphospholipid syndrome. Thrombosis Update. | Melas, N. (2021). Trombosis de la vena porta que ocurre después de la primera dosis de la vacuna de ARNm contra el SARS-CoV-2 en un paciente con síndrome antifosfolípido. Actualización sobre trombosis. https://www.sciencedirect.com/science/article/pii/S0196064421003425 | Andaska, E. A., Kulkarni, R., Chaudhary, M., & Sachdev, U. (2022). Tres casos de tromboembolismo venoso agudo en las hembras después de la vacunación para la enfermedad de Coronavirus 2019. Diario de la cirugía vascular: trastornos venosos y linfáticos, 10 (1), 14-17. https://jnnp.bmj.com/content/early/2021/09/29/jnnp-2021-327340. | Melas, N. (2021). Portal vein thrombosis occurring after the first dose of mRNA SARS-CoV-2 vaccine in a patient with antiphospholipid syndrome. Thrombosis Update. https://www.sciencedirect.com/science/article/pii/S2666572721000389 | Anderson, A., Seddon, M., Shahzad, K., & Lunevicius, R. (2021). Post-COVID-19 vaccination occurrence of splenic infarction due to arterial thrombosis. BMJ Case Reports CP, 14(12), e243846. https://pubmed.ncbi.nlm.nih.gov/34876440/ | Clark, R. T., Johnson, L., Billotti, J., Foulds, G., Ketels, T., Heard, K., & Hynes, E. C. (2021). Early outcomes of bivalirudin therapy for thrombotic thrombocytopenia and cerebral venous sinus thrombosis after Ad26. COV2. S vaccination. Annals of Emergency Medicine, 78(4), 511-514. | https://www.sciencedirect.com/science/article/pii/S0196064421003425 | Clark, R. T., Johnson, L., Billotti, J., Foulds, G., Ketels, T., Heard, K., & Hynes, E. C. (2021). Early outcomes of bivalirudin therapy for thrombotic thrombocytopenia and cerebral venous sinus thrombosis after Ad26. COV2. S vaccination. Annals of Emergency Medicine, 78(4), 511-514. https://www.sciencedirect.com/science/article/pii/S0196064421003425 | Arcolaci, A., Bronte, V., & Zanoni, G. (2021). Immunization practices and risk of anaphylaxis: a current update, comprehensive of COVID-19 vaccination data. Current opinion in allergy and clinical immunology, 21(5), 418-425. https://pubmed.ncbi.nlm.nih.gov/34269740/ | ||||
46 | Early results of bivalirudin treatment for thrombotic thrombocytopenia and cerebral venous sinus thrombosis after vaccination with Ad26.COV2.S: | https://www.sciencedirect.com/science/article/pii/S0196064421003425 | https://www.sciencedirect.com/science/article/pii/S0196064421003425 | Clark, R. T., Johnson, L., Billotti, J., Foulds, G., Ketels, T., Heard, K., & Hynes, E. C. (2021). Early outcomes of bivalirudin therapy for thrombotic thrombocytopenia and cerebral venous sinus thrombosis after Ad26. COV2. S vaccination. Annals of Emergency Medicine, 78(4), 511-514. | Clark, R. T., Johnson, L., Billotti, J., Foulds, G., Ketels, T., Heard, K. y Hynes, E. C. (2021). Resultados tempranos del tratamiento con bivalirudina para la trombocitopenia trombótica y la trombosis del seno venoso cerebral después del Ad26. COV2. Vacunación S. Anales de Medicina de Emergencia, 78(4), 511-514. https://www.sciencedirect.com/science/article/pii/S1443950621011562 | Andaska, E. A., Kulkarni, R., Chaudhary, M., & Sachdev, U. (2022). Tres casos de tromboembolismo venoso agudo en las hembras después de la vacunación para la enfermedad de Coronavirus 2019. Diario de la cirugía vascular: trastornos venosos y linfáticos, 10 (1), 14-17. https://www.sciencedirect.com/science/article/abs/pii/S1936879821003988 | Clark, R. T., Johnson, L., Billotti, J., Foulds, G., Ketels, T., Heard, K., & Hynes, E. C. (2021). Early outcomes of bivalirudin therapy for thrombotic thrombocytopenia and cerebral venous sinus thrombosis after Ad26. COV2. S vaccination. Annals of Emergency Medicine, 78(4), 511-514. https://www.sciencedirect.com/science/article/pii/S0196064421003425 | Andraska, E. A., Kulkarni, R., Chaudhary, M., & Sachdev, U. (2022). Three cases of acute venous thromboembolism in females after vaccination for coronavirus disease 2019. Journal of Vascular Surgery: Venous and Lymphatic Disorders, 10(1), 14-17. https://pubmed.ncbi.nlm.nih.gov/34352418/ | Pepe, S., Gregory, A. T., & Denniss, A. R. (2021). Myocarditis, Pericarditis and Cardiomyopathy After COVID-19 Vaccination☆. Heart, Lung and Circulation, 30(10), 1425-1429. | https://www.sciencedirect.com/science/article/pii/S1443950621011562 | Pepe, S., Gregory, A. T., & Denniss, A. R. (2021). Myocarditis, Pericarditis and Cardiomyopathy After COVID-19 Vaccination☆. Heart, Lung and Circulation, 30(10), 1425-1429. https://www.sciencedirect.com/science/article/pii/S1443950621011562 | Ardalan, M., Moslemi, H., Shafiei, S., Tabrizi, R., & Moselmi, M. (2021). Herpes‐like skin lesion after AstraZeneca vaccination for COVID‐19: A case report. Clinical Case Reports, 9(10). https://pubmed.ncbi.nlm.nih.gov/34631069/ | ||||
47 | Myocarditis, pericarditis and cardiomyopathy after COVID-19 vaccination: | https://www.sciencedirect.com/science/article/pii/S1443950621011562 | https://www.sciencedirect.com/science/article/pii/S1443950621011562 | Pepe, S., Gregory, A. T., & Denniss, A. R. (2021). Myocarditis, Pericarditis and Cardiomyopathy After COVID-19 Vaccination☆. Heart, Lung and Circulation, 30(10), 1425-1429. | Pepe, S., Gregory, AT y Denniss, AR (2021). Miocarditis, pericarditis y miocardiopatía tras la vacunación contra la COVID-19☆. Corazón, Pulmón y Circulación, 30(10), 1425-1429. https://www.sciencedirect.com/science/article/abs/pii/S0896841121000706 | Anderson, A., Seddon, M., Shahzad, K., & Lunevicius, R. (2021). Vacunación post-covid-19 ocurrencia de infarto esplénico debido a la trombosis arterial. BMJ Case Reports CP, 14 (12), E243846. https://pubmed.ncbi.nlm.nih.gov/33928773/ | Pepe, S., Gregory, A. T., & Denniss, A. R. (2021). Myocarditis, Pericarditis and Cardiomyopathy After COVID-19 Vaccination☆. Heart, Lung and Circulation, 30(10), 1425-1429. https://www.sciencedirect.com/science/article/pii/S1443950621011562 | Andraska, E. A., Kulkarni, R., Chaudhary, M., & Sachdev, U. (2022). Three cases of acute venous thromboembolism in females after vaccination for coronavirus disease 2019. Journal of Vascular Surgery: Venous and Lymphatic Disorders, 10(1), 14-17. https://www.sciencedirect.com/science/article/pii/S2213333X21003929 | McGonagle, D., De Marco, G., & Bridgewood, C. (2021). Differences in venous immunothrombosis in severe COVID-19 pneumonia and Vaccine-Induced Thrombotic Thrombocytopenia (VITT)–It's in the viral DNA. Journal of Autoimmunity. | https://www.sciencedirect.com/science/article/abs/pii/S0896841121000706 | McGonagle, D., De Marco, G., & Bridgewood, C. (2021). Differences in venous immunothrombosis in severe COVID-19 pneumonia and Vaccine-Induced Thrombotic Thrombocytopenia (VITT)–It's in the viral DNA. Journal of Autoimmunity. https://www.sciencedirect.com/science/article/abs/pii/S0896841121000706 | Armoni-Weiss, G., Sheffer-Levi, S., Horev, L., Klapholz, L., Avitan-Hersh, E., Zlotogorski, A., & Ramot, Y. (2021). Exacerbation of Hailey-Hailey Disease Following SARS-CoV-2 Vaccination. Acta dermato-venereologica, 101(9), adv00554-adv00554. https://pubmed.ncbi.nlm.nih.gov/34436620/ | ||||
48 | Mechanisms of immunothrombosis in vaccine-induced thrombotic thrombocytopenia (VITT) compared to natural SARS-CoV-2 infection: | https://www.sciencedirect.com/science/article/abs/pii/S0896841121000706 | https://www.sciencedirect.com/science/article/abs/pii/S0896841121000706 | McGonagle, D., De Marco, G., & Bridgewood, C. (2021). Differences in venous immunothrombosis in severe COVID-19 pneumonia and Vaccine-Induced Thrombotic Thrombocytopenia (VITT)–It's in the viral DNA. Journal of Autoimmunity. | McGonagle, D., De Marco, G. y Bridgewood, C. (2021). Diferencias en la inmunotrombosis venosa en la neumonía grave por COVID-19 y la trombocitopenia trombótica inducida por vacunas (VITT): está en el ADN viral. Revista de autoinmunidad. https://www.sciencedirect.com/science/article/pii/S0006497121009411 | Angelo, G., Francesca, G., Elena, M., Sara, S., Michelle, Z., & Mauro, T. (2021). Trombocitopenia inmune severa después de la vacunación de COVID-19: Informe de cuatro casos y revisión de la literatura. Células sanguíneas, moléculas y enfermedades. https://pubmed.ncbi.nlm.nih.gov/34591991/ | McGonagle, D., De Marco, G., & Bridgewood, C. (2021). Differences in venous immunothrombosis in severe COVID-19 pneumonia and Vaccine-Induced Thrombotic Thrombocytopenia (VITT)–It's in the viral DNA. Journal of Autoimmunity. https://www.sciencedirect.com/science/article/abs/pii/S0896841121000706 | Angelo, G., Francesca, G., Elena, M., Sara, S., Michelle, Z., & Mauro, T. (2021). Severe immune thrombocytopenia after COVID-19 vaccination: Report of four cases and review of the literature. Blood cells, molecules & diseases. https://pubmed.ncbi.nlm.nih.gov/34653943/. | Tiede, A., Sachs, U. J., Czwalinna, A., Werwitzke, S., Bikker, R., Krauss, J. K., ... & Ganser, A. (2021). Prothrombotic immune thrombocytopenia after COVID-19 vaccination. Blood, The Journal of the American Society of Hematology, 138(4), 350-353. | https://www.sciencedirect.com/science/article/pii/S0006497121009411 | Tiede, A., Sachs, U. J., Czwalinna, A., Werwitzke, S., Bikker, R., Krauss, J. K., ... & Ganser, A. (2021). Prothrombotic immune thrombocytopenia after COVID-19 vaccination. Blood, The Journal of the American Society of Hematology, 138(4), 350-353. https://www.sciencedirect.com/science/article/pii/S0006497121009411 | Arroliga, M. E., Dhanani, K., Arroliga, A. C., Huddleston, P. S., Trahan, J., Aguilar, T., & Weldon, D. (2021, September). Allergic reactions and adverse events associated with administration of mRNA-based vaccines. A health-care system experience. In Allergy and Asthma Proceedings (Vol. 42, No. 5, p. 395). OceanSide Publications. https://pubmed.ncbi.nlm.nih.gov/34474708/ | ||||
49 | Prothrombotic immune thrombocytopenia after COVID-19 vaccination: | https://www.sciencedirect.com/science/article/pii/S0006497121009411 | https://www.sciencedirect.com/science/article/pii/S0006497121009411 | Tiede, A., Sachs, U. J., Czwalinna, A., Werwitzke, S., Bikker, R., Krauss, J. K., ... & Ganser, A. (2021). Prothrombotic immune thrombocytopenia after COVID-19 vaccination. Blood, The Journal of the American Society of Hematology, 138(4), 350-353. | Tiede, A., Sachs, UJ, Czwalinna, A., Werwitzke, S., Bikker, R., Krauss, JK, ... y Ganser, A. (2021). Trombocitopenia inmune protrombótica después de la vacunación COVID-19. Sangre, Revista de la Sociedad Estadounidense de Hematología, 138 (4), 350-353. https://www.sciencedirect.com/science/article/pii/S2589936821000256 | Anillo, J., Gusano, M., Wollenberg, A., Thyssen, J. P., Jakob, T., Klimek, L., ... & Deleuran, M. (2021). Riesgo de reacciones alérgicas graves a las vacunas COVID-19 entre pacientes con enfermedades alérgicas de la piel, recomendaciones prácticas. Una declaración de posición de ETFAD con expertos externos. Diario de la Academia Europea de Dermatología y Venereología, 35 (6), E362-E365. https://pubmed.ncbi.nlm.nih.gov/34073536/ | Tiede, A., Sachs, U. J., Czwalinna, A., Werwitzke, S., Bikker, R., Krauss, J. K., ... & Ganser, A. (2021). Prothrombotic immune thrombocytopenia after COVID-19 vaccination. Blood, The Journal of the American Society of Hematology, 138(4), 350-353. https://www.sciencedirect.com/science/article/pii/S0006497121009411 | Annabi, E., Dupin, N., Sohier, P., Garel, B., Franck, N., Aractingi, S., ... & Oulès, B. (2021). Rare cutaneous adverse effects of COVID‐19 vaccines: a case series and review of the literature. Journal of the European Academy of Dermatology and Venereology. https://pubmed.ncbi.nlm.nih.gov/34363637/ | Tsilingiris, D., Vallianou, N. G., Karampela, Ι., & Dalamaga, Μ. (2021). Vaccine induced thrombotic thrombocytopenia: the shady chapter of a success story. Metabolism open, 11, 100101. | https://www.sciencedirect.com/science/article/pii/S2589936821000256 | Tsilingiris, D., Vallianou, N. G., Karampela, Ι., & Dalamaga, Μ. (2021). Vaccine induced thrombotic thrombocytopenia: the shady chapter of a success story. Metabolism open, 11, 100101. https://www.sciencedirect.com/science/article/pii/S2589936821000256 | Ashaari, S., Sohaib, H. A., & Bolger, K. (2021). A case report: symptomatic pericarditis post-COVID-19 vaccination. European Heart Journal-Case Reports, 5(10), ytab375. https://pubmed.ncbi.nlm.nih.gov/34693198/. | ||||
50 | Vaccine-induced thrombotic thrombocytopenia: the dark chapter of a success story: | https://www.sciencedirect.com/science/article/pii/S2589936821000256 | https://www.sciencedirect.com/science/article/pii/S2589936821000256 | Tsilingiris, D., Vallianou, N. G., Karampela, Ι., & Dalamaga, Μ. (2021). Vaccine induced thrombotic thrombocytopenia: the shady chapter of a success story. Metabolism open, 11, 100101. | Tsilingiris, D., Vallianou, N. G., Karampela, Ι. y Dalamaga, Μ. (2021). Trombocitopenia trombótica inducida por vacunas: el capítulo sombrío de una historia de éxito. Metabolismo abierto, 11, 100101. https://www.sciencedirect.com/science/article/pii/S1871402121002046 | Annabi, E., Dupin, N., Sohier, P., Garel, B., Franck, N., Aractingi, S., ... & Oulès, B. (2021). Efectos adversos cutáneos raros de las vacunas COVID-19: una serie de casos y revisión de la literatura. Diario de la Academia Europea de Dermatología y Venereología. https://www.sciencedirect.com/science/article/pii/S2214250921002018 | Tsilingiris, D., Vallianou, N. G., Karampela, Ι., & Dalamaga, Μ. (2021). Vaccine induced thrombotic thrombocytopenia: the shady chapter of a success story. Metabolism open, 11, 100101. https://www.sciencedirect.com/science/article/pii/S2589936821000256 | Anupama, Y. J., Patel, R. G., & Vankalakunti, M. (2021). Nephrotic syndrome following ChAdOx1 nCoV-19 vaccine against SARScoV-2. Kidney International Reports, 6(8), 2248. https://pubmed.ncbi.nlm.nih.gov/34250318/. | Dutta, A., Ghosh, R., Bhattacharya, D., Bhat, S., Ray, A., Pandit, A., ... & Dubey, S. (2021). Anti-PF4 antibody negative cerebral venous sinus thrombosis without thrombocytopenia following immunization with COVID-19 vaccine in an elderly non-comorbid Indian male, managed with conventional heparin-warfarin based anticoagulation. Diabetes & Metabolic Syndrome, 15(4), 102184. | https://www.sciencedirect.com/science/article/pii/S1871402121002046 | Dutta, A., Ghosh, R., Bhattacharya, D., Bhat, S., Ray, A., Pandit, A., ... & Dubey, S. (2021). Anti-PF4 antibody negative cerebral venous sinus thrombosis without thrombocytopenia following immunization with COVID-19 vaccine in an elderly non-comorbid Indian male, managed with conventional heparin-warfarin based anticoagulation. Diabetes & Metabolic Syndrome, 15(4), 102184. https://www.sciencedirect.com/science/article/pii/S1871402121002046 | Ashoor, A., Shephard, J., Lissidini, G., & Nicosia, L. (2021). Axillary adenopathy in patients with recent Covid-19 vaccination: a new diagnostic dilemma. Korean Journal of Radiology, 22(12), 2124. https://pubmed.ncbi.nlm.nih.gov/34825530/. | ||||
51 | Cerebral venous sinus thrombosis negative for anti-PF4 antibody without thrombocytopenia after immunization with COVID-19 vaccine in a non-comorbid elderly Indian male treated with conventional heparin-warfarin based anticoagulation: | https://www.sciencedirect.com/science/article/pii/S1871402121002046 | https://www.sciencedirect.com/science/article/pii/S1871402121002046 | Dutta, A., Ghosh, R., Bhattacharya, D., Bhat, S., Ray, A., Pandit, A., ... & Dubey, S. (2021). Anti-PF4 antibody negative cerebral venous sinus thrombosis without thrombocytopenia following immunization with COVID-19 vaccine in an elderly non-comorbid Indian male, managed with conventional heparin-warfarin based anticoagulation. Diabetes & Metabolic Syndrome, 15(4), 102184. | Dutta, A., Ghosh, R., Bhattacharya, D., Bhat, S., Ray, A., Pandit, A., ... y Dubey, S. (2021). Trombosis del seno venoso cerebral con anticuerpos anti-PF4 negativos sin trombocitopenia después de la inmunización con la vacuna COVID-19 en un varón indio anciano sin comorbilidad, tratado con anticoagulación convencional basada en heparina-warfarina. Diabetes y síndrome metabólico, 15(4), 102184. https://www.sciencedirect.com/science/article/pii/S0049384821004369 | Anupama, Y. J., Patel, R. G., y vankalakunti, M. (2021). Síndrome nefrótico después de la vacuna Chadox1 NCOV-19 contra SARSCOV-2. Informes de Ridney International, 6 (8), 2248. https://pubmed.ncbi.nlm.nih.gov/34059191/ | Dutta, A., Ghosh, R., Bhattacharya, D., Bhat, S., Ray, A., Pandit, A., ... & Dubey, S. (2021). Anti-PF4 antibody negative cerebral venous sinus thrombosis without thrombocytopenia following immunization with COVID-19 vaccine in an elderly non-comorbid Indian male, managed with conventional heparin-warfarin based anticoagulation. Diabetes & Metabolic Syndrome, 15(4), 102184. https://www.sciencedirect.com/science/article/pii/S1871402121002046 | Aomar-Millán, I. F., de Victoria-Carazo, J. M., Peregrina-Rivas, J. A., & Villegas-Rodríguez, I. (2021). COVID-19, Guillain-Barré syndrome, and the vaccine. A dangerous combination. Revista clinica espanola. https://pubmed.ncbi.nlm.nih.gov/34108736/. | Dalan, R., & Boehm, B. O. (2021). Thrombosis post COVID-19 vaccinations: Potential link to ACE pathways. Thrombosis Research, 206, 137. | https://www.sciencedirect.com/science/article/pii/S0049384821004369 | Dalan, R., & Boehm, B. O. (2021). Thrombosis post COVID-19 vaccinations: Potential link to ACE pathways. Thrombosis Research, 206, 137. https://www.sciencedirect.com/science/article/pii/S0049384821004369 | Ashrani, A. A., Crusan, D. J., Petterson, T., Bailey, K., & Heit, J. A. (2022). Age-and sex-specific incidence of cerebral venous sinus thrombosis associated with Ad26. COV2. S COVID-19 vaccination. JAMA internal medicine, 182(1), 80-83. https://pubmed.ncbi.nlm.nih.gov/34724036/. | ||||
52 | Thrombosis after COVID-19 vaccination: possible link to ACE pathways: | https://www.sciencedirect.com/science/article/pii/S0049384821004369 | https://www.sciencedirect.com/science/article/pii/S0049384821004369 | Dalan, R., & Boehm, B. O. (2021). Thrombosis post COVID-19 vaccinations: Potential link to ACE pathways. Thrombosis Research, 206, 137. | Dalan, R. y Boehm, BO (2021). Trombosis posterior a las vacunas COVID-19: vínculo potencial con las vías de la ECA. Investigación de trombosis, 206, 137. https://www.sciencedirect.com/science/article/pii/S0735109721051949 | Aomar-Millán, I. F., De Victoria-Carazo, J. M., Peregrina-Rivas, J. A., & Villegas-Rodríguez, I. (2021). COVID-19, Síndrome de Guillain-Barré, y la vacuna. Una combinación peligrosa. Revista Clinica Espanola. https://pubmed.ncbi.nlm.nih.gov/34796417/. | Dalan, R., & Boehm, B. O. (2021). Thrombosis post COVID-19 vaccinations: Potential link to ACE pathways. Thrombosis Research, 206, 137. https://www.sciencedirect.com/science/article/pii/S0049384821004369 | Arcolaci, A., Bronte, V., & Zanoni, G. (2021). Immunization practices and risk of anaphylaxis: a current update, comprehensive of COVID-19 vaccination data. Current opinion in allergy and clinical immunology, 21(5), 418-425. https://pubmed.ncbi.nlm.nih.gov/34269740/ | Bikdeli, B., Chatterjee, S., Arora, S., Monreal, M., Jimenez, D., Krumholz, H. M., ... & Piazza, G. (2021). Cerebral venous sinus thrombosis in the US population, after adenovirus-based SARS-CoV-2 vaccination, and after COVID-19. Journal of the American College of Cardiology, 78(4), 408-411. | https://www.sciencedirect.com/science/article/pii/S0735109721051949 | Bikdeli, B., Chatterjee, S., Arora, S., Monreal, M., Jimenez, D., Krumholz, H. M., ... & Piazza, G. (2021). Cerebral venous sinus thrombosis in the US population, after adenovirus-based SARS-CoV-2 vaccination, and after COVID-19. Journal of the American College of Cardiology, 78(4), 408-411. https://www.sciencedirect.com/science/article/pii/S0735109721051949 | Asmat, H., Fayeye, F., Alshakaty, H., & Patel, J. (2021). A rare case of COVID-19 vaccine-induced thrombotic thrombocytopaenia (VITT) involving the veno-splanchnic and pulmonary arterial circulation, from a UK district general hospital. BMJ Case Reports CP, 14(9), e244223. https://pubmed.ncbi.nlm.nih.gov/34535492/ | ||||
53 | Cerebral venous sinus thrombosis in the U.S. population after SARS-CoV-2 vaccination with adenovirus and after COVID-19: | https://www.sciencedirect.com/science/article/pii/S0735109721051949 | https://www.sciencedirect.com/science/article/pii/S0735109721051949 | Bikdeli, B., Chatterjee, S., Arora, S., Monreal, M., Jimenez, D., Krumholz, H. M., ... & Piazza, G. (2021). Cerebral venous sinus thrombosis in the US population, after adenovirus-based SARS-CoV-2 vaccination, and after COVID-19. Journal of the American College of Cardiology, 78(4), 408-411. | Bikdeli, B., Chatterjee, S., Arora, S., Monreal, M., Jiménez, D., Krumholz, H. M., ... & Piazza, G. (2021). Trombosis del seno venoso cerebral en la población de EE. UU., después de la vacunación contra el SARS-CoV-2 basada en adenovirus y después de la COVID-19. Revista del Colegio Americano de Cardiología, 78(4), 408-411. https://www.sciencedirect.com/science/article/pii/S0735675721005714 | Arcolaci, A., Bronte, V., & Zanoni, G. (2021). Prácticas de inmunización y riesgo de anafilaxis: una actualización actual, exhaustiva de los datos de vacunación COVID-19. Opinión actual en alergia y inmunología clínica, 21 (5), 418-425. https://pubmed.ncbi.nlm.nih.gov/34215453/ | Bikdeli, B., Chatterjee, S., Arora, S., Monreal, M., Jimenez, D., Krumholz, H. M., ... & Piazza, G. (2021). Cerebral venous sinus thrombosis in the US population, after adenovirus-based SARS-CoV-2 vaccination, and after COVID-19. Journal of the American College of Cardiology, 78(4), 408-411. https://www.sciencedirect.com/science/article/pii/S0735109721051949 | Ardalan, M., Moslemi, H., Shafiei, S., Tabrizi, R., & Moselmi, M. (2021). Herpes‐like skin lesion after AstraZeneca vaccination for COVID‐19: A case report. Clinical Case Reports, 9(10). https://pubmed.ncbi.nlm.nih.gov/34631069/ | Guan, C. Y., Tsai, S. H., Fan, J. S., Lin, Y. K., & Kao, C. C. (2022). Middle-age Asian male with cerebral venous thrombosis after COVID-19 AstraZeneca vaccination. The American Journal of Emergency Medicine, 51, 427-e3. | https://www.sciencedirect.com/science/article/pii/S0735675721005714 | Guan, C. Y., Tsai, S. H., Fan, J. S., Lin, Y. K., & Kao, C. C. (2022). Middle-age Asian male with cerebral venous thrombosis after COVID-19 AstraZeneca vaccination. The American Journal of Emergency Medicine, 51, 427-e3. https://www.sciencedirect.com/science/article/pii/S0735675721005714 | Aye, Y. N., Mai, A. S., Zhang, A., Lim, O. Z. H., Lin, N., Ng, C. H., ... & Chew, N. W. (2021). Acute myocardial infarction and myocarditis following COVID-19 vaccination. QJM: An International Journal of Medicine. https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8522388/ | ||||
54 | A rare case of a middle-aged Asian male with cerebral venous thrombosis after AstraZeneca COVID-19 vaccination: | https://www.sciencedirect.com/science/article/pii/S0735675721005714 | https://www.sciencedirect.com/science/article/pii/S0735675721005714 | Guan, C. Y., Tsai, S. H., Fan, J. S., Lin, Y. K., & Kao, C. C. (2022). Middle-age Asian male with cerebral venous thrombosis after COVID-19 AstraZeneca vaccination. The American Journal of Emergency Medicine, 51, 427-e3. | Guan, C. Y., Tsai, S. H., Fan, J. S., Lin, Y. K. y Kao, C. C. (2022). Varón asiático de mediana edad con trombosis venosa cerebral después de la vacuna COVID-19 AstraZeneca. Revista Estadounidense de Medicina de Emergencia, 51, 427-e3. https://www.sciencedirect.com/science/article/abs/pii/S088915912100163X | Ardalan, M., Moslemi, H., Shafiei, S., Tabrizi, R., & Moselmi, M. (2021). Lesión de la piel en forma de herpes después de la vacunación de AstraZeneca para COVID-19: un informe de caso. Informes de casos clínicos, 9 (10). https://pubmed.ncbi.nlm.nih.gov/34479129/ | Guan, C. Y., Tsai, S. H., Fan, J. S., Lin, Y. K., & Kao, C. C. (2022). Middle-age Asian male with cerebral venous thrombosis after COVID-19 AstraZeneca vaccination. The American Journal of Emergency Medicine, 51, 427-e3. https://www.sciencedirect.com/science/article/pii/S0735675721005714 | Armoni-Weiss, G., Sheffer-Levi, S., Horev, L., Klapholz, L., Avitan-Hersh, E., Zlotogorski, A., & Ramot, Y. (2021). Exacerbation of Hailey-Hailey Disease Following SARS-CoV-2 Vaccination. Acta dermato-venereologica, 101(9), adv00554-adv00554. https://pubmed.ncbi.nlm.nih.gov/34436620/ | Mehta, P. R., Mangion, S. A., Benger, M., Stanton, B. R., Czuprynska, J., Arya, R., & Sztriha, L. K. (2021). Cerebral venous sinus thrombosis and thrombocytopenia after COVID-19 vaccination–A report of two UK cases. Brain, behavior, and immunity, 95, 514-517. | https://www.sciencedirect.com/science/article/abs/pii/S088915912100163X | Mehta, P. R., Mangion, S. A., Benger, M., Stanton, B. R., Czuprynska, J., Arya, R., & Sztriha, L. K. (2021). Cerebral venous sinus thrombosis and thrombocytopenia after COVID-19 vaccination–A report of two UK cases. Brain, behavior, and immunity, 95, 514-517. https://www.sciencedirect.com/science/article/abs/pii/S088915912100163X | Azir, M., Inman, B., Webb, J., & Tannenbaum, L. (2021). STEMI Mimic: Focal Myocarditis in an Adolescent Patient After mRNA COVID-19 Vaccine. The Journal of emergency medicine, 61(6), e129-e132. https://pubmed.ncbi.nlm.nih.gov/34756746/ | ||||
55 | Cerebral venous sinus thrombosis and thrombocytopenia after COVID-19 vaccination: report of two cases in the United Kingdom: | https://www.sciencedirect.com/science/article/abs/pii/S088915912100163X | https://www.sciencedirect.com/science/article/abs/pii/S088915912100163X | Mehta, P. R., Mangion, S. A., Benger, M., Stanton, B. R., Czuprynska, J., Arya, R., & Sztriha, L. K. (2021). Cerebral venous sinus thrombosis and thrombocytopenia after COVID-19 vaccination–A report of two UK cases. Brain, behavior, and immunity, 95, 514-517. | Mehta, P. R., Mangion, S. A., Benger, M., Stanton, B. R., Czuprynska, J., Arya, R. y Sztriha, L. K. (2021). Trombosis del seno venoso cerebral y trombocitopenia después de la vacunación COVID-19: informe de dos casos en el Reino Unido. Cerebro, comportamiento e inmunidad, 95, 514-517. https://www.sciencedirect.com/science/article/abs/pii/S0006497121013963. | Armoni-Weiss, G., Sheffer-Levi, S., Horev, L., Klapholz, L., Avitan-Hersh, E., Zlotogorski, A., & Ramot, Y. (2021). Exacerbación de la enfermedad de Hailey-Hailey después de la vacunación de SARS-COV-2. Acta Dermato-venereologica, 101 (9), ADV00554-ADV00554. https://pubmed.ncbi.nlm.nih.gov/34116295/. | Mehta, P. R., Mangion, S. A., Benger, M., Stanton, B. R., Czuprynska, J., Arya, R., & Sztriha, L. K. (2021). Cerebral venous sinus thrombosis and thrombocytopenia after COVID-19 vaccination–A report of two UK cases. Brain, behavior, and immunity, 95, 514-517. https://www.sciencedirect.com/science/article/abs/pii/S088915912100163X | Arroliga, M. E., Dhanani, K., Arroliga, A. C., Huddleston, P. S., Trahan, J., Aguilar, T., & Weldon, D. (2021, September). Allergic reactions and adverse events associated with administration of mRNA-based vaccines. A health-care system experience. In Allergy and Asthma Proceedings (Vol. 42, No. 5, p. 395). OceanSide Publications. https://pubmed.ncbi.nlm.nih.gov/34474708/ | Paulsen, F. O., Schaefers, C., Langer, F., Frenzel, C., Wenzel, U., Hengel, F. E., ... & Seidel, C. (2021). Immune thrombocytopenic purpura after vaccination with COVID-19 vaccine (ChAdOx1 nCov-19). Blood, The Journal of the American Society of Hematology, 138(11), 996-999. | https://www.sciencedirect.com/science/article/abs/pii/S0006497121013963. | Paulsen, F. O., Schaefers, C., Langer, F., Frenzel, C., Wenzel, U., Hengel, F. E., ... & Seidel, C. (2021). Immune thrombocytopenic purpura after vaccination with COVID-19 vaccine (ChAdOx1 nCov-19). Blood, The Journal of the American Society of Hematology, 138(11), 996-999. https://www.sciencedirect.com/science/article/abs/pii/S0006497121013963. | Badier, L., Toledano, A., Porel, T., Dumond, S., Jouglen, J., Sailler, L., ... & Lafaurie, M. (2021). IgA vasculitis in adult patient following vaccination by ChadOx1 nCoV-19. Autoimmunity reviews. https://pubmed.ncbi.nlm.nih.gov/34509658/ | ||||
56 | Immune thrombocytopenic purpura after vaccination with COVID-19 vaccine (ChAdOx1 nCov-19): | https://www.sciencedirect.com/science/article/abs/pii/S0006497121013963. | https://www.sciencedirect.com/science/article/abs/pii/S0006497121013963. | Paulsen, F. O., Schaefers, C., Langer, F., Frenzel, C., Wenzel, U., Hengel, F. E., ... & Seidel, C. (2021). Immune thrombocytopenic purpura after vaccination with COVID-19 vaccine (ChAdOx1 nCov-19). Blood, The Journal of the American Society of Hematology, 138(11), 996-999. | Paulsen, F. O., Schaefers, C., Langer, F., Frenzel, C., Wenzel, U., Hengel, F. E., ... y Seidel, C. (2021). Púrpura trombocitopénica inmune después de la vacunación con la vacuna COVID-19 (ChAdOx1 nCov-19). Sangre, Revista de la Sociedad Estadounidense de Hematología, 138(11), 996-999. https://docs.google.com/document/d/1XzajasO8VMMnC3CdxSBKks1o7kiOLXFQ | Arroliga, M. E., Dhanani, K., Arroliga, A. C., Huddleston, P. S., Trahan, J., Aguilar, T. y Weldon, D. (2021, septiembre). Reacciones alérgicas y eventos adversos asociados con la administración de vacunas basadas en ARNm. Una experiencia del sistema de salud. En los procedimientos de alergia y asma (vol. 42, No. 5, p. 395). Publicaciones de Oceanside. https://www.tandfonline.com/doi/abs/10.1080/17843286.2021.1909447 | Paulsen, F. O., Schaefers, C., Langer, F., Frenzel, C., Wenzel, U., Hengel, F. E., ... & Seidel, C. (2021). Immune thrombocytopenic purpura after vaccination with COVID-19 vaccine (ChAdOx1 nCov-19). Blood, The Journal of the American Society of Hematology, 138(11), 996-999. https://www.sciencedirect.com/science/article/abs/pii/S0006497121013963. | Ashaari, S., Sohaib, H. A., & Bolger, K. (2021). A case report: symptomatic pericarditis post-COVID-19 vaccination. European Heart Journal-Case Reports, 5(10), ytab375. https://pubmed.ncbi.nlm.nih.gov/34693198/. | #N/A | #N/A | Badoiu, A., Moranne, O., Coudray, S., & Ion, I. M. (2021). Clinical Variant of Guillain–Barre Syndrome With Prominent Facial Diplegia After AstraZeneca Coronavirus Disease 2019 Vaccine. Journal of Clinical Neuromuscular Disease, 23(2), 115-116. https://pubmed.ncbi.nlm.nih.gov/34808658/ | |||||
57 | Antiphospholipid antibodies and risk of thrombophilia after COVID-19 vaccination: the straw that breaks the camel’s back?: | https://docs.google.com/document/d/1XzajasO8VMMnC3CdxSBKks1o7kiOLXFQ | https://docs.google.com/document/d/1XzajasO8VMMnC3CdxSBKks1o7kiOLXFQ | #VALUE! | Ashaari, S., Sohaib, H. A., & Bolger, K. (2021). Un informe de un caso: la pericarditis sintomática después de la vacunación posterior a la COVID-19. Informes de diario europeo del corazón, 5 (10), YTAB375. https://pubmed.ncbi.nlm.nih.gov/34797392/ | zzzz | Ashoor, A., Shephard, J., Lissidini, G., & Nicosia, L. (2021). Axillary adenopathy in patients with recent Covid-19 vaccination: a new diagnostic dilemma. Korean Journal of Radiology, 22(12), 2124. https://pubmed.ncbi.nlm.nih.gov/34825530/. | De Cristofaro, R., & Sanguinetti, M. (2021). Vaccine-induced thrombotic thrombocytopenia, a rare but severe case of friendly fire in the battle against COVID-19 pandemic: what pathogenesis?. European Journal of Internal Medicine. | https://www.sciencedirect.com/science/article/pii/S0953620521002314 | De Cristofaro, R., & Sanguinetti, M. (2021). Vaccine-induced thrombotic thrombocytopenia, a rare but severe case of friendly fire in the battle against COVID-19 pandemic: what pathogenesis?. European Journal of Internal Medicine. https://www.sciencedirect.com/science/article/pii/S0953620521002314 | Baker, A. T., Boyd, R. J., Sarkar, D., Teijeira-Crespo, A., Chan, C. K., Bates, E., ... & Borad, M. J. (2021). ChAdOx1 interacts with CAR and PF4 with implications for thrombosis with thrombocytopenia syndrome. Science advances, 7(49), eabl8213. https://www.science.org/doi/10.1126/sciadv.abl8213 | |||||
58 | Vaccine-induced thrombotic thrombocytopenia, a rare but severe case of friendly fire in the battle against the COVID-19 pandemic: What pathogenesis?: | https://www.sciencedirect.com/science/article/pii/S0953620521002314 | https://www.sciencedirect.com/science/article/pii/S0953620521002314 | De Cristofaro, R., & Sanguinetti, M. (2021). Vaccine-induced thrombotic thrombocytopenia, a rare but severe case of friendly fire in the battle against COVID-19 pandemic: what pathogenesis?. European Journal of Internal Medicine. | De Cristofaro, R. y Sanguinetti, M. (2021). Trombocitopenia trombótica inducida por vacunas, un caso raro pero grave de fuego amigo en la batalla contra la pandemia de COVID-19: ¿qué patogénesis?. Revista europea de medicina interna. https://www.sciencedirect.com/science/article/pii/S0213485321000839 | Ashrani, A. A., Crusan, D. J., Petterson, T., Bailey, K., & Heit, J. A. (2022). Incidencia específica de edad y sexo de trombosis sinusal venosa cerebral asociada con AD26. COV2. S covid-19 vacunación. Medicina interna de JAMA, 182 (1), 80-83. https://pubmed.ncbi.nlm.nih.gov/34839563/ | De Cristofaro, R., & Sanguinetti, M. (2021). Vaccine-induced thrombotic thrombocytopenia, a rare but severe case of friendly fire in the battle against COVID-19 pandemic: what pathogenesis?. European Journal of Internal Medicine. https://www.sciencedirect.com/science/article/pii/S0953620521002314 | Ashrani, A. A., Crusan, D. J., Petterson, T., Bailey, K., & Heit, J. A. (2022). Age-and sex-specific incidence of cerebral venous sinus thrombosis associated with Ad26. COV2. S COVID-19 vaccination. JAMA internal medicine, 182(1), 80-83. https://pubmed.ncbi.nlm.nih.gov/34724036/. | de trabajo multidisciplinar de FACME, G. (2021). Recomendaciones diagnóstico-terapéuticas del grupo de trabajo de expertos de FACME ad-hoc sobre el manejo de la trombosis venosa cerebral relacionada con la vacunación frente a COVID-19. Neurología, 36(6), 451-461. | https://www.sciencedirect.com/science/article/pii/S0213485321000839 | de trabajo multidisciplinar de FACME, G. (2021). Recomendaciones diagnóstico-terapéuticas del grupo de trabajo de expertos de FACME ad-hoc sobre el manejo de la trombosis venosa cerebral relacionada con la vacunación frente a COVID-19. Neurología, 36(6), 451-461. https://www.sciencedirect.com/science/article/pii/S0213485321000839 | Baldi, I., Azzolina, D., Francavilla, A., Bartolotta, P., Lorenzoni, G., Vanuzzo, D., & Gregori, D. (2021). Thrombotic Events after COVID-19 Vaccination in the Over-50s: Results from a Population-Based Study in Italy. Vaccines, 9(11), 1307. https://pubmed.ncbi.nlm.nih.gov/34835237/ | ||||
59 | Diagnostic-therapeutic recommendations of the ad-hoc FACME expert working group on the management of cerebral venous thrombosis related to COVID-19 vaccination: | https://www.sciencedirect.com/science/article/pii/S0213485321000839 | https://www.sciencedirect.com/science/article/pii/S0213485321000839 | de trabajo multidisciplinar de FACME, G. (2021). Recomendaciones diagnóstico-terapéuticas del grupo de trabajo de expertos de FACME ad-hoc sobre el manejo de la trombosis venosa cerebral relacionada con la vacunación frente a COVID-19. Neurología, 36(6), 451-461. | de trabajo multidisciplinar de FACME, G. (2021). Recomendaciones diagnóstico-terapéuticas del grupo de trabajo de expertos de FACME ad-hoc sobre el manejo de la trombosis venosa cerebral relacionada con la vacunación frente a COVID-19. Neurología, 36(6), 451-461. https://pubmed.ncbi.nlm.nih.gov/33918932/ | Asmat, H., Fayeye, F., Alshakaty, H., & Patel, J. (2021). Un caso raro de COVID-19 trombocitopa de trombocitopaenia inducida por la vacuna (VITT) que involucra la circulación arterial Veno-Splanicnic y pulmonar, de un hospital general del Distrito del Reino Unido. BMJ Case Reports CP, 14 (9), E244223. https://pubmed.ncbi.nlm.nih.gov/34527501/ | de trabajo multidisciplinar de FACME, G. (2021). Recomendaciones diagnóstico-terapéuticas del grupo de trabajo de expertos de FACME ad-hoc sobre el manejo de la trombosis venosa cerebral relacionada con la vacunación frente a COVID-19. Neurología, 36(6), 451-461. https://www.sciencedirect.com/science/article/pii/S0213485321000839 | Asmat, H., Fayeye, F., Alshakaty, H., & Patel, J. (2021). A rare case of COVID-19 vaccine-induced thrombotic thrombocytopaenia (VITT) involving the veno-splanchnic and pulmonary arterial circulation, from a UK district general hospital. BMJ Case Reports CP, 14(9), e244223. https://pubmed.ncbi.nlm.nih.gov/34535492/ | Wolf, M. E., Luz, B., Niehaus, L., Bhogal, P., Bäzner, H., & Henkes, H. (2021). Thrombocytopenia and intracranial venous sinus thrombosis after “COVID-19 vaccine AstraZeneca” exposure. Journal of clinical medicine, 10(8), 1599. | https://pubmed.ncbi.nlm.nih.gov/33918932/ | Wolf, M. E., Luz, B., Niehaus, L., Bhogal, P., Bäzner, H., & Henkes, H. (2021). Thrombocytopenia and intracranial venous sinus thrombosis after “COVID-19 vaccine AstraZeneca” exposure. Journal of clinical medicine, 10(8), 1599. https://pubmed.ncbi.nlm.nih.gov/33918932/ | Bandapaati, S., Bobba, H., & Navinan, M. R. (2021). Coeliac artery and splenic artery thrombosis complicated with splenic infarction 7 days following the first dose of Oxford vaccination, causal relationship or coincidence?. BMJ Case Reports CP, 14(7), e243799. https://pubmed.ncbi.nlm.nih.gov/34261633/. | ||||
60 | Thrombocytopenia and intracranial venous sinus thrombosis after exposure to the “AstraZeneca COVID-19 vaccine”: | https://pubmed.ncbi.nlm.nih.gov/33918932/ | https://pubmed.ncbi.nlm.nih.gov/33918932/ | Wolf, M. E., Luz, B., Niehaus, L., Bhogal, P., Bäzner, H., & Henkes, H. (2021). Thrombocytopenia and intracranial venous sinus thrombosis after “COVID-19 vaccine AstraZeneca” exposure. Journal of clinical medicine, 10(8), 1599. | Wolf, M. E., Luz, B., Niehaus, L., Bhogal, P., Bäzner, H. y Henkes, H. (2021). Trombocitopenia y trombosis del seno venoso intracraneal después de la exposición a la “vacuna COVID-19 AstraZeneca”. Revista de medicina clínica, 10(8), 1599. https://pubmed.ncbi.nlm.nih.gov/33606296/ | Asoor, A., Shephard, J., Lissidini, G., y Nicosia, L. (2021). Adenopatía axilar en pacientes con vacunación reciente de COVID-19: un nuevo dilema de diagnóstico. Diario coreano de radiología, 22 (12), 2124. https://pubmed.ncbi.nlm.nih.gov/34000278/ | Wolf, M. E., Luz, B., Niehaus, L., Bhogal, P., Bäzner, H., & Henkes, H. (2021). Thrombocytopenia and intracranial venous sinus thrombosis after “COVID-19 vaccine AstraZeneca” exposure. Journal of clinical medicine, 10(8), 1599. https://pubmed.ncbi.nlm.nih.gov/33918932/ | Aye, Y. N., Mai, A. S., Zhang, A., Lim, O. Z. H., Lin, N., Ng, C. H., ... & Chew, N. W. (2021). Acute myocardial infarction and myocarditis following COVID-19 vaccination. QJM: An International Journal of Medicine. https://pubmed.ncbi.nlm.nih.gov/34586408/ | Lee, E. J., Cines, D. B., Gernsheimer, T., Kessler, C., Michel, M., Tarantino, M. D., ... & Bussel, J. B. (2021). Thrombocytopenia following pfizer and Moderna SARS‐CoV‐2 vaccination. American journal of hematology. | https://pubmed.ncbi.nlm.nih.gov/33606296/ | Lee, E. J., Cines, D. B., Gernsheimer, T., Kessler, C., Michel, M., Tarantino, M. D., ... & Bussel, J. B. (2021). Thrombocytopenia following pfizer and Moderna SARS‐CoV‐2 vaccination. American journal of hematology. https://pubmed.ncbi.nlm.nih.gov/33606296/ | Banerjee, S., Sandhu, M., Tonzi, E., Tambe, A., & Gambhir, H. S. (2021). Immune-Mediated Thrombocytopenia Associated With Ad26. COV2. S (Janssen; Johnson & Johnson) Vaccine. American Journal of Therapeutics, 28(5), e604. https://pubmed.ncbi.nlm.nih.gov/34469919/. | ||||
61 | Thrombocytopenia following Pfizer and Moderna SARS-CoV-2 vaccination: | https://pubmed.ncbi.nlm.nih.gov/33606296/ | https://pubmed.ncbi.nlm.nih.gov/33606296/ | Lee, E. J., Cines, D. B., Gernsheimer, T., Kessler, C., Michel, M., Tarantino, M. D., ... & Bussel, J. B. (2021). Thrombocytopenia following pfizer and Moderna SARS‐CoV‐2 vaccination. American journal of hematology. | Lee, E. J., Cines, D. B., Gernsheimer, T., Kessler, C., Michel, M., Tarantino, M. D., ... & Bussel, J. B. (2021). Trombocitopenia después de la vacunación de Pfizer y Moderna contra el SARS-CoV-2. Revista americana de hematología. https://pubmed.ncbi.nlm.nih.gov/33854395/ | Aye, Y. N., Mai, A. S., Zhang, A., LIM, O. Z. H., Lin, N., NG, C. H., ... & MASTICO, N. W. (2021). Infarto de miocardio agudo y miocarditis después de la vacunación COVID-19. QJM: un Diario Internacional de Medicina. https://pubmed.ncbi.nlm.nih.gov/34539938/. | Lee, E. J., Cines, D. B., Gernsheimer, T., Kessler, C., Michel, M., Tarantino, M. D., ... & Bussel, J. B. (2021). Thrombocytopenia following pfizer and Moderna SARS‐CoV‐2 vaccination. American journal of hematology. https://pubmed.ncbi.nlm.nih.gov/33606296/ | Aye, Y. N., Mai, A. S., Zhang, A., Lim, O. Z. H., Lin, N., Ng, C. H., ... & Chew, N. W. (2021). Acute myocardial infarction and myocarditis following COVID-19 vaccination. QJM: An International Journal of Medicine. https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8522388/ | Helms, J. M., Ansteatt, K. T., Roberts, J. C., Kamatam, S., Foong, K. S., Labayog, J. M. S., & Tarantino, M. D. (2021). Severe, refractory immune thrombocytopenia occurring after SARS-CoV-2 vaccine. Journal of blood medicine, 12, 221. | https://pubmed.ncbi.nlm.nih.gov/33854395/ | Helms, J. M., Ansteatt, K. T., Roberts, J. C., Kamatam, S., Foong, K. S., Labayog, J. M. S., & Tarantino, M. D. (2021). Severe, refractory immune thrombocytopenia occurring after SARS-CoV-2 vaccine. Journal of blood medicine, 12, 221. https://pubmed.ncbi.nlm.nih.gov/33854395/ | Barda, N., Dagan, N., Ben-Shlomo, Y., Kepten, E., Waxman, J., Ohana, R., ... & Balicer, R. D. (2021). Safety of the BNT162b2 mRNA Covid-19 vaccine in a nationwide setting. New England Journal of Medicine. https://www.nejm.org/doi/full/10.1056/NEJMoa2110475 | ||||
62 | Severe and refractory immune thrombocytopenia occurring after SARS-CoV-2 vaccination: | https://pubmed.ncbi.nlm.nih.gov/33854395/ | https://pubmed.ncbi.nlm.nih.gov/33854395/ | Helms, J. M., Ansteatt, K. T., Roberts, J. C., Kamatam, S., Foong, K. S., Labayog, J. M. S., & Tarantino, M. D. (2021). Severe, refractory immune thrombocytopenia occurring after SARS-CoV-2 vaccine. Journal of blood medicine, 12, 221. | Helms, J. M., Ansteatt, K. T., Roberts, J. C., Kamatam, S., Foong, K. S., Labayog, J. M. S. y Tarantino, M. D. (2021). Trombocitopenia inmunitaria grave y refractaria que se produce después de la vacuna contra el SARS-CoV-2. Revista de medicina sanguínea, 12, 221. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7996471/ | Aye, Y. N., Mai, A. S., Zhang, A., LIM, O. Z. H., Lin, N., NG, C. H., ... & MASTICO, N. W. (2021). Infarto de miocardio agudo y miocarditis después de la vacunación COVID-19. QJM: un Diario Internacional de Medicina. https://www.ncbi.nlm.nih.gov/pubmed/34756746 | Helms, J. M., Ansteatt, K. T., Roberts, J. C., Kamatam, S., Foong, K. S., Labayog, J. M. S., & Tarantino, M. D. (2021). Severe, refractory immune thrombocytopenia occurring after SARS-CoV-2 vaccine. Journal of blood medicine, 12, 221. https://pubmed.ncbi.nlm.nih.gov/33854395/ | Aye, Y. N., Mai, A. S., Zhang, A., Lim, O. Z. H., Lin, N., Ng, C. H., ... & Chew, N. W. (2021). Acute myocardial infarction and myocarditis following COVID-19 vaccination. QJM: An International Journal of Medicine. https://www.ncbi.nlm.nih.gov/pubmed/34586408 | Malayala, S. V., Mohan, G., Vasireddy, D., & Atluri, P. (2021). Purpuric rash and thrombocytopenia after the mRNA-1273 (Moderna) COVID-19 vaccine. Cureus, 13(3). | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7996471/ | Malayala, S. V., Mohan, G., Vasireddy, D., & Atluri, P. (2021). Purpuric rash and thrombocytopenia after the mRNA-1273 (Moderna) COVID-19 vaccine. Cureus, 13(3). https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7996471/ | Bari, R., Bepari, A. K., & Reza, H. M. (2021). COVID-19: Lessons from Norway tragedy must be considered in vaccine rollout planning in least developed/developing countries. Open Medicine, 16(1), 1168-1169. https://pubmed.ncbi.nlm.nih.gov/34435142/ | ||||
63 | Purpuric rash and thrombocytopenia after mRNA-1273 (Modern) COVID-19 vaccine: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7996471/ | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7996471/ | Malayala, S. V., Mohan, G., Vasireddy, D., & Atluri, P. (2021). Purpuric rash and thrombocytopenia after the mRNA-1273 (Moderna) COVID-19 vaccine. Cureus, 13(3). | Malayala, SV, Mohan, G., Vasireddy, D. y Atluri, P. (2021). Erupción purpúrica y trombocitopenia después de la vacuna mRNA-1273 (Moderna) COVID-19. Cureus, 13(3). https://pubmed.ncbi.nlm.nih.gov/33863748/ | Aye, Y. N., Mai, A. S., Zhang, A., LIM, O. Z. H., Lin, N., NG, C. H., ... & MASTICO, N. W. (2021). Infarto de miocardio agudo y miocarditis después de la vacunación COVID-19. QJM: un Diario Internacional de Medicina. https://www.nejm.org/doi/10.1056/NEJMoa2110737 | Malayala, S. V., Mohan, G., Vasireddy, D., & Atluri, P. (2021). Purpuric rash and thrombocytopenia after the mRNA-1273 (Moderna) COVID-19 vaccine. Cureus, 13(3). https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7996471/ | Azir, M., Inman, B., Webb, J., & Tannenbaum, L. (2021). STEMI Mimic: Focal Myocarditis in an Adolescent Patient After mRNA COVID-19 Vaccine. The Journal of emergency medicine, 61(6), e129-e132. https://pubmed.ncbi.nlm.nih.gov/34756746/ | Smadja, D. M., Yue, Q. Y., Chocron, R., Sanchez, O., & Lillo-Le Louet, A. (2021). Vaccination against COVID-19: insight from arterial and venous thrombosis occurrence using data from VigiBase. European Respiratory Journal, 58(1). | https://pubmed.ncbi.nlm.nih.gov/33863748/ | Smadja, D. M., Yue, Q. Y., Chocron, R., Sanchez, O., & Lillo-Le Louet, A. (2021). Vaccination against COVID-19: insight from arterial and venous thrombosis occurrence using data from VigiBase. European Respiratory Journal, 58(1). https://pubmed.ncbi.nlm.nih.gov/33863748/ | Barral, M., Arrive, L., Mouhadi-Barnier, E., & Cornelis, F. H. (2021). Thromboaspiration and fibrinolysis infusion for portomesenteric thrombosis after AstraZeneca COVID-19 vaccine administration. Intensive Care Medicine, 47(9), 1034-1036. https://pubmed.ncbi.nlm.nih.gov/34132839/ | ||||
64 | COVID-19 vaccination: information on the occurrence of arterial and venous thrombosis using data from VigiBase: | https://pubmed.ncbi.nlm.nih.gov/33863748/ | https://pubmed.ncbi.nlm.nih.gov/33863748/ | Smadja, D. M., Yue, Q. Y., Chocron, R., Sanchez, O., & Lillo-Le Louet, A. (2021). Vaccination against COVID-19: insight from arterial and venous thrombosis occurrence using data from VigiBase. European Respiratory Journal, 58(1). | Smadja, D. M., Yue, Q. Y., Chocron, R., Sanchez, O. y Lillo-Le Louet, A. (2021). Vacunación contra COVID-19: información sobre la aparición de trombosis arterial y venosa utilizando datos de VigiBase. Revista respiratoria europea, 58 (1). https://onlinelibrary.wiley.com/doi/10.1002/ana.26172 | Azir, M., Inman, B., Webb, J., & Tannenbaum, L. (2021). STEMI MIMIC: miocarditis focal en un paciente adolescente después de la vacuna contra MRNA COVID-19. The Journal of Emergency Medicine, 61 (6), E129-E132. https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8587334/ | Smadja, D. M., Yue, Q. Y., Chocron, R., Sanchez, O., & Lillo-Le Louet, A. (2021). Vaccination against COVID-19: insight from arterial and venous thrombosis occurrence using data from VigiBase. European Respiratory Journal, 58(1). https://pubmed.ncbi.nlm.nih.gov/33863748/ | Azir, M., Inman, B., Webb, J., & Tannenbaum, L. (2021). STEMI Mimic: Focal Myocarditis in an Adolescent Patient After mRNA COVID-19 Vaccine. The Journal of emergency medicine, 61(6), e129-e132. https://www.ncbi.nlm.nih.gov/pubmed/34756746 | Schulz, J. B., Berlit, P., Diener, H. C., Gerloff, C., Greinacher, A., Klein, C., ... & Zimmermann, J. (2021). COVID‐19 vaccine‐associated cerebral venous thrombosis in Germany. Annals of neurology, 90(4), 627-639. | https://onlinelibrary.wiley.com/doi/10.1002/ana.26172 | Schulz, J. B., Berlit, P., Diener, H. C., Gerloff, C., Greinacher, A., Klein, C., ... & Zimmermann, J. (2021). COVID‐19 vaccine‐associated cerebral venous thrombosis in Germany. Annals of neurology, 90(4), 627-639. https://onlinelibrary.wiley.com/doi/10.1002/ana.26172 | Barsha, S. Y., Haque, M. M. A., Rashid, M. U., Rahman, M. L., Hossain, M. A., Zaman, S., ... & Hawlader, M. D. H. (2021). A case of acute encephalopathy and non-ST segment elevation myocardial infarction following mRNA-1273 vaccination: possible adverse effect?. Clinical and experimental vaccine research, 10(3), 293. https://pubmed.ncbi.nlm.nih.gov/34703815/ | ||||
65 | Cerebral venous thrombosis associated with the covid-19 vaccine in Germany: | https://onlinelibrary.wiley.com/doi/10.1002/ana.26172 | https://onlinelibrary.wiley.com/doi/10.1002/ana.26172 | Schulz, J. B., Berlit, P., Diener, H. C., Gerloff, C., Greinacher, A., Klein, C., ... & Zimmermann, J. (2021). COVID‐19 vaccine‐associated cerebral venous thrombosis in Germany. Annals of neurology, 90(4), 627-639. | Schulz, J. B., Berlit, P., Diener, H. C., Gerloff, C., Greinacher, A., Klein, C., ... y Zimmermann, J. (2021). Trombosis venosa cerebral asociada a la vacuna COVID-19 en Alemania. Anales de neurología, 90(4), 627-639. https://pubmed.ncbi.nlm.nih.gov/34133027/ | Azir, M., Inman, B., Webb, J., & Tannenbaum, L. (2021). STEMI MIMIC: miocarditis focal en un paciente adolescente después de la vacuna contra MRNA COVID-19. The Journal of Emergency Medicine, 61 (6), E129-E132. https://www.ncbi.nlm.nih.gov/pubmed/34432976 | Schulz, J. B., Berlit, P., Diener, H. C., Gerloff, C., Greinacher, A., Klein, C., ... & Zimmermann, J. (2021). COVID‐19 vaccine‐associated cerebral venous thrombosis in Germany. Annals of neurology, 90(4), 627-639. https://onlinelibrary.wiley.com/doi/10.1002/ana.26172 | Badier, L., Toledano, A., Porel, T., Dumond, S., Jouglen, J., Sailler, L., ... & Lafaurie, M. (2021). IgA vasculitis in adult patient following vaccination by ChadOx1 nCoV-19. Autoimmunity reviews. https://pubmed.ncbi.nlm.nih.gov/34509658/ | Fan, B. E., Shen, J. Y., Lim, X. R., Tu, T. M., Chang, C. C. R., Khin, H. S. W., ... & Prasad, B. M. R. V. (2021). Cerebral venous thrombosis post BNT162b2 mRNA SARS‐CoV‐2 vaccination: A black swan event. American Journal of Hematology, 96(9), E357. | https://pubmed.ncbi.nlm.nih.gov/34133027/ | Fan, B. E., Shen, J. Y., Lim, X. R., Tu, T. M., Chang, C. C. R., Khin, H. S. W., ... & Prasad, B. M. R. V. (2021). Cerebral venous thrombosis post BNT162b2 mRNA SARS‐CoV‐2 vaccination: A black swan event. American Journal of Hematology, 96(9), E357. https://pubmed.ncbi.nlm.nih.gov/34133027/ | Bayas, A., Menacher, M., Christ, M., Behrens, L., Rank, A., & Naumann, M. (2021). Bilateral superior ophthalmic vein thrombosis, ischaemic stroke, and immune thrombocytopenia after ChAdOx1 nCoV-19 vaccination. The Lancet, 397(10285), e11. https://pubmed.ncbi.nlm.nih.gov/33864750/ | ||||
66 | Cerebral venous thrombosis following BNT162b2 mRNA vaccination of BNT162b2 against SARS-CoV-2: a black swan event: | https://pubmed.ncbi.nlm.nih.gov/34133027/ | https://pubmed.ncbi.nlm.nih.gov/34133027/ | Fan, B. E., Shen, J. Y., Lim, X. R., Tu, T. M., Chang, C. C. R., Khin, H. S. W., ... & Prasad, B. M. R. V. (2021). Cerebral venous thrombosis post BNT162b2 mRNA SARS‐CoV‐2 vaccination: A black swan event. American Journal of Hematology, 96(9), E357. | Fan, B. E., Shen, J. Y., Lim, X. R., Tu, T. M., Chang, C. C. R., Khin, H. S. W., ... y Prasad, B. M. R. V. (2021). Trombosis venosa cerebral después de la vacunación con ARNm BNT162b2 SARS-CoV-2: un evento de cisne negro. Revista Estadounidense de Hematología, 96(9), E357. https://pubmed.ncbi.nlm.nih.gov/34001390/ | Badier, L., Toledano, A., Porel, T., Dumond, S., Jouglen, J., Siller, L., ... & lafaurie, M. (2021). Vasculitis IGA en paciente adulto después de la vacunación por Chadox1 NCOV-19. Reviews de autoinmunidad. https://pubmed.ncbi.nlm.nih.gov/34196469/. | Fan, B. E., Shen, J. Y., Lim, X. R., Tu, T. M., Chang, C. C. R., Khin, H. S. W., ... & Prasad, B. M. R. V. (2021). Cerebral venous thrombosis post BNT162b2 mRNA SARS‐CoV‐2 vaccination: A black swan event. American Journal of Hematology, 96(9), E357. https://pubmed.ncbi.nlm.nih.gov/34133027/ | Badoiu, A., Moranne, O., Coudray, S., & Ion, I. M. (2021). Clinical Variant of Guillain–Barre Syndrome With Prominent Facial Diplegia After AstraZeneca Coronavirus Disease 2019 Vaccine. Journal of Clinical Neuromuscular Disease, 23(2), 115-116. https://pubmed.ncbi.nlm.nih.gov/34808658/ | Ciccone, A., & Zanotti, B. (2021). The importance of recognizing cerebral venous thrombosis following anti-COVID-19 vaccination. European Journal of Internal Medicine, 89, 115-117. | https://pubmed.ncbi.nlm.nih.gov/34001390/ | Ciccone, A., & Zanotti, B. (2021). The importance of recognizing cerebral venous thrombosis following anti-COVID-19 vaccination. European Journal of Internal Medicine, 89, 115-117. https://pubmed.ncbi.nlm.nih.gov/34001390/ | Bencharattanaphakhi, R., & Rerknimitr, P. (2021). Sinovac COVID-19 vaccine–induced cutaneous leukocytoclastic vasculitis. JAAD case reports, 18, 1-3. https://pubmed.ncbi.nlm.nih.gov/34660867/. | ||||
67 | The importance of recognizing cerebral venous thrombosis following anti-COVID-19 vaccination: | https://pubmed.ncbi.nlm.nih.gov/34001390/ | https://pubmed.ncbi.nlm.nih.gov/34001390/ | Ciccone, A., & Zanotti, B. (2021). The importance of recognizing cerebral venous thrombosis following anti-COVID-19 vaccination. European Journal of Internal Medicine, 89, 115-117. | Ciccone, A. y Zanotti, B. (2021). La importancia de reconocer la trombosis venosa cerebral tras la vacunación anti-COVID-19. Revista europea de medicina interna, 89, 115-117. https://pubmed.ncbi.nlm.nih.gov/34181446/ | Badoiu, A., Moranne, O., Coudes, S., & Ion, I. M. (2021). Variante clínica del síndrome de Guillain-Barre con diplegia facial prominente después de la enfermedad de la enfermedad de AstraZeneca Coronavirus 2019. Diario de la enfermedad neuromuscular clínica, 23 (2), 115-116. https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(21)00646-0/fulltext. | Ciccone, A., & Zanotti, B. (2021). The importance of recognizing cerebral venous thrombosis following anti-COVID-19 vaccination. European Journal of Internal Medicine, 89, 115-117. https://pubmed.ncbi.nlm.nih.gov/34001390/ | Baker, A. T., Boyd, R. J., Sarkar, D., Teijeira-Crespo, A., Chan, C. K., Bates, E., ... & Borad, M. J. (2021). ChAdOx1 interacts with CAR and PF4 with implications for thrombosis with thrombocytopenia syndrome. Science advances, 7(49), eabl8213. https://www.science.org/doi/10.1126/sciadv.abl8213 | Sangli, S., Virani, A., Cheronis, N., Vannatter, B., Minich, C., Noronha, S., ... & Kaplan, R. B. (2021). Thrombosis with thrombocytopenia after the messenger RNA–1273 vaccine. Annals of internal medicine, 174(8), 1480-1482. | https://pubmed.ncbi.nlm.nih.gov/34181446/ | Sangli, S., Virani, A., Cheronis, N., Vannatter, B., Minich, C., Noronha, S., ... & Kaplan, R. B. (2021). Thrombosis with thrombocytopenia after the messenger RNA–1273 vaccine. Annals of internal medicine, 174(8), 1480-1482. https://pubmed.ncbi.nlm.nih.gov/34181446/ | Bennett, C., Chambers, L. M., Son, J., & Goje, O. (2021). Newly diagnosed immune thrombocytopenia in a pregnant patient after coronavirus disease 2019 vaccination. Journal of Obstetrics and Gynaecology Research, 47(11), 4077-4080. https://pubmed.ncbi.nlm.nih.gov/34420249/ | ||||
68 | Thrombosis with thrombocytopenia after messenger RNA vaccine -1273: | https://pubmed.ncbi.nlm.nih.gov/34181446/ | https://pubmed.ncbi.nlm.nih.gov/34181446/ | Sangli, S., Virani, A., Cheronis, N., Vannatter, B., Minich, C., Noronha, S., ... & Kaplan, R. B. (2021). Thrombosis with thrombocytopenia after the messenger RNA–1273 vaccine. Annals of internal medicine, 174(8), 1480-1482. | Sangli, S., Virani, A., Cheronis, N., Vannatter, B., Minich, C., Noronha, S., ... y Kaplan, R. B. (2021). Trombosis con trombocitopenia tras la vacuna ARN mensajero-1273. Anales de medicina interna, 174(8), 1480-1482. https://pubmed.ncbi.nlm.nih.gov/34174723/ | Baker, A. T., Boyd, R. J., Sarkar, D., Teijeira-Crespo, A., Chan, C. K., Bates, E., ... y Borad, M. J. (2021). El chadox1 interactúa con el automóvil y la PF4 con implicaciones para la trombosis con el síndrome de trombocitopenia. Avances de ciencias, 7 (49), EABL8213. https://pubmed.ncbi.nlm.nih.gov/34626338/ | Sangli, S., Virani, A., Cheronis, N., Vannatter, B., Minich, C., Noronha, S., ... & Kaplan, R. B. (2021). Thrombosis with thrombocytopenia after the messenger RNA–1273 vaccine. Annals of internal medicine, 174(8), 1480-1482. https://pubmed.ncbi.nlm.nih.gov/34181446/ | Baldi, I., Azzolina, D., Francavilla, A., Bartolotta, P., Lorenzoni, G., Vanuzzo, D., & Gregori, D. (2021). Thrombotic Events after COVID-19 Vaccination in the Over-50s: Results from a Population-Based Study in Italy. Vaccines, 9(11), 1307. https://pubmed.ncbi.nlm.nih.gov/34835237/ | Simpson, C. R., Shi, T., Vasileiou, E., Katikireddi, S. V., Kerr, S., Moore, E., ... & Sheikh, A. (2021). First-dose ChAdOx1 and BNT162b2 COVID-19 vaccines and thrombocytopenic, thromboembolic and hemorrhagic events in Scotland. Nature medicine, 27(7), 1290-1297. | https://www.nature.com/articles/s41591-021-01408-4 | Simpson, C. R., Shi, T., Vasileiou, E., Katikireddi, S. V., Kerr, S., Moore, E., ... & Sheikh, A. (2021). First-dose ChAdOx1 and BNT162b2 COVID-19 vaccines and thrombocytopenic, thromboembolic and hemorrhagic events in Scotland. Nature medicine, 27(7), 1290-1297. https://www.nature.com/articles/s41591-021-01408-4 | Berry, C. T., Eliliwi, M., Gallagher, S., Panaccione, S., Klein, W. M., Healy, A. L., ... & Kallas, R. (2021). Cutaneous small vessel vasculitis following single-dose Janssen Ad26. COV2. S vaccination. JAAD Case Reports, 15, 11-14. https://pubmed.ncbi.nlm.nih.gov/34337124/ | ||||
69 | Blood clots and bleeding after BNT162b2 and ChAdOx1 nCoV-19 vaccination: an analysis of European data: | https://pubmed.ncbi.nlm.nih.gov/34174723/ | https://pubmed.ncbi.nlm.nih.gov/34174723/ | Cari, L., Fiore, P., Alhosseini, M. N., Sava, G., & Nocentini, G. (2021). Blood clots and bleeding events following BNT162b2 and ChAdOx1 nCoV-19 vaccine: An analysis of European data. Journal of autoimmunity, 122, 102685. | Cari, L., Fiore, P., Alhosseini, M. N., Sava, G. y Nocentini, G. (2021). Coágulos de sangre y eventos hemorrágicos después de la vacuna BNT162b2 y ChAdOx1 nCoV-19: un análisis de datos europeos. Revista de autoinmunidad, 122, 102685. https://www.nature.com/articles/s41591-021-01408-4 | Baldi, I., Azzolina, D., Francavilla, A., Bartolotta, P., Lorenzoni, G., Vanuzzo, D., & Gregori, D. (2021). Eventos trombóticos Después de la vacunación de COVID-19 en los más de 50 años: resultados de un estudio basado en la población en Italia. Vacunas, 9 (11), 1307. https://pubmed.ncbi.nlm.nih.gov/34724036/. | Cari, L., Fiore, P., Alhosseini, M. N., Sava, G., & Nocentini, G. (2021). Blood clots and bleeding events following BNT162b2 and ChAdOx1 nCoV-19 vaccine: An analysis of European data. Journal of autoimmunity, 122, 102685. https://pubmed.ncbi.nlm.nih.gov/34174723/ | Bandapaati, S., Bobba, H., & Navinan, M. R. (2021). Coeliac artery and splenic artery thrombosis complicated with splenic infarction 7 days following the first dose of Oxford vaccination, causal relationship or coincidence?. BMJ Case Reports CP, 14(7), e243799. https://pubmed.ncbi.nlm.nih.gov/34261633/. | Kuter, D. J. (2021). Exacerbation of immune thrombocytopenia following COVID‐19 vaccination. British journal of haematology, 195(3), 365-370. | https://pubmed.ncbi.nlm.nih.gov/34075578/ | Kuter, D. J. (2021). Exacerbation of immune thrombocytopenia following COVID‐19 vaccination. British journal of haematology, 195(3), 365-370. https://pubmed.ncbi.nlm.nih.gov/34075578/ | Berto, M. B., Spano, G., Wagner, B., Bernhard, B., Häner, J., Huber, A. T., & Gräni, C. (2021). Takotsubo cardiomyopathy after mRNA COVID-19 vaccination. Heart, Lung and Circulation, 30(12), e119-e120. https://www.sciencedirect.com/science/article/pii/S1443950621011331 | ||||
70 | First dose of ChAdOx1 and BNT162b2 COVID-19 vaccines and thrombocytopenic, thromboembolic, and hemorrhagic events in Scotland: | https://www.nature.com/articles/s41591-021-01408-4 | https://www.nature.com/articles/s41591-021-01408-4 | Simpson, C. R., Shi, T., Vasileiou, E., Katikireddi, S. V., Kerr, S., Moore, E., ... & Sheikh, A. (2021). First-dose ChAdOx1 and BNT162b2 COVID-19 vaccines and thrombocytopenic, thromboembolic and hemorrhagic events in Scotland. Nature medicine, 27(7), 1290-1297. | Simpson, C. R., Shi, T., Vasileiou, E., Katikireddi, S. V., Kerr, S., Moore, E., ... y Sheikh, A. (2021). Primera dosis de vacunas ChAdOx1 y BNT162b2 COVID-19 y eventos trombocitopénicos, tromboembólicos y hemorrágicos en Escocia. Medicina natural, 27(7), 1290-1297. https://pubmed.ncbi.nlm.nih.gov/34075578/ | Bandapaati, S., Bobba, H., & Navinan, M. R. (2021). Arteria celíaca y trombosis arterial esplénica complicados con infarto esplénico 7 días después de la primera dosis de vacunación por Oxford, relación causal o coincidencia. BMJ Case Reports CP, 14 (7), E243799. https://pubmed.ncbi.nlm.nih.gov/34332437/. | Simpson, C. R., Shi, T., Vasileiou, E., Katikireddi, S. V., Kerr, S., Moore, E., ... & Sheikh, A. (2021). First-dose ChAdOx1 and BNT162b2 COVID-19 vaccines and thrombocytopenic, thromboembolic and hemorrhagic events in Scotland. Nature medicine, 27(7), 1290-1297. https://www.nature.com/articles/s41591-021-01408-4 | Banerjee, S., Sandhu, M., Tonzi, E., Tambe, A., & Gambhir, H. S. (2021). Immune-Mediated Thrombocytopenia Associated With Ad26. COV2. S (Janssen; Johnson & Johnson) Vaccine. American Journal of Therapeutics, 28(5), e604. https://pubmed.ncbi.nlm.nih.gov/34469919/. | de Bruijn, S., Maes, M. B., De Waele, L., Vanhoorelbeke, K., & Gadisseur, A. (2021). First report of a de novo iTTP episode associated with an mRNA‐based anti‐COVID‐19 vaccination. Journal of Thrombosis and Haemostasis, 19(8), 2014-2018. | https://pubmed.ncbi.nlm.nih.gov/34105244/ | de Bruijn, S., Maes, M. B., De Waele, L., Vanhoorelbeke, K., & Gadisseur, A. (2021). First report of a de novo iTTP episode associated with an mRNA‐based anti‐COVID‐19 vaccination. Journal of Thrombosis and Haemostasis, 19(8), 2014-2018. https://pubmed.ncbi.nlm.nih.gov/34105244/ | Bhan, C., Bheesham, N., Shakuntulla, F., Sharma, M., Sun, C., & Weinstein, M. (2021). An unusual presentation of acute deep vein thrombosis after the Moderna COVID-19 vaccine—a case report. Annals of Translational Medicine, 9(20). https://pubmed.ncbi.nlm.nih.gov/34790811/ | ||||
71 | Exacerbation of immune thrombocytopenia after COVID-19 vaccination: | https://pubmed.ncbi.nlm.nih.gov/34075578/ | https://pubmed.ncbi.nlm.nih.gov/34075578/ | Kuter, D. J. (2021). Exacerbation of immune thrombocytopenia following COVID‐19 vaccination. British journal of haematology, 195(3), 365-370. | Kuter, DJ (2021). Exacerbación de la trombocitopenia inmunitaria tras la vacunación contra la COVID-19. Revista británica de hematología, 195(3), 365-370. https://pubmed.ncbi.nlm.nih.gov/34105244/ | BANERJEE, S., SANDHU, M., Tonzi, E., Tambe, A., & Gambhir, H. S. (2021). Trombocitopenia inmune-mediada asociada con AD26. COV2. S (Janssen; Johnson & Johnson) vacuna. American Journal of Therapeutics, 28 (5), E604. https://pubmed.ncbi.nlm.nih.gov/34516272/. | Kuter, D. J. (2021). Exacerbation of immune thrombocytopenia following COVID‐19 vaccination. British journal of haematology, 195(3), 365-370. https://pubmed.ncbi.nlm.nih.gov/34075578/ | Barda, N., Dagan, N., Ben-Shlomo, Y., Kepten, E., Waxman, J., Ohana, R., ... & Balicer, R. D. (2021). Safety of the BNT162b2 mRNA Covid-19 vaccine in a nationwide setting. New England Journal of Medicine. https://www.ncbi.nlm.nih.gov/pubmed/34432976 | Vayne, C., Rollin, J., Gruel, Y., Pouplard, C., Galinat, H., Huet, O., ... & Susen, S. (2021). PF4 immunoassays in vaccine-induced thrombotic thrombocytopenia. New England Journal of Medicine, 385(4), 376-378. | https://www.nejm.org/doi/full/10.1056/NEJMc2106383 | Vayne, C., Rollin, J., Gruel, Y., Pouplard, C., Galinat, H., Huet, O., ... & Susen, S. (2021). PF4 immunoassays in vaccine-induced thrombotic thrombocytopenia. New England Journal of Medicine, 385(4), 376-378. https://www.nejm.org/doi/full/10.1056/NEJMc2106383 | Bhandari, M., Pradhan, A., Vishwakarma, P., & Sethi, R. (2021). Coronavirus and cardiovascular manifestations-getting to the heart of the matter. World Journal of Cardiology, 13(10), 556. https://www.ncbi.nlm.nih.gov/pubmed/34754400 | ||||
72 | First report of a de novo iTTP episode associated with a COVID-19 mRNA-based anti-COVID-19 vaccine: | https://pubmed.ncbi.nlm.nih.gov/34105244/ | https://pubmed.ncbi.nlm.nih.gov/34105244/ | de Bruijn, S., Maes, M. B., De Waele, L., Vanhoorelbeke, K., & Gadisseur, A. (2021). First report of a de novo iTTP episode associated with an mRNA‐based anti‐COVID‐19 vaccination. Journal of Thrombosis and Haemostasis, 19(8), 2014-2018. | de Bruijn, S., Maes, MB, De Waele, L., Vanhoorelbeke, K. y Gadisseur, A. (2021). Primer informe de un episodio de iTTP de novo asociado con una vacunación anti-COVID-19 basada en ARNm. Revista de Trombosis y Hemostasia, 19(8), 2014-2018. https://www.nejm.org/doi/full/10.1056/NEJMc2106383 | Barda, N., Dagan, N., Ben-Shlomo, Y., SAYEN, E., WAXMAN, J., OHANA, R., ... & BALIRER, R. D. (2021). Seguridad de la vacuna contra la COVID-19 de MRNA BNT162B2 en un entorno nacional. New England Journal of Medicine. https://www.ncbi.nlm.nih.gov/pubmed/34754400 | de Bruijn, S., Maes, M. B., De Waele, L., Vanhoorelbeke, K., & Gadisseur, A. (2021). First report of a de novo iTTP episode associated with an mRNA‐based anti‐COVID‐19 vaccination. Journal of Thrombosis and Haemostasis, 19(8), 2014-2018. https://pubmed.ncbi.nlm.nih.gov/34105244/ | Barda, N., Dagan, N., Ben-Shlomo, Y., Kepten, E., Waxman, J., Ohana, R., ... & Balicer, R. D. (2021). Safety of the BNT162b2 mRNA Covid-19 vaccine in a nationwide setting. New England Journal of Medicine. https://www.nejm.org/doi/full/10.1056/NEJMoa2110475 | Huynh, A., Kelton, J. G., Arnold, D. M., Daka, M., & Nazy, I. (2021). Antibody epitopes in vaccine-induced immune thrombotic thrombocytopaenia. Nature, 596(7873), 565-569. | https://www.nature.com/articles/s41586-021-03744-4 | Huynh, A., Kelton, J. G., Arnold, D. M., Daka, M., & Nazy, I. (2021). Antibody epitopes in vaccine-induced immune thrombotic thrombocytopaenia. Nature, 596(7873), 565-569. https://www.nature.com/articles/s41586-021-03744-4 | Bikdeli, B., Chatterjee, S., Arora, S., Monreal, M., Jimenez, D., Krumholz, H. M., ... & Piazza, G. (2021). Cerebral venous sinus thrombosis in the US population, after adenovirus-based SARS-CoV-2 vaccination, and after COVID-19. Journal of the American College of Cardiology, 78(4), 408-411. https://www.sciencedirect.com/science/article/pii/S0735109721051949 | ||||
73 | PF4 immunoassays in vaccine-induced thrombotic thrombocytopenia: | https://www.nejm.org/doi/full/10.1056/NEJMc2106383 | https://www.nejm.org/doi/full/10.1056/NEJMc2106383 | Vayne, C., Rollin, J., Gruel, Y., Pouplard, C., Galinat, H., Huet, O., ... & Susen, S. (2021). PF4 immunoassays in vaccine-induced thrombotic thrombocytopenia. New England Journal of Medicine, 385(4), 376-378. | Vayne, C., Rollin, J., Gruel, Y., Pouplard, C., Galinat, H., Huet, O., ... y Susen, S. (2021). Inmunoensayos de PF4 en trombocitopenia trombótica inducida por vacunas. Revista de Medicina de Nueva Inglaterra, 385(4), 376-378. https://www.nature.com/articles/s41586-021-03744-4 | Barda, N., Dagan, N., Ben-Shlomo, Y., SAYEN, E., WAXMAN, J., OHANA, R., ... & BALIRER, R. D. (2021). Seguridad de la vacuna contra la COVID-19 de MRNA BNT162B2 en un entorno nacional. New England Journal of Medicine. https://www.sciencedirect.com/science/article/pii/S1201971221007797 | Vayne, C., Rollin, J., Gruel, Y., Pouplard, C., Galinat, H., Huet, O., ... & Susen, S. (2021). PF4 immunoassays in vaccine-induced thrombotic thrombocytopenia. New England Journal of Medicine, 385(4), 376-378. https://www.nejm.org/doi/full/10.1056/NEJMc2106383 | Bari, R., Bepari, A. K., & Reza, H. M. (2021). COVID-19: Lessons from Norway tragedy must be considered in vaccine rollout planning in least developed/developing countries. Open Medicine, 16(1), 1168-1169. https://pubmed.ncbi.nlm.nih.gov/34435142/ | Bozkurt, B., Kamat, I., & Hotez, P. J. (2021). Myocarditis with COVID-19 mRNA vaccines. Circulation, 144(6), 471-484. | https://www.ahajournals.org/doi/pdf/10.1161/CIRCULATIONAHA.121.056135 | Bozkurt, B., Kamat, I., & Hotez, P. J. (2021). Myocarditis with COVID-19 mRNA vaccines. Circulation, 144(6), 471-484. https://www.ahajournals.org/doi/pdf/10.1161/CIRCULATIONAHA.121.056135 | Bjørnstad-Tuveng, T. H., Rudjord, A., & Anker, P. (2021). Fatal cerebral haemorrhage after COVID-19 vaccine. Tidsskrift for Den norske legeforening. https://pubmed.ncbi.nlm.nih.gov/33928772/ | ||||
74 | Antibody epitopes in vaccine-induced immune immune thrombotic thrombocytopenia: | https://www.nature.com/articles/s41586-021-03744-4 | https://www.nature.com/articles/s41586-021-03744-4 | Huynh, A., Kelton, J. G., Arnold, D. M., Daka, M., & Nazy, I. (2021). Antibody epitopes in vaccine-induced immune thrombotic thrombocytopaenia. Nature, 596(7873), 565-569. | Huynh, A., Kelton, JG, Arnold, D. M., Daka, M. y Nazy, I. (2021). Epítopos de anticuerpos en la trombocitopenia trombótica inmunitaria inducida por vacunas. Naturaleza, 596(7873), 565-569. https://www.ahajournals.org/doi/pdf/10.1161/CIRCULATIONAHA.121.056135 | Bari, R., BePari, A. K., & Reza, H. M. (2021). COVID-19: Las lecciones de la tragedia de Noruega deben considerarse en la planificación del despliegue de vacunas en los países menos desarrollados / en desarrollo. Medicina abierta, 16 (1), 1168-1169. https://pubmed.ncbi.nlm.nih.gov/34429981/ | Huynh, A., Kelton, J. G., Arnold, D. M., Daka, M., & Nazy, I. (2021). Antibody epitopes in vaccine-induced immune thrombotic thrombocytopaenia. Nature, 596(7873), 565-569. https://www.nature.com/articles/s41586-021-03744-4 | Barral, M., Arrive, L., Mouhadi-Barnier, E., & Cornelis, F. H. (2021). Thromboaspiration and fibrinolysis infusion for portomesenteric thrombosis after AstraZeneca COVID-19 vaccine administration. Intensive Care Medicine, 47(9), 1034-1036. https://pubmed.ncbi.nlm.nih.gov/34132839/ | Diaz, G. A., Parsons, G. T., Gering, S. K., Meier, A. R., Hutchinson, I. V., & Robicsek, A. (2021). Myocarditis and pericarditis after vaccination for COVID-19. Jama, 326(12), 1210-1212. | https://jamanetwork.com/journals/jama/fullarticle/2782900 | Diaz, G. A., Parsons, G. T., Gering, S. K., Meier, A. R., Hutchinson, I. V., & Robicsek, A. (2021). Myocarditis and pericarditis after vaccination for COVID-19. Jama, 326(12), 1210-1212. https://jamanetwork.com/journals/jama/fullarticle/2782900 | Blauenfeldt, R. A., Kristensen, S. R., Ernstsen, S. L., Kristensen, C. C. H., Simonsen, C. Z., & Hvas, A. M. (2021). Thrombocytopenia with acute ischemic stroke and bleeding in a patient newly vaccinated with an adenoviral vector‐based COVID‐19 vaccine. Journal of Thrombosis and Haemostasis, 19(7), 1771-1775. https://pubmed.ncbi.nlm.nih.gov/33877737/ | ||||
75 | Myocarditis with COVID-19 mRNA vaccines: | https://www.ahajournals.org/doi/pdf/10.1161/CIRCULATIONAHA.121.056135 | https://www.ahajournals.org/doi/pdf/10.1161/CIRCULATIONAHA.121.056135 | Bozkurt, B., Kamat, I., & Hotez, P. J. (2021). Myocarditis with COVID-19 mRNA vaccines. Circulation, 144(6), 471-484. | Bozkurt, B., Kamat, I. y Hotez, PJ (2021). Miocarditis con vacunas de ARNm de COVID-19. Circulación, 144(6), 471-484. https://jamanetwork.com/journals/jama/fullarticle/2782900 | Barral, M., Llegue, L., Mouhadi-Barnier, E., Y Cornelis, F. H. (2021). La infusión de tromboaspiración y fibrinolisis para la trombosis portomesentérica después de la administración de la vacuna contra AstraZeneca COVID-19. Medicina de cuidados intensivos, 47 (9), 1034-1036. https://pubmed.ncbi.nlm.nih.gov/34117206/ | Bozkurt, B., Kamat, I., & Hotez, P. J. (2021). Myocarditis with COVID-19 mRNA vaccines. Circulation, 144(6), 471-484. https://www.ahajournals.org/doi/pdf/10.1161/CIRCULATIONAHA.121.056135 | Barral, M., Arrive, L., Mouhadi-Barnier, E., & Cornelis, F. H. (2021). Thromboaspiration and fibrinolysis infusion for portomesenteric thrombosis after AstraZeneca COVID-19 vaccine administration. Intensive Care Medicine, 47(9), 1034-1036. https://pubmed.ncbi.nlm.nih.gov/34132839/. | Rosner, C. M., Genovese, L., Tehrani, B. N., Atkins, M., Bakhshi, H., Chaudhri, S., ... & Defilippi, C. R. (2021). Myocarditis temporally associated with COVID-19 vaccination. Circulation, 144(6), 502-505. | https://www.ahajournals.org/doi/pdf/10.1161/CIRCULATIONAHA.121.055891. | Rosner, C. M., Genovese, L., Tehrani, B. N., Atkins, M., Bakhshi, H., Chaudhri, S., ... & Defilippi, C. R. (2021). Myocarditis temporally associated with COVID-19 vaccination. Circulation, 144(6), 502-505. https://www.ahajournals.org/doi/pdf/10.1161/CIRCULATIONAHA.121.055891. | Blumenthal, K. G., Robinson, L. B., Camargo, C. A., Shenoy, E. S., Banerji, A., Landman, A. B., & Wickner, P. (2021). Acute allergic reactions to mRNA COVID-19 vaccines. Jama, 325(15), 1562-1565. https://pubmed.ncbi.nlm.nih.gov/33683290/ | ||||
76 | Myocarditis and pericarditis after COVID-19 vaccination: | https://jamanetwork.com/journals/jama/fullarticle/2782900 | https://jamanetwork.com/journals/jama/fullarticle/2782900 | Diaz, G. A., Parsons, G. T., Gering, S. K., Meier, A. R., Hutchinson, I. V., & Robicsek, A. (2021). Myocarditis and pericarditis after vaccination for COVID-19. Jama, 326(12), 1210-1212. | Diaz, G. A., Parsons, G. T., Gering, S. K., Meier, A. R., Hutchinson, I. V. y Robicsek, A. (2021). Miocarditis y pericarditis tras la vacunación contra COVID-19. Jama, 326(12), 1210-1212. https://www.ahajournals.org/doi/pdf/10.1161/CIRCULATIONAHA.121.055891. | Barral, M., Llegue, L., Mouhadi-Barnier, E., Y Cornelis, F. H. (2021). La infusión de tromboaspiración y fibrinolisis para la trombosis portomesentérica después de la administración de la vacuna contra AstraZeneca COVID-19. Medicina de cuidados intensivos, 47 (9), 1034-1036. https://pubmed.ncbi.nlm.nih.gov/34144250/ | Diaz, G. A., Parsons, G. T., Gering, S. K., Meier, A. R., Hutchinson, I. V., & Robicsek, A. (2021). Myocarditis and pericarditis after vaccination for COVID-19. Jama, 326(12), 1210-1212. https://jamanetwork.com/journals/jama/fullarticle/2782900 | Barsha, S. Y., Haque, M. M. A., Rashid, M. U., Rahman, M. L., Hossain, M. A., Zaman, S., ... & Hawlader, M. D. H. (2021). A case of acute encephalopathy and non-ST segment elevation myocardial infarction following mRNA-1273 vaccination: possible adverse effect?. Clinical and experimental vaccine research, 10(3), 293. https://pubmed.ncbi.nlm.nih.gov/34703815/ | García, B., Ortega, P., JA, B. F., León, C., Burgos, R., & Dorta, C. (2021). Acute myocarditis after administration of the BNT162b2 vaccine against COVID-19. Revista espanola de cardiologia, 74(9), 812-814. | https://pubmed.ncbi.nlm.nih.gov/33994339/ | García, B., Ortega, P., JA, B. F., León, C., Burgos, R., & Dorta, C. (2021). Acute myocarditis after administration of the BNT162b2 vaccine against COVID-19. Revista espanola de cardiologia, 74(9), 812-814. https://pubmed.ncbi.nlm.nih.gov/33994339/ | Bogdanov, G., Bogdanov, I., Kazandjieva, J., & Tsankov, N. (2021). Cutaneous adverse effects of the available COVID-19 vaccines. Clinics in dermatology, 39(3), 523-531. https://pubmed.ncbi.nlm.nih.gov/34518015/ | ||||
77 | Myocarditis temporally associated with COVID-19 vaccination: | https://www.ahajournals.org/doi/pdf/10.1161/CIRCULATIONAHA.121.055891. | https://www.ahajournals.org/doi/pdf/10.1161/CIRCULATIONAHA.121.055891. | Rosner, C. M., Genovese, L., Tehrani, B. N., Atkins, M., Bakhshi, H., Chaudhri, S., ... & Defilippi, C. R. (2021). Myocarditis temporally associated with COVID-19 vaccination. Circulation, 144(6), 502-505. | Rosner, C. M., Genovese, L., Tehrani, B. N., Atkins, M., Bakhshi, H., Chaudhri, S., ... y Defilippi, C. R. (2021). Miocarditis asociada temporalmente a la vacunación COVID-19. Circulación, 144(6), 502-505. https://pediatrics.aappublications.org/content/pediatrics/early/2021/08/12/peds.2021-053427.full.pdf | Barsha, S. Y., Caque, M. M. A., Rashid, M. U., Rahman, M. L., Hossain, M. A., Zaman, S., ... & Hawlader, M. D. H. (2021). Un caso de la encefalopatía aguda y el infarto de miocardio de elevación del segmento no ST después de la vacunación con MRNA-1273: ¿Posible efecto adverso? Investigación clínica y experimental de vacunas, 10 (3), 293. https://pubmed.ncbi.nlm.nih.gov/34369046/. | Rosner, C. M., Genovese, L., Tehrani, B. N., Atkins, M., Bakhshi, H., Chaudhri, S., ... & Defilippi, C. R. (2021). Myocarditis temporally associated with COVID-19 vaccination. Circulation, 144(6), 502-505. https://www.ahajournals.org/doi/pdf/10.1161/CIRCULATIONAHA.121.055891. | Bayas, A., Menacher, M., Christ, M., Behrens, L., Rank, A., & Naumann, M. (2021). Bilateral superior ophthalmic vein thrombosis, ischaemic stroke, and immune thrombocytopenia after ChAdOx1 nCoV-19 vaccination. The Lancet, 397(10285), e11. https://pubmed.ncbi.nlm.nih.gov/33864750/ | Sulemankhil, I., Abdelrahman, M., & Negi, S. I. (2021). Temporal association between the COVID-19 Ad26. COV2. S vaccine and acute myocarditis: a case report and literature review. Cardiovascular Revascularization Medicine. | https://www.sciencedirect.com/science/article/pii/S1553838921005789 | Sulemankhil, I., Abdelrahman, M., & Negi, S. I. (2021). Temporal association between the COVID-19 Ad26. COV2. S vaccine and acute myocarditis: a case report and literature review. Cardiovascular Revascularization Medicine. https://www.sciencedirect.com/science/article/pii/S1553838921005789 | Boivin, Z., & Martin, J. (2021). Untimely myocardial infarction or COVID-19 vaccine side effect. Cureus, 13(3). https://pubmed.ncbi.nlm.nih.gov/33824804/ | ||||
78 | COVID-19 Vaccination Associated with Myocarditis in Adolescents: | https://pediatrics.aappublications.org/content/pediatrics/early/2021/08/12/peds.2021-053427.full.pdf | https://pediatrics.aappublications.org/content/pediatrics/early/2021/08/12/peds.2021-053427.full.pdf | #VALUE! | Bayas, A., Menacher, M., Cristo, M., Behrens, L., Rank, A., & Naumann, M. (2021). Trombosis de la vena oftálmica superior bilateral, el accidente cerebrovascular isquémico y la trombocitopenia inmune después de la vacunación con Chadox1 NCOV-19. La lanceta, 397 (10285), E11. https://pubmed.ncbi.nlm.nih.gov/33914590/ | zzzz | Bencharattanaphakhi, R., & Rerknimitr, P. (2021). Sinovac COVID-19 vaccine–induced cutaneous leukocytoclastic vasculitis. JAAD case reports, 18, 1-3. https://pubmed.ncbi.nlm.nih.gov/34660867/. | Nassar, M., Nso, N., Gonzalez, C., Lakhdar, S., Alshamam, M., Elshafey, M., ... & Rizzo, V. (2021). COVID-19 vaccine-induced myocarditis: case report with literature review. Diabetes & metabolic syndrome, 15(5), 102205. | https://www.sciencedirect.com/science/article/pii/S1871402121002253 | Nassar, M., Nso, N., Gonzalez, C., Lakhdar, S., Alshamam, M., Elshafey, M., ... & Rizzo, V. (2021). COVID-19 vaccine-induced myocarditis: case report with literature review. Diabetes & metabolic syndrome, 15(5), 102205. https://www.sciencedirect.com/science/article/pii/S1871402121002253 | Bonato, S., Artoni, A., Lecchi, A., Schwarz, G., La Marca, S., Padovan, L., ... & Peyvandi, F. (2021). Massive cerebral venous thrombosis due to vaccine-induced immune thrombotic thrombocytopenia. haematologica, 106(11), 3021. https://pubmed.ncbi.nlm.nih.gov/34261296/ | |||||
79 | Acute myocarditis after administration of BNT162b2 vaccine against COVID-19: | https://pubmed.ncbi.nlm.nih.gov/33994339/ | https://pubmed.ncbi.nlm.nih.gov/33994339/ | García, B., Ortega, P., JA, B. F., León, C., Burgos, R., & Dorta, C. (2021). Acute myocarditis after administration of the BNT162b2 vaccine against COVID-19. Revista espanola de cardiologia, 74(9), 812-814. | García, B., Ortega, P., JA, B. F., León, C., Burgos, R., & Dorta, C. (2021). Miocarditis aguda tras la administración de la vacuna BNT162b2 contra COVID-19. Revista española de cardiología, 74(9), 812-814. https://www.sciencedirect.com/science/article/pii/S1553838921005789 | Bencharattanaphafakhi, R., & Rerknimitr, P. (2021). Sinovac Covid-19 Vasculitis leucocitoclástica cutánea inducida por la vacuna. Jaad Case Reports, 18, 1-3. https://pubmed.ncbi.nlm.nih.gov/34659268/ | García, B., Ortega, P., JA, B. F., León, C., Burgos, R., & Dorta, C. (2021). Acute myocarditis after administration of the BNT162b2 vaccine against COVID-19. Revista espanola de cardiologia, 74(9), 812-814. https://pubmed.ncbi.nlm.nih.gov/33994339/ | Bennett, C., Chambers, L. M., Son, J., & Goje, O. (2021). Newly diagnosed immune thrombocytopenia in a pregnant patient after coronavirus disease 2019 vaccination. Journal of Obstetrics and Gynaecology Research, 47(11), 4077-4080. https://pubmed.ncbi.nlm.nih.gov/34420249/ | Shaw, K. E., Cavalcante, J. L., Han, B. K., & Gössl, M. (2021). Possible association between COVID-19 vaccine and myocarditis: clinical and CMR findings. Cardiovascular Imaging, 14(9), 1856-1861. | https://www.sciencedirect.com/science/article/pii/S1936878X2100485X | Shaw, K. E., Cavalcante, J. L., Han, B. K., & Gössl, M. (2021). Possible association between COVID-19 vaccine and myocarditis: clinical and CMR findings. Cardiovascular Imaging, 14(9), 1856-1861. https://www.sciencedirect.com/science/article/pii/S1936878X2100485X | Bonifacio, G. B., Patel, D., Cook, S., Purcaru, E., Couzins, M., Domjan, J., ... & Kinton, L. (2022). Bilateral facial weakness with paraesthesia variant of Guillain-Barré syndrome following Vaxzevria COVID-19 vaccine. Journal of Neurology, Neurosurgery & Psychiatry, 93(3), 341-342. https://pubmed.ncbi.nlm.nih.gov/34261746/ | ||||
80 | Temporal association between COVID-19 vaccine Ad26.COV2.S and acute myocarditis: case report and review of the literature: | https://www.sciencedirect.com/science/article/pii/S1553838921005789 | https://www.sciencedirect.com/science/article/pii/S1553838921005789 | Sulemankhil, I., Abdelrahman, M., & Negi, S. I. (2021). Temporal association between the COVID-19 Ad26. COV2. S vaccine and acute myocarditis: a case report and literature review. Cardiovascular Revascularization Medicine. | Sulemankhil, I., Abdelrahman, M. y Negi, SI (2021). Asociación temporal entre el COVID-19 Ad26. COV2. Vacuna S y miocarditis aguda: reporte de un caso y revisión de la literatura. Medicina de Revascularización Cardiovascular. https://www.sciencedirect.com/science/article/pii/S1871402121002253 | Bennett, C., Chambers, L. M., Son, J., & GOJE, O. (2021). Thrombocitopenia inmunológica recién diagnosticada en un paciente embarazado después de la vacunación contra la enfermedad de Coronavirus 2019. Diario de la investigación de obstetricia y ginecología, 47 (11), 4077-4080. https://pubmed.ncbi.nlm.nih.gov/34610990/. | Sulemankhil, I., Abdelrahman, M., & Negi, S. I. (2021). Temporal association between the COVID-19 Ad26. COV2. S vaccine and acute myocarditis: a case report and literature review. Cardiovascular Revascularization Medicine. https://www.sciencedirect.com/science/article/pii/S1553838921005789 | Berry, C. T., Eliliwi, M., Gallagher, S., Panaccione, S., Klein, W. M., Healy, A. L., ... & Kallas, R. (2021). Cutaneous small vessel vasculitis following single-dose Janssen Ad26. COV2. S vaccination. JAAD Case Reports, 15, 11-14. https://pubmed.ncbi.nlm.nih.gov/34337124/ | Minocha, P. K., Better, D., Singh, R. K., & Hoque, T. (2021). Recurrence of acute myocarditis temporally associated with receipt of the mRNA coronavirus disease 2019 (COVID-19) vaccine in a male adolescent. The Journal of Pediatrics, 238, 321-323. | https://www.sciencedirect.com/science/article/pii/S002234762100617X | Minocha, P. K., Better, D., Singh, R. K., & Hoque, T. (2021). Recurrence of acute myocarditis temporally associated with receipt of the mRNA coronavirus disease 2019 (COVID-19) vaccine in a male adolescent. The Journal of Pediatrics, 238, 321-323. https://www.sciencedirect.com/science/article/pii/S002234762100617X | Book, B. A., Schmidt, B., & Foerster, A. M. (2021). Bilateral acute macular neuroretinopathy after vaccination against SARS-CoV-2. JAMA ophthalmology, 139(7), e212471-e212471. https://pubmed.ncbi.nlm.nih.gov/34287612/ | ||||
81 | COVID-19 vaccine-induced myocarditis: a case report with review of the literature: | https://www.sciencedirect.com/science/article/pii/S1871402121002253 | https://www.sciencedirect.com/science/article/pii/S1871402121002253 | Nassar, M., Nso, N., Gonzalez, C., Lakhdar, S., Alshamam, M., Elshafey, M., ... & Rizzo, V. (2021). COVID-19 vaccine-induced myocarditis: case report with literature review. Diabetes & metabolic syndrome, 15(5), 102205. | Nassar, M., Nso, N., González, C., Lakhdar, S., Alshamam, M., Elshafey, M., ... & Rizzo, V. (2021). Miocarditis inducida por la vacuna COVID-19: reporte de un caso con revisión de la literatura. Diabetes y síndrome metabólico, 15(5), 102205. https://www.sciencedirect.com/science/article/pii/S1936878X2100485X | Berry, C. T., Eliliwi, M., Gallagher, S., Panaccione, S., Klein, W. M., Healy, A. L., ... & Kallas, R. (2021). Vasculitis pequeña recipiente cutánea después de la dosis única Janssen AD26. COV2. La vacunación de s. JAAD Case Reports, 15, 11-14. https://pubmed.ncbi.nlm.nih.gov/34535924/ | Nassar, M., Nso, N., Gonzalez, C., Lakhdar, S., Alshamam, M., Elshafey, M., ... & Rizzo, V. (2021). COVID-19 vaccine-induced myocarditis: case report with literature review. Diabetes & metabolic syndrome, 15(5), 102205. https://www.sciencedirect.com/science/article/pii/S1871402121002253 | Berto, M. B., Spano, G., Wagner, B., Bernhard, B., Häner, J., Huber, A. T., & Gräni, C. (2021). Takotsubo cardiomyopathy after mRNA COVID-19 vaccination. Heart, Lung and Circulation, 30(12), e119-e120. https://www.sciencedirect.com/science/article/pii/S1443950621011331 | Abbate, A., Gavin, J., Madanchi, N., Kim, C., Shah, P. R., Klein, K., ... & Danielides, S. (2021). Fulminant myocarditis and systemic hyperinflammation temporally associated with BNT162b2 mRNA COVID-19 vaccination in two patients. International Journal of Cardiology, 340, 119-121. | https://www.sciencedirect.com/science/article/pii/S0167527321012286. | Abbate, A., Gavin, J., Madanchi, N., Kim, C., Shah, P. R., Klein, K., ... & Danielides, S. (2021). Fulminant myocarditis and systemic hyperinflammation temporally associated with BNT162b2 mRNA COVID-19 vaccination in two patients. International Journal of Cardiology, 340, 119-121. https://www.sciencedirect.com/science/article/pii/S0167527321012286. | Bostan, E., Elmas, L., Yel, B., & Yalici‐Armagan, B. (2021). Exacerbation of plaque psoriasis after inactivated and BNT162b2 mRNA COVID‐19 vaccines: A report of two cases. Dermatologic therapy. https://pubmed.ncbi.nlm.nih.gov/34427024/ | ||||
82 | Potential association between COVID-19 vaccine and myocarditis: clinical and CMR findings: | https://www.sciencedirect.com/science/article/pii/S1936878X2100485X | https://www.sciencedirect.com/science/article/pii/S1936878X2100485X | Shaw, K. E., Cavalcante, J. L., Han, B. K., & Gössl, M. (2021). Possible association between COVID-19 vaccine and myocarditis: clinical and CMR findings. Cardiovascular Imaging, 14(9), 1856-1861. | Shaw, K. E., Cavalcante, J. L., Han, B. K. y Gössl, M. (2021). Posible asociación entre la vacuna COVID-19 y la miocarditis: hallazgos clínicos y de RMC. Imágenes cardiovasculares, 14(9), 1856-1861. https://www.sciencedirect.com/science/article/pii/S002234762100617X | BERTO, M. B., SPANO, G., WAGNER, B., Bernhard, B., Häner, J., Huber, A. T., & Gräni, C. (2021). Cardiomiopatía Takotsubo después de la vacunación con MRNA COVID-19. Corazón, pulmón y circulación, 30 (12), E119-E120. https://pubmed.ncbi.nlm.nih.gov/34268277/ | Shaw, K. E., Cavalcante, J. L., Han, B. K., & Gössl, M. (2021). Possible association between COVID-19 vaccine and myocarditis: clinical and CMR findings. Cardiovascular Imaging, 14(9), 1856-1861. https://www.sciencedirect.com/science/article/pii/S1936878X2100485X | Bhan, C., Bheesham, N., Shakuntulla, F., Sharma, M., Sun, C., & Weinstein, M. (2021). An unusual presentation of acute deep vein thrombosis after the Moderna COVID-19 vaccine—a case report. Annals of Translational Medicine, 9(20). https://pubmed.ncbi.nlm.nih.gov/34790811/ | Habib, M. B., Hamamyh, T., Elyas, A., Altermanini, M., & Elhassan, M. (2021). Acute myocarditis following administration of BNT162b2 vaccine. IDCases, 25, e01197. | https://www.sciencedirect.com/science/article/pii/S2214250921001530 | Habib, M. B., Hamamyh, T., Elyas, A., Altermanini, M., & Elhassan, M. (2021). Acute myocarditis following administration of BNT162b2 vaccine. IDCases, 25, e01197. https://www.sciencedirect.com/science/article/pii/S2214250921001530 | Bostan, E., Gulseren, D., & Gokoz, O. (2021). New‐onset leukocytoclastic vasculitis after COVID‐19 vaccine. International Journal of Dermatology. https://pubmed.ncbi.nlm.nih.gov/34241833/ | ||||
83 | Recurrence of acute myocarditis temporally associated with receipt of coronavirus mRNA disease vaccine 2019 (COVID-19) in a male adolescent: | https://www.sciencedirect.com/science/article/pii/S002234762100617X | https://www.sciencedirect.com/science/article/pii/S002234762100617X | Minocha, P. K., Better, D., Singh, R. K., & Hoque, T. (2021). Recurrence of acute myocarditis temporally associated with receipt of the mRNA coronavirus disease 2019 (COVID-19) vaccine in a male adolescent. The Journal of Pediatrics, 238, 321-323. | Minocha, PK, Better, D., Singh, R. K. y Hoque, T. (2021). Recurrencia de miocarditis aguda asociada temporalmente con la recepción de la vacuna de ARNm contra la enfermedad del coronavirus 2019 (COVID-19) en un adolescente varón. La Revista de Pediatría, 238, 321-323. https://www.sciencedirect.com/science/article/pii/S0167527321012286. | Bhan, C., Bheesham, N., Shakuntulla, F., Sharma, M., Sun, C., & Weinstein, M. (2021). Una presentación inusual de la trombosis venosa aguda de la vena profunda después de la vacuna moderna COVID-19, un informe de caso. Anales de medicina traslacional, 9 (20). https://pubmed.ncbi.nlm.nih.gov/34023956/. | Minocha, P. K., Better, D., Singh, R. K., & Hoque, T. (2021). Recurrence of acute myocarditis temporally associated with receipt of the mRNA coronavirus disease 2019 (COVID-19) vaccine in a male adolescent. The Journal of Pediatrics, 238, 321-323. https://www.sciencedirect.com/science/article/pii/S002234762100617X | Bhandari, M., Pradhan, A., Vishwakarma, P., & Sethi, R. (2021). Coronavirus and cardiovascular manifestations-getting to the heart of the matter. World Journal of Cardiology, 13(10), 556. https://www.ncbi.nlm.nih.gov/pubmed/34754400 | Ujueta, F., Azimi, R., Lozier, M. R., Poppiti, R., & Ciment, A. (2021). Lymphohistocytic Myocarditis after Ad26. COV2. S viral vector COVID-19 vaccination. International journal of cardiology. Heart & vasculature. | https://www.sciencedirect.com/science/article/pii/S2352906721001573 | Ujueta, F., Azimi, R., Lozier, M. R., Poppiti, R., & Ciment, A. (2021). Lymphohistocytic Myocarditis after Ad26. COV2. S viral vector COVID-19 vaccination. International journal of cardiology. Heart & vasculature. https://www.sciencedirect.com/science/article/pii/S2352906721001573 | Bostan, E., Zaid, F., Akdogan, N., & Gokoz, O. (2022). Possible case of mRNA COVID‐19 vaccine‐induced small‐vessel vasculitis. Journal of Cosmetic Dermatology, 21(1), 51-53. https://pubmed.ncbi.nlm.nih.gov/34705320/. | ||||
84 | Fulminant myocarditis and systemic hyper inflammation temporally associated with BNT162b2 COVID-19 mRNA vaccination in two patients: | https://www.sciencedirect.com/science/article/pii/S0167527321012286. | https://www.sciencedirect.com/science/article/pii/S0167527321012286. | Abbate, A., Gavin, J., Madanchi, N., Kim, C., Shah, P. R., Klein, K., ... & Danielides, S. (2021). Fulminant myocarditis and systemic hyperinflammation temporally associated with BNT162b2 mRNA COVID-19 vaccination in two patients. International Journal of Cardiology, 340, 119-121. | Abbate, A., Gavin, J., Madanchi, N., Kim, C., Shah, P. R., Klein, K., ... y Danielides, S. (2021). Miocarditis fulminante e hiperinflamación sistémica asociada temporalmente con la vacuna COVID-19 con ARNm de BNT162b2 en dos pacientes. Revista Internacional de Cardiología, 340, 119-121. https://www.sciencedirect.com/science/article/pii/S2214250921001530 | Bhandari, M., Pradhan, A., Vishwakarma, P., & Sethi, R. (2021). Coronavirus y manifestaciones cardiovasculares: llegar al corazón del asunto. Diario mundial de cardiología, 13 (10), 556. https://www.ncbi.nlm.nih.gov/pubmed/34281357 | Abbate, A., Gavin, J., Madanchi, N., Kim, C., Shah, P. R., Klein, K., ... & Danielides, S. (2021). Fulminant myocarditis and systemic hyperinflammation temporally associated with BNT162b2 mRNA COVID-19 vaccination in two patients. International Journal of Cardiology, 340, 119-121. https://www.sciencedirect.com/science/article/pii/S0167527321012286. | Bikdeli, B., Chatterjee, S., Arora, S., Monreal, M., Jimenez, D., Krumholz, H. M., ... & Piazza, G. (2021). Cerebral venous sinus thrombosis in the US population, after adenovirus-based SARS-CoV-2 vaccination, and after COVID-19. Journal of the American College of Cardiology, 78(4), 408-411. https://pubmed.ncbi.nlm.nih.gov/34116145/ | Watkins, K., Griffin, G., Septaric, K., & Simon, E. L. (2021). Myocarditis after BNT162b2 vaccination in a healthy male. The American Journal of Emergency Medicine, 50, 815-e1. | https://www.sciencedirect.com/science/article/pii/S0735675721005362 | Watkins, K., Griffin, G., Septaric, K., & Simon, E. L. (2021). Myocarditis after BNT162b2 vaccination in a healthy male. The American Journal of Emergency Medicine, 50, 815-e1. https://www.sciencedirect.com/science/article/pii/S0735675721005362 | Bouattour, N., Hdiji, O., Sakka, S., Fakhfakh, E., Moalla, K., Daoud, S., ... & Mhiri, C. (2022). Guillain-Barré syndrome following the first dose of Pfizer-BioNTech COVID-19 vaccine: case report and review of reported cases. Neurological Sciences, 43(2), 755-761. https://pubmed.ncbi.nlm.nih.gov/34796417/. | ||||
85 | Acute myocarditis after administration of BNT162b2 vaccine: | https://www.sciencedirect.com/science/article/pii/S2214250921001530 | https://www.sciencedirect.com/science/article/pii/S2214250921001530 | Habib, M. B., Hamamyh, T., Elyas, A., Altermanini, M., & Elhassan, M. (2021). Acute myocarditis following administration of BNT162b2 vaccine. IDCases, 25, e01197. | Habib, M. B., Hamamyh, T., Elyas, A., Altermanini, M. y Elhassan, M. (2021). Miocarditis aguda tras la administración de la vacuna BNT162b2. IDCasos, 25, e01197. https://www.sciencedirect.com/science/article/pii/S2352906721001573 | Bikdeli, B., Chatterjee, S., Arora, S., Monreal, M., Jiménez, D., Krumholz, H. M., ... y Piazza, G. (2021). La trombosis sinusal venosa cerebral en la población de los Estados Unidos, después de la vacunación de SARS-COV-2 basada en adenovirus, y después de COVID-19. Revista del Colegio Americano de Cardiología, 78 (4), 408-411. https://pubmed.ncbi.nlm.nih.gov/34286453/. | Habib, M. B., Hamamyh, T., Elyas, A., Altermanini, M., & Elhassan, M. (2021). Acute myocarditis following administration of BNT162b2 vaccine. IDCases, 25, e01197. https://www.sciencedirect.com/science/article/pii/S2214250921001530 | Bikdeli, B., Chatterjee, S., Arora, S., Monreal, M., Jimenez, D., Krumholz, H. M., ... & Piazza, G. (2021). Cerebral venous sinus thrombosis in the US population, after adenovirus-based SARS-CoV-2 vaccination, and after COVID-19. Journal of the American College of Cardiology, 78(4), 408-411. https://www.sciencedirect.com/science/article/pii/S0735109721051949 | Patrignani, A., Schicchi, N., Calcagnoli, F., Falchetti, E., Ciampani, N., Argalia, G., & Mariani, A. (2021). Acute myocarditis following Comirnaty vaccination in a healthy man with previous SARS-CoV-2 infection. Radiology Case Reports, 16(11), 3321-3325. | https://www.sciencedirect.com/science/article/pii/S1930043321005549 | Patrignani, A., Schicchi, N., Calcagnoli, F., Falchetti, E., Ciampani, N., Argalia, G., & Mariani, A. (2021). Acute myocarditis following Comirnaty vaccination in a healthy man with previous SARS-CoV-2 infection. Radiology Case Reports, 16(11), 3321-3325. https://www.sciencedirect.com/science/article/pii/S1930043321005549 | Bourguignon, A., Arnold, D. M., Warkentin, T. E., Smith, J. W., Pannu, T., Shrum, J. M., ... & Nazy, I. (2021). Adjunct immune globulin for vaccine-induced immune thrombotic thrombocytopenia. New England Journal of Medicine, 385(8), 720-728. https://pubmed.ncbi.nlm.nih.gov/34107198/ | ||||
86 | Lymphohistocytic myocarditis after vaccination with COVID-19 Ad26.COV2.S viral vector: | https://www.sciencedirect.com/science/article/pii/S2352906721001573 | https://www.sciencedirect.com/science/article/pii/S2352906721001573 | Ujueta, F., Azimi, R., Lozier, M. R., Poppiti, R., & Ciment, A. (2021). Lymphohistocytic Myocarditis after Ad26. COV2. S viral vector COVID-19 vaccination. International journal of cardiology. Heart & vasculature. | Ujueta, F., Azimi, R., Lozier, M. R., Poppiti, R. y Ciment, A. (2021). Miocarditis linfohistocítica tras Ad26. COV2. Vacunación contra el vector viral S COVID-19. Revista internacional de cardiología. Corazón y vasculatura. https://www.sciencedirect.com/science/article/pii/S0735675721005362 | Bikdeli, B., Chatterjee, S., Arora, S., Monreal, M., Jiménez, D., Krumholz, H. M., ... y Piazza, G. (2021). La trombosis sinusal venosa cerebral en la población de los Estados Unidos, después de la vacunación de SARS-COV-2 basada en adenovirus, y después de COVID-19. Revista del Colegio Americano de Cardiología, 78 (4), 408-411. https://www.sciencedirect.com/science/article/pii/S0735675721005714 | Ujueta, F., Azimi, R., Lozier, M. R., Poppiti, R., & Ciment, A. (2021). Lymphohistocytic Myocarditis after Ad26. COV2. S viral vector COVID-19 vaccination. International journal of cardiology. Heart & vasculature. https://www.sciencedirect.com/science/article/pii/S2352906721001573 | Bjørnstad-Tuveng, T. H., Rudjord, A., & Anker, P. (2021). Fatal cerebral haemorrhage after COVID-19 vaccine. Tidsskrift for Den norske legeforening. https://pubmed.ncbi.nlm.nih.gov/33928772/ | Schauer, J., Buddhe, S., Colyer, J., Sagiv, E., Law, Y., Chikkabyrappa, S. M., & Portman, M. A. (2021). Myopericarditis after the Pfizer messenger ribonucleic acid coronavirus disease vaccine in adolescents. The Journal of pediatrics, 238, 317-320. | https://www.sciencedirect.com/science/article/pii/S002234762100665X | Schauer, J., Buddhe, S., Colyer, J., Sagiv, E., Law, Y., Chikkabyrappa, S. M., & Portman, M. A. (2021). Myopericarditis after the Pfizer messenger ribonucleic acid coronavirus disease vaccine in adolescents. The Journal of pediatrics, 238, 317-320. https://www.sciencedirect.com/science/article/pii/S002234762100665X | Boursier, C., Chevalier, E., Filippetti, L., Imbert, L., Roch, V., Huttin, O., ... & Marie, P. Y. (2021). 68Ga-DOTATOC digital-PET imaging of inflammatory cell infiltrates in myocarditis following COVID-19 vaccination. European journal of nuclear medicine and molecular imaging, 1-2. https://pubmed.ncbi.nlm.nih.gov/34746968/ | ||||
87 | Myocarditis following vaccination with BNT162b2 in a healthy male: | https://www.sciencedirect.com/science/article/pii/S0735675721005362 | https://www.sciencedirect.com/science/article/pii/S0735675721005362 | Watkins, K., Griffin, G., Septaric, K., & Simon, E. L. (2021). Myocarditis after BNT162b2 vaccination in a healthy male. The American Journal of Emergency Medicine, 50, 815-e1. | Watkins, K., Griffin, G., Septaric, K. y Simon, EL (2021). Miocarditis tras la vacunación con BNT162b2 en un varón sano. Revista Estadounidense de Medicina de Emergencia, 50, 815-e1. https://www.sciencedirect.com/science/article/pii/S1930043321005549 | Bjørnstad-Tuveng, T. H., Rudjord, A., & Anker, P. (2021). Hemorragia cerebral fatal después de la vacuna COVID-19. TIDSSSKRIFT PARA DEN NORSKE LEGEFORENDO. https://www.sciencedirect.com/science/article/pii/S2666602221000409 | Watkins, K., Griffin, G., Septaric, K., & Simon, E. L. (2021). Myocarditis after BNT162b2 vaccination in a healthy male. The American Journal of Emergency Medicine, 50, 815-e1. https://www.sciencedirect.com/science/article/pii/S0735675721005362 | Blauenfeldt, R. A., Kristensen, S. R., Ernstsen, S. L., Kristensen, C. C. H., Simonsen, C. Z., & Hvas, A. M. (2021). Thrombocytopenia with acute ischemic stroke and bleeding in a patient newly vaccinated with an adenoviral vector‐based COVID‐19 vaccine. Journal of Thrombosis and Haemostasis, 19(7), 1771-1775. https://pubmed.ncbi.nlm.nih.gov/33877737/ | Ramírez-García, A., Jiménez, S., Ximénez, I., Cacho, A., Aguado-Noya, R., & Cubero, J. (2021). Pericarditis tras la administración de la vacuna de ARNm BNT162b2 contra la COVID-19 Pericarditis after administration of the BNT162b2 mRNA COVID-19 vaccine. Revista espanola de cardiologia. | https://www.sciencedirect.com/science/article/pii/S1885585721002218 | Ramírez-García, A., Jiménez, S., Ximénez, I., Cacho, A., Aguado-Noya, R., & Cubero, J. (2021). Pericarditis tras la administración de la vacuna de ARNm BNT162b2 contra la COVID-19 Pericarditis after administration of the BNT162b2 mRNA COVID-19 vaccine. Revista espanola de cardiologia. https://www.sciencedirect.com/science/article/pii/S1885585721002218 | Bozkurt, B., Kamat, I., & Hotez, P. J. (2021). Myocarditis with COVID-19 mRNA vaccines. Circulation, 144(6), 471-484. https://www.ahajournals.org/doi/pdf/10.1161/CIRCULATIONAHA.121.056135 | ||||
88 | Acute myocarditis after Comirnaty (Pfizer) vaccination in a healthy male with previous SARS-CoV-2 infection: | https://www.sciencedirect.com/science/article/pii/S1930043321005549 | https://www.sciencedirect.com/science/article/pii/S1930043321005549 | Patrignani, A., Schicchi, N., Calcagnoli, F., Falchetti, E., Ciampani, N., Argalia, G., & Mariani, A. (2021). Acute myocarditis following Comirnaty vaccination in a healthy man with previous SARS-CoV-2 infection. Radiology Case Reports, 16(11), 3321-3325. | Patrignani, A., Schicchi, N., Calcagnoli, F., Falchetti, E., Ciampani, N., Argalia, G. y Mariani, A. (2021). Miocarditis aguda tras la vacunación Comirnaty en un hombre sano con infección previa por SARS-CoV-2. Informes de casos de radiología, 16(11), 3321-3325. https://www.sciencedirect.com/science/article/pii/S002234762100665X | Blauenfeldt, R. A., Kristensen, S. R., Ernstsen, S. L., Kristensen, C. C. H., Simonsen, C. Z., & HVAS, A. M. (2021). Trombocitopenia con accidente cerebrovascular isquémico agudo y sangrado en un paciente recién vacunado con una vacuna COVID-19 a base de vectores adenovirales. Journal of Trombosis y Haemostasis, 19 (7), 1771-1775. https://pubmed.ncbi.nlm.nih.gov/34254476/ | Patrignani, A., Schicchi, N., Calcagnoli, F., Falchetti, E., Ciampani, N., Argalia, G., & Mariani, A. (2021). Acute myocarditis following Comirnaty vaccination in a healthy man with previous SARS-CoV-2 infection. Radiology Case Reports, 16(11), 3321-3325. https://www.sciencedirect.com/science/article/pii/S1930043321005549 | Blumenthal, K. G., Robinson, L. B., Camargo, C. A., Shenoy, E. S., Banerji, A., Landman, A. B., & Wickner, P. (2021). Acute allergic reactions to mRNA COVID-19 vaccines. Jama, 325(15), 1562-1565. https://pubmed.ncbi.nlm.nih.gov/33683290/ | Williams, C. B., Choi, J. I., Hosseini, F., Roberts, J., Ramanathan, K., & Ong, K. (2021). Acute Myocarditis Following mRNA-1273 SARS-CoV-2 Vaccination. CJC open, 3(11), 1410-1412. | https://www.sciencedirect.com/science/article/pii/S2589790X21001931 | Williams, C. B., Choi, J. I., Hosseini, F., Roberts, J., Ramanathan, K., & Ong, K. (2021). Acute Myocarditis Following mRNA-1273 SARS-CoV-2 Vaccination. CJC open, 3(11), 1410-1412. https://www.sciencedirect.com/science/article/pii/S2589790X21001931 | Braun, T., Viard, M., Juenemann, M., Struffert, T., Schwarm, F., Huttner, H. B., & Roessler, F. C. (2021). Case Report: Take a Second Look: Covid-19 Vaccination-Related Cerebral Venous Thrombosis and Thrombotic Thrombocytopenia Syndrome. Frontiers in neurology, 12. https://pubmed.ncbi.nlm.nih.gov/34880826/ | ||||
89 | Myopericarditis after Pfizer mRNA COVID-19 vaccination in adolescents: | https://www.sciencedirect.com/science/article/pii/S002234762100665X | https://www.sciencedirect.com/science/article/pii/S002234762100665X | Schauer, J., Buddhe, S., Colyer, J., Sagiv, E., Law, Y., Chikkabyrappa, S. M., & Portman, M. A. (2021). Myopericarditis after the Pfizer messenger ribonucleic acid coronavirus disease vaccine in adolescents. The Journal of pediatrics, 238, 317-320. | Schauer, J., Buddhe, S., Colyer, J., Sagiv, E., Law, Y., Chikkabyrappa, S. M. y Portman, M. A. (2021). Miopericarditis después de la vacuna contra el coronavirus del ácido ribonucleico mensajero de Pfizer en adolescentes. La Revista de Pediatría, 238, 317-320. https://www.sciencedirect.com/science/article/pii/S1885585721002218 | Blumenthal, K. G., Robinson, L. B., Camargo, C. A. A., Shenoy, E. S., Banerji, A., Landman, A. B., & Wickner, P. (2021). Reacciones alérgicas agudas a las vacunas ARNm COVID-19. JAMA, 325 (15), 1562-1565. https://pubmed.ncbi.nlm.nih.gov/33919151/ | Schauer, J., Buddhe, S., Colyer, J., Sagiv, E., Law, Y., Chikkabyrappa, S. M., & Portman, M. A. (2021). Myopericarditis after the Pfizer messenger ribonucleic acid coronavirus disease vaccine in adolescents. The Journal of pediatrics, 238, 317-320. https://www.sciencedirect.com/science/article/pii/S002234762100665X | Bogdanov, G., Bogdanov, I., Kazandjieva, J., & Tsankov, N. (2021). Cutaneous adverse effects of the available COVID-19 vaccines. Clinics in dermatology, 39(3), 523-531. https://pubmed.ncbi.nlm.nih.gov/34518015/ | Ammirati, E., Cavalotti, C., Milazzo, A., Pedrotti, P., Soriano, F., Schroeder, J. W., ... & Oliva, F. (2021). Temporal relation between second dose BNT162b2 mRNA Covid-19 vaccine and cardiac involvement in a patient with previous SARS-COV-2 infection. International journal of cardiology. Heart & vasculature. | https://www.sciencedirect.com/science/article/pii/S2352906721000622 | Ammirati, E., Cavalotti, C., Milazzo, A., Pedrotti, P., Soriano, F., Schroeder, J. W., ... & Oliva, F. (2021). Temporal relation between second dose BNT162b2 mRNA Covid-19 vaccine and cardiac involvement in a patient with previous SARS-COV-2 infection. International journal of cardiology. Heart & vasculature. https://www.sciencedirect.com/science/article/pii/S2352906721000622 | Bril, F., Al Diffalha, S., Dean, M., & Fettig, D. M. (2021). Autoimmune hepatitis developing after coronavirus disease 2019 (COVID-19) vaccine: causality or casualty?. Journal of Hepatology, 75(1), 222-224. https://pubmed.ncbi.nlm.nih.gov/33862041/ | ||||
90 | Pericarditis after administration of BNT162b2 mRNA COVID-19 mRNA vaccine: | https://www.sciencedirect.com/science/article/pii/S1885585721002218 | https://www.sciencedirect.com/science/article/pii/S1885585721002218 | Ramírez-García, A., Jiménez, S., Ximénez, I., Cacho, A., Aguado-Noya, R., & Cubero, J. (2021). Pericarditis tras la administración de la vacuna de ARNm BNT162b2 contra la COVID-19 Pericarditis after administration of the BNT162b2 mRNA COVID-19 vaccine. Revista espanola de cardiologia. | Ramírez-García, A., Jiménez, S., Ximénez, I., Cacho, A., Aguado-Noya, R., & Cubero, J. (2021). Pericarditis tras la administración de la vacuna de ARNm BNT162b2 contra la COVID-19 Pericarditis tras la administración de la vacuna BNT162b2 mRNA COVID-19. Revista española de cardiología. https://www.sciencedirect.com/science/article/pii/S2589790X21001931 | Bogdanov, G., Bogdanov, I., Kazandjieva, J., & Tsankov, N. (2021). Efectos adversos cutáneos de las vacunas COVID-19 disponibles. Clínicas en Dermatología, 39 (3), 523-531. https://pubmed.ncbi.nlm.nih.gov/34347278/ | Ramírez-García, A., Jiménez, S., Ximénez, I., Cacho, A., Aguado-Noya, R., & Cubero, J. (2021). Pericarditis tras la administración de la vacuna de ARNm BNT162b2 contra la COVID-19 Pericarditis after administration of the BNT162b2 mRNA COVID-19 vaccine. Revista espanola de cardiologia. https://www.sciencedirect.com/science/article/pii/S1885585721002218 | Boivin, Z., & Martin, J. (2021). Untimely myocardial infarction or COVID-19 vaccine side effect. Cureus, 13(3). https://pubmed.ncbi.nlm.nih.gov/33824804/ | Das, B. B., Kohli, U., Ramachandran, P., Nguyen, H. H., Greil, G., Hussain, T., ... & Khan, D. (2021). Myopericarditis after messenger RNA coronavirus disease 2019 vaccination in adolescents 12 to 18 years of age. The Journal of Pediatrics, 238, 26-32. | https://www.sciencedirect.com/science/article/pii/S0022347621007368 | Das, B. B., Kohli, U., Ramachandran, P., Nguyen, H. H., Greil, G., Hussain, T., ... & Khan, D. (2021). Myopericarditis after messenger RNA coronavirus disease 2019 vaccination in adolescents 12 to 18 years of age. The Journal of Pediatrics, 238, 26-32. https://www.sciencedirect.com/science/article/pii/S0022347621007368 | Buchan, S. A., Seo, C. Y., Johnson, C., Alley, S., Kwong, J. C., Nasreen, S., ... & Wilson, S. E. (2021). Epidemiology of myocarditis and pericarditis following mRNA vaccines in Ontario, Canada: by vaccine product, schedule and interval. medRxiv. https://www.medrxiv.org/content/10.1101/2021.12.02.21267156v1 | ||||
91 | Acute myocarditis after vaccination with SARS-CoV-2 mRNA-1273 mRNA: | https://www.sciencedirect.com/science/article/pii/S2589790X21001931 | https://www.sciencedirect.com/science/article/pii/S2589790X21001931 | Williams, C. B., Choi, J. I., Hosseini, F., Roberts, J., Ramanathan, K., & Ong, K. (2021). Acute Myocarditis Following mRNA-1273 SARS-CoV-2 Vaccination. CJC open, 3(11), 1410-1412. | Williams, C. B., Choi, J. I., Hosseini, F., Roberts, J., Ramanathan, K. y Ong, K. (2021). Miocarditis aguda después de la vacunación con ARNm-1273 SARS-CoV-2. CJC abierto, 3(11), 1410-1412. https://www.sciencedirect.com/science/article/pii/S2352906721000622 | Boivin, Z., & Martin, J. (2021). Inmediatoria infarto de miocardio o efecto secundario de la vacuna COVID-19. CUREUS, 13 (3). https://pubmed.ncbi.nlm.nih.gov/34807248/ | Williams, C. B., Choi, J. I., Hosseini, F., Roberts, J., Ramanathan, K., & Ong, K. (2021). Acute Myocarditis Following mRNA-1273 SARS-CoV-2 Vaccination. CJC open, 3(11), 1410-1412. https://www.sciencedirect.com/science/article/pii/S2589790X21001931 | Bonato, S., Artoni, A., Lecchi, A., Schwarz, G., La Marca, S., Padovan, L., ... & Peyvandi, F. (2021). Massive cerebral venous thrombosis due to vaccine-induced immune thrombotic thrombocytopenia. haematologica, 106(11), 3021. https://pubmed.ncbi.nlm.nih.gov/34261296/ | Cimaglia, P., Tolomeo, P., & Rapezzi, C. (2022). Acute myocarditis after SARS-CoV-2 vaccination in a 24-year-old man. Revista portuguesa de cardiologia, 41(1), 71-72. | https://www.sciencedirect.com/science/article/pii/S0870255121003243 | Cimaglia, P., Tolomeo, P., & Rapezzi, C. (2022). Acute myocarditis after SARS-CoV-2 vaccination in a 24-year-old man. Revista portuguesa de cardiologia, 41(1), 71-72. https://www.sciencedirect.com/science/article/pii/S0870255121003243 | Buchhorn, R., Meyer, C., Schulze-Forster, K., Junker, J., & Heidecke, H. (2021). Autoantibody Release in Children after Corona Virus mRNA Vaccination: A Risk Factor of Multisystem Inflammatory Syndrome?. Vaccines, 9(11), 1353. https://www.ncbi.nlm.nih.gov/pubmed/34835284 | ||||
92 | Temporal relationship between the second dose of BNT162b2 mRNA Covid-19 vaccine and cardiac involvement in a patient with previous SARS-COV-2 infection: | https://www.sciencedirect.com/science/article/pii/S2352906721000622 | https://www.sciencedirect.com/science/article/pii/S2352906721000622 | Ammirati, E., Cavalotti, C., Milazzo, A., Pedrotti, P., Soriano, F., Schroeder, J. W., ... & Oliva, F. (2021). Temporal relation between second dose BNT162b2 mRNA Covid-19 vaccine and cardiac involvement in a patient with previous SARS-COV-2 infection. International journal of cardiology. Heart & vasculature. | Ammirati, E., Cavalotti, C., Milazzo, A., Pedrotti, P., Soriano, F., Schroeder, J. W., ... & Oliva, F. (2021). Relación temporal entre la segunda dosis de la vacuna BNT162b2 mRNA Covid-19 y la afectación cardíaca en un paciente con infección previa por SARS-COV-2. Revista internacional de cardiología. Corazón y vasculatura. https://www.sciencedirect.com/science/article/pii/S0022347621007368 | Bonato, S., Artoni, A., Lecchi, A., Schwarz, G., La Marca, S., Padovan, L., ... & Peyvandi, F. (2021). Trombosis venosa cerebral masiva debido a la trombocitopenia trombótica inmune inducida por la vacuna. Haematologica, 106 (11), 3021. https://pubmed.ncbi.nlm.nih.gov/34250318/. | Ammirati, E., Cavalotti, C., Milazzo, A., Pedrotti, P., Soriano, F., Schroeder, J. W., ... & Oliva, F. (2021). Temporal relation between second dose BNT162b2 mRNA Covid-19 vaccine and cardiac involvement in a patient with previous SARS-COV-2 infection. International journal of cardiology. Heart & vasculature. https://www.sciencedirect.com/science/article/pii/S2352906721000622 | Bonifacio, G. B., Patel, D., Cook, S., Purcaru, E., Couzins, M., Domjan, J., ... & Kinton, L. (2022). Bilateral facial weakness with paraesthesia variant of Guillain-Barré syndrome following Vaxzevria COVID-19 vaccine. Journal of Neurology, Neurosurgery & Psychiatry, 93(3), 341-342. https://pubmed.ncbi.nlm.nih.gov/34261746/ | Long, S. S. (2021). Important Insights into Myopericarditis after the Pfizer mRNA COVID-19 Vaccination in Adolescents. The Journal of Pediatrics, 238, 5. | https://www.sciencedirect.com/science/article/pii/S0022347621007496 | Long, S. S. (2021). Important Insights into Myopericarditis after the Pfizer mRNA COVID-19 Vaccination in Adolescents. The Journal of Pediatrics, 238, 5. https://www.sciencedirect.com/science/article/pii/S0022347621007496 | Burillo, J. C., Martínez, C. L., Arguedas, C. G., & Pueyo, F. M. (2021). Amyotrophic neuralgia secondary to Vaxzevri (AstraZeneca) COVID-19 vaccine. Neurologia (Barcelona, Spain). https://pubmed.ncbi.nlm.nih.gov/34330677/ | ||||
93 | Myopericarditis after vaccination with COVID-19 mRNA in adolescents 12 to 18 years of age: | https://www.sciencedirect.com/science/article/pii/S0022347621007368 | https://www.sciencedirect.com/science/article/pii/S0022347621007368 | Das, B. B., Kohli, U., Ramachandran, P., Nguyen, H. H., Greil, G., Hussain, T., ... & Khan, D. (2021). Myopericarditis after messenger RNA coronavirus disease 2019 vaccination in adolescents 12 to 18 years of age. The Journal of Pediatrics, 238, 26-32. | Das, B. B., Kohli, U., Ramachandran, P., Nguyen, H. H., Greil, G., Hussain, T., ... y Khan, D. (2021). Miopericarditis tras la vacunación contra la enfermedad por coronavirus de ARN mensajero 2019 en adolescentes de 12 a 18 años. La Revista de Pediatría, 238, 26-32. https://www.sciencedirect.com/science/article/pii/S0870255121003243 | Bonifacio, G. B., Patel, D., Cook, S., Purcaru, E., Couzins, M., Domjan, J., ... & Kinton, L. (2022). Debilidad facial bilateral con la variante de la parestesia del síndrome de Guillain-Barré siguiendo la vacuna contra Vaxzevria Covid-19. Revista de Neurología, Neurocirugía y Psiquiatría, 93 (3), 341-342. https://pubmed.ncbi.nlm.nih.gov/34217513/. | Das, B. B., Kohli, U., Ramachandran, P., Nguyen, H. H., Greil, G., Hussain, T., ... & Khan, D. (2021). Myopericarditis after messenger RNA coronavirus disease 2019 vaccination in adolescents 12 to 18 years of age. The Journal of Pediatrics, 238, 26-32. https://www.sciencedirect.com/science/article/pii/S0022347621007368 | Book, B. A., Schmidt, B., & Foerster, A. M. (2021). Bilateral acute macular neuroretinopathy after vaccination against SARS-CoV-2. JAMA ophthalmology, 139(7), e212471-e212471. https://pubmed.ncbi.nlm.nih.gov/34287612/ | Dickey, J. B., Albert, E., Badr, M., Laraja, K. M., Sena, L. M., Gerson, D. S., ... & Aurigemma, G. P. (2021). A series of patients with myocarditis following SARS-CoV-2 vaccination with mRNA-1279 and BNT162b2. Cardiovascular Imaging, 14(9), 1862-1863. | https://www.sciencedirect.com/science/article/pii/S1936878X21004861 | Dickey, J. B., Albert, E., Badr, M., Laraja, K. M., Sena, L. M., Gerson, D. S., ... & Aurigemma, G. P. (2021). A series of patients with myocarditis following SARS-CoV-2 vaccination with mRNA-1279 and BNT162b2. Cardiovascular Imaging, 14(9), 1862-1863. https://www.sciencedirect.com/science/article/pii/S1936878X21004861 | Burrows, A., Bartholomew, T., Rudd, J., & Walker, D. (2021). Sequential contralateral facial nerve palsies following COVID-19 vaccination first and second doses. BMJ Case Reports CP, 14(7), e243829. https://pubmed.ncbi.nlm.nih.gov/34281950/. | ||||
94 | Acute myocarditis after SARS-CoV-2 vaccination in a 24-year-old man: | https://www.sciencedirect.com/science/article/pii/S0870255121003243 | https://www.sciencedirect.com/science/article/pii/S0870255121003243 | Cimaglia, P., Tolomeo, P., & Rapezzi, C. (2022). Acute myocarditis after SARS-CoV-2 vaccination in a 24-year-old man. Revista portuguesa de cardiologia, 41(1), 71-72. | Cimaglia, P., Tolomeo, P. y Rapezzi, C. (2022). Miocarditis aguda tras la vacunación contra el SARS-CoV-2 en un hombre de 24 años. Revista portuguesa de cardiología, 41(1), 71-72. https://www.sciencedirect.com/science/article/pii/S0022347621007496 | BOSTAN, E., ELMAS, L., YEL, B., & Yalici-Armagan, B. (2021). Exacerbación de la psoriasis de la placa después de inactivada y BNT162B2 MRNA COVID-19 vacunas: un informe de dos casos. Terapia dermatológica. https://pubmed.ncbi.nlm.nih.gov/34510014/. | Cimaglia, P., Tolomeo, P., & Rapezzi, C. (2022). Acute myocarditis after SARS-CoV-2 vaccination in a 24-year-old man. Revista portuguesa de cardiologia, 41(1), 71-72. https://www.sciencedirect.com/science/article/pii/S0870255121003243 | Bostan, E., Elmas, L., Yel, B., & Yalici‐Armagan, B. (2021). Exacerbation of plaque psoriasis after inactivated and BNT162b2 mRNA COVID‐19 vaccines: A report of two cases. Dermatologic therapy. https://pubmed.ncbi.nlm.nih.gov/34427024/ | Berto, M. B., Spano, G., Wagner, B., Bernhard, B., Häner, J., Huber, A. T., & Gräni, C. (2021). Takotsubo cardiomyopathy after mRNA COVID-19 vaccination. Heart, Lung and Circulation, 30(12), e119-e120. | https://www.sciencedirect.com/science/article/pii/S1443950621011331 | Berto, M. B., Spano, G., Wagner, B., Bernhard, B., Häner, J., Huber, A. T., & Gräni, C. (2021). Takotsubo cardiomyopathy after mRNA COVID-19 vaccination. Heart, Lung and Circulation, 30(12), e119-e120. https://www.sciencedirect.com/science/article/pii/S1443950621011331 | Cabanillas, B., Akdis, C., & Novak, N. (2020). Allergic reactions to the first COVID-19 vaccine: a potential role of Polyethylene glycol. Allergy, 76(6), 1617-1618. https://pubmed.ncbi.nlm.nih.gov/33320974/ | ||||
95 | Important information on myopericarditis after vaccination with Pfizer COVID-19 mRNA in adolescents: | https://www.sciencedirect.com/science/article/pii/S0022347621007496 | https://www.sciencedirect.com/science/article/pii/S0022347621007496 | Long, S. S. (2021). Important Insights into Myopericarditis after the Pfizer mRNA COVID-19 Vaccination in Adolescents. The Journal of Pediatrics, 238, 5. | Long, SS (2021). Información importante sobre la miopericarditis después de la vacuna de ARNm de Pfizer contra la COVID-19 en adolescentes. La Revista de Pediatría, 238, 5. https://www.sciencedirect.com/science/article/pii/S1936878X21004861 | BOSTAN, E., Gulseren, D., & GoKoz, O. (2021). Vasculitis leucocitoclástica de nuevo inicio después de la vacuna COVID-19. Diario Internacional de Dermatología. https://pubmed.ncbi.nlm.nih.gov/34529877/. | Long, S. S. (2021). Important Insights into Myopericarditis after the Pfizer mRNA COVID-19 Vaccination in Adolescents. The Journal of Pediatrics, 238, 5. https://www.sciencedirect.com/science/article/pii/S0022347621007496 | Bostan, E., Gulseren, D., & Gokoz, O. (2021). New‐onset leukocytoclastic vasculitis after COVID‐19 vaccine. International Journal of Dermatology. https://pubmed.ncbi.nlm.nih.gov/34241833/ | Singh, B., Kaur, P., Cedeno, L., Brahimi, T., Patel, P., Virk, H., ... & Bikkina, M. (2021). COVID-19 mRNA vaccine and myocarditis. European Journal of Case Reports in Internal Medicine, 8(7). | https://pubmed.ncbi.nlm.nih.gov/34268277/ | Singh, B., Kaur, P., Cedeno, L., Brahimi, T., Patel, P., Virk, H., ... & Bikkina, M. (2021). COVID-19 mRNA vaccine and myocarditis. European Journal of Case Reports in Internal Medicine, 8(7). https://pubmed.ncbi.nlm.nih.gov/34268277/ | Calcaterra, G., Bassareo, P. P., Romeo, F., & Mehta, J. L. (2022). Concerning the unexpected prothrombotic state following some coronavirus disease 2019 vaccines. Journal of Cardiovascular Medicine, 23(2), 71-74. https://www.ncbi.nlm.nih.gov/pubmed/34366403 | ||||
96 | A series of patients with myocarditis after vaccination against SARS-CoV-2 with mRNA-1279 and BNT162b2: | https://www.sciencedirect.com/science/article/pii/S1936878X21004861 | https://www.sciencedirect.com/science/article/pii/S1936878X21004861 | Dickey, J. B., Albert, E., Badr, M., Laraja, K. M., Sena, L. M., Gerson, D. S., ... & Aurigemma, G. P. (2021). A series of patients with myocarditis following SARS-CoV-2 vaccination with mRNA-1279 and BNT162b2. Cardiovascular Imaging, 14(9), 1862-1863. | Dickey, J. B., Albert, E., Badr, M., Laraja, K. M., Sena, L. M., Gerson, D. S., ... & Aurigemma, G. P. (2021). Una serie de pacientes con miocarditis después de la vacunación contra el SARS-CoV-2 con mRNA-1279 y BNT162b2. Imágenes cardiovasculares, 14(9), 1862-1863. https://www.sciencedirect.com/science/article/pii/S1443950621011331 | BOSTAN, E., ZAINE, F., AKDOGAN, N., & GOKOZ, O. (2022). Posible caso de vásculitis de vásculos pequeños vaqueros inducidos por la vacuna contra el ARNm COVID-19. Diario de Dermatología Cosmética, 21 (1), 51-53. https://pubmed.ncbi.nlm.nih.gov/34779011/ | Dickey, J. B., Albert, E., Badr, M., Laraja, K. M., Sena, L. M., Gerson, D. S., ... & Aurigemma, G. P. (2021). A series of patients with myocarditis following SARS-CoV-2 vaccination with mRNA-1279 and BNT162b2. Cardiovascular Imaging, 14(9), 1862-1863. https://www.sciencedirect.com/science/article/pii/S1936878X21004861 | Bostan, E., Zaid, F., Akdogan, N., & Gokoz, O. (2022). Possible case of mRNA COVID‐19 vaccine‐induced small‐vessel vasculitis. Journal of Cosmetic Dermatology, 21(1), 51-53. https://pubmed.ncbi.nlm.nih.gov/34705320/. | Salah, H. M., & Mehta, J. L. (2021). COVID-19 vaccine and myocarditis. American Journal of Cardiology, 157, 146-148. | https://pubmed.ncbi.nlm.nih.gov/34399967/ | Salah, H. M., & Mehta, J. L. (2021). COVID-19 vaccine and myocarditis. American Journal of Cardiology, 157, 146-148. https://pubmed.ncbi.nlm.nih.gov/34399967/ | Calcaterra, G., Mehta, J. L., De Gregorio, C., Butera, G., Neroni, P., Fanos, V., & Bassareo, P. P. (2021). COVID 19 vaccine for adolescents. Concern about myocarditis and pericarditis. Pediatric Reports, 13(3), 530-533. https://www.mdpi.com/2036-7503/13/3/61. | ||||
97 | Takotsubo cardiomyopathy after vaccination with mRNA COVID-19: | https://www.sciencedirect.com/science/article/pii/S1443950621011331 | https://www.sciencedirect.com/science/article/pii/S1443950621011331 | Berto, M. B., Spano, G., Wagner, B., Bernhard, B., Häner, J., Huber, A. T., & Gräni, C. (2021). Takotsubo cardiomyopathy after mRNA COVID-19 vaccination. Heart, Lung and Circulation, 30(12), e119-e120. | Berto, M. B., Spano, G., Wagner, B., Bernhard, B., Häner, J., Huber, A. T. y Gräni, C. (2021). Miocardiopatía de Takotsubo después de la vacunación con ARNm COVID-19. Corazón, Pulmón y Circulación, 30(12), e119-e120. https://pubmed.ncbi.nlm.nih.gov/34268277/ | Bouattour, N., Honji, O., Sakka, S., Fakhfakh, E., Moalla, K., Daoud, S., ... & Mhiri, C. (2022). Síndrome de Guillain-Barré siguiendo la primera dosis de PFIZE-BIONTECH COVID-19 VACUNA: Informe de caso y revisión de los casos reportados. Ciencias neurológicas, 43 (2), 755-761. https://link.springer.com/article/10.1007%2Fs10072-021-05523-5. | Berto, M. B., Spano, G., Wagner, B., Bernhard, B., Häner, J., Huber, A. T., & Gräni, C. (2021). Takotsubo cardiomyopathy after mRNA COVID-19 vaccination. Heart, Lung and Circulation, 30(12), e119-e120. https://www.sciencedirect.com/science/article/pii/S1443950621011331 | Bouattour, N., Hdiji, O., Sakka, S., Fakhfakh, E., Moalla, K., Daoud, S., ... & Mhiri, C. (2022). Guillain-Barré syndrome following the first dose of Pfizer-BioNTech COVID-19 vaccine: case report and review of reported cases. Neurological Sciences, 43(2), 755-761. https://pubmed.ncbi.nlm.nih.gov/34796417/. | Kerneis, M., Bihan, K., & Salem, J. E. (2021). COVID-19 vaccines and myocarditis. Arch Cardiovasc Dis, 114(6-7), 515-517. | https://pubmed.ncbi.nlm.nih.gov/34246566/ | Kerneis, M., Bihan, K., & Salem, J. E. (2021). COVID-19 vaccines and myocarditis. Arch Cardiovasc Dis, 114(6-7), 515-517. https://pubmed.ncbi.nlm.nih.gov/34246566/ | Cardoso, F., Reis, A., Osório, C., Scigliano, H., & Nora, M. (2021). A case of cervical lymphadenopathy after vaccination against COVID-19. Cureus, 13(5). https://pubmed.ncbi.nlm.nih.gov/34141500/ | ||||
98 | COVID-19 mRNA vaccination and myocarditis: | https://pubmed.ncbi.nlm.nih.gov/34268277/ | https://pubmed.ncbi.nlm.nih.gov/34268277/ | Singh, B., Kaur, P., Cedeno, L., Brahimi, T., Patel, P., Virk, H., ... & Bikkina, M. (2021). COVID-19 mRNA vaccine and myocarditis. European Journal of Case Reports in Internal Medicine, 8(7). | Singh, B., Kaur, P., Cedeño, L., Brahimi, T., Patel, P., Virk, H., ... y Bikkina, M. (2021). Vacuna de ARNm COVID-19 y miocarditis. Revista europea de informes de casos de medicina interna, 8(7). https://pubmed.ncbi.nlm.nih.gov/34399967/ | Bourguignon, A., Arnold, D. M., Warkentin, T. E., Smith, J. W., Pannu, T., Shrum, J. M., ... & Nazy, I. (2021). Globulina inmune adjunta para la trombocitopenia trombótica inmune inducida por la vacuna. New England Journal of Medicine, 385 (8), 720-728. https://pubmed.ncbi.nlm.nih.gov/34355379/. | Singh, B., Kaur, P., Cedeno, L., Brahimi, T., Patel, P., Virk, H., ... & Bikkina, M. (2021). COVID-19 mRNA vaccine and myocarditis. European Journal of Case Reports in Internal Medicine, 8(7). https://pubmed.ncbi.nlm.nih.gov/34268277/ | Bourguignon, A., Arnold, D. M., Warkentin, T. E., Smith, J. W., Pannu, T., Shrum, J. M., ... & Nazy, I. (2021). Adjunct immune globulin for vaccine-induced immune thrombotic thrombocytopenia. New England Journal of Medicine, 385(8), 720-728. https://pubmed.ncbi.nlm.nih.gov/34107198/ | Shay, D. K., Shimabukuro, T. T., & DeStefano, F. (2021). Myocarditis occurring after immunization with mRNA-based COVID-19 vaccines. JAMA cardiology, 6(10), 1115-1117. | https://jamanetwork.com/journals/jamacardiology/fullarticle/2781600 | Shay, D. K., Shimabukuro, T. T., & DeStefano, F. (2021). Myocarditis occurring after immunization with mRNA-based COVID-19 vaccines. JAMA cardiology, 6(10), 1115-1117. https://jamanetwork.com/journals/jamacardiology/fullarticle/2781600 | Cari, L., Alhosseini, M. N., Fiore, P., Pierno, S., Pacor, S., Bergamo, A., ... & Nocentini, G. (2021). Cardiovascular, neurological, and pulmonary events following vaccination with the BNT162b2, ChAdOx1 nCoV-19, and Ad26. COV2. S vaccines: An analysis of European data. Journal of autoimmunity, 125, 102742. https://pubmed.ncbi.nlm.nih.gov/34710832/ | ||||
99 | COVID-19 vaccine and myocarditis: | https://pubmed.ncbi.nlm.nih.gov/34399967/ | https://pubmed.ncbi.nlm.nih.gov/34399967/ | Salah, H. M., & Mehta, J. L. (2021). COVID-19 vaccine and myocarditis. American Journal of Cardiology, 157, 146-148. | Salah, HM y Mehta, JL (2021). Vacuna COVID-19 y miocarditis. Revista Estadounidense de Cardiología, 157, 146-148. https://search.bvsalud.org/global-literature-on-novel-coronavirus-2019-ncov/resourc e/en/covidwho-1360706. | Boursier, C., Chevalier, E., Filippetti, L., Imbert, L., Roch, V., Huttin, O., ... & Marie, P. Y. (2021). 68GA-DOTATOC Digital-PET Imagenamiento de celdas inflamatorias Infiltrados en miocarditis después de la vacunación de COVID-19. Revista europea de medicina nuclear y imágenes moleculares, 1-2. https://pubmed.ncbi.nlm.nih.gov/34333695/. | Salah, H. M., & Mehta, J. L. (2021). COVID-19 vaccine and myocarditis. American Journal of Cardiology, 157, 146-148. https://pubmed.ncbi.nlm.nih.gov/34399967/ | Boursier, C., Chevalier, E., Filippetti, L., Imbert, L., Roch, V., Huttin, O., ... & Marie, P. Y. (2021). 68Ga-DOTATOC digital-PET imaging of inflammatory cell infiltrates in myocarditis following COVID-19 vaccination. European journal of nuclear medicine and molecular imaging, 1-2. https://pubmed.ncbi.nlm.nih.gov/34746968/ | Verma, A. K., Lavine, K. J., & Lin, C. Y. (2021). Myocarditis after Covid-19 mRNA vaccination. New England Journal of Medicine, 385(14), 1332-1334. | https://www.nejm.org/doi/full/10.1056/NEJMc2109975 | Verma, A. K., Lavine, K. J., & Lin, C. Y. (2021). Myocarditis after Covid-19 mRNA vaccination. New England Journal of Medicine, 385(14), 1332-1334. https://www.nejm.org/doi/full/10.1056/NEJMc2109975 | Cari, L., Fiore, P., Alhosseini, M. N., Sava, G., & Nocentini, G. (2021). Blood clots and bleeding events following BNT162b2 and ChAdOx1 nCoV-19 vaccine: An analysis of European data. Journal of autoimmunity, 122, 102685. https://www.sciencedirect.com/science/article/pii/S0896841121000937 | ||||
100 | Epidemiology and clinical features of myocarditis/pericarditis before the introduction of COVID-19 mRNA vaccine in Korean children: a multicenter study | search.bvsalud.org/global-literature-on-novel-coronavirus-2019-ncov/resourc e/en/covidwho-1360706. | https://search.bvsalud.org/global-literature-on-novel-coronavirus-2019-ncov/resourc e/en/covidwho-1360706. | https://search.bvsalud.org/global-literature-on-novel-coronavirus-2019-ncov/resourc e/en/covidwho-1360706. | #VALUE! | Bozkurt, B., Kamat, I., & Hotez, P. J. (2021). Miocarditis con vacunas de ARNm Covid-19. Circulación, 144 (6), 471-484. https://jamanetwork.com/journals/jama/fullarticle/2782900 | zzzz | Bozkurt, B., Kamat, I., & Hotez, P. J. (2021). Myocarditis with COVID-19 mRNA vaccines. Circulation, 144(6), 471-484. https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.121.056135 | Kim, H. W., Jenista, E. R., Wendell, D. C., Azevedo, C. F., Campbell, M. J., Darty, S. N., ... & Kim, R. J. (2021). Patients with acute myocarditis following mRNA COVID-19 vaccination. JAMA cardiology, 6(10), 1196-1201. | https://jamanetwork.com/journals/jamacardiology/fullarticle/2781602 | Kim, H. W., Jenista, E. R., Wendell, D. C., Azevedo, C. F., Campbell, M. J., Darty, S. N., ... & Kim, R. J. (2021). Patients with acute myocarditis following mRNA COVID-19 vaccination. JAMA cardiology, 6(10), 1196-1201. https://jamanetwork.com/journals/jamacardiology/fullarticle/2781602 | Carli, G., Nichele, I., Ruggeri, M., Barra, S., & Tosetto, A. (2021). Deep vein thrombosis (DVT) occurring shortly after the second dose of mRNA SARS-CoV-2 vaccine. Internal and emergency medicine, 16(3), 803-804. https://pubmed.ncbi.nlm.nih.gov/33687691/ | ||||
101 | COVID-19 vaccines and myocarditis: | https://pubmed.ncbi.nlm.nih.gov/34246566/ | https://pubmed.ncbi.nlm.nih.gov/34246566/ | Kerneis, M., Bihan, K., & Salem, J. E. (2021). COVID-19 vaccines and myocarditis. Arch Cardiovasc Dis, 114(6-7), 515-517. | Kerneis, M., Bihan, K. y Salem, JE (2021). Vacunas COVID-19 y miocarditis. Arch Cardiovasc Dis, 114(6-7), 515-517. https://www.cureus.com/articles/61030-myocarditis-and-other-cardiovascular-comp lications-of-the-mrna-based-covid-19-vaccines | Bozkurt, B., Kamat, I., & Hotez, P. J. (2021). Miocarditis con vacunas de ARNm Covid-19. Circulación, 144 (6), 471-484. https://media.jamanetwork.com/news-item/association-of-myocarditis-with-mrna-co vid-19-vaccine-in-children/ | Kerneis, M., Bihan, K., & Salem, J. E. (2021). COVID-19 vaccines and myocarditis. Arch Cardiovasc Dis, 114(6-7), 515-517. https://pubmed.ncbi.nlm.nih.gov/34246566/ | Bozkurt, B., Kamat, I., & Hotez, P. J. (2021). Myocarditis with COVID-19 mRNA vaccines. Circulation, 144(6), 471-484. https://www.ahajournals.org/doi/pdf/10.1161/CIRCULATIONAHA.121.056135 | Starekova, J., Bluemke, D. A., Bradham, W. S., Grist, T. M., Schiebler, M. L., & Reeder, S. B. (2021). Myocarditis associated with mRNA COVID-19 vaccination. Radiology, 301(2), E409-E411. | https://pubs.rsna.org/doi/10.1148/radiol.2021211430 | Starekova, J., Bluemke, D. A., Bradham, W. S., Grist, T. M., Schiebler, M. L., & Reeder, S. B. (2021). Myocarditis associated with mRNA COVID-19 vaccination. Radiology, 301(2), E409-E411. https://pubs.rsna.org/doi/10.1148/radiol.2021211430 | Castelli, G. P., Pognani, C., Sozzi, C., Franchini, M., & Vivona, L. (2021). Cerebral venous sinus thrombosis associated with thrombocytopenia post-vaccination for COVID-19. Critical Care, 25(1), 1-2. https://pubmed.ncbi.nlm.nih.gov/33845870/. | ||||
102 | Myocarditis and other cardiovascular complications of COVID-19 mRNA-based COVID-19 vaccines https://www.cureus.com/articles/61030-myocarditis-and-other-cardiovascular-comp lications-of-the-mrna-based-covid-19-vaccines | Myocarditis and other cardiovascular complications of COVID-19 mRNA-based COVID-19 vaccines | www.cureus.com/articles/61030-myocarditis-and-other-cardiovascular-comp lications-of-the-mrna-based-covid-19-vaccines | https://www.cureus.com/articles/61030-myocarditis-and-other-cardiovascular-comp lications-of-the-mrna-based-covid-19-vaccines | https://www.cureus.com/articles/61030-myocarditis-and-other-cardiovascular-comp lications-of-the-mrna-based-covid-19-vaccines | #VALUE! | Bozkurt, B., Kamat, I., & Hotez, P. J. (2021). Miocarditis con vacunas de ARNm Covid-19. Circulación, 144 (6), 471-484. https://www.ncbi.nlm.nih.gov/pubmed/34835284 | zzzz | Bozkurt, B., Kamat, I., & Hotez, P. J. (2021). Myocarditis with COVID-19 mRNA vaccines. Circulation, 144(6), 471-484. https://www.ncbi.nlm.nih.gov/pubmed/34281357 | Patel, Y. R., Louis, D. W., Atalay, M., Agarwal, S., & Shah, N. R. (2021). Cardiovascular magnetic resonance findings in young adult patients with acute myocarditis following mRNA COVID-19 vaccination: a case series. Journal of Cardiovascular Magnetic Resonance, 23(1), 1-8. | https://jcmr-online.biomedcentral.com/articles/10.1186/s12968-021-00795-4 | Patel, Y. R., Louis, D. W., Atalay, M., Agarwal, S., & Shah, N. R. (2021). Cardiovascular magnetic resonance findings in young adult patients with acute myocarditis following mRNA COVID-19 vaccination: a case series. Journal of Cardiovascular Magnetic Resonance, 23(1), 1-8. https://jcmr-online.biomedcentral.com/articles/10.1186/s12968-021-00795-4 | Català, A., Muñoz‐Santos, C., Galván‐Casas, C., Roncero Riesco, M., Revilla Nebreda, D., Solá‐Truyols, A., ... & Guilabert, A. (2022). Cutaneous reactions after SARS‐COV‐2 vaccination: a cross‐sectional Spanish nationwide study of 405 cases. British Journal of Dermatology, 186(1), 142-152. https://pubmed.ncbi.nlm.nih.gov/34254291/ | |||
103 | Myocarditis, pericarditis, and cardiomyopathy after COVID-19 vaccination: | https://pubmed.ncbi.nlm.nih.gov/34340927/ | https://pubmed.ncbi.nlm.nih.gov/34340927/ | Pepe, S., Gregory, A. T., & Denniss, A. R. (2021). Myocarditis, Pericarditis and Cardiomyopathy After COVID-19 Vaccination☆. Heart, Lung and Circulation, 30(10), 1425-1429. | Pepe, S., Gregory, AT y Denniss, AR (2021). Miocarditis, pericarditis y miocardiopatía tras la vacunación contra la COVID-19☆. Corazón, Pulmón y Circulación, 30(10), 1425-1429. https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.121.056135 | Braun, T., Viard, M., Jenemann, M., Struffert, T., Schwarm, F., Huttner, H. B., & Roessler, F. C. (2021). Informe de caso: Tome un segundo aspecto: COVID-19 Trombosis venosa cerebra cerebra relacionada con la vacunación y síndrome de trombocitopenia trombótica. Fronteras en neurología, 12. https://pubmed.ncbi.nlm.nih.gov/34587242/ | Pepe, S., Gregory, A. T., & Denniss, A. R. (2021). Myocarditis, Pericarditis and Cardiomyopathy After COVID-19 Vaccination☆. Heart, Lung and Circulation, 30(10), 1425-1429. https://pubmed.ncbi.nlm.nih.gov/34340927/ | Braun, T., Viard, M., Juenemann, M., Struffert, T., Schwarm, F., Huttner, H. B., & Roessler, F. C. (2021). Case Report: Take a Second Look: Covid-19 Vaccination-Related Cerebral Venous Thrombosis and Thrombotic Thrombocytopenia Syndrome. Frontiers in neurology, 12. https://pubmed.ncbi.nlm.nih.gov/34880826/ | Das, B. B., Moskowitz, W. B., Taylor, M. B., & Palmer, A. (2021). Myocarditis and pericarditis following mRNA COVID-19 vaccination: what do we know so far?. Children, 8(7), 607. | https://www.cps.ca/en/documents/position/clinical-guidance-for-youth-with-myocarditis-and-pericarditis | Das, B. B., Moskowitz, W. B., Taylor, M. B., & Palmer, A. (2021). Myocarditis and pericarditis following mRNA COVID-19 vaccination: what do we know so far?. Children, 8(7), 607. https://www.cps.ca/en/documents/position/clinical-guidance-for-youth-with-myocarditis-and-pericarditis | Cattaneo, M. (2021). Thrombosis with Thrombocytopenia Syndrome associated with viral vector COVID-19 vaccines. European Journal of Internal Medicine, 89, 22-24. https://www.sciencedirect.com/science/article/abs/pii/S0953620521001904 | ||||
104 | Myocarditis with covid-19 mRNA vaccines: | https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.121.056135 | https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.121.056135 | Bozkurt, B., Kamat, I., & Hotez, P. J. (2021). Myocarditis with COVID-19 mRNA vaccines. Circulation, 144(6), 471-484. | Bozkurt, B., Kamat, I. y Hotez, PJ (2021). Miocarditis con vacunas de ARNm de COVID-19. Circulación, 144(6), 471-484. https://media.jamanetwork.com/news-item/association-of-myocarditis-with-mrna-co vid-19-vaccine-in-children/ | Bril, F., Al Diffalha, S., Dean, M., & Fettig, D. M. (2021). Hepatitis autoinmune que se desarrolla después de la enfermedad de Coronavirus 2019 (COVID-19) Vacuna: ¿Causalidad o accidentes? Diario de hepatología, 75 (1), 222-224. https://pubmed.ncbi.nlm.nih.gov/34332438/ | Bozkurt, B., Kamat, I., & Hotez, P. J. (2021). Myocarditis with COVID-19 mRNA vaccines. Circulation, 144(6), 471-484. https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.121.056135 | Bril, F., Al Diffalha, S., Dean, M., & Fettig, D. M. (2021). Autoimmune hepatitis developing after coronavirus disease 2019 (COVID-19) vaccine: causality or casualty?. Journal of Hepatology, 75(1), 222-224. https://pubmed.ncbi.nlm.nih.gov/33862041/ | Kim, I. C., Kim, H., Lee, H. J., Kim, J. Y., & Kim, J. Y. (2021). Cardiac imaging of acute myocarditis following COVID-19 mRNA vaccination. Journal of Korean Medical Science, 36(32). | https://pubmed.ncbi.nlm.nih.gov/34402228/ | Kim, I. C., Kim, H., Lee, H. J., Kim, J. Y., & Kim, J. Y. (2021). Cardiac imaging of acute myocarditis following COVID-19 mRNA vaccination. Journal of Korean Medical Science, 36(32). https://pubmed.ncbi.nlm.nih.gov/34402228/ | Cavalli, G., Colafrancesco, S., De Luca, G., Rizzo, N., Priori, R., Conti, F., & Dagna, L. (2021). Cutaneous vasculitis following COVID-19 vaccination. The Lancet Rheumatology, 3(11), e743-e744. https://pubmed.ncbi.nlm.nih.gov/34611627/. | ||||
105 | Association of myocarditis with COVID-19 mRNA vaccine in children: | media.jamanetwork.com/news-item/association-of-myocarditis-with-mrna-co vid-19-vaccine-in-children/ | https://media.jamanetwork.com/news-item/association-of-myocarditis-with-mrna-co vid-19-vaccine-in-children/ | https://media.jamanetwork.com/news-item/association-of-myocarditis-with-mrna-co vid-19-vaccine-in-children/ | #VALUE! | Buchan, S. A., SEO, C. Y., Johnson, C., Alley, S., Kwong, J. C., Nasreen, S., ... & Wilson, S. E. (2021). Epidemiología de miocarditis y pericarditis después de las vacunas de ARNm en Ontario, Canadá: por producto de vacunación, horario e intervalo. medrxiv. https://pubmed.ncbi.nlm.nih.gov/33851711/ | zzzz | Buchan, S. A., Seo, C. Y., Johnson, C., Alley, S., Kwong, J. C., Nasreen, S., ... & Wilson, S. E. (2021). Epidemiology of myocarditis and pericarditis following mRNA vaccines in Ontario, Canada: by vaccine product, schedule and interval. medRxiv. https://www.medrxiv.org/content/10.1101/2021.12.02.21267156v1 | Tailor, P. D., Feighery, A. M., El-Sabawi, B., & Prasad, A. (2021). Case report: acute myocarditis following the second dose of mRNA-1273 SARS-CoV-2 vaccine. European Heart Journal-Case Reports, 5(8), ytab319. | https://academic.oup.com/ehjcr/article/5/8/ytab319/6339567 | Tailor, P. D., Feighery, A. M., El-Sabawi, B., & Prasad, A. (2021). Case report: acute myocarditis following the second dose of mRNA-1273 SARS-CoV-2 vaccine. European Heart Journal-Case Reports, 5(8), ytab319. https://academic.oup.com/ehjcr/article/5/8/ytab319/6339567 | Cebeci, F., & Kartal, İ. (2021). Petechial skin rash associated with CoronaVac vaccination: first cutaneous side effect report before phase 3 results. European Journal of Hospital Pharmacy. https://ejhp.bmj.com/content/early/2021/05/23/ejhpharm-2021-002794 | ||||
106 | Association of myocarditis with COVID-19 messenger RNA vaccine BNT162b2 in a case series of children: | https://jamanetwork.com/journals/jamacardiology/fullarticle/2783052 | https://jamanetwork.com/journals/jamacardiology/fullarticle/2783052 | Dionne, A., Sperotto, F., Chamberlain, S., Baker, A. L., Powell, A. J., Prakash, A., ... & Friedman, K. G. (2021). Association of myocarditis with BNT162b2 messenger RNA COVID-19 vaccine in a case series of children. JAMA cardiology, 6(12), 1446-1450. | Dionne, A., Sperotto, F., Chamberlain, S., Baker, A. L., Powell, A. J., Prakash, A., ... y Friedman, K. G. (2021). Asociación de miocarditis con la vacuna COVID-19 de ARN mensajero BNT162b2 en una serie de casos de niños. Cardiología JAMA, 6(12), 1446-1450. https://jamanetwork.com/journals/jamacardiology/fullarticle/2781601%5C | Buchhorn, R., Meyer, C., Schulze-Forster, K., Junker, J., & Heidecke, H. (2021). Autoanticody liberación en niños después de la vacunación contra el ARNm de virus de Corona: ¿Un factor de riesgo del síndrome inflamatorio multisistémico? Vacunas, 9 (11), 1353. https://www.ncbi.nlm.nih.gov/pubmed/34366403 | Dionne, A., Sperotto, F., Chamberlain, S., Baker, A. L., Powell, A. J., Prakash, A., ... & Friedman, K. G. (2021). Association of myocarditis with BNT162b2 messenger RNA COVID-19 vaccine in a case series of children. JAMA cardiology, 6(12), 1446-1450. https://jamanetwork.com/journals/jamacardiology/fullarticle/2783052 | Buchhorn, R., Meyer, C., Schulze-Forster, K., Junker, J., & Heidecke, H. (2021). Autoantibody Release in Children after Corona Virus mRNA Vaccination: A Risk Factor of Multisystem Inflammatory Syndrome?. Vaccines, 9(11), 1353. https://www.ncbi.nlm.nih.gov/pubmed/34835284 | Tano, E., San Martin, S., Girgis, S., Martinez-Fernandez, Y., & Sanchez Vegas, C. (2021). Perimyocarditis in adolescents after Pfizer-BioNTech COVID-19 vaccine. Journal of the Pediatric Infectious Diseases Society, 10(10), 962-966. | https://academic.oup.com/jpids/advance-article/doi/10.1093/jpids/piab060/6329543 | Tano, E., San Martin, S., Girgis, S., Martinez-Fernandez, Y., & Sanchez Vegas, C. (2021). Perimyocarditis in adolescents after Pfizer-BioNTech COVID-19 vaccine. Journal of the Pediatric Infectious Diseases Society, 10(10), 962-966. https://academic.oup.com/jpids/advance-article/doi/10.1093/jpids/piab060/6329543 | Cellina, M., D'Arrigo, A., Floridi, C., Oliva, G., & Carrafiello, G. (2022). Left Bell's palsy following the first dose of mRNA-1273 SARS-CoV-2 vaccine: A case report. Clinical Imaging, 82, 1-4. https://pubmed.ncbi.nlm.nih.gov/34763263/. | ||||
107 | Myocarditis after immunization with COVID-19 mRNA vaccines in members of the U.S. military: | https://jamanetwork.com/journals/jamacardiology/fullarticle/2781601%5C | https://jamanetwork.com/journals/jamacardiology/fullarticle/2781601%5C | Montgomery, J., Ryan, M., Engler, R., Hoffman, D., McClenathan, B., Collins, L., ... & Cooper, L. T. (2021). Myocarditis following immunization with mRNA COVID-19 vaccines in members of the US military. JAMA cardiology, 6(10), 1202-1206. | Montgomery, J., Ryan, M., Engler, R., Hoffman, D., McClenathan, B., Collins, L., ... y Cooper, LT (2021). Miocarditis tras la inmunización con vacunas de ARNm COVID-19 en miembros del ejército de EE. UU. Cardiología JAMA, 6(10), 1202-1206. https://jamanetwork.com/journals/jamacardiology/fullarticle/2781600 | Burillo, J. C., Martínez, C. L., Arguedas, C. G. y PUEYO, F. M. (2021). Neuralgia amiotrófica secundaria a Vaxzevri (AstraZeneca) COVID-19 VACUNA. Neurologia (Barcelona, España). https://pubmed.ncbi.nlm.nih.gov/34477089/ | Montgomery, J., Ryan, M., Engler, R., Hoffman, D., McClenathan, B., Collins, L., ... & Cooper, L. T. (2021). Myocarditis following immunization with mRNA COVID-19 vaccines in members of the US military. JAMA cardiology, 6(10), 1202-1206. https://jamanetwork.com/journals/jamacardiology/fullarticle/2781601%5C | Burillo, J. C., Martínez, C. L., Arguedas, C. G., & Pueyo, F. M. (2021). Amyotrophic neuralgia secondary to Vaxzevri (AstraZeneca) COVID-19 vaccine. Neurologia (Barcelona, Spain). https://pubmed.ncbi.nlm.nih.gov/34330677/ | Lazaros, G., Klein, A. L., Hatziantoniou, S., Tsioufis, C., Tsakris, A., & Anastassopoulou, C. (2021). The novel platform of mRNA COVID-19 vaccines and myocarditis: clues into the potential underlying mechanism. Vaccine, 39(35), 4925. | https://pubmed.ncbi.nlm.nih.gov/34312010/ | Lazaros, G., Klein, A. L., Hatziantoniou, S., Tsioufis, C., Tsakris, A., & Anastassopoulou, C. (2021). The novel platform of mRNA COVID-19 vaccines and myocarditis: clues into the potential underlying mechanism. Vaccine, 39(35), 4925. https://pubmed.ncbi.nlm.nih.gov/34312010/ | Čenščák, D., Ungermann, L., Štětkářová, I., & Ehler, E. (2021). Guillan-Barré Syndrome after the First Vaccination Dose against COVID-19: Case Report. ACTA MEDICA, 64(3), 183-186. https://pubmed.ncbi.nlm.nih.gov/34779385/. | ||||
108 | Myocarditis occurring after immunization with COVID-19 mRNA-based COVID-19 vaccines: | https://jamanetwork.com/journals/jamacardiology/fullarticle/2781600 | https://jamanetwork.com/journals/jamacardiology/fullarticle/2781600 | Shay, D. K., Shimabukuro, T. T., & DeStefano, F. (2021). Myocarditis occurring after immunization with mRNA-based COVID-19 vaccines. JAMA cardiology, 6(10), 1115-1117. | Shay, DK, Shimabukuro, TT y DeStefano, F. (2021). Miocarditis que ocurre después de la inmunización con vacunas COVID-19 basadas en ARNm. Cardiología JAMA, 6(10), 1115-1117. https://www.nejm.org/doi/full/10.1056/NEJMc2109975 | Burrows, A., Bartholomew, T., Rudd, J., & Walker, D. (2021). Palos de nervio facial contralateral secuencial después de la vacunación COVID-19 Primera y segunda dosis. BMJ Case Reports CP, 14 (7), E243829. https://pubmed.ncbi.nlm.nih.gov/34458035/ | Shay, D. K., Shimabukuro, T. T., & DeStefano, F. (2021). Myocarditis occurring after immunization with mRNA-based COVID-19 vaccines. JAMA cardiology, 6(10), 1115-1117. https://jamanetwork.com/journals/jamacardiology/fullarticle/2781600 | Burrows, A., Bartholomew, T., Rudd, J., & Walker, D. (2021). Sequential contralateral facial nerve palsies following COVID-19 vaccination first and second doses. BMJ Case Reports CP, 14(7), e243829. https://pubmed.ncbi.nlm.nih.gov/34281950/. | Deb, A., Abdelmalek, J., Iwuji, K., & Nugent, K. (2021). Acute myocardial injury following COVID-19 vaccination: a case report and review of current evidence from vaccine adverse events reporting system database. Journal of primary care & community health, 12, 21501327211029230. | https://pubmed.ncbi.nlm.nih.gov/34219532/ | Deb, A., Abdelmalek, J., Iwuji, K., & Nugent, K. (2021). Acute myocardial injury following COVID-19 vaccination: a case report and review of current evidence from vaccine adverse events reporting system database. Journal of primary care & community health, 12, 21501327211029230. https://pubmed.ncbi.nlm.nih.gov/34219532/ | Cereda, A., Conca, C., Barbieri, L., Ferrante, G., Tumminello, G., Lucreziotti, S., ... & Mafrici, A. (2021). Acute myocarditis after the second dose of SARS-CoV-2 vaccine: Serendipity or atypical causal relationship?. Anatolian Journal of Cardiology, 25(7), 522. https://pubmed.ncbi.nlm.nih.gov/34236331/ | ||||
109 | Myocarditis following immunization with Covid-19 mRNA: | https://www.nejm.org/doi/full/10.1056/NEJMc2109975 | https://www.nejm.org/doi/full/10.1056/NEJMc2109975 | Verma, A. K., Lavine, K. J., & Lin, C. Y. (2021). Myocarditis after Covid-19 mRNA vaccination. New England Journal of Medicine, 385(14), 1332-1334. | Verma, AK, Lavine, KJ y Lin, CY (2021). Miocarditis tras la vacunación con ARNm de Covid-19. Revista de Medicina de Nueva Inglaterra, 385(14), 1332-1334. https://jamanetwork.com/journals/jamacardiology/fullarticle/2781602 | Cabanillas, B., AKDIS, C., & NOVAK, N. (2020). Reacciones alérgicas a la primera vacuna Covid-19: un papel potencial del polietilenglicol. Alergia, 76 (6), 1617-1618. https://pubmed.ncbi.nlm.nih.gov/33384356/ | Verma, A. K., Lavine, K. J., & Lin, C. Y. (2021). Myocarditis after Covid-19 mRNA vaccination. New England Journal of Medicine, 385(14), 1332-1334. https://www.nejm.org/doi/full/10.1056/NEJMc2109975 | Cabanillas, B., Akdis, C., & Novak, N. (2020). Allergic reactions to the first COVID-19 vaccine: a potential role of Polyethylene glycol. Allergy, 76(6), 1617-1618. https://pubmed.ncbi.nlm.nih.gov/33320974/ | Han, T., Ma, W., Zhang, Y., & Wang, C. (2021). Be Alert to the Risk of Adverse Cardiovascular Events after COVID-19 Vaccination. Exploratory Research and Hypothesis in Medicine, (000), 0-0. | https://www.xiahepublishing.com/m/2472-0712/ERHM-2021-00033 | Han, T., Ma, W., Zhang, Y., & Wang, C. (2021). Be Alert to the Risk of Adverse Cardiovascular Events after COVID-19 Vaccination. Exploratory Research and Hypothesis in Medicine, (000), 0-0. https://www.xiahepublishing.com/m/2472-0712/ERHM-2021-00033 | Ceschia, N., Scheggi, V., Gori, A. M., Rogolino, A. A., Cesari, F., Giusti, B., ... & Marcucci, R. (2021). Diffuse prothrombotic syndrome after ChAdOx1 nCoV-19 vaccine administration: a case report. Journal of Medical Case Reports, 15(1), 1-4. https://pubmed.ncbi.nlm.nih.gov/34615534/ | ||||
110 | Patients with acute myocarditis after vaccination withCOVID-19 mRNA: | https://jamanetwork.com/journals/jamacardiology/fullarticle/2781602 | https://jamanetwork.com/journals/jamacardiology/fullarticle/2781602 | Kim, H. W., Jenista, E. R., Wendell, D. C., Azevedo, C. F., Campbell, M. J., Darty, S. N., ... & Kim, R. J. (2021). Patients with acute myocarditis following mRNA COVID-19 vaccination. JAMA cardiology, 6(10), 1196-1201. | Kim, HW, Jenista, E. R., Wendell, D. C., Azevedo, C. F., Campbell, M. J., Darty, S. N., ... y Kim, R. J. (2021). Pacientes con miocarditis aguda después de la vacunación con ARNm COVID-19. Cardiología JAMA, 6(10), 1196-1201. https://pubs.rsna.org/doi/10.1148/radiol.2021211430 | Calcaterra, G., Bassaroo, P. P., Romeo, F., & Mehta, J. L. (2022). Con respecto al estado protrombótico inesperado después de algunas vacunas de la enfermedad de Coronavirus 2019. Diario de medicina cardiovascular, 23 (2), 71-74. https://www.ncbi.nlm.nih.gov/pubmed/34564344 | Kim, H. W., Jenista, E. R., Wendell, D. C., Azevedo, C. F., Campbell, M. J., Darty, S. N., ... & Kim, R. J. (2021). Patients with acute myocarditis following mRNA COVID-19 vaccination. JAMA cardiology, 6(10), 1196-1201. https://jamanetwork.com/journals/jamacardiology/fullarticle/2781602 | Calcaterra, G., Bassareo, P. P., Romeo, F., & Mehta, J. L. (2022). Concerning the unexpected prothrombotic state following some coronavirus disease 2019 vaccines. Journal of Cardiovascular Medicine, 23(2), 71-74. https://www.ncbi.nlm.nih.gov/pubmed/34366403 | Viskin, D., Topilsky, Y., Aviram, G., Mann, T., Sadon, S., Hadad, Y., ... & Havakuk, O. (2021). Myocarditis Associated With COVID-19 Vaccination: Echocardiography, Cardiac Tomography, and Magnetic Resonance Imaging Findings. Circulation: Cardiovascular Imaging, 14(9), e013236. | https://www.ahajournals.org/doi/10.1161/CIRCIMAGING.121.013236 | Viskin, D., Topilsky, Y., Aviram, G., Mann, T., Sadon, S., Hadad, Y., ... & Havakuk, O. (2021). Myocarditis Associated With COVID-19 Vaccination: Echocardiography, Cardiac Tomography, and Magnetic Resonance Imaging Findings. Circulation: Cardiovascular Imaging, 14(9), e013236. https://www.ahajournals.org/doi/10.1161/CIRCIMAGING.121.013236 | Chai, Q., Nygaard, U., Schmidt, R. C., Zaremba, T., Møller, A. M., & Thorvig, C. M. (2022). Multisystem inflammatory syndrome in a male adolescent after his second Pfizer‐BioNTech COVID‐19 vaccine. Acta Paediatrica, 111(1), 125-127. https://www.ncbi.nlm.nih.gov/pubmed/34617315 | ||||
111 | Myocarditis associated with vaccination with COVID-19 mRNA: | https://pubs.rsna.org/doi/10.1148/radiol.2021211430 | https://pubs.rsna.org/doi/10.1148/radiol.2021211430 | Starekova, J., Bluemke, D. A., Bradham, W. S., Grist, T. M., Schiebler, M. L., & Reeder, S. B. (2021). Myocarditis associated with mRNA COVID-19 vaccination. Radiology, 301(2), E409-E411. | Starekova, J., Bluemke, D. A., Bradham, W. S., Grist, T. M., Schiebler, M. L. y Reeder, SB (2021). Miocarditis asociada a la vacunación con ARNm COVID-19. Radiología, 301(2), E409-E411. https://pediatrics.aappublications.org/content/148/3/e2021052478 | Calcaterra, G., Mehta, J. L., De Gregorio, C., Butera, G., Neroni, P., Fanos, V., & Bassaroo, P. P. (2021). Covid 19 vacuna para adolescentes. Preocupación por miocarditis y pericarditis. Informes pediátricos, 13 (3), 530-533. https://pubmed.ncbi.nlm.nih.gov/34133885/ | Starekova, J., Bluemke, D. A., Bradham, W. S., Grist, T. M., Schiebler, M. L., & Reeder, S. B. (2021). Myocarditis associated with mRNA COVID-19 vaccination. Radiology, 301(2), E409-E411. https://pubs.rsna.org/doi/10.1148/radiol.2021211430 | Calcaterra, G., Mehta, J. L., De Gregorio, C., Butera, G., Neroni, P., Fanos, V., & Bassareo, P. P. (2021). COVID 19 vaccine for adolescents. Concern about myocarditis and pericarditis. Pediatric Reports, 13(3), 530-533. https://www.mdpi.com/2036-7503/13/3/61. | Muthukumar, A., Narasimhan, M., Li, Q. Z., Mahimainathan, L., Hitto, I., Fuda, F., ... & De Lemos, J. A. (2021). In-depth evaluation of a case of presumed myocarditis after the second dose of COVID-19 mRNA vaccine. Circulation, 144(6), 487-498. | https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.121.056038 | Muthukumar, A., Narasimhan, M., Li, Q. Z., Mahimainathan, L., Hitto, I., Fuda, F., ... & De Lemos, J. A. (2021). In-depth evaluation of a case of presumed myocarditis after the second dose of COVID-19 mRNA vaccine. Circulation, 144(6), 487-498. https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.121.056038 | Chamling, B., Vehof, V., Drakos, S., Weil, M., Stalling, P., Vahlhaus, C., ... & Yilmaz, A. (2021). Occurrence of acute infarct-like myocarditis following COVID-19 vaccination: just an accidental co-incidence or rather vaccination-associated autoimmune myocarditis?. Clinical Research in Cardiology, 110(11), 1850-1854. https://pubmed.ncbi.nlm.nih.gov/34333695/ | ||||
112 | Symptomatic Acute Myocarditis in 7 Adolescents after Pfizer-BioNTech COVID-19 Vaccination: | https://pediatrics.aappublications.org/content/148/3/e2021052478 | https://pediatrics.aappublications.org/content/148/3/e2021052478 | Marshall, M., Ferguson, I. D., Lewis, P., Jaggi, P., Gagliardo, C., Collins, J. S., ... & Guzman-Cottrill, J. A. (2021). Symptomatic acute myocarditis in 7 adolescents after Pfizer-BioNTech COVID-19 vaccination. Pediatrics, 148(3). | Marshall, M., Ferguson, I. D., Lewis, P., Jaggi, P., Gagliardo, C., Collins, J. S., ... y Guzman-Cottrill, J. A. (2021). Miocarditis aguda sintomática en 7 adolescentes tras la vacunación contra el COVID-19 de Pfizer-BioNTech. Pediatría, 148(3). https://jcmr-online.biomedcentral.com/articles/10.1186/s12968-021-00795-4 | Calcaterra, G., Mehta, J. L., De Gregorio, C., Butera, G., Neroni, P., Fanos, V., & Bassaroo, P. P. (2021). Covid 19 vacuna para adolescentes. Preocupación por miocarditis y pericarditis. Informes pediátricos, 13 (3), 530-533. https://www.ncbi.nlm.nih.gov/pubmed/34617315 | Marshall, M., Ferguson, I. D., Lewis, P., Jaggi, P., Gagliardo, C., Collins, J. S., ... & Guzman-Cottrill, J. A. (2021). Symptomatic acute myocarditis in 7 adolescents after Pfizer-BioNTech COVID-19 vaccination. Pediatrics, 148(3). https://pediatrics.aappublications.org/content/148/3/e2021052478 | Calcaterra, G., Mehta, J. L., De Gregorio, C., Butera, G., Neroni, P., Fanos, V., & Bassareo, P. P. (2021). COVID 19 vaccine for adolescents. Concern about myocarditis and pericarditis. Pediatric Reports, 13(3), 530-533. https://www.ncbi.nlm.nih.gov/pubmed/34564344 | Chamling, B., Vehof, V., Drakos, S., Weil, M., Stalling, P., Vahlhaus, C., ... & Yilmaz, A. (2021). Occurrence of acute infarct-like myocarditis following COVID-19 vaccination: just an accidental co-incidence or rather vaccination-associated autoimmune myocarditis?. Clinical Research in Cardiology, 110(11), 1850-1854. | https://pubmed.ncbi.nlm.nih.gov/34333695/ | Chamling, B., Vehof, V., Drakos, S., Weil, M., Stalling, P., Vahlhaus, C., ... & Yilmaz, A. (2021). Occurrence of acute infarct-like myocarditis following COVID-19 vaccination: just an accidental co-incidence or rather vaccination-associated autoimmune myocarditis?. Clinical Research in Cardiology, 110(11), 1850-1854. https://pubmed.ncbi.nlm.nih.gov/34333695/ | Chang, J. C., & Hawley, H. B. (2021). Vaccine-Associated Thrombocytopenia and Thrombosis: Venous Endotheliopathy Leading to Venous Combined Micro-Macrothrombosis. Medicina, 57(11), 1163. https://pubmed.ncbi.nlm.nih.gov/34833382/ | ||||
113 | Cardiovascular magnetic resonance imaging findings in young adult patients with acute myocarditis after COVID-19 mRNA vaccination: a case series: | https://jcmr-online.biomedcentral.com/articles/10.1186/s12968-021-00795-4 | https://jcmr-online.biomedcentral.com/articles/10.1186/s12968-021-00795-4 | Patel, Y. R., Louis, D. W., Atalay, M., Agarwal, S., & Shah, N. R. (2021). Cardiovascular magnetic resonance findings in young adult patients with acute myocarditis following mRNA COVID-19 vaccination: a case series. Journal of Cardiovascular Magnetic Resonance, 23(1), 1-8. | Patel, YR, Louis, DW, Atalay, M., Agarwal, S. y Shah, NR (2021). Hallazgos de resonancia magnética cardiovascular en pacientes adultos jóvenes con miocarditis aguda después de la vacunación con ARNm COVID-19: una serie de casos. Revista de resonancia magnética cardiovascular, 23(1), 1-8. https://www.cps.ca/en/documents/position/clinical-guidance-for-youth-with-myocarditis-and-pericarditis | Cantante, M. E., Taub, I. B., & Kaelber, D. C. (2021). Riesgo de miocarditis de la infección de COVID-19 en personas menores de 20 años: un análisis basado en la población. medrxiv. https://www.ncbi.nlm.nih.gov/pubmed/34764489 | Patel, Y. R., Louis, D. W., Atalay, M., Agarwal, S., & Shah, N. R. (2021). Cardiovascular magnetic resonance findings in young adult patients with acute myocarditis following mRNA COVID-19 vaccination: a case series. Journal of Cardiovascular Magnetic Resonance, 23(1), 1-8. https://jcmr-online.biomedcentral.com/articles/10.1186/s12968-021-00795-4 | Cardoso, F., Reis, A., Osório, C., Scigliano, H., & Nora, M. (2021). A case of cervical lymphadenopathy after vaccination against COVID-19. Cureus, 13(5). https://pubmed.ncbi.nlm.nih.gov/34141500/ | D'Angelo, T., Cattafi, A., Carerj, M. L., Booz, C., Ascenti, G., Cicero, G., ... & Mazziotti, S. (2021). Myocarditis after SARS-CoV-2 vaccination: a vaccine-induced reaction?. Canadian Journal of Cardiology, 37(10), 1665-1667. | https://pubmed.ncbi.nlm.nih.gov/34118375/ | D'Angelo, T., Cattafi, A., Carerj, M. L., Booz, C., Ascenti, G., Cicero, G., ... & Mazziotti, S. (2021). Myocarditis after SARS-CoV-2 vaccination: a vaccine-induced reaction?. Canadian Journal of Cardiology, 37(10), 1665-1667. https://pubmed.ncbi.nlm.nih.gov/34118375/ | Chelala, L., Jeudy, J., Hossain, R., Rosenthal, G., Pietris, N., & White, C. (2021). Cardiac MRI findings of myocarditis after COVID-19 mRNA vaccination in adolescents. American Journal of Roentgenology. https://pubmed.ncbi.nlm.nih.gov/34704459/ | ||||
114 | Clinical Guidance for Young People with Myocarditis and Pericarditis after Vaccination with COVID-19 mRNA: | https://www.cps.ca/en/documents/position/clinical-guidance-for-youth-with-myocarditis-and-pericarditis | https://www.cps.ca/en/documents/position/clinical-guidance-for-youth-with-myocarditis-and-pericarditis | Das, B. B., Moskowitz, W. B., Taylor, M. B., & Palmer, A. (2021). Myocarditis and pericarditis following mRNA COVID-19 vaccination: what do we know so far?. Children, 8(7), 607. | Das, B. B., Moskowitz, W. B., Taylor, M. B. y Palmer, A. (2021). Miocarditis y pericarditis tras la vacunación con ARNm COVID-19: ¿qué sabemos hasta ahora? Niños, 8(7), 607. https://pubmed.ncbi.nlm.nih.gov/34402228/ | Cardoso, F., Reis, A., Osório, C., Scigliano, H., & Nora, M. (2021). Un caso de linfadenopatía cervical después de la vacunación contra COVID-19. CUREUS, 13 (5). https://pubmed.ncbi.nlm.nih.gov/34096896/ | Das, B. B., Moskowitz, W. B., Taylor, M. B., & Palmer, A. (2021). Myocarditis and pericarditis following mRNA COVID-19 vaccination: what do we know so far?. Children, 8(7), 607. https://www.cps.ca/en/documents/position/clinical-guidance-for-youth-with-myocarditis-and-pericarditis | Cari, L., Alhosseini, M. N., Fiore, P., Pierno, S., Pacor, S., Bergamo, A., ... & Nocentini, G. (2021). Cardiovascular, neurological, and pulmonary events following vaccination with the BNT162b2, ChAdOx1 nCoV-19, and Ad26. COV2. S vaccines: An analysis of European data. Journal of autoimmunity, 125, 102742. https://pubmed.ncbi.nlm.nih.gov/34710832/ | Park, J., Brekke, D. R., & Bratincsak, A. (2022). Self-limited myocarditis presenting with chest pain and ST segment elevation in adolescents after vaccination with the BNT162b2 mRNA vaccine. Cardiology in the Young, 32(1), 146-149. | https://pubmed.ncbi.nlm.nih.gov/34180390/ | Park, J., Brekke, D. R., & Bratincsak, A. (2022). Self-limited myocarditis presenting with chest pain and ST segment elevation in adolescents after vaccination with the BNT162b2 mRNA vaccine. Cardiology in the Young, 32(1), 146-149. https://pubmed.ncbi.nlm.nih.gov/34180390/ | Chen, C. C., Chen, H. Y., Lu, C. C., & Lin, S. H. (2021). Case Report: Anti-neutrophil Cytoplasmic Antibody-Associated Vasculitis With Acute Renal Failure and Pulmonary Hemorrhage May Occur After COVID-19 Vaccination. Frontiers in Medicine, 8. https://pubmed.ncbi.nlm.nih.gov/34859017/ | ||||
115 | Cardiac imaging of acute myocarditis after vaccination with COVID-19 mRNA: | https://pubmed.ncbi.nlm.nih.gov/34402228/ | https://pubmed.ncbi.nlm.nih.gov/34402228/ | Kim, I. C., Kim, H., Lee, H. J., Kim, J. Y., & Kim, J. Y. (2021). Cardiac imaging of acute myocarditis following COVID-19 mRNA vaccination. Journal of Korean Medical Science, 36(32). | Kim, I. C., Kim, H., Lee, H. J., Kim, J. Y. y Kim, J. Y. (2021). Imágenes cardíacas de miocarditis aguda después de la vacunación con ARNm de COVID-19. Revista de ciencia médica coreana, 36(32). https://academic.oup.com/ehjcr/article/5/8/ytab319/6339567 | Cari, L., Alhosseini, M. N., Fiore, P., Pierno, S., PLOR, S., BERGAMO, A., ... & NOCENTINI, G. (2021). Eventos cardiovasculares, neurológicos y pulmonares después de la vacunación con el BNT162B2, Chadox1 NCOV-19, y AD26. COV2. S Vacunas: un análisis de los datos europeos. Diario de autoinmunidad, 125, 102742. https://pubmed.ncbi.nlm.nih.gov/34695859/ | Kim, I. C., Kim, H., Lee, H. J., Kim, J. Y., & Kim, J. Y. (2021). Cardiac imaging of acute myocarditis following COVID-19 mRNA vaccination. Journal of Korean Medical Science, 36(32). https://pubmed.ncbi.nlm.nih.gov/34402228/ | Cari, L., Fiore, P., Alhosseini, M. N., Sava, G., & Nocentini, G. (2021). Blood clots and bleeding events following BNT162b2 and ChAdOx1 nCoV-19 vaccine: An analysis of European data. Journal of autoimmunity, 122, 102685. https://pubmed.ncbi.nlm.nih.gov/34174723/ | McLean, K., & Johnson, T. J. (2021). Myopericarditis in a previously healthy adolescent male following COVID‐19 vaccination: A case report. Academic Emergency Medicine, 28(8), 918-921. | https://pubmed.ncbi.nlm.nih.gov/34133825/ | McLean, K., & Johnson, T. J. (2021). Myopericarditis in a previously healthy adolescent male following COVID‐19 vaccination: A case report. Academic Emergency Medicine, 28(8), 918-921. https://pubmed.ncbi.nlm.nih.gov/34133825/ | Chen, J., Cai, Y., Chen, Y., Williams, A. P., Gao, Y., & Zeng, J. (2021). Nervous and muscular adverse events after COVID-19 vaccination: a systematic review and meta-analysis of clinical trials. Vaccines, 9(8), 939. https://pubmed.ncbi.nlm.nih.gov/34452064/. | ||||
116 | Case report: acute myocarditis after second dose of mRNA-1273 SARS-CoV-2 mRNA vaccine: | https://academic.oup.com/ehjcr/article/5/8/ytab319/6339567 | https://academic.oup.com/ehjcr/article/5/8/ytab319/6339567 | Tailor, P. D., Feighery, A. M., El-Sabawi, B., & Prasad, A. (2021). Case report: acute myocarditis following the second dose of mRNA-1273 SARS-CoV-2 vaccine. European Heart Journal-Case Reports, 5(8), ytab319. | Tailor, P. D., Feighery, A. M., El-Sabawi, B. y Prasad, A. (2021). Informe de caso: miocarditis aguda tras la segunda dosis de la vacuna mRNA-1273 SARS-CoV-2. European Heart Journal-Case Reports, 5(8), ytab319. https://science.gc.ca/eic/site/063.nsf/eng/h_98291.html | Cari, L., Fiore, P., Alhosseini, M. N., SAVA, G., Y NOCENTINI, G. (2021). Coágulos de sangre y eventos de sangrado después de la vacuna BNT162B2 y CHADOX1 NCOV-19: un análisis de los datos europeos. Diario de autoinmunidad, 122, 102685. https://www.nature.com/articles/s41591-021-01408-4 | Tailor, P. D., Feighery, A. M., El-Sabawi, B., & Prasad, A. (2021). Case report: acute myocarditis following the second dose of mRNA-1273 SARS-CoV-2 vaccine. European Heart Journal-Case Reports, 5(8), ytab319. https://academic.oup.com/ehjcr/article/5/8/ytab319/6339567 | Cari, L., Fiore, P., Alhosseini, M. N., Sava, G., & Nocentini, G. (2021). Blood clots and bleeding events following BNT162b2 and ChAdOx1 nCoV-19 vaccine: An analysis of European data. Journal of autoimmunity, 122, 102685. https://www.sciencedirect.com/science/article/pii/S0896841121000937 | Ehrlich, P., Klingel, K., Ohlmann-Knafo, S., Hüttinger, S., Sood, N., Pickuth, D., & Kindermann, M. (2021). Biopsy-proven lymphocytic myocarditis following first mRNA COVID-19 vaccination in a 40-year-old male: case report. Clinical Research in Cardiology, 110(11), 1855-1859. | https://pubmed.ncbi.nlm.nih.gov/34487236/ | Ehrlich, P., Klingel, K., Ohlmann-Knafo, S., Hüttinger, S., Sood, N., Pickuth, D., & Kindermann, M. (2021). Biopsy-proven lymphocytic myocarditis following first mRNA COVID-19 vaccination in a 40-year-old male: case report. Clinical Research in Cardiology, 110(11), 1855-1859. https://pubmed.ncbi.nlm.nih.gov/34487236/ | Chen, S., Fan, X. R., He, S., Zhang, J. W., & Li, S. J. (2021). Watch out for neuromyelitis optica spectrum disorder after inactivated virus vaccination for COVID-19. Neurological Sciences, 42(9), 3537-3539. https://pubmed.ncbi.nlm.nih.gov/34189662/ | ||||
117 | Myocarditis / pericarditis associated with COVID-19 vaccine: | https://science.gc.ca/eic/site/063.nsf/eng/h_98291.html | https://science.gc.ca/eic/site/063.nsf/eng/h_98291.html | #VALUE! | Cari, L., Fiore, P., Alhosseini, M. N., SAVA, G., Y NOCENTINI, G. (2021). Coágulos de sangre y eventos de sangrado después de la vacuna BNT162B2 y CHADOX1 NCOV-19: un análisis de los datos europeos. Diario de autoinmunidad, 122, 102685. https://www.sciencedirect.com/science/article/abs/pii/S1052305721003098 | zzzz | Cari, L., Fiore, P., Alhosseini, M. N., Sava, G., & Nocentini, G. (2021). Blood clots and bleeding events following BNT162b2 and ChAdOx1 nCoV-19 vaccine: An analysis of European data. Journal of autoimmunity, 122, 102685. https://www.sciencedirect.com/science/article/pii/S0896841121000937. | Knowlton, K. U. (2021). Insights From a Murine Model of Coronavirus Disease 2019 (COVID-19) mRNA Vaccination-Induced Myopericarditis: Could Accidental Intravenous Vaccine Injection Induce Myopericarditis?. Clinical Infectious Diseases. | https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciab741/6359059 | Knowlton, K. U. (2021). Insights From a Murine Model of Coronavirus Disease 2019 (COVID-19) mRNA Vaccination-Induced Myopericarditis: Could Accidental Intravenous Vaccine Injection Induce Myopericarditis?. Clinical Infectious Diseases. https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciab741/6359059 | Chen, V. M., Curnow, J. L., Tran, H. A., & Choi, P. Y. I. (2021). Australian and New Zealand approach to diagnosis and management of vaccine‐induced immune thrombosis and thrombocytopenia. Medical Journal of Australia, 215(6), 245-249. https://pubmed.ncbi.nlm.nih.gov/34490632/ | |||||
118 | Transient cardiac injury in adolescents receiving the BNT162b2 mRNA COVID-19 vaccine: | journals.lww.com/pidj/Abstract/9000/Transient_Cardiac_Injury_in_Adolesce nts_Receiving.95800.aspx | https://journals.lww.com/pidj/Abstract/9000/Transient_Cardiac_Injury_in_Adolesce nts_Receiving.95800.aspx | https://journals.lww.com/pidj/Abstract/9000/Transient_Cardiac_Injury_in_Adolesce nts_Receiving.95800.aspx | #VALUE! | Cari, L., Fiore, P., Alhosseini, M. N., SAVA, G., Y NOCENTINI, G. (2021). Coágulos de sangre y eventos de sangrado después de la vacuna BNT162B2 y CHADOX1 NCOV-19: un análisis de los datos europeos. Diario de autoinmunidad, 122, 102685. https://www.sciencedirect.com/science/article/pii/S2214250921002018. | zzzz | Carli, G., Nichele, I., Ruggeri, M., Barra, S., & Tosetto, A. (2021). Deep vein thrombosis (DVT) occurring shortly after the second dose of mRNA SARS-CoV-2 vaccine. Internal and emergency medicine, 16(3), 803-804. https://pubmed.ncbi.nlm.nih.gov/33687691/ | Khogali, F., & Abdelrahman, R. (2021). Unusual presentation of acute perimyocarditis following SARS-COV-2 mRNA-1237 Moderna vaccination. Cureus, 13(7). | https://pubmed.ncbi.nlm.nih.gov/34447639/ | Khogali, F., & Abdelrahman, R. (2021). Unusual presentation of acute perimyocarditis following SARS-COV-2 mRNA-1237 Moderna vaccination. Cureus, 13(7). https://pubmed.ncbi.nlm.nih.gov/34447639/ | Chen, Y. A., Huang, H. Y., Wu, S. H., & Huang, T. C. (2021). Thrombosis of the palmar digital vein after Oxford-AstraZeneca COVID-19 vaccination. International Journal of Dermatology, 60(11), e469-e471. https://pubmed.ncbi.nlm.nih.gov/34473841/. | ||||
119 | Perimyocarditis in adolescents after Pfizer-BioNTech COVID-19 vaccine: | https://academic.oup.com/jpids/advance-article/doi/10.1093/jpids/piab060/6329543 | https://academic.oup.com/jpids/advance-article/doi/10.1093/jpids/piab060/6329543 | Tano, E., San Martin, S., Girgis, S., Martinez-Fernandez, Y., & Sanchez Vegas, C. (2021). Perimyocarditis in adolescents after Pfizer-BioNTech COVID-19 vaccine. Journal of the Pediatric Infectious Diseases Society, 10(10), 962-966. | Tano, E., San Martín, S., Girgis, S., Martínez-Fernández, Y. y Sánchez Vegas, C. (2021). Perimiocarditis en adolescentes tras la vacuna Pfizer-BioNTech COVID-19. Revista de la Sociedad de Enfermedades Infecciosas Pediátricas, 10(10), 962-966. https://pubmed.ncbi.nlm.nih.gov/34312010/ | Carli, G., Nichele, I., Ruggeri, M., Barra, S., & Tosetto, A. (2021). La trombosis de la vena profunda (TVT) ocurre poco después de la segunda dosis de la vacuna contra el ARNm SARS-COV-2. Medicina interna y de emergencia, 16 (3), 803-804. https://pubmed.ncbi.nlm.nih.gov/34011137/. | Tano, E., San Martin, S., Girgis, S., Martinez-Fernandez, Y., & Sanchez Vegas, C. (2021). Perimyocarditis in adolescents after Pfizer-BioNTech COVID-19 vaccine. Journal of the Pediatric Infectious Diseases Society, 10(10), 962-966. https://academic.oup.com/jpids/advance-article/doi/10.1093/jpids/piab060/6329543 | Castelli, G. P., Pognani, C., Sozzi, C., Franchini, M., & Vivona, L. (2021). Cerebral venous sinus thrombosis associated with thrombocytopenia post-vaccination for COVID-19. Critical Care, 25(1), 1-2. https://pubmed.ncbi.nlm.nih.gov/33845870/. | Cereda, A., Conca, C., Barbieri, L., Ferrante, G., Tumminello, G., Lucreziotti, S., ... & Mafrici, A. (2021). Acute myocarditis after the second dose of SARS-CoV-2 vaccine: Serendipity or atypical causal relationship?. Anatolian Journal of Cardiology, 25(7), 522. | https://pubmed.ncbi.nlm.nih.gov/34236331/ | Cereda, A., Conca, C., Barbieri, L., Ferrante, G., Tumminello, G., Lucreziotti, S., ... & Mafrici, A. (2021). Acute myocarditis after the second dose of SARS-CoV-2 vaccine: Serendipity or atypical causal relationship?. Anatolian Journal of Cardiology, 25(7), 522. https://pubmed.ncbi.nlm.nih.gov/34236331/ | Cheng, N. (2021). Cerebral venous sinus thrombosis after Pfizer-BioNTech COVID-19 (BNT162b2) vaccination. Journal of Clinical Neurology (Seoul, Korea), 17(4), 573. https://pubmed.ncbi.nlm.nih.gov/34595867/ | ||||
120 | The new COVID-19 mRNA vaccine platform and myocarditis: clues to the possible underlying mechanism: | https://pubmed.ncbi.nlm.nih.gov/34312010/ | https://pubmed.ncbi.nlm.nih.gov/34312010/ | Lazaros, G., Klein, A. L., Hatziantoniou, S., Tsioufis, C., Tsakris, A., & Anastassopoulou, C. (2021). The novel platform of mRNA COVID-19 vaccines and myocarditis: clues into the potential underlying mechanism. Vaccine, 39(35), 4925. | Lazaros, G., Klein, A. L., Hatziantoniou, S., Tsioufis, C., Tsakris, A. y Anastassopoulou, C. (2021). La nueva plataforma de vacunas de ARNm COVID-19 y miocarditis: pistas sobre el posible mecanismo subyacente. Vacuna, 39(35), 4925. https://pubmed.ncbi.nlm.nih.gov/34219532/ | Carril, D. L., Neelapu, S. S., XU, G. y Weaver, O. (2021). COVID-19 Linfadenopatía axilar y cervical relacionada con la vacuna en pacientes con cáncer de mama actual o previo y otros malignos: hallazgos de imágenes transversales en MRI, CT y PET-CT. Diario Coreano de Radiología, 22 (12), 1938. https://pubmed.ncbi.nlm.nih.gov/33625299/. | Lazaros, G., Klein, A. L., Hatziantoniou, S., Tsioufis, C., Tsakris, A., & Anastassopoulou, C. (2021). The novel platform of mRNA COVID-19 vaccines and myocarditis: clues into the potential underlying mechanism. Vaccine, 39(35), 4925. https://pubmed.ncbi.nlm.nih.gov/34312010/ | Català, A., Muñoz‐Santos, C., Galván‐Casas, C., Roncero Riesco, M., Revilla Nebreda, D., Solá‐Truyols, A., ... & Guilabert, A. (2022). Cutaneous reactions after SARS‐COV‐2 vaccination: a cross‐sectional Spanish nationwide study of 405 cases. British Journal of Dermatology, 186(1), 142-152. https://pubmed.ncbi.nlm.nih.gov/34254291/ | Faissner, S., Richter, D., Ceylan, U., Schneider-Gold, C., & Gold, R. (2021). COVID-19 mRNA vaccine induced rhabdomyolysis and fasciitis. Journal of Neurology, 1-2. | https://pubmed.ncbi.nlm.nih.gov/34435250/ | Faissner, S., Richter, D., Ceylan, U., Schneider-Gold, C., & Gold, R. (2021). COVID-19 mRNA vaccine induced rhabdomyolysis and fasciitis. Journal of Neurology, 1-2. https://pubmed.ncbi.nlm.nih.gov/34435250/ | Chiang, C. Y., Chen, C. Y., Yu, W. L., Kan, W. C., & Feng, Y. H. (2021). Myocardial Infarction and Azygos Vein Thrombosis After ChAdOx1 nCoV-19 Vaccination in a Hemodialysis Patient. Cureus, 13(9). https://pubmed.ncbi.nlm.nih.gov/34650896/ | ||||
121 | Acute myocardial injury after COVID-19 vaccination: a case report and review of current evidence from the Vaccine Adverse Event Reporting System database: | https://pubmed.ncbi.nlm.nih.gov/34219532/ | https://pubmed.ncbi.nlm.nih.gov/34219532/ | Deb, A., Abdelmalek, J., Iwuji, K., & Nugent, K. (2021). Acute myocardial injury following COVID-19 vaccination: a case report and review of current evidence from vaccine adverse events reporting system database. Journal of primary care & community health, 12, 21501327211029230. | Deb, A., Abdelmalek, J., Iwuji, K. y Nugent, K. (2021). Lesión miocárdica aguda después de la vacunación COVID-19: informe de un caso y revisión de la evidencia actual de la base de datos del sistema de notificación de eventos adversos de la vacuna. Revista de atención primaria y salud comunitaria, 12, 21501327211029230. https://www.xiahepublishing.com/m/2472-0712/ERHM-2021-00033 | Castelli, G. P., Pognani, C., SOZZI, C., Franchini, M., & Vivona, L. (2021). Trombosis sinusus venosa cerebral asociada con la trombocitopenia después de la vacunación para COVID-19. Cuidados críticos, 25 (1), 1-2. https://pubmed.ncbi.nlm.nih.gov/34236343/ | Deb, A., Abdelmalek, J., Iwuji, K., & Nugent, K. (2021). Acute myocardial injury following COVID-19 vaccination: a case report and review of current evidence from vaccine adverse events reporting system database. Journal of primary care & community health, 12, 21501327211029230. https://pubmed.ncbi.nlm.nih.gov/34219532/ | Cattaneo, M. (2021). Thrombosis with Thrombocytopenia Syndrome associated with viral vector COVID-19 vaccines. European Journal of Internal Medicine, 89, 22-24. https://pubmed.ncbi.nlm.nih.gov/34092488/ | Nassar, M., Chung, H., Dhayaparan, Y., Nyein, A., Acevedo, B. J., Chicos, C., ... & Kimball, E. (2021). COVID-19 vaccine induced rhabdomyolysis: Case report with literature review. Diabetes & Metabolic Syndrome. | https://pubmed.ncbi.nlm.nih.gov/34186348/. | Nassar, M., Chung, H., Dhayaparan, Y., Nyein, A., Acevedo, B. J., Chicos, C., ... & Kimball, E. (2021). COVID-19 vaccine induced rhabdomyolysis: Case report with literature review. Diabetes & Metabolic Syndrome. https://pubmed.ncbi.nlm.nih.gov/34186348/. | Choi, G. J., Baek, S. H., Kim, J., Kim, J. H., Kwon, G. Y., Kim, D. K., ... & Kim, S. (2021). Fatal Systemic Capillary Leak Syndrome after SARS-CoV-2Vaccination in Patient with Multiple Myeloma. Emerging infectious diseases, 27(11), 2973. https://pubmed.ncbi.nlm.nih.gov/34459725/ | ||||
122 | Be alert to the risk of adverse cardiovascular events after COVID-19 vaccination: | https://www.xiahepublishing.com/m/2472-0712/ERHM-2021-00033 | https://www.xiahepublishing.com/m/2472-0712/ERHM-2021-00033 | Han, T., Ma, W., Zhang, Y., & Wang, C. (2021). Be Alert to the Risk of Adverse Cardiovascular Events after COVID-19 Vaccination. Exploratory Research and Hypothesis in Medicine, (000), 0-0. | Han, T., Ma, W., Zhang, Y. y Wang, C. (2021). Esté alerta al riesgo de eventos cardiovasculares adversos después de la vacunación contra el COVID-19. Investigación Exploratoria e Hipótesis en Medicina, (000), 0-0. https://www.ahajournals.org/doi/10.1161/CIRCIMAGING.121.013236 | Català, A., Muñoz-Santos, C., Galván-Casas, C., Roncero Riesco, M., Revilla Nebreda, D., Solá-Truyols, A., ... & Guilabert, A. (2022). Reacciones cutáneas después de la vacunación con SARS-COV-2: un estudio de 405 casos de 405 casos. British Journal of Dermatology, 186 (1), 142-152. https://pubmed.ncbi.nlm.nih.gov/34487581/ | Han, T., Ma, W., Zhang, Y., & Wang, C. (2021). Be Alert to the Risk of Adverse Cardiovascular Events after COVID-19 Vaccination. Exploratory Research and Hypothesis in Medicine, (000), 0-0. https://www.xiahepublishing.com/m/2472-0712/ERHM-2021-00033 | Cattaneo, M. (2021). Thrombosis with Thrombocytopenia Syndrome associated with viral vector COVID-19 vaccines. European Journal of Internal Medicine, 89, 22-24. https://www.sciencedirect.com/science/article/abs/pii/S0953620521001904 | Dufour, C., Co, T. K., & Liu, A. (2021). GM1 ganglioside antibody and COVID-19 related Guillain Barre Syndrome–a case report, systemic review and implication for vaccine development. Brain, Behavior, & Immunity-Health, 12, 100203. | https://www.sciencedirect.com/science/article/pii/S2666354621000065 | Dufour, C., Co, T. K., & Liu, A. (2021). GM1 ganglioside antibody and COVID-19 related Guillain Barre Syndrome–a case report, systemic review and implication for vaccine development. Brain, Behavior, & Immunity-Health, 12, 100203. https://www.sciencedirect.com/science/article/pii/S2666354621000065 | Choi, J. K., Kim, S., Kim, S. R., Jin, J. Y., Choi, S. W., Kim, H., ... & Kim, S. R. (2021). Intracerebral hemorrhage due to thrombosis with thrombocytopenia syndrome after vaccination against COVID-19: the first fatal case in korea. Journal of Korean Medical Science, 36(31). https://pubmed.ncbi.nlm.nih.gov/34402235/ | ||||
123 | Myocarditis associated with COVID-19 vaccination: echocardiographic, cardiac tomography, and magnetic resonance imaging findings: | https://www.ahajournals.org/doi/10.1161/CIRCIMAGING.121.013236 | https://www.ahajournals.org/doi/10.1161/CIRCIMAGING.121.013236 | Viskin, D., Topilsky, Y., Aviram, G., Mann, T., Sadon, S., Hadad, Y., ... & Havakuk, O. (2021). Myocarditis Associated With COVID-19 Vaccination: Echocardiography, Cardiac Tomography, and Magnetic Resonance Imaging Findings. Circulation: Cardiovascular Imaging, 14(9), e013236. | Viskin, D., Topilsky, Y., Aviram, G., Mann, T., Sadon, S., Hadad, Y., ... y Havakuk, O. (2021). Miocarditis asociada con la vacunación contra la COVID-19: hallazgos de ecocardiografía, tomografía cardíaca y resonancia magnética. Circulación: Imágenes cardiovasculares, 14(9), e013236. https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.121.056038 | Cattaneo, M. (2021). Trombosis con síndrome de trombocitopenia asociada con vectores virales COVID-19 vacunas. Diario Europeo de Medicina Interna, 89, 22-24. https://pubmed.ncbi.nlm.nih.gov/34261635/ | Viskin, D., Topilsky, Y., Aviram, G., Mann, T., Sadon, S., Hadad, Y., ... & Havakuk, O. (2021). Myocarditis Associated With COVID-19 Vaccination: Echocardiography, Cardiac Tomography, and Magnetic Resonance Imaging Findings. Circulation: Cardiovascular Imaging, 14(9), e013236. https://www.ahajournals.org/doi/10.1161/CIRCIMAGING.121.013236 | Cavalli, G., Colafrancesco, S., De Luca, G., Rizzo, N., Priori, R., Conti, F., & Dagna, L. (2021). Cutaneous vasculitis following COVID-19 vaccination. The Lancet Rheumatology, 3(11), e743-e744. https://pubmed.ncbi.nlm.nih.gov/34611627/. | Introna, A., Caputo, F., Santoro, C., Guerra, T., Ucci, M., Mezzapesa, D. M., & Trojano, M. (2021). Guillain-Barré syndrome after AstraZeneca COVID-19-vaccination: a causal or casual association?. Clinical Neurology and Neurosurgery, 208, 106887. | https://www.sciencedirect.com/science/article/pii/S0303846721004169 | Introna, A., Caputo, F., Santoro, C., Guerra, T., Ucci, M., Mezzapesa, D. M., & Trojano, M. (2021). Guillain-Barré syndrome after AstraZeneca COVID-19-vaccination: a causal or casual association?. Clinical Neurology and Neurosurgery, 208, 106887. https://www.sciencedirect.com/science/article/pii/S0303846721004169 | Choi, P. Y. I., Hsu, D., Tran, H. A., Tan, C. W., Enjeti, A., Chen, V. M. Y., ... & Bird, R. (2020). Immune thrombocytopenia following vaccination during the COVID-19 pandemic. Haematologica. https://pubmed.ncbi.nlm.nih.gov/34435486/ | ||||
124 | In-depth evaluation of a case of presumed myocarditis after the second dose of COVID-19 mRNA vaccine: | https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.121.056038 | https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.121.056038 | Muthukumar, A., Narasimhan, M., Li, Q. Z., Mahimainathan, L., Hitto, I., Fuda, F., ... & De Lemos, J. A. (2021). In-depth evaluation of a case of presumed myocarditis after the second dose of COVID-19 mRNA vaccine. Circulation, 144(6), 487-498. | Muthukumar, A., Narasimhan, M., Li, Q. Z., Mahimainathan, L., Hitto, I., Fuda, F., ... y De Lemos, J. A. (2021). Evaluación en profundidad de un caso de presunta miocarditis tras la segunda dosis de la vacuna de ARNm contra el COVID-19. Circulación, 144(6), 487-498. https://pubmed.ncbi.nlm.nih.gov/34333695/ | Cattaneo, M. (2021). Trombosis con síndrome de trombocitopenia asociada con vectores virales COVID-19 vacunas. Diario Europeo de Medicina Interna, 89, 22-24. https://www.sciencedirect.com/science/article/pii/S1665268121000557 | Muthukumar, A., Narasimhan, M., Li, Q. Z., Mahimainathan, L., Hitto, I., Fuda, F., ... & De Lemos, J. A. (2021). In-depth evaluation of a case of presumed myocarditis after the second dose of COVID-19 mRNA vaccine. Circulation, 144(6), 487-498. https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.121.056038 | Cebeci, F., & Kartal, İ. (2021). Petechial skin rash associated with CoronaVac vaccination: first cutaneous side effect report before phase 3 results. European Journal of Hospital Pharmacy. https://ejhp.bmj.com/content/early/2021/05/23/ejhpharm-2021-002794 | Min, Y. G., Ju, W., Ha, Y. E., Ban, J. J., Lee, S. A., Sung, J. J., & Shin, J. Y. (2021). Sensory Guillain-Barre syndrome following the ChAdOx1 nCov-19 vaccine: Report of two cases and review of literature. Journal of neuroimmunology, 359, 577691. | https://www.sciencedirect.com/science/article/pii/S0165572821002186 | Min, Y. G., Ju, W., Ha, Y. E., Ban, J. J., Lee, S. A., Sung, J. J., & Shin, J. Y. (2021). Sensory Guillain-Barre syndrome following the ChAdOx1 nCov-19 vaccine: Report of two cases and review of literature. Journal of neuroimmunology, 359, 577691. https://www.sciencedirect.com/science/article/pii/S0165572821002186 | Choi, S., Lee, S., Seo, J. W., Kim, M. J., Jeon, Y. H., Park, J. H., ... & Yeo, N. S. (2021). Myocarditis-induced sudden death after BNT162b2 mRNA COVID-19 vaccination in Korea: Case report focusing on histopathological findings. Journal of Korean medical science, 36(40). https://pubmed.ncbi.nlm.nih.gov/34664804/ | ||||
125 | Occurrence of acute infarct-like myocarditis after COVID-19 vaccination: just an accidental coincidence or rather a vaccination-associated autoimmune myocarditis?: | https://pubmed.ncbi.nlm.nih.gov/34333695/ | https://pubmed.ncbi.nlm.nih.gov/34333695/ | Chamling, B., Vehof, V., Drakos, S., Weil, M., Stalling, P., Vahlhaus, C., ... & Yilmaz, A. (2021). Occurrence of acute infarct-like myocarditis following COVID-19 vaccination: just an accidental co-incidence or rather vaccination-associated autoimmune myocarditis?. Clinical Research in Cardiology, 110(11), 1850-1854. | Chamling, B., Vehof, V., Drakos, S., Weil, M., Stalling, P., Vahlhaus, C., ... y Yilmaz, A. (2021). Aparición de miocarditis aguda similar a un infarto después de la vacunación COVID-19: ¿solo una coincidencia accidental o más bien una miocarditis autoinmune asociada a la vacunación? Investigación clínica en cardiología, 110(11), 1850-1854. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8216855/ | Cavalli, G., ColaFrancesco, S., De Luca, G., Rizzo, N., Priori, R., Conti, F., & Dagna, L. (2021). Vasculitis cutánea después de la vacunación COVID-19. La reumatología Lancet, 3 (11), E743-E744. https://pubmed.ncbi.nlm.nih.gov/34705320/. | Chamling, B., Vehof, V., Drakos, S., Weil, M., Stalling, P., Vahlhaus, C., ... & Yilmaz, A. (2021). Occurrence of acute infarct-like myocarditis following COVID-19 vaccination: just an accidental co-incidence or rather vaccination-associated autoimmune myocarditis?. Clinical Research in Cardiology, 110(11), 1850-1854. https://pubmed.ncbi.nlm.nih.gov/34333695/ | Cellina, M., D'Arrigo, A., Floridi, C., Oliva, G., & Carrafiello, G. (2022). Left Bell's palsy following the first dose of mRNA-1273 SARS-CoV-2 vaccine: A case report. Clinical Imaging, 82, 1-4. https://pubmed.ncbi.nlm.nih.gov/34763263/. | Ogbebor, O., Seth, H., Min, Z., & Bhanot, N. (2021). Guillain-Barré syndrome following the first dose of SARS-CoV-2 vaccine: a temporal occurrence, not a causal association. IDCases, 24, e01143. | https://www.sciencedirect.com/science/article/pii/S2214250921000998. | Ogbebor, O., Seth, H., Min, Z., & Bhanot, N. (2021). Guillain-Barré syndrome following the first dose of SARS-CoV-2 vaccine: a temporal occurrence, not a causal association. IDCases, 24, e01143. https://www.sciencedirect.com/science/article/pii/S2214250921000998. | Choi, Y. K., Moon, J. Y., Kim, J., Yoo, I. S., Kwon, G. Y., Bae, H., ... & Kym, S. (2022). Postvaccination multisystem inflammatory syndrome in adult with no evidence of prior SARS-CoV-2 Infection. Emerging infectious diseases, 28(2), 411. https://pubmed.ncbi.nlm.nih.gov/34852213/ | ||||
126 | Recurrence of acute myocarditis temporally associated with receipt of coronavirus mRNA disease vaccine 2019 (COVID-19) in a male adolescent: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8216855/ | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8216855/ | Minocha, P. K., Better, D., Singh, R. K., & Hoque, T. (2021). Recurrence of acute myocarditis temporally associated with receipt of the mRNA coronavirus disease 2019 (COVID-19) vaccine in a male adolescent. The Journal of Pediatrics, 238, 321-323. | Minocha, PK, Better, D., Singh, R. K. y Hoque, T. (2021). Recurrencia de miocarditis aguda asociada temporalmente con la recepción de la vacuna de ARNm contra la enfermedad del coronavirus 2019 (COVID-19) en un adolescente varón. La Revista de Pediatría, 238, 321-323. https://pubmed.ncbi.nlm.nih.gov/34118375/ | Cebeci, F., & Kartal, ©. (2021). Erupción de la piel petecial asociada con la vacunación de Coronavac: Primer informe de efecto secundario cutáneo antes de los resultados de la Fase 3. Revista europea de farmacia del hospital. https://ashpublications.org/blood/article/137/26/3670/475905/COVID-19-vaccines-induce-severe-hemolysis-in | Minocha, P. K., Better, D., Singh, R. K., & Hoque, T. (2021). Recurrence of acute myocarditis temporally associated with receipt of the mRNA coronavirus disease 2019 (COVID-19) vaccine in a male adolescent. The Journal of Pediatrics, 238, 321-323. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8216855/ | Čenščák, D., Ungermann, L., Štětkářová, I., & Ehler, E. (2021). Guillan-Barré Syndrome after the First Vaccination Dose against COVID-19: Case Report. ACTA MEDICA, 64(3), 183-186. https://pubmed.ncbi.nlm.nih.gov/34779385/. | Rossetti, A., Gheihman, G., O'Hare, M., & Kosowsky, J. M. (2021). Guillain-Barré Syndrome presenting as facial diplegia after COVID-19 vaccination: A case report. The Journal of Emergency Medicine, 61(6), e141-e145. | https://www.sciencedirect.com/science/article/pii/S0736467921006442 | Rossetti, A., Gheihman, G., O'Hare, M., & Kosowsky, J. M. (2021). Guillain-Barré Syndrome presenting as facial diplegia after COVID-19 vaccination: A case report. The Journal of Emergency Medicine, 61(6), e141-e145. https://www.sciencedirect.com/science/article/pii/S0736467921006442 | Chouchana, L., Blet, A., Al‐Khalaf, M., Kafil, T. S., Nair, G., Robblee, J., ... & Liu, P. P. (2022). Features of Inflammatory Heart Reactions Following mRNA COVID‐19 Vaccination at a Global Level. Clinical Pharmacology & Therapeutics. https://www.ncbi.nlm.nih.gov/pubmed/34860360 | ||||
127 | Myocarditis after SARS-CoV-2 vaccination: a vaccine-induced reaction?: | https://pubmed.ncbi.nlm.nih.gov/34118375/ | https://pubmed.ncbi.nlm.nih.gov/34118375/ | D'Angelo, T., Cattafi, A., Carerj, M. L., Booz, C., Ascenti, G., Cicero, G., ... & Mazziotti, S. (2021). Myocarditis after SARS-CoV-2 vaccination: a vaccine-induced reaction?. Canadian Journal of Cardiology, 37(10), 1665-1667. | D'Angelo, T., Cattafi, A., Carerj, M. L., Booz, C., Ascenti, G., Cicero, G., ... & Mazziotti, S. (2021). Miocarditis tras la vacunación contra el SARS-CoV-2: ¿una reacción inducida por la vacuna? Revista Canadiense de Cardiología, 37(10), 1665-1667. https://pubmed.ncbi.nlm.nih.gov/34180390/ | Celina, M., D'Arrigo, A., Floridi, C., Oliva, G. y Carrafiello, G. (2022). Dejó la parálisis de Bell Siguiendo la primera dosis de la vacuna contra MRNA-1273 SARS-COV-2: un informe de caso. Imágenes clínicas, 82, 1-4. https://pubmed.ncbi.nlm.nih.gov/34621891/ | D'Angelo, T., Cattafi, A., Carerj, M. L., Booz, C., Ascenti, G., Cicero, G., ... & Mazziotti, S. (2021). Myocarditis after SARS-CoV-2 vaccination: a vaccine-induced reaction?. Canadian Journal of Cardiology, 37(10), 1665-1667. https://pubmed.ncbi.nlm.nih.gov/34118375/ | Cereda, A., Conca, C., Barbieri, L., Ferrante, G., Tumminello, G., Lucreziotti, S., ... & Mafrici, A. (2021). Acute myocarditis after the second dose of SARS-CoV-2 vaccine: Serendipity or atypical causal relationship?. Anatolian Journal of Cardiology, 25(7), 522. https://pubmed.ncbi.nlm.nih.gov/34236331/ | Theuriet, J., Richard, C., Becker, J., Pegat, A., Bernard, E., & Vukusic, S. (2021). Guillain-Barré syndrome following first injection of ChAdOx1 nCoV-19 vaccine: First report. Revue neurologique, 177(10), 1305-1307. | https://www.sciencedirect.com/science/article/pii/S0035378721005853. | Theuriet, J., Richard, C., Becker, J., Pegat, A., Bernard, E., & Vukusic, S. (2021). Guillain-Barré syndrome following first injection of ChAdOx1 nCoV-19 vaccine: First report. Revue neurologique, 177(10), 1305-1307. https://www.sciencedirect.com/science/article/pii/S0035378721005853. | Christensen, S. K., Ballegaard, M., & Boesen, M. S. (2021). Guillian-Barrés syndrom efter mRNA-1273-COVID-19-vaccine. Ugeskr Læger, 183, V05210455. https://pubmed.ncbi.nlm.nih.gov/34477091/ | ||||
128 | Self-limited myocarditis presenting with chest pain and ST-segment elevation in adolescents after vaccination with the BNT162b2 mRNA vaccine: | https://pubmed.ncbi.nlm.nih.gov/34180390/ | https://pubmed.ncbi.nlm.nih.gov/34180390/ | Park, J., Brekke, D. R., & Bratincsak, A. (2022). Self-limited myocarditis presenting with chest pain and ST segment elevation in adolescents after vaccination with the BNT162b2 mRNA vaccine. Cardiology in the Young, 32(1), 146-149. | Park, J., Brekke, D. R. y Bratincsak, A. (2022). Miocarditis autolimitada que se presenta con dolor torácico y elevación del segmento ST en adolescentes después de la vacunación con la vacuna de ARNm BNT162b2. Cardiología en los jóvenes, 32(1), 146-149. https://pubmed.ncbi.nlm.nih.gov/34133825/ | Čenščák, D., Ungermann, L., Štětkářová, I., & Ehler, E. (2021). Síndrome de Guillan-Barré después de la primera dosis de vacunación contra COVID-19: Informe de caso. ACTA MEDICA, 64 (3), 183-186. https://pubmed.ncbi.nlm.nih.gov/34817727/. | Park, J., Brekke, D. R., & Bratincsak, A. (2022). Self-limited myocarditis presenting with chest pain and ST segment elevation in adolescents after vaccination with the BNT162b2 mRNA vaccine. Cardiology in the Young, 32(1), 146-149. https://pubmed.ncbi.nlm.nih.gov/34180390/ | Ceschia, N., Scheggi, V., Gori, A. M., Rogolino, A. A., Cesari, F., Giusti, B., ... & Marcucci, R. (2021). Diffuse prothrombotic syndrome after ChAdOx1 nCoV-19 vaccine administration: a case report. Journal of Medical Case Reports, 15(1), 1-4. https://pubmed.ncbi.nlm.nih.gov/34615534/ | Finsterer, J. (2021). SARS-CoV-2 vaccinations are unsafe for those experiencing post-vaccination Guillain-Barre syndrome. Annals of Medicine and Surgery. | https://www.sciencedirect.com/science/article/pii/S2049080121005343 | Finsterer, J. (2021). SARS-CoV-2 vaccinations are unsafe for those experiencing post-vaccination Guillain-Barre syndrome. Annals of Medicine and Surgery. https://www.sciencedirect.com/science/article/pii/S2049080121005343 | Chua, G. T., Kwan, M. Y. W., Chui, C. S., Smith, R. D., Cheung, E. C. L., Tian, T., ... & Ip, P. (2021). Epidemiology of Acute Myocarditis/Pericarditis in Hong Kong Adolescents Following Comirnaty Vaccination. Clinical Infectious Diseases. https://academic.oup.com/cid/advance-article-abstract/doi/10.1093/cid/ciab989/6445179 | ||||
129 | Myopericarditis in a previously healthy adolescent male after COVID-19 vaccination: Case report: | https://pubmed.ncbi.nlm.nih.gov/34133825/ | https://pubmed.ncbi.nlm.nih.gov/34133825/ | McLean, K., & Johnson, T. J. (2021). Myopericarditis in a previously healthy adolescent male following COVID‐19 vaccination: A case report. Academic Emergency Medicine, 28(8), 918-921. | McLean, K. y Johnson, TJ (2021). Miopericarditis en un adolescente previamente sano después de la vacunación contra la COVID-19: reporte de un caso. Medicina de emergencia académica, 28(8), 918-921. https://pubmed.ncbi.nlm.nih.gov/34487236/ | Cereda, A., Conca, C., Barbieri, L., Ferrante, G., Tumminello, G., Lucreziotti, S., ... & MAFRICI, A. (2021). Miocarditis aguda después de la segunda dosis de vacuna contra SARS-COV-2: ¿Serendipilidad o relación causal atípica? Diario Anatoliano de Cardiología, 25 (7), 522. https://pubmed.ncbi.nlm.nih.gov/34435250/ | McLean, K., & Johnson, T. J. (2021). Myopericarditis in a previously healthy adolescent male following COVID‐19 vaccination: A case report. Academic Emergency Medicine, 28(8), 918-921. https://pubmed.ncbi.nlm.nih.gov/34133825/ | Chai, Q., Nygaard, U., Schmidt, R. C., Zaremba, T., Møller, A. M., & Thorvig, C. M. (2022). Multisystem inflammatory syndrome in a male adolescent after his second Pfizer‐BioNTech COVID‐19 vaccine. Acta Paediatrica, 111(1), 125-127. https://www.ncbi.nlm.nih.gov/pubmed/34617315 | Al-Mashdali, A. F., Ata, Y. M., & Sadik, N. (2021). Post-COVID-19 vaccine acute hyperactive encephalopathy with dramatic response to methylprednisolone: A case report. Annals of Medicine and Surgery, 69, 102803. | https://www.sciencedirect.com/science/article/pii/S2049080121007536 | Al-Mashdali, A. F., Ata, Y. M., & Sadik, N. (2021). Post-COVID-19 vaccine acute hyperactive encephalopathy with dramatic response to methylprednisolone: A case report. Annals of Medicine and Surgery, 69, 102803. https://www.sciencedirect.com/science/article/pii/S2049080121007536 | Chuang, T. Y., Burda, K., Teklemariam, E., & Athar, K. (2021). Tolosa-Hunt syndrome presenting after COVID-19 vaccination. Cureus, 13(7). https://pubmed.ncbi.nlm.nih.gov/34513398/ | ||||
130 | Biopsy-proven lymphocytic myocarditis after first COVID-19 mRNA vaccination in a 40-year-old man: case report: | https://pubmed.ncbi.nlm.nih.gov/34487236/ | https://pubmed.ncbi.nlm.nih.gov/34487236/ | Ehrlich, P., Klingel, K., Ohlmann-Knafo, S., Hüttinger, S., Sood, N., Pickuth, D., & Kindermann, M. (2021). Biopsy-proven lymphocytic myocarditis following first mRNA COVID-19 vaccination in a 40-year-old male: case report. Clinical Research in Cardiology, 110(11), 1855-1859. | Ehrlich, P., Klingel, K., Ohlmann-Knafo, S., Hüttinger, S., Sood, N., Pickuth, D. y Kindermann, M. (2021). Miocarditis linfocítica comprobada por biopsia después de la primera vacunación con ARNm COVID-19 en un hombre de 40 años: informe de caso. Investigación clínica en cardiología, 110(11), 1855-1859. https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciab741/6359059 | Ceschia, N., Scheggi, V., Gori, A. M., Rogolino, A. A., Cesari, F., Giusti, B., ... y Marcucci, R. (2021). Síndrome protrombótico difuso después de la administración de la vacuna contra Chadox1 NCOV-19: un informe de caso. Diario de informes de casos médicos, 15 (1), 1-4. https://pubmed.ncbi.nlm.nih.gov/34352418/ | Ehrlich, P., Klingel, K., Ohlmann-Knafo, S., Hüttinger, S., Sood, N., Pickuth, D., & Kindermann, M. (2021). Biopsy-proven lymphocytic myocarditis following first mRNA COVID-19 vaccination in a 40-year-old male: case report. Clinical Research in Cardiology, 110(11), 1855-1859. https://pubmed.ncbi.nlm.nih.gov/34487236/ | Chamling, B., Vehof, V., Drakos, S., Weil, M., Stalling, P., Vahlhaus, C., ... & Yilmaz, A. (2021). Occurrence of acute infarct-like myocarditis following COVID-19 vaccination: just an accidental co-incidence or rather vaccination-associated autoimmune myocarditis?. Clinical Research in Cardiology, 110(11), 1850-1854. https://pubmed.ncbi.nlm.nih.gov/34333695/ | Sato, K., Mano, T., Niimi, Y., Toda, T., Iwata, A., & Iwatsubo, T. (2021). Facial nerve palsy following the administration of COVID-19 mRNA vaccines: analysis of a self-reporting database. International Journal of Infectious Diseases, 111, 310-312. | https://www.sciencedirect.com/science/article/pii/S1201971221007049 | Sato, K., Mano, T., Niimi, Y., Toda, T., Iwata, A., & Iwatsubo, T. (2021). Facial nerve palsy following the administration of COVID-19 mRNA vaccines: analysis of a self-reporting database. International Journal of Infectious Diseases, 111, 310-312. https://www.sciencedirect.com/science/article/pii/S1201971221007049 | Ciccone, A. (2021). SARS-CoV-2 vaccine-induced cerebral venous thrombosis. European journal of internal medicine, 89, 19-21. https://pubmed.ncbi.nlm.nih.gov/34090750/. | ||||
131 | Insights from a murine model of COVID-19 mRNA vaccine-induced myopericarditis: could accidental intravenous injection of a vaccine induce myopericarditis | https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciab741/6359059 | https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciab741/6359059 | Knowlton, K. U. (2021). Insights From a Murine Model of Coronavirus Disease 2019 (COVID-19) mRNA Vaccination-Induced Myopericarditis: Could Accidental Intravenous Vaccine Injection Induce Myopericarditis?. Clinical Infectious Diseases. | Knowlton, KU (2021). Perspectivas de un modelo murino de miopericarditis inducida por la vacunación con ARNm de la enfermedad por coronavirus 2019 (COVID-19): ¿podría la inyección intravenosa accidental de vacuna inducir miopericarditis? Enfermedades Infecciosas Clínicas. https://pubmed.ncbi.nlm.nih.gov/34447639/ | Chai, Q., Nygaard, U., Schmidt, R. C., Zaremba, T., Møller, A. M. y Thorvig, C. M. (2022). Síndrome inflamatorio multisistémico en un adolescente masculino después de su segunda vacuna PFIZE-BIONTECH COVID-19. ACTA PEDIATRICA, 111 (1), 125-127. https://www.ncbi.nlm.nih.gov/pubmed/34333695 | Knowlton, K. U. (2021). Insights From a Murine Model of Coronavirus Disease 2019 (COVID-19) mRNA Vaccination-Induced Myopericarditis: Could Accidental Intravenous Vaccine Injection Induce Myopericarditis?. Clinical Infectious Diseases. https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciab741/6359059 | Chamling, B., Vehof, V., Drakos, S., Weil, M., Stalling, P., Vahlhaus, C., ... & Yilmaz, A. (2021). Occurrence of acute infarct-like myocarditis following COVID-19 vaccination: just an accidental co-incidence or rather vaccination-associated autoimmune myocarditis?. Clinical Research in Cardiology, 110(11), 1850-1854. https://pubmed.ncbi.nlm.nih.gov/34333695/. | Corrêa, D. G., Cañete, L. A. Q., Dos Santos, G. A. C., de Oliveira, R. V., Brandão, C. O., & da Cruz Jr, L. C. H. (2021). Neurological symptoms and neuroimaging alterations related with COVID-19 vaccine: Cause or coincidence?. Clinical Imaging, 80, 348-352. | https://www.sciencedirect.com/science/article/pii/S0899707121003557. | Corrêa, D. G., Cañete, L. A. Q., Dos Santos, G. A. C., de Oliveira, R. V., Brandão, C. O., & da Cruz Jr, L. C. H. (2021). Neurological symptoms and neuroimaging alterations related with COVID-19 vaccine: Cause or coincidence?. Clinical Imaging, 80, 348-352. https://www.sciencedirect.com/science/article/pii/S0899707121003557. | Ciccone, A., & Zanotti, B. (2021). The importance of recognizing cerebral venous thrombosis following anti-COVID-19 vaccination. European Journal of Internal Medicine, 89, 115-117. https://pubmed.ncbi.nlm.nih.gov/34001390/ | ||||
132 | Unusual presentation of acute perimyocarditis after modern SARS-COV-2 mRNA-1237 vaccination: | https://pubmed.ncbi.nlm.nih.gov/34447639/ | https://pubmed.ncbi.nlm.nih.gov/34447639/ | Khogali, F., & Abdelrahman, R. (2021). Unusual presentation of acute perimyocarditis following SARS-COV-2 mRNA-1237 Moderna vaccination. Cureus, 13(7). | Khogali, F. y Abdelrahman, R. (2021). Presentación inusual de perimiocarditis aguda después de la vacunación con SARS-COV-2 mRNA-1237 Moderna. Cureus, 13(7). https://bmccardiovascdisord.biomedcentral.com/articles/10.1186/s12872-021-02183 | Chamlling, B., Vehefof, V., Drakos, S., Weil, M., Stalling, P., Vahlhaus, C., ... & Yilmaz, A. (2021). Ocurrencia de miocarditis de forma de infarto aguda después de la vacunación de COVID-19: ¡solo una co-incidencia accidental o miocarditis autoinmune asociada a la vacuna. Investigación clínica en cardiología, 110 (11), 1850-1854. https://pubmed.ncbi.nlm.nih.gov/34185045/ | Khogali, F., & Abdelrahman, R. (2021). Unusual presentation of acute perimyocarditis following SARS-COV-2 mRNA-1237 Moderna vaccination. Cureus, 13(7). https://pubmed.ncbi.nlm.nih.gov/34447639/ | Chamling, B., Vehof, V., Drakos, S., Weil, M., Stalling, P., Vahlhaus, C., ... & Yilmaz, A. (2021). Occurrence of acute infarct-like myocarditis following COVID-19 vaccination: just an accidental co-incidence or rather vaccination-associated autoimmune myocarditis?. Clinical Research in Cardiology, 110(11), 1850-1854. https://www.ncbi.nlm.nih.gov/pubmed/34333695 | Aladdin, Y., & Shirah, B. (2021). New-onset refractory status epilepticus following the ChAdOx1 nCoV-19 vaccine. Journal of Neuroimmunology, 357, 577629. | https://www.sciencedirect.com/science/article/pii/S0165572821001569 | Aladdin, Y., & Shirah, B. (2021). New-onset refractory status epilepticus following the ChAdOx1 nCoV-19 vaccine. Journal of Neuroimmunology, 357, 577629. https://www.sciencedirect.com/science/article/pii/S0165572821001569 | Cimaglia, P., Tolomeo, P., & Rapezzi, C. (2022). Acute myocarditis after SARS-CoV-2 vaccination in a 24-year-old man. Revista portuguesa de cardiologia, 41(1), 71-72. https://www.sciencedirect.com/science/article/pii/S0870255121003243 | ||||
133 | Perimyocarditis after the first dose of mRNA-1273 SARS-CoV-2 (Modern) mRNA-1273 vaccine in a young healthy male: case report: | https://bmccardiovascdisord.biomedcentral.com/articles/10.1186/s12872-021-02183 | https://bmccardiovascdisord.biomedcentral.com/articles/10.1186/s12872-021-02183 | #VALUE! | Chamlling, B., Vehefof, V., Drakos, S., Weil, M., Stalling, P., Vahlhaus, C., ... & Yilmaz, A. (2021). Ocurrencia de miocarditis de forma de infarto aguda después de la vacunación de COVID-19: ¡solo una co-incidencia accidental o miocarditis autoinmune asociada a la vacuna. Investigación clínica en cardiología, 110 (11), 1850-1854. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8216855/ | zzzz | Chang, J. C., & Hawley, H. B. (2021). Vaccine-Associated Thrombocytopenia and Thrombosis: Venous Endotheliopathy Leading to Venous Combined Micro-Macrothrombosis. Medicina, 57(11), 1163. https://pubmed.ncbi.nlm.nih.gov/34833382/ | Vegezzi, E., Ravaglia, S., Buongarzone, G., Bini, P., Diamanti, L., Gastaldi, M., ... & Marchioni, E. (2021). Acute myelitis and ChAdOx1 nCoV-19 vaccine: Casual or causal association?. Journal of Neuroimmunology, 359, 577686. | https://www.sciencedirect.com/science/article/pii/S0165572821002137 | Vegezzi, E., Ravaglia, S., Buongarzone, G., Bini, P., Diamanti, L., Gastaldi, M., ... & Marchioni, E. (2021). Acute myelitis and ChAdOx1 nCoV-19 vaccine: Casual or causal association?. Journal of Neuroimmunology, 359, 577686. https://www.sciencedirect.com/science/article/pii/S0165572821002137 | Cines, D. B., & Bussel, J. B. (2021). SARS-CoV-2 vaccine–induced immune thrombotic thrombocytopenia. New England Journal of Medicine, 384(23), 2254-2256. https://www.nejm.org/doi/full/10.1056/nejme2106315 | |||||
134 | Acute myocarditis after the second dose of SARS-CoV-2 vaccine: serendipity or causal relationship: | https://pubmed.ncbi.nlm.nih.gov/34236331/ | https://pubmed.ncbi.nlm.nih.gov/34236331/ | Cereda, A., Conca, C., Barbieri, L., Ferrante, G., Tumminello, G., Lucreziotti, S., ... & Mafrici, A. (2021). Acute myocarditis after the second dose of SARS-CoV-2 vaccine: Serendipity or atypical causal relationship?. Anatolian Journal of Cardiology, 25(7), 522. | Cereda, A., Conca, C., Barbieri, L., Ferrante, G., Tumminello, G., Lucreziotti, S., ... & Mafrici, A. (2021). Miocarditis aguda tras la segunda dosis de la vacuna SARS-CoV-2: ¿Serendipia o relación causal atípica?. Revista de Cardiología de Anatolia, 25 (7), 522. https://pubmed.ncbi.nlm.nih.gov/34435250/ | Chamlling, B., Vehefof, V., Drakos, S., Weil, M., Stalling, P., Vahlhaus, C., ... & Yilmaz, A. (2021). Ocurrencia de miocarditis de forma de infarto aguda después de la vacunación de COVID-19: ¡solo una co-incidencia accidental o miocarditis autoinmune asociada a la vacuna. Investigación clínica en cardiología, 110 (11), 1850-1854. https://www.ncbi.nlm.nih.gov/pubmed/34833382 | Cereda, A., Conca, C., Barbieri, L., Ferrante, G., Tumminello, G., Lucreziotti, S., ... & Mafrici, A. (2021). Acute myocarditis after the second dose of SARS-CoV-2 vaccine: Serendipity or atypical causal relationship?. Anatolian Journal of Cardiology, 25(7), 522. https://pubmed.ncbi.nlm.nih.gov/34236331/ | Chang, J. C., & Hawley, H. B. (2021). Vaccine-Associated Thrombocytopenia and Thrombosis: Venous Endotheliopathy Leading to Venous Combined Micro-Macrothrombosis. Medicina, 57(11), 1163. https://www.ncbi.nlm.nih.gov/pubmed/34833382 | Cirillo, N., & Doan, R. (2021). Bell's palsy and SARS-CoV-2 vaccines—an unfolding story. The Lancet Infectious Diseases, 21(9), 1210-1211. | https://www.sciencedirect.com/science/article/pii/S1473309921002735 | Cirillo, N., & Doan, R. (2021). Bell's palsy and SARS-CoV-2 vaccines—an unfolding story. The Lancet Infectious Diseases, 21(9), 1210-1211. https://www.sciencedirect.com/science/article/pii/S1473309921002735 | Cinotti, E., Perrot, J. L., Bruzziches, F., Tognetti, L., Batsikosta, A., Sorrentino, E., ... & Rubegni, P. (2021). Eosinophilic dermatosis after AstraZeneca COVID-19 vaccination. Journal of the European Academy of Dermatology and Venereology: JEADV. https://pubmed.ncbi.nlm.nih.gov/34753210/. | ||||
135 | Rhabdomyolysis and fasciitis induced by the COVID-19 mRNA vaccine: | https://pubmed.ncbi.nlm.nih.gov/34435250/ | https://pubmed.ncbi.nlm.nih.gov/34435250/ | Faissner, S., Richter, D., Ceylan, U., Schneider-Gold, C., & Gold, R. (2021). COVID-19 mRNA vaccine induced rhabdomyolysis and fasciitis. Journal of Neurology, 1-2. | Faissner, S., Richter, D., Ceylan, U., Schneider-Gold, C. y Gold, R. (2021). La vacuna de ARNm COVID-19 indujo rabdomiólisis y fascitis. Revista de Neurología, 1-2. https://pubmed.ncbi.nlm.nih.gov/34186348/. | Chang, J. C., & Hawley, H. B. (2021). Trombocitopenia y trombosis asociada a la vacuna: la endoteliopatía venosa que conduce a la micro-macrotrotrombosis combinada venosa. Medicina, 57 (11), 1163. https://pubmed.ncbi.nlm.nih.gov/34670287/ | Faissner, S., Richter, D., Ceylan, U., Schneider-Gold, C., & Gold, R. (2021). COVID-19 mRNA vaccine induced rhabdomyolysis and fasciitis. Journal of Neurology, 1-2. https://pubmed.ncbi.nlm.nih.gov/34435250/ | Chelala, L., Jeudy, J., Hossain, R., Rosenthal, G., Pietris, N., & White, C. (2021). Cardiac MRI findings of myocarditis after COVID-19 mRNA vaccination in adolescents. American Journal of Roentgenology. https://pubmed.ncbi.nlm.nih.gov/34704459/ | Repajic, M., Lai, X. L., Xu, P., & Liu, A. (2021). Bell’s Palsy after second dose of Pfizer COVID-19 vaccination in a patient with history of recurrent Bell’s palsy. Brain, Behavior, & Immunity-Health, 13, 100217. | https://www.sciencedirect.com/science/article/pii/S266635462100020X | Repajic, M., Lai, X. L., Xu, P., & Liu, A. (2021). Bell’s Palsy after second dose of Pfizer COVID-19 vaccination in a patient with history of recurrent Bell’s palsy. Brain, Behavior, & Immunity-Health, 13, 100217. https://www.sciencedirect.com/science/article/pii/S266635462100020X | Cirillo, N. (2021). Reported orofacial adverse effects of COVID‐19 vaccines: The knowns and the unknowns. Journal of Oral Pathology & Medicine, 50(4), 424-427. https://pubmed.ncbi.nlm.nih.gov/33527524/ | ||||
136 | COVID-19 vaccine-induced rhabdomyolysis: case report with literature review: | https://pubmed.ncbi.nlm.nih.gov/34186348/. | https://pubmed.ncbi.nlm.nih.gov/34186348/. | Nassar, M., Chung, H., Dhayaparan, Y., Nyein, A., Acevedo, B. J., Chicos, C., ... & Kimball, E. (2021). COVID-19 vaccine induced rhabdomyolysis: Case report with literature review. Diabetes & Metabolic Syndrome. | Nassar, M., Chung, H., Dhayaparan, Y., Nyein, A., Acevedo, B. J., Chicos, C., ... & Kimball, E. (2021). Rabdomiólisis inducida por la vacuna COVID-19: reporte de un caso con revisión de la literatura. Diabetes y síndrome metabólico. https://www.sciencedirect.com/science/article/pii/S2666354621000065 | Chang, J. C., & Hawley, H. B. (2021). Trombocitopenia y trombosis asociada a la vacuna: la endoteliopatía venosa que conduce a la micro-macrotrotrombosis combinada venosa. Medicina, 57 (11), 1163. https://www.ncbi.nlm.nih.gov/pubmed/34704459 | Nassar, M., Chung, H., Dhayaparan, Y., Nyein, A., Acevedo, B. J., Chicos, C., ... & Kimball, E. (2021). COVID-19 vaccine induced rhabdomyolysis: Case report with literature review. Diabetes & Metabolic Syndrome. https://pubmed.ncbi.nlm.nih.gov/34186348/. | Chelala, L., Jeudy, J., Hossain, R., Rosenthal, G., Pietris, N., & White, C. (2021). Cardiac MRI findings of myocarditis after COVID-19 mRNA vaccination in adolescents. American Journal of Roentgenology. https://www.ncbi.nlm.nih.gov/pubmed/34704459 | Fowler, N., Martinez, N. R. M., Pallares, B. V., & Maldonado, R. S. (2021). Acute-onset central serous retinopathy after immunization with COVID-19 mRNA vaccine. American Journal of Ophthalmology Case Reports, 23, 101136. | https://www.sciencedirect.com/science/article/pii/S2451993621001456. | Fowler, N., Martinez, N. R. M., Pallares, B. V., & Maldonado, R. S. (2021). Acute-onset central serous retinopathy after immunization with COVID-19 mRNA vaccine. American Journal of Ophthalmology Case Reports, 23, 101136. https://www.sciencedirect.com/science/article/pii/S2451993621001456. | Cirillo, N., & Doan, R. (2021). Bell's palsy and SARS-CoV-2 vaccines—an unfolding story. The Lancet Infectious Diseases, 21(9), 1210-1211. https://www.sciencedirect.com/science/article/pii/S1473309921002735 | ||||
137 | GM1 ganglioside antibody and COVID-19-related Guillain Barre syndrome: case report, systemic review, and implications for vaccine development: | https://www.sciencedirect.com/science/article/pii/S2666354621000065 | https://www.sciencedirect.com/science/article/pii/S2666354621000065 | Dufour, C., Co, T. K., & Liu, A. (2021). GM1 ganglioside antibody and COVID-19 related Guillain Barre Syndrome–a case report, systemic review and implication for vaccine development. Brain, Behavior, & Immunity-Health, 12, 100203. | Dufour, C., Co, TK y Liu, A. (2021). Anticuerpo gangliósido GM1 y síndrome de Guillain Barré relacionado con COVID-19: informe de un caso, revisión sistémica e implicaciones para el desarrollo de vacunas. Cerebro, comportamiento e inmunidad-Salud, 12, 100203. https://www.sciencedirect.com/science/article/pii/S0303846721004169 | Chelala, L., Jeudy, J., Hossain, R., Rosenthal, G., Pietris, N., & White, C. (2021). Los hallazgos de la MRI cardíaca de la miocarditis después de la vacunación con ARNm de COVID-19 en adolescentes. American Journal of Roentgenology. https://academic.oup.com/ehjcimaging/advance-article/doi/10.1093/ehjci/jeab230/6421640 | Dufour, C., Co, T. K., & Liu, A. (2021). GM1 ganglioside antibody and COVID-19 related Guillain Barre Syndrome–a case report, systemic review and implication for vaccine development. Brain, Behavior, & Immunity-Health, 12, 100203. https://www.sciencedirect.com/science/article/pii/S2666354621000065 | Chen, C. C., Chen, H. Y., Lu, C. C., & Lin, S. H. (2021). Case Report: Anti-neutrophil Cytoplasmic Antibody-Associated Vasculitis With Acute Renal Failure and Pulmonary Hemorrhage May Occur After COVID-19 Vaccination. Frontiers in Medicine, 8. https://pubmed.ncbi.nlm.nih.gov/34859017/ | de Terreros Caro, G. G., Díaz, S. G., Alé, M. P., & Gimeno, M. M. (2021). Bell’s palsy following COVID-19 vaccination: A case report. Neurologia (Barcelona, Spain). | https://www.sciencedirect.com/science/article/pii/S217358082100122X. | de Terreros Caro, G. G., Díaz, S. G., Alé, M. P., & Gimeno, M. M. (2021). Bell’s palsy following COVID-19 vaccination: A case report. Neurologia (Barcelona, Spain). https://www.sciencedirect.com/science/article/pii/S217358082100122X. | Cirillo, N., & Doan, R. (2022). The association between COVID-19 vaccination and Bell's palsy. The Lancet Infectious Diseases, 22(1), 5-6. https://pubmed.ncbi.nlm.nih.gov/34411533/ | ||||
138 | Guillain-Barré syndrome after AstraZeneca COVID-19 vaccination: causal or casual association: | https://www.sciencedirect.com/science/article/pii/S0303846721004169 | https://www.sciencedirect.com/science/article/pii/S0303846721004169 | Introna, A., Caputo, F., Santoro, C., Guerra, T., Ucci, M., Mezzapesa, D. M., & Trojano, M. (2021). Guillain-Barré syndrome after AstraZeneca COVID-19-vaccination: a causal or casual association?. Clinical Neurology and Neurosurgery, 208, 106887. | Introna, A., Caputo, F., Santoro, C., Guerra, T., Ucci, M., Mezzapesa, D. M. y Trojano, M. (2021). Síndrome de Guillain-Barré después de la vacuna AstraZeneca COVID-19: ¿una asociación causal o casual?. Neurología Clínica y Neurocirugía, 208, 106887. https://www.sciencedirect.com/science/article/pii/S0165572821002186 | Chelala, L., Jeudy, J., Hossain, R., Rosenthal, G., Pietris, N., & White, C. (2021). Los hallazgos de la MRI cardíaca de la miocarditis después de la vacunación con ARNm de COVID-19 en adolescentes. American Journal of Roentgenology. https://www.ncbi.nlm.nih.gov/pubmed/34664804 | Introna, A., Caputo, F., Santoro, C., Guerra, T., Ucci, M., Mezzapesa, D. M., & Trojano, M. (2021). Guillain-Barré syndrome after AstraZeneca COVID-19-vaccination: a causal or casual association?. Clinical Neurology and Neurosurgery, 208, 106887. https://www.sciencedirect.com/science/article/pii/S0303846721004169 | Chen, J., Cai, Y., Chen, Y., Williams, A. P., Gao, Y., & Zeng, J. (2021). Nervous and muscular adverse events after COVID-19 vaccination: a systematic review and meta-analysis of clinical trials. Vaccines, 9(8), 939. https://pubmed.ncbi.nlm.nih.gov/34452064/. | Krantz, M. S., Stone Jr, C. A., Rolando, L. A., Nobis, A. E., Koo, G., Corey, K. B., ... & Phillips, E. J. (2021). An academic hospital experience screening mRNA COVID-19 vaccine risk using patient allergy history. The Journal of Allergy and Clinical Immunology: In Practice, 9(10), 3807-3810. | https://www.sciencedirect.com/science/article/pii/S2213219821007972 | Krantz, M. S., Stone Jr, C. A., Rolando, L. A., Nobis, A. E., Koo, G., Corey, K. B., ... & Phillips, E. J. (2021). An academic hospital experience screening mRNA COVID-19 vaccine risk using patient allergy history. The Journal of Allergy and Clinical Immunology: In Practice, 9(10), 3807-3810. https://www.sciencedirect.com/science/article/pii/S2213219821007972 | Clark, R. T., Johnson, L., Billotti, J., Foulds, G., Ketels, T., Heard, K., & Hynes, E. C. (2021). Early outcomes of bivalirudin therapy for thrombotic thrombocytopenia and cerebral venous sinus thrombosis after Ad26. COV2. S vaccination. Annals of Emergency Medicine, 78(4), 511-514. https://www.sciencedirect.com/science/article/pii/S0196064421003425 | ||||
139 | Sensory Guillain-Barré syndrome after ChAdOx1 nCov-19 vaccine: report of two cases and review of the literature: | https://www.sciencedirect.com/science/article/pii/S0165572821002186 | https://www.sciencedirect.com/science/article/pii/S0165572821002186 | Min, Y. G., Ju, W., Ha, Y. E., Ban, J. J., Lee, S. A., Sung, J. J., & Shin, J. Y. (2021). Sensory Guillain-Barre syndrome following the ChAdOx1 nCov-19 vaccine: Report of two cases and review of literature. Journal of neuroimmunology, 359, 577691. | Min, Y. G., Ju, W., Ha, Y. E., Ban, J. J., Lee, S. A., Sung, J. J. y Shin, J. Y. (2021). Síndrome sensorial de Guillain-Barré tras la vacuna ChAdOx1 nCov-19: reporte de dos casos y revisión de la literatura. Revista de neuroinmunología, 359, 577691. https://www.sciencedirect.com/science/article/pii/S2214250921000998. | Chen, C. C., Chen, H. Y., LU, C. C., & Lin, S. H. (2021). Informe de caso: la vasculitis asociada a anticuerpos citoplásmicos anti-neutrófilos con insuficiencia renal aguda y hemorragia pulmonar puede ocurrir después de la vacunación de COVID-19. Fronteras en medicina, 8. https://pubmed.ncbi.nlm.nih.gov/34783899/ | Min, Y. G., Ju, W., Ha, Y. E., Ban, J. J., Lee, S. A., Sung, J. J., & Shin, J. Y. (2021). Sensory Guillain-Barre syndrome following the ChAdOx1 nCov-19 vaccine: Report of two cases and review of literature. Journal of neuroimmunology, 359, 577691. https://www.sciencedirect.com/science/article/pii/S0165572821002186 | Chen, S., Fan, X. R., He, S., Zhang, J. W., & Li, S. J. (2021). Watch out for neuromyelitis optica spectrum disorder after inactivated virus vaccination for COVID-19. Neurological Sciences, 42(9), 3537-3539. https://pubmed.ncbi.nlm.nih.gov/34189662/ | Singh, B., Kaur, P., Kumar, V., & Maroules, M. (2021). COVID-19 vaccine induced Axillary and Pectoral Lymphadenopathy on PET scan. Radiology Case Reports, 16(7), 1819-1821. | https://www.sciencedirect.com/science/article/pii/S1930043321002612 | Singh, B., Kaur, P., Kumar, V., & Maroules, M. (2021). COVID-19 vaccine induced Axillary and Pectoral Lymphadenopathy on PET scan. Radiology Case Reports, 16(7), 1819-1821. https://www.sciencedirect.com/science/article/pii/S1930043321002612 | Clarke, R., Ioannou, A., Katz, T. A., Vliegenthart, R. J. S., Aarnoudse-Moens, C. S. H., Wilms, J., ... & Kilbride, H. (2021). Should T2 mapping be used in cases of recurrent myocarditis to differentiate between the acute inflammation and chronic scar?. The Journal of pediatrics. https://www.ncbi.nlm.nih.gov/pubmed/34933012 | ||||
140 | Guillain-Barré syndrome after the first dose of SARS-CoV-2 vaccine: a temporary occurrence, not a causal association: | https://www.sciencedirect.com/science/article/pii/S2214250921000998. | https://www.sciencedirect.com/science/article/pii/S2214250921000998. | Ogbebor, O., Seth, H., Min, Z., & Bhanot, N. (2021). Guillain-Barré syndrome following the first dose of SARS-CoV-2 vaccine: a temporal occurrence, not a causal association. IDCases, 24, e01143. | Ogbebor, O., Seth, H., Min, Z. y Bhanot, N. (2021). Síndrome de Guillain-Barré después de la primera dosis de la vacuna SARS-CoV-2: una ocurrencia temporal, no una asociación causal. IDCasos, 24, e01143. https://www.sciencedirect.com/science/article/pii/S0736467921006442 | Chen, J., Cai, Y., Chen, Y., Williams, A. P., Gao, Y., & Zeng, J. (2021). Eventos adversos nerviosos y musculares después de la vacunación COVID-19: una revisión sistemática y un metanálisis de los ensayos clínicos. Vacunas, 9 (8), 939. https://pubmed.ncbi.nlm.nih.gov/33917902/ | Ogbebor, O., Seth, H., Min, Z., & Bhanot, N. (2021). Guillain-Barré syndrome following the first dose of SARS-CoV-2 vaccine: a temporal occurrence, not a causal association. IDCases, 24, e01143. https://www.sciencedirect.com/science/article/pii/S2214250921000998. | Chen, V. M., Curnow, J. L., Tran, H. A., & Choi, P. Y. I. (2021). Australian and New Zealand approach to diagnosis and management of vaccine‐induced immune thrombosis and thrombocytopenia. Medical Journal of Australia, 215(6), 245-249. https://pubmed.ncbi.nlm.nih.gov/34490632/ | Shakoor, M. T., Birkenbach, M. P., & Lynch, M. (2021). ANCA-associated vasculitis following Pfizer-BioNTech COVID-19 vaccine. American Journal of Kidney Diseases, 78(4), 611-613. | https://www.sciencedirect.com/science/article/pii/S0272638621007423 | Shakoor, M. T., Birkenbach, M. P., & Lynch, M. (2021). ANCA-associated vasculitis following Pfizer-BioNTech COVID-19 vaccine. American Journal of Kidney Diseases, 78(4), 611-613. https://www.sciencedirect.com/science/article/pii/S0272638621007423 | Clayton-Chubb, D., Schneider, D., Freeman, E., Kemp, W., & Roberts, S. K. (2021). Autoimmune hepatitis developing after the ChAdOx1 nCoV-19 (Oxford-AstraZeneca) vaccine. Journal of Hepatology, 75(5), 1249-1250. https://pubmed.ncbi.nlm.nih.gov/34171435/ | ||||
141 | Guillain-Barré syndrome presenting as facial diplegia after vaccination with COVID-19: a case report: | https://www.sciencedirect.com/science/article/pii/S0736467921006442 | https://www.sciencedirect.com/science/article/pii/S0736467921006442 | Rossetti, A., Gheihman, G., O'Hare, M., & Kosowsky, J. M. (2021). Guillain-Barré Syndrome presenting as facial diplegia after COVID-19 vaccination: A case report. The Journal of Emergency Medicine, 61(6), e141-e145. | Rossetti, A., Gheihman, G., O'Hare, M. y Kosowsky, JM (2021). Síndrome de Guillain-Barré que se presenta como diplejía facial después de la vacunación COVID-19: reporte de un caso. La Revista de Medicina de Emergencia, 61(6), e141-e145. https://www.sciencedirect.com/science/article/pii/S0035378721005853. | Chen, S., Fan, X. R., él, S., Zhang, J. W., & Li, S. J. (2021). Tenga cuidado con el trastorno del espectro de la neuromielitis Optica después de la vacunación inactivada del virus para COVID-19. Ciencias neurológicas, 42 (9), 3537-3539. https://pubmed.ncbi.nlm.nih.gov/34660149/ | Rossetti, A., Gheihman, G., O'Hare, M., & Kosowsky, J. M. (2021). Guillain-Barré Syndrome presenting as facial diplegia after COVID-19 vaccination: A case report. The Journal of Emergency Medicine, 61(6), e141-e145. https://www.sciencedirect.com/science/article/pii/S0736467921006442 | Chen, Y. A., Huang, H. Y., Wu, S. H., & Huang, T. C. (2021). Thrombosis of the palmar digital vein after Oxford-AstraZeneca COVID-19 vaccination. International Journal of Dermatology, 60(11), e469-e471. https://pubmed.ncbi.nlm.nih.gov/34473841/. | Guerrero, A. J., Estirado, A. D., Quirós, J. C., & Rojas-Pérez-Ezquerra, P. (2021). Delayed cutaneous reactions after the administration of mRNA vaccines against COVID-19. The Journal of Allergy and Clinical Immunology: In Practice, 9(10), 3811-3813. | https://www.sciencedirect.com/science/article/pii/S2213219821007996 | Guerrero, A. J., Estirado, A. D., Quirós, J. C., & Rojas-Pérez-Ezquerra, P. (2021). Delayed cutaneous reactions after the administration of mRNA vaccines against COVID-19. The Journal of Allergy and Clinical Immunology: In Practice, 9(10), 3811-3813. https://www.sciencedirect.com/science/article/pii/S2213219821007996 | Cleaver, J., Ibitoye, R., Morrison, H., Flood, R., Crewdson, K., Marsh, A., ... & Mortimer, A. (2021). Endovascular treatment for vaccine-induced cerebral venous sinus thrombosis and thrombocytopenia following ChAdOx1 nCoV-19 vaccination: a report of three cases. Journal of neurointerventional surgery. https://pubmed.ncbi.nlm.nih.gov/34782400/ | ||||
142 | Guillain-Barré syndrome after the first injection of ChAdOx1 nCoV-19 vaccine: first report: | https://www.sciencedirect.com/science/article/pii/S0035378721005853. | https://www.sciencedirect.com/science/article/pii/S0035378721005853. | Theuriet, J., Richard, C., Becker, J., Pegat, A., Bernard, E., & Vukusic, S. (2021). Guillain-Barré syndrome following first injection of ChAdOx1 nCoV-19 vaccine: First report. Revue neurologique, 177(10), 1305-1307. | Theuriet, J., Richard, C., Becker, J., Pegat, A., Bernard, E. y Vukusic, S. (2021). Síndrome de Guillain-Barré tras la primera inyección de la vacuna ChAdOx1 nCoV-19: primer informe. Revista neurológica, 177(10), 1305-1307. https://www.sciencedirect.com/science/article/pii/S2049080121005343 | Chen, V. M., Curnow, J. L., Tran, H. A., & Choi, P. Y. I. (2021). Enfoque australiano y Nueva Zelanda para el diagnóstico y la gestión de la trombosis inmune inducida por la vacuna y la trombocitopenia. Diario Médico de Australia, 215 (6), 245-249. https://pubmed.ncbi.nlm.nih.gov/33909350/ | Theuriet, J., Richard, C., Becker, J., Pegat, A., Bernard, E., & Vukusic, S. (2021). Guillain-Barré syndrome following first injection of ChAdOx1 nCoV-19 vaccine: First report. Revue neurologique, 177(10), 1305-1307. https://www.sciencedirect.com/science/article/pii/S0035378721005853. | Cheng, N. (2021). Cerebral venous sinus thrombosis after Pfizer-BioNTech COVID-19 (BNT162b2) vaccination. Journal of Clinical Neurology (Seoul, Korea), 17(4), 573. https://pubmed.ncbi.nlm.nih.gov/34595867/ | McMahon, D. E., Kovarik, C. L., Damsky, W., Rosenbach, M., Lipoff, J. B., Tyagi, A., ... & Freeman, E. E. (2022). Clinical and pathologic correlation of cutaneous COVID-19 vaccine reactions including V-REPP: A registry-based study. Journal of the American Academy of Dermatology, 86(1), 113-121. | https://www.sciencedirect.com/science/article/pii/S0190962221024427 | McMahon, D. E., Kovarik, C. L., Damsky, W., Rosenbach, M., Lipoff, J. B., Tyagi, A., ... & Freeman, E. E. (2022). Clinical and pathologic correlation of cutaneous COVID-19 vaccine reactions including V-REPP: A registry-based study. Journal of the American Academy of Dermatology, 86(1), 113-121. https://www.sciencedirect.com/science/article/pii/S0190962221024427 | Cliff-Patel, N., Moncrieff, L., & Ziauddin, V. (2021). Renal vein thrombosis and pulmonary embolism secondary to vaccine-induced thrombotic thrombocytopenia (VITT). European Journal of Case Reports in Internal Medicine, 8(7). https://pubmed.ncbi.nlm.nih.gov/34268278/. | ||||
143 | SARS-CoV-2 vaccines are not safe for those with Guillain-Barre syndrome following vaccination: | https://www.sciencedirect.com/science/article/pii/S2049080121005343 | https://www.sciencedirect.com/science/article/pii/S2049080121005343 | Finsterer, J. (2021). SARS-CoV-2 vaccinations are unsafe for those experiencing post-vaccination Guillain-Barre syndrome. Annals of Medicine and Surgery. | Finsterer, J. (2021). Las vacunas contra el SARS-CoV-2 no son seguras para quienes padecen el síndrome de Guillain-Barré posvacunación. Anales de Medicina y Cirugía. https://www.sciencedirect.com/science/article/pii/S2049080121007536 | Chen, Y. A., Huang, H. Y., Wu, S. H., & Huang, T. C. (2021). Trombosis de la vena digital Palmar después de Oxford-AstraZeneca COVID-19 Vacunación. Diario Internacional de Dermatología, 60 (11), E469-E471. https://pubmed.ncbi.nlm.nih.gov/34189756/ | Finsterer, J. (2021). SARS-CoV-2 vaccinations are unsafe for those experiencing post-vaccination Guillain-Barre syndrome. Annals of Medicine and Surgery. https://www.sciencedirect.com/science/article/pii/S2049080121005343 | Chiang, C. Y., Chen, C. Y., Yu, W. L., Kan, W. C., & Feng, Y. H. (2021). Myocardial Infarction and Azygos Vein Thrombosis After ChAdOx1 nCoV-19 Vaccination in a Hemodialysis Patient. Cureus, 13(9). https://pubmed.ncbi.nlm.nih.gov/34650896/ | Turner, P. J., Ansotegui, I. J., Campbell, D. E., Cardona, V., Ebisawa, M., El-Gamal, Y., ... & WAO Anaphylaxis Committee. (2021). COVID-19 vaccine-associated anaphylaxis: a statement of the World Allergy Organization Anaphylaxis Committee. World Allergy Organization Journal, 14(2), 100517. | https://www.sciencedirect.com/science/article/pii/S1939455121000119. | Turner, P. J., Ansotegui, I. J., Campbell, D. E., Cardona, V., Ebisawa, M., El-Gamal, Y., ... & WAO Anaphylaxis Committee. (2021). COVID-19 vaccine-associated anaphylaxis: a statement of the World Allergy Organization Anaphylaxis Committee. World Allergy Organization Journal, 14(2), 100517. https://www.sciencedirect.com/science/article/pii/S1939455121000119. | Cohen, D., Krauthammer, S. H., Wolf, I., & Even-Sapir, E. (2021). Hypermetabolic lymphadenopathy following administration of BNT162b2 mRNA Covid-19 vaccine: incidence assessed by [18F] FDG PET-CT and relevance to study interpretation. European Journal of Nuclear Medicine and Molecular Imaging, 48(6), 1854-1863. https://pubmed.ncbi.nlm.nih.gov/33774684/ | ||||
144 | Acute hyperactive encephalopathy following COVID-19 vaccination with dramatic response to methylprednisolone: a case report: | https://www.sciencedirect.com/science/article/pii/S2049080121007536 | https://www.sciencedirect.com/science/article/pii/S2049080121007536 | Al-Mashdali, A. F., Ata, Y. M., & Sadik, N. (2021). Post-COVID-19 vaccine acute hyperactive encephalopathy with dramatic response to methylprednisolone: A case report. Annals of Medicine and Surgery, 69, 102803. | Al-Mashdali, A. F., Ata, Y. M. y Sadik, N. (2021). Encefalopatía hiperactiva aguda posterior a la vacuna COVID-19 con respuesta dramática a la metilprednisolona: reporte de un caso. Anales de Medicina y Cirugía, 69, 102803. https://www.sciencedirect.com/science/article/pii/S1201971221007049 | Cheng, N. (2021). Trombosis sinusus venosa cerebral después de Pfizer-Biontech COVID-19 (BNT162B2) Vacunación. Diario de Neurología Clínica (Seúl, Corea), 17 (4), 573. https://pubmed.ncbi.nlm.nih.gov/34820240/ | Al-Mashdali, A. F., Ata, Y. M., & Sadik, N. (2021). Post-COVID-19 vaccine acute hyperactive encephalopathy with dramatic response to methylprednisolone: A case report. Annals of Medicine and Surgery, 69, 102803. https://www.sciencedirect.com/science/article/pii/S2049080121007536 | Choi, G. J., Baek, S. H., Kim, J., Kim, J. H., Kwon, G. Y., Kim, D. K., ... & Kim, S. (2021). Fatal Systemic Capillary Leak Syndrome after SARS-CoV-2Vaccination in Patient with Multiple Myeloma. Emerging infectious diseases, 27(11), 2973. https://pubmed.ncbi.nlm.nih.gov/34459725/ | Akiyama, H., Kakiuchi, S., Rikitake, J., Matsuba, H., Sekinada, D., Kozuki, Y., & Iwata, N. (2021). Immune thrombocytopenia associated with Pfizer-BioNTech’s BNT162b2 mRNA COVID-19 vaccine. IDCases, 25, e01245. | https://www.sciencedirect.com/science/article/pii/S2214250921002018. | Akiyama, H., Kakiuchi, S., Rikitake, J., Matsuba, H., Sekinada, D., Kozuki, Y., & Iwata, N. (2021). Immune thrombocytopenia associated with Pfizer-BioNTech’s BNT162b2 mRNA COVID-19 vaccine. IDCases, 25, e01245. https://www.sciencedirect.com/science/article/pii/S2214250921002018. | Cohen, S. R., Prussick, L., Kahn, J. S., Gao, D. X., Radfar, A., & Rosmarin, D. (2021). Leukocytoclastic vasculitis flare following the COVID‐19 vaccine. International Journal of Dermatology, 60(8), 1032-1033. https://pubmed.ncbi.nlm.nih.gov/33928638/ | ||||
145 | Facial nerve palsy following administration of COVID-19 mRNA vaccines: analysis of self-report database: | https://www.sciencedirect.com/science/article/pii/S1201971221007049 | https://www.sciencedirect.com/science/article/pii/S1201971221007049 | Sato, K., Mano, T., Niimi, Y., Toda, T., Iwata, A., & Iwatsubo, T. (2021). Facial nerve palsy following the administration of COVID-19 mRNA vaccines: analysis of a self-reporting database. International Journal of Infectious Diseases, 111, 310-312. | Sato, K., Mano, T., Niimi, Y., Toda, T., Iwata, A. e Iwatsubo, T. (2021). Parálisis del nervio facial después de la administración de vacunas de ARNm COVID-19: análisis de una base de datos de autoinforme. Revista Internacional de Enfermedades Infecciosas, 111, 310-312. https://www.sciencedirect.com/science/article/pii/S0899707121003557. | Chiang, C. Y., Chen, C. Y., Yu, W. L., Kan, W. C., & Feng, Y. H. (2021). Infarto miocárdico y trombosis de la vena Azygos después de la vacunación con Chadox1 NCOV-19 en un paciente de hemodiálisis. CUREUS, 13 (9). https://pubmed.ncbi.nlm.nih.gov/34625447/ | Sato, K., Mano, T., Niimi, Y., Toda, T., Iwata, A., & Iwatsubo, T. (2021). Facial nerve palsy following the administration of COVID-19 mRNA vaccines: analysis of a self-reporting database. International Journal of Infectious Diseases, 111, 310-312. https://www.sciencedirect.com/science/article/pii/S1201971221007049 | Choi, J. K., Kim, S., Kim, S. R., Jin, J. Y., Choi, S. W., Kim, H., ... & Kim, S. R. (2021). Intracerebral hemorrhage due to thrombosis with thrombocytopenia syndrome after vaccination against COVID-19: the first fatal case in korea. Journal of Korean Medical Science, 36(31). https://pubmed.ncbi.nlm.nih.gov/34402235/ | Kong, J., Cuevas-Castillo, F., Nassar, M., Lei, C. M., Idrees, Z., Fix, W. C., ... & Mathew, A. (2021). Bullous drug eruption after second dose of mRNA-1273 (Moderna) COVID-19 vaccine: Case report. Journal of Infection and Public Health, 14(10), 1392-1394. | https://www.sciencedirect.com/science/article/pii/S1876034121001878. | Kong, J., Cuevas-Castillo, F., Nassar, M., Lei, C. M., Idrees, Z., Fix, W. C., ... & Mathew, A. (2021). Bullous drug eruption after second dose of mRNA-1273 (Moderna) COVID-19 vaccine: Case report. Journal of Infection and Public Health, 14(10), 1392-1394. https://www.sciencedirect.com/science/article/pii/S1876034121001878. | Colaneri, M., De Filippo, M., Licari, A., Marseglia, A., Maiocchi, L., Ricciardi, A., ... & Bruno, R. (2021). COVID vaccination and asthma exacerbation: might there be a link?. International Journal of Infectious Diseases, 112, 243-246. https://www.ncbi.nlm.nih.gov/pubmed/34547487 | ||||
146 | Neurological symptoms and neuroimaging alterations related to COVID-19 vaccine: cause or coincidence: | https://www.sciencedirect.com/science/article/pii/S0899707121003557. | https://www.sciencedirect.com/science/article/pii/S0899707121003557. | Corrêa, D. G., Cañete, L. A. Q., Dos Santos, G. A. C., de Oliveira, R. V., Brandão, C. O., & da Cruz Jr, L. C. H. (2021). Neurological symptoms and neuroimaging alterations related with COVID-19 vaccine: Cause or coincidence?. Clinical Imaging, 80, 348-352. | Corrêa, D. G., Cañete, L. A. Q., Dos Santos, G. A. C., de Oliveira, R. V., Brandão, C. O., & da Cruz Jr, L. C. H. (2021). Síntomas neurológicos y alteraciones de neuroimagen relacionados con la vacuna COVID-19: ¿Causa o coincidencia?. Imágenes clínicas, 80, 348-352. https://www.sciencedirect.com/science/article/pii/S0165572821001569 | Choi, G. J., Baek, S. H., Kim, J., Kim, J. H., Kwon, G. Y., Kim, D. K., ... & Kim, S. (2021). Síndrome de fugas capilares sistémicas fatales después de SARS-COV-2Vacination en paciente con mieloma múltiple. Enfermedades infecciosas emergentes, 27 (11), 2973. https://pubmed.ncbi.nlm.nih.gov/34463066/ | Corrêa, D. G., Cañete, L. A. Q., Dos Santos, G. A. C., de Oliveira, R. V., Brandão, C. O., & da Cruz Jr, L. C. H. (2021). Neurological symptoms and neuroimaging alterations related with COVID-19 vaccine: Cause or coincidence?. Clinical Imaging, 80, 348-352. https://www.sciencedirect.com/science/article/pii/S0899707121003557. | Choi, P. Y. I., Hsu, D., Tran, H. A., Tan, C. W., Enjeti, A., Chen, V. M. Y., ... & Bird, R. (2020). Immune thrombocytopenia following vaccination during the COVID-19 pandemic. Haematologica. https://pubmed.ncbi.nlm.nih.gov/34435486/ | Shimabukuro, T. T., Kim, S. Y., Myers, T. R., Moro, P. L., Oduyebo, T., Panagiotakopoulos, L., ... & Meaney-Delman, D. M. (2021). Preliminary findings of mRNA Covid-19 vaccine safety in pregnant persons. New England Journal of Medicine. | https://www.nejm.org/doi/full/10.1056/NEJMoa2104983. | Shimabukuro, T. T., Kim, S. Y., Myers, T. R., Moro, P. L., Oduyebo, T., Panagiotakopoulos, L., ... & Meaney-Delman, D. M. (2021). Preliminary findings of mRNA Covid-19 vaccine safety in pregnant persons. New England Journal of Medicine. https://www.nejm.org/doi/full/10.1056/NEJMoa2104983. | Colella, G., Orlandi, M., & Cirillo, N. (2021). Bell’s palsy following COVID-19 vaccination. Journal of Neurology, 268(10), 3589-3591. https://pubmed.ncbi.nlm.nih.gov/33611630/ | ||||
147 | New-onset refractory status epilepticus after ChAdOx1 nCoV-19 vaccination: | https://www.sciencedirect.com/science/article/pii/S0165572821001569 | https://www.sciencedirect.com/science/article/pii/S0165572821001569 | Aladdin, Y., & Shirah, B. (2021). New-onset refractory status epilepticus following the ChAdOx1 nCoV-19 vaccine. Journal of Neuroimmunology, 357, 577629. | Aladdin, Y. y Shirah, B. (2021). Estado epiléptico refractario de nueva aparición después de la vacuna ChAdOx1 nCoV-19. Revista de Neuroinmunología, 357, 577629. https://www.sciencedirect.com/science/article/pii/S0165572821002137 | Choi, J. K., Kim, S., Kim, S. R., Jin, J. Y., Choi, S. W., Kim, H., ... & Kim, S. R. (2021). Hemorragia intracerebral Debido a la trombosis con síndrome de trombocitopenia después de la vacunación contra COVID-19: el primer caso fatal en Corea. Diario de la ciencia médica coreana, 36 (31). https://pubmed.ncbi.nlm.nih.gov/34446426/ | Aladdin, Y., & Shirah, B. (2021). New-onset refractory status epilepticus following the ChAdOx1 nCoV-19 vaccine. Journal of Neuroimmunology, 357, 577629. https://www.sciencedirect.com/science/article/pii/S0165572821001569 | Choi, S., Lee, S., Seo, J. W., Kim, M. J., Jeon, Y. H., Park, J. H., ... & Yeo, N. S. (2021). Myocarditis-induced sudden death after BNT162b2 mRNA COVID-19 vaccination in Korea: Case report focusing on histopathological findings. Journal of Korean medical science, 36(40). https://pubmed.ncbi.nlm.nih.gov/34664804/ | Khayat-Khoei, M., Bhattacharyya, S., Katz, J., Harrison, D., Tauhid, S., Bruso, P., ... & Bakshi, R. (2022). COVID-19 mRNA vaccination leading to CNS inflammation: a case series. Journal of neurology, 269(3), 1093-1106. | https://link.springer.com/article/10.1007/s00415-021-10780-7 | Khayat-Khoei, M., Bhattacharyya, S., Katz, J., Harrison, D., Tauhid, S., Bruso, P., ... & Bakshi, R. (2022). COVID-19 mRNA vaccination leading to CNS inflammation: a case series. Journal of neurology, 269(3), 1093-1106. https://link.springer.com/article/10.1007/s00415-021-10780-7 | Colia, R., Rotondo, C., Corrado, A., & Cantatore, F. P. (2021). Cutaneous vasculitis after severe acute respiratory syndrome coronavirus 2 vaccine. Rheumatology Advances in Practice, 5(3), rkab050. https://pubmed.ncbi.nlm.nih.gov/34557622/. | ||||
148 | Acute myelitis and ChAdOx1 nCoV-19 vaccine: coincidental or causal association: | https://www.sciencedirect.com/science/article/pii/S0165572821002137 | https://www.sciencedirect.com/science/article/pii/S0165572821002137 | Vegezzi, E., Ravaglia, S., Buongarzone, G., Bini, P., Diamanti, L., Gastaldi, M., ... & Marchioni, E. (2021). Acute myelitis and ChAdOx1 nCoV-19 vaccine: Casual or causal association?. Journal of Neuroimmunology, 359, 577686. | Vegezzi, E., Ravaglia, S., Buongarzone, G., Bini, P., Diamanti, L., Gastaldi, M., ... y Marchioni, E. (2021). Mielitis aguda y vacuna ChAdOx1 nCoV-19: ¿asociación casual o causal?. Revista de Neuroinmunología, 359, 577686. https://www.sciencedirect.com/science/article/pii/S1473309921002735 | Choi, P. Y. I., HSU, D., TRAN, H. A. A., TAN, C. W., ENJETI, A., Chen, V. M. Y., ... & Bird, R. (2020). Thrombocitopenia inmune después de la vacunación durante la pandemia COVID-19. Hematologica. https://pubmed.ncbi.nlm.nih.gov/34435142/ | Vegezzi, E., Ravaglia, S., Buongarzone, G., Bini, P., Diamanti, L., Gastaldi, M., ... & Marchioni, E. (2021). Acute myelitis and ChAdOx1 nCoV-19 vaccine: Casual or causal association?. Journal of Neuroimmunology, 359, 577686. https://www.sciencedirect.com/science/article/pii/S0165572821002137 | Choi, S., Lee, S., Seo, J. W., Kim, M. J., Jeon, Y. H., Park, J. H., ... & Yeo, N. S. (2021). Myocarditis-induced sudden death after BNT162b2 mRNA COVID-19 vaccination in Korea: Case report focusing on histopathological findings. Journal of Korean medical science, 36(40). https://www.ncbi.nlm.nih.gov/pubmed/34664804 | Shimabukuro, T., & Nair, N. (2021). Allergic reactions including anaphylaxis after receipt of the first dose of Pfizer-BioNTech COVID-19 vaccine. Jama, 325(8), 780-781. | https://pubmed.ncbi.nlm.nih.gov/33475702/ | Shimabukuro, T., & Nair, N. (2021). Allergic reactions including anaphylaxis after receipt of the first dose of Pfizer-BioNTech COVID-19 vaccine. Jama, 325(8), 780-781. https://pubmed.ncbi.nlm.nih.gov/33475702/ | Conticini, E., d'Alessandro, M., Bergantini, L., Bargagli, E., Gentili, F., Mazzei, M. A., ... & Frediani, B. (2021). Relapse of microscopic polyangiitis after vaccination against COVID‐19: A case report. Journal of medical virology. https://pubmed.ncbi.nlm.nih.gov/34251683/. | ||||
149 | Bell’s palsy and SARS-CoV-2 vaccines: an unfolding story: | https://www.sciencedirect.com/science/article/pii/S1473309921002735 | https://www.sciencedirect.com/science/article/pii/S1473309921002735 | Cirillo, N., & Doan, R. (2021). Bell's palsy and SARS-CoV-2 vaccines—an unfolding story. The Lancet Infectious Diseases, 21(9), 1210-1211. | Cirillo, N. y Doan, R. (2021). La parálisis de Bell y las vacunas contra el SARS-CoV-2: una historia en desarrollo. The Lancet Infectious Diseases, 21(9), 1210-1211. https://www.sciencedirect.com/science/article/pii/S266635462100020X | Choi, S., Lee, S., SEO, J. W., Kim, M. J., Jeon, Y. H., Park, J. H., ... & Yeo, N. S. (2021). La muerte súbita inducida por miocarditis después de la vacunación contra BNT162B2 MRNA COVID-19 en Corea: Informe de caso centrado en los hallazgos histopatológicos. Diario de la ciencia médica coreana, 36 (40). https://pubmed.ncbi.nlm.nih.gov/34605853/ | Cirillo, N., & Doan, R. (2021). Bell's palsy and SARS-CoV-2 vaccines—an unfolding story. The Lancet Infectious Diseases, 21(9), 1210-1211. https://www.sciencedirect.com/science/article/pii/S1473309921002735 | Choi, Y. K., Moon, J. Y., Kim, J., Yoo, I. S., Kwon, G. Y., Bae, H., ... & Kym, S. (2022). Postvaccination multisystem inflammatory syndrome in adult with no evidence of prior SARS-CoV-2 Infection. Emerging infectious diseases, 28(2), 411. https://pubmed.ncbi.nlm.nih.gov/34852213/ | Cabanillas, B., Akdis, C., & Novak, N. (2020). Allergic reactions to the first COVID-19 vaccine: a potential role of Polyethylene glycol. Allergy, 76(6), 1617-1618. | https://pubmed.ncbi.nlm.nih.gov/33320974/ | Cabanillas, B., Akdis, C., & Novak, N. (2020). Allergic reactions to the first COVID-19 vaccine: a potential role of Polyethylene glycol. Allergy, 76(6), 1617-1618. https://pubmed.ncbi.nlm.nih.gov/33320974/ | Cooper, K. M., & Switzer, B. (2021). Severe immune thrombocytopenic purpura after SARS-CoV-2 vaccine. Archive of Clinical Cases, 8(2), 31. https://pubmed.ncbi.nlm.nih.gov/34754937/ | ||||
150 | Bell’s palsy after the second dose of the Pfizer COVID-19 vaccine in a patient with a history of recurrent Bell’s palsy: | https://www.sciencedirect.com/science/article/pii/S266635462100020X | https://www.sciencedirect.com/science/article/pii/S266635462100020X | Repajic, M., Lai, X. L., Xu, P., & Liu, A. (2021). Bell’s Palsy after second dose of Pfizer COVID-19 vaccination in a patient with history of recurrent Bell’s palsy. Brain, Behavior, & Immunity-Health, 13, 100217. | Repajic, M., Lai, X. L., Xu, P. y Liu, A. (2021). Parálisis de Bell después de la segunda dosis de la vacuna Pfizer COVID-19 en un paciente con antecedentes de parálisis de Bell recurrente. Cerebro, comportamiento e inmunidad-Salud, 13, 100217. https://www.sciencedirect.com/science/article/pii/S2451993621001456. | Choi, S., Lee, S., SEO, J. W., Kim, M. J., Jeon, Y. H., Park, J. H., ... & Yeo, N. S. (2021). La muerte súbita inducida por miocarditis después de la vacunación contra BNT162B2 MRNA COVID-19 en Corea: Informe de caso centrado en los hallazgos histopatológicos. Diario de la ciencia médica coreana, 36 (40). https://www.ncbi.nlm.nih.gov/pubmed/34860360 | Repajic, M., Lai, X. L., Xu, P., & Liu, A. (2021). Bell’s Palsy after second dose of Pfizer COVID-19 vaccination in a patient with history of recurrent Bell’s palsy. Brain, Behavior, & Immunity-Health, 13, 100217. https://www.sciencedirect.com/science/article/pii/S266635462100020X | Chouchana, L., Blet, A., Al‐Khalaf, M., Kafil, T. S., Nair, G., Robblee, J., ... & Liu, P. P. (2022). Features of Inflammatory Heart Reactions Following mRNA COVID‐19 Vaccination at a Global Level. Clinical Pharmacology & Therapeutics. https://www.ncbi.nlm.nih.gov/pubmed/34860360 | de Vrieze, J. (2021). Pfizer's vaccine raises allergy concerns. | https://pubmed.ncbi.nlm.nih.gov/33384356/ | de Vrieze, J. (2021). Pfizer's vaccine raises allergy concerns. https://pubmed.ncbi.nlm.nih.gov/33384356/ | Corrêa, D. G., Cañete, L. A. Q., Dos Santos, G. A. C., de Oliveira, R. V., Brandão, C. O., & da Cruz Jr, L. C. H. (2021). Neurological symptoms and neuroimaging alterations related with COVID-19 vaccine: Cause or coincidence?. Clinical Imaging, 80, 348-352. https://www.sciencedirect.com/science/article/pii/S0899707121003557. | ||||
151 | Acute-onset central serous retinopathy after immunization with COVID-19 mRNA vaccine:. | https://www.sciencedirect.com/science/article/pii/S2451993621001456. | https://www.sciencedirect.com/science/article/pii/S2451993621001456. | Fowler, N., Martinez, N. R. M., Pallares, B. V., & Maldonado, R. S. (2021). Acute-onset central serous retinopathy after immunization with COVID-19 mRNA vaccine. American Journal of Ophthalmology Case Reports, 23, 101136. | Fowler, N., Martinez, N. R. M., Pallares, B. V. y Maldonado, R. S. (2021). Retinopatía serosa central de aparición aguda después de la inmunización con la vacuna de ARNm de COVID-19. Informes de casos del American Journal of Ophthalmology, 23, 101136. https://www.sciencedirect.com/science/article/pii/S217358082100122X. | Choi, Y. K., Moon, J. Y., Kim, J., Yoo, I. S., Kwon, G. Y., BAE, H., ... & KYM, S. (2022). Síndrome inflamatorio multisistémico de postvacinación en adultos sin evidencia de infección previa de SARS-COV-2. Enfermedades infecciosas emergentes, 28 (2), 411. https://pubmed.ncbi.nlm.nih.gov/34866122/ | Fowler, N., Martinez, N. R. M., Pallares, B. V., & Maldonado, R. S. (2021). Acute-onset central serous retinopathy after immunization with COVID-19 mRNA vaccine. American Journal of Ophthalmology Case Reports, 23, 101136. https://www.sciencedirect.com/science/article/pii/S2451993621001456. | Christensen, S. K., Ballegaard, M., & Boesen, M. S. (2021). Guillian-Barrés syndrom efter mRNA-1273-COVID-19-vaccine. Ugeskr Læger, 183, V05210455. https://pubmed.ncbi.nlm.nih.gov/34477091/ | COVID, C., & Team, R. (2021). Allergic reactions including anaphylaxis after receipt of the first dose of Pfizer-BioNTech COVID-19 vaccine—United States, December 14–23, 2020. Morbidity and Mortality Weekly Report, 70(2), 46. | https://pubmed.ncbi.nlm.nih.gov/33444297/ | COVID, C., & Team, R. (2021). Allergic reactions including anaphylaxis after receipt of the first dose of Pfizer-BioNTech COVID-19 vaccine—United States, December 14–23, 2020. Morbidity and Mortality Weekly Report, 70(2), 46. https://pubmed.ncbi.nlm.nih.gov/33444297/ | Cory, P., Lawrence, H., Abdulrahim, H., Mahmood-Rao, H., Hussein, A., & Gane, J. (2021). Lessons of the month 3: Haemophagocytic lymphohistiocytosis following COVID-19 vaccination (ChAdOx1 nCoV-19). Clinical Medicine, 21(6), e677-e679. https://pubmed.ncbi.nlm.nih.gov/34862234/ | ||||
152 | Bell’s palsy after COVID-19 vaccination: case report: | https://www.sciencedirect.com/science/article/pii/S217358082100122X. | https://www.sciencedirect.com/science/article/pii/S217358082100122X. | de Terreros Caro, G. G., Díaz, S. G., Alé, M. P., & Gimeno, M. M. (2021). Bell’s palsy following COVID-19 vaccination: A case report. Neurologia (Barcelona, Spain). | de Terreros Caro, G. G., Díaz, S. G., Alé, M. P., & Gimeno, M. M. (2021). Parálisis de Bell después de la vacunación COVID-19: reporte de un caso. Neurología (Barcelona, España). https://www.sciencedirect.com/science/article/pii/S2213219821007972 | Chouchana, L., Blet, A., Al-Khalaf, M., Kafil, T. S., Nair, G., Robblee, J., ... & Liu, P. P. (2022). Características de las reacciones inflamatorias del corazón posteriores a la vacunación con MRNA COVID-19 a nivel global. Farmacología clínica y terapéutica. https://www.ncbi.nlm.nih.gov/pubmed/34849657 | de Terreros Caro, G. G., Díaz, S. G., Alé, M. P., & Gimeno, M. M. (2021). Bell’s palsy following COVID-19 vaccination: A case report. Neurologia (Barcelona, Spain). https://www.sciencedirect.com/science/article/pii/S217358082100122X. | Chua, G. T., Kwan, M. Y. W., Chui, C. S., Smith, R. D., Cheung, E. C. L., Tian, T., ... & Ip, P. (2021). Epidemiology of Acute Myocarditis/Pericarditis in Hong Kong Adolescents Following Comirnaty Vaccination. Clinical Infectious Diseases. https://academic.oup.com/cid/advance-article-abstract/doi/10.1093/cid/ciab989/6445179 | COVID, C., & Team, R. (2021). Allergic reactions including anaphylaxis after receipt of the first dose of Moderna COVID-19 vaccine—United States, December 21, 2020–January 10, 2021. Morbidity and Mortality Weekly Report, 70(4), 125. | https://pubmed.ncbi.nlm.nih.gov/33507892/ | COVID, C., & Team, R. (2021). Allergic reactions including anaphylaxis after receipt of the first dose of Moderna COVID-19 vaccine—United States, December 21, 2020–January 10, 2021. Morbidity and Mortality Weekly Report, 70(4), 125. https://pubmed.ncbi.nlm.nih.gov/33507892/ | Costentin, G., Ozkul-Wermester, O., Triquenot, A., Le Cam-Duchez, V., Massy, N., Benhamou, Y., & Massardier, E. (2021). Acute ischemic stroke revealing ChAdOx1 nCov-19 vaccine-induced immune thrombotic thrombocytopenia: impact on recanalization strategy. Journal of Stroke and Cerebrovascular Diseases, 30(9), 105942. https://pubmed.ncbi.nlm.nih.gov/34175640/ | ||||
153 | An academic hospital experience assessing the risk of COVID-19 mRNA vaccine using patient’s allergy history: | https://www.sciencedirect.com/science/article/pii/S2213219821007972 | https://www.sciencedirect.com/science/article/pii/S2213219821007972 | Krantz, M. S., Stone Jr, C. A., Rolando, L. A., Nobis, A. E., Koo, G., Corey, K. B., ... & Phillips, E. J. (2021). An academic hospital experience screening mRNA COVID-19 vaccine risk using patient allergy history. The Journal of Allergy and Clinical Immunology: In Practice, 9(10), 3807-3810. | Krantz, M. S., Stone Jr, C. A., Rolando, L. A., Nobis, A. E., Koo, G., Corey, K. B., ... y Phillips, E. J. (2021). Una experiencia de un hospital académico en la detección del riesgo de la vacuna de ARNm contra la COVID-19 utilizando el historial de alergias del paciente. The Journal of Allergy and Clinical Immunology: In Practice, 9(10), 3807-3810. https://www.sciencedirect.com/science/article/pii/S1930043321002612 | Christensen, S. K., Ballegaard, M., & Boesen, M. S. (2021). Syndrom de Guillian-Barrés Efter MRNA-1273-COVID-19-vacuna. Ugeskr Læger, 183, V05210455. https://pubmed.ncbi.nlm.nih.gov/33975372/. | Krantz, M. S., Stone Jr, C. A., Rolando, L. A., Nobis, A. E., Koo, G., Corey, K. B., ... & Phillips, E. J. (2021). An academic hospital experience screening mRNA COVID-19 vaccine risk using patient allergy history. The Journal of Allergy and Clinical Immunology: In Practice, 9(10), 3807-3810. https://www.sciencedirect.com/science/article/pii/S2213219821007972 | Chua, G. T., Kwan, M. Y. W., Chui, C. S., Smith, R. D., Cheung, E. C. L., Tian, T., ... & Ip, P. (2021). Epidemiology of Acute Myocarditis/Pericarditis in Hong Kong Adolescents Following Comirnaty Vaccination. Clinical Infectious Diseases. https://pubmed.ncbi.nlm.nih.gov/34849657/. | Lee, E., Lee, Y. K., Kim, T. E., Hwang, I., Jung, Y. H., Lee, H. R., ... & Lee, Y. K. (2021). Reports of anaphylaxis after coronavirus disease 2019 vaccination, South Korea, 26 February to 30 April 2021. Eurosurveillance, 26(33), 2100694. | https://pubmed.ncbi.nlm.nih.gov/34414880/ | Lee, E., Lee, Y. K., Kim, T. E., Hwang, I., Jung, Y. H., Lee, H. R., ... & Lee, Y. K. (2021). Reports of anaphylaxis after coronavirus disease 2019 vaccination, South Korea, 26 February to 30 April 2021. Eurosurveillance, 26(33), 2100694. https://pubmed.ncbi.nlm.nih.gov/34414880/ | Coto‐Segura, P., Fernández‐Prada, M., Mir‐Bonafé, M., García‐García, B., González‐Iglesias, I., Alonso‐Penanes, P., ... & Martinón‐Torres, F. (2021). Vesiculobullous skin reactions induced by COVID‐19 mRNA vaccine: report of four cases and review of the literature. Clinical and experimental dermatology. https://pubmed.ncbi.nlm.nih.gov/34236711/ | ||||
154 | COVID-19 vaccine-induced axillary and pectoral lymphadenopathy in PET: | https://www.sciencedirect.com/science/article/pii/S1930043321002612 | https://www.sciencedirect.com/science/article/pii/S1930043321002612 | Singh, B., Kaur, P., Kumar, V., & Maroules, M. (2021). COVID-19 vaccine induced Axillary and Pectoral Lymphadenopathy on PET scan. Radiology Case Reports, 16(7), 1819-1821. | Singh, B., Kaur, P., Kumar, V. y Maroules, M. (2021). Linfadenopatía axilar y pectoral inducida por la vacuna COVID-19 en la exploración por PET. Informes de casos de radiología, 16(7), 1819-1821. https://www.sciencedirect.com/science/article/pii/S0272638621007423 | Chua, G. T., Kwan, M. Y. W., Chui, C. S., Smith, R. D., Cheung, E. C. L., Tian, T., ... & IP, P. (2021). Epidemiología de miocarditis aguda / pericarditis en adolescentes de Hong Kong después de la vacunación contra la comilería. Enfermedades infecciosas clínicas. https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciab926/6420408 | Singh, B., Kaur, P., Kumar, V., & Maroules, M. (2021). COVID-19 vaccine induced Axillary and Pectoral Lymphadenopathy on PET scan. Radiology Case Reports, 16(7), 1819-1821. https://www.sciencedirect.com/science/article/pii/S1930043321002612 | Chua, G. T., Kwan, M. Y. W., Chui, C. S., Smith, R. D., Cheung, E. C. L., Tian, T., ... & Ip, P. (2021). Epidemiology of Acute Myocarditis/Pericarditis in Hong Kong Adolescents Following Comirnaty Vaccination. Clinical Infectious Diseases. https://www.ncbi.nlm.nih.gov/pubmed/34849657 | Shimabukuro, T. T., Cole, M., & Su, J. R. (2021). Reports of anaphylaxis after receipt of mRNA COVID-19 vaccines in the US—December 14, 2020-January 18, 2021. Jama, 325(11), 1101-1102. | https://pubmed.ncbi.nlm.nih.gov/33576785/ | Shimabukuro, T. T., Cole, M., & Su, J. R. (2021). Reports of anaphylaxis after receipt of mRNA COVID-19 vaccines in the US—December 14, 2020-January 18, 2021. Jama, 325(11), 1101-1102. https://pubmed.ncbi.nlm.nih.gov/33576785/ | COVID, C., & Team, R. (2021). Allergic reactions including anaphylaxis after receipt of the first dose of Moderna COVID-19 vaccine—United States, December 21, 2020–January 10, 2021. Morbidity and Mortality Weekly Report, 70(4), 125. https://pubmed.ncbi.nlm.nih.gov/33507892/ | ||||
155 | ANCA-associated vasculitis after Pfizer-BioNTech COVID-19 vaccine: | https://www.sciencedirect.com/science/article/pii/S0272638621007423 | https://www.sciencedirect.com/science/article/pii/S0272638621007423 | Shakoor, M. T., Birkenbach, M. P., & Lynch, M. (2021). ANCA-associated vasculitis following Pfizer-BioNTech COVID-19 vaccine. American Journal of Kidney Diseases, 78(4), 611-613. | Shakoor, MT, Birkenbach, MP y Lynch, M. (2021). Vasculitis asociada a ANCA tras la vacuna Pfizer-BioNTech COVID-19. Revista Estadounidense de Enfermedades Renales, 78(4), 611-613. https://www.sciencedirect.com/science/article/pii/S2213219821007996 | Chua, G. T., Kwan, M. Y. W., Chui, C. S., Smith, R. D., Cheung, E. C. L., Tian, T., ... & IP, P. (2021). Epidemiología de miocarditis aguda / pericarditis en adolescentes de Hong Kong después de la vacunación contra la comilería. Enfermedades infecciosas clínicas. https://pubmed.ncbi.nlm.nih.gov/34664804/ | Shakoor, M. T., Birkenbach, M. P., & Lynch, M. (2021). ANCA-associated vasculitis following Pfizer-BioNTech COVID-19 vaccine. American Journal of Kidney Diseases, 78(4), 611-613. https://www.sciencedirect.com/science/article/pii/S0272638621007423 | Chuang, T. Y., Burda, K., Teklemariam, E., & Athar, K. (2021). Tolosa-Hunt syndrome presenting after COVID-19 vaccination. Cureus, 13(7). https://pubmed.ncbi.nlm.nih.gov/34513398/ | Arcolaci, A., Bronte, V., & Zanoni, G. (2021). Immunization practices and risk of anaphylaxis: a current update, comprehensive of COVID-19 vaccination data. Current opinion in allergy and clinical immunology, 21(5), 418-425. | https://pubmed.ncbi.nlm.nih.gov/34269740/ | Arcolaci, A., Bronte, V., & Zanoni, G. (2021). Immunization practices and risk of anaphylaxis: a current update, comprehensive of COVID-19 vaccination data. Current opinion in allergy and clinical immunology, 21(5), 418-425. https://pubmed.ncbi.nlm.nih.gov/34269740/ | COVID, C., & Team, R. (2021). Allergic reactions including anaphylaxis after receipt of the first dose of Pfizer-BioNTech COVID-19 vaccine—United States, December 14–23, 2020. Morbidity and Mortality Weekly Report, 70(2), 46. https://pubmed.ncbi.nlm.nih.gov/33444297/ | ||||
156 | Late cutaneous reactions after administration of COVID-19 mRNA vaccines: | https://www.sciencedirect.com/science/article/pii/S2213219821007996 | https://www.sciencedirect.com/science/article/pii/S2213219821007996 | Guerrero, A. J., Estirado, A. D., Quirós, J. C., & Rojas-Pérez-Ezquerra, P. (2021). Delayed cutaneous reactions after the administration of mRNA vaccines against COVID-19. The Journal of Allergy and Clinical Immunology: In Practice, 9(10), 3811-3813. | Guerrero, A. J., Estirado, A. D., Quirós, J. C., & Rojas-Pérez-Ezquerra, P. (2021). Reacciones cutáneas tardías tras la administración de vacunas de ARNm contra COVID-19. The Journal of Allergy and Clinical Immunology: In Practice, 9(10), 3811-3813. https://www.sciencedirect.com/science/article/pii/S1871402121001880 | Chua, G. T., Kwan, M. Y. W., Chui, C. S., Smith, R. D., Cheung, E. C. L., Tian, T., ... & IP, P. (2021). Epidemiología de miocarditis aguda / pericarditis en adolescentes de Hong Kong después de la vacunación contra la comilería. Enfermedades infecciosas clínicas. https://www.ncbi.nlm.nih.gov/pubmed/34933012 | Guerrero, A. J., Estirado, A. D., Quirós, J. C., & Rojas-Pérez-Ezquerra, P. (2021). Delayed cutaneous reactions after the administration of mRNA vaccines against COVID-19. The Journal of Allergy and Clinical Immunology: In Practice, 9(10), 3811-3813. https://www.sciencedirect.com/science/article/pii/S2213219821007996 | Ciccone, A. (2021). SARS-CoV-2 vaccine-induced cerebral venous thrombosis. European journal of internal medicine, 89, 19-21. https://pubmed.ncbi.nlm.nih.gov/34090750/. | Desai, A. P., Desai, A. P., & Loomis, G. J. (2021). Relationship between pre-existing allergies and anaphylactic reactions post mRNA COVID-19 vaccine administration. Vaccine, 39(32), 4407-4409. | https://pubmed.ncbi.nlm.nih.gov/34215453/ | Desai, A. P., Desai, A. P., & Loomis, G. J. (2021). Relationship between pre-existing allergies and anaphylactic reactions post mRNA COVID-19 vaccine administration. Vaccine, 39(32), 4407-4409. https://pubmed.ncbi.nlm.nih.gov/34215453/ | Crane, P., Wong, C., Mehta, N., & Barlis, P. (2021). Takotsubo (stress) cardiomyopathy after ChAdOx1 nCoV-19 vaccination. BMJ Case Reports CP, 14(10), e246580. https://pubmed.ncbi.nlm.nih.gov/34625447/ | ||||
157 | COVID-19 vaccine-induced rhabdomyolysis: case report with review of the literature: | https://www.sciencedirect.com/science/article/pii/S1871402121001880 | https://www.sciencedirect.com/science/article/pii/S1871402121001880 | Nassar, M., Chung, H., Dhayaparan, Y., Nyein, A., Acevedo, B. J., Chicos, C., ... & Kimball, E. (2021). COVID-19 vaccine induced rhabdomyolysis: Case report with literature review. Diabetes & Metabolic Syndrome. | Nassar, M., Chung, H., Dhayaparan, Y., Nyein, A., Acevedo, B. J., Chicos, C., ... & Kimball, E. (2021). Rabdomiólisis inducida por la vacuna COVID-19: reporte de un caso con revisión de la literatura. Diabetes y síndrome metabólico. https://www.sciencedirect.com/science/article/pii/S0190962221024427 | Chuang, T. Y., Burda, K., Teklemariam, E., Y Athar, K. (2021). Síndrome de Tolosa-Hunt Presentando después de la vacunación COVID-19. CUREUS, 13 (7). https://pubmed.ncbi.nlm.nih.gov/34362727/ | Nassar, M., Chung, H., Dhayaparan, Y., Nyein, A., Acevedo, B. J., Chicos, C., ... & Kimball, E. (2021). COVID-19 vaccine induced rhabdomyolysis: Case report with literature review. Diabetes & Metabolic Syndrome. https://www.sciencedirect.com/science/article/pii/S1871402121001880 | Ciccone, A., & Zanotti, B. (2021). The importance of recognizing cerebral venous thrombosis following anti-COVID-19 vaccination. European Journal of Internal Medicine, 89, 115-117. https://pubmed.ncbi.nlm.nih.gov/34001390/ | Turk, V. E. (2021). Anaphylaxis associated with the mRNA COVID-19 vaccines: approach to allergy investigation. Clinical Immunology, 227, 108748. | https://pubmed.ncbi.nlm.nih.gov/33932618/ | Turk, V. E. (2021). Anaphylaxis associated with the mRNA COVID-19 vaccines: approach to allergy investigation. Clinical Immunology, 227, 108748. https://pubmed.ncbi.nlm.nih.gov/33932618/ | Crea, F. (2021). Thrombosis in peripheral artery disease and thrombotic thrombocytopenia after adenoviral COVID-19 vaccination. European Heart Journal, 42(39), 3995-3999. https://pubmed.ncbi.nlm.nih.gov/34649281/. | ||||
158 | Clinical and pathologic correlates of skin reactions to COVID-19 vaccine, including V-REPP: a registry-based study: | https://www.sciencedirect.com/science/article/pii/S0190962221024427 | https://www.sciencedirect.com/science/article/pii/S0190962221024427 | McMahon, D. E., Kovarik, C. L., Damsky, W., Rosenbach, M., Lipoff, J. B., Tyagi, A., ... & Freeman, E. E. (2022). Clinical and pathologic correlation of cutaneous COVID-19 vaccine reactions including V-REPP: A registry-based study. Journal of the American Academy of Dermatology, 86(1), 113-121. | McMahon, D. E., Kovarik, C. L., Damsky, W., Rosenbach, M., Lipoff, J. B., Tyagi, A., ... y Freeman, E. E. (2022). Correlación clínica y patológica de las reacciones cutáneas a la vacuna COVID-19, incluido V-REPP: un estudio basado en registros. Revista de la Academia Estadounidense de Dermatología, 86(1), 113-121. https://www.sciencedirect.com/science/article/abs/pii/S0735675721004381. | Ciccone, A. (2021). Trombosis venosa cerebral cerebral inducida por vacunas SARS-COV-2. Diario Europeo de Medicina Interna, 89, 19-21. https://pubmed.ncbi.nlm.nih.gov/34312301/. | McMahon, D. E., Kovarik, C. L., Damsky, W., Rosenbach, M., Lipoff, J. B., Tyagi, A., ... & Freeman, E. E. (2022). Clinical and pathologic correlation of cutaneous COVID-19 vaccine reactions including V-REPP: A registry-based study. Journal of the American Academy of Dermatology, 86(1), 113-121. https://www.sciencedirect.com/science/article/pii/S0190962221024427 | Cimaglia, P., Tolomeo, P., & Rapezzi, C. (2022). Acute myocarditis after SARS-CoV-2 vaccination in a 24-year-old man. Revista portuguesa de cardiologia, 41(1), 71-72. https://pubmed.ncbi.nlm.nih.gov/34334935/. | Klimek, L., Novak, N., Hamelmann, E., Werfel, T., Wagenmann, M., Taube, C., ... & Worm, M. (2021). Severe allergic reactions after COVID-19 vaccination with the Pfizer/BioNTech vaccine in Great Britain and USA. Allergo journal international, 30(2), 51-55. | https://pubmed.ncbi.nlm.nih.gov/33643776/ | Klimek, L., Novak, N., Hamelmann, E., Werfel, T., Wagenmann, M., Taube, C., ... & Worm, M. (2021). Severe allergic reactions after COVID-19 vaccination with the Pfizer/BioNTech vaccine in Great Britain and USA. Allergo journal international, 30(2), 51-55. https://pubmed.ncbi.nlm.nih.gov/33643776/ | Crossette-Thambiah, C., Pericleous, C., Asmar, N., Bomsztyk, J., Ranger, A., Shlebak, A., ... & Arachchillage, D. J. (2021). Clinical and biological features of cerebral venous sinus thrombosis following ChAdOx1 nCov-19 vaccination. Journal of Neurology, Neurosurgery & Psychiatry. https://jnnp.bmj.com/content/early/2021/09/29/jnnp-2021-327340. | ||||
159 | Thrombosis with thrombocytopenia syndrome associated with COVID-19 vaccines:. | https://www.sciencedirect.com/science/article/abs/pii/S0735675721004381. | https://www.sciencedirect.com/science/article/abs/pii/S0735675721004381. | Long, B., Bridwell, R., & Gottlieb, M. (2021). Thrombosis with thrombocytopenia syndrome associated with COVID-19 vaccines. The American journal of emergency medicine, 49, 58-61. | Long, B., Bridwell, R. y Gottlieb, M. (2021). Síndrome de trombosis con trombocitopenia asociado a las vacunas COVID-19. La revista americana de medicina de emergencia, 49, 58-61. https://www.sciencedirect.com/science/article/pii/S1939455121000119. | Ciccone, A., & Zanotti, B. (2021). La importancia de reconocer la trombosis venosa cerebral después de la vacunación anti-covid-19. Diario Europeo de Medicina Interna, 89, 115-117. https://pubmed.ncbi.nlm.nih.gov/34181446/ | Long, B., Bridwell, R., & Gottlieb, M. (2021). Thrombosis with thrombocytopenia syndrome associated with COVID-19 vaccines. The American journal of emergency medicine, 49, 58-61. https://www.sciencedirect.com/science/article/abs/pii/S0735675721004381. | Cimaglia, P., Tolomeo, P., & Rapezzi, C. (2022). Acute myocarditis after SARS-CoV-2 vaccination in a 24-year-old man. Revista portuguesa de cardiologia, 41(1), 71-72. https://www.sciencedirect.com/science/article/pii/S0870255121003243 | Moghimi, S. M. (2021). Allergic reactions and anaphylaxis to lipid nanoparticle-based COVID-19 vaccines. Molecular Therapy. | https://pubmed.ncbi.nlm.nih.gov/33571463/ | Moghimi, S. M. (2021). Allergic reactions and anaphylaxis to lipid nanoparticle-based COVID-19 vaccines. Molecular Therapy. https://pubmed.ncbi.nlm.nih.gov/33571463/ | Cugno, M., Consonni, D., Lombardi, A., Bono, P., Oggioni, M., Uceda Renteria, S., ... & Gori, A. (2021). Increased risk of urticaria/angioedema after BNT162b2 mRNA COVID-19 vaccine in health care workers taking ACE inhibitors. Vaccines, 9(9), 1011. https://pubmed.ncbi.nlm.nih.gov/34579248/ | ||||
160 | COVID-19 vaccine-associated anaphylaxis: a statement from the Anaphylaxis Committee of the World Allergy Organization:. | https://www.sciencedirect.com/science/article/pii/S1939455121000119. | https://www.sciencedirect.com/science/article/pii/S1939455121000119. | Turner, P. J., Ansotegui, I. J., Campbell, D. E., Cardona, V., Ebisawa, M., El-Gamal, Y., ... & WAO Anaphylaxis Committee. (2021). COVID-19 vaccine-associated anaphylaxis: a statement of the World Allergy Organization Anaphylaxis Committee. World Allergy Organization Journal, 14(2), 100517. | Turner, P. J., Ansotegui, I. J., Campbell, D. E., Cardona, V., Ebisawa, M., El-Gamal, Y., ... y Comité de Anafilaxis de WAO. (2021). Anafilaxia asociada a la vacuna COVID-19: declaración del Comité de Anafilaxis de la Organización Mundial de Alergias. Revista de la Organización Mundial de Alergia, 14(2), 100517. https://www.sciencedirect.com/science/article/pii/S1871402121002046. | Cimaglia, P., Tolomeo, P., y Romizzi, C. (2022). Miocarditis aguda después de la vacunación con SARS-COV-2 en un hombre de 24 años. Revista Portuguesa de Cardiologia, 41 (1), 71-72. https://pubmed.ncbi.nlm.nih.gov/34746968/ | Turner, P. J., Ansotegui, I. J., Campbell, D. E., Cardona, V., Ebisawa, M., El-Gamal, Y., ... & WAO Anaphylaxis Committee. (2021). COVID-19 vaccine-associated anaphylaxis: a statement of the World Allergy Organization Anaphylaxis Committee. World Allergy Organization Journal, 14(2), 100517. https://www.sciencedirect.com/science/article/pii/S1939455121000119. | Cines, D. B., & Bussel, J. B. (2021). SARS-CoV-2 vaccine–induced immune thrombotic thrombocytopenia. New England Journal of Medicine, 384(23), 2254-2256. https://www.nejm.org/doi/full/10.1056/nejme2106315 | Cirillo, N. (2021). Reported orofacial adverse effects of COVID‐19 vaccines: The knowns and the unknowns. Journal of Oral Pathology & Medicine, 50(4), 424-427. | https://pubmed.ncbi.nlm.nih.gov/33527524/ | Cirillo, N. (2021). Reported orofacial adverse effects of COVID‐19 vaccines: The knowns and the unknowns. Journal of Oral Pathology & Medicine, 50(4), 424-427. https://pubmed.ncbi.nlm.nih.gov/33527524/ | Cuker, A. (2021). Thrombosis with thrombocytopenia syndrome after COVID-19 vaccination. Clinical advances in hematology & oncology: H&O, 19(7), 446-449. https://pubmed.ncbi.nlm.nih.gov/34236343/ | ||||
161 | Cerebral venous sinus thrombosis negative for anti-PF4 antibody without thrombocytopenia after immunization with COVID-19 vaccine in an elderly, non-comorbid Indian male treated with conventional heparin-warfarin-based anticoagulation:. | https://www.sciencedirect.com/science/article/pii/S1871402121002046. | https://www.sciencedirect.com/science/article/pii/S1871402121002046. | Dutta, A., Ghosh, R., Bhattacharya, D., Bhat, S., Ray, A., Pandit, A., ... & Dubey, S. (2021). Anti-PF4 antibody negative cerebral venous sinus thrombosis without thrombocytopenia following immunization with COVID-19 vaccine in an elderly non-comorbid Indian male, managed with conventional heparin-warfarin based anticoagulation. Diabetes & Metabolic Syndrome, 15(4), 102184. | Dutta, A., Ghosh, R., Bhattacharya, D., Bhat, S., Ray, A., Pandit, A., ... y Dubey, S. (2021). Trombosis del seno venoso cerebral con anticuerpos anti-PF4 negativos sin trombocitopenia después de la inmunización con la vacuna COVID-19 en un varón indio anciano sin comorbilidad, tratado con anticoagulación convencional basada en heparina-warfarina. Diabetes y síndrome metabólico, 15(4), 102184. https://www.sciencedirect.com/science/article/abs/pii/S188558572100133X | Cimaglia, P., Tolomeo, P., y Romizzi, C. (2022). Miocarditis aguda después de la vacunación con SARS-COV-2 en un hombre de 24 años. Revista Portuguesa de Cardiologia, 41 (1), 71-72. https://www.sciencedirect.com/science/article/pii/S0022347621007496 | Dutta, A., Ghosh, R., Bhattacharya, D., Bhat, S., Ray, A., Pandit, A., ... & Dubey, S. (2021). Anti-PF4 antibody negative cerebral venous sinus thrombosis without thrombocytopenia following immunization with COVID-19 vaccine in an elderly non-comorbid Indian male, managed with conventional heparin-warfarin based anticoagulation. Diabetes & Metabolic Syndrome, 15(4), 102184. https://www.sciencedirect.com/science/article/pii/S1871402121002046. | Cinotti, E., Perrot, J. L., Bruzziches, F., Tognetti, L., Batsikosta, A., Sorrentino, E., ... & Rubegni, P. (2021). Eosinophilic dermatosis after AstraZeneca COVID-19 vaccination. Journal of the European Academy of Dermatology and Venereology: JEADV. https://pubmed.ncbi.nlm.nih.gov/34753210/. | Bogdanov, G., Bogdanov, I., Kazandjieva, J., & Tsankov, N. (2021). Cutaneous adverse effects of the available COVID-19 vaccines. Clinics in dermatology, 39(3), 523-531. | https://pubmed.ncbi.nlm.nih.gov/34518015/ | Bogdanov, G., Bogdanov, I., Kazandjieva, J., & Tsankov, N. (2021). Cutaneous adverse effects of the available COVID-19 vaccines. Clinics in dermatology, 39(3), 523-531. https://pubmed.ncbi.nlm.nih.gov/34518015/ | D'Angelo, T., Cattafi, A., Carerj, M. L., Booz, C., Ascenti, G., Cicero, G., ... & Mazziotti, S. (2021). Myocarditis after SARS-CoV-2 vaccination: a vaccine-induced reaction?. Canadian Journal of Cardiology, 37(10), 1665-1667. https://pubmed.ncbi.nlm.nih.gov/34118375/ | ||||
162 | Acute myocarditis after administration of BNT162b2 vaccine against COVID-19:. | https://www.sciencedirect.com/science/article/abs/pii/S188558572100133X | https://www.sciencedirect.com/science/article/abs/pii/S188558572100133X | García, B., Ortega, P., JA, B. F., León, C., Burgos, R., & Dorta, C. (2021). Acute myocarditis after administration of the BNT162b2 vaccine against COVID-19. Revista espanola de cardiologia, 74(9), 812-814. | García, B., Ortega, P., JA, B. F., León, C., Burgos, R., & Dorta, C. (2021). Miocarditis aguda tras la administración de la vacuna BNT162b2 contra COVID-19. Revista española de cardiología, 74(9), 812-814. https://www.sciencedirect.com/science/article/pii/S0896841121000937. | Cines, D. B., y Bussel, J. B. (2021). Thrombocitopenia trombótica inmune inducida por la vacuna contra el SARS-COV-2. New England Journal of Medicine, 384 (23), 2254-2256. https://jamanetwork.com/journals/jamacardiology/fullarticle/2781601 | García, B., Ortega, P., JA, B. F., León, C., Burgos, R., & Dorta, C. (2021). Acute myocarditis after administration of the BNT162b2 vaccine against COVID-19. Revista espanola de cardiologia, 74(9), 812-814. https://www.sciencedirect.com/science/article/abs/pii/S188558572100133X | Cirillo, N. (2021). Reported orofacial adverse effects of COVID‐19 vaccines: The knowns and the unknowns. Journal of Oral Pathology & Medicine, 50(4), 424-427. https://pubmed.ncbi.nlm.nih.gov/33527524/ | Iguchi, T., Umeda, H., Kojima, M., Kanno, Y., Tanaka, Y., Kinoshita, N., & Sato, D. (2021). Cumulative adverse event reporting of anaphylaxis after mRNA COVID-19 vaccine (Pfizer-BioNTech) injections in Japan: the first-month report. Drug safety, 44(11), 1209-1214. | https://pubmed.ncbi.nlm.nih.gov/34347278/ | Iguchi, T., Umeda, H., Kojima, M., Kanno, Y., Tanaka, Y., Kinoshita, N., & Sato, D. (2021). Cumulative adverse event reporting of anaphylaxis after mRNA COVID-19 vaccine (Pfizer-BioNTech) injections in Japan: the first-month report. Drug safety, 44(11), 1209-1214. https://pubmed.ncbi.nlm.nih.gov/34347278/ | D’Agati, V. D., Kudose, S., Bomback, A. S., Adamidis, A., & Tartini, A. (2021). Minimal change disease and acute kidney injury following the Pfizer-BioNTech COVID-19 vaccine. Kidney international, 100(2), 461-463. https://pubmed.ncbi.nlm.nih.gov/34000278/ | ||||
163 | Blood clots and bleeding after BNT162b2 and ChAdOx1 nCoV-19 vaccine: an analysis of European data:. | https://www.sciencedirect.com/science/article/pii/S0896841121000937. | https://www.sciencedirect.com/science/article/pii/S0896841121000937. | Cari, L., Fiore, P., Alhosseini, M. N., Sava, G., & Nocentini, G. (2021). Blood clots and bleeding events following BNT162b2 and ChAdOx1 nCoV-19 vaccine: An analysis of European data. Journal of autoimmunity, 122, 102685. | Cari, L., Fiore, P., Alhosseini, M. N., Sava, G. y Nocentini, G. (2021). Coágulos de sangre y eventos hemorrágicos después de la vacuna BNT162b2 y ChAdOx1 nCoV-19: un análisis de datos europeos. Revista de autoinmunidad, 122, 102685. https://www.sciencedirect.com/science/article/pii/S2214250921002018. | Cinotti, E., Perrot, J. L., Bruzziches, F., Tognetti, L., Batsikosta, A., Sorrentino, E., ... y Rubegni, P. (2021). Dermatosis eosinofílica después de la vacunación de AstraZeneca COVID-19. Diario de la Academia Europea de Dermatología y Venereología: Jeadv. https://pubmed.ncbi.nlm.nih.gov/34653943/. | Cari, L., Fiore, P., Alhosseini, M. N., Sava, G., & Nocentini, G. (2021). Blood clots and bleeding events following BNT162b2 and ChAdOx1 nCoV-19 vaccine: An analysis of European data. Journal of autoimmunity, 122, 102685. https://www.sciencedirect.com/science/article/pii/S0896841121000937. | Cirillo, N., & Doan, R. (2021). Bell's palsy and SARS-CoV-2 vaccines—an unfolding story. The Lancet Infectious Diseases, 21(9), 1210-1211. https://www.sciencedirect.com/science/article/pii/S1473309921002735 | Alnæs, M., Storaas, T., Sørensen, M., Stylianou, E., & Tøndell, A. (2021). Covid-19-vaksiner gir økt risiko for anafylaksi. Tidsskrift for Den norske legeforening. | https://pubmed.ncbi.nlm.nih.gov/33685103/ | Alnæs, M., Storaas, T., Sørensen, M., Stylianou, E., & Tøndell, A. (2021). Covid-19-vaksiner gir økt risiko for anafylaksi. Tidsskrift for Den norske legeforening. https://pubmed.ncbi.nlm.nih.gov/33685103/ | D’agostino, V., Caranci, F., Negro, A., Piscitelli, V., Tuccillo, B., Fasano, F., ... & Grassi, R. (2021). A rare case of cerebral venous thrombosis and disseminated intravascular coagulation temporally associated to the COVID-19 vaccine administration. Journal of personalized medicine, 11(4), 285. https://pubmed.ncbi.nlm.nih.gov/33917902/ | ||||
164 | immune thrombocytopenia associated with Pfizer-BioNTech’s COVID-19 BNT162b2 mRNA vaccine:. | https://www.sciencedirect.com/science/article/pii/S2214250921002018. | https://www.sciencedirect.com/science/article/pii/S2214250921002018. | Akiyama, H., Kakiuchi, S., Rikitake, J., Matsuba, H., Sekinada, D., Kozuki, Y., & Iwata, N. (2021). Immune thrombocytopenia associated with Pfizer-BioNTech’s BNT162b2 mRNA COVID-19 vaccine. IDCases, 25, e01245. | Akiyama, H., Kakiuchi, S., Rikitake, J., Matsuba, H., Sekinada, D., Kozuki, Y. e Iwata, N. (2021). Trombocitopenia inmune asociada con la vacuna COVID-19 de ARNm BNT162b2 de Pfizer-BioNTech. IDCasos, 25, e01245. https://www.sciencedirect.com/science/article/pii/S1876034121001878. | Cirillo, N. (2021). Informó efectos adversos orfaciales de las vacunas COVID-19: las conocidas y las incógnitas. Diario de patología oral y medicina, 50 (4), 424-427. https://pubmed.ncbi.nlm.nih.gov/34518015/ | Akiyama, H., Kakiuchi, S., Rikitake, J., Matsuba, H., Sekinada, D., Kozuki, Y., & Iwata, N. (2021). Immune thrombocytopenia associated with Pfizer-BioNTech’s BNT162b2 mRNA COVID-19 vaccine. IDCases, 25, e01245. https://www.sciencedirect.com/science/article/pii/S2214250921002018. | Cirillo, N., & Doan, R. (2022). The association between COVID-19 vaccination and Bell's palsy. The Lancet Infectious Diseases, 22(1), 5-6. https://pubmed.ncbi.nlm.nih.gov/34411533/ | Abi Zeid Daou, C., Natout, M. A., & El Hadi, N. (2021). Biphasic anaphylaxis after exposure to the first dose of Pfizer‐BioNTech COVID‐19 mRNA vaccine. Journal of medical virology, 93(10), 6027-6029. | https://pubmed.ncbi.nlm.nih.gov/34050949/ | Abi Zeid Daou, C., Natout, M. A., & El Hadi, N. (2021). Biphasic anaphylaxis after exposure to the first dose of Pfizer‐BioNTech COVID‐19 mRNA vaccine. Journal of medical virology, 93(10), 6027-6029. https://pubmed.ncbi.nlm.nih.gov/34050949/ | Dalan, R., & Boehm, B. O. (2021). Thrombosis post COVID-19 vaccinations: Potential link to ACE pathways. Thrombosis Research, 206, 137. https://www.sciencedirect.com/science/article/pii/S0049384821004369 | ||||
165 | Bullous drug eruption after the second dose of COVID-19 mRNA-1273 (Moderna) vaccine: Case report: | https://www.sciencedirect.com/science/article/pii/S1876034121001878. | https://www.sciencedirect.com/science/article/pii/S1876034121001878. | Kong, J., Cuevas-Castillo, F., Nassar, M., Lei, C. M., Idrees, Z., Fix, W. C., ... & Mathew, A. (2021). Bullous drug eruption after second dose of mRNA-1273 (Moderna) COVID-19 vaccine: Case report. Journal of Infection and Public Health, 14(10), 1392-1394. | Kong, J., Cuevas-Castillo, F., Nassar, M., Lei, C. M., Idrees, Z., Fix, W. C., ... & Mathew, A. (2021). Erupción ampollosa por fármaco después de la segunda dosis de la vacuna COVID-19 mRNA-1273 (Moderna): informe de caso. Revista de Infección y Salud Pública, 14(10), 1392-1394. https://scivisionpub.com/pdfs/covid19rna-based-vaccines-and-the-risk-of-prion-dis ease-1503.pdf | Cirillo, N., & Doan, R. (2021). La parálisis de Bell y las vacunas SARS-COV-2, una historia de despliegue. Las enfermedades infecciosas de la lanceta, 21 (9), 1210-1211. https://www.sciencedirect.com/science/article/pii/S266635462100020X | Kong, J., Cuevas-Castillo, F., Nassar, M., Lei, C. M., Idrees, Z., Fix, W. C., ... & Mathew, A. (2021). Bullous drug eruption after second dose of mRNA-1273 (Moderna) COVID-19 vaccine: Case report. Journal of Infection and Public Health, 14(10), 1392-1394. https://www.sciencedirect.com/science/article/pii/S1876034121001878. | Clark, R. T., Johnson, L., Billotti, J., Foulds, G., Ketels, T., Heard, K., & Hynes, E. C. (2021). Early outcomes of bivalirudin therapy for thrombotic thrombocytopenia and cerebral venous sinus thrombosis after Ad26. COV2. S vaccination. Annals of Emergency Medicine, 78(4), 511-514. https://pubmed.ncbi.nlm.nih.gov/34226070/ | Klimek, L., Novak, N., Cabanillas, B., Jutel, M., Bousquet, J., & Akdis, C. A. (2021). Allergenic components of the mRNA‐1273 vaccine for COVID‐19: possible involvement of polyethylene glycol and IgG‐mediated complement activation. Allergy, 76(11), 3307-3313. | https://pubmed.ncbi.nlm.nih.gov/33657648/ | Klimek, L., Novak, N., Cabanillas, B., Jutel, M., Bousquet, J., & Akdis, C. A. (2021). Allergenic components of the mRNA‐1273 vaccine for COVID‐19: possible involvement of polyethylene glycol and IgG‐mediated complement activation. Allergy, 76(11), 3307-3313. https://pubmed.ncbi.nlm.nih.gov/33657648/ | Dalwadi, V., Hancock, D., Ballout, A. A., & Geraci, A. (2021). Axonal-variant Guillian-Barre syndrome temporally associated with mRNA-based Moderna SARS-CoV-2 vaccine. Cureus, 13(9). https://pubmed.ncbi.nlm.nih.gov/34722067/ | ||||
166 | COVID-19 RNA-based vaccines and the risk of prion disease: https://scivisionpub.com/pdfs/covid19rna-based-vaccines-and-the-risk-of-prion-dis ease-1503.pdf | COVID-19 RNA-based vaccines and the risk of prion disease: | scivisionpub.com/pdfs/covid19rna-based-vaccines-and-the-risk-of-prion-dis ease-1503.pdf | https://scivisionpub.com/pdfs/covid19rna-based-vaccines-and-the-risk-of-prion-dis ease-1503.pdf | https://scivisionpub.com/pdfs/covid19rna-based-vaccines-and-the-risk-of-prion-dis ease-1503.pdf | #VALUE! | Cirillo, N., & Doan, R. (2022). La asociación entre la vacunación COVID-19 y la parálisis de Bell. Las enfermedades infecciosas Lancet, 22 (1), 5-6. https://pubmed.ncbi.nlm.nih.gov/33611630/ | zzzz | Clark, R. T., Johnson, L., Billotti, J., Foulds, G., Ketels, T., Heard, K., & Hynes, E. C. (2021). Early outcomes of bivalirudin therapy for thrombotic thrombocytopenia and cerebral venous sinus thrombosis after Ad26. COV2. S vaccination. Annals of Emergency Medicine, 78(4), 511-514. https://www.sciencedirect.com/science/article/pii/S0196064421003425 | Sellaturay, P., Nasser, S., Islam, S., Gurugama, P., & Ewan, P. W. (2021). Polyethylene glycol (PEG) is a cause of anaphylaxis to the Pfizer/BioNTech mRNA COVID‐19 vaccine. Clinical and Experimental Allergy, 51(6), 861. | https://pubmed.ncbi.nlm.nih.gov/33825239/ | Sellaturay, P., Nasser, S., Islam, S., Gurugama, P., & Ewan, P. W. (2021). Polyethylene glycol (PEG) is a cause of anaphylaxis to the Pfizer/BioNTech mRNA COVID‐19 vaccine. Clinical and Experimental Allergy, 51(6), 861. https://pubmed.ncbi.nlm.nih.gov/33825239/ | Dang, Y. L., & Bryson, A. (2021). Miller-Fisher Syndrome and Guillain-Barre Syndrome overlap syndrome in a patient post Oxford-AstraZeneca SARS-CoV-2 vaccination. BMJ Case Reports CP, 14(11), e246701. https://pubmed.ncbi.nlm.nih.gov/34848426/. | |||
167 | This study notes that 115 pregnant women lost their babies, out of 827 who participated in a study on the safety of covid-19 vaccines: | https://www.nejm.org/doi/full/10.1056/NEJMoa2104983. | https://www.nejm.org/doi/full/10.1056/NEJMoa2104983. | Shimabukuro, T. T., Kim, S. Y., Myers, T. R., Moro, P. L., Oduyebo, T., Panagiotakopoulos, L., ... & Meaney-Delman, D. M. (2021). Preliminary findings of mRNA Covid-19 vaccine safety in pregnant persons. New England Journal of Medicine. | Shimabukuro, T. T., Kim, S. Y., Myers, T. R., Moro, P. L., Oduyebo, T., Panagiotakopoulos, L., ... y Meaney-Delman, D. M. (2021). Hallazgos preliminares sobre la seguridad de la vacuna de ARNm Covid-19 en personas embarazadas. Revista de Medicina de Nueva Inglaterra. https://www.researchsquare.com/article/rs-477964/v1 | Clark, R. T., Johnson, L., Billotti, J., Foulds, G., Ketels, T., escuchó, K., e Hynes, E. C. (2021). Resultados tempranos de la terapia de bivalirudina para la trombocitopenia trombótica y la trombosis sinusita venosa cerebral después de la AD26. COV2. La vacunación de s. Anales de medicina de emergencia, 78 (4), 511-514. https://pubmed.ncbi.nlm.nih.gov/34101024/. | Shimabukuro, T. T., Kim, S. Y., Myers, T. R., Moro, P. L., Oduyebo, T., Panagiotakopoulos, L., ... & Meaney-Delman, D. M. (2021). Preliminary findings of mRNA Covid-19 vaccine safety in pregnant persons. New England Journal of Medicine. https://www.nejm.org/doi/full/10.1056/NEJMoa2104983. | Clarke, R., Ioannou, A., Katz, T. A., Vliegenthart, R. J. S., Aarnoudse-Moens, C. S. H., Wilms, J., ... & Kilbride, H. (2021). Should T2 mapping be used in cases of recurrent myocarditis to differentiate between the acute inflammation and chronic scar?. The Journal of pediatrics. https://www.ncbi.nlm.nih.gov/pubmed/34933012 | Blumenthal, K. G., Robinson, L. B., Camargo, C. A., Shenoy, E. S., Banerji, A., Landman, A. B., & Wickner, P. (2021). Acute allergic reactions to mRNA COVID-19 vaccines. Jama, 325(15), 1562-1565. | https://pubmed.ncbi.nlm.nih.gov/33683290/ | Blumenthal, K. G., Robinson, L. B., Camargo, C. A., Shenoy, E. S., Banerji, A., Landman, A. B., & Wickner, P. (2021). Acute allergic reactions to mRNA COVID-19 vaccines. Jama, 325(15), 1562-1565. https://pubmed.ncbi.nlm.nih.gov/33683290/ | Das, B. B., Kohli, U., Ramachandran, P., Nguyen, H. H., Greil, G., Hussain, T., ... & Khan, D. (2021). Myopericarditis after messenger RNA coronavirus disease 2019 vaccination in adolescents 12 to 18 years of age. The Journal of Pediatrics, 238, 26-32. https://www.sciencedirect.com/science/article/pii/S0022347621007368 | ||||
168 | Process-related impurities in the ChAdOx1 nCov-19 vaccine: | https://www.researchsquare.com/article/rs-477964/v1 | https://www.researchsquare.com/article/rs-477964/v1 | #VALUE! | Clark, R. T., Johnson, L., Billotti, J., Foulds, G., Ketels, T., escuchó, K., e Hynes, E. C. (2021). Resultados tempranos de la terapia de bivalirudina para la trombocitopenia trombótica y la trombosis sinusita venosa cerebral después de la AD26. COV2. La vacunación de s. Anales de medicina de emergencia, 78 (4), 511-514. https://www.sciencedirect.com/science/article/pii/S1443950621011562 | zzzz | Clayton-Chubb, D., Schneider, D., Freeman, E., Kemp, W., & Roberts, S. K. (2021). Autoimmune hepatitis developing after the ChAdOx1 nCoV-19 (Oxford-AstraZeneca) vaccine. Journal of Hepatology, 75(5), 1249-1250. https://pubmed.ncbi.nlm.nih.gov/34171435/ | Restivo, V., Candore, G., Barrale, M., Caravello, E., Graziano, G., Onida, R., ... & Brusca, I. (2021). Allergy to polyethilenglicole of anti-SARS CoV2 vaccine recipient: a case report of young adult recipient and the management of future exposure to SARS-CoV2. Vaccines, 9(5), 412. | https://pubmed.ncbi.nlm.nih.gov/33919151/ | Restivo, V., Candore, G., Barrale, M., Caravello, E., Graziano, G., Onida, R., ... & Brusca, I. (2021). Allergy to polyethilenglicole of anti-SARS CoV2 vaccine recipient: a case report of young adult recipient and the management of future exposure to SARS-CoV2. Vaccines, 9(5), 412. https://pubmed.ncbi.nlm.nih.gov/33919151/ | Das, B. B., Moskowitz, W. B., Taylor, M. B., & Palmer, A. (2021). Myocarditis and pericarditis following mRNA COVID-19 vaccination: what do we know so far?. Children, 8(7), 607. https://www.cps.ca/en/documents/position/clinical-guidance-for-youth-with-myocarditis-and-pericarditis | |||||
169 | COVID-19 mRNA vaccine causing CNS inflammation: a case series: | https://link.springer.com/article/10.1007/s00415-021-10780-7 | https://link.springer.com/article/10.1007/s00415-021-10780-7 | Khayat-Khoei, M., Bhattacharyya, S., Katz, J., Harrison, D., Tauhid, S., Bruso, P., ... & Bakshi, R. (2022). COVID-19 mRNA vaccination leading to CNS inflammation: a case series. Journal of neurology, 269(3), 1093-1106. | Khayat-Khoei, M., Bhattacharyya, S., Katz, J., Harrison, D., Tauhid, S., Bruso, P., ... y Bakshi, R. (2022). Vacunación con ARNm de COVID-19 que provoca inflamación del SNC: una serie de casos. Revista de neurología, 269(3), 1093-1106. https://pubmed.ncbi.nlm.nih.gov/33475702/ | Clarke, R., Ioannou, A., Katz, T. A., Vliegenthart, R. J. S., Aarnoudse-Moens, C. S. H., Wilms, J., ... & Kilbride, H. (2021). ¿Se debe usar el mapeo T2 en casos de miocarditis recurrente para diferenciar entre la inflamación aguda y la cicatriz crónica? La revista de pediatría. https://www.ncbi.nlm.nih.gov/pubmed/34547487 | Khayat-Khoei, M., Bhattacharyya, S., Katz, J., Harrison, D., Tauhid, S., Bruso, P., ... & Bakshi, R. (2022). COVID-19 mRNA vaccination leading to CNS inflammation: a case series. Journal of neurology, 269(3), 1093-1106. https://link.springer.com/article/10.1007/s00415-021-10780-7 | Cleaver, J., Ibitoye, R., Morrison, H., Flood, R., Crewdson, K., Marsh, A., ... & Mortimer, A. (2021). Endovascular treatment for vaccine-induced cerebral venous sinus thrombosis and thrombocytopenia following ChAdOx1 nCoV-19 vaccination: a report of three cases. Journal of neurointerventional surgery. https://pubmed.ncbi.nlm.nih.gov/34782400/ | Hashimoto, T., Ozaki, A., Bhandari, D., Sawano, T., Sah, R., & Tanimoto, T. (2021). High anaphylaxis rates following vaccination with the Pfizer BNT162b2 mRNA vaccine against COVID-19 in Japanese healthcare workers: a secondary analysis of initial post-approval safety data. Journal of Travel Medicine, 28(7), taab090. | https://pubmed.ncbi.nlm.nih.gov/34128049/ | Hashimoto, T., Ozaki, A., Bhandari, D., Sawano, T., Sah, R., & Tanimoto, T. (2021). High anaphylaxis rates following vaccination with the Pfizer BNT162b2 mRNA vaccine against COVID-19 in Japanese healthcare workers: a secondary analysis of initial post-approval safety data. Journal of Travel Medicine, 28(7), taab090. https://pubmed.ncbi.nlm.nih.gov/34128049/ | Dash, S., Behera, B., Sethy, M., Mishra, J., & Garg, S. (2021). COVID‐19 vaccine‐induced urticarial vasculitis. Dermatologic Therapy. https://pubmed.ncbi.nlm.nih.gov/34369046/. | ||||
170 | Allergic reactions, including anaphylaxis, after receiving the first dose of the Pfizer-BioNTech COVID-19 vaccine: | https://pubmed.ncbi.nlm.nih.gov/33475702/ | https://pubmed.ncbi.nlm.nih.gov/33475702/ | Shimabukuro, T., & Nair, N. (2021). Allergic reactions including anaphylaxis after receipt of the first dose of Pfizer-BioNTech COVID-19 vaccine. Jama, 325(8), 780-781. | Shimabukuro, T. y Nair, N. (2021). Reacciones alérgicas, incluida anafilaxia, después de recibir la primera dosis de la vacuna Pfizer-BioNTech COVID-19. Jama, 325(8), 780-781. https://pubmed.ncbi.nlm.nih.gov/33320974/ | Clayton-Chubb, D., Schneider, D., Freeman, E., Kemp, W., & Roberts, S. K. (2021). Hepatitis autoinmune que se desarrolla después de la vacuna Chadox1 NCOV-19 (Oxford-AstraZeneca). Diario de hepatología, 75 (5), 1249-1250. https://pubmed.ncbi.nlm.nih.gov/34447349/ | Shimabukuro, T., & Nair, N. (2021). Allergic reactions including anaphylaxis after receipt of the first dose of Pfizer-BioNTech COVID-19 vaccine. Jama, 325(8), 780-781. https://pubmed.ncbi.nlm.nih.gov/33475702/ | Cliff-Patel, N., Moncrieff, L., & Ziauddin, V. (2021). Renal vein thrombosis and pulmonary embolism secondary to vaccine-induced thrombotic thrombocytopenia (VITT). European Journal of Case Reports in Internal Medicine, 8(7). https://pubmed.ncbi.nlm.nih.gov/34268278/. | Arroliga, M. E., Dhanani, K., Arroliga, A. C., Huddleston, P. S., Trahan, J., Aguilar, T., & Weldon, D. (2021, September). Allergic reactions and adverse events associated with administration of mRNA-based vaccines. A health-care system experience. In Allergy and Asthma Proceedings (Vol. 42, No. 5, p. 395). OceanSide Publications. | https://pubmed.ncbi.nlm.nih.gov/34474708/ | Arroliga, M. E., Dhanani, K., Arroliga, A. C., Huddleston, P. S., Trahan, J., Aguilar, T., & Weldon, D. (2021, September). Allergic reactions and adverse events associated with administration of mRNA-based vaccines. A health-care system experience. In Allergy and Asthma Proceedings (Vol. 42, No. 5, p. 395). OceanSide Publications. https://pubmed.ncbi.nlm.nih.gov/34474708/ | David, R., Hanna, P., Lee, K., & Ritchie, A. (2021). Relapsed ANCA associated vasculitis following Oxford AstraZeneca ChAdOx1-S COVID-19 vaccination: A case series of two patients. Nephrology (Carlton, Vic.), 27(1), 109-110. https://pubmed.ncbi.nlm.nih.gov/34755433/ | ||||
171 | Allergic reactions to the first COVID-19 vaccine: a potential role of polyethylene glycol: | https://pubmed.ncbi.nlm.nih.gov/33320974/ | https://pubmed.ncbi.nlm.nih.gov/33320974/ | Cabanillas, B., Akdis, C., & Novak, N. (2020). Allergic reactions to the first COVID-19 vaccine: a potential role of Polyethylene glycol. Allergy, 76(6), 1617-1618. | Cabanillas, B., Akdis, C. y Novak, N. (2020). Reacciones alérgicas a la primera vacuna COVID-19: un papel potencial del polietilenglicol. Alergia, 76(6), 1617-1618. https://pubmed.ncbi.nlm.nih.gov/33384356/ | Cleaver, J., Ibitoye, R., Morrison, H., Inundación, R., CREWDSON, K., Marsh, A., ... & Mortimer, A. (2021). Tratamiento endovascular para la trombosis sinusita venosa cerebral inducida por la vacuna y la trombocitopenia después de la vacunación con Chadox1 NCOV-19: un informe de tres casos. Diario de la cirugía neurointervencional. https://pubmed.ncbi.nlm.nih.gov/34710832/ | Cabanillas, B., Akdis, C., & Novak, N. (2020). Allergic reactions to the first COVID-19 vaccine: a potential role of Polyethylene glycol. Allergy, 76(6), 1617-1618. https://pubmed.ncbi.nlm.nih.gov/33320974/ | Cohen, D., Krauthammer, S. H., Wolf, I., & Even-Sapir, E. (2021). Hypermetabolic lymphadenopathy following administration of BNT162b2 mRNA Covid-19 vaccine: incidence assessed by [18F] FDG PET-CT and relevance to study interpretation. European Journal of Nuclear Medicine and Molecular Imaging, 48(6), 1854-1863. https://pubmed.ncbi.nlm.nih.gov/33774684/ | Tuyls, S., Van Der Brempt, X., Faber, M., Gadisseur, R., Dezfoulian, B., Schrijvers, R., & Froidure, A. (2021). Allergic reactions to COVID-19 vaccines: statement of the Belgian Society for Allergy and Clinical Immunology (BelSACI). Acta Clinica Belgica, 1-6. | https://www.tandfonline.com/doi/abs/10.1080/17843286.2021.1909447 | Tuyls, S., Van Der Brempt, X., Faber, M., Gadisseur, R., Dezfoulian, B., Schrijvers, R., & Froidure, A. (2021). Allergic reactions to COVID-19 vaccines: statement of the Belgian Society for Allergy and Clinical Immunology (BelSACI). Acta Clinica Belgica, 1-6. https://www.tandfonline.com/doi/abs/10.1080/17843286.2021.1909447 | David, S. S. B., Potasman, I., & Rahamim-Cohen, D. (2021). Rate of recurrent guillain-barré syndrome after mRNA COVID-19 vaccine BNT162b2. JAMA neurology, 78(11), 1409-1411. https://jamanetwork.com/journals/jamaneurology/fullarticle/2783708 | ||||
172 | Pfizer Vaccine Raises Allergy Concerns: | https://pubmed.ncbi.nlm.nih.gov/33384356/ | https://pubmed.ncbi.nlm.nih.gov/33384356/ | de Vrieze, J. (2021). Pfizer's vaccine raises allergy concerns. | de Vrieze, J. (2021). La vacuna de Pfizer genera preocupaciones sobre las alergias. https://pubmed.ncbi.nlm.nih.gov/33444297/ | Cliff-Patel, N., Moncrieff, L., & Ziauddin, V. (2021). Trombosis de vena renal y embolia pulmonar secundaria a la trombocitopenia trombótica inducida por la vacuna (VITT). Revista europea de informes de casos en medicina interna, 8 (7). https://pubmed.ncbi.nlm.nih.gov/33990339/. | de Vrieze, J. (2021). Pfizer's vaccine raises allergy concerns. https://pubmed.ncbi.nlm.nih.gov/33384356/ | Cohen, S. R., Prussick, L., Kahn, J. S., Gao, D. X., Radfar, A., & Rosmarin, D. (2021). Leukocytoclastic vasculitis flare following the COVID‐19 vaccine. International Journal of Dermatology, 60(8), 1032-1033. https://pubmed.ncbi.nlm.nih.gov/33928638/ | Kelso, J. M. (2021). IgE‐mediated allergy to polyethylene glycol (PEG) as a cause of anaphylaxis to mRNA COVID‐19 vaccines. Clinical and Experimental Allergy. | https://pubmed.ncbi.nlm.nih.gov/34318537/ | Kelso, J. M. (2021). IgE‐mediated allergy to polyethylene glycol (PEG) as a cause of anaphylaxis to mRNA COVID‐19 vaccines. Clinical and Experimental Allergy. https://pubmed.ncbi.nlm.nih.gov/34318537/ | de Bruijn, S., Maes, M. B., De Waele, L., Vanhoorelbeke, K., & Gadisseur, A. (2021). First report of a de novo iTTP episode associated with an mRNA‐based anti‐COVID‐19 vaccination. Journal of Thrombosis and Haemostasis, 19(8), 2014-2018. https://pubmed.ncbi.nlm.nih.gov/34105244/ | ||||
173 | Allergic reactions, including anaphylaxis, after receiving the first dose of Pfizer-BioNTech COVID-19 vaccine – United States, December 14-23, 2020: | https://pubmed.ncbi.nlm.nih.gov/33444297/ | https://pubmed.ncbi.nlm.nih.gov/33444297/ | COVID, C., & Team, R. (2021). Allergic reactions including anaphylaxis after receipt of the first dose of Pfizer-BioNTech COVID-19 vaccine—United States, December 14–23, 2020. Morbidity and Mortality Weekly Report, 70(2), 46. | COVID, C. y Equipo, R. (2021). Reacciones alérgicas, incluida anafilaxia, después de recibir la primera dosis de la vacuna Pfizer-BioNTech COVID-19, Estados Unidos, 14 al 23 de diciembre de 2020. Morbidity and Mortality Weekly Report, 70(2), 46. https://pubmed.ncbi.nlm.nih.gov/33507892/ | Cohen, D., Krauthammer, S. H., Lobo, I., e incluso Sapir, E. (2021). Linfadenopatía hipermetabólica después de la administración de la vacuna contra el ARNm COVID-19 de BNT162B2: incidencia evaluada por [18F] PET-CT y relevancia para estudiar la interpretación. Diario Europeo de Medicina Nuclear y Imágenes Moleculares, 48 (6), 1854-1863. https://pubmed.ncbi.nlm.nih.gov/33985872/ | COVID, C., & Team, R. (2021). Allergic reactions including anaphylaxis after receipt of the first dose of Pfizer-BioNTech COVID-19 vaccine—United States, December 14–23, 2020. Morbidity and Mortality Weekly Report, 70(2), 46. https://pubmed.ncbi.nlm.nih.gov/33444297/ | Colaneri, M., De Filippo, M., Licari, A., Marseglia, A., Maiocchi, L., Ricciardi, A., ... & Bruno, R. (2021). COVID vaccination and asthma exacerbation: might there be a link?. International Journal of Infectious Diseases, 112, 243-246. https://www.ncbi.nlm.nih.gov/pubmed/34547487 | Phillips, E. J. (2021). Allergic Reactions After COVID-19 Vaccination—Putting Risk Into Perspective. JAMA Network Open, 4(8), e2122326-e2122326. | https://pubmed.ncbi.nlm.nih.gov/34463751/ | Phillips, E. J. (2021). Allergic Reactions After COVID-19 Vaccination—Putting Risk Into Perspective. JAMA Network Open, 4(8), e2122326-e2122326. https://pubmed.ncbi.nlm.nih.gov/34463751/ | De Cristofaro, R., & Sanguinetti, M. (2021). Vaccine-induced thrombotic thrombocytopenia, a rare but severe case of friendly fire in the battle against COVID-19 pandemic: what pathogenesis?. European Journal of Internal Medicine. https://www.sciencedirect.com/science/article/pii/S0953620521002314 | ||||
174 | Allergic reactions, including anaphylaxis, after receiving first dose of Modern COVID-19 vaccine – United States, December 21, 2020-January 10, 2021: | https://pubmed.ncbi.nlm.nih.gov/33507892/ | https://pubmed.ncbi.nlm.nih.gov/33507892/ | COVID, C., & Team, R. (2021). Allergic reactions including anaphylaxis after receipt of the first dose of Moderna COVID-19 vaccine—United States, December 21, 2020–January 10, 2021. Morbidity and Mortality Weekly Report, 70(4), 125. | COVID, C. y Equipo, R. (2021). Reacciones alérgicas, incluida anafilaxia, después de recibir la primera dosis de la vacuna Moderna COVID-19: Estados Unidos, 21 de diciembre de 2020 al 10 de enero de 2021. Informe semanal de morbilidad y mortalidad, 70(4), 125. https://pubmed.ncbi.nlm.nih.gov/34414880/ | Cohen, S. R., Prussick, L., Kahn, J. S., Gao, D. X., Radfar, A., & Rosmarin, D. (2021). Llamada de vasculitis leucocitoclástica después de la vacuna COVID-19. Diario Internacional de Dermatología, 60 (8), 1032-1033. https://pubmed.ncbi.nlm.nih.gov/34836739/ | COVID, C., & Team, R. (2021). Allergic reactions including anaphylaxis after receipt of the first dose of Moderna COVID-19 vaccine—United States, December 21, 2020–January 10, 2021. Morbidity and Mortality Weekly Report, 70(4), 125. https://pubmed.ncbi.nlm.nih.gov/33507892/ | Colella, G., Orlandi, M., & Cirillo, N. (2021). Bell’s palsy following COVID-19 vaccination. Journal of Neurology, 268(10), 3589-3591. https://pubmed.ncbi.nlm.nih.gov/33611630/ | Krutzke, L., Roesler, R., Wiese, S., & Kochanek, S. (2021). Process-related impurities in the ChAdOx1 nCov-19 vaccine. | https://pubmed.ncbi.nlm.nih.gov/33846043/188 | Krutzke, L., Roesler, R., Wiese, S., & Kochanek, S. (2021). Process-related impurities in the ChAdOx1 nCov-19 vaccine. https://pubmed.ncbi.nlm.nih.gov/33846043/188 | de Mélo Silva Jr, M. L., & Lopes, D. P. (2021). Large hemorrhagic stroke after ChAdOx1 nCoV‐19 vaccination: A case report. Acta Neurologica Scandinavica, 144(6), 717-718. https://pubmed.ncbi.nlm.nih.gov/34273119/ | ||||
175 | Reports of anaphylaxis after coronavirus disease vaccination 2019, South Korea, February 26-April 30, 2021: | https://pubmed.ncbi.nlm.nih.gov/34414880/ | https://pubmed.ncbi.nlm.nih.gov/34414880/ | Lee, E., Lee, Y. K., Kim, T. E., Hwang, I., Jung, Y. H., Lee, H. R., ... & Lee, Y. K. (2021). Reports of anaphylaxis after coronavirus disease 2019 vaccination, South Korea, 26 February to 30 April 2021. Eurosurveillance, 26(33), 2100694. | Lee, E., Lee, Y. K., Kim, T. E., Hwang, I., Jung, Y. H., Lee, H. R., ... y Lee, Y. K. (2021). Informes de anafilaxia después de la vacunación contra la enfermedad por coronavirus de 2019, Corea del Sur, 26 de febrero al 30 de abril de 2021. Eurosurveillance, 26(33), 2100694. https://pubmed.ncbi.nlm.nih.gov/33576785/ | COLANERI, M., DE FILIPPO, M., LARIARI, A., MARSEGLIA, A., Maiocchi, L., Ricciardi, A., ... & Bruno, R. (2021). Vacunación de covid y exacerbación del asma: ¿Podría haber un enlace? Diario Internacional de Enfermedades Infecciosas, 112, 243-246. https://www.ncbi.nlm.nih.gov/pubmed/34339728 | Lee, E., Lee, Y. K., Kim, T. E., Hwang, I., Jung, Y. H., Lee, H. R., ... & Lee, Y. K. (2021). Reports of anaphylaxis after coronavirus disease 2019 vaccination, South Korea, 26 February to 30 April 2021. Eurosurveillance, 26(33), 2100694. https://pubmed.ncbi.nlm.nih.gov/34414880/ | Colia, R., Rotondo, C., Corrado, A., & Cantatore, F. P. (2021). Cutaneous vasculitis after severe acute respiratory syndrome coronavirus 2 vaccine. Rheumatology Advances in Practice, 5(3), rkab050. https://pubmed.ncbi.nlm.nih.gov/34557622/. | Ring, J., Worm, M., Wollenberg, A., Thyssen, J. P., Jakob, T., Klimek, L., ... & Deleuran, M. (2021). Risk of severe allergic reactions to COVID‐19 vaccines among patients with allergic skin diseases–practical recommendations. A position statement of ETFAD with external experts. Journal of the European Academy of Dermatology and Venereology, 35(6), e362-e365. | https://pubmed.ncbi.nlm.nih.gov/33752263/ | Ring, J., Worm, M., Wollenberg, A., Thyssen, J. P., Jakob, T., Klimek, L., ... & Deleuran, M. (2021). Risk of severe allergic reactions to COVID‐19 vaccines among patients with allergic skin diseases–practical recommendations. A position statement of ETFAD with external experts. Journal of the European Academy of Dermatology and Venereology, 35(6), e362-e365. https://pubmed.ncbi.nlm.nih.gov/33752263/ | De Michele, M., Iacobucci, M., Chistolini, A., Nicolini, E., Pulcinelli, F., Cerbelli, B., ... & Toni, D. (2021). Malignant cerebral infarction after ChAdOx1 nCov-19 vaccination: a catastrophic variant of vaccine-induced immune thrombotic thrombocytopenia. Nature Communications, 12(1), 1-7. https://pubmed.ncbi.nlm.nih.gov/34341358/ | ||||
176 | Reports of anaphylaxis after receiving COVID-19 mRNA vaccines in the U.S.-Dec 14, 2020-Jan 18, 2021: | https://pubmed.ncbi.nlm.nih.gov/33576785/ | https://pubmed.ncbi.nlm.nih.gov/33576785/ | Shimabukuro, T. T., Cole, M., & Su, J. R. (2021). Reports of anaphylaxis after receipt of mRNA COVID-19 vaccines in the US—December 14, 2020-January 18, 2021. Jama, 325(11), 1101-1102. | Shimabukuro, TT, Cole, M. y Su, JR (2021). Informes de anafilaxia después de recibir vacunas de ARNm contra la COVID-19 en los EE. UU.: del 14 de diciembre de 2020 al 18 de enero de 2021. Jama, 325(11), 1101-1102. https://pubmed.ncbi.nlm.nih.gov/34269740/ | Colella, G., Orlandi, M., & Cirillo, N. (2021). La parálisis de Bell siguiendo la vacunación COVID-19. Diario de Neurología, 268 (10), 3589-3591. https://pubmed.ncbi.nlm.nih.gov/33981305/ | Shimabukuro, T. T., Cole, M., & Su, J. R. (2021). Reports of anaphylaxis after receipt of mRNA COVID-19 vaccines in the US—December 14, 2020-January 18, 2021. Jama, 325(11), 1101-1102. https://pubmed.ncbi.nlm.nih.gov/33576785/ | Conticini, E., d'Alessandro, M., Bergantini, L., Bargagli, E., Gentili, F., Mazzei, M. A., ... & Frediani, B. (2021). Relapse of microscopic polyangiitis after vaccination against COVID‐19: A case report. Journal of medical virology. https://pubmed.ncbi.nlm.nih.gov/34251683/. | Pomara, C., Sessa, F., Ciaccio, M., Dieli, F., Esposito, M., Giammanco, G. M., ... & Zamboni, P. (2021). COVID-19 vaccine and death: causality algorithm according to the WHO eligibility diagnosis. Diagnostics, 11(6), 955. | https://pubmed.ncbi.nlm.nih.gov/34073536/ | Pomara, C., Sessa, F., Ciaccio, M., Dieli, F., Esposito, M., Giammanco, G. M., ... & Zamboni, P. (2021). COVID-19 vaccine and death: causality algorithm according to the WHO eligibility diagnosis. Diagnostics, 11(6), 955. https://pubmed.ncbi.nlm.nih.gov/34073536/ | de Terreros Caro, G. G., Díaz, S. G., Alé, M. P., & Gimeno, M. M. (2021). Bell’s palsy following COVID-19 vaccination: A case report. Neurologia (Barcelona, Spain). https://www.sciencedirect.com/science/article/pii/S217358082100122X. | ||||
177 | Immunization practices and risk of anaphylaxis: a current, comprehensive update of COVID-19 vaccination data: | https://pubmed.ncbi.nlm.nih.gov/34269740/ | https://pubmed.ncbi.nlm.nih.gov/34269740/ | Arcolaci, A., Bronte, V., & Zanoni, G. (2021). Immunization practices and risk of anaphylaxis: a current update, comprehensive of COVID-19 vaccination data. Current opinion in allergy and clinical immunology, 21(5), 418-425. | Arcolaci, A., Brontë, V. y Zanoni, G. (2021). Prácticas de vacunación y riesgo de anafilaxia: una actualización actual y completa de los datos de vacunación COVID-19. Opinión actual en alergia e inmunología clínica, 21(5), 418-425. https://pubmed.ncbi.nlm.nih.gov/34215453/ | Colia, R., Rotondo, C., Corrado, A., & Cantatale, F. P. (2021). Vasculitis cutánea después del síndrome respiratorio agudo severo CORONAVIRUS 2 VACUNA. Avances de reumatología en la práctica, 5 (3), RKAB050. https://pubmed.ncbi.nlm.nih.gov/34510694/ | Arcolaci, A., Bronte, V., & Zanoni, G. (2021). Immunization practices and risk of anaphylaxis: a current update, comprehensive of COVID-19 vaccination data. Current opinion in allergy and clinical immunology, 21(5), 418-425. https://pubmed.ncbi.nlm.nih.gov/34269740/ | Cooper, K. M., & Switzer, B. (2021). Severe immune thrombocytopenic purpura after SARS-CoV-2 vaccine. Archive of Clinical Cases, 8(2), 31. https://pubmed.ncbi.nlm.nih.gov/34754937/ | Holmes, G. A., Desai, M., Limone, B., Love, J., Tawfik, M., Wong, L., & Furukawa, B. (2021). A case series of cutaneous COVID-19 vaccine reactions at Loma Linda University Department of Dermatology. JAAD Case Reports, 16, 53-57. | https://pubmed.ncbi.nlm.nih.gov/34423106/ | Holmes, G. A., Desai, M., Limone, B., Love, J., Tawfik, M., Wong, L., & Furukawa, B. (2021). A case series of cutaneous COVID-19 vaccine reactions at Loma Linda University Department of Dermatology. JAAD Case Reports, 16, 53-57. https://pubmed.ncbi.nlm.nih.gov/34423106/ | de trabajo multidisciplinar de FACME, G. (2021). Recomendaciones diagnóstico-terapéuticas del grupo de trabajo de expertos de FACME ad-hoc sobre el manejo de la trombosis venosa cerebral relacionada con la vacunación frente a COVID-19. Neurología, 36(6), 451-461. https://www.sciencedirect.com/science/article/pii/S0213485321000839 | ||||
178 | Relationship between pre-existing allergies and anaphylactic reactions following administration of COVID-19 mRNA vaccine: | https://pubmed.ncbi.nlm.nih.gov/34215453/ | https://pubmed.ncbi.nlm.nih.gov/34215453/ | Desai, A. P., Desai, A. P., & Loomis, G. J. (2021). Relationship between pre-existing allergies and anaphylactic reactions post mRNA COVID-19 vaccine administration. Vaccine, 39(32), 4407-4409. | Desai, AP, Desai, AP y Loomis, GJ (2021). Relación entre alergias preexistentes y reacciones anafilácticas posteriores a la administración de la vacuna de ARNm COVID-19. Vacuna, 39(32), 4407-4409. https://pubmed.ncbi.nlm.nih.gov/33932618/ | Conticini, E., D'Alessandro, M., Bergantini, L., Bargargli, E., Gentili, F., Mazzei, M. A., ... & Frediani, B. (2021). Recaída de la poliangitis microscópica después de la vacunación contra COVID-19: un informe de caso. Diario de virología médica. https://pubmed.ncbi.nlm.nih.gov/34557622/. | Desai, A. P., Desai, A. P., & Loomis, G. J. (2021). Relationship between pre-existing allergies and anaphylactic reactions post mRNA COVID-19 vaccine administration. Vaccine, 39(32), 4407-4409. https://pubmed.ncbi.nlm.nih.gov/34215453/ | Corrêa, D. G., Cañete, L. A. Q., Dos Santos, G. A. C., de Oliveira, R. V., Brandão, C. O., & da Cruz Jr, L. C. H. (2021). Neurological symptoms and neuroimaging alterations related with COVID-19 vaccine: Cause or coincidence?. Clinical Imaging, 80, 348-352. https://pubmed.ncbi.nlm.nih.gov/34507266/ | McMahon, D. E., Amerson, E., Rosenbach, M., Lipoff, J. B., Moustafa, D., Tyagi, A., ... & Freeman, E. E. (2021). Cutaneous reactions reported after Moderna and Pfizer COVID-19 vaccination: a registry-based study of 414 cases. Journal of the American Academy of Dermatology, 85(1), 46-55. | https://pubmed.ncbi.nlm.nih.gov/33838206/ | McMahon, D. E., Amerson, E., Rosenbach, M., Lipoff, J. B., Moustafa, D., Tyagi, A., ... & Freeman, E. E. (2021). Cutaneous reactions reported after Moderna and Pfizer COVID-19 vaccination: a registry-based study of 414 cases. Journal of the American Academy of Dermatology, 85(1), 46-55. https://pubmed.ncbi.nlm.nih.gov/33838206/ | de Vrieze, J. (2021). Pfizer's vaccine raises allergy concerns. https://pubmed.ncbi.nlm.nih.gov/33384356/ | ||||
179 | Anaphylaxis Associated with COVID-19 mRNA Vaccines: Approach to Allergy Research: | https://pubmed.ncbi.nlm.nih.gov/33932618/ | https://pubmed.ncbi.nlm.nih.gov/33932618/ | Turk, V. E. (2021). Anaphylaxis associated with the mRNA COVID-19 vaccines: approach to allergy investigation. Clinical Immunology, 227, 108748. | Turk, VE (2021). Anafilaxia asociada con las vacunas de ARNm COVID-19: enfoque para la investigación de alergias. Inmunología clínica, 227, 108748. https://pubmed.ncbi.nlm.nih.gov/33643776/ | Cooper, K. M., & Switzer, B. (2021). Púrpura trombocitopénica inmune severa después de la vacuna contra SARS-COV-2. Archivo de casos clínicos, 8 (2), 31. https://pubmed.ncbi.nlm.nih.gov/33771584/ | Turk, V. E. (2021). Anaphylaxis associated with the mRNA COVID-19 vaccines: approach to allergy investigation. Clinical Immunology, 227, 108748. https://pubmed.ncbi.nlm.nih.gov/33932618/ | Corrêa, D. G., Cañete, L. A. Q., Dos Santos, G. A. C., de Oliveira, R. V., Brandão, C. O., & da Cruz Jr, L. C. H. (2021). Neurological symptoms and neuroimaging alterations related with COVID-19 vaccine: Cause or coincidence?. Clinical Imaging, 80, 348-352. https://www.sciencedirect.com/science/article/pii/S0899707121003557. | Català, A., Muñoz‐Santos, C., Galván‐Casas, C., Roncero Riesco, M., Revilla Nebreda, D., Solá‐Truyols, A., ... & Guilabert, A. (2022). Cutaneous reactions after SARS‐COV‐2 vaccination: a cross‐sectional Spanish nationwide study of 405 cases. British Journal of Dermatology, 186(1), 142-152. | https://pubmed.ncbi.nlm.nih.gov/34254291/ | Català, A., Muñoz‐Santos, C., Galván‐Casas, C., Roncero Riesco, M., Revilla Nebreda, D., Solá‐Truyols, A., ... & Guilabert, A. (2022). Cutaneous reactions after SARS‐COV‐2 vaccination: a cross‐sectional Spanish nationwide study of 405 cases. British Journal of Dermatology, 186(1), 142-152. https://pubmed.ncbi.nlm.nih.gov/34254291/ | Deb, A., Abdelmalek, J., Iwuji, K., & Nugent, K. (2021). Acute myocardial injury following COVID-19 vaccination: a case report and review of current evidence from vaccine adverse events reporting system database. Journal of primary care & community health, 12, 21501327211029230. https://pubmed.ncbi.nlm.nih.gov/34219532/ | ||||
180 | Severe Allergic Reactions after COVID-19 Vaccination with the Pfizer / BioNTech Vaccine in Great Britain and the USA: Position Statement of the German Allergy Societies: German Medical Association of Allergologists (AeDA), German Society for Allergology and Clinical Immunology (DGAKI) and Society for Pediatric Allergology and Environmental Medicine (GPA): | https://pubmed.ncbi.nlm.nih.gov/33643776/ | https://pubmed.ncbi.nlm.nih.gov/33643776/ | Klimek, L., Novak, N., Hamelmann, E., Werfel, T., Wagenmann, M., Taube, C., ... & Worm, M. (2021). Severe allergic reactions after COVID-19 vaccination with the Pfizer/BioNTech vaccine in Great Britain and USA. Allergo journal international, 30(2), 51-55. | Klimek, L., Novak, N., Hamelmann, E., Werfel, T., Wagenmann, M., Taube, C., ... y Worm, M. (2021). Reacciones alérgicas graves tras la vacunación COVID-19 con la vacuna Pfizer/BioNTech en Gran Bretaña y Estados Unidos. Revista Allergo internacional, 30(2), 51-55. https://pubmed.ncbi.nlm.nih.gov/33571463/ | Corrêa, D. G., Cañete, L. A. Q., DOS SANTOS, G. A. C., DE OLIVEIRA, R. V., Brandão, C. O., & da Cruz JR, L. C. H. H. (2021). Síntomas neurológicos y alteraciones de neuroimagen relacionados con la vacuna COVID-19: Causa o coincidencia. Imágenes clínicas, 80, 348-352. https://pubmed.ncbi.nlm.nih.gov/34459725/ | Klimek, L., Novak, N., Hamelmann, E., Werfel, T., Wagenmann, M., Taube, C., ... & Worm, M. (2021). Severe allergic reactions after COVID-19 vaccination with the Pfizer/BioNTech vaccine in Great Britain and USA. Allergo journal international, 30(2), 51-55. https://pubmed.ncbi.nlm.nih.gov/33643776/ | Cory, P., Lawrence, H., Abdulrahim, H., Mahmood-Rao, H., Hussein, A., & Gane, J. (2021). Lessons of the month 3: Haemophagocytic lymphohistiocytosis following COVID-19 vaccination (ChAdOx1 nCoV-19). Clinical Medicine, 21(6), e677-e679. https://pubmed.ncbi.nlm.nih.gov/34862234/ | Fathy, R. A., McMahon, D. E., Lee, C., Chamberlin, G. C., Rosenbach, M., Lipoff, J. B., ... & Freeman, E. E. (2022). Varicella‐zoster and herpes simplex virus reactivation post‐COVID‐19 vaccination: a review of 40 cases in an International Dermatology Registry. Journal of the European Academy of Dermatology and Venereology, 36(1), e6-e9. | https://pubmed.ncbi.nlm.nih.gov/34487581/ | Fathy, R. A., McMahon, D. E., Lee, C., Chamberlin, G. C., Rosenbach, M., Lipoff, J. B., ... & Freeman, E. E. (2022). Varicella‐zoster and herpes simplex virus reactivation post‐COVID‐19 vaccination: a review of 40 cases in an International Dermatology Registry. Journal of the European Academy of Dermatology and Venereology, 36(1), e6-e9. https://pubmed.ncbi.nlm.nih.gov/34487581/ | DeDent, A. M., & Farrand, E. (2022). Vaccine-induced interstitial lung disease: a rare reaction to COVID-19 vaccination. Thorax, 77(1), 9-10. https://pubmed.ncbi.nlm.nih.gov/34510014/. | ||||
181 | Allergic reactions and anaphylaxis to LNP-based COVID-19 vaccines: | https://pubmed.ncbi.nlm.nih.gov/33571463/ | https://pubmed.ncbi.nlm.nih.gov/33571463/ | Moghimi, S. M. (2021). Allergic reactions and anaphylaxis to lipid nanoparticle-based COVID-19 vaccines. Molecular Therapy. | Moghimi, SM (2021). Reacciones alérgicas y anafilaxia a las vacunas COVID-19 basadas en nanopartículas lipídicas. Terapia molecular. https://pubmed.ncbi.nlm.nih.gov/33527524/ | Corrêa, D. G., Cañete, L. A. Q., DOS SANTOS, G. A. C., DE OLIVEIRA, R. V., Brandão, C. O., & da Cruz JR, L. C. H. H. (2021). Síntomas neurológicos y alteraciones de neuroimagen relacionados con la vacuna COVID-19: Causa o coincidencia. Imágenes clínicas, 80, 348-352. https://www.sciencedirect.com/science/article/pii/S0165572821001569 | Moghimi, S. M. (2021). Allergic reactions and anaphylaxis to lipid nanoparticle-based COVID-19 vaccines. Molecular Therapy. https://pubmed.ncbi.nlm.nih.gov/33571463/ | Costentin, G., Ozkul-Wermester, O., Triquenot, A., Le Cam-Duchez, V., Massy, N., Benhamou, Y., & Massardier, E. (2021). Acute ischemic stroke revealing ChAdOx1 nCov-19 vaccine-induced immune thrombotic thrombocytopenia: impact on recanalization strategy. Journal of Stroke and Cerebrovascular Diseases, 30(9), 105942. https://pubmed.ncbi.nlm.nih.gov/34175640/ | Franchini, M., Liumbruno, G. M., & Pezzo, M. (2021). COVID‐19 Vaccine‐associated Immune Thrombosis and Thrombocytopenia (VITT): diagnostic and therapeutic recommendations for a new syndrome. European Journal of Haematology, 107(2), 173-180. | https://pubmed.ncbi.nlm.nih.gov/33987882/ | Franchini, M., Liumbruno, G. M., & Pezzo, M. (2021). COVID‐19 Vaccine‐associated Immune Thrombosis and Thrombocytopenia (VITT): diagnostic and therapeutic recommendations for a new syndrome. European Journal of Haematology, 107(2), 173-180. https://pubmed.ncbi.nlm.nih.gov/33987882/ | Desai, A. P., Desai, A. P., & Loomis, G. J. (2021). Relationship between pre-existing allergies and anaphylactic reactions post mRNA COVID-19 vaccine administration. Vaccine, 39(32), 4407-4409. https://pubmed.ncbi.nlm.nih.gov/34215453/ | ||||
182 | Reported orofacial adverse effects from COVID-19 vaccines: the known and the unknown: | https://pubmed.ncbi.nlm.nih.gov/33527524/ | https://pubmed.ncbi.nlm.nih.gov/33527524/ | Cirillo, N. (2021). Reported orofacial adverse effects of COVID‐19 vaccines: The knowns and the unknowns. Journal of Oral Pathology & Medicine, 50(4), 424-427. | Cirillo, N. (2021). Efectos adversos orofaciales informados de las vacunas COVID-19: lo conocido y lo desconocido. Revista de Patología y Medicina Oral, 50(4), 424-427. https://pubmed.ncbi.nlm.nih.gov/34518015/ | Cory, P., Lawrence, H., Abdulrahim, H., Mahmood-Rao, H., Hussein, A., & Gane, J. (2021). Lecciones del mes 3: Linfohistiocitosis hemofagocítica después de la vacunación COVID-19 (Chadox1 NCOV-19). Medicina clínica, 21 (6), E677-E679. https://pubmed.ncbi.nlm.nih.gov/34396358/. | Cirillo, N. (2021). Reported orofacial adverse effects of COVID‐19 vaccines: The knowns and the unknowns. Journal of Oral Pathology & Medicine, 50(4), 424-427. https://pubmed.ncbi.nlm.nih.gov/33527524/ | Coto‐Segura, P., Fernández‐Prada, M., Mir‐Bonafé, M., García‐García, B., González‐Iglesias, I., Alonso‐Penanes, P., ... & Martinón‐Torres, F. (2021). Vesiculobullous skin reactions induced by COVID‐19 mRNA vaccine: report of four cases and review of the literature. Clinical and experimental dermatology. https://pubmed.ncbi.nlm.nih.gov/34236711/ | Favaloro, E. J. (2021). Laboratory testing for suspected COVID‐19 vaccine–induced (immune) thrombotic thrombocytopenia. International Journal of Laboratory Hematology, 43(4), 559-570. | https://pubmed.ncbi.nlm.nih.gov/34138513/ | Favaloro, E. J. (2021). Laboratory testing for suspected COVID‐19 vaccine–induced (immune) thrombotic thrombocytopenia. International Journal of Laboratory Hematology, 43(4), 559-570. https://pubmed.ncbi.nlm.nih.gov/34138513/ | Dhoot, R., Kansal, A., Handran, C., Haykal, T., Ronald, J., Kappus, M., ... & Strouse, J. J. (2021). Thrombocytopenia and splanchnic thrombosis after Ad26. COV2. S vaccination successfully treated with transjugular intrahepatic portosystemic shunting and thrombectomy. American journal of hematology. https://onlinelibrary.wiley.com/doi/10.1002/ajh.26258 | ||||
183 | Cutaneous adverse effects of available COVID-19 vaccines: | https://pubmed.ncbi.nlm.nih.gov/34518015/ | https://pubmed.ncbi.nlm.nih.gov/34518015/ | Bogdanov, G., Bogdanov, I., Kazandjieva, J., & Tsankov, N. (2021). Cutaneous adverse effects of the available COVID-19 vaccines. Clinics in dermatology, 39(3), 523-531. | Bogdanov, G., Bogdanov, I., Kazandjieva, J. y Tsankov, N. (2021). Efectos adversos cutáneos de las vacunas COVID-19 disponibles. Clínicas en dermatología, 39(3), 523-531. https://pubmed.ncbi.nlm.nih.gov/34347278/ | Costentin, G., Ozkul-Wermester, O., Triquenot, A., Le Cam-Duchez, V., Massy, N., Benhamou, Y., y Massardier, E. (2021). Trazo isquémico agudo que revela la trombocitopenia trombótica inmune inducida por la vacuna contra la vacuna: impacto en la estrategia de recanalización. Diario de accidentes cerebrovasculares y enfermedades cerebrovasculares, 30 (9), 105942. https://pubmed.ncbi.nlm.nih.gov/34153802/ | Bogdanov, G., Bogdanov, I., Kazandjieva, J., & Tsankov, N. (2021). Cutaneous adverse effects of the available COVID-19 vaccines. Clinics in dermatology, 39(3), 523-531. https://pubmed.ncbi.nlm.nih.gov/34518015/ | COVID, C., & Team, R. (2021). Allergic reactions including anaphylaxis after receipt of the first dose of Moderna COVID-19 vaccine—United States, December 21, 2020–January 10, 2021. Morbidity and Mortality Weekly Report, 70(4), 125. https://pubmed.ncbi.nlm.nih.gov/33507892/ | Choi, J. K., Kim, S., Kim, S. R., Jin, J. Y., Choi, S. W., Kim, H., ... & Kim, S. R. (2021). Intracerebral hemorrhage due to thrombosis with thrombocytopenia syndrome after vaccination against COVID-19: the first fatal case in korea. Journal of Korean Medical Science, 36(31). | https://pubmed.ncbi.nlm.nih.gov/34402235/ | Choi, J. K., Kim, S., Kim, S. R., Jin, J. Y., Choi, S. W., Kim, H., ... & Kim, S. R. (2021). Intracerebral hemorrhage due to thrombosis with thrombocytopenia syndrome after vaccination against COVID-19: the first fatal case in korea. Journal of Korean Medical Science, 36(31). https://pubmed.ncbi.nlm.nih.gov/34402235/ | Dias, L., Soares-dos-Reis, R., Meira, J., Ferrão, D., Soares, P. R., Pastor, A., ... & Carvalho, M. (2021). Cerebral venous thrombosis after BNT162b2 mRNA SARS-CoV-2 vaccine. Journal of Stroke and Cerebrovascular Diseases, 30(8), 105906. https://www.sciencedirect.com/science/article/abs/pii/S1052305721003098 | ||||
184 | Cumulative adverse event report of anaphylaxis following injections of COVID-19 mRNA vaccine (Pfizer-BioNTech) in Japan: the first month report: | https://pubmed.ncbi.nlm.nih.gov/34347278/ | https://pubmed.ncbi.nlm.nih.gov/34347278/ | Iguchi, T., Umeda, H., Kojima, M., Kanno, Y., Tanaka, Y., Kinoshita, N., & Sato, D. (2021). Cumulative adverse event reporting of anaphylaxis after mRNA COVID-19 vaccine (Pfizer-BioNTech) injections in Japan: the first-month report. Drug safety, 44(11), 1209-1214. | Iguchi, T., Umeda, H., Kojima, M., Kanno, Y., Tanaka, Y., Kinoshita, N. y Sato, D. (2021). Informe acumulativo de eventos adversos de anafilaxia después de las inyecciones de la vacuna de ARNm COVID-19 (Pfizer-BioNTech) en Japón: informe del primer mes. Seguridad de los medicamentos, 44(11), 1209-1214. https://pubmed.ncbi.nlm.nih.gov/33685103/ | Coto-Segura, P., Fernández-Prada, M., Mir-Bonafé, M., García-García, B., González-Iglesias, I., Alonso-Penanes, P., ... & Martinón-Torres, F. (2021). Reacciones vesiculobulosas de la piel inducidas por COVID-19 Vacuna de ARNm: Informe de cuatro casos y revisión de la literatura. Dermatología clínica y experimental. https://pubmed.ncbi.nlm.nih.gov/34525282/ | Iguchi, T., Umeda, H., Kojima, M., Kanno, Y., Tanaka, Y., Kinoshita, N., & Sato, D. (2021). Cumulative adverse event reporting of anaphylaxis after mRNA COVID-19 vaccine (Pfizer-BioNTech) injections in Japan: the first-month report. Drug safety, 44(11), 1209-1214. https://pubmed.ncbi.nlm.nih.gov/34347278/ | COVID, C., & Team, R. (2021). Allergic reactions including anaphylaxis after receipt of the first dose of Pfizer-BioNTech COVID-19 vaccine—United States, December 14–23, 2020. Morbidity and Mortality Weekly Report, 70(2), 46. https://pubmed.ncbi.nlm.nih.gov/33444297/ | Hippisley-Cox, J., Patone, M., Mei, X. W., Saatci, D., Dixon, S., Khunti, K., ... & Coupland, C. A. (2021). Risk of thrombocytopenia and thromboembolism after covid-19 vaccination and SARS-CoV-2 positive testing: self-controlled case series study. bmj, 374. | https://pubmed.ncbi.nlm.nih.gov/34446426/ | Hippisley-Cox, J., Patone, M., Mei, X. W., Saatci, D., Dixon, S., Khunti, K., ... & Coupland, C. A. (2021). Risk of thrombocytopenia and thromboembolism after covid-19 vaccination and SARS-CoV-2 positive testing: self-controlled case series study. bmj, 374. https://pubmed.ncbi.nlm.nih.gov/34446426/ | Diaz, G. A., Parsons, G. T., Gering, S. K., Meier, A. R., Hutchinson, I. V., & Robicsek, A. (2021). Myocarditis and pericarditis after vaccination for COVID-19. Jama, 326(12), 1210-1212. https://jamanetwork.com/journals/jama/fullarticle/2782900 | ||||
185 | COVID-19 vaccines increase the risk of anaphylaxis: | https://pubmed.ncbi.nlm.nih.gov/33685103/ | https://pubmed.ncbi.nlm.nih.gov/33685103/ | Alnæs, M., Storaas, T., Sørensen, M., Stylianou, E., & Tøndell, A. (2021). Covid-19-vaksiner gir økt risiko for anafylaksi. Tidsskrift for Den norske legeforening. | Alnæs, M., Storaas, T., Sørensen, M., Stylianou, E. y Tøndell, A. (2021). La vacuna Covid-19 es un riesgo de anafylaksi. Tidsskrift para Den norske legeforening. https://pubmed.ncbi.nlm.nih.gov/34050949/ | Covid, C., & Team, R. (2021). Reacciones alérgicas que incluyen anafilaxis después de la recepción de la primera dosis de Moderna COVID-19 Vaccine-Estados Unidos, 21 de diciembre, 2020 al 10 de enero de 2021. Informe semanal de morbilidad y mortalidad, 70 (4), 125. https://pubmed.ncbi.nlm.nih.gov/34414880/ | Alnæs, M., Storaas, T., Sørensen, M., Stylianou, E., & Tøndell, A. (2021). Covid-19-vaksiner gir økt risiko for anafylaksi. Tidsskrift for Den norske legeforening. https://pubmed.ncbi.nlm.nih.gov/33685103/ | COVID, C., & Team, R. (2021). Allergic reactions including anaphylaxis after receipt of the first dose of Pfizer-BioNTech COVID-19 vaccine—United States, December 14–23, 2020. Morbidity and Mortality Weekly Report, 70(2), 46. https://www.ncbi.nlm.nih.gov/pubmed/33444297 | Chen, J., Cai, Y., Chen, Y., Williams, A. P., Gao, Y., & Zeng, J. (2021). Nervous and muscular adverse events after COVID-19 vaccination: a systematic review and meta-analysis of clinical trials. Vaccines, 9(8), 939. | https://pubmed.ncbi.nlm.nih.gov/34452064/. | Chen, J., Cai, Y., Chen, Y., Williams, A. P., Gao, Y., & Zeng, J. (2021). Nervous and muscular adverse events after COVID-19 vaccination: a systematic review and meta-analysis of clinical trials. Vaccines, 9(8), 939. https://pubmed.ncbi.nlm.nih.gov/34452064/. | Dickey, J. B., Albert, E., Badr, M., Laraja, K. M., Sena, L. M., Gerson, D. S., ... & Aurigemma, G. P. (2021). A series of patients with myocarditis following SARS-CoV-2 vaccination with mRNA-1279 and BNT162b2. Cardiovascular Imaging, 14(9), 1862-1863. https://www.sciencedirect.com/science/article/pii/S1936878X21004861 | ||||
186 | Biphasic anaphylaxis after exposure to the first dose of the Pfizer-BioNTech COVID-19 mRNA vaccine COVID-19: | https://pubmed.ncbi.nlm.nih.gov/34050949/ | https://pubmed.ncbi.nlm.nih.gov/34050949/ | Abi Zeid Daou, C., Natout, M. A., & El Hadi, N. (2021). Biphasic anaphylaxis after exposure to the first dose of Pfizer‐BioNTech COVID‐19 mRNA vaccine. Journal of medical virology, 93(10), 6027-6029. | Abi Zeid Daou, C., Natout, MA y El Hadi, N. (2021). Anafilaxia bifásica después de la exposición a la primera dosis de la vacuna de ARNm de Pfizer‐BioNTech COVID‐19. Revista de virología médica, 93(10), 6027-6029. https://pubmed.ncbi.nlm.nih.gov/33657648/ | Covid, C., & Team, R. (2021). Reacciones alérgicas que incluyen anafilaxis después de la recepción de la primera dosis de Pfizer-BionTech COVID-19 Vaccine-Estados Unidos, del 14 al 23 de diciembre, 2020. Informe semanal de morbilidad y mortalidad, 70 (2), 46. https://pubmed.ncbi.nlm.nih.gov/33507892/ | Abi Zeid Daou, C., Natout, M. A., & El Hadi, N. (2021). Biphasic anaphylaxis after exposure to the first dose of Pfizer‐BioNTech COVID‐19 mRNA vaccine. Journal of medical virology, 93(10), 6027-6029. https://pubmed.ncbi.nlm.nih.gov/34050949/ | Crane, P., Wong, C., Mehta, N., & Barlis, P. (2021). Takotsubo (stress) cardiomyopathy after ChAdOx1 nCoV-19 vaccination. BMJ Case Reports CP, 14(10), e246580. https://pubmed.ncbi.nlm.nih.gov/34625447/ | D’agostino, V., Caranci, F., Negro, A., Piscitelli, V., Tuccillo, B., Fasano, F., ... & Grassi, R. (2021). A rare case of cerebral venous thrombosis and disseminated intravascular coagulation temporally associated to the COVID-19 vaccine administration. Journal of personalized medicine, 11(4), 285. | https://pubmed.ncbi.nlm.nih.gov/33917902/ | D’agostino, V., Caranci, F., Negro, A., Piscitelli, V., Tuccillo, B., Fasano, F., ... & Grassi, R. (2021). A rare case of cerebral venous thrombosis and disseminated intravascular coagulation temporally associated to the COVID-19 vaccine administration. Journal of personalized medicine, 11(4), 285. https://pubmed.ncbi.nlm.nih.gov/33917902/ | Dicks, A. B., & Gray, B. H. (2021). Images in Vascular Medicine: Leukocytoclastic vasculitis after COVID-19 vaccine booster. Vascular Medicine, 1358863X211055507. https://pubmed.ncbi.nlm.nih.gov/34720009/ | ||||
187 | Allergenic components of the mRNA-1273 vaccine for COVID-19: possible involvement of polyethylene glycol and IgG-mediated complement activation: | https://pubmed.ncbi.nlm.nih.gov/33657648/ | https://pubmed.ncbi.nlm.nih.gov/33657648/ | Klimek, L., Novak, N., Cabanillas, B., Jutel, M., Bousquet, J., & Akdis, C. A. (2021). Allergenic components of the mRNA‐1273 vaccine for COVID‐19: possible involvement of polyethylene glycol and IgG‐mediated complement activation. Allergy, 76(11), 3307-3313. | Klimek, L., Novak, N., Cabanillas, B., Jutel, M., Bousquet, J. y Akdis, C. A. (2021). Componentes alergénicos de la vacuna mRNA-1273 para COVID-19: posible participación del polietilenglicol y la activación del complemento mediada por IgG. Alergia, 76(11), 3307-3313. https://pubmed.ncbi.nlm.nih.gov/33825239/ | Covid, C., & Team, R. (2021). Reacciones alérgicas que incluyen anafilaxis después de la recepción de la primera dosis de Pfizer-BionTech COVID-19 Vaccine-Estados Unidos, del 14 al 23 de diciembre, 2020. Informe semanal de morbilidad y mortalidad, 70 (2), 46. https://www.ncbi.nlm.nih.gov/pubmed/34192428 | Klimek, L., Novak, N., Cabanillas, B., Jutel, M., Bousquet, J., & Akdis, C. A. (2021). Allergenic components of the mRNA‐1273 vaccine for COVID‐19: possible involvement of polyethylene glycol and IgG‐mediated complement activation. Allergy, 76(11), 3307-3313. https://pubmed.ncbi.nlm.nih.gov/33657648/ | Crea, F. (2021). Thrombosis in peripheral artery disease and thrombotic thrombocytopenia after adenoviral COVID-19 vaccination. European Heart Journal, 42(39), 3995-3999. https://pubmed.ncbi.nlm.nih.gov/34649281/. | Wang, R. L., Chiang, W. F., Shyu, H. Y., Chen, M. H., Lin, C. I., Wu, K. A., ... & Hsiao, P. J. (2021). COVID-19 vaccine-associated acute cerebral venous thrombosis and pulmonary artery embolism. QJM: An International Journal of Medicine. | https://pubmed.ncbi.nlm.nih.gov/34247246/. | Wang, R. L., Chiang, W. F., Shyu, H. Y., Chen, M. H., Lin, C. I., Wu, K. A., ... & Hsiao, P. J. (2021). COVID-19 vaccine-associated acute cerebral venous thrombosis and pulmonary artery embolism. QJM: An International Journal of Medicine. https://pubmed.ncbi.nlm.nih.gov/34247246/. | Dijk, W. E. V., & Schutgens, R. E. (2022). Relapse of immune thrombocytopenia after COVID‐19 vaccination. European Journal of Haematology, 108(1), 84-85. https://pubmed.ncbi.nlm.nih.gov/34591991/ | ||||
188 | Polyethylene glycol (PEG) is a cause of anaphylaxis to Pfizer / BioNTech mRNA COVID-19 vaccine: | https://pubmed.ncbi.nlm.nih.gov/33825239/ | https://pubmed.ncbi.nlm.nih.gov/33825239/ | Sellaturay, P., Nasser, S., Islam, S., Gurugama, P., & Ewan, P. W. (2021). Polyethylene glycol (PEG) is a cause of anaphylaxis to the Pfizer/BioNTech mRNA COVID‐19 vaccine. Clinical and Experimental Allergy, 51(6), 861. | Sellaturay, P., Nasser, S., Islam, S., Gurugama, P. y Ewan, PW (2021). El polietilenglicol (PEG) es una causa de anafilaxia para la vacuna de ARNm COVID-19 de Pfizer/BioNTech. Alergia clínica y experimental, 51(6), 861. https://pubmed.ncbi.nlm.nih.gov/33683290/ | Crane, P., Wong, C., Mehta, N., & Barlis, P. (2021). Cardiomiopatía takotsubo (estrés) después de la vacunación de Chadox1 NCOV-19. Caso BMJ Informes CP, 14 (10), E246580. https://pubmed.ncbi.nlm.nih.gov/34696248/ | Sellaturay, P., Nasser, S., Islam, S., Gurugama, P., & Ewan, P. W. (2021). Polyethylene glycol (PEG) is a cause of anaphylaxis to the Pfizer/BioNTech mRNA COVID‐19 vaccine. Clinical and Experimental Allergy, 51(6), 861. https://pubmed.ncbi.nlm.nih.gov/33825239/ | Crossette-Thambiah, C., Pericleous, C., Asmar, N., Bomsztyk, J., Ranger, A., Shlebak, A., ... & Arachchillage, D. J. (2021). Clinical and biological features of cerebral venous sinus thrombosis following ChAdOx1 nCov-19 vaccination. Journal of Neurology, Neurosurgery & Psychiatry. https://jnnp.bmj.com/content/early/2021/09/29/jnnp-2021-327340. | Barral, M., Arrive, L., Mouhadi-Barnier, E., & Cornelis, F. H. (2021). Thromboaspiration and fibrinolysis infusion for portomesenteric thrombosis after AstraZeneca COVID-19 vaccine administration. Intensive Care Medicine, 47(9), 1034-1036. | https://pubmed.ncbi.nlm.nih.gov/34132839/ | Barral, M., Arrive, L., Mouhadi-Barnier, E., & Cornelis, F. H. (2021). Thromboaspiration and fibrinolysis infusion for portomesenteric thrombosis after AstraZeneca COVID-19 vaccine administration. Intensive Care Medicine, 47(9), 1034-1036. https://pubmed.ncbi.nlm.nih.gov/34132839/ | Dimopoulou, D., Spyridis, N., Vartzelis, G., Tsolia, M. N., & Maritsi, D. N. (2021). Safety and tolerability of the COVID-19 mRNA-vaccine in adolescents with juvenile idiopathic arthritis on treatment with TNF-inhibitors. Arthritis & Rheumatology (Hoboken, NJ). https://www.ncbi.nlm.nih.gov/pubmed/34492161 | ||||
189 | Acute allergic reactions to COVID-19 mRNA vaccines: | https://pubmed.ncbi.nlm.nih.gov/33683290/ | https://pubmed.ncbi.nlm.nih.gov/33683290/ | Blumenthal, K. G., Robinson, L. B., Camargo, C. A., Shenoy, E. S., Banerji, A., Landman, A. B., & Wickner, P. (2021). Acute allergic reactions to mRNA COVID-19 vaccines. Jama, 325(15), 1562-1565. | Blumenthal, K. G., Robinson, L. B., Camargo, C. A., Shenoy, E. S., Banerji, A., Landman, A. B. y Wickner, P. (2021). Reacciones alérgicas agudas a las vacunas de ARNm COVID-19. Jama, 325(15), 1562-1565. https://pubmed.ncbi.nlm.nih.gov/33919151/ | CREA, F. (2021). La trombosis en la enfermedad de la arteria periférica y la trombocitopenia trombótica después de la vacuna adenoviral covid-19. European Heart Journal, 42 (39), 3995-3999. https://pubmed.ncbi.nlm.nih.gov/34420249/ | Blumenthal, K. G., Robinson, L. B., Camargo, C. A., Shenoy, E. S., Banerji, A., Landman, A. B., & Wickner, P. (2021). Acute allergic reactions to mRNA COVID-19 vaccines. Jama, 325(15), 1562-1565. https://pubmed.ncbi.nlm.nih.gov/33683290/ | Cugno, M., Consonni, D., Lombardi, A., Bono, P., Oggioni, M., Uceda Renteria, S., ... & Gori, A. (2021). Increased risk of urticaria/angioedema after BNT162b2 mRNA COVID-19 vaccine in health care workers taking ACE inhibitors. Vaccines, 9(9), 1011. https://pubmed.ncbi.nlm.nih.gov/34579248/ | Al-Maqbali, J. S., Al Rasbi, S., Kashoub, M. S., Al Hinaai, A. M., Farhan, H., Al Rawahi, B., & Al Alawi, A. M. (2021). A 59-year-old woman with extensive deep vein thrombosis and pulmonary thromboembolism 7 days following a first dose of the Pfizer-BioNTech BNT162b2 mRNA COVID-19 vaccine. The American journal of case reports, 22, e932946-1. | https://pubmed.ncbi.nlm.nih.gov/34117206/ | Al-Maqbali, J. S., Al Rasbi, S., Kashoub, M. S., Al Hinaai, A. M., Farhan, H., Al Rawahi, B., & Al Alawi, A. M. (2021). A 59-year-old woman with extensive deep vein thrombosis and pulmonary thromboembolism 7 days following a first dose of the Pfizer-BioNTech BNT162b2 mRNA COVID-19 vaccine. The American journal of case reports, 22, e932946-1. https://pubmed.ncbi.nlm.nih.gov/34117206/ | Dimopoulou, D., Vartzelis, G., Dasoula, F., Tsolia, M., & Maritsi, D. (2022). Immunogenicity of the COVID-19 mRNA vaccine in adolescents with juvenile idiopathic arthritis on treatment with TNF inhibitors. Annals of the Rheumatic Diseases, 81(4), 592-593. https://www.ncbi.nlm.nih.gov/pubmed/34844930 | ||||
190 | Polyethylene glycole allergy of the SARS CoV2 vaccine recipient: case report of a young adult recipient and management of future exposure to SARS-CoV2: | https://pubmed.ncbi.nlm.nih.gov/33919151/ | https://pubmed.ncbi.nlm.nih.gov/33919151/ | Restivo, V., Candore, G., Barrale, M., Caravello, E., Graziano, G., Onida, R., ... & Brusca, I. (2021). Allergy to polyethilenglicole of anti-SARS CoV2 vaccine recipient: a case report of young adult recipient and the management of future exposure to SARS-CoV2. Vaccines, 9(5), 412. | Restivo, V., Candore, G., Barrale, M., Caravello, E., Graziano, G., Onida, R., ... & Brusca, I. (2021). Alergia al polietilenglicole de un receptor de la vacuna anti-SARS CoV2: informe de un caso de un receptor adulto joven y el manejo de la exposición futura al SARS-CoV2. Vacunas, 9(5), 412. https://pubmed.ncbi.nlm.nih.gov/34128049/ | Crossette-Thambiah, C., Pericleos, C., Asmar, N., Bomsztyk, J., Ranger, A., Shlebak, A., ... & Arachchillage, D. J. (2021). Características clínicas y biológicas de la trombosis sinusita venosa cerebral después de la vacunación con Chadox1 NCOV-19. Diario de Neurología, Neurocirugía y Psiquiatría. https://pubmed.ncbi.nlm.nih.gov/34632750/ | Restivo, V., Candore, G., Barrale, M., Caravello, E., Graziano, G., Onida, R., ... & Brusca, I. (2021). Allergy to polyethilenglicole of anti-SARS CoV2 vaccine recipient: a case report of young adult recipient and the management of future exposure to SARS-CoV2. Vaccines, 9(5), 412. https://pubmed.ncbi.nlm.nih.gov/33919151/ | Cuker, A. (2021). Thrombosis with thrombocytopenia syndrome after COVID-19 vaccination. Clinical advances in hematology & oncology: H&O, 19(7), 446-449. https://pubmed.ncbi.nlm.nih.gov/34236343/ | Geeraerts, T., Montastruc, F., Bonneville, F., Mémier, V., Raposo, N., & Toulouse Vitt Study Group. (2021). Oxford-AstraZeneca COVID-19 vaccine-induced cerebral venous thrombosis and thrombocytopaenia: a missed opportunity for a rapid return of experience. Anaesthesia, Critical Care & Pain Medicine. | https://pubmed.ncbi.nlm.nih.gov/34033927/ | Geeraerts, T., Montastruc, F., Bonneville, F., Mémier, V., Raposo, N., & Toulouse Vitt Study Group. (2021). Oxford-AstraZeneca COVID-19 vaccine-induced cerebral venous thrombosis and thrombocytopaenia: a missed opportunity for a rapid return of experience. Anaesthesia, Critical Care & Pain Medicine. https://pubmed.ncbi.nlm.nih.gov/34033927/ | Dionne, A., Sperotto, F., Chamberlain, S., Baker, A. L., Powell, A. J., Prakash, A., ... & Friedman, K. G. (2021). Association of myocarditis with BNT162b2 messenger RNA COVID-19 vaccine in a case series of children. JAMA cardiology, 6(12), 1446-1450. https://pubmed.ncbi.nlm.nih.gov/34374740/ | ||||
191 | Elevated rates of anaphylaxis after vaccination with Pfizer BNT162b2 mRNA vaccine against COVID-19 in Japanese healthcare workers; a secondary analysis of initial post-approval safety data: | https://pubmed.ncbi.nlm.nih.gov/34128049/ | https://pubmed.ncbi.nlm.nih.gov/34128049/ | Hashimoto, T., Ozaki, A., Bhandari, D., Sawano, T., Sah, R., & Tanimoto, T. (2021). High anaphylaxis rates following vaccination with the Pfizer BNT162b2 mRNA vaccine against COVID-19 in Japanese healthcare workers: a secondary analysis of initial post-approval safety data. Journal of Travel Medicine, 28(7), taab090. | Hashimoto, T., Ozaki, A., Bhandari, D., Sawano, T., Sah, R. y Tanimoto, T. (2021). Altas tasas de anafilaxia después de la vacunación con la vacuna de ARNm BNT162b2 de Pfizer contra COVID-19 en trabajadores de la salud japoneses: un análisis secundario de los datos de seguridad iniciales posteriores a la aprobación. Revista de medicina de viajes, 28(7), taab090. https://pubmed.ncbi.nlm.nih.gov/34474708/ | CUGNO, M., CONSONNI, D., LOMBARDI, A., Bono, P., Ogoni, M., UCEDA RENTERIA, S., ... & GORI, A. (2021). Mayor riesgo de urticaria / angioedema después de BNT162B2 MRNA COVID-19 Vacuna en los trabajadores de la salud que toman inhibidores de la ECE. Vacunas, 9 (9), 1011. https://pubmed.ncbi.nlm.nih.gov/34843991/ | Hashimoto, T., Ozaki, A., Bhandari, D., Sawano, T., Sah, R., & Tanimoto, T. (2021). High anaphylaxis rates following vaccination with the Pfizer BNT162b2 mRNA vaccine against COVID-19 in Japanese healthcare workers: a secondary analysis of initial post-approval safety data. Journal of Travel Medicine, 28(7), taab090. https://pubmed.ncbi.nlm.nih.gov/34128049/ | D'Angelo, T., Cattafi, A., Carerj, M. L., Booz, C., Ascenti, G., Cicero, G., ... & Mazziotti, S. (2021). Myocarditis after SARS-CoV-2 vaccination: a vaccine-induced reaction?. Canadian Journal of Cardiology, 37(10), 1665-1667. https://pubmed.ncbi.nlm.nih.gov/34118375/ | Vidula, M. K., Ambrose, M., Glassberg, H., Chokshi, N., Chen, T., Ferrari, V. A., & Han, Y. (2021). Myocarditis and other cardiovascular complications of the mRNA-based COVID-19 vaccines. Cureus, 13(6). | https://pubmed.ncbi.nlm.nih.gov/34277198/ | Vidula, M. K., Ambrose, M., Glassberg, H., Chokshi, N., Chen, T., Ferrari, V. A., & Han, Y. (2021). Myocarditis and other cardiovascular complications of the mRNA-based COVID-19 vaccines. Cureus, 13(6). https://pubmed.ncbi.nlm.nih.gov/34277198/ | Douxfils, J., Favresse, J., Dogné, J. M., Lecompte, T., Susen, S., Cordonnier, C., ... & Mullier, F. (2021). Hypotheses behind the very rare cases of thrombosis with thrombocytopenia syndrome after SARS-CoV-2 vaccination. Thrombosis research, 203, 163-171. https://www.sciencedirect.com/science/article/abs/pii/S0049384821003315 | ||||
192 | Allergic reactions and adverse events associated with administration of mRNA-based vaccines. A health system experience: | https://pubmed.ncbi.nlm.nih.gov/34474708/ | https://pubmed.ncbi.nlm.nih.gov/34474708/ | Arroliga, M. E., Dhanani, K., Arroliga, A. C., Huddleston, P. S., Trahan, J., Aguilar, T., & Weldon, D. (2021, September). Allergic reactions and adverse events associated with administration of mRNA-based vaccines. A health-care system experience. In Allergy and Asthma Proceedings (Vol. 42, No. 5, p. 395). OceanSide Publications. | Arroliga, M. E., Dhanani, K., Arroliga, A. C., Huddleston, P. S., Trahan, J., Aguilar, T. y Weldon, D. (septiembre de 2021). Reacciones alérgicas y eventos adversos asociados con la administración de vacunas basadas en ARNm. Una experiencia en el sistema de salud. En Procedimientos de alergia y asma (Vol. 42, No. 5, p. 395). Publicaciones de OceanSide. https://www.tandfonline.com/doi/abs/10.1080/17843286.2021.1909447 | Cuker, A. (2021). Trombosis con síndrome de trombocitopenia después de la vacunación de COVID-19. Avances clínicos en hematología y oncología: H & O, 19 (7), 446-449. https://pubmed.ncbi.nlm.nih.gov/34364657/. | Arroliga, M. E., Dhanani, K., Arroliga, A. C., Huddleston, P. S., Trahan, J., Aguilar, T., & Weldon, D. (2021, September). Allergic reactions and adverse events associated with administration of mRNA-based vaccines. A health-care system experience. In Allergy and Asthma Proceedings (Vol. 42, No. 5, p. 395). OceanSide Publications. https://pubmed.ncbi.nlm.nih.gov/34474708/ | D’Agati, V. D., Kudose, S., Bomback, A. S., Adamidis, A., & Tartini, A. (2021). Minimal change disease and acute kidney injury following the Pfizer-BioNTech COVID-19 vaccine. Kidney international, 100(2), 461-463. https://pubmed.ncbi.nlm.nih.gov/34000278/ | Watad, A., De Marco, G., Mahajna, H., Druyan, A., Eltity, M., Hijazi, N., ... & McGonagle, D. (2021). Immune-mediated disease flares or new-onset disease in 27 subjects following mRNA/DNA SARS-CoV-2 vaccination. Vaccines, 9(5), 435. | https://pubmed.ncbi.nlm.nih.gov/33946748/ | Watad, A., De Marco, G., Mahajna, H., Druyan, A., Eltity, M., Hijazi, N., ... & McGonagle, D. (2021). Immune-mediated disease flares or new-onset disease in 27 subjects following mRNA/DNA SARS-CoV-2 vaccination. Vaccines, 9(5), 435. https://pubmed.ncbi.nlm.nih.gov/33946748/ | Douxfils, J., Vayne, C., Pouplard, C., Lecompte, T., Favresse, J., Potier, F., ... & Mullier, F. (2021). Fatal exacerbation of ChadOx1-nCoV-19-induced thrombotic thrombocytopenia syndrome after initial successful therapy with intravenous immunoglobulins-a rational for monitoring immunoglobulin G levels. haematologica, 106(12), 3249. https://pubmed.ncbi.nlm.nih.gov/34382387/ | ||||
193 | Allergic reactions to COVID-19 vaccines: statement of the Belgian Society of Allergy and Clinical Immunology (BelSACI): | https://www.tandfonline.com/doi/abs/10.1080/17843286.2021.1909447 | https://www.tandfonline.com/doi/abs/10.1080/17843286.2021.1909447 | Tuyls, S., Van Der Brempt, X., Faber, M., Gadisseur, R., Dezfoulian, B., Schrijvers, R., & Froidure, A. (2021). Allergic reactions to COVID-19 vaccines: statement of the Belgian Society for Allergy and Clinical Immunology (BelSACI). Acta Clinica Belgica, 1-6. | Tuyls, S., Van Der Brempt, X., Faber, M., Gadisseur, R., Dezfoulian, B., Schrijvers, R. y Froidure, A. (2021). Reacciones alérgicas a las vacunas COVID-19: declaración de la Sociedad Belga de Alergia e Inmunología Clínica (BelSACI). Acta Clínica Bélgica, 1-6. https://pubmed.ncbi.nlm.nih.gov/34318537/ | D'AGATI, V. D., Kudose, S., Bomback, A. S., Adamidis, A., & Tartini, A. (2021). Cambio mínimo de la enfermedad y lesión renal aguda después de la vacuna Pfizer-Biontech COVID-19. Ridney International, 100 (2), 461-463. https://pubmed.ncbi.nlm.nih.gov/34655312/. | Tuyls, S., Van Der Brempt, X., Faber, M., Gadisseur, R., Dezfoulian, B., Schrijvers, R., & Froidure, A. (2021). Allergic reactions to COVID-19 vaccines: statement of the Belgian Society for Allergy and Clinical Immunology (BelSACI). Acta Clinica Belgica, 1-6. https://www.tandfonline.com/doi/abs/10.1080/17843286.2021.1909447 | D’agostino, V., Caranci, F., Negro, A., Piscitelli, V., Tuccillo, B., Fasano, F., ... & Grassi, R. (2021). A rare case of cerebral venous thrombosis and disseminated intravascular coagulation temporally associated to the COVID-19 vaccine administration. Journal of personalized medicine, 11(4), 285. https://pubmed.ncbi.nlm.nih.gov/33917902/ | Knowlton, K. U. (2021). Insights from a murine model of COVID-19 mRNA vaccination-induced myopericarditis: Could accidental intravenous vaccine injection induce myopericarditis?. Clin. infect. dis. | https://pubmed.ncbi.nlm.nih.gov/34453510/ | Knowlton, K. U. (2021). Insights from a murine model of COVID-19 mRNA vaccination-induced myopericarditis: Could accidental intravenous vaccine injection induce myopericarditis?. Clin. infect. dis. https://pubmed.ncbi.nlm.nih.gov/34453510/ | Dufour, C., Co, T. K., & Liu, A. (2021). GM1 ganglioside antibody and COVID-19 related Guillain Barre Syndrome–a case report, systemic review and implication for vaccine development. Brain, Behavior, & Immunity-Health, 12, 100203. https://www.sciencedirect.com/science/article/pii/S2666354621000065 | ||||
194 | .IgE-mediated allergy to polyethylene glycol (PEG) as a cause of anaphylaxis to COVID-19 mRNA vaccines: | https://pubmed.ncbi.nlm.nih.gov/34318537/ | https://pubmed.ncbi.nlm.nih.gov/34318537/ | Kelso, J. M. (2021). IgE‐mediated allergy to polyethylene glycol (PEG) as a cause of anaphylaxis to mRNA COVID‐19 vaccines. Clinical and Experimental Allergy. | Kelso, JM (2021). Alergia mediada por IgE al polietilenglicol (PEG) como causa de anafilaxia a las vacunas de ARNm COVID-19. Alergia Clínica y Experimental. https://pubmed.ncbi.nlm.nih.gov/34463751/ | D'Agostino, V., CARANCI, F., Negro, A., Piscitelli, V., Tuccillo, B., Fasano, F., ... & Grassi, R. (2021). Un caso raro de trombosis venosa cerebral y la coagulación intravascular diseminada se asocia temporalmente a la administración de vacunas COVID-19. Diario de medicina personalizada, 11 (4), 285. https://pubmed.ncbi.nlm.nih.gov/34256983/ | Kelso, J. M. (2021). IgE‐mediated allergy to polyethylene glycol (PEG) as a cause of anaphylaxis to mRNA COVID‐19 vaccines. Clinical and Experimental Allergy. https://pubmed.ncbi.nlm.nih.gov/34318537/ | Dalan, R., & Boehm, B. O. (2021). Thrombosis post COVID-19 vaccinations: Potential link to ACE pathways. Thrombosis Research, 206, 137. https://pubmed.ncbi.nlm.nih.gov/34479129/ | Tarawneh, O., & Tarawneh, H. (2021). Immune thrombocytopenia in a 22‐year‐old post Covid‐19 vaccine. American journal of hematology. | https://pubmed.ncbi.nlm.nih.gov/33476455/ | Tarawneh, O., & Tarawneh, H. (2021). Immune thrombocytopenia in a 22‐year‐old post Covid‐19 vaccine. American journal of hematology. https://pubmed.ncbi.nlm.nih.gov/33476455/ | Dutta, A., Ghosh, R., Bhattacharya, D., Bhat, S., Ray, A., Pandit, A., ... & Dubey, S. (2021). Anti-PF4 antibody negative cerebral venous sinus thrombosis without thrombocytopenia following immunization with COVID-19 vaccine in an elderly non-comorbid Indian male, managed with conventional heparin-warfarin based anticoagulation. Diabetes & Metabolic Syndrome, 15(4), 102184. https://www.sciencedirect.com/science/article/pii/S1871402121002046 | ||||
195 | Allergic reactions after COVID-19 vaccination: putting the risk in perspective: | https://pubmed.ncbi.nlm.nih.gov/34463751/ | https://pubmed.ncbi.nlm.nih.gov/34463751/ | Phillips, E. J. (2021). Allergic Reactions After COVID-19 Vaccination—Putting Risk Into Perspective. JAMA Network Open, 4(8), e2122326-e2122326. | Phillips, EJ (2021). Reacciones alérgicas después de la vacunación contra el COVID-19: poner el riesgo en perspectiva. Red JAMA abierta, 4(8), e2122326-e2122326. https://pubmed.ncbi.nlm.nih.gov/33846043/188 | D'Angelo, T., Cattafi, A., Carerj, M. L., Booz, C., Ascenti, G., Cicero, G., ... & Mazziotti, S. (2021). Miocarditis después de la vacunación de SARS-COV-2: ¿una reacción inducida por la vacuna? Revista canadiense de cardiología, 37 (10), 1665-1667. https://pubmed.ncbi.nlm.nih.gov/34180390/ | Phillips, E. J. (2021). Allergic Reactions After COVID-19 Vaccination—Putting Risk Into Perspective. JAMA Network Open, 4(8), e2122326-e2122326. https://pubmed.ncbi.nlm.nih.gov/34463751/ | Dalan, R., & Boehm, B. O. (2021). Thrombosis post COVID-19 vaccinations: Potential link to ACE pathways. Thrombosis Research, 206, 137. https://www.sciencedirect.com/science/article/pii/S0049384821004369 | Okuda, S., Hirooka, Y., & Sugiyama, M. (2021). Propylthiouracil-Induced Antineutrophil Cytoplasmic Antibody-Associated Vasculitis after COVID-19 Vaccination. Vaccines, 9(8), 842. | https://pubmed.ncbi.nlm.nih.gov/34451967/ | Okuda, S., Hirooka, Y., & Sugiyama, M. (2021). Propylthiouracil-Induced Antineutrophil Cytoplasmic Antibody-Associated Vasculitis after COVID-19 Vaccination. Vaccines, 9(8), 842. https://pubmed.ncbi.nlm.nih.gov/34451967/ | Edler, C., Klein, A., Schröder, A. S., Sperhake, J. P., & Ondruschka, B. (2021). Deaths associated with newly launched SARS-CoV-2 vaccination (Comirnaty®). Legal Medicine, 51, 101895. https://pubmed.ncbi.nlm.nih.gov/33895650/ | ||||
196 | Anaphylactic reactions to COVID-19 mRNA vaccines: a call for further studies: https://pubmed.ncbi.nlm.nih.gov/33846043/188 | Anaphylactic reactions to COVID-19 mRNA vaccines: a call for further studies: | https://pubmed.ncbi.nlm.nih.gov/33846043/188 | https://pubmed.ncbi.nlm.nih.gov/33846043/188 | Krutzke, L., Roesler, R., Wiese, S., & Kochanek, S. (2021). Process-related impurities in the ChAdOx1 nCov-19 vaccine. | Krutzke, L., Roesler, R., Wiese, S. y Kochanek, S. (2021). Impurezas relacionadas con el proceso en la vacuna ChAdOx1 nCov-19. https://pubmed.ncbi.nlm.nih.gov/33752263/ | Dalan, R., & Boehm, B. O. (2021). Trombosis Post COVID-19 Vacunas: Enlace potencial a las vías de ACE. Investigación de trombosis, 206, 137. https://pubmed.ncbi.nlm.nih.gov/34546608/ | Krutzke, L., Roesler, R., Wiese, S., & Kochanek, S. (2021). Process-related impurities in the ChAdOx1 nCov-19 vaccine. https://pubmed.ncbi.nlm.nih.gov/33846043/188 | Dalwadi, V., Hancock, D., Ballout, A. A., & Geraci, A. (2021). Axonal-variant Guillian-Barre syndrome temporally associated with mRNA-based Moderna SARS-CoV-2 vaccine. Cureus, 13(9). https://pubmed.ncbi.nlm.nih.gov/34722067/ | Koch, M., Fuld, S., Middeke, J. M., Fantana, J., von Bonin, S., & Beyer-Westendorf, J. (2021). Secondary Immune Thrombocytopenia (ITP) Associated with ChAdOx1 Covid-19 Vaccination–A Case Report. TH Open, 5(03), e315-e318. | https://pubmed.ncbi.nlm.nih.gov/34377889/ | Koch, M., Fuld, S., Middeke, J. M., Fantana, J., von Bonin, S., & Beyer-Westendorf, J. (2021). Secondary Immune Thrombocytopenia (ITP) Associated with ChAdOx1 Covid-19 Vaccination–A Case Report. TH Open, 5(03), e315-e318. https://pubmed.ncbi.nlm.nih.gov/34377889/ | Ehrlich, P., Klingel, K., Ohlmann-Knafo, S., Hüttinger, S., Sood, N., Pickuth, D., & Kindermann, M. (2021). Biopsy-proven lymphocytic myocarditis following first mRNA COVID-19 vaccination in a 40-year-old male: case report. Clinical Research in Cardiology, 110(11), 1855-1859. https://pubmed.ncbi.nlm.nih.gov/34487236/ | |||
197 | Risk of severe allergic reactions to COVID-19 vaccines among patients with allergic skin disease: practical recommendations. An ETFAD position statement with external experts: | https://pubmed.ncbi.nlm.nih.gov/33752263/ | https://pubmed.ncbi.nlm.nih.gov/33752263/ | Ring, J., Worm, M., Wollenberg, A., Thyssen, J. P., Jakob, T., Klimek, L., ... & Deleuran, M. (2021). Risk of severe allergic reactions to COVID‐19 vaccines among patients with allergic skin diseases–practical recommendations. A position statement of ETFAD with external experts. Journal of the European Academy of Dermatology and Venereology, 35(6), e362-e365. | Ring, J., Worm, M., Wollenberg, A., Thyssen, J. P., Jakob, T., Klimek, L., ... y Deleuran, M. (2021). Riesgo de reacciones alérgicas graves a las vacunas COVID-19 entre pacientes con enfermedades alérgicas de la piel: recomendaciones prácticas. Una declaración de posición de la ETFAD con expertos externos. Revista de la Academia Europea de Dermatología y Venereología, 35(6), e362-e365. https://pubmed.ncbi.nlm.nih.gov/34073536/ | Dalan, R., & Boehm, B. O. (2021). Trombosis Post COVID-19 Vacunas: Enlace potencial a las vías de ACE. Investigación de trombosis, 206, 137. https://www.sciencedirect.com/science/article/pii/S0735109721051949 | Ring, J., Worm, M., Wollenberg, A., Thyssen, J. P., Jakob, T., Klimek, L., ... & Deleuran, M. (2021). Risk of severe allergic reactions to COVID‐19 vaccines among patients with allergic skin diseases–practical recommendations. A position statement of ETFAD with external experts. Journal of the European Academy of Dermatology and Venereology, 35(6), e362-e365. https://pubmed.ncbi.nlm.nih.gov/33752263/ | Dang, Y. L., & Bryson, A. (2021). Miller-Fisher Syndrome and Guillain-Barre Syndrome overlap syndrome in a patient post Oxford-AstraZeneca SARS-CoV-2 vaccination. BMJ Case Reports CP, 14(11), e246701. https://pubmed.ncbi.nlm.nih.gov/34848426/. | MacIntyre, C. R., Veness, B., Berger, D., Hamad, N., & Bari, N. (2021). Thrombosis with Thrombocytopenia Syndrome (TTS) following AstraZeneca ChAdOx1 nCoV-19 (AZD1222) COVID-19 vaccination–A risk–benefit analysis for people< 60 years in Australia. Vaccine, 39(34), 4784-4787. | https://pubmed.ncbi.nlm.nih.gov/34272095/ | MacIntyre, C. R., Veness, B., Berger, D., Hamad, N., & Bari, N. (2021). Thrombosis with Thrombocytopenia Syndrome (TTS) following AstraZeneca ChAdOx1 nCoV-19 (AZD1222) COVID-19 vaccination–A risk–benefit analysis for people< 60 years in Australia. Vaccine, 39(34), 4784-4787. https://pubmed.ncbi.nlm.nih.gov/34272095/ | El Sahly, H. M., Baden, L. R., Essink, B., Doblecki-Lewis, S., Martin, J. M., Anderson, E. J., ... & Miller, J. (2021). Efficacy of the mRNA-1273 SARS-CoV-2 vaccine at completion of blinded phase. New England Journal of Medicine, 385(19), 1774-1785. https://www.ncbi.nlm.nih.gov/pubmed/34551225 | ||||
198 | COVID-19 vaccine and death: causality algorithm according to the WHO eligibility diagnosis: | https://pubmed.ncbi.nlm.nih.gov/34073536/ | https://pubmed.ncbi.nlm.nih.gov/34073536/ | Pomara, C., Sessa, F., Ciaccio, M., Dieli, F., Esposito, M., Giammanco, G. M., ... & Zamboni, P. (2021). COVID-19 vaccine and death: causality algorithm according to the WHO eligibility diagnosis. Diagnostics, 11(6), 955. | Pomara, C., Sessa, F., Ciaccio, M., Dieli, F., Esposito, M., Giammanco, G. M., ... & Zamboni, P. (2021). Vacuna COVID-19 y muerte: algoritmo de causalidad según el diagnóstico de elegibilidad de la OMS. Diagnóstico, 11(6), 955. https://pubmed.ncbi.nlm.nih.gov/34423106/ | Dalwadi, V., Hancock, D., Bollout, A. A. A., & Geraci, A. (2021). Síndrome de la variante de Guillian-Barre axonal asociada temporalmente con la vacuna MODERA SARS-COV-2 basada en ARNm. CUREUS, 13 (9). https://pubmed.ncbi.nlm.nih.gov/33968610/ | Pomara, C., Sessa, F., Ciaccio, M., Dieli, F., Esposito, M., Giammanco, G. M., ... & Zamboni, P. (2021). COVID-19 vaccine and death: causality algorithm according to the WHO eligibility diagnosis. Diagnostics, 11(6), 955. https://pubmed.ncbi.nlm.nih.gov/34073536/ | Das, B. B., Kohli, U., Ramachandran, P., Nguyen, H. H., Greil, G., Hussain, T., ... & Khan, D. (2021). Myopericarditis after messenger RNA coronavirus disease 2019 vaccination in adolescents 12 to 18 years of age. The Journal of Pediatrics, 238, 26-32. https://www.ncbi.nlm.nih.gov/pubmed/34339728 | Shemer, A., Pras, E., Einan-Lifshitz, A., Dubinsky-Pertzov, B., & Hecht, I. (2021). Association of COVID-19 vaccination and facial nerve palsy: a case-control study. JAMA Otolaryngology–Head & Neck Surgery, 147(8), 739-743. | https://pubmed.ncbi.nlm.nih.gov/34165512/ | Shemer, A., Pras, E., Einan-Lifshitz, A., Dubinsky-Pertzov, B., & Hecht, I. (2021). Association of COVID-19 vaccination and facial nerve palsy: a case-control study. JAMA Otolaryngology–Head & Neck Surgery, 147(8), 739-743. https://pubmed.ncbi.nlm.nih.gov/34165512/ | Elrashdy, F., Tambuwala, M. M., Hassan, S. S., Adadi, P., Seyran, M., Abd El-Aziz, T. M., ... & Uversky, V. N. (2021). Autoimmunity roots of the thrombotic events after COVID-19 vaccination. Autoimmunity reviews, 20(11), 102941. https://www.sciencedirect.com/science/article/abs/pii/S1568997221002160 | ||||
199 | Fatal brain hemorrhage after COVID-19 vaccine: | https://pubmed.ncbi.nlm.nih.gov/33928772/ | https://pubmed.ncbi.nlm.nih.gov/34423106/ | Holmes, G. A., Desai, M., Limone, B., Love, J., Tawfik, M., Wong, L., & Furukawa, B. (2021). A case series of cutaneous COVID-19 vaccine reactions at Loma Linda University Department of Dermatology. JAAD Case Reports, 16, 53-57. | Holmes, G. A., Desai, M., Limone, B., Love, J., Tawfik, M., Wong, L. y Furukawa, B. (2021). Una serie de casos de reacciones cutáneas a la vacuna COVID-19 en el Departamento de Dermatología de la Universidad de Loma Linda. Informes de casos de JAAD, 16, 53-57. https://pubmed.ncbi.nlm.nih.gov/33838206/ | Dang, Y. L., & BRYON, A. (2021). El síndrome de Miller-Fisher y el síndrome de Guillain-Barre se superponen al síndrome de un paciente después de la vacunación Oxford-AstraZeneca SARS-COV-2. BMJ Case Reports CP, 14 (11), E246701. https://pubmed.ncbi.nlm.nih.gov/34591186/ | Holmes, G. A., Desai, M., Limone, B., Love, J., Tawfik, M., Wong, L., & Furukawa, B. (2021). A case series of cutaneous COVID-19 vaccine reactions at Loma Linda University Department of Dermatology. JAAD Case Reports, 16, 53-57. https://pubmed.ncbi.nlm.nih.gov/34423106/ | Das, B. B., Kohli, U., Ramachandran, P., Nguyen, H. H., Greil, G., Hussain, T., ... & Khan, D. (2021). Myopericarditis after messenger RNA coronavirus disease 2019 vaccination in adolescents 12 to 18 years of age. The Journal of Pediatrics, 238, 26-32. https://www.sciencedirect.com/science/article/pii/S0022347621007368 | Cirillo, N., & Doan, R. (2022). The association between COVID-19 vaccination and Bell's palsy. The Lancet Infectious Diseases, 22(1), 5-6. | https://pubmed.ncbi.nlm.nih.gov/34411533/ | Cirillo, N., & Doan, R. (2022). The association between COVID-19 vaccination and Bell's palsy. The Lancet Infectious Diseases, 22(1), 5-6. https://pubmed.ncbi.nlm.nih.gov/34411533/ | ElSheikh, R. H., Haseeb, A., Eleiwa, T. K., & Elhusseiny, A. M. (2021). Acute uveitis following COVID-19 vaccination. Ocular immunology and inflammation, 1-3. https://pubmed.ncbi.nlm.nih.gov/34851795/. | ||||
200 | A case series of skin reactions to COVID-19 vaccine in the Department of Dermatology at Loma Linda University: | https://pubmed.ncbi.nlm.nih.gov/34423106/ | https://pubmed.ncbi.nlm.nih.gov/33838206/ | McMahon, D. E., Amerson, E., Rosenbach, M., Lipoff, J. B., Moustafa, D., Tyagi, A., ... & Freeman, E. E. (2021). Cutaneous reactions reported after Moderna and Pfizer COVID-19 vaccination: a registry-based study of 414 cases. Journal of the American Academy of Dermatology, 85(1), 46-55. | McMahon, DE, Amerson, E., Rosenbach, M., Lipoff, JB, Moustafa, D., Tyagi, A., ... y Freeman, EE (2021). Reacciones cutáneas notificadas después de la vacunación COVID-19 de Moderna y Pfizer: un estudio basado en registros de 414 casos. Revista de la Academia Estadounidense de Dermatología, 85(1), 46-55. https://pubmed.ncbi.nlm.nih.gov/34517079/ | Das, B. B., Kohli, U., Ramachandran, P., Nguyen, H. H., Greil, G., Hussain, T., ... & Khan, D. (2021). Myopericarditis después de la enfermedad de Messenger Rna Coronavirus 2019 Vacunación en adolescentes de 12 a 18 años de edad. El Journal of Pediattics, 238, 26-32. https://www.ncbi.nlm.nih.gov/pubmed/34356586 | McMahon, D. E., Amerson, E., Rosenbach, M., Lipoff, J. B., Moustafa, D., Tyagi, A., ... & Freeman, E. E. (2021). Cutaneous reactions reported after Moderna and Pfizer COVID-19 vaccination: a registry-based study of 414 cases. Journal of the American Academy of Dermatology, 85(1), 46-55. https://pubmed.ncbi.nlm.nih.gov/33838206/ | Das, B. B., Moskowitz, W. B., Taylor, M. B., & Palmer, A. (2021). Myocarditis and pericarditis following mRNA COVID-19 vaccination: what do we know so far?. Children, 8(7), 607. https://www.cps.ca/en/documents/position/clinical-guidance-for-youth-with-myocarditis-and-pericarditis | Colella, G., Orlandi, M., & Cirillo, N. (2021). Bell’s palsy following COVID-19 vaccination. Journal of Neurology, 268(10), 3589-3591. | https://pubmed.ncbi.nlm.nih.gov/33611630/ | Colella, G., Orlandi, M., & Cirillo, N. (2021). Bell’s palsy following COVID-19 vaccination. Journal of Neurology, 268(10), 3589-3591. https://pubmed.ncbi.nlm.nih.gov/33611630/ | Endo, B., Bahamon, S., & Martínez-Pulgarín, D. F. (2021). Central retinal vein occlusion after mRNA SARS-CoV-2 vaccination: A case report. Indian journal of ophthalmology, 69(10), 2865. https://pubmed.ncbi.nlm.nih.gov/34571653/. | ||||
201 | Skin reactions reported after Moderna and Pfizer’s COVID-19 vaccination: a study based on a registry of 414 cases: | https://pubmed.ncbi.nlm.nih.gov/33838206/ | https://pubmed.ncbi.nlm.nih.gov/34517079/ | McMahon, D. E., Kovarik, C. L., Damsky, W., Rosenbach, M., Lipoff, J. B., Tyagi, A., ... & Freeman, E. E. (2022). Clinical and pathologic correlation of cutaneous COVID-19 vaccine reactions including V-REPP: A registry-based study. Journal of the American Academy of Dermatology, 86(1), 113-121. | McMahon, D. E., Kovarik, C. L., Damsky, W., Rosenbach, M., Lipoff, J. B., Tyagi, A., ... y Freeman, E. E. (2022). Correlación clínica y patológica de las reacciones cutáneas a la vacuna COVID-19, incluido V-REPP: un estudio basado en registros. Revista de la Academia Estadounidense de Dermatología, 86(1), 113-121. https://pubmed.ncbi.nlm.nih.gov/34254291/ | Das, B. B., Kohli, U., Ramachandran, P., Nguyen, H. H., Greil, G., Hussain, T., ... & Khan, D. (2021). Myopericarditis después de la enfermedad de Messenger Rna Coronavirus 2019 Vacunación en adolescentes de 12 a 18 años de edad. El Journal of Pediattics, 238, 26-32. https://www.sciencedirect.com/science/article/pii/S0870255121003243 | McMahon, D. E., Kovarik, C. L., Damsky, W., Rosenbach, M., Lipoff, J. B., Tyagi, A., ... & Freeman, E. E. (2022). Clinical and pathologic correlation of cutaneous COVID-19 vaccine reactions including V-REPP: A registry-based study. Journal of the American Academy of Dermatology, 86(1), 113-121. https://pubmed.ncbi.nlm.nih.gov/34517079/ | Das, B. B., Moskowitz, W. B., Taylor, M. B., & Palmer, A. (2021). Myocarditis and pericarditis following mRNA COVID-19 vaccination: what do we know so far?. Children, 8(7), 607. https://www.ncbi.nlm.nih.gov/pubmed/34356586 | Román, G. C., Gracia, F., Torres, A., Palacios, A., Gracia, K., & Harris, D. (2021). Acute transverse myelitis (ATM): clinical review of 43 patients with COVID-19-associated ATM and 3 post-vaccination ATM serious adverse events with the ChAdOx1 nCoV-19 vaccine (AZD1222). Frontiers in immunology, 12, 879. | https://pubmed.ncbi.nlm.nih.gov/33981305/ | Román, G. C., Gracia, F., Torres, A., Palacios, A., Gracia, K., & Harris, D. (2021). Acute transverse myelitis (ATM): clinical review of 43 patients with COVID-19-associated ATM and 3 post-vaccination ATM serious adverse events with the ChAdOx1 nCoV-19 vaccine (AZD1222). Frontiers in immunology, 12, 879. https://pubmed.ncbi.nlm.nih.gov/33981305/ | Erdem, N. Ş., Demirci, S., Özel, T., Mamadova, K., Karaali, K., Çelik, H. T., ... & Özkaynak, S. S. (2021). Acute transverse myelitis after inactivated COVID-19 vaccine. Ideggyogyaszati Szemle, 74(7-08), 273-276. https://pubmed.ncbi.nlm.nih.gov/34370410/ | ||||
202 | Clinical and pathologic correlates of skin reactions to COVID-19 vaccine, including V-REPP: a registry-based study: | https://pubmed.ncbi.nlm.nih.gov/34517079/ | https://pubmed.ncbi.nlm.nih.gov/34254291/ | Català, A., Muñoz‐Santos, C., Galván‐Casas, C., Roncero Riesco, M., Revilla Nebreda, D., Solá‐Truyols, A., ... & Guilabert, A. (2022). Cutaneous reactions after SARS‐COV‐2 vaccination: a cross‐sectional Spanish nationwide study of 405 cases. British Journal of Dermatology, 186(1), 142-152. | Català, A., Muñoz‐Santos, C., Galván‐Casas, C., Roncero Riesco, M., Revilla Nebreda, D., Solá‐Truyols, A., ... & Guilabert, A. (2022). Reacciones cutáneas tras la vacunación SARS-COV-2: un estudio transversal a nivel nacional español de 405 casos. Revista Británica de Dermatología, 186(1), 142-152. https://pubmed.ncbi.nlm.nih.gov/34487581/ | Das, B. B., Moskowitz, W. B., Taylor, M. B., & Palmer, A. (2021). Miocarditis y pericarditis después de la vacunación con MRNA COVID-19: ¿Qué sabemos hasta ahora? Niños, 8 (7), 607. https://pubmed.ncbi.nlm.nih.gov/34402228/ | Català, A., Muñoz‐Santos, C., Galván‐Casas, C., Roncero Riesco, M., Revilla Nebreda, D., Solá‐Truyols, A., ... & Guilabert, A. (2022). Cutaneous reactions after SARS‐COV‐2 vaccination: a cross‐sectional Spanish nationwide study of 405 cases. British Journal of Dermatology, 186(1), 142-152. https://pubmed.ncbi.nlm.nih.gov/34254291/ | Dash, S., Behera, B., Sethy, M., Mishra, J., & Garg, S. (2021). COVID‐19 vaccine‐induced urticarial vasculitis. Dermatologic Therapy. https://pubmed.ncbi.nlm.nih.gov/34369046/. | Iftikhar, H., Noor, S. M. U., Masood, M., & Bashir, K. (2021). Bell’s palsy after 24 hours of mRNA-1273 SARS-CoV-2 vaccine. Cureus, 13(6). | https://pubmed.ncbi.nlm.nih.gov/34336436/ | Iftikhar, H., Noor, S. M. U., Masood, M., & Bashir, K. (2021). Bell’s palsy after 24 hours of mRNA-1273 SARS-CoV-2 vaccine. Cureus, 13(6). https://pubmed.ncbi.nlm.nih.gov/34336436/ | Erler, A., Fiedler, J., Koch, A., Heldmann, F., & Schütz, A. (2021). Leukocytoclastic Vasculitis After Vaccination With a SARS‐CoV‐2 Vaccine. Arthritis & Rheumatology, 73(12), 2188-2188. https://pubmed.ncbi.nlm.nih.gov/34196469/. | ||||
203 | Skin reactions after vaccination against SARS-COV-2: a nationwide Spanish cross-sectional study of 405 cases: | https://pubmed.ncbi.nlm.nih.gov/34254291/ | https://pubmed.ncbi.nlm.nih.gov/34487581/ | Fathy, R. A., McMahon, D. E., Lee, C., Chamberlin, G. C., Rosenbach, M., Lipoff, J. B., ... & Freeman, E. E. (2022). Varicella‐zoster and herpes simplex virus reactivation post‐COVID‐19 vaccination: a review of 40 cases in an International Dermatology Registry. Journal of the European Academy of Dermatology and Venereology, 36(1), e6-e9. | Fathy, R. A., McMahon, D. E., Lee, C., Chamberlin, G. C., Rosenbach, M., Lipoff, J. B., ... y Freeman, E. E. (2022). Reactivación del virus varicela-zoster y herpes simple después de la vacunación COVID-19: una revisión de 40 casos en un Registro Internacional de Dermatología. Revista de la Academia Europea de Dermatología y Venereología, 36(1), e6-e9. https://pubmed.ncbi.nlm.nih.gov/33987882/ | Das, B. B., Moskowitz, W. B., Taylor, M. B., & Palmer, A. (2021). Miocarditis y pericarditis después de la vacunación con MRNA COVID-19: ¿Qué sabemos hasta ahora? Niños, 8 (7), 607. https://www.ncbi.nlm.nih.gov/pubmed/34219532 | Fathy, R. A., McMahon, D. E., Lee, C., Chamberlin, G. C., Rosenbach, M., Lipoff, J. B., ... & Freeman, E. E. (2022). Varicella‐zoster and herpes simplex virus reactivation post‐COVID‐19 vaccination: a review of 40 cases in an International Dermatology Registry. Journal of the European Academy of Dermatology and Venereology, 36(1), e6-e9. https://pubmed.ncbi.nlm.nih.gov/34487581/ | David, R., Hanna, P., Lee, K., & Ritchie, A. (2021). Relapsed ANCA associated vasculitis following Oxford AstraZeneca ChAdOx1-S COVID-19 vaccination: A case series of two patients. Nephrology (Carlton, Vic.), 27(1), 109-110. https://pubmed.ncbi.nlm.nih.gov/34755433/ | Burrows, A., Bartholomew, T., Rudd, J., & Walker, D. (2021). Sequential contralateral facial nerve palsies following COVID-19 vaccination first and second doses. BMJ Case Reports CP, 14(7), e243829. | https://pubmed.ncbi.nlm.nih.gov/34281950/. | Burrows, A., Bartholomew, T., Rudd, J., & Walker, D. (2021). Sequential contralateral facial nerve palsies following COVID-19 vaccination first and second doses. BMJ Case Reports CP, 14(7), e243829. https://pubmed.ncbi.nlm.nih.gov/34281950/. | Esba, L. C. A., & Al Jeraisy, M. (2021). Reported adverse effects following COVID-19 vaccination at a tertiary care hospital, focus on cerebral venous sinus thrombosis (CVST). Expert Review of Vaccines, 20(8), 1037-1042. https://pubmed.ncbi.nlm.nih.gov/34092166/ | ||||
204 | Varicella zoster virus and herpes simplex virus reactivation after vaccination with COVID-19: review of 40 cases in an international dermatologic registry: | https://pubmed.ncbi.nlm.nih.gov/34487581/ | https://pubmed.ncbi.nlm.nih.gov/33987882/ | Franchini, M., Liumbruno, G. M., & Pezzo, M. (2021). COVID‐19 Vaccine‐associated Immune Thrombosis and Thrombocytopenia (VITT): diagnostic and therapeutic recommendations for a new syndrome. European Journal of Haematology, 107(2), 173-180. | Franchini, M., Liumbruno, G. M. y Pezzo, M. (2021). Trombosis inmune y trombocitopenia asociadas a la vacuna COVID-19 (VITT): recomendaciones diagnósticas y terapéuticas para un nuevo síndrome. Revista europea de hematología, 107(2), 173-180. https://pubmed.ncbi.nlm.nih.gov/34138513/ | Dash, S., Behera, B., Sethy, M., Mishra, J., & Garg, S. (2021). COVID-19 Vasculitis urticarial inducida por la vacuna. Terapia dermatológica. https://pubmed.ncbi.nlm.nih.gov/34280507/. | Franchini, M., Liumbruno, G. M., & Pezzo, M. (2021). COVID‐19 Vaccine‐associated Immune Thrombosis and Thrombocytopenia (VITT): diagnostic and therapeutic recommendations for a new syndrome. European Journal of Haematology, 107(2), 173-180. https://pubmed.ncbi.nlm.nih.gov/33987882/ | David, S. S. B., Potasman, I., & Rahamim-Cohen, D. (2021). Rate of recurrent guillain-barré syndrome after mRNA COVID-19 vaccine BNT162b2. JAMA neurology, 78(11), 1409-1411. https://jamanetwork.com/journals/jamaneurology/fullarticle/2783708 | Tahir, N., Koorapati, G., Prasad, S., Jeelani, H. M., Sherchan, R., Shrestha, J., & Shayuk, M. (2021). SARS-CoV-2 vaccination-induced transverse myelitis. Cureus, 13(7). | https://pubmed.ncbi.nlm.nih.gov/34458035/ | Tahir, N., Koorapati, G., Prasad, S., Jeelani, H. M., Sherchan, R., Shrestha, J., & Shayuk, M. (2021). SARS-CoV-2 vaccination-induced transverse myelitis. Cureus, 13(7). https://pubmed.ncbi.nlm.nih.gov/34458035/ | Etemadifar, M., Sigari, A. A., Sedaghat, N., Salari, M., & Nouri, H. (2021). Acute relapse and poor immunization following COVID-19 vaccination in a rituximab-treated multiple sclerosis patient. Human vaccines & immunotherapeutics, 17(10), 3481-3483. https://pubmed.ncbi.nlm.nih.gov/34015240/ | ||||
205 | Immune thrombosis and thrombocytopenia (VITT) associated with the COVID-19 vaccine: diagnostic and therapeutic recommendations for a new syndrome: | https://pubmed.ncbi.nlm.nih.gov/33987882/ | https://pubmed.ncbi.nlm.nih.gov/34138513/ | Favaloro, E. J. (2021). Laboratory testing for suspected COVID‐19 vaccine–induced (immune) thrombotic thrombocytopenia. International Journal of Laboratory Hematology, 43(4), 559-570. | Favaloro, E. J. (2021). Pruebas de laboratorio para detectar sospecha de trombocitopenia trombótica (inmune) inducida por la vacuna COVID-19. Revista Internacional de Hematología de Laboratorio, 43(4), 559-570. https://pubmed.ncbi.nlm.nih.gov/34402235/ | David, R., Hanna, P., Lee, K., & Ritchie, A. (2021). Vasculitis asociada a ANCA recaída después de la vacunación de Oxford AstraZeneca Chadox1-S COVID-19: una serie de casos de dos pacientes. Nefrología (Carlton, Vic.), 27 (1), 109-110. https://pubmed.ncbi.nlm.nih.gov/34839830/ | Favaloro, E. J. (2021). Laboratory testing for suspected COVID‐19 vaccine–induced (immune) thrombotic thrombocytopenia. International Journal of Laboratory Hematology, 43(4), 559-570. https://pubmed.ncbi.nlm.nih.gov/34138513/ | de Bruijn, S., Maes, M. B., De Waele, L., Vanhoorelbeke, K., & Gadisseur, A. (2021). First report of a de novo iTTP episode associated with an mRNA‐based anti‐COVID‐19 vaccination. Journal of Thrombosis and Haemostasis, 19(8), 2014-2018. https://pubmed.ncbi.nlm.nih.gov/34105244/ | Shemer, A., Pras, E., & Hecht, I. (2021). Peripheral facial nerve palsy following BNT162b2 (COVID-19) vaccination. Israel Medical Association Journal: Imaj, 142-143. | https://pubmed.ncbi.nlm.nih.gov/33734623/ | Shemer, A., Pras, E., & Hecht, I. (2021). Peripheral facial nerve palsy following BNT162b2 (COVID-19) vaccination. Israel Medical Association Journal: Imaj, 142-143. https://pubmed.ncbi.nlm.nih.gov/33734623/ | Facetti, S., Giraldi, M., Vecchi, A. L., Rogiani, S., & Nassiacos, D. (2021). Acute myocarditis in a young adult two days after Pfizer vaccination. Giornale italiano di cardiologia (2006), 22(11), 891-893. https://pubmed.ncbi.nlm.nih.gov/34709227/ | ||||
206 | Laboratory testing for suspicion of COVID-19 vaccine-induced thrombotic (immune) thrombocytopenia: | https://pubmed.ncbi.nlm.nih.gov/34138513/ | https://pubmed.ncbi.nlm.nih.gov/34402235/ | Choi, J. K., Kim, S., Kim, S. R., Jin, J. Y., Choi, S. W., Kim, H., ... & Kim, S. R. (2021). Intracerebral hemorrhage due to thrombosis with thrombocytopenia syndrome after vaccination against COVID-19: the first fatal case in korea. Journal of Korean Medical Science, 36(31). | Choi, JK, Kim, S., Kim, SR, Jin, JY, Choi, SW, Kim, H., ... y Kim, SR (2021). Hemorragia intracerebral por trombosis con síndrome de trombocitopenia tras vacunación contra COVID-19: el primer caso mortal en Corea. Revista de ciencia médica coreana, 36(31). https://pubmed.ncbi.nlm.nih.gov/34446426/ | David, S. S. B., Potasman, I., & Rahamim-Cohen, D. (2021). Tasa de síndrome recurrente de Guilain-Barré después de MRNA COVID-19 VACCINE BNT162B2. JAMA NEUROLOGÍA, 78 (11), 1409-1411. https://www.pedneur.com/article/S0887-8994(21)00221-6/fulltext. | Choi, J. K., Kim, S., Kim, S. R., Jin, J. Y., Choi, S. W., Kim, H., ... & Kim, S. R. (2021). Intracerebral hemorrhage due to thrombosis with thrombocytopenia syndrome after vaccination against COVID-19: the first fatal case in korea. Journal of Korean Medical Science, 36(31). https://pubmed.ncbi.nlm.nih.gov/34402235/ | De Cristofaro, R., & Sanguinetti, M. (2021). Vaccine-induced thrombotic thrombocytopenia, a rare but severe case of friendly fire in the battle against COVID-19 pandemic: what pathogenesis?. European Journal of Internal Medicine. https://www.sciencedirect.com/science/article/pii/S0953620521002314 | Reyes-Capo, D. P., Stevens, S. M., & Cavuoto, K. M. (2021). Acute abducens nerve palsy following COVID-19 vaccination. Journal of American Association for Pediatric Ophthalmology and Strabismus, 25(5), 302-303. | https://pubmed.ncbi.nlm.nih.gov/34044114/. | Reyes-Capo, D. P., Stevens, S. M., & Cavuoto, K. M. (2021). Acute abducens nerve palsy following COVID-19 vaccination. Journal of American Association for Pediatric Ophthalmology and Strabismus, 25(5), 302-303. https://pubmed.ncbi.nlm.nih.gov/34044114/. | Faermann, R., Nissan, N., Halshtok-Neiman, O., Shalmon, A., Gotlieb, M., Yagil, Y., ... & Sklair-Levy, M. (2021). COVID-19 vaccination induced lymphadenopathy in a specialized breast imaging clinic in Israel: Analysis of 163 cases. Academic Radiology, 28(9), 1191-1197. https://pubmed.ncbi.nlm.nih.gov/34257025/. | ||||
207 | Intracerebral hemorrhage due to thrombosis with thrombocytopenia syndrome after COVID-19 vaccination: the first fatal case in Korea: | https://pubmed.ncbi.nlm.nih.gov/34402235/ | https://pubmed.ncbi.nlm.nih.gov/34446426/ | Hippisley-Cox, J., Patone, M., Mei, X. W., Saatci, D., Dixon, S., Khunti, K., ... & Coupland, C. A. (2021). Risk of thrombocytopenia and thromboembolism after covid-19 vaccination and SARS-CoV-2 positive testing: self-controlled case series study. bmj, 374. | Hippisley-Cox, J., Patone, M., Mei, XW, Saatci, D., Dixon, S., Khunti, K., ... y Coupland, CA (2021). Riesgo de trombocitopenia y tromboembolismo después de la vacunación contra el covid-19 y pruebas positivas de SARS-CoV-2: estudio de serie de casos autocontrolado. bmj, 374. https://pubmed.ncbi.nlm.nih.gov/34365148/. | De Bruijn, S., Maes, M. B., de Waele, L., Vanhoorelbeke, K., & Gadisseur, A. (2021). Primer informe de un episodio de ITTP de Deno Novo asociado con una vacunación anti-covid-19 basada en ARNm. Diario de trombosis y haemostasis, 19 (8), 2014-2018. https://www.nejm.org/doi/full/10.1056/NEJMc2106383 | Hippisley-Cox, J., Patone, M., Mei, X. W., Saatci, D., Dixon, S., Khunti, K., ... & Coupland, C. A. (2021). Risk of thrombocytopenia and thromboembolism after covid-19 vaccination and SARS-CoV-2 positive testing: self-controlled case series study. bmj, 374. https://pubmed.ncbi.nlm.nih.gov/34446426/ | de Mélo Silva Jr, M. L., & Lopes, D. P. (2021). Large hemorrhagic stroke after ChAdOx1 nCoV‐19 vaccination: A case report. Acta Neurologica Scandinavica, 144(6), 717-718. https://pubmed.ncbi.nlm.nih.gov/34273119/ | Pappaterra, M. C., Rivera, E. J., & Oliver, A. L. (2022). Transient Oculomotor Palsy Following the Administration of the Messenger RNA-1273 Vaccine for SARS-CoV-2 Diplopia Following the COVID-19 Vaccine. Journal of Neuro-Ophthalmology. | https://pubmed.ncbi.nlm.nih.gov/34369471/ | Pappaterra, M. C., Rivera, E. J., & Oliver, A. L. (2022). Transient Oculomotor Palsy Following the Administration of the Messenger RNA-1273 Vaccine for SARS-CoV-2 Diplopia Following the COVID-19 Vaccine. Journal of Neuro-Ophthalmology. https://pubmed.ncbi.nlm.nih.gov/34369471/ | Faissner, S., Richter, D., Ceylan, U., Schneider-Gold, C., & Gold, R. (2021). COVID-19 mRNA vaccine induced rhabdomyolysis and fasciitis. Journal of Neurology, 1-2. https://pubmed.ncbi.nlm.nih.gov/34435250/ | ||||
208 | Risk of thrombocytopenia and thromboembolism after covid-19 vaccination and positive SARS-CoV-2 tests: self-controlled case series study: | https://pubmed.ncbi.nlm.nih.gov/34446426/ | https://pubmed.ncbi.nlm.nih.gov/34365148/. | Sharifian-Dorche, M., Bahmanyar, M., Sharifian-Dorche, A., Mohammadi, P., Nomovi, M., & Mowla, A. (2021). Vaccine-induced immune thrombotic thrombocytopenia and cerebral venous sinus thrombosis post COVID-19 vaccination; a systematic review. Journal of the neurological sciences, 428, 117607. | Sharifian-Dorche, M., Bahmanyar, M., Sharifian-Dorche, A., Mohammadi, P., Nomovi, M. y Mowla, A. (2021). Trombocitopenia trombótica inmunitaria inducida por vacuna y trombosis del seno venoso cerebral después de la vacunación contra COVID-19; una revisión sistemática. Revista de ciencias neurológicas, 428, 117607. https://pubmed.ncbi.nlm.nih.gov/34452064/. | De Cristofaro, R., & Sanguinetti, M. (2021). Trombocitopenia trombótica inducida por la vacuna, un caso raro pero severo de fuego amistoso en la batalla contra la pandemia de COVID-19: ¿Qué patogénesis? Diario Europeo de Medicina Interna. https://www.sciencedirect.com/science/article/pii/S0213485321000839 | Sharifian-Dorche, M., Bahmanyar, M., Sharifian-Dorche, A., Mohammadi, P., Nomovi, M., & Mowla, A. (2021). Vaccine-induced immune thrombotic thrombocytopenia and cerebral venous sinus thrombosis post COVID-19 vaccination; a systematic review. Journal of the neurological sciences, 428, 117607. https://pubmed.ncbi.nlm.nih.gov/34365148/. | De Michele, M., Iacobucci, M., Chistolini, A., Nicolini, E., Pulcinelli, F., Cerbelli, B., ... & Toni, D. (2021). Malignant cerebral infarction after ChAdOx1 nCov-19 vaccination: a catastrophic variant of vaccine-induced immune thrombotic thrombocytopenia. Nature Communications, 12(1), 1-7. https://pubmed.ncbi.nlm.nih.gov/34341358/ | Nishizawa, Y., Hoshina, Y., & Baker, V. (2021). Bell’s palsy following the Ad26. COV2. S COVID-19 vaccination. QJM: An International Journal of Medicine. | https://pubmed.ncbi.nlm.nih.gov/34014316/ | Nishizawa, Y., Hoshina, Y., & Baker, V. (2021). Bell’s palsy following the Ad26. COV2. S COVID-19 vaccination. QJM: An International Journal of Medicine. https://pubmed.ncbi.nlm.nih.gov/34014316/ | Falkenhain‐López, D., Gutiérrez‐Collar, C., Arroyo‐Andrés, J., Gallego‐Gutiérrez, I., Rodríguez‐Peralto, J. L., & Sánchez‐Velázquez, A. (2021). Widespread purpura annularis telangiectodes following mRNA SARS‐CoV‐2 vaccine. Journal of the European Academy of Dermatology and Venereology. https://pubmed.ncbi.nlm.nih.gov/34236717/. | ||||
209 | Vaccine-induced immune thrombotic thrombocytopenia and cerebral venous sinus thrombosis after covid-19 vaccination; a systematic review: | https://pubmed.ncbi.nlm.nih.gov/34365148/. | https://pubmed.ncbi.nlm.nih.gov/34452064/. | Chen, J., Cai, Y., Chen, Y., Williams, A. P., Gao, Y., & Zeng, J. (2021). Nervous and muscular adverse events after COVID-19 vaccination: a systematic review and meta-analysis of clinical trials. Vaccines, 9(8), 939. | Chen, J., Cai, Y., Chen, Y., Williams, A. P., Gao, Y. y Zeng, J. (2021). Eventos adversos nerviosos y musculares después de la vacunación COVID-19: una revisión sistemática y metanálisis de ensayos clínicos. Vacunas, 9(8), 939. https://pubmed.ncbi.nlm.nih.gov/33917902/ | De Mélo Silva Jr, M. L., & Lopes, D. P. (2021). Trazo hemorrágico grande después de la vacunación con Chadox1 NCOV-19: un informe de caso. ACTA NEULOLOGICA Scandinavica, 144 (6), 717-718. https://pubmed.ncbi.nlm.nih.gov/34276917/ | Chen, J., Cai, Y., Chen, Y., Williams, A. P., Gao, Y., & Zeng, J. (2021). Nervous and muscular adverse events after COVID-19 vaccination: a systematic review and meta-analysis of clinical trials. Vaccines, 9(8), 939. https://pubmed.ncbi.nlm.nih.gov/34452064/. | de Terreros Caro, G. G., Díaz, S. G., Alé, M. P., & Gimeno, M. M. (2021). Bell’s palsy following COVID-19 vaccination: A case report. Neurologia (Barcelona, Spain). https://pubmed.ncbi.nlm.nih.gov/34330676/ | Nasuelli, N. A., De Marchi, F., Cecchin, M., De Paoli, I., Onorato, S., Pettinaroli, R., ... & Godi, L. (2021). A case of acute demyelinating polyradiculoneuropathy with bilateral facial palsy after ChAdOx1 nCoV-19 vaccine. Neurological Sciences, 42(11), 4747-4749. | https://pubmed.ncbi.nlm.nih.gov/34272622/ | Nasuelli, N. A., De Marchi, F., Cecchin, M., De Paoli, I., Onorato, S., Pettinaroli, R., ... & Godi, L. (2021). A case of acute demyelinating polyradiculoneuropathy with bilateral facial palsy after ChAdOx1 nCoV-19 vaccine. Neurological Sciences, 42(11), 4747-4749. https://pubmed.ncbi.nlm.nih.gov/34272622/ | Fan, B. E., Shen, J. Y., Lim, X. R., Tu, T. M., Chang, C. C. R., Khin, H. S. W., ... & Prasad, B. M. R. V. (2021). Cerebral venous thrombosis post BNT162b2 mRNA SARS‐CoV‐2 vaccination: A black swan event. American Journal of Hematology, 96(9), E357. https://pubmed.ncbi.nlm.nih.gov/34133027/ | ||||
210 | Nerve and muscle adverse events after vaccination with COVID-19: a systematic review and meta-analysis of clinical trials: | https://pubmed.ncbi.nlm.nih.gov/34452064/. | https://pubmed.ncbi.nlm.nih.gov/33917902/ | D’agostino, V., Caranci, F., Negro, A., Piscitelli, V., Tuccillo, B., Fasano, F., ... & Grassi, R. (2021). A rare case of cerebral venous thrombosis and disseminated intravascular coagulation temporally associated to the COVID-19 vaccine administration. Journal of personalized medicine, 11(4), 285. | D’agostino, V., Caranci, F., Negro, A., Piscitelli, V., Tuccillo, B., Fasano, F., ... & Grassi, R. (2021). Un caso raro de trombosis venosa cerebral y coagulación intravascular diseminada asociada temporalmente a la administración de la vacuna COVID-19. Revista de medicina personalizada, 11(4), 285. https://pubmed.ncbi.nlm.nih.gov/34256983/ | De Michele, M., Iacobucci, M., Chistolini, A., Nicolini, E., Pulcinelli, F., Cerbelli, B., ... & Toni, D. (2021). Infarto cerebral maligno después de la vacunación de Chadox1 NCOV-19: una variante catastrófica de la trombocitopenia trombótica inmune inducida por la vacuna. Comunicaciones de la naturaleza, 12 (1), 1-7. https://pubmed.ncbi.nlm.nih.gov/34261633/. | D’agostino, V., Caranci, F., Negro, A., Piscitelli, V., Tuccillo, B., Fasano, F., ... & Grassi, R. (2021). A rare case of cerebral venous thrombosis and disseminated intravascular coagulation temporally associated to the COVID-19 vaccine administration. Journal of personalized medicine, 11(4), 285. https://pubmed.ncbi.nlm.nih.gov/33917902/ | de Terreros Caro, G. G., Díaz, S. G., Alé, M. P., & Gimeno, M. M. (2021). Bell’s palsy following COVID-19 vaccination: A case report. Neurologia (Barcelona, Spain). https://www.sciencedirect.com/science/article/pii/S217358082100122X. | Christensen, S. K., Ballegaard, M., & Boesen, M. S. (2021). Guillian-Barrés syndrom efter mRNA-1273-COVID-19-vaccine. Ugeskr Læger, 183, V05210455. | https://pubmed.ncbi.nlm.nih.gov/34477091/ | Christensen, S. K., Ballegaard, M., & Boesen, M. S. (2021). Guillian-Barrés syndrom efter mRNA-1273-COVID-19-vaccine. Ugeskr Læger, 183, V05210455. https://pubmed.ncbi.nlm.nih.gov/34477091/ | Fanni, D., Saba, L., Demontis, R., Gerosa, C., Chighine, A., Nioi, M., ... & Faa, G. (2021). Vaccine-induced severe thrombotic thrombocytopenia following COVID-19 vaccination: a report of an autoptic case and review of the literature. https://pubmed.ncbi.nlm.nih.gov/34355379/. | ||||
211 | A rare case of cerebral venous thrombosis and disseminated intravascular coagulation temporally associated with administration of COVID-19 vaccine: | https://pubmed.ncbi.nlm.nih.gov/33917902/ | https://pubmed.ncbi.nlm.nih.gov/34256983/ | Varona, J. F., García-Isidro, M., Moeinvaziri, M., Ramos-López, M., & Fernández-Domínguez, M. (2021). Primary adrenal insufficiency associated with Oxford-AstraZeneca ChAdOx1 nCoV-19 vaccine-induced immune thrombotic thrombocytopenia (VITT). European Journal of Internal Medicine, 91, 90-92. | Varona, J. F., García-Isidro, M., Moeinvaziri, M., Ramos-López, M., & Fernández-Domínguez, M. (2021). Insuficiencia suprarrenal primaria asociada con la trombocitopenia trombótica inmunitaria (VITT) inducida por la vacuna Oxford-AstraZeneca ChAdOx1 nCoV-19. Revista europea de medicina interna, 91, 90-92. https://pubmed.ncbi.nlm.nih.gov/34247246/. | De Terreros Caro, G. G., Díaz, S. G., Alé, M. P., & Gimeno, M. M. (2021). Parálisis de Bell siguiendo la vacunación COVID-19: un informe de caso. Neurologia (Barcelona, España). https://pubmed.ncbi.nlm.nih.gov/34272622/ | Varona, J. F., García-Isidro, M., Moeinvaziri, M., Ramos-López, M., & Fernández-Domínguez, M. (2021). Primary adrenal insufficiency associated with Oxford-AstraZeneca ChAdOx1 nCoV-19 vaccine-induced immune thrombotic thrombocytopenia (VITT). European Journal of Internal Medicine, 91, 90-92. https://pubmed.ncbi.nlm.nih.gov/34256983/ | de trabajo multidisciplinar de FACME, G. (2021). Recomendaciones diagnóstico-terapéuticas del grupo de trabajo de expertos de FACME ad-hoc sobre el manejo de la trombosis venosa cerebral relacionada con la vacunación frente a COVID-19. Neurología, 36(6), 451-461. https://www.sciencedirect.com/science/article/pii/S0213485321000839 | Volk, G. F., Kuttenreich, A. M., Geitner, M., & Guntinas-Lichius, O. (2021). Acute facial paresis as a possible complication of vaccination against SARS-CoV-2. Laryngo-Rhino-Otologie. | https://pubmed.ncbi.nlm.nih.gov/33975372/. | Volk, G. F., Kuttenreich, A. M., Geitner, M., & Guntinas-Lichius, O. (2021). Acute facial paresis as a possible complication of vaccination against SARS-CoV-2. Laryngo-Rhino-Otologie. https://pubmed.ncbi.nlm.nih.gov/33975372/. | Fathy, R. A., McMahon, D. E., Lee, C., Chamberlin, G. C., Rosenbach, M., Lipoff, J. B., ... & Freeman, E. E. (2022). Varicella‐zoster and herpes simplex virus reactivation post‐COVID‐19 vaccination: a review of 40 cases in an International Dermatology Registry. Journal of the European Academy of Dermatology and Venereology, 36(1), e6-e9. https://pubmed.ncbi.nlm.nih.gov/34487581/ | ||||
212 | Primary adrenal insufficiency associated with thrombotic immune thrombocytopenia induced by Oxford-AstraZeneca ChAdOx1 nCoV-19 vaccine (VITT): | https://pubmed.ncbi.nlm.nih.gov/34256983/ | https://pubmed.ncbi.nlm.nih.gov/34247246/. | Wang, R. L., Chiang, W. F., Shyu, H. Y., Chen, M. H., Lin, C. I., Wu, K. A., ... & Hsiao, P. J. (2021). COVID-19 vaccine-associated acute cerebral venous thrombosis and pulmonary artery embolism. QJM: An International Journal of Medicine. | Wang, R. L., Chiang, W. F., Shyu, H. Y., Chen, M. H., Lin, C. I., Wu, K. A., ... y Hsiao, P. J. (2021). Trombosis venosa cerebral aguda y embolia de la arteria pulmonar asociadas a la vacuna COVID-19. QJM: Revista internacional de medicina. https://pubmed.ncbi.nlm.nih.gov/34132839/ | De Terreros Caro, G. G., Díaz, S. G., Alé, M. P., & Gimeno, M. M. (2021). Parálisis de Bell siguiendo la vacunación COVID-19: un informe de caso. Neurologia (Barcelona, España). https://www.sciencedirect.com/science/article/pii/S2213219821007972 | Wang, R. L., Chiang, W. F., Shyu, H. Y., Chen, M. H., Lin, C. I., Wu, K. A., ... & Hsiao, P. J. (2021). COVID-19 vaccine-associated acute cerebral venous thrombosis and pulmonary artery embolism. QJM: An International Journal of Medicine. https://pubmed.ncbi.nlm.nih.gov/34247246/. | de Vrieze, J. (2021). Pfizer's vaccine raises allergy concerns. https://pubmed.ncbi.nlm.nih.gov/33384356/ | Obermann, M., Krasniqi, M., Ewers, N., Fayad, J., & Haeberle, U. (2021). Bell’s palsy following COVID-19 vaccination with high CSF antibody response. Neurological Sciences, 42(11), 4397-4399. | https://pubmed.ncbi.nlm.nih.gov/34322761/. | Obermann, M., Krasniqi, M., Ewers, N., Fayad, J., & Haeberle, U. (2021). Bell’s palsy following COVID-19 vaccination with high CSF antibody response. Neurological Sciences, 42(11), 4397-4399. https://pubmed.ncbi.nlm.nih.gov/34322761/. | Favaloro, E. J. (2021). Laboratory testing for suspected COVID‐19 vaccine–induced (immune) thrombotic thrombocytopenia. International Journal of Laboratory Hematology, 43(4), 559-570. https://pubmed.ncbi.nlm.nih.gov/34138513/ | ||||
213 | Acute cerebral venous thrombosis and pulmonary artery embolism associated with the COVID-19 vaccine: | https://pubmed.ncbi.nlm.nih.gov/34247246/. | https://pubmed.ncbi.nlm.nih.gov/34132839/ | Barral, M., Arrive, L., Mouhadi-Barnier, E., & Cornelis, F. H. (2021). Thromboaspiration and fibrinolysis infusion for portomesenteric thrombosis after AstraZeneca COVID-19 vaccine administration. Intensive Care Medicine, 47(9), 1034-1036. | Barral, M., Arrive, L., Mouhadi-Barnier, E. y Cornelis, FH (2021). Infusión de tromboaspiración y fibrinólisis para la trombosis portomesentérica después de la administración de la vacuna AstraZeneca COVID-19. Medicina de cuidados intensivos, 47(9), 1034-1036. https://pubmed.ncbi.nlm.nih.gov/34117206/ | De Trabajo Multidisciplinar de FACME, G. (2021). Recomendaciones Diagnóstico-Terapéuticas del Grupo de Trabajo de Expertos de Facme Ad-Hoc Sobre El Manejo De la Trombosis Venosa Cerebral Relacionada con la Vacunación FRENTE A COVID-19. NEUROLOGÍA, 36 (6), 451-461. https://pubmed.ncbi.nlm.nih.gov/33918932/ | Barral, M., Arrive, L., Mouhadi-Barnier, E., & Cornelis, F. H. (2021). Thromboaspiration and fibrinolysis infusion for portomesenteric thrombosis after AstraZeneca COVID-19 vaccine administration. Intensive Care Medicine, 47(9), 1034-1036. https://pubmed.ncbi.nlm.nih.gov/34132839/ | Deb, A., Abdelmalek, J., Iwuji, K., & Nugent, K. (2021). Acute myocardial injury following COVID-19 vaccination: a case report and review of current evidence from vaccine adverse events reporting system database. Journal of primary care & community health, 12, 21501327211029230. https://pubmed.ncbi.nlm.nih.gov/34219532/ | Finsterer, J., & Scorza, F. A. (2021). SARS-CoV-2 or SARS-CoV-2 vaccination associated Parsonage-Turner syndrome. Comment on:“Neuralgic amyotrophy and Covid 19 infection: 2 cases of spinal accessory nerve palsy” by Coll et al. Joint Bone Spine 2021; 88: 105196. Joint Bone Spine. | https://pubmed.ncbi.nlm.nih.gov/34139321/. | Finsterer, J., & Scorza, F. A. (2021). SARS-CoV-2 or SARS-CoV-2 vaccination associated Parsonage-Turner syndrome. Comment on:“Neuralgic amyotrophy and Covid 19 infection: 2 cases of spinal accessory nerve palsy” by Coll et al. Joint Bone Spine 2021; 88: 105196. Joint Bone Spine. https://pubmed.ncbi.nlm.nih.gov/34139321/. | Fazlollahi, A., Zahmatyar, M., Noori, M., Nejadghaderi, S. A., Sullman, M. J., Shekarriz‐Foumani, R., ... & Safiri, S. (2021). Cardiac complications following mRNA COVID‐19 vaccines: A systematic review of case reports and case series. Reviews in medical virology, e2318. https://www.ncbi.nlm.nih.gov/pubmed/34921468 | ||||
214 | Thromboaspiration infusion and fibrinolysis for portomesenteric thrombosis after administration of AstraZeneca COVID-19 vaccine: | https://pubmed.ncbi.nlm.nih.gov/34132839/ | https://pubmed.ncbi.nlm.nih.gov/34117206/ | Al-Maqbali, J. S., Al Rasbi, S., Kashoub, M. S., Al Hinaai, A. M., Farhan, H., Al Rawahi, B., & Al Alawi, A. M. (2021). A 59-year-old woman with extensive deep vein thrombosis and pulmonary thromboembolism 7 days following a first dose of the Pfizer-BioNTech BNT162b2 mRNA COVID-19 vaccine. The American journal of case reports, 22, e932946-1. | Al-Maqbali, J. S., Al Rasbi, S., Kashoub, M. S., Al Hinaai, A. M., Farhan, H., Al Rawahi, B. y Al Alawi, A. M. (2021). Una mujer de 59 años con trombosis venosa profunda extensa y tromboembolismo pulmonar 7 días después de una primera dosis de la vacuna de ARNm COVID-19 BNT162b2 de Pfizer-BioNTech. La revista estadounidense de informes de casos, 22, e932946-1. https://pubmed.ncbi.nlm.nih.gov/34033927/ | De Vrieze, J. (2021). La vacuna de Pfizer aumenta las preocupaciones de alergias. https://pubmed.ncbi.nlm.nih.gov/33444297/ | Al-Maqbali, J. S., Al Rasbi, S., Kashoub, M. S., Al Hinaai, A. M., Farhan, H., Al Rawahi, B., & Al Alawi, A. M. (2021). A 59-year-old woman with extensive deep vein thrombosis and pulmonary thromboembolism 7 days following a first dose of the Pfizer-BioNTech BNT162b2 mRNA COVID-19 vaccine. The American journal of case reports, 22, e932946-1. https://pubmed.ncbi.nlm.nih.gov/34117206/ | Deb, A., Abdelmalek, J., Iwuji, K., & Nugent, K. (2021). Acute myocardial injury following COVID-19 vaccination: a case report and review of current evidence from vaccine adverse events reporting system database. Journal of primary care & community health, 12, 21501327211029230. https://www.ncbi.nlm.nih.gov/pubmed/34219532 | Martin-Villares, C., Vazquez-Feito, A., Gonzalez-Gimeno, M. J., & de la Nogal-Fernandez, B. (2022). Bell’s palsy following a single dose of mRNA SARS-CoV-2 vaccine: a case report. Journal of Neurology, 269(1), 47-48. | https://pubmed.ncbi.nlm.nih.gov/34032902/. | Martin-Villares, C., Vazquez-Feito, A., Gonzalez-Gimeno, M. J., & de la Nogal-Fernandez, B. (2022). Bell’s palsy following a single dose of mRNA SARS-CoV-2 vaccine: a case report. Journal of Neurology, 269(1), 47-48. https://pubmed.ncbi.nlm.nih.gov/34032902/. | Fazolo, T., Lima, K., Fontoura, J. C., de Souza, P. O., Hilario, G., Zorzetto, R., ... & Bonorino, C. (2021). Pediatric COVID-19 patients in South Brazil show abundant viral mRNA and strong specific anti-viral responses. Nature communications, 12(1), 1-13. https://www.ncbi.nlm.nih.gov/pubmed/34824230 | ||||
215 | 59-year-old woman with extensive deep venous thrombosis and pulmonary thromboembolism 7 days after a first dose of Pfizer-BioNTech BNT162b2 mRNA vaccine COVID-19: | https://pubmed.ncbi.nlm.nih.gov/34117206/ | https://pubmed.ncbi.nlm.nih.gov/34033927/ | Geeraerts, T., Montastruc, F., Bonneville, F., Mémier, V., Raposo, N., & Toulouse Vitt Study Group. (2021). Oxford-AstraZeneca COVID-19 vaccine-induced cerebral venous thrombosis and thrombocytopaenia: a missed opportunity for a rapid return of experience. Anaesthesia, Critical Care & Pain Medicine. | Geeraerts, T., Montastruc, F., Bonneville, F., Mémier, V., Raposo, N. y Grupo de estudio Toulouse Vitt. (2021). Trombosis venosa cerebral y trombocitopenia inducidas por la vacuna Oxford-AstraZeneca COVID-19: una oportunidad perdida para un rápido retorno de la experiencia. Anestesia, cuidados críticos y medicina del dolor. https://pubmed.ncbi.nlm.nih.gov/34277198/ | Deb, A., Abdelmalek, J., Iwuji, K., & Nugent, K. (2021). Lesión de miocardio agudo después de la vacunación COVID-19: un informe de caso y revisión de la evidencia actual de la base de datos de sistemas de informes de eventos adversos de vacunas. Diario de atención primaria y salud comunitaria, 12, 21501327211029230. https://www.ncbi.nlm.nih.gov/pubmed/34246585 | Geeraerts, T., Montastruc, F., Bonneville, F., Mémier, V., Raposo, N., & Toulouse Vitt Study Group. (2021). Oxford-AstraZeneca COVID-19 vaccine-induced cerebral venous thrombosis and thrombocytopaenia: a missed opportunity for a rapid return of experience. Anaesthesia, Critical Care & Pain Medicine. https://pubmed.ncbi.nlm.nih.gov/34033927/ | DeDent, A. M., & Farrand, E. (2022). Vaccine-induced interstitial lung disease: a rare reaction to COVID-19 vaccination. Thorax, 77(1), 9-10. https://pubmed.ncbi.nlm.nih.gov/34510014/. | Bril, F., Al Diffalha, S., Dean, M., & Fettig, D. M. (2021). Autoimmune hepatitis developing after coronavirus disease 2019 (COVID-19) vaccine: causality or casualty?. Journal of Hepatology, 75(1), 222-224. | https://pubmed.ncbi.nlm.nih.gov/33862041/ | Bril, F., Al Diffalha, S., Dean, M., & Fettig, D. M. (2021). Autoimmune hepatitis developing after coronavirus disease 2019 (COVID-19) vaccine: causality or casualty?. Journal of Hepatology, 75(1), 222-224. https://pubmed.ncbi.nlm.nih.gov/33862041/ | Fearon, C., Parwani, P., Gow-Lee, B., & Abramov, D. (2021). Takotsubo syndrome after receiving the COVID-19 vaccine. Journal of Cardiology Cases, 24(5), 223-226. https://pubmed.ncbi.nlm.nih.gov/34539938/. | ||||
216 | Cerebral venous thrombosis and vaccine-induced thrombocytopenia.a. Oxford-AstraZeneca COVID-19: a missed opportunity for a rapid return on experience: | https://pubmed.ncbi.nlm.nih.gov/34033927/ | https://pubmed.ncbi.nlm.nih.gov/34277198/ | Vidula, M. K., Ambrose, M., Glassberg, H., Chokshi, N., Chen, T., Ferrari, V. A., & Han, Y. (2021). Myocarditis and other cardiovascular complications of the mRNA-based COVID-19 vaccines. Cureus, 13(6). | Vidula, M. K., Ambrose, M., Glassberg, H., Chokshi, N., Chen, T., Ferrari, V. A. y Han, Y. (2021). Miocarditis y otras complicaciones cardiovasculares de las vacunas COVID-19 basadas en ARNm. Cureus, 13(6). https://pubmed.ncbi.nlm.nih.gov/34364831/ | Deb, A., Abdelmalek, J., Iwuji, K., & Nugent, K. (2021). Lesión de miocardio agudo después de la vacunación COVID-19: un informe de caso y revisión de la evidencia actual de la base de datos de sistemas de informes de eventos adversos de vacunas. Diario de atención primaria y salud comunitaria, 12, 21501327211029230. https://www.xiahepublishing.com/m/2472-0712/ERHM-2021-00033 | Vidula, M. K., Ambrose, M., Glassberg, H., Chokshi, N., Chen, T., Ferrari, V. A., & Han, Y. (2021). Myocarditis and other cardiovascular complications of the mRNA-based COVID-19 vaccines. Cureus, 13(6). https://pubmed.ncbi.nlm.nih.gov/34277198/ | Desai, A. P., Desai, A. P., & Loomis, G. J. (2021). Relationship between pre-existing allergies and anaphylactic reactions post mRNA COVID-19 vaccine administration. Vaccine, 39(32), 4407-4409. https://pubmed.ncbi.nlm.nih.gov/34215453/ | Vuille-Lessard, É., Montani, M., Bosch, J., & Semmo, N. (2021). Autoimmune hepatitis triggered by SARS-CoV-2 vaccination. Journal of autoimmunity, 123, 102710. | https://pubmed.ncbi.nlm.nih.gov/34332438/ | Vuille-Lessard, É., Montani, M., Bosch, J., & Semmo, N. (2021). Autoimmune hepatitis triggered by SARS-CoV-2 vaccination. Journal of autoimmunity, 123, 102710. https://pubmed.ncbi.nlm.nih.gov/34332438/ | Fernández-Prada, M., Rivero-Calle, I., Calvache-González, A., & Martinón-Torres, F. (2021). Acute onset supraclavicular lymphadenopathy coinciding with intramuscular mRNA vaccination against COVID-19 may be related to vaccine injection technique, Spain, January and February 2021. Eurosurveillance, 26(10), 2100193. https://pubmed.ncbi.nlm.nih.gov/33706861/ | ||||
217 | Myocarditis and other cardiovascular complications of mRNA-based COVID-19 vaccines: | https://pubmed.ncbi.nlm.nih.gov/34277198/ | https://pubmed.ncbi.nlm.nih.gov/34364831/ | Ramírez-García, A., Jiménez, S., Ximénez, I., Cacho, A., Aguado-Noya, R., & Cubero, J. (2021). Pericarditis tras la administración de la vacuna de ARNm BNT162b2 contra la COVID-19 Pericarditis after administration of the BNT162b2 mRNA COVID-19 vaccine. Revista espanola de cardiologia. | Ramírez-García, A., Jiménez, S., Ximénez, I., Cacho, A., Aguado-Noya, R., & Cubero, J. (2021). Pericarditis tras la administración de la vacuna de ARNm BNT162b2 contra la COVID-19 Pericarditis tras la administración de la vacuna BNT162b2 mRNA COVID-19. Revista española de cardiología. https://pubmed.ncbi.nlm.nih.gov/34514306/ | Dedente, A. M., & Farrand, E. (2022). Enfermedad pulmonar intersticial inducida por la vacuna: una reacción rara a la vacunación de COVID-19. Tórax, 77 (1), 9-10. https://pubmed.ncbi.nlm.nih.gov/34236711/ | Ramírez-García, A., Jiménez, S., Ximénez, I., Cacho, A., Aguado-Noya, R., & Cubero, J. (2021). Pericarditis tras la administración de la vacuna de ARNm BNT162b2 contra la COVID-19 Pericarditis after administration of the BNT162b2 mRNA COVID-19 vaccine. Revista espanola de cardiologia. https://pubmed.ncbi.nlm.nih.gov/34364831/ | Dhoot, R., Kansal, A., Handran, C., Haykal, T., Ronald, J., Kappus, M., ... & Strouse, J. J. (2021). Thrombocytopenia and splanchnic thrombosis after Ad26. COV2. S vaccination successfully treated with transjugular intrahepatic portosystemic shunting and thrombectomy. American journal of hematology. https://onlinelibrary.wiley.com/doi/10.1002/ajh.26258 | Ghielmetti, M., Schaufelberger, H. D., Mieli-Vergani, G., Cerny, A., Dayer, E., Vergani, D., & Beretta-Piccoli, B. T. (2021). Acute autoimmune-like hepatitis with atypical anti-mitochondrial antibody after mRNA COVID-19 vaccination: A novel clinical entity?. Journal of Autoimmunity, 123, 102706. | https://pubmed.ncbi.nlm.nih.gov/34293683/. | Ghielmetti, M., Schaufelberger, H. D., Mieli-Vergani, G., Cerny, A., Dayer, E., Vergani, D., & Beretta-Piccoli, B. T. (2021). Acute autoimmune-like hepatitis with atypical anti-mitochondrial antibody after mRNA COVID-19 vaccination: A novel clinical entity?. Journal of Autoimmunity, 123, 102706. https://pubmed.ncbi.nlm.nih.gov/34293683/. | Fikenzer, S., & Laufs, U. (2021). Correction to: Response to Letter to the editors referring to Fikenzer, S., Uhe, T., Lavall, D., Rudolph, U., Falz, R., Busse, M., Hepp, P., & Laufs, U.(2020). Effects of surgical and FFP2/N95 face masks on cardiopulmonary exercise capacity. Clinical research in cardiology: official journal of the German Cardiac Society, 1–9. Advance online publication. https://doi. org/10.1007/s00392-020-01704-y. Clinical Research in Cardiology, 110(8), 1352-1352. https://www.ncbi.nlm.nih.gov/pubmed/34170372 | ||||
218 | Pericarditis after administration of COVID-19 mRNA BNT162b2 vaccine: | https://pubmed.ncbi.nlm.nih.gov/34364831/ | https://pubmed.ncbi.nlm.nih.gov/34514306/ | Tailor, P. D., Feighery, A. M., El-Sabawi, B., & Prasad, A. (2021). Case report: acute myocarditis following the second dose of mRNA-1273 SARS-CoV-2 vaccine. European Heart Journal-Case Reports, 5(8), ytab319. | Tailor, P. D., Feighery, A. M., El-Sabawi, B. y Prasad, A. (2021). Informe de caso: miocarditis aguda tras la segunda dosis de la vacuna mRNA-1273 SARS-CoV-2. European Heart Journal-Case Reports, 5(8), ytab319. https://pubmed.ncbi.nlm.nih.gov/33946748/ | Desai, A. P., Desai, A. P., & Loomis, G. J. (2021). La relación entre las alergias preexistentes y las reacciones anafilácticas postergan la administración de la vacuna contra MRNA COVID-19. Vacuna, 39 (32), 4407-4409. https://pubmed.ncbi.nlm.nih.gov/33932618/ | Tailor, P. D., Feighery, A. M., El-Sabawi, B., & Prasad, A. (2021). Case report: acute myocarditis following the second dose of mRNA-1273 SARS-CoV-2 vaccine. European Heart Journal-Case Reports, 5(8), ytab319. https://pubmed.ncbi.nlm.nih.gov/34514306/ | Dias, L., Soares-dos-Reis, R., Meira, J., Ferrão, D., Soares, P. R., Pastor, A., ... & Carvalho, M. (2021). Cerebral venous thrombosis after BNT162b2 mRNA SARS-CoV-2 vaccine. Journal of Stroke and Cerebrovascular Diseases, 30(8), 105906. https://pubmed.ncbi.nlm.nih.gov/34111775/. | Rela, M., Jothimani, D., Vij, M., Rajakumar, A., & Rammohan, A. (2021). Auto-immune hepatitis following COVID vaccination. Journal of Autoimmunity, 123, 102688. | https://pubmed.ncbi.nlm.nih.gov/34225251/ | Rela, M., Jothimani, D., Vij, M., Rajakumar, A., & Rammohan, A. (2021). Auto-immune hepatitis following COVID vaccination. Journal of Autoimmunity, 123, 102688. https://pubmed.ncbi.nlm.nih.gov/34225251/ | Finsterer, J. (2021). Lobar bleeding with ventricular rupture shortly after first dosage of an mRNA-based SARS-CoV-2 vaccine. Brain hemorrhages. https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8553377/ | ||||
219 | Unusual presentation of acute pericarditis after vaccination against SARS-COV-2 mRNA-1237 Modern: | https://pubmed.ncbi.nlm.nih.gov/34447639/ | https://pubmed.ncbi.nlm.nih.gov/33946748/ | Watad, A., De Marco, G., Mahajna, H., Druyan, A., Eltity, M., Hijazi, N., ... & McGonagle, D. (2021). Immune-mediated disease flares or new-onset disease in 27 subjects following mRNA/DNA SARS-CoV-2 vaccination. Vaccines, 9(5), 435. | Watad, A., De Marco, G., Mahajna, H., Druyan, A., Eltity, M., Hijazi, N., ... y McGonagle, D. (2021). Brotes de enfermedades inmunomediadas o enfermedades de nueva aparición en 27 sujetos después de la vacunación con ARNm/ADN SARS-CoV-2. Vacunas, 9(5), 435. https://pubmed.ncbi.nlm.nih.gov/34453510/ | Dhoot, R., Kansal, A., Handran, C., Haykal, T., Ronald, J., Kappus, M., ... & Strouse, J. J. (2021). Trombocitopenia y trombosis splanicnica después de AD26. COV2. S Vacunación tratada con éxito con derivación y trombectomía intrahepática transjugular y trombectomía. American Journal of Hematology. https://pubmed.ncbi.nlm.nih.gov/34579636/ | Watad, A., De Marco, G., Mahajna, H., Druyan, A., Eltity, M., Hijazi, N., ... & McGonagle, D. (2021). Immune-mediated disease flares or new-onset disease in 27 subjects following mRNA/DNA SARS-CoV-2 vaccination. Vaccines, 9(5), 435. https://pubmed.ncbi.nlm.nih.gov/33946748/ | Dias, L., Soares-dos-Reis, R., Meira, J., Ferrão, D., Soares, P. R., Pastor, A., ... & Carvalho, M. (2021). Cerebral venous thrombosis after BNT162b2 mRNA SARS-CoV-2 vaccine. Journal of Stroke and Cerebrovascular Diseases, 30(8), 105906. https://www.sciencedirect.com/science/article/abs/pii/S1052305721003098 | Prasad, A., Hurlburt, G., Podury, S., Tandon, M., Kingree, S., & Sriwastava, S. (2021). A novel case of bifacial diplegia variant of guillain-Barré syndrome following Janssen COVID-19 vaccination. Neurology International, 13(3), 404-409. | https://pubmed.ncbi.nlm.nih.gov/34449715/ | Prasad, A., Hurlburt, G., Podury, S., Tandon, M., Kingree, S., & Sriwastava, S. (2021). A novel case of bifacial diplegia variant of guillain-Barré syndrome following Janssen COVID-19 vaccination. Neurology International, 13(3), 404-409. https://pubmed.ncbi.nlm.nih.gov/34449715/ | Finsterer, J. (2021). SARS-CoV-2 vaccinations are unsafe for those experiencing post-vaccination Guillain-Barre syndrome. Annals of Medicine and Surgery. https://www.sciencedirect.com/science/article/pii/S2049080121005343 | ||||
220 | Case report: acute myocarditis after second dose of SARS-CoV-2 mRNA-1273 vaccine mRNA-1273: | https://pubmed.ncbi.nlm.nih.gov/34514306/ | https://pubmed.ncbi.nlm.nih.gov/34453510/ | Knowlton, K. U. (2021). Insights from a murine model of COVID-19 mRNA vaccination-induced myopericarditis: Could accidental intravenous vaccine injection induce myopericarditis?. Clin. infect. dis. | Knowlton, KU (2021). Perspectivas de un modelo murino de miopericarditis inducida por la vacunación con ARNm de COVID-19: ¿Podría la inyección intravenosa accidental de vacuna inducir miopericarditis? Clínico. infectar. dis. https://pubmed.ncbi.nlm.nih.gov/33476455/ | DIAS, L., SOARES-DOS-REIS, R., Meira, J., Ferrão, D., SOARES, P. R., PASTOR, A., ... & CARVALHO, M. (2021). Trombosis venosa cerebral después de la vacuna contra BNT162B2 MRNA SARS-COV-2. Diario de accidentes cerebrovasculares y enfermedades cerebrovasculares, 30 (8), 105906. https://pubmed.ncbi.nlm.nih.gov/34045111/ | Knowlton, K. U. (2021). Insights from a murine model of COVID-19 mRNA vaccination-induced myopericarditis: Could accidental intravenous vaccine injection induce myopericarditis?. Clin. infect. dis. https://pubmed.ncbi.nlm.nih.gov/34453510/ | Diaz, G. A., Parsons, G. T., Gering, S. K., Meier, A. R., Hutchinson, I. V., & Robicsek, A. (2021). Myocarditis and pericarditis after vaccination for COVID-19. Jama, 326(12), 1210-1212. https://jamanetwork.com/journals/jama/fullarticle/2782900 | Hwang, J., Lee, S. B., Lee, S. W., Lee, M. H., Koyanagi, A., Jacob, L., ... & Smith, L. (2021). Comparison of vaccine-induced thrombotic events between ChAdOx1 nCoV-19 and Ad26. COV. 2. S vaccines. Journal of autoimmunity, 122, 102681. | https://pubmed.ncbi.nlm.nih.gov/34139631/. | Hwang, J., Lee, S. B., Lee, S. W., Lee, M. H., Koyanagi, A., Jacob, L., ... & Smith, L. (2021). Comparison of vaccine-induced thrombotic events between ChAdOx1 nCoV-19 and Ad26. COV. 2. S vaccines. Journal of autoimmunity, 122, 102681. https://pubmed.ncbi.nlm.nih.gov/34139631/. | Finsterer, J. (2021). SARS-CoV-2 vaccinations may not only be complicated by GBS but also by distal small fibre neuropathy. Journal of Neuroimmunology. https://pubmed.ncbi.nlm.nih.gov/34525410/ | ||||
221 | Immune-mediated disease outbreaks or recent-onset disease in 27 subjects after mRNA/DNA vaccination against SARS-CoV-2: | https://pubmed.ncbi.nlm.nih.gov/33946748/ | https://pubmed.ncbi.nlm.nih.gov/33476455/ | Tarawneh, O., & Tarawneh, H. (2021). Immune thrombocytopenia in a 22‐year‐old post Covid‐19 vaccine. American journal of hematology. | Tarawneh, O. y Tarawneh, H. (2021). Trombocitopenia inmune en una persona de 22 años postvacuna Covid-19. Revista americana de hematología. https://pubmed.ncbi.nlm.nih.gov/34451967/ | DIAS, L., SOARES-DOS-REIS, R., Meira, J., Ferrão, D., SOARES, P. R., PASTOR, A., ... & CARVALHO, M. (2021). Trombosis venosa cerebral después de la vacuna contra BNT162B2 MRNA SARS-COV-2. Diario de accidentes cerebrovasculares y enfermedades cerebrovasculares, 30 (8), 105906. https://www.sciencedirect.com/science/article/pii/S0953620521002363 | Tarawneh, O., & Tarawneh, H. (2021). Immune thrombocytopenia in a 22‐year‐old post Covid‐19 vaccine. American journal of hematology. https://pubmed.ncbi.nlm.nih.gov/33476455/ | Dickey, J. B., Albert, E., Badr, M., Laraja, K. M., Sena, L. M., Gerson, D. S., ... & Aurigemma, G. P. (2021). A series of patients with myocarditis following SARS-CoV-2 vaccination with mRNA-1279 and BNT162b2. Cardiovascular Imaging, 14(9), 1862-1863. https://pubmed.ncbi.nlm.nih.gov/34246585/ | Bayas, A., Menacher, M., Christ, M., Behrens, L., Rank, A., & Naumann, M. (2021). Bilateral superior ophthalmic vein thrombosis, ischaemic stroke, and immune thrombocytopenia after ChAdOx1 nCoV-19 vaccination. The Lancet, 397(10285), e11. | https://pubmed.ncbi.nlm.nih.gov/33864750/ | Bayas, A., Menacher, M., Christ, M., Behrens, L., Rank, A., & Naumann, M. (2021). Bilateral superior ophthalmic vein thrombosis, ischaemic stroke, and immune thrombocytopenia after ChAdOx1 nCoV-19 vaccination. The Lancet, 397(10285), e11. https://pubmed.ncbi.nlm.nih.gov/33864750/ | Finsterer, J. (2022). Neurological side effects of SARS‐CoV‐2 vaccinations. Acta Neurologica Scandinavica, 145(1), 5-9. https://pubmed.ncbi.nlm.nih.gov/34750810/ | ||||
222 | Insights from a murine model of myopericarditis induced by COVID-19 mRNA vaccine: could accidental intravenous injection of a vaccine induce myopericarditis: | https://pubmed.ncbi.nlm.nih.gov/34453510/ | https://pubmed.ncbi.nlm.nih.gov/34451967/ | Okuda, S., Hirooka, Y., & Sugiyama, M. (2021). Propylthiouracil-Induced Antineutrophil Cytoplasmic Antibody-Associated Vasculitis after COVID-19 Vaccination. Vaccines, 9(8), 842. | Okuda, S., Hirooka, Y. y Sugiyama, M. (2021). Vasculitis asociada a anticuerpos anticitoplasma de neutrófilos inducida por propiltiouracilo después de la vacunación contra la COVID-19. Vacunas, 9(8), 842. https://pubmed.ncbi.nlm.nih.gov/34377889/ | Díaz, G. A., Parsons, G. T., Gering, S. K., Meier, A. R., Hutchinson, I. V., & Robicsek, A. (2021). Miocarditis y pericarditis después de la vacunación para COVID-19. Jama, 326 (12), 1210-1212. https://www.ahajournals.org/doi/pdf/10.1161/CIRCULATIONAHA.121.055891. | Okuda, S., Hirooka, Y., & Sugiyama, M. (2021). Propylthiouracil-Induced Antineutrophil Cytoplasmic Antibody-Associated Vasculitis after COVID-19 Vaccination. Vaccines, 9(8), 842. https://pubmed.ncbi.nlm.nih.gov/34451967/ | Dickey, J. B., Albert, E., Badr, M., Laraja, K. M., Sena, L. M., Gerson, D. S., ... & Aurigemma, G. P. (2021). A series of patients with myocarditis following SARS-CoV-2 vaccination with mRNA-1279 and BNT162b2. Cardiovascular Imaging, 14(9), 1862-1863. https://www.ncbi.nlm.nih.gov/pubmed/34246585 | Furie, K. L., Cushman, M., Elkind, M. S., Lyden, P. D., Saposnik, G., & American Heart Association/American Stroke Association Stroke Council Leadership. (2021). Diagnosis and management of cerebral venous sinus thrombosis with vaccine-induced immune thrombotic thrombocytopenia. Stroke, 52(7), 2478-2482. | https://pubmed.ncbi.nlm.nih.gov/33914590/ | Furie, K. L., Cushman, M., Elkind, M. S., Lyden, P. D., Saposnik, G., & American Heart Association/American Stroke Association Stroke Council Leadership. (2021). Diagnosis and management of cerebral venous sinus thrombosis with vaccine-induced immune thrombotic thrombocytopenia. Stroke, 52(7), 2478-2482. https://pubmed.ncbi.nlm.nih.gov/33914590/ | Finsterer, J., & Korn, M. (2021). Aphasia seven days after second dose of an mRNA-based SARS-CoV-2 vaccine. Brain Hemorrhages, 2(4), 165-167. https://www.sciencedirect.com/science/article/pii/S2589238X21000292#f0005 | ||||
223 | Immune thrombocytopenia in a 22-year-old post Covid-19 vaccine: | https://pubmed.ncbi.nlm.nih.gov/33476455/ | https://pubmed.ncbi.nlm.nih.gov/34377889/ | Koch, M., Fuld, S., Middeke, J. M., Fantana, J., von Bonin, S., & Beyer-Westendorf, J. (2021). Secondary Immune Thrombocytopenia (ITP) Associated with ChAdOx1 Covid-19 Vaccination–A Case Report. TH Open, 5(03), e315-e318. | Koch, M., Fuld, S., Middeke, JM, Fantana, J., von Bonin, S. y Beyer-Westendorf, J. (2021). Trombocitopenia inmunitaria secundaria (PTI) asociada con la vacunación ChAdOx1 Covid-19: informe de un caso. TH Abierto, 5(03), e315-e318. https://pubmed.ncbi.nlm.nih.gov/34272095/ | Dickey, J. B., Albert, E., Badr, M., Laraja, K. M., Sena, L. M., Gerson, D. S., ... & Aurigemma, G. P. (2021). Una serie de pacientes con miocarditis después de la vacunación de SARS-COV-2 con MRNA-1279 y BNT162B2. Imagen cardiovascular, 14 (9), 1862-1863. https://pubmed.ncbi.nlm.nih.gov/34228985/ | Koch, M., Fuld, S., Middeke, J. M., Fantana, J., von Bonin, S., & Beyer-Westendorf, J. (2021). Secondary Immune Thrombocytopenia (ITP) Associated with ChAdOx1 Covid-19 Vaccination–A Case Report. TH Open, 5(03), e315-e318. https://pubmed.ncbi.nlm.nih.gov/34377889/ | Dickey, J. B., Albert, E., Badr, M., Laraja, K. M., Sena, L. M., Gerson, D. S., ... & Aurigemma, G. P. (2021). A series of patients with myocarditis following SARS-CoV-2 vaccination with mRNA-1279 and BNT162b2. Cardiovascular Imaging, 14(9), 1862-1863. https://www.sciencedirect.com/science/article/pii/S1936878X21004861 | Varas, G. M., Flores, A. C., & Casado, M. S. Venous sinus thrombosis following vaccination with ChAdOx1 nCov-19. Medicina intensiva, S0210-5691. | https://pubmed.ncbi.nlm.nih.gov/34420802/ | Varas, G. M., Flores, A. C., & Casado, M. S. Venous sinus thrombosis following vaccination with ChAdOx1 nCov-19. Medicina intensiva, S0210-5691. https://pubmed.ncbi.nlm.nih.gov/34420802/ | Finsterer, J., & Redzic, Z. (2021). Symptomatic peduncular, cavernous bleeding following SARS-CoV-2 vaccination induced immune thrombocytopenia. Brain Hemorrhages, 2(4), 169-171. https://pubmed.ncbi.nlm.nih.gov/34549178/. | ||||
224 | propylthiouracil-induced neutrophil anti-cytoplasmic antibody-associated vasculitis after COVID-19 vaccination: | https://pubmed.ncbi.nlm.nih.gov/34451967/ | https://pubmed.ncbi.nlm.nih.gov/34272095/ | MacIntyre, C. R., Veness, B., Berger, D., Hamad, N., & Bari, N. (2021). Thrombosis with Thrombocytopenia Syndrome (TTS) following AstraZeneca ChAdOx1 nCoV-19 (AZD1222) COVID-19 vaccination–A risk–benefit analysis for people< 60 years in Australia. Vaccine, 39(34), 4784-4787. | MacIntyre, C. R., Veness, B., Berger, D., Hamad, N. y Bari, N. (2021). Trombosis con síndrome de trombocitopenia (TTS) después de la vacuna COVID-19 ChAdOx1 nCoV-19 (AZD1222) de AstraZeneca: un análisis de riesgo-beneficio para personas <60 años en Australia. Vacuna, 39(34), 4784-4787. https://pubmed.ncbi.nlm.nih.gov/34165512/ | Dickey, J. B., Albert, E., Badr, M., Laraja, K. M., Sena, L. M., Gerson, D. S., ... & Aurigemma, G. P. (2021). Una serie de pacientes con miocarditis después de la vacunación de SARS-COV-2 con MRNA-1279 y BNT162B2. Imagen cardiovascular, 14 (9), 1862-1863. https://www.ncbi.nlm.nih.gov/pubmed/34492161 | MacIntyre, C. R., Veness, B., Berger, D., Hamad, N., & Bari, N. (2021). Thrombosis with Thrombocytopenia Syndrome (TTS) following AstraZeneca ChAdOx1 nCoV-19 (AZD1222) COVID-19 vaccination–A risk–benefit analysis for people< 60 years in Australia. Vaccine, 39(34), 4784-4787. https://pubmed.ncbi.nlm.nih.gov/34272095/ | Dicks, A. B., & Gray, B. H. (2021). Images in Vascular Medicine: Leukocytoclastic vasculitis after COVID-19 vaccine booster. Vascular Medicine, 1358863X211055507. https://pubmed.ncbi.nlm.nih.gov/34720009/ | Krzywicka, K., Heldner, M. R., Sánchez van Kammen, M., van Haaps, T., Hiltunen, S., Silvis, S. M., ... & Ferro, J. M. (2021). Post‐SARS‐CoV‐2‐vaccination cerebral venous sinus thrombosis: an analysis of cases notified to the European Medicines Agency. European journal of neurology, 28(11), 3656-3662. | https://pubmed.ncbi.nlm.nih.gov/34293217/ | Krzywicka, K., Heldner, M. R., Sánchez van Kammen, M., van Haaps, T., Hiltunen, S., Silvis, S. M., ... & Ferro, J. M. (2021). Post‐SARS‐CoV‐2‐vaccination cerebral venous sinus thrombosis: an analysis of cases notified to the European Medicines Agency. European journal of neurology, 28(11), 3656-3662. https://pubmed.ncbi.nlm.nih.gov/34293217/ | Finsterer, J., & Scorza, F. A. (2021). SARS-CoV-2 or SARS-CoV-2 vaccination associated Parsonage-Turner syndrome. Comment on:“Neuralgic amyotrophy and Covid 19 infection: 2 cases of spinal accessory nerve palsy” by Coll et al. Joint Bone Spine 2021; 88: 105196. Joint Bone Spine. https://pubmed.ncbi.nlm.nih.gov/34139321/. | ||||
225 | Secondary immune thrombocytopenia (ITP) associated with ChAdOx1 Covid-19 vaccine: case report: | https://pubmed.ncbi.nlm.nih.gov/34377889/ | https://pubmed.ncbi.nlm.nih.gov/34165512/ | Shemer, A., Pras, E., Einan-Lifshitz, A., Dubinsky-Pertzov, B., & Hecht, I. (2021). Association of COVID-19 vaccination and facial nerve palsy: a case-control study. JAMA Otolaryngology–Head & Neck Surgery, 147(8), 739-743. | Shemer, A., Pras, E., Einan-Lifshitz, A., Dubinsky-Pertzov, B. y Hecht, I. (2021). Asociación de la vacunación COVID-19 y la parálisis del nervio facial: un estudio de casos y controles. JAMA Otorrinolaringología – Cirugía de cabeza y cuello, 147(8), 739-743. https://pubmed.ncbi.nlm.nih.gov/34411533/ | Dickey, J. B., Albert, E., Badr, M., Laraja, K. M., Sena, L. M., Gerson, D. S., ... & Aurigemma, G. P. (2021). Una serie de pacientes con miocarditis después de la vacunación de SARS-COV-2 con MRNA-1279 y BNT162B2. Imagen cardiovascular, 14 (9), 1862-1863. https://www.sciencedirect.com/science/article/pii/S1443950621011331 | Shemer, A., Pras, E., Einan-Lifshitz, A., Dubinsky-Pertzov, B., & Hecht, I. (2021). Association of COVID-19 vaccination and facial nerve palsy: a case-control study. JAMA Otolaryngology–Head & Neck Surgery, 147(8), 739-743. https://pubmed.ncbi.nlm.nih.gov/34165512/ | Dijk, W. E. V., & Schutgens, R. E. (2022). Relapse of immune thrombocytopenia after COVID‐19 vaccination. European Journal of Haematology, 108(1), 84-85. https://pubmed.ncbi.nlm.nih.gov/34591991/ | Pottegård, A., Lund, L. C., Karlstad, Ø., Dahl, J., Andersen, M., Hallas, J., ... & Hviid, A. (2021). Arterial events, venous thromboembolism, thrombocytopenia, and bleeding after vaccination with Oxford-AstraZeneca ChAdOx1-S in Denmark and Norway: population based cohort study. bmj, 373. | https://pubmed.ncbi.nlm.nih.gov/33952445/ | Pottegård, A., Lund, L. C., Karlstad, Ø., Dahl, J., Andersen, M., Hallas, J., ... & Hviid, A. (2021). Arterial events, venous thromboembolism, thrombocytopenia, and bleeding after vaccination with Oxford-AstraZeneca ChAdOx1-S in Denmark and Norway: population based cohort study. bmj, 373. https://pubmed.ncbi.nlm.nih.gov/33952445/ | Finsterer, J., Scorza, F. A., & Scorza, C. A. (2021). Post SARS-CoV-2 vaccination Guillain-Barre syndrome in 19 patients. Clinics, 76. https://pubmed.ncbi.nlm.nih.gov/34644738/. | ||||
226 | Thrombosis with thrombocytopenia syndrome (TTS) following AstraZeneca ChAdOx1 nCoV-19 (AZD1222) COVID-19 vaccination: risk-benefit analysis for persons <60 years in Australia: | https://pubmed.ncbi.nlm.nih.gov/34272095/ | https://pubmed.ncbi.nlm.nih.gov/34411533/ | Cirillo, N., & Doan, R. (2022). The association between COVID-19 vaccination and Bell's palsy. The Lancet Infectious Diseases, 22(1), 5-6. | Cirillo, N. y Doan, R. (2022). La asociación entre la vacunación COVID-19 y la parálisis de Bell. The Lancet Infectious Diseases, 22(1), 5-6. https://pubmed.ncbi.nlm.nih.gov/33611630/ | Dicks, A. B., & Gray, B. H. (2021). Imágenes en medicina vascular: vasculitis leucocitoclástica después de covid-19 refuerzo de vacunas. Medicina vascular, 1358863x211055507. https://pubmed.ncbi.nlm.nih.gov/34518812/ | Cirillo, N., & Doan, R. (2022). The association between COVID-19 vaccination and Bell's palsy. The Lancet Infectious Diseases, 22(1), 5-6. https://pubmed.ncbi.nlm.nih.gov/34411533/ | Dimopoulou, D., Spyridis, N., Vartzelis, G., Tsolia, M. N., & Maritsi, D. N. (2021). Safety and tolerability of the COVID-19 mRNA-vaccine in adolescents with juvenile idiopathic arthritis on treatment with TNF-inhibitors. Arthritis & Rheumatology (Hoboken, NJ). https://www.ncbi.nlm.nih.gov/pubmed/34492161 | De Michele, M., Iacobucci, M., Chistolini, A., Nicolini, E., Pulcinelli, F., Cerbelli, B., ... & Toni, D. (2021). Malignant cerebral infarction after ChAdOx1 nCov-19 vaccination: a catastrophic variant of vaccine-induced immune thrombotic thrombocytopenia. Nature Communications, 12(1), 1-7. | https://pubmed.ncbi.nlm.nih.gov/34341358/ | De Michele, M., Iacobucci, M., Chistolini, A., Nicolini, E., Pulcinelli, F., Cerbelli, B., ... & Toni, D. (2021). Malignant cerebral infarction after ChAdOx1 nCov-19 vaccination: a catastrophic variant of vaccine-induced immune thrombotic thrombocytopenia. Nature Communications, 12(1), 1-7. https://pubmed.ncbi.nlm.nih.gov/34341358/ | Flower, L., Bares, Z., Santiapillai, G., & Harris, S. (2021). Acute ST-segment elevation myocardial infarction secondary to vaccine-induced immune thrombosis with thrombocytopaenia (VITT). BMJ Case Reports CP, 14(9), e245218. https://pubmed.ncbi.nlm.nih.gov/34580132/. | ||||
227 | COVID-19 vaccination association and facial nerve palsy: A case-control study: | https://pubmed.ncbi.nlm.nih.gov/34165512/ | https://pubmed.ncbi.nlm.nih.gov/33611630/ | Colella, G., Orlandi, M., & Cirillo, N. (2021). Bell’s palsy following COVID-19 vaccination. Journal of Neurology, 268(10), 3589-3591. | Colella, G., Orlandi, M. y Cirillo, N. (2021). Parálisis de Bell tras la vacunación contra el COVID-19. Revista de Neurología, 268(10), 3589-3591. https://pubmed.ncbi.nlm.nih.gov/33981305/ | DIJK, W. E. V., & Schutgens, R. E. (2022). Recaída de la trombocitopenia inmune después de la vacunación de COVID-19. Diario Europeo de Hematología, 108 (1), 84-85. https://pubmed.ncbi.nlm.nih.gov/34650382/ | Colella, G., Orlandi, M., & Cirillo, N. (2021). Bell’s palsy following COVID-19 vaccination. Journal of Neurology, 268(10), 3589-3591. https://pubmed.ncbi.nlm.nih.gov/33611630/ | Dimopoulou, D., Vartzelis, G., Dasoula, F., Tsolia, M., & Maritsi, D. (2022). Immunogenicity of the COVID-19 mRNA vaccine in adolescents with juvenile idiopathic arthritis on treatment with TNF inhibitors. Annals of the Rheumatic Diseases, 81(4), 592-593. https://www.ncbi.nlm.nih.gov/pubmed/34844930 | Bandapaati, S., Bobba, H., & Navinan, M. R. (2021). Coeliac artery and splenic artery thrombosis complicated with splenic infarction 7 days following the first dose of Oxford vaccination, causal relationship or coincidence?. BMJ Case Reports CP, 14(7), e243799. | https://pubmed.ncbi.nlm.nih.gov/34261633/. | Bandapaati, S., Bobba, H., & Navinan, M. R. (2021). Coeliac artery and splenic artery thrombosis complicated with splenic infarction 7 days following the first dose of Oxford vaccination, causal relationship or coincidence?. BMJ Case Reports CP, 14(7), e243799. https://pubmed.ncbi.nlm.nih.gov/34261633/. | Foltran, D., Delmas, C., Flumian, C., De Paoli, P., Salvo, F., Gautier, S., ... & Montastruc, F. (2022). Myocarditis and pericarditis in adolescents after first and second doses of mRNA COVID-19 vaccines. European Heart Journal-Quality of Care and Clinical Outcomes, 8(2), 99-103. https://academic.oup.com/ehjqcco/advance-article/doi/10.1093/ehjqcco/qcab090/6442104 | ||||
228 | The association between COVID-19 vaccination and Bell’s palsy: | https://pubmed.ncbi.nlm.nih.gov/34411533/ | https://pubmed.ncbi.nlm.nih.gov/33981305/ | Román, G. C., Gracia, F., Torres, A., Palacios, A., Gracia, K., & Harris, D. (2021). Acute transverse myelitis (ATM): clinical review of 43 patients with COVID-19-associated ATM and 3 post-vaccination ATM serious adverse events with the ChAdOx1 nCoV-19 vaccine (AZD1222). Frontiers in immunology, 12, 879. | Román, G. C., Gracia, F., Torres, A., Palacios, A., Gracia, K., & Harris, D. (2021). Mielitis transversa aguda (ATM): revisión clínica de 43 pacientes con ATM asociada a COVID-19 y 3 eventos adversos graves de ATM posvacunación con la vacuna ChAdOx1 nCoV-19 (AZD1222). Fronteras en inmunología, 12, 879. https://pubmed.ncbi.nlm.nih.gov/34336436/ | Dimopoulou, D., Spyridis, N., Vartzelis, G., Tsolia, M. N., & Maritsi, D. N. (2021). Seguridad y tolerabilidad de la vacuna contra el ARNA COVID-19 en adolescentes con artritis idiopática juvenil en tratamiento con inhibidores de TNF. Artritis y reumatología (Hoboken, NJ). https://www.ncbi.nlm.nih.gov/pubmed/34844930 | Román, G. C., Gracia, F., Torres, A., Palacios, A., Gracia, K., & Harris, D. (2021). Acute transverse myelitis (ATM): clinical review of 43 patients with COVID-19-associated ATM and 3 post-vaccination ATM serious adverse events with the ChAdOx1 nCoV-19 vaccine (AZD1222). Frontiers in immunology, 12, 879. https://pubmed.ncbi.nlm.nih.gov/33981305/ | Dionne, A., Sperotto, F., Chamberlain, S., Baker, A. L., Powell, A. J., Prakash, A., ... & Friedman, K. G. (2021). Association of myocarditis with BNT162b2 messenger RNA COVID-19 vaccine in a case series of children. JAMA cardiology, 6(12), 1446-1450. https://jamanetwork.com/journals/jamacardiology/fullarticle/2783052 | Kragholm, K., Sessa, M., Mulvad, T., Andersen, M. P., Collatz-Christensen, H., Blomberg, S. N., ... & Sogaard, P. (2021). Thrombocytopenia after COVID-19 vaccination. Journal of Autoimmunity, 123, 102712. | https://pubmed.ncbi.nlm.nih.gov/34332437/. | Kragholm, K., Sessa, M., Mulvad, T., Andersen, M. P., Collatz-Christensen, H., Blomberg, S. N., ... & Sogaard, P. (2021). Thrombocytopenia after COVID-19 vaccination. Journal of Autoimmunity, 123, 102712. https://pubmed.ncbi.nlm.nih.gov/34332437/. | Forgacs, D., Jang, H., Abreu, R. B., Hanley, H. B., Gattiker, J. L., Jefferson, A. M., & Ross, T. M. (2021). SARS-CoV-2 mRNA Vaccines Elicit Different Responses in Immunologically Naïve and Pre-Immune Humans. Frontiers in immunology, 12. https://www.ncbi.nlm.nih.gov/pubmed/34646267 | ||||
229 | Bell’s palsy after COVID-19 vaccination: | https://pubmed.ncbi.nlm.nih.gov/33611630/ | https://pubmed.ncbi.nlm.nih.gov/34336436/ | Iftikhar, H., Noor, S. M. U., Masood, M., & Bashir, K. (2021). Bell’s palsy after 24 hours of mRNA-1273 SARS-CoV-2 vaccine. Cureus, 13(6). | Iftikhar, H., Noor, SMU, Masood, M. y Bashir, K. (2021). Parálisis de Bell después de 24 horas de administración de la vacuna mRNA-1273 SARS-CoV-2. Cureus, 13(6). https://pubmed.ncbi.nlm.nih.gov/34281950/. | Dimopoulou, D., Vartzelis, G., Dasoula, F., Tsolia, M., & Maritsi, D. (2022). Inmunogenicidad de la vacuna contra el ARNm Covid-19 en adolescentes con artritis idiopática juvenil en tratamiento con inhibidores de TNF. Anales de las enfermedades reumáticas, 81 (4), 592-593. https://www.ncbi.nlm.nih.gov/pubmed/34487236 | Iftikhar, H., Noor, S. M. U., Masood, M., & Bashir, K. (2021). Bell’s palsy after 24 hours of mRNA-1273 SARS-CoV-2 vaccine. Cureus, 13(6). https://pubmed.ncbi.nlm.nih.gov/34336436/ | Dionne, A., Sperotto, F., Chamberlain, S., Baker, A. L., Powell, A. J., Prakash, A., ... & Friedman, K. G. (2021). Association of myocarditis with BNT162b2 messenger RNA COVID-19 vaccine in a case series of children. JAMA cardiology, 6(12), 1446-1450. https://pubmed.ncbi.nlm.nih.gov/34374740/ | Castelli, G. P., Pognani, C., Sozzi, C., Franchini, M., & Vivona, L. (2021). Cerebral venous sinus thrombosis associated with thrombocytopenia post-vaccination for COVID-19. Critical Care, 25(1), 1-2. | https://pubmed.ncbi.nlm.nih.gov/33845870/. | Castelli, G. P., Pognani, C., Sozzi, C., Franchini, M., & Vivona, L. (2021). Cerebral venous sinus thrombosis associated with thrombocytopenia post-vaccination for COVID-19. Critical Care, 25(1), 1-2. https://pubmed.ncbi.nlm.nih.gov/33845870/. | Fousse, M., Schub, D., Merzou, F., Fassbender, K., Sester, M., Kettner, M., ... & Goi Júnior, J. R. (2022). Case report: cerebral sinus vein thrombosis in two patients with AstraZeneca SARS-CoV-2 vaccination. Journal of neurology, 269(2), 583-586. https://pubmed.ncbi.nlm.nih.gov/34609603/ | ||||
230 | Acute transverse myelitis (ATM): clinical review of 43 patients with COVID-19-associated ATM and 3 serious adverse events of post-vaccination ATM with ChAdOx1 nCoV-19 vaccine (AZD1222): | https://pubmed.ncbi.nlm.nih.gov/33981305/ | https://pubmed.ncbi.nlm.nih.gov/34281950/. | Burrows, A., Bartholomew, T., Rudd, J., & Walker, D. (2021). Sequential contralateral facial nerve palsies following COVID-19 vaccination first and second doses. BMJ Case Reports CP, 14(7), e243829. | Burrows, A., Bartholomew, T., Rudd, J. y Walker, D. (2021). Parálisis secuenciales del nervio facial contralateral después de la primera y segunda dosis de la vacuna COVID-19. BMJ Case Reports CP, 14(7), e243829. https://pubmed.ncbi.nlm.nih.gov/34458035/ | Dionne, A., Sperotto, F., Chamberlain, S., Baker, A. L. L., Powell, A. J., Prakash, A., ... & Friedman, K. G. (2021). Asociación de miocarditis con BNT162B2 Messenger RNA COVID-19 vacuna en una serie de niños. Cardiología de Jama, 6 (12), 1446-1450. https://jamanetwork.com/journals/jamacardiology/fullarticle/2781601%5C | Burrows, A., Bartholomew, T., Rudd, J., & Walker, D. (2021). Sequential contralateral facial nerve palsies following COVID-19 vaccination first and second doses. BMJ Case Reports CP, 14(7), e243829. https://pubmed.ncbi.nlm.nih.gov/34281950/. | Douxfils, J., Favresse, J., Dogné, J. M., Lecompte, T., Susen, S., Cordonnier, C., ... & Mullier, F. (2021). Hypotheses behind the very rare cases of thrombosis with thrombocytopenia syndrome after SARS-CoV-2 vaccination. Thrombosis research, 203, 163-171. https://www.sciencedirect.com/science/article/abs/pii/S0049384821003315 | Cuker, A. (2021). Thrombosis with thrombocytopenia syndrome after COVID-19 vaccination. Clinical advances in hematology & oncology: H&O, 19(7), 446-449. | https://pubmed.ncbi.nlm.nih.gov/34236343/ | Cuker, A. (2021). Thrombosis with thrombocytopenia syndrome after COVID-19 vaccination. Clinical advances in hematology & oncology: H&O, 19(7), 446-449. https://pubmed.ncbi.nlm.nih.gov/34236343/ | Fowler, N., Martinez, N. R. M., Pallares, B. V., & Maldonado, R. S. (2021). Acute-onset central serous retinopathy after immunization with COVID-19 mRNA vaccine. American Journal of Ophthalmology Case Reports, 23, 101136. https://www.sciencedirect.com/science/article/pii/S2451993621001456. | ||||
231 | Bell’s palsy after 24 hours of mRNA-1273 SARS-CoV-2 mRNA-1273 vaccine: | https://pubmed.ncbi.nlm.nih.gov/34336436/ | https://pubmed.ncbi.nlm.nih.gov/34458035/ | Tahir, N., Koorapati, G., Prasad, S., Jeelani, H. M., Sherchan, R., Shrestha, J., & Shayuk, M. (2021). SARS-CoV-2 vaccination-induced transverse myelitis. Cureus, 13(7). | Tahir, N., Koorapati, G., Prasad, S., Jeelani, H. M., Sherchan, R., Shrestha, J. y Shayuk, M. (2021). Mielitis transversa inducida por la vacunación contra el SARS-CoV-2. Cureus, 13(7). https://pubmed.ncbi.nlm.nih.gov/33734623/ | Dionne, A., Sperotto, F., Chamberlain, S., Baker, A. L. L., Powell, A. J., Prakash, A., ... & Friedman, K. G. (2021). Asociación de miocarditis con BNT162B2 Messenger RNA COVID-19 vacuna en una serie de niños. Cardiología de Jama, 6 (12), 1446-1450. https://www.nejm.org/doi/full/10.1056/NEJMoa2104840?query=recirc_curatedRelated_article | Tahir, N., Koorapati, G., Prasad, S., Jeelani, H. M., Sherchan, R., Shrestha, J., & Shayuk, M. (2021). SARS-CoV-2 vaccination-induced transverse myelitis. Cureus, 13(7). https://pubmed.ncbi.nlm.nih.gov/34458035/ | Douxfils, J., Vayne, C., Pouplard, C., Lecompte, T., Favresse, J., Potier, F., ... & Mullier, F. (2021). Fatal exacerbation of ChadOx1-nCoV-19-induced thrombotic thrombocytopenia syndrome after initial successful therapy with intravenous immunoglobulins-a rational for monitoring immunoglobulin G levels. haematologica, 106(12), 3249. https://pubmed.ncbi.nlm.nih.gov/34382387/ | Sung, J. G., Sobieszczyk, P. S., & Bhatt, D. L. (2021). Acute myocardial infarction within 24 hours after COVID-19 vaccination. The American Journal of Cardiology, 156, 129-131. | https://pubmed.ncbi.nlm.nih.gov/34364657/. | Sung, J. G., Sobieszczyk, P. S., & Bhatt, D. L. (2021). Acute myocardial infarction within 24 hours after COVID-19 vaccination. The American Journal of Cardiology, 156, 129-131. https://pubmed.ncbi.nlm.nih.gov/34364657/. | Franchini, M., Liumbruno, G. M., & Pezzo, M. (2021). COVID‐19 Vaccine‐associated Immune Thrombosis and Thrombocytopenia (VITT): diagnostic and therapeutic recommendations for a new syndrome. European Journal of Haematology, 107(2), 173-180. https://pubmed.ncbi.nlm.nih.gov/33987882/ | ||||
232 | Sequential contralateral facial nerve palsy after first and second doses of COVID-19 vaccine: | https://pubmed.ncbi.nlm.nih.gov/34281950/. | https://pubmed.ncbi.nlm.nih.gov/33734623/ | Shemer, A., Pras, E., & Hecht, I. (2021). Peripheral facial nerve palsy following BNT162b2 (COVID-19) vaccination. Israel Medical Association Journal: Imaj, 142-143. | Shemer, A., Pras, E. y Hecht, I. (2021). Parálisis del nervio facial periférico después de la vacunación BNT162b2 (COVID-19). Revista de la Asociación Médica de Israel: Imaj, 142-143. https://pubmed.ncbi.nlm.nih.gov/34044114/. | Douxfils, J., Favresse, J., Dogné, J. M., Lecompte, T., Susen, S., Cordonnier, C., ... & Mullier, F. (2021). Las hipótesis detrás de los casos muy raros de trombosis con síndrome de trombocitopenia después de la vacunación SARS-COV-2. Investigación de trombosis, 203, 163-171. https://www.sciencedirect.com/science/article/pii/S0896841121000937 | Shemer, A., Pras, E., & Hecht, I. (2021). Peripheral facial nerve palsy following BNT162b2 (COVID-19) vaccination. Israel Medical Association Journal: Imaj, 142-143. https://pubmed.ncbi.nlm.nih.gov/33734623/ | Dufour, C., Co, T. K., & Liu, A. (2021). GM1 ganglioside antibody and COVID-19 related Guillain Barre Syndrome–a case report, systemic review and implication for vaccine development. Brain, Behavior, & Immunity-Health, 12, 100203. https://www.sciencedirect.com/science/article/pii/S2666354621000065 | Book, B. A., Schmidt, B., & Foerster, A. M. (2021). Bilateral acute macular neuroretinopathy after vaccination against SARS-CoV-2. JAMA ophthalmology, 139(7), e212471-e212471. | https://pubmed.ncbi.nlm.nih.gov/34287612/ | Book, B. A., Schmidt, B., & Foerster, A. M. (2021). Bilateral acute macular neuroretinopathy after vaccination against SARS-CoV-2. JAMA ophthalmology, 139(7), e212471-e212471. https://pubmed.ncbi.nlm.nih.gov/34287612/ | Franchini, M., Testa, S., Pezzo, M., Glingani, C., Caruso, B., Terenziani, I., ... & Castelli, G. (2021). Cerebral venous thrombosis and thrombocytopenia post-COVID-19 vaccination. Thrombosis research, 202, 182-183. https://pubmed.ncbi.nlm.nih.gov/33878469/. | ||||
233 | Transverse myelitis induced by SARS-CoV-2 vaccination: | https://pubmed.ncbi.nlm.nih.gov/34458035/ | https://pubmed.ncbi.nlm.nih.gov/34044114/. | Reyes-Capo, D. P., Stevens, S. M., & Cavuoto, K. M. (2021). Acute abducens nerve palsy following COVID-19 vaccination. Journal of American Association for Pediatric Ophthalmology and Strabismus, 25(5), 302-303. | Reyes-Capo, D. P., Stevens, S. M. y Cavuoto, KM (2021). Parálisis aguda del nervio abductor tras la vacunación contra la COVID-19. Revista de la Asociación Estadounidense de Oftalmología Pediátrica y Estrabismo, 25(5), 302-303. https://pubmed.ncbi.nlm.nih.gov/34492394/ | Douxfils, J., Vayne, C., Poullard, C., Lecompte, T., Favresse, J., Potier, F., ... & Mullier, F. (2021). Exacerbación fatal del síndrome de trombocitopenia trombótica inducida por Chadox1-NCOV-19 después de la terapia con éxito inicial con inmunoglobulinas intravenosas, una racional para monitorear los niveles de inmunoglobulina g. Haematologica, 106 (12), 3249. https://pubmed.ncbi.nlm.nih.gov/34416184/. | Reyes-Capo, D. P., Stevens, S. M., & Cavuoto, K. M. (2021). Acute abducens nerve palsy following COVID-19 vaccination. Journal of American Association for Pediatric Ophthalmology and Strabismus, 25(5), 302-303. https://pubmed.ncbi.nlm.nih.gov/34044114/. | Dutta, A., Ghosh, R., Bhattacharya, D., Bhat, S., Ray, A., Pandit, A., ... & Dubey, S. (2021). Anti-PF4 antibody negative cerebral venous sinus thrombosis without thrombocytopenia following immunization with COVID-19 vaccine in an elderly non-comorbid Indian male, managed with conventional heparin-warfarin based anticoagulation. Diabetes & Metabolic Syndrome, 15(4), 102184. https://pubmed.ncbi.nlm.nih.gov/34186376/ | Syed, K., Chaudhary, H., & Donato, A. (2021). Central Venous Sinus Thrombosis with Subarachnoid Hemorrhage Following an mRNA COVID-19 Vaccination: Are These Reports Merely Co-Incidental?. The American journal of case reports, 22, e933397-1. | https://pubmed.ncbi.nlm.nih.gov/34478433/ | Syed, K., Chaudhary, H., & Donato, A. (2021). Central Venous Sinus Thrombosis with Subarachnoid Hemorrhage Following an mRNA COVID-19 Vaccination: Are These Reports Merely Co-Incidental?. The American journal of case reports, 22, e933397-1. https://pubmed.ncbi.nlm.nih.gov/34478433/ | Frank, A., Radparvar, S., Manasia, A., Bassily-Marcus, A., & Kohli-Seth, R. (2021). Prolonged anaphylaxis to pfizer coronavirus disease 2019 vaccine: a case report and mechanism of action. Critical Care Explorations, 3(4). https://pubmed.ncbi.nlm.nih.gov/33834172/ | ||||
234 | Peripheral facial nerve palsy after vaccination with BNT162b2 (COVID-19): | https://pubmed.ncbi.nlm.nih.gov/33734623/ | https://pubmed.ncbi.nlm.nih.gov/34492394/ | Sato, K., Mano, T., Niimi, Y., Toda, T., Iwata, A., & Iwatsubo, T. (2021). Facial nerve palsy following the administration of COVID-19 mRNA vaccines: analysis of a self-reporting database. International Journal of Infectious Diseases, 111, 310-312. | Sato, K., Mano, T., Niimi, Y., Toda, T., Iwata, A. e Iwatsubo, T. (2021). Parálisis del nervio facial después de la administración de vacunas de ARNm COVID-19: análisis de una base de datos de autoinforme. Revista Internacional de Enfermedades Infecciosas, 111, 310-312. https://pubmed.ncbi.nlm.nih.gov/34369471/ | Dufour, C., CO, T. K., Y LIU, A. (2021). GM1 Ganglióside Anticuerpo y COVID-19 CUERBED GUÍRRE BARRE SYNDROME: un informe de caso, revisión sistémica y implicación para el desarrollo de la vacuna. Cerebro, comportamiento, e inmunidad-salud, 12, 100203. https://www.sciencedirect.com/science/article/pii/S0303846721004169 | Sato, K., Mano, T., Niimi, Y., Toda, T., Iwata, A., & Iwatsubo, T. (2021). Facial nerve palsy following the administration of COVID-19 mRNA vaccines: analysis of a self-reporting database. International Journal of Infectious Diseases, 111, 310-312. https://pubmed.ncbi.nlm.nih.gov/34492394/ | Dutta, A., Ghosh, R., Bhattacharya, D., Bhat, S., Ray, A., Pandit, A., ... & Dubey, S. (2021). Anti-PF4 antibody negative cerebral venous sinus thrombosis without thrombocytopenia following immunization with COVID-19 vaccine in an elderly non-comorbid Indian male, managed with conventional heparin-warfarin based anticoagulation. Diabetes & Metabolic Syndrome, 15(4), 102184. https://www.sciencedirect.com/science/article/pii/S1871402121002046 | Zakaria, Z., Sapiai, N. A., & Ghani, A. R. I. (2021). Cerebral venous sinus thrombosis 2 weeks after the first dose of mRNA SARS-CoV-2 vaccine. Acta neurochirurgica, 163(8), 2359-2362. | https://pubmed.ncbi.nlm.nih.gov/34101024/ | Zakaria, Z., Sapiai, N. A., & Ghani, A. R. I. (2021). Cerebral venous sinus thrombosis 2 weeks after the first dose of mRNA SARS-CoV-2 vaccine. Acta neurochirurgica, 163(8), 2359-2362. https://pubmed.ncbi.nlm.nih.gov/34101024/ | Fritzen, M., Funchal, G. D. G., Luiz, M. O., & Durigon, G. S. (2022). Leukocytoclastic vasculitis after exposure to COVID-19 vaccine. Anais brasileiros de dermatologia, 97(1), 118-121. https://pubmed.ncbi.nlm.nih.gov/34836739/ | ||||
235 | Acute abducens nerve palsy after COVID-19 vaccination: | https://pubmed.ncbi.nlm.nih.gov/34044114/. | https://pubmed.ncbi.nlm.nih.gov/34369471/ | Pappaterra, M. C., Rivera, E. J., & Oliver, A. L. (2022). Transient Oculomotor Palsy Following the Administration of the Messenger RNA-1273 Vaccine for SARS-CoV-2 Diplopia Following the COVID-19 Vaccine. Journal of Neuro-Ophthalmology. | Pappaterra, M. C., Rivera, E. J. y Oliver, A. L. (2022). Parálisis oculomotora transitoria tras la administración de la vacuna ARN mensajero-1273 para la diplopía del SARS-CoV-2 tras la vacuna COVID-19. Revista de Neurooftalmología. https://pubmed.ncbi.nlm.nih.gov/34014316/ | Dutta, A., Ghosh, R., Bhattacharya, D., Bhat, S., Ray, A., Pandit, A., ... & Dubey, S. (2021). Anti-PF4 anticuerpo negativo cerebral sinusal de la trombosis sin trombocitopenia después de la inmunización con la vacuna COVID-19 en un anciano no comorbido indio, logrado con anticoagulación basada en heparina-warfarina convencional. Diabetes y síndrome metabólico, 15 (4), 102184. https://pubmed.ncbi.nlm.nih.gov/34101024/ | Pappaterra, M. C., Rivera, E. J., & Oliver, A. L. (2022). Transient Oculomotor Palsy Following the Administration of the Messenger RNA-1273 Vaccine for SARS-CoV-2 Diplopia Following the COVID-19 Vaccine. Journal of Neuro-Ophthalmology. https://pubmed.ncbi.nlm.nih.gov/34369471/ | Dutta, A., Ghosh, R., Bhattacharya, D., Bhat, S., Ray, A., Pandit, A., ... & Dubey, S. (2021). Anti-PF4 antibody negative cerebral venous sinus thrombosis without thrombocytopenia following immunization with COVID-19 vaccine in an elderly non-comorbid Indian male, managed with conventional heparin-warfarin based anticoagulation. Diabetes & Metabolic Syndrome, 15(4), 102184. https://www.sciencedirect.com/science/article/pii/S1871402121002046. | Tølbøll Sørensen, A. L., Rolland, M., Hartmann, J., Harboe, Z. B., Roed, C., Jensen, T. Ø., ... & Stensballe, J. (2021). A case of thrombocytopenia and multiple thromboses after vaccination with ChAdOx1 nCoV-19 against SARS-CoV-2. Blood Advances, 5(12), 2569-2574. | https://pubmed.ncbi.nlm.nih.gov/34137813/ | Tølbøll Sørensen, A. L., Rolland, M., Hartmann, J., Harboe, Z. B., Roed, C., Jensen, T. Ø., ... & Stensballe, J. (2021). A case of thrombocytopenia and multiple thromboses after vaccination with ChAdOx1 nCoV-19 against SARS-CoV-2. Blood Advances, 5(12), 2569-2574. https://pubmed.ncbi.nlm.nih.gov/34137813/ | Fueyo-Rodriguez, O., Valente-Acosta, B., Jimenez-Soto, R., Neme-Yunes, Y., Inclán-Alarcón, S. I., Trejo-Gonzalez, R., & García-Salcido, M. Á. (2021). Secondary immune thrombocytopenia supposedly attributable to COVID-19 vaccination. BMJ Case Reports CP, 14(5), e242220. https://casereports.bmj.com/content/14/5/e242220.abstract. | ||||
236 | Facial nerve palsy after administration of COVID-19 mRNA vaccines: analysis of self-report database: | https://pubmed.ncbi.nlm.nih.gov/34492394/ | https://pubmed.ncbi.nlm.nih.gov/34014316/ | Nishizawa, Y., Hoshina, Y., & Baker, V. (2021). Bell’s palsy following the Ad26. COV2. S COVID-19 vaccination. QJM: An International Journal of Medicine. | Nishizawa, Y., Hoshina, Y. y Baker, V. (2021). Parálisis de Bell tras el anuncio 26. COV2. S Vacunación contra el COVID-19. QJM: Revista internacional de medicina. https://pubmed.ncbi.nlm.nih.gov/34330676/ | Dutta, A., Ghosh, R., Bhattacharya, D., Bhat, S., Ray, A., Pandit, A., ... & Dubey, S. (2021). Anti-PF4 anticuerpo negativo cerebral sinusal de la trombosis sin trombocitopenia después de la inmunización con la vacuna COVID-19 en un anciano no comorbido indio, logrado con anticoagulación basada en heparina-warfarina convencional. Diabetes y síndrome metabólico, 15 (4), 102184. https://www.sciencedirect.com/science/article/abs/pii/S188558572100133X | Nishizawa, Y., Hoshina, Y., & Baker, V. (2021). Bell’s palsy following the Ad26. COV2. S COVID-19 vaccination. QJM: An International Journal of Medicine. https://pubmed.ncbi.nlm.nih.gov/34014316/ | Edler, C., Klein, A., Schröder, A. S., Sperhake, J. P., & Ondruschka, B. (2021). Deaths associated with newly launched SARS-CoV-2 vaccination (Comirnaty®). Legal Medicine, 51, 101895. https://pubmed.ncbi.nlm.nih.gov/33895650/ | Marcucci, R., & Marietta, M. (2021). Vaccine-induced thrombotic thrombocytopenia: the elusive link between thrombosis and adenovirus-based SARS-CoV-2 vaccines. Internal and emergency medicine, 16(5), 1113-1119. | https://pubmed.ncbi.nlm.nih.gov/34191218/ | Marcucci, R., & Marietta, M. (2021). Vaccine-induced thrombotic thrombocytopenia: the elusive link between thrombosis and adenovirus-based SARS-CoV-2 vaccines. Internal and emergency medicine, 16(5), 1113-1119. https://pubmed.ncbi.nlm.nih.gov/34191218/ | Fujikawa, P., Shah, F. A., Braford, M., Patel, K., & Madey, J. (2021). Neuromyelitis Optica in a Healthy Female After Severe Acute Respiratory Syndrome Coronavirus 2 mRNA-1273 Vaccine. Cureus, 13(9). https://pubmed.ncbi.nlm.nih.gov/34660149/ | ||||
237 | Transient oculomotor paralysis after administration of RNA-1273 messenger vaccine for SARS-CoV-2 diplopia after COVID-19 vaccine: | https://pubmed.ncbi.nlm.nih.gov/34369471/ | https://pubmed.ncbi.nlm.nih.gov/34330676/ | de Terreros Caro, G. G., Díaz, S. G., Alé, M. P., & Gimeno, M. M. (2021). Bell’s palsy following COVID-19 vaccination: A case report. Neurologia (Barcelona, Spain). | de Terreros Caro, G. G., Díaz, S. G., Alé, M. P., & Gimeno, M. M. (2021). Parálisis de Bell después de la vacunación COVID-19: reporte de un caso. Neurología (Barcelona, España). https://pubmed.ncbi.nlm.nih.gov/34272622/ | Dutta, A., Ghosh, R., Bhattacharya, D., Bhat, S., Ray, A., Pandit, A., ... & Dubey, S. (2021). Anti-PF4 anticuerpo negativo cerebral sinusal de la trombosis sin trombocitopenia después de la inmunización con la vacuna COVID-19 en un anciano no comorbido indio, logrado con anticoagulación basada en heparina-warfarina convencional. Diabetes y síndrome metabólico, 15 (4), 102184. https://www.sciencedirect.com/science/article/pii/S0049384821004369 | de Terreros Caro, G. G., Díaz, S. G., Alé, M. P., & Gimeno, M. M. (2021). Bell’s palsy following COVID-19 vaccination: A case report. Neurologia (Barcelona, Spain). https://pubmed.ncbi.nlm.nih.gov/34330676/ | Ehrlich, P., Klingel, K., Ohlmann-Knafo, S., Hüttinger, S., Sood, N., Pickuth, D., & Kindermann, M. (2021). Biopsy-proven lymphocytic myocarditis following first mRNA COVID-19 vaccination in a 40-year-old male: case report. Clinical Research in Cardiology, 110(11), 1855-1859. https://pubmed.ncbi.nlm.nih.gov/34487236/ | Costentin, G., Ozkul-Wermester, O., Triquenot, A., Le Cam-Duchez, V., Massy, N., Benhamou, Y., & Massardier, E. (2021). Acute ischemic stroke revealing ChAdOx1 nCov-19 vaccine-induced immune thrombotic thrombocytopenia: impact on recanalization strategy. Journal of Stroke and Cerebrovascular Diseases, 30(9), 105942. | https://pubmed.ncbi.nlm.nih.gov/34175640/ | Costentin, G., Ozkul-Wermester, O., Triquenot, A., Le Cam-Duchez, V., Massy, N., Benhamou, Y., & Massardier, E. (2021). Acute ischemic stroke revealing ChAdOx1 nCov-19 vaccine-induced immune thrombotic thrombocytopenia: impact on recanalization strategy. Journal of Stroke and Cerebrovascular Diseases, 30(9), 105942. https://pubmed.ncbi.nlm.nih.gov/34175640/ | Fukushima, T., Tomita, M., Ikeda, S., & Hattori, N. (2021). A case of sensory ataxic Guillain–Barré syndrome with immunoglobulin G anti-GM1 antibodies following the first dose of mRNA COVID-19 vaccine BNT162b2 (Pfizer). QJM: An International Journal of Medicine. https://pubmed.ncbi.nlm.nih.gov/34871447/ | ||||
238 | Bell’s palsy after Ad26.COV2.S COVID-19 vaccination: | https://pubmed.ncbi.nlm.nih.gov/34014316/ | https://pubmed.ncbi.nlm.nih.gov/34272622/ | Nasuelli, N. A., De Marchi, F., Cecchin, M., De Paoli, I., Onorato, S., Pettinaroli, R., ... & Godi, L. (2021). A case of acute demyelinating polyradiculoneuropathy with bilateral facial palsy after ChAdOx1 nCoV-19 vaccine. Neurological Sciences, 42(11), 4747-4749. | Nasuelli, N. A., De Marchi, F., Cecchin, M., De Paoli, I., Onorato, S., Pettinaroli, R., ... & Godi, L. (2021). Un caso de polirradiculoneuropatía desmielinizante aguda con parálisis facial bilateral después de la vacuna ChAdOx1 nCoV-19. Ciencias Neurológicas, 42(11), 4747-4749. https://pubmed.ncbi.nlm.nih.gov/34477091/ | Edler, C., Klein, A., Schröder, A. S., Sperhake, J. P., & Ondruschka, B. (2021). Muertes asociadas con la vacunación de SARS-COV-2 recién lanzados (ComirnAty®). Medicina legal, 51, 101895. https://pubmed.ncbi.nlm.nih.gov/34425384/ | Nasuelli, N. A., De Marchi, F., Cecchin, M., De Paoli, I., Onorato, S., Pettinaroli, R., ... & Godi, L. (2021). A case of acute demyelinating polyradiculoneuropathy with bilateral facial palsy after ChAdOx1 nCoV-19 vaccine. Neurological Sciences, 42(11), 4747-4749. https://pubmed.ncbi.nlm.nih.gov/34272622/ | Ehrlich, P., Klingel, K., Ohlmann-Knafo, S., Hüttinger, S., Sood, N., Pickuth, D., & Kindermann, M. (2021). Biopsy-proven lymphocytic myocarditis following first mRNA COVID-19 vaccination in a 40-year-old male: case report. Clinical Research in Cardiology, 110(11), 1855-1859. https://www.ncbi.nlm.nih.gov/pubmed/34487236 | Malik, B., Kalantary, A., Rikabi, K., & Kunadi, A. (2021). Pulmonary embolism, transient ischaemic attack and thrombocytopenia after the Johnson & Johnson COVID-19 vaccine. BMJ Case Reports CP, 14(7), e243975. | https://pubmed.ncbi.nlm.nih.gov/34261635/ | Malik, B., Kalantary, A., Rikabi, K., & Kunadi, A. (2021). Pulmonary embolism, transient ischaemic attack and thrombocytopenia after the Johnson & Johnson COVID-19 vaccine. BMJ Case Reports CP, 14(7), e243975. https://pubmed.ncbi.nlm.nih.gov/34261635/ | Furer, V., Eviatar, T., Zisman, D., Peleg, H., Paran, D., Levartovsky, D., ... & Elkayam, O. (2021). Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in adult patients with autoimmune inflammatory rheumatic diseases and in the general population: a multicentre study. Annals of the rheumatic diseases, 80(10), 1330-1338. https://www.ncbi.nlm.nih.gov/pubmed/34127481 | ||||
239 | Bell’s palsy after COVID-19 vaccination: case report: | https://pubmed.ncbi.nlm.nih.gov/34330676/ | https://pubmed.ncbi.nlm.nih.gov/34477091/ | Christensen, S. K., Ballegaard, M., & Boesen, M. S. (2021). Guillian-Barrés syndrom efter mRNA-1273-COVID-19-vaccine. Ugeskr Læger, 183, V05210455. | Christensen, SK, Ballegaard, M. y Boesen, MS (2021). Síndrome de Guillian-Barrés tras la vacuna mRNA-1273-COVID-19. Ugeskr Læger, 183, V05210455. https://pubmed.ncbi.nlm.nih.gov/33975372/. | Ehrlich, P., Klingel, K., Ohlmann-Knofo, S., Hüttinger, S., Sood, N., Pickuth, D., & Kindermann, M. (2021). La miocarditis linfocítica probada por la biopsia después de la primera vacunación contra el ARNm Covid-19 en un macho de 40 años: informe de caso. Investigación clínica en cardiología, 110 (11), 1855-1859. https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciab741/6359059 | Christensen, S. K., Ballegaard, M., & Boesen, M. S. (2021). Guillian-Barrés syndrom efter mRNA-1273-COVID-19-vaccine. Ugeskr Læger, 183, V05210455. https://pubmed.ncbi.nlm.nih.gov/34477091/ | El Sahly, H. M., Baden, L. R., Essink, B., Doblecki-Lewis, S., Martin, J. M., Anderson, E. J., ... & Miller, J. (2021). Efficacy of the mRNA-1273 SARS-CoV-2 vaccine at completion of blinded phase. New England Journal of Medicine, 385(19), 1774-1785. https://www.ncbi.nlm.nih.gov/pubmed/34551225 | Warkentin, T. E., & Greinacher, A. (2021). Spontaneous HIT syndrome: knee replacement, infection, and parallels with vaccine-induced immune thrombotic thrombocytopenia. Thrombosis Research, 204, 40-51. | https://pubmed.ncbi.nlm.nih.gov/34144250/ | Warkentin, T. E., & Greinacher, A. (2021). Spontaneous HIT syndrome: knee replacement, infection, and parallels with vaccine-induced immune thrombotic thrombocytopenia. Thrombosis Research, 204, 40-51. https://pubmed.ncbi.nlm.nih.gov/34144250/ | Furie, K. L., Cushman, M., Elkind, M. S., Lyden, P. D., Saposnik, G., & American Heart Association/American Stroke Association Stroke Council Leadership. (2021). Diagnosis and management of cerebral venous sinus thrombosis with vaccine-induced immune thrombotic thrombocytopenia. Stroke, 52(7), 2478-2482. https://pubmed.ncbi.nlm.nih.gov/33914590/ | ||||
240 | A case of acute demyelinating polyradiculoneuropathy with bilateral facial palsy following ChAdOx1 nCoV-19 vaccination: | https://pubmed.ncbi.nlm.nih.gov/34272622/ | https://pubmed.ncbi.nlm.nih.gov/33975372/. | Volk, G. F., Kuttenreich, A. M., Geitner, M., & Guntinas-Lichius, O. (2021). Acute facial paresis as a possible complication of vaccination against SARS-CoV-2. Laryngo-Rhino-Otologie. | Volk, G. F., Kuttenreich, A. M., Geitner, M. y Guntinas-Lichius, O. (2021). Paresia facial aguda como posible complicación de la vacunación contra el SARS-CoV-2. Laringo-Rino-Otología. https://pubmed.ncbi.nlm.nih.gov/34322761/. | Ehrlich, P., Klingel, K., Ohlmann-Knofo, S., Hüttinger, S., Sood, N., Pickuth, D., & Kindermann, M. (2021). La miocarditis linfocítica probada por la biopsia después de la primera vacunación contra el ARNm Covid-19 en un macho de 40 años: informe de caso. Investigación clínica en cardiología, 110 (11), 1855-1859. https://www.ncbi.nlm.nih.gov/pubmed/34551225 | Volk, G. F., Kuttenreich, A. M., Geitner, M., & Guntinas-Lichius, O. (2021). Acute facial paresis as a possible complication of vaccination against SARS-CoV-2. Laryngo-Rhino-Otologie. https://pubmed.ncbi.nlm.nih.gov/33975372/. | Elrashdy, F., Tambuwala, M. M., Hassan, S. S., Adadi, P., Seyran, M., Abd El-Aziz, T. M., ... & Uversky, V. N. (2021). Autoimmunity roots of the thrombotic events after COVID-19 vaccination. Autoimmunity reviews, 20(11), 102941. https://pubmed.ncbi.nlm.nih.gov/34508917/ | Carli, G., Nichele, I., Ruggeri, M., Barra, S., & Tosetto, A. (2021). Deep vein thrombosis (DVT) occurring shortly after the second dose of mRNA SARS-CoV-2 vaccine. Internal and emergency medicine, 16(3), 803-804. | https://pubmed.ncbi.nlm.nih.gov/33687691/ | Carli, G., Nichele, I., Ruggeri, M., Barra, S., & Tosetto, A. (2021). Deep vein thrombosis (DVT) occurring shortly after the second dose of mRNA SARS-CoV-2 vaccine. Internal and emergency medicine, 16(3), 803-804. https://pubmed.ncbi.nlm.nih.gov/33687691/ | Gabarin, N., Patterson, S., Pai, M., Afzaal, T., Nazy, I., Sheppard, J. A. I., ... & Warkentin, T. E. (2021). Venous thromboembolism and mild thrombocytopenia after ChAdOx1 nCoV-19 vaccination. Thrombosis and Haemostasis, 121(12), 1677-1680. https://pubmed.ncbi.nlm.nih.gov/34384129/ | ||||
241 | Guillian Barré syndrome after vaccination with mRNA-1273 against COVID-19: | https://pubmed.ncbi.nlm.nih.gov/34477091/ | https://pubmed.ncbi.nlm.nih.gov/34322761/. | Obermann, M., Krasniqi, M., Ewers, N., Fayad, J., & Haeberle, U. (2021). Bell’s palsy following COVID-19 vaccination with high CSF antibody response. Neurological Sciences, 42(11), 4397-4399. | Obermann, M., Krasniqi, M., Ewers, N., Fayad, J. y Haeberle, U. (2021). Parálisis de Bell después de la vacunación COVID-19 con alta respuesta de anticuerpos en el LCR. Ciencias Neurológicas, 42(11), 4397-4399. https://pubmed.ncbi.nlm.nih.gov/34139321/. | El Sahly, H. M., Baden, L. R., Essink, B., Doblecki-Lewis, S., Martin, J. M., Anderson, E. J., ... & Miller, J. (2021). Eficacia de la vacuna contra el MRNA-1273 SARS-COV-2 al finalizar la fase ciega. New England Journal of Medicine, 385 (19), 1774-1785. https://www.ncbi.nlm.nih.gov/pubmed/34709227 | Obermann, M., Krasniqi, M., Ewers, N., Fayad, J., & Haeberle, U. (2021). Bell’s palsy following COVID-19 vaccination with high CSF antibody response. Neurological Sciences, 42(11), 4397-4399. https://pubmed.ncbi.nlm.nih.gov/34322761/. | Elrashdy, F., Tambuwala, M. M., Hassan, S. S., Adadi, P., Seyran, M., Abd El-Aziz, T. M., ... & Uversky, V. N. (2021). Autoimmunity roots of the thrombotic events after COVID-19 vaccination. Autoimmunity reviews, 20(11), 102941. https://pubmed.ncbi.nlm.nih.gov/34508917/. | Althaus, K., Möller, P., Uzun, G., Singh, A., Beck, A., Bettag, M., ... & Bakchoul, T. (2021). Antibody-mediated procoagulant platelets in SARS-CoV-2-vaccination associated immune thrombotic thrombocytopenia. Haematologica, 106(8), 2170. | https://pubmed.ncbi.nlm.nih.gov/34011137/. | Althaus, K., Möller, P., Uzun, G., Singh, A., Beck, A., Bettag, M., ... & Bakchoul, T. (2021). Antibody-mediated procoagulant platelets in SARS-CoV-2-vaccination associated immune thrombotic thrombocytopenia. Haematologica, 106(8), 2170. https://pubmed.ncbi.nlm.nih.gov/34011137/. | Gadi, S. R., Brunker, P. A., Al‐Samkari, H., Sykes, D. B., Saff, R. R., Lo, J., ... & Leaf, R. K. (2021). Severe autoimmune hemolytic anemia following receipt of SARS‐CoV‐2 mRNA vaccine. Transfusion, 61(11), 3267-3271. https://onlinelibrary.wiley.com/doi/10.1111/trf.16672 | ||||
242 | Acute facial paralysis as a possible complication of SARS-CoV-2 vaccination: | https://pubmed.ncbi.nlm.nih.gov/33975372/. | https://pubmed.ncbi.nlm.nih.gov/34139321/. | Finsterer, J., & Scorza, F. A. (2021). SARS-CoV-2 or SARS-CoV-2 vaccination associated Parsonage-Turner syndrome. Comment on:“Neuralgic amyotrophy and Covid 19 infection: 2 cases of spinal accessory nerve palsy” by Coll et al. Joint Bone Spine 2021; 88: 105196. Joint Bone Spine. | Finsterer, J. y Scorza, FA (2021). Síndrome de Parsonage-Turner asociado a la vacunación contra el SARS-CoV-2 o el SARS-CoV-2. Comentar en: “Amiotrofia neural e infección por Covid 19: 2 casos de parálisis del nervio espinal accesorio” de Coll et al. Articulación ósea columna vertebral 2021; 88: 105196. Articulación ósea de la columna vertebral. https://pubmed.ncbi.nlm.nih.gov/34032902/. | Elrashdy, F., Tambuwala, M. M., Hassan, S. S., Adadi, P., Seyran, M., Abd El-Aziz, T. M., ... & Uversky, V. N. (2021). Raíces autoinmunidad de los eventos trombóticos después de la vacunación de COVID-19. Comentarios de autoinmunity, 20 (11), 102941. https://pubmed.ncbi.nlm.nih.gov/34370974/ | Finsterer, J., & Scorza, F. A. (2021). SARS-CoV-2 or SARS-CoV-2 vaccination associated Parsonage-Turner syndrome. Comment on:“Neuralgic amyotrophy and Covid 19 infection: 2 cases of spinal accessory nerve palsy” by Coll et al. Joint Bone Spine 2021; 88: 105196. Joint Bone Spine. https://pubmed.ncbi.nlm.nih.gov/34139321/. | Elrashdy, F., Tambuwala, M. M., Hassan, S. S., Adadi, P., Seyran, M., Abd El-Aziz, T. M., ... & Uversky, V. N. (2021). Autoimmunity roots of the thrombotic events after COVID-19 vaccination. Autoimmunity reviews, 20(11), 102941. https://www.sciencedirect.com/science/article/abs/pii/S1568997221002160 | Wiedmann, M., Skattør, T., Stray-Pedersen, A., Romundstad, L., Antal, E. A., Marthinsen, P. B., ... & Skjelland, M. (2021). Vaccine induced immune thrombotic thrombocytopenia causing a severe form of cerebral venous thrombosis with high fatality rate: a case series. Frontiers in neurology, 1302. | https://pubmed.ncbi.nlm.nih.gov/34393988/. | Wiedmann, M., Skattør, T., Stray-Pedersen, A., Romundstad, L., Antal, E. A., Marthinsen, P. B., ... & Skjelland, M. (2021). Vaccine induced immune thrombotic thrombocytopenia causing a severe form of cerebral venous thrombosis with high fatality rate: a case series. Frontiers in neurology, 1302. https://pubmed.ncbi.nlm.nih.gov/34393988/. | Galindo, R., Chow, H., & Rongkavilit, C. (2021). COVID-19 in children: clinical manifestations and pharmacologic interventions including vaccine trials. Pediatric Clinics, 68(5), 961-976. https://www.ncbi.nlm.nih.gov/pubmed/34538306 | ||||
243 | Bell’s palsy after COVID-19 vaccination with high antibody response in CSF: | https://pubmed.ncbi.nlm.nih.gov/34322761/. | https://pubmed.ncbi.nlm.nih.gov/34032902/. | Martin-Villares, C., Vazquez-Feito, A., Gonzalez-Gimeno, M. J., & de la Nogal-Fernandez, B. (2022). Bell’s palsy following a single dose of mRNA SARS-CoV-2 vaccine: a case report. Journal of Neurology, 269(1), 47-48. | Martín-Villares, C., Vázquez-Feito, A., González-Gimeno, M. J. y de la Nogal-Fernández, B. (2022). Parálisis de Bell después de una dosis única de la vacuna de ARNm SARS-CoV-2: reporte de un caso. Revista de Neurología, 269(1), 47-48. https://pubmed.ncbi.nlm.nih.gov/33862041/ | Elrashdy, F., Tambuwala, M. M., Hassan, S. S., Adadi, P., Seyran, M., Abd El-Aziz, T. M., ... & Uversky, V. N. (2021). Raíces autoinmunidad de los eventos trombóticos después de la vacunación de COVID-19. Comentarios de autoinmunity, 20 (11), 102941. https://www.jcehepatology.com/article/S0973-6883(21)00545-4/fulltext. | Martin-Villares, C., Vazquez-Feito, A., Gonzalez-Gimeno, M. J., & de la Nogal-Fernandez, B. (2022). Bell’s palsy following a single dose of mRNA SARS-CoV-2 vaccine: a case report. Journal of Neurology, 269(1), 47-48. https://pubmed.ncbi.nlm.nih.gov/34032902/. | ElSheikh, R. H., Haseeb, A., Eleiwa, T. K., & Elhusseiny, A. M. (2021). Acute uveitis following COVID-19 vaccination. Ocular immunology and inflammation, 1-3. https://pubmed.ncbi.nlm.nih.gov/34851795/. | Marchandot, B., Carmona, A., Trimaille, A., Curtiaud, A., & Morel, O. (2021). Procoagulant microparticles: a possible link between vaccine-induced immune thrombocytopenia (VITT) and cerebral sinus venous thrombosis. Journal of Thrombosis and Thrombolysis, 52(3), 689-691. | https://pubmed.ncbi.nlm.nih.gov/34129181/. | Marchandot, B., Carmona, A., Trimaille, A., Curtiaud, A., & Morel, O. (2021). Procoagulant microparticles: a possible link between vaccine-induced immune thrombocytopenia (VITT) and cerebral sinus venous thrombosis. Journal of Thrombosis and Thrombolysis, 52(3), 689-691. https://pubmed.ncbi.nlm.nih.gov/34129181/. | Ganga, K., Solyar, A. Y., & Ganga, R. (2021). Massive Cervical Lymphadenopathy Post-COVID-19 Vaccination. Ear, Nose & Throat Journal, 01455613211048984. https://pubmed.ncbi.nlm.nih.gov/34601889/ | ||||
244 | Parsonage-Turner syndrome associated with SARS-CoV-2 or SARS-CoV-2 vaccination. Comment on: “Neuralgic amyotrophy and COVID-19 infection: 2 cases of accessory spinal nerve palsy” by Coll et al. Articular Spine 2021; 88: 10519: | https://pubmed.ncbi.nlm.nih.gov/34139321/. | https://pubmed.ncbi.nlm.nih.gov/33862041/ | Bril, F., Al Diffalha, S., Dean, M., & Fettig, D. M. (2021). Autoimmune hepatitis developing after coronavirus disease 2019 (COVID-19) vaccine: causality or casualty?. Journal of Hepatology, 75(1), 222-224. | Bril, F., Al Diffalha, S., Dean, M. y Fettig, DM (2021). Hepatitis autoinmune que se desarrolla después de la vacuna contra la enfermedad por coronavirus 2019 (COVID-19): ¿causalidad o víctima?. Revista de Hepatología, 75(1), 222-224. https://pubmed.ncbi.nlm.nih.gov/34332438/ | Elrashdy, F., Tambuwala, M. M., Hassan, S. S., Adadi, P., Seyran, M., Abd El-Aziz, T. M., ... & Uversky, V. N. (2021). Raíces autoinmunidad de los eventos trombóticos después de la vacunación de COVID-19. Comentarios de autoinmunity, 20 (11), 102941. https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)01788-8/fulltext | Bril, F., Al Diffalha, S., Dean, M., & Fettig, D. M. (2021). Autoimmune hepatitis developing after coronavirus disease 2019 (COVID-19) vaccine: causality or casualty?. Journal of Hepatology, 75(1), 222-224. https://pubmed.ncbi.nlm.nih.gov/33862041/ | Endo, B., Bahamon, S., & Martínez-Pulgarín, D. F. (2021). Central retinal vein occlusion after mRNA SARS-CoV-2 vaccination: A case report. Indian journal of ophthalmology, 69(10), 2865. https://pubmed.ncbi.nlm.nih.gov/34571653/. | Gras-Champel, V., Liabeuf, S., Baud, M., Albucher, J. F., Benkebil, M., Boulay, C., ... & French Network of Pharmacovigilance Centres. (2021). Atypical thrombosis associated with VaxZevria®(AstraZeneca) vaccine: data from the French network of regional pharmacovigilance centres. Therapie. | https://pubmed.ncbi.nlm.nih.gov/34083026/. | Gras-Champel, V., Liabeuf, S., Baud, M., Albucher, J. F., Benkebil, M., Boulay, C., ... & French Network of Pharmacovigilance Centres. (2021). Atypical thrombosis associated with VaxZevria®(AstraZeneca) vaccine: data from the French network of regional pharmacovigilance centres. Therapie. https://pubmed.ncbi.nlm.nih.gov/34083026/. | Gangat, N., Guglielmelli, P., Betti, S., Farrukh, F., Carobbio, A., Barbui, T., ... & Tefferi, A. (2021). Cerebral venous thrombosis and myeloproliferative neoplasms: A three‐center study of 74 consecutive cases. American journal of hematology, 96(12), 1580-1586. https://pubmed.ncbi.nlm.nih.gov/34453762/. | ||||
245 | Bell’s palsy after a single dose of vaccine mRNA. SARS-CoV-2: case report: | https://pubmed.ncbi.nlm.nih.gov/34032902/. | https://pubmed.ncbi.nlm.nih.gov/34332438/ | Vuille-Lessard, É., Montani, M., Bosch, J., & Semmo, N. (2021). Autoimmune hepatitis triggered by SARS-CoV-2 vaccination. Journal of autoimmunity, 123, 102710. | Vuille-Lessard, É., Montani, M., Bosch, J. y Semmo, N. (2021). Hepatitis autoinmune desencadenada por la vacunación contra el SARS-CoV-2. Revista de autoinmunidad, 123, 102710. https://pubmed.ncbi.nlm.nih.gov/34293683/. | Elsheikh, R. H., Haseeb, A., Eleiwa, T. K., & Elhusseiny, A. M. (2021). Uveítis aguda después de la vacunación COVID-19. Inmunología ocular e inflamación, 1-3. https://pubmed.ncbi.nlm.nih.gov/34849386/ | Vuille-Lessard, É., Montani, M., Bosch, J., & Semmo, N. (2021). Autoimmune hepatitis triggered by SARS-CoV-2 vaccination. Journal of autoimmunity, 123, 102710. https://pubmed.ncbi.nlm.nih.gov/34332438/ | Erdem, N. Ş., Demirci, S., Özel, T., Mamadova, K., Karaali, K., Çelik, H. T., ... & Özkaynak, S. S. (2021). Acute transverse myelitis after inactivated COVID-19 vaccine. Ideggyogyaszati Szemle, 74(7-08), 273-276. https://pubmed.ncbi.nlm.nih.gov/34370410/ | Taylor, P., Allen, L., Shrikrishnapalasuriyar, N., Stechman, M., & Rees, A. (2021). Vaccine‐induced thrombosis and thrombocytopenia with bilateral adrenal haemorrhage. Clinical Endocrinology. | https://pubmed.ncbi.nlm.nih.gov/34235757/. | Taylor, P., Allen, L., Shrikrishnapalasuriyar, N., Stechman, M., & Rees, A. (2021). Vaccine‐induced thrombosis and thrombocytopenia with bilateral adrenal haemorrhage. Clinical Endocrinology. https://pubmed.ncbi.nlm.nih.gov/34235757/. | Gangi, A., Mobashwera, B., Ganczakowski, M., & Ayto, R. (2021). Imaging and hematologic findings in thrombosis and thrombocytopenia after ChAdOx1 nCoV-19 (AstraZeneca) vaccination. Radiology, 211546. https://pubmed.ncbi.nlm.nih.gov/34402666/ | ||||
246 | Autoimmune hepatitis developing after coronavirus disease vaccine 2019 (COVID-19): causality or victim?: | https://pubmed.ncbi.nlm.nih.gov/33862041/ | https://pubmed.ncbi.nlm.nih.gov/34293683/. | Ghielmetti, M., Schaufelberger, H. D., Mieli-Vergani, G., Cerny, A., Dayer, E., Vergani, D., & Beretta-Piccoli, B. T. (2021). Acute autoimmune-like hepatitis with atypical anti-mitochondrial antibody after mRNA COVID-19 vaccination: A novel clinical entity?. Journal of Autoimmunity, 123, 102706. | Ghielmetti, M., Schaufelberger, H. D., Mieli-Vergani, G., Cerny, A., Dayer, E., Vergani, D. y Beretta-Piccoli, B. T. (2021). Hepatitis aguda de tipo autoinmune con anticuerpo antimitocondrial atípico después de la vacunación con ARNm COVID-19: ¿una entidad clínica novedosa? Revista de autoinmunidad, 123, 102706. https://pubmed.ncbi.nlm.nih.gov/34225251/ | Endo, B., Bahamon, S., y Martínez-Pulgarín, D. F. (2021). Oclusión de la vena de retina central después de la vacunación con MRNA SARS-COV-2: un informe de caso. Diario indio de oftalmología, 69 (10), 2865. https://pubmed.ncbi.nlm.nih.gov/34835275/. | Ghielmetti, M., Schaufelberger, H. D., Mieli-Vergani, G., Cerny, A., Dayer, E., Vergani, D., & Beretta-Piccoli, B. T. (2021). Acute autoimmune-like hepatitis with atypical anti-mitochondrial antibody after mRNA COVID-19 vaccination: A novel clinical entity?. Journal of Autoimmunity, 123, 102706. https://pubmed.ncbi.nlm.nih.gov/34293683/. | Erler, A., Fiedler, J., Koch, A., Heldmann, F., & Schütz, A. (2021). Leukocytoclastic Vasculitis After Vaccination With a SARS‐CoV‐2 Vaccine. Arthritis & Rheumatology, 73(12), 2188-2188. https://pubmed.ncbi.nlm.nih.gov/34196469/. | Chen, Y. A., Huang, H. Y., Wu, S. H., & Huang, T. C. (2021). Thrombosis of the palmar digital vein after Oxford-AstraZeneca COVID-19 vaccination. International Journal of Dermatology, 60(11), e469-e471. | https://pubmed.ncbi.nlm.nih.gov/34473841/. | Chen, Y. A., Huang, H. Y., Wu, S. H., & Huang, T. C. (2021). Thrombosis of the palmar digital vein after Oxford-AstraZeneca COVID-19 vaccination. International Journal of Dermatology, 60(11), e469-e471. https://pubmed.ncbi.nlm.nih.gov/34473841/. | Ganzel, C., & Ben-Chetrit, E. (2021). Immune Thrombocytopenia Following the Pfizer-BioNTech BNT162b2 mRNA COVID-19 Vaccine. The Israel Medical Association Journal: IMAJ, 23(6), 341-341. https://pubmed.ncbi.nlm.nih.gov/34155844/ | ||||
247 | Autoimmune hepatitis triggered by vaccination against SARS-CoV-2: | https://pubmed.ncbi.nlm.nih.gov/34332438/ | https://pubmed.ncbi.nlm.nih.gov/34225251/ | Rela, M., Jothimani, D., Vij, M., Rajakumar, A., & Rammohan, A. (2021). Auto-immune hepatitis following COVID vaccination. Journal of Autoimmunity, 123, 102688. | Rela, M., Jothimani, D., Vij, M., Rajakumar, A. y Rammohan, A. (2021). Hepatitis autoinmune tras la vacunación COVID. Revista de autoinmunidad, 123, 102688. https://pubmed.ncbi.nlm.nih.gov/34449715/ | Erdem, N. ş., Demirci, S., Özel, T., Mamadova, K., Karaali, K., Çelik, H. T., ... & Özkaynak, S. S. S. (2021). Mielitis transversal aguda después de la vacuna inactivada de COVID-19. Ideggyogyaszati Szemle, 74 (7-08), 273-276. https://pubmed.ncbi.nlm.nih.gov/34579245/. | Rela, M., Jothimani, D., Vij, M., Rajakumar, A., & Rammohan, A. (2021). Auto-immune hepatitis following COVID vaccination. Journal of Autoimmunity, 123, 102688. https://pubmed.ncbi.nlm.nih.gov/34225251/ | Esba, L. C. A., & Al Jeraisy, M. (2021). Reported adverse effects following COVID-19 vaccination at a tertiary care hospital, focus on cerebral venous sinus thrombosis (CVST). Expert Review of Vaccines, 20(8), 1037-1042. https://pubmed.ncbi.nlm.nih.gov/34092166/ | Ramessur, R., Saffar, N., Czako, B., Agarwal, A., & Batta, K. (2021). Cutaneous thrombosis associated with skin necrosis following Oxford‐AstraZeneca COVID‐19 vaccination. Clinical and Experimental Dermatology. | https://pubmed.ncbi.nlm.nih.gov/34189756/ | Ramessur, R., Saffar, N., Czako, B., Agarwal, A., & Batta, K. (2021). Cutaneous thrombosis associated with skin necrosis following Oxford‐AstraZeneca COVID‐19 vaccination. Clinical and Experimental Dermatology. https://pubmed.ncbi.nlm.nih.gov/34189756/ | Gao, J. J., Tseng, H. P., Lin, C. L., Shiu, J. S., Lee, M. H., & Liu, C. H. (2021). Acute transverse myelitis following COVID-19 vaccination. Vaccines, 9(9), 1008. https://pubmed.ncbi.nlm.nih.gov/34579245/. | ||||
248 | Acute autoimmune-like hepatitis with atypical antimitochondrial antibody after vaccination with COVID-19 mRNA: a new clinical entity: | https://pubmed.ncbi.nlm.nih.gov/34293683/. | https://pubmed.ncbi.nlm.nih.gov/34449715/ | Prasad, A., Hurlburt, G., Podury, S., Tandon, M., Kingree, S., & Sriwastava, S. (2021). A novel case of bifacial diplegia variant of guillain-Barré syndrome following Janssen COVID-19 vaccination. Neurology International, 13(3), 404-409. | Prasad, A., Hurlburt, G., Podury, S., Tandon, M., Kingree, S. y Sriwastava, S. (2021). Un nuevo caso de variante de diplejía bifacial del síndrome de Guillain-Barré tras la vacuna Janssen COVID-19. Neurología Internacional, 13(3), 404-409. https://pubmed.ncbi.nlm.nih.gov/34139631/. | Erler, A., Fiedler, J., Koch, A., Handmann, F., & Schütz, A. (2021). Vasculitis leucocitoclástica después de la vacunación con una vacuna contra SARS-COV-2. Artritis y reumatología, 73 (12), 2188-2188. https://pubmed.ncbi.nlm.nih.gov/34350668/ | Prasad, A., Hurlburt, G., Podury, S., Tandon, M., Kingree, S., & Sriwastava, S. (2021). A novel case of bifacial diplegia variant of guillain-Barré syndrome following Janssen COVID-19 vaccination. Neurology International, 13(3), 404-409. https://pubmed.ncbi.nlm.nih.gov/34449715/ | Etemadifar, M., Sigari, A. A., Sedaghat, N., Salari, M., & Nouri, H. (2021). Acute relapse and poor immunization following COVID-19 vaccination in a rituximab-treated multiple sclerosis patient. Human vaccines & immunotherapeutics, 17(10), 3481-3483. https://pubmed.ncbi.nlm.nih.gov/34015240/ | Kow, C. S., & Hasan, S. S. (2021). Cerebral venous thrombosis following COVID-19 vaccination. Journal of Stroke and Cerebrovascular Diseases, 30(10). | https://pubmed.ncbi.nlm.nih.gov/34045111/. | Kow, C. S., & Hasan, S. S. (2021). Cerebral venous thrombosis following COVID-19 vaccination. Journal of Stroke and Cerebrovascular Diseases, 30(10). https://pubmed.ncbi.nlm.nih.gov/34045111/. | García-Azorín, D., Do, T. P., Gantenbein, A. R., Hansen, J. M., Souza, M. N. P., Obermann, M., ... & Kristoffersen, E. S. (2021). Delayed headache after COVID-19 vaccination: a red flag for vaccine induced cerebral venous thrombosis. The journal of headache and pain, 22(1), 1-5. https://pubmed.ncbi.nlm.nih.gov/34535076/ | ||||
249 | Autoimmune hepatitis after COVID vaccine: | https://pubmed.ncbi.nlm.nih.gov/34225251/ | https://pubmed.ncbi.nlm.nih.gov/34139631/. | Hwang, J., Lee, S. B., Lee, S. W., Lee, M. H., Koyanagi, A., Jacob, L., ... & Smith, L. (2021). Comparison of vaccine-induced thrombotic events between ChAdOx1 nCoV-19 and Ad26. COV. 2. S vaccines. Journal of autoimmunity, 122, 102681. | Hwang, J., Lee, S. B., Lee, S. W., Lee, M. H., Koyanagi, A., Jacob, L., ... y Smith, L. (2021). Comparación de eventos trombóticos inducidos por la vacuna entre ChAdOx1 nCoV-19 y Ad26. COV. 2. Vacunas S. Revista de autoinmunidad, 122, 102681. https://pubmed.ncbi.nlm.nih.gov/33864750/ | ESBA, L. C. A., & Al Jeraisy, M. (2021). Los efectos adversos reportados después de la vacunación de COVID-19 en un hospital de atención terciaria, se centran en la trombosis sinusita venosa cerebral (CVST). Revisión de expertos de las vacunas, 20 (8), 1037-1042. https://pubmed.ncbi.nlm.nih.gov/34291477/ | Hwang, J., Lee, S. B., Lee, S. W., Lee, M. H., Koyanagi, A., Jacob, L., ... & Smith, L. (2021). Comparison of vaccine-induced thrombotic events between ChAdOx1 nCoV-19 and Ad26. COV. 2. S vaccines. Journal of autoimmunity, 122, 102681. https://pubmed.ncbi.nlm.nih.gov/34139631/. | Facetti, S., Giraldi, M., Vecchi, A. L., Rogiani, S., & Nassiacos, D. (2021). Acute myocarditis in a young adult two days after Pfizer vaccination. Giornale italiano di cardiologia (2006), 22(11), 891-893. https://pubmed.ncbi.nlm.nih.gov/34709227/ | González-Romero, N., & Sánchez, V. (2021). Lipschütz Ulcers After the AstraZeneca COVID-19 Vaccine. Actas Dermo-sifiliograficas. | https://pubmed.ncbi.nlm.nih.gov/34366434/. | González-Romero, N., & Sánchez, V. (2021). Lipschütz Ulcers After the AstraZeneca COVID-19 Vaccine. Actas Dermo-sifiliograficas. https://pubmed.ncbi.nlm.nih.gov/34366434/. | García, B., Ortega, P., JA, B. F., León, C., Burgos, R., & Dorta, C. (2021). Acute myocarditis after administration of the BNT162b2 vaccine against COVID-19. Revista espanola de cardiologia, 74(9), 812-814. https://pubmed.ncbi.nlm.nih.gov/33994339/ | ||||
250 | A novel case of bifacial diplegia variant of Guillain-Barré syndrome after vaccination with Janssen COVID-19: | https://pubmed.ncbi.nlm.nih.gov/34449715/ | https://pubmed.ncbi.nlm.nih.gov/33864750/ | Bayas, A., Menacher, M., Christ, M., Behrens, L., Rank, A., & Naumann, M. (2021). Bilateral superior ophthalmic vein thrombosis, ischaemic stroke, and immune thrombocytopenia after ChAdOx1 nCoV-19 vaccination. The Lancet, 397(10285), e11. | Bayas, A., Menacher, M., Christ, M., Behrens, L., Rank, A. y Naumann, M. (2021). Trombosis bilateral de la vena oftálmica superior, accidente cerebrovascular isquémico y trombocitopenia inmune después de la vacunación ChAdOx1 nCoV-19. The Lancet, 397(10285), e11. https://pubmed.ncbi.nlm.nih.gov/33914590/ | Etemadifar, M., Sigari, A. A. A., Sedaghat, N., Salari, M., & Nouri, H. (2021). Recaída aguda y mala inmunización después de la vacunación de COVID-19 en un paciente de esclerosis múltiple tratado con rituximab. Vacunas humanas e inmunoterapiautica, 17 (10), 3481-3483. https://pubmed.ncbi.nlm.nih.gov/34482558/ | Bayas, A., Menacher, M., Christ, M., Behrens, L., Rank, A., & Naumann, M. (2021). Bilateral superior ophthalmic vein thrombosis, ischaemic stroke, and immune thrombocytopenia after ChAdOx1 nCoV-19 vaccination. The Lancet, 397(10285), e11. https://pubmed.ncbi.nlm.nih.gov/33864750/ | Facetti, S., Giraldi, M., Vecchi, A. L., Rogiani, S., & Nassiacos, D. (2021). Acute myocarditis in a young adult two days after Pfizer vaccination. Giornale italiano di cardiologia (2006), 22(11), 891-893. https://www.ncbi.nlm.nih.gov/pubmed/34709227 | Burillo, J. C., Martínez, C. L., Arguedas, C. G., & Pueyo, F. M. (2021). Amyotrophic neuralgia secondary to Vaxzevri (AstraZeneca) COVID-19 vaccine. Neurologia (Barcelona, Spain). | https://pubmed.ncbi.nlm.nih.gov/34330677/ | Burillo, J. C., Martínez, C. L., Arguedas, C. G., & Pueyo, F. M. (2021). Amyotrophic neuralgia secondary to Vaxzevri (AstraZeneca) COVID-19 vaccine. Neurologia (Barcelona, Spain). https://pubmed.ncbi.nlm.nih.gov/34330677/ | Garg, R. K., & Paliwal, V. K. (2021). Spectrum of neurological complications following COVID-19 vaccination. Neurological Sciences, 1-38. https://pubmed.ncbi.nlm.nih.gov/34719776/ | ||||
251 | Comparison of vaccine-induced thrombotic events between ChAdOx1 nCoV-19 and Ad26.COV.2.S vaccines: | https://pubmed.ncbi.nlm.nih.gov/34139631/. | https://pubmed.ncbi.nlm.nih.gov/33914590/ | Furie, K. L., Cushman, M., Elkind, M. S., Lyden, P. D., Saposnik, G., & American Heart Association/American Stroke Association Stroke Council Leadership. (2021). Diagnosis and management of cerebral venous sinus thrombosis with vaccine-induced immune thrombotic thrombocytopenia. Stroke, 52(7), 2478-2482. | Furie, K. L., Cushman, M., Elkind, M. S., Lyden, P. D., Saposnik, G. y Liderazgo del Consejo de Accidentes Cerebrovasculares de la Asociación Estadounidense del Corazón/Asociación Estadounidense de Accidentes Cerebrovasculares. (2021). Diagnóstico y tratamiento de la trombosis del seno venoso cerebral con trombocitopenia trombótica inmunitaria inducida por vacunas. Accidente cerebrovascular, 52(7), 2478-2482. https://pubmed.ncbi.nlm.nih.gov/34420802/ | Facetti, S., Giraldi, M., Vecchi, A. L., Rogiani, S., & Nassiacos, D. (2021). Miocarditis aguda en un adulto joven dos días después de la vacunación de Pfizer. GIORNALE ITALIANO DI CARDIOLOGIA (2006), 22 (11), 891-893. https://pubmed.ncbi.nlm.nih.gov/34778411/ | Furie, K. L., Cushman, M., Elkind, M. S., Lyden, P. D., Saposnik, G., & American Heart Association/American Stroke Association Stroke Council Leadership. (2021). Diagnosis and management of cerebral venous sinus thrombosis with vaccine-induced immune thrombotic thrombocytopenia. Stroke, 52(7), 2478-2482. https://pubmed.ncbi.nlm.nih.gov/33914590/ | Faermann, R., Nissan, N., Halshtok-Neiman, O., Shalmon, A., Gotlieb, M., Yagil, Y., ... & Sklair-Levy, M. (2021). COVID-19 vaccination induced lymphadenopathy in a specialized breast imaging clinic in Israel: Analysis of 163 cases. Academic Radiology, 28(9), 1191-1197. https://pubmed.ncbi.nlm.nih.gov/34257025/. | Wolthers, S. A., Stenberg, J., Nielsen, H. B., Stensballe, J., & Pedersen, H. P. (2021). Content area. Ugeskr Læger, 183, V05210425. | https://pubmed.ncbi.nlm.nih.gov/34477089/ | Wolthers, S. A., Stenberg, J., Nielsen, H. B., Stensballe, J., & Pedersen, H. P. (2021). Content area. Ugeskr Læger, 183, V05210425. https://pubmed.ncbi.nlm.nih.gov/34477089/ | Gargano, J. W., Wallace, M., Hadler, S. C., Langley, G., Su, J. R., Oster, M. E., ... & Oliver, S. E. (2021). Use of mRNA COVID-19 vaccine after reports of myocarditis among vaccine recipients: update from the Advisory Committee on Immunization Practices—United States, June 2021. Morbidity and Mortality Weekly Report, 70(27), 977. https://www.ncbi.nlm.nih.gov/pubmed/34237049 | ||||
252 | Bilateral superior ophthalmic vein thrombosis, ischemic stroke and immune thrombocytopenia after vaccination with ChAdOx1 nCoV-19: | https://pubmed.ncbi.nlm.nih.gov/33864750/ | https://pubmed.ncbi.nlm.nih.gov/34420802/ | Varas, G. M., Flores, A. C., & Casado, M. S. Venous sinus thrombosis following vaccination with ChAdOx1 nCov-19. Medicina intensiva, S0210-5691. | Varas, G. M., Flores, A. C. y Casado, M. S. Trombosis del seno venoso después de la vacunación con ChAdOx1 nCov-19. Medicina intensiva, S0210-5691. https://pubmed.ncbi.nlm.nih.gov/34293217/ | Facetti, S., Giraldi, M., Vecchi, A. L., Rogiani, S., & Nassiacos, D. (2021). Miocarditis aguda en un adulto joven dos días después de la vacunación de Pfizer. GIORNALE ITALIANO DI CARDIOLOGIA (2006), 22 (11), 891-893. https://www.ncbi.nlm.nih.gov/pubmed/34921468 | Varas, G. M., Flores, A. C., & Casado, M. S. Venous sinus thrombosis following vaccination with ChAdOx1 nCov-19. Medicina intensiva, S0210-5691. https://pubmed.ncbi.nlm.nih.gov/34420802/ | Faissner, S., Richter, D., Ceylan, U., Schneider-Gold, C., & Gold, R. (2021). COVID-19 mRNA vaccine induced rhabdomyolysis and fasciitis. Journal of Neurology, 1-2. https://pubmed.ncbi.nlm.nih.gov/34435250/ | Rzymski, P., Perek, B., & Flisiak, R. (2021). Thrombotic thrombocytopenia after COVID-19 vaccination: in search of the underlying mechanism. Vaccines, 9(6), 559. | https://pubmed.ncbi.nlm.nih.gov/34071883/ | Rzymski, P., Perek, B., & Flisiak, R. (2021). Thrombotic thrombocytopenia after COVID-19 vaccination: in search of the underlying mechanism. Vaccines, 9(6), 559. https://pubmed.ncbi.nlm.nih.gov/34071883/ | Garnier, M., Curado, A., Billoir, P., Barbay, V., Demeyere, M., & Dacher, J. N. (2021). Imaging of Oxford/AstraZeneca COVID-19 vaccine-induced immune thrombotic thrombocytopenia. Diagnostic and interventional imaging. https://pubmed.ncbi.nlm.nih.gov/33962903/. | ||||
253 | Diagnosis and treatment of cerebral venous sinus thrombosis with vaccine-induced immune-immune thrombotic thrombocytopenia: | https://pubmed.ncbi.nlm.nih.gov/33914590/ | https://pubmed.ncbi.nlm.nih.gov/34293217/ | Krzywicka, K., Heldner, M. R., Sánchez van Kammen, M., van Haaps, T., Hiltunen, S., Silvis, S. M., ... & Ferro, J. M. (2021). Post‐SARS‐CoV‐2‐vaccination cerebral venous sinus thrombosis: an analysis of cases notified to the European Medicines Agency. European journal of neurology, 28(11), 3656-3662. | Krzywicka, K., Heldner, M. R., Sánchez van Kammen, M., van Haaps, T., Hiltunen, S., Silvis, S. M., ... & Ferro, J. M. (2021). Trombosis del seno venoso cerebral posterior a la vacunación contra el SARS-CoV-2: un análisis de los casos notificados a la Agencia Europea de Medicamentos. Revista europea de neurología, 28(11), 3656-3662. https://pubmed.ncbi.nlm.nih.gov/33952445/ | Faermann, R., Nissan, N., Halshtok-Neiman, O., Shalmon, A., Gotlieb, M., Yagil, Y., ... y Sklair-Levy, M. (2021). COVID-19 Inbolada Induce Linfadenopatía en una clínica especializada de imágenes de mama en Israel: análisis de 163 casos. Radiología académica, 28 (9), 1191-1197. https://pubmed.ncbi.nlm.nih.gov/34836672/. | Krzywicka, K., Heldner, M. R., Sánchez van Kammen, M., van Haaps, T., Hiltunen, S., Silvis, S. M., ... & Ferro, J. M. (2021). Post‐SARS‐CoV‐2‐vaccination cerebral venous sinus thrombosis: an analysis of cases notified to the European Medicines Agency. European journal of neurology, 28(11), 3656-3662. https://pubmed.ncbi.nlm.nih.gov/34293217/ | Faissner, S., Richter, D., Ceylan, U., Schneider-Gold, C., & Gold, R. (2021). COVID-19 mRNA vaccine induced rhabdomyolysis and fasciitis. Journal of Neurology, 1-2. https://pubmed.ncbi.nlm.nih.gov/34435250/. | Aleem, A., & Shah, H. (2021). Gastric Varices. StatPearls [Internet]. | https://pubmed.ncbi.nlm.nih.gov/34033367/ | Aleem, A., & Shah, H. (2021). Gastric Varices. StatPearls [Internet]. https://pubmed.ncbi.nlm.nih.gov/34033367/ | Garreffa, E., Hamad, A., O'Sullivan, C. C., Hazim, A. Z., York, J., Puri, S., ... & Goetz, M. P. (2021). Regional lymphadenopathy following COVID-19 vaccination: Literature review and considerations for patient management in breast cancer care. European Journal of Cancer, 159, 38-51. https://pubmed.ncbi.nlm.nih.gov/34731748/ | ||||
254 | Venous sinus thrombosis after vaccination with ChAdOx1 nCov-19: | https://pubmed.ncbi.nlm.nih.gov/34420802/ | https://pubmed.ncbi.nlm.nih.gov/33952445/ | Pottegård, A., Lund, L. C., Karlstad, Ø., Dahl, J., Andersen, M., Hallas, J., ... & Hviid, A. (2021). Arterial events, venous thromboembolism, thrombocytopenia, and bleeding after vaccination with Oxford-AstraZeneca ChAdOx1-S in Denmark and Norway: population based cohort study. bmj, 373. | Pottegård, A., Lund, L. C., Karlstad, Ø., Dahl, J., Andersen, M., Hallas, J., ... y Hviid, A. (2021). Eventos arteriales, tromboembolismo venoso, trombocitopenia y hemorragia después de la vacunación con Oxford-AstraZeneca ChAdOx1-S en Dinamarca y Noruega: estudio de cohorte poblacional. bmj, 373. https://pubmed.ncbi.nlm.nih.gov/34108714/ | Faissner, S., Richter, D., Ceylan, U., Schneider-Gold, C., & Gold, R. (2021). COVID-19 Vacuna contra el ARNA indujo la rabdomiolisis y la fascitis. Diario de Neurología, 1-2. https://pubmed.ncbi.nlm.nih.gov/34186348/. | Pottegård, A., Lund, L. C., Karlstad, Ø., Dahl, J., Andersen, M., Hallas, J., ... & Hviid, A. (2021). Arterial events, venous thromboembolism, thrombocytopenia, and bleeding after vaccination with Oxford-AstraZeneca ChAdOx1-S in Denmark and Norway: population based cohort study. bmj, 373. https://pubmed.ncbi.nlm.nih.gov/33952445/ | Falkenhain‐López, D., Gutiérrez‐Collar, C., Arroyo‐Andrés, J., Gallego‐Gutiérrez, I., Rodríguez‐Peralto, J. L., & Sánchez‐Velázquez, A. (2021). Widespread purpura annularis telangiectodes following mRNA SARS‐CoV‐2 vaccine. Journal of the European Academy of Dermatology and Venereology. https://pubmed.ncbi.nlm.nih.gov/34236717/. | Abbattista, M., Martinelli, I., & Peyvandi, F. (2021). Comparison of adverse drug reactions among four COVID‐19 vaccines in Europe using the EudraVigilance database: thrombosis at unusual sites. Journal of Thrombosis and Haemostasis, 19(10), 2554-2558. | https://pubmed.ncbi.nlm.nih.gov/34375510/ | Abbattista, M., Martinelli, I., & Peyvandi, F. (2021). Comparison of adverse drug reactions among four COVID‐19 vaccines in Europe using the EudraVigilance database: thrombosis at unusual sites. Journal of Thrombosis and Haemostasis, 19(10), 2554-2558. https://pubmed.ncbi.nlm.nih.gov/34375510/ | Gatti, M., Raschi, E., Moretti, U., Ardizzoni, A., Poluzzi, E., & Diemberger, I. (2021). Influenza vaccination and myo-pericarditis in patients receiving immune checkpoint inhibitors: investigating the likelihood of interaction through the vaccine adverse event reporting system and VigiBase. Vaccines, 9(1), 19. https://www.ncbi.nlm.nih.gov/pubmed/33406694 | ||||
255 | Cerebral venous sinus thrombosis following vaccination against SARS-CoV-2: an analysis of cases reported to the European Medicines Agency: | https://pubmed.ncbi.nlm.nih.gov/34293217/ | https://pubmed.ncbi.nlm.nih.gov/34108714/ | Simpson, C. R., Shi, T., Vasileiou, E., Katikireddi, S. V., Kerr, S., Moore, E., ... & Sheikh, A. (2021). First-dose ChAdOx1 and BNT162b2 COVID-19 vaccines and thrombocytopenic, thromboembolic and hemorrhagic events in Scotland. Nature medicine, 27(7), 1290-1297. | Simpson, C. R., Shi, T., Vasileiou, E., Katikireddi, S. V., Kerr, S., Moore, E., ... y Sheikh, A. (2021). Primera dosis de vacunas ChAdOx1 y BNT162b2 COVID-19 y eventos trombocitopénicos, tromboembólicos y hemorrágicos en Escocia. Medicina natural, 27(7), 1290-1297. https://pubmed.ncbi.nlm.nih.gov/34288044/ | Faissner, S., Richter, D., Ceylan, U., Schneider-Gold, C., & Gold, R. (2021). COVID-19 Vacuna contra el ARNA indujo la rabdomiolisis y la fascitis. Diario de Neurología, 1-2. https://pubmed.ncbi.nlm.nih.gov/34363637/ | Simpson, C. R., Shi, T., Vasileiou, E., Katikireddi, S. V., Kerr, S., Moore, E., ... & Sheikh, A. (2021). First-dose ChAdOx1 and BNT162b2 COVID-19 vaccines and thrombocytopenic, thromboembolic and hemorrhagic events in Scotland. Nature medicine, 27(7), 1290-1297. https://pubmed.ncbi.nlm.nih.gov/34108714/ | Fan, B. E., Shen, J. Y., Lim, X. R., Tu, T. M., Chang, C. C. R., Khin, H. S. W., ... & Prasad, B. M. R. V. (2021). Cerebral venous thrombosis post BNT162b2 mRNA SARS‐CoV‐2 vaccination: A black swan event. American Journal of Hematology, 96(9), E357. https://pubmed.ncbi.nlm.nih.gov/34133027/ | Bourguignon, A., Arnold, D. M., Warkentin, T. E., Smith, J. W., Pannu, T., Shrum, J. M., ... & Nazy, I. (2021). Adjunct immune globulin for vaccine-induced immune thrombotic thrombocytopenia. New England Journal of Medicine, 385(8), 720-728. | https://pubmed.ncbi.nlm.nih.gov/34107198/ | Bourguignon, A., Arnold, D. M., Warkentin, T. E., Smith, J. W., Pannu, T., Shrum, J. M., ... & Nazy, I. (2021). Adjunct immune globulin for vaccine-induced immune thrombotic thrombocytopenia. New England Journal of Medicine, 385(8), 720-728. https://pubmed.ncbi.nlm.nih.gov/34107198/ | Gautam, N., Saluja, P., Fudim, M., Jambhekar, K., Pandey, T., & Al'Aref, S. (2021). A late presentation of COVID-19 vaccine-induced myocarditis. Cureus, 13(9). https://www.ncbi.nlm.nih.gov/pubmed/34660088 | ||||
256 | Risk of thrombocytopenia and thromboembolism after covid-19 vaccination and positive SARS-CoV-2 tests: self-controlled case series study: | https://pubmed.ncbi.nlm.nih.gov/34446426/ | https://pubmed.ncbi.nlm.nih.gov/34288044/ | Schulz, J. B., Berlit, P., Diener, H. C., Gerloff, C., Greinacher, A., Klein, C., ... & Zimmermann, J. (2021). COVID‐19 vaccine‐associated cerebral venous thrombosis in Germany. Annals of neurology, 90(4), 627-639. | Schulz, J. B., Berlit, P., Diener, H. C., Gerloff, C., Greinacher, A., Klein, C., ... y Zimmermann, J. (2021). Trombosis venosa cerebral asociada a la vacuna COVID-19 en Alemania. Anales de neurología, 90(4), 627-639. https://pubmed.ncbi.nlm.nih.gov/34341358/ | Falkenhain-López, D., Gutiérrez-Collar, C., Arroyo-Andrés, J., Gallego-Gutiérrez, I., Rodríguez-Peralto, J. L., & Sánchez-Velázquez, A. (2021). TelangiecOdodos de Purpura Annularis generalizados después de la vacuna contra el ARNA SARS-COV-2. Diario de la Academia Europea de Dermatología y Venereología. https://pubmed.ncbi.nlm.nih.gov/34729467/. | Schulz, J. B., Berlit, P., Diener, H. C., Gerloff, C., Greinacher, A., Klein, C., ... & Zimmermann, J. (2021). COVID‐19 vaccine‐associated cerebral venous thrombosis in Germany. Annals of neurology, 90(4), 627-639. https://pubmed.ncbi.nlm.nih.gov/34288044/ | Fanni, D., Saba, L., Demontis, R., Gerosa, C., Chighine, A., Nioi, M., ... & Faa, G. (2021). Vaccine-induced severe thrombotic thrombocytopenia following COVID-19 vaccination: a report of an autoptic case and review of the literature. https://pubmed.ncbi.nlm.nih.gov/34355379/. | Fanni, D., Saba, L., Demontis, R., Gerosa, C., Chighine, A., Nioi, M., ... & Faa, G. (2021). Vaccine-induced severe thrombotic thrombocytopenia following COVID-19 vaccination: a report of an autoptic case and review of the literature. | https://pubmed.ncbi.nlm.nih.gov/34355379/. | Fanni, D., Saba, L., Demontis, R., Gerosa, C., Chighine, A., Nioi, M., ... & Faa, G. (2021). Vaccine-induced severe thrombotic thrombocytopenia following COVID-19 vaccination: a report of an autoptic case and review of the literature. https://pubmed.ncbi.nlm.nih.gov/34355379/. | Geeraerts, T., Montastruc, F., Bonneville, F., Mémier, V., Raposo, N., & Toulouse Vitt Study Group. (2021). Oxford-AstraZeneca COVID-19 vaccine-induced cerebral venous thrombosis and thrombocytopaenia: a missed opportunity for a rapid return of experience. Anaesthesia, Critical Care & Pain Medicine. https://pubmed.ncbi.nlm.nih.gov/34033927/ | ||||
257 | Blood clots and bleeding after BNT162b2 and ChAdOx1 nCoV-19 vaccination: an analysis of European data: | https://pubmed.ncbi.nlm.nih.gov/34174723/ | https://pubmed.ncbi.nlm.nih.gov/34341358/ | De Michele, M., Iacobucci, M., Chistolini, A., Nicolini, E., Pulcinelli, F., Cerbelli, B., ... & Toni, D. (2021). Malignant cerebral infarction after ChAdOx1 nCov-19 vaccination: a catastrophic variant of vaccine-induced immune thrombotic thrombocytopenia. Nature Communications, 12(1), 1-7. | De Michele, M., Iacobucci, M., Chistolini, A., Nicolini, E., Pulcinelli, F., Cerbelli, B., ... & Toni, D. (2021). Infarto cerebral maligno después de la vacunación ChAdOx1 nCov-19: una variante catastrófica de trombocitopenia trombótica inmune inducida por la vacuna. Comunicaciones de la naturaleza, 12(1), 1-7. https://pubmed.ncbi.nlm.nih.gov/34261633/. | Fan, B. E., Shen, J. Y., LIM, X. R., TU, T. M., Chang, C. C. R., Khin, H. S. W., ... & Prasad, B. M. R. V. (2021). Trombosis venosa cerebral Post BNT162B2 MRNA SARS-COV-2 Vacunación: un evento de cisne negro. American Journal of Hematology, 96 (9), E357. https://pubmed.ncbi.nlm.nih.gov/34001390/ | De Michele, M., Iacobucci, M., Chistolini, A., Nicolini, E., Pulcinelli, F., Cerbelli, B., ... & Toni, D. (2021). Malignant cerebral infarction after ChAdOx1 nCov-19 vaccination: a catastrophic variant of vaccine-induced immune thrombotic thrombocytopenia. Nature Communications, 12(1), 1-7. https://pubmed.ncbi.nlm.nih.gov/34341358/ | Fathy, R. A., McMahon, D. E., Lee, C., Chamberlin, G. C., Rosenbach, M., Lipoff, J. B., ... & Freeman, E. E. (2022). Varicella‐zoster and herpes simplex virus reactivation post‐COVID‐19 vaccination: a review of 40 cases in an International Dermatology Registry. Journal of the European Academy of Dermatology and Venereology, 36(1), e6-e9. https://pubmed.ncbi.nlm.nih.gov/34487581/ | Wiest, N. E., Johns, G. S., & Edwards, E. (2021). A case of acute pulmonary embolus after mRNA SARS-CoV-2 immunization. Vaccines, 9(8), 903. | https://pubmed.ncbi.nlm.nih.gov/34452028/ | Wiest, N. E., Johns, G. S., & Edwards, E. (2021). A case of acute pulmonary embolus after mRNA SARS-CoV-2 immunization. Vaccines, 9(8), 903. https://pubmed.ncbi.nlm.nih.gov/34452028/ | Gellad, W. F. (2021). Myocarditis after vaccination against covid-19. bmj, 375. https://www.ncbi.nlm.nih.gov/pubmed/34916217 | ||||
258 | Arterial events, venous thromboembolism, thrombocytopenia and bleeding after vaccination with Oxford-AstraZeneca ChAdOx1-S in Denmark and Norway: population-based cohort study: | https://pubmed.ncbi.nlm.nih.gov/33952445/ | https://pubmed.ncbi.nlm.nih.gov/34261633/. | Bandapaati, S., Bobba, H., & Navinan, M. R. (2021). Coeliac artery and splenic artery thrombosis complicated with splenic infarction 7 days following the first dose of Oxford vaccination, causal relationship or coincidence?. BMJ Case Reports CP, 14(7), e243799. | Bandapaati, S., Bobba, H. y Navinan, MR (2021). Trombosis de la arteria celíaca y de la arteria esplénica complicada con infarto esplénico a los 7 días de la primera dosis de la vacuna Oxford, ¿relación causal o coincidencia?. Informes de casos de BMJ CP, 14(7), e243799. https://pubmed.ncbi.nlm.nih.gov/34332437/. | Fanni, D., Saba, L., Demontis, R., Gerosa, C., Chighine, A., Nioi, M., ... & FAA, G. (2021). Trombocitopenia trombótica severa inducida por la vacuna después de la vacunación de COVID-19: un informe de un caso autopético y revisión de la literatura. https://pubmed.ncbi.nlm.nih.gov/34452028/ | Bandapaati, S., Bobba, H., & Navinan, M. R. (2021). Coeliac artery and splenic artery thrombosis complicated with splenic infarction 7 days following the first dose of Oxford vaccination, causal relationship or coincidence?. BMJ Case Reports CP, 14(7), e243799. https://pubmed.ncbi.nlm.nih.gov/34261633/. | Favaloro, E. J. (2021). Laboratory testing for suspected COVID‐19 vaccine–induced (immune) thrombotic thrombocytopenia. International Journal of Laboratory Hematology, 43(4), 559-570. https://pubmed.ncbi.nlm.nih.gov/34138513/ | Gessler, F., Schmitz, A. K., Dubinski, D., Bernstock, J. D., Lehmann, F., Won, S. Y., ... & Schuss, P. (2021). Neurosurgical considerations regarding decompressive craniectomy for intracerebral hemorrhage after SARS-CoV-2-vaccination in vaccine induced thrombotic thrombocytopenia—VITT. Journal of Clinical Medicine, 10(13), 2777. | https://pubmed.ncbi.nlm.nih.gov/34202817/ | Gessler, F., Schmitz, A. K., Dubinski, D., Bernstock, J. D., Lehmann, F., Won, S. Y., ... & Schuss, P. (2021). Neurosurgical considerations regarding decompressive craniectomy for intracerebral hemorrhage after SARS-CoV-2-vaccination in vaccine induced thrombotic thrombocytopenia—VITT. Journal of Clinical Medicine, 10(13), 2777. https://pubmed.ncbi.nlm.nih.gov/34202817/ | Gerber, G. F., Yuan, X., Yu, J., Cher, B. A., Braunstein, E. M., Chaturvedi, S., & Brodsky, R. A. (2021). COVID-19 vaccines induce severe hemolysis in paroxysmal nocturnal hemoglobinuria. Blood, The Journal of the American Society of Hematology, 137(26), 3670-3673. https://ashpublications.org/blood/article/137/26/3670/475905/COVID-19-vaccines-induce-severe-hemolysis-in | ||||
259 | First dose of ChAdOx1 and BNT162b2 COVID-19 vaccines and thrombocytopenic, thromboembolic and hemorrhagic events in Scotland: | https://pubmed.ncbi.nlm.nih.gov/34108714/ | https://pubmed.ncbi.nlm.nih.gov/34332437/. | Kragholm, K., Sessa, M., Mulvad, T., Andersen, M. P., Collatz-Christensen, H., Blomberg, S. N., ... & Sogaard, P. (2021). Thrombocytopenia after COVID-19 vaccination. Journal of Autoimmunity, 123, 102712. | Kragholm, K., Sessa, M., Mulvad, T., Andersen, M. P., Collatz-Christensen, H., Blomberg, S. N., ... y Sogaard, P. (2021). Trombocitopenia tras la vacunación COVID-19. Revista de autoinmunidad, 123, 102712. https://pubmed.ncbi.nlm.nih.gov/33845870/. | Fathy, R. A., McMahon, D. E., Lee, C., Chamberlin, G. C., Rosenbach, M., Lipoff, J. B., ... & Freeman, E. E. (2022). Varicella-zoster y herpes reactivación del virus simple Post-covid-19 Vacunación: una revisión de 40 casos en un Registro Internacional de Dermatología. Diario de la Academia Europea de Dermatología y Venereología, 36 (1), E6-E9. https://pubmed.ncbi.nlm.nih.gov/33987882/ | Kragholm, K., Sessa, M., Mulvad, T., Andersen, M. P., Collatz-Christensen, H., Blomberg, S. N., ... & Sogaard, P. (2021). Thrombocytopenia after COVID-19 vaccination. Journal of Autoimmunity, 123, 102712. https://pubmed.ncbi.nlm.nih.gov/34332437/. | Fazlollahi, A., Zahmatyar, M., Noori, M., Nejadghaderi, S. A., Sullman, M. J., Shekarriz‐Foumani, R., ... & Safiri, S. (2021). Cardiac complications following mRNA COVID‐19 vaccines: A systematic review of case reports and case series. Reviews in medical virology, e2318. https://www.ncbi.nlm.nih.gov/pubmed/34921468 | Park, Y. S. (2021). Thrombosis and severe acute respiratory syndrome coronavirus 2 vaccines: vaccine-induced immune thrombotic thrombocytopenia. Clinical and experimental pediatrics, 64(8), 400. | https://pubmed.ncbi.nlm.nih.gov/34237213/. | Park, Y. S. (2021). Thrombosis and severe acute respiratory syndrome coronavirus 2 vaccines: vaccine-induced immune thrombotic thrombocytopenia. Clinical and experimental pediatrics, 64(8), 400. https://pubmed.ncbi.nlm.nih.gov/34237213/. | Gessler, F., Schmitz, A. K., Dubinski, D., Bernstock, J. D., Lehmann, F., Won, S. Y., ... & Schuss, P. (2021). Neurosurgical considerations regarding decompressive craniectomy for intracerebral hemorrhage after SARS-CoV-2-vaccination in vaccine induced thrombotic thrombocytopenia—VITT. Journal of Clinical Medicine, 10(13), 2777. https://pubmed.ncbi.nlm.nih.gov/34202817/ | ||||
260 | Cerebral venous thrombosis associated with COVID-19 vaccine in Germany: | https://pubmed.ncbi.nlm.nih.gov/34288044/ | https://pubmed.ncbi.nlm.nih.gov/33845870/. | Castelli, G. P., Pognani, C., Sozzi, C., Franchini, M., & Vivona, L. (2021). Cerebral venous sinus thrombosis associated with thrombocytopenia post-vaccination for COVID-19. Critical Care, 25(1), 1-2. | Castelli, G. P., Pognani, C., Sozzi, C., Franchini, M. y Vivona, L. (2021). Trombosis del seno venoso cerebral asociada a trombocitopenia posvacunación para COVID-19. Cuidados críticos, 25(1), 1-2. https://pubmed.ncbi.nlm.nih.gov/34236343/ | Favaloro, E. J. (2021). Pruebas de laboratorio para sospechas de trombocitopenia trombótica inducida por vacunas (inmunes). Diario Internacional de Hematología de Laboratorio, 43 (4), 559-570. https://pubmed.ncbi.nlm.nih.gov/34402235/ | Castelli, G. P., Pognani, C., Sozzi, C., Franchini, M., & Vivona, L. (2021). Cerebral venous sinus thrombosis associated with thrombocytopenia post-vaccination for COVID-19. Critical Care, 25(1), 1-2. https://pubmed.ncbi.nlm.nih.gov/33845870/. | Fazolo, T., Lima, K., Fontoura, J. C., de Souza, P. O., Hilario, G., Zorzetto, R., ... & Bonorino, C. (2021). Pediatric COVID-19 patients in South Brazil show abundant viral mRNA and strong specific anti-viral responses. Nature communications, 12(1), 1-13. https://www.ncbi.nlm.nih.gov/pubmed/34824230 | Maayan, H., Kirgner, I., Gutwein, O., Herzog‐Tzarfati, K., Rahimi‐Levene, N., Koren‐Michowitz, M., & Blickstein, D. (2021). Acquired thrombotic thrombocytopenic purpura: A rare disease associated with BNT162b2 vaccine. Journal of Thrombosis and Haemostasis, 19(9), 2314-2317. | https://pubmed.ncbi.nlm.nih.gov/34105247/. | Maayan, H., Kirgner, I., Gutwein, O., Herzog‐Tzarfati, K., Rahimi‐Levene, N., Koren‐Michowitz, M., & Blickstein, D. (2021). Acquired thrombotic thrombocytopenic purpura: A rare disease associated with BNT162b2 vaccine. Journal of Thrombosis and Haemostasis, 19(9), 2314-2317. https://pubmed.ncbi.nlm.nih.gov/34105247/. | Ghielmetti, M., Schaufelberger, H. D., Mieli-Vergani, G., Cerny, A., Dayer, E., Vergani, D., & Beretta-Piccoli, B. T. (2021). Acute autoimmune-like hepatitis with atypical anti-mitochondrial antibody after mRNA COVID-19 vaccination: A novel clinical entity?. Journal of Autoimmunity, 123, 102706. https://pubmed.ncbi.nlm.nih.gov/34293683/. | ||||
261 | Malignant cerebral infarction after vaccination with ChAdOx1 nCov-19: a catastrophic variant of vaccine-induced immune-mediated thrombotic thrombocytopenia: | https://pubmed.ncbi.nlm.nih.gov/34341358/ | https://pubmed.ncbi.nlm.nih.gov/34236343/ | Cuker, A. (2021). Thrombosis with thrombocytopenia syndrome after COVID-19 vaccination. Clinical advances in hematology & oncology: H&O, 19(7), 446-449. | Cuker, A. (2021). Síndrome de trombosis con trombocitopenia tras la vacunación contra COVID-19. Avances clínicos en hematología y oncología: H&O, 19(7), 446-449. https://pubmed.ncbi.nlm.nih.gov/34364657/. | Fazlolahi, A., Zahmatyar, M., Noori, M., Nejadgoderi, S. A., Sullman, M. J., Shekarriz-Foumani, R., ... & Safiri, S. (2021). Complicaciones cardíacas Siguiendo las vacunas ARNm COVID-19: una revisión sistemática de los informes de casos y las series de casos. Opiniones en virología médica, E2318. https://www.ncbi.nlm.nih.gov/pubmed/34824230 | Cuker, A. (2021). Thrombosis with thrombocytopenia syndrome after COVID-19 vaccination. Clinical advances in hematology & oncology: H&O, 19(7), 446-449. https://pubmed.ncbi.nlm.nih.gov/34236343/ | Fearon, C., Parwani, P., Gow-Lee, B., & Abramov, D. (2021). Takotsubo syndrome after receiving the COVID-19 vaccine. Journal of Cardiology Cases, 24(5), 223-226. https://pubmed.ncbi.nlm.nih.gov/34539938/. | Holm, S., Kared, H., Michelsen, A. E., Kong, X. Y., Dahl, T. B., Schultz, N. H., ... & Halvorsen, B. (2021). Immune complexes, innate immunity, and NETosis in ChAdOx1 vaccine-induced thrombocytopenia. European heart journal, 42(39), 4064-4072. | https://pubmed.ncbi.nlm.nih.gov/34405870/. | Holm, S., Kared, H., Michelsen, A. E., Kong, X. Y., Dahl, T. B., Schultz, N. H., ... & Halvorsen, B. (2021). Immune complexes, innate immunity, and NETosis in ChAdOx1 vaccine-induced thrombocytopenia. European heart journal, 42(39), 4064-4072. https://pubmed.ncbi.nlm.nih.gov/34405870/. | Gillion, V., Jadoul, M., Demoulin, N., Aydin, S., & Devresse, A. (2021). Granulomatous vasculitis after the AstraZeneca anti–SARS-CoV-2 vaccine. Kidney International, 100(3), 706-707. https://pubmed.ncbi.nlm.nih.gov/34237323/. | ||||
262 | celiac artery and splenic artery thrombosis complicated by splenic infarction 7 days after the first dose of Oxford vaccine, causal relationship or coincidence: | https://pubmed.ncbi.nlm.nih.gov/34261633/. | https://pubmed.ncbi.nlm.nih.gov/34364657/. | Sung, J. G., Sobieszczyk, P. S., & Bhatt, D. L. (2021). Acute myocardial infarction within 24 hours after COVID-19 vaccination. The American Journal of Cardiology, 156, 129-131. | Sung, JG, Sobieszczyk, PS y Bhatt, DL (2021). Infarto agudo de miocardio dentro de las 24 horas posteriores a la vacunación contra la COVID-19. La Revista Estadounidense de Cardiología, 156, 129-131. https://pubmed.ncbi.nlm.nih.gov/34287612/ | Fazolo, T., Lima, K., FONTOURA, J. C., DE SOUZA, P. O., HILARIO, G., ZORZETTO, R., ... & BONORINO, C. (2021). Los pacientes con COVID-19 pediátricos en el sur de Brasil muestran abundante ARNm viral y fuertes respuestas antivirales específicas. Comunicaciones de la naturaleza, 12 (1), 1-13. https://www.ncbi.nlm.nih.gov/pubmed/34170372 | Sung, J. G., Sobieszczyk, P. S., & Bhatt, D. L. (2021). Acute myocardial infarction within 24 hours after COVID-19 vaccination. The American Journal of Cardiology, 156, 129-131. https://pubmed.ncbi.nlm.nih.gov/34364657/. | Fernández-Prada, M., Rivero-Calle, I., Calvache-González, A., & Martinón-Torres, F. (2021). Acute onset supraclavicular lymphadenopathy coinciding with intramuscular mRNA vaccination against COVID-19 may be related to vaccine injection technique, Spain, January and February 2021. Eurosurveillance, 26(10), 2100193. https://pubmed.ncbi.nlm.nih.gov/33706861/ | Saraceno, J. J. F., Souza, G. M., dos Santos Finamor, L. P., Nascimento, H. M., & Belfort, R. (2021). Vogt-Koyanagi-Harada syndrome following COVID-19 and ChAdOx1 nCoV-19 (AZD1222) vaccine. International journal of retina and vitreous, 7(1), 1-7. | https://pubmed.ncbi.nlm.nih.gov/34462013/. | Saraceno, J. J. F., Souza, G. M., dos Santos Finamor, L. P., Nascimento, H. M., & Belfort, R. (2021). Vogt-Koyanagi-Harada syndrome following COVID-19 and ChAdOx1 nCoV-19 (AZD1222) vaccine. International journal of retina and vitreous, 7(1), 1-7. https://pubmed.ncbi.nlm.nih.gov/34462013/. | Giovane, R., & Campbell, J. (2021). Bilateral Thalamic Stroke: A Case of COVID-19 Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT) or a Coincidence Due to Underlying Risk Factors?. Cureus, 13(10). https://pubmed.ncbi.nlm.nih.gov/34820232/. | ||||
263 | Primary adrenal insufficiency associated with Oxford-AstraZeneca ChAdOx1 nCoV-19 (VITT) vaccine-induced immune thrombotic thrombocytopenia: | https://pubmed.ncbi.nlm.nih.gov/34256983/ | https://pubmed.ncbi.nlm.nih.gov/34287612/ | Book, B. A., Schmidt, B., & Foerster, A. M. (2021). Bilateral acute macular neuroretinopathy after vaccination against SARS-CoV-2. JAMA ophthalmology, 139(7), e212471-e212471. | Libro, B. A., Schmidt, B. y Foerster, A. M. (2021). Neurorretinopatía macular aguda bilateral tras la vacunación contra el SARS-CoV-2. Oftalmología JAMA, 139(7), e212471-e212471. https://pubmed.ncbi.nlm.nih.gov/34478433/ | Fearon, C., Parwani, P., GOW-LEE, B., & Abramov, D. (2021). Síndrome de TakotSubo después de recibir la vacuna COVID-19. Diario de casos de cardiología, 24 (5), 223-226. https://pubmed.ncbi.nlm.nih.gov/34731486/. | Book, B. A., Schmidt, B., & Foerster, A. M. (2021). Bilateral acute macular neuroretinopathy after vaccination against SARS-CoV-2. JAMA ophthalmology, 139(7), e212471-e212471. https://pubmed.ncbi.nlm.nih.gov/34287612/ | Fikenzer, S., & Laufs, U. (2021). Correction to: Response to Letter to the editors referring to Fikenzer, S., Uhe, T., Lavall, D., Rudolph, U., Falz, R., Busse, M., Hepp, P., & Laufs, U.(2020). Effects of surgical and FFP2/N95 face masks on cardiopulmonary exercise capacity. Clinical research in cardiology: official journal of the German Cardiac Society, 1–9. Advance online publication. https://doi. org/10.1007/s00392-020-01704-y. Clinical Research in Cardiology, 110(8), 1352-1352. https://www.ncbi.nlm.nih.gov/pubmed/34170372 | Papasavvas, I., & Herbort, C. P. (2021). Reactivation of Vogt-Koyanagi-Harada disease under control for more than 6 years, following anti-SARS-CoV-2 vaccination. Journal of Ophthalmic Inflammation and Infection, 11(1), 1-6. | https://pubmed.ncbi.nlm.nih.gov/34224024/. | Papasavvas, I., & Herbort, C. P. (2021). Reactivation of Vogt-Koyanagi-Harada disease under control for more than 6 years, following anti-SARS-CoV-2 vaccination. Journal of Ophthalmic Inflammation and Infection, 11(1), 1-6. https://pubmed.ncbi.nlm.nih.gov/34224024/. | Göbel, C. H., Heinze, A., Karstedt, S., Morscheck, M., Tashiro, L., Cirkel, A., ... & Göbel, H. (2021). Headache Attributed to Vaccination Against COVID-19 (Coronavirus SARS-CoV-2) with the ChAdOx1 nCoV-19 (AZD1222) Vaccine: A Multicenter Observational Cohort Study. Pain and Therapy, 10(2), 1309-1330. https://pubmed.ncbi.nlm.nih.gov/34313952/ | ||||
264 | Thrombocytopenia after COVID-19 vaccination: | https://pubmed.ncbi.nlm.nih.gov/34332437/. | https://pubmed.ncbi.nlm.nih.gov/34478433/ | Syed, K., Chaudhary, H., & Donato, A. (2021). Central Venous Sinus Thrombosis with Subarachnoid Hemorrhage Following an mRNA COVID-19 Vaccination: Are These Reports Merely Co-Incidental?. The American journal of case reports, 22, e933397-1. | Syed, K., Chaudhary, H. y Donato, A. (2021). Trombosis del seno venoso central con hemorragia subaracnoidea después de una vacuna de ARNm contra el COVID-19: ¿son estos informes simplemente coincidentes? La revista estadounidense de informes de casos, 22, e933397-1. https://pubmed.ncbi.nlm.nih.gov/34186376/ | Fernández-Prada, M., Rivero-Calle, I., Calvache-González, A., & Martinón-Torres, F. (2021). La linfadenopatía supraclavicular de inicio aguda que coincide con la vacunación contra el ARNm intramuscular contra COVID-19 puede estar relacionada con la técnica de inyección de vacunas, España, enero y febrero de 2021. Eurasurveillance, 26 (10), 2100193. https://pubmed.ncbi.nlm.nih.gov/34116295/ | Syed, K., Chaudhary, H., & Donato, A. (2021). Central Venous Sinus Thrombosis with Subarachnoid Hemorrhage Following an mRNA COVID-19 Vaccination: Are These Reports Merely Co-Incidental?. The American journal of case reports, 22, e933397-1. https://pubmed.ncbi.nlm.nih.gov/34478433/ | Finsterer, J. (2021). Lobar bleeding with ventricular rupture shortly after first dosage of an mRNA-based SARS-CoV-2 vaccine. Brain hemorrhages. https://pubmed.ncbi.nlm.nih.gov/34729467/. | Zuhorn, F., Graf, T., Klingebiel, R., Schäbitz, W. R., & Rogalewski, A. (2021). Postvaccinal encephalitis after ChAdOx1 nCov‐19. Annals of neurology, 90(3), 506-511. | https://pubmed.ncbi.nlm.nih.gov/34324214/ | Zuhorn, F., Graf, T., Klingebiel, R., Schäbitz, W. R., & Rogalewski, A. (2021). Postvaccinal encephalitis after ChAdOx1 nCov‐19. Annals of neurology, 90(3), 506-511. https://pubmed.ncbi.nlm.nih.gov/34324214/ | Goldman, S., Bron, D., Tousseyn, T., Vierasu, I., Dewispelaere, L., Heimann, P., ... & Goldman, M. (2021). Rapid progression of angioimmunoblastic T Cell lymphoma following BNT162b2 mRNA vaccine booster shot: a case report. Frontiers in medicine, 2409. https://www.frontiersin.org/articles/10.3389/fmed.2021.798095/ | ||||
265 | Cerebral venous sinus thrombosis associated with thrombocytopenia after COVID-19 vaccination: | https://pubmed.ncbi.nlm.nih.gov/33845870/. | https://pubmed.ncbi.nlm.nih.gov/34186376/ | Dutta, A., Ghosh, R., Bhattacharya, D., Bhat, S., Ray, A., Pandit, A., ... & Dubey, S. (2021). Anti-PF4 antibody negative cerebral venous sinus thrombosis without thrombocytopenia following immunization with COVID-19 vaccine in an elderly non-comorbid Indian male, managed with conventional heparin-warfarin based anticoagulation. Diabetes & Metabolic Syndrome, 15(4), 102184. | Dutta, A., Ghosh, R., Bhattacharya, D., Bhat, S., Ray, A., Pandit, A., ... y Dubey, S. (2021). Trombosis del seno venoso cerebral con anticuerpos anti-PF4 negativos sin trombocitopenia después de la inmunización con la vacuna COVID-19 en un varón indio anciano sin comorbilidad, tratado con anticoagulación convencional basada en heparina-warfarina. Diabetes y síndrome metabólico, 15(4), 102184. https://pubmed.ncbi.nlm.nih.gov/34101024/ | Fikenzer, S., & Laufs, U. (2021). Corrección a: Respuesta a la letra a los editores que se refieren a Fikenzer, S., UHE, T., Lavall, D., Rudolph, U., Falz, R., Busse, M., Hepp, P., & Laufs, U . (2020). Efectos de las máscaras de cara quirúrgica y FFP2 / N95 sobre la capacidad de ejercicio cardiopulmonar. Investigación clínica en Cardiología: Diario Oficial de la Sociedad Cardiac Alemana, 1-9. Publicación anticipada en línea. https: // doi. org / 10.1007 / s00392-020-01704-y. Investigación clínica en cardiología, 110 (8), 1352-1352. https://www.ncbi.nlm.nih.gov/pubmed/34849667 | Dutta, A., Ghosh, R., Bhattacharya, D., Bhat, S., Ray, A., Pandit, A., ... & Dubey, S. (2021). Anti-PF4 antibody negative cerebral venous sinus thrombosis without thrombocytopenia following immunization with COVID-19 vaccine in an elderly non-comorbid Indian male, managed with conventional heparin-warfarin based anticoagulation. Diabetes & Metabolic Syndrome, 15(4), 102184. https://pubmed.ncbi.nlm.nih.gov/34186376/ | Finsterer, J. (2021). Lobar bleeding with ventricular rupture shortly after first dosage of an mRNA-based SARS-CoV-2 vaccine. Brain hemorrhages. https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8553377/ | Choi, G. J., Baek, S. H., Kim, J., Kim, J. H., Kwon, G. Y., Kim, D. K., ... & Kim, S. (2021). Fatal Systemic Capillary Leak Syndrome after SARS-CoV-2Vaccination in Patient with Multiple Myeloma. Emerging infectious diseases, 27(11), 2973. | https://pubmed.ncbi.nlm.nih.gov/34459725/ | Choi, G. J., Baek, S. H., Kim, J., Kim, J. H., Kwon, G. Y., Kim, D. K., ... & Kim, S. (2021). Fatal Systemic Capillary Leak Syndrome after SARS-CoV-2Vaccination in Patient with Multiple Myeloma. Emerging infectious diseases, 27(11), 2973. https://pubmed.ncbi.nlm.nih.gov/34459725/ | González-Romero, N., & Sánchez, V. (2021). Lipschütz Ulcers After the AstraZeneca COVID-19 Vaccine. Actas Dermo-sifiliograficas. https://pubmed.ncbi.nlm.nih.gov/34366434/. | ||||
266 | Thrombosis with thrombocytopenia syndrome after COVID-19 immunization: | https://pubmed.ncbi.nlm.nih.gov/34236343/ | https://pubmed.ncbi.nlm.nih.gov/34101024/ | Zakaria, Z., Sapiai, N. A., & Ghani, A. R. I. (2021). Cerebral venous sinus thrombosis 2 weeks after the first dose of mRNA SARS-CoV-2 vaccine. Acta neurochirurgica, 163(8), 2359-2362. | Zakaria, Z., Sapiai, N. A. y Ghani, A. R. I. (2021). Trombosis del seno venoso cerebral 2 semanas después de la primera dosis de la vacuna de ARNm del SARS-CoV-2. Acta neurochirurgica, 163(8), 2359-2362. https://pubmed.ncbi.nlm.nih.gov/34137813/ | FINSTERER, J. (2021). Las vacunas de SARS-COV-2 pueden no solo ser complicadas por GBS sino también por neuropatía de fibra pequeña distal. Diario de Neuroimmunology. https://pubmed.ncbi.nlm.nih.gov/34808658/ | Zakaria, Z., Sapiai, N. A., & Ghani, A. R. I. (2021). Cerebral venous sinus thrombosis 2 weeks after the first dose of mRNA SARS-CoV-2 vaccine. Acta neurochirurgica, 163(8), 2359-2362. https://pubmed.ncbi.nlm.nih.gov/34101024/ | Finsterer, J. (2021). SARS-CoV-2 vaccinations are unsafe for those experiencing post-vaccination Guillain-Barre syndrome. Annals of Medicine and Surgery. https://www.sciencedirect.com/science/article/pii/S2049080121005343 | Hyun, H., Song, J. Y., Seong, H., Yoon, J. G., Noh, J. Y., Cheong, H. J., & Kim, W. J. (2021). Polyarthralgia and Myalgia Syndrome after ChAdOx1 nCOV-19 Vaccination. Journal of Korean Medical Science, 36(34). | https://pubmed.ncbi.nlm.nih.gov/34463066/ | Hyun, H., Song, J. Y., Seong, H., Yoon, J. G., Noh, J. Y., Cheong, H. J., & Kim, W. J. (2021). Polyarthralgia and Myalgia Syndrome after ChAdOx1 nCOV-19 Vaccination. Journal of Korean Medical Science, 36(34). https://pubmed.ncbi.nlm.nih.gov/34463066/ | Gordon, S. F., Clothier, H. J., Morgan, H., Buttery, J. P., Phuong, L. K., Monagle, P., ... & Crawford, N. W. (2021). Immune thrombocytopenia following immunisation with Vaxzevria ChadOx1-S (AstraZeneca) vaccine, Victoria, Australia. Vaccine, 39(48), 7052-7057. https://pubmed.ncbi.nlm.nih.gov/34756770/ | ||||
267 | Acute myocardial infarction within 24 hours after COVID-19 vaccination: | https://pubmed.ncbi.nlm.nih.gov/34364657/. | https://pubmed.ncbi.nlm.nih.gov/34137813/ | Tølbøll Sørensen, A. L., Rolland, M., Hartmann, J., Harboe, Z. B., Roed, C., Jensen, T. Ø., ... & Stensballe, J. (2021). A case of thrombocytopenia and multiple thromboses after vaccination with ChAdOx1 nCoV-19 against SARS-CoV-2. Blood Advances, 5(12), 2569-2574. | Tølbøll Sørensen, A. L., Rolland, M., Hartmann, J., Harboe, Z. B., Roed, C., Jensen, T. Ø., ... y Stensballe, J. (2021). Un caso de trombocitopenia y trombosis múltiples tras la vacunación con ChAdOx1 nCoV-19 contra el SARS-CoV-2. Avances de sangre, 5(12), 2569-2574. https://pubmed.ncbi.nlm.nih.gov/34191218/ | FINSTERER, J. (2021). Las vacunas SARS-COV-2 no son seguras para aquellos que experimentan el síndrome de Guillain-Barre posterior al vacunación. Anales de medicina y cirugía. https://www.sciencedirect.com/science/article/pii/S2049080121007536 | Tølbøll Sørensen, A. L., Rolland, M., Hartmann, J., Harboe, Z. B., Roed, C., Jensen, T. Ø., ... & Stensballe, J. (2021). A case of thrombocytopenia and multiple thromboses after vaccination with ChAdOx1 nCoV-19 against SARS-CoV-2. Blood Advances, 5(12), 2569-2574. https://pubmed.ncbi.nlm.nih.gov/34137813/ | Finsterer, J. (2021). SARS-CoV-2 vaccinations may not only be complicated by GBS but also by distal small fibre neuropathy. Journal of Neuroimmunology. https://pubmed.ncbi.nlm.nih.gov/34525410/ | İremli, B. G., Şendur, S. N., & Ünlütürk, U. (2021). Three cases of subacute thyroiditis following SARS-CoV-2 vaccine: postvaccination ASIA syndrome. The Journal of Clinical Endocrinology & Metabolism, 106(9), 2600-2605. | https://pubmed.ncbi.nlm.nih.gov/34043800/. | İremli, B. G., Şendur, S. N., & Ünlütürk, U. (2021). Three cases of subacute thyroiditis following SARS-CoV-2 vaccine: postvaccination ASIA syndrome. The Journal of Clinical Endocrinology & Metabolism, 106(9), 2600-2605. https://pubmed.ncbi.nlm.nih.gov/34043800/. | Graf, T., Thiele, T., Klingebiel, R., Greinacher, A., Schäbitz, W. R., & Greeve, I. (2021). Immediate high-dose intravenous immunoglobulins followed by direct thrombin-inhibitor treatment is crucial for survival in Sars-Covid-19-adenoviral vector vaccine-induced immune thrombotic thrombocytopenia VITT with cerebral sinus venous and portal vein thrombosis. Journal of Neurology, 268(12), 4483-4485. https://pubmed.ncbi.nlm.nih.gov/34023956/. | ||||
268 | Bilateral acute macular neuroretinopathy after SARS-CoV-2 vaccination: | https://pubmed.ncbi.nlm.nih.gov/34287612/ | https://pubmed.ncbi.nlm.nih.gov/34191218/ | Marcucci, R., & Marietta, M. (2021). Vaccine-induced thrombotic thrombocytopenia: the elusive link between thrombosis and adenovirus-based SARS-CoV-2 vaccines. Internal and emergency medicine, 16(5), 1113-1119. | Marcucci, R. y Marietta, M. (2021). Trombocitopenia trombótica inducida por vacunas: el vínculo difícil de alcanzar entre la trombosis y las vacunas contra el SARS-CoV-2 basadas en adenovirus. Medicina interna y de emergencia, 16(5), 1113-1119. https://pubmed.ncbi.nlm.nih.gov/34175640/ | FINSTERER, J. (2021). Lobar sangrado con rotura ventricular poco después de la primera dosis de una vacuna SARS-COV-2 basada en ARNm. Hemorragias cerebrales. https://pubmed.ncbi.nlm.nih.gov/33932458/ | Marcucci, R., & Marietta, M. (2021). Vaccine-induced thrombotic thrombocytopenia: the elusive link between thrombosis and adenovirus-based SARS-CoV-2 vaccines. Internal and emergency medicine, 16(5), 1113-1119. https://pubmed.ncbi.nlm.nih.gov/34191218/ | Finsterer, J. (2022). Neurological side effects of SARS‐CoV‐2 vaccinations. Acta Neurologica Scandinavica, 145(1), 5-9. https://pubmed.ncbi.nlm.nih.gov/34750810/ | Jain, E., Pandav, K., Regmi, P., Michel, G., & Altshuler, I. (2021). Facial diplegia: a rare, atypical variant of Guillain-Barré syndrome and Ad26. COV2. S Vaccine. Cureus, 13(7). | https://pubmed.ncbi.nlm.nih.gov/34447646/ | Jain, E., Pandav, K., Regmi, P., Michel, G., & Altshuler, I. (2021). Facial diplegia: a rare, atypical variant of Guillain-Barré syndrome and Ad26. COV2. S Vaccine. Cureus, 13(7). https://pubmed.ncbi.nlm.nih.gov/34447646/ | Gras-Champel, V., Liabeuf, S., Baud, M., Albucher, J. F., Benkebil, M., Boulay, C., ... & French Network of Pharmacovigilance Centres. (2021). Atypical thrombosis associated with VaxZevria®(AstraZeneca) vaccine: data from the French network of regional pharmacovigilance centres. Therapie. https://pubmed.ncbi.nlm.nih.gov/34083026/. | ||||
269 | central venous sinus thrombosis with subarachnoid hemorrhage after COVID-19 mRNA vaccination: are these reports merely coincidental: | https://pubmed.ncbi.nlm.nih.gov/34478433/ | https://pubmed.ncbi.nlm.nih.gov/34175640/ | Costentin, G., Ozkul-Wermester, O., Triquenot, A., Le Cam-Duchez, V., Massy, N., Benhamou, Y., & Massardier, E. (2021). Acute ischemic stroke revealing ChAdOx1 nCov-19 vaccine-induced immune thrombotic thrombocytopenia: impact on recanalization strategy. Journal of Stroke and Cerebrovascular Diseases, 30(9), 105942. | Costentin, G., Ozkul-Wermester, O., Triquenot, A., Le Cam-Duchez, V., Massy, N., Benhamou, Y. y Massardier, E. (2021). Accidente cerebrovascular isquémico agudo que revela trombocitopenia trombótica inmunitaria inducida por la vacuna ChAdOx1 nCov-19: impacto en la estrategia de recanalización. Revista de accidentes cerebrovasculares y enfermedades cerebrovasculares, 30(9), 105942. https://pubmed.ncbi.nlm.nih.gov/34153802/ | FINSTERER, J. (2021). Lobar sangrado con rotura ventricular poco después de la primera dosis de una vacuna SARS-COV-2 basada en ARNm. Hemorragias cerebrales. https://www.ahajournals.org/doi/10.1161/circ.144.suppl_1.10712 | Costentin, G., Ozkul-Wermester, O., Triquenot, A., Le Cam-Duchez, V., Massy, N., Benhamou, Y., & Massardier, E. (2021). Acute ischemic stroke revealing ChAdOx1 nCov-19 vaccine-induced immune thrombotic thrombocytopenia: impact on recanalization strategy. Journal of Stroke and Cerebrovascular Diseases, 30(9), 105942. https://pubmed.ncbi.nlm.nih.gov/34175640/ | Finsterer, J., & Korn, M. (2021). Aphasia seven days after second dose of an mRNA-based SARS-CoV-2 vaccine. Brain Hemorrhages, 2(4), 165-167. https://www.sciencedirect.com/science/article/pii/S2589238X21000292#f0005 | Trogstad, L., Robertson, A. H., Mjaaland, S., & Magnus, P. (2021). Association between ChAdOx1 nCoV-19 vaccination and bleeding episodes: Large population-based cohort study. Vaccine, 39(40), 5854-5857. | https://pubmed.ncbi.nlm.nih.gov/34479760/. | Trogstad, L., Robertson, A. H., Mjaaland, S., & Magnus, P. (2021). Association between ChAdOx1 nCoV-19 vaccination and bleeding episodes: Large population-based cohort study. Vaccine, 39(40), 5854-5857. https://pubmed.ncbi.nlm.nih.gov/34479760/. | Greenhawt, M., Abrams, E. M., Shaker, M., Chu, D. K., Khan, D., Akin, C., ... & Golden, D. B. (2021). The risk of allergic reaction to SARS-CoV-2 vaccines and recommended evaluation and management: a systematic review, meta-analysis, GRADE assessment, and international consensus approach. The Journal of Allergy and Clinical Immunology: In Practice, 9(10), 3546-3567. https://www.ncbi.nlm.nih.gov/pubmed/34153517 | ||||
270 | Intracerebral hemorrhage due to thrombosis with thrombocytopenia syndrome after COVID-19 vaccination: the first fatal case in Korea: | https://pubmed.ncbi.nlm.nih.gov/34402235/ | https://pubmed.ncbi.nlm.nih.gov/34153802/ | Aladdin, Y., & Shirah, B. (2021). New-onset refractory status epilepticus following the ChAdOx1 nCoV-19 vaccine. Journal of Neuroimmunology, 357, 577629. | Aladdin, Y. y Shirah, B. (2021). Estado epiléptico refractario de nueva aparición después de la vacuna ChAdOx1 nCoV-19. Revista de Neuroinmunología, 357, 577629. https://pubmed.ncbi.nlm.nih.gov/34092488/ | FINSTERER, J. (2022). Efectos secundarios neurológicos de las vacunas de SARS-COV-2. Acta Neurologica Scandinavica, 145 (1), 5-9. https://pubmed.ncbi.nlm.nih.gov/34639132/ | Aladdin, Y., & Shirah, B. (2021). New-onset refractory status epilepticus following the ChAdOx1 nCoV-19 vaccine. Journal of Neuroimmunology, 357, 577629. https://pubmed.ncbi.nlm.nih.gov/34153802/ | Finsterer, J., & Redzic, Z. (2021). Symptomatic peduncular, cavernous bleeding following SARS-CoV-2 vaccination induced immune thrombocytopenia. Brain Hemorrhages, 2(4), 169-171. https://pubmed.ncbi.nlm.nih.gov/34549178/. | Esba, L. C. A., & Al Jeraisy, M. (2021). Reported adverse effects following COVID-19 vaccination at a tertiary care hospital, focus on cerebral venous sinus thrombosis (CVST). Expert Review of Vaccines, 20(8), 1037-1042. | https://pubmed.ncbi.nlm.nih.gov/34092166/ | Esba, L. C. A., & Al Jeraisy, M. (2021). Reported adverse effects following COVID-19 vaccination at a tertiary care hospital, focus on cerebral venous sinus thrombosis (CVST). Expert Review of Vaccines, 20(8), 1037-1042. https://pubmed.ncbi.nlm.nih.gov/34092166/ | Greinacher, A., Selleng, K., Palankar, R., Wesche, J., Handtke, S., Wolff, M., ... & Renné, T. (2021). Insights in ChAdOx1 nCoV-19 vaccine-induced immune thrombotic thrombocytopenia. Blood, The Journal of the American Society of Hematology, 138(22), 2256-2268. https://pubmed.ncbi.nlm.nih.gov/34587242/ | ||||
271 | Cerebral venous sinus thrombosis negative for anti-PF4 antibody without thrombocytopenia after immunization with COVID-19 vaccine in a non-comorbid elderly Indian male treated with conventional heparin-warfarin-based anticoagulation: | https://pubmed.ncbi.nlm.nih.gov/34186376/ | https://pubmed.ncbi.nlm.nih.gov/34092488/ | Cattaneo, M. (2021). Thrombosis with Thrombocytopenia Syndrome associated with viral vector COVID-19 vaccines. European Journal of Internal Medicine, 89, 22-24. | Cattaneo, M. (2021). Síndrome de Trombosis con Trombocitopenia asociado a vacunas de vector viral COVID-19. Revista Europea de Medicina Interna, 89, 22-24. https://pubmed.ncbi.nlm.nih.gov/34261635/ | FINSTERER, J., & Korn, M. (2021). Afasia siete días después de la segunda dosis de una vacuna SARS-COV-2 basada en ARNm. Hemorragias cerebrales, 2 (4), 165-167. https://www.sciencedirect.com/science/article/abs/pii/S0896841121000895 | Cattaneo, M. (2021). Thrombosis with Thrombocytopenia Syndrome associated with viral vector COVID-19 vaccines. European Journal of Internal Medicine, 89, 22-24. https://pubmed.ncbi.nlm.nih.gov/34092488/ | Finsterer, J., & Scorza, F. A. (2021). SARS-CoV-2 or SARS-CoV-2 vaccination associated Parsonage-Turner syndrome. Comment on:“Neuralgic amyotrophy and Covid 19 infection: 2 cases of spinal accessory nerve palsy” by Coll et al. Joint Bone Spine 2021; 88: 105196. Joint Bone Spine. https://pubmed.ncbi.nlm.nih.gov/34139321/. | Kreuter, A., Licciardi‐Fernandez, M. J., Burmann, S. N., Burkert, B., Oellig, F., & Michalowitz, A. L. (2022). Induction and exacerbation of subacute cutaneous lupus erythematosus following mRNA‐based or adenoviral vector‐based SARS‐CoV‐2 vaccination. Clinical and Experimental Dermatology, 47(1), 161-163. | https://pubmed.ncbi.nlm.nih.gov/34291477/ | Kreuter, A., Licciardi‐Fernandez, M. J., Burmann, S. N., Burkert, B., Oellig, F., & Michalowitz, A. L. (2022). Induction and exacerbation of subacute cutaneous lupus erythematosus following mRNA‐based or adenoviral vector‐based SARS‐CoV‐2 vaccination. Clinical and Experimental Dermatology, 47(1), 161-163. https://pubmed.ncbi.nlm.nih.gov/34291477/ | Gresele, P., Marietta, M., Ageno, W., Marcucci, R., Contino, L., Donadini, M. P., ... & De Stefano, V. (2021). Management of cerebral and splanchnic vein thrombosis associated with thrombocytopenia in subjects previously vaccinated with Vaxzevria (AstraZeneca): a position statement from the Italian Society for the Study of Haemostasis and Thrombosis (SISET). Blood Transfusion, 19(4), 281. https://pubmed.ncbi.nlm.nih.gov/33871350/ | ||||
272 | Cerebral venous sinus thrombosis 2 weeks after first dose of SARS-CoV-2 mRNA vaccine: | https://pubmed.ncbi.nlm.nih.gov/34101024/ | https://pubmed.ncbi.nlm.nih.gov/34261635/ | Malik, B., Kalantary, A., Rikabi, K., & Kunadi, A. (2021). Pulmonary embolism, transient ischaemic attack and thrombocytopenia after the Johnson & Johnson COVID-19 vaccine. BMJ Case Reports CP, 14(7), e243975. | Malik, B., Kalantary, A., Rikabi, K. y Kunadi, A. (2021). Embolia pulmonar, ataque isquémico transitorio y trombocitopenia tras la vacuna Johnson & Johnson COVID-19. Informes de casos de BMJ CP, 14(7), e243975. https://pubmed.ncbi.nlm.nih.gov/34132839/. | FINSTERER, J., & REDZIC, Z. (2021). Sintomático Peduncario, sangrado cavernoso después de la vacunación contra SARS-COV-2, la trombocitopenia inmune inducida. Hemorragias cerebrales, 2 (4), 169-171. https://pubmed.ncbi.nlm.nih.gov/34656887/ | Malik, B., Kalantary, A., Rikabi, K., & Kunadi, A. (2021). Pulmonary embolism, transient ischaemic attack and thrombocytopenia after the Johnson & Johnson COVID-19 vaccine. BMJ Case Reports CP, 14(7), e243975. https://pubmed.ncbi.nlm.nih.gov/34261635/ | Finsterer, J., Scorza, F. A., & Scorza, C. A. (2021). Post SARS-CoV-2 vaccination Guillain-Barre syndrome in 19 patients. Clinics, 76. https://pubmed.ncbi.nlm.nih.gov/34644738/. | Irvine, N. J., & Wiles, B. L. (2021). Petechiae and Desquamation of Fingers Following Immunization With BTN162b2 Messenger RNA (mRNA) COVID-19 Vaccine. Cureus, 13(8). | https://pubmed.ncbi.nlm.nih.gov/34513435/ | Irvine, N. J., & Wiles, B. L. (2021). Petechiae and Desquamation of Fingers Following Immunization With BTN162b2 Messenger RNA (mRNA) COVID-19 Vaccine. Cureus, 13(8). https://pubmed.ncbi.nlm.nih.gov/34513435/ | Gresele, P., Momi, S., Marcucci, R., Ramundo, F., De Stefano, V., & Tripodi, A. (2021). Interactions of adenoviruses with platelets and coagulation and the vaccine-induced immune thrombotic thrombocytopenia syndrome. haematologica, 106(12), 3034. https://pubmed.ncbi.nlm.nih.gov/34407607/. | ||||
273 | A case of multiple thrombocytopenia and thrombosis following vaccination with ChAdOx1 nCoV-19 against SARS-CoV-2: | https://pubmed.ncbi.nlm.nih.gov/34137813/ | https://pubmed.ncbi.nlm.nih.gov/34132839/. | Barral, M., Arrive, L., Mouhadi-Barnier, E., & Cornelis, F. H. (2021). Thromboaspiration and fibrinolysis infusion for portomesenteric thrombosis after AstraZeneca COVID-19 vaccine administration. Intensive Care Medicine, 47(9), 1034-1036. | Barral, M., Arrive, L., Mouhadi-Barnier, E. y Cornelis, FH (2021). Infusión de tromboaspiración y fibrinólisis para la trombosis portomesentérica después de la administración de la vacuna AstraZeneca COVID-19. Medicina de cuidados intensivos, 47(9), 1034-1036. https://pubmed.ncbi.nlm.nih.gov/34144250/ | FINSTERER, J., & Scorza, F. A. (2021). SARS-COV-2 o SARS-COV-2 Síndrome de Parsonage-Turner asociado. Comentario sobre: "Amigrofia neuralgic y covid 19 infección: 2 casos de parálisis del nervio accesorio espinal" de Coll et al. Espina ósea conjunta 2021; 88: 105196. Columna vertebral conjunta. https://pubmed.ncbi.nlm.nih.gov/34032902/. | Barral, M., Arrive, L., Mouhadi-Barnier, E., & Cornelis, F. H. (2021). Thromboaspiration and fibrinolysis infusion for portomesenteric thrombosis after AstraZeneca COVID-19 vaccine administration. Intensive Care Medicine, 47(9), 1034-1036. https://pubmed.ncbi.nlm.nih.gov/34132839/. | Flower, L., Bares, Z., Santiapillai, G., & Harris, S. (2021). Acute ST-segment elevation myocardial infarction secondary to vaccine-induced immune thrombosis with thrombocytopaenia (VITT). BMJ Case Reports CP, 14(9), e245218. https://pubmed.ncbi.nlm.nih.gov/34580132/. | Lensen, R., Netea, M. G., & Rosendaal, F. R. (2021). Hepatitis C virus reactivation following COVID-19 vaccination–A case report. International Medical Case Reports Journal, 14, 573. | https://pubmed.ncbi.nlm.nih.gov/34512037/ | Lensen, R., Netea, M. G., & Rosendaal, F. R. (2021). Hepatitis C virus reactivation following COVID-19 vaccination–A case report. International Medical Case Reports Journal, 14, 573. https://pubmed.ncbi.nlm.nih.gov/34512037/ | Grossman, M. E., Appel, G., Little, A. J., & Ko, C. J. (2021). Post‐COVID‐19 vaccination IgA vasculitis in an adult. Journal of cutaneous pathology. https://pubmed.ncbi.nlm.nih.gov/34779011/ | ||||
274 | Vaccine-induced thrombotic thrombocytopenia: the elusive link between thrombosis and adenovirus-based SARS-CoV-2 vaccines: | https://pubmed.ncbi.nlm.nih.gov/34191218/ | https://pubmed.ncbi.nlm.nih.gov/34144250/ | Warkentin, T. E., & Greinacher, A. (2021). Spontaneous HIT syndrome: knee replacement, infection, and parallels with vaccine-induced immune thrombotic thrombocytopenia. Thrombosis Research, 204, 40-51. | Warkentin, TE y Greinacher, A. (2021). Síndrome HIT espontáneo: reemplazo de rodilla, infección y paralelos con la trombocitopenia trombótica inmune inducida por vacunas. Investigación de trombosis, 204, 40-51. https://pubmed.ncbi.nlm.nih.gov/33687691/ | FINSTERER, J., Scorza, F. A., & Scorza, C. A. (2021). Post SARS-COV-2 Vacunación del síndrome de Guillain-Barre en 19 pacientes. Clínicas, 76. https://pubmed.ncbi.nlm.nih.gov/34649856/ | Warkentin, T. E., & Greinacher, A. (2021). Spontaneous HIT syndrome: knee replacement, infection, and parallels with vaccine-induced immune thrombotic thrombocytopenia. Thrombosis Research, 204, 40-51. https://pubmed.ncbi.nlm.nih.gov/34144250/ | Foltran, D., Delmas, C., Flumian, C., De Paoli, P., Salvo, F., Gautier, S., ... & Montastruc, F. (2022). Myocarditis and pericarditis in adolescents after first and second doses of mRNA COVID-19 vaccines. European Heart Journal-Quality of Care and Clinical Outcomes, 8(2), 99-103. https://academic.oup.com/ehjqcco/advance-article/doi/10.1093/ehjqcco/qcab090/6442104 | Khan, T. A., Sidhu, N., Khan, L., Sen, S., Hussain, N., Tandon, R., & Gupta, N. (2021). Bilateral immune-mediated keratolysis after immunization with SARS-CoV-2 recombinant viral vector vaccine. Cornea, 40(12), 1629-1632. | https://pubmed.ncbi.nlm.nih.gov/34483273/. | Khan, T. A., Sidhu, N., Khan, L., Sen, S., Hussain, N., Tandon, R., & Gupta, N. (2021). Bilateral immune-mediated keratolysis after immunization with SARS-CoV-2 recombinant viral vector vaccine. Cornea, 40(12), 1629-1632. https://pubmed.ncbi.nlm.nih.gov/34483273/. | Guan, C. Y., Tsai, S. H., Fan, J. S., Lin, Y. K., & Kao, C. C. (2022). Middle-age Asian male with cerebral venous thrombosis after COVID-19 AstraZeneca vaccination. The American Journal of Emergency Medicine, 51, 427-e3. https://www.sciencedirect.com/science/article/pii/S0735675721005714 | ||||
275 | Acute ischemic stroke revealing immune thrombotic thrombocytopenia induced by ChAdOx1 nCov-19 vaccine: impact on recanalization strategy: | https://pubmed.ncbi.nlm.nih.gov/34175640/ | https://pubmed.ncbi.nlm.nih.gov/33687691/ | Carli, G., Nichele, I., Ruggeri, M., Barra, S., & Tosetto, A. (2021). Deep vein thrombosis (DVT) occurring shortly after the second dose of mRNA SARS-CoV-2 vaccine. Internal and emergency medicine, 16(3), 803-804. | Carli, G., Nichele, I., Ruggeri, M., Barra, S. y Tosetto, A. (2021). La trombosis venosa profunda (TVP) se produce poco después de la segunda dosis de la vacuna de ARNm del SARS-CoV-2. Medicina interna y de emergencia, 16(3), 803-804. https://pubmed.ncbi.nlm.nih.gov/34011137/. | Flor, L., Bares, Z., Santiapillai, G., Y Harris, S. (2021). Infarto agudo de la elevación del segmento de ST-segmento secundario secundario a la trombosis inmune inducida por la vacuna con trombocitopaenia (VITT). BMJ Case Reports CP, 14 (9), E245218. https://pubmed.ncbi.nlm.nih.gov/34535492/ | Carli, G., Nichele, I., Ruggeri, M., Barra, S., & Tosetto, A. (2021). Deep vein thrombosis (DVT) occurring shortly after the second dose of mRNA SARS-CoV-2 vaccine. Internal and emergency medicine, 16(3), 803-804. https://pubmed.ncbi.nlm.nih.gov/33687691/ | Foltran, D., Delmas, C., Flumian, C., De Paoli, P., Salvo, F., Gautier, S., ... & Montastruc, F. (2022). Myocarditis and pericarditis in adolescents after first and second doses of mRNA COVID-19 vaccines. European Heart Journal-Quality of Care and Clinical Outcomes, 8(2), 99-103. https://pubmed.ncbi.nlm.nih.gov/34849667/ | Jasaraj, R. B., Shrestha, D. B., Gaire, S., & Kassem, M. (2021). Immune Thrombocytopenic Purpura Following Pfizer-BioNTech COVID-19 Vaccine in an Elderly Female. Cureus, 13(8). | https://pubmed.ncbi.nlm.nih.gov/34513446/ | Jasaraj, R. B., Shrestha, D. B., Gaire, S., & Kassem, M. (2021). Immune Thrombocytopenic Purpura Following Pfizer-BioNTech COVID-19 Vaccine in an Elderly Female. Cureus, 13(8). https://pubmed.ncbi.nlm.nih.gov/34513446/ | Guerrero, A. J., Estirado, A. D., Quirós, J. C., & Rojas-Pérez-Ezquerra, P. (2021). Delayed cutaneous reactions after the administration of mRNA vaccines against COVID-19. The Journal of Allergy and Clinical Immunology: In Practice, 9(10), 3811-3813. https://www.sciencedirect.com/science/article/pii/S2213219821007996 | ||||
276 | New-onset refractory status epilepticus after ChAdOx1 nCoV-19 vaccine: | https://pubmed.ncbi.nlm.nih.gov/34153802/ | https://pubmed.ncbi.nlm.nih.gov/34011137/. | Althaus, K., Möller, P., Uzun, G., Singh, A., Beck, A., Bettag, M., ... & Bakchoul, T. (2021). Antibody-mediated procoagulant platelets in SARS-CoV-2-vaccination associated immune thrombotic thrombocytopenia. Haematologica, 106(8), 2170. | Althaus, K., Möller, P., Uzun, G., Singh, A., Beck, A., Bettag, M., ... y Bakchoul, T. (2021). Plaquetas procoagulantes mediadas por anticuerpos en la trombocitopenia trombótica inmunitaria asociada a la vacunación contra el SARS-CoV-2. Hematológica, 106(8), 2170. https://pubmed.ncbi.nlm.nih.gov/34393988/. | Foltran, D., Delmas, C., Flumian, C., De Paoli, P., Salvo, F., Gautier, S., ... & Montastruc, F. (2022). Miocarditis y pericarditis en adolescentes después de la primera y segunda dosis de las vacunas de MRNA COVID-19. CORAZÓN EUROPEO DE LA CALIDAD DE LA CALIDAD DE LA CUIDADA Y RESULTADOS CLÍNICOS, 8 (2), 99-103. https://pubmed.ncbi.nlm.nih.gov/34319393/ | Althaus, K., Möller, P., Uzun, G., Singh, A., Beck, A., Bettag, M., ... & Bakchoul, T. (2021). Antibody-mediated procoagulant platelets in SARS-CoV-2-vaccination associated immune thrombotic thrombocytopenia. Haematologica, 106(8), 2170. https://pubmed.ncbi.nlm.nih.gov/34011137/. | Foltran, D., Delmas, C., Flumian, C., De Paoli, P., Salvo, F., Gautier, S., ... & Montastruc, F. (2022). Myocarditis and pericarditis in adolescents after first and second doses of mRNA COVID-19 vaccines. European Heart Journal-Quality of Care and Clinical Outcomes, 8(2), 99-103. https://www.ncbi.nlm.nih.gov/pubmed/34849667 | Scavone, M., Clerici, B., Birocchi, S., Mencarini, T., Calogiuri, M., Ghali, C., ... & Podda, G. M. (2021). Platelet activation and modulation in thrombosis with thrombocytopenia syndrome associated with ChAdOx1 nCov-19 vaccine. haematologica, 106(12), 3228. | https://pubmed.ncbi.nlm.nih.gov/34474550/ | Scavone, M., Clerici, B., Birocchi, S., Mencarini, T., Calogiuri, M., Ghali, C., ... & Podda, G. M. (2021). Platelet activation and modulation in thrombosis with thrombocytopenia syndrome associated with ChAdOx1 nCov-19 vaccine. haematologica, 106(12), 3228. https://pubmed.ncbi.nlm.nih.gov/34474550/ | Gundry, S. R. (2021). Observational Findings of PULS Cardiac Test Findings for Inflammatory Markers in Patients Receiving mRNA Vaccines. Circulation, 144(Suppl_1), A10712-A10712. https://www.ahajournals.org/doi/10.1161/circ.144.suppl_1.10712 | ||||
277 | Thrombosis with thrombocytopenia syndrome associated with COVID-19 viral vector vaccines: | https://pubmed.ncbi.nlm.nih.gov/34092488/ | https://pubmed.ncbi.nlm.nih.gov/34393988/. | Wiedmann, M., Skattør, T., Stray-Pedersen, A., Romundstad, L., Antal, E. A., Marthinsen, P. B., ... & Skjelland, M. (2021). Vaccine induced immune thrombotic thrombocytopenia causing a severe form of cerebral venous thrombosis with high fatality rate: a case series. Frontiers in neurology, 1302. | Wiedmann, M., Skattør, T., Stray-Pedersen, A., Romundstad, L., Antal, E. A., Marthinsen, P. B., ... y Skjelland, M. (2021). Trombocitopenia trombótica inmunitaria inducida por vacuna que causa una forma grave de trombosis venosa cerebral con una alta tasa de mortalidad: una serie de casos. Fronteras en neurología, 1302. https://pubmed.ncbi.nlm.nih.gov/34129181/. | Foltran, D., Delmas, C., Flumian, C., De Paoli, P., Salvo, F., Gautier, S., ... & Montastruc, F. (2022). Miocarditis y pericarditis en adolescentes después de la primera y segunda dosis de las vacunas de MRNA COVID-19. CORAZÓN EUROPEO DE LA CALIDAD DE LA CALIDAD DE LA CUIDADA Y RESULTADOS CLÍNICOS, 8 (2), 99-103. https://www.mdpi.com/2036-7503/13/3/61. | Wiedmann, M., Skattør, T., Stray-Pedersen, A., Romundstad, L., Antal, E. A., Marthinsen, P. B., ... & Skjelland, M. (2021). Vaccine induced immune thrombotic thrombocytopenia causing a severe form of cerebral venous thrombosis with high fatality rate: a case series. Frontiers in neurology, 1302. https://pubmed.ncbi.nlm.nih.gov/34393988/. | Forgacs, D., Jang, H., Abreu, R. B., Hanley, H. B., Gattiker, J. L., Jefferson, A. M., & Ross, T. M. (2021). SARS-CoV-2 mRNA Vaccines Elicit Different Responses in Immunologically Naïve and Pre-Immune Humans. Frontiers in immunology, 12. https://www.ncbi.nlm.nih.gov/pubmed/34646267 | An, Q. J., Qin, D. A., & Pei, J. X. (2021). Reactive arthritis after COVID-19 vaccination. Human Vaccines & Immunotherapeutics, 17(9), 2954-2956. | https://pubmed.ncbi.nlm.nih.gov/34033732/. | An, Q. J., Qin, D. A., & Pei, J. X. (2021). Reactive arthritis after COVID-19 vaccination. Human Vaccines & Immunotherapeutics, 17(9), 2954-2956. https://pubmed.ncbi.nlm.nih.gov/34033732/. | Günther, A., Brämer, D., Pletz, M. W., Kamradt, T., Baumgart, S., Mayer, T. E., ... & Thiele, T. (2021). Complicated Long Term Vaccine Induced Thrombotic Immune Thrombocytopenia—A Case Report. Vaccines, 9(11), 1344. https://pubmed.ncbi.nlm.nih.gov/34835275/. | ||||
278 | Pulmonary embolism, transient ischemic attack, and thrombocytopenia after Johnson & Johnson COVID-19 vaccine: | https://pubmed.ncbi.nlm.nih.gov/34261635/ | https://pubmed.ncbi.nlm.nih.gov/34129181/. | Marchandot, B., Carmona, A., Trimaille, A., Curtiaud, A., & Morel, O. (2021). Procoagulant microparticles: a possible link between vaccine-induced immune thrombocytopenia (VITT) and cerebral sinus venous thrombosis. Journal of Thrombosis and Thrombolysis, 52(3), 689-691. | Marchandot, B., Carmona, A., Trimaille, A., Curtiaud, A. y Morel, O. (2021). Micropartículas procoagulantes: un posible vínculo entre la trombocitopenia inmune inducida por vacunas (VITT) y la trombosis venosa del seno cerebral. Revista de trombosis y trombólisis, 52(3), 689-691. https://pubmed.ncbi.nlm.nih.gov/34083026/. | Foltran, D., Delmas, C., Flumian, C., De Paoli, P., Salvo, F., Gautier, S., ... & Montastruc, F. (2022). Miocarditis y pericarditis en adolescentes después de la primera y segunda dosis de las vacunas de MRNA COVID-19. CORAZÓN EUROPEO DE LA CALIDAD DE LA CALIDAD DE LA CUIDADA Y RESULTADOS CLÍNICOS, 8 (2), 99-103. https://www.ncbi.nlm.nih.gov/pubmed/34646267 | Marchandot, B., Carmona, A., Trimaille, A., Curtiaud, A., & Morel, O. (2021). Procoagulant microparticles: a possible link between vaccine-induced immune thrombocytopenia (VITT) and cerebral sinus venous thrombosis. Journal of Thrombosis and Thrombolysis, 52(3), 689-691. https://pubmed.ncbi.nlm.nih.gov/34129181/. | Fousse, M., Schub, D., Merzou, F., Fassbender, K., Sester, M., Kettner, M., ... & Goi Júnior, J. R. (2022). Case report: cerebral sinus vein thrombosis in two patients with AstraZeneca SARS-CoV-2 vaccination. Journal of neurology, 269(2), 583-586. https://pubmed.ncbi.nlm.nih.gov/34609603/ | Vera-Lastra, O., Ordinola Navarro, A., Cruz Domiguez, M. P., Medina, G., Sánchez Valadez, T. I., & Jara, L. J. (2021). Two cases of Graves' disease following SARS-CoV-2 vaccination: an autoimmune/inflammatory syndrome induced by adjuvants. Thyroid, 31(9), 1436-1439. | https://pubmed.ncbi.nlm.nih.gov/33858208/ | Vera-Lastra, O., Ordinola Navarro, A., Cruz Domiguez, M. P., Medina, G., Sánchez Valadez, T. I., & Jara, L. J. (2021). Two cases of Graves' disease following SARS-CoV-2 vaccination: an autoimmune/inflammatory syndrome induced by adjuvants. Thyroid, 31(9), 1436-1439. https://pubmed.ncbi.nlm.nih.gov/33858208/ | Gupta, A., Sardar, P., Cash, M. E., Milani, R. V., & Lavie, C. J. (2021). Covid-19 vaccine-induced thrombosis and thrombocytopenia-a commentary on an important and practical clinical dilemma. Progress in cardiovascular diseases. https://www.sciencedirect.com/science/article/abs/pii/S0033062021000505 | ||||
279 | Thromboaspiration infusion and fibrinolysis for portomesenteric thrombosis after administration of the AstraZeneca COVID-19 vaccine: | https://pubmed.ncbi.nlm.nih.gov/34132839/. | https://pubmed.ncbi.nlm.nih.gov/34083026/. | Gras-Champel, V., Liabeuf, S., Baud, M., Albucher, J. F., Benkebil, M., Boulay, C., ... & French Network of Pharmacovigilance Centres. (2021). Atypical thrombosis associated with VaxZevria®(AstraZeneca) vaccine: data from the French network of regional pharmacovigilance centres. Therapie. | Gras-Champel, V., Liabeuf, S., Baud, M., Albucher, J. F., Benkebil, M., Boulay, C., ... y Red francesa de centros de farmacovigilancia. (2021). Trombosis atípica asociada a la vacuna VaxZevria®(AstraZeneca): datos de la red francesa de centros regionales de farmacovigilancia. Terapia. https://pubmed.ncbi.nlm.nih.gov/34235757/. | Fowler, N., Martínez, N. R. M., Pallares, B. V., & Maldonado, R. S. (2021). Retinopatía serosa central de inicio agudo después de la vacuna contra la inmunización con COVID-19 Vacuna de ARNm. American Journal of Oftalmology Case Reports, 23, 101136. https://www.sciencedirect.com/science/article/pii/S217358082100122X. | Gras-Champel, V., Liabeuf, S., Baud, M., Albucher, J. F., Benkebil, M., Boulay, C., ... & French Network of Pharmacovigilance Centres. (2021). Atypical thrombosis associated with VaxZevria®(AstraZeneca) vaccine: data from the French network of regional pharmacovigilance centres. Therapie. https://pubmed.ncbi.nlm.nih.gov/34083026/. | Fowler, N., Martinez, N. R. M., Pallares, B. V., & Maldonado, R. S. (2021). Acute-onset central serous retinopathy after immunization with COVID-19 mRNA vaccine. American Journal of Ophthalmology Case Reports, 23, 101136. https://www.sciencedirect.com/science/article/pii/S2451993621001456. | Etemadifar, M., Sigari, A. A., Sedaghat, N., Salari, M., & Nouri, H. (2021). Acute relapse and poor immunization following COVID-19 vaccination in a rituximab-treated multiple sclerosis patient. Human vaccines & immunotherapeutics, 17(10), 3481-3483. | https://pubmed.ncbi.nlm.nih.gov/34015240/ | Etemadifar, M., Sigari, A. A., Sedaghat, N., Salari, M., & Nouri, H. (2021). Acute relapse and poor immunization following COVID-19 vaccination in a rituximab-treated multiple sclerosis patient. Human vaccines & immunotherapeutics, 17(10), 3481-3483. https://pubmed.ncbi.nlm.nih.gov/34015240/ | Gürtler, L., Seitz, R., & Schramm, W. (2021). Cerebral venous thrombosis after COVID-19 vaccination: is the risk of thrombosis increased by intravascular application of the vaccine?. Infection, 49(5), 1071-1074. https://pubmed.ncbi.nlm.nih.gov/34286453/. | ||||
280 | Spontaneous HIT syndrome: knee replacement, infection, and parallels with vaccine-induced immune thrombotic thrombocytopenia: | https://pubmed.ncbi.nlm.nih.gov/34144250/ | https://pubmed.ncbi.nlm.nih.gov/34235757/. | Taylor, P., Allen, L., Shrikrishnapalasuriyar, N., Stechman, M., & Rees, A. (2021). Vaccine‐induced thrombosis and thrombocytopenia with bilateral adrenal haemorrhage. Clinical Endocrinology. | Taylor, P., Allen, L., Shrikrishnapalasuriyar, N., Stechman, M. y Rees, A. (2021). Trombosis y trombocitopenia inducidas por vacunas con hemorragia suprarrenal bilateral. Endocrinología Clínica. https://pubmed.ncbi.nlm.nih.gov/34473841/. | Franchini, M., Liumbruno, G. M., & Pezzo, M. (2021). COVID-19 Trombosis inmune asociada a la vacuna y trombocitopenia (VITT): recomendaciones diagnósticas y terapéuticas para un nuevo síndrome. Diario Europeo de Hematología, 107 (2), 173-180. https://pubmed.ncbi.nlm.nih.gov/34138513/ | Taylor, P., Allen, L., Shrikrishnapalasuriyar, N., Stechman, M., & Rees, A. (2021). Vaccine‐induced thrombosis and thrombocytopenia with bilateral adrenal haemorrhage. Clinical Endocrinology. https://pubmed.ncbi.nlm.nih.gov/34235757/. | Franchini, M., Liumbruno, G. M., & Pezzo, M. (2021). COVID‐19 Vaccine‐associated Immune Thrombosis and Thrombocytopenia (VITT): diagnostic and therapeutic recommendations for a new syndrome. European Journal of Haematology, 107(2), 173-180. https://pubmed.ncbi.nlm.nih.gov/33987882/ | Wantavornprasert, K., Noppakun, N., Klaewsongkram, J., & Rerknimitr, P. (2022). Generalized bullous fixed drug eruption after Oxford–AstraZeneca (ChAdOx1 nCoV‐19) vaccination. Clinical and Experimental Dermatology, 47(2), 428-432. | https://pubmed.ncbi.nlm.nih.gov/34482558/ | Wantavornprasert, K., Noppakun, N., Klaewsongkram, J., & Rerknimitr, P. (2022). Generalized bullous fixed drug eruption after Oxford–AstraZeneca (ChAdOx1 nCoV‐19) vaccination. Clinical and Experimental Dermatology, 47(2), 428-432. https://pubmed.ncbi.nlm.nih.gov/34482558/ | Guzmán‐Pérez, L., Puerta‐Peña, M., Falkenhain‐López, D., Montero‐Menárguez, J., Gutiérrez‐Collar, C., Rodríguez‐Peralto, J. L., & Sanz‐Bueno, J. (2021). Small‐vessel vasculitis following Oxford‐AstraZeneca vaccination against SARS‐CoV‐2. Journal of the European Academy of Dermatology and Venereology. https://pubmed.ncbi.nlm.nih.gov/34310763/ | ||||
281 | Deep venous thrombosis (DVT) occurring shortly after second dose of SARS-CoV-2 mRNA vaccine: | https://pubmed.ncbi.nlm.nih.gov/33687691/ | https://pubmed.ncbi.nlm.nih.gov/34473841/. | Chen, Y. A., Huang, H. Y., Wu, S. H., & Huang, T. C. (2021). Thrombosis of the palmar digital vein after Oxford-AstraZeneca COVID-19 vaccination. International Journal of Dermatology, 60(11), e469-e471. | Chen, Y. A., Huang, H. Y., Wu, S. H. y Huang, T. C. (2021). Trombosis de la vena digital palmar tras la vacunación Oxford-AstraZeneca COVID-19. Revista Internacional de Dermatología, 60(11), e469-e471. https://pubmed.ncbi.nlm.nih.gov/34189756/ | Franchini, M., Testa, S., Pezzo, M., Glingani, C., Caruso, B., Terenziani, I., ... & Castelli, G. (2021). Trombosis venosa cerebral y trombocitopenia Post-covid-19 vacunación. Investigación de trombosis, 202, 182-183. https://pubmed.ncbi.nlm.nih.gov/33857630/. | Chen, Y. A., Huang, H. Y., Wu, S. H., & Huang, T. C. (2021). Thrombosis of the palmar digital vein after Oxford-AstraZeneca COVID-19 vaccination. International Journal of Dermatology, 60(11), e469-e471. https://pubmed.ncbi.nlm.nih.gov/34473841/. | Franchini, M., Testa, S., Pezzo, M., Glingani, C., Caruso, B., Terenziani, I., ... & Castelli, G. (2021). Cerebral venous thrombosis and thrombocytopenia post-COVID-19 vaccination. Thrombosis research, 202, 182-183. https://pubmed.ncbi.nlm.nih.gov/33878469/. | von Tresckow, J., von Tresckow, B., Reinhardt, H. C., Herrmann, K., & Berliner, C. (2021). Thymic hyperplasia after mRNA based COVID-19 vaccination. Radiology Case Reports, 16(12), 3744-3745. | https://pubmed.ncbi.nlm.nih.gov/34462647/ | von Tresckow, J., von Tresckow, B., Reinhardt, H. C., Herrmann, K., & Berliner, C. (2021). Thymic hyperplasia after mRNA based COVID-19 vaccination. Radiology Case Reports, 16(12), 3744-3745. https://pubmed.ncbi.nlm.nih.gov/34462647/ | Haaf, P., Kuster, G. M., Mueller, C., Berger, C. T., Monney, P., Burger, P., ... & Tanner, F. C. (2021). The very low risk of myocarditis and pericarditis after mRNA COVID-19 vaccination should not discourage vaccination. Swiss Medical Weekly, (41). https://www.ncbi.nlm.nih.gov/pubmed/34668687 | ||||
282 | Procoagulant antibody-mediated procoagulant platelets in immune thrombotic thrombocytopenia associated with SARS-CoV-2 vaccination: | https://pubmed.ncbi.nlm.nih.gov/34011137/. | https://pubmed.ncbi.nlm.nih.gov/34189756/ | Ramessur, R., Saffar, N., Czako, B., Agarwal, A., & Batta, K. (2021). Cutaneous thrombosis associated with skin necrosis following Oxford‐AstraZeneca COVID‐19 vaccination. Clinical and Experimental Dermatology. | Ramessur, R., Saffar, N., Czako, B., Agarwal, A. y Batta, K. (2021). Trombosis cutánea asociada con necrosis cutánea después de la vacunación Oxford‐AstraZeneca COVID‐19. Dermatología Clínica y Experimental. https://pubmed.ncbi.nlm.nih.gov/34045111/. | Frank, A., RadParvar, S., Manasia, A., Bassily-Marcus, A. y Kohli-Seth, R. (2021). Anafilaxia prolongada a la enfermedad de la enfermedad de Coronavirus de Pfizer 2019: un informe de caso y un mecanismo de acción. Exploraciones de cuidados críticos, 3 (4). https://pubmed.ncbi.nlm.nih.gov/34579211/ | Ramessur, R., Saffar, N., Czako, B., Agarwal, A., & Batta, K. (2021). Cutaneous thrombosis associated with skin necrosis following Oxford‐AstraZeneca COVID‐19 vaccination. Clinical and Experimental Dermatology. https://pubmed.ncbi.nlm.nih.gov/34189756/ | Frank, A., Radparvar, S., Manasia, A., Bassily-Marcus, A., & Kohli-Seth, R. (2021). Prolonged anaphylaxis to pfizer coronavirus disease 2019 vaccine: a case report and mechanism of action. Critical Care Explorations, 3(4). https://pubmed.ncbi.nlm.nih.gov/33834172/ | Vogrig, A., Janes, F., Gigli, G. L., Curcio, F., Del Negro, I., D’Agostini, S., ... & Valente, M. (2021). Acute disseminated encephalomyelitis after SARS-CoV-2 vaccination. Clinical Neurology and Neurosurgery, 208, 106839. | https://pubmed.ncbi.nlm.nih.gov/34325334/ | Vogrig, A., Janes, F., Gigli, G. L., Curcio, F., Del Negro, I., D’Agostini, S., ... & Valente, M. (2021). Acute disseminated encephalomyelitis after SARS-CoV-2 vaccination. Clinical Neurology and Neurosurgery, 208, 106839. https://pubmed.ncbi.nlm.nih.gov/34325334/ | Haakonsen, H. B., & Nystedt, A. (2021). Deep vein thrombosis more than two weeks after vaccination against COVID-19. Tidsskrift for Den norske legeforening. https://pubmed.ncbi.nlm.nih.gov/33928773/ | ||||
283 | Vaccine-induced immune thrombotic thrombocytopenia causing a severe form of cerebral venous thrombosis with high mortality rate: a case series: | https://pubmed.ncbi.nlm.nih.gov/34393988/. | https://pubmed.ncbi.nlm.nih.gov/34045111/. | Kow, C. S., & Hasan, S. S. (2021). Cerebral venous thrombosis following COVID-19 vaccination. Journal of Stroke and Cerebrovascular Diseases, 30(10). | Kow, CS y Hasan, SS (2021). Trombosis venosa cerebral tras la vacunación COVID-19. Revista de accidentes cerebrovasculares y enfermedades cerebrovasculares, 30 (10). https://pubmed.ncbi.nlm.nih.gov/34366434/. | Fritzen, M., Funchal, G. D. G., Luiz, M. O., & Durigon, G. S. (2022). Vasculitis leucocitoclástica después de la exposición a la vacuna COVID-19. Anais Brasileiros de Dermatologia, 97 (1), 118-121. https://pubmed.ncbi.nlm.nih.gov/34495381/. | Kow, C. S., & Hasan, S. S. (2021). Cerebral venous thrombosis following COVID-19 vaccination. Journal of Stroke and Cerebrovascular Diseases, 30(10). https://pubmed.ncbi.nlm.nih.gov/34045111/. | Fritzen, M., Funchal, G. D. G., Luiz, M. O., & Durigon, G. S. (2022). Leukocytoclastic vasculitis after exposure to COVID-19 vaccine. Anais brasileiros de dermatologia, 97(1), 118-121. https://pubmed.ncbi.nlm.nih.gov/34836739/ | Chuang, T. Y., Burda, K., Teklemariam, E., & Athar, K. (2021). Tolosa-Hunt syndrome presenting after COVID-19 vaccination. Cureus, 13(7). | https://pubmed.ncbi.nlm.nih.gov/34513398/ | Chuang, T. Y., Burda, K., Teklemariam, E., & Athar, K. (2021). Tolosa-Hunt syndrome presenting after COVID-19 vaccination. Cureus, 13(7). https://pubmed.ncbi.nlm.nih.gov/34513398/ | Habib, M. B., Hamamyh, T., Elyas, A., Altermanini, M., & Elhassan, M. (2021). Acute myocarditis following administration of BNT162b2 vaccine. IDCases, 25, e01197. https://www.sciencedirect.com/science/article/pii/S2214250921001530 | ||||
284 | Procoagulant microparticles: a possible link between vaccine-induced immune thrombocytopenia (VITT) and cerebral sinus venous thrombosis: | https://pubmed.ncbi.nlm.nih.gov/34129181/. | https://pubmed.ncbi.nlm.nih.gov/34366434/. | González-Romero, N., & Sánchez, V. (2021). Lipschütz Ulcers After the AstraZeneca COVID-19 Vaccine. Actas Dermo-sifiliograficas. | González-Romero, N., & Sánchez, V. (2021). Úlceras de Lipschütz tras la vacuna AstraZeneca COVID-19. Actas Dermo-sifiliograficas. https://pubmed.ncbi.nlm.nih.gov/34330677/ | Fueyo-Rodriguez, O., Valente-Acosta, B., Jiménez-Soto, R., Neme-Yunes, Y., Inclán-Alarcón, S. I., Trejo-González, R., y García-Salcido, M. Á. (2021). La trombocitopenia inmune secundaria supuestamente atribuible a la vacunación de COVID-19. BMJ Case Reports CP, 14 (5), E242220. https://pubmed.ncbi.nlm.nih.gov/34155844/ | González-Romero, N., & Sánchez, V. (2021). Lipschütz Ulcers After the AstraZeneca COVID-19 Vaccine. Actas Dermo-sifiliograficas. https://pubmed.ncbi.nlm.nih.gov/34366434/. | Fueyo-Rodriguez, O., Valente-Acosta, B., Jimenez-Soto, R., Neme-Yunes, Y., Inclán-Alarcón, S. I., Trejo-Gonzalez, R., & García-Salcido, M. Á. (2021). Secondary immune thrombocytopenia supposedly attributable to COVID-19 vaccination. BMJ Case Reports CP, 14(5), e242220. https://casereports.bmj.com/content/14/5/e242220.abstract. | Robichaud, J., Côté, C., & Côté, F. (2021). Systemic capillary leak syndrome after ChAdOx1 nCOV-19 (Oxford–AstraZeneca) vaccination. CMAJ, 193(34), E1341-E1344. | https://pubmed.ncbi.nlm.nih.gov/34362727/ | Robichaud, J., Côté, C., & Côté, F. (2021). Systemic capillary leak syndrome after ChAdOx1 nCOV-19 (Oxford–AstraZeneca) vaccination. CMAJ, 193(34), E1341-E1344. https://pubmed.ncbi.nlm.nih.gov/34362727/ | Hafeez, M. U., Ikram, M., Shafiq, Z., Sarfraz, A., Sarfraz, Z., Jaiswal, V., ... & Chérrez-Ojeda, I. (2021). COVID-19 vaccine-associated thrombosis with thrombocytopenia syndrome (TTS): A systematic review and post hoc analysis. Clinical and Applied Thrombosis/Hemostasis, 27, 10760296211048815. https://pubmed.ncbi.nlm.nih.gov/34698582/. | ||||
285 | Atypical thrombosis associated with the vaccine VaxZevria® (AstraZeneca): data from the French network of regional pharmacovigilance centers: | https://pubmed.ncbi.nlm.nih.gov/34083026/. | https://pubmed.ncbi.nlm.nih.gov/34330677/ | Burillo, J. C., Martínez, C. L., Arguedas, C. G., & Pueyo, F. M. (2021). Amyotrophic neuralgia secondary to Vaxzevri (AstraZeneca) COVID-19 vaccine. Neurologia (Barcelona, Spain). | Burillo, J. C., Martínez, C. L., Arguedas, C. G., & Pueyo, F. M. (2021). Neuralgia amiotrófica secundaria a la vacuna Vaxzevri (AstraZeneca) COVID-19. Neurología (Barcelona, España). https://pubmed.ncbi.nlm.nih.gov/34477089/ | Fujikawa, P., Shah, F. A., Braford, M., Patel, K., & Madey, J. (2021). Neuromielitis Optica en una mujer sana después del síndrome respiratorio agudo severo Coronavirus 2 MRNA-1273 Vacuna. CUREUS, 13 (9). https://pubmed.ncbi.nlm.nih.gov/34131771/ | Burillo, J. C., Martínez, C. L., Arguedas, C. G., & Pueyo, F. M. (2021). Amyotrophic neuralgia secondary to Vaxzevri (AstraZeneca) COVID-19 vaccine. Neurologia (Barcelona, Spain). https://pubmed.ncbi.nlm.nih.gov/34330677/ | Fujikawa, P., Shah, F. A., Braford, M., Patel, K., & Madey, J. (2021). Neuromyelitis Optica in a Healthy Female After Severe Acute Respiratory Syndrome Coronavirus 2 mRNA-1273 Vaccine. Cureus, 13(9). https://pubmed.ncbi.nlm.nih.gov/34660149/ | Banerjee, S., Sandhu, M., Tonzi, E., Tambe, A., & Gambhir, H. S. (2021). Immune-Mediated Thrombocytopenia Associated With Ad26. COV2. S (Janssen; Johnson & Johnson) Vaccine. American Journal of Therapeutics, 28(5), e604. | https://pubmed.ncbi.nlm.nih.gov/34469919/. | Banerjee, S., Sandhu, M., Tonzi, E., Tambe, A., & Gambhir, H. S. (2021). Immune-Mediated Thrombocytopenia Associated With Ad26. COV2. S (Janssen; Johnson & Johnson) Vaccine. American Journal of Therapeutics, 28(5), e604. https://pubmed.ncbi.nlm.nih.gov/34469919/. | Haimei, M. A. (2021). Concern About the Adverse Effects of Thrombocytopenia and Thrombosis After Adenovirus-Vectored COVID-19 Vaccination. Clinical and Applied Thrombosis/Hemostasis, 27, 10760296211040110. https://pubmed.ncbi.nlm.nih.gov/34541935/ | ||||
286 | Acute cerebral venous thrombosis and pulmonary artery embolism associated with the COVID-19 vaccine: | https://pubmed.ncbi.nlm.nih.gov/34247246/. | https://pubmed.ncbi.nlm.nih.gov/34477089/ | Wolthers, S. A., Stenberg, J., Nielsen, H. B., Stensballe, J., & Pedersen, H. P. (2021). Content area. Ugeskr Læger, 183, V05210425. | Wolthers, S. A., Stenberg, J., Nielsen, H. B., Stensballe, J. y Pedersen, H. P. (2021). Área de contenidos. Ugeskr Læger, 183, V05210425. https://pubmed.ncbi.nlm.nih.gov/34071883/ | Fukushima, T., Tomita, M., Ikeda, S., & Hattori, N. (2021). Un caso de síndrome de Guillain-Barré sensorial con inmunoglobulina G Anticuerpos anti-GM1 que siguen la primera dosis de la vacuna contra MRNA COVID-19 (PFIZIZE). QJM: un Diario Internacional de Medicina. https://pubmed.ncbi.nlm.nih.gov/34579259/ | Wolthers, S. A., Stenberg, J., Nielsen, H. B., Stensballe, J., & Pedersen, H. P. (2021). Content area. Ugeskr Læger, 183, V05210425. https://pubmed.ncbi.nlm.nih.gov/34477089/ | Fukushima, T., Tomita, M., Ikeda, S., & Hattori, N. (2021). A case of sensory ataxic Guillain–Barré syndrome with immunoglobulin G anti-GM1 antibodies following the first dose of mRNA COVID-19 vaccine BNT162b2 (Pfizer). QJM: An International Journal of Medicine. https://pubmed.ncbi.nlm.nih.gov/34871447/ | Al-Samkari, H., Leaf, R. K., & Goodarzi, K. (2021). Transient Thrombocytopenia With Glycoprotein-Specific Platelet Autoantibodies After Ad26. COV2. S Vaccination: A Case Report. Annals of Internal Medicine, 174(11), 1632-1633. | https://pubmed.ncbi.nlm.nih.gov/34516272/. | Al-Samkari, H., Leaf, R. K., & Goodarzi, K. (2021). Transient Thrombocytopenia With Glycoprotein-Specific Platelet Autoantibodies After Ad26. COV2. S Vaccination: A Case Report. Annals of Internal Medicine, 174(11), 1632-1633. https://pubmed.ncbi.nlm.nih.gov/34516272/. | Hajjo, R., Sabbah, D. A., Bardaweel, S. K., & Tropsha, A. (2021). Shedding the Light on Post-Vaccine Myocarditis and Pericarditis in COVID-19 and Non-COVID-19 Vaccine Recipients. Vaccines, 9(10), 1186. https://pubmed.ncbi.nlm.nih.gov/34696294/ | ||||
287 | Vaccine-induced thrombosis and thrombocytopenia with bilateral adrenal haemorrhage: | https://pubmed.ncbi.nlm.nih.gov/34235757/. | https://pubmed.ncbi.nlm.nih.gov/34071883/ | Rzymski, P., Perek, B., & Flisiak, R. (2021). Thrombotic thrombocytopenia after COVID-19 vaccination: in search of the underlying mechanism. Vaccines, 9(6), 559. | Rzymski, P., Perek, B. y Flisiak, R. (2021). Trombocitopenia trombótica tras la vacunación COVID-19: en busca del mecanismo subyacente. Vacunas, 9(6), 559. https://pubmed.ncbi.nlm.nih.gov/34033367/ | Furer, V., Eviator, T., Zisman, D., Peleg, H., Paran, D., LEVARTOVSKY, D., ... & ELKAYAM, O. (2021). Inmunogenicidad y seguridad de la vacuna contra el ARNm COVID-19 BNT162B2 en pacientes adultos con enfermedades reumáticas inflamatorias autoinmunes y en la población general: un estudio multicéntrico. Anales de las enfermedades reumáticas, 80 (10), 1330-1338. https://www.ncbi.nlm.nih.gov/pubmed/34538306 | Rzymski, P., Perek, B., & Flisiak, R. (2021). Thrombotic thrombocytopenia after COVID-19 vaccination: in search of the underlying mechanism. Vaccines, 9(6), 559. https://pubmed.ncbi.nlm.nih.gov/34071883/ | Furer, V., Eviatar, T., Zisman, D., Peleg, H., Paran, D., Levartovsky, D., ... & Elkayam, O. (2021). Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in adult patients with autoimmune inflammatory rheumatic diseases and in the general population: a multicentre study. Annals of the rheumatic diseases, 80(10), 1330-1338. https://www.ncbi.nlm.nih.gov/pubmed/34127481 | Snapiri, O., Danziger, C. R., Shirman, N., Weissbach, A., Lowenthal, A., Ayalon, I., ... & Bilavsky, E. (2021). Transient cardiac injury in adolescents receiving the BNT162b2 mRNA COVID-19 vaccine. The Pediatric Infectious Disease Journal, 40(10), e360. | https://pubmed.ncbi.nlm.nih.gov/34077949/ | Snapiri, O., Danziger, C. R., Shirman, N., Weissbach, A., Lowenthal, A., Ayalon, I., ... & Bilavsky, E. (2021). Transient cardiac injury in adolescents receiving the BNT162b2 mRNA COVID-19 vaccine. The Pediatric Infectious Disease Journal, 40(10), e360. https://pubmed.ncbi.nlm.nih.gov/34077949/ | Hakroush, S., & Tampe, B. (2021). Case report: ANCA-associated vasculitis presenting with rhabdomyolysis and pauci-immune crescentic glomerulonephritis after Pfizer-BioNTech COVID-19 mRNA vaccination. Frontiers in Immunology, 12. https://pubmed.ncbi.nlm.nih.gov/34659268/ | ||||
288 | Palmar digital vein thrombosis after Oxford-AstraZeneca COVID-19 vaccination: | https://pubmed.ncbi.nlm.nih.gov/34473841/. | https://pubmed.ncbi.nlm.nih.gov/34033367/ | Aleem, A., & Shah, H. (2021). Gastric Varices. StatPearls [Internet]. | Aleem, A. y Shah, H. (2021). Varices Gástricas. StatPearls [Internet]. https://pubmed.ncbi.nlm.nih.gov/34375510/ | Furie, K. L., Cushman, M., Elkind, M. S., Lyden, P. D., Saposnik, G., & American Heart Association / American Stroke Association Council Leadership. (2021). Diagnóstico y manejo de la trombosis sinusita venosa cerebral con trombocitopenia trombótica inmune inducida por la vacuna. Trazo, 52 (7), 2478-2482. https://pubmed.ncbi.nlm.nih.gov/34420802/ | Aleem, A., & Shah, H. (2021). Gastric Varices. StatPearls [Internet]. https://pubmed.ncbi.nlm.nih.gov/34033367/ | Furie, K. L., Cushman, M., Elkind, M. S., Lyden, P. D., Saposnik, G., & American Heart Association/American Stroke Association Stroke Council Leadership. (2021). Diagnosis and management of cerebral venous sinus thrombosis with vaccine-induced immune thrombotic thrombocytopenia. Stroke, 52(7), 2478-2482. https://pubmed.ncbi.nlm.nih.gov/33914590/ | Clayton-Chubb, D., Schneider, D., Freeman, E., Kemp, W., & Roberts, S. K. (2021). Autoimmune hepatitis developing after the ChAdOx1 nCoV-19 (Oxford-AstraZeneca) vaccine. Journal of Hepatology, 75(5), 1249-1250. | https://pubmed.ncbi.nlm.nih.gov/34171435/ | Clayton-Chubb, D., Schneider, D., Freeman, E., Kemp, W., & Roberts, S. K. (2021). Autoimmune hepatitis developing after the ChAdOx1 nCoV-19 (Oxford-AstraZeneca) vaccine. Journal of Hepatology, 75(5), 1249-1250. https://pubmed.ncbi.nlm.nih.gov/34171435/ | Han, T., Ma, W., Zhang, Y., & Wang, C. (2021). Be Alert to the Risk of Adverse Cardiovascular Events after COVID-19 Vaccination. Exploratory Research and Hypothesis in Medicine, (000), 0-0. https://www.xiahepublishing.com/m/2472-0712/ERHM-2021-00033 | ||||
289 | Cutaneous thrombosis associated with cutaneous necrosis following Oxford-AstraZeneca COVID-19 vaccination: | https://pubmed.ncbi.nlm.nih.gov/34189756/ | https://pubmed.ncbi.nlm.nih.gov/34375510/ | Abbattista, M., Martinelli, I., & Peyvandi, F. (2021). Comparison of adverse drug reactions among four COVID‐19 vaccines in Europe using the EudraVigilance database: thrombosis at unusual sites. Journal of Thrombosis and Haemostasis, 19(10), 2554-2558. | Abbattista, M., Martinelli, I. y Peyvandi, F. (2021). Comparación de reacciones adversas a medicamentos entre cuatro vacunas COVID-19 en Europa utilizando la base de datos EudraVigilance: trombosis en sitios inusuales. Revista de trombosis y hemostasia, 19(10), 2554-2558. https://pubmed.ncbi.nlm.nih.gov/34107198/ | Fusse, M., Schub, D., Merzou, F., Fassbender, K., Serster, M., Kettner, M., ... & goi júnior, J. R. (2022). Informe de caso: trombosis de la vena sinusal cerebral en dos pacientes con la vacunación de AstraZeneca Sars-CoV-2. Diario de Neurología, 269 (2), 583-586. https://pubmed.ncbi.nlm.nih.gov/34557507/ | Abbattista, M., Martinelli, I., & Peyvandi, F. (2021). Comparison of adverse drug reactions among four COVID‐19 vaccines in Europe using the EudraVigilance database: thrombosis at unusual sites. Journal of Thrombosis and Haemostasis, 19(10), 2554-2558. https://pubmed.ncbi.nlm.nih.gov/34375510/ | Gabarin, N., Patterson, S., Pai, M., Afzaal, T., Nazy, I., Sheppard, J. A. I., ... & Warkentin, T. E. (2021). Venous thromboembolism and mild thrombocytopenia after ChAdOx1 nCoV-19 vaccination. Thrombosis and Haemostasis, 121(12), 1677-1680. https://pubmed.ncbi.nlm.nih.gov/34384129/ | Maniscalco, G. T., Manzo, V., Di Battista, M. E., Salvatore, S., Moreggia, O., Scavone, C., & Capuano, A. (2021). Severe multiple sclerosis relapse after COVID-19 vaccination: a case report. Frontiers in Neurology, 1398. | https://pubmed.ncbi.nlm.nih.gov/34447349/ | Maniscalco, G. T., Manzo, V., Di Battista, M. E., Salvatore, S., Moreggia, O., Scavone, C., & Capuano, A. (2021). Severe multiple sclerosis relapse after COVID-19 vaccination: a case report. Frontiers in Neurology, 1398. https://pubmed.ncbi.nlm.nih.gov/34447349/ | Hanneman, K., Iwanochko, R. M., & Thavendiranathan, P. (2021). Evolution of lymphadenopathy at PET/MRI after COVID-19 vaccination. Radiology, 299(3), E282-E282. https://pubmed.ncbi.nlm.nih.gov/33625301/. | ||||
290 | Cerebral venous thrombosis following COVID-19 vaccination: | https://pubmed.ncbi.nlm.nih.gov/34045111/. | https://pubmed.ncbi.nlm.nih.gov/34107198/ | Bourguignon, A., Arnold, D. M., Warkentin, T. E., Smith, J. W., Pannu, T., Shrum, J. M., ... & Nazy, I. (2021). Adjunct immune globulin for vaccine-induced immune thrombotic thrombocytopenia. New England Journal of Medicine, 385(8), 720-728. | Bourguignon, A., Arnold, D. M., Warkentin, T. E., Smith, J. W., Pannu, T., Shrum, J. M., ... y Nazy, I. (2021). Inmunoglobulina complementaria para la trombocitopenia trombótica inmunitaria inducida por vacunas. Revista de Medicina de Nueva Inglaterra, 385(8), 720-728. https://pubmed.ncbi.nlm.nih.gov/34355379/. | Gabarin, N., Patterson, S., Pai, M., Afzaal, T., Nazy, I., Sheppard, J. A. A., ... & Warkentin, T. E. (2021). Tromboembolismo venoso y trombocitopenia leve después de la vacunación con Chadox1 NCOV-19. Trombosis y haemostasis, 121 (12), 1677-1680. https://pubmed.ncbi.nlm.nih.gov/34382387/ | Bourguignon, A., Arnold, D. M., Warkentin, T. E., Smith, J. W., Pannu, T., Shrum, J. M., ... & Nazy, I. (2021). Adjunct immune globulin for vaccine-induced immune thrombotic thrombocytopenia. New England Journal of Medicine, 385(8), 720-728. https://pubmed.ncbi.nlm.nih.gov/34107198/ | Gabarin, N., Patterson, S., Pai, M., Afzaal, T., Nazy, I., Sheppard, J. A. I., ... & Warkentin, T. E. (2021). Venous thromboembolism and mild thrombocytopenia after ChAdOx1 nCoV-19 vaccination. Thrombosis and Haemostasis, 121(12), 1677-1680. https://pubmed.ncbi.nlm.nih.gov/34384129/. | Ai, S., Awford, A., & Roncolato, F. (2021). Hemophagocytic lymphohistiocytosis following ChAdOx1 nCov‐19 vaccination. Journal of Medical Virology. | https://pubmed.ncbi.nlm.nih.gov/34406660/. | Ai, S., Awford, A., & Roncolato, F. (2021). Hemophagocytic lymphohistiocytosis following ChAdOx1 nCov‐19 vaccination. Journal of Medical Virology. https://pubmed.ncbi.nlm.nih.gov/34406660/. | Hasegawa, T., & Yazaki, Y. (2021). Unusual Site of Deep Vein Thrombosis After mRNA Coronavirus Disease-2019 (COVID-19) Vaccination. Circulation Journal, CJ-21. https://pubmed.ncbi.nlm.nih.gov/34840204/ | ||||
291 | Lipschütz ulcers after AstraZeneca COVID-19 vaccination: | https://pubmed.ncbi.nlm.nih.gov/34366434/. | https://pubmed.ncbi.nlm.nih.gov/34355379/. | Fanni, D., Saba, L., Demontis, R., Gerosa, C., Chighine, A., Nioi, M., ... & Faa, G. (2021). Vaccine-induced severe thrombotic thrombocytopenia following COVID-19 vaccination: a report of an autoptic case and review of the literature. | Fanni, D., Saba, L., Demontis, R., Gerosa, C., Chighine, A., Nioi, M., ... y Faa, G. (2021). Trombocitopenia trombótica grave inducida por la vacuna después de la vacunación COVID-19: informe de un caso autóptico y revisión de la literatura. https://pubmed.ncbi.nlm.nih.gov/34452028/ | Gabarin, N., Patterson, S., Pai, M., Afzaal, T., Nazy, I., Sheppard, J. A. A., ... & Warkentin, T. E. (2021). Tromboembolismo venoso y trombocitopenia leve después de la vacunación con Chadox1 NCOV-19. Trombosis y haemostasis, 121 (12), 1677-1680. https://pubmed.ncbi.nlm.nih.gov/34755433/ | Fanni, D., Saba, L., Demontis, R., Gerosa, C., Chighine, A., Nioi, M., ... & Faa, G. (2021). Vaccine-induced severe thrombotic thrombocytopenia following COVID-19 vaccination: a report of an autoptic case and review of the literature. https://pubmed.ncbi.nlm.nih.gov/34355379/. | Gadi, S. R., Brunker, P. A., Al‐Samkari, H., Sykes, D. B., Saff, R. R., Lo, J., ... & Leaf, R. K. (2021). Severe autoimmune hemolytic anemia following receipt of SARS‐CoV‐2 mRNA vaccine. Transfusion, 61(11), 3267-3271. https://onlinelibrary.wiley.com/doi/10.1111/trf.16672 | Badier, L., Toledano, A., Porel, T., Dumond, S., Jouglen, J., Sailler, L., ... & Lafaurie, M. (2021). IgA vasculitis in adult patient following vaccination by ChadOx1 nCoV-19. Autoimmunity reviews. | https://pubmed.ncbi.nlm.nih.gov/34509658/ | Badier, L., Toledano, A., Porel, T., Dumond, S., Jouglen, J., Sailler, L., ... & Lafaurie, M. (2021). IgA vasculitis in adult patient following vaccination by ChadOx1 nCoV-19. Autoimmunity reviews. https://pubmed.ncbi.nlm.nih.gov/34509658/ | Hashimoto, T., Ozaki, A., Bhandari, D., Sawano, T., Sah, R., & Tanimoto, T. (2021). High anaphylaxis rates following vaccination with the Pfizer BNT162b2 mRNA vaccine against COVID-19 in Japanese healthcare workers: a secondary analysis of initial post-approval safety data. Journal of Travel Medicine, 28(7), taab090. https://pubmed.ncbi.nlm.nih.gov/34128049/ | ||||
292 | Amyotrophic Neuralgia secondary to Vaxzevri vaccine (AstraZeneca) COVID-19: | https://pubmed.ncbi.nlm.nih.gov/34330677/ | https://pubmed.ncbi.nlm.nih.gov/34452028/ | Wiest, N. E., Johns, G. S., & Edwards, E. (2021). A case of acute pulmonary embolus after mRNA SARS-CoV-2 immunization. Vaccines, 9(8), 903. | Wiest, N. E., Johns, G. S. y Edwards, E. (2021). Un caso de embolia pulmonar aguda después de la inmunización con ARNm SARS-CoV-2. Vacunas, 9(8), 903. https://pubmed.ncbi.nlm.nih.gov/34202817/ | GADI, S. R., Brunker, P. A., Al-Samkari, H., Sykes, D. B., SAFF, R. R., LO, J., ... & HABE, R. K. (2021). Anemia hemolítica autoinmune grave después de la recepción de la vacuna contra ARNm de SARS-COV-2. Transfusión, 61 (11), 3267-3271. https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciab707/6353927?s=09&login=false | Wiest, N. E., Johns, G. S., & Edwards, E. (2021). A case of acute pulmonary embolus after mRNA SARS-CoV-2 immunization. Vaccines, 9(8), 903. https://pubmed.ncbi.nlm.nih.gov/34452028/ | Gadi, S. R., Brunker, P. A., Al‐Samkari, H., Sykes, D. B., Saff, R. R., Lo, J., ... & Leaf, R. K. (2021). Severe autoimmune hemolytic anemia following receipt of SARS‐CoV‐2 mRNA vaccine. Transfusion, 61(11), 3267-3271. https://pubmed.ncbi.nlm.nih.gov/34549821/ | Erler, A., Fiedler, J., Koch, A., Heldmann, F., & Schütz, A. (2021). Leukocytoclastic Vasculitis After Vaccination With a SARS‐CoV‐2 Vaccine. Arthritis & Rheumatology, 73(12), 2188-2188. | https://pubmed.ncbi.nlm.nih.gov/34196469/. | Erler, A., Fiedler, J., Koch, A., Heldmann, F., & Schütz, A. (2021). Leukocytoclastic Vasculitis After Vaccination With a SARS‐CoV‐2 Vaccine. Arthritis & Rheumatology, 73(12), 2188-2188. https://pubmed.ncbi.nlm.nih.gov/34196469/. | Hasnie, A. A., Hasnie, U. A., Patel, N., Aziz, M. U., Xie, M., Lloyd, S. G., & Prabhu, S. D. (2021). Perimyocarditis following first dose of the mRNA-1273 SARS-CoV-2 (Moderna) vaccine in a healthy young male: a case report. BMC Cardiovascular Disorders, 21(1), 1-6. https://www.ncbi.nlm.nih.gov/pubmed/34348657 | ||||
293 | Thrombosis with thrombocytopenia after Messenger vaccine RNA-1273: | https://pubmed.ncbi.nlm.nih.gov/34181446/ | https://pubmed.ncbi.nlm.nih.gov/34202817/ | Gessler, F., Schmitz, A. K., Dubinski, D., Bernstock, J. D., Lehmann, F., Won, S. Y., ... & Schuss, P. (2021). Neurosurgical considerations regarding decompressive craniectomy for intracerebral hemorrhage after SARS-CoV-2-vaccination in vaccine induced thrombotic thrombocytopenia—VITT. Journal of Clinical Medicine, 10(13), 2777. | Gessler, F., Schmitz, A. K., Dubinski, D., Bernstock, J. D., Lehmann, F., Won, S. Y., ... y Schuss, P. (2021). Consideraciones neuroquirúrgicas con respecto a la craniectomía descompresiva para la hemorragia intracerebral después de la vacunación contra el SARS-CoV-2 en la trombocitopenia trombótica inducida por la vacuna (VITT). Revista de Medicina Clínica, 10(13), 2777. https://pubmed.ncbi.nlm.nih.gov/34237213/. | GADI, S. R., Brunker, P. A., Al-Samkari, H., Sykes, D. B., SAFF, R. R., LO, J., ... & HABE, R. K. (2021). Anemia hemolítica autoinmune grave después de la recepción de la vacuna contra ARNm de SARS-COV-2. Transfusión, 61 (11), 3267-3271. https://pubmed.ncbi.nlm.nih.gov/34528522/ | Gessler, F., Schmitz, A. K., Dubinski, D., Bernstock, J. D., Lehmann, F., Won, S. Y., ... & Schuss, P. (2021). Neurosurgical considerations regarding decompressive craniectomy for intracerebral hemorrhage after SARS-CoV-2-vaccination in vaccine induced thrombotic thrombocytopenia—VITT. Journal of Clinical Medicine, 10(13), 2777. https://pubmed.ncbi.nlm.nih.gov/34202817/ | Galindo, R., Chow, H., & Rongkavilit, C. (2021). COVID-19 in children: clinical manifestations and pharmacologic interventions including vaccine trials. Pediatric Clinics, 68(5), 961-976. https://www.ncbi.nlm.nih.gov/pubmed/34538306 | Nagrani, P., Jindal, R., & Goyal, D. (2021). Onset/flare of psoriasis following the ChAdOx1 nCoV‐19 Corona virus vaccine (Oxford‐AstraZeneca/Covishield): Report of two cases. Dermatologic Therapy. | https://pubmed.ncbi.nlm.nih.gov/34350668/ | Nagrani, P., Jindal, R., & Goyal, D. (2021). Onset/flare of psoriasis following the ChAdOx1 nCoV‐19 Corona virus vaccine (Oxford‐AstraZeneca/Covishield): Report of two cases. Dermatologic Therapy. https://pubmed.ncbi.nlm.nih.gov/34350668/ | Hause, A. M., Gee, J., Baggs, J., Abara, W. E., Marquez, P., Thompson, D., ... & Shay, D. K. (2021). COVID-19 vaccine safety in adolescents aged 12–17 years—United States, December 14, 2020–July 16, 2021. Morbidity and Mortality Weekly Report, 70(31), 1053. https://www.ncbi.nlm.nih.gov/pubmed/34351881 | ||||
294 | Intracerebral hemorrhage twelve days after vaccination with ChAdOx1 nCoV-19: | https://pubmed.ncbi.nlm.nih.gov/34477089/ | https://pubmed.ncbi.nlm.nih.gov/34237213/. | Park, Y. S. (2021). Thrombosis and severe acute respiratory syndrome coronavirus 2 vaccines: vaccine-induced immune thrombotic thrombocytopenia. Clinical and experimental pediatrics, 64(8), 400. | Park, YS (2021). Trombosis y síndrome respiratorio agudo severo vacunas contra el coronavirus 2: trombocitopenia trombótica inmune inducida por vacunas. Pediatría clínica y experimental, 64(8), 400. https://pubmed.ncbi.nlm.nih.gov/34105247/. | Gales, K. J., Baumblatt, J., Chege, W., Goud, R., & Nair, N. (2021). La trombocitopenia, incluida la trombocitopenia inmune después de la recepción de las vacunas ARNm COVID-19 informadas al sistema de informes de eventos adversos de la vacuna (Vaers). Vacuna, 39 (25), 3329-3332. https://pediatrics.aappublications.org/content/early/2021/06/04/peds.2021-052478 | Park, Y. S. (2021). Thrombosis and severe acute respiratory syndrome coronavirus 2 vaccines: vaccine-induced immune thrombotic thrombocytopenia. Clinical and experimental pediatrics, 64(8), 400. https://pubmed.ncbi.nlm.nih.gov/34237213/. | Ganga, K., Solyar, A. Y., & Ganga, R. (2021). Massive Cervical Lymphadenopathy Post-COVID-19 Vaccination. Ear, Nose & Throat Journal, 01455613211048984. https://pubmed.ncbi.nlm.nih.gov/34601889/ | Armoni-Weiss, G., Sheffer-Levi, S., Horev, L., Klapholz, L., Avitan-Hersh, E., Zlotogorski, A., & Ramot, Y. (2021). Exacerbation of Hailey-Hailey Disease Following SARS-CoV-2 Vaccination. Acta dermato-venereologica, 101(9), adv00554-adv00554. | https://pubmed.ncbi.nlm.nih.gov/34436620/ | Armoni-Weiss, G., Sheffer-Levi, S., Horev, L., Klapholz, L., Avitan-Hersh, E., Zlotogorski, A., & Ramot, Y. (2021). Exacerbation of Hailey-Hailey Disease Following SARS-CoV-2 Vaccination. Acta dermato-venereologica, 101(9), adv00554-adv00554. https://pubmed.ncbi.nlm.nih.gov/34436620/ | Helmchen, C., Buttler, G. M., Markewitz, R., Hummel, K., Wiendl, H., & Boppel, T. (2022). Acute bilateral optic/chiasm neuritis with longitudinal extensive transverse myelitis in longstanding stable multiple sclerosis following vector-based vaccination against the SARS-CoV-2. Journal of Neurology, 269(1), 49-54. https://pubmed.ncbi.nlm.nih.gov/34131771/ | ||||
295 | Thrombotic thrombocytopenia after vaccination with COVID-19: in search of the underlying mechanism: | https://pubmed.ncbi.nlm.nih.gov/34071883/ | https://pubmed.ncbi.nlm.nih.gov/34105247/. | Maayan, H., Kirgner, I., Gutwein, O., Herzog‐Tzarfati, K., Rahimi‐Levene, N., Koren‐Michowitz, M., & Blickstein, D. (2021). Acquired thrombotic thrombocytopenic purpura: A rare disease associated with BNT162b2 vaccine. Journal of Thrombosis and Haemostasis, 19(9), 2314-2317. | Maayan, H., Kirgner, I., Gutwein, O., Herzog‐Tzarfati, K., Rahimi‐Levene, N., Koren‐Michowitz, M. y Blickstein, D. (2021). Púrpura trombocitopénica trombótica adquirida: una enfermedad rara asociada con la vacuna BNT162b2. Revista de trombosis y hemostasia, 19(9), 2314-2317. https://pubmed.ncbi.nlm.nih.gov/34405870/. | Gales, K. J., Baumblatt, J., Chege, W., Goud, R., & Nair, N. (2021). La trombocitopenia, incluida la trombocitopenia inmune después de la recepción de las vacunas ARNm COVID-19 informadas al sistema de informes de eventos adversos de la vacuna (Vaers). Vacuna, 39 (25), 3329-3332. https://pubmed.ncbi.nlm.nih.gov/34416184/ | Maayan, H., Kirgner, I., Gutwein, O., Herzog‐Tzarfati, K., Rahimi‐Levene, N., Koren‐Michowitz, M., & Blickstein, D. (2021). Acquired thrombotic thrombocytopenic purpura: A rare disease associated with BNT162b2 vaccine. Journal of Thrombosis and Haemostasis, 19(9), 2314-2317. https://pubmed.ncbi.nlm.nih.gov/34105247/. | Gangat, N., Guglielmelli, P., Betti, S., Farrukh, F., Carobbio, A., Barbui, T., ... & Tefferi, A. (2021). Cerebral venous thrombosis and myeloproliferative neoplasms: A three‐center study of 74 consecutive cases. American journal of hematology, 96(12), 1580-1586. https://pubmed.ncbi.nlm.nih.gov/34453762/. | Kim, B., Park, Y., Kim, E. K., & Lee, S. H. (2021). Supraclavicular lymphadenopathy after COVID-19 vaccination in Korea: serial follow-up using ultrasonography. Clinical Imaging, 79, 201-203. | https://pubmed.ncbi.nlm.nih.gov/34116295/. | Kim, B., Park, Y., Kim, E. K., & Lee, S. H. (2021). Supraclavicular lymphadenopathy after COVID-19 vaccination in Korea: serial follow-up using ultrasonography. Clinical Imaging, 79, 201-203. https://pubmed.ncbi.nlm.nih.gov/34116295/. | Helms, J. M., Ansteatt, K. T., Roberts, J. C., Kamatam, S., Foong, K. S., Labayog, J. M. S., & Tarantino, M. D. (2021). Severe, refractory immune thrombocytopenia occurring after SARS-CoV-2 vaccine. Journal of blood medicine, 12, 221. https://pubmed.ncbi.nlm.nih.gov/33854395/ | ||||
296 | Coronavirus (COVID-19) Vaccine-induced immune thrombotic thrombocytopenia (VITT): | https://pubmed.ncbi.nlm.nih.gov/34033367/ | https://pubmed.ncbi.nlm.nih.gov/34405870/. | Holm, S., Kared, H., Michelsen, A. E., Kong, X. Y., Dahl, T. B., Schultz, N. H., ... & Halvorsen, B. (2021). Immune complexes, innate immunity, and NETosis in ChAdOx1 vaccine-induced thrombocytopenia. European heart journal, 42(39), 4064-4072. | Holm, S., Kared, H., Michelsen, A. E., Kong, X. Y., Dahl, T. B., Schultz, N. H., ... y Halvorsen, B. (2021). Complejos inmunes, inmunidad innata y NETosis en la trombocitopenia inducida por la vacuna ChAdOx1. Revista europea del corazón, 42(39), 4064-4072. https://pubmed.ncbi.nlm.nih.gov/34416410/. | Gales, K. J., Baumblatt, J., Chege, W., Goud, R., & Nair, N. (2021). La trombocitopenia, incluida la trombocitopenia inmune después de la recepción de las vacunas ARNm COVID-19 informadas al sistema de informes de eventos adversos de la vacuna (Vaers). Vacuna, 39 (25), 3329-3332. https://www.ncbi.nlm.nih.gov/pubmed/34614329 | Holm, S., Kared, H., Michelsen, A. E., Kong, X. Y., Dahl, T. B., Schultz, N. H., ... & Halvorsen, B. (2021). Immune complexes, innate immunity, and NETosis in ChAdOx1 vaccine-induced thrombocytopenia. European heart journal, 42(39), 4064-4072. https://pubmed.ncbi.nlm.nih.gov/34405870/. | Gangi, A., Mobashwera, B., Ganczakowski, M., & Ayto, R. (2021). Imaging and hematologic findings in thrombosis and thrombocytopenia after ChAdOx1 nCoV-19 (AstraZeneca) vaccination. Radiology, 211546. https://pubmed.ncbi.nlm.nih.gov/34402666/ | Sookaromdee, P., & Wiwanitkit, V. (2021). COVID-19 vaccine, immune thrombotic thrombocytopenia, jaundice, hyperviscosity: concern on cases with underlying liver problem. Annals of Hepatology, 24, 100525. | https://pubmed.ncbi.nlm.nih.gov/34509271/. | Sookaromdee, P., & Wiwanitkit, V. (2021). COVID-19 vaccine, immune thrombotic thrombocytopenia, jaundice, hyperviscosity: concern on cases with underlying liver problem. Annals of Hepatology, 24, 100525. https://pubmed.ncbi.nlm.nih.gov/34509271/. | Hendren, N. S., Carter, S., & Grodin, J. L. (2021). Severe COVID-19 vaccine associated myocarditis: Zebra or unicorn?. International journal of cardiology, 343, 197-198. https://www.internationaljournalofcardiology.com/article/S0167-5273(21)01477-7/fulltext. | ||||
297 | Comparison of adverse drug reactions among four COVID-19 vaccines in Europe using the EudraVigilance database: Thrombosis in unusual sites: | https://pubmed.ncbi.nlm.nih.gov/34375510/ | https://pubmed.ncbi.nlm.nih.gov/34416410/. | Min, Y. G., Ju, W., Ha, Y. E., Ban, J. J., Lee, S. A., Sung, J. J., & Shin, J. Y. (2021). Sensory Guillain-Barre syndrome following the ChAdOx1 nCov-19 vaccine: Report of two cases and review of literature. Journal of neuroimmunology, 359, 577691. | Min, Y. G., Ju, W., Ha, Y. E., Ban, J. J., Lee, S. A., Sung, J. J. y Shin, J. Y. (2021). Síndrome sensorial de Guillain-Barré tras la vacuna ChAdOx1 nCov-19: reporte de dos casos y revisión de la literatura. Revista de neuroinmunología, 359, 577691. https://pubmed.ncbi.nlm.nih.gov/34462013/. | Galindo, R., Chow, H., & Rongkavilit, C. (2021). Covid-19 en niños: manifestaciones clínicas y intervenciones farmacológicas, incluidos los ensayos de vacunas. Clínicas pediátricas, 68 (5), 961-976. https://www.ncbi.nlm.nih.gov/pubmed/34237049 | Min, Y. G., Ju, W., Ha, Y. E., Ban, J. J., Lee, S. A., Sung, J. J., & Shin, J. Y. (2021). Sensory Guillain-Barre syndrome following the ChAdOx1 nCov-19 vaccine: Report of two cases and review of literature. Journal of neuroimmunology, 359, 577691. https://pubmed.ncbi.nlm.nih.gov/34416410/. | Ganzel, C., & Ben-Chetrit, E. (2021). Immune Thrombocytopenia Following the Pfizer-BioNTech BNT162b2 mRNA COVID-19 Vaccine. The Israel Medical Association Journal: IMAJ, 23(6), 341-341. https://pubmed.ncbi.nlm.nih.gov/34155844/ | Muir, K. W., & Perry, R. J. (2021). The International Cerebral Venous Thrombosis Consortium report on cerebral venous thrombosis following vaccination against SARS-CoV-2. European Journal of Neurology, 28(11), 3543-3544. | https://pubmed.ncbi.nlm.nih.gov/34462996/ | Muir, K. W., & Perry, R. J. (2021). The International Cerebral Venous Thrombosis Consortium report on cerebral venous thrombosis following vaccination against SARS-CoV-2. European Journal of Neurology, 28(11), 3543-3544. https://pubmed.ncbi.nlm.nih.gov/34462996/ | Hidayat, R., Diafiri, D., Zairinal, R. A., Arifin, G. R., Azzahroh, F., Widjaya, N., ... & Haris, S. (2021). Acute Ischaemic Stroke Incidence after Coronavirus Vaccine in Indonesia: Case Series. Current neurovascular research, 18(3), 360-363. https://pubmed.ncbi.nlm.nih.gov/34579636/ | ||||
298 | Immunoglobulin adjuvant for vaccine-induced immune thrombotic thrombocytopenia: | https://pubmed.ncbi.nlm.nih.gov/34107198/ | https://pubmed.ncbi.nlm.nih.gov/34462013/. | Saraceno, J. J. F., Souza, G. M., dos Santos Finamor, L. P., Nascimento, H. M., & Belfort, R. (2021). Vogt-Koyanagi-Harada syndrome following COVID-19 and ChAdOx1 nCoV-19 (AZD1222) vaccine. International journal of retina and vitreous, 7(1), 1-7. | Saraceno, J. J. F., Souza, G. M., dos Santos Finamor, L. P., Nascimento, H. M. y Belfort, R. (2021). Síndrome de Vogt-Koyanagi-Harada después de la vacuna COVID-19 y ChAdOx1 nCoV-19 (AZD1222). Revista internacional de retina y vítreo, 7(1), 1-7. https://pubmed.ncbi.nlm.nih.gov/34224024/. | GANGA, K., SOLYAR, A. Y., & GANGA, R. (2021). Linfadenopatía cervical masiva Post-covid-19 vacunación. Oreja, nariz y diario de garganta, 01455613211048984. https://pubmed.ncbi.nlm.nih.gov/34081948/ | Saraceno, J. J. F., Souza, G. M., dos Santos Finamor, L. P., Nascimento, H. M., & Belfort, R. (2021). Vogt-Koyanagi-Harada syndrome following COVID-19 and ChAdOx1 nCoV-19 (AZD1222) vaccine. International journal of retina and vitreous, 7(1), 1-7. https://pubmed.ncbi.nlm.nih.gov/34462013/. | Gao, J. J., Tseng, H. P., Lin, C. L., Shiu, J. S., Lee, M. H., & Liu, C. H. (2021). Acute transverse myelitis following COVID-19 vaccination. Vaccines, 9(9), 1008. https://pubmed.ncbi.nlm.nih.gov/34579245/. | Choi, P. Y. I., Hsu, D., Tran, H. A., Tan, C. W., Enjeti, A., Chen, V. M. Y., ... & Bird, R. (2020). Immune thrombocytopenia following vaccination during the COVID-19 pandemic. Haematologica. | https://pubmed.ncbi.nlm.nih.gov/34435486/ | Choi, P. Y. I., Hsu, D., Tran, H. A., Tan, C. W., Enjeti, A., Chen, V. M. Y., ... & Bird, R. (2020). Immune thrombocytopenia following vaccination during the COVID-19 pandemic. Haematologica. https://pubmed.ncbi.nlm.nih.gov/34435486/ | Hiller, N., Goldberg, S. N., Cohen-Cymberknoh, M., Vainstein, V., & Simanovsky, N. (2021). Lymphadenopathy associated with the COVID-19 vaccine. Cureus, 13(2). https://pubmed.ncbi.nlm.nih.gov/33786231/ | ||||
299 | Severe vaccine-induced thrombotic thrombocytopenia following vaccination with COVID-19: an autopsy case report and review of the literature: | https://pubmed.ncbi.nlm.nih.gov/34355379/. | https://pubmed.ncbi.nlm.nih.gov/34224024/. | Papasavvas, I., & Herbort, C. P. (2021). Reactivation of Vogt-Koyanagi-Harada disease under control for more than 6 years, following anti-SARS-CoV-2 vaccination. Journal of Ophthalmic Inflammation and Infection, 11(1), 1-6. | Papasavvas, I. y Herbort, CP (2021). Reactivación de la enfermedad de Vogt-Koyanagi-Harada bajo control durante más de 6 años, tras la vacunación anti-SARS-CoV-2. Revista de inflamación e infección oftálmica, 11(1), 1-6. https://pubmed.ncbi.nlm.nih.gov/34324214/ | Gangat, N., Guglielmelli, P., Betti, S., Farrukh, F., Carobbio, A., Barbui, T., ... & Tefferi, A. (2021). Trombosis venosa cerebral y neoplasias mieloproliferativas: un estudio de tres centros de 74 casos consecutivos. American Journal of Hematology, 96 (12), 1580-1586. https://pubmed.ncbi.nlm.nih.gov/34660652/. | Papasavvas, I., & Herbort, C. P. (2021). Reactivation of Vogt-Koyanagi-Harada disease under control for more than 6 years, following anti-SARS-CoV-2 vaccination. Journal of Ophthalmic Inflammation and Infection, 11(1), 1-6. https://pubmed.ncbi.nlm.nih.gov/34224024/. | García-Azorín, D., Do, T. P., Gantenbein, A. R., Hansen, J. M., Souza, M. N. P., Obermann, M., ... & Kristoffersen, E. S. (2021). Delayed headache after COVID-19 vaccination: a red flag for vaccine induced cerebral venous thrombosis. The journal of headache and pain, 22(1), 1-5. https://pubmed.ncbi.nlm.nih.gov/34535076/ | Bari, R., Bepari, A. K., & Reza, H. M. (2021). COVID-19: Lessons from Norway tragedy must be considered in vaccine rollout planning in least developed/developing countries. Open Medicine, 16(1), 1168-1169. | https://pubmed.ncbi.nlm.nih.gov/34435142/ | Bari, R., Bepari, A. K., & Reza, H. M. (2021). COVID-19: Lessons from Norway tragedy must be considered in vaccine rollout planning in least developed/developing countries. Open Medicine, 16(1), 1168-1169. https://pubmed.ncbi.nlm.nih.gov/34435142/ | Hines, A. M., Murphy, N., Mullin, C., Barillas, J., & Barrientos, J. C. (2021). Henoch-Schönlein purpura presenting post COVID-19 vaccination. Vaccine. https://pubmed.ncbi.nlm.nih.gov/34247902/. | ||||
300 | A case of acute pulmonary embolism after immunization with SARS-CoV-2 mRNA: | https://pubmed.ncbi.nlm.nih.gov/34452028/ | https://pubmed.ncbi.nlm.nih.gov/34324214/ | Zuhorn, F., Graf, T., Klingebiel, R., Schäbitz, W. R., & Rogalewski, A. (2021). Postvaccinal encephalitis after ChAdOx1 nCov‐19. Annals of neurology, 90(3), 506-511. | Zuhorn, F., Graf, T., Klingebiel, R., Schäbitz, W. R. y Rogalewski, A. (2021). Encefalitis posvacunal después de ChAdOx1 nCov-19. Anales de neurología, 90(3), 506-511. https://pubmed.ncbi.nlm.nih.gov/34507266/ | Gangi, A., MOBASHWERA, B., Ganczakowski, M., & Ayto, R. (2021). Imágenes y hallazgos hematológicos en trombosis y trombocitopenia después de la vacunación de Chadox1 NCOV-19 (AstraZeneca). Radiología, 211546. https://pubmed.ncbi.nlm.nih.gov/34508917/ | Zuhorn, F., Graf, T., Klingebiel, R., Schäbitz, W. R., & Rogalewski, A. (2021). Postvaccinal encephalitis after ChAdOx1 nCov‐19. Annals of neurology, 90(3), 506-511. https://pubmed.ncbi.nlm.nih.gov/34324214/ | García, B., Ortega, P., JA, B. F., León, C., Burgos, R., & Dorta, C. (2021). Acute myocarditis after administration of the BNT162b2 vaccine against COVID-19. Revista espanola de cardiologia, 74(9), 812-814. https://pubmed.ncbi.nlm.nih.gov/33994339/ | Leung, V. S., & Lin, Y. (2021). Rituximab‐induced acute lympholysis and pancytopenia after COVID‐19 vaccination. Clinical Case Reports, 9(8), e04517. | https://pubmed.ncbi.nlm.nih.gov/34429981/ | Leung, V. S., & Lin, Y. (2021). Rituximab‐induced acute lympholysis and pancytopenia after COVID‐19 vaccination. Clinical Case Reports, 9(8), e04517. https://pubmed.ncbi.nlm.nih.gov/34429981/ | Hines, A., Shen, J. G., Olazagasti, C., & Shams, S. (2021). Immune thrombocytopenic purpura and acute liver injury after COVID-19 vaccine. BMJ Case Reports CP, 14(7), e242678. https://casereports.bmj.com/content/14/7/e242678. | ||||
301 | Neurosurgical considerations regarding decompressive craniectomy for intracerebral hemorrhage after SARS-CoV-2 vaccination in vaccine-induced thrombotic thrombocytopenia-VITT: | https://pubmed.ncbi.nlm.nih.gov/34202817/ | https://pubmed.ncbi.nlm.nih.gov/34507266/ | Corrêa, D. G., Cañete, L. A. Q., Dos Santos, G. A. C., de Oliveira, R. V., Brandão, C. O., & da Cruz Jr, L. C. H. (2021). Neurological symptoms and neuroimaging alterations related with COVID-19 vaccine: Cause or coincidence?. Clinical Imaging, 80, 348-352. | Corrêa, D. G., Cañete, L. A. Q., Dos Santos, G. A. C., de Oliveira, R. V., Brandão, C. O., & da Cruz Jr, L. C. H. (2021). Síntomas neurológicos y alteraciones de neuroimagen relacionados con la vacuna COVID-19: ¿Causa o coincidencia?. Imágenes clínicas, 80, 348-352. https://pubmed.ncbi.nlm.nih.gov/34459725/ | Ganzel, C., & Ben-Chetrit, E. (2021). Trombocitopenia inmune después de la vacuna PFIZ-BIONTECH BNT162B2 MRNA COVID-19. The Israel Medical Association Journal: IMAJ, 23 (6), 341-341. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8176657/. | Corrêa, D. G., Cañete, L. A. Q., Dos Santos, G. A. C., de Oliveira, R. V., Brandão, C. O., & da Cruz Jr, L. C. H. (2021). Neurological symptoms and neuroimaging alterations related with COVID-19 vaccine: Cause or coincidence?. Clinical Imaging, 80, 348-352. https://pubmed.ncbi.nlm.nih.gov/34507266/ | García, B., Ortega, P., JA, B. F., León, C., Burgos, R., & Dorta, C. (2021). Acute myocarditis after administration of the BNT162b2 vaccine against COVID-19. Revista espanola de cardiologia, 74(9), 812-814. https://www.revespcardiol.org/en-linkresolver-acute-myocarditis-after-administration-bnt162b2-S188558572100133X. | Bostan, E., Elmas, L., Yel, B., & Yalici‐Armagan, B. (2021). Exacerbation of plaque psoriasis after inactivated and BNT162b2 mRNA COVID‐19 vaccines: A report of two cases. Dermatologic therapy. | https://pubmed.ncbi.nlm.nih.gov/34427024/ | Bostan, E., Elmas, L., Yel, B., & Yalici‐Armagan, B. (2021). Exacerbation of plaque psoriasis after inactivated and BNT162b2 mRNA COVID‐19 vaccines: A report of two cases. Dermatologic therapy. https://pubmed.ncbi.nlm.nih.gov/34427024/ | Hinton, J., e Gala, A. B., & Corbett, S. (2021, December). mRNA COVID-19 Vaccine–Related Anaphylactoid Reaction and Coronary Thrombosis. In Mayo Clinic Proceedings (Vol. 96, No. 12, pp. 3182-3183). Elsevier. https://pubmed.ncbi.nlm.nih.gov/34863404/. | ||||
302 | Thrombosis and SARS-CoV-2 vaccines: vaccine-induced immune thrombotic thrombocytopenia: | https://pubmed.ncbi.nlm.nih.gov/34237213/. | https://pubmed.ncbi.nlm.nih.gov/34459725/ | Choi, G. J., Baek, S. H., Kim, J., Kim, J. H., Kwon, G. Y., Kim, D. K., ... & Kim, S. (2021). Fatal Systemic Capillary Leak Syndrome after SARS-CoV-2Vaccination in Patient with Multiple Myeloma. Emerging infectious diseases, 27(11), 2973. | Choi, G. J., Baek, S. H., Kim, J., Kim, J. H., Kwon, G. Y., Kim, D. K., ... y Kim, S. (2021). Síndrome de fuga capilar sistémica fatal después de la vacunación contra el SARS-CoV-2 en pacientes con mieloma múltiple. Enfermedades infecciosas emergentes, 27(11), 2973. https://pubmed.ncbi.nlm.nih.gov/34463066/ | Gao, J. J., Tseng, H. P., Lin, C. L., Shiu, J. S., Lee, M. H. H., & Liu, C. H. (2021). Mielitis transversal aguda después de la vacunación de COVID-19. Vacunas, 9 (9), 1008. https://pubmed.ncbi.nlm.nih.gov/34182207/ | Choi, G. J., Baek, S. H., Kim, J., Kim, J. H., Kwon, G. Y., Kim, D. K., ... & Kim, S. (2021). Fatal Systemic Capillary Leak Syndrome after SARS-CoV-2Vaccination in Patient with Multiple Myeloma. Emerging infectious diseases, 27(11), 2973. https://pubmed.ncbi.nlm.nih.gov/34459725/ | García, B., Ortega, P., JA, B. F., León, C., Burgos, R., & Dorta, C. (2021). Acute myocarditis after administration of the BNT162b2 vaccine against COVID-19. Revista espanola de cardiologia, 74(9), 812-814. https://www.sciencedirect.com/science/article/abs/pii/S188558572100133X | DeDent, A. M., & Farrand, E. (2022). Vaccine-induced interstitial lung disease: a rare reaction to COVID-19 vaccination. Thorax, 77(1), 9-10. | https://pubmed.ncbi.nlm.nih.gov/34510014/. | DeDent, A. M., & Farrand, E. (2022). Vaccine-induced interstitial lung disease: a rare reaction to COVID-19 vaccination. Thorax, 77(1), 9-10. https://pubmed.ncbi.nlm.nih.gov/34510014/. | Hippisley-Cox, J., Patone, M., Mei, X. W., Saatci, D., Dixon, S., Khunti, K., ... & Coupland, C. A. (2021). Risk of thrombocytopenia and thromboembolism after covid-19 vaccination and SARS-CoV-2 positive testing: self-controlled case series study. bmj, 374. https://pubmed.ncbi.nlm.nih.gov/34446426/ | ||||
303 | Acquired thrombotic thrombocytopenic thrombocytopenic purpura: a rare disease associated with the BNT162b2 vaccine: | https://pubmed.ncbi.nlm.nih.gov/34105247/. | https://pubmed.ncbi.nlm.nih.gov/34463066/ | Hyun, H., Song, J. Y., Seong, H., Yoon, J. G., Noh, J. Y., Cheong, H. J., & Kim, W. J. (2021). Polyarthralgia and Myalgia Syndrome after ChAdOx1 nCOV-19 Vaccination. Journal of Korean Medical Science, 36(34). | Hyun, H., Song, JY, Seong, H., Yoon, JG, Noh, JY, Cheong, HJ y Kim, WJ (2021). Síndrome de poliartralgia y mialgia después de la vacunación con ChAdOx1 nCOV-19. Revista de ciencia médica coreana, 36(34). https://pubmed.ncbi.nlm.nih.gov/34043800/. | García-Azorín, D., DO, T. P., GANTENBEIN, A. R., Hansen, J. M., Souza, M. N. P., Obermann, M., ... & Kristoffersen, E. S. (2021). Dolor de cabeza retrasado después de la vacunación de COVID-19: una bandera roja para la vacuna inducida por la trombosis venosa cerebral. El diario de dolor de cabeza y dolor, 22 (1), 1-5. https://pubmed.ncbi.nlm.nih.gov/34379914/. | Hyun, H., Song, J. Y., Seong, H., Yoon, J. G., Noh, J. Y., Cheong, H. J., & Kim, W. J. (2021). Polyarthralgia and Myalgia Syndrome after ChAdOx1 nCOV-19 Vaccination. Journal of Korean Medical Science, 36(34). https://pubmed.ncbi.nlm.nih.gov/34463066/ | Garg, R. K., & Paliwal, V. K. (2021). Spectrum of neurological complications following COVID-19 vaccination. Neurological Sciences, 1-38. https://pubmed.ncbi.nlm.nih.gov/34719776/ | Coto‐Segura, P., Fernández‐Prada, M., Mir‐Bonafé, M., García‐García, B., González‐Iglesias, I., Alonso‐Penanes, P., ... & Martinón‐Torres, F. (2021). Vesiculobullous skin reactions induced by COVID‐19 mRNA vaccine: report of four cases and review of the literature. Clinical and experimental dermatology. | https://pubmed.ncbi.nlm.nih.gov/34236711/ | Coto‐Segura, P., Fernández‐Prada, M., Mir‐Bonafé, M., García‐García, B., González‐Iglesias, I., Alonso‐Penanes, P., ... & Martinón‐Torres, F. (2021). Vesiculobullous skin reactions induced by COVID‐19 mRNA vaccine: report of four cases and review of the literature. Clinical and experimental dermatology. https://pubmed.ncbi.nlm.nih.gov/34236711/ | Ho, J. S., Sia, C. H., Ngiam, J. N., Loh, P. H., Chew, N. W., Kong, W. K., & Poh, K. K. (2021). A review of COVID-19 vaccination and the reported cardiac manifestations. Singapore medical journal. https://www.ncbi.nlm.nih.gov/pubmed/34808708 | ||||
304 | Immune complexes, innate immunity and NETosis in ChAdOx1 vaccine-induced thrombocytopenia: | https://pubmed.ncbi.nlm.nih.gov/34405870/. | https://pubmed.ncbi.nlm.nih.gov/34043800/. | İremli, B. G., Şendur, S. N., & Ünlütürk, U. (2021). Three cases of subacute thyroiditis following SARS-CoV-2 vaccine: postvaccination ASIA syndrome. The Journal of Clinical Endocrinology & Metabolism, 106(9), 2600-2605. | İremli, BG, Şendur, SN y Ünlütürk, U. (2021). Tres casos de tiroiditis subaguda tras la vacuna SARS-CoV-2: síndrome ASIA posvacunación. La Revista de Endocrinología Clínica y Metabolismo, 106(9), 2600-2605. https://pubmed.ncbi.nlm.nih.gov/34447646/ | García, B., Ortega, P., JA, B. F., León, C., Burgos, R., & Dorta, C. (2021). Miocarditis aguda después de la administración de la vacuna BNT162B2 contra COVID-19. Revista Española de Cardiologia, 74 (9), 812-814. https://www.sciencedirect.com/science/article/pii/S0248866321007098 | İremli, B. G., Şendur, S. N., & Ünlütürk, U. (2021). Three cases of subacute thyroiditis following SARS-CoV-2 vaccine: postvaccination ASIA syndrome. The Journal of Clinical Endocrinology & Metabolism, 106(9), 2600-2605. https://pubmed.ncbi.nlm.nih.gov/34043800/. | Gargano, J. W., Wallace, M., Hadler, S. C., Langley, G., Su, J. R., Oster, M. E., ... & Oliver, S. E. (2021). Use of mRNA COVID-19 vaccine after reports of myocarditis among vaccine recipients: update from the Advisory Committee on Immunization Practices—United States, June 2021. Morbidity and Mortality Weekly Report, 70(27), 977. https://www.ncbi.nlm.nih.gov/pubmed/34237049 | Salih, F., Schönborn, L., Kohler, S., Franke, C., Möckel, M., Dörner, T., ... & Endres, M. (2021). Vaccine-induced thrombocytopenia with severe headache. New England Journal of Medicine, 385(22), 2103-2105. | https://pubmed.ncbi.nlm.nih.gov/34525282/ | Salih, F., Schönborn, L., Kohler, S., Franke, C., Möckel, M., Dörner, T., ... & Endres, M. (2021). Vaccine-induced thrombocytopenia with severe headache. New England Journal of Medicine, 385(22), 2103-2105. https://pubmed.ncbi.nlm.nih.gov/34525282/ | Høeg, T. B. (2021). SARS-CoV-2 mRNA vaccination-associated myocarditis in children ages 12–17: a stratified national database analysis. medRxiv [Onine]. Preprint, 8. https://www.medrxiv.org/content/10.1101/2021.08.30.21262866v1 | ||||
305 | Sensory Guillain-Barré syndrome following ChAdOx1 nCov-19 vaccine: report of two cases and review of the literature: | https://pubmed.ncbi.nlm.nih.gov/34416410/. | https://pubmed.ncbi.nlm.nih.gov/34447646/ | Jain, E., Pandav, K., Regmi, P., Michel, G., & Altshuler, I. (2021). Facial diplegia: a rare, atypical variant of Guillain-Barré syndrome and Ad26. COV2. S Vaccine. Cureus, 13(7). | Jain, E., Pandav, K., Regmi, P., Michel, G. y Altshuler, I. (2021). Diplejía facial: una variante rara y atípica del síndrome de Guillain-Barré y Ad26. COV2. Vacuna S. Cureus, 13(7). https://pubmed.ncbi.nlm.nih.gov/34479760/. | García, B., Ortega, P., JA, B. F., León, C., Burgos, R., & Dorta, C. (2021). Miocarditis aguda después de la administración de la vacuna BNT162B2 contra COVID-19. Revista Española de Cardiologia, 74 (9), 812-814. https://www.sciencedirect.com/science/article/pii/S0896841121000937. | Jain, E., Pandav, K., Regmi, P., Michel, G., & Altshuler, I. (2021). Facial diplegia: a rare, atypical variant of Guillain-Barré syndrome and Ad26. COV2. S Vaccine. Cureus, 13(7). https://pubmed.ncbi.nlm.nih.gov/34447646/ | Garnier, M., Curado, A., Billoir, P., Barbay, V., Demeyere, M., & Dacher, J. N. (2021). Imaging of Oxford/AstraZeneca COVID-19 vaccine-induced immune thrombotic thrombocytopenia. Diagnostic and interventional imaging. https://pubmed.ncbi.nlm.nih.gov/33962903/. | Vollmann, D., Eiffert, H., & Schuster, A. (2021). Acute perimyocarditis following first dose of mRNA vaccine against COVID-19. Deutsches Ärzteblatt International, 118(31-32), 546. | https://pubmed.ncbi.nlm.nih.gov/34515024/ | Vollmann, D., Eiffert, H., & Schuster, A. (2021). Acute perimyocarditis following first dose of mRNA vaccine against COVID-19. Deutsches Ärzteblatt International, 118(31-32), 546. https://pubmed.ncbi.nlm.nih.gov/34515024/ | Holm, S., Kared, H., Michelsen, A. E., Kong, X. Y., Dahl, T. B., Schultz, N. H., ... & Halvorsen, B. (2021). Immune complexes, innate immunity, and NETosis in ChAdOx1 vaccine-induced thrombocytopenia. European heart journal, 42(39), 4064-4072. https://pubmed.ncbi.nlm.nih.gov/34405870/. | ||||
306 | Vogt-Koyanagi-Harada syndrome after COVID-19 and ChAdOx1 nCoV-19 (AZD1222) vaccination: | https://pubmed.ncbi.nlm.nih.gov/34462013/. | https://pubmed.ncbi.nlm.nih.gov/34479760/. | Trogstad, L., Robertson, A. H., Mjaaland, S., & Magnus, P. (2021). Association between ChAdOx1 nCoV-19 vaccination and bleeding episodes: Large population-based cohort study. Vaccine, 39(40), 5854-5857. | Trogstad, L., Robertson, AH, Mjaaland, S. y Magnus, P. (2021). Asociación entre la vacunación ChAdOx1 nCoV-19 y los episodios hemorrágicos: gran estudio de cohorte poblacional. Vacuna, 39(40), 5854-5857. https://pubmed.ncbi.nlm.nih.gov/34416319/. | García, B., Ortega, P., JA, B. F., León, C., Burgos, R., & Dorta, C. (2021). Miocarditis aguda después de la administración de la vacuna BNT162B2 contra COVID-19. Revista Española de Cardiologia, 74 (9), 812-814. https://www.sciencedirect.com/science/article/pii/S1553838921005789 | Trogstad, L., Robertson, A. H., Mjaaland, S., & Magnus, P. (2021). Association between ChAdOx1 nCoV-19 vaccination and bleeding episodes: Large population-based cohort study. Vaccine, 39(40), 5854-5857. https://pubmed.ncbi.nlm.nih.gov/34479760/. | Garreffa, E., Hamad, A., O'Sullivan, C. C., Hazim, A. Z., York, J., Puri, S., ... & Goetz, M. P. (2021). Regional lymphadenopathy following COVID-19 vaccination: Literature review and considerations for patient management in breast cancer care. European Journal of Cancer, 159, 38-51. https://pubmed.ncbi.nlm.nih.gov/34731748/ | Annabi, E., Dupin, N., Sohier, P., Garel, B., Franck, N., Aractingi, S., ... & Oulès, B. (2021). Rare cutaneous adverse effects of COVID‐19 vaccines: a case series and review of the literature. Journal of the European Academy of Dermatology and Venereology. | https://pubmed.ncbi.nlm.nih.gov/34363637/ | Annabi, E., Dupin, N., Sohier, P., Garel, B., Franck, N., Aractingi, S., ... & Oulès, B. (2021). Rare cutaneous adverse effects of COVID‐19 vaccines: a case series and review of the literature. Journal of the European Academy of Dermatology and Venereology. https://pubmed.ncbi.nlm.nih.gov/34363637/ | Holmes, G. A., Desai, M., Limone, B., Love, J., Tawfik, M., Wong, L., & Furukawa, B. (2021). A case series of cutaneous COVID-19 vaccine reactions at Loma Linda University Department of Dermatology. JAAD Case Reports, 16, 53-57. https://pubmed.ncbi.nlm.nih.gov/34423106/ | ||||
307 | Reactivation of Vogt-Koyanagi-Harada disease under control for more than 6 years, after anti-SARS-CoV-2 vaccination: | https://pubmed.ncbi.nlm.nih.gov/34224024/. | https://pubmed.ncbi.nlm.nih.gov/34416319/. | Abbate, A., Gavin, J., Madanchi, N., Kim, C., Shah, P. R., Klein, K., ... & Danielides, S. (2021). Fulminant myocarditis and systemic hyperinflammation temporally associated with BNT162b2 mRNA COVID-19 vaccination in two patients. International Journal of Cardiology, 340, 119-121. | Abbate, A., Gavin, J., Madanchi, N., Kim, C., Shah, P. R., Klein, K., ... y Danielides, S. (2021). Miocarditis fulminante e hiperinflamación sistémica asociada temporalmente con la vacuna COVID-19 con ARNm de BNT162b2 en dos pacientes. Revista Internacional de Cardiología, 340, 119-121. https://pubmed.ncbi.nlm.nih.gov/34092166/ | Garg, R. K., & Paliwal, V. K. (2021). Espectro de complicaciones neurológicas después de la vacunación de COVID-19. Ciencias neurológicas, 1-38. https://pubmed.ncbi.nlm.nih.gov/34373413/ | Abbate, A., Gavin, J., Madanchi, N., Kim, C., Shah, P. R., Klein, K., ... & Danielides, S. (2021). Fulminant myocarditis and systemic hyperinflammation temporally associated with BNT162b2 mRNA COVID-19 vaccination in two patients. International Journal of Cardiology, 340, 119-121. https://pubmed.ncbi.nlm.nih.gov/34416319/. | Gatti, M., Raschi, E., Moretti, U., Ardizzoni, A., Poluzzi, E., & Diemberger, I. (2021). Influenza vaccination and myo-pericarditis in patients receiving immune checkpoint inhibitors: investigating the likelihood of interaction through the vaccine adverse event reporting system and VigiBase. Vaccines, 9(1), 19. https://www.ncbi.nlm.nih.gov/pubmed/33406694 | Fueyo-Rodriguez, O., Valente-Acosta, B., Jimenez-Soto, R., Neme-Yunes, Y., Inclán-Alarcón, S. I., Trejo-Gonzalez, R., & García-Salcido, M. Á. (2021). Secondary immune thrombocytopenia supposedly attributable to COVID-19 vaccination. BMJ Case Reports CP, 14(5), e242220. | https://casereports.bmj.com/content/14/5/e242220.abstract. | Fueyo-Rodriguez, O., Valente-Acosta, B., Jimenez-Soto, R., Neme-Yunes, Y., Inclán-Alarcón, S. I., Trejo-Gonzalez, R., & García-Salcido, M. Á. (2021). Secondary immune thrombocytopenia supposedly attributable to COVID-19 vaccination. BMJ Case Reports CP, 14(5), e242220. https://casereports.bmj.com/content/14/5/e242220.abstract. | Hsiao, Y. T., Tsai, M. J., Chen, Y. H., & Hsu, C. F. (2021). Acute transverse myelitis after COVID-19 vaccination. Medicina, 57(10), 1010. https://pubmed.ncbi.nlm.nih.gov/34684047/. | ||||
308 | Post-vaccinal encephalitis after ChAdOx1 nCov-19: | https://pubmed.ncbi.nlm.nih.gov/34324214/ | https://pubmed.ncbi.nlm.nih.gov/34092166/ | Esba, L. C. A., & Al Jeraisy, M. (2021). Reported adverse effects following COVID-19 vaccination at a tertiary care hospital, focus on cerebral venous sinus thrombosis (CVST). Expert Review of Vaccines, 20(8), 1037-1042. | Esba, LCA y Al Jeraisy, M. (2021). Los efectos adversos informados después de la vacunación COVID-19 en un hospital de atención terciaria se centran en la trombosis del seno venoso cerebral (CVST). Revisión de expertos sobre vacunas, 20(8), 1037-1042. https://pubmed.ncbi.nlm.nih.gov/34291477/ | Gargano, J. W. W., Wallace, M., Hadler, S. C., Langley, G., Su, J. R., Oster, M. E., ... & Oliver, S. E. (2021). Uso de la vacuna contra MRNA COVID-19 después de informes de miocarditis entre los beneficiarios de la vacuna: actualización del Comité Asesor sobre Prácticas de Inmunización-Estados Unidos, de junio de 2021. Informe semanal de morbilidad y mortalidad, 70 (27), 977. https://www.ncbi.nlm.nih.gov/pubmed/33406694 | Esba, L. C. A., & Al Jeraisy, M. (2021). Reported adverse effects following COVID-19 vaccination at a tertiary care hospital, focus on cerebral venous sinus thrombosis (CVST). Expert Review of Vaccines, 20(8), 1037-1042. https://pubmed.ncbi.nlm.nih.gov/34092166/ | Gautam, N., Saluja, P., Fudim, M., Jambhekar, K., Pandey, T., & Al'Aref, S. (2021). A late presentation of COVID-19 vaccine-induced myocarditis. Cureus, 13(9). https://www.ncbi.nlm.nih.gov/pubmed/34660088 | Ganzel, C., & Ben-Chetrit, E. (2021). Immune Thrombocytopenia Following the Pfizer-BioNTech BNT162b2 mRNA COVID-19 Vaccine. The Israel Medical Association Journal: IMAJ, 23(6), 341-341. | https://pubmed.ncbi.nlm.nih.gov/34155844/ | Ganzel, C., & Ben-Chetrit, E. (2021). Immune Thrombocytopenia Following the Pfizer-BioNTech BNT162b2 mRNA COVID-19 Vaccine. The Israel Medical Association Journal: IMAJ, 23(6), 341-341. https://pubmed.ncbi.nlm.nih.gov/34155844/ | Huh, K., Na, Y., Kim, Y. E., Radnaabaatar, M., Peck, K. R., & Jung, J. (2021). Predicted and observed incidence of thromboembolic events among Koreans vaccinated with ChAdOx1 nCoV-19 vaccine. Journal of Korean medical science, 36(27). https://pubmed.ncbi.nlm.nih.gov/34254476/ | ||||
309 | Neurological symptoms and neuroimaging alterations related to COVID-19 vaccine: cause or coincidence?: | https://pubmed.ncbi.nlm.nih.gov/34507266/ | https://pubmed.ncbi.nlm.nih.gov/34291477/ | Kreuter, A., Licciardi‐Fernandez, M. J., Burmann, S. N., Burkert, B., Oellig, F., & Michalowitz, A. L. (2022). Induction and exacerbation of subacute cutaneous lupus erythematosus following mRNA‐based or adenoviral vector‐based SARS‐CoV‐2 vaccination. Clinical and Experimental Dermatology, 47(1), 161-163. | Kreuter, A., Licciardi‐Fernandez, M. J., Burmann, S. N., Burkert, B., Oellig, F. y Michalowitz, A. L. (2022). Inducción y exacerbación del lupus eritematoso cutáneo subagudo después de la vacunación contra el SARS-CoV-2 basada en ARNm o en vectores adenovirales. Dermatología clínica y experimental, 47(1), 161-163. https://pubmed.ncbi.nlm.nih.gov/34513435/ | Garnier, M., Cura, A., Billoir, P., Barbayo, V., Demeyere, M., & Dacher, J. N. (2021). Imágenes de Oxford / AstraZeneca COVID-19 Thrombocitopenia inmune inducida por la vacuna. Diagnóstico e imágenes intervencionistas. https://pubmed.ncbi.nlm.nih.gov/34796065/. | Kreuter, A., Licciardi‐Fernandez, M. J., Burmann, S. N., Burkert, B., Oellig, F., & Michalowitz, A. L. (2022). Induction and exacerbation of subacute cutaneous lupus erythematosus following mRNA‐based or adenoviral vector‐based SARS‐CoV‐2 vaccination. Clinical and Experimental Dermatology, 47(1), 161-163. https://pubmed.ncbi.nlm.nih.gov/34291477/ | Geeraerts, T., Montastruc, F., Bonneville, F., Mémier, V., Raposo, N., & Toulouse Vitt Study Group. (2021). Oxford-AstraZeneca COVID-19 vaccine-induced cerebral venous thrombosis and thrombocytopaenia: a missed opportunity for a rapid return of experience. Anaesthesia, Critical Care & Pain Medicine. https://pubmed.ncbi.nlm.nih.gov/34033927/ | Idogun, P. O., Ward, M. C., Teklie, Y., Wiese-Rometsch, W., & Baker, J. (2021). Newly diagnosed idiopathic thrombocytopenia post COVID-19 vaccine administration. Cureus, 13(5). | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8176657/. | Idogun, P. O., Ward, M. C., Teklie, Y., Wiese-Rometsch, W., & Baker, J. (2021). Newly diagnosed idiopathic thrombocytopenia post COVID-19 vaccine administration. Cureus, 13(5). https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8176657/. | Hussain, H., Sehring, M., & Soriano, S. (2021). Deep Venous Thrombosis after Ad26. COV2. S Vaccination in Adult Male. Case Reports in Critical Care, 2021. https://pubmed.ncbi.nlm.nih.gov/34659839/. | ||||
310 | Fatal systemic capillary leak syndrome after SARS-COV-2 vaccination in a patient with multiple myeloma: | https://pubmed.ncbi.nlm.nih.gov/34459725/ | https://pubmed.ncbi.nlm.nih.gov/34513435/ | Irvine, N. J., & Wiles, B. L. (2021). Petechiae and Desquamation of Fingers Following Immunization With BTN162b2 Messenger RNA (mRNA) COVID-19 Vaccine. Cureus, 13(8). | Irvine, Nueva Jersey y Wiles, BL (2021). Petequias y descamación de los dedos después de la inmunización con la vacuna COVID-19 de ARN mensajero (ARNm) BTN162b2. Cureus, 13(8). https://pubmed.ncbi.nlm.nih.gov/34512037/ | Garreffa, E., Hamad, A., O'Sullivan, C. C., Hazim, A. Z., York, J., Puri, S., ... & goetz, M. P. (2021). Linfadenopatía regional después de la vacunación COVID-19: Revisión y consideraciones de la literatura para la gestión del paciente en la atención de cáncer de mama. Diario Europeo de Cáncer, 159, 38-51. https://pubmed.ncbi.nlm.nih.gov/34906409/ | Irvine, N. J., & Wiles, B. L. (2021). Petechiae and Desquamation of Fingers Following Immunization With BTN162b2 Messenger RNA (mRNA) COVID-19 Vaccine. Cureus, 13(8). https://pubmed.ncbi.nlm.nih.gov/34513435/ | Geeraerts, T., Montastruc, F., Bonneville, F., Mémier, V., Raposo, N., & Toulouse Vitt Study Group. (2021). Oxford-AstraZeneca COVID-19 vaccine-induced cerebral venous thrombosis and thrombocytopaenia: a missed opportunity for a rapid return of experience. Anaesthesia, Critical Care & Pain Medicine. https://www.sciencedirect.com/science/article/pii/S235255682100093X | Julian, J. A., Mathern, D. R., & Fernando, D. (2021). Idiopathic thrombocytopenic purpura and the moderna Covid-19 vaccine. Annals of emergency medicine, 77(6), 654-656. | https://www.annemergmed.com/article/S0196-0644(21)00122-0/fulltext. | Julian, J. A., Mathern, D. R., & Fernando, D. (2021). Idiopathic thrombocytopenic purpura and the moderna Covid-19 vaccine. Annals of emergency medicine, 77(6), 654-656. https://www.annemergmed.com/article/S0196-0644(21)00122-0/fulltext. | Huynh, A., Kelton, J. G., Arnold, D. M., Daka, M., & Nazy, I. (2021). Antibody epitopes in vaccine-induced immune thrombotic thrombocytopaenia. Nature, 596(7873), 565-569. https://www.nature.com/articles/s41586-021-03744-4 | ||||
311 | Polyarthralgia and myalgia syndrome after vaccination with ChAdOx1 nCOV-19: | https://pubmed.ncbi.nlm.nih.gov/34463066/ | https://pubmed.ncbi.nlm.nih.gov/34512037/ | Lensen, R., Netea, M. G., & Rosendaal, F. R. (2021). Hepatitis C virus reactivation following COVID-19 vaccination–A case report. International Medical Case Reports Journal, 14, 573. | Lensen, R., Netea, MG y Rosendaal, FR (2021). Reactivación del virus de la hepatitis C después de la vacunación COVID-19: informe de un caso. Revista internacional de informes de casos médicos, 14, 573. https://pubmed.ncbi.nlm.nih.gov/34483273/. | Gatti, M., Raschi, E., Moretti, U., Ardizzoni, A., Poluzzi, E., y Diemberger, I. (2021). Vacunación contra la influenza y la myo-pericarditis en pacientes que reciben inhibidores de los puntos de control inmunitarios: investigando la probabilidad de interacción a través del sistema de informes de eventos adversos de la vacuna y vigibase. Vacunas, 9 (1), 19. https://www.ncbi.nlm.nih.gov/pubmed/34660088 | Lensen, R., Netea, M. G., & Rosendaal, F. R. (2021). Hepatitis C virus reactivation following COVID-19 vaccination–A case report. International Medical Case Reports Journal, 14, 573. https://pubmed.ncbi.nlm.nih.gov/34512037/ | Gellad, W. F. (2021). Myocarditis after vaccination against covid-19. bmj, 375. https://www.ncbi.nlm.nih.gov/pubmed/34916217 | Hines, A., Shen, J. G., Olazagasti, C., & Shams, S. (2021). Immune thrombocytopenic purpura and acute liver injury after COVID-19 vaccine. BMJ Case Reports CP, 14(7), e242678. | https://casereports.bmj.com/content/14/7/e242678. | Hines, A., Shen, J. G., Olazagasti, C., & Shams, S. (2021). Immune thrombocytopenic purpura and acute liver injury after COVID-19 vaccine. BMJ Case Reports CP, 14(7), e242678. https://casereports.bmj.com/content/14/7/e242678. | Hwang, J., Lee, S. B., Lee, S. W., Lee, M. H., Koyanagi, A., Jacob, L., ... & Smith, L. (2021). Comparison of vaccine-induced thrombotic events between ChAdOx1 nCoV-19 and Ad26. COV. 2. S vaccines. Journal of autoimmunity, 122, 102681. https://pubmed.ncbi.nlm.nih.gov/34139631/. | ||||
312 | Three cases of subacute thyroiditis after SARS-CoV-2 vaccination: post-vaccination ASIA syndrome: | https://pubmed.ncbi.nlm.nih.gov/34043800/. | https://pubmed.ncbi.nlm.nih.gov/34483273/. | Khan, T. A., Sidhu, N., Khan, L., Sen, S., Hussain, N., Tandon, R., & Gupta, N. (2021). Bilateral immune-mediated keratolysis after immunization with SARS-CoV-2 recombinant viral vector vaccine. Cornea, 40(12), 1629-1632. | Khan, T. A., Sidhu, N., Khan, L., Sen, S., Hussain, N., Tandon, R. y Gupta, N. (2021). Queratólisis bilateral inmunomediada después de la inmunización con la vacuna de vector viral recombinante SARS-CoV-2. Córnea, 40(12), 1629-1632. https://pubmed.ncbi.nlm.nih.gov/34513446/ | Gautam, N., Saluja, P., Fudim, M., Jambhekar, K., Pandey, T., & Al'aref, S. (2021). Una presentación tardía de la miocarditis inducida por vacunas COVID-19. CUREUS, 13 (9). https://www.ncbi.nlm.nih.gov/pubmed/34916217 | Khan, T. A., Sidhu, N., Khan, L., Sen, S., Hussain, N., Tandon, R., & Gupta, N. (2021). Bilateral immune-mediated keratolysis after immunization with SARS-CoV-2 recombinant viral vector vaccine. Cornea, 40(12), 1629-1632. https://pubmed.ncbi.nlm.nih.gov/34483273/. | Gerber, G. F., Yuan, X., Yu, J., Cher, B. A., Braunstein, E. M., Chaturvedi, S., & Brodsky, R. A. (2021). COVID-19 vaccines induce severe hemolysis in paroxysmal nocturnal hemoglobinuria. Blood, The Journal of the American Society of Hematology, 137(26), 3670-3673. https://ashpublications.org/blood/article/137/26/3670/475905/COVID-19-vaccines-induce-severe-hemolysis-in | Portuguese, A. J., Sunga, C., Kruse-Jarres, R., Gernsheimer, T., & Abkowitz, J. (2021). Autoimmune-and complement-mediated hematologic condition recrudescence following SARS-CoV-2 vaccination. Blood Advances, 5(13), 2794-2798. | https://ashpublications.org/bloodadvances/article/5/13/2794/476324/Autoimmune-and-complement-mediated-hematologic | Portuguese, A. J., Sunga, C., Kruse-Jarres, R., Gernsheimer, T., & Abkowitz, J. (2021). Autoimmune-and complement-mediated hematologic condition recrudescence following SARS-CoV-2 vaccination. Blood Advances, 5(13), 2794-2798. https://ashpublications.org/bloodadvances/article/5/13/2794/476324/Autoimmune-and-complement-mediated-hematologic | Hwang, J., Lee, S., Lee, S., Lee, M., Koyanagi, A., Jacob, L., Tizaoui, K., Yon, D., Shin, J., & Smith, L. (2021). Comparison of vaccine-induced thrombotic events between ChAdOx1 nCoV-19 and Ad26. COV. 2. S vaccines. Journal of autoimmunity, 122, 102681. https://www.sciencedirect.com/science/article/abs/pii/S0896841121000895 | ||||
313 | Facial diplegia: a rare and atypical variant of Guillain-Barré syndrome and the Ad26.COV2.S vaccine: | https://pubmed.ncbi.nlm.nih.gov/34447646/ | https://pubmed.ncbi.nlm.nih.gov/34513446/ | Jasaraj, R. B., Shrestha, D. B., Gaire, S., & Kassem, M. (2021). Immune Thrombocytopenic Purpura Following Pfizer-BioNTech COVID-19 Vaccine in an Elderly Female. Cureus, 13(8). | Jasaraj, R. B., Shrestha, D. B., Gaire, S. y Kassem, M. (2021). Púrpura trombocitopénica inmunitaria después de la vacuna COVID-19 de Pfizer-BioNTech en una mujer anciana. Cureus, 13(8). https://pubmed.ncbi.nlm.nih.gov/34474550/ | Geeraerts, T., Montastruc, F., Bonneville, F., Mémier, V., Raposo, N. y Toulouse Vitt Group. (2021). OXFORD-ASTRAZENECA COVID-19 TRUBRESIS VANEBRAL INDUCTICA CEREREBRAL Y TROMBOCITPAENIA: una oportunidad perdida por un rápido retorno de la experiencia. Anestesia, cuidados críticos y medicina para el dolor. https://pubmed.ncbi.nlm.nih.gov/34277198/ | Jasaraj, R. B., Shrestha, D. B., Gaire, S., & Kassem, M. (2021). Immune Thrombocytopenic Purpura Following Pfizer-BioNTech COVID-19 Vaccine in an Elderly Female. Cureus, 13(8). https://pubmed.ncbi.nlm.nih.gov/34513446/ | Gessler, F., Schmitz, A. K., Dubinski, D., Bernstock, J. D., Lehmann, F., Won, S. Y., ... & Schuss, P. (2021). Neurosurgical considerations regarding decompressive craniectomy for intracerebral hemorrhage after SARS-CoV-2-vaccination in vaccine induced thrombotic thrombocytopenia—VITT. Journal of Clinical Medicine, 10(13), 2777. https://pubmed.ncbi.nlm.nih.gov/34202817/ | Cebeci, F., & Kartal, İ. (2021). Petechial skin rash associated with CoronaVac vaccination: first cutaneous side effect report before phase 3 results. European Journal of Hospital Pharmacy. | https://ejhp.bmj.com/content/early/2021/05/23/ejhpharm-2021-002794 | Cebeci, F., & Kartal, İ. (2021). Petechial skin rash associated with CoronaVac vaccination: first cutaneous side effect report before phase 3 results. European Journal of Hospital Pharmacy. https://ejhp.bmj.com/content/early/2021/05/23/ejhpharm-2021-002794 | Hwang, J., Park, S. H., Lee, S. W., Lee, S. B., Lee, M. H., Jeong, G. H., ... & Smith, L. (2021). Predictors of mortality in thrombotic thrombocytopenia after adenoviral COVID-19 vaccination: the FAPIC score. European heart journal, 42(39), 4053-4063. https://pubmed.ncbi.nlm.nih.gov/34545400/ | ||||
314 | Association between ChAdOx1 nCoV-19 vaccination and bleeding episodes: large population-based cohort study: | https://pubmed.ncbi.nlm.nih.gov/34479760/. | https://pubmed.ncbi.nlm.nih.gov/34474550/ | Scavone, M., Clerici, B., Birocchi, S., Mencarini, T., Calogiuri, M., Ghali, C., ... & Podda, G. M. (2021). Platelet activation and modulation in thrombosis with thrombocytopenia syndrome associated with ChAdOx1 nCov-19 vaccine. haematologica, 106(12), 3228. | Scavone, M., Clerici, B., Birocchi, S., Mencarini, T., Calogiuri, M., Ghali, C., ... y Podda, G. M. (2021). Activación y modulación plaquetaria en la trombosis con síndrome de trombocitopenia asociada a la vacuna ChAdOx1 nCov-19. hematológica, 106(12), 3228. https://pubmed.ncbi.nlm.nih.gov/34033732/. | Geeraerts, T., Montastruc, F., Bonneville, F., Mémier, V., Raposo, N. y Toulouse Vitt Group. (2021). OXFORD-ASTRAZENECA COVID-19 TRUBRESIS VANEBRAL INDUCTICA CEREREBRAL Y TROMBOCITPAENIA: una oportunidad perdida por un rápido retorno de la experiencia. Anestesia, cuidados críticos y medicina para el dolor. https://pubmed.ncbi.nlm.nih.gov/34876440/ | Scavone, M., Clerici, B., Birocchi, S., Mencarini, T., Calogiuri, M., Ghali, C., ... & Podda, G. M. (2021). Platelet activation and modulation in thrombosis with thrombocytopenia syndrome associated with ChAdOx1 nCov-19 vaccine. haematologica, 106(12), 3228. https://pubmed.ncbi.nlm.nih.gov/34474550/ | Ghielmetti, M., Schaufelberger, H. D., Mieli-Vergani, G., Cerny, A., Dayer, E., Vergani, D., & Beretta-Piccoli, B. T. (2021). Acute autoimmune-like hepatitis with atypical anti-mitochondrial antibody after mRNA COVID-19 vaccination: A novel clinical entity?. Journal of Autoimmunity, 123, 102706. https://pubmed.ncbi.nlm.nih.gov/34293683/. | Gerber, G. F., Yuan, X., Yu, J., Cher, B. A., Braunstein, E. M., Chaturvedi, S., & Brodsky, R. A. (2021). COVID-19 vaccines induce severe hemolysis in paroxysmal nocturnal hemoglobinuria. Blood, The Journal of the American Society of Hematology, 137(26), 3670-3673. | https://ashpublications.org/blood/article/137/26/3670/475905/COVID-19-vaccines-induce-severe-hemolysis-in | Gerber, G. F., Yuan, X., Yu, J., Cher, B. A., Braunstein, E. M., Chaturvedi, S., & Brodsky, R. A. (2021). COVID-19 vaccines induce severe hemolysis in paroxysmal nocturnal hemoglobinuria. Blood, The Journal of the American Society of Hematology, 137(26), 3670-3673. https://ashpublications.org/blood/article/137/26/3670/475905/COVID-19-vaccines-induce-severe-hemolysis-in | Hyun, H., Song, J. Y., Seong, H., Yoon, J. G., Noh, J. Y., Cheong, H. J., & Kim, W. J. (2021). Polyarthralgia and Myalgia Syndrome after ChAdOx1 nCOV-19 Vaccination. Journal of Korean Medical Science, 36(34). https://pubmed.ncbi.nlm.nih.gov/34463066/ | ||||
315 | fulminant myocarditis and systemic hyperinflammation temporally associated with BNT162b2 COVID-19 mRNA vaccination in two patients: | https://pubmed.ncbi.nlm.nih.gov/34416319/. | https://pubmed.ncbi.nlm.nih.gov/34033732/. | An, Q. J., Qin, D. A., & Pei, J. X. (2021). Reactive arthritis after COVID-19 vaccination. Human Vaccines & Immunotherapeutics, 17(9), 2954-2956. | An, QJ, Qin, DA y Pei, JX (2021). Artritis reactiva después de la vacunación COVID-19. Vacunas humanas e inmunoterapia, 17(9), 2954-2956. https://pubmed.ncbi.nlm.nih.gov/33858208/ | Gellad, W. F. (2021). Miocarditis después de la vacunación contra COVID-19. BMJ, 375. https://www.ncbi.nlm.nih.gov/pubmed/34153517 | An, Q. J., Qin, D. A., & Pei, J. X. (2021). Reactive arthritis after COVID-19 vaccination. Human Vaccines & Immunotherapeutics, 17(9), 2954-2956. https://pubmed.ncbi.nlm.nih.gov/34033732/. | Gillion, V., Jadoul, M., Demoulin, N., Aydin, S., & Devresse, A. (2021). Granulomatous vasculitis after the AstraZeneca anti–SARS-CoV-2 vaccine. Kidney International, 100(3), 706-707. https://pubmed.ncbi.nlm.nih.gov/34237323/. | Walter, U., Volmer, E., Wittstock, M., Storch, A., Weber, M. A., & Großmann, A. (2021). Cerebral venous sinus thrombosis after COVID-19 vaccination: Neurological and radiological management. Der Radiologe. | https://pubmed.ncbi.nlm.nih.gov/34327553/. | Walter, U., Volmer, E., Wittstock, M., Storch, A., Weber, M. A., & Großmann, A. (2021). Cerebral venous sinus thrombosis after COVID-19 vaccination: Neurological and radiological management. Der Radiologe. https://pubmed.ncbi.nlm.nih.gov/34327553/. | Iba, T., & Levy, J. H. (2021). The roles of platelets in COVID-19-associated coagulopathy and vaccine-induced immune thrombotic thrombocytopenia. Trends in cardiovascular medicine. https://www.sciencedirect.com/science/article/pii/S1050173821000967 | ||||
316 | Adverse effects reported after COVID-19 vaccination in a tertiary care hospital, centered on cerebral venous sinus thrombosis (CVST): | https://pubmed.ncbi.nlm.nih.gov/34092166/ | https://pubmed.ncbi.nlm.nih.gov/33858208/ | Vera-Lastra, O., Ordinola Navarro, A., Cruz Domiguez, M. P., Medina, G., Sánchez Valadez, T. I., & Jara, L. J. (2021). Two cases of Graves' disease following SARS-CoV-2 vaccination: an autoimmune/inflammatory syndrome induced by adjuvants. Thyroid, 31(9), 1436-1439. | Vera-Lastra, O., Ordinola Navarro, A., Cruz Domiguez, M. P., Medina, G., Sánchez Valadez, T. I., & Jara, L. J. (2021). Dos casos de enfermedad de Graves tras la vacunación contra el SARS-CoV-2: un síndrome autoinmune/inflamatorio inducido por adyuvantes. Tiroides, 31(9), 1436-1439. https://pubmed.ncbi.nlm.nih.gov/34015240/ | Gerber, G. F., Yuan, X., Yu, J., Cher, B. A., Braunstein, E. M., Chaturvedi, S., & Brodsky, R. A. (2021). Las vacunas COVID-19 inducen la hemólisis severa en hemoglobinuria nocturna paroxística. Sangre, la revista de la Sociedad Americana de Hematología, 137 (26), 3670-3673. https://pubmed.ncbi.nlm.nih.gov/34288044/. | Vera-Lastra, O., Ordinola Navarro, A., Cruz Domiguez, M. P., Medina, G., Sánchez Valadez, T. I., & Jara, L. J. (2021). Two cases of Graves' disease following SARS-CoV-2 vaccination: an autoimmune/inflammatory syndrome induced by adjuvants. Thyroid, 31(9), 1436-1439. https://pubmed.ncbi.nlm.nih.gov/33858208/ | Giovane, R., & Campbell, J. (2021). Bilateral Thalamic Stroke: A Case of COVID-19 Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT) or a Coincidence Due to Underlying Risk Factors?. Cureus, 13(10). https://pubmed.ncbi.nlm.nih.gov/34820232/. | Franchini, M., Testa, S., Pezzo, M., Glingani, C., Caruso, B., Terenziani, I., ... & Castelli, G. (2021). Cerebral venous thrombosis and thrombocytopenia post-COVID-19 vaccination. Thrombosis research, 202, 182-183. | https://pubmed.ncbi.nlm.nih.gov/33878469/. | Franchini, M., Testa, S., Pezzo, M., Glingani, C., Caruso, B., Terenziani, I., ... & Castelli, G. (2021). Cerebral venous thrombosis and thrombocytopenia post-COVID-19 vaccination. Thrombosis research, 202, 182-183. https://pubmed.ncbi.nlm.nih.gov/33878469/. | Idogun, P. O., Ward, M. C., Teklie, Y., Wiese-Rometsch, W., & Baker, J. (2021). Newly diagnosed idiopathic thrombocytopenia post COVID-19 vaccine administration. Cureus, 13(5). https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8176657/. | ||||
317 | Induction and exacerbation of subacute cutaneous lupus erythematosus erythematosus after mRNA- or adenoviral vector-based SARS-CoV-2 vaccination: | https://pubmed.ncbi.nlm.nih.gov/34291477/ | https://pubmed.ncbi.nlm.nih.gov/34015240/ | Etemadifar, M., Sigari, A. A., Sedaghat, N., Salari, M., & Nouri, H. (2021). Acute relapse and poor immunization following COVID-19 vaccination in a rituximab-treated multiple sclerosis patient. Human vaccines & immunotherapeutics, 17(10), 3481-3483. | Etemadifar, M., Sigari, A. A., Sedaghat, N., Salari, M. y Nouri, H. (2021). Recaída aguda e inmunización deficiente después de la vacuna COVID-19 en un paciente con esclerosis múltiple tratado con rituximab. Vacunas humanas e inmunoterapia, 17(10), 3481-3483. https://pubmed.ncbi.nlm.nih.gov/34482558/ | Gessler, F., Schmitz, A. K., Dubinski, D., Bernstock, J. D., Lehmann, F., Won, S. Y., ... & Schuss, P. (2021). Consideraciones neuroquirúrgicas con respecto a la craniectomía descompresiva para la hemorragia intracerebral después del SARS-COV-2-vacunación en la vacuna contra la trombocitopenia-Vitt inducida por la vacuna. Diario de la medicina clínica, 10 (13), 2777. https://pubmed.ncbi.nlm.nih.gov/34237213/. | Etemadifar, M., Sigari, A. A., Sedaghat, N., Salari, M., & Nouri, H. (2021). Acute relapse and poor immunization following COVID-19 vaccination in a rituximab-treated multiple sclerosis patient. Human vaccines & immunotherapeutics, 17(10), 3481-3483. https://pubmed.ncbi.nlm.nih.gov/34015240/ | Göbel, C. H., Heinze, A., Karstedt, S., Morscheck, M., Tashiro, L., Cirkel, A., ... & Göbel, H. (2021). Headache Attributed to Vaccination Against COVID-19 (Coronavirus SARS-CoV-2) with the ChAdOx1 nCoV-19 (AZD1222) Vaccine: A Multicenter Observational Cohort Study. Pain and Therapy, 10(2), 1309-1330. https://pubmed.ncbi.nlm.nih.gov/34313952/ | Ciccone, A. (2021). SARS-CoV-2 vaccine-induced cerebral venous thrombosis. European journal of internal medicine, 89, 19-21. | https://pubmed.ncbi.nlm.nih.gov/34090750/. | Ciccone, A. (2021). SARS-CoV-2 vaccine-induced cerebral venous thrombosis. European journal of internal medicine, 89, 19-21. https://pubmed.ncbi.nlm.nih.gov/34090750/. | Ifeanyi, N., Chinenye, N., Oladiran, O., David, E., Mmonu, C., & Ogbonna-Nwosu, C. (2021). Isolated pulmonary embolism following COVID vaccination: 2 case reports and a review of post-acute pulmonary embolism complications and follow-up. Journal of Community Hospital Internal Medicine Perspectives, 11(6), 877-879. https://pubmed.ncbi.nlm.nih.gov/34804412/ | ||||
318 | Petechiae and peeling of fingers after immunization with BTN162b2 messenger RNA (mRNA)-based COVID-19 vaccine: | https://pubmed.ncbi.nlm.nih.gov/34513435/ | https://pubmed.ncbi.nlm.nih.gov/34482558/ | Wantavornprasert, K., Noppakun, N., Klaewsongkram, J., & Rerknimitr, P. (2022). Generalized bullous fixed drug eruption after Oxford–AstraZeneca (ChAdOx1 nCoV‐19) vaccination. Clinical and Experimental Dermatology, 47(2), 428-432. | Wantavornprasert, K., Noppakun, N., Klaewsongkram, J. y Rerknimitr, P. (2022). Erupción ampollosa generalizada fija por fármaco después de la vacunación Oxford-AstraZeneca (ChAdOx1 nCoV-19). Dermatología clínica y experimental, 47(2), 428-432. https://pubmed.ncbi.nlm.nih.gov/34480607/ | Ghielmetti, M., Schaufelberger, H. D. D., Mieli-Vergani, G., Cerny, A., Dayer, E., Vergani, D., & Beretta-Piccoli, B. T. (2021). Hepatitis aguda autoinmune, con anticuerpo anti-mitocondrial atípico después de la vacunación con MRNA COVID-19: una nueva entidad clínica. Diario de autoinmunidad, 123, 102706. https://pubmed.ncbi.nlm.nih.gov/34225251/ | Wantavornprasert, K., Noppakun, N., Klaewsongkram, J., & Rerknimitr, P. (2022). Generalized bullous fixed drug eruption after Oxford–AstraZeneca (ChAdOx1 nCoV‐19) vaccination. Clinical and Experimental Dermatology, 47(2), 428-432. https://pubmed.ncbi.nlm.nih.gov/34482558/ | Goldman, S., Bron, D., Tousseyn, T., Vierasu, I., Dewispelaere, L., Heimann, P., ... & Goldman, M. (2021). Rapid progression of angioimmunoblastic T Cell lymphoma following BNT162b2 mRNA vaccine booster shot: a case report. Frontiers in medicine, 2409. https://www.frontiersin.org/articles/10.3389/fmed.2021.798095/ | Walter, U., Fuchs, M., Grossmann, A., Walter, M., Thiele, T., Storch, A., & Wittstock, M. (2021). Adenovirus-vectored COVID-19 vaccine–induced immune thrombosis of carotid artery: a case report. Neurology, 97(15), 716-719. | https://pubmed.ncbi.nlm.nih.gov/34312301/. | Walter, U., Fuchs, M., Grossmann, A., Walter, M., Thiele, T., Storch, A., & Wittstock, M. (2021). Adenovirus-vectored COVID-19 vaccine–induced immune thrombosis of carotid artery: a case report. Neurology, 97(15), 716-719. https://pubmed.ncbi.nlm.nih.gov/34312301/. | Iftikhar, H., Noor, S. M. U., Masood, M., & Bashir, K. (2021). Bell’s palsy after 24 hours of mRNA-1273 SARS-CoV-2 vaccine. Cureus, 13(6). https://pubmed.ncbi.nlm.nih.gov/34336436/ | ||||
319 | Hepatitis C virus reactivation after COVID-19 vaccination: a case report: | https://pubmed.ncbi.nlm.nih.gov/34512037/ | https://pubmed.ncbi.nlm.nih.gov/34480607/ | Khayat-Khoei, M., Bhattacharyya, S., Katz, J., Harrison, D., Tauhid, S., Bruso, P., ... & Bakshi, R. (2022). COVID-19 mRNA vaccination leading to CNS inflammation: a case series. Journal of neurology, 269(3), 1093-1106. | Khayat-Khoei, M., Bhattacharyya, S., Katz, J., Harrison, D., Tauhid, S., Bruso, P., ... y Bakshi, R. (2022). Vacunación con ARNm de COVID-19 que provoca inflamación del SNC: una serie de casos. Revista de neurología, 269(3), 1093-1106. https://pubmed.ncbi.nlm.nih.gov/34462647/ | Gillion, V., Jadoul, M., Demoulin, N., Aydin, S., & Devresse, A. (2021). Vasculitis granulomatosa después de la vacuna contra el astrazeneca anti-SARS-COV-2. Ridney International, 100 (3), 706-707. https://pubmed.ncbi.nlm.nih.gov/34851795/. | Khayat-Khoei, M., Bhattacharyya, S., Katz, J., Harrison, D., Tauhid, S., Bruso, P., ... & Bakshi, R. (2022). COVID-19 mRNA vaccination leading to CNS inflammation: a case series. Journal of neurology, 269(3), 1093-1106. https://pubmed.ncbi.nlm.nih.gov/34480607/ | González-Romero, N., & Sánchez, V. (2021). Lipschütz Ulcers After the AstraZeneca COVID-19 Vaccine. Actas Dermo-sifiliograficas. https://pubmed.ncbi.nlm.nih.gov/34366434/. | Yahyavi-Firouz-Abadi, N., & Naik, R. P. (2021). Cerebral venous sinus thrombosis associated with vaccine-induced thrombotic thrombocytopenia. The Neuroradiology Journal, 19714009211036687. | https://pubmed.ncbi.nlm.nih.gov/34333995/ | Yahyavi-Firouz-Abadi, N., & Naik, R. P. (2021). Cerebral venous sinus thrombosis associated with vaccine-induced thrombotic thrombocytopenia. The Neuroradiology Journal, 19714009211036687. https://pubmed.ncbi.nlm.nih.gov/34333995/ | Igual-Rouilleault, A. C., Soriano, I., Quan, P. L., Fernández-Montero, A., Elizalde, A., & Pina, L. (2021). Unilateral axillary adenopathy induced by COVID-19 vaccine: US follow-up evaluation. European Radiology, 1-8. https://pubmed.ncbi.nlm.nih.gov/34655312/. | ||||
320 | Bilateral immune-mediated keratolysis after immunization with SARS-CoV-2 recombinant viral vector vaccine: | https://pubmed.ncbi.nlm.nih.gov/34483273/. | https://pubmed.ncbi.nlm.nih.gov/34462647/ | von Tresckow, J., von Tresckow, B., Reinhardt, H. C., Herrmann, K., & Berliner, C. (2021). Thymic hyperplasia after mRNA based COVID-19 vaccination. Radiology Case Reports, 16(12), 3744-3745. | von Tresckow, J., von Tresckow, B., Reinhardt, H. C., Herrmann, K. y Berliner, C. (2021). Hiperplasia tímica después de la vacunación COVID-19 basada en ARNm. Informes de casos de radiología, 16(12), 3744-3745. https://pubmed.ncbi.nlm.nih.gov/34325334/ | Giovane, R., & Campbell, J. (2021). Talámico bilateral Talámico: un caso de COVID-19 TROMBOGOTROTROPENIA DE TROMBÓTICO INMUNE INDUSIDA: VITT) O UNA COINGIDA Debido a factores de riesgo subyacentes. CUREUS, 13 (10). https://onlinelibrary.wiley.com/doi/10.1002/ajh.26258 | von Tresckow, J., von Tresckow, B., Reinhardt, H. C., Herrmann, K., & Berliner, C. (2021). Thymic hyperplasia after mRNA based COVID-19 vaccination. Radiology Case Reports, 16(12), 3744-3745. https://pubmed.ncbi.nlm.nih.gov/34462647/ | Gordon, S. F., Clothier, H. J., Morgan, H., Buttery, J. P., Phuong, L. K., Monagle, P., ... & Crawford, N. W. (2021). Immune thrombocytopenia following immunisation with Vaxzevria ChadOx1-S (AstraZeneca) vaccine, Victoria, Australia. Vaccine, 39(48), 7052-7057. https://pubmed.ncbi.nlm.nih.gov/34756770/ | Jamme, M., Mosnino, E., Hayon, J., & Franchineau, G. (2021). Fatal cerebral venous sinus thrombosis after COVID-19 vaccination. Intensive Care Medicine, 1. | https://pubmed.ncbi.nlm.nih.gov/33983464/ | Jamme, M., Mosnino, E., Hayon, J., & Franchineau, G. (2021). Fatal cerebral venous sinus thrombosis after COVID-19 vaccination. Intensive Care Medicine, 1. https://pubmed.ncbi.nlm.nih.gov/33983464/ | Iguchi, T., Umeda, H., Kojima, M., Kanno, Y., Tanaka, Y., Kinoshita, N., & Sato, D. (2021). Cumulative adverse event reporting of anaphylaxis after mRNA COVID-19 vaccine (Pfizer-BioNTech) injections in Japan: the first-month report. Drug safety, 44(11), 1209-1214. https://pubmed.ncbi.nlm.nih.gov/34347278/ | ||||
321 | Immune-mediated thrombocytopenic purpura after Pfizer-BioNTech COVID-19 vaccine in an elderly woman: | https://pubmed.ncbi.nlm.nih.gov/34513446/ | https://pubmed.ncbi.nlm.nih.gov/34325334/ | Vogrig, A., Janes, F., Gigli, G. L., Curcio, F., Del Negro, I., D’Agostini, S., ... & Valente, M. (2021). Acute disseminated encephalomyelitis after SARS-CoV-2 vaccination. Clinical Neurology and Neurosurgery, 208, 106839. | Vogrig, A., Janes, F., Gigli, G. L., Curcio, F., Del Negro, I., D’Agostini, S., ... & Valente, M. (2021). Encefalomielitis aguda diseminada tras la vacunación contra el SARS-CoV-2. Neurología Clínica y Neurocirugía, 208, 106839. https://pubmed.ncbi.nlm.nih.gov/34513398/ | Göbel, C. H. H., Heinze, A., Karstedt, S., Morscheck, M., Tashiro, L., Cirkel, A., ... & Göbel, H. (2021). Dolor de cabeza atribuido a la vacunación contra COVID-19 (Coronavirus SARS-COV-2) con la vacuna Chadox1 NCOV-19 (AZD1222): un estudio de cohorte de observación multicéntrico. Dolor y terapia, 10 (2), 1309-1330. https://pubmed.ncbi.nlm.nih.gov/34274191/ | Vogrig, A., Janes, F., Gigli, G. L., Curcio, F., Del Negro, I., D’Agostini, S., ... & Valente, M. (2021). Acute disseminated encephalomyelitis after SARS-CoV-2 vaccination. Clinical Neurology and Neurosurgery, 208, 106839. https://pubmed.ncbi.nlm.nih.gov/34325334/ | Graf, T., Thiele, T., Klingebiel, R., Greinacher, A., Schäbitz, W. R., & Greeve, I. (2021). Immediate high-dose intravenous immunoglobulins followed by direct thrombin-inhibitor treatment is crucial for survival in Sars-Covid-19-adenoviral vector vaccine-induced immune thrombotic thrombocytopenia VITT with cerebral sinus venous and portal vein thrombosis. Journal of Neurology, 268(12), 4483-4485. https://pubmed.ncbi.nlm.nih.gov/34023956/. | Gürtler, L., Seitz, R., & Schramm, W. (2021). Cerebral venous thrombosis after COVID-19 vaccination: is the risk of thrombosis increased by intravascular application of the vaccine?. Infection, 49(5), 1071-1074. | https://pubmed.ncbi.nlm.nih.gov/34286453/. | Gürtler, L., Seitz, R., & Schramm, W. (2021). Cerebral venous thrombosis after COVID-19 vaccination: is the risk of thrombosis increased by intravascular application of the vaccine?. Infection, 49(5), 1071-1074. https://pubmed.ncbi.nlm.nih.gov/34286453/. | Ikenberg, B., Demleitner, A. F., Thiele, T., Wiestler, B., Götze, K., Mößmer, G., & Lingor, P. (2021). Cerebral venous sinus thrombosis after ChAdOx1 nCov-19 vaccination with a misleading first cerebral MRI scan. Stroke and vascular neurology, 6(4). https://pubmed.ncbi.nlm.nih.gov/34244448/ | ||||
322 | Platelet activation and modulation in thrombosis with thrombocytopenia syndrome associated with the ChAdO × 1 nCov-19 vaccine: | https://pubmed.ncbi.nlm.nih.gov/34474550/ | https://pubmed.ncbi.nlm.nih.gov/34513398/ | Chuang, T. Y., Burda, K., Teklemariam, E., & Athar, K. (2021). Tolosa-Hunt syndrome presenting after COVID-19 vaccination. Cureus, 13(7). | Chuang, T. Y., Burda, K., Teklemariam, E. y Athar, K. (2021). Síndrome de Tolosa-Hunt que se presenta tras la vacunación contra la COVID-19. Cureus, 13(7). https://pubmed.ncbi.nlm.nih.gov/34362727/ | Goldman, S., Bron, D., Tousseyn, T., Vierasu, I., Dewispelaer, L., Heimann, P., ... & Goldman, M. (2021). Progresión rápida del linfoma de células T angioimmunoblásticas después de BNT162B2 ARNm Vaccine Booster Shot: Un informe de caso. Fronteras en medicina, 2409. https://pubmed.ncbi.nlm.nih.gov/33591026/ | Chuang, T. Y., Burda, K., Teklemariam, E., & Athar, K. (2021). Tolosa-Hunt syndrome presenting after COVID-19 vaccination. Cureus, 13(7). https://pubmed.ncbi.nlm.nih.gov/34513398/ | Gras-Champel, V., Liabeuf, S., Baud, M., Albucher, J. F., Benkebil, M., Boulay, C., ... & French Network of Pharmacovigilance Centres. (2021). Atypical thrombosis associated with VaxZevria®(AstraZeneca) vaccine: data from the French network of regional pharmacovigilance centres. Therapie. https://pubmed.ncbi.nlm.nih.gov/34083026/. | Ikenberg, B., Demleitner, A. F., Thiele, T., Wiestler, B., Götze, K., Mößmer, G., & Lingor, P. (2021). Cerebral venous sinus thrombosis after ChAdOx1 nCov-19 vaccination with a misleading first cerebral MRI scan. Stroke and vascular neurology, 6(4). | https://pubmed.ncbi.nlm.nih.gov/34244448/ | Ikenberg, B., Demleitner, A. F., Thiele, T., Wiestler, B., Götze, K., Mößmer, G., & Lingor, P. (2021). Cerebral venous sinus thrombosis after ChAdOx1 nCov-19 vaccination with a misleading first cerebral MRI scan. Stroke and vascular neurology, 6(4). https://pubmed.ncbi.nlm.nih.gov/34244448/ | Introna, A., Caputo, F., Santoro, C., Guerra, T., Ucci, M., Mezzapesa, D. M., & Trojano, M. (2021). Guillain-Barré syndrome after AstraZeneca COVID-19-vaccination: a causal or casual association?. Clinical Neurology and Neurosurgery, 208, 106887. https://www.sciencedirect.com/science/article/pii/S0303846721004169 | ||||
323 | Reactive arthritis after COVID-19 vaccination: | https://pubmed.ncbi.nlm.nih.gov/34033732/. | https://pubmed.ncbi.nlm.nih.gov/34362727/ | Robichaud, J., Côté, C., & Côté, F. (2021). Systemic capillary leak syndrome after ChAdOx1 nCOV-19 (Oxford–AstraZeneca) vaccination. CMAJ, 193(34), E1341-E1344. | Robichaud, J., Côté, C. y Côté, F. (2021). Síndrome de fuga capilar sistémica después de la vacunación ChAdOx1 nCOV-19 (Oxford-AstraZeneca). CMAJ, 193(34), E1341-E1344. https://pubmed.ncbi.nlm.nih.gov/34469919/. | González-Romero, N., & Sánchez, V. (2021). Lipschütz úlceras después de la vacuna de AstraZeneca Covid-19. Actas Dermo-Sifiliograficas. https://pubmed.ncbi.nlm.nih.gov/34330677/ | Robichaud, J., Côté, C., & Côté, F. (2021). Systemic capillary leak syndrome after ChAdOx1 nCOV-19 (Oxford–AstraZeneca) vaccination. CMAJ, 193(34), E1341-E1344. https://pubmed.ncbi.nlm.nih.gov/34362727/ | Greenhawt, M., Abrams, E. M., Shaker, M., Chu, D. K., Khan, D., Akin, C., ... & Golden, D. B. (2021). The risk of allergic reaction to SARS-CoV-2 vaccines and recommended evaluation and management: a systematic review, meta-analysis, GRADE assessment, and international consensus approach. The Journal of Allergy and Clinical Immunology: In Practice, 9(10), 3546-3567. https://www.ncbi.nlm.nih.gov/pubmed/34153517 | Gresele, P., Momi, S., Marcucci, R., Ramundo, F., De Stefano, V., & Tripodi, A. (2021). Interactions of adenoviruses with platelets and coagulation and the vaccine-induced immune thrombotic thrombocytopenia syndrome. haematologica, 106(12), 3034. | https://pubmed.ncbi.nlm.nih.gov/34407607/. | Gresele, P., Momi, S., Marcucci, R., Ramundo, F., De Stefano, V., & Tripodi, A. (2021). Interactions of adenoviruses with platelets and coagulation and the vaccine-induced immune thrombotic thrombocytopenia syndrome. haematologica, 106(12), 3034. https://pubmed.ncbi.nlm.nih.gov/34407607/. | Ioannou, A. (2021). Myocarditis should be considered in those with a troponin rise and unobstructed coronary arteries following Pfizer-BioNTech COVID-19 vaccination. QJM: An International Journal of Medicine, 1, 1. https://www.ncbi.nlm.nih.gov/pubmed/34463755 | ||||
324 | Two cases of Graves’ disease after SARS-CoV-2 vaccination: an autoimmune / inflammatory syndrome induced by adjuvants: | https://pubmed.ncbi.nlm.nih.gov/33858208/ | https://pubmed.ncbi.nlm.nih.gov/34469919/. | Banerjee, S., Sandhu, M., Tonzi, E., Tambe, A., & Gambhir, H. S. (2021). Immune-Mediated Thrombocytopenia Associated With Ad26. COV2. S (Janssen; Johnson & Johnson) Vaccine. American Journal of Therapeutics, 28(5), e604. | Banerjee, S., Sandhu, M., Tonzi, E., Tambe, A. y Gambhir, HS (2021). Trombocitopenia inmunomediada asociada a Ad26. COV2. Vacuna S (Janssen; Johnson & Johnson). Revista Estadounidense de Terapéutica, 28(5), e604. https://pubmed.ncbi.nlm.nih.gov/34516272/. | Gordon, S. F., Clother, H. J., Morgan, H., Matary, J. P., Phuong, L. K., Monagle, P., ... & Crawford, N. W. (2021). Trombocitopenia inmune después de la inmunización con la vacuna contra Vaxzevria Chadox1-S (AstraZeneca), Victoria, Australia. Vacuna, 39 (48), 7052-7057. https://jamanetwork.com/journals/jamaneurology/fullarticle/2784622 | Banerjee, S., Sandhu, M., Tonzi, E., Tambe, A., & Gambhir, H. S. (2021). Immune-Mediated Thrombocytopenia Associated With Ad26. COV2. S (Janssen; Johnson & Johnson) Vaccine. American Journal of Therapeutics, 28(5), e604. https://pubmed.ncbi.nlm.nih.gov/34469919/. | Greinacher, A., Selleng, K., Palankar, R., Wesche, J., Handtke, S., Wolff, M., ... & Renné, T. (2021). Insights in ChAdOx1 nCoV-19 vaccine-induced immune thrombotic thrombocytopenia. Blood, The Journal of the American Society of Hematology, 138(22), 2256-2268. https://pubmed.ncbi.nlm.nih.gov/34587242/ | Göbel, C. H., Heinze, A., Karstedt, S., Morscheck, M., Tashiro, L., Cirkel, A., ... & Göbel, H. (2021). Headache Attributed to Vaccination Against COVID-19 (Coronavirus SARS-CoV-2) with the ChAdOx1 nCoV-19 (AZD1222) Vaccine: A Multicenter Observational Cohort Study. Pain and Therapy, 10(2), 1309-1330. | https://pubmed.ncbi.nlm.nih.gov/34313952/ | Göbel, C. H., Heinze, A., Karstedt, S., Morscheck, M., Tashiro, L., Cirkel, A., ... & Göbel, H. (2021). Headache Attributed to Vaccination Against COVID-19 (Coronavirus SARS-CoV-2) with the ChAdOx1 nCoV-19 (AZD1222) Vaccine: A Multicenter Observational Cohort Study. Pain and Therapy, 10(2), 1309-1330. https://pubmed.ncbi.nlm.nih.gov/34313952/ | Ioannou, A. (2021). T2 mapping should be utilized in cases of suspected myocarditis to confirm an acute inflammatory process. QJM: An International Journal of Medicine. https://www.ncbi.nlm.nih.gov/pubmed/34931681 | ||||
325 | Acute relapse and impaired immunization after COVID-19 vaccination in a patient with multiple sclerosis treated with rituximab: | https://pubmed.ncbi.nlm.nih.gov/34015240/ | https://pubmed.ncbi.nlm.nih.gov/34516272/. | Al-Samkari, H., Leaf, R. K., & Goodarzi, K. (2021). Transient Thrombocytopenia With Glycoprotein-Specific Platelet Autoantibodies After Ad26. COV2. S Vaccination: A Case Report. Annals of Internal Medicine, 174(11), 1632-1633. | Al-Samkari, H., Leaf, R. K. y Goodarzi, K. (2021). Trombocitopenia transitoria con autoanticuerpos plaquetarios específicos de glicoproteína después de Ad26. COV2. Vacunación S: Reporte de un caso. Anales de Medicina Interna, 174(11), 1632-1633. https://pubmed.ncbi.nlm.nih.gov/34512961/ | Graf, T., Thiele, T., Klingebiel, R., Greinacher, A., Schäbitz, W. R., & Greeve, I. (2021). Las inmunoglobulinas intravenosas de alta dosis inmediatas seguidas del tratamiento con inhibidores de la trombina directa son cruciales para la supervivencia en el vector de trombocitopenia trombocitopenia de trombocitopenia trombocitopenia de trombocitopenia Vitt con seno cerebral de la trombosis venosa y portal. Diario de Neurología, 268 (12), 4483-4485. https://pubmed.ncbi.nlm.nih.gov/34629931/ | Al-Samkari, H., Leaf, R. K., & Goodarzi, K. (2021). Transient Thrombocytopenia With Glycoprotein-Specific Platelet Autoantibodies After Ad26. COV2. S Vaccination: A Case Report. Annals of Internal Medicine, 174(11), 1632-1633. https://pubmed.ncbi.nlm.nih.gov/34516272/. | Gresele, P., Marietta, M., Ageno, W., Marcucci, R., Contino, L., Donadini, M. P., ... & De Stefano, V. (2021). Management of cerebral and splanchnic vein thrombosis associated with thrombocytopenia in subjects previously vaccinated with Vaxzevria (AstraZeneca): a position statement from the Italian Society for the Study of Haemostasis and Thrombosis (SISET). Blood Transfusion, 19(4), 281. https://pubmed.ncbi.nlm.nih.gov/33871350/ | Lavin, M., Elder, P. T., O’Keeffe, D., Enright, H., Ryan, E., Kelly, A., ... & O’Donnell, J. S. (2021). Vaccine‐induced immune thrombotic thrombocytopenia (VITT)–a novel clinico‐pathological entity with heterogeneous clinical presentations. British Journal of Haematology, 195(1), 76-84. | https://pubmed.ncbi.nlm.nih.gov/34159588/. | Lavin, M., Elder, P. T., O’Keeffe, D., Enright, H., Ryan, E., Kelly, A., ... & O’Donnell, J. S. (2021). Vaccine‐induced immune thrombotic thrombocytopenia (VITT)–a novel clinico‐pathological entity with heterogeneous clinical presentations. British Journal of Haematology, 195(1), 76-84. https://pubmed.ncbi.nlm.nih.gov/34159588/. | İremli, B. G., Şendur, S. N., & Ünlütürk, U. (2021). Three cases of subacute thyroiditis following SARS-CoV-2 vaccine: postvaccination ASIA syndrome. The Journal of Clinical Endocrinology & Metabolism, 106(9), 2600-2605. https://pubmed.ncbi.nlm.nih.gov/34043800/. | ||||
326 | Widespread fixed bullous drug eruption after vaccination with ChAdOx1 nCoV-19: | https://pubmed.ncbi.nlm.nih.gov/34482558/ | https://pubmed.ncbi.nlm.nih.gov/34512961/ | Al-Mashdali, A. F., Ata, Y. M., & Sadik, N. (2021). Post-COVID-19 vaccine acute hyperactive encephalopathy with dramatic response to methylprednisolone: A case report. Annals of Medicine and Surgery, 69, 102803. | Al-Mashdali, A. F., Ata, Y. M. y Sadik, N. (2021). Encefalopatía hiperactiva aguda posterior a la vacuna COVID-19 con respuesta dramática a la metilprednisolona: reporte de un caso. Anales de Medicina y Cirugía, 69, 102803. https://pubmed.ncbi.nlm.nih.gov/34077949/ | Gras-Champel, V., LiAbeuf, S., Baud, M., Albucher, J. F., Benkebil, M., Boulay, C., ... & Francia Red de Centros de Farmacovigilancia. (2021). Trombosis atípica asociada con la vacuna contra Vaxzevria® (AstraZeneca): datos de la red francesa de centros de farmacovigilancia regionales. Terapia. https://pubmed.ncbi.nlm.nih.gov/34235757/. | Al-Mashdali, A. F., Ata, Y. M., & Sadik, N. (2021). Post-COVID-19 vaccine acute hyperactive encephalopathy with dramatic response to methylprednisolone: A case report. Annals of Medicine and Surgery, 69, 102803. https://pubmed.ncbi.nlm.nih.gov/34512961/ | Gresele, P., Momi, S., Marcucci, R., Ramundo, F., De Stefano, V., & Tripodi, A. (2021). Interactions of adenoviruses with platelets and coagulation and the vaccine-induced immune thrombotic thrombocytopenia syndrome. haematologica, 106(12), 3034. https://pubmed.ncbi.nlm.nih.gov/34407607/ | Gangi, A., Mobashwera, B., Ganczakowski, M., & Ayto, R. (2021). Imaging and hematologic findings in thrombosis and thrombocytopenia after ChAdOx1 nCoV-19 (AstraZeneca) vaccination. Radiology, 211546. | https://pubmed.ncbi.nlm.nih.gov/34402666/ | Gangi, A., Mobashwera, B., Ganczakowski, M., & Ayto, R. (2021). Imaging and hematologic findings in thrombosis and thrombocytopenia after ChAdOx1 nCoV-19 (AstraZeneca) vaccination. Radiology, 211546. https://pubmed.ncbi.nlm.nih.gov/34402666/ | Irvine, N. J., & Wiles, B. L. (2021). Petechiae and Desquamation of Fingers Following Immunization With BTN162b2 Messenger RNA (mRNA) COVID-19 Vaccine. Cureus, 13(8). https://pubmed.ncbi.nlm.nih.gov/34513435/ | ||||
327 | COVID-19 mRNA vaccine causing CNS inflammation: a case series: | https://pubmed.ncbi.nlm.nih.gov/34480607/ | https://pubmed.ncbi.nlm.nih.gov/34077949/ | Snapiri, O., Danziger, C. R., Shirman, N., Weissbach, A., Lowenthal, A., Ayalon, I., ... & Bilavsky, E. (2021). Transient cardiac injury in adolescents receiving the BNT162b2 mRNA COVID-19 vaccine. The Pediatric Infectious Disease Journal, 40(10), e360. | Snapiri, O., Danziger, C. R., Shirman, N., Weissbach, A., Lowenthal, A., Ayalon, I., ... y Bilavsky, E. (2021). Lesión cardíaca transitoria en adolescentes que reciben la vacuna COVID-19 de ARNm BNT162b2. The Pediatric Infectious Disease Journal, 40(10), e360. https://pubmed.ncbi.nlm.nih.gov/34171435/ | Greenhawt, M., Abrams, E. M., Shaker, M., Chu, D. K., Khan, D., Akin, C., ... & Golden, D. B. (2021). El riesgo de reacción alérgica a las vacunas SARS-COV-2 y la evaluación y gestión recomendadas: una revisión sistemática, el metanálisis, la evaluación de grado y el enfoque de consenso internacional. La revista de alergia y inmunología clínica: en la práctica, 9 (10), 3546-3567. https://www.ncbi.nlm.nih.gov/pubmed/34668687 | Snapiri, O., Danziger, C. R., Shirman, N., Weissbach, A., Lowenthal, A., Ayalon, I., ... & Bilavsky, E. (2021). Transient cardiac injury in adolescents receiving the BNT162b2 mRNA COVID-19 vaccine. The Pediatric Infectious Disease Journal, 40(10), e360. https://pubmed.ncbi.nlm.nih.gov/34077949/ | Gresele, P., Momi, S., Marcucci, R., Ramundo, F., De Stefano, V., & Tripodi, A. (2021). Interactions of adenoviruses with platelets and coagulation and the vaccine-induced immune thrombotic thrombocytopenia syndrome. haematologica, 106(12), 3034. https://pubmed.ncbi.nlm.nih.gov/34407607/. | Şimşek, F., & Tosunoğlu, R. (2021). Massive cerebral venous thrombosis and venous watershed infarction as late complications of COVID-19: a case report. Neurological Sciences, 42(11), 4421-4423. | https://pubmed.ncbi.nlm.nih.gov/34373991/ | Şimşek, F., & Tosunoğlu, R. (2021). Massive cerebral venous thrombosis and venous watershed infarction as late complications of COVID-19: a case report. Neurological Sciences, 42(11), 4421-4423. https://pubmed.ncbi.nlm.nih.gov/34373991/ | Isaak, A., Feisst, A., & Luetkens, J. A. (2021). Myocarditis following COVID-19 vaccination. Radiology, 301(1), E378-E379. https://www.ncbi.nlm.nih.gov/pubmed/34342500 | ||||
328 | Thymic hyperplasia after Covid-19 mRNA-based vaccination with Covid-19: | https://pubmed.ncbi.nlm.nih.gov/34462647/ | https://pubmed.ncbi.nlm.nih.gov/34171435/ | Clayton-Chubb, D., Schneider, D., Freeman, E., Kemp, W., & Roberts, S. K. (2021). Autoimmune hepatitis developing after the ChAdOx1 nCoV-19 (Oxford-AstraZeneca) vaccine. Journal of Hepatology, 75(5), 1249-1250. | Clayton-Chubb, D., Schneider, D., Freeman, E., Kemp, W. y Roberts, SK (2021). Hepatitis autoinmune que se desarrolla después de la vacuna ChAdOx1 nCoV-19 (Oxford-AstraZeneca). Revista de Hepatología, 75(5), 1249-1250. https://pubmed.ncbi.nlm.nih.gov/34447349/ | Greinacher, A., Selleng, K., Palankar, R., Wesche, J., Handtke, S., Wolff, M., ... & Renné, T. (2021). Perspectivas en la trombocitopenia trombótica inmune inducida por la vacuna contra la vacuna. Sangre, la revista de la American Society of Hematology, 138 (22), 2256-2268. https://pubmed.ncbi.nlm.nih.gov/34868465/ | Clayton-Chubb, D., Schneider, D., Freeman, E., Kemp, W., & Roberts, S. K. (2021). Autoimmune hepatitis developing after the ChAdOx1 nCoV-19 (Oxford-AstraZeneca) vaccine. Journal of Hepatology, 75(5), 1249-1250. https://pubmed.ncbi.nlm.nih.gov/34171435/ | Grossman, M. E., Appel, G., Little, A. J., & Ko, C. J. (2021). Post‐COVID‐19 vaccination IgA vasculitis in an adult. Journal of cutaneous pathology. https://pubmed.ncbi.nlm.nih.gov/34779011/ | Chen, V. M., Curnow, J. L., Tran, H. A., & Choi, P. Y. I. (2021). Australian and New Zealand approach to diagnosis and management of vaccine‐induced immune thrombosis and thrombocytopenia. Medical Journal of Australia, 215(6), 245-249. | https://pubmed.ncbi.nlm.nih.gov/34490632/ | Chen, V. M., Curnow, J. L., Tran, H. A., & Choi, P. Y. I. (2021). Australian and New Zealand approach to diagnosis and management of vaccine‐induced immune thrombosis and thrombocytopenia. Medical Journal of Australia, 215(6), 245-249. https://pubmed.ncbi.nlm.nih.gov/34490632/ | Ismail, I. I., & Salama, S. (2022). A systematic review of cases of CNS demyelination following COVID-19 vaccination. Journal of neuroimmunology, 362, 577765. https://pubmed.ncbi.nlm.nih.gov/34839149/ | ||||
329 | Acute disseminated encephalomyelitis following vaccination against SARS-CoV-2: | https://pubmed.ncbi.nlm.nih.gov/34325334/ | https://pubmed.ncbi.nlm.nih.gov/34447349/ | Maniscalco, G. T., Manzo, V., Di Battista, M. E., Salvatore, S., Moreggia, O., Scavone, C., & Capuano, A. (2021). Severe multiple sclerosis relapse after COVID-19 vaccination: a case report. Frontiers in Neurology, 1398. | Maniscalco, G. T., Manzo, V., Di Battista, M. E., Salvatore, S., Moreggia, O., Scavone, C. y Capuano, A. (2021). Recaída grave de la esclerosis múltiple después de la vacunación COVID-19: reporte de un caso. Fronteras en neurología, 1398. https://pubmed.ncbi.nlm.nih.gov/34514078/ | Gresele, P., Marietta, M., Ageno, W., Marcucci, R., Continuo, L., Donadini, M. P., ... & de Stefano, V. (2021). Gestión de la trombosis de la vena cerebral y esplandesa asociada con la trombocitopenia en sujetos previamente vacunados con Vaxzevria (AstraZeneca): una declaración de posición de la sociedad italiana para el estudio de la haemostasis y la trombosis (SISET). Transfusión de sangre, 19 (4), 281. https://www.sciencedirect.com/science/article/pii/S0022510X21003014 | Maniscalco, G. T., Manzo, V., Di Battista, M. E., Salvatore, S., Moreggia, O., Scavone, C., & Capuano, A. (2021). Severe multiple sclerosis relapse after COVID-19 vaccination: a case report. Frontiers in Neurology, 1398. https://pubmed.ncbi.nlm.nih.gov/34447349/ | Guan, C. Y., Tsai, S. H., Fan, J. S., Lin, Y. K., & Kao, C. C. (2022). Middle-age Asian male with cerebral venous thrombosis after COVID-19 AstraZeneca vaccination. The American Journal of Emergency Medicine, 51, 427-e3. https://pubmed.ncbi.nlm.nih.gov/34274191/ | Sørvoll, I. H., Horvei, K. D., Ernstsen, S. L., Lægreid, I. J., Lund, S., Grønli, R. H., ... & Ahlen, M. T. (2021). An observational study to identify the prevalence of thrombocytopenia and anti‐PF4/polyanion antibodies in Norwegian health care workers after COVID‐19 vaccination. Journal of Thrombosis and Haemostasis, 19(7), 1813-1818. | https://pubmed.ncbi.nlm.nih.gov/33909350/ | Sørvoll, I. H., Horvei, K. D., Ernstsen, S. L., Lægreid, I. J., Lund, S., Grønli, R. H., ... & Ahlen, M. T. (2021). An observational study to identify the prevalence of thrombocytopenia and anti‐PF4/polyanion antibodies in Norwegian health care workers after COVID‐19 vaccination. Journal of Thrombosis and Haemostasis, 19(7), 1813-1818. https://pubmed.ncbi.nlm.nih.gov/33909350/ | Istampoulouoglou, I., Dimitriou, G., Späni, S., Christ, A., Zimmermanns, B., Koechlin, S., ... & Leuppi-Taegtmeyer, A. B. (2021). Myocarditis and pericarditis in association with COVID-19 mRNA-vaccination: cases from a regional pharmacovigilance centre. Global cardiology science & practice, 2021(3). https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8587334/ | ||||
330 | Tolosa-Hunt syndrome occurring after COVID-19 vaccination: | https://pubmed.ncbi.nlm.nih.gov/34513398/ | https://pubmed.ncbi.nlm.nih.gov/34514078/ | Ujueta, F., Azimi, R., Lozier, M. R., Poppiti, R., & Ciment, A. (2021). Lymphohistocytic Myocarditis after Ad26. COV2. S viral vector COVID-19 vaccination. International journal of cardiology. Heart & vasculature. | Ujueta, F., Azimi, R., Lozier, M. R., Poppiti, R. y Ciment, A. (2021). Miocarditis linfohistocítica tras Ad26. COV2. Vacunación contra el vector viral S COVID-19. Revista internacional de cardiología. Corazón y vasculatura. https://pubmed.ncbi.nlm.nih.gov/34406660/. | Gresele, P., Momi, S., Marcucci, R., Ramundo, F., De Stefano, V., & Tripodi, A. (2021). Interacciones de adenovirus con plaquetas y coagulación y el síndrome de trombocitopenia de trombocitopenia trombótica inmune inducida por la vacuna. Haematologica, 106 (12), 3034. https://pubmed.ncbi.nlm.nih.gov/34264514/. | Ujueta, F., Azimi, R., Lozier, M. R., Poppiti, R., & Ciment, A. (2021). Lymphohistocytic Myocarditis after Ad26. COV2. S viral vector COVID-19 vaccination. International journal of cardiology. Heart & vasculature. https://pubmed.ncbi.nlm.nih.gov/34514078/ | Guan, C. Y., Tsai, S. H., Fan, J. S., Lin, Y. K., & Kao, C. C. (2022). Middle-age Asian male with cerebral venous thrombosis after COVID-19 AstraZeneca vaccination. The American Journal of Emergency Medicine, 51, 427-e3. https://www.sciencedirect.com/science/article/pii/S0735675721005714 | Blauenfeldt, R. A., Kristensen, S. R., Ernstsen, S. L., Kristensen, C. C. H., Simonsen, C. Z., & Hvas, A. M. (2021). Thrombocytopenia with acute ischemic stroke and bleeding in a patient newly vaccinated with an adenoviral vector‐based COVID‐19 vaccine. Journal of Thrombosis and Haemostasis, 19(7), 1771-1775. | https://pubmed.ncbi.nlm.nih.gov/33877737/ | Blauenfeldt, R. A., Kristensen, S. R., Ernstsen, S. L., Kristensen, C. C. H., Simonsen, C. Z., & Hvas, A. M. (2021). Thrombocytopenia with acute ischemic stroke and bleeding in a patient newly vaccinated with an adenoviral vector‐based COVID‐19 vaccine. Journal of Thrombosis and Haemostasis, 19(7), 1771-1775. https://pubmed.ncbi.nlm.nih.gov/33877737/ | Iwata, H., Kamiya, K., Kado, S., Nakaya, T., Kawata, H., Komine, M., & Ohtsuki, M. (2021). Case of immunoglobulin A vasculitis following coronavirus disease 2019 vaccination. The Journal of Dermatology, 48(12), e598-e599. https://pubmed.ncbi.nlm.nih.gov/34535924/ | ||||
331 | Systemic capillary extravasation syndrome following vaccination with ChAdOx1 nCOV-19 (Oxford-AstraZeneca): | https://pubmed.ncbi.nlm.nih.gov/34362727/ | https://pubmed.ncbi.nlm.nih.gov/34406660/. | Ai, S., Awford, A., & Roncolato, F. (2021). Hemophagocytic lymphohistiocytosis following ChAdOx1 nCov‐19 vaccination. Journal of Medical Virology. | Ai, S., Awford, A. y Roncolato, F. (2021). Linfohistiocitosis hemofagocítica después de la vacunación ChAdOx1 nCov-19. Revista de Virología Médica. https://pubmed.ncbi.nlm.nih.gov/34509658/ | Gresele, P., Momi, S., Marcucci, R., Ramundo, F., De Stefano, V., & Tripodi, A. (2021). Interacciones de adenovirus con plaquetas y coagulación y el síndrome de trombocitopenia de trombocitopenia trombótica inmune inducida por la vacuna. Haematologica, 106 (12), 3034. https://pubmed.ncbi.nlm.nih.gov/34313952/ | Ai, S., Awford, A., & Roncolato, F. (2021). Hemophagocytic lymphohistiocytosis following ChAdOx1 nCov‐19 vaccination. Journal of Medical Virology. https://pubmed.ncbi.nlm.nih.gov/34406660/. | Guerrero, A. J., Estirado, A. D., Quirós, J. C., & Rojas-Pérez-Ezquerra, P. (2021). Delayed cutaneous reactions after the administration of mRNA vaccines against COVID-19. The Journal of Allergy and Clinical Immunology: In Practice, 9(10), 3811-3813. https://www.sciencedirect.com/science/article/pii/S2213219821007996 | Huh, K., Na, Y., Kim, Y. E., Radnaabaatar, M., Peck, K. R., & Jung, J. (2021). Predicted and observed incidence of thromboembolic events among Koreans vaccinated with ChAdOx1 nCoV-19 vaccine. Journal of Korean medical science, 36(27). | https://pubmed.ncbi.nlm.nih.gov/34254476/ | Huh, K., Na, Y., Kim, Y. E., Radnaabaatar, M., Peck, K. R., & Jung, J. (2021). Predicted and observed incidence of thromboembolic events among Koreans vaccinated with ChAdOx1 nCoV-19 vaccine. Journal of Korean medical science, 36(27). https://pubmed.ncbi.nlm.nih.gov/34254476/ | Izzedine, H., Bonilla, M., & Jhaveri, K. D. (2021). Nephrotic syndrome and vasculitis following SARS-CoV-2 vaccine: true association or circumstantial?. Nephrology Dialysis Transplantation. https://pubmed.ncbi.nlm.nih.gov/34245294/. | ||||
332 | Immune-mediated thrombocytopenia associated with Ad26.COV2.S vaccine (Janssen; Johnson & Johnson): | https://pubmed.ncbi.nlm.nih.gov/34469919/. | https://pubmed.ncbi.nlm.nih.gov/34509658/ | Badier, L., Toledano, A., Porel, T., Dumond, S., Jouglen, J., Sailler, L., ... & Lafaurie, M. (2021). IgA vasculitis in adult patient following vaccination by ChadOx1 nCoV-19. Autoimmunity reviews. | Badier, L., Toledano, A., Porel, T., Dumond, S., Jouglen, J., Sailler, L., ... & Lafaurie, M. (2021). Vasculitis por IgA en paciente adulto tras vacunación con ChadOx1 nCoV-19. Revisiones de autoinmunidad. https://pubmed.ncbi.nlm.nih.gov/34196469/. | Grossman, M. E., Appel, G., Little, A. J., & Ko, C. J. (2021). Vacunación post-covid-19 Vasculitis IgA en un adulto. Diario de patología cutánea. https://pubmed.ncbi.nlm.nih.gov/33928459/ | Badier, L., Toledano, A., Porel, T., Dumond, S., Jouglen, J., Sailler, L., ... & Lafaurie, M. (2021). IgA vasculitis in adult patient following vaccination by ChadOx1 nCoV-19. Autoimmunity reviews. https://pubmed.ncbi.nlm.nih.gov/34509658/ | Gundry, S. R. (2021). Observational Findings of PULS Cardiac Test Findings for Inflammatory Markers in Patients Receiving mRNA Vaccines. Circulation, 144(Suppl_1), A10712-A10712. https://www.ahajournals.org/doi/10.1161/circ.144.suppl_1.10712 | Uaprasert, N., Panrong, K., Tungjitviboonkun, S., Dussadee, K., Decharatanachart, P., Kaveevorayan, P., ... & Rojnuckarin, P. (2022). ChAdOx1 nCoV-19 vaccine-associated thrombocytopenia: three cases of immune thrombocytopenia after 107 720 doses of ChAdOx1 vaccination in Thailand. Blood Coagulation & Fibrinolysis, 33(1), 67-70. | https://pubmed.ncbi.nlm.nih.gov/34483267/. | Uaprasert, N., Panrong, K., Tungjitviboonkun, S., Dussadee, K., Decharatanachart, P., Kaveevorayan, P., ... & Rojnuckarin, P. (2022). ChAdOx1 nCoV-19 vaccine-associated thrombocytopenia: three cases of immune thrombocytopenia after 107 720 doses of ChAdOx1 vaccination in Thailand. Blood Coagulation & Fibrinolysis, 33(1), 67-70. https://pubmed.ncbi.nlm.nih.gov/34483267/. | Jaafar, R., Boschi, C., Aherfi, S., Bancod, A., Le Bideau, M., Edouard, S., ... & La Scola, B. (2021). High individual heterogeneity of neutralizing activities against the original strain and nine different variants of SARS-CoV-2. Viruses, 13(11), 2177. https://www.ncbi.nlm.nih.gov/pubmed/34834983 | ||||
333 | Transient thrombocytopenia with glycoprotein-specific platelet autoantibodies after vaccination with Ad26.COV2.S: case report: | https://pubmed.ncbi.nlm.nih.gov/34516272/. | https://pubmed.ncbi.nlm.nih.gov/34196469/. | Erler, A., Fiedler, J., Koch, A., Heldmann, F., & Schütz, A. (2021). Leukocytoclastic Vasculitis After Vaccination With a SARS‐CoV‐2 Vaccine. Arthritis & Rheumatology, 73(12), 2188-2188. | Erler, A., Fiedler, J., Koch, A., Heldmann, F. y Schütz, A. (2021). Vasculitis leucocitoclástica después de la vacunación con una vacuna contra el SARS-CoV-2. Artritis y reumatología, 73(12), 2188-2188. https://pubmed.ncbi.nlm.nih.gov/34350668/ | Guan, C. Y., Tsai, S. H., Fan, J. S., Lin, Y. K., & Kao, C. C. (2022). Hombre asiático de la edad media con trombosis venosa cerebral después de COVID-19 Astrazeneca Vacunación. The American Journal of Emergency Medicine, 51, 427-E3. https://pubmed.ncbi.nlm.nih.gov/34129181/ | Erler, A., Fiedler, J., Koch, A., Heldmann, F., & Schütz, A. (2021). Leukocytoclastic Vasculitis After Vaccination With a SARS‐CoV‐2 Vaccine. Arthritis & Rheumatology, 73(12), 2188-2188. https://pubmed.ncbi.nlm.nih.gov/34196469/. | Günther, A., Brämer, D., Pletz, M. W., Kamradt, T., Baumgart, S., Mayer, T. E., ... & Thiele, T. (2021). Complicated Long Term Vaccine Induced Thrombotic Immune Thrombocytopenia—A Case Report. Vaccines, 9(11), 1344. https://pubmed.ncbi.nlm.nih.gov/34835275/. | de Mélo Silva Jr, M. L., & Lopes, D. P. (2021). Large hemorrhagic stroke after ChAdOx1 nCoV‐19 vaccination: A case report. Acta Neurologica Scandinavica, 144(6), 717-718. | https://pubmed.ncbi.nlm.nih.gov/34273119/ | de Mélo Silva Jr, M. L., & Lopes, D. P. (2021). Large hemorrhagic stroke after ChAdOx1 nCoV‐19 vaccination: A case report. Acta Neurologica Scandinavica, 144(6), 717-718. https://pubmed.ncbi.nlm.nih.gov/34273119/ | Jabagi, M. J., Botton, J., Bertrand, M., Weill, A., Farrington, P., Zureik, M., & Dray-Spira, R. (2022). Myocardial infarction, stroke, and pulmonary embolism after BNT162b2 MRNA COVID-19 vaccine in people aged 75 years or older. Jama, 327(1), 80-82. https://pubmed.ncbi.nlm.nih.gov/34807248/ | ||||
334 | Acute hyperactive encephalopathy following COVID-19 vaccination with dramatic response to methylprednisolone: case report: | https://pubmed.ncbi.nlm.nih.gov/34512961/ | https://pubmed.ncbi.nlm.nih.gov/34350668/ | Nagrani, P., Jindal, R., & Goyal, D. (2021). Onset/flare of psoriasis following the ChAdOx1 nCoV‐19 Corona virus vaccine (Oxford‐AstraZeneca/Covishield): Report of two cases. Dermatologic Therapy. | Nagrani, P., Jindal, R. y Goyal, D. (2021). Inicio/brote de psoriasis después de la vacuna contra el virus Corona ChAdOx1 nCoV-19 (Oxford-AstraZeneca/Covishield): Informe de dos casos. Terapia dermatológica. https://pubmed.ncbi.nlm.nih.gov/34436620/ | Guan, C. Y., Tsai, S. H., Fan, J. S., Lin, Y. K., & Kao, C. C. (2022). Hombre asiático de la edad media con trombosis venosa cerebral después de COVID-19 Astrazeneca Vacunación. The American Journal of Emergency Medicine, 51, 427-E3. https://www.sciencedirect.com/science/article/abs/pii/S088915912100163X | Nagrani, P., Jindal, R., & Goyal, D. (2021). Onset/flare of psoriasis following the ChAdOx1 nCoV‐19 Corona virus vaccine (Oxford‐AstraZeneca/Covishield): Report of two cases. Dermatologic Therapy. https://pubmed.ncbi.nlm.nih.gov/34350668/ | Gupta, A., Sardar, P., Cash, M. E., Milani, R. V., & Lavie, C. J. (2021). Covid-19 vaccine-induced thrombosis and thrombocytopenia-a commentary on an important and practical clinical dilemma. Progress in cardiovascular diseases. https://www.sciencedirect.com/science/article/abs/pii/S0033062021000505 | Panovska-Stavridis, I., Pivkova-Veljanovska, A., Trajkova, S., Lazarevska, M., Grozdanova, A., & Filipche, V. (2021). A rare case of superior ophthalmic vein thrombosis and thrombocytopenia following ChAdOx1 nCoV-19 vaccine against SARS-CoV-2. Mediterranean Journal of Hematology and Infectious Diseases, 13(1). | https://pubmed.ncbi.nlm.nih.gov/34276917/ | Panovska-Stavridis, I., Pivkova-Veljanovska, A., Trajkova, S., Lazarevska, M., Grozdanova, A., & Filipche, V. (2021). A rare case of superior ophthalmic vein thrombosis and thrombocytopenia following ChAdOx1 nCoV-19 vaccine against SARS-CoV-2. Mediterranean Journal of Hematology and Infectious Diseases, 13(1). https://pubmed.ncbi.nlm.nih.gov/34276917/ | Jain, E., Pandav, K., Regmi, P., Michel, G., & Altshuler, I. (2021). Facial diplegia: a rare, atypical variant of Guillain-Barré syndrome and Ad26. COV2. S Vaccine. Cureus, 13(7). https://pubmed.ncbi.nlm.nih.gov/34447646/ | ||||
335 | Transient cardiac injury in adolescents receiving the BNT162b2 mRNA COVID-19 vaccine: | https://pubmed.ncbi.nlm.nih.gov/34077949/ | https://pubmed.ncbi.nlm.nih.gov/34436620/ | Armoni-Weiss, G., Sheffer-Levi, S., Horev, L., Klapholz, L., Avitan-Hersh, E., Zlotogorski, A., & Ramot, Y. (2021). Exacerbation of Hailey-Hailey Disease Following SARS-CoV-2 Vaccination. Acta dermato-venereologica, 101(9), adv00554-adv00554. | Armoni-Weiss, G., Sheffer-Levi, S., Horev, L., Klapholz, L., Avitan-Hersh, E., Zlotogorski, A. y Ramot, Y. (2021). Exacerbación de la enfermedad de Hailey-Hailey tras la vacunación contra el SARS-CoV-2. Acta dermato-venereologica, 101(9), adv00554-adv00554. https://pubmed.ncbi.nlm.nih.gov/34116295/. | Guerrero, A. J., Estirado, A. D., Quirós, J. C., & Rojas-Pérez-Ezquerra, P. (2021). Reacciones cutáneas retrasadas después de la administración de vacunas de ARNm contra COVID-19. La revista de alergia y inmunología clínica: en la práctica, 9 (10), 3811-3813. https://www.sciencedirect.com/science/article/pii/S1871402121001880 | Armoni-Weiss, G., Sheffer-Levi, S., Horev, L., Klapholz, L., Avitan-Hersh, E., Zlotogorski, A., & Ramot, Y. (2021). Exacerbation of Hailey-Hailey Disease Following SARS-CoV-2 Vaccination. Acta dermato-venereologica, 101(9), adv00554-adv00554. https://pubmed.ncbi.nlm.nih.gov/34436620/ | Gürtler, L., Seitz, R., & Schramm, W. (2021). Cerebral venous thrombosis after COVID-19 vaccination: is the risk of thrombosis increased by intravascular application of the vaccine?. Infection, 49(5), 1071-1074. https://pubmed.ncbi.nlm.nih.gov/34286453/. | Cliff-Patel, N., Moncrieff, L., & Ziauddin, V. (2021). Renal vein thrombosis and pulmonary embolism secondary to vaccine-induced thrombotic thrombocytopenia (VITT). European Journal of Case Reports in Internal Medicine, 8(7). | https://pubmed.ncbi.nlm.nih.gov/34268278/. | Cliff-Patel, N., Moncrieff, L., & Ziauddin, V. (2021). Renal vein thrombosis and pulmonary embolism secondary to vaccine-induced thrombotic thrombocytopenia (VITT). European Journal of Case Reports in Internal Medicine, 8(7). https://pubmed.ncbi.nlm.nih.gov/34268278/. | Jain, S. S., Steele, J. M., Fonseca, B., Huang, S., Shah, S., Maskatia, S. A., ... & Grosse-Wortmann, L. (2021). COVID-19 Vaccination–Associated Myocarditis in Adolescents. Pediatrics, 148(5). https://publications.aap.org/pediatrics/article/148/5/e2021053427/181357 | ||||
336 | Autoimmune hepatitis developing after ChAdOx1 nCoV-19 vaccine (Oxford-AstraZeneca): | https://pubmed.ncbi.nlm.nih.gov/34171435/ | https://pubmed.ncbi.nlm.nih.gov/34116295/. | Kim, B., Park, Y., Kim, E. K., & Lee, S. H. (2021). Supraclavicular lymphadenopathy after COVID-19 vaccination in Korea: serial follow-up using ultrasonography. Clinical Imaging, 79, 201-203. | Kim, B., Park, Y., Kim, EK y Lee, SH (2021). Linfadenopatía supraclavicular después de la vacunación COVID-19 en Corea: seguimiento en serie mediante ecografía. Imágenes clínicas, 79, 201-203. https://pubmed.ncbi.nlm.nih.gov/34509271/. | Gundry, S. R. (2021). Hallazgos observacionales de los hallazgos de las pruebas cardíacas de Puls para los marcadores inflamatorios en pacientes que reciben vacunas de ARNm. Circulación, 144 (Suppl_1), A10712-A10712. https://www.science.org/doi/10.1126/sciadv.abl8213 | Kim, B., Park, Y., Kim, E. K., & Lee, S. H. (2021). Supraclavicular lymphadenopathy after COVID-19 vaccination in Korea: serial follow-up using ultrasonography. Clinical Imaging, 79, 201-203. https://pubmed.ncbi.nlm.nih.gov/34116295/. | Guzmán‐Pérez, L., Puerta‐Peña, M., Falkenhain‐López, D., Montero‐Menárguez, J., Gutiérrez‐Collar, C., Rodríguez‐Peralto, J. L., & Sanz‐Bueno, J. (2021). Small‐vessel vasculitis following Oxford‐AstraZeneca vaccination against SARS‐CoV‐2. Journal of the European Academy of Dermatology and Venereology. https://pubmed.ncbi.nlm.nih.gov/34310763/ | Jones, M., Boisvert, A., Landry, J., & Petrasek, P. F. (2021). Limb ischemia and pulmonary artery thrombosis after the ChAdOx1 nCoV-19 (Oxford–AstraZeneca) vaccine: a case of vaccine-induced immune thrombotic thrombocytopenia. CMAJ, 193(24), E906-E910. | https://pubmed.ncbi.nlm.nih.gov/33990339/. | Jones, M., Boisvert, A., Landry, J., & Petrasek, P. F. (2021). Limb ischemia and pulmonary artery thrombosis after the ChAdOx1 nCoV-19 (Oxford–AstraZeneca) vaccine: a case of vaccine-induced immune thrombotic thrombocytopenia. CMAJ, 193(24), E906-E910. https://pubmed.ncbi.nlm.nih.gov/33990339/. | James, J., Jose, J., Gafoor, V. A., Smita, B., & Balaram, N. (2021). Guillain‐Barré syndrome following ChAdOx1 nCoV‐19 COVID‐19 vaccination: A case series. Neurology and Clinical Neuroscience, 9(5), 402-405. https://pubmed.ncbi.nlm.nih.gov/34548920/ | ||||
337 | Severe relapse of multiple sclerosis after COVID-19 vaccination: a case report: | https://pubmed.ncbi.nlm.nih.gov/34447349/ | https://pubmed.ncbi.nlm.nih.gov/34509271/. | Sookaromdee, P., & Wiwanitkit, V. (2021). COVID-19 vaccine, immune thrombotic thrombocytopenia, jaundice, hyperviscosity: concern on cases with underlying liver problem. Annals of Hepatology, 24, 100525. | Sookaromdee, P. y Wiwanitkit, V. (2021). Vacuna COVID-19, trombocitopenia trombótica inmune, ictericia, hiperviscosidad: preocupación en casos con problema hepático subyacente. Anales de hepatología, 24, 100525. https://pubmed.ncbi.nlm.nih.gov/34462996/ | Günther, A., Brämer, D., Pletz, M. W., Kamradt, T., Baumgart, S., Mayer, T. E., ... & Thiele, T. (2021). Complicada vacuna a largo plazo indujo la trombocitopenia inmune trombótica: un informe de caso. Vacunas, 9 (11), 1344. https://pubmed.ncbi.nlm.nih.gov/34659839/. | Sookaromdee, P., & Wiwanitkit, V. (2021). COVID-19 vaccine, immune thrombotic thrombocytopenia, jaundice, hyperviscosity: concern on cases with underlying liver problem. Annals of Hepatology, 24, 100525. https://pubmed.ncbi.nlm.nih.gov/34509271/. | Haaf, P., Kuster, G. M., Mueller, C., Berger, C. T., Monney, P., Burger, P., ... & Tanner, F. C. (2021). The very low risk of myocarditis and pericarditis after mRNA COVID-19 vaccination should not discourage vaccination. Swiss Medical Weekly, (41). https://www.ncbi.nlm.nih.gov/pubmed/34668687 | Vaira, L. A., Podda, L., Doneddu, P., Careddu, M. G., Fozza, C., & De Riu, G. (2021). Secondary thrombocytopenia after SARS-CoV-2 vaccine: Report of a case of hemorrhage and hematoma after minor oral surgery. Journal of Stomatology, Oral and Maxillofacial Surgery. | https://pubmed.ncbi.nlm.nih.gov/34314875/. | Vaira, L. A., Podda, L., Doneddu, P., Careddu, M. G., Fozza, C., & De Riu, G. (2021). Secondary thrombocytopenia after SARS-CoV-2 vaccine: Report of a case of hemorrhage and hematoma after minor oral surgery. Journal of Stomatology, Oral and Maxillofacial Surgery. https://pubmed.ncbi.nlm.nih.gov/34314875/. | Jamme, M., Mosnino, E., Hayon, J., & Franchineau, G. (2021). Fatal cerebral venous sinus thrombosis after COVID-19 vaccination. Intensive Care Medicine, 1. https://pubmed.ncbi.nlm.nih.gov/33983464/ | ||||
338 | Lymphohistocytic myocarditis after vaccination with the COVID-19 viral vector Ad26.COV2.S: | https://pubmed.ncbi.nlm.nih.gov/34514078/ | https://pubmed.ncbi.nlm.nih.gov/34462996/ | Muir, K. W., & Perry, R. J. (2021). The International Cerebral Venous Thrombosis Consortium report on cerebral venous thrombosis following vaccination against SARS-CoV-2. European Journal of Neurology, 28(11), 3543-3544. | Muir, KW y Perry, RJ (2021). El informe del Consorcio Internacional de Trombosis Venosa Cerebral sobre la trombosis venosa cerebral tras la vacunación contra el SARS-CoV-2. Revista europea de neurología, 28(11), 3543-3544. https://pubmed.ncbi.nlm.nih.gov/34435486/ | Gupta, A., Sardar, P., Cash, M. E., Milani, R. V., & Lavie, C. J. (2021). COVID-19 Trombosis inducida por la vacuna y trombocitopenia: un comentario sobre un dilema clínico importante y práctico. Progreso en enfermedades cardiovasculares. https://www.sciencedirect.com/science/article/abs/pii/S0953620521001904 | Muir, K. W., & Perry, R. J. (2021). The International Cerebral Venous Thrombosis Consortium report on cerebral venous thrombosis following vaccination against SARS-CoV-2. European Journal of Neurology, 28(11), 3543-3544. https://pubmed.ncbi.nlm.nih.gov/34462996/ | Haakonsen, H. B., & Nystedt, A. (2021). Deep vein thrombosis more than two weeks after vaccination against COVID-19. Tidsskrift for Den norske legeforening. https://pubmed.ncbi.nlm.nih.gov/33928773/ | Gabarin, N., Patterson, S., Pai, M., Afzaal, T., Nazy, I., Sheppard, J. A. I., ... & Warkentin, T. E. (2021). Venous thromboembolism and mild thrombocytopenia after ChAdOx1 nCoV-19 vaccination. Thrombosis and Haemostasis, 121(12), 1677-1680. | https://pubmed.ncbi.nlm.nih.gov/34384129/ | Gabarin, N., Patterson, S., Pai, M., Afzaal, T., Nazy, I., Sheppard, J. A. I., ... & Warkentin, T. E. (2021). Venous thromboembolism and mild thrombocytopenia after ChAdOx1 nCoV-19 vaccination. Thrombosis and Haemostasis, 121(12), 1677-1680. https://pubmed.ncbi.nlm.nih.gov/34384129/ | Jasaraj, R. B., Shrestha, D. B., Gaire, S., & Kassem, M. (2021). Immune Thrombocytopenic Purpura Following Pfizer-BioNTech COVID-19 Vaccine in an Elderly Female. Cureus, 13(8). https://pubmed.ncbi.nlm.nih.gov/34513446/ | ||||
339 | Hemophagocytic lymphohistiocytosis after vaccination with ChAdOx1 nCov-19: | https://pubmed.ncbi.nlm.nih.gov/34406660/. | https://pubmed.ncbi.nlm.nih.gov/34435486/ | Choi, P. Y. I., Hsu, D., Tran, H. A., Tan, C. W., Enjeti, A., Chen, V. M. Y., ... & Bird, R. (2020). Immune thrombocytopenia following vaccination during the COVID-19 pandemic. Haematologica. | Choi, P. Y. I., Hsu, D., Tran, H. A., Tan, C. W., Enjeti, A., Chen, V. M. Y., ... y Bird, R. (2020). Trombocitopenia inmunitaria tras la vacunación durante la pandemia de COVID-19. Hematológica. https://pubmed.ncbi.nlm.nih.gov/34435142/ | Gürtler, L., Seitz, R., & Schramm, W. (2021). Trombosis venosa cerebral después de la vacunación COVID-19: ¿El riesgo de trombosis aumentó mediante la aplicación intravascular de la vacuna? Infección, 49 (5), 1071-1074. https://pubmed.ncbi.nlm.nih.gov/34244448/ | Choi, P. Y. I., Hsu, D., Tran, H. A., Tan, C. W., Enjeti, A., Chen, V. M. Y., ... & Bird, R. (2020). Immune thrombocytopenia following vaccination during the COVID-19 pandemic. Haematologica. https://pubmed.ncbi.nlm.nih.gov/34435486/ | Habib, M. B., Hamamyh, T., Elyas, A., Altermanini, M., & Elhassan, M. (2021). Acute myocarditis following administration of BNT162b2 vaccine. IDCases, 25, e01197. https://www.sciencedirect.com/science/article/pii/S2214250921001530 | Douxfils, J., Vayne, C., Pouplard, C., Lecompte, T., Favresse, J., Potier, F., ... & Mullier, F. (2021). Fatal exacerbation of ChadOx1-nCoV-19-induced thrombotic thrombocytopenia syndrome after initial successful therapy with intravenous immunoglobulins-a rational for monitoring immunoglobulin G levels. haematologica, 106(12), 3249. | https://pubmed.ncbi.nlm.nih.gov/34382387/ | Douxfils, J., Vayne, C., Pouplard, C., Lecompte, T., Favresse, J., Potier, F., ... & Mullier, F. (2021). Fatal exacerbation of ChadOx1-nCoV-19-induced thrombotic thrombocytopenia syndrome after initial successful therapy with intravenous immunoglobulins-a rational for monitoring immunoglobulin G levels. haematologica, 106(12), 3249. https://pubmed.ncbi.nlm.nih.gov/34382387/ | Jeon, Y. H., Lim, D. H., Choi, S. W., & Choi, S. J. (2021). A flare of Still’s disease following COVID-19 vaccination in a 34-year-old patient. Rheumatology international, 1-6. https://pubmed.ncbi.nlm.nih.gov/34797392/ | ||||
340 | IgA vasculitis in adult patient after vaccination with ChadOx1 nCoV-19: | https://pubmed.ncbi.nlm.nih.gov/34509658/ | https://pubmed.ncbi.nlm.nih.gov/34435142/ | Bari, R., Bepari, A. K., & Reza, H. M. (2021). COVID-19: Lessons from Norway tragedy must be considered in vaccine rollout planning in least developed/developing countries. Open Medicine, 16(1), 1168-1169. | Bari, R., Bepari, AK y Reza, HM (2021). COVID-19: Se deben considerar las lecciones de la tragedia de Noruega al planificar el lanzamiento de vacunas en los países menos desarrollados o en desarrollo. Medicina abierta, 16(1), 1168-1169. https://pubmed.ncbi.nlm.nih.gov/34429981/ | Guzmán-Pérez, L., Puerta-Peña, M., Falkenhain-López, D., Montero-Menárguez, J., Gutiérrez-Collar, C., Rodríguez-Peralto, JL y Sanz-Bueno, J. (2021 ). Vasculitis de pequeños vasos después de la vacunación Oxford-AstraZeneca contra SARS-COV-2. Diario de la Academia Europea de Dermatología y Venereología. https://pubmed.ncbi.nlm.nih.gov/34251683/. | Bari, R., Bepari, A. K., & Reza, H. M. (2021). COVID-19: Lessons from Norway tragedy must be considered in vaccine rollout planning in least developed/developing countries. Open Medicine, 16(1), 1168-1169. https://pubmed.ncbi.nlm.nih.gov/34435142/ | Hafeez, M. U., Ikram, M., Shafiq, Z., Sarfraz, A., Sarfraz, Z., Jaiswal, V., ... & Chérrez-Ojeda, I. (2021). COVID-19 vaccine-associated thrombosis with thrombocytopenia syndrome (TTS): A systematic review and post hoc analysis. Clinical and Applied Thrombosis/Hemostasis, 27, 10760296211048815. https://pubmed.ncbi.nlm.nih.gov/34698582/. | Villa, M., Díaz-Crespo, F., de José, A. P., Verdalles, Ú., Verde, E., Ruiz, F. A., ... & Goicoechea, M. (2021). A case of ANCA-associated vasculitis after AZD1222 (Oxford–AstraZeneca) SARS-CoV-2 vaccination: casualty or causality?. Kidney International, 100(4), 937-938. | https://pubmed.ncbi.nlm.nih.gov/34416184/. | Villa, M., Díaz-Crespo, F., de José, A. P., Verdalles, Ú., Verde, E., Ruiz, F. A., ... & Goicoechea, M. (2021). A case of ANCA-associated vasculitis after AZD1222 (Oxford–AstraZeneca) SARS-CoV-2 vaccination: casualty or causality?. Kidney International, 100(4), 937-938. https://pubmed.ncbi.nlm.nih.gov/34416184/. | Jeong, J., & Choi, H. S. (2021). Sudden sensorineural hearing loss after COVID-19 vaccination. International Journal of Infectious Diseases, 113, 341-343. https://pubmed.ncbi.nlm.nih.gov/34670143/. | ||||
341 | A case of leukocytoclastic vasculitis after vaccination with a SARS-CoV2 vaccine: case report: | https://pubmed.ncbi.nlm.nih.gov/34196469/. | https://pubmed.ncbi.nlm.nih.gov/34429981/ | Leung, V. S., & Lin, Y. (2021). Rituximab‐induced acute lympholysis and pancytopenia after COVID‐19 vaccination. Clinical Case Reports, 9(8), e04517. | Leung, VS y Lin, Y. (2021). Linfolisis aguda y pancitopenia inducidas por rituximab después de la vacunación contra la COVID-19. Informes de casos clínicos, 9(8), e04517. https://pubmed.ncbi.nlm.nih.gov/34427024/ | Haaf, P., Kuster, G. M., Mueller, C., Berger, C. T., Monney, P., Hamburguesa, P., ... & Tanner, F. C. (2021). El riesgo muy bajo de miocarditis y pericarditis después de la vacunación con MRNA COVID-19 no debe desalentar la vacunación. Swiss Medical Weekly, (41). https://www.ncbi.nlm.nih.gov/pubmed/34348657 | Leung, V. S., & Lin, Y. (2021). Rituximab‐induced acute lympholysis and pancytopenia after COVID‐19 vaccination. Clinical Case Reports, 9(8), e04517. https://pubmed.ncbi.nlm.nih.gov/34429981/ | Haimei, M. A. (2021). Concern About the Adverse Effects of Thrombocytopenia and Thrombosis After Adenovirus-Vectored COVID-19 Vaccination. Clinical and Applied Thrombosis/Hemostasis, 27, 10760296211040110. https://pubmed.ncbi.nlm.nih.gov/34541935/ | Mendes-de-Almeida, D. P., Martins-Gonçalves, R., Morato-Santos, R., De Carvalho, G. A. C., Martins, S. A., Palhinha, L., ... & Kurtz, P. (2021). Intracerebral hemorrhage associated with vaccine-induced thrombotic thrombocytopenia following ChAdOx1 nCOVID-19 vaccine in a pregnant woman. haematologica, 106(11), 3025. | https://pubmed.ncbi.nlm.nih.gov/34261297/ | Mendes-de-Almeida, D. P., Martins-Gonçalves, R., Morato-Santos, R., De Carvalho, G. A. C., Martins, S. A., Palhinha, L., ... & Kurtz, P. (2021). Intracerebral hemorrhage associated with vaccine-induced thrombotic thrombocytopenia following ChAdOx1 nCOVID-19 vaccine in a pregnant woman. haematologica, 106(11), 3025. https://pubmed.ncbi.nlm.nih.gov/34261297/ | Jhaveri, R., Adler-Shohet, F. C., Blyth, C. C., Chiotos, K., Gerber, J. S., Green, M., ... & Zaoutis, T. (2021). Weighing the Risks of Perimyocarditis With the Benefits of SARS-CoV-2 mRNA Vaccination in Adolescents. Journal of the Pediatric Infectious Diseases Society, 10(10), 937-939. https://www.ncbi.nlm.nih.gov/pubmed/34270752 | ||||
342 | Onset / outbreak of psoriasis after Corona virus ChAdOx1 nCoV-19 vaccine (Oxford-AstraZeneca / Covishield): report of two cases: | https://pubmed.ncbi.nlm.nih.gov/34350668/ | https://pubmed.ncbi.nlm.nih.gov/34427024/ | Bostan, E., Elmas, L., Yel, B., & Yalici‐Armagan, B. (2021). Exacerbation of plaque psoriasis after inactivated and BNT162b2 mRNA COVID‐19 vaccines: A report of two cases. Dermatologic therapy. | Bostan, E., Elmas, L., Yel, B. y Yalici‐Armagan, B. (2021). Exacerbación de la psoriasis en placas después de las vacunas COVID-19 de ARNm inactivadas y BNT162b2: informe de dos casos. Terapia dermatológica. https://pubmed.ncbi.nlm.nih.gov/34510014/. | Haakonsen, H. B., & Nystedt, A. (2021). Profunda trombosis venosa más de dos semanas después de la vacunación contra COVID-19. TIDSSSKRIFT PARA DEN NORSKE LEGEFORENDO. https://pubmed.ncbi.nlm.nih.gov/34880826/ | Bostan, E., Elmas, L., Yel, B., & Yalici‐Armagan, B. (2021). Exacerbation of plaque psoriasis after inactivated and BNT162b2 mRNA COVID‐19 vaccines: A report of two cases. Dermatologic therapy. https://pubmed.ncbi.nlm.nih.gov/34427024/ | Hajjo, R., Sabbah, D. A., Bardaweel, S. K., & Tropsha, A. (2021). Shedding the Light on Post-Vaccine Myocarditis and Pericarditis in COVID-19 and Non-COVID-19 Vaccine Recipients. Vaccines, 9(10), 1186. https://pubmed.ncbi.nlm.nih.gov/34696294/ | Bonato, S., Artoni, A., Lecchi, A., Schwarz, G., La Marca, S., Padovan, L., ... & Peyvandi, F. (2021). Massive cerebral venous thrombosis due to vaccine-induced immune thrombotic thrombocytopenia. haematologica, 106(11), 3021. | https://pubmed.ncbi.nlm.nih.gov/34261296/ | Bonato, S., Artoni, A., Lecchi, A., Schwarz, G., La Marca, S., Padovan, L., ... & Peyvandi, F. (2021). Massive cerebral venous thrombosis due to vaccine-induced immune thrombotic thrombocytopenia. haematologica, 106(11), 3021. https://pubmed.ncbi.nlm.nih.gov/34261296/ | Jin, W. J., Ahn, S. W., Jang, S. H., Hong, S. M., Seol, J. E., & Kim, H. (2021). Leukocytoclastic vasculitis after coronavirus disease 2019 vaccination. The Journal of Dermatology. https://pubmed.ncbi.nlm.nih.gov/34713472/803 | ||||
343 | Hailey-Hailey disease exacerbation after SARS-CoV-2 vaccination: | https://pubmed.ncbi.nlm.nih.gov/34436620/ | https://pubmed.ncbi.nlm.nih.gov/34510014/. | DeDent, A. M., & Farrand, E. (2022). Vaccine-induced interstitial lung disease: a rare reaction to COVID-19 vaccination. Thorax, 77(1), 9-10. | DeDent, AM y Farrand, E. (2022). Enfermedad pulmonar intersticial inducida por vacuna: una reacción poco común a la vacuna COVID-19. Tórax, 77(1), 9-10. https://pubmed.ncbi.nlm.nih.gov/34236711/ | Habib, M. B., Hamamyh, T., Elyas, A., Altermanini, M., & Elhassan, M. (2021). Miocarditis aguda después de la administración de la vacuna BNT162B2. Idrases, 25, E01197. https://www.sciencedirect.com/science/article/pii/S2352906721001573 | DeDent, A. M., & Farrand, E. (2022). Vaccine-induced interstitial lung disease: a rare reaction to COVID-19 vaccination. Thorax, 77(1), 9-10. https://pubmed.ncbi.nlm.nih.gov/34510014/. | Hakroush, S., & Tampe, B. (2021). Case report: ANCA-associated vasculitis presenting with rhabdomyolysis and pauci-immune crescentic glomerulonephritis after Pfizer-BioNTech COVID-19 mRNA vaccination. Frontiers in Immunology, 12. https://pubmed.ncbi.nlm.nih.gov/34659268/ | Anupama, Y. J., Patel, R. G., & Vankalakunti, M. (2021). Nephrotic syndrome following ChAdOx1 nCoV-19 vaccine against SARScoV-2. Kidney International Reports, 6(8), 2248. | https://pubmed.ncbi.nlm.nih.gov/34250318/. | Anupama, Y. J., Patel, R. G., & Vankalakunti, M. (2021). Nephrotic syndrome following ChAdOx1 nCoV-19 vaccine against SARScoV-2. Kidney International Reports, 6(8), 2248. https://pubmed.ncbi.nlm.nih.gov/34250318/. | John, N. A., John, J., Kamble, P., Singhal, A., Daulatabad, V., & Vamshidhar, I. S. (2021). COVID 19 vaccine in patients of hypercoagulable disorders: a clinical perspective. Hormone Molecular Biology and Clinical Investigation. https://pubmed.ncbi.nlm.nih.gov/34786893/ | ||||
344 | Supraclavicular lymphadenopathy after COVID-19 vaccination in Korea: serial follow-up by ultrasonography: | https://pubmed.ncbi.nlm.nih.gov/34116295/. | https://pubmed.ncbi.nlm.nih.gov/34236711/ | Coto‐Segura, P., Fernández‐Prada, M., Mir‐Bonafé, M., García‐García, B., González‐Iglesias, I., Alonso‐Penanes, P., ... & Martinón‐Torres, F. (2021). Vesiculobullous skin reactions induced by COVID‐19 mRNA vaccine: report of four cases and review of the literature. Clinical and experimental dermatology. | Coto‐Segura, P., Fernández‐Prada, M., Mir‐Bonafé, M., García‐García, B., González‐Iglesias, I., Alonso‐Penanes, P., ... & Martinón‐Torres, F. (2021). Reacciones cutáneas vesiculoampollosas inducidas por la vacuna de ARNm de COVID-19: informe de cuatro casos y revisión de la literatura. Dermatología clínica y experimental. https://pubmed.ncbi.nlm.nih.gov/34525282/ | Hafeez, M. U., IKRAM, M., SHAFIQ, Z., SARFAZ, A., SARFAZ, Z., JAISWAL, V., ... & CHÉRREZ-OJEDA, I. (2021). COVID-19 Trombosis asociada a la vacuna con síndrome de trombocitopenia (TTS): una revisión sistemática y un análisis post hoc. Trombosis clínica y aplicada / Hemostasia, 27, 10760296211048815. https://pubmed.ncbi.nlm.nih.gov/34751013/. | Coto‐Segura, P., Fernández‐Prada, M., Mir‐Bonafé, M., García‐García, B., González‐Iglesias, I., Alonso‐Penanes, P., ... & Martinón‐Torres, F. (2021). Vesiculobullous skin reactions induced by COVID‐19 mRNA vaccine: report of four cases and review of the literature. Clinical and experimental dermatology. https://pubmed.ncbi.nlm.nih.gov/34236711/ | Han, T., Ma, W., Zhang, Y., & Wang, C. (2021). Be Alert to the Risk of Adverse Cardiovascular Events after COVID-19 Vaccination. Exploratory Research and Hypothesis in Medicine, (000), 0-0. https://www.xiahepublishing.com/m/2472-0712/ERHM-2021-00033 | Turi, M. C., Spitaleri, F., Gori, A. M., Parruti, G., Rogolino, A. A., Albani, A., ... & Marcucci, R. (2021). A case of vaccine-induced immune thrombotic thrombocytopenia with massive artero-venous thrombosis. Blood Transfusion, 19(4), 343. | https://pubmed.ncbi.nlm.nih.gov/34059191/ | Turi, M. C., Spitaleri, F., Gori, A. M., Parruti, G., Rogolino, A. A., Albani, A., ... & Marcucci, R. (2021). A case of vaccine-induced immune thrombotic thrombocytopenia with massive artero-venous thrombosis. Blood Transfusion, 19(4), 343. https://pubmed.ncbi.nlm.nih.gov/34059191/ | Jones, M., Boisvert, A., Landry, J., & Petrasek, P. F. (2021). Limb ischemia and pulmonary artery thrombosis after the ChAdOx1 nCoV-19 (Oxford–AstraZeneca) vaccine: a case of vaccine-induced immune thrombotic thrombocytopenia. CMAJ, 193(24), E906-E910. https://pubmed.ncbi.nlm.nih.gov/33990339/. | ||||
345 | COVID-19 vaccine, immune thrombotic thrombocytopenia, jaundice, hyperviscosity: concern in cases with underlying hepatic problems: | https://pubmed.ncbi.nlm.nih.gov/34509271/. | https://pubmed.ncbi.nlm.nih.gov/34525282/ | Salih, F., Schönborn, L., Kohler, S., Franke, C., Möckel, M., Dörner, T., ... & Endres, M. (2021). Vaccine-induced thrombocytopenia with severe headache. New England Journal of Medicine, 385(22), 2103-2105. | Salih, F., Schönborn, L., Kohler, S., Franke, C., Möckel, M., Dörner, T., ... y Endres, M. (2021). Trombocitopenia inducida por vacuna con dolor de cabeza intenso. Revista de Medicina de Nueva Inglaterra, 385(22), 2103-2105. https://pubmed.ncbi.nlm.nih.gov/34515024/ | Haimei, M. A. (2021). Preocupación por los efectos adversos de la trombocitopenia y la trombosis después de la vacunación con COVID-19 de vector de adenovirus. Trombosis clínica y aplicada / Hemostasia, 27, 10760296211040110. https://pubmed.ncbi.nlm.nih.gov/34646685/ | Salih, F., Schönborn, L., Kohler, S., Franke, C., Möckel, M., Dörner, T., ... & Endres, M. (2021). Vaccine-induced thrombocytopenia with severe headache. New England Journal of Medicine, 385(22), 2103-2105. https://pubmed.ncbi.nlm.nih.gov/34525282/ | Hanneman, K., Iwanochko, R. M., & Thavendiranathan, P. (2021). Evolution of lymphadenopathy at PET/MRI after COVID-19 vaccination. Radiology, 299(3), E282-E282. https://pubmed.ncbi.nlm.nih.gov/33625301/. | Underdown, M. J., & Nuss, R. (2021). Thrombocytopenia in a teen with sickle cell disease following COVID‐19 vaccination. Pediatric Blood & Cancer. | https://pubmed.ncbi.nlm.nih.gov/34331506/ | Underdown, M. J., & Nuss, R. (2021). Thrombocytopenia in a teen with sickle cell disease following COVID‐19 vaccination. Pediatric Blood & Cancer. https://pubmed.ncbi.nlm.nih.gov/34331506/ | Joob, B., & Wiwanitkit, V. (2021). Acute myocarditis after coronavirus disease 2019 vaccination. Anatolian Journal of Cardiology, 25(11), 841. https://pubmed.ncbi.nlm.nih.gov/34734821/ | ||||
346 | Report of the International Cerebral Venous Thrombosis Consortium on cerebral venous thrombosis after SARS-CoV-2 vaccination: | https://pubmed.ncbi.nlm.nih.gov/34462996/ | https://pubmed.ncbi.nlm.nih.gov/34515024/ | Vollmann, D., Eiffert, H., & Schuster, A. (2021). Acute perimyocarditis following first dose of mRNA vaccine against COVID-19. Deutsches Ärzteblatt International, 118(31-32), 546. | Vollmann, D., Eiffert, H. y Schuster, A. (2021). Perimiocarditis aguda tras la primera dosis de la vacuna de ARNm contra COVID-19. Deutsches Ärzteblatt International, 118(31-32), 546. https://pubmed.ncbi.nlm.nih.gov/34435250/. | Hajjo, R., Sabbah, D. A., Bardaweel, S. K., & Tropsha, A. (2021). Derramando la luz sobre la miocarditis posterior a la vacuna y la pericarditis en COVID-19 y los receptores de vacunas no covid-19. Vacunas, 9 (10), 1186. https://journals.lww.com/pec-online/Abstract/2021/11000/Myocarditis_Following_mRNA_COVID_19_Vaccine.9.aspx | Vollmann, D., Eiffert, H., & Schuster, A. (2021). Acute perimyocarditis following first dose of mRNA vaccine against COVID-19. Deutsches Ärzteblatt International, 118(31-32), 546. https://pubmed.ncbi.nlm.nih.gov/34515024/ | Hasegawa, T., & Yazaki, Y. (2021). Unusual Site of Deep Vein Thrombosis After mRNA Coronavirus Disease-2019 (COVID-19) Vaccination. Circulation Journal, CJ-21. https://pubmed.ncbi.nlm.nih.gov/34840204/ | Høeg, T. B. (2021). SARS-CoV-2 mRNA vaccination-associated myocarditis in children ages 12–17: a stratified national database analysis. medRxiv [Onine]. Preprint, 8. | https://www.medrxiv.org/content/10.1101/2021.08.30.21262866v1 | Høeg, T. B. (2021). SARS-CoV-2 mRNA vaccination-associated myocarditis in children ages 12–17: a stratified national database analysis. medRxiv [Onine]. Preprint, 8. https://www.medrxiv.org/content/10.1101/2021.08.30.21262866v1 | Joob, B., & Wiwanitkit, V. (2021). Change of blood viscosity after COVID-19 vaccination: estimation for persons with underlying metabolic syndrome. International Journal of Physiology, Pathophysiology and Pharmacology, 13(5), 148. https://pubmed.ncbi.nlm.nih.gov/34868465/ | ||||
347 | Immune thrombocytopenia after vaccination during the COVID-19 pandemic: | https://pubmed.ncbi.nlm.nih.gov/34435486/ | https://pubmed.ncbi.nlm.nih.gov/34435250/. | Faissner, S., Richter, D., Ceylan, U., Schneider-Gold, C., & Gold, R. (2021). COVID-19 mRNA vaccine induced rhabdomyolysis and fasciitis. Journal of Neurology, 1-2. | Faissner, S., Richter, D., Ceylan, U., Schneider-Gold, C. y Gold, R. (2021). La vacuna de ARNm COVID-19 indujo rabdomiólisis y fascitis. Revista de Neurología, 1-2. https://pubmed.ncbi.nlm.nih.gov/34363637/ | Hakroush, S., & Tampe, B. (2021). Informe de caso: vasculitis asociada a ANCA que presenta con rabdomiolisis y glomerulonefritis crientica pauci-inmune después de Pfizer-BionTech COVID-19 Vacunación de ARNm. Fronteras en inmunología, 12. https://pubmed.ncbi.nlm.nih.gov/34848431/ | Faissner, S., Richter, D., Ceylan, U., Schneider-Gold, C., & Gold, R. (2021). COVID-19 mRNA vaccine induced rhabdomyolysis and fasciitis. Journal of Neurology, 1-2. https://pubmed.ncbi.nlm.nih.gov/34435250/. | Hashimoto, T., Ozaki, A., Bhandari, D., Sawano, T., Sah, R., & Tanimoto, T. (2021). High anaphylaxis rates following vaccination with the Pfizer BNT162b2 mRNA vaccine against COVID-19 in Japanese healthcare workers: a secondary analysis of initial post-approval safety data. Journal of Travel Medicine, 28(7), taab090. https://pubmed.ncbi.nlm.nih.gov/34128049/ | Kafil, T., Lamacie, M. M., Chenier, S., Taggart, H., Ghosh, N., Dick, A., ... & Crean, A. M. (2021). mRNA COVID-19 Vaccination and Development of CMR-confirmed Myopericarditis. medRxiv. | https://www.medrxiv.org/content/10.1101/2021.09.13.21262182v1.full?s=09. | Kafil, T., Lamacie, M. M., Chenier, S., Taggart, H., Ghosh, N., Dick, A., ... & Crean, A. M. (2021). mRNA COVID-19 Vaccination and Development of CMR-confirmed Myopericarditis. medRxiv. https://www.medrxiv.org/content/10.1101/2021.09.13.21262182v1.full?s=09. | Julian, J. A., Mathern, D. R., & Fernando, D. (2021). Idiopathic thrombocytopenic purpura and the moderna Covid-19 vaccine. Annals of emergency medicine, 77(6), 654-656. https://www.annemergmed.com/article/S0196-0644(21)00122-0/fulltext. | ||||
348 | COVID-19: lessons from the Norwegian tragedy should be taken into account in planning for vaccine launch in less developed/developing countries: | https://pubmed.ncbi.nlm.nih.gov/34435142/ | https://pubmed.ncbi.nlm.nih.gov/34363637/ | Annabi, E., Dupin, N., Sohier, P., Garel, B., Franck, N., Aractingi, S., ... & Oulès, B. (2021). Rare cutaneous adverse effects of COVID‐19 vaccines: a case series and review of the literature. Journal of the European Academy of Dermatology and Venereology. | Annabi, E., Dupin, N., Sohier, P., Garel, B., Franck, N., Aractingi, S., ... y Oulès, B. (2021). Efectos adversos cutáneos raros de las vacunas COVID-19: una serie de casos y revisión de la literatura. Revista de la Academia Europea de Dermatología y Venereología. https://www.sciencedirect.com/science/article/pii/S2214250921002018 | Han, T., MA, W., Zhang, Y., y Wang, C. (2021). Estar alerta al riesgo de eventos cardiovasculares adversos después de la vacunación COVID-19. Investigación exploratoria e hipótesis en medicina, (000), 0-0. https://www.ahajournals.org/doi/10.1161/CIRCIMAGING.121.013236 | Annabi, E., Dupin, N., Sohier, P., Garel, B., Franck, N., Aractingi, S., ... & Oulès, B. (2021). Rare cutaneous adverse effects of COVID‐19 vaccines: a case series and review of the literature. Journal of the European Academy of Dermatology and Venereology. https://pubmed.ncbi.nlm.nih.gov/34363637/ | Hasnie, A. A., Hasnie, U. A., Patel, N., Aziz, M. U., Xie, M., Lloyd, S. G., & Prabhu, S. D. (2021). Perimyocarditis following first dose of the mRNA-1273 SARS-CoV-2 (Moderna) vaccine in a healthy young male: a case report. BMC Cardiovascular Disorders, 21(1), 1-6. https://www.ncbi.nlm.nih.gov/pubmed/34348657 | Gadi, S. R., Brunker, P. A., Al‐Samkari, H., Sykes, D. B., Saff, R. R., Lo, J., ... & Leaf, R. K. (2021). Severe autoimmune hemolytic anemia following receipt of SARS‐CoV‐2 mRNA vaccine. Transfusion, 61(11), 3267-3271. | https://onlinelibrary.wiley.com/doi/10.1111/trf.16672 | Gadi, S. R., Brunker, P. A., Al‐Samkari, H., Sykes, D. B., Saff, R. R., Lo, J., ... & Leaf, R. K. (2021). Severe autoimmune hemolytic anemia following receipt of SARS‐CoV‐2 mRNA vaccine. Transfusion, 61(11), 3267-3271. https://onlinelibrary.wiley.com/doi/10.1111/trf.16672 | Kadwalwala, M., Chadha, B., Ortoleva, J., & Joyce, M. (2021). Multimodality imaging and histopathology in a young man presenting with fulminant lymphocytic myocarditis and cardiogenic shock after mRNA-1273 vaccination. BMJ Case Reports CP, 14(11), e246059. https://pubmed.ncbi.nlm.nih.gov/34848416/ | ||||
349 | Rituximab-induced acute lympholysis and pancytopenia following vaccination with COVID-19: | https://pubmed.ncbi.nlm.nih.gov/34429981/ | https://www.sciencedirect.com/science/article/pii/S2214250921002018 | Akiyama, H., Kakiuchi, S., Rikitake, J., Matsuba, H., Sekinada, D., Kozuki, Y., & Iwata, N. (2021). Immune thrombocytopenia associated with Pfizer-BioNTech’s BNT162b2 mRNA COVID-19 vaccine. IDCases, 25, e01245. | Akiyama, H., Kakiuchi, S., Rikitake, J., Matsuba, H., Sekinada, D., Kozuki, Y. e Iwata, N. (2021). Trombocitopenia inmune asociada con la vacuna COVID-19 de ARNm BNT162b2 de Pfizer-BioNTech. IDCasos, 25, e01245. https://casereports.bmj.com/content/14/5/e242220.abstract. | Hanneman, K., Iwanochko, R. M., & Thavendiranathan, P. (2021). Evolución de la linfadenopatía en PET / MRI después de la vacunación COVID-19. Radiología, 299 (3), E282-E282. https://pubmed.ncbi.nlm.nih.gov/34332438/. | Akiyama, H., Kakiuchi, S., Rikitake, J., Matsuba, H., Sekinada, D., Kozuki, Y., & Iwata, N. (2021). Immune thrombocytopenia associated with Pfizer-BioNTech’s BNT162b2 mRNA COVID-19 vaccine. IDCases, 25, e01245. https://www.sciencedirect.com/science/article/pii/S2214250921002018 | Hause, A. M., Gee, J., Baggs, J., Abara, W. E., Marquez, P., Thompson, D., ... & Shay, D. K. (2021). COVID-19 vaccine safety in adolescents aged 12–17 years—United States, December 14, 2020–July 16, 2021. Morbidity and Mortality Weekly Report, 70(31), 1053. https://www.ncbi.nlm.nih.gov/pubmed/34351881 | Li, C., Chen, Y., Zhao, Y., Christopher Lung, D., Ye, Z., Song, W., ... & Yuen, K. Y. (2021). Corrigendum to: Intravenous Injection of Coronavirus Disease 2019 (COVID-19) mRNA Vaccine Can Induce Acute Myopericarditis in Mouse Model. Clinical Infectious Diseases, 73(12), 2372-2373. | https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciab707/6353927?s=09&login=false | Li, C., Chen, Y., Zhao, Y., Christopher Lung, D., Ye, Z., Song, W., ... & Yuen, K. Y. (2021). Corrigendum to: Intravenous Injection of Coronavirus Disease 2019 (COVID-19) mRNA Vaccine Can Induce Acute Myopericarditis in Mouse Model. Clinical Infectious Diseases, 73(12), 2372-2373. https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciab707/6353927?s=09&login=false | Kafil, T., Lamacie, M. M., Chenier, S., Taggart, H., Ghosh, N., Dick, A., ... & Crean, A. M. (2021). mRNA COVID-19 Vaccination and Development of CMR-confirmed Myopericarditis. medRxiv. https://www.medrxiv.org/content/10.1101/2021.09.13.21262182v1.full?s=09. | ||||
350 | Exacerbation of plaque psoriasis after COVID-19 inactivated mRNA and BNT162b2 vaccines: report of two cases: | https://pubmed.ncbi.nlm.nih.gov/34427024/ | https://casereports.bmj.com/content/14/5/e242220.abstract. | Fueyo-Rodriguez, O., Valente-Acosta, B., Jimenez-Soto, R., Neme-Yunes, Y., Inclán-Alarcón, S. I., Trejo-Gonzalez, R., & García-Salcido, M. Á. (2021). Secondary immune thrombocytopenia supposedly attributable to COVID-19 vaccination. BMJ Case Reports CP, 14(5), e242220. | Fueyo-Rodríguez, O., Valente-Acosta, B., Jiménez-Soto, R., Neme-Yunes, Y., Inclán-Alarcón, S. I., Trejo-González, R., & García-Salcido, M. Á. (2021). Trombocitopenia inmunitaria secundaria supuestamente atribuible a la vacunación contra la COVID-19. Informes de casos de BMJ CP, 14(5), e242220. https://pubmed.ncbi.nlm.nih.gov/34155844/ | Hasegawa, T., & Yazaki, Y. (2021). Sitio inusual de la trombosis venosa profunda después de la vacunación contra la enfermedad de MRNA Coronavirus (COVID-19). Diario de circulación, CJ-21. https://pubmed.ncbi.nlm.nih.gov/34750810/ | Fueyo-Rodriguez, O., Valente-Acosta, B., Jimenez-Soto, R., Neme-Yunes, Y., Inclán-Alarcón, S. I., Trejo-Gonzalez, R., & García-Salcido, M. Á. (2021). Secondary immune thrombocytopenia supposedly attributable to COVID-19 vaccination. BMJ Case Reports CP, 14(5), e242220. https://casereports.bmj.com/content/14/5/e242220.abstract. | Helmchen, C., Buttler, G. M., Markewitz, R., Hummel, K., Wiendl, H., & Boppel, T. (2022). Acute bilateral optic/chiasm neuritis with longitudinal extensive transverse myelitis in longstanding stable multiple sclerosis following vector-based vaccination against the SARS-CoV-2. Journal of Neurology, 269(1), 49-54. https://pubmed.ncbi.nlm.nih.gov/34131771/ | Rose, J., & McCullough, P. A. (2021). A report on myocarditis adverse events in the US vaccine adverse events reporting system (VAERS) in association with COVID-19 injectable biological products. Current problems in cardiology. | https://pubmed.ncbi.nlm.nih.gov/34601006/ | Rose, J., & McCullough, P. A. (2021). A report on myocarditis adverse events in the US vaccine adverse events reporting system (VAERS) in association with COVID-19 injectable biological products. Current problems in cardiology. https://pubmed.ncbi.nlm.nih.gov/34601006/ | Kanabar, G., & Wilkinson, P. (2021). Guillain‐Barré syndrome presenting with facial diplegia following COVID‐19 vaccination in two patients. BMJ Case Reports CP, 14(10), e244527. https://pubmed.ncbi.nlm.nih.gov/34649856/ | ||||
351 | Vaccine-induced interstitial lung disease: a rare reaction to COVID-19 vaccine: | https://pubmed.ncbi.nlm.nih.gov/34510014/. | https://pubmed.ncbi.nlm.nih.gov/34155844/ | Ganzel, C., & Ben-Chetrit, E. (2021). Immune Thrombocytopenia Following the Pfizer-BioNTech BNT162b2 mRNA COVID-19 Vaccine. The Israel Medical Association Journal: IMAJ, 23(6), 341-341. | Ganzel, C. y Ben-Chetrit, E. (2021). Trombocitopenia inmune después de la vacuna COVID-19 de ARNm BNT162b2 de Pfizer-BioNTech. Revista de la Asociación Médica de Israel: IMAJ, 23(6), 341-341. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8176657/. | Hashimoto, T., Ozaki, A., Bhandari, D., Sawano, T., SAH, R., & Tanimoto, T. (2021). Las altas tasas de anafilaxis después de la vacunación con la vacuna contra el ARNm de PFIZE BNT162B2 contra COVID-19 en los trabajadores de la salud japonesa: un análisis secundario de los datos iniciales de seguridad posteriores a la aprobación. Diario de Medicina de Viajes, 28 (7), TAAB090. https://pubmed.ncbi.nlm.nih.gov/34474708/ | Ganzel, C., & Ben-Chetrit, E. (2021). Immune Thrombocytopenia Following the Pfizer-BioNTech BNT162b2 mRNA COVID-19 Vaccine. The Israel Medical Association Journal: IMAJ, 23(6), 341-341. https://pubmed.ncbi.nlm.nih.gov/34155844/ | Helms, J. M., Ansteatt, K. T., Roberts, J. C., Kamatam, S., Foong, K. S., Labayog, J. M. S., & Tarantino, M. D. (2021). Severe, refractory immune thrombocytopenia occurring after SARS-CoV-2 vaccine. Journal of blood medicine, 12, 221. https://pubmed.ncbi.nlm.nih.gov/33854395/ | Barda, N., Dagan, N., Ben-Shlomo, Y., Kepten, E., Waxman, J., Ohana, R., ... & Balicer, R. D. (2021). Safety of the BNT162b2 mRNA Covid-19 vaccine in a nationwide setting. New England Journal of Medicine. | https://www.nejm.org/doi/full/10.1056/NEJMoa2110475 | Barda, N., Dagan, N., Ben-Shlomo, Y., Kepten, E., Waxman, J., Ohana, R., ... & Balicer, R. D. (2021). Safety of the BNT162b2 mRNA Covid-19 vaccine in a nationwide setting. New England Journal of Medicine. https://www.nejm.org/doi/full/10.1056/NEJMoa2110475 | Kaneta, K., Yokoi, K., Jojima, K., Kotooka, N., & Node, K. (2021). Young Male With Myocarditis Following mRNA-1273 Vaccination Against Coronavirus Disease-2019 (COVID-19). Circulation Journal, CJ-21. https://pubmed.ncbi.nlm.nih.gov/34744118/ | ||||
352 | Vesiculobullous cutaneous reactions induced by COVID-19 mRNA vaccine: report of four cases and review of the literature: | https://pubmed.ncbi.nlm.nih.gov/34236711/ | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8176657/. | Idogun, P. O., Ward, M. C., Teklie, Y., Wiese-Rometsch, W., & Baker, J. (2021). Newly diagnosed idiopathic thrombocytopenia post COVID-19 vaccine administration. Cureus, 13(5). | Idogun, PO, Ward, M. C., Teklie, Y., Wiese-Rometsch, W. y Baker, J. (2021). Trombocitopenia idiopática recién diagnosticada después de la administración de la vacuna COVID-19. Cureus, 13(5). https://www.annemergmed.com/article/S0196-0644(21)00122-0/fulltext. | Hasnie, A. A., Hasnie, U. A., Patel, N., Aziz, M. U., Xie, M., Lloyd, S. G. & Prabhu, S. D. (2021). La perimyocarditis después de la primera dosis de la vacuna contra el MRNA-1273 SARS-COV-2 (MODERNA) en un hombre joven sano: un informe de caso. Trastornos cardiovasculares BMC, 21 (1), 1-6. https://www.ncbi.nlm.nih.gov/pubmed/34351881 | Idogun, P. O., Ward, M. C., Teklie, Y., Wiese-Rometsch, W., & Baker, J. (2021). Newly diagnosed idiopathic thrombocytopenia post COVID-19 vaccine administration. Cureus, 13(5). https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8176657/. | Helms, J. M., Ansteatt, K. T., Roberts, J. C., Kamatam, S., Foong, K. S., Labayog, J. M. S., & Tarantino, M. D. (2021). Severe, refractory immune thrombocytopenia occurring after SARS-CoV-2 vaccine. Journal of blood medicine, 12, 221. https://www.ncbi.nlm.nih.gov/pubmed/33854395 | Pan, L., Zhang, Y., Cui, Y., & Wu, X. (2021). Bilateral uveitis after inoculation with COVID-19 vaccine: A case report. International Journal of Infectious Diseases, 113, 116-118. | https://www.sciencedirect.com/science/article/pii/S1201971221007797 | Pan, L., Zhang, Y., Cui, Y., & Wu, X. (2021). Bilateral uveitis after inoculation with COVID-19 vaccine: A case report. International Journal of Infectious Diseases, 113, 116-118. https://www.sciencedirect.com/science/article/pii/S1201971221007797 | Kar, B. R., Singh, B. S., Mohapatra, L., & Agrawal, I. (2021). Cutaneous small‐vessel vasculitis following COVID‐19 vaccine. Journal of Cosmetic Dermatology, 20(11), 3382. https://pubmed.ncbi.nlm.nih.gov/34529877/. | ||||
353 | Vaccine-induced thrombocytopenia with severe headache: | https://pubmed.ncbi.nlm.nih.gov/34525282/ | https://www.annemergmed.com/article/S0196-0644(21)00122-0/fulltext. | Julian, J. A., Mathern, D. R., & Fernando, D. (2021). Idiopathic thrombocytopenic purpura and the moderna Covid-19 vaccine. Annals of emergency medicine, 77(6), 654-656. | Julián, J. A., Mathern, D. R. y Fernando, D. (2021). Púrpura trombocitopénica idiopática y la vacuna moderna Covid-19. Anales de medicina de emergencia, 77(6), 654-656. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8014568/. | Hause, A. M., Gee, J., Baggs, J., Abara, W. E., Márquez, P., Thompson, D., ... & Shay, D. K. (2021). COVID-19 Seguridad de la vacuna en adolescentes de 12 a 17 años, Estados Unidos, 14 de diciembre, 2020 al 16 de julio de 2021. Informe semanal de morbilidad y mortalidad, 70 (31), 1053. https://www.ncbi.nlm.nih.gov/pubmed/33854395 | Julian, J. A., Mathern, D. R., & Fernando, D. (2021). Idiopathic thrombocytopenic purpura and the moderna Covid-19 vaccine. Annals of emergency medicine, 77(6), 654-656. https://www.annemergmed.com/article/S0196-0644(21)00122-0/fulltext. | Hendren, N. S., Carter, S., & Grodin, J. L. (2021). Severe COVID-19 vaccine associated myocarditis: Zebra or unicorn?. International journal of cardiology, 343, 197-198. https://www.internationaljournalofcardiology.com/article/S0167-5273(21)01477-7/fulltext. | Tun, G. S. Z., Gleeson, D., Al-Joudeh, A., & Dube, A. (2022). Immune-mediated hepatitis with the Moderna vaccine, no longer a coincidence but confirmed. Journal of Hepatology, 76(3), 747-749. | https://www.sciencedirect.com/science/article/pii/S0168827821020936 | Tun, G. S. Z., Gleeson, D., Al-Joudeh, A., & Dube, A. (2022). Immune-mediated hepatitis with the Moderna vaccine, no longer a coincidence but confirmed. Journal of Hepatology, 76(3), 747-749. https://www.sciencedirect.com/science/article/pii/S0168827821020936 | Kaul, R., Sreenivasan, J., Goel, A., Malik, A., Bandyopadhyay, D., Jin, C., ... & Panza, J. A. (2021). Myocarditis following COVID-19 vaccination. International Journal of Cardiology. Heart & Vasculature. https://www.sciencedirect.com/science/article/pii/S2352906721001603 | ||||
354 | Acute perimyocarditis after the first dose of COVID-19 mRNA vaccine: | https://pubmed.ncbi.nlm.nih.gov/34515024/ | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8014568/. | Lee, E. J., Cines, D. B., Gernsheimer, T., Kessler, C., Michel, M., Tarantino, M. D., ... & Bussel, J. B. (2021). Thrombocytopenia following pfizer and Moderna SARS‐CoV‐2 vaccination. American journal of hematology. | Lee, E. J., Cines, D. B., Gernsheimer, T., Kessler, C., Michel, M., Tarantino, M. D., ... & Bussel, J. B. (2021). Trombocitopenia después de la vacunación de Pfizer y Moderna contra el SARS-CoV-2. Revista americana de hematología. https://casereports.bmj.com/content/14/7/e242678. | Helmchen, C., Buttler, G. M., Markewitz, R., Hummel, K., Wiendl, H., & Boppel, T. (2022). Neuritis óptica / quiasma bilateral aguda con mielitis transversal extensa longitudinal en esclerosis múltiple estable de larga data después de la vacunación basada en vectores contra el SARS-COV-2. Diario de Neurología, 269 (1), 49-54. https://pubmed.ncbi.nlm.nih.gov/34635376/ | Lee, E. J., Cines, D. B., Gernsheimer, T., Kessler, C., Michel, M., Tarantino, M. D., ... & Bussel, J. B. (2021). Thrombocytopenia following pfizer and Moderna SARS‐CoV‐2 vaccination. American journal of hematology. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8014568/. | Hidayat, R., Diafiri, D., Zairinal, R. A., Arifin, G. R., Azzahroh, F., Widjaya, N., ... & Haris, S. (2021). Acute Ischaemic Stroke Incidence after Coronavirus Vaccine in Indonesia: Case Series. Current neurovascular research, 18(3), 360-363. https://pubmed.ncbi.nlm.nih.gov/34579636/ | Liu, J., Wang, J., Xu, J., Xia, H., Wang, Y., Zhang, C., ... & Liu, Z. (2021). Comprehensive investigations revealed consistent pathophysiological alterations after vaccination with COVID-19 vaccines. Cell discovery, 7(1), 1-15. | https://www.nature.com/articles/s41421-021-00329-3 | Liu, J., Wang, J., Xu, J., Xia, H., Wang, Y., Zhang, C., ... & Liu, Z. (2021). Comprehensive investigations revealed consistent pathophysiological alterations after vaccination with COVID-19 vaccines. Cell discovery, 7(1), 1-15. https://www.nature.com/articles/s41421-021-00329-3 | Kaulen, L. D., Doubrovinskaia, S., Mooshage, C., Jordan, B., Purrucker, J., Haubner, C., ... & Schönenberger, S. (2022). Neurological autoimmune diseases following vaccinations against SARS‐CoV‐2: a case series. European Journal of Neurology, 29(2), 555-563. https://pubmed.ncbi.nlm.nih.gov/34668274/. | ||||
355 | Rhabdomyolysis and fasciitis induced by COVID-19 mRNA vaccine: | https://pubmed.ncbi.nlm.nih.gov/34435250/. | https://casereports.bmj.com/content/14/7/e242678. | Hines, A., Shen, J. G., Olazagasti, C., & Shams, S. (2021). Immune thrombocytopenic purpura and acute liver injury after COVID-19 vaccine. BMJ Case Reports CP, 14(7), e242678. | Hines, A., Shen, JG, Olazagasti, C. y Shams, S. (2021). Púrpura trombocitopénica inmunitaria y lesión hepática aguda después de la vacuna COVID-19. BMJ Case Reports CP, 14(7), e242678. https://ashpublications.org/bloodadvances/article/5/13/2794/476324/Autoimmune-and-complement-mediated-hematologic | Helms, J. M., Ansteatt, K. T., Roberts, J. C., Kamatam, S., FOONG, K. S., Labayog, J. M. S., & Tarantino, M. D. (2021). Trombocitopenia inmune severa, refractaria que se produce después de la vacuna contra SARS-COV-2. Diario de la medicina de sangre, 12, 221. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7996471/ | Hines, A., Shen, J. G., Olazagasti, C., & Shams, S. (2021). Immune thrombocytopenic purpura and acute liver injury after COVID-19 vaccine. BMJ Case Reports CP, 14(7), e242678. https://casereports.bmj.com/content/14/7/e242678. | Hiller, N., Goldberg, S. N., Cohen-Cymberknoh, M., Vainstein, V., & Simanovsky, N. (2021). Lymphadenopathy associated with the COVID-19 vaccine. Cureus, 13(2). https://pubmed.ncbi.nlm.nih.gov/33786231/ | Finsterer, J. (2021). Lobar bleeding with ventricular rupture shortly after first dosage of an mRNA-based SARS-CoV-2 vaccine. Brain hemorrhages. | https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8553377/ | Finsterer, J. (2021). Lobar bleeding with ventricular rupture shortly after first dosage of an mRNA-based SARS-CoV-2 vaccine. Brain hemorrhages. https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8553377/ | Kawano, H., Hashimoto, Y., & Hirano, T. (2021). Cerebral vein/venous sinus thrombosis with thrombocytopenia syndrome after COVID-19 vaccination. Rinsho Shinkeigaku= Clinical Neurology. https://pubmed.ncbi.nlm.nih.gov/34373413/ | ||||
356 | Rare cutaneous adverse effects of COVID-19 vaccines: a case series and review of the literature: | https://pubmed.ncbi.nlm.nih.gov/34363637/ | https://ashpublications.org/bloodadvances/article/5/13/2794/476324/Autoimmune-and-complement-mediated-hematologic | Portuguese, A. J., Sunga, C., Kruse-Jarres, R., Gernsheimer, T., & Abkowitz, J. (2021). Autoimmune-and complement-mediated hematologic condition recrudescence following SARS-CoV-2 vaccination. Blood Advances, 5(13), 2794-2798. | Portuguese, AJ, Sunga, C., Kruse-Jarres, R., Gernsheimer, T. y Abkowitz, J. (2021). Recrudecimiento de la condición hematológica autoinmune y mediada por el complemento después de la vacunación contra el SARS-CoV-2. Avances de sangre, 5(13), 2794-2798. https://ejhp.bmj.com/content/early/2021/05/23/ejhpharm-2021-002794 | Helms, J. M., Ansteatt, K. T., Roberts, J. C., Kamatam, S., FOONG, K. S., Labayog, J. M. S., & Tarantino, M. D. (2021). Trombocitopenia inmune severa, refractaria que se produce después de la vacuna contra SARS-COV-2. Diario de la medicina de sangre, 12, 221. https://www.ncbi.nlm.nih.gov/pubmed/34446426 | Portuguese, A. J., Sunga, C., Kruse-Jarres, R., Gernsheimer, T., & Abkowitz, J. (2021). Autoimmune-and complement-mediated hematologic condition recrudescence following SARS-CoV-2 vaccination. Blood Advances, 5(13), 2794-2798. https://ashpublications.org/bloodadvances/article/5/13/2794/476324/Autoimmune-and-complement-mediated-hematologic | Hines, A. M., Murphy, N., Mullin, C., Barillas, J., & Barrientos, J. C. (2021). Henoch-Schönlein purpura presenting post COVID-19 vaccination. Vaccine. https://pubmed.ncbi.nlm.nih.gov/34247902/. | Gundry, S. R. (2021). Observational Findings of PULS Cardiac Test Findings for Inflammatory Markers in Patients Receiving mRNA Vaccines. Circulation, 144(Suppl_1), A10712-A10712. | https://www.ahajournals.org/doi/10.1161/circ.144.suppl_1.10712 | Gundry, S. R. (2021). Observational Findings of PULS Cardiac Test Findings for Inflammatory Markers in Patients Receiving mRNA Vaccines. Circulation, 144(Suppl_1), A10712-A10712. https://www.ahajournals.org/doi/10.1161/circ.144.suppl_1.10712 | Keir, G., Maria, N. I., & Kirsch, C. F. (2021). Unique imaging findings of neurologic phantosmia following Pfizer-BioNtech COVID-19 vaccination: a case report. Topics in Magnetic Resonance Imaging, 30(3), 133-137. https://pubmed.ncbi.nlm.nih.gov/34096896/ | ||||
357 | Immune thrombocytopenia associated with the Pfizer-BioNTech COVID-19 mRNA vaccine BNT162b2: | https://www.sciencedirect.com/science/article/pii/S2214250921002018 | https://ejhp.bmj.com/content/early/2021/05/23/ejhpharm-2021-002794 | Cebeci, F., & Kartal, İ. (2021). Petechial skin rash associated with CoronaVac vaccination: first cutaneous side effect report before phase 3 results. European Journal of Hospital Pharmacy. | Cebeci, F. y Kartal, İ. (2021). Erupción cutánea petequial asociada a la vacunación CoronaVac: primer informe de efectos secundarios cutáneos antes de los resultados de la fase 3. Revista europea de farmacia hospitalaria. https://ashpublications.org/blood/article/137/26/3670/475905/COVID-19-vaccines-induce-severe-hemolysis-in | Hendren, N. S., Carter, S., & Grodin, J. L. (2021). COVIDH SEVERA DE COVID-19 MIACARDIZIZA ASOCIADA: CEBRA O UNICORN. Diario Internacional de Cardiología, 343, 197-198. https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8522388/ | Cebeci, F., & Kartal, İ. (2021). Petechial skin rash associated with CoronaVac vaccination: first cutaneous side effect report before phase 3 results. European Journal of Hospital Pharmacy. https://ejhp.bmj.com/content/early/2021/05/23/ejhpharm-2021-002794 | Hines, A., Shen, J. G., Olazagasti, C., & Shams, S. (2021). Immune thrombocytopenic purpura and acute liver injury after COVID-19 vaccine. BMJ Case Reports CP, 14(7), e242678. https://casereports.bmj.com/content/14/7/e242678. | Baker, A. T., Boyd, R. J., Sarkar, D., Teijeira-Crespo, A., Chan, C. K., Bates, E., ... & Borad, M. J. (2021). ChAdOx1 interacts with CAR and PF4 with implications for thrombosis with thrombocytopenia syndrome. Science advances, 7(49), eabl8213. | https://www.science.org/doi/10.1126/sciadv.abl8213 | Baker, A. T., Boyd, R. J., Sarkar, D., Teijeira-Crespo, A., Chan, C. K., Bates, E., ... & Borad, M. J. (2021). ChAdOx1 interacts with CAR and PF4 with implications for thrombosis with thrombocytopenia syndrome. Science advances, 7(49), eabl8213. https://www.science.org/doi/10.1126/sciadv.abl8213 | Kelso, J. M. (2021). IgE‐mediated allergy to polyethylene glycol (PEG) as a cause of anaphylaxis to mRNA COVID‐19 vaccines. Clinical and Experimental Allergy. https://pubmed.ncbi.nlm.nih.gov/34318537/ | ||||
358 | Secondary immune thrombocytopenia putatively attributable to COVID-19 vaccination: | https://casereports.bmj.com/content/14/5/e242220.abstract. | https://ashpublications.org/blood/article/137/26/3670/475905/COVID-19-vaccines-induce-severe-hemolysis-in | Gerber, G. F., Yuan, X., Yu, J., Cher, B. A., Braunstein, E. M., Chaturvedi, S., & Brodsky, R. A. (2021). COVID-19 vaccines induce severe hemolysis in paroxysmal nocturnal hemoglobinuria. Blood, The Journal of the American Society of Hematology, 137(26), 3670-3673. | Gerber, G. F., Yuan, X., Yu, J., Cher, B. A., Braunstein, E. M., Chaturvedi, S. y Brodsky, R. A. (2021). Las vacunas COVID-19 inducen hemólisis grave en la hemoglobinuria paroxística nocturna. Sangre, Revista de la Sociedad Estadounidense de Hematología, 137 (26), 3670-3673. https://pubmed.ncbi.nlm.nih.gov/34288044/. | Hidayat, R., DIAFIRI, D., Zairinal, R. A., Arifin, G. R., Azzahroh, F., Widjaya, N., ... & Haris, S. (2021). Incidencia de accidente cerebrovascular isquémica aguda después de la vacuna contra la coronavirus en Indonesia: serie de casos. Investigación neurovascular actual, 18 (3), 360-363. https://pubmed.ncbi.nlm.nih.gov/34614491/ | Gerber, G. F., Yuan, X., Yu, J., Cher, B. A., Braunstein, E. M., Chaturvedi, S., & Brodsky, R. A. (2021). COVID-19 vaccines induce severe hemolysis in paroxysmal nocturnal hemoglobinuria. Blood, The Journal of the American Society of Hematology, 137(26), 3670-3673. https://ashpublications.org/blood/article/137/26/3670/475905/COVID-19-vaccines-induce-severe-hemolysis-in | Hinton, J., e Gala, A. B., & Corbett, S. (2021, December). mRNA COVID-19 Vaccine–Related Anaphylactoid Reaction and Coronary Thrombosis. In Mayo Clinic Proceedings (Vol. 96, No. 12, pp. 3182-3183). Elsevier. https://pubmed.ncbi.nlm.nih.gov/34863404/. | Rodriguez, E. V., Bouazza, F. Z., Dauby, N., Mullier, F., d’Otreppe, S., Jissendi Tchofo, P., ... & Cliquennois, M. (2021). Fatal vaccine-induced immune thrombotic thrombocytopenia (VITT) post Ad26. COV2. S: first documented case outside US. Infection, 1-6. | https://pubmed.ncbi.nlm.nih.gov/34626338/ | Rodriguez, E. V., Bouazza, F. Z., Dauby, N., Mullier, F., d’Otreppe, S., Jissendi Tchofo, P., ... & Cliquennois, M. (2021). Fatal vaccine-induced immune thrombotic thrombocytopenia (VITT) post Ad26. COV2. S: first documented case outside US. Infection, 1-6. https://pubmed.ncbi.nlm.nih.gov/34626338/ | Kemper, M., Lenz, G., & Mesters, R. M. (2021). Successful Treatment of Vaccine-Induced Immune Thrombotic Thrombocytopenia in a 26-Year-Old Female Patient. Acta Haematologica, 1-4. https://pubmed.ncbi.nlm.nih.gov/34614491/ | ||||
359 | Immune thrombocytopenia following Pfizer-BioNTech BNT162b2 mRNA COVID-19 vaccine: | https://pubmed.ncbi.nlm.nih.gov/34155844/ | https://pubmed.ncbi.nlm.nih.gov/34288044/. | Schulz, J. B., Berlit, P., Diener, H. C., Gerloff, C., Greinacher, A., Klein, C., ... & Zimmermann, J. (2021). COVID‐19 vaccine‐associated cerebral venous thrombosis in Germany. Annals of neurology, 90(4), 627-639. | Schulz, J. B., Berlit, P., Diener, H. C., Gerloff, C., Greinacher, A., Klein, C., ... y Zimmermann, J. (2021). Trombosis venosa cerebral asociada a la vacuna COVID-19 en Alemania. Anales de neurología, 90(4), 627-639. https://pubmed.ncbi.nlm.nih.gov/34327553/. | Hiller, N., Goldberg, S. N., Cohen-Cymberknok, M., Vainstein, V., & Simanovsky, N. (2021). Linfadenopatía asociada a la vacuna COVID-19. CUREUS, 13 (2). https://pubmed.ncbi.nlm.nih.gov/33625301/. | Schulz, J. B., Berlit, P., Diener, H. C., Gerloff, C., Greinacher, A., Klein, C., ... & Zimmermann, J. (2021). COVID‐19 vaccine‐associated cerebral venous thrombosis in Germany. Annals of neurology, 90(4), 627-639. https://pubmed.ncbi.nlm.nih.gov/34288044/. | Hippisley-Cox, J., Patone, M., Mei, X. W., Saatci, D., Dixon, S., Khunti, K., ... & Coupland, C. A. (2021). Risk of thrombocytopenia and thromboembolism after covid-19 vaccination and SARS-CoV-2 positive testing: self-controlled case series study. bmj, 374. https://pubmed.ncbi.nlm.nih.gov/34446426/ | Weber, C., von Hundelshausen, P., & Siess, W. (2021). VITT after ChAdOx1 nCoV-19 Vaccination. The New England journal of medicine. | https://pubmed.ncbi.nlm.nih.gov/34731555/ | Weber, C., von Hundelshausen, P., & Siess, W. (2021). VITT after ChAdOx1 nCoV-19 Vaccination. The New England journal of medicine. https://pubmed.ncbi.nlm.nih.gov/34731555/ | Kenda, J., Lovrič, D., Škerget, M., & Milivojević, N. (2021). Treatment of ChAdOx1 nCoV-19 vaccine-induced immune thrombotic thrombocytopenia related acute ischemic stroke. Journal of Stroke and Cerebrovascular Diseases, 30(11), 106072. https://pubmed.ncbi.nlm.nih.gov/34461442/ | ||||
360 | Newly diagnosed idiopathic thrombocytopenia after COVID-19 vaccine administration: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8176657/. | https://pubmed.ncbi.nlm.nih.gov/34327553/. | Walter, U., Volmer, E., Wittstock, M., Storch, A., Weber, M. A., & Großmann, A. (2021). Cerebral venous sinus thrombosis after COVID-19 vaccination: Neurological and radiological management. Der Radiologe. | Walter, U., Volmer, E., Wittstock, M., Storch, A., Weber, MA y Großmann, A. (2021). Trombosis del seno venoso cerebral después de la vacunación COVID-19: manejo neurológico y radiológico. El radiólogo. https://pubmed.ncbi.nlm.nih.gov/33878469/. | Hines, A. M., Murphy, N., Mullin, C., Barillas, J. y Barrientos, J. C. (2021). Henoch-Schönlein Purpura presentando la vacunación posterior a COVID-19. Vacuna. https://pubmed.ncbi.nlm.nih.gov/34696186/. | Walter, U., Volmer, E., Wittstock, M., Storch, A., Weber, M. A., & Großmann, A. (2021). Cerebral venous sinus thrombosis after COVID-19 vaccination: Neurological and radiological management. Der Radiologe. https://pubmed.ncbi.nlm.nih.gov/34327553/. | Hippisley-Cox, J., Patone, M., Mei, X. W., Saatci, D., Dixon, S., Khunti, K., ... & Coupland, C. A. (2021). Risk of thrombocytopenia and thromboembolism after covid-19 vaccination and SARS-CoV-2 positive testing: self-controlled case series study. bmj, 374. https://www.ncbi.nlm.nih.gov/pubmed/34446426 | Kenda, J., Lovrič, D., Škerget, M., & Milivojević, N. (2021). Treatment of ChAdOx1 nCoV-19 vaccine-induced immune thrombotic thrombocytopenia related acute ischemic stroke. Journal of Stroke and Cerebrovascular Diseases, 30(11), 106072. | https://pubmed.ncbi.nlm.nih.gov/34461442/ | Kenda, J., Lovrič, D., Škerget, M., & Milivojević, N. (2021). Treatment of ChAdOx1 nCoV-19 vaccine-induced immune thrombotic thrombocytopenia related acute ischemic stroke. Journal of Stroke and Cerebrovascular Diseases, 30(11), 106072. https://pubmed.ncbi.nlm.nih.gov/34461442/ | Kerneis, M., Bihan, K., & Salem, J. E. (2021). COVID-19 vaccines and myocarditis. Arch Cardiovasc Dis, 114(6-7), 515-517. https://pubmed.ncbi.nlm.nih.gov/34246566/ | ||||
361 | Idiopathic thrombocytopenic purpura and the Modern Covid-19 vaccine: | https://www.annemergmed.com/article/S0196-0644(21)00122-0/fulltext. | https://pubmed.ncbi.nlm.nih.gov/33878469/. | Franchini, M., Testa, S., Pezzo, M., Glingani, C., Caruso, B., Terenziani, I., ... & Castelli, G. (2021). Cerebral venous thrombosis and thrombocytopenia post-COVID-19 vaccination. Thrombosis research, 202, 182-183. | Franchini, M., Testa, S., Pezzo, M., Glingani, C., Caruso, B., Terenziani, I., ... & Castelli, G. (2021). Trombosis venosa cerebral y trombocitopenia posvacunación COVID-19. Investigación de trombosis, 202, 182-183. https://pubmed.ncbi.nlm.nih.gov/33857630/. | Hines, A., Shen, J. G., Olazagasti, C., y Shams, S. (2021). Púrpura trombocitopénica inmune y lesión hepática aguda después de la vacuna COVID-19. BMJ Case Reports CP, 14 (7), E242678. https://ashpublications.org/bloodadvances/article/5/13/2794/476324/Autoimmune-and-complement-mediated-hematologic | Franchini, M., Testa, S., Pezzo, M., Glingani, C., Caruso, B., Terenziani, I., ... & Castelli, G. (2021). Cerebral venous thrombosis and thrombocytopenia post-COVID-19 vaccination. Thrombosis research, 202, 182-183. https://pubmed.ncbi.nlm.nih.gov/33878469/. | Ho, J. S., Sia, C. H., Ngiam, J. N., Loh, P. H., Chew, N. W., Kong, W. K., & Poh, K. K. (2021). A review of COVID-19 vaccination and the reported cardiac manifestations. Singapore medical journal. https://www.ncbi.nlm.nih.gov/pubmed/34808708 | Garg, R. K., & Paliwal, V. K. (2021). Spectrum of neurological complications following COVID-19 vaccination. Neurological Sciences, 1-38. | https://pubmed.ncbi.nlm.nih.gov/34719776/ | Garg, R. K., & Paliwal, V. K. (2021). Spectrum of neurological complications following COVID-19 vaccination. Neurological Sciences, 1-38. https://pubmed.ncbi.nlm.nih.gov/34719776/ | Keshavarz, P., Yazdanpanah, F., Rafiee, F., & Mizandari, M. (2021). Lymphadenopathy following COVID-19 vaccination: imaging findings review. Academic radiology, 28(8), 1058-1071. https://pubmed.ncbi.nlm.nih.gov/33985872/ | ||||
362 | Thrombocytopenia after Pfizer and Moderna SARS vaccination – CoV -2: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8014568/. | https://pubmed.ncbi.nlm.nih.gov/33857630/. | Mehta, P. R., Mangion, S. A., Benger, M., Stanton, B. R., Czuprynska, J., Arya, R., & Sztriha, L. K. (2021). Cerebral venous sinus thrombosis and thrombocytopenia after COVID-19 vaccination–A report of two UK cases. Brain, behavior, and immunity, 95, 514-517. | Mehta, P. R., Mangion, S. A., Benger, M., Stanton, B. R., Czuprynska, J., Arya, R. y Sztriha, L. K. (2021). Trombosis del seno venoso cerebral y trombocitopenia después de la vacunación COVID-19: informe de dos casos en el Reino Unido. Cerebro, comportamiento e inmunidad, 95, 514-517. https://pubmed.ncbi.nlm.nih.gov/34090750/. | Hinton, J., E Gala, A. B., & Corbett, S. (2021, diciembre). ARNm COVID-19 Reacción anafilactoide relacionada con la vacuna y la trombosis coronaria. En los procedimientos de la clínica Mayo (vol. 96, No. 12, pp. 3182-3183). Elsevier https://www.sciencedirect.com/science/article/pii/S235255682100093X | Mehta, P. R., Mangion, S. A., Benger, M., Stanton, B. R., Czuprynska, J., Arya, R., & Sztriha, L. K. (2021). Cerebral venous sinus thrombosis and thrombocytopenia after COVID-19 vaccination–A report of two UK cases. Brain, behavior, and immunity, 95, 514-517. https://pubmed.ncbi.nlm.nih.gov/33857630/. | Høeg, T. B. (2021). SARS-CoV-2 mRNA vaccination-associated myocarditis in children ages 12–17: a stratified national database analysis. medRxiv [Onine]. Preprint, 8. https://www.medrxiv.org/content/10.1101/2021.08.30.21262866v1 | Kawano, H., Hashimoto, Y., & Hirano, T. (2021). Cerebral vein/venous sinus thrombosis with thrombocytopenia syndrome after COVID-19 vaccination. Rinsho Shinkeigaku= Clinical Neurology. | https://pubmed.ncbi.nlm.nih.gov/34373413/ | Kawano, H., Hashimoto, Y., & Hirano, T. (2021). Cerebral vein/venous sinus thrombosis with thrombocytopenia syndrome after COVID-19 vaccination. Rinsho Shinkeigaku= Clinical Neurology. https://pubmed.ncbi.nlm.nih.gov/34373413/ | Khan, E., Shrestha, A. K., Colantonio, M. A., Liberio, R. N., & Sriwastava, S. (2021). Acute transverse myelitis following SARS-CoV-2 vaccination: a case report and review of literature. Journal of Neurology, 1-12. https://pubmed.ncbi.nlm.nih.gov/34482455/. | ||||
363 | Immune thrombocytopenic purpura and acute liver injury after COVID-19 vaccination: | https://casereports.bmj.com/content/14/7/e242678. | https://pubmed.ncbi.nlm.nih.gov/34090750/. | Ciccone, A. (2021). SARS-CoV-2 vaccine-induced cerebral venous thrombosis. European journal of internal medicine, 89, 19-21. | Ciccone, A. (2021). Trombosis venosa cerebral inducida por la vacuna SARS-CoV-2. Revista europea de medicina interna, 89, 19-21. https://pubmed.ncbi.nlm.nih.gov/34312301/. | Hippisley-Cox, J., Patone, M., Mei, X. W., Saatci, D., Dixon, S., Khunti, K., ... & Coupland, C. A. (2021). Riesgo de trombocitopenia y tromboembolismo después de la vacunación de COVID-19 y pruebas positivas SARS-COV-2: Estudio de series de casos autocontroladas. BMJ, 374. https://pubmed.ncbi.nlm.nih.gov/34365148/. | Ciccone, A. (2021). SARS-CoV-2 vaccine-induced cerebral venous thrombosis. European journal of internal medicine, 89, 19-21. https://pubmed.ncbi.nlm.nih.gov/34090750/. | Høeg, T. B. (2021). SARS-CoV-2 mRNA vaccination-associated myocarditis in children ages 12–17: a stratified national database analysis. medRxiv [Onine]. Preprint, 8. https://www.medrxiv.org/content/10.1101/2021.08.30.21262866v1. | Strobel, D., Haberkamp, S., & Zundler, S. (2021). Portal Vein Thrombosis due to Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT) after Covid Vaccination with ChAdOx1 nCoV-19. Ultraschall in der Medizin-European Journal of Ultrasound, 42(05), 551-552. | https://pubmed.ncbi.nlm.nih.gov/34598301/ | Strobel, D., Haberkamp, S., & Zundler, S. (2021). Portal Vein Thrombosis due to Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT) after Covid Vaccination with ChAdOx1 nCoV-19. Ultraschall in der Medizin-European Journal of Ultrasound, 42(05), 551-552. https://pubmed.ncbi.nlm.nih.gov/34598301/ | Khan, T. A., Sidhu, N., Khan, L., Sen, S., Hussain, N., Tandon, R., & Gupta, N. (2021). Bilateral immune-mediated keratolysis after immunization with SARS-CoV-2 recombinant viral vector vaccine. Cornea, 40(12), 1629-1632. https://pubmed.ncbi.nlm.nih.gov/34483273/. | ||||
364 | Collection of complement-mediated and autoimmune-mediated hematologic conditions after SARS-CoV-2 vaccination: | https://ashpublications.org/bloodadvances/article/5/13/2794/476324/Autoimmune-and-complement-mediated-hematologic | https://pubmed.ncbi.nlm.nih.gov/34312301/. | Walter, U., Fuchs, M., Grossmann, A., Walter, M., Thiele, T., Storch, A., & Wittstock, M. (2021). Adenovirus-vectored COVID-19 vaccine–induced immune thrombosis of carotid artery: a case report. Neurology, 97(15), 716-719. | Walter, U., Fuchs, M., Grossmann, A., Walter, M., Thiele, T., Storch, A. y Wittstock, M. (2021). Trombosis inmune de la arteria carótida inducida por la vacuna COVID-19 vectorizada por adenovirus: reporte de un caso. Neurología, 97(15), 716-719. https://pubmed.ncbi.nlm.nih.gov/34333995/ | Hippisley-Cox, J., Patone, M., Mei, X. W., Saatci, D., Dixon, S., Khunti, K., ... & Coupland, C. A. (2021). Riesgo de trombocitopenia y tromboembolismo después de la vacunación de COVID-19 y pruebas positivas SARS-COV-2: Estudio de series de casos autocontroladas. BMJ, 374. https://www.ncbi.nlm.nih.gov/pubmed/34808708 | Walter, U., Fuchs, M., Grossmann, A., Walter, M., Thiele, T., Storch, A., & Wittstock, M. (2021). Adenovirus-vectored COVID-19 vaccine–induced immune thrombosis of carotid artery: a case report. Neurology, 97(15), 716-719. https://pubmed.ncbi.nlm.nih.gov/34312301/. | Holm, S., Kared, H., Michelsen, A. E., Kong, X. Y., Dahl, T. B., Schultz, N. H., ... & Halvorsen, B. (2021). Immune complexes, innate immunity, and NETosis in ChAdOx1 vaccine-induced thrombocytopenia. European heart journal, 42(39), 4064-4072. https://pubmed.ncbi.nlm.nih.gov/34405870/. | Waraich, A., & Williams, G. (2021). Haematuria, a widespread petechial rash, and headaches following the Oxford AstraZeneca ChAdOx1 nCoV-19 Vaccination. BMJ Case Reports CP, 14(10), e245440. | https://pubmed.ncbi.nlm.nih.gov/34620638/ | Waraich, A., & Williams, G. (2021). Haematuria, a widespread petechial rash, and headaches following the Oxford AstraZeneca ChAdOx1 nCoV-19 Vaccination. BMJ Case Reports CP, 14(10), e245440. https://pubmed.ncbi.nlm.nih.gov/34620638/ | Kharkar, V., Vishwanath, T., Mahajan, S., Joshi, R., & Gole, P. (2021). Asymmetrical cutaneous vasculitis following COVID‐19 vaccination with unusual eosinophil preponderance. Clinical and Experimental Dermatology. https://pubmed.ncbi.nlm.nih.gov/34115904/. | ||||
365 | Petechial rash associated with CoronaVac vaccination: first report of cutaneous side effects before phase 3 results: | https://ejhp.bmj.com/content/early/2021/05/23/ejhpharm-2021-002794 | https://pubmed.ncbi.nlm.nih.gov/34333995/ | Yahyavi-Firouz-Abadi, N., & Naik, R. P. (2021). Cerebral venous sinus thrombosis associated with vaccine-induced thrombotic thrombocytopenia. The Neuroradiology Journal, 19714009211036687. | Yahyavi-Firouz-Abadi, N. y Naik, RP (2021). Trombosis del seno venoso cerebral asociada con trombocitopenia trombótica inducida por vacunas. La Revista de Neurorradiología, 19714009211036687. https://pubmed.ncbi.nlm.nih.gov/34455073/ | Ho, J. S., SIA, C. H., Ngiam, J. N., LOH, P. H., Masticar, N. W., Kong, W. K., & Poh, K. K. (2021). Una revisión de la vacunación COVID-19 y las manifestaciones cardíacas reportadas. Diario Médico de Singapore. https://www.ncbi.nlm.nih.gov/pubmed/34347278 | Yahyavi-Firouz-Abadi, N., & Naik, R. P. (2021). Cerebral venous sinus thrombosis associated with vaccine-induced thrombotic thrombocytopenia. The Neuroradiology Journal, 19714009211036687. https://pubmed.ncbi.nlm.nih.gov/34333995/ | Holmes, G. A., Desai, M., Limone, B., Love, J., Tawfik, M., Wong, L., & Furukawa, B. (2021). A case series of cutaneous COVID-19 vaccine reactions at Loma Linda University Department of Dermatology. JAAD Case Reports, 16, 53-57. https://pubmed.ncbi.nlm.nih.gov/34423106/ | Chiang, C. Y., Chen, C. Y., Yu, W. L., Kan, W. C., & Feng, Y. H. (2021). Myocardial Infarction and Azygos Vein Thrombosis After ChAdOx1 nCoV-19 Vaccination in a Hemodialysis Patient. Cureus, 13(9). | https://pubmed.ncbi.nlm.nih.gov/34650896/ | Chiang, C. Y., Chen, C. Y., Yu, W. L., Kan, W. C., & Feng, Y. H. (2021). Myocardial Infarction and Azygos Vein Thrombosis After ChAdOx1 nCoV-19 Vaccination in a Hemodialysis Patient. Cureus, 13(9). https://pubmed.ncbi.nlm.nih.gov/34650896/ | Khayat-Khoei, M., Bhattacharyya, S., Katz, J., Harrison, D., Tauhid, S., Bruso, P., ... & Bakshi, R. (2022). COVID-19 mRNA vaccination leading to CNS inflammation: a case series. Journal of neurology, 269(3), 1093-1106. https://link.springer.com/article/10.1007/s00415-021-10780-7 | ||||
366 | COVID-19 vaccines induce severe hemolysis in paroxysmal nocturnal hemoglobinuria: | https://ashpublications.org/blood/article/137/26/3670/475905/COVID-19-vaccines-induce-severe-hemolysis-in | https://pubmed.ncbi.nlm.nih.gov/34455073/ | Iba, T., & Levy, J. H. (2021). The roles of platelets in COVID-19-associated coagulopathy and vaccine-induced immune thrombotic thrombocytopenia. Trends in cardiovascular medicine. | Iba, T. y Levy, JH (2021). El papel de las plaquetas en la coagulopatía asociada a COVID-19 y la trombocitopenia trombótica inmunitaria inducida por vacunas. Tendencias en medicina cardiovascular. https://pubmed.ncbi.nlm.nih.gov/34111775/. | Høeg, T. B. (2021). MYOCARDITIS asociado con la vacunación contra la vacunación contra el ARNA de SARS-COV-2 en niños de 12 a 17 años: un análisis nacional de base de datos nacional estratificado. medrxiv [Onine]. Preprint, 8. https://www.medrxiv.org/content/10.1101/2021.09.13.21262182v1.full?s=09. | Iba, T., & Levy, J. H. (2021). The roles of platelets in COVID-19-associated coagulopathy and vaccine-induced immune thrombotic thrombocytopenia. Trends in cardiovascular medicine. https://pubmed.ncbi.nlm.nih.gov/34455073/ | Hsiao, Y. T., Tsai, M. J., Chen, Y. H., & Hsu, C. F. (2021). Acute transverse myelitis after COVID-19 vaccination. Medicina, 57(10), 1010. https://pubmed.ncbi.nlm.nih.gov/34684047/. | Crane, P., Wong, C., Mehta, N., & Barlis, P. (2021). Takotsubo (stress) cardiomyopathy after ChAdOx1 nCoV-19 vaccination. BMJ Case Reports CP, 14(10), e246580. | https://pubmed.ncbi.nlm.nih.gov/34625447/ | Crane, P., Wong, C., Mehta, N., & Barlis, P. (2021). Takotsubo (stress) cardiomyopathy after ChAdOx1 nCoV-19 vaccination. BMJ Case Reports CP, 14(10), e246580. https://pubmed.ncbi.nlm.nih.gov/34625447/ | Kherlopian, A., Zhao, C., Ge, L., Forward, E., & Fischer, G. (2021). A case of toxic epidermal necrolysis after ChAdOx1 nCov-19 (AZD1222) vaccination. The Australasian Journal of Dermatology. https://pubmed.ncbi.nlm.nih.gov/34751429/. | ||||
367 | Cerebral venous thrombosis associated with COVID-19 vaccine in Germany: | https://pubmed.ncbi.nlm.nih.gov/34288044/. | https://pubmed.ncbi.nlm.nih.gov/34111775/. | Dias, L., Soares-dos-Reis, R., Meira, J., Ferrão, D., Soares, P. R., Pastor, A., ... & Carvalho, M. (2021). Cerebral venous thrombosis after BNT162b2 mRNA SARS-CoV-2 vaccine. Journal of Stroke and Cerebrovascular Diseases, 30(8), 105906. | Dias, L., Soares-dos-Reis, R., Meira, J., Ferrão, D., Soares, P. R., Pastor, A., ... & Carvalho, M. (2021). Trombosis venosa cerebral después de la vacuna BNT162b2 mRNA SARS-CoV-2. Revista de accidentes cerebrovasculares y enfermedades cerebrovasculares, 30(8), 105906. https://pubmed.ncbi.nlm.nih.gov/34045111/ | Høeg, T. B. (2021). MYOCARDITIS asociado con la vacunación contra la vacunación contra el ARNA de SARS-COV-2 en niños de 12 a 17 años: un análisis nacional de base de datos nacional estratificado. medrxiv [Onine]. Preprint, 8. https://www.sciencedirect.com/science/article/pii/S0168827821020936 | Dias, L., Soares-dos-Reis, R., Meira, J., Ferrão, D., Soares, P. R., Pastor, A., ... & Carvalho, M. (2021). Cerebral venous thrombosis after BNT162b2 mRNA SARS-CoV-2 vaccine. Journal of Stroke and Cerebrovascular Diseases, 30(8), 105906. https://pubmed.ncbi.nlm.nih.gov/34111775/. | Huh, K., Na, Y., Kim, Y. E., Radnaabaatar, M., Peck, K. R., & Jung, J. (2021). Predicted and observed incidence of thromboembolic events among Koreans vaccinated with ChAdOx1 nCoV-19 vaccine. Journal of Korean medical science, 36(27). https://pubmed.ncbi.nlm.nih.gov/34254476/ | Michiels, Y., Houhou-Fidouh, N., Collin, G., Berger, J., & Kohli, E. (2021). Humoral Response Induced by Prime-Boost Vaccination with the ChAdOx1 nCoV-19 and mRNA BNT162b2 Vaccines in a Teriflunomide-Treated Multiple Sclerosis Patient. Vaccines, 9(10), 1140. | https://pubmed.ncbi.nlm.nih.gov/34696248/ | Michiels, Y., Houhou-Fidouh, N., Collin, G., Berger, J., & Kohli, E. (2021). Humoral Response Induced by Prime-Boost Vaccination with the ChAdOx1 nCoV-19 and mRNA BNT162b2 Vaccines in a Teriflunomide-Treated Multiple Sclerosis Patient. Vaccines, 9(10), 1140. https://pubmed.ncbi.nlm.nih.gov/34696248/ | Khogali, F., & Abdelrahman, R. (2021). Unusual presentation of acute perimyocarditis following SARS-COV-2 mRNA-1237 Moderna vaccination. Cureus, 13(7). https://pubmed.ncbi.nlm.nih.gov/34447639/ | ||||
368 | Cerebral venous sinus thrombosis after COVID-19 vaccination : Neurological and radiological management: | https://pubmed.ncbi.nlm.nih.gov/34327553/. | https://pubmed.ncbi.nlm.nih.gov/34045111/ | Kow, C. S., & Hasan, S. S. (2021). Cerebral venous thrombosis following COVID-19 vaccination. Journal of Stroke and Cerebrovascular Diseases, 30(10). | Kow, CS y Hasan, SS (2021). Trombosis venosa cerebral tras la vacunación COVID-19. Revista de accidentes cerebrovasculares y enfermedades cerebrovasculares, 30 (10). https://pubmed.ncbi.nlm.nih.gov/33983464/ | Holm, S., Kared, H., Michelsen, A. E., Kong, X. Y., Dahl, T. B., Schultz, N. H., ... & Halvorsen, B. (2021). Complejos inmunes, inmunidad innata y netosis en la trombocitopenia inducida por la vacuna en Chadox1. European Heart Journal, 42 (39), 4064-4072. https://pubmed.ncbi.nlm.nih.gov/34416410/. | Kow, C. S., & Hasan, S. S. (2021). Cerebral venous thrombosis following COVID-19 vaccination. Journal of Stroke and Cerebrovascular Diseases, 30(10). https://pubmed.ncbi.nlm.nih.gov/34045111/ | Hussain, H., Sehring, M., & Soriano, S. (2021). Deep Venous Thrombosis after Ad26. COV2. S Vaccination in Adult Male. Case Reports in Critical Care, 2021. https://pubmed.ncbi.nlm.nih.gov/34659839/. | James, J., Jose, J., Gafoor, V. A., Smita, B., & Balaram, N. (2021). Guillain‐Barré syndrome following ChAdOx1 nCoV‐19 COVID‐19 vaccination: A case series. Neurology and Clinical Neuroscience, 9(5), 402-405. | https://pubmed.ncbi.nlm.nih.gov/34548920/ | James, J., Jose, J., Gafoor, V. A., Smita, B., & Balaram, N. (2021). Guillain‐Barré syndrome following ChAdOx1 nCoV‐19 COVID‐19 vaccination: A case series. Neurology and Clinical Neuroscience, 9(5), 402-405. https://pubmed.ncbi.nlm.nih.gov/34548920/ | Khouri, C., Roustit, M., & Cracowski, J. L. (2021). Adverse event reporting and Bell's palsy risk after COVID-19 vaccination. The Lancet Infectious Diseases, 21(11), 1490-1491. https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(21)00646-0/fulltext. | ||||
369 | Cerebral venous thrombosis and thrombocytopenia after COVID-19 vaccination: | https://pubmed.ncbi.nlm.nih.gov/33878469/. | https://pubmed.ncbi.nlm.nih.gov/33983464/ | Jamme, M., Mosnino, E., Hayon, J., & Franchineau, G. (2021). Fatal cerebral venous sinus thrombosis after COVID-19 vaccination. Intensive Care Medicine, 1. | Jamme, M., Mosnino, E., Hayon, J. y Franchineau, G. (2021). Trombosis mortal del seno venoso cerebral después de la vacunación contra la COVID-19. Medicina de Cuidados Intensivos, 1. https://pubmed.ncbi.nlm.nih.gov/34116145/ | Holmes, G. A., Desai, M., Limone, B., Amor, J., Tawfik, M., Wong, L., & Furukawa, B. (2021). Una serie de casos de reacciones de vacunas COVID-19 CUTÁNICAS en el Departamento de Dermatología de Loma Linda. JAAD Case Reports, 16, 53-57. https://pubmed.ncbi.nlm.nih.gov/33838206/ | Jamme, M., Mosnino, E., Hayon, J., & Franchineau, G. (2021). Fatal cerebral venous sinus thrombosis after COVID-19 vaccination. Intensive Care Medicine, 1. https://pubmed.ncbi.nlm.nih.gov/33983464/ | Huynh, A., Kelton, J. G., Arnold, D. M., Daka, M., & Nazy, I. (2021). Antibody epitopes in vaccine-induced immune thrombotic thrombocytopaenia. Nature, 596(7873), 565-569. https://www.nature.com/articles/s41586-021-03744-4 | Major, A., Carll, T., Chan, C. W., Christenson, C., Aldarweesh, F., Wool, G. D., & Cohen, K. S. (2022). Refractory vaccine‐induced immune thrombotic thrombocytopenia (VITT) managed with delayed therapeutic plasma exchange (TPE). Journal of clinical apheresis, 37(1), 117-121. | https://pubmed.ncbi.nlm.nih.gov/34672380/ | Major, A., Carll, T., Chan, C. W., Christenson, C., Aldarweesh, F., Wool, G. D., & Cohen, K. S. (2022). Refractory vaccine‐induced immune thrombotic thrombocytopenia (VITT) managed with delayed therapeutic plasma exchange (TPE). Journal of clinical apheresis, 37(1), 117-121. https://pubmed.ncbi.nlm.nih.gov/34672380/ | Kim, B., Park, Y., Kim, E. K., & Lee, S. H. (2021). Supraclavicular lymphadenopathy after COVID-19 vaccination in Korea: serial follow-up using ultrasonography. Clinical Imaging, 79, 201-203. https://pubmed.ncbi.nlm.nih.gov/34116295/. | ||||
370 | Cerebral venous sinus thrombosis and thrombocytopenia after COVID-19 vaccination: report of two cases in the United Kingdom: | https://pubmed.ncbi.nlm.nih.gov/33857630/. | https://pubmed.ncbi.nlm.nih.gov/34116145/ | Bikdeli, B., Chatterjee, S., Arora, S., Monreal, M., Jimenez, D., Krumholz, H. M., ... & Piazza, G. (2021). Cerebral venous sinus thrombosis in the US population, after adenovirus-based SARS-CoV-2 vaccination, and after COVID-19. Journal of the American College of Cardiology, 78(4), 408-411. | Bikdeli, B., Chatterjee, S., Arora, S., Monreal, M., Jiménez, D., Krumholz, H. M., ... & Piazza, G. (2021). Trombosis del seno venoso cerebral en la población de EE. UU., después de la vacunación contra el SARS-CoV-2 basada en adenovirus y después de la COVID-19. Revista del Colegio Americano de Cardiología, 78(4), 408-411. https://pubmed.ncbi.nlm.nih.gov/34286453/. | Hsiao, Y. T., Tsai, M. J., Chen, Y. H., & Hsu, C. F. (2021). Mielitis transversal aguda después de la vacunación de COVID-19. Medicina, 57 (10), 1010. https://pubmed.ncbi.nlm.nih.gov/34541935/ | Bikdeli, B., Chatterjee, S., Arora, S., Monreal, M., Jimenez, D., Krumholz, H. M., ... & Piazza, G. (2021). Cerebral venous sinus thrombosis in the US population, after adenovirus-based SARS-CoV-2 vaccination, and after COVID-19. Journal of the American College of Cardiology, 78(4), 408-411. https://pubmed.ncbi.nlm.nih.gov/34116145/ | Hwang, J., Lee, S. B., Lee, S. W., Lee, M. H., Koyanagi, A., Jacob, L., ... & Smith, L. (2021). Comparison of vaccine-induced thrombotic events between ChAdOx1 nCoV-19 and Ad26. COV. 2. S vaccines. Journal of autoimmunity, 122, 102681. https://pubmed.ncbi.nlm.nih.gov/34139631/. | Purkayastha, P., Mckechnie, C., Kalkur, P., & Scully, M. (2021). Rare case of COVID-19 vaccine-associated intracranial haemorrhage with venous sinus thrombosis. BMJ Case Reports CP, 14(9), e245092. | https://pubmed.ncbi.nlm.nih.gov/34556531/ | Purkayastha, P., Mckechnie, C., Kalkur, P., & Scully, M. (2021). Rare case of COVID-19 vaccine-associated intracranial haemorrhage with venous sinus thrombosis. BMJ Case Reports CP, 14(9), e245092. https://pubmed.ncbi.nlm.nih.gov/34556531/ | Kim, D., Choi, J. H., Jang, J. Y., So, O., Cho, E., Choi, H., ... & Park, K. T. (2021). A Case Report for Myopericarditis after BNT162b2 COVID-19 mRNA Vaccination in a Korean Young Male. Journal of Korean Medical Science, 36(39). https://pubmed.ncbi.nlm.nih.gov/34636504/ | ||||
371 | Cerebral venous thrombosis induced by SARS-CoV-2 vaccine: | https://pubmed.ncbi.nlm.nih.gov/34090750/. | https://pubmed.ncbi.nlm.nih.gov/34286453/. | Gürtler, L., Seitz, R., & Schramm, W. (2021). Cerebral venous thrombosis after COVID-19 vaccination: is the risk of thrombosis increased by intravascular application of the vaccine?. Infection, 49(5), 1071-1074. | Gürtler, L., Seitz, R. y Schramm, W. (2021). Trombosis venosa cerebral tras la vacunación COVID-19: ¿aumenta el riesgo de trombosis por la aplicación intravascular de la vacuna?. Infección, 49(5), 1071-1074. https://pubmed.ncbi.nlm.nih.gov/34244448/ | Huh, K., Na, Y., Kim, Y. E., Radnabaatar, M., Peck, K. R., & Jung, J. (2021). Se predice y observó la incidencia de eventos tromboembólicos entre los coreanos vacunados con la vacuna Chadox1 NCOV-19. Diario de la ciencia médica coreana, 36 (27). https://pubmed.ncbi.nlm.nih.gov/34483267/. | Gürtler, L., Seitz, R., & Schramm, W. (2021). Cerebral venous thrombosis after COVID-19 vaccination: is the risk of thrombosis increased by intravascular application of the vaccine?. Infection, 49(5), 1071-1074. https://pubmed.ncbi.nlm.nih.gov/34286453/. | Hwang, J., Lee, S., Lee, S., Lee, M., Koyanagi, A., Jacob, L., Tizaoui, K., Yon, D., Shin, J., & Smith, L. (2021). Comparison of vaccine-induced thrombotic events between ChAdOx1 nCoV-19 and Ad26. COV. 2. S vaccines. Journal of autoimmunity, 122, 102681. https://www.sciencedirect.com/science/article/abs/pii/S0896841121000895 | García-Azorín, D., Do, T. P., Gantenbein, A. R., Hansen, J. M., Souza, M. N. P., Obermann, M., ... & Kristoffersen, E. S. (2021). Delayed headache after COVID-19 vaccination: a red flag for vaccine induced cerebral venous thrombosis. The journal of headache and pain, 22(1), 1-5. | https://pubmed.ncbi.nlm.nih.gov/34535076/ | García-Azorín, D., Do, T. P., Gantenbein, A. R., Hansen, J. M., Souza, M. N. P., Obermann, M., ... & Kristoffersen, E. S. (2021). Delayed headache after COVID-19 vaccination: a red flag for vaccine induced cerebral venous thrombosis. The journal of headache and pain, 22(1), 1-5. https://pubmed.ncbi.nlm.nih.gov/34535076/ | Kim, G., Choi, E. J., Park, H. S., Lee, J. H., Lee, J. H., & Lee, K. H. (2021). A case report of immune thrombocytopenia after ChAdOx1 nCoV-19 vaccination. Journal of Korean medical science, 36(43). https://pubmed.ncbi.nlm.nih.gov/34751013/. | ||||
372 | Carotid artery immune thrombosis induced by adenovirus-vectored COVID-19 vaccine: case report: | https://pubmed.ncbi.nlm.nih.gov/34312301/. | https://pubmed.ncbi.nlm.nih.gov/34244448/ | Ikenberg, B., Demleitner, A. F., Thiele, T., Wiestler, B., Götze, K., Mößmer, G., & Lingor, P. (2021). Cerebral venous sinus thrombosis after ChAdOx1 nCov-19 vaccination with a misleading first cerebral MRI scan. Stroke and vascular neurology, 6(4). | Ikenberg, B., Demleitner, A. F., Thiele, T., Wiestler, B., Götze, K., Mößmer, G. y Lingor, P. (2021). Trombosis del seno venoso cerebral después de la vacunación ChAdOx1 nCov-19 con una primera resonancia magnética cerebral engañosa. Accidente cerebrovascular y neurología vascular, 6 (4). https://pubmed.ncbi.nlm.nih.gov/34226070/ | HUSSIN, H., SEAHRING, M., Y SORIANO, S. (2021). Trombosis venosa profunda después de AD26. COV2. La vacunación en hombre adulta. Informes de casos en cuidados críticos, 2021. https://pubmed.ncbi.nlm.nih.gov/34668274/. | Ikenberg, B., Demleitner, A. F., Thiele, T., Wiestler, B., Götze, K., Mößmer, G., & Lingor, P. (2021). Cerebral venous sinus thrombosis after ChAdOx1 nCov-19 vaccination with a misleading first cerebral MRI scan. Stroke and vascular neurology, 6(4). https://pubmed.ncbi.nlm.nih.gov/34244448/ | Hwang, J., Park, S. H., Lee, S. W., Lee, S. B., Lee, M. H., Jeong, G. H., ... & Smith, L. (2021). Predictors of mortality in thrombotic thrombocytopenia after adenoviral COVID-19 vaccination: the FAPIC score. European heart journal, 42(39), 4053-4063. https://pubmed.ncbi.nlm.nih.gov/34545400/ | Pavord, S., Scully, M., Hunt, B. J., Lester, W., Bagot, C., Craven, B., ... & Makris, M. (2021). Clinical features of vaccine-induced immune thrombocytopenia and thrombosis. New England Journal of Medicine, 385(18), 1680-1689. | https://pubmed.ncbi.nlm.nih.gov/34379914/. | Pavord, S., Scully, M., Hunt, B. J., Lester, W., Bagot, C., Craven, B., ... & Makris, M. (2021). Clinical features of vaccine-induced immune thrombocytopenia and thrombosis. New England Journal of Medicine, 385(18), 1680-1689. https://pubmed.ncbi.nlm.nih.gov/34379914/. | Kim, H. W., Jenista, E. R., Wendell, D. C., Azevedo, C. F., Campbell, M. J., Darty, S. N., ... & Kim, R. J. (2021). Patients with acute myocarditis following mRNA COVID-19 vaccination. JAMA cardiology, 6(10), 1196-1201. https://jamanetwork.com/journals/jamacardiology/fullarticle/2781602 | ||||
373 | Cerebral venous sinus thrombosis associated with vaccine-induced thrombotic thrombocytopenia: | https://pubmed.ncbi.nlm.nih.gov/34333995/ | https://pubmed.ncbi.nlm.nih.gov/34226070/ | Clark, R. T., Johnson, L., Billotti, J., Foulds, G., Ketels, T., Heard, K., & Hynes, E. C. (2021). Early outcomes of bivalirudin therapy for thrombotic thrombocytopenia and cerebral venous sinus thrombosis after Ad26. COV2. S vaccination. Annals of Emergency Medicine, 78(4), 511-514. | Clark, R. T., Johnson, L., Billotti, J., Foulds, G., Ketels, T., Heard, K. y Hynes, E. C. (2021). Resultados tempranos del tratamiento con bivalirudina para la trombocitopenia trombótica y la trombosis del seno venoso cerebral después del Ad26. COV2. Vacunación S. Anales de Medicina de Emergencia, 78(4), 511-514. https://pubmed.ncbi.nlm.nih.gov/34101024/. | HUYNH, A., KELTON, J. G., Arnold, D. M., Daka, M., & Nazy, I. (2021). Epítopos de anticuerpos en trombocitopainia inmune inducida por la vacuna. Naturaleza, 596 (7873), 565-569. https://www.ahajournals.org/doi/pdf/10.1161/CIRCULATIONAHA.121.056135 | Clark, R. T., Johnson, L., Billotti, J., Foulds, G., Ketels, T., Heard, K., & Hynes, E. C. (2021). Early outcomes of bivalirudin therapy for thrombotic thrombocytopenia and cerebral venous sinus thrombosis after Ad26. COV2. S vaccination. Annals of Emergency Medicine, 78(4), 511-514. https://pubmed.ncbi.nlm.nih.gov/34226070/ | Hyun, H., Song, J. Y., Seong, H., Yoon, J. G., Noh, J. Y., Cheong, H. J., & Kim, W. J. (2021). Polyarthralgia and Myalgia Syndrome after ChAdOx1 nCOV-19 Vaccination. Journal of Korean Medical Science, 36(34). https://pubmed.ncbi.nlm.nih.gov/34463066/ | Hwang, J., Park, S. H., Lee, S. W., Lee, S. B., Lee, M. H., Jeong, G. H., ... & Smith, L. (2021). Predictors of mortality in thrombotic thrombocytopenia after adenoviral COVID-19 vaccination: the FAPIC score. European heart journal, 42(39), 4053-4063. | https://pubmed.ncbi.nlm.nih.gov/34545400/ | Hwang, J., Park, S. H., Lee, S. W., Lee, S. B., Lee, M. H., Jeong, G. H., ... & Smith, L. (2021). Predictors of mortality in thrombotic thrombocytopenia after adenoviral COVID-19 vaccination: the FAPIC score. European heart journal, 42(39), 4053-4063. https://pubmed.ncbi.nlm.nih.gov/34545400/ | Kim, I. C., Kim, H., Lee, H. J., Kim, J. Y., & Kim, J. Y. (2021). Cardiac imaging of acute myocarditis following COVID-19 mRNA vaccination. Journal of Korean Medical Science, 36(32). https://pubmed.ncbi.nlm.nih.gov/34402228/ | ||||
374 | The roles of platelets in COVID-19-associated coagulopathy and vaccine-induced immune-immune thrombotic thrombocytopenia: | https://pubmed.ncbi.nlm.nih.gov/34455073/ | https://pubmed.ncbi.nlm.nih.gov/34101024/. | Zakaria, Z., Sapiai, N. A., & Ghani, A. R. I. (2021). Cerebral venous sinus thrombosis 2 weeks after the first dose of mRNA SARS-CoV-2 vaccine. Acta neurochirurgica, 163(8), 2359-2362. | Zakaria, Z., Sapiai, N. A. y Ghani, A. R. I. (2021). Trombosis del seno venoso cerebral 2 semanas después de la primera dosis de la vacuna de ARNm del SARS-CoV-2. Acta neurochirurgica, 163(8), 2359-2362. https://pubmed.ncbi.nlm.nih.gov/34407607/. | Hwang, J., Lee, S. B., Lee, S. W., Lee, M. H., Koyanagi, A., Jacob, L., ... & Smith, L. (2021). Comparación de eventos trombóticos inducidos por la vacuna entre Chadox1 NCOV-19 y AD26. COV. 2. Vacunas. Diario de autoinmunidad, 122, 102681. https://pubmed.ncbi.nlm.nih.gov/33864750/ | Zakaria, Z., Sapiai, N. A., & Ghani, A. R. I. (2021). Cerebral venous sinus thrombosis 2 weeks after the first dose of mRNA SARS-CoV-2 vaccine. Acta neurochirurgica, 163(8), 2359-2362. https://pubmed.ncbi.nlm.nih.gov/34101024/. | Iba, T., & Levy, J. H. (2021). The roles of platelets in COVID-19-associated coagulopathy and vaccine-induced immune thrombotic thrombocytopenia. Trends in cardiovascular medicine. https://pubmed.ncbi.nlm.nih.gov/34455073/ | Al-Mayhani, T., Saber, S., Stubbs, M. J., Losseff, N. A., Perry, R. J., Simister, R. J., ... & Werring, D. J. (2021). Ischaemic stroke as a presenting feature of ChAdOx1 nCoV-19 vaccine-induced immune thrombotic thrombocytopenia. Journal of Neurology, Neurosurgery & Psychiatry, 92(11), 1247-1248. | https://pubmed.ncbi.nlm.nih.gov/34035134/ | Al-Mayhani, T., Saber, S., Stubbs, M. J., Losseff, N. A., Perry, R. J., Simister, R. J., ... & Werring, D. J. (2021). Ischaemic stroke as a presenting feature of ChAdOx1 nCoV-19 vaccine-induced immune thrombotic thrombocytopenia. Journal of Neurology, Neurosurgery & Psychiatry, 92(11), 1247-1248. https://pubmed.ncbi.nlm.nih.gov/34035134/ | Kinariwalla, N., London, A. O., Soliman, Y. S., Niedt, G. W., Husain, S., & Gallitano, S. M. (2022). A case of generalized Sweet syndrome with vasculitis triggered by recent COVID-19 vaccination. JAAD Case Reports, 19, 64-67. https://pubmed.ncbi.nlm.nih.gov/34849386/ | ||||
375 | Cerebral venous thrombosis after the BNT162b2 mRNA SARS-CoV-2 vaccine: | https://pubmed.ncbi.nlm.nih.gov/34111775/. | https://pubmed.ncbi.nlm.nih.gov/34407607/. | Gresele, P., Momi, S., Marcucci, R., Ramundo, F., De Stefano, V., & Tripodi, A. (2021). Interactions of adenoviruses with platelets and coagulation and the vaccine-induced immune thrombotic thrombocytopenia syndrome. haematologica, 106(12), 3034. | Gresele, P., Momi, S., Marcucci, R., Ramundo, F., De Stefano, V. y Tripodi, A. (2021). Interacciones de los adenovirus con las plaquetas y la coagulación y el síndrome de trombocitopenia trombótica inmune inducido por vacunas. hematológica, 106(12), 3034. https://pubmed.ncbi.nlm.nih.gov/34313952/ | Hwang, J., Lee, S., Lee, S., Lee, M., Koyanagi, A., Jacob, L., Tizaoui, K., Yon, D., Shin, J., & Smith, L. (2021). Comparación de eventos trombóticos inducidos por la vacuna entre Chadox1 NCOV-19 y AD26. COV. 2. Vacunas. Diario de autoinmunidad, 122, 102681. https://www.sciencedirect.com/science/article/abs/pii/S0049384821003315 | Gresele, P., Momi, S., Marcucci, R., Ramundo, F., De Stefano, V., & Tripodi, A. (2021). Interactions of adenoviruses with platelets and coagulation and the vaccine-induced immune thrombotic thrombocytopenia syndrome. haematologica, 106(12), 3034. https://pubmed.ncbi.nlm.nih.gov/34407607/. | Iba, T., & Levy, J. H. (2021). The roles of platelets in COVID-19-associated coagulopathy and vaccine-induced immune thrombotic thrombocytopenia. Trends in cardiovascular medicine. https://www.sciencedirect.com/science/article/pii/S1050173821000967 | Koh, J. S., Hoe, R. H. M., Yong, M. H., Chiew, H. J., Goh, Y., Yong, K. P., ... & Umapathi, T. (2021). Hospital-based observational study of neurological disorders in patients recently vaccinated with COVID-19 mRNA vaccines. Journal of the neurological sciences, 430, 120030. | https://pubmed.ncbi.nlm.nih.gov/34688190/ | Koh, J. S., Hoe, R. H. M., Yong, M. H., Chiew, H. J., Goh, Y., Yong, K. P., ... & Umapathi, T. (2021). Hospital-based observational study of neurological disorders in patients recently vaccinated with COVID-19 mRNA vaccines. Journal of the neurological sciences, 430, 120030. https://pubmed.ncbi.nlm.nih.gov/34688190/ | King, W. W., Petersen, M. R., Matar, R. M., Budweg, J. B., Pardo, L. C., & Petersen, J. W. (2021). Myocarditis following mRNA vaccination against SARS-CoV-2, a case series. American Heart Journal Plus: Cardiology Research and Practice, 8, 100042. https://www.sciencedirect.com/science/article/pii/S2666602221000409 | ||||
376 | Cerebral venous thrombosis after COVID-19 vaccination: | https://pubmed.ncbi.nlm.nih.gov/34045111/ | https://pubmed.ncbi.nlm.nih.gov/34313952/ | Göbel, C. H., Heinze, A., Karstedt, S., Morscheck, M., Tashiro, L., Cirkel, A., ... & Göbel, H. (2021). Headache Attributed to Vaccination Against COVID-19 (Coronavirus SARS-CoV-2) with the ChAdOx1 nCoV-19 (AZD1222) Vaccine: A Multicenter Observational Cohort Study. Pain and Therapy, 10(2), 1309-1330. | Göbel, C. H., Heinze, A., Karstedt, S., Morscheck, M., Tashiro, L., Cirkel, A., ... y Göbel, H. (2021). Dolor de cabeza atribuido a la vacunación contra COVID-19 (Coronavirus SARS-CoV-2) con la vacuna ChAdOx1 nCoV-19 (AZD1222): un estudio de cohorte observacional multicéntrico. Dolor y terapia, 10(2), 1309-1330. https://pubmed.ncbi.nlm.nih.gov/34274191/ | Hwang, J., Park, S. H., Lee, S. W., Lee, S. B., Lee, M. H., Jeong, G. H., ... & Smith, L. (2021). Predictores de mortalidad en trombocitopenia trombótica después de la vacunación a adenoviral COVID-19: la puntuación FAPIC. European Heart Journal, 42 (39), 4053-4063. https://pubmed.ncbi.nlm.nih.gov/34035134/ | Göbel, C. H., Heinze, A., Karstedt, S., Morscheck, M., Tashiro, L., Cirkel, A., ... & Göbel, H. (2021). Headache Attributed to Vaccination Against COVID-19 (Coronavirus SARS-CoV-2) with the ChAdOx1 nCoV-19 (AZD1222) Vaccine: A Multicenter Observational Cohort Study. Pain and Therapy, 10(2), 1309-1330. https://pubmed.ncbi.nlm.nih.gov/34313952/ | Idogun, P. O., Ward, M. C., Teklie, Y., Wiese-Rometsch, W., & Baker, J. (2021). Newly diagnosed idiopathic thrombocytopenia post COVID-19 vaccine administration. Cureus, 13(5). https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8176657/. | Cleaver, J., Ibitoye, R., Morrison, H., Flood, R., Crewdson, K., Marsh, A., ... & Mortimer, A. (2021). Endovascular treatment for vaccine-induced cerebral venous sinus thrombosis and thrombocytopenia following ChAdOx1 nCoV-19 vaccination: a report of three cases. Journal of neurointerventional surgery. | https://pubmed.ncbi.nlm.nih.gov/34782400/ | Cleaver, J., Ibitoye, R., Morrison, H., Flood, R., Crewdson, K., Marsh, A., ... & Mortimer, A. (2021). Endovascular treatment for vaccine-induced cerebral venous sinus thrombosis and thrombocytopenia following ChAdOx1 nCoV-19 vaccination: a report of three cases. Journal of neurointerventional surgery. https://pubmed.ncbi.nlm.nih.gov/34782400/ | Kircheis, R. (2021). Coagulopathies after vaccination against SARS-CoV-2 may be derived from a combined effect of SARS-CoV-2 spike protein and adenovirus vector-triggered signaling pathways. International Journal of Molecular Sciences, 22(19), 10791. https://pubmed.ncbi.nlm.nih.gov/34639132/ | ||||
377 | Lethal cerebral venous sinus thrombosis after COVID-19 vaccination: | https://pubmed.ncbi.nlm.nih.gov/33983464/ | https://pubmed.ncbi.nlm.nih.gov/34274191/ | Guan, C. Y., Tsai, S. H., Fan, J. S., Lin, Y. K., & Kao, C. C. (2022). Middle-age Asian male with cerebral venous thrombosis after COVID-19 AstraZeneca vaccination. The American Journal of Emergency Medicine, 51, 427-e3. | Guan, C. Y., Tsai, S. H., Fan, J. S., Lin, Y. K. y Kao, C. C. (2022). Varón asiático de mediana edad con trombosis venosa cerebral después de la vacuna COVID-19 AstraZeneca. Revista Estadounidense de Medicina de Emergencia, 51, 427-e3. https://pubmed.ncbi.nlm.nih.gov/34129181/ | Hyun, H., Song, J. Y., SEONG, H., Yoon, J. G., NOH, J. Y., Cheong, H. J., & Kim, W. J. (2021). Síndrome de Polyarthralgia y Myalgia después de la vacunación de Chadox1 NCOV-19. Diario de la ciencia médica coreana, 36 (34). https://pubmed.ncbi.nlm.nih.gov/34043800/. | Guan, C. Y., Tsai, S. H., Fan, J. S., Lin, Y. K., & Kao, C. C. (2022). Middle-age Asian male with cerebral venous thrombosis after COVID-19 AstraZeneca vaccination. The American Journal of Emergency Medicine, 51, 427-e3. https://pubmed.ncbi.nlm.nih.gov/34274191/ | Ifeanyi, N., Chinenye, N., Oladiran, O., David, E., Mmonu, C., & Ogbonna-Nwosu, C. (2021). Isolated pulmonary embolism following COVID vaccination: 2 case reports and a review of post-acute pulmonary embolism complications and follow-up. Journal of Community Hospital Internal Medicine Perspectives, 11(6), 877-879. https://pubmed.ncbi.nlm.nih.gov/34804412/ | Cari, L., Alhosseini, M. N., Fiore, P., Pierno, S., Pacor, S., Bergamo, A., ... & Nocentini, G. (2021). Cardiovascular, neurological, and pulmonary events following vaccination with the BNT162b2, ChAdOx1 nCoV-19, and Ad26. COV2. S vaccines: An analysis of European data. Journal of autoimmunity, 125, 102742. | https://pubmed.ncbi.nlm.nih.gov/34710832/ | Cari, L., Alhosseini, M. N., Fiore, P., Pierno, S., Pacor, S., Bergamo, A., ... & Nocentini, G. (2021). Cardiovascular, neurological, and pulmonary events following vaccination with the BNT162b2, ChAdOx1 nCoV-19, and Ad26. COV2. S vaccines: An analysis of European data. Journal of autoimmunity, 125, 102742. https://pubmed.ncbi.nlm.nih.gov/34710832/ | Klein, N. P., Lewis, N., Goddard, K., Fireman, B., Zerbo, O., Hanson, K. E., ... & Weintraub, E. S. (2021). Surveillance for adverse events after COVID-19 mRNA vaccination. JAMA, 326(14), 1390-1399. https://www.ncbi.nlm.nih.gov/pubmed/34477808 | ||||
378 | Cerebral venous sinus thrombosis in the U.S. population, After SARS-CoV-2 vaccination with adenovirus and after COVID-19: | https://pubmed.ncbi.nlm.nih.gov/34116145/ | https://pubmed.ncbi.nlm.nih.gov/34129181/ | Marchandot, B., Carmona, A., Trimaille, A., Curtiaud, A., & Morel, O. (2021). Procoagulant microparticles: a possible link between vaccine-induced immune thrombocytopenia (VITT) and cerebral sinus venous thrombosis. Journal of Thrombosis and Thrombolysis, 52(3), 689-691. | Marchandot, B., Carmona, A., Trimaille, A., Curtiaud, A. y Morel, O. (2021). Micropartículas procoagulantes: un posible vínculo entre la trombocitopenia inmune inducida por vacunas (VITT) y la trombosis venosa del seno cerebral. Revista de trombosis y trombólisis, 52(3), 689-691. https://pubmed.ncbi.nlm.nih.gov/33929487/. | IBA, T., & Levy, J. H. (2021). Los roles de las plaquetas en la coagulopatía asociada a Covid-19 y la trombocitopenia trombótica inmune inducida por la vacuna. Tendencias en medicina cardiovascular. https://pubmed.ncbi.nlm.nih.gov/34111775/. | Marchandot, B., Carmona, A., Trimaille, A., Curtiaud, A., & Morel, O. (2021). Procoagulant microparticles: a possible link between vaccine-induced immune thrombocytopenia (VITT) and cerebral sinus venous thrombosis. Journal of Thrombosis and Thrombolysis, 52(3), 689-691. https://pubmed.ncbi.nlm.nih.gov/34129181/ | Iftikhar, H., Noor, S. M. U., Masood, M., & Bashir, K. (2021). Bell’s palsy after 24 hours of mRNA-1273 SARS-CoV-2 vaccine. Cureus, 13(6). https://pubmed.ncbi.nlm.nih.gov/34336436/ | Lippi, G., & Favaloro, E. J. (2021, October). Cerebral Venous Thrombosis Developing after COVID-19 Vaccination: VITT, VATT, TTS, and More. In Seminars in thrombosis and hemostasis. Thieme Medical Publishers, Inc.. | https://pubmed.ncbi.nlm.nih.gov/34695859/ | Lippi, G., & Favaloro, E. J. (2021, October). Cerebral Venous Thrombosis Developing after COVID-19 Vaccination: VITT, VATT, TTS, and More. In Seminars in thrombosis and hemostasis. Thieme Medical Publishers, Inc.. https://pubmed.ncbi.nlm.nih.gov/34695859/ | Klimek, L., Bergmann, K. C., Brehler, R., Pfützner, W., Zuberbier, T., Hartmann, K., ... & Worm, M. (2021). Practical handling of allergic reactions to COVID-19 vaccines. Allergo journal international, 30(3), 79-95. https://www.ncbi.nlm.nih.gov/pubmed/33898162 | ||||
379 | Cerebral venous thrombosis after COVID-19 vaccination: is the risk of thrombosis increased by intravascular administration of the vaccine: | https://pubmed.ncbi.nlm.nih.gov/34286453/. | https://pubmed.ncbi.nlm.nih.gov/33929487/. | See, I., Su, J. R., Lale, A., Woo, E. J., Guh, A. Y., Shimabukuro, T. T., ... & Broder, K. R. (2021). US case reports of cerebral venous sinus thrombosis with thrombocytopenia after Ad26. COV2. S vaccination, March 2 to April 21, 2021. Jama, 325(24), 2448-2456. | Véase, I., Su, J. R., Lale, A., Woo, E. J., Guh, A. Y., Shimabukuro, T. T., ... y Broder, K. R. (2021). Informes de casos estadounidenses de trombosis del seno venoso cerebral con trombocitopenia después del Ad26. COV2. Vacunación S, 2 de marzo al 21 de abril de 2021. Jama, 325(24), 2448-2456. https://pubmed.ncbi.nlm.nih.gov/34159588/. | IBA, T., & Levy, J. H. (2021). Los roles de las plaquetas en la coagulopatía asociada a Covid-19 y la trombocitopenia trombótica inmune inducida por la vacuna. Tendencias en medicina cardiovascular. https://www.sciencedirect.com/science/article/abs/pii/S1568997221002160 | See, I., Su, J. R., Lale, A., Woo, E. J., Guh, A. Y., Shimabukuro, T. T., ... & Broder, K. R. (2021). US case reports of cerebral venous sinus thrombosis with thrombocytopenia after Ad26. COV2. S vaccination, March 2 to April 21, 2021. Jama, 325(24), 2448-2456. https://pubmed.ncbi.nlm.nih.gov/33929487/. | Igual-Rouilleault, A. C., Soriano, I., Quan, P. L., Fernández-Montero, A., Elizalde, A., & Pina, L. (2021). Unilateral axillary adenopathy induced by COVID-19 vaccine: US follow-up evaluation. European Radiology, 1-8. https://pubmed.ncbi.nlm.nih.gov/34655312/. | Gangat, N., Guglielmelli, P., Betti, S., Farrukh, F., Carobbio, A., Barbui, T., ... & Tefferi, A. (2021). Cerebral venous thrombosis and myeloproliferative neoplasms: A three‐center study of 74 consecutive cases. American journal of hematology, 96(12), 1580-1586. | https://pubmed.ncbi.nlm.nih.gov/34453762/. | Gangat, N., Guglielmelli, P., Betti, S., Farrukh, F., Carobbio, A., Barbui, T., ... & Tefferi, A. (2021). Cerebral venous thrombosis and myeloproliferative neoplasms: A three‐center study of 74 consecutive cases. American journal of hematology, 96(12), 1580-1586. https://pubmed.ncbi.nlm.nih.gov/34453762/. | Klimek, L., Novak, N., Cabanillas, B., Jutel, M., Bousquet, J., & Akdis, C. A. (2021). Allergenic components of the mRNA‐1273 vaccine for COVID‐19: possible involvement of polyethylene glycol and IgG‐mediated complement activation. Allergy, 76(11), 3307-3313. https://pubmed.ncbi.nlm.nih.gov/33657648/ | ||||
380 | Central venous sinus thrombosis with subarachnoid hemorrhage after COVID-19 mRNA vaccination: are these reports merely coincidental: | https://pubmed.ncbi.nlm.nih.gov/34478433/ | https://pubmed.ncbi.nlm.nih.gov/34159588/. | Lavin, M., Elder, P. T., O’Keeffe, D., Enright, H., Ryan, E., Kelly, A., ... & O’Donnell, J. S. (2021). Vaccine‐induced immune thrombotic thrombocytopenia (VITT)–a novel clinico‐pathological entity with heterogeneous clinical presentations. British Journal of Haematology, 195(1), 76-84. | Lavin, M., Elder, P. T., O'Keeffe, D., Enright, H., Ryan, E., Kelly, A., ... y O'Donnell, J. S. (2021). Trombocitopenia trombótica inmunitaria inducida por vacuna (VITT): una nueva entidad clínico-patológica con presentaciones clínicas heterogéneas. Revista Británica de Hematología, 195(1), 76-84. https://pubmed.ncbi.nlm.nih.gov/34402666/ | Idogun, P. O., Ward, M. C., Teklie, Y., Wiese-Rometsch, W., & Baker, J. (2021). Thrombocitopenia idiopitopenia idiopática recién diagnosticada Administración de vacunas posteriores a COVID-19. CUREUS, 13 (5). https://www.annemergmed.com/article/S0196-0644(21)00122-0/fulltext. | Lavin, M., Elder, P. T., O’Keeffe, D., Enright, H., Ryan, E., Kelly, A., ... & O’Donnell, J. S. (2021). Vaccine‐induced immune thrombotic thrombocytopenia (VITT)–a novel clinico‐pathological entity with heterogeneous clinical presentations. British Journal of Haematology, 195(1), 76-84. https://pubmed.ncbi.nlm.nih.gov/34159588/. | Iguchi, T., Umeda, H., Kojima, M., Kanno, Y., Tanaka, Y., Kinoshita, N., & Sato, D. (2021). Cumulative adverse event reporting of anaphylaxis after mRNA COVID-19 vaccine (Pfizer-BioNTech) injections in Japan: the first-month report. Drug safety, 44(11), 1209-1214. https://pubmed.ncbi.nlm.nih.gov/34347278/ | Okada, Y., Sakai, R., Sato-Fitoussi, M., Nodera, M., Yoshinaga, S., Shibata, A., ... & Amano, K. (2021). Potential triggers for thrombocytopenia and/or hemorrhage by the BNT162b2 vaccine, Pfizer-BioNTech. Frontiers in Medicine, 8. | https://pubmed.ncbi.nlm.nih.gov/34660652/. | Okada, Y., Sakai, R., Sato-Fitoussi, M., Nodera, M., Yoshinaga, S., Shibata, A., ... & Amano, K. (2021). Potential triggers for thrombocytopenia and/or hemorrhage by the BNT162b2 vaccine, Pfizer-BioNTech. Frontiers in Medicine, 8. https://pubmed.ncbi.nlm.nih.gov/34660652/. | Klimek, L., Novak, N., Hamelmann, E., Werfel, T., Wagenmann, M., Taube, C., ... & Worm, M. (2021). Severe allergic reactions after COVID-19 vaccination with the Pfizer/BioNTech vaccine in Great Britain and USA. Allergo journal international, 30(2), 51-55. https://pubmed.ncbi.nlm.nih.gov/33643776/ | ||||
381 | Cerebral venous sinus thrombosis after ChAdOx1 nCov-19 vaccination with a misleading first brain MRI: | https://pubmed.ncbi.nlm.nih.gov/34244448/ | https://pubmed.ncbi.nlm.nih.gov/34402666/ | Gangi, A., Mobashwera, B., Ganczakowski, M., & Ayto, R. (2021). Imaging and hematologic findings in thrombosis and thrombocytopenia after ChAdOx1 nCoV-19 (AstraZeneca) vaccination. Radiology, 211546. | Gangi, A., Mobashwera, B., Ganczakowski, M. y Ayto, R. (2021). Hallazgos hematológicos y de imágenes en trombosis y trombocitopenia después de la vacunación con ChAdOx1 nCoV-19 (AstraZeneca). Radiología, 211546. https://pubmed.ncbi.nlm.nih.gov/34508917/ | IFTIKHAR, H., NOOR, S. M. U., MAOOD, M., BASHIR, K. (2021). Palsy de Bell después de 24 horas de vacuna contra MRNA-1273 SARS-COV-2. CUREUS, 13 (6). https://pubmed.ncbi.nlm.nih.gov/34281950/. | Gangi, A., Mobashwera, B., Ganczakowski, M., & Ayto, R. (2021). Imaging and hematologic findings in thrombosis and thrombocytopenia after ChAdOx1 nCoV-19 (AstraZeneca) vaccination. Radiology, 211546. https://pubmed.ncbi.nlm.nih.gov/34402666/ | Iguchi, T., Umeda, H., Kojima, M., Kanno, Y., Tanaka, Y., Kinoshita, N., & Sato, D. (2021). Cumulative adverse event reporting of anaphylaxis after mRNA COVID-19 vaccine (Pfizer-BioNTech) injections in Japan: the first-month report. Drug safety, 44(11), 1209-1214. https://www.ncbi.nlm.nih.gov/pubmed/34347278 | Lioudaki, S., Kontopodis, N., Pontikoglou, C., Gkalea, V., Pappas, T., Matsouka, C., ... & Ioannou, C. V. (2022). Multiple sites of arterial thrombosis in a 35-year old patient after ChAdOx1 (AstraZeneca) vaccination, requiring emergent femoral and carotid surgical thrombectomy. Annals of Vascular Surgery, 79, 438-e1. | https://pubmed.ncbi.nlm.nih.gov/34644642/ | Lioudaki, S., Kontopodis, N., Pontikoglou, C., Gkalea, V., Pappas, T., Matsouka, C., ... & Ioannou, C. V. (2022). Multiple sites of arterial thrombosis in a 35-year old patient after ChAdOx1 (AstraZeneca) vaccination, requiring emergent femoral and carotid surgical thrombectomy. Annals of Vascular Surgery, 79, 438-e1. https://pubmed.ncbi.nlm.nih.gov/34644642/ | Knowlton, K. U. (2021). Insights From a Murine Model of Coronavirus Disease 2019 (COVID-19) mRNA Vaccination-Induced Myopericarditis: Could Accidental Intravenous Vaccine Injection Induce Myopericarditis?. Clinical Infectious Diseases. https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciab741/6359059 | ||||
382 | Early results of bivalirudin treatment for thrombotic thrombocytopenia and cerebral venous sinus thrombosis after vaccination with Ad26.COV2.S: | https://pubmed.ncbi.nlm.nih.gov/34226070/ | https://pubmed.ncbi.nlm.nih.gov/34508917/ | Elrashdy, F., Tambuwala, M. M., Hassan, S. S., Adadi, P., Seyran, M., Abd El-Aziz, T. M., ... & Uversky, V. N. (2021). Autoimmunity roots of the thrombotic events after COVID-19 vaccination. Autoimmunity reviews, 20(11), 102941. | Elrashdy, F., Tambuwala, M. M., Hassan, S. S., Adadi, P., Seyran, M., Abd El-Aziz, T. M., ... y Uversky, V. N. (2021). Raíces de autoinmunidad de los eventos trombóticos después de la vacunación COVID-19. Revisiones de autoinmunidad, 20(11), 102941. https://pubmed.ncbi.nlm.nih.gov/34370974/ | Igreani, N., Chinenye, N., Oladeiran, O., David, E., Monu, C., & Ogbonna-Nwosu, C. (2021). Embolia pulmonar aislada después de la vacunación de COVID: 2 informes de casos y una revisión de las complicaciones y el seguimiento de la embolia pulmonar posgute. Perspectivas de la medicina interna del Hospital Comunitario, 11 (6), 877-879. https://pubmed.ncbi.nlm.nih.gov/34571653/. | Elrashdy, F., Tambuwala, M. M., Hassan, S. S., Adadi, P., Seyran, M., Abd El-Aziz, T. M., ... & Uversky, V. N. (2021). Autoimmunity roots of the thrombotic events after COVID-19 vaccination. Autoimmunity reviews, 20(11), 102941. https://pubmed.ncbi.nlm.nih.gov/34508917/ | Ikenberg, B., Demleitner, A. F., Thiele, T., Wiestler, B., Götze, K., Mößmer, G., & Lingor, P. (2021). Cerebral venous sinus thrombosis after ChAdOx1 nCov-19 vaccination with a misleading first cerebral MRI scan. Stroke and vascular neurology, 6(4). https://pubmed.ncbi.nlm.nih.gov/34244448/ | Watts, I., Smith, D., Mounter, S., Baker, E. H., Hitchings, A. W., & Gill, D. (2021). A case series of vaccine‐induced thrombotic thrombocytopenia in a London teaching hospital. British Journal of Clinical Pharmacology. | https://pubmed.ncbi.nlm.nih.gov/34694650/ | Watts, I., Smith, D., Mounter, S., Baker, E. H., Hitchings, A. W., & Gill, D. (2021). A case series of vaccine‐induced thrombotic thrombocytopenia in a London teaching hospital. British Journal of Clinical Pharmacology. https://pubmed.ncbi.nlm.nih.gov/34694650/ | Knowlton, K. U. (2021). Insights from a murine model of COVID-19 mRNA vaccination-induced myopericarditis: Could accidental intravenous vaccine injection induce myopericarditis?. Clin. infect. dis. https://pubmed.ncbi.nlm.nih.gov/34453510/ | ||||
383 | Cerebral venous sinus thrombosis associated with post-vaccination thrombocytopenia by COVID-19: | https://pubmed.ncbi.nlm.nih.gov/33845870/. | https://pubmed.ncbi.nlm.nih.gov/34370974/ | Lee, E. J., & Lee, A. I. (2021). Cerebral venous sinus thrombosis after vaccination: the UK experience. The Lancet, 398(10306), 1107-1109. | Lee, EJ y Lee, AI (2021). Trombosis del seno venoso cerebral después de la vacunación: la experiencia del Reino Unido. The Lancet, 398(10306), 1107-1109. https://pubmed.ncbi.nlm.nih.gov/34373991/ | Igual-Rouilleault, A. C., Soriano, I., Quan, P. L., Fernández-Montero, A., Elizalde, A., & Pina, L. (2021). Adenopatía axilar unilateral inducida por COVID-19 VACUNA: Evaluación de seguimiento de los EE. UU. Radiología europea, 1-8. https://pubmed.ncbi.nlm.nih.gov/34187985/. | Lee, E. J., & Lee, A. I. (2021). Cerebral venous sinus thrombosis after vaccination: the UK experience. The Lancet, 398(10306), 1107-1109. https://pubmed.ncbi.nlm.nih.gov/34370974/ | Introna, A., Caputo, F., Santoro, C., Guerra, T., Ucci, M., Mezzapesa, D. M., & Trojano, M. (2021). Guillain-Barré syndrome after AstraZeneca COVID-19-vaccination: a causal or casual association?. Clinical Neurology and Neurosurgery, 208, 106887. https://www.sciencedirect.com/science/article/pii/S0303846721004169 | Nowak, V. A., Scully, M., Davagnanam, I., & Bremner, F. (2021). Neuro-ophthalmic complications with ChAdOx1 nCoV-19 vaccine-induced thrombocytopenia and thrombosis. British Journal of Hospital Medicine, 82(10), 1-4. | https://pubmed.ncbi.nlm.nih.gov/34726934/ | Nowak, V. A., Scully, M., Davagnanam, I., & Bremner, F. (2021). Neuro-ophthalmic complications with ChAdOx1 nCoV-19 vaccine-induced thrombocytopenia and thrombosis. British Journal of Hospital Medicine, 82(10), 1-4. https://pubmed.ncbi.nlm.nih.gov/34726934/ | Koch, M., Fuld, S., Middeke, J. M., Fantana, J., von Bonin, S., & Beyer-Westendorf, J. (2021). Secondary Immune Thrombocytopenia (ITP) Associated with ChAdOx1 Covid-19 Vaccination–A Case Report. TH Open, 5(03), e315-e318. https://pubmed.ncbi.nlm.nih.gov/34377889/ | ||||
384 | Cerebral venous sinus thrombosis 2 weeks after the first dose of SARS-CoV-2 mRNA vaccine: | https://pubmed.ncbi.nlm.nih.gov/34101024/. | https://pubmed.ncbi.nlm.nih.gov/34373991/ | Şimşek, F., & Tosunoğlu, R. (2021). Massive cerebral venous thrombosis and venous watershed infarction as late complications of COVID-19: a case report. Neurological Sciences, 42(11), 4421-4423. | Şimşek, F. y Tosunoğlu, R. (2021). Trombosis venosa cerebral masiva e infarto de cuenca venosa como complicaciones tardías de COVID-19: reporte de un caso. Ciencias Neurológicas, 42(11), 4421-4423. https://pubmed.ncbi.nlm.nih.gov/34490632/ | Iguchi, T., Umeda, H., Kojima, M., Kanno, Y., Tanaka, Y., Kinoshita, N., & Sato, D. (2021). Información acumulativa de eventos adversos de la anafilaxia Después de las inyecciones de vacuna contra MRNA COVID-19 (PFIZER-BIONTECH) en Japón: el informe del primer mes. Seguridad de los medicamentos, 44 (11), 1209-1214. https://pubmed.ncbi.nlm.nih.gov/33685103/ | Şimşek, F., & Tosunoğlu, R. (2021). Massive cerebral venous thrombosis and venous watershed infarction as late complications of COVID-19: a case report. Neurological Sciences, 42(11), 4421-4423. https://pubmed.ncbi.nlm.nih.gov/34373991/ | Ioannou, A. (2021). Myocarditis should be considered in those with a troponin rise and unobstructed coronary arteries following Pfizer-BioNTech COVID-19 vaccination. QJM: An International Journal of Medicine, 1, 1. https://www.ncbi.nlm.nih.gov/pubmed/34463755 | Baldi, I., Azzolina, D., Francavilla, A., Bartolotta, P., Lorenzoni, G., Vanuzzo, D., & Gregori, D. (2021). Thrombotic Events after COVID-19 Vaccination in the Over-50s: Results from a Population-Based Study in Italy. Vaccines, 9(11), 1307. | https://pubmed.ncbi.nlm.nih.gov/34835237/ | Baldi, I., Azzolina, D., Francavilla, A., Bartolotta, P., Lorenzoni, G., Vanuzzo, D., & Gregori, D. (2021). Thrombotic Events after COVID-19 Vaccination in the Over-50s: Results from a Population-Based Study in Italy. Vaccines, 9(11), 1307. https://pubmed.ncbi.nlm.nih.gov/34835237/ | Koh, J. S., Hoe, R. H. M., Yong, M. H., Chiew, H. J., Goh, Y., Yong, K. P., ... & Umapathi, T. (2021). Hospital-based observational study of neurological disorders in patients recently vaccinated with COVID-19 mRNA vaccines. Journal of the neurological sciences, 430, 120030. https://pubmed.ncbi.nlm.nih.gov/34688190/ | ||||
385 | Vaccine-induced immune thrombotic thrombocytopenia causing a severe form of cerebral venous thrombosis with a high mortality rate: a case series: | https://pubmed.ncbi.nlm.nih.gov/34393988/. | https://pubmed.ncbi.nlm.nih.gov/34490632/ | Chen, V. M., Curnow, J. L., Tran, H. A., & Choi, P. Y. I. (2021). Australian and New Zealand approach to diagnosis and management of vaccine‐induced immune thrombosis and thrombocytopenia. Medical Journal of Australia, 215(6), 245-249. | Chen, V. M., Curnow, J. L., Tran, H. A. y Choi, P. Y. I. (2021). Enfoque australiano y neozelandés para el diagnóstico y tratamiento de la trombosis inmunitaria y la trombocitopenia inducidas por vacunas. Revista médica de Australia, 215(6), 245-249. https://pubmed.ncbi.nlm.nih.gov/33909350/ | Iguchi, T., Umeda, H., Kojima, M., Kanno, Y., Tanaka, Y., Kinoshita, N., & Sato, D. (2021). Información acumulativa de eventos adversos de la anafilaxia Después de las inyecciones de vacuna contra MRNA COVID-19 (PFIZER-BIONTECH) en Japón: el informe del primer mes. Seguridad de los medicamentos, 44 (11), 1209-1214. https://www.ncbi.nlm.nih.gov/pubmed/34544112 | Chen, V. M., Curnow, J. L., Tran, H. A., & Choi, P. Y. I. (2021). Australian and New Zealand approach to diagnosis and management of vaccine‐induced immune thrombosis and thrombocytopenia. Medical Journal of Australia, 215(6), 245-249. https://pubmed.ncbi.nlm.nih.gov/34490632/ | Ioannou, A. (2021). T2 mapping should be utilized in cases of suspected myocarditis to confirm an acute inflammatory process. QJM: An International Journal of Medicine. https://www.ncbi.nlm.nih.gov/pubmed/34931681 | Ashrani, A. A., Crusan, D. J., Petterson, T., Bailey, K., & Heit, J. A. (2022). Age-and sex-specific incidence of cerebral venous sinus thrombosis associated with Ad26. COV2. S COVID-19 vaccination. JAMA internal medicine, 182(1), 80-83. | https://pubmed.ncbi.nlm.nih.gov/34724036/. | Ashrani, A. A., Crusan, D. J., Petterson, T., Bailey, K., & Heit, J. A. (2022). Age-and sex-specific incidence of cerebral venous sinus thrombosis associated with Ad26. COV2. S COVID-19 vaccination. JAMA internal medicine, 182(1), 80-83. https://pubmed.ncbi.nlm.nih.gov/34724036/. | Kohli, U., Desai, L., Chowdhury, D., Harahsheh, A. S., Yonts, A. B., Ansong, A., ... & Ang, J. Y. (2021). mRNA Coronavirus-19 Vaccine-Associated Myopericarditis in Adolescents: A Survey Study. The Journal of pediatrics. https://www.ncbi.nlm.nih.gov/pubmed/34952008 | ||||
386 | Adenovirus interactions with platelets and coagulation and vaccine-associated autoimmune thrombocytopenia thrombosis syndrome: | https://pubmed.ncbi.nlm.nih.gov/34407607/. | https://pubmed.ncbi.nlm.nih.gov/33909350/ | Sørvoll, I. H., Horvei, K. D., Ernstsen, S. L., Lægreid, I. J., Lund, S., Grønli, R. H., ... & Ahlen, M. T. (2021). An observational study to identify the prevalence of thrombocytopenia and anti‐PF4/polyanion antibodies in Norwegian health care workers after COVID‐19 vaccination. Journal of Thrombosis and Haemostasis, 19(7), 1813-1818. | Sørvoll, I. H., Horvei, K. D., Ernstsen, S. L., Lægreid, I. J., Lund, S., Grønli, R. H., ... y Ahlen, M. T. (2021). Un estudio observacional para identificar la prevalencia de trombocitopenia y anticuerpos anti‐PF4/polianión en trabajadores de la salud noruegos después de la vacunación contra la COVID‐19. Revista de trombosis y hemostasia, 19 (7), 1813-1818. https://pubmed.ncbi.nlm.nih.gov/33981305/. | Ikenberg, B., Demleitner, A. F., Thiele, T., Wiestler, B., Götze, K., Mößmer, G., & Lingor, P. (2021). Trombosis sinusal venosa cerebral después de la vacunación de Chadox1 NCOV-19 con una primera exploración de MRI cerebral engañosa. Trayoto y neurología vascular, 6 (4). https://pubmed.ncbi.nlm.nih.gov/34226070/ | Sørvoll, I. H., Horvei, K. D., Ernstsen, S. L., Lægreid, I. J., Lund, S., Grønli, R. H., ... & Ahlen, M. T. (2021). An observational study to identify the prevalence of thrombocytopenia and anti‐PF4/polyanion antibodies in Norwegian health care workers after COVID‐19 vaccination. Journal of Thrombosis and Haemostasis, 19(7), 1813-1818. https://pubmed.ncbi.nlm.nih.gov/33909350/ | İremli, B. G., Şendur, S. N., & Ünlütürk, U. (2021). Three cases of subacute thyroiditis following SARS-CoV-2 vaccine: postvaccination ASIA syndrome. The Journal of Clinical Endocrinology & Metabolism, 106(9), 2600-2605. https://pubmed.ncbi.nlm.nih.gov/34043800/. | Kuzumi, A., Yoshizaki, A., Chiba, K., Mitsuo, S., Matsuda, K. M., Norimatsu, Y., ... & Sato, S. (2022). Genital necrosis with cutaneous thrombosis after COVID‐19 mRNA vaccination. Journal of the European Academy of Dermatology and Venereology, 36(3), e185-e186. | https://pubmed.ncbi.nlm.nih.gov/34839563/ | Kuzumi, A., Yoshizaki, A., Chiba, K., Mitsuo, S., Matsuda, K. M., Norimatsu, Y., ... & Sato, S. (2022). Genital necrosis with cutaneous thrombosis after COVID‐19 mRNA vaccination. Journal of the European Academy of Dermatology and Venereology, 36(3), e185-e186. https://pubmed.ncbi.nlm.nih.gov/34839563/ | Koizumi, T., Awaya, T., Yoshioka, K., Kitano, S., Hayama, H., Amemiya, K., ... & Nakamura, M. (2021). Myocarditis after COVID-19 mRNA vaccines. QJM: An International Journal of Medicine, 114(10), 741-743. https://pubmed.ncbi.nlm.nih.gov/34546329/. | ||||
387 | Headache attributed to COVID-19 (SARS-CoV-2 coronavirus) vaccination with the ChAdOx1 nCoV-19 (AZD1222) vaccine: a multicenter observational cohort study: | https://pubmed.ncbi.nlm.nih.gov/34313952/ | https://pubmed.ncbi.nlm.nih.gov/33981305/. | Román, G. C., Gracia, F., Torres, A., Palacios, A., Gracia, K., & Harris, D. (2021). Acute transverse myelitis (ATM): clinical review of 43 patients with COVID-19-associated ATM and 3 post-vaccination ATM serious adverse events with the ChAdOx1 nCoV-19 vaccine (AZD1222). Frontiers in immunology, 12, 879. | Román, G. C., Gracia, F., Torres, A., Palacios, A., Gracia, K., & Harris, D. (2021). Mielitis transversa aguda (ATM): revisión clínica de 43 pacientes con ATM asociada a COVID-19 y 3 eventos adversos graves de ATM posvacunación con la vacuna ChAdOx1 nCoV-19 (AZD1222). Fronteras en inmunología, 12, 879. https://pubmed.ncbi.nlm.nih.gov/33877737/ | INTRONA, A., CAPUTO, F., SANTORO, CA., GUERRA, T., UCCI, M., Mezzapesa, D. M., & Trojano, M. (2021). Síndrome de Guillain-Barré después de AstraZeneca covid-19-vacunación: ¿Una asociación causal o casual? Neurología clínica y neurocirugía, 208, 106887. https://www.sciencedirect.com/science/article/pii/S0165572821002186 | Román, G. C., Gracia, F., Torres, A., Palacios, A., Gracia, K., & Harris, D. (2021). Acute transverse myelitis (ATM): clinical review of 43 patients with COVID-19-associated ATM and 3 post-vaccination ATM serious adverse events with the ChAdOx1 nCoV-19 vaccine (AZD1222). Frontiers in immunology, 12, 879. https://pubmed.ncbi.nlm.nih.gov/33981305/. | Irvine, N. J., & Wiles, B. L. (2021). Petechiae and Desquamation of Fingers Following Immunization With BTN162b2 Messenger RNA (mRNA) COVID-19 Vaccine. Cureus, 13(8). https://pubmed.ncbi.nlm.nih.gov/34513435/ | Yagi, Y., Asami, Y., Kyoya, M., & Yokota, T. (2022). Cerebral venous sinus thrombosis after mRNA-based COVID-19 vaccination. Neurological Sciences, 43(1), 41-43. | https://pubmed.ncbi.nlm.nih.gov/34783932/. | Yagi, Y., Asami, Y., Kyoya, M., & Yokota, T. (2022). Cerebral venous sinus thrombosis after mRNA-based COVID-19 vaccination. Neurological Sciences, 43(1), 41-43. https://pubmed.ncbi.nlm.nih.gov/34783932/. | Kong, J., Cuevas-Castillo, F., Nassar, M., Lei, C. M., Idrees, Z., Fix, W. C., ... & Mathew, A. (2021). Bullous drug eruption after second dose of mRNA-1273 (Moderna) COVID-19 vaccine: Case report. Journal of Infection and Public Health, 14(10), 1392-1394. https://www.sciencedirect.com/science/article/pii/S1876034121001878. | ||||
388 | Adverse effects reported after COVID-19 vaccination in a tertiary care hospital, focus on cerebral venous sinus thrombosis (CVST): | https://pubmed.ncbi.nlm.nih.gov/34092166/ | https://pubmed.ncbi.nlm.nih.gov/33877737/ | Blauenfeldt, R. A., Kristensen, S. R., Ernstsen, S. L., Kristensen, C. C. H., Simonsen, C. Z., & Hvas, A. M. (2021). Thrombocytopenia with acute ischemic stroke and bleeding in a patient newly vaccinated with an adenoviral vector‐based COVID‐19 vaccine. Journal of Thrombosis and Haemostasis, 19(7), 1771-1775. | Blauenfeldt, R. A., Kristensen, S. R., Ernstsen, S. L., Kristensen, C. C. H., Simonsen, C. Z. y Hvas, A. M. (2021). Trombocitopenia con accidente cerebrovascular isquémico agudo y hemorragia en un paciente recién vacunado con una vacuna COVID-19 basada en vectores adenovirales. Revista de trombosis y hemostasia, 19 (7), 1771-1775. https://pubmed.ncbi.nlm.nih.gov/34254476/ | Ioannou, A. (2021). La asignación de T2 debe utilizarse en casos de miocarditis sospechada para confirmar un proceso inflamatorio agudo. QJM: un Diario Internacional de Medicina. https://www.ncbi.nlm.nih.gov/pubmed/34342500 | Blauenfeldt, R. A., Kristensen, S. R., Ernstsen, S. L., Kristensen, C. C. H., Simonsen, C. Z., & Hvas, A. M. (2021). Thrombocytopenia with acute ischemic stroke and bleeding in a patient newly vaccinated with an adenoviral vector‐based COVID‐19 vaccine. Journal of Thrombosis and Haemostasis, 19(7), 1771-1775. https://pubmed.ncbi.nlm.nih.gov/33877737/ | Isaak, A., Feisst, A., & Luetkens, J. A. (2021). Myocarditis following COVID-19 vaccination. Radiology, 301(1), E378-E379. https://www.ncbi.nlm.nih.gov/pubmed/34342500 | Thachil, J. (2021, October). COVID-19 vaccine-induced immune thrombosis with thrombocytopenia (VITT) and the shades of grey in thrombus formation. In Seminars in thrombosis and hemostasis. Thieme Medical Publishers, Inc.. | https://pubmed.ncbi.nlm.nih.gov/34624910/ | Thachil, J. (2021, October). COVID-19 vaccine-induced immune thrombosis with thrombocytopenia (VITT) and the shades of grey in thrombus formation. In Seminars in thrombosis and hemostasis. Thieme Medical Publishers, Inc.. https://pubmed.ncbi.nlm.nih.gov/34624910/ | Konu, Y. R., Gbeasor-Komlanvi, F. A., Yerima, M., Sadio, A. J., Tchankoni, M. K., Zida-Compaore, W. I. C., ... & Ekouevi, D. K. (2021). Prevalence of severe adverse events among health professionals after receiving the first dose of the ChAdOx1 nCoV-19 coronavirus vaccine (Covishield) in Togo, March 2021. Archives of Public Health, 79(1), 1-9. https://pubmed.ncbi.nlm.nih.gov/34819146/. | ||||
389 | Cerebral venous sinus thrombosis following vaccination against SARS-CoV-2: an analysis of cases reported to the European Medicines Agency: | https://pubmed.ncbi.nlm.nih.gov/34293217/ | https://pubmed.ncbi.nlm.nih.gov/34254476/ | Huh, K., Na, Y., Kim, Y. E., Radnaabaatar, M., Peck, K. R., & Jung, J. (2021). Predicted and observed incidence of thromboembolic events among Koreans vaccinated with ChAdOx1 nCoV-19 vaccine. Journal of Korean medical science, 36(27). | Huh, K., Na, Y., Kim, Y. E., Radnaabaatar, M., Peck, K. R. y Jung, J. (2021). Incidencia prevista y observada de eventos tromboembólicos entre los coreanos vacunados con la vacuna ChAdOx1 nCoV-19. Revista de ciencia médica coreana, 36(27). https://pubmed.ncbi.nlm.nih.gov/34483267/. | Ioannou, A. (2021). La miocarditis debe considerarse en aquellos con un aumento de troponina y las arterias coronarias sin obstrucciones después de la vacunación de PFIZE-BIONTECH COVID-19. QJM: Un Diario Internacional de Medicina, 1, 1. https://www.ncbi.nlm.nih.gov/pubmed/34931681 | Huh, K., Na, Y., Kim, Y. E., Radnaabaatar, M., Peck, K. R., & Jung, J. (2021). Predicted and observed incidence of thromboembolic events among Koreans vaccinated with ChAdOx1 nCoV-19 vaccine. Journal of Korean medical science, 36(27). https://pubmed.ncbi.nlm.nih.gov/34254476/ | Ismail, I. I., & Salama, S. (2022). A systematic review of cases of CNS demyelination following COVID-19 vaccination. Journal of neuroimmunology, 362, 577765. https://pubmed.ncbi.nlm.nih.gov/34839149/ | Maramattom, B. V., Philips, G., Thomas, J., & Santhamma, S. G. N. (2021). Inflammatory myositis after ChAdOx1 vaccination. The Lancet Rheumatology, 3(11), e747-e749. | https://pubmed.ncbi.nlm.nih.gov/34585145/ | Maramattom, B. V., Philips, G., Thomas, J., & Santhamma, S. G. N. (2021). Inflammatory myositis after ChAdOx1 vaccination. The Lancet Rheumatology, 3(11), e747-e749. https://pubmed.ncbi.nlm.nih.gov/34585145/ | Kostoff, R. N., Calina, D., Kanduc, D., Briggs, M. B., Vlachoyiannopoulos, P., Svistunov, A. A., & Tsatsakis, A. (2021). Erratum to “Why are we vaccinating children against COVID-19?”[Toxicol. Rep. 8C (2021) 1665–1684/1193]. Toxicology Reports. https://www.ncbi.nlm.nih.gov/pubmed/34642628 | ||||
390 | A rare case of a middle-age Asian male with cerebral venous thrombosis after COVID-19 AstraZeneca vaccination: | https://pubmed.ncbi.nlm.nih.gov/34274191/ | https://pubmed.ncbi.nlm.nih.gov/34483267/. | Uaprasert, N., Panrong, K., Tungjitviboonkun, S., Dussadee, K., Decharatanachart, P., Kaveevorayan, P., ... & Rojnuckarin, P. (2022). ChAdOx1 nCoV-19 vaccine-associated thrombocytopenia: three cases of immune thrombocytopenia after 107 720 doses of ChAdOx1 vaccination in Thailand. Blood Coagulation & Fibrinolysis, 33(1), 67-70. | Uaprasert, N., Panrong, K., Tungjitviboonkun, S., Dussadee, K., Decharatanachart, P., Kaveevorayan, P., ... y Rojnuckarin, P. (2022). Trombocitopenia asociada a la vacuna ChAdOx1 nCoV-19: tres casos de trombocitopenia inmunitaria después de 107 720 dosis de la vacuna ChAdOx1 en Tailandia. Coagulación sanguínea y fibrinólisis, 33(1), 67-70. https://pubmed.ncbi.nlm.nih.gov/34273119/ | İremli, B. G., şendur, S. N., & Ünlütürk, U. (2021). Tres casos de tiroiditis subaguda después de la vacuna contra SARS-COV-2: Síndrome de Asia posvocante. The Journal of Clinical Endocrinology & Metabolism, 106 (9), 2600-2605. https://pubmed.ncbi.nlm.nih.gov/34447646/ | Uaprasert, N., Panrong, K., Tungjitviboonkun, S., Dussadee, K., Decharatanachart, P., Kaveevorayan, P., ... & Rojnuckarin, P. (2022). ChAdOx1 nCoV-19 vaccine-associated thrombocytopenia: three cases of immune thrombocytopenia after 107 720 doses of ChAdOx1 vaccination in Thailand. Blood Coagulation & Fibrinolysis, 33(1), 67-70. https://pubmed.ncbi.nlm.nih.gov/34483267/. | Istampoulouoglou, I., Dimitriou, G., Späni, S., Christ, A., Zimmermanns, B., Koechlin, S., ... & Leuppi-Taegtmeyer, A. B. (2021). Myocarditis and pericarditis in association with COVID-19 mRNA-vaccination: cases from a regional pharmacovigilance centre. Global cardiology science & practice, 2021(3). https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8587334/ | Flower, L., Bares, Z., Santiapillai, G., & Harris, S. (2021). Acute ST-segment elevation myocardial infarction secondary to vaccine-induced immune thrombosis with thrombocytopaenia (VITT). BMJ Case Reports CP, 14(9), e245218. | https://pubmed.ncbi.nlm.nih.gov/34580132/. | Flower, L., Bares, Z., Santiapillai, G., & Harris, S. (2021). Acute ST-segment elevation myocardial infarction secondary to vaccine-induced immune thrombosis with thrombocytopaenia (VITT). BMJ Case Reports CP, 14(9), e245218. https://pubmed.ncbi.nlm.nih.gov/34580132/. | Kostoff, R. N., Calina, D., Kanduc, D., Briggs, M. B., Vlachoyiannopoulos, P., Svistunov, A. A., & Tsatsakis, A. (2021). Why are we vaccinating children against COVID-19?. Toxicology reports, 8, 1665-1684. https://www.ncbi.nlm.nih.gov/pubmed/34540594 | ||||
391 | Cerebral venous sinus thrombosis negative for anti-PF4 antibody without thrombocytopenia after immunization with COVID-19 vaccine in a non-comorbid elderly Indian male treated with conventional heparin-warfarin-based anticoagulation: | https://pubmed.ncbi.nlm.nih.gov/34186376/ | https://pubmed.ncbi.nlm.nih.gov/34273119/ | de Mélo Silva Jr, M. L., & Lopes, D. P. (2021). Large hemorrhagic stroke after ChAdOx1 nCoV‐19 vaccination: A case report. Acta Neurologica Scandinavica, 144(6), 717-718. | de Mélo Silva Jr, ML y Lopes, DP (2021). Gran accidente cerebrovascular hemorrágico después de la vacunación ChAdOx1 nCoV-19: reporte de un caso. Acta Neurologica Scandinavica, 144(6), 717-718. https://pubmed.ncbi.nlm.nih.gov/34276917/ | Irvine, N. J., y Wiles, B. L. (2021). Petechiae y descamación de los dedos después de la inmunización con la vacuna COVID-19 de COVID-19 Messenger RNA (ARNm) de BTN162B2. CUREUS, 13 (8). https://pubmed.ncbi.nlm.nih.gov/34512037/ | de Mélo Silva Jr, M. L., & Lopes, D. P. (2021). Large hemorrhagic stroke after ChAdOx1 nCoV‐19 vaccination: A case report. Acta Neurologica Scandinavica, 144(6), 717-718. https://pubmed.ncbi.nlm.nih.gov/34273119/ | Istampoulouoglou, I., Dimitriou, G., Späni, S., Christ, A., Zimmermanns, B., Koechlin, S., ... & Leuppi-Taegtmeyer, A. B. (2021). Myocarditis and pericarditis in association with COVID-19 mRNA-vaccination: cases from a regional pharmacovigilance centre. Global cardiology science & practice, 2021(3). https://www.ncbi.nlm.nih.gov/pubmed/34805376 | Asmat, H., Fayeye, F., Alshakaty, H., & Patel, J. (2021). A rare case of COVID-19 vaccine-induced thrombotic thrombocytopaenia (VITT) involving the veno-splanchnic and pulmonary arterial circulation, from a UK district general hospital. BMJ Case Reports CP, 14(9), e244223. | https://pubmed.ncbi.nlm.nih.gov/34535492/ | Asmat, H., Fayeye, F., Alshakaty, H., & Patel, J. (2021). A rare case of COVID-19 vaccine-induced thrombotic thrombocytopaenia (VITT) involving the veno-splanchnic and pulmonary arterial circulation, from a UK district general hospital. BMJ Case Reports CP, 14(9), e244223. https://pubmed.ncbi.nlm.nih.gov/34535492/ | Kounis, N. G., Koniari, I., Mplani, V., Kouni, S. N., Plotas, P., & Tsigkas, G. (2022). Acute Myocardial Infarction Within 24 Hours After COVID-19 Vaccination: Is Kounis Syndrome the Culprit?. American Journal of Cardiology, 162, 207. https://pubmed.ncbi.nlm.nih.gov/34702550/ | ||||
392 | Arterial events, venous thromboembolism, thrombocytopenia and bleeding after vaccination with Oxford-AstraZeneca ChAdOx1-S in Denmark and Norway: population-based cohort study: | https://pubmed.ncbi.nlm.nih.gov/33952445/ | https://pubmed.ncbi.nlm.nih.gov/34276917/ | Panovska-Stavridis, I., Pivkova-Veljanovska, A., Trajkova, S., Lazarevska, M., Grozdanova, A., & Filipche, V. (2021). A rare case of superior ophthalmic vein thrombosis and thrombocytopenia following ChAdOx1 nCoV-19 vaccine against SARS-CoV-2. Mediterranean Journal of Hematology and Infectious Diseases, 13(1). | Panovska-Stavridis, I., Pivkova-Veljanovska, A., Trajkova, S., Lazarevska, M., Grozdanova, A. y Filipche, V. (2021). Un caso raro de trombosis de la vena oftálmica superior y trombocitopenia después de la vacuna ChAdOx1 nCoV-19 contra el SARS-CoV-2. Revista Mediterránea de Hematología y Enfermedades Infecciosas, 13(1). https://pubmed.ncbi.nlm.nih.gov/34268278/. | Isaak, A., Feisst, A., & Luetkens, J. A. (2021). Miocarditis después de la vacunación de COVID-19. Radiología, 301 (1), E378-E379. https://www.ncbi.nlm.nih.gov/pubmed/34805376 | Panovska-Stavridis, I., Pivkova-Veljanovska, A., Trajkova, S., Lazarevska, M., Grozdanova, A., & Filipche, V. (2021). A rare case of superior ophthalmic vein thrombosis and thrombocytopenia following ChAdOx1 nCoV-19 vaccine against SARS-CoV-2. Mediterranean Journal of Hematology and Infectious Diseases, 13(1). https://pubmed.ncbi.nlm.nih.gov/34276917/ | Iwata, H., Kamiya, K., Kado, S., Nakaya, T., Kawata, H., Komine, M., & Ohtsuki, M. (2021). Case of immunoglobulin A vasculitis following coronavirus disease 2019 vaccination. The Journal of Dermatology, 48(12), e598-e599. https://pubmed.ncbi.nlm.nih.gov/34535924/ | Alalwan, A. A., Abou Trabeh, A., Premchandran, D., & Razeem, M. (2021). COVID-19 Vaccine-Induced Thrombotic Thrombocytopenia: A Case Series. Cureus, 13(9). | https://pubmed.ncbi.nlm.nih.gov/34527501/ | Alalwan, A. A., Abou Trabeh, A., Premchandran, D., & Razeem, M. (2021). COVID-19 Vaccine-Induced Thrombotic Thrombocytopenia: A Case Series. Cureus, 13(9). https://pubmed.ncbi.nlm.nih.gov/34527501/ | Kounis, N. G., Mplani, V., Koniari, I., & Velissaris, D. (2022). Hypersensitivity myocarditis and COVID-19 vaccines. Kardiologia Polska (Polish Heart Journal), 80(1), 109-110. https://pubmed.ncbi.nlm.nih.gov/34856634/. | ||||
393 | Procoagulant microparticles: a possible link between vaccine-induced immune thrombocytopenia (VITT) and cerebral sinus venous thrombosis: | https://pubmed.ncbi.nlm.nih.gov/34129181/ | https://pubmed.ncbi.nlm.nih.gov/34268278/. | Cliff-Patel, N., Moncrieff, L., & Ziauddin, V. (2021). Renal vein thrombosis and pulmonary embolism secondary to vaccine-induced thrombotic thrombocytopenia (VITT). European Journal of Case Reports in Internal Medicine, 8(7). | Cliff-Patel, N., Moncrieff, L. y Ziauddin, V. (2021). Trombosis de la vena renal y embolia pulmonar secundaria a trombocitopenia trombótica inducida por vacunas (TTVI). Revista europea de informes de casos de medicina interna, 8(7). https://pubmed.ncbi.nlm.nih.gov/33990339/. | Ismail, I. I., & Salama, S. (2022). Una revisión sistemática de los casos de desmielinización del CNS después de la vacunación COVID-19. Diario de Neuroimmunology, 362, 577765. https://pubmed.ncbi.nlm.nih.gov/33685772/ | Cliff-Patel, N., Moncrieff, L., & Ziauddin, V. (2021). Renal vein thrombosis and pulmonary embolism secondary to vaccine-induced thrombotic thrombocytopenia (VITT). European Journal of Case Reports in Internal Medicine, 8(7). https://pubmed.ncbi.nlm.nih.gov/34268278/. | Izzedine, H., Bonilla, M., & Jhaveri, K. D. (2021). Nephrotic syndrome and vasculitis following SARS-CoV-2 vaccine: true association or circumstantial?. Nephrology Dialysis Transplantation. https://pubmed.ncbi.nlm.nih.gov/34245294/. | Gordon, S. F., Clothier, H. J., Morgan, H., Buttery, J. P., Phuong, L. K., Monagle, P., ... & Crawford, N. W. (2021). Immune thrombocytopenia following immunisation with Vaxzevria ChadOx1-S (AstraZeneca) vaccine, Victoria, Australia. Vaccine, 39(48), 7052-7057. | https://pubmed.ncbi.nlm.nih.gov/34756770/ | Gordon, S. F., Clothier, H. J., Morgan, H., Buttery, J. P., Phuong, L. K., Monagle, P., ... & Crawford, N. W. (2021). Immune thrombocytopenia following immunisation with Vaxzevria ChadOx1-S (AstraZeneca) vaccine, Victoria, Australia. Vaccine, 39(48), 7052-7057. https://pubmed.ncbi.nlm.nih.gov/34756770/ | Kow, C. S., & Hasan, S. S. (2021). Cerebral venous thrombosis following COVID-19 vaccination. Journal of Stroke and Cerebrovascular Diseases, 30(10). https://pubmed.ncbi.nlm.nih.gov/34045111/. | ||||
394 | S. case reports of cerebral venous sinus thrombosis with thrombocytopenia after vaccination with Ad26.COV2.S, March 2-April 21, 2021: | https://pubmed.ncbi.nlm.nih.gov/33929487/. | https://pubmed.ncbi.nlm.nih.gov/33990339/. | Jones, M., Boisvert, A., Landry, J., & Petrasek, P. F. (2021). Limb ischemia and pulmonary artery thrombosis after the ChAdOx1 nCoV-19 (Oxford–AstraZeneca) vaccine: a case of vaccine-induced immune thrombotic thrombocytopenia. CMAJ, 193(24), E906-E910. | Jones, M., Boisvert, A., Landry, J. y Petrasek, PF (2021). Isquemia de las extremidades y trombosis de la arteria pulmonar después de la vacuna ChAdOx1 nCoV-19 (Oxford-AstraZeneca): un caso de trombocitopenia trombótica inmunitaria inducida por la vacuna. CMAJ, 193(24), E906-E910. https://pubmed.ncbi.nlm.nih.gov/34314875/. | Istammoulolooglou, I., Dimitriou, G., Späni, S., Cristo, A., Zimmermanns, B., Koechlin, S., ... & Leuppi-Taegtmeyer, A. B. (2021). Miocarditis y pericarditis en asociación con COVID-19 MRNA-vacunación: casos de un centro de farmacovigilancia regional. Cicatrismo y práctica global de cardiología, 2021 (3). https://pubmed.ncbi.nlm.nih.gov/34546329/. | Jones, M., Boisvert, A., Landry, J., & Petrasek, P. F. (2021). Limb ischemia and pulmonary artery thrombosis after the ChAdOx1 nCoV-19 (Oxford–AstraZeneca) vaccine: a case of vaccine-induced immune thrombotic thrombocytopenia. CMAJ, 193(24), E906-E910. https://pubmed.ncbi.nlm.nih.gov/33990339/. | Jaafar, R., Boschi, C., Aherfi, S., Bancod, A., Le Bideau, M., Edouard, S., ... & La Scola, B. (2021). High individual heterogeneity of neutralizing activities against the original strain and nine different variants of SARS-CoV-2. Viruses, 13(11), 2177. https://www.ncbi.nlm.nih.gov/pubmed/34834983 | Van Kammen, M. S., De Sousa, D. A., Poli, S., Cordonnier, C., Heldner, M. R., Van De Munckhof, A., ... & Arslan, Y. (2021). Characteristics and outcomes of patients with cerebral venous sinus thrombosis in SARS-CoV-2 vaccine–induced immune thrombotic thrombocytopenia. JAMA neurology, 78(11), 1314-1323. | https://jamanetwork.com/journals/jamaneurology/fullarticle/2784622 | Van Kammen, M. S., De Sousa, D. A., Poli, S., Cordonnier, C., Heldner, M. R., Van De Munckhof, A., ... & Arslan, Y. (2021). Characteristics and outcomes of patients with cerebral venous sinus thrombosis in SARS-CoV-2 vaccine–induced immune thrombotic thrombocytopenia. JAMA neurology, 78(11), 1314-1323. https://jamanetwork.com/journals/jamaneurology/fullarticle/2784622 | Kragholm, K., Sessa, M., Mulvad, T., Andersen, M. P., Collatz-Christensen, H., Blomberg, S. N., ... & Sogaard, P. (2021). Thrombocytopenia after COVID-19 vaccination. Journal of Autoimmunity, 123, 102712. https://pubmed.ncbi.nlm.nih.gov/34332437/. | ||||
395 | Malignant cerebral infarction after vaccination with ChAdOx1 nCov-19: a catastrophic variant of vaccine-induced immune-mediated thrombotic thrombocytopenia: | https://pubmed.ncbi.nlm.nih.gov/34341358/ | https://pubmed.ncbi.nlm.nih.gov/34314875/. | Vaira, L. A., Podda, L., Doneddu, P., Careddu, M. G., Fozza, C., & De Riu, G. (2021). Secondary thrombocytopenia after SARS-CoV-2 vaccine: Report of a case of hemorrhage and hematoma after minor oral surgery. Journal of Stomatology, Oral and Maxillofacial Surgery. | Vaira, L. A., Podda, L., Doneddu, P., Careddu, M. G., Fozza, C. y De Riu, G. (2021). Trombocitopenia secundaria tras vacuna SARS-CoV-2: Reporte de un caso de hemorragia y hematoma luego de cirugía oral menor. Revista de Estomatología, Cirugía Oral y Maxilofacial. https://pubmed.ncbi.nlm.nih.gov/34384129/ | Istammoulolooglou, I., Dimitriou, G., Späni, S., Cristo, A., Zimmermanns, B., Koechlin, S., ... & Leuppi-Taegtmeyer, A. B. (2021). Miocarditis y pericarditis en asociación con COVID-19 MRNA-vacunación: casos de un centro de farmacovigilancia regional. Cicatrismo y práctica global de cardiología, 2021 (3). https://www.ncbi.nlm.nih.gov/pubmed/34834983 | Vaira, L. A., Podda, L., Doneddu, P., Careddu, M. G., Fozza, C., & De Riu, G. (2021). Secondary thrombocytopenia after SARS-CoV-2 vaccine: Report of a case of hemorrhage and hematoma after minor oral surgery. Journal of Stomatology, Oral and Maxillofacial Surgery. https://pubmed.ncbi.nlm.nih.gov/34314875/. | Jabagi, M. J., Botton, J., Bertrand, M., Weill, A., Farrington, P., Zureik, M., & Dray-Spira, R. (2022). Myocardial infarction, stroke, and pulmonary embolism after BNT162b2 MRNA COVID-19 vaccine in people aged 75 years or older. Jama, 327(1), 80-82. https://pubmed.ncbi.nlm.nih.gov/34807248/ | Saleh, A., & Collins, J. (2021). Case study of thrombosis and thrombocytopenia syndrome following administration of the AstraZeneca COVID-19 vaccine. Australian Journal of General Practice, 50. | https://pubmed.ncbi.nlm.nih.gov/34781321/ | Saleh, A., & Collins, J. (2021). Case study of thrombosis and thrombocytopenia syndrome following administration of the AstraZeneca COVID-19 vaccine. Australian Journal of General Practice, 50. https://pubmed.ncbi.nlm.nih.gov/34781321/ | Krajewski, P. K., & Szepietowski, J. C. (2021). Immune thrombocytopenic purpura associated with COVID‐19 Pfizer‐BioNTech BNT16B2b2 mRNA vaccine. Journal of the European Academy of Dermatology and Venereology. https://pubmed.ncbi.nlm.nih.gov/34077572/ | ||||
396 | Acute ischemic stroke revealing immune thrombotic thrombocytopenia induced by ChAdOx1 nCov-19 vaccine: impact on recanalization strategy: | https://pubmed.ncbi.nlm.nih.gov/34175640/ | https://pubmed.ncbi.nlm.nih.gov/34384129/ | Gabarin, N., Patterson, S., Pai, M., Afzaal, T., Nazy, I., Sheppard, J. A. I., ... & Warkentin, T. E. (2021). Venous thromboembolism and mild thrombocytopenia after ChAdOx1 nCoV-19 vaccination. Thrombosis and Haemostasis, 121(12), 1677-1680. | Gabarin, N., Patterson, S., Pai, M., Afzaal, T., Nazy, I., Sheppard, J. A. I., ... y Warkentin, T. E. (2021). Tromboembolismo venoso y trombocitopenia leve después de la vacunación ChAdOx1 nCoV-19. Trombosis y hemostasia, 121 (12), 1677-1680. https://pubmed.ncbi.nlm.nih.gov/34382387/ | Iwata, H., Kamiya, K., Kado, S., Nakaya, T., Kawata, H., Komine, M., & Ohtsuki, M. (2021). Caso de inmunoglobulina Una vasculitis después de la vacunación contra la enfermedad de Coronavirus 2019. El Journal of Dermatology, 48 (12), E598-E599. https://www.frontiersin.org/articles/10.3389/fmed.2021.798095/ | Gabarin, N., Patterson, S., Pai, M., Afzaal, T., Nazy, I., Sheppard, J. A. I., ... & Warkentin, T. E. (2021). Venous thromboembolism and mild thrombocytopenia after ChAdOx1 nCoV-19 vaccination. Thrombosis and Haemostasis, 121(12), 1677-1680. https://pubmed.ncbi.nlm.nih.gov/34384129/ | Jain, E., Pandav, K., Regmi, P., Michel, G., & Altshuler, I. (2021). Facial diplegia: a rare, atypical variant of Guillain-Barré syndrome and Ad26. COV2. S Vaccine. Cureus, 13(7). https://pubmed.ncbi.nlm.nih.gov/34447646/ | Maramattom, B. V., Moidu, F. M., Varikkottil, S., & Syed, A. A. (2021). Cerebral venous sinus thrombosis after ChAdOx1 vaccination: the first case of definite thrombosis with thrombocytopenia syndrome from India. BMJ Case Reports CP, 14(10), e246455. | https://pubmed.ncbi.nlm.nih.gov/34706921/ | Maramattom, B. V., Moidu, F. M., Varikkottil, S., & Syed, A. A. (2021). Cerebral venous sinus thrombosis after ChAdOx1 vaccination: the first case of definite thrombosis with thrombocytopenia syndrome from India. BMJ Case Reports CP, 14(10), e246455. https://pubmed.ncbi.nlm.nih.gov/34706921/ | Krantz, M. S., Stone Jr, C. A., Rolando, L. A., Nobis, A. E., Koo, G., Corey, K. B., ... & Phillips, E. J. (2021). An academic hospital experience screening mRNA COVID-19 vaccine risk using patient allergy history. The Journal of Allergy and Clinical Immunology: In Practice, 9(10), 3807-3810. https://www.sciencedirect.com/science/article/pii/S2213219821007972 | ||||
397 | Vaccine-induced immune thrombotic immune thrombocytopenia (VITT): a new clinicopathologic entity with heterogeneous clinical presentations: | https://pubmed.ncbi.nlm.nih.gov/34159588/. | https://pubmed.ncbi.nlm.nih.gov/34382387/ | Douxfils, J., Vayne, C., Pouplard, C., Lecompte, T., Favresse, J., Potier, F., ... & Mullier, F. (2021). Fatal exacerbation of ChadOx1-nCoV-19-induced thrombotic thrombocytopenia syndrome after initial successful therapy with intravenous immunoglobulins-a rational for monitoring immunoglobulin G levels. haematologica, 106(12), 3249. | Douxfils, J., Vayne, C., Pouplard, C., Lecompte, T., Favresse, J., Potier, F., ... y Mullier, F. (2021). Exacerbación fatal del síndrome de trombocitopenia trombótica inducida por ChadOx1-nCoV-19 después de una terapia inicial exitosa con inmunoglobulinas intravenosas, una lógica para monitorear los niveles de inmunoglobulina G. hematológica, 106(12), 3249. https://pubmed.ncbi.nlm.nih.gov/34416184/. | Izzedine, H., Bonilla, M., JHAVERI, K. D. (2021). Síndrome nefrótico y vasculitis después de la vacuna contra SARS-COV-2: ¿Asociación verdadera o circunstancial? Trasplante de diálisis de nefrología. https://pubmed.ncbi.nlm.nih.gov/34599716/. | Douxfils, J., Vayne, C., Pouplard, C., Lecompte, T., Favresse, J., Potier, F., ... & Mullier, F. (2021). Fatal exacerbation of ChadOx1-nCoV-19-induced thrombotic thrombocytopenia syndrome after initial successful therapy with intravenous immunoglobulins-a rational for monitoring immunoglobulin G levels. haematologica, 106(12), 3249. https://pubmed.ncbi.nlm.nih.gov/34382387/ | Jain, S. S., Steele, J. M., Fonseca, B., Huang, S., Shah, S., Maskatia, S. A., ... & Grosse-Wortmann, L. (2021). COVID-19 Vaccination–Associated Myocarditis in Adolescents. Pediatrics, 148(5). https://publications.aap.org/pediatrics/article/148/5/e2021053427/181357 | Hafeez, M. U., Ikram, M., Shafiq, Z., Sarfraz, A., Sarfraz, Z., Jaiswal, V., ... & Chérrez-Ojeda, I. (2021). COVID-19 vaccine-associated thrombosis with thrombocytopenia syndrome (TTS): A systematic review and post hoc analysis. Clinical and Applied Thrombosis/Hemostasis, 27, 10760296211048815. | https://pubmed.ncbi.nlm.nih.gov/34698582/. | Hafeez, M. U., Ikram, M., Shafiq, Z., Sarfraz, A., Sarfraz, Z., Jaiswal, V., ... & Chérrez-Ojeda, I. (2021). COVID-19 vaccine-associated thrombosis with thrombocytopenia syndrome (TTS): A systematic review and post hoc analysis. Clinical and Applied Thrombosis/Hemostasis, 27, 10760296211048815. https://pubmed.ncbi.nlm.nih.gov/34698582/. | Kremsner, P. G., Mann, P., Kroidl, A., Leroux-Roels, I., Schindler, C., Gabor, J. J., ... & Oostvogels, L. (2021). Safety and immunogenicity of an mRNA-lipid nanoparticle vaccine candidate against SARS-CoV-2. Wiener klinische Wochenschrift, 133(17), 931-941. https://www.ncbi.nlm.nih.gov/pubmed/34378087 | ||||
398 | Imaging and hematologic findings in thrombosis and thrombocytopenia after vaccination with ChAdOx1 nCoV-19 (AstraZeneca): | https://pubmed.ncbi.nlm.nih.gov/34402666/ | https://pubmed.ncbi.nlm.nih.gov/34416184/. | Villa, M., Díaz-Crespo, F., de José, A. P., Verdalles, Ú., Verde, E., Ruiz, F. A., ... & Goicoechea, M. (2021). A case of ANCA-associated vasculitis after AZD1222 (Oxford–AstraZeneca) SARS-CoV-2 vaccination: casualty or causality?. Kidney International, 100(4), 937-938. | Villa, M., Díaz-Crespo, F., de José, A. P., Verdalles, Ú., Verde, E., Ruiz, F. A., ... & Goicoechea, M. (2021). Un caso de vasculitis asociada a ANCA después de la vacunación contra el SARS-CoV-2 AZD1222 (Oxford-AstraZeneca): ¿víctima o causalidad?. Riñón Internacional, 100(4), 937-938. https://pubmed.ncbi.nlm.nih.gov/34261297/ | JAAFAR, R., BOSCHI, CA., AHERFI, S., BANCOD, A., Le Bideau, M., Edouard, S., ... & la Scola, B. (2021). Alta heterogeneidad individual de actividades neutralizantes contra la cepa original y nueve variantes diferentes de SARS-COV-2. Virus, 13 (11), 2177. https://www.ncbi.nlm.nih.gov/pubmed/34389692 | Villa, M., Díaz-Crespo, F., de José, A. P., Verdalles, Ú., Verde, E., Ruiz, F. A., ... & Goicoechea, M. (2021). A case of ANCA-associated vasculitis after AZD1222 (Oxford–AstraZeneca) SARS-CoV-2 vaccination: casualty or causality?. Kidney International, 100(4), 937-938. https://pubmed.ncbi.nlm.nih.gov/34416184/. | Jain, S. S., Steele, J. M., Fonseca, B., Huang, S., Shah, S., Maskatia, S. A., ... & Grosse-Wortmann, L. (2021). COVID-19 Vaccination–Associated Myocarditis in Adolescents. Pediatrics, 148(5). https://www.ncbi.nlm.nih.gov/pubmed/34389692 | Kim, G., Choi, E. J., Park, H. S., Lee, J. H., Lee, J. H., & Lee, K. H. (2021). A case report of immune thrombocytopenia after ChAdOx1 nCoV-19 vaccination. Journal of Korean medical science, 36(43). | https://pubmed.ncbi.nlm.nih.gov/34751013/. | Kim, G., Choi, E. J., Park, H. S., Lee, J. H., Lee, J. H., & Lee, K. H. (2021). A case report of immune thrombocytopenia after ChAdOx1 nCoV-19 vaccination. Journal of Korean medical science, 36(43). https://pubmed.ncbi.nlm.nih.gov/34751013/. | Kreuter, A., Licciardi‐Fernandez, M. J., Burmann, S. N., Burkert, B., Oellig, F., & Michalowitz, A. L. (2022). Induction and exacerbation of subacute cutaneous lupus erythematosus following mRNA‐based or adenoviral vector‐based SARS‐CoV‐2 vaccination. Clinical and Experimental Dermatology, 47(1), 161-163. https://pubmed.ncbi.nlm.nih.gov/34291477/ | ||||
399 | Autoimmunity roots of thrombotic events after vaccination with COVID-19: | https://pubmed.ncbi.nlm.nih.gov/34508917/ | https://pubmed.ncbi.nlm.nih.gov/34261297/ | Mendes-de-Almeida, D. P., Martins-Gonçalves, R., Morato-Santos, R., De Carvalho, G. A. C., Martins, S. A., Palhinha, L., ... & Kurtz, P. (2021). Intracerebral hemorrhage associated with vaccine-induced thrombotic thrombocytopenia following ChAdOx1 nCOVID-19 vaccine in a pregnant woman. haematologica, 106(11), 3025. | Mendes-de-Almeida, D. P., Martins-Gonçalves, R., Morato-Santos, R., De Carvalho, G. A. C., Martins, S. A., Palhinha, L., ... & Kurtz, P. (2021). Hemorragia intracerebral asociada con trombocitopenia trombótica inducida por la vacuna después de la vacuna ChAdOx1 nCOVID-19 en una mujer embarazada. hematológica, 106(11), 3025. https://pubmed.ncbi.nlm.nih.gov/34261296/ | Jabagi, M. J., Botton, J., Bertrand, M., Weill, A., Farrington, P., Zureik, M., & Dray-Spira, R. (2022). Infarto de miocardio, accidente cerebrovascular y embolia pulmonar después de la vacuna contra la COVID-19 de ARNm de BNT162B2 en personas de 75 años o más. JAMA, 327 (1), 80-82. https://pubmed.ncbi.nlm.nih.gov/34148772/ | Mendes-de-Almeida, D. P., Martins-Gonçalves, R., Morato-Santos, R., De Carvalho, G. A. C., Martins, S. A., Palhinha, L., ... & Kurtz, P. (2021). Intracerebral hemorrhage associated with vaccine-induced thrombotic thrombocytopenia following ChAdOx1 nCOVID-19 vaccine in a pregnant woman. haematologica, 106(11), 3025. https://pubmed.ncbi.nlm.nih.gov/34261297/ | James, J., Jose, J., Gafoor, V. A., Smita, B., & Balaram, N. (2021). Guillain‐Barré syndrome following ChAdOx1 nCoV‐19 COVID‐19 vaccination: A case series. Neurology and Clinical Neuroscience, 9(5), 402-405. https://pubmed.ncbi.nlm.nih.gov/34548920/ | Hsiao, Y. T., Tsai, M. J., Chen, Y. H., & Hsu, C. F. (2021). Acute transverse myelitis after COVID-19 vaccination. Medicina, 57(10), 1010. | https://pubmed.ncbi.nlm.nih.gov/34684047/. | Hsiao, Y. T., Tsai, M. J., Chen, Y. H., & Hsu, C. F. (2021). Acute transverse myelitis after COVID-19 vaccination. Medicina, 57(10), 1010. https://pubmed.ncbi.nlm.nih.gov/34684047/. | Kripalani, Y., Lakkappan, V., Parulekar, L., Shaikh, A., Singh, R., & Vyas, P. (2021). A rare case of Guillain-Barre syndrome following COVID-19 vaccination. European Journal of Case Reports in Internal Medicine, 8(9). https://pubmed.ncbi.nlm.nih.gov/34671572/ | ||||
400 | Cerebral venous sinus thrombosis after vaccination: the UK experience: | https://pubmed.ncbi.nlm.nih.gov/34370974/ | https://pubmed.ncbi.nlm.nih.gov/34261296/ | Bonato, S., Artoni, A., Lecchi, A., Schwarz, G., La Marca, S., Padovan, L., ... & Peyvandi, F. (2021). Massive cerebral venous thrombosis due to vaccine-induced immune thrombotic thrombocytopenia. haematologica, 106(11), 3021. | Bonato, S., Artoni, A., Lecchi, A., Schwarz, G., La Marca, S., Padovan, L., ... & Peyvandi, F. (2021). Trombosis venosa cerebral masiva debido a trombocitopenia trombótica inmune inducida por vacunas. hematológica, 106(11), 3021. https://pubmed.ncbi.nlm.nih.gov/34250318/. | Jain, E., Pandav, K., Regmi, P., Michel, G., & Altshuler, I. (2021). Diplegia facial: una variante rara y atípica del síndrome de Guillain-Barré y AD26. COV2. La vacuna. CUREUS, 13 (7). https://pubmed.ncbi.nlm.nih.gov/34479760/. | Bonato, S., Artoni, A., Lecchi, A., Schwarz, G., La Marca, S., Padovan, L., ... & Peyvandi, F. (2021). Massive cerebral venous thrombosis due to vaccine-induced immune thrombotic thrombocytopenia. haematologica, 106(11), 3021. https://pubmed.ncbi.nlm.nih.gov/34261296/ | Jamme, M., Mosnino, E., Hayon, J., & Franchineau, G. (2021). Fatal cerebral venous sinus thrombosis after COVID-19 vaccination. Intensive Care Medicine, 1. https://pubmed.ncbi.nlm.nih.gov/33983464/ | Haimei, M. A. (2021). Concern About the Adverse Effects of Thrombocytopenia and Thrombosis After Adenovirus-Vectored COVID-19 Vaccination. Clinical and Applied Thrombosis/Hemostasis, 27, 10760296211040110. | https://pubmed.ncbi.nlm.nih.gov/34541935/ | Haimei, M. A. (2021). Concern About the Adverse Effects of Thrombocytopenia and Thrombosis After Adenovirus-Vectored COVID-19 Vaccination. Clinical and Applied Thrombosis/Hemostasis, 27, 10760296211040110. https://pubmed.ncbi.nlm.nih.gov/34541935/ | Krutzke, L., Roesler, R., Wiese, S., & Kochanek, S. (2021). Process-related impurities in the ChAdOx1 nCov-19 vaccine. https://pubmed.ncbi.nlm.nih.gov/33846043/188 | ||||
401 | Massive cerebral venous thrombosis and venous basin infarction as late complications of COVID-19: a case report: | https://pubmed.ncbi.nlm.nih.gov/34373991/ | https://pubmed.ncbi.nlm.nih.gov/34250318/. | Anupama, Y. J., Patel, R. G., & Vankalakunti, M. (2021). Nephrotic syndrome following ChAdOx1 nCoV-19 vaccine against SARScoV-2. Kidney International Reports, 6(8), 2248. | Anupama, YJ, Patel, RG y Vankalakunti, M. (2021). Síndrome nefrótico tras la vacuna ChAdOx1 nCoV-19 contra el SARScoV-2. Informes internacionales del riñón, 6(8), 2248. https://pubmed.ncbi.nlm.nih.gov/34059191/ | Jain, S. S. S., Steele, J. M., Fonseca, B., Huang, S., Shah, S., Maskatia, S. A., ... & Grosse-Wortmann, L. (2021). COVID-19 miocarditis asociada a la vacunación en adolescentes. Pediatría, 148 (5). https://pubmed.ncbi.nlm.nih.gov/34704459/ | Anupama, Y. J., Patel, R. G., & Vankalakunti, M. (2021). Nephrotic syndrome following ChAdOx1 nCoV-19 vaccine against SARScoV-2. Kidney International Reports, 6(8), 2248. https://pubmed.ncbi.nlm.nih.gov/34250318/. | Jasaraj, R. B., Shrestha, D. B., Gaire, S., & Kassem, M. (2021). Immune Thrombocytopenic Purpura Following Pfizer-BioNTech COVID-19 Vaccine in an Elderly Female. Cureus, 13(8). https://pubmed.ncbi.nlm.nih.gov/34513446/ | Wilting, F. N., Kotsopoulos, A. M., Platteel, A. C., & van Oers, J. A. (2021). Intracerebral hemorrhage and thrombocytopenia after AstraZeneca COVID-19 vaccine: Clinical and diagnostic challenges of vaccine-induced thrombotic thrombocytopenia. Cureus, 13(9). | https://pubmed.ncbi.nlm.nih.gov/34646685/ | Wilting, F. N., Kotsopoulos, A. M., Platteel, A. C., & van Oers, J. A. (2021). Intracerebral hemorrhage and thrombocytopenia after AstraZeneca COVID-19 vaccine: Clinical and diagnostic challenges of vaccine-induced thrombotic thrombocytopenia. Cureus, 13(9). https://pubmed.ncbi.nlm.nih.gov/34646685/ | Krzywicka, K., Heldner, M. R., Sánchez van Kammen, M., van Haaps, T., Hiltunen, S., Silvis, S. M., ... & Ferro, J. M. (2021). Post‐SARS‐CoV‐2‐vaccination cerebral venous sinus thrombosis: an analysis of cases notified to the European Medicines Agency. European journal of neurology, 28(11), 3656-3662. https://pubmed.ncbi.nlm.nih.gov/34293217/ | ||||
402 | Australian and New Zealand approach to the diagnosis and treatment of vaccine-induced immune thrombosis and immune thrombocytopenia: | https://pubmed.ncbi.nlm.nih.gov/34490632/ | https://pubmed.ncbi.nlm.nih.gov/34059191/ | Turi, M. C., Spitaleri, F., Gori, A. M., Parruti, G., Rogolino, A. A., Albani, A., ... & Marcucci, R. (2021). A case of vaccine-induced immune thrombotic thrombocytopenia with massive artero-venous thrombosis. Blood Transfusion, 19(4), 343. | Turi, M. C., Spitaleri, F., Gori, A. M., Parruti, G., Rogolino, A. A., Albani, A., ... & Marcucci, R. (2021). Un caso de trombocitopenia trombótica inmunitaria inducida por vacuna con trombosis arterovenosa masiva. Transfusión de sangre, 19(4), 343. https://pubmed.ncbi.nlm.nih.gov/34331506/ | Jain, S. S. S., Steele, J. M., Fonseca, B., Huang, S., Shah, S., Maskatia, S. A., ... & Grosse-Wortmann, L. (2021). COVID-19 miocarditis asociada a la vacunación en adolescentes. Pediatría, 148 (5). https://www.ncbi.nlm.nih.gov/pubmed/34270752 | Turi, M. C., Spitaleri, F., Gori, A. M., Parruti, G., Rogolino, A. A., Albani, A., ... & Marcucci, R. (2021). A case of vaccine-induced immune thrombotic thrombocytopenia with massive artero-venous thrombosis. Blood Transfusion, 19(4), 343. https://pubmed.ncbi.nlm.nih.gov/34059191/ | Jeon, Y. H., Lim, D. H., Choi, S. W., & Choi, S. J. (2021). A flare of Still’s disease following COVID-19 vaccination in a 34-year-old patient. Rheumatology international, 1-6. https://pubmed.ncbi.nlm.nih.gov/34797392/ | Leclerc, S., Royal, V., Lamarche, C., & Laurin, L. P. (2021). Minimal change disease with severe acute kidney injury following the Oxford-AstraZeneca COVID-19 vaccine: a case report. American Journal of Kidney Diseases, 78(4), 607-610. | https://pubmed.ncbi.nlm.nih.gov/34242687/. | Leclerc, S., Royal, V., Lamarche, C., & Laurin, L. P. (2021). Minimal change disease with severe acute kidney injury following the Oxford-AstraZeneca COVID-19 vaccine: a case report. American Journal of Kidney Diseases, 78(4), 607-610. https://pubmed.ncbi.nlm.nih.gov/34242687/. | Kulkarni, P. A., & Prasad, V. (2021). Understanding risk of thrombosis with thrombocytopenia syndrome after Ad26. COV2. S vaccination. Frontiers of medicine, 15(6), 938-941. https://pubmed.ncbi.nlm.nih.gov/34595694/ | ||||
403 | An observational study to identify the prevalence of thrombocytopenia and anti-PF4 / polyanion antibodies in Norwegian health care workers after COVID-19 vaccination: | https://pubmed.ncbi.nlm.nih.gov/33909350/ | https://pubmed.ncbi.nlm.nih.gov/34331506/ | Underdown, M. J., & Nuss, R. (2021). Thrombocytopenia in a teen with sickle cell disease following COVID‐19 vaccination. Pediatric Blood & Cancer. | Underdown, MJ y Nuss, R. (2021). Trombocitopenia en un adolescente con anemia de células falciformes después de la vacunación contra la COVID-19. Sangre y cáncer pediátricos. https://www.medrxiv.org/content/10.1101/2021.08.30.21262866v1 | James, J., Jose, J., Gafoor, V. A., Smita, B., & Balaram, N. (2021). Síndrome de Guillain-Barré siguiendo a Chadox1 NCOV-19 COVID-19 Vacunación: una serie de casos. Neurología y neurociencia clínica, 9 (5), 402-405. https://pubmed.ncbi.nlm.nih.gov/34672380/ | Underdown, M. J., & Nuss, R. (2021). Thrombocytopenia in a teen with sickle cell disease following COVID‐19 vaccination. Pediatric Blood & Cancer. https://pubmed.ncbi.nlm.nih.gov/34331506/ | Jeong, J., & Choi, H. S. (2021). Sudden sensorineural hearing loss after COVID-19 vaccination. International Journal of Infectious Diseases, 113, 341-343. https://pubmed.ncbi.nlm.nih.gov/34670143/. | Fousse, M., Schub, D., Merzou, F., Fassbender, K., Sester, M., Kettner, M., ... & Goi Júnior, J. R. (2022). Case report: cerebral sinus vein thrombosis in two patients with AstraZeneca SARS-CoV-2 vaccination. Journal of neurology, 269(2), 583-586. | https://pubmed.ncbi.nlm.nih.gov/34609603/ | Fousse, M., Schub, D., Merzou, F., Fassbender, K., Sester, M., Kettner, M., ... & Goi Júnior, J. R. (2022). Case report: cerebral sinus vein thrombosis in two patients with AstraZeneca SARS-CoV-2 vaccination. Journal of neurology, 269(2), 583-586. https://pubmed.ncbi.nlm.nih.gov/34609603/ | Kustin, T., Harel, N., Finkel, U., Perchik, S., Harari, S., Tahor, M., ... & Stern, A. (2021). Evidence for increased breakthrough rates of SARS-CoV-2 variants of concern in BNT162b2-mRNA-vaccinated individuals. Nature medicine, 27(8), 1379-1384. https://www.ncbi.nlm.nih.gov/pubmed/34127854 | ||||
404 | Acute transverse myelitis (ATM): clinical review of 43 patients with COVID-19-associated ATM and 3 serious adverse events of post-vaccination ATM with ChAdOx1 nCoV-19 (AZD1222) vaccine: | https://pubmed.ncbi.nlm.nih.gov/33981305/. | https://www.medrxiv.org/content/10.1101/2021.08.30.21262866v1 | Høeg, T. B. (2021). SARS-CoV-2 mRNA vaccination-associated myocarditis in children ages 12–17: a stratified national database analysis. medRxiv [Onine]. Preprint, 8. | Høeg, TB (2021). Miocarditis asociada a la vacunación con ARNm del SARS-CoV-2 en niños de 12 a 17 años: un análisis estratificado de una base de datos nacional. medRxiv [en línea]. Preimpresión, 8. https://www.medrxiv.org/content/10.1101/2021.09.13.21262182v1.full?s=09. | Jammite, M., Mosnino, E., Hayon, J., & Franchineau, G. (2021). Trombosis sinusal venosa cerebral fatal después de la vacunación de COVID-19. Medicina de cuidados intensivos, 1. https://pubmed.ncbi.nlm.nih.gov/34116145/ | Høeg, T. B. (2021). SARS-CoV-2 mRNA vaccination-associated myocarditis in children ages 12–17: a stratified national database analysis. medRxiv [Onine]. Preprint, 8. https://www.medrxiv.org/content/10.1101/2021.08.30.21262866v1 | Jhaveri, R., Adler-Shohet, F. C., Blyth, C. C., Chiotos, K., Gerber, J. S., Green, M., ... & Zaoutis, T. (2021). Weighing the Risks of Perimyocarditis With the Benefits of SARS-CoV-2 mRNA Vaccination in Adolescents. Journal of the Pediatric Infectious Diseases Society, 10(10), 937-939. https://www.ncbi.nlm.nih.gov/pubmed/34270752 | Leerunyakul, K., Pakornphadungsit, K., & Suchonwanit, P. (2021). Case Report: Pityriasis Rosea-Like Eruption Following COVID-19 Vaccination. Frontiers in Medicine, 8. | https://pubmed.ncbi.nlm.nih.gov/34557507/ | Leerunyakul, K., Pakornphadungsit, K., & Suchonwanit, P. (2021). Case Report: Pityriasis Rosea-Like Eruption Following COVID-19 Vaccination. Frontiers in Medicine, 8. https://pubmed.ncbi.nlm.nih.gov/34557507/ | Kuter, D. J. (2021). Exacerbation of immune thrombocytopenia following COVID‐19 vaccination. British journal of haematology, 195(3), 365-370. https://pubmed.ncbi.nlm.nih.gov/34075578/ | ||||
405 | A case of acute demyelinating polyradiculoneuropathy with bilateral facial palsy after ChAdOx1 nCoV-19 vaccine:. | https://pubmed.ncbi.nlm.nih.gov/34272622/ | https://www.medrxiv.org/content/10.1101/2021.09.13.21262182v1.full?s=09. | Kafil, T., Lamacie, M. M., Chenier, S., Taggart, H., Ghosh, N., Dick, A., ... & Crean, A. M. (2021). mRNA COVID-19 Vaccination and Development of CMR-confirmed Myopericarditis. medRxiv. | Kafil, T., Lamacie, M. M., Chenier, S., Taggart, H., Ghosh, N., Dick, A., ... y Crean, A. M. (2021). Vacunación con ARNm COVID-19 y desarrollo de miopericarditis confirmada por CMR. medRxiv. https://onlinelibrary.wiley.com/doi/10.1111/trf.16672 | JASARAJ, R. B., Shrestha, D. B., Gaire, S., & Kassem, M. (2021). Púrpura trombocitopénica inmune después de la vacuna PFIZE-BIONTECH COVID-19 en una mujer mayor. CUREUS, 13 (8). https://pubmed.ncbi.nlm.nih.gov/34474550/ | Kafil, T., Lamacie, M. M., Chenier, S., Taggart, H., Ghosh, N., Dick, A., ... & Crean, A. M. (2021). mRNA COVID-19 Vaccination and Development of CMR-confirmed Myopericarditis. medRxiv. https://www.medrxiv.org/content/10.1101/2021.09.13.21262182v1.full?s=09. | Jin, W. J., Ahn, S. W., Jang, S. H., Hong, S. M., Seol, J. E., & Kim, H. (2021). Leukocytoclastic vasculitis after coronavirus disease 2019 vaccination. The Journal of Dermatology. https://pubmed.ncbi.nlm.nih.gov/34713472/803 | Tan, W. Y., Yusof Khan, A. H. K., Mohd Yaakob, M. N., Abdul Rashid, A. M., Loh, W. C., Baharin, J., ... & Hoo, F. K. (2021). Longitudinal extensive transverse myelitis following ChAdOx1 nCOV-19 vaccine: a case report. BMC neurology, 21(1), 1-4. | https://pubmed.ncbi.nlm.nih.gov/34641797/. | Tan, W. Y., Yusof Khan, A. H. K., Mohd Yaakob, M. N., Abdul Rashid, A. M., Loh, W. C., Baharin, J., ... & Hoo, F. K. (2021). Longitudinal extensive transverse myelitis following ChAdOx1 nCOV-19 vaccine: a case report. BMC neurology, 21(1), 1-4. https://pubmed.ncbi.nlm.nih.gov/34641797/. | Kuzumi, A., Yoshizaki, A., Chiba, K., Mitsuo, S., Matsuda, K. M., Norimatsu, Y., ... & Sato, S. (2022). Genital necrosis with cutaneous thrombosis after COVID‐19 mRNA vaccination. Journal of the European Academy of Dermatology and Venereology, 36(3), e185-e186. https://pubmed.ncbi.nlm.nih.gov/34839563/ | ||||
406 | Thrombocytopenia with acute ischemic stroke and hemorrhage in a patient recently vaccinated with an adenoviral vector-based COVID-19 vaccine:. | https://pubmed.ncbi.nlm.nih.gov/33877737/ | https://onlinelibrary.wiley.com/doi/10.1111/trf.16672 | Gadi, S. R., Brunker, P. A., Al‐Samkari, H., Sykes, D. B., Saff, R. R., Lo, J., ... & Leaf, R. K. (2021). Severe autoimmune hemolytic anemia following receipt of SARS‐CoV‐2 mRNA vaccine. Transfusion, 61(11), 3267-3271. | Gadi, S. R., Brunker, P. A., Al‐Samkari, H., Sykes, D. B., Saff, R. R., Lo, J., ... y Leaf, R. K. (2021). Anemia hemolítica autoinmune grave después de recibir la vacuna de ARNm del SARS-CoV-2. Transfusión, 61(11), 3267-3271. https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciab707/6353927?s=09&login=false | Jeon, Y. H., LIM, D. H., Choi, S. W., & Choi, S. J. (2021). Una llamarada de la enfermedad de Still después de la vacunación de COVID-19 en un paciente de 34 años. Reumatología Internacional, 1-6. https://pubmed.ncbi.nlm.nih.gov/34862234/ | Gadi, S. R., Brunker, P. A., Al‐Samkari, H., Sykes, D. B., Saff, R. R., Lo, J., ... & Leaf, R. K. (2021). Severe autoimmune hemolytic anemia following receipt of SARS‐CoV‐2 mRNA vaccine. Transfusion, 61(11), 3267-3271. https://onlinelibrary.wiley.com/doi/10.1111/trf.16672 | John, N. A., John, J., Kamble, P., Singhal, A., Daulatabad, V., & Vamshidhar, I. S. (2021). COVID 19 vaccine in patients of hypercoagulable disorders: a clinical perspective. Hormone Molecular Biology and Clinical Investigation. https://pubmed.ncbi.nlm.nih.gov/34786893/ | Miqdadi, A., & Herrag, M. (2021). Acute eosinophilic pneumonia associated with the anti-COVID-19 vaccine AZD1222. Cureus, 13(10). | https://pubmed.ncbi.nlm.nih.gov/34812326/. | Miqdadi, A., & Herrag, M. (2021). Acute eosinophilic pneumonia associated with the anti-COVID-19 vaccine AZD1222. Cureus, 13(10). https://pubmed.ncbi.nlm.nih.gov/34812326/. | Kwan, M. Y., Chua, G. T., Chow, C. B., Tsao, S. S., To, K. K., Yuen, K. Y., ... & Ip, P. (2021). mRNA COVID vaccine and myocarditis in adolescents. Hong Kong Med J, 27(5), 326-327. https://www.ncbi.nlm.nih.gov/pubmed/34393110 | ||||
407 | Predicted and observed incidence of thromboembolic events among Koreans vaccinated with the ChAdOx1 nCoV-19 vaccine: | https://pubmed.ncbi.nlm.nih.gov/34254476/ | https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciab707/6353927?s=09&login=false | Li, C., Chen, Y., Zhao, Y., Christopher Lung, D., Ye, Z., Song, W., ... & Yuen, K. Y. (2021). Corrigendum to: Intravenous Injection of Coronavirus Disease 2019 (COVID-19) mRNA Vaccine Can Induce Acute Myopericarditis in Mouse Model. Clinical Infectious Diseases, 73(12), 2372-2373. | Li, C., Chen, Y., Zhao, Y., Christopher Lung, D., Ye, Z., Song, W., ... y Yuen, K. Y. (2021). Corrección de errores de: La inyección intravenosa de la vacuna de ARNm de la enfermedad del coronavirus 2019 (COVID-19) puede inducir miopericarditis aguda en un modelo de ratón. Enfermedades infecciosas clínicas, 73(12), 2372-2373. https://pubmed.ncbi.nlm.nih.gov/34601006/ | Jeong, J., & Choi, H. S. (2021). Pérdida auditiva sensorinal súbita después de la vacunación de COVID-19. Diario Internacional de Enfermedades Infecciosas, 113, 341-343. https://pubmed.ncbi.nlm.nih.gov/34819146/. | Li, C., Chen, Y., Zhao, Y., Christopher Lung, D., Ye, Z., Song, W., ... & Yuen, K. Y. (2021). Corrigendum to: Intravenous Injection of Coronavirus Disease 2019 (COVID-19) mRNA Vaccine Can Induce Acute Myopericarditis in Mouse Model. Clinical Infectious Diseases, 73(12), 2372-2373. https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciab707/6353927?s=09&login=false | Jones, M., Boisvert, A., Landry, J., & Petrasek, P. F. (2021). Limb ischemia and pulmonary artery thrombosis after the ChAdOx1 nCoV-19 (Oxford–AstraZeneca) vaccine: a case of vaccine-induced immune thrombotic thrombocytopenia. CMAJ, 193(24), E906-E910. https://pubmed.ncbi.nlm.nih.gov/33990339/. | Monagle, P., Ng, A. P., Linden, M., Ignjatovic, V., Farley, A., Taoudi, S., ... & Torresi, J. (2021). Vaccine‐induced immune thrombosis and thrombocytopenia syndrome following adenovirus‐vectored severe acute respiratory syndrome coronavirus 2 vaccination: a novel hypothesis regarding mechanisms and implications for future vaccine development. Immunology and Cell Biology, 99(10), 1006-1010. | https://pubmed.ncbi.nlm.nih.gov/34664303/. | Monagle, P., Ng, A. P., Linden, M., Ignjatovic, V., Farley, A., Taoudi, S., ... & Torresi, J. (2021). Vaccine‐induced immune thrombosis and thrombocytopenia syndrome following adenovirus‐vectored severe acute respiratory syndrome coronavirus 2 vaccination: a novel hypothesis regarding mechanisms and implications for future vaccine development. Immunology and Cell Biology, 99(10), 1006-1010. https://pubmed.ncbi.nlm.nih.gov/34664303/. | Kwon, H., & Kim, T. (2022). Autoimmune encephalitis following ChAdOx1-S SARS-CoV-2 vaccination. Neurological Sciences, 43(3), 1487-1489. https://pubmed.ncbi.nlm.nih.gov/34846583/ | ||||
408 | First dose of ChAdOx1 and BNT162b2 COVID-19 vaccines and thrombocytopenic, thromboembolic, and hemorrhagic events in Scotland: | https://pubmed.ncbi.nlm.nih.gov/34108714/ | https://pubmed.ncbi.nlm.nih.gov/34601006/ | Rose, J., & McCullough, P. A. (2021). A report on myocarditis adverse events in the US vaccine adverse events reporting system (VAERS) in association with COVID-19 injectable biological products. Current problems in cardiology. | Rose, J. y McCullough, PA (2021). Un informe sobre los eventos adversos de miocarditis en el sistema de notificación de eventos adversos de vacunas (VAERS) de EE. UU. en asociación con productos biológicos inyectables COVID-19. Problemas actuales en cardiología. https://www.nejm.org/doi/full/10.1056/NEJMoa2110475 | JHHAVERI, R., Adler-Shohet, F. C., Blyth, C. C., Chiotos, K., Gerber, J. S., Green, M., ... & Zaoutis, T. (2021). Pesando los riesgos de la perimyocarditis con los beneficios de la vacunación del ARNm de SARS-COV-2 en adolescentes. Diario de la sociedad de enfermedades infecciosas pediátricas, 10 (10), 937-939. https://www.ncbi.nlm.nih.gov/pubmed/34744118 | Rose, J., & McCullough, P. A. (2021). A report on myocarditis adverse events in the US vaccine adverse events reporting system (VAERS) in association with COVID-19 injectable biological products. Current problems in cardiology. https://pubmed.ncbi.nlm.nih.gov/34601006/ | Joob, B., & Wiwanitkit, V. (2021). Acute myocarditis after coronavirus disease 2019 vaccination. Anatolian Journal of Cardiology, 25(11), 841. https://pubmed.ncbi.nlm.nih.gov/34734821/ | Crea, F. (2021). Thrombosis in peripheral artery disease and thrombotic thrombocytopenia after adenoviral COVID-19 vaccination. European Heart Journal, 42(39), 3995-3999. | https://pubmed.ncbi.nlm.nih.gov/34649281/. | Crea, F. (2021). Thrombosis in peripheral artery disease and thrombotic thrombocytopenia after adenoviral COVID-19 vaccination. European Heart Journal, 42(39), 3995-3999. https://pubmed.ncbi.nlm.nih.gov/34649281/. | Laisuan, W., Wongsa, C., Chiewchalermsri, C., Thongngarm, T., Rerkpattanapipat, T., Iamrahong, P., ... & Sompornrattanaphan, M. (2021). CoronaVac COVID-19 Vaccine-Induced Anaphylaxis: Clinical Characteristics and Revaccination Outcomes. Journal of Asthma and Allergy, 14, 1209. https://pubmed.ncbi.nlm.nih.gov/34675550/. | ||||
409 | ChAdOx1 nCoV-19 vaccine-associated thrombocytopenia: three cases of immune thrombocytopenia after 107,720 doses of ChAdOx1 vaccination in Thailand: | https://pubmed.ncbi.nlm.nih.gov/34483267/. | https://www.nejm.org/doi/full/10.1056/NEJMoa2110475 | Barda, N., Dagan, N., Ben-Shlomo, Y., Kepten, E., Waxman, J., Ohana, R., ... & Balicer, R. D. (2021). Safety of the BNT162b2 mRNA Covid-19 vaccine in a nationwide setting. New England Journal of Medicine. | Barda, N., Dagan, N., Ben-Shlomo, Y., Kepten, E., Waxman, J., Ohana, R., ... y Balicer, R. D. (2021). Seguridad de la vacuna BNT162b2 mRNA Covid-19 a nivel nacional. Revista de Medicina de Nueva Inglaterra. https://www.sciencedirect.com/science/article/pii/S1201971221007797 | Jin, W. J., Ahn, S. W., Jang, S. H., Hong, S. M., Seol, J. E., & Kim, H. (2021). Vasculitis leucocitoclástica después de la enfermedad de la enfermedad de Coronavirus 2019. El Journal of Dermatology. https://pubmed.ncbi.nlm.nih.gov/34819272/ | Barda, N., Dagan, N., Ben-Shlomo, Y., Kepten, E., Waxman, J., Ohana, R., ... & Balicer, R. D. (2021). Safety of the BNT162b2 mRNA Covid-19 vaccine in a nationwide setting. New England Journal of Medicine. https://www.nejm.org/doi/full/10.1056/NEJMoa2110475 | Joob, B., & Wiwanitkit, V. (2021). Change of blood viscosity after COVID-19 vaccination: estimation for persons with underlying metabolic syndrome. International Journal of Physiology, Pathophysiology and Pharmacology, 13(5), 148. https://pubmed.ncbi.nlm.nih.gov/34868465/ | Bennett, C., Chambers, L. M., Son, J., & Goje, O. (2021). Newly diagnosed immune thrombocytopenia in a pregnant patient after coronavirus disease 2019 vaccination. Journal of Obstetrics and Gynaecology Research, 47(11), 4077-4080. | https://pubmed.ncbi.nlm.nih.gov/34420249/ | Bennett, C., Chambers, L. M., Son, J., & Goje, O. (2021). Newly diagnosed immune thrombocytopenia in a pregnant patient after coronavirus disease 2019 vaccination. Journal of Obstetrics and Gynaecology Research, 47(11), 4077-4080. https://pubmed.ncbi.nlm.nih.gov/34420249/ | Lane, D. L., Neelapu, S. S., Xu, G., & Weaver, O. (2021). COVID-19 vaccine-related axillary and cervical lymphadenopathy in patients with current or prior breast cancer and other malignancies: cross-sectional imaging findings on MRI, CT, and PET-CT. Korean Journal of Radiology, 22(12), 1938. https://pubmed.ncbi.nlm.nih.gov/34719892/ | ||||
410 | Pulmonary embolism, transient ischemic attack, and thrombocytopenia after Johnson & Johnson COVID-19 vaccine: | https://pubmed.ncbi.nlm.nih.gov/34261635/ | https://www.sciencedirect.com/science/article/pii/S1201971221007797 | Pan, L., Zhang, Y., Cui, Y., & Wu, X. (2021). Bilateral uveitis after inoculation with COVID-19 vaccine: A case report. International Journal of Infectious Diseases, 113, 116-118. | Pan, L., Zhang, Y., Cui, Y. y Wu, X. (2021). Uveítis bilateral tras la inoculación con la vacuna COVID-19: reporte de un caso. Revista Internacional de Enfermedades Infecciosas, 113, 116-118. https://www.medrxiv.org/content/10.1101/2021.08.30.21262866v1. | John, N. A., John, J., Kamble, P., Singhal, A., Daulatabad, V., & Vamshidhar, I. S. (2021). COVID 19 Vacuna en pacientes de trastornos hipercoagulables: una perspectiva clínica. Biología molecular hormonal y investigación clínica. https://pubmed.ncbi.nlm.nih.gov/34833382/ | Pan, L., Zhang, Y., Cui, Y., & Wu, X. (2021). Bilateral uveitis after inoculation with COVID-19 vaccine: A case report. International Journal of Infectious Diseases, 113, 116-118. https://www.sciencedirect.com/science/article/pii/S1201971221007797 | Julian, J. A., Mathern, D. R., & Fernando, D. (2021). Idiopathic thrombocytopenic purpura and the moderna Covid-19 vaccine. Annals of emergency medicine, 77(6), 654-656. https://www.annemergmed.com/article/S0196-0644(21)00122-0/fulltext. | Palaiodimou, L., Stefanou, M. I., Katsanos, A. H., de Sousa, D. A., Coutinho, J. M., Lagiou, P., ... & Tsivgoulis, G. (2021). Cerebral venous sinus thrombosis and thrombotic events after vector-based COVID-19 vaccines: a systematic review and meta-analysis. Neurology, 97(21), e2136-e2147. | https://pubmed.ncbi.nlm.nih.gov/34610990/. | Palaiodimou, L., Stefanou, M. I., Katsanos, A. H., de Sousa, D. A., Coutinho, J. M., Lagiou, P., ... & Tsivgoulis, G. (2021). Cerebral venous sinus thrombosis and thrombotic events after vector-based COVID-19 vaccines: a systematic review and meta-analysis. Neurology, 97(21), e2136-e2147. https://pubmed.ncbi.nlm.nih.gov/34610990/. | Larson, V., Seidenberg, R., Caplan, A., Brinster, N. K., Meehan, S. A., & Kim, R. H. (2022). Clinical and histopathological spectrum of delayed adverse cutaneous reactions following COVID‐19 vaccination. Journal of cutaneous pathology, 49(1), 34-41. https://pubmed.ncbi.nlm.nih.gov/34292611/. | ||||
411 | Neurosurgical considerations with respect to decompressive craniectomy for intracerebral hemorrhage after SARS-CoV-2 vaccination in vaccine-induced thrombotic thrombocytopenia-VITT: | https://pubmed.ncbi.nlm.nih.gov/34202817/ | https://www.medrxiv.org/content/10.1101/2021.08.30.21262866v1. | Høeg, T. B. (2021). SARS-CoV-2 mRNA vaccination-associated myocarditis in children ages 12–17: a stratified national database analysis. medRxiv [Onine]. Preprint, 8. | Høeg, TB (2021). Miocarditis asociada a la vacunación con ARNm del SARS-CoV-2 en niños de 12 a 17 años: un análisis estratificado de una base de datos nacional. medRxiv [en línea]. Preimpresión, 8. https://www.sciencedirect.com/science/article/pii/S0168827821020936 | Jones, M., Boisvert, A., Landry, J., & Petrasek, P. F. (2021). La isquemia de las extremidades y la trombosis de la arteria pulmonar después de la vacuna Chadox1 NCOV-19 (OXFORD-ASTRAZENECA): un caso de trombocitopenia trombótica inmune inducida por la vacuna. CMAJ, 193 (24), E906-E910. https://pubmed.ncbi.nlm.nih.gov/34314875/. | Høeg, T. B. (2021). SARS-CoV-2 mRNA vaccination-associated myocarditis in children ages 12–17: a stratified national database analysis. medRxiv [Onine]. Preprint, 8. https://www.medrxiv.org/content/10.1101/2021.08.30.21262866v1. | Kadwalwala, M., Chadha, B., Ortoleva, J., & Joyce, M. (2021). Multimodality imaging and histopathology in a young man presenting with fulminant lymphocytic myocarditis and cardiogenic shock after mRNA-1273 vaccination. BMJ Case Reports CP, 14(11), e246059. https://pubmed.ncbi.nlm.nih.gov/34848416/ | Majid, I., & Mearaj, S. (2021). Sweet syndrome after Oxford‐AstraZeneca COVID‐19 vaccine (AZD1222) in an elderly female. Dermatologic Therapy, 34(6), e15146. | https://pubmed.ncbi.nlm.nih.gov/34590397/ | Majid, I., & Mearaj, S. (2021). Sweet syndrome after Oxford‐AstraZeneca COVID‐19 vaccine (AZD1222) in an elderly female. Dermatologic Therapy, 34(6), e15146. https://pubmed.ncbi.nlm.nih.gov/34590397/ | Lavin, M., Elder, P. T., O’Keeffe, D., Enright, H., Ryan, E., Kelly, A., ... & O’Donnell, J. S. (2021). Vaccine‐induced immune thrombotic thrombocytopenia (VITT)–a novel clinico‐pathological entity with heterogeneous clinical presentations. British Journal of Haematology, 195(1), 76-84. https://pubmed.ncbi.nlm.nih.gov/34159588/. | ||||
412 | Large hemorrhagic stroke after vaccination against ChAdOx1 nCoV-19: a case report: | https://pubmed.ncbi.nlm.nih.gov/34273119/ | https://www.sciencedirect.com/science/article/pii/S0168827821020936 | Tun, G. S. Z., Gleeson, D., Al-Joudeh, A., & Dube, A. (2022). Immune-mediated hepatitis with the Moderna vaccine, no longer a coincidence but confirmed. Journal of Hepatology, 76(3), 747-749. | Tun, G. S. Z., Gleeson, D., Al-Joudeh, A. y Dube, A. (2022). La hepatitis inmunomediada con la vacuna Moderna, ya no es una coincidencia sino una confirmación. Revista de hepatología, 76(3), 747-749. https://www.nature.com/articles/s41421-021-00329-3 | Joob, B., & Wiwanitkit, V. (2021). Cambio de viscosidad sanguínea después de la vacunación de COVID-19: estimación para personas con síndrome metabólico subyacente. Diario Internacional de Fisiología, Fisiophisología y Farmacología, 13 (5), 148. https://pubmed.ncbi.nlm.nih.gov/34097311/ | Tun, G. S. Z., Gleeson, D., Al-Joudeh, A., & Dube, A. (2022). Immune-mediated hepatitis with the Moderna vaccine, no longer a coincidence but confirmed. Journal of Hepatology, 76(3), 747-749. https://www.sciencedirect.com/science/article/pii/S0168827821020936 | Kafil, T., Lamacie, M. M., Chenier, S., Taggart, H., Ghosh, N., Dick, A., ... & Crean, A. M. (2021). mRNA COVID-19 Vaccination and Development of CMR-confirmed Myopericarditis. medRxiv. https://www.medrxiv.org/content/10.1101/2021.09.13.21262182v1.full?s=09. | Jeong, J., & Choi, H. S. (2021). Sudden sensorineural hearing loss after COVID-19 vaccination. International Journal of Infectious Diseases, 113, 341-343. | https://pubmed.ncbi.nlm.nih.gov/34670143/. | Jeong, J., & Choi, H. S. (2021). Sudden sensorineural hearing loss after COVID-19 vaccination. International Journal of Infectious Diseases, 113, 341-343. https://pubmed.ncbi.nlm.nih.gov/34670143/. | Lazaros, G., Anastassopoulou, C., Hatziantoniou, S., Kalos, T., Soulaidopoulos, S., Lazarou, E., ... & Tsioufis, C. (2021). A case series of acute pericarditis following COVID-19 vaccination in the context of recent reports from Europe and the United States. Vaccine, 39(45), 6585-6590. https://pubmed.ncbi.nlm.nih.gov/34635376/ | ||||
413 | Polyarthralgia and myalgia syndrome after vaccination with ChAdOx1 nCOV-19: | https://pubmed.ncbi.nlm.nih.gov/34463066/ | https://www.nature.com/articles/s41421-021-00329-3 | Liu, J., Wang, J., Xu, J., Xia, H., Wang, Y., Zhang, C., ... & Liu, Z. (2021). Comprehensive investigations revealed consistent pathophysiological alterations after vaccination with COVID-19 vaccines. Cell discovery, 7(1), 1-15. | Liu, J., Wang, J., Xu, J., Xia, H., Wang, Y., Zhang, C., ... y Liu, Z. (2021). Investigaciones exhaustivas revelaron alteraciones fisiopatológicas constantes después de la vacunación con vacunas COVID-19. Descubrimiento de células, 7(1), 1-15. https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8553377/ | Joob, B., & Wiwanitkit, V. (2021). Miocarditis aguda después de la enfermedad de la enfermedad de Coronavirus 2019. Diario Anatoliano de Cardiología, 25 (11), 841. https://pubmed.ncbi.nlm.nih.gov/34246585/ | Liu, J., Wang, J., Xu, J., Xia, H., Wang, Y., Zhang, C., ... & Liu, Z. (2021). Comprehensive investigations revealed consistent pathophysiological alterations after vaccination with COVID-19 vaccines. Cell discovery, 7(1), 1-15. https://www.nature.com/articles/s41421-021-00329-3 | Kanabar, G., & Wilkinson, P. (2021). Guillain‐Barré syndrome presenting with facial diplegia following COVID‐19 vaccination in two patients. BMJ Case Reports CP, 14(10), e244527. https://pubmed.ncbi.nlm.nih.gov/34649856/ | Konu, Y. R., Gbeasor-Komlanvi, F. A., Yerima, M., Sadio, A. J., Tchankoni, M. K., Zida-Compaore, W. I. C., ... & Ekouevi, D. K. (2021). Prevalence of severe adverse events among health professionals after receiving the first dose of the ChAdOx1 nCoV-19 coronavirus vaccine (Covishield) in Togo, March 2021. Archives of Public Health, 79(1), 1-9. | https://pubmed.ncbi.nlm.nih.gov/34819146/. | Konu, Y. R., Gbeasor-Komlanvi, F. A., Yerima, M., Sadio, A. J., Tchankoni, M. K., Zida-Compaore, W. I. C., ... & Ekouevi, D. K. (2021). Prevalence of severe adverse events among health professionals after receiving the first dose of the ChAdOx1 nCoV-19 coronavirus vaccine (Covishield) in Togo, March 2021. Archives of Public Health, 79(1), 1-9. https://pubmed.ncbi.nlm.nih.gov/34819146/. | Lazaros, G., Klein, A. L., Hatziantoniou, S., Tsioufis, C., Tsakris, A., & Anastassopoulou, C. (2021). The novel platform of mRNA COVID-19 vaccines and myocarditis: clues into the potential underlying mechanism. Vaccine, 39(35), 4925. https://pubmed.ncbi.nlm.nih.gov/34312010/ | ||||
414 | A rare case of thrombosis and thrombocytopenia of the superior ophthalmic vein after ChAdOx1 nCoV-19 vaccination against SARS-CoV-2: | https://pubmed.ncbi.nlm.nih.gov/34276917/ | https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8553377/ | Finsterer, J. (2021). Lobar bleeding with ventricular rupture shortly after first dosage of an mRNA-based SARS-CoV-2 vaccine. Brain hemorrhages. | Finsterer, J. (2021). Sangrado lobar con rotura ventricular poco después de la primera dosis de una vacuna contra el SARS-CoV-2 basada en ARNm. Hemorragias cerebrales. https://www.ahajournals.org/doi/10.1161/circ.144.suppl_1.10712 | Julian, J. A., Mathern, D. R., & Fernando, D. (2021). Púrpura trombocitopénica idiopática y la vacuna moderna COVID-19. Anales de medicina de emergencia, 77 (6), 654-656. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8014568/. | Finsterer, J. (2021). Lobar bleeding with ventricular rupture shortly after first dosage of an mRNA-based SARS-CoV-2 vaccine. Brain hemorrhages. https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8553377/ | Kaneta, K., Yokoi, K., Jojima, K., Kotooka, N., & Node, K. (2021). Young Male With Myocarditis Following mRNA-1273 Vaccination Against Coronavirus Disease-2019 (COVID-19). Circulation Journal, CJ-21. https://pubmed.ncbi.nlm.nih.gov/34744118/ | Matar, E., Manser, D., Spies, J. M., Worthington, J. M., & Parratt, K. L. (2021). Acute Hemichorea‐Hemiballismus Following COVID‐19 (AZD1222) Vaccination. Movement Disorders. | https://pubmed.ncbi.nlm.nih.gov/34581453/ | Matar, E., Manser, D., Spies, J. M., Worthington, J. M., & Parratt, K. L. (2021). Acute Hemichorea‐Hemiballismus Following COVID‐19 (AZD1222) Vaccination. Movement Disorders. https://pubmed.ncbi.nlm.nih.gov/34581453/ | Łaźniak-Pfajfer, A., Surmacz, R., Rajewska-Tabor, J., Pyda, M., Lesiak, M., & Bobkowski, W. (2021). Myocarditis associated with COVID-19 vaccination in three teenage males. Polish Archives of Internal Medicine. https://pubmed.ncbi.nlm.nih.gov/34851078/. | ||||
415 | Thrombosis and severe acute respiratory syndrome Coronavirus 2 vaccines: vaccine-induced immune thrombotic thrombocytopenia: | https://pubmed.ncbi.nlm.nih.gov/34237213/. | https://www.ahajournals.org/doi/10.1161/circ.144.suppl_1.10712 | Gundry, S. R. (2021). Observational Findings of PULS Cardiac Test Findings for Inflammatory Markers in Patients Receiving mRNA Vaccines. Circulation, 144(Suppl_1), A10712-A10712. | Gundry, SR (2021). Hallazgos observacionales de las pruebas cardíacas PULS para marcadores inflamatorios en pacientes que reciben vacunas de ARNm. Circulación, 144(Supl_1), A10712-A10712. https://www.science.org/doi/10.1126/sciadv.abl8213 | Kadwalwala, M., Chadha, B., Ortoleva, J., & Joyce, M. (2021). Imágenes multimodalidad e histopatología en un joven que presenta una miocarditis linfocítica fulminante y un shock cardiogénico después de la vacunación con MRNA-1273. BMJ Case Reports CP, 14 (11), E246059. https://pubmed.ncbi.nlm.nih.gov/34636504/ | Gundry, S. R. (2021). Observational Findings of PULS Cardiac Test Findings for Inflammatory Markers in Patients Receiving mRNA Vaccines. Circulation, 144(Suppl_1), A10712-A10712. https://www.ahajournals.org/doi/10.1161/circ.144.suppl_1.10712 | Kaneta, K., Yokoi, K., Jojima, K., Kotooka, N., & Node, K. (2021). Young Male With Myocarditis Following mRNA-1273 Vaccination Against Coronavirus Disease-2019 (COVID-19). Circulation Journal, CJ-21. https://www.ncbi.nlm.nih.gov/pubmed/34744118 | Rossi, A., Magri, F., Michelini, S., Caro, G., Di Fraia, M., Fortuna, M. C., ... & Carlesimo, M. (2021). Recurrence of alopecia areata after covid‐19 vaccination: A report of three cases in Italy. Journal of cosmetic dermatology, 20(12), 3753-3757. | https://pubmed.ncbi.nlm.nih.gov/34741583/ | Rossi, A., Magri, F., Michelini, S., Caro, G., Di Fraia, M., Fortuna, M. C., ... & Carlesimo, M. (2021). Recurrence of alopecia areata after covid‐19 vaccination: A report of three cases in Italy. Journal of cosmetic dermatology, 20(12), 3753-3757. https://pubmed.ncbi.nlm.nih.gov/34741583/ | Leclerc, S., Royal, V., Lamarche, C., & Laurin, L. P. (2021). Minimal change disease with severe acute kidney injury following the Oxford-AstraZeneca COVID-19 vaccine: a case report. American Journal of Kidney Diseases, 78(4), 607-610. https://pubmed.ncbi.nlm.nih.gov/34242687/. | ||||
416 | Renal vein thrombosis and pulmonary embolism secondary to vaccine-induced thrombotic immune thrombocytopenia (VITT): | https://pubmed.ncbi.nlm.nih.gov/34268278/. | https://www.science.org/doi/10.1126/sciadv.abl8213 | Baker, A. T., Boyd, R. J., Sarkar, D., Teijeira-Crespo, A., Chan, C. K., Bates, E., ... & Borad, M. J. (2021). ChAdOx1 interacts with CAR and PF4 with implications for thrombosis with thrombocytopenia syndrome. Science advances, 7(49), eabl8213. | Baker, A. T., Boyd, R. J., Sarkar, D., Teijeira-Crespo, A., Chan, C. K., Bates, E., ... y Borad, M. J. (2021). ChAdOx1 interactúa con CAR y PF4 con implicaciones para la trombosis con síndrome de trombocitopenia. La ciencia avanza, 7(49), eabl8213. https://pubmed.ncbi.nlm.nih.gov/34626338/ | Kafil, T., Lamacie, M. M., Chenier, S., Taggart, H., Ghosh, N., Dick, A., ... & Crean, A. M. (2021). MRNA COVID-19 Vacunación y desarrollo de miopericaditis confirmada por CMR. medrxiv. https://onlinelibrary.wiley.com/doi/10.1111/trf.16672 | Baker, A. T., Boyd, R. J., Sarkar, D., Teijeira-Crespo, A., Chan, C. K., Bates, E., ... & Borad, M. J. (2021). ChAdOx1 interacts with CAR and PF4 with implications for thrombosis with thrombocytopenia syndrome. Science advances, 7(49), eabl8213. https://www.science.org/doi/10.1126/sciadv.abl8213 | Kar, B. R., Singh, B. S., Mohapatra, L., & Agrawal, I. (2021). Cutaneous small‐vessel vasculitis following COVID‐19 vaccine. Journal of Cosmetic Dermatology, 20(11), 3382. https://pubmed.ncbi.nlm.nih.gov/34529877/. | Ardalan, M., Moslemi, H., Shafiei, S., Tabrizi, R., & Moselmi, M. (2021). Herpes‐like skin lesion after AstraZeneca vaccination for COVID‐19: A case report. Clinical Case Reports, 9(10). | https://pubmed.ncbi.nlm.nih.gov/34631069/ | Ardalan, M., Moslemi, H., Shafiei, S., Tabrizi, R., & Moselmi, M. (2021). Herpes‐like skin lesion after AstraZeneca vaccination for COVID‐19: A case report. Clinical Case Reports, 9(10). https://pubmed.ncbi.nlm.nih.gov/34631069/ | Lee, E. J., & Lee, A. I. (2021). Cerebral venous sinus thrombosis after vaccination: the UK experience. The Lancet, 398(10306), 1107-1109. https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)01788-8/fulltext | ||||
417 | Limb ischemia and pulmonary artery thrombosis after ChAdOx1 nCoV-19 vaccine (Oxford-AstraZeneca): a case of vaccine-induced immune thrombotic thrombocytopenia: | https://pubmed.ncbi.nlm.nih.gov/33990339/. | https://pubmed.ncbi.nlm.nih.gov/34626338/ | Rodriguez, E. V., Bouazza, F. Z., Dauby, N., Mullier, F., d’Otreppe, S., Jissendi Tchofo, P., ... & Cliquennois, M. (2021). Fatal vaccine-induced immune thrombotic thrombocytopenia (VITT) post Ad26. COV2. S: first documented case outside US. Infection, 1-6. | Rodríguez, E. V., Bouazza, F. Z., Dauby, N., Mullier, F., d’Otreppe, S., Jissendi Tchofo, P., ... & Cliquennois, M. (2021). Trombocitopenia trombótica inmunitaria inducida por vacuna (VITT) mortal después del Ad26. COV2. S: primer caso documentado fuera de EE. UU. Infección, 1-6. https://europepmc.org/article/PPR/PPR304469435 | Kanabar, G., & Wilkinson, P. (2021). Síndrome de Guillain-Barré presentando con diplegia facial después de la vacunación de COVID-19 en dos pacientes. BMJ Case Reports CP, 14 (10), E244527. https://pubmed.ncbi.nlm.nih.gov/34671572/ | Rodriguez, E. V., Bouazza, F. Z., Dauby, N., Mullier, F., d’Otreppe, S., Jissendi Tchofo, P., ... & Cliquennois, M. (2021). Fatal vaccine-induced immune thrombotic thrombocytopenia (VITT) post Ad26. COV2. S: first documented case outside US. Infection, 1-6. https://pubmed.ncbi.nlm.nih.gov/34626338/ | Kaul, R., Sreenivasan, J., Goel, A., Malik, A., Bandyopadhyay, D., Jin, C., ... & Panza, J. A. (2021). Myocarditis following COVID-19 vaccination. International Journal of Cardiology. Heart & Vasculature. https://www.ncbi.nlm.nih.gov/pubmed/34568540 | Sandhu, S., Bhatnagar, A., Kumar, H., Dixit, P. K., Paliwal, G., Suhag, D. K., ... & Mitra, D. (2021). Leukocytoclastic vasculitis as a cutaneous manifestation of ChAdOx1 nCoV‐19 corona virus vaccine (recombinant). Dermatologic therapy, 34(6), e15141. | https://pubmed.ncbi.nlm.nih.gov/34546608/ | Sandhu, S., Bhatnagar, A., Kumar, H., Dixit, P. K., Paliwal, G., Suhag, D. K., ... & Mitra, D. (2021). Leukocytoclastic vasculitis as a cutaneous manifestation of ChAdOx1 nCoV‐19 corona virus vaccine (recombinant). Dermatologic therapy, 34(6), e15141. https://pubmed.ncbi.nlm.nih.gov/34546608/ | Lee, E. J., Cines, D. B., Gernsheimer, T., Kessler, C., Michel, M., Tarantino, M. D., ... & Bussel, J. B. (2021). Thrombocytopenia following pfizer and Moderna SARS‐CoV‐2 vaccination. American journal of hematology. https://pubmed.ncbi.nlm.nih.gov/33606296/ | ||||
418 | Association between ChAdOx1 nCoV-19 vaccination and bleeding episodes: large population-based cohort study: | https://pubmed.ncbi.nlm.nih.gov/34479760/. | https://europepmc.org/article/PPR/PPR304469435 | #VALUE! | Kaneta, K., Yokoi, K., Jojima, K., Kotooka, N., & Nodo, K. (2021). Hombre joven con miocarditis después de la vacunación con MRNA-1273 contra la enfermedad de Coronavirus-2019 (COVID-19). Diario de circulación, CJ-21. https://pubmed.ncbi.nlm.nih.gov/34334935/. | zzzz | Kaul, R., Sreenivasan, J., Goel, A., Malik, A., Bandyopadhyay, D., Jin, C., ... & Panza, J. A. (2021). Myocarditis following COVID-19 vaccination. International Journal of Cardiology. Heart & Vasculature. https://www.sciencedirect.com/science/article/pii/S2352906721001603 | Lin, C. Y., Huang, L. Y., Wu, K. A., Chan, J. S., Wu, K. L., Shyu, H. Y., & Hsiao, P. J. (2021). Abdominal pain and bilateral adrenal haemorrhage of COVID-19 vaccine-induced immune thrombotic thrombocytopenia. QJM: An International Journal of Medicine. | https://pubmed.ncbi.nlm.nih.gov/34546343/ | Lin, C. Y., Huang, L. Y., Wu, K. A., Chan, J. S., Wu, K. L., Shyu, H. Y., & Hsiao, P. J. (2021). Abdominal pain and bilateral adrenal haemorrhage of COVID-19 vaccine-induced immune thrombotic thrombocytopenia. QJM: An International Journal of Medicine. https://pubmed.ncbi.nlm.nih.gov/34546343/ | Lee, E., Chew, N. W., Ng, P., & Yeo, T. J. (2021). Reply to" Letter to the editor: Myocarditis should be considered in those with a troponin rise and unobstructed coronary arteries following PfizerBioNTech COVID-19 vaccination". QJM: Monthly Journal of the Association of Physicians. https://www.ncbi.nlm.nih.gov/pubmed/34463770 | |||||
419 | Secondary thrombocytopenia after SARS-CoV-2 vaccination: case report of haemorrhage and hematoma after minor oral surgery: | https://pubmed.ncbi.nlm.nih.gov/34314875/. | https://pubmed.ncbi.nlm.nih.gov/34731555/ | Weber, C., von Hundelshausen, P., & Siess, W. (2021). VITT after ChAdOx1 nCoV-19 Vaccination. The New England journal of medicine. | Weber, C., von Hundelshausen, P. y Siess, W. (2021). VITT después de la vacunación ChAdOx1 nCoV-19. La revista de medicina de Nueva Inglaterra. https://pubmed.ncbi.nlm.nih.gov/34159588/ | Kaneta, K., Yokoi, K., Jojima, K., Kotooka, N., & Nodo, K. (2021). Hombre joven con miocarditis después de la vacunación con MRNA-1273 contra la enfermedad de Coronavirus-2019 (COVID-19). Diario de circulación, CJ-21. https://www.ncbi.nlm.nih.gov/pubmed/34568540 | Weber, C., von Hundelshausen, P., & Siess, W. (2021). VITT after ChAdOx1 nCoV-19 Vaccination. The New England journal of medicine. https://pubmed.ncbi.nlm.nih.gov/34731555/ | Kaulen, L. D., Doubrovinskaia, S., Mooshage, C., Jordan, B., Purrucker, J., Haubner, C., ... & Schönenberger, S. (2022). Neurological autoimmune diseases following vaccinations against SARS‐CoV‐2: a case series. European Journal of Neurology, 29(2), 555-563. https://pubmed.ncbi.nlm.nih.gov/34668274/. | Sepahvand, M., Yazdi, N., Rohani, M., & Emamikhah, M. (2022). Cervical longitudinally extensive myelitis after vaccination with inactivated virus-based COVID-19 vaccine. Radiology Case Reports, 17(2), 303-305. | https://pubmed.ncbi.nlm.nih.gov/34849183/ | Sepahvand, M., Yazdi, N., Rohani, M., & Emamikhah, M. (2022). Cervical longitudinally extensive myelitis after vaccination with inactivated virus-based COVID-19 vaccine. Radiology Case Reports, 17(2), 303-305. https://pubmed.ncbi.nlm.nih.gov/34849183/ | Lee, E., Lee, Y. K., Kim, T. E., Hwang, I., Jung, Y. H., Lee, H. R., ... & Lee, Y. K. (2021). Reports of anaphylaxis after coronavirus disease 2019 vaccination, South Korea, 26 February to 30 April 2021. Eurosurveillance, 26(33), 2100694. https://pubmed.ncbi.nlm.nih.gov/34414880/ | ||||
420 | Venous thromboembolism and mild thrombocytopenia after vaccination with ChAdOx1 nCoV-19: | https://pubmed.ncbi.nlm.nih.gov/34384129/ | https://pubmed.ncbi.nlm.nih.gov/34159588/ | Lavin, M., Elder, P. T., O’Keeffe, D., Enright, H., Ryan, E., Kelly, A., ... & O’Donnell, J. S. (2021). Vaccine‐induced immune thrombotic thrombocytopenia (VITT)–a novel clinico‐pathological entity with heterogeneous clinical presentations. British Journal of Haematology, 195(1), 76-84. | Lavin, M., Elder, P. T., O'Keeffe, D., Enright, H., Ryan, E., Kelly, A., ... y O'Donnell, J. S. (2021). Trombocitopenia trombótica inmunitaria inducida por vacuna (VITT): una nueva entidad clínico-patológica con presentaciones clínicas heterogéneas. Revista Británica de Hematología, 195(1), 76-84. https://pubmed.ncbi.nlm.nih.gov/34461442/ | Kar, B. R., Singh, B. S., Mohapatra, L., y Agrawal, I. (2021). Vasculitis cutánea de pequeño recipiente después de la vacuna COVID-19. Diario de la dermatología cosmética, 20 (11), 3382. https://pubmed.ncbi.nlm.nih.gov/33928638/ | Lavin, M., Elder, P. T., O’Keeffe, D., Enright, H., Ryan, E., Kelly, A., ... & O’Donnell, J. S. (2021). Vaccine‐induced immune thrombotic thrombocytopenia (VITT)–a novel clinico‐pathological entity with heterogeneous clinical presentations. British Journal of Haematology, 195(1), 76-84. https://pubmed.ncbi.nlm.nih.gov/34159588/ | Kawano, H., Hashimoto, Y., & Hirano, T. (2021). Cerebral vein/venous sinus thrombosis with thrombocytopenia syndrome after COVID-19 vaccination. Rinsho Shinkeigaku= Clinical Neurology. https://pubmed.ncbi.nlm.nih.gov/34373413/ | Shahrigharahkoshan, S., Gagnon, L. P., & Mathieu, S. (2021). Cutaneous Leukocytoclastic Vasculitis Induction Following ChAdOx1 nCoV-19 Vaccine. Cureus, 13(10). | https://pubmed.ncbi.nlm.nih.gov/34853744/. | Shahrigharahkoshan, S., Gagnon, L. P., & Mathieu, S. (2021). Cutaneous Leukocytoclastic Vasculitis Induction Following ChAdOx1 nCoV-19 Vaccine. Cureus, 13(10). https://pubmed.ncbi.nlm.nih.gov/34853744/. | Leerunyakul, K., Pakornphadungsit, K., & Suchonwanit, P. (2021). Case Report: Pityriasis Rosea-Like Eruption Following COVID-19 Vaccination. Frontiers in Medicine, 8. https://pubmed.ncbi.nlm.nih.gov/34557507/ | ||||
421 | Fatal exacerbation of ChadOx1-nCoV-19-induced thrombotic thrombocytopenia syndrome after successful initial therapy with intravenous immunoglobulins: a rationale for monitoring immunoglobulin G levels: | https://pubmed.ncbi.nlm.nih.gov/34382387/ | https://pubmed.ncbi.nlm.nih.gov/34461442/ | Kenda, J., Lovrič, D., Škerget, M., & Milivojević, N. (2021). Treatment of ChAdOx1 nCoV-19 vaccine-induced immune thrombotic thrombocytopenia related acute ischemic stroke. Journal of Stroke and Cerebrovascular Diseases, 30(11), 106072. | Kenda, J., Lovrič, D., Škerget, M. y Milivojević, N. (2021). Tratamiento del accidente cerebrovascular isquémico agudo relacionado con trombocitopenia trombótica inmune inducida por la vacuna ChAdOx1 nCoV-19. Revista de accidentes cerebrovasculares y enfermedades cerebrovasculares, 30(11), 106072. https://pubmed.ncbi.nlm.nih.gov/34719776/ | Kaul, R., Sreenivasan, J., Goel, A., Malik, A., Bandyopadhyay, D., Jin, C., ... y Panza, J. A. (2021). Miocarditis después de la vacunación de COVID-19. Diario Internacional de Cardiología. Corazón y vasculatura. https://pubmed.ncbi.nlm.nih.gov/34712717/. | Kenda, J., Lovrič, D., Škerget, M., & Milivojević, N. (2021). Treatment of ChAdOx1 nCoV-19 vaccine-induced immune thrombotic thrombocytopenia related acute ischemic stroke. Journal of Stroke and Cerebrovascular Diseases, 30(11), 106072. https://pubmed.ncbi.nlm.nih.gov/34461442/ | Keir, G., Maria, N. I., & Kirsch, C. F. (2021). Unique imaging findings of neurologic phantosmia following Pfizer-BioNtech COVID-19 vaccination: a case report. Topics in Magnetic Resonance Imaging, 30(3), 133-137. https://pubmed.ncbi.nlm.nih.gov/34096896/ | Kherlopian, A., Zhao, C., Ge, L., Forward, E., & Fischer, G. (2021). A case of toxic epidermal necrolysis after ChAdOx1 nCov-19 (AZD1222) vaccination. The Australasian Journal of Dermatology. | https://pubmed.ncbi.nlm.nih.gov/34751429/. | Kherlopian, A., Zhao, C., Ge, L., Forward, E., & Fischer, G. (2021). A case of toxic epidermal necrolysis after ChAdOx1 nCov-19 (AZD1222) vaccination. The Australasian Journal of Dermatology. https://pubmed.ncbi.nlm.nih.gov/34751429/. | Lehman, C. D., D’Alessandro, H. A., Mendoza, D. P., Succi, M. D., Kambadakone, A., & Lamb, L. R. (2021). Unilateral lymphadenopathy after COVID-19 vaccination: a practical management plan for radiologists across specialties. Journal of the American College of Radiology, 18(6), 843-852. https://pubmed.ncbi.nlm.nih.gov/33713605/ | ||||
422 | A case of ANCA-associated vasculitis after AZD1222 (Oxford-AstraZeneca) SARS-CoV-2 vaccination: victim or causality?: | https://pubmed.ncbi.nlm.nih.gov/34416184/. | https://pubmed.ncbi.nlm.nih.gov/34719776/ | Garg, R. K., & Paliwal, V. K. (2021). Spectrum of neurological complications following COVID-19 vaccination. Neurological Sciences, 1-38. | Garg, RK y Paliwal, VK (2021). Espectro de complicaciones neurológicas tras la vacunación COVID-19. Ciencias Neurológicas, 1-38. https://pubmed.ncbi.nlm.nih.gov/34373413/ | Kaul, R., Sreenivasan, J., Goel, A., Malik, A., Bandyopadhyay, D., Jin, C., ... y Panza, J. A. (2021). Miocarditis después de la vacunación de COVID-19. Diario Internacional de Cardiología. Corazón y vasculatura. https://www.ncbi.nlm.nih.gov/pubmed/34447639 | Garg, R. K., & Paliwal, V. K. (2021). Spectrum of neurological complications following COVID-19 vaccination. Neurological Sciences, 1-38. https://pubmed.ncbi.nlm.nih.gov/34719776/ | Kelso, J. M. (2021). IgE‐mediated allergy to polyethylene glycol (PEG) as a cause of anaphylaxis to mRNA COVID‐19 vaccines. Clinical and Experimental Allergy. https://pubmed.ncbi.nlm.nih.gov/34318537/ | Ng, X. L., Betzler, B. K., Testi, I., Ho, S. L., Tien, M., Ngo, W. K., ... & Agrawal, R. (2021). Ocular adverse events after COVID-19 vaccination. Ocular immunology and inflammation, 1-9. | https://pubmed.ncbi.nlm.nih.gov/34559576/ | Ng, X. L., Betzler, B. K., Testi, I., Ho, S. L., Tien, M., Ngo, W. K., ... & Agrawal, R. (2021). Ocular adverse events after COVID-19 vaccination. Ocular immunology and inflammation, 1-9. https://pubmed.ncbi.nlm.nih.gov/34559576/ | Lensen, R., Netea, M. G., & Rosendaal, F. R. (2021). Hepatitis C virus reactivation following COVID-19 vaccination–A case report. International Medical Case Reports Journal, 14, 573. https://pubmed.ncbi.nlm.nih.gov/34512037/ | ||||
423 | Intracerebral hemorrhage associated with vaccine-induced thrombotic thrombocytopenia after ChAdOx1 nCOVID-19 vaccination in a pregnant woman: | https://pubmed.ncbi.nlm.nih.gov/34261297/ | https://pubmed.ncbi.nlm.nih.gov/34373413/ | Kawano, H., Hashimoto, Y., & Hirano, T. (2021). Cerebral vein/venous sinus thrombosis with thrombocytopenia syndrome after COVID-19 vaccination. Rinsho Shinkeigaku= Clinical Neurology. | Kawano, H., Hashimoto, Y. y Hirano, T. (2021). Trombosis de vena cerebral/seno venoso con síndrome de trombocitopenia después de la vacunación contra COVID-19. Rinsho Shinkeigaku= Neurología Clínica. https://pubmed.ncbi.nlm.nih.gov/34598301/ | Kaulen, L. D., Doubrovinskaia, S., Mooshage, C., Jordania, B., Purrugador, J., Haubner, C., ... & Schönenberger, S. (2022). Enfermedades autoinmunes neurológicas después de las vacunas contra SARS-COV-2: una serie de casos. Revista Europea de Neurología, 29 (2), 555-563. https://pubmed.ncbi.nlm.nih.gov/34549821/ | Kawano, H., Hashimoto, Y., & Hirano, T. (2021). Cerebral vein/venous sinus thrombosis with thrombocytopenia syndrome after COVID-19 vaccination. Rinsho Shinkeigaku= Clinical Neurology. https://pubmed.ncbi.nlm.nih.gov/34373413/ | Kemper, M., Lenz, G., & Mesters, R. M. (2021). Successful Treatment of Vaccine-Induced Immune Thrombotic Thrombocytopenia in a 26-Year-Old Female Patient. Acta Haematologica, 1-4. https://pubmed.ncbi.nlm.nih.gov/34614491/ | Uvais, N. A. (2021). Depression following ChAdOx1-S/nCoV-19 vaccine. The European Journal of Psychiatry. | https://pubmed.ncbi.nlm.nih.gov/34608345/. | Uvais, N. A. (2021). Depression following ChAdOx1-S/nCoV-19 vaccine. The European Journal of Psychiatry. https://pubmed.ncbi.nlm.nih.gov/34608345/. | Leung, V. S., & Lin, Y. (2021). Rituximab‐induced acute lympholysis and pancytopenia after COVID‐19 vaccination. Clinical Case Reports, 9(8), e04517. https://pubmed.ncbi.nlm.nih.gov/34429981/ | ||||
424 | Massive cerebral venous thrombosis due to vaccine-induced immune thrombotic thrombocytopenia: | https://pubmed.ncbi.nlm.nih.gov/34261296/ | https://pubmed.ncbi.nlm.nih.gov/34598301/ | Strobel, D., Haberkamp, S., & Zundler, S. (2021). Portal Vein Thrombosis due to Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT) after Covid Vaccination with ChAdOx1 nCoV-19. Ultraschall in der Medizin-European Journal of Ultrasound, 42(05), 551-552. | Strobel, D., Haberkamp, S. y Zundler, S. (2021). Trombosis de la vena porta debido a trombocitopenia trombótica inmunitaria inducida por vacuna (VITT) después de la vacunación contra Covid con ChAdOx1 nCoV-19. Ultraschall in der Medizin-Revista europea de ultrasonido, 42(05), 551-552. https://pubmed.ncbi.nlm.nih.gov/34620638/ | Kawano, H., Hashimoto, Y., & Hirano, T. (2021). Vena cerebral / trombosis sinusita venosa con síndrome de trombocitopenia después de la vacunación de COVID-19. Rinssho shinkeigaku = neurología clínica. https://pubmed.ncbi.nlm.nih.gov/34598301/ | Strobel, D., Haberkamp, S., & Zundler, S. (2021). Portal Vein Thrombosis due to Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT) after Covid Vaccination with ChAdOx1 nCoV-19. Ultraschall in der Medizin-European Journal of Ultrasound, 42(05), 551-552. https://pubmed.ncbi.nlm.nih.gov/34598301/ | Kenda, J., Lovrič, D., Škerget, M., & Milivojević, N. (2021). Treatment of ChAdOx1 nCoV-19 vaccine-induced immune thrombotic thrombocytopenia related acute ischemic stroke. Journal of Stroke and Cerebrovascular Diseases, 30(11), 106072. https://pubmed.ncbi.nlm.nih.gov/34461442/ | David, R., Hanna, P., Lee, K., & Ritchie, A. (2021). Relapsed ANCA associated vasculitis following Oxford AstraZeneca ChAdOx1-S COVID-19 vaccination: A case series of two patients. Nephrology (Carlton, Vic.), 27(1), 109-110. | https://pubmed.ncbi.nlm.nih.gov/34755433/ | David, R., Hanna, P., Lee, K., & Ritchie, A. (2021). Relapsed ANCA associated vasculitis following Oxford AstraZeneca ChAdOx1-S COVID-19 vaccination: A case series of two patients. Nephrology (Carlton, Vic.), 27(1), 109-110. https://pubmed.ncbi.nlm.nih.gov/34755433/ | Levin, D., Shimon, G., Fadlon-Derai, M., Gershovitz, L., Shovali, A., Sebbag, A., ... & Gordon, B. (2021). Myocarditis following COVID-19 vaccination–a case series. Vaccine, 39(42), 6195-6200. https://www.sciencedirect.com/science/article/pii/S0264410X21011725?via%3Dihub. | ||||
425 | Nephrotic syndrome after ChAdOx1 nCoV-19 vaccine against SARScoV-2: | https://pubmed.ncbi.nlm.nih.gov/34250318/. | https://pubmed.ncbi.nlm.nih.gov/34620638/ | Waraich, A., & Williams, G. (2021). Haematuria, a widespread petechial rash, and headaches following the Oxford AstraZeneca ChAdOx1 nCoV-19 Vaccination. BMJ Case Reports CP, 14(10), e245440. | Waraich, A. y Williams, G. (2021). Hematuria, erupción petequial generalizada y dolores de cabeza después de la vacuna Oxford AstraZeneca ChAdOx1 nCoV-19. Informes de casos de BMJ CP, 14(10), e245440. https://pubmed.ncbi.nlm.nih.gov/34650896/ | Keir, G., María, N. I., & Kirsch, C. F. (2021). Hallazgos únicos de imágenes de fantasmia neurológica después de PFIZE-BIONTECH COVID-19 Vacunación: un informe de caso. Temas en imágenes de resonancia magnética, 30 (3), 133-137. https://pubmed.ncbi.nlm.nih.gov/34835256/ | Waraich, A., & Williams, G. (2021). Haematuria, a widespread petechial rash, and headaches following the Oxford AstraZeneca ChAdOx1 nCoV-19 Vaccination. BMJ Case Reports CP, 14(10), e245440. https://pubmed.ncbi.nlm.nih.gov/34620638/ | Kerneis, M., Bihan, K., & Salem, J. E. (2021). COVID-19 vaccines and myocarditis. Arch Cardiovasc Dis, 114(6-7), 515-517. https://pubmed.ncbi.nlm.nih.gov/34246566/ | Mungmunpuntipantip, R., & Wiwanitkit, V. (2021). Thromboses of major arteries and ChAdOx1 nCov-19 vaccination. Neurological Research and Practice, 3(1), 1-1. | https://pubmed.ncbi.nlm.nih.gov/34839830/ | Mungmunpuntipantip, R., & Wiwanitkit, V. (2021). Thromboses of major arteries and ChAdOx1 nCov-19 vaccination. Neurological Research and Practice, 3(1), 1-1. https://pubmed.ncbi.nlm.nih.gov/34839830/ | Li, C., Chen, Y., Zhao, Y., Christopher Lung, D., Ye, Z., Song, W., ... & Yuen, K. Y. (2021). Corrigendum to: Intravenous Injection of Coronavirus Disease 2019 (COVID-19) mRNA Vaccine Can Induce Acute Myopericarditis in Mouse Model. Clinical Infectious Diseases, 73(12), 2372-2373. https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciab707/6353927?s=09&login=false | ||||
426 | A case of vaccine-induced immune-immune thrombotic thrombocytopenia with massive arteriovenous thrombosis: | https://pubmed.ncbi.nlm.nih.gov/34059191/ | https://pubmed.ncbi.nlm.nih.gov/34650896/ | Chiang, C. Y., Chen, C. Y., Yu, W. L., Kan, W. C., & Feng, Y. H. (2021). Myocardial Infarction and Azygos Vein Thrombosis After ChAdOx1 nCoV-19 Vaccination in a Hemodialysis Patient. Cureus, 13(9). | Chiang, C. Y., Chen, C. Y., Yu, W. L., Kan, W. C. y Feng, Y. H. (2021). Infarto de miocardio y trombosis de la vena ácigos después de la vacunación con ChAdOx1 nCoV-19 en un paciente en hemodiálisis. Cureus, 13(9). https://pubmed.ncbi.nlm.nih.gov/34625447/ | KELLO, J. M. (2021). Alergia mediada por IgE al polietilenglicol (PEG) como una causa de la anafilaxia a las vacunas de MRNA COVID-19. Alergia clínica y experimental. https://pubmed.ncbi.nlm.nih.gov/34463751/ | Chiang, C. Y., Chen, C. Y., Yu, W. L., Kan, W. C., & Feng, Y. H. (2021). Myocardial Infarction and Azygos Vein Thrombosis After ChAdOx1 nCoV-19 Vaccination in a Hemodialysis Patient. Cureus, 13(9). https://pubmed.ncbi.nlm.nih.gov/34650896/ | Keshavarz, P., Yazdanpanah, F., Rafiee, F., & Mizandari, M. (2021). Lymphadenopathy following COVID-19 vaccination: imaging findings review. Academic radiology, 28(8), 1058-1071. https://pubmed.ncbi.nlm.nih.gov/33985872/ | Park, J. Y., & Yi, S. Y. (2021). Rare case of contralateral supraclavicular lymphadenopathy after COVID-19 vaccination: Computed tomography and ultrasonography findings. Radiology Case Reports, 16(12), 3879-3881. | https://pubmed.ncbi.nlm.nih.gov/34667486/ | Park, J. Y., & Yi, S. Y. (2021). Rare case of contralateral supraclavicular lymphadenopathy after COVID-19 vaccination: Computed tomography and ultrasonography findings. Radiology Case Reports, 16(12), 3879-3881. https://pubmed.ncbi.nlm.nih.gov/34667486/ | Li, J., Hui, A., Zhang, X., Yang, Y., Tang, R., Ye, H., ... & Zhu, F. (2021). Safety and immunogenicity of the SARS-CoV-2 BNT162b1 mRNA vaccine in younger and older Chinese adults: a randomized, placebo-controlled, double-blind phase 1 study. Nature medicine, 27(6), 1062-1070. https://www.ncbi.nlm.nih.gov/pubmed/33888900 | ||||
427 | Cutaneous thrombosis associated with cutaneous necrosis following Oxford-AstraZeneca COVID-19 vaccination: | https://pubmed.ncbi.nlm.nih.gov/34189756/ | https://pubmed.ncbi.nlm.nih.gov/34625447/ | Crane, P., Wong, C., Mehta, N., & Barlis, P. (2021). Takotsubo (stress) cardiomyopathy after ChAdOx1 nCoV-19 vaccination. BMJ Case Reports CP, 14(10), e246580. | Crane, P., Wong, C., Mehta, N. y Barlis, P. (2021). Miocardiopatía de Takotsubo (estrés) después de la vacunación ChAdOx1 nCoV-19. Informes de casos de BMJ CP, 14(10), e246580. https://pubmed.ncbi.nlm.nih.gov/34696248/ | Kemper, M., Lenz, G., & Mesters, R. M. (2021). Tratamiento exitoso de la trombocitopenia trombótica inmune inducida por la vacuna en un paciente femenino de 26 años. Acta Haematologica, 1-4. https://pubmed.ncbi.nlm.nih.gov/34790684/ | Crane, P., Wong, C., Mehta, N., & Barlis, P. (2021). Takotsubo (stress) cardiomyopathy after ChAdOx1 nCoV-19 vaccination. BMJ Case Reports CP, 14(10), e246580. https://pubmed.ncbi.nlm.nih.gov/34625447/ | Khan, E., Shrestha, A. K., Colantonio, M. A., Liberio, R. N., & Sriwastava, S. (2021). Acute transverse myelitis following SARS-CoV-2 vaccination: a case report and review of literature. Journal of Neurology, 1-12. https://pubmed.ncbi.nlm.nih.gov/34482455/. | Ungari, M., & Pezzarossa, E. (2022). Cutaneous Lymphocytic Vasculitis After Administration of the Second Dose of AZD1222 (Oxford–AstraZeneca) Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination: Casuality or Causality?. The American Journal of Dermatopathology, 44(1), 80-82. | https://pubmed.ncbi.nlm.nih.gov/34726187/. | Ungari, M., & Pezzarossa, E. (2022). Cutaneous Lymphocytic Vasculitis After Administration of the Second Dose of AZD1222 (Oxford–AstraZeneca) Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination: Casuality or Causality?. The American Journal of Dermatopathology, 44(1), 80-82. https://pubmed.ncbi.nlm.nih.gov/34726187/. | Li, L., Robinson, L. B., Patel, R., Landman, A. B., Fu, X., Shenoy, E. S., ... & Blumenthal, K. G. (2021). Association of Self-reported High-Risk Allergy History With Allergy Symptoms After COVID-19 Vaccination. JAMA network open, 4(10), e2131034-e2131034. https://pubmed.ncbi.nlm.nih.gov/34698847/ | ||||
428 | Thrombocytopenia in an adolescent with sickle cell anemia after COVID-19 vaccination: | https://pubmed.ncbi.nlm.nih.gov/34331506/ | https://pubmed.ncbi.nlm.nih.gov/34696248/ | Michiels, Y., Houhou-Fidouh, N., Collin, G., Berger, J., & Kohli, E. (2021). Humoral Response Induced by Prime-Boost Vaccination with the ChAdOx1 nCoV-19 and mRNA BNT162b2 Vaccines in a Teriflunomide-Treated Multiple Sclerosis Patient. Vaccines, 9(10), 1140. | Michiels, Y., Houhou-Fidouh, N., Collin, G., Berger, J. y Kohli, E. (2021). Respuesta humoral inducida por la vacunación Prime-Boost con las vacunas ChAdOx1 nCoV-19 y mRNA BNT162b2 en un paciente con esclerosis múltiple tratado con teriflunomida. Vacunas, 9(10), 1140. https://pubmed.ncbi.nlm.nih.gov/34548920/ | Kenda, J., Lovrič, D., Škerget, M., & Milivojević, N. (2021). Tratamiento de la trombocitopenia inmune trombocitopenia inmunológica inducida por la vacuna. Diario de accidentes cerebrovasculares y enfermedades cerebrovasculares, 30 (11), 106072. https://pubmed.ncbi.nlm.nih.gov/34719776/ | Michiels, Y., Houhou-Fidouh, N., Collin, G., Berger, J., & Kohli, E. (2021). Humoral Response Induced by Prime-Boost Vaccination with the ChAdOx1 nCoV-19 and mRNA BNT162b2 Vaccines in a Teriflunomide-Treated Multiple Sclerosis Patient. Vaccines, 9(10), 1140. https://pubmed.ncbi.nlm.nih.gov/34696248/ | Khan, T. A., Sidhu, N., Khan, L., Sen, S., Hussain, N., Tandon, R., & Gupta, N. (2021). Bilateral immune-mediated keratolysis after immunization with SARS-CoV-2 recombinant viral vector vaccine. Cornea, 40(12), 1629-1632. https://pubmed.ncbi.nlm.nih.gov/34483273/. | Masset, C., Lebot-Bouras, S., Branchereau, J., Renaudin, K., & Cantarovich, D. (2021). Pancreas allograft rejection occurring after ChAdOx1 nCoV-19 vaccine. Diabetes & Metabolism. | https://pubmed.ncbi.nlm.nih.gov/34781027/ | Masset, C., Lebot-Bouras, S., Branchereau, J., Renaudin, K., & Cantarovich, D. (2021). Pancreas allograft rejection occurring after ChAdOx1 nCoV-19 vaccine. Diabetes & Metabolism. https://pubmed.ncbi.nlm.nih.gov/34781027/ | Li, M., Yuan, J., Lv, G., Brown, J., Jiang, X., & Lu, Z. K. (2021). Myocarditis and Pericarditis following COVID-19 Vaccination: Inequalities in Age and Vaccine Types. Journal of personalized medicine, 11(11), 1106. https://www.mdpi.com/2075-4426/11/11/1106 | ||||
429 | Vaccine-induced thrombocytopenia with severe headache: | https://pubmed.ncbi.nlm.nih.gov/34525282/ | https://pubmed.ncbi.nlm.nih.gov/34548920/ | James, J., Jose, J., Gafoor, V. A., Smita, B., & Balaram, N. (2021). Guillain‐Barré syndrome following ChAdOx1 nCoV‐19 COVID‐19 vaccination: A case series. Neurology and Clinical Neuroscience, 9(5), 402-405. | James, J., José, J., Gafoor, V. A., Smita, B. y Balaram, N. (2021). Síndrome de Guillain-Barré después de la vacunación ChAdOx1 nCoV-19 COVID-19: una serie de casos. Neurología y neurociencia clínica, 9(5), 402-405. https://pubmed.ncbi.nlm.nih.gov/34672380/ | Kerneis, M., Bihan, K., & Salem, J. E. (2021). COVID-19 Vacunas y miocarditis. Arch Cardiovasc dis, 114 (6-7), 515-517. https://www.cureus.com/articles/61030-myocarditis-and-other-cardiovascular-comp lications-of-the-mrna-based-covid-19-vaccines | James, J., Jose, J., Gafoor, V. A., Smita, B., & Balaram, N. (2021). Guillain‐Barré syndrome following ChAdOx1 nCoV‐19 COVID‐19 vaccination: A case series. Neurology and Clinical Neuroscience, 9(5), 402-405. https://pubmed.ncbi.nlm.nih.gov/34548920/ | Kharkar, V., Vishwanath, T., Mahajan, S., Joshi, R., & Gole, P. (2021). Asymmetrical cutaneous vasculitis following COVID‐19 vaccination with unusual eosinophil preponderance. Clinical and Experimental Dermatology. https://pubmed.ncbi.nlm.nih.gov/34115904/. | Kulkarni, P. A., & Prasad, V. (2021). Understanding risk of thrombosis with thrombocytopenia syndrome after Ad26. COV2. S vaccination. Frontiers of medicine, 15(6), 938-941. | https://pubmed.ncbi.nlm.nih.gov/34595694/ | Kulkarni, P. A., & Prasad, V. (2021). Understanding risk of thrombosis with thrombocytopenia syndrome after Ad26. COV2. S vaccination. Frontiers of medicine, 15(6), 938-941. https://pubmed.ncbi.nlm.nih.gov/34595694/ | Liang, I., Swaminathan, S., & Lee, A. (2021). Emergence of de novo cutaneous vasculitis post coronavirus disease (COVID-19) vaccination. Clinical rheumatology, 1-2. https://pubmed.ncbi.nlm.nih.gov/34599716/. | ||||
430 | Myocarditis associated with SARS-CoV-2 mRNA vaccination in children aged 12 to 17 years: stratified analysis of a national database: | https://www.medrxiv.org/content/10.1101/2021.08.30.21262866v1 | https://pubmed.ncbi.nlm.nih.gov/34672380/ | Major, A., Carll, T., Chan, C. W., Christenson, C., Aldarweesh, F., Wool, G. D., & Cohen, K. S. (2022). Refractory vaccine‐induced immune thrombotic thrombocytopenia (VITT) managed with delayed therapeutic plasma exchange (TPE). Journal of clinical apheresis, 37(1), 117-121. | Major, A., Carll, T., Chan, CW, Christenson, C., Aldarweesh, F., Wool, GD y Cohen, KS (2022). Trombocitopenia trombótica inmunitaria (TTVI) refractaria inducida por la vacuna tratada con recambio plasmático terapéutico retardado (TPE). Revista de aféresis clínica, 37(1), 117-121. https://pubmed.ncbi.nlm.nih.gov/34556531/ | Keshavarz, P., Yazdanpah, F., Rafiee, F., & Mizandari, M. (2021). Linfadenopatía después de la vacunación COVID-19: Revisión de hallazgos de imágenes. Radiología académica, 28 (8), 1058-1071. https://pubmed.ncbi.nlm.nih.gov/34735411/ | Major, A., Carll, T., Chan, C. W., Christenson, C., Aldarweesh, F., Wool, G. D., & Cohen, K. S. (2022). Refractory vaccine‐induced immune thrombotic thrombocytopenia (VITT) managed with delayed therapeutic plasma exchange (TPE). Journal of clinical apheresis, 37(1), 117-121. https://pubmed.ncbi.nlm.nih.gov/34672380/ | Khayat-Khoei, M., Bhattacharyya, S., Katz, J., Harrison, D., Tauhid, S., Bruso, P., ... & Bakshi, R. (2022). COVID-19 mRNA vaccination leading to CNS inflammation: a case series. Journal of neurology, 269(3), 1093-1106. https://link.springer.com/article/10.1007/s00415-021-10780-7 | Rerknimitr, P., Puaratanaarunkon, T., Wongtada, C., Wittayabusarakam, N., Krithin, S., Paitoonpong, L., ... & Klaewsongkram, J. (2022). Cutaneous adverse reactions from 35,229 doses of Sinovac and AstraZeneca COVID‐19 vaccination: a prospective cohort study in healthcare workers. Journal of the European Academy of Dermatology and Venereology, 36(3), e158-e161. | https://pubmed.ncbi.nlm.nih.gov/34661934/ | Rerknimitr, P., Puaratanaarunkon, T., Wongtada, C., Wittayabusarakam, N., Krithin, S., Paitoonpong, L., ... & Klaewsongkram, J. (2022). Cutaneous adverse reactions from 35,229 doses of Sinovac and AstraZeneca COVID‐19 vaccination: a prospective cohort study in healthcare workers. Journal of the European Academy of Dermatology and Venereology, 36(3), e158-e161. https://pubmed.ncbi.nlm.nih.gov/34661934/ | Lim, J. H., Han, M. H., Kim, Y. J., Kim, M. S., Jung, H. Y., Choi, J. Y., ... & Park, S. H. (2021). New-onset nephrotic syndrome after Janssen COVID-19 vaccination: a case report and literature review. Journal of Korean Medical Science, 36(30). https://pubmed.ncbi.nlm.nih.gov/34342187/. | ||||
431 | COVID-19 mRNA vaccination and development of CMR-confirmed myopericarditis: | https://www.medrxiv.org/content/10.1101/2021.09.13.21262182v1.full?s=09. | https://pubmed.ncbi.nlm.nih.gov/34556531/ | Purkayastha, P., Mckechnie, C., Kalkur, P., & Scully, M. (2021). Rare case of COVID-19 vaccine-associated intracranial haemorrhage with venous sinus thrombosis. BMJ Case Reports CP, 14(9), e245092. | Purkayastha, P., Mckechnie, C., Kalkur, P. y Scully, M. (2021). Caso raro de hemorragia intracraneal asociada a la vacuna COVID-19 con trombosis del seno venoso. BMJ Case Reports CP, 14(9), e245092. https://pubmed.ncbi.nlm.nih.gov/34535076/ | Khan, E., Shrestha, A. K., Colantonio, M. A., Liberio, R. N., & Sriwastava, S. (2021). Mielitis transversal aguda después de la vacunación con SARS-COV-2: un informe de caso y revisión de la literatura. Diario de Neurología, 1-12. https://pubmed.ncbi.nlm.nih.gov/34114269/. | Purkayastha, P., Mckechnie, C., Kalkur, P., & Scully, M. (2021). Rare case of COVID-19 vaccine-associated intracranial haemorrhage with venous sinus thrombosis. BMJ Case Reports CP, 14(9), e245092. https://pubmed.ncbi.nlm.nih.gov/34556531/ | Khayat-Khoei, M., Bhattacharyya, S., Katz, J., Harrison, D., Tauhid, S., Bruso, P., ... & Bakshi, R. (2022). COVID-19 mRNA vaccination leading to CNS inflammation: a case series. Journal of neurology, 269(3), 1093-1106. https://pubmed.ncbi.nlm.nih.gov/34480607/ | Mustafa, Z., & Burster, T. (2021). Comments on Thrombosis After Vaccination: The Leader Sequence of the Spike Protein Might Be Responsible for Thrombosis and Antibody-Mediated Thrombocytopenia. Viral immunology, 34(10), 669-672. | https://pubmed.ncbi.nlm.nih.gov/34788138 | Mustafa, Z., & Burster, T. (2021). Comments on Thrombosis After Vaccination: The Leader Sequence of the Spike Protein Might Be Responsible for Thrombosis and Antibody-Mediated Thrombocytopenia. Viral immunology, 34(10), 669-672. https://pubmed.ncbi.nlm.nih.gov/34788138 | Lim, J., Lee, S. A., Khil, E. K., Byeon, S. J., Kang, H. J., & Choi, J. A. (2021, October). COVID-19 vaccine-related axillary lymphadenopathy in breast cancer patients: Case series with a review of literature. In Seminars in oncology. WB Saunders. https://pubmed.ncbi.nlm.nih.gov/34836672/. | ||||
432 | Severe autoimmune hemolytic anemia after receipt of SARS-CoV-2 mRNA vaccine: | https://onlinelibrary.wiley.com/doi/10.1111/trf.16672 | https://pubmed.ncbi.nlm.nih.gov/34535076/ | García-Azorín, D., Do, T. P., Gantenbein, A. R., Hansen, J. M., Souza, M. N. P., Obermann, M., ... & Kristoffersen, E. S. (2021). Delayed headache after COVID-19 vaccination: a red flag for vaccine induced cerebral venous thrombosis. The journal of headache and pain, 22(1), 1-5. | García-Azorín, D., Do, T. P., Gantenbein, A. R., Hansen, J. M., Souza, M. N. P., Obermann, M., ... & Kristoffersen, E. S. (2021). Dolor de cabeza retrasado después de la vacunación COVID-19: una señal de alerta de trombosis venosa cerebral inducida por la vacuna. El diario del dolor de cabeza y del dolor, 22(1), 1-5. https://pubmed.ncbi.nlm.nih.gov/34379914/. | Khan, T. A., Sidhu, N., Khan, L., Sen, S., Hussain, N., Tandon, R., y Gupta, N. (2021). Keratólisis mediada por la mediación inmunológica bilateral después de la inmunización con la vacuna viral viral recombinante de SARS-COV-2. Córnea, 40 (12), 1629-1632. https://pubmed.ncbi.nlm.nih.gov/34513446/ | García-Azorín, D., Do, T. P., Gantenbein, A. R., Hansen, J. M., Souza, M. N. P., Obermann, M., ... & Kristoffersen, E. S. (2021). Delayed headache after COVID-19 vaccination: a red flag for vaccine induced cerebral venous thrombosis. The journal of headache and pain, 22(1), 1-5. https://pubmed.ncbi.nlm.nih.gov/34535076/ | Kherlopian, A., Zhao, C., Ge, L., Forward, E., & Fischer, G. (2021). A case of toxic epidermal necrolysis after ChAdOx1 nCov-19 (AZD1222) vaccination. The Australasian Journal of Dermatology. https://pubmed.ncbi.nlm.nih.gov/34751429/. | Cinotti, E., Perrot, J. L., Bruzziches, F., Tognetti, L., Batsikosta, A., Sorrentino, E., ... & Rubegni, P. (2021). Eosinophilic dermatosis after AstraZeneca COVID-19 vaccination. Journal of the European Academy of Dermatology and Venereology: JEADV. | https://pubmed.ncbi.nlm.nih.gov/34753210/. | Cinotti, E., Perrot, J. L., Bruzziches, F., Tognetti, L., Batsikosta, A., Sorrentino, E., ... & Rubegni, P. (2021). Eosinophilic dermatosis after AstraZeneca COVID-19 vaccination. Journal of the European Academy of Dermatology and Venereology: JEADV. https://pubmed.ncbi.nlm.nih.gov/34753210/. | Lim, X. R., Leung, B. P., Ng, C. Y. L., Tan, J. W. L., Chan, G. Y. L., Loh, C. M., ... & Leong, K. P. (2021). Pseudo-anaphylactic reactions to Pfizer BNT162b2 vaccine: report of 3 cases of anaphylaxis post Pfizer BNT162b2 vaccination. Vaccines, 9(9), 974. https://pubmed.ncbi.nlm.nih.gov/34579211/ | ||||
433 | Intravenous injection of coronavirus disease 2019 (COVID-19) mRNA vaccine can induce acute myopericarditis in a mouse model: https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciab707/6353927?s=09&login=false | Intravenous injection of coronavirus disease 2019 (COVID-19) mRNA vaccine can induce acute myopericarditis in a mouse model: | https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciab707/6353927?s=09&login=false | https://pubmed.ncbi.nlm.nih.gov/34379914/. | Pavord, S., Scully, M., Hunt, B. J., Lester, W., Bagot, C., Craven, B., ... & Makris, M. (2021). Clinical features of vaccine-induced immune thrombocytopenia and thrombosis. New England Journal of Medicine, 385(18), 1680-1689. | Pavord, S., Scully, M., Hunt, B. J., Lester, W., Bagot, C., Craven, B., ... y Makris, M. (2021). Características clínicas de la trombocitopenia y trombosis inmunitarias inducidas por vacunas. Revista de Medicina de Nueva Inglaterra, 385(18), 1680-1689. https://pubmed.ncbi.nlm.nih.gov/34545400/ | Kharkar, V., Vishwanath, T., Mahajan, S., Joshi, R., & Gole, P. (2021). Vasculitis cutánea asimétrica después de la vacunación de COVID-19 con preponderancia de eosinófilo inusual. Dermatología clínica y experimental. https://pubmed.ncbi.nlm.nih.gov/34247902/. | Pavord, S., Scully, M., Hunt, B. J., Lester, W., Bagot, C., Craven, B., ... & Makris, M. (2021). Clinical features of vaccine-induced immune thrombocytopenia and thrombosis. New England Journal of Medicine, 385(18), 1680-1689. https://pubmed.ncbi.nlm.nih.gov/34379914/. | Khogali, F., & Abdelrahman, R. (2021). Unusual presentation of acute perimyocarditis following SARS-COV-2 mRNA-1237 Moderna vaccination. Cureus, 13(7). https://pubmed.ncbi.nlm.nih.gov/34447639/ | Angelo, G., Francesca, G., Elena, M., Sara, S., Michelle, Z., & Mauro, T. (2021). Severe immune thrombocytopenia after COVID-19 vaccination: Report of four cases and review of the literature. Blood cells, molecules & diseases. | https://pubmed.ncbi.nlm.nih.gov/34653943/. | Angelo, G., Francesca, G., Elena, M., Sara, S., Michelle, Z., & Mauro, T. (2021). Severe immune thrombocytopenia after COVID-19 vaccination: Report of four cases and review of the literature. Blood cells, molecules & diseases. https://pubmed.ncbi.nlm.nih.gov/34653943/. | Lim, Y., Kim, M. C., Kim, K. H., Jeong, I. S., Cho, Y. S., Choi, Y. D., & Lee, J. E. (2021). Case Report: Acute Fulminant Myocarditis and Cardiogenic Shock After Messenger RNA Coronavirus Disease 2019 Vaccination Requiring Extracorporeal Cardiopulmonary Resuscitation. Frontiers in Cardiovascular Medicine, 8. https://pubmed.ncbi.nlm.nih.gov/34778411/ | |||
434 | A report of myocarditis adverse events in the U.S. Vaccine Adverse Event Reporting System. (VAERS) in association with COVID-19 injectable biologics: | https://pubmed.ncbi.nlm.nih.gov/34601006/ | https://pubmed.ncbi.nlm.nih.gov/34545400/ | Hwang, J., Park, S. H., Lee, S. W., Lee, S. B., Lee, M. H., Jeong, G. H., ... & Smith, L. (2021). Predictors of mortality in thrombotic thrombocytopenia after adenoviral COVID-19 vaccination: the FAPIC score. European heart journal, 42(39), 4053-4063. | Hwang, J., Park, S. H., Lee, S. W., Lee, S. B., Lee, M. H., Jeong, G. H., ... y Smith, L. (2021). Predictores de mortalidad en trombocitopenia trombótica después de la vacunación adenoviral COVID-19: la puntuación FAPIC. Revista europea del corazón, 42(39), 4053-4063. https://pubmed.ncbi.nlm.nih.gov/34035134/ | Khayat-Khoei, M., Bhattacharyya, S., Katz, J., Harrison, D., Tauhid, S., Bruso, P., ... & Bakshi, R. (2022). COVID-19 Vacunación de ARNm que conduce a la inflamación del SNC: una serie de casos. Diario de Neurología, 269 (3), 1093-1106. https://pubmed.ncbi.nlm.nih.gov/33475702/ | Hwang, J., Park, S. H., Lee, S. W., Lee, S. B., Lee, M. H., Jeong, G. H., ... & Smith, L. (2021). Predictors of mortality in thrombotic thrombocytopenia after adenoviral COVID-19 vaccination: the FAPIC score. European heart journal, 42(39), 4053-4063. https://pubmed.ncbi.nlm.nih.gov/34545400/ | Khogali, F., & Abdelrahman, R. (2021). Unusual presentation of acute perimyocarditis following SARS-COV-2 mRNA-1237 Moderna vaccination. Cureus, 13(7). https://www.ncbi.nlm.nih.gov/pubmed/34447639 | Dijk, W. E. V., & Schutgens, R. E. (2022). Relapse of immune thrombocytopenia after COVID‐19 vaccination. European Journal of Haematology, 108(1), 84-85. | https://pubmed.ncbi.nlm.nih.gov/34591991/ | Dijk, W. E. V., & Schutgens, R. E. (2022). Relapse of immune thrombocytopenia after COVID‐19 vaccination. European Journal of Haematology, 108(1), 84-85. https://pubmed.ncbi.nlm.nih.gov/34591991/ | Lin, C. Y., Huang, L. Y., Wu, K. A., Chan, J. S., Wu, K. L., Shyu, H. Y., & Hsiao, P. J. (2021). Abdominal pain and bilateral adrenal haemorrhage of COVID-19 vaccine-induced immune thrombotic thrombocytopenia. QJM: An International Journal of Medicine. https://pubmed.ncbi.nlm.nih.gov/34546343/ | ||||
435 | This study concludes that: “The vaccine was associated with an excess risk of myocarditis (1 to 5 events per 100,000 persons). The risk of this potentially serious adverse event and of many other serious adverse events increased substantially after SARS-CoV-2 infection”: | https://www.nejm.org/doi/full/10.1056/NEJMoa2110475 | https://pubmed.ncbi.nlm.nih.gov/34035134/ | Al-Mayhani, T., Saber, S., Stubbs, M. J., Losseff, N. A., Perry, R. J., Simister, R. J., ... & Werring, D. J. (2021). Ischaemic stroke as a presenting feature of ChAdOx1 nCoV-19 vaccine-induced immune thrombotic thrombocytopenia. Journal of Neurology, Neurosurgery & Psychiatry, 92(11), 1247-1248. | Al-Mayhani, T., Sabre, S., Stubbs, M. J., Losseff, N. A., Perry, R. J., Simister, R. J., ... y Werring, D. J. (2021). Accidente cerebrovascular isquémico como característica de presentación de la trombocitopenia trombótica inmune inducida por la vacuna ChAdOx1 nCoV-19. Revista de Neurología, Neurocirugía y Psiquiatría, 92(11), 1247-1248. https://pubmed.ncbi.nlm.nih.gov/34688190/ | Khayat-Khoei, M., Bhattacharyya, S., Katz, J., Harrison, D., Tauhid, S., Bruso, P., ... & Bakshi, R. (2022). COVID-19 Vacunación de ARNm que conduce a la inflamación del SNC: una serie de casos. Diario de Neurología, 269 (3), 1093-1106. https://pubmed.ncbi.nlm.nih.gov/34462647/ | Al-Mayhani, T., Saber, S., Stubbs, M. J., Losseff, N. A., Perry, R. J., Simister, R. J., ... & Werring, D. J. (2021). Ischaemic stroke as a presenting feature of ChAdOx1 nCoV-19 vaccine-induced immune thrombotic thrombocytopenia. Journal of Neurology, Neurosurgery & Psychiatry, 92(11), 1247-1248. https://pubmed.ncbi.nlm.nih.gov/34035134/ | Khouri, C., Roustit, M., & Cracowski, J. L. (2021). Adverse event reporting and Bell's palsy risk after COVID-19 vaccination. The Lancet Infectious Diseases, 21(11), 1490-1491. https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(21)00646-0/fulltext. | Violi, F., Cammisotto, V., Pastori, D., & Pignatelli, P. (2021). Thrombosis in pre-and post-vaccination phase of COVID-19. European Heart Journal Supplements, 23(Supplement_E), E184-E188. | https://pubmed.ncbi.nlm.nih.gov/34650382/ | Violi, F., Cammisotto, V., Pastori, D., & Pignatelli, P. (2021). Thrombosis in pre-and post-vaccination phase of COVID-19. European Heart Journal Supplements, 23(Supplement_E), E184-E188. https://pubmed.ncbi.nlm.nih.gov/34650382/ | Lin, W., Ko, C. A., Sung, Y. F., Chen, Y. C., Lee, J. T., Lin, Y. Q., & Lin, Y. K. (2021). Cerebral Venous Sinus Thrombosis, Pulmonary Embolism, and Thrombocytopenia After COVID-19 Vaccination in a Taiwanese Man: A Case Report and Literature Review. Frontiers in Neurology, 1670. https://pubmed.ncbi.nlm.nih.gov/34630307/ | ||||
436 | Bilateral uveitis after inoculation with COVID-19 vaccine: a case report: | https://www.sciencedirect.com/science/article/pii/S1201971221007797 | https://pubmed.ncbi.nlm.nih.gov/34688190/ | Koh, J. S., Hoe, R. H. M., Yong, M. H., Chiew, H. J., Goh, Y., Yong, K. P., ... & Umapathi, T. (2021). Hospital-based observational study of neurological disorders in patients recently vaccinated with COVID-19 mRNA vaccines. Journal of the neurological sciences, 430, 120030. | Koh, J. S., Hoe, R. H. M., Yong, M. H., Chiew, H. J., Goh, Y., Yong, K. P., ... y Umapathi, T. (2021). Estudio observacional hospitalario de trastornos neurológicos en pacientes recientemente vacunados con vacunas de ARNm COVID-19. Revista de ciencias neurológicas, 430, 120030. https://pubmed.ncbi.nlm.nih.gov/34782400/ | Kherlopian, A., Zhao, C., GE, L., Adelante, E., & Fischer, G. (2021). Un caso de necrólisis epidérmica tóxica después de la vacunación con la vacunación de Chadox1 NCOV-19 (AZD1222). El Diario Australasia de Dermatología. https://pubmed.ncbi.nlm.nih.gov/34559576/ | Koh, J. S., Hoe, R. H. M., Yong, M. H., Chiew, H. J., Goh, Y., Yong, K. P., ... & Umapathi, T. (2021). Hospital-based observational study of neurological disorders in patients recently vaccinated with COVID-19 mRNA vaccines. Journal of the neurological sciences, 430, 120030. https://pubmed.ncbi.nlm.nih.gov/34688190/ | Kim, B., Park, Y., Kim, E. K., & Lee, S. H. (2021). Supraclavicular lymphadenopathy after COVID-19 vaccination in Korea: serial follow-up using ultrasonography. Clinical Imaging, 79, 201-203. https://pubmed.ncbi.nlm.nih.gov/34116295/ | Stassi, C., Mondello, C., Baldino, G., Cardia, L., Asmundo, A., & Ventura Spagnolo, E. (2021). An Insight into the Role of Postmortem Immunohistochemistry in the Comprehension of the Inflammatory Pathophysiology of COVID-19 Disease and Vaccine-Related Thrombotic Adverse Events: A Narrative Review. International journal of molecular sciences, 22(21), 12024. | https://pubmed.ncbi.nlm.nih.gov/34769454/ | Stassi, C., Mondello, C., Baldino, G., Cardia, L., Asmundo, A., & Ventura Spagnolo, E. (2021). An Insight into the Role of Postmortem Immunohistochemistry in the Comprehension of the Inflammatory Pathophysiology of COVID-19 Disease and Vaccine-Related Thrombotic Adverse Events: A Narrative Review. International journal of molecular sciences, 22(21), 12024. https://pubmed.ncbi.nlm.nih.gov/34769454/ | Ling, L., Bagshaw, S. M., & Villeneuve, P. M. (2021). Guillain–Barré syndrome after SARS-CoV-2 vaccination in a patient with previous vaccine-associated Guillain–Barré syndrome. CMAJ, 193(46), E1766-E1769. https://pubmed.ncbi.nlm.nih.gov/34810163/ | ||||
437 | Myocarditis associated with SARS-CoV-2 mRNA vaccination in children aged 12 to 17 years: stratified analysis of a national database: | https://www.medrxiv.org/content/10.1101/2021.08.30.21262866v1. | https://pubmed.ncbi.nlm.nih.gov/34782400/ | Cleaver, J., Ibitoye, R., Morrison, H., Flood, R., Crewdson, K., Marsh, A., ... & Mortimer, A. (2021). Endovascular treatment for vaccine-induced cerebral venous sinus thrombosis and thrombocytopenia following ChAdOx1 nCoV-19 vaccination: a report of three cases. Journal of neurointerventional surgery. | Cleaver, J., Ibitoye, R., Morrison, H., Flood, R., Crewdson, K., Marsh, A., ... y Mortimer, A. (2021). Tratamiento endovascular para la trombosis y trombocitopenia del seno venoso cerebral inducida por la vacuna después de la vacunación con ChAdOx1 nCoV-19: informe de tres casos. Revista de cirugía neurointervencionista. https://pubmed.ncbi.nlm.nih.gov/34710832/ | Khogali, F., & Abdelrahman, R. (2021). Presentación inusual de perimyocarditis aguda después de la vacunación MODERA MODINA DE MRNA-1237 SARS-COV-2. CUREUS, 13 (7). https://bmccardiovascdisord.biomedcentral.com/articles/10.1186/s12872-021-02183 | Cleaver, J., Ibitoye, R., Morrison, H., Flood, R., Crewdson, K., Marsh, A., ... & Mortimer, A. (2021). Endovascular treatment for vaccine-induced cerebral venous sinus thrombosis and thrombocytopenia following ChAdOx1 nCoV-19 vaccination: a report of three cases. Journal of neurointerventional surgery. https://pubmed.ncbi.nlm.nih.gov/34782400/ | Kim, B., Park, Y., Kim, E. K., & Lee, S. H. (2021). Supraclavicular lymphadenopathy after COVID-19 vaccination in Korea: serial follow-up using ultrasonography. Clinical Imaging, 79, 201-203. https://pubmed.ncbi.nlm.nih.gov/34116295/. | John, N. A., John, J., Kamble, P., Singhal, A., Daulatabad, V., & Vamshidhar, I. S. (2021). COVID 19 vaccine in patients of hypercoagulable disorders: a clinical perspective. Hormone Molecular Biology and Clinical Investigation. | https://pubmed.ncbi.nlm.nih.gov/34786893/ | John, N. A., John, J., Kamble, P., Singhal, A., Daulatabad, V., & Vamshidhar, I. S. (2021). COVID 19 vaccine in patients of hypercoagulable disorders: a clinical perspective. Hormone Molecular Biology and Clinical Investigation. https://pubmed.ncbi.nlm.nih.gov/34786893/ | Lioudaki, S., Kontopodis, N., Pontikoglou, C., Gkalea, V., Pappas, T., Matsouka, C., ... & Ioannou, C. V. (2022). Multiple sites of arterial thrombosis in a 35-year old patient after ChAdOx1 (AstraZeneca) vaccination, requiring emergent femoral and carotid surgical thrombectomy. Annals of Vascular Surgery, 79, 438-e1. https://pubmed.ncbi.nlm.nih.gov/34644642/ | ||||
438 | Immune-mediated hepatitis with the Moderna vaccine is no longer a coincidence but confirmed: | https://www.sciencedirect.com/science/article/pii/S0168827821020936 | https://pubmed.ncbi.nlm.nih.gov/34710832/ | Cari, L., Alhosseini, M. N., Fiore, P., Pierno, S., Pacor, S., Bergamo, A., ... & Nocentini, G. (2021). Cardiovascular, neurological, and pulmonary events following vaccination with the BNT162b2, ChAdOx1 nCoV-19, and Ad26. COV2. S vaccines: An analysis of European data. Journal of autoimmunity, 125, 102742. | Cari, L., Alhosseini, M. N., Fiore, P., Pierno, S., Pacor, S., Bergamo, A., ... & Nocentini, G. (2021). Eventos cardiovasculares, neurológicos y pulmonares después de la vacunación con BNT162b2, ChAdOx1 nCoV-19 y Ad26. COV2. Vacunas S: un análisis de datos europeos. Revista de autoinmunidad, 125, 102742. https://pubmed.ncbi.nlm.nih.gov/34695859/ | Khogali, F., & Abdelrahman, R. (2021). Presentación inusual de perimyocarditis aguda después de la vacunación MODERA MODINA DE MRNA-1237 SARS-COV-2. CUREUS, 13 (7). https://www.ncbi.nlm.nih.gov/pubmed/34185046 | Cari, L., Alhosseini, M. N., Fiore, P., Pierno, S., Pacor, S., Bergamo, A., ... & Nocentini, G. (2021). Cardiovascular, neurological, and pulmonary events following vaccination with the BNT162b2, ChAdOx1 nCoV-19, and Ad26. COV2. S vaccines: An analysis of European data. Journal of autoimmunity, 125, 102742. https://pubmed.ncbi.nlm.nih.gov/34710832/ | Kim, D., Choi, J. H., Jang, J. Y., So, O., Cho, E., Choi, H., ... & Park, K. T. (2021). A Case Report for Myopericarditis after BNT162b2 COVID-19 mRNA Vaccination in a Korean Young Male. Journal of Korean Medical Science, 36(39). https://pubmed.ncbi.nlm.nih.gov/34636504/ | Chang, J. C., & Hawley, H. B. (2021). Vaccine-Associated Thrombocytopenia and Thrombosis: Venous Endotheliopathy Leading to Venous Combined Micro-Macrothrombosis. Medicina, 57(11), 1163. | https://pubmed.ncbi.nlm.nih.gov/34833382/ | Chang, J. C., & Hawley, H. B. (2021). Vaccine-Associated Thrombocytopenia and Thrombosis: Venous Endotheliopathy Leading to Venous Combined Micro-Macrothrombosis. Medicina, 57(11), 1163. https://pubmed.ncbi.nlm.nih.gov/34833382/ | Lippi, G., & Favaloro, E. J. (2021, October). Cerebral Venous Thrombosis Developing after COVID-19 Vaccination: VITT, VATT, TTS, and More. In Seminars in thrombosis and hemostasis. Thieme Medical Publishers, Inc.. https://pubmed.ncbi.nlm.nih.gov/34695859/ | ||||
439 | Extensive investigations revealed consistent pathophysiologic alterations after vaccination with COVID-19 vaccines: | https://www.nature.com/articles/s41421-021-00329-3 | https://pubmed.ncbi.nlm.nih.gov/34695859/ | Lippi, G., & Favaloro, E. J. (2021, October). Cerebral Venous Thrombosis Developing after COVID-19 Vaccination: VITT, VATT, TTS, and More. In Seminars in thrombosis and hemostasis. Thieme Medical Publishers, Inc.. | Lippi, G. y Favaloro, EJ (2021, octubre). Trombosis venosa cerebral que se desarrolla después de la vacunación contra el COVID-19: VITT, VATT, TTS y más. En Seminarios de Trombosis y Hemostasia. Thieme Medical Publishers, Inc.. https://pubmed.ncbi.nlm.nih.gov/34453762/. | Khouri, C., Roustit, M., & Cracowski, J. L. (2021). Informes de eventos adversos y riesgo de parálisis de Bell después de la vacunación COVID-19. Las enfermedades infecciosas de la lanceta, 21 (11), 1490-1491. https://pubmed.ncbi.nlm.nih.gov/34522557/ | Lippi, G., & Favaloro, E. J. (2021, October). Cerebral Venous Thrombosis Developing after COVID-19 Vaccination: VITT, VATT, TTS, and More. In Seminars in thrombosis and hemostasis. Thieme Medical Publishers, Inc.. https://pubmed.ncbi.nlm.nih.gov/34695859/ | Kim, G., Choi, E. J., Park, H. S., Lee, J. H., Lee, J. H., & Lee, K. H. (2021). A case report of immune thrombocytopenia after ChAdOx1 nCoV-19 vaccination. Journal of Korean medical science, 36(43). https://pubmed.ncbi.nlm.nih.gov/34751013/. | Rodríguez-Pardo, J., Gilo-Arrojo, F., Ruiz-Ares, G., Sánchez-Manso, J. C., Valiente-Gordillo, E., de Celis, E., ... & Díez-Tejedor, E. (2021). Thrombosis and Thrombocytopenia Syndrome Causing Isolated Symptomatic Carotid Occlusion after Covid-19 Vaccine. Thrombosis and Haemostasis. | https://pubmed.ncbi.nlm.nih.gov/34670287/ | Rodríguez-Pardo, J., Gilo-Arrojo, F., Ruiz-Ares, G., Sánchez-Manso, J. C., Valiente-Gordillo, E., de Celis, E., ... & Díez-Tejedor, E. (2021). Thrombosis and Thrombocytopenia Syndrome Causing Isolated Symptomatic Carotid Occlusion after Covid-19 Vaccine. Thrombosis and Haemostasis. https://pubmed.ncbi.nlm.nih.gov/34670287/ | Liu, J., Wang, J., Xu, J., Xia, H., Wang, Y., Zhang, C., ... & Liu, Z. (2021). Comprehensive investigations revealed consistent pathophysiological alterations after vaccination with COVID-19 vaccines. Cell discovery, 7(1), 1-15. https://www.nature.com/articles/s41421-021-00329-3 | ||||
440 | Lobar hemorrhage with ventricular rupture shortly after the first dose of an mRNA-based SARS-CoV-2 vaccine: | https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8553377/ | https://pubmed.ncbi.nlm.nih.gov/34453762/. | Gangat, N., Guglielmelli, P., Betti, S., Farrukh, F., Carobbio, A., Barbui, T., ... & Tefferi, A. (2021). Cerebral venous thrombosis and myeloproliferative neoplasms: A three‐center study of 74 consecutive cases. American journal of hematology, 96(12), 1580-1586. | Gangat, N., Guglielmelli, P., Betti, S., Farrukh, F., Carobbio, A., Barbui, T., ... y Tefferi, A. (2021). Trombosis venosa cerebral y neoplasias mieloproliferativas: un estudio en tres centros de 74 casos consecutivos. Revista americana de hematología, 96(12), 1580-1586. https://pubmed.ncbi.nlm.nih.gov/34660652/. | Kim, B., Park, Y., Kim, E. K., & Lee, S. H. (2021). Linfadenopatía supraclavicular después de la vacunación de COVID-19 en Corea: seguimiento en serie utilizando la ecografía. Imágenes clínicas, 79, 201-203. https://pubmed.ncbi.nlm.nih.gov/33661328/ | Gangat, N., Guglielmelli, P., Betti, S., Farrukh, F., Carobbio, A., Barbui, T., ... & Tefferi, A. (2021). Cerebral venous thrombosis and myeloproliferative neoplasms: A three‐center study of 74 consecutive cases. American journal of hematology, 96(12), 1580-1586. https://pubmed.ncbi.nlm.nih.gov/34453762/. | Kim, H. W., Jenista, E. R., Wendell, D. C., Azevedo, C. F., Campbell, M. J., Darty, S. N., ... & Kim, R. J. (2021). Patients with acute myocarditis following mRNA COVID-19 vaccination. JAMA cardiology, 6(10), 1196-1201. https://jamanetwork.com/journals/jamacardiology/fullarticle/2781602 | Bhan, C., Bheesham, N., Shakuntulla, F., Sharma, M., Sun, C., & Weinstein, M. (2021). An unusual presentation of acute deep vein thrombosis after the Moderna COVID-19 vaccine—a case report. Annals of Translational Medicine, 9(20). | https://pubmed.ncbi.nlm.nih.gov/34790811/ | Bhan, C., Bheesham, N., Shakuntulla, F., Sharma, M., Sun, C., & Weinstein, M. (2021). An unusual presentation of acute deep vein thrombosis after the Moderna COVID-19 vaccine—a case report. Annals of Translational Medicine, 9(20). https://pubmed.ncbi.nlm.nih.gov/34790811/ | Long, B., Bridwell, R., & Gottlieb, M. (2021). Thrombosis with thrombocytopenia syndrome associated with COVID-19 vaccines. The American journal of emergency medicine, 49, 58-61. https://www.sciencedirect.com/science/article/abs/pii/S0735675721004381 | ||||
441 | Mrna COVID vaccines dramatically increase endothelial inflammatory markers and risk of Acute Coronary Syndrome as measured by PULS cardiac testing: a caution: | https://www.ahajournals.org/doi/10.1161/circ.144.suppl_1.10712 | https://pubmed.ncbi.nlm.nih.gov/34660652/. | Okada, Y., Sakai, R., Sato-Fitoussi, M., Nodera, M., Yoshinaga, S., Shibata, A., ... & Amano, K. (2021). Potential triggers for thrombocytopenia and/or hemorrhage by the BNT162b2 vaccine, Pfizer-BioNTech. Frontiers in Medicine, 8. | Okada, Y., Sakai, R., Sato-Fitoussi, M., Nodera, M., Yoshinaga, S., Shibata, A., ... y Amano, K. (2021). Posibles desencadenantes de trombocitopenia y/o hemorragia por la vacuna BNT162b2, Pfizer-BioNTech. Fronteras en Medicina, 8. https://pubmed.ncbi.nlm.nih.gov/34644642/ | Kim, B., Park, Y., Kim, E. K., & Lee, S. H. (2021). Linfadenopatía supraclavicular después de la vacunación de COVID-19 en Corea: seguimiento en serie utilizando la ecografía. Imágenes clínicas, 79, 201-203. https://pubmed.ncbi.nlm.nih.gov/34509271/. | Okada, Y., Sakai, R., Sato-Fitoussi, M., Nodera, M., Yoshinaga, S., Shibata, A., ... & Amano, K. (2021). Potential triggers for thrombocytopenia and/or hemorrhage by the BNT162b2 vaccine, Pfizer-BioNTech. Frontiers in Medicine, 8. https://pubmed.ncbi.nlm.nih.gov/34660652/. | Kim, H. W., Jenista, E. R., Wendell, D. C., Azevedo, C. F., Campbell, M. J., Darty, S. N., ... & Kim, R. J. (2021). Patients with acute myocarditis following mRNA COVID-19 vaccination. JAMA cardiology, 6(10), 1196-1201. https://jamanetwork.com/journals/jamacardiology/fullarticle/2781602. | Graf, T., Thiele, T., Klingebiel, R., Greinacher, A., Schäbitz, W. R., & Greeve, I. (2021). Immediate high-dose intravenous immunoglobulins followed by direct thrombin-inhibitor treatment is crucial for survival in Sars-Covid-19-adenoviral vector vaccine-induced immune thrombotic thrombocytopenia VITT with cerebral sinus venous and portal vein thrombosis. Journal of Neurology, 268(12), 4483-4485. | https://pubmed.ncbi.nlm.nih.gov/34023956/. | Graf, T., Thiele, T., Klingebiel, R., Greinacher, A., Schäbitz, W. R., & Greeve, I. (2021). Immediate high-dose intravenous immunoglobulins followed by direct thrombin-inhibitor treatment is crucial for survival in Sars-Covid-19-adenoviral vector vaccine-induced immune thrombotic thrombocytopenia VITT with cerebral sinus venous and portal vein thrombosis. Journal of Neurology, 268(12), 4483-4485. https://pubmed.ncbi.nlm.nih.gov/34023956/. | Long, S. S. (2021). Important Insights into Myopericarditis after the Pfizer mRNA COVID-19 Vaccination in Adolescents. The Journal of Pediatrics, 238, 5. https://www.sciencedirect.com/science/article/pii/S0022347621007496 | ||||
442 | ChAdOx1 interacts with CAR and PF4 with implications for thrombosis with thrombocytopenia syndrome: https://www.science.org/doi/10.1126/sciadv.abl8213 | ChAdOx1 interacts with CAR and PF4 with implications for thrombosis with thrombocytopenia syndrome: | https://www.science.org/doi/10.1126/sciadv.abl8213 | https://pubmed.ncbi.nlm.nih.gov/34644642/ | Lioudaki, S., Kontopodis, N., Pontikoglou, C., Gkalea, V., Pappas, T., Matsouka, C., ... & Ioannou, C. V. (2022). Multiple sites of arterial thrombosis in a 35-year old patient after ChAdOx1 (AstraZeneca) vaccination, requiring emergent femoral and carotid surgical thrombectomy. Annals of Vascular Surgery, 79, 438-e1. | Lioudaki, S., Kontopodis, N., Pontikoglou, C., Gkalea, V., Pappas, T., Matsouka, C., ... & Ioannou, C. V. (2022). Múltiples sitios de trombosis arterial en un paciente de 35 años después de la vacunación con ChAdOx1 (AstraZeneca), que requirió trombectomía quirúrgica emergente femoral y carotídea. Anales de Cirugía Vascular, 79, 438-e1. https://pubmed.ncbi.nlm.nih.gov/34694650/ | Kim, D., Choi, J. H., Jang, J. Y., SO, O., CHO, E., Choi, H., ... & Park, K. T. (2021). Un informe de casos para miopericaDITIS después de la vacunación contra el ARNA COVID-19 de BNT162B2 en un macho joven coreano. Diario de la ciencia médica coreana, 36 (39). https://pubmed.ncbi.nlm.nih.gov/34367386/ | Lioudaki, S., Kontopodis, N., Pontikoglou, C., Gkalea, V., Pappas, T., Matsouka, C., ... & Ioannou, C. V. (2022). Multiple sites of arterial thrombosis in a 35-year old patient after ChAdOx1 (AstraZeneca) vaccination, requiring emergent femoral and carotid surgical thrombectomy. Annals of Vascular Surgery, 79, 438-e1. https://pubmed.ncbi.nlm.nih.gov/34644642/ | Kim, H. W., Jenista, E. R., Wendell, D. C., Azevedo, C. F., Campbell, M. J., Darty, S. N., ... & Kim, R. J. (2021). Patients with acute myocarditis following mRNA COVID-19 vaccination. JAMA cardiology, 6(10), 1196-1201. https://www.ncbi.nlm.nih.gov/pubmed/34185046 | Waggiallah, H. A. (2021). Thrombosis formation after COVID-19 vaccination immunological aspects. Saudi journal of biological sciences. | https://pubmed.ncbi.nlm.nih.gov/34629931/ | Waggiallah, H. A. (2021). Thrombosis formation after COVID-19 vaccination immunological aspects. Saudi journal of biological sciences. https://pubmed.ncbi.nlm.nih.gov/34629931/ | Lorente, E. (2021). Idiopathic Ipsilateral External Jugular Vein Thrombophlebitis After Coronavirus Disease (COVID-19) Vaccination. AJR Am J Roentgenol, 767-767. https://pubmed.ncbi.nlm.nih.gov/33624509/. | |||
443 | Lethal vaccine-induced immune thrombotic immune thrombocytopenia (VITT) following announcement 26.COV2.S: first documented case outside the U.S.: | https://pubmed.ncbi.nlm.nih.gov/34626338/ | https://pubmed.ncbi.nlm.nih.gov/34694650/ | Watts, I., Smith, D., Mounter, S., Baker, E. H., Hitchings, A. W., & Gill, D. (2021). A case series of vaccine‐induced thrombotic thrombocytopenia in a London teaching hospital. British Journal of Clinical Pharmacology. | Watts, I., Smith, D., Mounter, S., Baker, EH, Hitchings, AW y Gill, D. (2021). Una serie de casos de trombocitopenia trombótica inducida por vacunas en un hospital universitario de Londres. Revista británica de farmacología clínica. https://pubmed.ncbi.nlm.nih.gov/34726934/ | Kim, G., Choi, E. J., Park, H. S., Lee, J. H., Lee, J. H., & Lee, K. H. (2021). Un informe de casos de trombocitopenia inmune después de la vacunación con Chadox1 NCOV-19. Diario de la ciencia médica coreana, 36 (43). https://pubmed.ncbi.nlm.nih.gov/34684047/. | Watts, I., Smith, D., Mounter, S., Baker, E. H., Hitchings, A. W., & Gill, D. (2021). A case series of vaccine‐induced thrombotic thrombocytopenia in a London teaching hospital. British Journal of Clinical Pharmacology. https://pubmed.ncbi.nlm.nih.gov/34694650/ | Kim, I. C., Kim, H., Lee, H. J., Kim, J. Y., & Kim, J. Y. (2021). Cardiac imaging of acute myocarditis following COVID-19 mRNA vaccination. Journal of Korean Medical Science, 36(32). https://pubmed.ncbi.nlm.nih.gov/34402228/ | Sriwastava, S., Shrestha, A. K., Khalid, S. H., Colantonio, M. A., Nwafor, D., & Srivastava, S. (2021). Spectrum of Neuroimaging Findings in Post-COVID-19 Vaccination: A Case Series and Review of Literature. Neurology International, 13(4), 622-639. | https://pubmed.ncbi.nlm.nih.gov/34842783/ | Sriwastava, S., Shrestha, A. K., Khalid, S. H., Colantonio, M. A., Nwafor, D., & Srivastava, S. (2021). Spectrum of Neuroimaging Findings in Post-COVID-19 Vaccination: A Case Series and Review of Literature. Neurology International, 13(4), 622-639. https://pubmed.ncbi.nlm.nih.gov/34842783/ | Luk, A., Clarke, B., Dahdah, N., Ducharme, A., Krahn, A., McCrindle, B., ... & McDonald, M. (2021). Myocarditis and pericarditis after Covid-19 mRNA vaccination: practical considerations for care providers. Canadian Journal of Cardiology, 37(10), 1629-1634. https://www.sciencedirect.com/science/article/pii/S0828282X21006243 | ||||
444 | A prothrombotic thrombocytopenic disorder resembling heparin-induced thrombocytopenia after coronavirus-19 vaccination: https://europepmc.org/article/PPR/PPR304469435 | A prothrombotic thrombocytopenic disorder resembling heparin-induced thrombocytopenia after coronavirus-19 vaccination: | https://europepmc.org/article/PPR/PPR304469435 | https://pubmed.ncbi.nlm.nih.gov/34726934/ | Nowak, V. A., Scully, M., Davagnanam, I., & Bremner, F. (2021). Neuro-ophthalmic complications with ChAdOx1 nCoV-19 vaccine-induced thrombocytopenia and thrombosis. British Journal of Hospital Medicine, 82(10), 1-4. | Nowak, V. A., Scully, M., Davagnanam, I. y Bremner, F. (2021). Complicaciones neurooftálmicas con trombocitopenia y trombosis inducidas por la vacuna ChAdOx1 nCoV-19. Revista Británica de Medicina Hospitalaria, 82(10), 1-4. https://pubmed.ncbi.nlm.nih.gov/34835237/ | Kim, H. W., Jenista, E. R., Wendell, D. C., Azevedo, C. F., Campbell, M. J., Darty, S. N., ... & Kim, R. J. (2021). Pacientes con miocarditis aguda después de la vacunación con MRNA COVID-19. Cardiología de Jama, 6 (10), 1196-1201. https://pubs.rsna.org/doi/10.1148/radiol.2021211430 | Nowak, V. A., Scully, M., Davagnanam, I., & Bremner, F. (2021). Neuro-ophthalmic complications with ChAdOx1 nCoV-19 vaccine-induced thrombocytopenia and thrombosis. British Journal of Hospital Medicine, 82(10), 1-4. https://pubmed.ncbi.nlm.nih.gov/34726934/ | Kim, I. C., Kim, H., Lee, H. J., Kim, J. Y., & Kim, J. Y. (2021). Cardiac imaging of acute myocarditis following COVID-19 mRNA vaccination. Journal of Korean Medical Science, 36(32). https://www.ncbi.nlm.nih.gov/pubmed/34402228 | Lin, W., Ko, C. A., Sung, Y. F., Chen, Y. C., Lee, J. T., Lin, Y. Q., & Lin, Y. K. (2021). Cerebral Venous Sinus Thrombosis, Pulmonary Embolism, and Thrombocytopenia After COVID-19 Vaccination in a Taiwanese Man: A Case Report and Literature Review. Frontiers in Neurology, 1670. | https://pubmed.ncbi.nlm.nih.gov/34630307/ | Lin, W., Ko, C. A., Sung, Y. F., Chen, Y. C., Lee, J. T., Lin, Y. Q., & Lin, Y. K. (2021). Cerebral Venous Sinus Thrombosis, Pulmonary Embolism, and Thrombocytopenia After COVID-19 Vaccination in a Taiwanese Man: A Case Report and Literature Review. Frontiers in Neurology, 1670. https://pubmed.ncbi.nlm.nih.gov/34630307/ | Maayan, H., Kirgner, I., Gutwein, O., Herzog‐Tzarfati, K., Rahimi‐Levene, N., Koren‐Michowitz, M., & Blickstein, D. (2021). Acquired thrombotic thrombocytopenic purpura: A rare disease associated with BNT162b2 vaccine. Journal of Thrombosis and Haemostasis, 19(9), 2314-2317. https://pubmed.ncbi.nlm.nih.gov/34105247/. | |||
445 | VITT (vaccine-induced immune thrombotic thrombocytopenia) after vaccination with ChAdOx1 nCoV-19: | https://pubmed.ncbi.nlm.nih.gov/34731555/ | https://pubmed.ncbi.nlm.nih.gov/34835237/ | Baldi, I., Azzolina, D., Francavilla, A., Bartolotta, P., Lorenzoni, G., Vanuzzo, D., & Gregori, D. (2021). Thrombotic Events after COVID-19 Vaccination in the Over-50s: Results from a Population-Based Study in Italy. Vaccines, 9(11), 1307. | Baldi, I., Azzolina, D., Francavilla, A., Bartolotta, P., Lorenzoni, G., Vanuzzo, D. y Gregori, D. (2021). Eventos trombóticos después de la vacunación COVID-19 en personas mayores de 50 años: resultados de un estudio poblacional realizado en Italia. Vacunas, 9(11), 1307. https://pubmed.ncbi.nlm.nih.gov/34724036/. | Kim, H. W., Jenista, E. R., Wendell, D. C., Azevedo, C. F., Campbell, M. J., Darty, S. N., ... & Kim, R. J. (2021). Pacientes con miocarditis aguda después de la vacunación con MRNA COVID-19. Cardiología de Jama, 6 (10), 1196-1201. https://www.ncbi.nlm.nih.gov/pubmed/34402228 | Baldi, I., Azzolina, D., Francavilla, A., Bartolotta, P., Lorenzoni, G., Vanuzzo, D., & Gregori, D. (2021). Thrombotic Events after COVID-19 Vaccination in the Over-50s: Results from a Population-Based Study in Italy. Vaccines, 9(11), 1307. https://pubmed.ncbi.nlm.nih.gov/34835237/ | Kinariwalla, N., London, A. O., Soliman, Y. S., Niedt, G. W., Husain, S., & Gallitano, S. M. (2022). A case of generalized Sweet syndrome with vasculitis triggered by recent COVID-19 vaccination. JAAD Case Reports, 19, 64-67. https://pubmed.ncbi.nlm.nih.gov/34849386/ | Premkumar, M., Bhujade, H., Karki, T., Chaluvashetty, S. B., Kaur, H., Duseja, A. K., & Singh, V. (2021). New Portal Vein Thrombosis in Cirrhosis-is the thrombophilia exacerbated due to Vaccine or COVID-19?. Journal of Clinical and Experimental Hepatology. | https://www.jcehepatology.com/article/S0973-6883(21)00545-4/fulltext. | Premkumar, M., Bhujade, H., Karki, T., Chaluvashetty, S. B., Kaur, H., Duseja, A. K., & Singh, V. (2021). New Portal Vein Thrombosis in Cirrhosis-is the thrombophilia exacerbated due to Vaccine or COVID-19?. Journal of Clinical and Experimental Hepatology. https://www.jcehepatology.com/article/S0973-6883(21)00545-4/fulltext. | MacIntyre, C. R., Veness, B., Berger, D., Hamad, N., & Bari, N. (2021). Thrombosis with Thrombocytopenia Syndrome (TTS) following AstraZeneca ChAdOx1 nCoV-19 (AZD1222) COVID-19 vaccination–A risk–benefit analysis for people< 60 years in Australia. Vaccine, 39(34), 4784-4787. https://pubmed.ncbi.nlm.nih.gov/34272095/ | ||||
446 | Vaccine-induced immune thrombotic thrombocytopenia (VITT): a new clinicopathologic entity with heterogeneous clinical presentations: | https://pubmed.ncbi.nlm.nih.gov/34159588/ | https://pubmed.ncbi.nlm.nih.gov/34724036/. | Ashrani, A. A., Crusan, D. J., Petterson, T., Bailey, K., & Heit, J. A. (2022). Age-and sex-specific incidence of cerebral venous sinus thrombosis associated with Ad26. COV2. S COVID-19 vaccination. JAMA internal medicine, 182(1), 80-83. | Ashrani, A. A., Crusan, D. J., Petterson, T., Bailey, K. y Heit, J. A. (2022). Incidencia específica por edad y sexo de trombosis del seno venoso cerebral asociada con Ad26. COV2. S Vacunación contra el COVID-19. Medicina interna JAMA, 182 (1), 80-83. https://pubmed.ncbi.nlm.nih.gov/34839563/ | Kim, H. W., Jenista, E. R., Wendell, D. C., Azevedo, C. F., Campbell, M. J., Darty, S. N., ... & Kim, R. J. (2021). Pacientes con miocarditis aguda después de la vacunación con MRNA COVID-19. Cardiología de Jama, 6 (10), 1196-1201. https://www.sciencedirect.com/science/article/pii/S0264410X21011725?via%3Dihub. | Ashrani, A. A., Crusan, D. J., Petterson, T., Bailey, K., & Heit, J. A. (2022). Age-and sex-specific incidence of cerebral venous sinus thrombosis associated with Ad26. COV2. S COVID-19 vaccination. JAMA internal medicine, 182(1), 80-83. https://pubmed.ncbi.nlm.nih.gov/34724036/. | King, W. W., Petersen, M. R., Matar, R. M., Budweg, J. B., Pardo, L. C., & Petersen, J. W. (2021). Myocarditis following mRNA vaccination against SARS-CoV-2, a case series. American Heart Journal Plus: Cardiology Research and Practice, 8, 100042. https://pubmed.ncbi.nlm.nih.gov/34396358/. | Garnier, M., Curado, A., Billoir, P., Barbay, V., Demeyere, M., & Dacher, J. N. (2021). Imaging of Oxford/AstraZeneca COVID-19 vaccine-induced immune thrombotic thrombocytopenia. Diagnostic and interventional imaging. | https://pubmed.ncbi.nlm.nih.gov/33962903/. | Garnier, M., Curado, A., Billoir, P., Barbay, V., Demeyere, M., & Dacher, J. N. (2021). Imaging of Oxford/AstraZeneca COVID-19 vaccine-induced immune thrombotic thrombocytopenia. Diagnostic and interventional imaging. https://pubmed.ncbi.nlm.nih.gov/33962903/. | Madelon, N., Lauper, K., Breville, G., Sabater Royo, I., Goldstein, R., Andrey, D. O., ... & Eberhardt, C. S. (2021). Robust T cell responses in anti-CD20 treated patients following COVID-19 vaccination: a prospective cohort study. Clinical Infectious Diseases. https://www.ncbi.nlm.nih.gov/pubmed/34791081 | ||||
447 | Treatment of acute ischemic stroke associated with ChAdOx1 nCoV-19 vaccine-induced immune thrombotic thrombocytopenia: | https://pubmed.ncbi.nlm.nih.gov/34461442/ | https://pubmed.ncbi.nlm.nih.gov/34839563/ | Kuzumi, A., Yoshizaki, A., Chiba, K., Mitsuo, S., Matsuda, K. M., Norimatsu, Y., ... & Sato, S. (2022). Genital necrosis with cutaneous thrombosis after COVID‐19 mRNA vaccination. Journal of the European Academy of Dermatology and Venereology, 36(3), e185-e186. | Kuzumi, A., Yoshizaki, A., Chiba, K., Mitsuo, S., Matsuda, K. M., Norimatsu, Y., ... y Sato, S. (2022). Necrosis genital con trombosis cutánea después de la vacunación con ARNm de COVID-19. Revista de la Academia Europea de Dermatología y Venereología, 36(3), e185-e186. https://pubmed.ncbi.nlm.nih.gov/34783932/. | Kim, I. C., Kim, H., Lee, H. J., Kim, J. Y., & Kim, J. Y. (2021). Imágenes cardiacas de miocarditis aguda después de la vacunación de ARNm Covid-19. Diario de la ciencia médica coreana, 36 (32). https://academic.oup.com/ehjcr/article/5/8/ytab319/6339567 | Kuzumi, A., Yoshizaki, A., Chiba, K., Mitsuo, S., Matsuda, K. M., Norimatsu, Y., ... & Sato, S. (2022). Genital necrosis with cutaneous thrombosis after COVID‐19 mRNA vaccination. Journal of the European Academy of Dermatology and Venereology, 36(3), e185-e186. https://pubmed.ncbi.nlm.nih.gov/34839563/ | King, W. W., Petersen, M. R., Matar, R. M., Budweg, J. B., Pardo, L. C., & Petersen, J. W. (2021). Myocarditis following mRNA vaccination against SARS-CoV-2, a case series. American Heart Journal Plus: Cardiology Research and Practice, 8, 100042. https://www.ncbi.nlm.nih.gov/pubmed/34396358 | Yamaguchi, Y., Kimihira, L., Nagasawa, H., Seo, K., & Wada, M. (2021). Cerebral Venous Sinus Thrombosis After BNT162b2 mRNA COVID-19 Vaccination. Cureus, 13(10). | https://pubmed.ncbi.nlm.nih.gov/34796065/. | Yamaguchi, Y., Kimihira, L., Nagasawa, H., Seo, K., & Wada, M. (2021). Cerebral Venous Sinus Thrombosis After BNT162b2 mRNA COVID-19 Vaccination. Cureus, 13(10). https://pubmed.ncbi.nlm.nih.gov/34796065/. | Maeda, M., Isawa, T., & Tada, N. (2021). Definite Acute Myocarditis After Coronavirus Disease 2019 mRNA Vaccination. Circulation Journal, CJ-21. https://pubmed.ncbi.nlm.nih.gov/34866122/ | ||||
448 | Spectrum of neurological complications after COVID-19 vaccination: https://pubmed.ncbi.nlm.nih.gov/34719776/ | Spectrum of neurological complications after COVID-19 vaccination: | https://pubmed.ncbi.nlm.nih.gov/34719776/ | https://pubmed.ncbi.nlm.nih.gov/34783932/. | Yagi, Y., Asami, Y., Kyoya, M., & Yokota, T. (2022). Cerebral venous sinus thrombosis after mRNA-based COVID-19 vaccination. Neurological Sciences, 43(1), 41-43. | Yagi, Y., Asami, Y., Kyoya, M. y Yokota, T. (2022). Trombosis del seno venoso cerebral después de la vacunación COVID-19 basada en ARNm. Ciencias Neurológicas, 43(1), 41-43. https://pubmed.ncbi.nlm.nih.gov/34624910/ | Kim, I. C., Kim, H., Lee, H. J., Kim, J. Y., & Kim, J. Y. (2021). Imágenes cardiacas de miocarditis aguda después de la vacunación de ARNm Covid-19. Diario de la ciencia médica coreana, 36 (32). https://www.ncbi.nlm.nih.gov/pubmed/34396358 | Yagi, Y., Asami, Y., Kyoya, M., & Yokota, T. (2022). Cerebral venous sinus thrombosis after mRNA-based COVID-19 vaccination. Neurological Sciences, 43(1), 41-43. https://pubmed.ncbi.nlm.nih.gov/34783932/. | King, W. W., Petersen, M. R., Matar, R. M., Budweg, J. B., Pardo, L. C., & Petersen, J. W. (2021). Myocarditis following mRNA vaccination against SARS-CoV-2, a case series. American Heart Journal Plus: Cardiology Research and Practice, 8, 100042. https://www.sciencedirect.com/science/article/pii/S2666602221000409 | Cugno, M., Consonni, D., Lombardi, A., Bono, P., Oggioni, M., Uceda Renteria, S., ... & Gori, A. (2021). Increased risk of urticaria/angioedema after BNT162b2 mRNA COVID-19 vaccine in health care workers taking ACE inhibitors. Vaccines, 9(9), 1011. | https://pubmed.ncbi.nlm.nih.gov/34579248/ | Cugno, M., Consonni, D., Lombardi, A., Bono, P., Oggioni, M., Uceda Renteria, S., ... & Gori, A. (2021). Increased risk of urticaria/angioedema after BNT162b2 mRNA COVID-19 vaccine in health care workers taking ACE inhibitors. Vaccines, 9(9), 1011. https://pubmed.ncbi.nlm.nih.gov/34579248/ | Majid, I., & Mearaj, S. (2021). Sweet syndrome after Oxford‐AstraZeneca COVID‐19 vaccine (AZD1222) in an elderly female. Dermatologic Therapy, 34(6), e15146. https://pubmed.ncbi.nlm.nih.gov/34590397/ | |||
449 | Cerebral venous sinus thrombosis after vaccination: the UK experience: | https://pubmed.ncbi.nlm.nih.gov/34370974/ | https://pubmed.ncbi.nlm.nih.gov/34624910/ | Thachil, J. (2021, October). COVID-19 vaccine-induced immune thrombosis with thrombocytopenia (VITT) and the shades of grey in thrombus formation. In Seminars in thrombosis and hemostasis. Thieme Medical Publishers, Inc.. | Thachil, J. (2021, octubre). Trombosis inmune con trombocitopenia (VITT) inducida por la vacuna COVID-19 y tonos de gris en la formación de trombos. En Seminarios de Trombosis y Hemostasia. Thieme Medical Publishers, Inc.. https://pubmed.ncbi.nlm.nih.gov/34585145/ | Kinariwalla, N., Londres, A. O., Soliman, Y. S., Niedt, G. W., Husain, S., & Gallitano, S. M. (2022). Un caso de síndrome dulce generalizado con vasculitis desencadenada por la vacunación reciente de COVID-19. Jaad Case Reports, 19, 64-67. https://pubmed.ncbi.nlm.nih.gov/34310763/ | Thachil, J. (2021, October). COVID-19 vaccine-induced immune thrombosis with thrombocytopenia (VITT) and the shades of grey in thrombus formation. In Seminars in thrombosis and hemostasis. Thieme Medical Publishers, Inc.. https://pubmed.ncbi.nlm.nih.gov/34624910/ | Kircheis, R. (2021). Coagulopathies after vaccination against SARS-CoV-2 may be derived from a combined effect of SARS-CoV-2 spike protein and adenovirus vector-triggered signaling pathways. International Journal of Molecular Sciences, 22(19), 10791. https://pubmed.ncbi.nlm.nih.gov/34639132/ | van Dijk, M. M., Veldman, H. D., Aarts, F., Barten, D. G., van den Bergh, J. P., & Dielis, A. W. (2022). A case of unusual mild clinical presentation of COVID-19 vaccine-induced immune thrombotic thrombocytopenia with splanchnic vein thrombosis. Annals of hepatology, 27(1), 100590. | https://pubmed.ncbi.nlm.nih.gov/34843991/ | van Dijk, M. M., Veldman, H. D., Aarts, F., Barten, D. G., van den Bergh, J. P., & Dielis, A. W. (2022). A case of unusual mild clinical presentation of COVID-19 vaccine-induced immune thrombotic thrombocytopenia with splanchnic vein thrombosis. Annals of hepatology, 27(1), 100590. https://pubmed.ncbi.nlm.nih.gov/34843991/ | Major, A., Carll, T., Chan, C. W., Christenson, C., Aldarweesh, F., Wool, G. D., & Cohen, K. S. (2022). Refractory vaccine‐induced immune thrombotic thrombocytopenia (VITT) managed with delayed therapeutic plasma exchange (TPE). Journal of clinical apheresis, 37(1), 117-121. https://pubmed.ncbi.nlm.nih.gov/34672380/ | ||||
450 | Cerebral venous vein/venous sinus thrombosis with thrombocytopenia syndrome after COVID-19 vaccination: | https://pubmed.ncbi.nlm.nih.gov/34373413/ | https://pubmed.ncbi.nlm.nih.gov/34585145/ | Maramattom, B. V., Philips, G., Thomas, J., & Santhamma, S. G. N. (2021). Inflammatory myositis after ChAdOx1 vaccination. The Lancet Rheumatology, 3(11), e747-e749. | Maramattom, BV, Philips, G., Thomas, J. y Santhamma, SGN (2021). Miositis inflamatoria después de la vacunación con ChAdOx1. The Lancet Rheumatology, 3(11), e747-e749. https://pubmed.ncbi.nlm.nih.gov/34580132/. | King, W. W., Petersen, M. R., Matar, R. M., Buda, J. B., Pardo, L. C., & Petersen, J. W. (2021). Miocarditis después de la vacunación con ARNm contra SARS-COV-2, una serie de casos. American Heart Journal Plus: Investigación y práctica de cardiología, 8, 100042. https://pubmed.ncbi.nlm.nih.gov/34848426/. | Maramattom, B. V., Philips, G., Thomas, J., & Santhamma, S. G. N. (2021). Inflammatory myositis after ChAdOx1 vaccination. The Lancet Rheumatology, 3(11), e747-e749. https://pubmed.ncbi.nlm.nih.gov/34585145/ | Klein, N. P., Lewis, N., Goddard, K., Fireman, B., Zerbo, O., Hanson, K. E., ... & Weintraub, E. S. (2021). Surveillance for adverse events after COVID-19 mRNA vaccination. JAMA, 326(14), 1390-1399. https://www.ncbi.nlm.nih.gov/pubmed/34477808 | Cheng, N. (2021). Cerebral venous sinus thrombosis after Pfizer-BioNTech COVID-19 (BNT162b2) vaccination. Journal of Clinical Neurology (Seoul, Korea), 17(4), 573. | https://pubmed.ncbi.nlm.nih.gov/34595867/ | Cheng, N. (2021). Cerebral venous sinus thrombosis after Pfizer-BioNTech COVID-19 (BNT162b2) vaccination. Journal of Clinical Neurology (Seoul, Korea), 17(4), 573. https://pubmed.ncbi.nlm.nih.gov/34595867/ | Maki, H., Aikawa, T., Ibe, T., Oyama-Manabe, N., & Fujita, H. (2022). Biventricular systolic dysfunction in acute myocarditis after SARS-CoV-2 mRNA-1273 vaccination. European Heart Journal-Cardiovascular Imaging, 23(2), e87-e87. https://pubmed.ncbi.nlm.nih.gov/34601566/ | ||||
451 | Portal vein thrombosis due to vaccine-induced immune thrombotic immune thrombocytopenia (VITT) after Covid vaccination with ChAdOx1 nCoV-19: | https://pubmed.ncbi.nlm.nih.gov/34598301/ | https://pubmed.ncbi.nlm.nih.gov/34580132/. | Flower, L., Bares, Z., Santiapillai, G., & Harris, S. (2021). Acute ST-segment elevation myocardial infarction secondary to vaccine-induced immune thrombosis with thrombocytopaenia (VITT). BMJ Case Reports CP, 14(9), e245218. | Flower, L., Bares, Z., Santiapillai, G. y Harris, S. (2021). Infarto agudo de miocardio con elevación del segmento ST secundario a trombosis inmune con trombocitopenia inducida por vacuna (VITT). BMJ Case Reports CP, 14(9), e245218. https://pubmed.ncbi.nlm.nih.gov/34535492/ | King, W. W., Petersen, M. R., Matar, R. M., Buda, J. B., Pardo, L. C., & Petersen, J. W. (2021). Miocarditis después de la vacunación con ARNm contra SARS-COV-2, una serie de casos. American Heart Journal Plus: Investigación y práctica de cardiología, 8, 100042. https://www.ncbi.nlm.nih.gov/pubmed/34477808 | Flower, L., Bares, Z., Santiapillai, G., & Harris, S. (2021). Acute ST-segment elevation myocardial infarction secondary to vaccine-induced immune thrombosis with thrombocytopaenia (VITT). BMJ Case Reports CP, 14(9), e245218. https://pubmed.ncbi.nlm.nih.gov/34580132/. | Klimek, L., Bergmann, K. C., Brehler, R., Pfützner, W., Zuberbier, T., Hartmann, K., ... & Worm, M. (2021). Practical handling of allergic reactions to COVID-19 vaccines. Allergo journal international, 30(3), 79-95. https://www.ncbi.nlm.nih.gov/pubmed/33898162 | Malayala, S. V., Papudesi, B. N., Sharma, R., Vusqa, U. T., & Raza, A. (2021). A case of idiopathic thrombocytopenic purpura after booster dose of BNT162b2 (Pfizer-Biontech) COVID-19 vaccine. Cureus, 13(10). | https://pubmed.ncbi.nlm.nih.gov/34820240/ | Malayala, S. V., Papudesi, B. N., Sharma, R., Vusqa, U. T., & Raza, A. (2021). A case of idiopathic thrombocytopenic purpura after booster dose of BNT162b2 (Pfizer-Biontech) COVID-19 vaccine. Cureus, 13(10). https://pubmed.ncbi.nlm.nih.gov/34820240/ | Malamud, E., Otallah, S. I., Caress, J. B., & Lapid, D. J. (2022). Guillain-Barré Syndrome After COVID-19 Vaccination in an Adolescent. Pediatric neurology, 126, 9-10. https://www.pedneur.com/article/S0887-8994(21)00221-6/fulltext. | ||||
452 | Hematuria, a generalized petechial rash and headaches after Oxford AstraZeneca ChAdOx1 nCoV-19 vaccination: | https://pubmed.ncbi.nlm.nih.gov/34620638/ | https://pubmed.ncbi.nlm.nih.gov/34535492/ | Asmat, H., Fayeye, F., Alshakaty, H., & Patel, J. (2021). A rare case of COVID-19 vaccine-induced thrombotic thrombocytopaenia (VITT) involving the veno-splanchnic and pulmonary arterial circulation, from a UK district general hospital. BMJ Case Reports CP, 14(9), e244223. | Asmat, H., Fayeye, F., Alshakaty, H. y Patel, J. (2021). Un caso raro de trombocitopenia trombótica (VITT) inducida por la vacuna COVID-19 que afecta la circulación arterial venoesplácnica y pulmonar, en un hospital general de distrito del Reino Unido. BMJ Case Reports CP, 14(9), e244223. https://pubmed.ncbi.nlm.nih.gov/34527501/ | King, W. W., Petersen, M. R., Matar, R. M., Buda, J. B., Pardo, L. C., & Petersen, J. W. (2021). Miocarditis después de la vacunación con ARNm contra SARS-COV-2, una serie de casos. American Heart Journal Plus: Investigación y práctica de cardiología, 8, 100042. https://www.sciencedirect.com/science/article/pii/S2213333X21003929 | Asmat, H., Fayeye, F., Alshakaty, H., & Patel, J. (2021). A rare case of COVID-19 vaccine-induced thrombotic thrombocytopaenia (VITT) involving the veno-splanchnic and pulmonary arterial circulation, from a UK district general hospital. BMJ Case Reports CP, 14(9), e244223. https://pubmed.ncbi.nlm.nih.gov/34535492/ | Klimek, L., Novak, N., Cabanillas, B., Jutel, M., Bousquet, J., & Akdis, C. A. (2021). Allergenic components of the mRNA‐1273 vaccine for COVID‐19: possible involvement of polyethylene glycol and IgG‐mediated complement activation. Allergy, 76(11), 3307-3313. https://pubmed.ncbi.nlm.nih.gov/33657648/ | Von Hundelshausen, P., Lorenz, R., Siess, W., & Weber, C. (2021). Vaccine-induced immune thrombotic thrombocytopenia (VITT): targeting pathomechanisms with Bruton tyrosine kinase inhibitors. Thrombosis and haemostasis. | https://pubmed.ncbi.nlm.nih.gov/33851389/ | Von Hundelshausen, P., Lorenz, R., Siess, W., & Weber, C. (2021). Vaccine-induced immune thrombotic thrombocytopenia (VITT): targeting pathomechanisms with Bruton tyrosine kinase inhibitors. Thrombosis and haemostasis. https://pubmed.ncbi.nlm.nih.gov/33851389/ | Malayala, S. V., Mohan, G., Vasireddy, D., & Atluri, P. (2021). Purpuric rash and thrombocytopenia after the mRNA-1273 (Moderna) COVID-19 vaccine. Cureus, 13(3). https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7996471/ | ||||
453 | Myocardial infarction and azygos vein thrombosis after vaccination with ChAdOx1 nCoV-19 in a hemodialysis patient: | https://pubmed.ncbi.nlm.nih.gov/34650896/ | https://pubmed.ncbi.nlm.nih.gov/34527501/ | Alalwan, A. A., Abou Trabeh, A., Premchandran, D., & Razeem, M. (2021). COVID-19 Vaccine-Induced Thrombotic Thrombocytopenia: A Case Series. Cureus, 13(9). | Alalwan, A. A., Abou Trabeh, A., Premchandran, D. y Razeem, M. (2021). Trombocitopenia trombótica inducida por la vacuna COVID-19: una serie de casos. Cureus, 13(9). https://pubmed.ncbi.nlm.nih.gov/34756770/ | Kircheis, R. (2021). Las coagulopatías después de la vacunación contra el SARS-COV-2 pueden derivarse de un efecto combinado de la proteína de punta de SARS-COV-2 y las vías de señalización activadas por vector de adenovirus. Diario Internacional de Ciencias Moleculares, 22 (19), 10791. https://pubmed.ncbi.nlm.nih.gov/34804412/ | Alalwan, A. A., Abou Trabeh, A., Premchandran, D., & Razeem, M. (2021). COVID-19 Vaccine-Induced Thrombotic Thrombocytopenia: A Case Series. Cureus, 13(9). https://pubmed.ncbi.nlm.nih.gov/34527501/ | Klimek, L., Novak, N., Hamelmann, E., Werfel, T., Wagenmann, M., Taube, C., ... & Worm, M. (2021). Severe allergic reactions after COVID-19 vaccination with the Pfizer/BioNTech vaccine in Great Britain and USA. Allergo journal international, 30(2), 51-55. https://pubmed.ncbi.nlm.nih.gov/33643776/ | Yocum, A., & Simon, E. L. (2021). Thrombotic thrombocytopenic purpura after Ad26. COV2-S vaccination. The American journal of emergency medicine, 49, 441-e3. | https://pubmed.ncbi.nlm.nih.gov/33980419/ | Yocum, A., & Simon, E. L. (2021). Thrombotic thrombocytopenic purpura after Ad26. COV2-S vaccination. The American journal of emergency medicine, 49, 441-e3. https://pubmed.ncbi.nlm.nih.gov/33980419/ | Malayala, S. V., Papudesi, B. N., Sharma, R., Vusqa, U. T., & Raza, A. (2021). A case of idiopathic thrombocytopenic purpura after booster dose of BNT162b2 (Pfizer-Biontech) COVID-19 vaccine. Cureus, 13(10). https://pubmed.ncbi.nlm.nih.gov/34820240/ | ||||
454 | Takotsubo (stress) cardiomyopathy after vaccination with ChAdOx1 nCoV-19: | https://pubmed.ncbi.nlm.nih.gov/34625447/ | https://pubmed.ncbi.nlm.nih.gov/34756770/ | Gordon, S. F., Clothier, H. J., Morgan, H., Buttery, J. P., Phuong, L. K., Monagle, P., ... & Crawford, N. W. (2021). Immune thrombocytopenia following immunisation with Vaxzevria ChadOx1-S (AstraZeneca) vaccine, Victoria, Australia. Vaccine, 39(48), 7052-7057. | Gordon, S. F., Clothier, H. J., Morgan, H., Buttery, J. P., Phuong, L. K., Monagle, P., ... y Crawford, N. W. (2021). Trombocitopenia inmunitaria tras la inmunización con la vacuna Vaxzevria ChadOx1-S (AstraZeneca), Victoria, Australia. Vacuna, 39(48), 7052-7057. https://jamanetwork.com/journals/jamaneurology/fullarticle/2784622 | Klein, N. P., Lewis, N., Goddard, K., Bomber, B., Zerbo, O., Hanson, K. E., ... & Weintraub, E. S. (2021). Vigilancia para eventos adversos después de la vacunación con ARNm Covid-19. JAMA, 326 (14), 1390-1399. https://www.ncbi.nlm.nih.gov/pubmed/33898162 | Gordon, S. F., Clothier, H. J., Morgan, H., Buttery, J. P., Phuong, L. K., Monagle, P., ... & Crawford, N. W. (2021). Immune thrombocytopenia following immunisation with Vaxzevria ChadOx1-S (AstraZeneca) vaccine, Victoria, Australia. Vaccine, 39(48), 7052-7057. https://pubmed.ncbi.nlm.nih.gov/34756770/ | Klimek, L., Novak, N., Hamelmann, E., Werfel, T., Wagenmann, M., Taube, C., ... & Worm, M. (2021). Severe allergic reactions after COVID-19 vaccination with the Pfizer/BioNTech vaccine in Great Britain and USA. Allergo journal international, 30(2), 51-55. https://www.ncbi.nlm.nih.gov/pubmed/33643776 | Sessa, M., Kragholm, K., Hviid, A., & Andersen, M. (2021). Thromboembolic events in younger women exposed to Pfizer-BioNTech or Moderna COVID-19 vaccines. Expert Opinion on Drug Safety, 20(11), 1451-1453. | https://pubmed.ncbi.nlm.nih.gov/34264151/ | Sessa, M., Kragholm, K., Hviid, A., & Andersen, M. (2021). Thromboembolic events in younger women exposed to Pfizer-BioNTech or Moderna COVID-19 vaccines. Expert Opinion on Drug Safety, 20(11), 1451-1453. https://pubmed.ncbi.nlm.nih.gov/34264151/ | Malik, B., Kalantary, A., Rikabi, K., & Kunadi, A. (2021). Pulmonary embolism, transient ischaemic attack and thrombocytopenia after the Johnson & Johnson COVID-19 vaccine. BMJ Case Reports CP, 14(7), e243975. https://pubmed.ncbi.nlm.nih.gov/34261635/ | ||||
455 | Humoral response induced by Prime-Boost vaccination with ChAdOx1 nCoV-19 and BNT162b2 mRNA vaccines in a patient with multiple sclerosis treated with teriflunomide: | https://pubmed.ncbi.nlm.nih.gov/34696248/ | https://jamanetwork.com/journals/jamaneurology/fullarticle/2784622 | Van Kammen, M. S., De Sousa, D. A., Poli, S., Cordonnier, C., Heldner, M. R., Van De Munckhof, A., ... & Arslan, Y. (2021). Characteristics and outcomes of patients with cerebral venous sinus thrombosis in SARS-CoV-2 vaccine–induced immune thrombotic thrombocytopenia. JAMA neurology, 78(11), 1314-1323. | Van Kammen, M. S., De Sousa, D. A., Poli, S., Cordonnier, C., Heldner, M. R., Van De Munckhof, A., ... y Arslan, Y. (2021). Características y resultados de pacientes con trombosis del seno venoso cerebral en trombocitopenia trombótica inmune inducida por la vacuna SARS-CoV-2. Neurología JAMA, 78(11), 1314-1323. https://pubmed.ncbi.nlm.nih.gov/34781321/ | Klimek, L., Bergmann, K. C., Brehler, R., Pfützner, W., Zuberbier, T., Hartmann, K., ... & Worm, M. (2021). Manejo práctico de reacciones alérgicas a las vacunas COVID-19. AllerGo Journal International, 30 (3), 79-95. https://www.ncbi.nlm.nih.gov/pubmed/33643776 | Van Kammen, M. S., De Sousa, D. A., Poli, S., Cordonnier, C., Heldner, M. R., Van De Munckhof, A., ... & Arslan, Y. (2021). Characteristics and outcomes of patients with cerebral venous sinus thrombosis in SARS-CoV-2 vaccine–induced immune thrombotic thrombocytopenia. JAMA neurology, 78(11), 1314-1323. https://jamanetwork.com/journals/jamaneurology/fullarticle/2784622 | Knowlton, K. U. (2021). Insights From a Murine Model of Coronavirus Disease 2019 (COVID-19) mRNA Vaccination-Induced Myopericarditis: Could Accidental Intravenous Vaccine Injection Induce Myopericarditis?. Clinical Infectious Diseases. https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciab741/6359059 | Soltani Hekmat, A., & Javanmardi, K. (2021). Possible Risk of Thrombotic Events following Oxford-AstraZeneca COVID-19 Vaccination in Women Receiving Estrogen. BioMed Research International, 2021. | https://pubmed.ncbi.nlm.nih.gov/34734086/ | Soltani Hekmat, A., & Javanmardi, K. (2021). Possible Risk of Thrombotic Events following Oxford-AstraZeneca COVID-19 Vaccination in Women Receiving Estrogen. BioMed Research International, 2021. https://pubmed.ncbi.nlm.nih.gov/34734086/ | Mangat, C., & Milosavljevic, N. (2021). BNT162b2 Vaccination during Pregnancy Protects Both the Mother and Infant: Anti-SARS-CoV-2 S Antibodies Persistently Positive in an Infant at 6 Months of Age. Case Reports in Pediatrics, 2021. https://www.ncbi.nlm.nih.gov/pubmed/34676123 | ||||
456 | Guillain-Barré syndrome after ChAdOx1 nCoV-19 COVID-19 vaccination: a case series: | https://pubmed.ncbi.nlm.nih.gov/34548920/ | https://pubmed.ncbi.nlm.nih.gov/34781321/ | Saleh, A., & Collins, J. (2021). Case study of thrombosis and thrombocytopenia syndrome following administration of the AstraZeneca COVID-19 vaccine. Australian Journal of General Practice, 50. | Saleh, A. y Collins, J. (2021). Estudio de caso de síndrome de trombosis y trombocitopenia tras la administración de la vacuna AstraZeneca COVID-19. Revista australiana de práctica general, 50. https://pubmed.ncbi.nlm.nih.gov/34062319/ | KLIMEK, L., NOVAK, N., CABANILLAS, B., JUTEL, M., BOUSQUET, J., Y AKDIS, C. A. (2021). Componentes alergénicos de la vacuna contra el MRNA-1273 para COVID-19: Posible participación de la activación de complemento de polietilenglicol e IgG mediada por IgG. Alergia, 76 (11), 3307-3313. https://pubmed.ncbi.nlm.nih.gov/33825239/ | Saleh, A., & Collins, J. (2021). Case study of thrombosis and thrombocytopenia syndrome following administration of the AstraZeneca COVID-19 vaccine. Australian Journal of General Practice, 50. https://pubmed.ncbi.nlm.nih.gov/34781321/ | Knowlton, K. U. (2021). Insights from a murine model of COVID-19 mRNA vaccination-induced myopericarditis: Could accidental intravenous vaccine injection induce myopericarditis?. Clin. infect. dis. https://pubmed.ncbi.nlm.nih.gov/34453510/ | Mungmunpuntipantip, R., & Wiwanitkit, V. (2021). Thrombosis after adenovirus-vectored COVID-19 vaccination: a concern on underlying illness. Clinical and Applied Thrombosis/Hemostasis, 27, 10760296211060446. | https://pubmed.ncbi.nlm.nih.gov/34755555/ | Mungmunpuntipantip, R., & Wiwanitkit, V. (2021). Thrombosis after adenovirus-vectored COVID-19 vaccination: a concern on underlying illness. Clinical and Applied Thrombosis/Hemostasis, 27, 10760296211060446. https://pubmed.ncbi.nlm.nih.gov/34755555/ | Maniscalco, G. T., Manzo, V., Di Battista, M. E., Salvatore, S., Moreggia, O., Scavone, C., & Capuano, A. (2021). Severe multiple sclerosis relapse after COVID-19 vaccination: a case report. Frontiers in Neurology, 1398. https://pubmed.ncbi.nlm.nih.gov/34447349/ | ||||
457 | Refractory vaccine-induced immune thrombotic thrombocytopenia (VITT) treated with delayed therapeutic plasma exchange (TPE): https://pubmed.ncbi.nlm.nih.gov/34672380/ | Refractory vaccine-induced immune thrombotic thrombocytopenia (VITT) treated with delayed therapeutic plasma exchange (TPE): | https://pubmed.ncbi.nlm.nih.gov/34672380/ | https://pubmed.ncbi.nlm.nih.gov/34062319/ | Long, B., Bridwell, R., & Gottlieb, M. (2021). Thrombosis with thrombocytopenia syndrome associated with COVID-19 vaccines. The American journal of emergency medicine, 49, 58-61. | Long, B., Bridwell, R. y Gottlieb, M. (2021). Síndrome de trombosis con trombocitopenia asociado a las vacunas COVID-19. La revista americana de medicina de emergencia, 49, 58-61. https://pubmed.ncbi.nlm.nih.gov/34706921/ | Klimek, L., Novak, N., Hamelmann, E., Werfel, T., Wagenmann, M., Taube, C., ... & Worm, M. (2021). Reacciones alérgicas severas después de la vacunación de COVID-19 con la vacuna Pfizer / Biontech en Gran Bretaña y Estados Unidos. AllerGo Journal International, 30 (2), 51-55. https://pubmed.ncbi.nlm.nih.gov/33571463/ | Long, B., Bridwell, R., & Gottlieb, M. (2021). Thrombosis with thrombocytopenia syndrome associated with COVID-19 vaccines. The American journal of emergency medicine, 49, 58-61. https://pubmed.ncbi.nlm.nih.gov/34062319/ | Koch, M., Fuld, S., Middeke, J. M., Fantana, J., von Bonin, S., & Beyer-Westendorf, J. (2021). Secondary Immune Thrombocytopenia (ITP) Associated with ChAdOx1 Covid-19 Vaccination–A Case Report. TH Open, 5(03), e315-e318. https://pubmed.ncbi.nlm.nih.gov/34377889/ | Waqar, S. H. B., Khan, A. A., & Memon, S. (2021). Thrombotic thrombocytopenic purpura: a new menace after COVID bnt162b2 vaccine. International Journal of Hematology, 114(5), 626-629. | https://pubmed.ncbi.nlm.nih.gov/34264514/. | Waqar, S. H. B., Khan, A. A., & Memon, S. (2021). Thrombotic thrombocytopenic purpura: a new menace after COVID bnt162b2 vaccine. International Journal of Hematology, 114(5), 626-629. https://pubmed.ncbi.nlm.nih.gov/34264514/. | Mansour, J., Short, R. G., Bhalla, S., Woodard, P. K., Verma, A., Robinson, X., & Raptis, D. A. (2021). Acute myocarditis after a second dose of the mRNA COVID-19 vaccine: a report of two cases. Clinical Imaging, 78, 247-249. https://www.clinicalimaging.org/article/S0899-7071(21)00265-5/fulltext. | |||
458 | Rare case of COVID-19 vaccine-associated intracranial hemorrhage with venous sinus thrombosis: https://pubmed.ncbi.nlm.nih.gov/34556531/ | Rare case of COVID-19 vaccine-associated intracranial hemorrhage with venous sinus thrombosis: | https://pubmed.ncbi.nlm.nih.gov/34556531/ | https://pubmed.ncbi.nlm.nih.gov/34706921/ | Maramattom, B. V., Moidu, F. M., Varikkottil, S., & Syed, A. A. (2021). Cerebral venous sinus thrombosis after ChAdOx1 vaccination: the first case of definite thrombosis with thrombocytopenia syndrome from India. BMJ Case Reports CP, 14(10), e246455. | Maramattom, BV, Moidu, FM, Varikkottil, S. y Syed, AA (2021). Trombosis del seno venoso cerebral después de la vacunación ChAdOx1: el primer caso de trombosis definitiva con síndrome de trombocitopenia en la India. Informes de casos de BMJ CP, 14(10), e246455. https://pubmed.ncbi.nlm.nih.gov/34698582/. | Klimek, L., Novak, N., Hamelmann, E., Werfel, T., Wagenmann, M., Taube, C., ... & Worm, M. (2021). Reacciones alérgicas severas después de la vacunación de COVID-19 con la vacuna Pfizer / Biontech en Gran Bretaña y Estados Unidos. AllerGo Journal International, 30 (2), 51-55. https://www.ncbi.nlm.nih.gov/pubmed/34952008 | Maramattom, B. V., Moidu, F. M., Varikkottil, S., & Syed, A. A. (2021). Cerebral venous sinus thrombosis after ChAdOx1 vaccination: the first case of definite thrombosis with thrombocytopenia syndrome from India. BMJ Case Reports CP, 14(10), e246455. https://pubmed.ncbi.nlm.nih.gov/34706921/ | Koh, J. S., Hoe, R. H. M., Yong, M. H., Chiew, H. J., Goh, Y., Yong, K. P., ... & Umapathi, T. (2021). Hospital-based observational study of neurological disorders in patients recently vaccinated with COVID-19 mRNA vaccines. Journal of the neurological sciences, 430, 120030. https://pubmed.ncbi.nlm.nih.gov/34688190/ | Hasegawa, T., & Yazaki, Y. (2021). Unusual Site of Deep Vein Thrombosis After mRNA Coronavirus Disease-2019 (COVID-19) Vaccination. Circulation Journal, CJ-21. | https://pubmed.ncbi.nlm.nih.gov/34840204/ | Hasegawa, T., & Yazaki, Y. (2021). Unusual Site of Deep Vein Thrombosis After mRNA Coronavirus Disease-2019 (COVID-19) Vaccination. Circulation Journal, CJ-21. https://pubmed.ncbi.nlm.nih.gov/34840204/ | Maramattom, B. V., Krishnan, P., Paul, R., Padmanabhan, S., Cherukudal Vishnu Nampoothiri, S., Syed, A. A., & Mangat, H. S. (2021). Guillain‐Barré syndrome following ChAdOx1‐S/nCoV‐19 vaccine. Annals of neurology, 90(2), 312-314. https://pubmed.ncbi.nlm.nih.gov/34114256/. | |||
459 | Delayed headache after COVID-19 vaccination: a warning sign for vaccine-induced cerebral venous thrombosis: https://pubmed.ncbi.nlm.nih.gov/34535076/ | Delayed headache after COVID-19 vaccination: a warning sign for vaccine-induced cerebral venous thrombosis: | https://pubmed.ncbi.nlm.nih.gov/34535076/ | https://pubmed.ncbi.nlm.nih.gov/34698582/. | Hafeez, M. U., Ikram, M., Shafiq, Z., Sarfraz, A., Sarfraz, Z., Jaiswal, V., ... & Chérrez-Ojeda, I. (2021). COVID-19 vaccine-associated thrombosis with thrombocytopenia syndrome (TTS): A systematic review and post hoc analysis. Clinical and Applied Thrombosis/Hemostasis, 27, 10760296211048815. | Hafeez, M. U., Ikram, M., Shafiq, Z., Sarfraz, A., Sarfraz, Z., Jaiswal, V., ... & Chérrez-Ojeda, I. (2021). Trombosis con síndrome de trombocitopenia (TTS) asociada a la vacuna COVID-19: una revisión sistemática y un análisis post hoc. Trombosis/Hemostasia clínica y aplicada, 27, 10760296211048815. https://pubmed.ncbi.nlm.nih.gov/34751013/. | Knowlton, K. U. (2021). Perspectivas de un modelo murino de la enfermedad de Coronavirus 2019 (COVID-19) MIOPERARDITis inducida por la vacuna contra el ARNm: ¿podría inyectar la inyección de vacunas intravenosas accidentales inducir a miopericaditis? Enfermedades infecciosas clínicas. https://pubmed.ncbi.nlm.nih.gov/34447639/ | Hafeez, M. U., Ikram, M., Shafiq, Z., Sarfraz, A., Sarfraz, Z., Jaiswal, V., ... & Chérrez-Ojeda, I. (2021). COVID-19 vaccine-associated thrombosis with thrombocytopenia syndrome (TTS): A systematic review and post hoc analysis. Clinical and Applied Thrombosis/Hemostasis, 27, 10760296211048815. https://pubmed.ncbi.nlm.nih.gov/34698582/. | Kohli, U., Desai, L., Chowdhury, D., Harahsheh, A. S., Yonts, A. B., Ansong, A., ... & Ang, J. Y. (2021). mRNA Coronavirus-19 Vaccine-Associated Myopericarditis in Adolescents: A Survey Study. The Journal of pediatrics. https://www.ncbi.nlm.nih.gov/pubmed/34952008 | Finsterer, J. (2022). Neurological side effects of SARS‐CoV‐2 vaccinations. Acta Neurologica Scandinavica, 145(1), 5-9. | https://pubmed.ncbi.nlm.nih.gov/34750810/ | Finsterer, J. (2022). Neurological side effects of SARS‐CoV‐2 vaccinations. Acta Neurologica Scandinavica, 145(1), 5-9. https://pubmed.ncbi.nlm.nih.gov/34750810/ | Maramattom, B. V., Moidu, F. M., Varikkottil, S., & Syed, A. A. (2021). Cerebral venous sinus thrombosis after ChAdOx1 vaccination: the first case of definite thrombosis with thrombocytopenia syndrome from India. BMJ Case Reports CP, 14(10), e246455. https://pubmed.ncbi.nlm.nih.gov/34706921/ | |||
460 | Clinical features of vaccine-induced thrombocytopenia and immune thrombosis: | https://pubmed.ncbi.nlm.nih.gov/34379914/. | https://pubmed.ncbi.nlm.nih.gov/34751013/. | Kim, G., Choi, E. J., Park, H. S., Lee, J. H., Lee, J. H., & Lee, K. H. (2021). A case report of immune thrombocytopenia after ChAdOx1 nCoV-19 vaccination. Journal of Korean medical science, 36(43). | Kim, G., Choi, EJ, Park, HS, Lee, JH, Lee, JH y Lee, KH (2021). Reporte de un caso de trombocitopenia inmune después de la vacunación con ChAdOx1 nCoV-19. Revista de ciencia médica coreana, 36(43). https://pubmed.ncbi.nlm.nih.gov/34684047/. | Knowlton, K. U. (2021). Perspectivas de un modelo murino de miopericaditis inducida por vacunación contra el ARNm de COVID-19: ¿Podría la inyección accidental de vacunas intravenosas inducir a miopericaditis? Clin. infectar. dis. https://pubmed.ncbi.nlm.nih.gov/33476455/ | Kim, G., Choi, E. J., Park, H. S., Lee, J. H., Lee, J. H., & Lee, K. H. (2021). A case report of immune thrombocytopenia after ChAdOx1 nCoV-19 vaccination. Journal of Korean medical science, 36(43). https://pubmed.ncbi.nlm.nih.gov/34751013/. | Koizumi, T., Awaya, T., Yoshioka, K., Kitano, S., Hayama, H., Amemiya, K., ... & Nakamura, M. (2021). Myocarditis after COVID-19 mRNA vaccines. QJM: An International Journal of Medicine, 114(10), 741-743. https://pubmed.ncbi.nlm.nih.gov/34546329/. | Kircheis, R. (2021). Coagulopathies after vaccination against SARS-CoV-2 may be derived from a combined effect of SARS-CoV-2 spike protein and adenovirus vector-triggered signaling pathways. International Journal of Molecular Sciences, 22(19), 10791. | https://pubmed.ncbi.nlm.nih.gov/34639132/ | Kircheis, R. (2021). Coagulopathies after vaccination against SARS-CoV-2 may be derived from a combined effect of SARS-CoV-2 spike protein and adenovirus vector-triggered signaling pathways. International Journal of Molecular Sciences, 22(19), 10791. https://pubmed.ncbi.nlm.nih.gov/34639132/ | Maramattom, B. V., Philips, G., Thomas, J., & Santhamma, S. G. N. (2021). Inflammatory myositis after ChAdOx1 vaccination. The Lancet Rheumatology, 3(11), e747-e749. https://pubmed.ncbi.nlm.nih.gov/34585145/ | ||||
461 | Predictors of mortality in thrombotic thrombocytopenia after adenoviral COVID-19 vaccination: the FAPIC score: | https://pubmed.ncbi.nlm.nih.gov/34545400/ | https://pubmed.ncbi.nlm.nih.gov/34684047/. | Hsiao, Y. T., Tsai, M. J., Chen, Y. H., & Hsu, C. F. (2021). Acute transverse myelitis after COVID-19 vaccination. Medicina, 57(10), 1010. | Hsiao, YT, Tsai, MJ, Chen, YH y Hsu, CF (2021). Mielitis transversa aguda después de la vacunación contra COVID-19. Medicina, 57(10), 1010. https://pubmed.ncbi.nlm.nih.gov/34541935/ | Koch, M., Fuld, S., Middeke, J. M., Fantana, J., Von Bonin, S., & Beyer-Westendorf, J. (2021). Thrombocitopenia inmune secundaria (PTP) asociada con la vacunación de COVID-19-19 de Chadox1, un informe de caso. ABIERTO, 5 (03), E315-E318. https://pubmed.ncbi.nlm.nih.gov/34272095/ | Hsiao, Y. T., Tsai, M. J., Chen, Y. H., & Hsu, C. F. (2021). Acute transverse myelitis after COVID-19 vaccination. Medicina, 57(10), 1010. https://pubmed.ncbi.nlm.nih.gov/34684047/. | Kong, J., Cuevas-Castillo, F., Nassar, M., Lei, C. M., Idrees, Z., Fix, W. C., ... & Mathew, A. (2021). Bullous drug eruption after second dose of mRNA-1273 (Moderna) COVID-19 vaccine: Case report. Journal of Infection and Public Health, 14(10), 1392-1394. https://www.sciencedirect.com/science/article/pii/S1876034121001878. | Ifeanyi, N., Chinenye, N., Oladiran, O., David, E., Mmonu, C., & Ogbonna-Nwosu, C. (2021). Isolated pulmonary embolism following COVID vaccination: 2 case reports and a review of post-acute pulmonary embolism complications and follow-up. Journal of Community Hospital Internal Medicine Perspectives, 11(6), 877-879. | https://pubmed.ncbi.nlm.nih.gov/34804412/ | Ifeanyi, N., Chinenye, N., Oladiran, O., David, E., Mmonu, C., & Ogbonna-Nwosu, C. (2021). Isolated pulmonary embolism following COVID vaccination: 2 case reports and a review of post-acute pulmonary embolism complications and follow-up. Journal of Community Hospital Internal Medicine Perspectives, 11(6), 877-879. https://pubmed.ncbi.nlm.nih.gov/34804412/ | Marchandot, B., Carmona, A., Trimaille, A., Curtiaud, A., & Morel, O. (2021). Procoagulant microparticles: a possible link between vaccine-induced immune thrombocytopenia (VITT) and cerebral sinus venous thrombosis. Journal of Thrombosis and Thrombolysis, 52(3), 689-691. https://pubmed.ncbi.nlm.nih.gov/34129181/. | ||||
462 | Ischemic stroke as a presenting feature of immune thrombotic thrombocytopenia induced by ChAdOx1-nCoV-19 vaccination: | https://pubmed.ncbi.nlm.nih.gov/34035134/ | https://pubmed.ncbi.nlm.nih.gov/34541935/ | Haimei, M. A. (2021). Concern About the Adverse Effects of Thrombocytopenia and Thrombosis After Adenovirus-Vectored COVID-19 Vaccination. Clinical and Applied Thrombosis/Hemostasis, 27, 10760296211040110. | Haimei, MA (2021). Preocupación por los efectos adversos de la trombocitopenia y la trombosis después de la vacunación contra el COVID-19 vectorizada por adenovirus. Trombosis/Hemostasia clínica y aplicada, 27, 10760296211040110. https://pubmed.ncbi.nlm.nih.gov/34646685/ | Koh, J. S., Hoe, R. H. M., Yong, M. H., Chiew, H. J., Goh, Y., Yong, K. P., ... & Umapathi, T. (2021). Estudio observacional basado en el hospital de los trastornos neurológicos en pacientes recientemente vacunados con vacunas con COVID-19 ARNm. Diario de las Ciencias Neurológicas, 430, 120030. https://pubmed.ncbi.nlm.nih.gov/34782400/ | Haimei, M. A. (2021). Concern About the Adverse Effects of Thrombocytopenia and Thrombosis After Adenovirus-Vectored COVID-19 Vaccination. Clinical and Applied Thrombosis/Hemostasis, 27, 10760296211040110. https://pubmed.ncbi.nlm.nih.gov/34541935/ | Konu, Y. R., Gbeasor-Komlanvi, F. A., Yerima, M., Sadio, A. J., Tchankoni, M. K., Zida-Compaore, W. I. C., ... & Ekouevi, D. K. (2021). Prevalence of severe adverse events among health professionals after receiving the first dose of the ChAdOx1 nCoV-19 coronavirus vaccine (Covishield) in Togo, March 2021. Archives of Public Health, 79(1), 1-9. https://pubmed.ncbi.nlm.nih.gov/34819146/. | Endo, B., Bahamon, S., & Martínez-Pulgarín, D. F. (2021). Central retinal vein occlusion after mRNA SARS-CoV-2 vaccination: A case report. Indian journal of ophthalmology, 69(10), 2865. | https://pubmed.ncbi.nlm.nih.gov/34571653/. | Endo, B., Bahamon, S., & Martínez-Pulgarín, D. F. (2021). Central retinal vein occlusion after mRNA SARS-CoV-2 vaccination: A case report. Indian journal of ophthalmology, 69(10), 2865. https://pubmed.ncbi.nlm.nih.gov/34571653/. | Marcucci, R., & Marietta, M. (2021). Vaccine-induced thrombotic thrombocytopenia: the elusive link between thrombosis and adenovirus-based SARS-CoV-2 vaccines. Internal and emergency medicine, 16(5), 1113-1119. https://pubmed.ncbi.nlm.nih.gov/34191218/ | ||||
463 | In-hospital observational study of neurological disorders in patients recently vaccinated with COVID-19 mRNA vaccines: | https://pubmed.ncbi.nlm.nih.gov/34688190/ | https://pubmed.ncbi.nlm.nih.gov/34646685/ | Wilting, F. N., Kotsopoulos, A. M., Platteel, A. C., & van Oers, J. A. (2021). Intracerebral hemorrhage and thrombocytopenia after AstraZeneca COVID-19 vaccine: Clinical and diagnostic challenges of vaccine-induced thrombotic thrombocytopenia. Cureus, 13(9). | Wilting, F. N., Kotsopoulos, A. M., Platteel, A. C. y van Oers, J. A. (2021). Hemorragia intracerebral y trombocitopenia después de la vacuna AstraZeneca COVID-19: desafíos clínicos y diagnósticos de la trombocitopenia trombótica inducida por la vacuna. Cureus, 13(9). https://pubmed.ncbi.nlm.nih.gov/34242687/. | Kohli, U., Desai, L., Chowdhury, D., Harahsheh, A. S., YETS, A. B., Ansong, A., ... & Ang, J. Y. (2021). MRNA Coronavirus-19 Myopericarditis asociada a la vacuna en adolescentes: un estudio de encuesta. La revista de pediatría. https://www.ncbi.nlm.nih.gov/pubmed/34642628 | Wilting, F. N., Kotsopoulos, A. M., Platteel, A. C., & van Oers, J. A. (2021). Intracerebral hemorrhage and thrombocytopenia after AstraZeneca COVID-19 vaccine: Clinical and diagnostic challenges of vaccine-induced thrombotic thrombocytopenia. Cureus, 13(9). https://pubmed.ncbi.nlm.nih.gov/34646685/ | Kostoff, R. N., Calina, D., Kanduc, D., Briggs, M. B., Vlachoyiannopoulos, P., Svistunov, A. A., & Tsatsakis, A. (2021). Erratum to “Why are we vaccinating children against COVID-19?”[Toxicol. Rep. 8C (2021) 1665–1684/1193]. Toxicology Reports. https://www.ncbi.nlm.nih.gov/pubmed/34642628 | Günther, A., Brämer, D., Pletz, M. W., Kamradt, T., Baumgart, S., Mayer, T. E., ... & Thiele, T. (2021). Complicated Long Term Vaccine Induced Thrombotic Immune Thrombocytopenia—A Case Report. Vaccines, 9(11), 1344. | https://pubmed.ncbi.nlm.nih.gov/34835275/. | Günther, A., Brämer, D., Pletz, M. W., Kamradt, T., Baumgart, S., Mayer, T. E., ... & Thiele, T. (2021). Complicated Long Term Vaccine Induced Thrombotic Immune Thrombocytopenia—A Case Report. Vaccines, 9(11), 1344. https://pubmed.ncbi.nlm.nih.gov/34835275/. | Mark, C., Gupta, S., Punnett, A., Upton, J., Orkin, J., Atkinson, A., ... & Alexander, S. (2021). Safety of administration of BNT162b2 mRNA (Pfizer‐BioNTech) COVID‐19 vaccine in youths and young adults with a history of acute lymphoblastic leukemia and allergy to PEG‐asparaginase. Pediatric Blood & Cancer, 68(11), e29295. https://www.ncbi.nlm.nih.gov/pubmed/34398511 | ||||
464 | Endovascular treatment for vaccine-induced cerebral venous sinus thrombosis and thrombocytopenia after vaccination with ChAdOx1 nCoV-19: report of three cases: | https://pubmed.ncbi.nlm.nih.gov/34782400/ | https://pubmed.ncbi.nlm.nih.gov/34242687/. | Leclerc, S., Royal, V., Lamarche, C., & Laurin, L. P. (2021). Minimal change disease with severe acute kidney injury following the Oxford-AstraZeneca COVID-19 vaccine: a case report. American Journal of Kidney Diseases, 78(4), 607-610. | Leclerc, S., Royal, V., Lamarche, C. y Laurin, LP (2021). Enfermedad de cambios mínimos con lesión renal aguda grave después de la vacuna Oxford-AstraZeneca COVID-19: reporte de un caso. Revista Estadounidense de Enfermedades Renales, 78(4), 607-610. https://pubmed.ncbi.nlm.nih.gov/34609603/ | Koizumi, T., Alawa, T., Yoshioka, K., Kitano, S., Hayama, H., Amemiya, K., ... & Nakamura, M. (2021). Miocarditis después de las vacunas con COVID-19 ARNm. QJM: Un Diario Internacional de Medicina, 114 (10), 741-743. https://jamanetwork.com/journals/jamacardiology/fullarticle/2781602. | Leclerc, S., Royal, V., Lamarche, C., & Laurin, L. P. (2021). Minimal change disease with severe acute kidney injury following the Oxford-AstraZeneca COVID-19 vaccine: a case report. American Journal of Kidney Diseases, 78(4), 607-610. https://pubmed.ncbi.nlm.nih.gov/34242687/. | Kostoff, R. N., Calina, D., Kanduc, D., Briggs, M. B., Vlachoyiannopoulos, P., Svistunov, A. A., & Tsatsakis, A. (2021). Why are we vaccinating children against COVID-19?. Toxicology reports, 8, 1665-1684. https://www.ncbi.nlm.nih.gov/pubmed/34540594 | Hussain, H., Sehring, M., & Soriano, S. (2021). Deep Venous Thrombosis after Ad26. COV2. S Vaccination in Adult Male. Case Reports in Critical Care, 2021. | https://pubmed.ncbi.nlm.nih.gov/34659839/. | Hussain, H., Sehring, M., & Soriano, S. (2021). Deep Venous Thrombosis after Ad26. COV2. S Vaccination in Adult Male. Case Reports in Critical Care, 2021. https://pubmed.ncbi.nlm.nih.gov/34659839/. | Marshall, M., Ferguson, I. D., Lewis, P., Jaggi, P., Gagliardo, C., Collins, J. S., ... & Guzman-Cottrill, J. A. (2021). Symptomatic acute myocarditis in 7 adolescents after Pfizer-BioNTech COVID-19 vaccination. Pediatrics, 148(3). https://pediatrics.aappublications.org/content/early/2021/06/04/peds.2021-052478 | ||||
465 | Cardiovascular, neurological, and pulmonary events after vaccination with BNT162b2, ChAdOx1 nCoV-19, and Ad26.COV2.S vaccines: an analysis of European data: | https://pubmed.ncbi.nlm.nih.gov/34710832/ | https://pubmed.ncbi.nlm.nih.gov/34609603/ | Fousse, M., Schub, D., Merzou, F., Fassbender, K., Sester, M., Kettner, M., ... & Goi Júnior, J. R. (2022). Case report: cerebral sinus vein thrombosis in two patients with AstraZeneca SARS-CoV-2 vaccination. Journal of neurology, 269(2), 583-586. | Fousse, M., Schub, D., Merzou, F., Fassbender, K., Sester, M., Kettner, M., ... & Goi Júnior, J. R. (2022). Reporte de caso: trombosis de la vena del seno cerebral en dos pacientes con vacuna AstraZeneca SARS-CoV-2. Revista de neurología, 269(2), 583-586. https://pubmed.ncbi.nlm.nih.gov/34557507/ | Kong, J., Cuevas-Castillo, F., Nassar, M., Lei, C. M., Idrees, Z., Fix, W. C., ... & Mathew, A. (2021). Erupción de drogas amonestas después de la segunda dosis de MRNA-1273 (MODERNA) COVID-19 VACUNA: Informe de caso. Diario de infecciones y salud pública, 14 (10), 1392-1394. https://scivisionpub.com/pdfs/covid19rna-based-vaccines-and-the-risk-of-prion-dis ease-1503.pdf | Fousse, M., Schub, D., Merzou, F., Fassbender, K., Sester, M., Kettner, M., ... & Goi Júnior, J. R. (2022). Case report: cerebral sinus vein thrombosis in two patients with AstraZeneca SARS-CoV-2 vaccination. Journal of neurology, 269(2), 583-586. https://pubmed.ncbi.nlm.nih.gov/34609603/ | Kounis, N. G., Koniari, I., Mplani, V., Kouni, S. N., Plotas, P., & Tsigkas, G. (2022). Acute Myocardial Infarction Within 24 Hours After COVID-19 Vaccination: Is Kounis Syndrome the Culprit?. American Journal of Cardiology, 162, 207. https://pubmed.ncbi.nlm.nih.gov/34702550/ | Kaulen, L. D., Doubrovinskaia, S., Mooshage, C., Jordan, B., Purrucker, J., Haubner, C., ... & Schönenberger, S. (2022). Neurological autoimmune diseases following vaccinations against SARS‐CoV‐2: a case series. European Journal of Neurology, 29(2), 555-563. | https://pubmed.ncbi.nlm.nih.gov/34668274/. | Kaulen, L. D., Doubrovinskaia, S., Mooshage, C., Jordan, B., Purrucker, J., Haubner, C., ... & Schönenberger, S. (2022). Neurological autoimmune diseases following vaccinations against SARS‐CoV‐2: a case series. European Journal of Neurology, 29(2), 555-563. https://pubmed.ncbi.nlm.nih.gov/34668274/. | Martin-Villares, C., Vazquez-Feito, A., Gonzalez-Gimeno, M. J., & de la Nogal-Fernandez, B. (2022). Bell’s palsy following a single dose of mRNA SARS-CoV-2 vaccine: a case report. Journal of Neurology, 269(1), 47-48. https://pubmed.ncbi.nlm.nih.gov/34032902/. | ||||
466 | Cerebral venous thrombosis developing after vaccination. COVID-19: VITT, VATT, TTS and more: | https://pubmed.ncbi.nlm.nih.gov/34695859/ | https://pubmed.ncbi.nlm.nih.gov/34557507/ | Leerunyakul, K., Pakornphadungsit, K., & Suchonwanit, P. (2021). Case Report: Pityriasis Rosea-Like Eruption Following COVID-19 Vaccination. Frontiers in Medicine, 8. | Leerunyakul, K., Pakornphadungsit, K. y Suchonwanit, P. (2021). Informe de caso: Erupción similar a la pitiriasis rosada después de la vacunación contra el COVID-19. Fronteras en Medicina, 8. https://pubmed.ncbi.nlm.nih.gov/34641797/. | Konu, Y. R., Gbeasor-Komlanvi, F. A. A., Yerima, M., Sadio, A. J., Tchankoni, M. K., Zida-Compaore, W. I. C., ... & Ekouent, D. K. (2021). Prevalencia de eventos adversos graves entre los profesionales de la salud después de recibir la primera dosis de la vacuna Chadox1 NCOV-19 Coronavirus (Covishield) en Togo, de marzo de 2021. Archivos de salud pública, 79 (1), 1-9. https://pubmed.ncbi.nlm.nih.gov/34581453/ | Leerunyakul, K., Pakornphadungsit, K., & Suchonwanit, P. (2021). Case Report: Pityriasis Rosea-Like Eruption Following COVID-19 Vaccination. Frontiers in Medicine, 8. https://pubmed.ncbi.nlm.nih.gov/34557507/ | Kounis, N. G., Mplani, V., Koniari, I., & Velissaris, D. (2022). Hypersensitivity myocarditis and COVID-19 vaccines. Kardiologia Polska (Polish Heart Journal), 80(1), 109-110. https://pubmed.ncbi.nlm.nih.gov/34856634/. | Vaishya, R., Sibal, A., Singh, S. K., Malani, A., & Das, S. (2021). Emergence of COVID-19 variants among ChAdOx1 nCoV-19 (recombinant) vaccine recipients. The Indian journal of medical research, 153(5-6), 559. | https://pubmed.ncbi.nlm.nih.gov/34528522/ | Vaishya, R., Sibal, A., Singh, S. K., Malani, A., & Das, S. (2021). Emergence of COVID-19 variants among ChAdOx1 nCoV-19 (recombinant) vaccine recipients. The Indian journal of medical research, 153(5-6), 559. https://pubmed.ncbi.nlm.nih.gov/34528522/ | Martins-Filho, P. R., Quintans-Júnior, L. J., de Souza Araújo, A. A., Sposato, K. B., Tavares, C. S., Gurgel, R. Q., ... & Santos, V. S. (2021). Socio-economic inequalities and COVID-19 incidence and mortality in Brazilian children: a nationwide register-based study. Public Health, 190, 4-6. https://www.ncbi.nlm.nih.gov/pubmed/33316478 | ||||
467 | Cerebral venous thrombosis and myeloproliferative neoplasms: a three-center study of 74 consecutive cases: | https://pubmed.ncbi.nlm.nih.gov/34453762/. | https://pubmed.ncbi.nlm.nih.gov/34641797/. | Tan, W. Y., Yusof Khan, A. H. K., Mohd Yaakob, M. N., Abdul Rashid, A. M., Loh, W. C., Baharin, J., ... & Hoo, F. K. (2021). Longitudinal extensive transverse myelitis following ChAdOx1 nCOV-19 vaccine: a case report. BMC neurology, 21(1), 1-4. | Tan, W. Y., Yusof Khan, A. H. K., Mohd Yaakob, M. N., Abdul Rashid, A. M., Loh, W. C., Baharin, J., ... y Hoo, F. K. (2021). Mielitis transversa longitudinal extensa después de la vacuna ChAdOx1 nCOV-19: reporte de un caso. Neurología BMC, 21 (1), 1-4. https://pubmed.ncbi.nlm.nih.gov/34812326/. | Kostoff, R. N., Calina, D., Kanduc, D., Briggs, M. B., Vlachoyiannopoulos, P., Svistunov, A. A. A., & Tsatsakis, A. (2021). ¿Por qué estamos vacunando a los niños contra COVID-19? Informes de toxicología, 8, 1665-1684. https://www.ncbi.nlm.nih.gov/pubmed/34378087 | Tan, W. Y., Yusof Khan, A. H. K., Mohd Yaakob, M. N., Abdul Rashid, A. M., Loh, W. C., Baharin, J., ... & Hoo, F. K. (2021). Longitudinal extensive transverse myelitis following ChAdOx1 nCOV-19 vaccine: a case report. BMC neurology, 21(1), 1-4. https://pubmed.ncbi.nlm.nih.gov/34641797/. | Kow, C. S., & Hasan, S. S. (2021). Cerebral venous thrombosis following COVID-19 vaccination. Journal of Stroke and Cerebrovascular Diseases, 30(10). https://pubmed.ncbi.nlm.nih.gov/34045111/ | Uaprasert, N., Watanaboonyongcharoen, P., Vichitratchaneekorn, R., Trithiphen, S., Akkawat, B., Sukperm, A., ... & Rojnuckarin, P. (2021). Prevalence of thrombocytopenia, anti–platelet factor 4 antibodies and D‐dimer elevation in Thai people After ChAdOx1 nCoV‐19 vaccination. Research and Practice in Thrombosis and Haemostasis, 5(6), e12580. | https://pubmed.ncbi.nlm.nih.gov/34568726/ | Uaprasert, N., Watanaboonyongcharoen, P., Vichitratchaneekorn, R., Trithiphen, S., Akkawat, B., Sukperm, A., ... & Rojnuckarin, P. (2021). Prevalence of thrombocytopenia, anti–platelet factor 4 antibodies and D‐dimer elevation in Thai people After ChAdOx1 nCoV‐19 vaccination. Research and Practice in Thrombosis and Haemostasis, 5(6), e12580. https://pubmed.ncbi.nlm.nih.gov/34568726/ | Mason, M. C., Liaqat, A., Morrow, J., Basso, R., & Gujrati, Y. (2021). Bilateral facial nerve palsy and COVID-19 vaccination: causation or coincidence?. Cureus, 13(8). https://pubmed.ncbi.nlm.nih.gov/34522557/ | ||||
468 | Possible triggers of thrombocytopenia and/or hemorrhage by BNT162b2 vaccine, Pfizer-BioNTech: | https://pubmed.ncbi.nlm.nih.gov/34660652/. | https://pubmed.ncbi.nlm.nih.gov/34812326/. | Miqdadi, A., & Herrag, M. (2021). Acute eosinophilic pneumonia associated with the anti-COVID-19 vaccine AZD1222. Cureus, 13(10). | Miqdadi, A. y Herrag, M. (2021). Neumonía eosinofílica aguda asociada a la vacuna anti-COVID-19 AZD1222. Cureus, 13(10). https://pubmed.ncbi.nlm.nih.gov/34006408/ | Kostoff, R. N., Calina, D., Kanduc, D., Briggs, M. B., Vlachoyiannopoulos, P., Svistunov, A. A. A., & Tsatsakis, A. (2021). Errratum para "¿Por qué estamos vacunando a los niños contra COVID-19?" [Toxicol. Rep. 8c (2021) 1665-1684 / 1193]. Informes de toxicología. https://www.ncbi.nlm.nih.gov/pubmed/34540594 | Miqdadi, A., & Herrag, M. (2021). Acute eosinophilic pneumonia associated with the anti-COVID-19 vaccine AZD1222. Cureus, 13(10). https://pubmed.ncbi.nlm.nih.gov/34812326/. | Kow, C. S., & Hasan, S. S. (2021). Cerebral venous thrombosis following COVID-19 vaccination. Journal of Stroke and Cerebrovascular Diseases, 30(10). https://pubmed.ncbi.nlm.nih.gov/34045111/. | Chua, G. T., Kwan, M. Y. W., Chui, C. S., Smith, R. D., Cheung, E. C. L., Tian, T., ... & Ip, P. (2021). Epidemiology of Acute Myocarditis/Pericarditis in Hong Kong Adolescents Following Comirnaty Vaccination. Clinical Infectious Diseases. | https://academic.oup.com/cid/advance-article-abstract/doi/10.1093/cid/ciab989/6445179 | Chua, G. T., Kwan, M. Y. W., Chui, C. S., Smith, R. D., Cheung, E. C. L., Tian, T., ... & Ip, P. (2021). Epidemiology of Acute Myocarditis/Pericarditis in Hong Kong Adolescents Following Comirnaty Vaccination. Clinical Infectious Diseases. https://academic.oup.com/cid/advance-article-abstract/doi/10.1093/cid/ciab989/6445179 | Masset, C., Lebot-Bouras, S., Branchereau, J., Renaudin, K., & Cantarovich, D. (2021). Pancreas allograft rejection occurring after ChAdOx1 nCoV-19 vaccine. Diabetes & Metabolism. https://pubmed.ncbi.nlm.nih.gov/34781027/ | ||||
469 | Multiple sites of arterial thrombosis in a 35-year-old patient after vaccination with ChAdOx1 (AstraZeneca), which required emergency femoral and carotid surgical thrombectomy: | https://pubmed.ncbi.nlm.nih.gov/34644642/ | https://pubmed.ncbi.nlm.nih.gov/34006408/ | Welsh, K. J., Baumblatt, J., Chege, W., Goud, R., & Nair, N. (2021). Thrombocytopenia including immune thrombocytopenia after receipt of mRNA COVID-19 vaccines reported to the Vaccine Adverse Event Reporting System (VAERS). Vaccine, 39(25), 3329-3332. | Welsh, KJ, Baumblatt, J., Chege, W., Goud, R. y Nair, N. (2021). Trombocitopenia, incluida la trombocitopenia inmunitaria después de recibir vacunas de ARNm contra la COVID-19, notificada al Sistema de notificación de eventos adversos a las vacunas (VAERS). Vacuna, 39(25), 3329-3332. https://pubmed.ncbi.nlm.nih.gov/34416184/ | Kounis, N. G., Koniari, I., MPLANI, V., Kouni, S. N., Plotras, P., & Tsigkas, G. (2022). Infarto de miocardio agudo dentro de las 24 horas posteriores a la vacunación COVID-19: ¿Es el síndrome de Kounis el culpable? American Journal of Cardiology, 162, 207. https://pubmed.ncbi.nlm.nih.gov/33895650/ | Welsh, K. J., Baumblatt, J., Chege, W., Goud, R., & Nair, N. (2021). Thrombocytopenia including immune thrombocytopenia after receipt of mRNA COVID-19 vaccines reported to the Vaccine Adverse Event Reporting System (VAERS). Vaccine, 39(25), 3329-3332. https://pubmed.ncbi.nlm.nih.gov/34006408/ | Kragholm, K., Sessa, M., Mulvad, T., Andersen, M. P., Collatz-Christensen, H., Blomberg, S. N., ... & Sogaard, P. (2021). Thrombocytopenia after COVID-19 vaccination. Journal of Autoimmunity, 123, 102712. https://pubmed.ncbi.nlm.nih.gov/34332437/. | Perez, Y., Levy, E. R., Joshi, A. Y., Virk, A., Rodriguez-Porcel, M., Johnson, M., ... & Swift, M. D. (2021). Myocarditis Following COVID-19 mRNA Vaccine: A Case Series and Incidence Rate Determination. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America. | https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciab926/6420408 | Perez, Y., Levy, E. R., Joshi, A. Y., Virk, A., Rodriguez-Porcel, M., Johnson, M., ... & Swift, M. D. (2021). Myocarditis Following COVID-19 mRNA Vaccine: A Case Series and Incidence Rate Determination. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America. https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciab926/6420408 | Masuccio, F. G., Comi, C., & Solaro, C. (2021). Guillain–Barrè syndrome following COVID-19 vaccine mRNA-1273: a case report. Acta Neurologica Belgica, 1-3. https://pubmed.ncbi.nlm.nih.gov/34767184/. | ||||
470 | Case series of vaccine-induced thrombotic thrombocytopenia in a London teaching hospital: | https://pubmed.ncbi.nlm.nih.gov/34694650/ | https://pubmed.ncbi.nlm.nih.gov/34416184/ | Villa, M., Díaz-Crespo, F., de José, A. P., Verdalles, Ú., Verde, E., Ruiz, F. A., ... & Goicoechea, M. (2021). A case of ANCA-associated vasculitis after AZD1222 (Oxford–AstraZeneca) SARS-CoV-2 vaccination: casualty or causality?. Kidney International, 100(4), 937-938. | Villa, M., Díaz-Crespo, F., de José, A. P., Verdalles, Ú., Verde, E., Ruiz, F. A., ... & Goicoechea, M. (2021). Un caso de vasculitis asociada a ANCA después de la vacunación contra el SARS-CoV-2 AZD1222 (Oxford-AstraZeneca): ¿víctima o causalidad?. Riñón Internacional, 100(4), 937-938. https://pubmed.ncbi.nlm.nih.gov/34664303/. | Kounis, N. G., MPLANI, V., Koniari, I., & Velissaris, D. (2022). Hipersensibilidad miocarditis y vacunas COVID-19. Kardiologia Polska (diario de corazón polaco), 80 (1), 109-110. https://www.internationaljournalofcardiology.com/article/S0167-5273(21)01477-7/fulltext. | Villa, M., Díaz-Crespo, F., de José, A. P., Verdalles, Ú., Verde, E., Ruiz, F. A., ... & Goicoechea, M. (2021). A case of ANCA-associated vasculitis after AZD1222 (Oxford–AstraZeneca) SARS-CoV-2 vaccination: casualty or causality?. Kidney International, 100(4), 937-938. https://pubmed.ncbi.nlm.nih.gov/34416184/ | Krajewski, P. K., & Szepietowski, J. C. (2021). Immune thrombocytopenic purpura associated with COVID‐19 Pfizer‐BioNTech BNT16B2b2 mRNA vaccine. Journal of the European Academy of Dermatology and Venereology. https://pubmed.ncbi.nlm.nih.gov/34077572/ | Li, M., Yuan, J., Lv, G., Brown, J., Jiang, X., & Lu, Z. K. (2021). Myocarditis and Pericarditis following COVID-19 Vaccination: Inequalities in Age and Vaccine Types. Journal of personalized medicine, 11(11), 1106. | https://www.mdpi.com/2075-4426/11/11/1106 | Li, M., Yuan, J., Lv, G., Brown, J., Jiang, X., & Lu, Z. K. (2021). Myocarditis and Pericarditis following COVID-19 Vaccination: Inequalities in Age and Vaccine Types. Journal of personalized medicine, 11(11), 1106. https://www.mdpi.com/2075-4426/11/11/1106 | Matar, E., Manser, D., Spies, J. M., Worthington, J. M., & Parratt, K. L. (2021). Acute Hemichorea‐Hemiballismus Following COVID‐19 (AZD1222) Vaccination. Movement Disorders. https://pubmed.ncbi.nlm.nih.gov/34581453/ | ||||
471 | Neuro-ophthalmic complications with thrombocytopenia and thrombosis induced by ChAdOx1 nCoV-19 vaccine: | https://pubmed.ncbi.nlm.nih.gov/34726934/ | https://pubmed.ncbi.nlm.nih.gov/34664303/. | Monagle, P., Ng, A. P., Linden, M., Ignjatovic, V., Farley, A., Taoudi, S., ... & Torresi, J. (2021). Vaccine‐induced immune thrombosis and thrombocytopenia syndrome following adenovirus‐vectored severe acute respiratory syndrome coronavirus 2 vaccination: a novel hypothesis regarding mechanisms and implications for future vaccine development. Immunology and Cell Biology, 99(10), 1006-1010. | Monagle, P., Ng, A. P., Linden, M., Ignjatovic, V., Farley, A., Taoudi, S., ... y Torresi, J. (2021). Síndrome de trombosis inmunitaria y trombocitopenia inducida por vacuna después de la vacunación contra el coronavirus 2 del síndrome respiratorio agudo severo vectorizado por adenovirus: una nueva hipótesis sobre los mecanismos y las implicaciones para el desarrollo futuro de vacunas. Inmunología y biología celular, 99(10), 1006-1010. https://pubmed.ncbi.nlm.nih.gov/34649281/. | Kow, C. S., & Hasan, S. S. (2021). Trombosis venosa cerebral después de la vacunación COVID-19. Diario de accidentes cerebrovasculares y enfermedades cerebrovasculares, 30 (10). https://pubmed.ncbi.nlm.nih.gov/33983464/ | Monagle, P., Ng, A. P., Linden, M., Ignjatovic, V., Farley, A., Taoudi, S., ... & Torresi, J. (2021). Vaccine‐induced immune thrombosis and thrombocytopenia syndrome following adenovirus‐vectored severe acute respiratory syndrome coronavirus 2 vaccination: a novel hypothesis regarding mechanisms and implications for future vaccine development. Immunology and Cell Biology, 99(10), 1006-1010. https://pubmed.ncbi.nlm.nih.gov/34664303/. | Krantz, M. S., Stone Jr, C. A., Rolando, L. A., Nobis, A. E., Koo, G., Corey, K. B., ... & Phillips, E. J. (2021). An academic hospital experience screening mRNA COVID-19 vaccine risk using patient allergy history. The Journal of Allergy and Clinical Immunology: In Practice, 9(10), 3807-3810. https://www.sciencedirect.com/science/article/pii/S2213219821007972 | Park, H., Yun, K. W., Kim, K. R., Song, S. H., Ahn, B., Kim, D. R., ... & Kim, Y. J. (2021). Epidemiology and Clinical Features of Myocarditis/Pericarditis before the Introduction of mRNA COVID-19 Vaccine in Korean Children: a Multicenter Study. Journal of Korean Medical Science, 36(32). | https://pubmed.ncbi.nlm.nih.gov/34402230/ | Park, H., Yun, K. W., Kim, K. R., Song, S. H., Ahn, B., Kim, D. R., ... & Kim, Y. J. (2021). Epidemiology and Clinical Features of Myocarditis/Pericarditis before the Introduction of mRNA COVID-19 Vaccine in Korean Children: a Multicenter Study. Journal of Korean Medical Science, 36(32). https://pubmed.ncbi.nlm.nih.gov/34402230/ | Matarneh, A. S., Al‐battah, A. H., Farooqui, K., Ghamoodi, M., & Alhatou, M. (2021). COVID‐19 vaccine causing Guillain‐Barre syndrome, a rare potential side effect. Clinical Case Reports, 9(9), e04756. https://pubmed.ncbi.nlm.nih.gov/34484780/ | ||||
472 | Thrombotic events after COVID-19 vaccination in over 50 years of age: results of a population-based study in Italy: | https://pubmed.ncbi.nlm.nih.gov/34835237/ | https://pubmed.ncbi.nlm.nih.gov/34649281/. | Crea, F. (2021). Thrombosis in peripheral artery disease and thrombotic thrombocytopenia after adenoviral COVID-19 vaccination. European Heart Journal, 42(39), 3995-3999. | Crea, F. (2021). Trombosis en la enfermedad arterial periférica y trombocitopenia trombótica después de la vacunación adenoviral COVID-19. Revista Europea del Corazón, 42(39), 3995-3999. https://pubmed.ncbi.nlm.nih.gov/34420249/ | Kow, C. S., & Hasan, S. S. (2021). Trombosis venosa cerebral después de la vacunación COVID-19. Diario de accidentes cerebrovasculares y enfermedades cerebrovasculares, 30 (10). https://pubmed.ncbi.nlm.nih.gov/34366434/. | Crea, F. (2021). Thrombosis in peripheral artery disease and thrombotic thrombocytopenia after adenoviral COVID-19 vaccination. European Heart Journal, 42(39), 3995-3999. https://pubmed.ncbi.nlm.nih.gov/34649281/. | Kremsner, P. G., Mann, P., Kroidl, A., Leroux-Roels, I., Schindler, C., Gabor, J. J., ... & Oostvogels, L. (2021). Safety and immunogenicity of an mRNA-lipid nanoparticle vaccine candidate against SARS-CoV-2. Wiener klinische Wochenschrift, 133(17), 931-941. https://www.ncbi.nlm.nih.gov/pubmed/34378087 | Hajjo, R., Sabbah, D. A., Bardaweel, S. K., & Tropsha, A. (2021). Shedding the Light on Post-Vaccine Myocarditis and Pericarditis in COVID-19 and Non-COVID-19 Vaccine Recipients. Vaccines, 9(10), 1186. | https://pubmed.ncbi.nlm.nih.gov/34696294/ | Hajjo, R., Sabbah, D. A., Bardaweel, S. K., & Tropsha, A. (2021). Shedding the Light on Post-Vaccine Myocarditis and Pericarditis in COVID-19 and Non-COVID-19 Vaccine Recipients. Vaccines, 9(10), 1186. https://pubmed.ncbi.nlm.nih.gov/34696294/ | Maye, J. A., Chong, H. P., Rajagopal, V., & Petchey, W. (2021). Reactivation of IgA vasculitis following COVID-19 vaccination. BMJ Case Reports CP, 14(11), e247188. https://pubmed.ncbi.nlm.nih.gov/34848431/ | ||||
473 | Intracerebral hemorrhage associated with vaccine-induced thrombotic thrombocytopenia after ChAdOx1 nCOVID-19 vaccination in a pregnant woman: | https://pubmed.ncbi.nlm.nih.gov/34261297/ | https://pubmed.ncbi.nlm.nih.gov/34420249/ | Bennett, C., Chambers, L. M., Son, J., & Goje, O. (2021). Newly diagnosed immune thrombocytopenia in a pregnant patient after coronavirus disease 2019 vaccination. Journal of Obstetrics and Gynaecology Research, 47(11), 4077-4080. | Bennett, C., Chambers, L. M., Son, J. y Goje, O. (2021). Trombocitopenia inmunitaria recién diagnosticada en una paciente embarazada después de la vacunación contra la enfermedad por coronavirus de 2019. Revista de Investigación en Obstetricia y Ginecología, 47(11), 4077-4080. https://pubmed.ncbi.nlm.nih.gov/34610990/. | Kragholm, K., Sessa, M., Mulvad, T., Andersen, M. P., Collatz-Christensen, H., Blomberg, S. N., ... & SOGAARD, P. (2021). Trombocitopenia después de la vacunación de Covid-19. Diario de autoinmunidad, 123, 102712. https://pubmed.ncbi.nlm.nih.gov/33845870/. | Bennett, C., Chambers, L. M., Son, J., & Goje, O. (2021). Newly diagnosed immune thrombocytopenia in a pregnant patient after coronavirus disease 2019 vaccination. Journal of Obstetrics and Gynaecology Research, 47(11), 4077-4080. https://pubmed.ncbi.nlm.nih.gov/34420249/ | Kreuter, A., Licciardi‐Fernandez, M. J., Burmann, S. N., Burkert, B., Oellig, F., & Michalowitz, A. L. (2022). Induction and exacerbation of subacute cutaneous lupus erythematosus following mRNA‐based or adenoviral vector‐based SARS‐CoV‐2 vaccination. Clinical and Experimental Dermatology, 47(1), 161-163. https://pubmed.ncbi.nlm.nih.gov/34291477/ | Visclosky, T., Theyyunni, N., Klekowski, N., & Bradin, S. (2021). Myocarditis Following mRNA COVID-19 Vaccine. Pediatric emergency care, 37(11), 583-584. | https://journals.lww.com/pec-online/Abstract/2021/11000/Myocarditis_Following_mRNA_COVID_19_Vaccine.9.aspx | Visclosky, T., Theyyunni, N., Klekowski, N., & Bradin, S. (2021). Myocarditis Following mRNA COVID-19 Vaccine. Pediatric emergency care, 37(11), 583-584. https://journals.lww.com/pec-online/Abstract/2021/11000/Myocarditis_Following_mRNA_COVID_19_Vaccine.9.aspx | Mayfield, J., Bandi, S., Ganti, L., & Rubero, J. (2021). Anaphylaxis after Moderna COVID-19 vaccine. Therapeutic Advances in Vaccines and Immunotherapy, 9, 25151355211048418. https://pubmed.ncbi.nlm.nih.gov/34734159/. | ||||
474 | Age- and sex-specific incidence of cerebral venous sinus thrombosis associated with Ad26.COV2.S COVID-19 vaccination: | https://pubmed.ncbi.nlm.nih.gov/34724036/. | https://pubmed.ncbi.nlm.nih.gov/34610990/. | Palaiodimou, L., Stefanou, M. I., Katsanos, A. H., de Sousa, D. A., Coutinho, J. M., Lagiou, P., ... & Tsivgoulis, G. (2021). Cerebral venous sinus thrombosis and thrombotic events after vector-based COVID-19 vaccines: a systematic review and meta-analysis. Neurology, 97(21), e2136-e2147. | Palaiodimou, L., Stefanou, M. I., Katsanos, A. H., de Sousa, D. A., Coutinho, J. M., Lagiou, P., ... & Tsivgoulis, G. (2021). Trombosis del seno venoso cerebral y eventos trombóticos después de las vacunas COVID-19 basadas en vectores: una revisión sistemática y un metanálisis. Neurología, 97(21), e2136-e2147. https://pubmed.ncbi.nlm.nih.gov/34590397/ | Krajewski, P. K. y Szepietowski, J. C. (2021). Púrpura trombocitopénica inmune asociada con COVID-19 PFIZER-BIONTECH BNT16B2B2 Vacuna de ARNm. Diario de la Academia Europea de Dermatología y Venereología. https://pubmed.ncbi.nlm.nih.gov/34884407/. | Palaiodimou, L., Stefanou, M. I., Katsanos, A. H., de Sousa, D. A., Coutinho, J. M., Lagiou, P., ... & Tsivgoulis, G. (2021). Cerebral venous sinus thrombosis and thrombotic events after vector-based COVID-19 vaccines: a systematic review and meta-analysis. Neurology, 97(21), e2136-e2147. https://pubmed.ncbi.nlm.nih.gov/34610990/. | Kripalani, Y., Lakkappan, V., Parulekar, L., Shaikh, A., Singh, R., & Vyas, P. (2021). A rare case of Guillain-Barre syndrome following COVID-19 vaccination. European Journal of Case Reports in Internal Medicine, 8(9). https://pubmed.ncbi.nlm.nih.gov/34671572/ | Mevorach, D., Anis, E., Cedar, N., Bromberg, M., Haas, E. J., Nadir, E., ... & Alroy-Preis, S. (2021). Myocarditis after BNT162b2 mRNA vaccine against Covid-19 in Israel. New England Journal of Medicine, 385(23), 2140-2149. | https://pubmed.ncbi.nlm.nih.gov/34614328/. | Mevorach, D., Anis, E., Cedar, N., Bromberg, M., Haas, E. J., Nadir, E., ... & Alroy-Preis, S. (2021). Myocarditis after BNT162b2 mRNA vaccine against Covid-19 in Israel. New England Journal of Medicine, 385(23), 2140-2149. https://pubmed.ncbi.nlm.nih.gov/34614328/. | McGonagle, D., De Marco, G., & Bridgewood, C. (2021). Differences in venous immunothrombosis in severe COVID-19 pneumonia and Vaccine-Induced Thrombotic Thrombocytopenia (VITT)–It's in the viral DNA. Journal of Autoimmunity. https://www.sciencedirect.com/science/article/abs/pii/S0896841121000706 | ||||
475 | Genital necrosis with cutaneous thrombosis following vaccination with COVID-19 mRNA: | https://pubmed.ncbi.nlm.nih.gov/34839563/ | https://pubmed.ncbi.nlm.nih.gov/34590397/ | Majid, I., & Mearaj, S. (2021). Sweet syndrome after Oxford‐AstraZeneca COVID‐19 vaccine (AZD1222) in an elderly female. Dermatologic Therapy, 34(6), e15146. | Majid, I. y Mearaj, S. (2021). Síndrome de Sweet después de la vacuna Oxford‐AstraZeneca COVID‐19 (AZD1222) en una mujer anciana. Terapia dermatológica, 34(6), e15146. https://pubmed.ncbi.nlm.nih.gov/34670143/. | Krantz, M. S., Stone JR, C. A., Rolando, L. A., Nobis, A. E., Koo, G., Corey, K. B., ... & Phillips, E. J. (2021). Una experiencia académica del hospital que prueba el riesgo de vacunas ARNm COVID-19 utilizando la historia de la alergia al paciente. La revista de alergia y inmunología clínica: en la práctica, 9 (10), 3807-3810. https://www.sciencedirect.com/science/article/pii/S1930043321002612 | Majid, I., & Mearaj, S. (2021). Sweet syndrome after Oxford‐AstraZeneca COVID‐19 vaccine (AZD1222) in an elderly female. Dermatologic Therapy, 34(6), e15146. https://pubmed.ncbi.nlm.nih.gov/34590397/ | Krutzke, L., Roesler, R., Wiese, S., & Kochanek, S. (2021). Process-related impurities in the ChAdOx1 nCov-19 vaccine. https://pubmed.ncbi.nlm.nih.gov/33846043/188 | Kounis, N. G., Mplani, V., Koniari, I., & Velissaris, D. (2022). Hypersensitivity myocarditis and COVID-19 vaccines. Kardiologia Polska (Polish Heart Journal), 80(1), 109-110. | https://pubmed.ncbi.nlm.nih.gov/34856634/. | Kounis, N. G., Mplani, V., Koniari, I., & Velissaris, D. (2022). Hypersensitivity myocarditis and COVID-19 vaccines. Kardiologia Polska (Polish Heart Journal), 80(1), 109-110. https://pubmed.ncbi.nlm.nih.gov/34856634/. | McLean, K., & Johnson, T. J. (2021). Myopericarditis in a previously healthy adolescent male following COVID‐19 vaccination: A case report. Academic Emergency Medicine, 28(8), 918-921. https://pubmed.ncbi.nlm.nih.gov/34133825/ | ||||
476 | Cerebral venous sinus thrombosis after mRNA-based COVID-19 vaccination: | https://pubmed.ncbi.nlm.nih.gov/34783932/. | https://pubmed.ncbi.nlm.nih.gov/34670143/. | Jeong, J., & Choi, H. S. (2021). Sudden sensorineural hearing loss after COVID-19 vaccination. International Journal of Infectious Diseases, 113, 341-343. | Jeong, J. y Choi, HS (2021). Pérdida auditiva neurosensorial repentina después de la vacuna COVID-19. Revista Internacional de Enfermedades Infecciosas, 113, 341-343. https://pubmed.ncbi.nlm.nih.gov/34819146/. | Kremsner, P. G., Mann, P., Koidl, A., Leroux-Roels, I., Schindler, C., Gabor, J. J., ... & Oostvogels, L. (2021). Seguridad e inmunogenicidad de un candidato de vacuna contra nanopartículas de ARNm-lipid contra SARS-COV-2. Wiener Klinische Wochenschrift, 133 (17), 931-941. https://www.ncbi.nlm.nih.gov/pubmed/34127854 | Jeong, J., & Choi, H. S. (2021). Sudden sensorineural hearing loss after COVID-19 vaccination. International Journal of Infectious Diseases, 113, 341-343. https://pubmed.ncbi.nlm.nih.gov/34670143/. | Krzywicka, K., Heldner, M. R., Sánchez van Kammen, M., van Haaps, T., Hiltunen, S., Silvis, S. M., ... & Ferro, J. M. (2021). Post‐SARS‐CoV‐2‐vaccination cerebral venous sinus thrombosis: an analysis of cases notified to the European Medicines Agency. European journal of neurology, 28(11), 3656-3662. https://pubmed.ncbi.nlm.nih.gov/34293217/ | Hendren, N. S., Carter, S., & Grodin, J. L. (2021). Severe COVID-19 vaccine associated myocarditis: Zebra or unicorn?. International journal of cardiology, 343, 197-198. | https://www.internationaljournalofcardiology.com/article/S0167-5273(21)01477-7/fulltext. | Hendren, N. S., Carter, S., & Grodin, J. L. (2021). Severe COVID-19 vaccine associated myocarditis: Zebra or unicorn?. International journal of cardiology, 343, 197-198. https://www.internationaljournalofcardiology.com/article/S0167-5273(21)01477-7/fulltext. | McMahon, D. E., Amerson, E., Rosenbach, M., Lipoff, J. B., Moustafa, D., Tyagi, A., ... & Freeman, E. E. (2021). Cutaneous reactions reported after Moderna and Pfizer COVID-19 vaccination: a registry-based study of 414 cases. Journal of the American Academy of Dermatology, 85(1), 46-55. https://pubmed.ncbi.nlm.nih.gov/33838206/ | ||||
477 | COVID-19 vaccine-induced immune thrombosis with thrombocytopenia thrombosis (VITT) and shades of gray in thrombus formation: | https://pubmed.ncbi.nlm.nih.gov/34624910/ | https://pubmed.ncbi.nlm.nih.gov/34819146/. | Konu, Y. R., Gbeasor-Komlanvi, F. A., Yerima, M., Sadio, A. J., Tchankoni, M. K., Zida-Compaore, W. I. C., ... & Ekouevi, D. K. (2021). Prevalence of severe adverse events among health professionals after receiving the first dose of the ChAdOx1 nCoV-19 coronavirus vaccine (Covishield) in Togo, March 2021. Archives of Public Health, 79(1), 1-9. | Konu, Y. R., Gbeasor-Komlanvi, F. A., Yerima, M., Sadio, A. J., Tchankoni, M. K., Zida-Compaore, W. I. C., ... y Ekouevi, D. K. (2021). Prevalencia de eventos adversos graves entre profesionales de la salud después de recibir la primera dosis de la vacuna contra el coronavirus ChAdOx1 nCoV-19 (Covishield) en Togo, marzo de 2021. Archives of Public Health, 79(1), 1-9. https://pubmed.ncbi.nlm.nih.gov/34581453/ | Kreuter, A., Licciardi-Fernández, M. J., Burmann, S. N., Burkert, B., Ollig, F. y Michalowitz, A. L. (2022). Inducción y exacerbación del eritematoso cutáneo subagudo después de la vacunación de SARS-COV-2 basada en ARNA a base de vectores. Dermatología clínica y experimental, 47 (1), 161-163. https://pubmed.ncbi.nlm.nih.gov/34513435/ | Konu, Y. R., Gbeasor-Komlanvi, F. A., Yerima, M., Sadio, A. J., Tchankoni, M. K., Zida-Compaore, W. I. C., ... & Ekouevi, D. K. (2021). Prevalence of severe adverse events among health professionals after receiving the first dose of the ChAdOx1 nCoV-19 coronavirus vaccine (Covishield) in Togo, March 2021. Archives of Public Health, 79(1), 1-9. https://pubmed.ncbi.nlm.nih.gov/34819146/. | Kulkarni, P. A., & Prasad, V. (2021). Understanding risk of thrombosis with thrombocytopenia syndrome after Ad26. COV2. S vaccination. Frontiers of medicine, 15(6), 938-941. https://pubmed.ncbi.nlm.nih.gov/34595694/ | Aye, Y. N., Mai, A. S., Zhang, A., Lim, O. Z. H., Lin, N., Ng, C. H., ... & Chew, N. W. (2021). Acute myocardial infarction and myocarditis following COVID-19 vaccination. QJM: An International Journal of Medicine. | https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8522388/ | Aye, Y. N., Mai, A. S., Zhang, A., Lim, O. Z. H., Lin, N., Ng, C. H., ... & Chew, N. W. (2021). Acute myocardial infarction and myocarditis following COVID-19 vaccination. QJM: An International Journal of Medicine. https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8522388/ | McMahon, D. E., Kovarik, C. L., Damsky, W., Rosenbach, M., Lipoff, J. B., Tyagi, A., ... & Freeman, E. E. (2022). Clinical and pathologic correlation of cutaneous COVID-19 vaccine reactions including V-REPP: A registry-based study. Journal of the American Academy of Dermatology, 86(1), 113-121. https://www.sciencedirect.com/science/article/pii/S0190962221024427 | ||||
478 | Inflammatory myositis after vaccination with ChAdOx1: | https://pubmed.ncbi.nlm.nih.gov/34585145/ | https://pubmed.ncbi.nlm.nih.gov/34581453/ | Matar, E., Manser, D., Spies, J. M., Worthington, J. M., & Parratt, K. L. (2021). Acute Hemichorea‐Hemiballismus Following COVID‐19 (AZD1222) Vaccination. Movement Disorders. | Matar, E., Manser, D., Spies, JM, Worthington, JM y Parratt, KL (2021). Hemicorea-hemibalismo agudo después de la vacunación contra COVID-19 (AZD1222). Trastornos del movimiento. https://pubmed.ncbi.nlm.nih.gov/34741583/ | Kripalani, Y., Lakkappan, V., Parulekar, L., Shaikh, A., Singh, R., & Vyas, P. (2021). Un caso raro de síndrome de Guillain-Barre después de la vacunación COVID-19. Revista europea de informes de casos en medicina interna, 8 (9). https://pubmed.ncbi.nlm.nih.gov/33758714/ | Matar, E., Manser, D., Spies, J. M., Worthington, J. M., & Parratt, K. L. (2021). Acute Hemichorea‐Hemiballismus Following COVID‐19 (AZD1222) Vaccination. Movement Disorders. https://pubmed.ncbi.nlm.nih.gov/34581453/ | Kustin, T., Harel, N., Finkel, U., Perchik, S., Harari, S., Tahor, M., ... & Stern, A. (2021). Evidence for increased breakthrough rates of SARS-CoV-2 variants of concern in BNT162b2-mRNA-vaccinated individuals. Nature medicine, 27(8), 1379-1384. https://www.ncbi.nlm.nih.gov/pubmed/34127854 | Witberg, G., Barda, N., Hoss, S., Richter, I., Wiessman, M., Aviv, Y., ... & Kornowski, R. (2021). Myocarditis after Covid-19 vaccination in a large health care organization. New England Journal of Medicine. | https://www.nejm.org/doi/10.1056/NEJMoa2110737 | Witberg, G., Barda, N., Hoss, S., Richter, I., Wiessman, M., Aviv, Y., ... & Kornowski, R. (2021). Myocarditis after Covid-19 vaccination in a large health care organization. New England Journal of Medicine. https://www.nejm.org/doi/10.1056/NEJMoa2110737 | Mehta, N., Sales, R. M., Babagbemi, K., Levy, A. D., McGrath, A. L., Drotman, M., & Dodelzon, K. (2021). Unilateral axillary adenopathy in the setting of COVID-19 vaccine: Follow-up. Clinical Imaging, 80, 83-87. https://pubmed.ncbi.nlm.nih.gov/34298342/ | ||||
479 | Acute ST-segment elevation myocardial infarction secondary to vaccine-induced immune thrombosis with thrombocytopenia (VITT): | https://pubmed.ncbi.nlm.nih.gov/34580132/. | https://pubmed.ncbi.nlm.nih.gov/34741583/ | Rossi, A., Magri, F., Michelini, S., Caro, G., Di Fraia, M., Fortuna, M. C., ... & Carlesimo, M. (2021). Recurrence of alopecia areata after covid‐19 vaccination: A report of three cases in Italy. Journal of cosmetic dermatology, 20(12), 3753-3757. | Rossi, A., Magri, F., Michelini, S., Caro, G., Di Fraia, M., Fortuna, M. C., ... & Carlesimo, M. (2021). Recurrencia de alopecia areata después de la vacunación contra el covid-19: informe de tres casos en Italia. Revista de dermatología cosmética, 20(12), 3753-3757. https://pubmed.ncbi.nlm.nih.gov/34631069/ | Krutzke, L., Roesler, R., Wiese, S., & Kochanek, S. (2021). Impurezas relacionadas con el proceso en la vacuna Chadox1 NCOV-19. https://pubmed.ncbi.nlm.nih.gov/33752263/ | Rossi, A., Magri, F., Michelini, S., Caro, G., Di Fraia, M., Fortuna, M. C., ... & Carlesimo, M. (2021). Recurrence of alopecia areata after covid‐19 vaccination: A report of three cases in Italy. Journal of cosmetic dermatology, 20(12), 3753-3757. https://pubmed.ncbi.nlm.nih.gov/34741583/ | Kuter, D. J. (2021). Exacerbation of immune thrombocytopenia following COVID‐19 vaccination. British journal of haematology, 195(3), 365-370. https://pubmed.ncbi.nlm.nih.gov/34075578/ | Truong, D. T., Dionne, A., Muniz, J. C., McHugh, K. E., Portman, M. A., Lambert, L. M., ... & Newburger, J. W. (2021). Clinically suspected myocarditis temporally related to COVID-19 vaccination in adolescents and young adults. Circulation. | https://www.ahajournals.org/doi/abs/10.1161/CIRCULATIONAHA.121.056583?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed | Truong, D. T., Dionne, A., Muniz, J. C., McHugh, K. E., Portman, M. A., Lambert, L. M., ... & Newburger, J. W. (2021). Clinically suspected myocarditis temporally related to COVID-19 vaccination in adolescents and young adults. Circulation. https://www.ahajournals.org/doi/abs/10.1161/CIRCULATIONAHA.121.056583?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed | Mehta, P. R., Mangion, S. A., Benger, M., Stanton, B. R., Czuprynska, J., Arya, R., & Sztriha, L. K. (2021). Cerebral venous sinus thrombosis and thrombocytopenia after COVID-19 vaccination–A report of two UK cases. Brain, behavior, and immunity, 95, 514-517. https://www.sciencedirect.com/science/article/abs/pii/S088915912100163X | ||||
480 | A rare case of COVID-19 vaccine-induced thrombotic thrombocytopenia (VITT) affecting the venosplanchnic and pulmonary arterial circulation from a UK district general hospital: | https://pubmed.ncbi.nlm.nih.gov/34535492/ | https://pubmed.ncbi.nlm.nih.gov/34631069/ | Ardalan, M., Moslemi, H., Shafiei, S., Tabrizi, R., & Moselmi, M. (2021). Herpes‐like skin lesion after AstraZeneca vaccination for COVID‐19: A case report. Clinical Case Reports, 9(10). | Ardalan, M., Moslemi, H., Shafiei, S., Tabrizi, R. y Moselmi, M. (2021). Lesión cutánea similar al herpes después de la vacunación con AstraZeneca para COVID-19: reporte de un caso. Informes de casos clínicos, 9(10). https://pubmed.ncbi.nlm.nih.gov/34479129/ | Krzywicka, K., Hellner, M. R., Sánchez van Kammen, M., Van Haapaps, T., Hiltrunen, S., Silvis, S. M., ... & Ferro, J. M. (2021). Post-SARS-COV-2-Vacunación Cerebral SINUSH SINUSOS DE SINUSOS: Un análisis de casos notificados a la Agencia Europea de Medicamentos. Revista Europea de Neurología, 28 (11), 3656-3662. https://pubmed.ncbi.nlm.nih.gov/33952445/ | Ardalan, M., Moslemi, H., Shafiei, S., Tabrizi, R., & Moselmi, M. (2021). Herpes‐like skin lesion after AstraZeneca vaccination for COVID‐19: A case report. Clinical Case Reports, 9(10). https://pubmed.ncbi.nlm.nih.gov/34631069/ | Kuzumi, A., Yoshizaki, A., Chiba, K., Mitsuo, S., Matsuda, K. M., Norimatsu, Y., ... & Sato, S. (2022). Genital necrosis with cutaneous thrombosis after COVID‐19 mRNA vaccination. Journal of the European Academy of Dermatology and Venereology, 36(3), e185-e186. https://pubmed.ncbi.nlm.nih.gov/34839563/ | Azir, M., Inman, B., Webb, J., & Tannenbaum, L. (2021). STEMI Mimic: Focal Myocarditis in an Adolescent Patient After mRNA COVID-19 Vaccine. The Journal of emergency medicine, 61(6), e129-e132. | https://pubmed.ncbi.nlm.nih.gov/34756746/ | Azir, M., Inman, B., Webb, J., & Tannenbaum, L. (2021). STEMI Mimic: Focal Myocarditis in an Adolescent Patient After mRNA COVID-19 Vaccine. The Journal of emergency medicine, 61(6), e129-e132. https://pubmed.ncbi.nlm.nih.gov/34756746/ | Melas, N. (2021). Portal vein thrombosis occurring after the first dose of mRNA SARS-CoV-2 vaccine in a patient with antiphospholipid syndrome. Thrombosis Update. https://www.sciencedirect.com/science/article/pii/S2666572721000389 | ||||
481 | COVID-19 vaccine-induced thrombotic thrombocytopenia: a case series: | https://pubmed.ncbi.nlm.nih.gov/34527501/ | https://pubmed.ncbi.nlm.nih.gov/34479129/ | Dalan, R., & Boehm, B. O. (2021). Thrombosis post COVID-19 vaccinations: Potential link to ACE pathways. Thrombosis Research, 206, 137. | Dalan, R. y Boehm, BO (2021). Trombosis posterior a las vacunas COVID-19: vínculo potencial con las vías de la ECA. Investigación de trombosis, 206, 137. https://pubmed.ncbi.nlm.nih.gov/34546608/ | Kulkarni, P. A., & Prasad, V. (2021). Comprender el riesgo de trombosis con síndrome de trombocitopenia después de AD26. COV2. La vacunación de s. Fronteras de la medicina, 15 (6), 938-941. https://pubmed.ncbi.nlm.nih.gov/34661934/ | Dalan, R., & Boehm, B. O. (2021). Thrombosis post COVID-19 vaccinations: Potential link to ACE pathways. Thrombosis Research, 206, 137. https://pubmed.ncbi.nlm.nih.gov/34479129/ | Kwan, M. Y., Chua, G. T., Chow, C. B., Tsao, S. S., To, K. K., Yuen, K. Y., ... & Ip, P. (2021). mRNA COVID vaccine and myocarditis in adolescents. Hong Kong Med J, 27(5), 326-327. https://www.ncbi.nlm.nih.gov/pubmed/34393110 | Istampoulouoglou, I., Dimitriou, G., Späni, S., Christ, A., Zimmermanns, B., Koechlin, S., ... & Leuppi-Taegtmeyer, A. B. (2021). Myocarditis and pericarditis in association with COVID-19 mRNA-vaccination: cases from a regional pharmacovigilance centre. Global cardiology science & practice, 2021(3). | https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8587334/ | Istampoulouoglou, I., Dimitriou, G., Späni, S., Christ, A., Zimmermanns, B., Koechlin, S., ... & Leuppi-Taegtmeyer, A. B. (2021). Myocarditis and pericarditis in association with COVID-19 mRNA-vaccination: cases from a regional pharmacovigilance centre. Global cardiology science & practice, 2021(3). https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8587334/ | Mendes-de-Almeida, D. P., Martins-Gonçalves, R., Morato-Santos, R., De Carvalho, G. A. C., Martins, S. A., Palhinha, L., ... & Kurtz, P. (2021). Intracerebral hemorrhage associated with vaccine-induced thrombotic thrombocytopenia following ChAdOx1 nCOVID-19 vaccine in a pregnant woman. haematologica, 106(11), 3025. https://pubmed.ncbi.nlm.nih.gov/34261297/ | ||||
482 | Thrombosis with thrombocytopenia syndrome (TTS) after vaccination with AstraZeneca ChAdOx1 nCoV-19 (AZD1222) COVID-19: a risk-benefit analysis for persons <60% risk-benefit analysis for people <60 years in Australia: | https://pubmed.ncbi.nlm.nih.gov/34272095/ | https://pubmed.ncbi.nlm.nih.gov/34546608/ | Sandhu, S., Bhatnagar, A., Kumar, H., Dixit, P. K., Paliwal, G., Suhag, D. K., ... & Mitra, D. (2021). Leukocytoclastic vasculitis as a cutaneous manifestation of ChAdOx1 nCoV‐19 corona virus vaccine (recombinant). Dermatologic therapy, 34(6), e15141. | Sandhu, S., Bhatnagar, A., Kumar, H., Dixit, PK, Paliwal, G., Suhag, DK, ... y Mitra, D. (2021). Vasculitis leucocitoclástica como manifestación cutánea de la vacuna contra el virus corona ChAdOx1 nCoV-19 (recombinante). Terapia dermatológica, 34(6), e15141. https://pubmed.ncbi.nlm.nih.gov/34546343/ | Kustin, T., Harel, N., Finkel, U., Perchik, S., Harari, S., Tahor, M., ... & Stern, A. (2021). Evidencia de aumento de las tasas de avance de las variantes de preocupación SARS-COV-2 en los individuos BNT162B2-MRNA-vacunados. Medicina natural, 27 (8), 1379-1384. https://www.ncbi.nlm.nih.gov/pubmed/34393110 | Sandhu, S., Bhatnagar, A., Kumar, H., Dixit, P. K., Paliwal, G., Suhag, D. K., ... & Mitra, D. (2021). Leukocytoclastic vasculitis as a cutaneous manifestation of ChAdOx1 nCoV‐19 corona virus vaccine (recombinant). Dermatologic therapy, 34(6), e15141. https://pubmed.ncbi.nlm.nih.gov/34546608/ | Kwon, H., & Kim, T. (2022). Autoimmune encephalitis following ChAdOx1-S SARS-CoV-2 vaccination. Neurological Sciences, 43(3), 1487-1489. https://pubmed.ncbi.nlm.nih.gov/34846583/ | Koizumi, T., Awaya, T., Yoshioka, K., Kitano, S., Hayama, H., Amemiya, K., ... & Nakamura, M. (2021). Myocarditis after COVID-19 mRNA vaccines. QJM: An International Journal of Medicine, 114(10), 741-743. | https://pubmed.ncbi.nlm.nih.gov/34546329/. | Koizumi, T., Awaya, T., Yoshioka, K., Kitano, S., Hayama, H., Amemiya, K., ... & Nakamura, M. (2021). Myocarditis after COVID-19 mRNA vaccines. QJM: An International Journal of Medicine, 114(10), 741-743. https://pubmed.ncbi.nlm.nih.gov/34546329/. | Mevorach, D., Anis, E., Cedar, N., Bromberg, M., Haas, E. J., Nadir, E., ... & Alroy-Preis, S. (2021). Myocarditis after BNT162b2 mRNA vaccine against Covid-19 in Israel. New England Journal of Medicine, 385(23), 2140-2149. https://pubmed.ncbi.nlm.nih.gov/34614328/. | ||||
483 | Immune thrombocytopenia after immunization with Vaxzevria ChadOx1-S vaccine (AstraZeneca), Victoria, Australia: | https://pubmed.ncbi.nlm.nih.gov/34756770/ | https://pubmed.ncbi.nlm.nih.gov/34546343/ | Lin, C. Y., Huang, L. Y., Wu, K. A., Chan, J. S., Wu, K. L., Shyu, H. Y., & Hsiao, P. J. (2021). Abdominal pain and bilateral adrenal haemorrhage of COVID-19 vaccine-induced immune thrombotic thrombocytopenia. QJM: An International Journal of Medicine. | Lin, C. Y., Huang, L. Y., Wu, K. A., Chan, J. S., Wu, K. L., Shyu, H. Y. y Hsiao, P. J. (2021). Dolor abdominal y hemorragia suprarrenal bilateral de la trombocitopenia trombótica inmunitaria inducida por la vacuna COVID-19. QJM: Revista internacional de medicina. https://pubmed.ncbi.nlm.nih.gov/34849183/ | Kuter, D. J. (2021). Exacerbación de la trombocitopenia inmune después de la vacunación de COVID-19. British Journal of Hematology, 195 (3), 365-370. https://pubmed.ncbi.nlm.nih.gov/34105244/ | Lin, C. Y., Huang, L. Y., Wu, K. A., Chan, J. S., Wu, K. L., Shyu, H. Y., & Hsiao, P. J. (2021). Abdominal pain and bilateral adrenal haemorrhage of COVID-19 vaccine-induced immune thrombotic thrombocytopenia. QJM: An International Journal of Medicine. https://pubmed.ncbi.nlm.nih.gov/34546343/ | Laisuan, W., Wongsa, C., Chiewchalermsri, C., Thongngarm, T., Rerkpattanapipat, T., Iamrahong, P., ... & Sompornrattanaphan, M. (2021). CoronaVac COVID-19 Vaccine-Induced Anaphylaxis: Clinical Characteristics and Revaccination Outcomes. Journal of Asthma and Allergy, 14, 1209. https://pubmed.ncbi.nlm.nih.gov/34675550/. | Levin, D., Shimon, G., Fadlon-Derai, M., Gershovitz, L., Shovali, A., Sebbag, A., ... & Gordon, B. (2021). Myocarditis following COVID-19 vaccination–a case series. Vaccine, 39(42), 6195-6200. | https://www.sciencedirect.com/science/article/pii/S0264410X21011725?via%3Dihub. | Levin, D., Shimon, G., Fadlon-Derai, M., Gershovitz, L., Shovali, A., Sebbag, A., ... & Gordon, B. (2021). Myocarditis following COVID-19 vaccination–a case series. Vaccine, 39(42), 6195-6200. https://www.sciencedirect.com/science/article/pii/S0264410X21011725?via%3Dihub. | Michiels, Y., Houhou-Fidouh, N., Collin, G., Berger, J., & Kohli, E. (2021). Humoral Response Induced by Prime-Boost Vaccination with the ChAdOx1 nCoV-19 and mRNA BNT162b2 Vaccines in a Teriflunomide-Treated Multiple Sclerosis Patient. Vaccines, 9(10), 1140. https://pubmed.ncbi.nlm.nih.gov/34696248/ | ||||
484 | Characteristics and outcomes of patients with cerebral venous sinus thrombosis in thrombotic immune thrombocytopenia induced by SARS-CoV-2 vaccine: | https://jamanetwork.com/journals/jamaneurology/fullarticle/2784622 | https://pubmed.ncbi.nlm.nih.gov/34849183/ | Sepahvand, M., Yazdi, N., Rohani, M., & Emamikhah, M. (2022). Cervical longitudinally extensive myelitis after vaccination with inactivated virus-based COVID-19 vaccine. Radiology Case Reports, 17(2), 303-305. | Sepahvand, M., Yazdi, N., Rohani, M. y Emamikhah, M. (2022). Mielitis cervical longitudinalmente extensa después de la vacunación con la vacuna COVID-19 basada en virus inactivados. Informes de casos de radiología, 17(2), 303-305. https://pubmed.ncbi.nlm.nih.gov/34853744/. | Kuzumi, A., Yoshizaki, A., Chiba, K., Mitsuo, S., Matsuda, K. M., Norimatsu, Y., ... & Sato, S. (2022). Necrosis genital con trombosis cutánea después de la vacunación con COVID-19 ARNm. Diario de la Academia Europea de Dermatología y Venereología, 36 (3), E185-E186. https://pubmed.ncbi.nlm.nih.gov/34783932/. | Sepahvand, M., Yazdi, N., Rohani, M., & Emamikhah, M. (2022). Cervical longitudinally extensive myelitis after vaccination with inactivated virus-based COVID-19 vaccine. Radiology Case Reports, 17(2), 303-305. https://pubmed.ncbi.nlm.nih.gov/34849183/ | Lane, D. L., Neelapu, S. S., Xu, G., & Weaver, O. (2021). COVID-19 vaccine-related axillary and cervical lymphadenopathy in patients with current or prior breast cancer and other malignancies: cross-sectional imaging findings on MRI, CT, and PET-CT. Korean Journal of Radiology, 22(12), 1938. https://pubmed.ncbi.nlm.nih.gov/34719892/ | Jain, S. S., Steele, J. M., Fonseca, B., Huang, S., Shah, S., Maskatia, S. A., ... & Grosse-Wortmann, L. (2021). COVID-19 Vaccination–Associated Myocarditis in Adolescents. Pediatrics, 148(5). | https://publications.aap.org/pediatrics/article/148/5/e2021053427/181357 | Jain, S. S., Steele, J. M., Fonseca, B., Huang, S., Shah, S., Maskatia, S. A., ... & Grosse-Wortmann, L. (2021). COVID-19 Vaccination–Associated Myocarditis in Adolescents. Pediatrics, 148(5). https://publications.aap.org/pediatrics/article/148/5/e2021053427/181357 | Min, Y. G., Ju, W., Ha, Y. E., Ban, J. J., Lee, S. A., Sung, J. J., & Shin, J. Y. (2021). Sensory Guillain-Barre syndrome following the ChAdOx1 nCov-19 vaccine: Report of two cases and review of literature. Journal of neuroimmunology, 359, 577691. https://www.sciencedirect.com/science/article/pii/S0165572821002186 | ||||
485 | Case study of thrombosis and thrombocytopenia syndrome after administration of the AstraZeneca COVID-19 vaccine: | https://pubmed.ncbi.nlm.nih.gov/34781321/ | https://pubmed.ncbi.nlm.nih.gov/34853744/. | Shahrigharahkoshan, S., Gagnon, L. P., & Mathieu, S. (2021). Cutaneous Leukocytoclastic Vasculitis Induction Following ChAdOx1 nCoV-19 Vaccine. Cureus, 13(10). | Shahrigharahkoshan, S., Gagnon, L. P. y Mathieu, S. (2021). Inducción de vasculitis leucocitoclástica cutánea después de la vacuna ChAdOx1 nCoV-19. Cureus, 13(10). https://pubmed.ncbi.nlm.nih.gov/34751429/. | Kwan, M. Y., Chua, G. T., Chow, C. B., TSAO, S. S., A, K. K., Yuen, K. Y., ... & IP, P. (2021). MRNA covid vacuna y miocarditis en adolescentes. Hong Kong Med J, 27 (5), 326-327. https://www.ncbi.nlm.nih.gov/pubmed/34463770 | Shahrigharahkoshan, S., Gagnon, L. P., & Mathieu, S. (2021). Cutaneous Leukocytoclastic Vasculitis Induction Following ChAdOx1 nCoV-19 Vaccine. Cureus, 13(10). https://pubmed.ncbi.nlm.nih.gov/34853744/. | Larson, V., Seidenberg, R., Caplan, A., Brinster, N. K., Meehan, S. A., & Kim, R. H. (2022). Clinical and histopathological spectrum of delayed adverse cutaneous reactions following COVID‐19 vaccination. Journal of cutaneous pathology, 49(1), 34-41. https://pubmed.ncbi.nlm.nih.gov/34292611/. | Chelala, L., Jeudy, J., Hossain, R., Rosenthal, G., Pietris, N., & White, C. (2021). Cardiac MRI findings of myocarditis after COVID-19 mRNA vaccination in adolescents. American Journal of Roentgenology. | https://pubmed.ncbi.nlm.nih.gov/34704459/ | Chelala, L., Jeudy, J., Hossain, R., Rosenthal, G., Pietris, N., & White, C. (2021). Cardiac MRI findings of myocarditis after COVID-19 mRNA vaccination in adolescents. American Journal of Roentgenology. https://pubmed.ncbi.nlm.nih.gov/34704459/ | Minocha, P. K., Better, D., Singh, R. K., & Hoque, T. (2021). Recurrence of acute myocarditis temporally associated with receipt of the mRNA coronavirus disease 2019 (COVID-19) vaccine in a male adolescent. The Journal of Pediatrics, 238, 321-323. https://www.sciencedirect.com/science/article/pii/S002234762100617X | ||||
486 | Thrombosis with Thrombocytopenia Syndrome Associated with COVID-19 Vaccines: | https://pubmed.ncbi.nlm.nih.gov/34062319/ | https://pubmed.ncbi.nlm.nih.gov/34751429/. | Kherlopian, A., Zhao, C., Ge, L., Forward, E., & Fischer, G. (2021). A case of toxic epidermal necrolysis after ChAdOx1 nCov-19 (AZD1222) vaccination. The Australasian Journal of Dermatology. | Kherlopian, A., Zhao, C., Ge, L., Forward, E. y Fischer, G. (2021). Un caso de necrólisis epidérmica tóxica después de la vacunación con ChAdOx1 nCov-19 (AZD1222). La Revista de Dermatología de Australasia. https://pubmed.ncbi.nlm.nih.gov/34559576/ | Kwon, H., & Kim, T. (2022). Encefalitis autoinmune después de la vacunación de SARS-COV-2 de Chadox1-S. Ciencias neurológicas, 43 (3), 1487-1489. https://pubmed.ncbi.nlm.nih.gov/34411532/ | Kherlopian, A., Zhao, C., Ge, L., Forward, E., & Fischer, G. (2021). A case of toxic epidermal necrolysis after ChAdOx1 nCov-19 (AZD1222) vaccination. The Australasian Journal of Dermatology. https://pubmed.ncbi.nlm.nih.gov/34751429/. | Lavin, M., Elder, P. T., O’Keeffe, D., Enright, H., Ryan, E., Kelly, A., ... & O’Donnell, J. S. (2021). Vaccine‐induced immune thrombotic thrombocytopenia (VITT)–a novel clinico‐pathological entity with heterogeneous clinical presentations. British Journal of Haematology, 195(1), 76-84. https://pubmed.ncbi.nlm.nih.gov/34159588/ | Shiyovich, A., Witberg, G., Aviv, Y., Eisen, A., Orvin, K., Wiessman, M., ... & Hamdan, A. (2021). Myocarditis following COVID-19 vaccination: magnetic resonance imaging study. European Heart Journal-Cardiovascular Imaging. | https://academic.oup.com/ehjcimaging/advance-article/doi/10.1093/ehjci/jeab230/6421640 | Shiyovich, A., Witberg, G., Aviv, Y., Eisen, A., Orvin, K., Wiessman, M., ... & Hamdan, A. (2021). Myocarditis following COVID-19 vaccination: magnetic resonance imaging study. European Heart Journal-Cardiovascular Imaging. https://academic.oup.com/ehjcimaging/advance-article/doi/10.1093/ehjci/jeab230/6421640 | Miqdad, M. A., Nasser, H., Alshehri, A., & Mourad, A. R. (2021). Acute Myocarditis Following the Administration of the Second BNT162b2 COVID-19 Vaccine Dose. Cureus, 13(10). https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8599115/ | ||||
487 | Cerebral venous sinus thrombosis following vaccination with ChAdOx1: the first case of definite thrombosis with thrombocytopenia syndrome in India: | https://pubmed.ncbi.nlm.nih.gov/34706921/ | https://pubmed.ncbi.nlm.nih.gov/34559576/ | Ng, X. L., Betzler, B. K., Testi, I., Ho, S. L., Tien, M., Ngo, W. K., ... & Agrawal, R. (2021). Ocular adverse events after COVID-19 vaccination. Ocular immunology and inflammation, 1-9. | Ng, X. L., Betzler, B. K., Testi, I., Ho, S. L., Tien, M., Ngo, W. K., ... y Agrawal, R. (2021). Eventos adversos oculares tras la vacunación COVID-19. Inmunología ocular e inflamación, 1-9. https://pubmed.ncbi.nlm.nih.gov/34608345/. | Laisuan, W., Wongsa, C., Chiewchalermsri, C., Thongngarm, T., Rerkpattanapipat, T., Iamrahong, P., ... & Sompornrattanaphan, M. (2021). Coronavac covid-19 anafilaxia inducida por la vacuna: características clínicas y resultados de revacciones. Diario de asma y alergia, 14, 1209. https://pubmed.ncbi.nlm.nih.gov/34734159/. | Ng, X. L., Betzler, B. K., Testi, I., Ho, S. L., Tien, M., Ngo, W. K., ... & Agrawal, R. (2021). Ocular adverse events after COVID-19 vaccination. Ocular immunology and inflammation, 1-9. https://pubmed.ncbi.nlm.nih.gov/34559576/ | Lavin, M., Elder, P. T., O’Keeffe, D., Enright, H., Ryan, E., Kelly, A., ... & O’Donnell, J. S. (2021). Vaccine‐induced immune thrombotic thrombocytopenia (VITT)–a novel clinico‐pathological entity with heterogeneous clinical presentations. British Journal of Haematology, 195(1), 76-84. https://pubmed.ncbi.nlm.nih.gov/34159588/. | Miqdad, M. A., Nasser, H., Alshehri, A., & Mourad, A. R. (2021). Acute Myocarditis Following the Administration of the Second BNT162b2 COVID-19 Vaccine Dose. Cureus, 13(10). | https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8599115/ | Miqdad, M. A., Nasser, H., Alshehri, A., & Mourad, A. R. (2021). Acute Myocarditis Following the Administration of the Second BNT162b2 COVID-19 Vaccine Dose. Cureus, 13(10). https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8599115/ | Miqdadi, A., & Herrag, M. (2021). Acute eosinophilic pneumonia associated with the anti-COVID-19 vaccine AZD1222. Cureus, 13(10). https://pubmed.ncbi.nlm.nih.gov/34812326/. | ||||
488 | COVID-19 vaccine-associated thrombosis with thrombocytopenia syndrome (TTS): systematic review and post hoc analysis: | https://pubmed.ncbi.nlm.nih.gov/34698582/. | https://pubmed.ncbi.nlm.nih.gov/34608345/. | Uvais, N. A. (2021). Depression following ChAdOx1-S/nCoV-19 vaccine. The European Journal of Psychiatry. | Uvais, NA (2021). Depresión tras la vacuna ChAdOx1-S/nCoV-19. La Revista Europea de Psiquiatría. https://pubmed.ncbi.nlm.nih.gov/34384129/. | Largo, S. S. (2021). Perspectivas importantes en la miopericaditis después de la vacunación contra los ARNm COVID-19 de Pfizer en adolescentes. El Journal of Pediattics, 238, 5. https://www.ncbi.nlm.nih.gov/pubmed/34375696 | Uvais, N. A. (2021). Depression following ChAdOx1-S/nCoV-19 vaccine. The European Journal of Psychiatry. https://pubmed.ncbi.nlm.nih.gov/34608345/. | Lazaros, G., Anastassopoulou, C., Hatziantoniou, S., Kalos, T., Soulaidopoulos, S., Lazarou, E., ... & Tsioufis, C. (2021). A case series of acute pericarditis following COVID-19 vaccination in the context of recent reports from Europe and the United States. Vaccine, 39(45), 6585-6590. https://pubmed.ncbi.nlm.nih.gov/34635376/ | Kaul, R., Sreenivasan, J., Goel, A., Malik, A., Bandyopadhyay, D., Jin, C., ... & Panza, J. A. (2021). Myocarditis following COVID-19 vaccination. International Journal of Cardiology. Heart & Vasculature. | https://www.sciencedirect.com/science/article/pii/S2352906721001603 | Kaul, R., Sreenivasan, J., Goel, A., Malik, A., Bandyopadhyay, D., Jin, C., ... & Panza, J. A. (2021). Myocarditis following COVID-19 vaccination. International Journal of Cardiology. Heart & Vasculature. https://www.sciencedirect.com/science/article/pii/S2352906721001603 | Mitchell, O. R., Couzins, M., Dave, R., Bekker, J., & Brennan, P. A. (2021). COVID-19 vaccination and low cervical lymphadenopathy in the two week neck lump clinic-a follow up audit. British Journal of Oral and Maxillofacial Surgery, 59(6), 720-721. https://pubmed.ncbi.nlm.nih.gov/33947605/. | ||||
489 | Case report of immune thrombocytopenia after vaccination with ChAdOx1 nCoV-19: | https://pubmed.ncbi.nlm.nih.gov/34751013/. | https://pubmed.ncbi.nlm.nih.gov/34384129/. | Gabarin, N., Patterson, S., Pai, M., Afzaal, T., Nazy, I., Sheppard, J. A. I., ... & Warkentin, T. E. (2021). Venous thromboembolism and mild thrombocytopenia after ChAdOx1 nCoV-19 vaccination. Thrombosis and Haemostasis, 121(12), 1677-1680. | Gabarin, N., Patterson, S., Pai, M., Afzaal, T., Nazy, I., Sheppard, J. A. I., ... y Warkentin, T. E. (2021). Tromboembolismo venoso y trombocitopenia leve después de la vacunación ChAdOx1 nCoV-19. Trombosis y hemostasia, 121 (12), 1677-1680. https://pubmed.ncbi.nlm.nih.gov/34755433/ | Largo, S. S. (2021). Perspectivas importantes en la miopericaditis después de la vacunación contra los ARNm COVID-19 de Pfizer en adolescentes. El Journal of Pediattics, 238, 5. https://www.sciencedirect.com/science/article/pii/S1936878X21004861 | Gabarin, N., Patterson, S., Pai, M., Afzaal, T., Nazy, I., Sheppard, J. A. I., ... & Warkentin, T. E. (2021). Venous thromboembolism and mild thrombocytopenia after ChAdOx1 nCoV-19 vaccination. Thrombosis and Haemostasis, 121(12), 1677-1680. https://pubmed.ncbi.nlm.nih.gov/34384129/. | Lazaros, G., Klein, A. L., Hatziantoniou, S., Tsioufis, C., Tsakris, A., & Anastassopoulou, C. (2021). The novel platform of mRNA COVID-19 vaccines and myocarditis: clues into the potential underlying mechanism. Vaccine, 39(35), 4925. https://pubmed.ncbi.nlm.nih.gov/34312010/ | Alania-Torres, E., Morillas-Climent, H., García-Escrivá, A., Vinueza-Buitrón, P., Poquet-Catalá, I., Zorio, E., ... & Valle-Muñoz, A. (2021). Case Report: Probable Myocarditis After Covid-19 mRNA Vaccine in a Patient With Arrhythmogenic Left Ventricular Cardiomyopathy. Frontiers in Cardiovascular Medicine, 1351. | https://pubmed.ncbi.nlm.nih.gov/34712717/. | Alania-Torres, E., Morillas-Climent, H., García-Escrivá, A., Vinueza-Buitrón, P., Poquet-Catalá, I., Zorio, E., ... & Valle-Muñoz, A. (2021). Case Report: Probable Myocarditis After Covid-19 mRNA Vaccine in a Patient With Arrhythmogenic Left Ventricular Cardiomyopathy. Frontiers in Cardiovascular Medicine, 1351. https://pubmed.ncbi.nlm.nih.gov/34712717/. | Mitchell, O. R., Dave, R., Bekker, J., & Brennan, P. A. (2021). Supraclavicular lymphadenopathy following COVID-19 vaccination: an increasing presentation to the two-week wait neck lump clinic?. British Journal of Oral and Maxillofacial Surgery, 59(3), 384-385. https://pubmed.ncbi.nlm.nih.gov/33685772/ | ||||
490 | Acute transverse myelitis after COVID-19 vaccination: | https://pubmed.ncbi.nlm.nih.gov/34684047/. | https://pubmed.ncbi.nlm.nih.gov/34755433/ | David, R., Hanna, P., Lee, K., & Ritchie, A. (2021). Relapsed ANCA associated vasculitis following Oxford AstraZeneca ChAdOx1-S COVID-19 vaccination: A case series of two patients. Nephrology (Carlton, Vic.), 27(1), 109-110. | David, R., Hanna, P., Lee, K. y Ritchie, A. (2021). Vasculitis recidivante asociada a ANCA después de la vacunación Oxford AstraZeneca ChAdOx1-S COVID-19: una serie de casos de dos pacientes. Nefrología (Carlton, Vic.), 27(1), 109-110. https://pubmed.ncbi.nlm.nih.gov/34839830/ | Larson, V., Seidenberg, R., Caplan, A., Brinster, N. K., Meehan, S. A., & Kim, R. H. (2022). Espectro clínico e histopatológico de reacciones cutáneas adversas retrasadas después de la vacunación COVID-19. Diario de patología cutánea, 49 (1), 34-41. https://pubmed.ncbi.nlm.nih.gov/34530771/. | David, R., Hanna, P., Lee, K., & Ritchie, A. (2021). Relapsed ANCA associated vasculitis following Oxford AstraZeneca ChAdOx1-S COVID-19 vaccination: A case series of two patients. Nephrology (Carlton, Vic.), 27(1), 109-110. https://pubmed.ncbi.nlm.nih.gov/34755433/ | Łaźniak-Pfajfer, A., Surmacz, R., Rajewska-Tabor, J., Pyda, M., Lesiak, M., & Bobkowski, W. (2021). Myocarditis associated with COVID-19 vaccination in three teenage males. Polish Archives of Internal Medicine. https://pubmed.ncbi.nlm.nih.gov/34851078/. | Schmitt, P., Demoulin, R., Poyet, R., Capilla, E., Rohel, G., Pons, F., ... & Cellarier, G. R. (2021). Acute Myocarditis after COVID-19 vaccination: A case report. La Revue de medecine interne, 42(11), 797-800. | https://www.sciencedirect.com/science/article/pii/S0248866321007098 | Schmitt, P., Demoulin, R., Poyet, R., Capilla, E., Rohel, G., Pons, F., ... & Cellarier, G. R. (2021). Acute Myocarditis after COVID-19 vaccination: A case report. La Revue de medecine interne, 42(11), 797-800. https://www.sciencedirect.com/science/article/pii/S0248866321007098 | Mizrahi, B., Lotan, R., Kalkstein, N., Peretz, A., Perez, G., Ben-Tov, A., ... & Patalon, T. (2021). Correlation of SARS-CoV-2-breakthrough infections to time-from-vaccine. Nature communications, 12(1), 1-5. https://www.ncbi.nlm.nih.gov/pubmed/34737312 | ||||
491 | Concerns for adverse effects of thrombocytopenia and thrombosis after adenovirus-vectored COVID-19 vaccination: | https://pubmed.ncbi.nlm.nih.gov/34541935/ | https://pubmed.ncbi.nlm.nih.gov/34839830/ | Mungmunpuntipantip, R., & Wiwanitkit, V. (2021). Thromboses of major arteries and ChAdOx1 nCov-19 vaccination. Neurological Research and Practice, 3(1), 1-1. | Mungmunpuntipantip, R. y Wiwanitkit, V. (2021). Trombos de arterias principales y vacunación ChAdOx1 nCov-19. Investigación y práctica neurológica, 3(1), 1-1. https://pubmed.ncbi.nlm.nih.gov/34667486/ | Lavin, M., Elder, P. T., O'Keefffe, D., Enright, H., Ryan, E., Kelly, A., ... & O'Donnell, J. S. (2021). Trombocitopenia trombótica inmune inducida por la vacuna (Vitt) -a nueva entidad clínico-patológica con presentaciones clínicas heterogéneas. British Journal of Hematology, 195 (1), 76-84. https://pubmed.ncbi.nlm.nih.gov/34402666/ | Mungmunpuntipantip, R., & Wiwanitkit, V. (2021). Thromboses of major arteries and ChAdOx1 nCov-19 vaccination. Neurological Research and Practice, 3(1), 1-1. https://pubmed.ncbi.nlm.nih.gov/34839830/ | Leclerc, S., Royal, V., Lamarche, C., & Laurin, L. P. (2021). Minimal change disease with severe acute kidney injury following the Oxford-AstraZeneca COVID-19 vaccine: a case report. American Journal of Kidney Diseases, 78(4), 607-610. https://pubmed.ncbi.nlm.nih.gov/34242687/. | Ambati, S., Colon, M., Mihic, M., Sanchez, J., & Bakar, A. (2021). Acute myopericarditis after covid-19 vaccine in teenagers. Case reports in cardiology, 2021. | https://pubmed.ncbi.nlm.nih.gov/34589238/. | Ambati, S., Colon, M., Mihic, M., Sanchez, J., & Bakar, A. (2021). Acute myopericarditis after covid-19 vaccine in teenagers. Case reports in cardiology, 2021. https://pubmed.ncbi.nlm.nih.gov/34589238/. | Moffitt, K., Cheung, E., Yeung, T., Stamoulis, C., & Malley, R. (2021). Analysis of Staphylococcus aureus transcriptome in pediatric soft tissue abscesses and comparison to murine infections. Infection and immunity, 89(4), e00715-20. https://www.ncbi.nlm.nih.gov/pubmed/33526560 | ||||
492 | Major hemorrhagic stroke after ChAdOx1 nCoV-19 vaccination: a case report: | https://pubmed.ncbi.nlm.nih.gov/34273119/ | https://pubmed.ncbi.nlm.nih.gov/34667486/ | Park, J. Y., & Yi, S. Y. (2021). Rare case of contralateral supraclavicular lymphadenopathy after COVID-19 vaccination: Computed tomography and ultrasonography findings. Radiology Case Reports, 16(12), 3879-3881. | Park, JY y Yi, SY (2021). Caso raro de linfadenopatía supraclavicular contralateral después de la vacunación COVID-19: hallazgos de tomografía computarizada y ecografía. Informes de casos de radiología, 16(12), 3879-3881. https://pubmed.ncbi.nlm.nih.gov/34726187/. | Lavin, M., Elder, P. T., O'Keefffe, D., Enright, H., Ryan, E., Kelly, A., ... & O'Donnell, J. S. (2021). Trombocitopenia trombótica inmune inducida por la vacuna (Vitt) -a nueva entidad clínico-patológica con presentaciones clínicas heterogéneas. British Journal of Hematology, 195 (1), 76-84. https://pubmed.ncbi.nlm.nih.gov/34461442/ | Park, J. Y., & Yi, S. Y. (2021). Rare case of contralateral supraclavicular lymphadenopathy after COVID-19 vaccination: Computed tomography and ultrasonography findings. Radiology Case Reports, 16(12), 3879-3881. https://pubmed.ncbi.nlm.nih.gov/34667486/ | Lee, E. J., & Lee, A. I. (2021). Cerebral venous sinus thrombosis after vaccination: the UK experience. The Lancet, 398(10306), 1107-1109. https://pubmed.ncbi.nlm.nih.gov/34370974/ | Nevet, A. (2021). Acute myocarditis associated with anti-COVID-19 vaccination. Clinical and Experimental Vaccine Research, 10(2), 196. | https://ecevr.org/DOIx.php?id=10.7774/cevr.2021.10.2.196. | Nevet, A. (2021). Acute myocarditis associated with anti-COVID-19 vaccination. Clinical and Experimental Vaccine Research, 10(2), 196. https://ecevr.org/DOIx.php?id=10.7774/cevr.2021.10.2.196. | Moghimi, S. M. (2021). Allergic reactions and anaphylaxis to lipid nanoparticle-based COVID-19 vaccines. Molecular Therapy. https://pubmed.ncbi.nlm.nih.gov/33571463/ | ||||
493 | Cerebral venous sinus thrombosis after COVID-19 vaccination: neurologic and radiologic management: | https://pubmed.ncbi.nlm.nih.gov/34327553/. | https://pubmed.ncbi.nlm.nih.gov/34726187/. | Ungari, M., & Pezzarossa, E. (2022). Cutaneous Lymphocytic Vasculitis After Administration of the Second Dose of AZD1222 (Oxford–AstraZeneca) Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination: Casuality or Causality?. The American Journal of Dermatopathology, 44(1), 80-82. | Ungari, M. y Pezzarossa, E. (2022). Vasculitis linfocítica cutánea tras la administración de la segunda dosis de AZD1222 (Oxford-AstraZeneca) Vacunación contra el coronavirus 2 contra el síndrome respiratorio agudo severo: ¿casualidad o causalidad?. La Revista Estadounidense de Dermatopatología, 44(1), 80-82. https://pubmed.ncbi.nlm.nih.gov/34781027/ | Lazaros, G., Anastassopoulou, C., Hatziantoniou, S., Kalos, T., Soulaidopoulos, S., Lázarou, E., ... & Tsioufis, C. (2021). Una serie de casos de pericarditis aguda después de la vacunación de COVID-19 en el contexto de informes recientes de Europa y los Estados Unidos. Vacuna, 39 (45), 6585-6590. https://pubmed.ncbi.nlm.nih.gov/34749492/ | Ungari, M., & Pezzarossa, E. (2022). Cutaneous Lymphocytic Vasculitis After Administration of the Second Dose of AZD1222 (Oxford–AstraZeneca) Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination: Casuality or Causality?. The American Journal of Dermatopathology, 44(1), 80-82. https://pubmed.ncbi.nlm.nih.gov/34726187/. | Lee, E. J., & Lee, A. I. (2021). Cerebral venous sinus thrombosis after vaccination: the UK experience. The Lancet, 398(10306), 1107-1109. https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)01788-8/fulltext | Foltran, D., Delmas, C., Flumian, C., De Paoli, P., Salvo, F., Gautier, S., ... & Montastruc, F. (2022). Myocarditis and pericarditis in adolescents after first and second doses of mRNA COVID-19 vaccines. European Heart Journal-Quality of Care and Clinical Outcomes, 8(2), 99-103. | https://academic.oup.com/ehjqcco/advance-article/doi/10.1093/ehjqcco/qcab090/6442104 | Foltran, D., Delmas, C., Flumian, C., De Paoli, P., Salvo, F., Gautier, S., ... & Montastruc, F. (2022). Myocarditis and pericarditis in adolescents after first and second doses of mRNA COVID-19 vaccines. European Heart Journal-Quality of Care and Clinical Outcomes, 8(2), 99-103. https://academic.oup.com/ehjqcco/advance-article/doi/10.1093/ehjqcco/qcab090/6442104 | Mohamed, L., Madsen, A. M. R., Schaltz-Buchholzer, F., Ostenfeld, A., Netea, M. G., Benn, C. S., & Kofoed, P. E. (2021). Reactivation of BCG vaccination scars after vaccination with mRNA-Covid-vaccines: two case reports. BMC infectious diseases, 21(1), 1-4. https://www.ncbi.nlm.nih.gov/pubmed/34930152 | ||||
494 | Thrombocytopenia with acute ischemic stroke and hemorrhage in a patient recently vaccinated with an adenoviral vector-based COVID-19 vaccine: | https://pubmed.ncbi.nlm.nih.gov/33877737/ | https://pubmed.ncbi.nlm.nih.gov/34781027/ | Masset, C., Lebot-Bouras, S., Branchereau, J., Renaudin, K., & Cantarovich, D. (2021). Pancreas allograft rejection occurring after ChAdOx1 nCoV-19 vaccine. Diabetes & Metabolism. | Masset, C., Lebot-Bouras, S., Branchereau, J., Renaudin, K. y Cantarovich, D. (2021). Rechazo de aloinjerto de páncreas que se produce después de la vacuna ChAdOx1 nCoV-19. Diabetes y metabolismo. https://pubmed.ncbi.nlm.nih.gov/34595694/ | Lazaros, G., Klein, A. L., Hatziantoniou, S., Tsioufis, C., Tsakris, A., & Anastassopoulou, C. (2021). La novela Plataforma de Vaccias y miocarditis COVID-19 ARNm COVID-19: pistas en el posible mecanismo subyacente. Vacuna, 39 (35), 4925. https://pubmed.ncbi.nlm.nih.gov/34219532/ | Masset, C., Lebot-Bouras, S., Branchereau, J., Renaudin, K., & Cantarovich, D. (2021). Pancreas allograft rejection occurring after ChAdOx1 nCoV-19 vaccine. Diabetes & Metabolism. https://pubmed.ncbi.nlm.nih.gov/34781027/ | Lee, E. J., Cines, D. B., Gernsheimer, T., Kessler, C., Michel, M., Tarantino, M. D., ... & Bussel, J. B. (2021). Thrombocytopenia following pfizer and Moderna SARS‐CoV‐2 vaccination. American journal of hematology. https://pubmed.ncbi.nlm.nih.gov/33606296/ | Calcaterra, G., Mehta, J. L., De Gregorio, C., Butera, G., Neroni, P., Fanos, V., & Bassareo, P. P. (2021). COVID 19 vaccine for adolescents. Concern about myocarditis and pericarditis. Pediatric Reports, 13(3), 530-533. | https://www.mdpi.com/2036-7503/13/3/61. | Calcaterra, G., Mehta, J. L., De Gregorio, C., Butera, G., Neroni, P., Fanos, V., & Bassareo, P. P. (2021). COVID 19 vaccine for adolescents. Concern about myocarditis and pericarditis. Pediatric Reports, 13(3), 530-533. https://www.mdpi.com/2036-7503/13/3/61. | Mohta, A., Arora, A., Srinivasa, R., & Mehta, R. D. (2021). Recurrent herpes zoster after COVID‐19 vaccination in patients with chronic urticaria being treated with cyclosporine—A report of 3 cases. Journal of Cosmetic Dermatology, 20(11), 3384. https://pubmed.ncbi.nlm.nih.gov/34510694/ | ||||
495 | Intracerebral hemorrhage and thrombocytopenia after AstraZeneca COVID-19 vaccine: clinical and diagnostic challenges of vaccine-induced thrombotic thrombocytopenia: | https://pubmed.ncbi.nlm.nih.gov/34646685/ | https://pubmed.ncbi.nlm.nih.gov/34595694/ | Kulkarni, P. A., & Prasad, V. (2021). Understanding risk of thrombosis with thrombocytopenia syndrome after Ad26. COV2. S vaccination. Frontiers of medicine, 15(6), 938-941. | Kulkarni, PA y Prasad, V. (2021). Comprensión del riesgo de trombosis con síndrome de trombocitopenia después del Ad26. COV2. Vacunación S. Fronteras de la medicina, 15(6), 938-941. https://pubmed.ncbi.nlm.nih.gov/34661934/ | Łaźniak-pfajfer, A., Surmacz, R., Rajewska-Tabor, J., Pyda, M., Lesiak, M., & Bobkowski, W. (2021). Miocarditis asociada con la vacunación COVID-19 en tres machos adolescentes. Archivos polacos de la medicina interna. https://pubmed.ncbi.nlm.nih.gov/34496880/ | Kulkarni, P. A., & Prasad, V. (2021). Understanding risk of thrombosis with thrombocytopenia syndrome after Ad26. COV2. S vaccination. Frontiers of medicine, 15(6), 938-941. https://pubmed.ncbi.nlm.nih.gov/34595694/ | Lee, E. J., Cines, D. B., Gernsheimer, T., Kessler, C., Michel, M., Tarantino, M. D., ... & Bussel, J. B. (2021). Thrombocytopenia following pfizer and Moderna SARS‐CoV‐2 vaccination. American journal of hematology. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8014568/. | Nagasaka, T., Koitabashi, N., Ishibashi, Y., Aihara, K., Takama, N., Ohyama, Y., ... & Kaneko, Y. (2021). Acute myocarditis associated with COVID-19 vaccination: A case report. Journal of Cardiology Cases. | https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8639400/ | Nagasaka, T., Koitabashi, N., Ishibashi, Y., Aihara, K., Takama, N., Ohyama, Y., ... & Kaneko, Y. (2021). Acute myocarditis associated with COVID-19 vaccination: A case report. Journal of Cardiology Cases. https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8639400/ | Monagle, P., Ng, A. P., Linden, M., Ignjatovic, V., Farley, A., Taoudi, S., ... & Torresi, J. (2021). Vaccine‐induced immune thrombosis and thrombocytopenia syndrome following adenovirus‐vectored severe acute respiratory syndrome coronavirus 2 vaccination: a novel hypothesis regarding mechanisms and implications for future vaccine development. Immunology and Cell Biology, 99(10), 1006-1010. https://pubmed.ncbi.nlm.nih.gov/34664303/. | ||||
496 | Minimal change disease with severe acute kidney injury after Oxford-AstraZeneca COVID-19 vaccine: case report: | https://pubmed.ncbi.nlm.nih.gov/34242687/. | https://pubmed.ncbi.nlm.nih.gov/34661934/ | Rerknimitr, P., Puaratanaarunkon, T., Wongtada, C., Wittayabusarakam, N., Krithin, S., Paitoonpong, L., ... & Klaewsongkram, J. (2022). Cutaneous adverse reactions from 35,229 doses of Sinovac and AstraZeneca COVID‐19 vaccination: a prospective cohort study in healthcare workers. Journal of the European Academy of Dermatology and Venereology, 36(3), e158-e161. | Rerknimitr, P., Puaratanaarunkon, T., Wongtada, C., Wittayabusarakam, N., Krithin, S., Paitoonpong, L., ... y Klaewsongkram, J. (2022). Reacciones adversas cutáneas de 35.229 dosis de la vacuna Sinovac y AstraZeneca COVID-19: un estudio de cohorte prospectivo en trabajadores de la salud. Revista de la Academia Europea de Dermatología y Venereología, 36(3), e158-e161. https://pubmed.ncbi.nlm.nih.gov/34788138 | Leclerc, S., Royal, V., Lamarche, C., & Laurin, L. P. (2021). Enfermedad del cambio mínimo con una leal riñón aguda severa después de la vacuna Oxford-AstraZeneca COVID-19: un informe de caso. Diario americano de enfermedades renales, 78 (4), 607-610. https://pubmed.ncbi.nlm.nih.gov/34609603/ | Rerknimitr, P., Puaratanaarunkon, T., Wongtada, C., Wittayabusarakam, N., Krithin, S., Paitoonpong, L., ... & Klaewsongkram, J. (2022). Cutaneous adverse reactions from 35,229 doses of Sinovac and AstraZeneca COVID‐19 vaccination: a prospective cohort study in healthcare workers. Journal of the European Academy of Dermatology and Venereology, 36(3), e158-e161. https://pubmed.ncbi.nlm.nih.gov/34661934/ | Lee, E. J., Cines, D. B., Gernsheimer, T., Kessler, C., Michel, M., Tarantino, M. D., ... & Bussel, J. B. (2021). Thrombocytopenia following pfizer and Moderna SARS‐CoV‐2 vaccination. American journal of hematology. https://www.ncbi.nlm.nih.gov/pubmed/33606296 | Murakami, Y., Shinohara, M., Oka, Y., Wada, R., Noike, R., Ohara, H., ... & Ikeda, T. (2022). Myocarditis Following a COVID-19 Messenger RNA Vaccination: A Japanese Case Series. Internal Medicine, 8731-21. | https://pubmed.ncbi.nlm.nih.gov/34840235/. | Murakami, Y., Shinohara, M., Oka, Y., Wada, R., Noike, R., Ohara, H., ... & Ikeda, T. (2022). Myocarditis Following a COVID-19 Messenger RNA Vaccination: A Japanese Case Series. Internal Medicine, 8731-21. https://pubmed.ncbi.nlm.nih.gov/34840235/. | Montgomery, J., Ryan, M., Engler, R., Hoffman, D., McClenathan, B., Collins, L., ... & Cooper, L. T. (2021). Myocarditis following immunization with mRNA COVID-19 vaccines in members of the US military. JAMA cardiology, 6(10), 1202-1206. https://jamanetwork.com/journals/jamacardiology/fullarticle/2781601 | ||||
497 | Case report: cerebral sinus vein thrombosis in two patients with AstraZeneca SARS-CoV-2 vaccine: | https://pubmed.ncbi.nlm.nih.gov/34609603/ | https://pubmed.ncbi.nlm.nih.gov/34788138 | Mustafa, Z., & Burster, T. (2021). Comments on Thrombosis After Vaccination: The Leader Sequence of the Spike Protein Might Be Responsible for Thrombosis and Antibody-Mediated Thrombocytopenia. Viral immunology, 34(10), 669-672. | Mustafa, Z. y Burster, T. (2021). Comentarios sobre la trombosis después de la vacunación: la secuencia líder de la proteína Spike podría ser responsable de la trombosis y la trombocitopenia mediada por anticuerpos. Inmunología viral, 34(10), 669-672. https://pubmed.ncbi.nlm.nih.gov/34753210/. | Lee, E. J., & Lee, A. I. (2021). Trombosis sinusal venosa cerebral después de la vacunación: la experiencia del Reino Unido. La lanceta, 398 (10306), 1107-1109. https://pubmed.ncbi.nlm.nih.gov/34373991/ | Mustafa, Z., & Burster, T. (2021). Comments on Thrombosis After Vaccination: The Leader Sequence of the Spike Protein Might Be Responsible for Thrombosis and Antibody-Mediated Thrombocytopenia. Viral immunology, 34(10), 669-672. https://pubmed.ncbi.nlm.nih.gov/34788138 | Lee, E., Chew, N. W., Ng, P., & Yeo, T. J. (2021). Reply to" Letter to the editor: Myocarditis should be considered in those with a troponin rise and unobstructed coronary arteries following PfizerBioNTech COVID-19 vaccination". QJM: Monthly Journal of the Association of Physicians. https://www.ncbi.nlm.nih.gov/pubmed/34463770 | Onderko, L., Starobin, B., Riviere, A. E., Hohl, P. K., Phillips, C. T., Morgan, R. B., ... & Afari, M. E. (2021). Myocarditis in the Setting of Recent COVID-19 Vaccination. Case Reports in Cardiology, 2021. | https://pubmed.ncbi.nlm.nih.gov/34712497/. | Onderko, L., Starobin, B., Riviere, A. E., Hohl, P. K., Phillips, C. T., Morgan, R. B., ... & Afari, M. E. (2021). Myocarditis in the Setting of Recent COVID-19 Vaccination. Case Reports in Cardiology, 2021. https://pubmed.ncbi.nlm.nih.gov/34712497/. | Morehouse, Z. P., Paulus, A., Jasti, S. A., & Bing, X. (2021). A Rare Variant of Guillain-Barre Syndrome Following Ad26. COV2. S Vaccination. Cureus, 13(9). https://pubmed.ncbi.nlm.nih.gov/34703690/. | ||||
498 | Case report: Pityriasis rosea-like rash after vaccination with COVID-19: | https://pubmed.ncbi.nlm.nih.gov/34557507/ | https://pubmed.ncbi.nlm.nih.gov/34753210/. | Cinotti, E., Perrot, J. L., Bruzziches, F., Tognetti, L., Batsikosta, A., Sorrentino, E., ... & Rubegni, P. (2021). Eosinophilic dermatosis after AstraZeneca COVID-19 vaccination. Journal of the European Academy of Dermatology and Venereology: JEADV. | Cinotti, E., Perrot, J. L., Bruzziches, F., Tognetti, L., Batsikosta, A., Sorrentino, E., ... & Rubegni, P. (2021). Dermatosis eosinofílica tras la vacuna AstraZeneca COVID-19. Revista de la Academia Europea de Dermatología y Venereología: JEADV. https://pubmed.ncbi.nlm.nih.gov/34653943/. | Lee, E. J., & Lee, A. I. (2021). Trombosis sinusal venosa cerebral después de la vacunación: la experiencia del Reino Unido. La lanceta, 398 (10306), 1107-1109. https://www.nejm.org/doi/full/10.1056/nejme2106315 | Cinotti, E., Perrot, J. L., Bruzziches, F., Tognetti, L., Batsikosta, A., Sorrentino, E., ... & Rubegni, P. (2021). Eosinophilic dermatosis after AstraZeneca COVID-19 vaccination. Journal of the European Academy of Dermatology and Venereology: JEADV. https://pubmed.ncbi.nlm.nih.gov/34753210/. | Lee, E., Lee, Y. K., Kim, T. E., Hwang, I., Jung, Y. H., Lee, H. R., ... & Lee, Y. K. (2021). Reports of anaphylaxis after coronavirus disease 2019 vaccination, South Korea, 26 February to 30 April 2021. Eurosurveillance, 26(33), 2100694. https://pubmed.ncbi.nlm.nih.gov/34414880/ | Mansour, J., Short, R. G., Bhalla, S., Woodard, P. K., Verma, A., Robinson, X., & Raptis, D. A. (2021). Acute myocarditis after a second dose of the mRNA COVID-19 vaccine: a report of two cases. Clinical Imaging, 78, 247-249. | https://www.clinicalimaging.org/article/S0899-7071(21)00265-5/fulltext. | Mansour, J., Short, R. G., Bhalla, S., Woodard, P. K., Verma, A., Robinson, X., & Raptis, D. A. (2021). Acute myocarditis after a second dose of the mRNA COVID-19 vaccine: a report of two cases. Clinical Imaging, 78, 247-249. https://www.clinicalimaging.org/article/S0899-7071(21)00265-5/fulltext. | Mortazavi, S. (2021). COVID-19 vaccination–associated axillary adenopathy: imaging findings and follow-up recommendations in 23 women. American Journal of Roentgenology, 217(4), 857-858. https://pubmed.ncbi.nlm.nih.gov/33624520/ | ||||
499 | Extensive longitudinal transverse myelitis after ChAdOx1 nCOV-19 vaccine: case report: | https://pubmed.ncbi.nlm.nih.gov/34641797/. | https://pubmed.ncbi.nlm.nih.gov/34653943/. | Angelo, G., Francesca, G., Elena, M., Sara, S., Michelle, Z., & Mauro, T. (2021). Severe immune thrombocytopenia after COVID-19 vaccination: Report of four cases and review of the literature. Blood cells, molecules & diseases. | Angelo, G., Francesca, G., Elena, M., Sara, S., Michelle, Z. y Mauro, T. (2021). Trombocitopenia inmune grave después de la vacunación contra COVID-19: informe de cuatro casos y revisión de la literatura. Células sanguíneas, moléculas y enfermedades. https://pubmed.ncbi.nlm.nih.gov/34591991/ | Lee, E. J., Cines, D. B., GERNSHEIMER, T., Kessler, C., Michel, M., Tarantino, M. D., ... y Bussel, J. B. (2021). Trombocitopenia después de Pfizer y Moderna SARS-COV-2 vacunación. American Journal of Hematology. https://casereports.bmj.com/content/14/7/e242678. | Angelo, G., Francesca, G., Elena, M., Sara, S., Michelle, Z., & Mauro, T. (2021). Severe immune thrombocytopenia after COVID-19 vaccination: Report of four cases and review of the literature. Blood cells, molecules & diseases. https://pubmed.ncbi.nlm.nih.gov/34653943/. | Leerunyakul, K., Pakornphadungsit, K., & Suchonwanit, P. (2021). Case Report: Pityriasis Rosea-Like Eruption Following COVID-19 Vaccination. Frontiers in Medicine, 8. https://pubmed.ncbi.nlm.nih.gov/34557507/ | Ceschia, N., Scheggi, V., Gori, A. M., Rogolino, A. A., Cesari, F., Giusti, B., ... & Marcucci, R. (2021). Diffuse prothrombotic syndrome after ChAdOx1 nCoV-19 vaccine administration: a case report. Journal of Medical Case Reports, 15(1), 1-4. | https://pubmed.ncbi.nlm.nih.gov/34615534/ | Ceschia, N., Scheggi, V., Gori, A. M., Rogolino, A. A., Cesari, F., Giusti, B., ... & Marcucci, R. (2021). Diffuse prothrombotic syndrome after ChAdOx1 nCoV-19 vaccine administration: a case report. Journal of Medical Case Reports, 15(1), 1-4. https://pubmed.ncbi.nlm.nih.gov/34615534/ | Mouch, S. A., Roguin, A., Hellou, E., Ishai, A., Shoshan, U., Mahamid, L., ... & Yanay, N. B. (2021). Myocarditis following COVID-19 mRNA vaccination. Vaccine, 39(29), 3790-3793. https://www.ncbi.nlm.nih.gov/pubmed/34092429 | ||||
500 | Acute eosinophilic pneumonia associated with anti-COVID-19 vaccine AZD1222: | https://pubmed.ncbi.nlm.nih.gov/34812326/. | https://pubmed.ncbi.nlm.nih.gov/34591991/ | Dijk, W. E. V., & Schutgens, R. E. (2022). Relapse of immune thrombocytopenia after COVID‐19 vaccination. European Journal of Haematology, 108(1), 84-85. | Dijk, WEV y Schutgens, RE (2022). Recaída de la trombocitopenia inmunitaria después de la vacunación contra la COVID-19. Revista europea de hematología, 108(1), 84-85. https://pubmed.ncbi.nlm.nih.gov/34650382/ | Lee, E. J., Cines, D. B., GERNSHEIMER, T., Kessler, C., Michel, M., Tarantino, M. D., ... y Bussel, J. B. (2021). Trombocitopenia después de Pfizer y Moderna SARS-COV-2 vacunación. American Journal of Hematology. https://pubmed.ncbi.nlm.nih.gov/33854395/ | Dijk, W. E. V., & Schutgens, R. E. (2022). Relapse of immune thrombocytopenia after COVID‐19 vaccination. European Journal of Haematology, 108(1), 84-85. https://pubmed.ncbi.nlm.nih.gov/34591991/ | Lehman, C. D., D’Alessandro, H. A., Mendoza, D. P., Succi, M. D., Kambadakone, A., & Lamb, L. R. (2021). Unilateral lymphadenopathy after COVID-19 vaccination: a practical management plan for radiologists across specialties. Journal of the American College of Radiology, 18(6), 843-852. https://pubmed.ncbi.nlm.nih.gov/33713605/ | Crossette-Thambiah, C., Pericleous, C., Asmar, N., Bomsztyk, J., Ranger, A., Shlebak, A., ... & Arachchillage, D. J. (2021). Clinical and biological features of cerebral venous sinus thrombosis following ChAdOx1 nCov-19 vaccination. Journal of Neurology, Neurosurgery & Psychiatry. | https://jnnp.bmj.com/content/early/2021/09/29/jnnp-2021-327340. | Crossette-Thambiah, C., Pericleous, C., Asmar, N., Bomsztyk, J., Ranger, A., Shlebak, A., ... & Arachchillage, D. J. (2021). Clinical and biological features of cerebral venous sinus thrombosis following ChAdOx1 nCov-19 vaccination. Journal of Neurology, Neurosurgery & Psychiatry. https://jnnp.bmj.com/content/early/2021/09/29/jnnp-2021-327340. | Mücke, V. T., Knop, V., Mücke, M. M., Ochsendorf, F., & Zeuzem, S. (2021). First description of immune complex vasculitis after COVID-19 vaccination with BNT162b2: a case report. BMC Infectious Diseases, 21(1), 1-6. https://pubmed.ncbi.nlm.nih.gov/34530771/. | ||||
501 | Thrombocytopenia, including immune thrombocytopenia after receiving COVID-19 mRNA vaccines reported to the Vaccine Adverse Event Reporting System (VAERS): | https://pubmed.ncbi.nlm.nih.gov/34006408/ | https://pubmed.ncbi.nlm.nih.gov/34650382/ | Violi, F., Cammisotto, V., Pastori, D., & Pignatelli, P. (2021). Thrombosis in pre-and post-vaccination phase of COVID-19. European Heart Journal Supplements, 23(Supplement_E), E184-E188. | Violi, F., Cammisotto, V., Pastori, D. y Pignatelli, P. (2021). Trombosis en fase pre y posvacunación de COVID-19. Suplementos del European Heart Journal, 23 (Supplement_E), E184-E188. https://pubmed.ncbi.nlm.nih.gov/34769454/ | Lee, E. J., Cines, D. B., GERNSHEIMER, T., Kessler, C., Michel, M., Tarantino, M. D., ... y Bussel, J. B. (2021). Trombocitopenia después de Pfizer y Moderna SARS-COV-2 vacunación. American Journal of Hematology. https://www.ncbi.nlm.nih.gov/pubmed/34535317 | Violi, F., Cammisotto, V., Pastori, D., & Pignatelli, P. (2021). Thrombosis in pre-and post-vaccination phase of COVID-19. European Heart Journal Supplements, 23(Supplement_E), E184-E188. https://pubmed.ncbi.nlm.nih.gov/34650382/ | Lensen, R., Netea, M. G., & Rosendaal, F. R. (2021). Hepatitis C virus reactivation following COVID-19 vaccination–A case report. International Medical Case Reports Journal, 14, 573. https://pubmed.ncbi.nlm.nih.gov/34512037/ | Zur-Wyrozumska, K. (2021). CAd26. COV2-S vaccination can reveal inherited thrombophilia: massive cerebral venous sinus thrombosis in a young male with normal platelet count. Pol. Arch. Med. Wew.(Online). | https://pubmed.ncbi.nlm.nih.gov/34632750/ | Zur-Wyrozumska, K. (2021). CAd26. COV2-S vaccination can reveal inherited thrombophilia: massive cerebral venous sinus thrombosis in a young male with normal platelet count. Pol. Arch. Med. Wew.(Online). https://pubmed.ncbi.nlm.nih.gov/34632750/ | Muir, K. W., & Perry, R. J. (2021). The International Cerebral Venous Thrombosis Consortium report on cerebral venous thrombosis following vaccination against SARS-CoV-2. European Journal of Neurology, 28(11), 3543-3544. https://pubmed.ncbi.nlm.nih.gov/34462996/ | ||||
502 | A case of ANCA-associated vasculitis after AZD1222 (Oxford-AstraZeneca) SARS-CoV-2 vaccination: victim or causality?: | https://pubmed.ncbi.nlm.nih.gov/34416184/ | https://pubmed.ncbi.nlm.nih.gov/34769454/ | Stassi, C., Mondello, C., Baldino, G., Cardia, L., Asmundo, A., & Ventura Spagnolo, E. (2021). An Insight into the Role of Postmortem Immunohistochemistry in the Comprehension of the Inflammatory Pathophysiology of COVID-19 Disease and Vaccine-Related Thrombotic Adverse Events: A Narrative Review. International journal of molecular sciences, 22(21), 12024. | Stassi, C., Mondello, C., Baldino, G., Cardia, L., Asmundo, A. y Ventura Spagnolo, E. (2021). Una visión del papel de la inmunohistoquímica postmortem en la comprensión de la fisiopatología inflamatoria de la enfermedad COVID-19 y los eventos trombóticos adversos relacionados con la vacuna: una revisión narrativa. Revista internacional de ciencias moleculares, 22(21), 12024. https://pubmed.ncbi.nlm.nih.gov/34786893/ | Lee, E., Lee, Y. K., Kim, T. E., Hwang, I., Jung, Y. H., Lee, H. R., ... & Lee, Y. K. (2021). Informes de anafilaxis después de la vacunación contra la enfermedad de Coronavirus 2019, Corea del Sur, 26 de febrero al 30 de abril de 2021. Eurasurveillance, 26 (33), 2100694. https://pubmed.ncbi.nlm.nih.gov/33576785/ | Stassi, C., Mondello, C., Baldino, G., Cardia, L., Asmundo, A., & Ventura Spagnolo, E. (2021). An Insight into the Role of Postmortem Immunohistochemistry in the Comprehension of the Inflammatory Pathophysiology of COVID-19 Disease and Vaccine-Related Thrombotic Adverse Events: A Narrative Review. International journal of molecular sciences, 22(21), 12024. https://pubmed.ncbi.nlm.nih.gov/34769454/ | Leung, V. S., & Lin, Y. (2021). Rituximab‐induced acute lympholysis and pancytopenia after COVID‐19 vaccination. Clinical Case Reports, 9(8), e04517. https://pubmed.ncbi.nlm.nih.gov/34429981/ | Ambrosetti, M., & Pontali, E. (2021). COVID-19 vaccine-induced thrombosis. The International Journal of Tuberculosis and Lung Disease, 25(9), 691-692. | https://pubmed.ncbi.nlm.nih.gov/34802488/. | Ambrosetti, M., & Pontali, E. (2021). COVID-19 vaccine-induced thrombosis. The International Journal of Tuberculosis and Lung Disease, 25(9), 691-692. https://pubmed.ncbi.nlm.nih.gov/34802488/. | Mungmunpuntipamtip, R., & Wiwanitkit, V. (2021). Deaths associated with newly launched SARS-CoV-2 vaccination. Legal Medicine (Tokyo, Japan), 53, 101956. https://pubmed.ncbi.nlm.nih.gov/34425384/ | ||||
503 | Vaccine-induced immune thrombosis and thrombocytopenia syndrome after adenovirus-vectored severe acute respiratory syndrome coronavirus 2 vaccination: a new hypothesis on mechanisms and implications for future vaccine development: | https://pubmed.ncbi.nlm.nih.gov/34664303/. | https://pubmed.ncbi.nlm.nih.gov/34786893/ | John, N. A., John, J., Kamble, P., Singhal, A., Daulatabad, V., & Vamshidhar, I. S. (2021). COVID 19 vaccine in patients of hypercoagulable disorders: a clinical perspective. Hormone Molecular Biology and Clinical Investigation. | John, N. A., John, J., Kamble, P., Singhal, A., Daulatabad, V. y Vamshidhar, I. S. (2021). Vacuna COVID 19 en pacientes con trastornos de hipercoagulabilidad: una perspectiva clínica. Biología molecular hormonal e investigación clínica. https://pubmed.ncbi.nlm.nih.gov/34833382/ | Lee, E., Masticar, N. W., NG, P., & YEO, T. J. (2021). Responder a "Carta al editor: La miocarditis debe considerarse en aquellos con un aumento de troponina y las arterias coronarias sin obstrucciones después de la vacunación de PfizerbionTech COVID-19". QJM: Diario Mensual de la Asociación de Médicos. https://www.ncbi.nlm.nih.gov/pubmed/33606296 | John, N. A., John, J., Kamble, P., Singhal, A., Daulatabad, V., & Vamshidhar, I. S. (2021). COVID 19 vaccine in patients of hypercoagulable disorders: a clinical perspective. Hormone Molecular Biology and Clinical Investigation. https://pubmed.ncbi.nlm.nih.gov/34786893/ | Levin, D., Shimon, G., Fadlon-Derai, M., Gershovitz, L., Shovali, A., Sebbag, A., ... & Gordon, B. (2021). Myocarditis following COVID-19 vaccination–a case series. Vaccine, 39(42), 6195-6200. https://www.ncbi.nlm.nih.gov/pubmed/34535317 | Ostrowski, S. R., Søgaard, O. S., Tolstrup, M., Stærke, N. B., Lundgren, J., Østergaard, L., & Hvas, A. M. (2021). Inflammation and Platelet Activation After COVID-19 Vaccines-Possible Mechanisms Behind Vaccine-Induced Immune Thrombocytopenia and Thrombosis. Frontiers in immunology, 12, 779453-779453. | https://pubmed.ncbi.nlm.nih.gov/34887867/. | Ostrowski, S. R., Søgaard, O. S., Tolstrup, M., Stærke, N. B., Lundgren, J., Østergaard, L., & Hvas, A. M. (2021). Inflammation and Platelet Activation After COVID-19 Vaccines-Possible Mechanisms Behind Vaccine-Induced Immune Thrombocytopenia and Thrombosis. Frontiers in immunology, 12, 779453-779453. https://pubmed.ncbi.nlm.nih.gov/34887867/. | Mungmunpuntipantip, R., & Wiwanitkit, V. (2021). Thromboses of major arteries and ChAdOx1 nCov-19 vaccination. Neurological Research and Practice, 3(1), 1-1. https://pubmed.ncbi.nlm.nih.gov/34839830/ | ||||
504 | Thrombosis in peripheral artery disease and thrombotic thrombocytopenia following adenoviral COVID-19 vaccination: | https://pubmed.ncbi.nlm.nih.gov/34649281/. | https://pubmed.ncbi.nlm.nih.gov/34833382/ | Chang, J. C., & Hawley, H. B. (2021). Vaccine-Associated Thrombocytopenia and Thrombosis: Venous Endotheliopathy Leading to Venous Combined Micro-Macrothrombosis. Medicina, 57(11), 1163. | Chang, JC y Hawley, HB (2021). Trombocitopenia y trombosis asociadas a vacunas: endoteliopatía venosa que conduce a micromacrotrombosis venosa combinada. Medicina, 57(11), 1163. https://pubmed.ncbi.nlm.nih.gov/34670287/ | Leerunyakul, K., Pakornphadungsit, K., y Suchonwanit, P. (2021). Informe del caso: la erupción similar a la rosea de PityRiasis después de la vacunación de COVID-19. Fronteras en medicina, 8. https://pubmed.ncbi.nlm.nih.gov/34641797/. | Chang, J. C., & Hawley, H. B. (2021). Vaccine-Associated Thrombocytopenia and Thrombosis: Venous Endotheliopathy Leading to Venous Combined Micro-Macrothrombosis. Medicina, 57(11), 1163. https://pubmed.ncbi.nlm.nih.gov/34833382/ | Levin, D., Shimon, G., Fadlon-Derai, M., Gershovitz, L., Shovali, A., Sebbag, A., ... & Gordon, B. (2021). Myocarditis following COVID-19 vaccination–a case series. Vaccine, 39(42), 6195-6200. https://www.sciencedirect.com/science/article/pii/S0264410X21011725?via%3Dihub. | Hinton, J., e Gala, A. B., & Corbett, S. (2021, December). mRNA COVID-19 Vaccine–Related Anaphylactoid Reaction and Coronary Thrombosis. In Mayo Clinic Proceedings (Vol. 96, No. 12, pp. 3182-3183). Elsevier. | https://pubmed.ncbi.nlm.nih.gov/34863404/. | Hinton, J., e Gala, A. B., & Corbett, S. (2021, December). mRNA COVID-19 Vaccine–Related Anaphylactoid Reaction and Coronary Thrombosis. In Mayo Clinic Proceedings (Vol. 96, No. 12, pp. 3182-3183). Elsevier. https://pubmed.ncbi.nlm.nih.gov/34863404/. | Mungmunpuntipantip, R., & Wiwanitkit, V. (2021). Thrombosis after adenovirus-vectored COVID-19 vaccination: a concern on underlying illness. Clinical and Applied Thrombosis/Hemostasis, 27, 10760296211060446. https://pubmed.ncbi.nlm.nih.gov/34755555/ | ||||
505 | Newly diagnosed immune thrombocytopenia in a pregnant patient after coronavirus disease 2019 vaccination: | https://pubmed.ncbi.nlm.nih.gov/34420249/ | https://pubmed.ncbi.nlm.nih.gov/34670287/ | Rodríguez-Pardo, J., Gilo-Arrojo, F., Ruiz-Ares, G., Sánchez-Manso, J. C., Valiente-Gordillo, E., de Celis, E., ... & Díez-Tejedor, E. (2021). Thrombosis and Thrombocytopenia Syndrome Causing Isolated Symptomatic Carotid Occlusion after Covid-19 Vaccine. Thrombosis and Haemostasis. | Rodríguez-Pardo, J., Gilo-Arrojo, F., Ruiz-Ares, G., Sánchez-Manso, J. C., Valiente-Gordillo, E., de Celis, E., ... & Díez-Tejedor, E. (2021). Síndrome de trombosis y trombocitopenia que causa oclusión carotídea sintomática aislada después de la vacuna Covid-19. Trombosis y Hemostasia. https://pubmed.ncbi.nlm.nih.gov/34790811/ | Lehman, C. D., D'Alessandro, H. A., Mendoza, D. P., Succi, M. D., Kambadakone, A., & Lamb, L. R. (2021). Linfadenopatía unilateral después de la vacunación de COVID-19: un plan de gestión práctico para los radiólogos a través de especialidades. Revista del Colegio Americano de Radiología, 18 (6), 843-852. https://pubmed.ncbi.nlm.nih.gov/34298342/ | Rodríguez-Pardo, J., Gilo-Arrojo, F., Ruiz-Ares, G., Sánchez-Manso, J. C., Valiente-Gordillo, E., de Celis, E., ... & Díez-Tejedor, E. (2021). Thrombosis and Thrombocytopenia Syndrome Causing Isolated Symptomatic Carotid Occlusion after Covid-19 Vaccine. Thrombosis and Haemostasis. https://pubmed.ncbi.nlm.nih.gov/34670287/ | Li, C., Chen, Y., Zhao, Y., Christopher Lung, D., Ye, Z., Song, W., ... & Yuen, K. Y. (2021). Corrigendum to: Intravenous Injection of Coronavirus Disease 2019 (COVID-19) mRNA Vaccine Can Induce Acute Myopericarditis in Mouse Model. Clinical Infectious Diseases, 73(12), 2372-2373. https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciab707/6353927?s=09&login=false | Anderson, A., Seddon, M., Shahzad, K., & Lunevicius, R. (2021). Post-COVID-19 vaccination occurrence of splenic infarction due to arterial thrombosis. BMJ Case Reports CP, 14(12), e243846. | https://pubmed.ncbi.nlm.nih.gov/34876440/ | Anderson, A., Seddon, M., Shahzad, K., & Lunevicius, R. (2021). Post-COVID-19 vaccination occurrence of splenic infarction due to arterial thrombosis. BMJ Case Reports CP, 14(12), e243846. https://pubmed.ncbi.nlm.nih.gov/34876440/ | Murakami, Y., Shinohara, M., Oka, Y., Wada, R., Noike, R., Ohara, H., ... & Ikeda, T. (2022). Myocarditis Following a COVID-19 Messenger RNA Vaccination: A Japanese Case Series. Internal Medicine, 8731-21. https://pubmed.ncbi.nlm.nih.gov/34840235/. | ||||
506 | Cerebral venous sinus thrombosis and thrombotic events after vector-based COVID-19 vaccines: systematic review and meta-analysis: | https://pubmed.ncbi.nlm.nih.gov/34610990/. | https://pubmed.ncbi.nlm.nih.gov/34790811/ | Bhan, C., Bheesham, N., Shakuntulla, F., Sharma, M., Sun, C., & Weinstein, M. (2021). An unusual presentation of acute deep vein thrombosis after the Moderna COVID-19 vaccine—a case report. Annals of Translational Medicine, 9(20). | Bhan, C., Bheesham, N., Shakuntulla, F., Sharma, M., Sun, C. y Weinstein, M. (2021). Una presentación inusual de trombosis venosa profunda aguda después de la vacuna Moderna COVID-19: informe de un caso. Anales de medicina traslacional, 9 (20). https://pubmed.ncbi.nlm.nih.gov/34023956/. | LENSEN, R., NETEA, M. G., & ROSENDAAL, F. R. (2021). Reactivación del virus de la hepatitis C después de la vacunación COVID-19: un informe de caso. Informes de casos médicos internacionales Diario, 14, 573. https://pubmed.ncbi.nlm.nih.gov/34483273/. | Bhan, C., Bheesham, N., Shakuntulla, F., Sharma, M., Sun, C., & Weinstein, M. (2021). An unusual presentation of acute deep vein thrombosis after the Moderna COVID-19 vaccine—a case report. Annals of Translational Medicine, 9(20). https://pubmed.ncbi.nlm.nih.gov/34790811/ | Li, J., Hui, A., Zhang, X., Yang, Y., Tang, R., Ye, H., ... & Zhu, F. (2021). Safety and immunogenicity of the SARS-CoV-2 BNT162b1 mRNA vaccine in younger and older Chinese adults: a randomized, placebo-controlled, double-blind phase 1 study. Nature medicine, 27(6), 1062-1070. https://www.ncbi.nlm.nih.gov/pubmed/33888900 | Haakonsen, H. B., & Nystedt, A. (2021). Deep vein thrombosis more than two weeks after vaccination against COVID-19. Tidsskrift for Den norske legeforening. | https://pubmed.ncbi.nlm.nih.gov/33928773/ | Haakonsen, H. B., & Nystedt, A. (2021). Deep vein thrombosis more than two weeks after vaccination against COVID-19. Tidsskrift for Den norske legeforening. https://pubmed.ncbi.nlm.nih.gov/33928773/ | Mustafa, Z., & Burster, T. (2021). Comments on Thrombosis After Vaccination: The Leader Sequence of the Spike Protein Might Be Responsible for Thrombosis and Antibody-Mediated Thrombocytopenia. Viral immunology, 34(10), 669-672. https://pubmed.ncbi.nlm.nih.gov/34788138 | ||||
507 | Sweet’s syndrome after Oxford-AstraZeneca COVID-19 vaccine (AZD1222) in an elderly woman: | https://pubmed.ncbi.nlm.nih.gov/34590397/ | https://pubmed.ncbi.nlm.nih.gov/34023956/. | Graf, T., Thiele, T., Klingebiel, R., Greinacher, A., Schäbitz, W. R., & Greeve, I. (2021). Immediate high-dose intravenous immunoglobulins followed by direct thrombin-inhibitor treatment is crucial for survival in Sars-Covid-19-adenoviral vector vaccine-induced immune thrombotic thrombocytopenia VITT with cerebral sinus venous and portal vein thrombosis. Journal of Neurology, 268(12), 4483-4485. | Graf, T., Thiele, T., Klingebiel, R., Greinacher, A., Schäbitz, W. R. y Greeve, I. (2021). La administración inmediata de inmunoglobulinas intravenosas en dosis altas seguidas de un tratamiento directo con inhibidores de trombina es crucial para la supervivencia en la trombocitopenia trombótica inmunitaria VITT inducida por la vacuna del vector adenoviral Sars-Covid-19 con trombosis de la vena porta y del seno cerebral. Revista de Neurología, 268(12), 4483-4485. https://pubmed.ncbi.nlm.nih.gov/34629931/ | Leung, V. S., & Lin, Y. (2021). Linfólisis aguda inducida por rituximab y pancitopenia después de la vacunación de COVID-19. Informes de casos clínicos, 9 (8), E04517. https://pubmed.ncbi.nlm.nih.gov/34427024/ | Graf, T., Thiele, T., Klingebiel, R., Greinacher, A., Schäbitz, W. R., & Greeve, I. (2021). Immediate high-dose intravenous immunoglobulins followed by direct thrombin-inhibitor treatment is crucial for survival in Sars-Covid-19-adenoviral vector vaccine-induced immune thrombotic thrombocytopenia VITT with cerebral sinus venous and portal vein thrombosis. Journal of Neurology, 268(12), 4483-4485. https://pubmed.ncbi.nlm.nih.gov/34023956/. | Li, L., Robinson, L. B., Patel, R., Landman, A. B., Fu, X., Shenoy, E. S., ... & Blumenthal, K. G. (2021). Association of Self-reported High-Risk Allergy History With Allergy Symptoms After COVID-19 Vaccination. JAMA network open, 4(10), e2131034-e2131034. https://pubmed.ncbi.nlm.nih.gov/34698847/ | Braun, T., Viard, M., Juenemann, M., Struffert, T., Schwarm, F., Huttner, H. B., & Roessler, F. C. (2021). Case Report: Take a Second Look: Covid-19 Vaccination-Related Cerebral Venous Thrombosis and Thrombotic Thrombocytopenia Syndrome. Frontiers in neurology, 12. | https://pubmed.ncbi.nlm.nih.gov/34880826/ | Braun, T., Viard, M., Juenemann, M., Struffert, T., Schwarm, F., Huttner, H. B., & Roessler, F. C. (2021). Case Report: Take a Second Look: Covid-19 Vaccination-Related Cerebral Venous Thrombosis and Thrombotic Thrombocytopenia Syndrome. Frontiers in neurology, 12. https://pubmed.ncbi.nlm.nih.gov/34880826/ | Muthukumar, A., Narasimhan, M., Li, Q. Z., Mahimainathan, L., Hitto, I., Fuda, F., ... & De Lemos, J. A. (2021). In-depth evaluation of a case of presumed myocarditis after the second dose of COVID-19 mRNA vaccine. Circulation, 144(6), 487-498. https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.121.056038 | ||||
508 | Sudden sensorineural hearing loss after COVID-19 vaccination: | https://pubmed.ncbi.nlm.nih.gov/34670143/. | https://pubmed.ncbi.nlm.nih.gov/34629931/ | Waggiallah, H. A. (2021). Thrombosis formation after COVID-19 vaccination immunological aspects. Saudi journal of biological sciences. | Waggiallah, HA (2021). Formación de trombosis tras aspectos inmunológicos de la vacunación COVID-19. Revista saudí de ciencias biológicas. https://pubmed.ncbi.nlm.nih.gov/34842783/ | Levin, D., Shimon, G., Fadlon-Derai, M., Gershovitz, L., Shovali, A., Sebbag, A., ... & Gordon, B. (2021). Miocarditis después de la vacunación COVID-19: una serie de casos. Vacuna, 39 (42), 6195-6200. https://publications.aap.org/pediatrics/article/148/5/e2021053427/181357 | Waggiallah, H. A. (2021). Thrombosis formation after COVID-19 vaccination immunological aspects. Saudi journal of biological sciences. https://pubmed.ncbi.nlm.nih.gov/34629931/ | Li, M., Yuan, J., Lv, G., Brown, J., Jiang, X., & Lu, Z. K. (2021). Myocarditis and Pericarditis following COVID-19 Vaccination: Inequalities in Age and Vaccine Types. Journal of personalized medicine, 11(11), 1106. https://www.mdpi.com/2075-4426/11/11/1106 | Greinacher, A., Selleng, K., Palankar, R., Wesche, J., Handtke, S., Wolff, M., ... & Renné, T. (2021). Insights in ChAdOx1 nCoV-19 vaccine-induced immune thrombotic thrombocytopenia. Blood, The Journal of the American Society of Hematology, 138(22), 2256-2268. | https://pubmed.ncbi.nlm.nih.gov/34587242/ | Greinacher, A., Selleng, K., Palankar, R., Wesche, J., Handtke, S., Wolff, M., ... & Renné, T. (2021). Insights in ChAdOx1 nCoV-19 vaccine-induced immune thrombotic thrombocytopenia. Blood, The Journal of the American Society of Hematology, 138(22), 2256-2268. https://pubmed.ncbi.nlm.nih.gov/34587242/ | Nagasaka, T., Koitabashi, N., Ishibashi, Y., Aihara, K., Takama, N., Ohyama, Y., ... & Kaneko, Y. (2021). Acute myocarditis associated with COVID-19 vaccination: A case report. Journal of Cardiology Cases. https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8639400/ | ||||
509 | Prevalence of serious adverse events among health care professionals after receiving the first dose of ChAdOx1 nCoV-19 coronavirus vaccine (Covishield) in Togo, March 2021: | https://pubmed.ncbi.nlm.nih.gov/34819146/. | https://pubmed.ncbi.nlm.nih.gov/34842783/ | Sriwastava, S., Shrestha, A. K., Khalid, S. H., Colantonio, M. A., Nwafor, D., & Srivastava, S. (2021). Spectrum of Neuroimaging Findings in Post-COVID-19 Vaccination: A Case Series and Review of Literature. Neurology International, 13(4), 622-639. | Sriwastava, S., Shrestha, A. K., Khalid, S. H., Colantonio, M. A., Nwafor, D. y Srivastava, S. (2021). Espectro de hallazgos de neuroimagen en la vacunación posterior a COVID-19: una serie de casos y revisión de la literatura. Neurología Internacional, 13(4), 622-639. https://pubmed.ncbi.nlm.nih.gov/34630307/ | Levin, D., Shimon, G., Fadlon-Derai, M., Gershovitz, L., Shovali, A., Sebbag, A., ... & Gordon, B. (2021). Miocarditis después de la vacunación COVID-19: una serie de casos. Vacuna, 39 (42), 6195-6200. https://www.ncbi.nlm.nih.gov/pubmed/33888900 | Sriwastava, S., Shrestha, A. K., Khalid, S. H., Colantonio, M. A., Nwafor, D., & Srivastava, S. (2021). Spectrum of Neuroimaging Findings in Post-COVID-19 Vaccination: A Case Series and Review of Literature. Neurology International, 13(4), 622-639. https://pubmed.ncbi.nlm.nih.gov/34842783/ | Li, M., Yuan, J., Lv, G., Brown, J., Jiang, X., & Lu, Z. K. (2021). Myocarditis and Pericarditis following COVID-19 Vaccination: Inequalities in Age and Vaccine Types. Journal of personalized medicine, 11(11), 1106. https://www.ncbi.nlm.nih.gov/pubmed/34834458 | Joob, B., & Wiwanitkit, V. (2021). Change of blood viscosity after COVID-19 vaccination: estimation for persons with underlying metabolic syndrome. International Journal of Physiology, Pathophysiology and Pharmacology, 13(5), 148. | https://pubmed.ncbi.nlm.nih.gov/34868465/ | Joob, B., & Wiwanitkit, V. (2021). Change of blood viscosity after COVID-19 vaccination: estimation for persons with underlying metabolic syndrome. International Journal of Physiology, Pathophysiology and Pharmacology, 13(5), 148. https://pubmed.ncbi.nlm.nih.gov/34868465/ | Nagrani, P., Jindal, R., & Goyal, D. (2021). Onset/flare of psoriasis following the ChAdOx1 nCoV‐19 Corona virus vaccine (Oxford‐AstraZeneca/Covishield): Report of two cases. Dermatologic Therapy. https://pubmed.ncbi.nlm.nih.gov/34350668/ | ||||
510 | Acute hemichorea-hemibalismus after COVID-19 (AZD1222) vaccination: | https://pubmed.ncbi.nlm.nih.gov/34581453/ | https://pubmed.ncbi.nlm.nih.gov/34630307/ | Lin, W., Ko, C. A., Sung, Y. F., Chen, Y. C., Lee, J. T., Lin, Y. Q., & Lin, Y. K. (2021). Cerebral Venous Sinus Thrombosis, Pulmonary Embolism, and Thrombocytopenia After COVID-19 Vaccination in a Taiwanese Man: A Case Report and Literature Review. Frontiers in Neurology, 1670. | Lin, W., Ko, C. A., Sung, Y. F., Chen, Y. C., Lee, J. T., Lin, Y. Q. y Lin, Y. K. (2021). Trombosis del seno venoso cerebral, embolia pulmonar y trombocitopenia después de la vacunación contra la COVID-19 en un hombre taiwanés: informe de un caso y revisión de la literatura. Fronteras en neurología, 1670. https://pubmed.ncbi.nlm.nih.gov/34508917/. | Li, C., Chen, Y., Zhao, Y., Christopher Lung, D., Ye, Z., Canción, W., ... & Yuen, K. Y. (2021). Corrigendum a: Inyección intravenosa de la enfermedad de Coronavirus 2019 (COVID-19) La vacuna contra el ARNm puede inducir la miopericaditis aguda en el modelo de ratón. Enfermedades infecciosas clínicas, 73 (12), 2372-2373. https://pubmed.ncbi.nlm.nih.gov/34601006/ | Lin, W., Ko, C. A., Sung, Y. F., Chen, Y. C., Lee, J. T., Lin, Y. Q., & Lin, Y. K. (2021). Cerebral Venous Sinus Thrombosis, Pulmonary Embolism, and Thrombocytopenia After COVID-19 Vaccination in a Taiwanese Man: A Case Report and Literature Review. Frontiers in Neurology, 1670. https://pubmed.ncbi.nlm.nih.gov/34630307/ | Liang, I., Swaminathan, S., & Lee, A. (2021). Emergence of de novo cutaneous vasculitis post coronavirus disease (COVID-19) vaccination. Clinical rheumatology, 1-2. https://pubmed.ncbi.nlm.nih.gov/34599716/. | Ramdeny, S., Lang, A., Al‐Izzi, S., Hung, A., Anwar, I., & Kumar, P. (2021). Management of a patient with a rare congenital limb malformation syndrome after SARS‐CoV‐2 vaccine‐induced thrombosis and thrombocytopenia (VITT). British Journal of Haematology. | https://pubmed.ncbi.nlm.nih.gov/34097311/ | Ramdeny, S., Lang, A., Al‐Izzi, S., Hung, A., Anwar, I., & Kumar, P. (2021). Management of a patient with a rare congenital limb malformation syndrome after SARS‐CoV‐2 vaccine‐induced thrombosis and thrombocytopenia (VITT). British Journal of Haematology. https://pubmed.ncbi.nlm.nih.gov/34097311/ | Naitlho, A., Lahlou, W., Bourial, A., Rais, H., Ismaili, N., Abousahfa, I., & Belyamani, L. (2021). A Rare Case of Henoch-Schönlein Purpura Following a COVID-19 Vaccine—Case Report. SN comprehensive clinical medicine, 3(12), 2618-2621. https://pubmed.ncbi.nlm.nih.gov/34518812/ | ||||
511 | Recurrence of alopecia areata after covid-19 vaccination: a report of three cases in Italy: | https://pubmed.ncbi.nlm.nih.gov/34741583/ | https://pubmed.ncbi.nlm.nih.gov/34508917/. | Elrashdy, F., Tambuwala, M. M., Hassan, S. S., Adadi, P., Seyran, M., Abd El-Aziz, T. M., ... & Uversky, V. N. (2021). Autoimmunity roots of the thrombotic events after COVID-19 vaccination. Autoimmunity reviews, 20(11), 102941. | Elrashdy, F., Tambuwala, M. M., Hassan, S. S., Adadi, P., Seyran, M., Abd El-Aziz, T. M., ... y Uversky, V. N. (2021). Raíces de autoinmunidad de los eventos trombóticos después de la vacunación COVID-19. Revisiones de autoinmunidad, 20(11), 102941. https://www.jcehepatology.com/article/S0973-6883(21)00545-4/fulltext. | Li, J., Hui, A., Zhang, X., Yang, Y., Tang, R., YE, H., ... & Zhu, F. (2021). Seguridad e inmunogenicidad de la vacuna contra el ARNA SARS-COV-2 BNT162B1 en adultos chinos más jóvenes y mayores: un estudio de fase 1 aleatorizado, controlado por placebo. Medicina natural, 27 (6), 1062-1070. https://www.ncbi.nlm.nih.gov/pubmed/34834458 | Elrashdy, F., Tambuwala, M. M., Hassan, S. S., Adadi, P., Seyran, M., Abd El-Aziz, T. M., ... & Uversky, V. N. (2021). Autoimmunity roots of the thrombotic events after COVID-19 vaccination. Autoimmunity reviews, 20(11), 102941. https://pubmed.ncbi.nlm.nih.gov/34508917/. | Lim, J. H., Han, M. H., Kim, Y. J., Kim, M. S., Jung, H. Y., Choi, J. Y., ... & Park, S. H. (2021). New-onset nephrotic syndrome after Janssen COVID-19 vaccination: a case report and literature review. Journal of Korean Medical Science, 36(30). https://pubmed.ncbi.nlm.nih.gov/34342187/. | Giovane, R., & Campbell, J. (2021). Bilateral Thalamic Stroke: A Case of COVID-19 Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT) or a Coincidence Due to Underlying Risk Factors?. Cureus, 13(10). | https://pubmed.ncbi.nlm.nih.gov/34820232/. | Giovane, R., & Campbell, J. (2021). Bilateral Thalamic Stroke: A Case of COVID-19 Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT) or a Coincidence Due to Underlying Risk Factors?. Cureus, 13(10). https://pubmed.ncbi.nlm.nih.gov/34820232/. | Nassar, M., Chung, H., Dhayaparan, Y., Nyein, A., Acevedo, B. J., Chicos, C., ... & Kimball, E. (2021). COVID-19 vaccine induced rhabdomyolysis: Case report with literature review. Diabetes & Metabolic Syndrome. https://pubmed.ncbi.nlm.nih.gov/34186348/. | ||||
512 | Shingles-like skin lesion after vaccination with AstraZeneca for COVID-19: a case report: | https://pubmed.ncbi.nlm.nih.gov/34631069/ | https://www.jcehepatology.com/article/S0973-6883(21)00545-4/fulltext. | Premkumar, M., Bhujade, H., Karki, T., Chaluvashetty, S. B., Kaur, H., Duseja, A. K., & Singh, V. (2021). New Portal Vein Thrombosis in Cirrhosis-is the thrombophilia exacerbated due to Vaccine or COVID-19?. Journal of Clinical and Experimental Hepatology. | Premkumar, M., Bhujade, H., Karki, T., Chaluvashetty, S. B., Kaur, H., Duseja, A. K. y Singh, V. (2021). Nueva trombosis de la vena porta en la cirrosis: ¿la trombofilia se exacerba debido a la vacuna o al COVID-19? Revista de hepatología clínica y experimental. https://pubmed.ncbi.nlm.nih.gov/33962903/. | Li, L., Robinson, L. B., Patel, R., Landman, A. B., Fu, X., Shenoy, E. S., ... & Blumenthal, K. G. (2021). Asociación de la historia de alergia al alto riesgo autoinformada con síntomas de alergia después de la vacunación COVID-19. Red de Jama Abrir, 4 (10), E2131034-E2131034. https://pubmed.ncbi.nlm.nih.gov/34020815/ | Premkumar, M., Bhujade, H., Karki, T., Chaluvashetty, S. B., Kaur, H., Duseja, A. K., & Singh, V. (2021). New Portal Vein Thrombosis in Cirrhosis-is the thrombophilia exacerbated due to Vaccine or COVID-19?. Journal of Clinical and Experimental Hepatology. https://www.jcehepatology.com/article/S0973-6883(21)00545-4/fulltext. | Lim, J., Lee, S. A., Khil, E. K., Byeon, S. J., Kang, H. J., & Choi, J. A. (2021, October). COVID-19 vaccine-related axillary lymphadenopathy in breast cancer patients: Case series with a review of literature. In Seminars in oncology. WB Saunders. https://pubmed.ncbi.nlm.nih.gov/34836672/. | Dhoot, R., Kansal, A., Handran, C., Haykal, T., Ronald, J., Kappus, M., ... & Strouse, J. J. (2021). Thrombocytopenia and splanchnic thrombosis after Ad26. COV2. S vaccination successfully treated with transjugular intrahepatic portosystemic shunting and thrombectomy. American journal of hematology. | https://onlinelibrary.wiley.com/doi/10.1002/ajh.26258 | Dhoot, R., Kansal, A., Handran, C., Haykal, T., Ronald, J., Kappus, M., ... & Strouse, J. J. (2021). Thrombocytopenia and splanchnic thrombosis after Ad26. COV2. S vaccination successfully treated with transjugular intrahepatic portosystemic shunting and thrombectomy. American journal of hematology. https://onlinelibrary.wiley.com/doi/10.1002/ajh.26258 | Nassar, M., Nso, N., Gonzalez, C., Lakhdar, S., Alshamam, M., Elshafey, M., ... & Rizzo, V. (2021). COVID-19 vaccine-induced myocarditis: case report with literature review. Diabetes & metabolic syndrome, 15(5), 102205. https://www.sciencedirect.com/science/article/pii/S1871402121002253 | ||||
513 | Thrombosis after COVID-19 vaccination: possible link to ACE pathways: | https://pubmed.ncbi.nlm.nih.gov/34479129/ | https://pubmed.ncbi.nlm.nih.gov/33962903/. | Garnier, M., Curado, A., Billoir, P., Barbay, V., Demeyere, M., & Dacher, J. N. (2021). Imaging of Oxford/AstraZeneca COVID-19 vaccine-induced immune thrombotic thrombocytopenia. Diagnostic and interventional imaging. | Garnier, M., Curado, A., Billoir, P., Barbay, V., Demeyere, M. y Dacher, JN (2021). Imágenes de la trombocitopenia trombótica inmunitaria inducida por la vacuna Oxford/AstraZeneca COVID-19. Imagenología diagnóstica e intervencionista. https://pubmed.ncbi.nlm.nih.gov/34796065/. | Li, M., Yuan, J., LV, G., Brown, J., Jiang, X., & Lu, Z. K. (2021). Miocarditis y pericarditis después de la vacunación COVID-19: desigualdades en la edad y los tipos de vacunas. Diario de medicina personalizada, 11 (11), 1106. https://pubmed.ncbi.nlm.nih.gov/34402230/ | Garnier, M., Curado, A., Billoir, P., Barbay, V., Demeyere, M., & Dacher, J. N. (2021). Imaging of Oxford/AstraZeneca COVID-19 vaccine-induced immune thrombotic thrombocytopenia. Diagnostic and interventional imaging. https://pubmed.ncbi.nlm.nih.gov/33962903/. | Lim, X. R., Leung, B. P., Ng, C. Y. L., Tan, J. W. L., Chan, G. Y. L., Loh, C. M., ... & Leong, K. P. (2021). Pseudo-anaphylactic reactions to Pfizer BNT162b2 vaccine: report of 3 cases of anaphylaxis post Pfizer BNT162b2 vaccination. Vaccines, 9(9), 974. https://pubmed.ncbi.nlm.nih.gov/34579211/ | Hidayat, R., Diafiri, D., Zairinal, R. A., Arifin, G. R., Azzahroh, F., Widjaya, N., ... & Haris, S. (2021). Acute Ischaemic Stroke Incidence after Coronavirus Vaccine in Indonesia: Case Series. Current neurovascular research, 18(3), 360-363. | https://pubmed.ncbi.nlm.nih.gov/34579636/ | Hidayat, R., Diafiri, D., Zairinal, R. A., Arifin, G. R., Azzahroh, F., Widjaya, N., ... & Haris, S. (2021). Acute Ischaemic Stroke Incidence after Coronavirus Vaccine in Indonesia: Case Series. Current neurovascular research, 18(3), 360-363. https://pubmed.ncbi.nlm.nih.gov/34579636/ | Nastro, F., Fabbrocini, G., di Vico, F., & Marasca, C. (2021). Small vessel vasculitis related to varicella‐zoster virus after Pfizer‐BioNTech COVID‐19 vaccine. Journal of the European Academy of Dermatology and Venereology. https://pubmed.ncbi.nlm.nih.gov/34310759/. | ||||
514 | Thrombocytopenia in an adolescent with sickle cell anemia after COVID-19 vaccination: | https://pubmed.ncbi.nlm.nih.gov/34331506/ | https://pubmed.ncbi.nlm.nih.gov/34796065/. | Yamaguchi, Y., Kimihira, L., Nagasawa, H., Seo, K., & Wada, M. (2021). Cerebral Venous Sinus Thrombosis After BNT162b2 mRNA COVID-19 Vaccination. Cureus, 13(10). | Yamaguchi, Y., Kimihira, L., Nagasawa, H., Seo, K. y Wada, M. (2021). Trombosis del seno venoso cerebral después de la vacunación contra el COVID-19 con ARNm de BNT162b2. Cureus, 13(10). https://pubmed.ncbi.nlm.nih.gov/34579248/ | Li, M., Yuan, J., LV, G., Brown, J., Jiang, X., & Lu, Z. K. (2021). Miocarditis y pericarditis después de la vacunación COVID-19: desigualdades en la edad y los tipos de vacunas. Diario de medicina personalizada, 11 (11), 1106. https://www.ncbi.nlm.nih.gov/pubmed/34778411 | Yamaguchi, Y., Kimihira, L., Nagasawa, H., Seo, K., & Wada, M. (2021). Cerebral Venous Sinus Thrombosis After BNT162b2 mRNA COVID-19 Vaccination. Cureus, 13(10). https://pubmed.ncbi.nlm.nih.gov/34796065/. | Lim, Y., Kim, M. C., Kim, K. H., Jeong, I. S., Cho, Y. S., Choi, Y. D., & Lee, J. E. (2021). Case Report: Acute Fulminant Myocarditis and Cardiogenic Shock After Messenger RNA Coronavirus Disease 2019 Vaccination Requiring Extracorporeal Cardiopulmonary Resuscitation. Frontiers in Cardiovascular Medicine, 8. https://pubmed.ncbi.nlm.nih.gov/34778411/ | Kemper, M., Lenz, G., & Mesters, R. M. (2021). Successful Treatment of Vaccine-Induced Immune Thrombotic Thrombocytopenia in a 26-Year-Old Female Patient. Acta Haematologica, 1-4. | https://pubmed.ncbi.nlm.nih.gov/34614491/ | Kemper, M., Lenz, G., & Mesters, R. M. (2021). Successful Treatment of Vaccine-Induced Immune Thrombotic Thrombocytopenia in a 26-Year-Old Female Patient. Acta Haematologica, 1-4. https://pubmed.ncbi.nlm.nih.gov/34614491/ | Nasuelli, N. A., De Marchi, F., Cecchin, M., De Paoli, I., Onorato, S., Pettinaroli, R., ... & Godi, L. (2021). A case of acute demyelinating polyradiculoneuropathy with bilateral facial palsy after ChAdOx1 nCoV-19 vaccine. Neurological Sciences, 42(11), 4747-4749. https://pubmed.ncbi.nlm.nih.gov/34272622/ | ||||
515 | Leukocytoclastic vasculitis as a cutaneous manifestation of ChAdOx1 corona virus vaccine nCoV-19 (recombinant): | https://pubmed.ncbi.nlm.nih.gov/34546608/ | https://pubmed.ncbi.nlm.nih.gov/34579248/ | Cugno, M., Consonni, D., Lombardi, A., Bono, P., Oggioni, M., Uceda Renteria, S., ... & Gori, A. (2021). Increased risk of urticaria/angioedema after BNT162b2 mRNA COVID-19 vaccine in health care workers taking ACE inhibitors. Vaccines, 9(9), 1011. | Cugno, M., Consonni, D., Lombardi, A., Bono, P., Oggioni, M., Uceda Renteria, S., ... & Gori, A. (2021). Mayor riesgo de urticaria/angioedema después de la vacuna COVID-19 de ARNm de BNT162b2 en trabajadores de la salud que toman inhibidores de la ECA. Vacunas, 9(9), 1011. https://pubmed.ncbi.nlm.nih.gov/34843991/ | Liang, I., Swaminathan, S., & Lee, A. (2021). La aparición de la vasculitis cutánea de novo posterior a la enfermedad de la enfermedad de Coronavirus (COVID-19) Vacunación. RHEUMATOLOGÍA CLÍNICA, 1-2. https://pubmed.ncbi.nlm.nih.gov/34115904/. | Cugno, M., Consonni, D., Lombardi, A., Bono, P., Oggioni, M., Uceda Renteria, S., ... & Gori, A. (2021). Increased risk of urticaria/angioedema after BNT162b2 mRNA COVID-19 vaccine in health care workers taking ACE inhibitors. Vaccines, 9(9), 1011. https://pubmed.ncbi.nlm.nih.gov/34579248/ | Lim, Y., Kim, M. C., Kim, K. H., Jeong, I. S., Cho, Y. S., Choi, Y. D., & Lee, J. E. (2021). Case Report: Acute Fulminant Myocarditis and Cardiogenic Shock After Messenger RNA Coronavirus Disease 2019 Vaccination Requiring Extracorporeal Cardiopulmonary Resuscitation. Frontiers in Cardiovascular Medicine, 8. https://www.ncbi.nlm.nih.gov/pubmed/34778411 | Su, P. H., Yu, Y. C., Chen, W. H., Lin, H. C., Chen, Y. T., Cheng, M. H., & Huang, Y. M. (2021). Case Report: Vaccine-Induced Immune Thrombotic Thrombocytopenia in a Pancreatic Cancer Patient After Vaccination With Messenger RNA− 1273. Frontiers in Medicine, 8. | https://pubmed.ncbi.nlm.nih.gov/34790684/ | Su, P. H., Yu, Y. C., Chen, W. H., Lin, H. C., Chen, Y. T., Cheng, M. H., & Huang, Y. M. (2021). Case Report: Vaccine-Induced Immune Thrombotic Thrombocytopenia in a Pancreatic Cancer Patient After Vaccination With Messenger RNA− 1273. Frontiers in Medicine, 8. https://pubmed.ncbi.nlm.nih.gov/34790684/ | Nawwar, A. A., Searle, J., Singh, R., & Lyburn, I. D. (2021). Oxford-AstraZeneca COVID-19 vaccination induced lymphadenopathy on [18F] choline PET/CT—not only an FDG finding. European Journal of Nuclear Medicine and Molecular Imaging, 48(8), 2657-2658. https://pubmed.ncbi.nlm.nih.gov/33661328/ | ||||
516 | Abdominal pain and bilateral adrenal hemorrhage from immune thrombotic thrombocytopenia induced by COVID-19 vaccine: | https://pubmed.ncbi.nlm.nih.gov/34546343/ | https://pubmed.ncbi.nlm.nih.gov/34843991/ | van Dijk, M. M., Veldman, H. D., Aarts, F., Barten, D. G., van den Bergh, J. P., & Dielis, A. W. (2022). A case of unusual mild clinical presentation of COVID-19 vaccine-induced immune thrombotic thrombocytopenia with splanchnic vein thrombosis. Annals of hepatology, 27(1), 100590. | van Dijk, M. M., Veldman, H. D., Aarts, F., Barten, D. G., van den Bergh, J. P. y Dielis, A. W. (2022). Un caso de presentación clínica leve inusual de trombocitopenia trombótica inmunitaria inducida por la vacuna COVID-19 con trombosis de la vena esplácnica. Anales de hepatología, 27 (1), 100590. https://pubmed.ncbi.nlm.nih.gov/34595867/ | Libro, B. A., Schmidt, B., & Foerster, A. M. (2021). Neuroretinopatía macular aguda bilateral después de la vacunación contra SARS-COV-2. Oftalmología de Jama, 139 (7), E212471-E212471. https://pubmed.ncbi.nlm.nih.gov/34478433/ | van Dijk, M. M., Veldman, H. D., Aarts, F., Barten, D. G., van den Bergh, J. P., & Dielis, A. W. (2022). A case of unusual mild clinical presentation of COVID-19 vaccine-induced immune thrombotic thrombocytopenia with splanchnic vein thrombosis. Annals of hepatology, 27(1), 100590. https://pubmed.ncbi.nlm.nih.gov/34843991/ | Lin, C. Y., Huang, L. Y., Wu, K. A., Chan, J. S., Wu, K. L., Shyu, H. Y., & Hsiao, P. J. (2021). Abdominal pain and bilateral adrenal haemorrhage of COVID-19 vaccine-induced immune thrombotic thrombocytopenia. QJM: An International Journal of Medicine. https://pubmed.ncbi.nlm.nih.gov/34546343/ | Lorente, E. (2021). Idiopathic Ipsilateral External Jugular Vein Thrombophlebitis After Coronavirus Disease (COVID-19) Vaccination. AJR Am J Roentgenol, 767-767. | https://pubmed.ncbi.nlm.nih.gov/33624509/. | Lorente, E. (2021). Idiopathic Ipsilateral External Jugular Vein Thrombophlebitis After Coronavirus Disease (COVID-19) Vaccination. AJR Am J Roentgenol, 767-767. https://pubmed.ncbi.nlm.nih.gov/33624509/. | Negrea, L., & Rovin, B. H. (2021). Gross hematuria following vaccination for severe acute respiratory syndrome coronavirus 2 in 2 patients with IgA nephropathy. Kidney international, 99(6), 1487. https://pubmed.ncbi.nlm.nih.gov/33771584/ | ||||
517 | Longitudinally extensive cervical myelitis after vaccination with inactivated virus based COVID-19 vaccine: | https://pubmed.ncbi.nlm.nih.gov/34849183/ | https://pubmed.ncbi.nlm.nih.gov/34595867/ | Cheng, N. (2021). Cerebral venous sinus thrombosis after Pfizer-BioNTech COVID-19 (BNT162b2) vaccination. Journal of Clinical Neurology (Seoul, Korea), 17(4), 573. | Cheng, N. (2021). Trombosis del seno venoso cerebral después de la vacunación Pfizer-BioNTech COVID-19 (BNT162b2). Revista de Neurología Clínica (Seúl, Corea), 17(4), 573. https://pubmed.ncbi.nlm.nih.gov/34820240/ | Lim, J. H., Han, M. H., Kim, Y. J., Kim, M. S., Jung, H. Y., Choi, J. Y., ... & Park, S. H. (2021). Síndrome nefrótico de nuevo inicio después de Janssen COVID-19 Vacunación: un informe de casos y revisión de la literatura. Diario de la ciencia médica coreana, 36 (30). https://pubmed.ncbi.nlm.nih.gov/34601889/ | Cheng, N. (2021). Cerebral venous sinus thrombosis after Pfizer-BioNTech COVID-19 (BNT162b2) vaccination. Journal of Clinical Neurology (Seoul, Korea), 17(4), 573. https://pubmed.ncbi.nlm.nih.gov/34595867/ | Lin, W., Ko, C. A., Sung, Y. F., Chen, Y. C., Lee, J. T., Lin, Y. Q., & Lin, Y. K. (2021). Cerebral Venous Sinus Thrombosis, Pulmonary Embolism, and Thrombocytopenia After COVID-19 Vaccination in a Taiwanese Man: A Case Report and Literature Review. Frontiers in Neurology, 1670. https://pubmed.ncbi.nlm.nih.gov/34630307/ | Sumi, T., Nagahisa, Y., Matsuura, K., Sekikawa, M., Yamada, Y., Nakata, H., & Chiba, H. (2021). Lung squamous cell carcinoma with hemoptysis after vaccination with tozinameran (BNT162b2, Pfizer‐BioNTech). Thoracic Cancer, 12(22), 3072-3075. | https://pubmed.ncbi.nlm.nih.gov/34612003/ | Sumi, T., Nagahisa, Y., Matsuura, K., Sekikawa, M., Yamada, Y., Nakata, H., & Chiba, H. (2021). Lung squamous cell carcinoma with hemoptysis after vaccination with tozinameran (BNT162b2, Pfizer‐BioNTech). Thoracic Cancer, 12(22), 3072-3075. https://pubmed.ncbi.nlm.nih.gov/34612003/ | Nevet, A. (2021). Acute myocarditis associated with anti-COVID-19 vaccination. Clinical and Experimental Vaccine Research, 10(2), 196. https://ecevr.org/DOIx.php?id=10.7774/cevr.2021.10.2.196. | ||||
518 | Induction of cutaneous leukocytoclastic vasculitis after ChAdOx1 nCoV-19 vaccine: | https://pubmed.ncbi.nlm.nih.gov/34853744/. | https://pubmed.ncbi.nlm.nih.gov/34820240/ | Malayala, S. V., Papudesi, B. N., Sharma, R., Vusqa, U. T., & Raza, A. (2021). A case of idiopathic thrombocytopenic purpura after booster dose of BNT162b2 (Pfizer-Biontech) COVID-19 vaccine. Cureus, 13(10). | Malayala, SV, Papudesi, BN, Sharma, R., Vusqa, UT y Raza, A. (2021). Un caso de púrpura trombocitopénica idiopática después de una dosis de refuerzo de la vacuna BNT162b2 (Pfizer-Biontech) COVID-19. Cureus, 13(10). https://pubmed.ncbi.nlm.nih.gov/33851389/ | LIM, J., Lee, S. A. A., Khil, E. K., Byeon, S. J., Kang, H. J., & Choi, J. A. (2021, octubre). COVID-19 Linfadenopatía axilar relacionada con la vacuna en pacientes con cáncer de mama: series de casos con una revisión de la literatura. En seminarios en oncología. WB Saunders. https://pubmed.ncbi.nlm.nih.gov/34280870/ | Malayala, S. V., Papudesi, B. N., Sharma, R., Vusqa, U. T., & Raza, A. (2021). A case of idiopathic thrombocytopenic purpura after booster dose of BNT162b2 (Pfizer-Biontech) COVID-19 vaccine. Cureus, 13(10). https://pubmed.ncbi.nlm.nih.gov/34820240/ | Ling, L., Bagshaw, S. M., & Villeneuve, P. M. (2021). Guillain–Barré syndrome after SARS-CoV-2 vaccination in a patient with previous vaccine-associated Guillain–Barré syndrome. CMAJ, 193(46), E1766-E1769. https://pubmed.ncbi.nlm.nih.gov/34810163/ | Abou‐Ismail, M. Y., Moser, K. A., Smock, K. J., & Lim, M. Y. (2021). Vaccine‐induced thrombotic thrombocytopenia following Ad26. COV2. S vaccine in a man presenting as acute venous thromboembolism. American Journal of Hematology. | https://pubmed.ncbi.nlm.nih.gov/34096082/ | Abou‐Ismail, M. Y., Moser, K. A., Smock, K. J., & Lim, M. Y. (2021). Vaccine‐induced thrombotic thrombocytopenia following Ad26. COV2. S vaccine in a man presenting as acute venous thromboembolism. American Journal of Hematology. https://pubmed.ncbi.nlm.nih.gov/34096082/ | Ng, X. L., Betzler, B. K., Testi, I., Ho, S. L., Tien, M., Ngo, W. K., ... & Agrawal, R. (2021). Ocular adverse events after COVID-19 vaccination. Ocular immunology and inflammation, 1-9. https://pubmed.ncbi.nlm.nih.gov/34559576/ | ||||
519 | A case of toxic epidermal necrolysis after vaccination with ChAdOx1 nCoV-19 (AZD1222): | https://pubmed.ncbi.nlm.nih.gov/34751429/. | https://pubmed.ncbi.nlm.nih.gov/33851389/ | Von Hundelshausen, P., Lorenz, R., Siess, W., & Weber, C. (2021). Vaccine-induced immune thrombotic thrombocytopenia (VITT): targeting pathomechanisms with Bruton tyrosine kinase inhibitors. Thrombosis and haemostasis. | Von Hundelshausen, P., Lorenz, R., Siess, W. y Weber, C. (2021). Trombocitopenia trombótica inmunitaria inducida por vacuna (VITT): dirigida a los patomecanismos con inhibidores de la tirosina quinasa de Bruton. Trombosis y hemostasia. https://pubmed.ncbi.nlm.nih.gov/33980419/ | Lim, X. R., Leung, B. P., NG, C. Y. L., Tan, J. W. L., Chan, G. Y. L., LOH, C. M., ... & Leong, K. P. (2021). Reacciones pseudo-anafilácticas a Pfizer BNT162B2 Vacuna: Informe de 3 casos de anafilaxis Post Pfizer BNT162B2 Vacunación. Vacunas, 9 (9), 974. https://pubmed.ncbi.nlm.nih.gov/34343674/ | Von Hundelshausen, P., Lorenz, R., Siess, W., & Weber, C. (2021). Vaccine-induced immune thrombotic thrombocytopenia (VITT): targeting pathomechanisms with Bruton tyrosine kinase inhibitors. Thrombosis and haemostasis. https://pubmed.ncbi.nlm.nih.gov/33851389/ | Lioudaki, S., Kontopodis, N., Pontikoglou, C., Gkalea, V., Pappas, T., Matsouka, C., ... & Ioannou, C. V. (2022). Multiple sites of arterial thrombosis in a 35-year old patient after ChAdOx1 (AstraZeneca) vaccination, requiring emergent femoral and carotid surgical thrombectomy. Annals of Vascular Surgery, 79, 438-e1. https://pubmed.ncbi.nlm.nih.gov/34644642/ | Łaźniak-Pfajfer, A., Surmacz, R., Rajewska-Tabor, J., Pyda, M., Lesiak, M., & Bobkowski, W. (2021). Myocarditis associated with COVID-19 vaccination in three teenage males. Polish Archives of Internal Medicine. | https://pubmed.ncbi.nlm.nih.gov/34851078/. | Łaźniak-Pfajfer, A., Surmacz, R., Rajewska-Tabor, J., Pyda, M., Lesiak, M., & Bobkowski, W. (2021). Myocarditis associated with COVID-19 vaccination in three teenage males. Polish Archives of Internal Medicine. https://pubmed.ncbi.nlm.nih.gov/34851078/. | Nishiguchi, Y., Matsuyama, H., Maeda, K., Shindo, A., & Tomimoto, H. (2021). Miller Fisher syndrome following BNT162b2 mRNA coronavirus 2019 vaccination. BMC neurology, 21(1), 1-6. https://pubmed.ncbi.nlm.nih.gov/34789193/. | ||||
520 | Ocular adverse events following COVID-19 vaccination: | https://pubmed.ncbi.nlm.nih.gov/34559576/ | https://pubmed.ncbi.nlm.nih.gov/33980419/ | Yocum, A., & Simon, E. L. (2021). Thrombotic thrombocytopenic purpura after Ad26. COV2-S vaccination. The American journal of emergency medicine, 49, 441-e3. | Yocum, A. y Simon, EL (2021). Púrpura trombocitopénica trombótica después de Ad26. Vacunación COV2-S. La revista americana de medicina de emergencia, 49, 441-e3. https://pubmed.ncbi.nlm.nih.gov/34264151/ | Lim, Y., Kim, M. C., Kim, K. H., Jeong, I. S., CHO, Y. S., Choi, Y. D., & Lee, J. E. (2021). Informe de caso: miocarditis fulminante aguda y shock cardiogénico después del mensajero ARN CORONAVIRUS Enfermedad 2019 Vacunación que requiere la reanimación cardiopulmonar extracorpórea. Fronteras en medicina cardiovascular, 8. https://pubmed.ncbi.nlm.nih.gov/34734821/ | Yocum, A., & Simon, E. L. (2021). Thrombotic thrombocytopenic purpura after Ad26. COV2-S vaccination. The American journal of emergency medicine, 49, 441-e3. https://pubmed.ncbi.nlm.nih.gov/33980419/ | Lippi, G., & Favaloro, E. J. (2021, October). Cerebral Venous Thrombosis Developing after COVID-19 Vaccination: VITT, VATT, TTS, and More. In Seminars in thrombosis and hemostasis. Thieme Medical Publishers, Inc.. https://pubmed.ncbi.nlm.nih.gov/34695859/ | Tinoco, M., Leite, S., Faria, B., Cardoso, S., Von Hafe, P., Dias, G., ... & Lourenço, A. (2021). Perimyocarditis Following COVID-19 Vaccination. Clinical Medicine Insights: Cardiology, 15, 11795468211056634. | https://pubmed.ncbi.nlm.nih.gov/34866957/ | Tinoco, M., Leite, S., Faria, B., Cardoso, S., Von Hafe, P., Dias, G., ... & Lourenço, A. (2021). Perimyocarditis Following COVID-19 Vaccination. Clinical Medicine Insights: Cardiology, 15, 11795468211056634. https://pubmed.ncbi.nlm.nih.gov/34866957/ | Nishizawa, Y., Hoshina, Y., & Baker, V. (2021). Bell’s palsy following the Ad26. COV2. S COVID-19 vaccination. QJM: An International Journal of Medicine. https://pubmed.ncbi.nlm.nih.gov/34014316/ | ||||
521 | Depression after ChAdOx1-S / nCoV-19 vaccination: | https://pubmed.ncbi.nlm.nih.gov/34608345/. | https://pubmed.ncbi.nlm.nih.gov/34264151/ | Sessa, M., Kragholm, K., Hviid, A., & Andersen, M. (2021). Thromboembolic events in younger women exposed to Pfizer-BioNTech or Moderna COVID-19 vaccines. Expert Opinion on Drug Safety, 20(11), 1451-1453. | Sessa, M., Kragholm, K., Hviid, A. y Andersen, M. (2021). Eventos tromboembólicos en mujeres más jóvenes expuestas a las vacunas Pfizer-BioNTech o Moderna COVID-19. Opinión de expertos sobre seguridad de los medicamentos, 20(11), 1451-1453. https://pubmed.ncbi.nlm.nih.gov/34734086/ | Lim, Y., Kim, M. C., Kim, K. H., Jeong, I. S., CHO, Y. S., Choi, Y. D., & Lee, J. E. (2021). Informe de caso: miocarditis fulminante aguda y shock cardiogénico después del mensajero ARN CORONAVIRUS Enfermedad 2019 Vacunación que requiere la reanimación cardiopulmonar extracorpórea. Fronteras en medicina cardiovascular, 8. https://www.ncbi.nlm.nih.gov/pubmed/34332972 | Sessa, M., Kragholm, K., Hviid, A., & Andersen, M. (2021). Thromboembolic events in younger women exposed to Pfizer-BioNTech or Moderna COVID-19 vaccines. Expert Opinion on Drug Safety, 20(11), 1451-1453. https://pubmed.ncbi.nlm.nih.gov/34264151/ | Liu, J., Wang, J., Xu, J., Xia, H., Wang, Y., Zhang, C., ... & Liu, Z. (2021). Comprehensive investigations revealed consistent pathophysiological alterations after vaccination with COVID-19 vaccines. Cell discovery, 7(1), 1-15. https://www.nature.com/articles/s41421-021-00329-3 | Choi, S., Lee, S., Seo, J. W., Kim, M. J., Jeon, Y. H., Park, J. H., ... & Yeo, N. S. (2021). Myocarditis-induced sudden death after BNT162b2 mRNA COVID-19 vaccination in Korea: Case report focusing on histopathological findings. Journal of Korean medical science, 36(40). | https://pubmed.ncbi.nlm.nih.gov/34664804/ | Choi, S., Lee, S., Seo, J. W., Kim, M. J., Jeon, Y. H., Park, J. H., ... & Yeo, N. S. (2021). Myocarditis-induced sudden death after BNT162b2 mRNA COVID-19 vaccination in Korea: Case report focusing on histopathological findings. Journal of Korean medical science, 36(40). https://pubmed.ncbi.nlm.nih.gov/34664804/ | Noseda, R., Ripellino, P., Ghidossi, S., Bertoli, R., & Ceschi, A. (2021). Reporting of acute inflammatory neuropathies with COVID-19 vaccines: subgroup disproportionality analyses in VigiBase. Vaccines, 9(9), 1022. https://pubmed.ncbi.nlm.nih.gov/34579259/ | ||||
522 | Venous thromboembolism and mild thrombocytopenia after ChAdOx1 nCoV-19 vaccination: | https://pubmed.ncbi.nlm.nih.gov/34384129/. | https://pubmed.ncbi.nlm.nih.gov/34734086/ | Soltani Hekmat, A., & Javanmardi, K. (2021). Possible Risk of Thrombotic Events following Oxford-AstraZeneca COVID-19 Vaccination in Women Receiving Estrogen. BioMed Research International, 2021. | Soltani Hekmat, A. y Javanmardi, K. (2021). Posible riesgo de eventos trombóticos después de la vacunación Oxford-AstraZeneca COVID-19 en mujeres que reciben estrógeno. BioMed Research Internacional, 2021. https://pubmed.ncbi.nlm.nih.gov/34755555/ | Lin, C. Y., Huang, L. Y., Wu, K. A., Chan, J. S., Wu, K. L., Shyu, H. Y., & Hsiao, P. J. (2021). Dolor abdominal y hemorragia suprarrenal bilateral de covid-19 trombocitopenia inmune inducida por la vacuna. QJM: un Diario Internacional de Medicina. https://pubmed.ncbi.nlm.nih.gov/34849183/ | Soltani Hekmat, A., & Javanmardi, K. (2021). Possible Risk of Thrombotic Events following Oxford-AstraZeneca COVID-19 Vaccination in Women Receiving Estrogen. BioMed Research International, 2021. https://pubmed.ncbi.nlm.nih.gov/34734086/ | Long, B., Bridwell, R., & Gottlieb, M. (2021). Thrombosis with thrombocytopenia syndrome associated with COVID-19 vaccines. The American journal of emergency medicine, 49, 58-61. https://pubmed.ncbi.nlm.nih.gov/34062319/ | Simone, A., Herald, J., Chen, A., Gulati, N., Shen, A. Y. J., Lewin, B., & Lee, M. S. (2021). Acute myocarditis following COVID-19 mRNA vaccination in adults aged 18 years or older. JAMA Internal Medicine, 181(12), 1668-1670. | https://pubmed.ncbi.nlm.nih.gov/34605853/ | Simone, A., Herald, J., Chen, A., Gulati, N., Shen, A. Y. J., Lewin, B., & Lee, M. S. (2021). Acute myocarditis following COVID-19 mRNA vaccination in adults aged 18 years or older. JAMA Internal Medicine, 181(12), 1668-1670. https://pubmed.ncbi.nlm.nih.gov/34605853/ | Notghi, A. A., Atley, J., & Silva, M. (2021). Lessons of the month 1: Longitudinal extensive transverse myelitis following AstraZeneca COVID-19 vaccination. Clinical Medicine, 21(5), e535. https://pubmed.ncbi.nlm.nih.gov/34507942/. | ||||
523 | Recurrent ANCA-associated vasculitis after Oxford AstraZeneca ChAdOx1-S COVID-19 vaccination: a case series of two patients: | https://pubmed.ncbi.nlm.nih.gov/34755433/ | https://pubmed.ncbi.nlm.nih.gov/34755555/ | Mungmunpuntipantip, R., & Wiwanitkit, V. (2021). Thrombosis after adenovirus-vectored COVID-19 vaccination: a concern on underlying illness. Clinical and Applied Thrombosis/Hemostasis, 27, 10760296211060446. | Mungmunpuntipantip, R. y Wiwanitkit, V. (2021). Trombosis después de la vacunación COVID-19 con vector de adenovirus: una preocupación sobre la enfermedad subyacente. Trombosis/Hemostasia clínica y aplicada, 27, 10760296211060446. https://pubmed.ncbi.nlm.nih.gov/34407607/ | Lin, W., KO, C. A., Sung, Y. F., Chen, Y. C., Lee, J. T., Lin, Y. Q., & Lin, Y. K. (2021). Trombosis sinusal venosa cerebral, embolia pulmonar y trombocitopenia después de la vacunación de COVID-19 en un hombre taiwanés: un informe de caso y una revisión de la literatura. Fronteras en neurología, 1670. https://pubmed.ncbi.nlm.nih.gov/34508917/. | Mungmunpuntipantip, R., & Wiwanitkit, V. (2021). Thrombosis after adenovirus-vectored COVID-19 vaccination: a concern on underlying illness. Clinical and Applied Thrombosis/Hemostasis, 27, 10760296211060446. https://pubmed.ncbi.nlm.nih.gov/34755555/ | Long, B., Bridwell, R., & Gottlieb, M. (2021). Thrombosis with thrombocytopenia syndrome associated with COVID-19 vaccines. The American journal of emergency medicine, 49, 58-61. https://www.sciencedirect.com/science/article/abs/pii/S0735675721004381 | Kaneta, K., Yokoi, K., Jojima, K., Kotooka, N., & Node, K. (2021). Young Male With Myocarditis Following mRNA-1273 Vaccination Against Coronavirus Disease-2019 (COVID-19). Circulation Journal, CJ-21. | https://pubmed.ncbi.nlm.nih.gov/34744118/ | Kaneta, K., Yokoi, K., Jojima, K., Kotooka, N., & Node, K. (2021). Young Male With Myocarditis Following mRNA-1273 Vaccination Against Coronavirus Disease-2019 (COVID-19). Circulation Journal, CJ-21. https://pubmed.ncbi.nlm.nih.gov/34744118/ | Nowak, V. A., Scully, M., Davagnanam, I., & Bremner, F. (2021). Neuro-ophthalmic complications with ChAdOx1 nCoV-19 vaccine-induced thrombocytopenia and thrombosis. British Journal of Hospital Medicine, 82(10), 1-4. https://pubmed.ncbi.nlm.nih.gov/34726934/ | ||||
524 | Major artery thrombosis and vaccination against ChAdOx1 nCov-19: | https://pubmed.ncbi.nlm.nih.gov/34839830/ | https://pubmed.ncbi.nlm.nih.gov/34407607/ | Gresele, P., Momi, S., Marcucci, R., Ramundo, F., De Stefano, V., & Tripodi, A. (2021). Interactions of adenoviruses with platelets and coagulation and the vaccine-induced immune thrombotic thrombocytopenia syndrome. haematologica, 106(12), 3034. | Gresele, P., Momi, S., Marcucci, R., Ramundo, F., De Stefano, V. y Tripodi, A. (2021). Interacciones de los adenovirus con las plaquetas y la coagulación y el síndrome de trombocitopenia trombótica inmune inducido por vacunas. hematológica, 106(12), 3034. https://pubmed.ncbi.nlm.nih.gov/34264514/. | Ling, L., Bagshaw, S. M., y Villeneuve, P. M. (2021). Síndrome de Guillain-Barré después de la vacunación de SARS-COV-2 en un paciente con el síndrome de Guillain-Barré asociado a la vacuna anterior. CMAJ, 193 (46), E1766-E1769. https://onlinelibrary.wiley.com/doi/10.1002/ana.26218. | Gresele, P., Momi, S., Marcucci, R., Ramundo, F., De Stefano, V., & Tripodi, A. (2021). Interactions of adenoviruses with platelets and coagulation and the vaccine-induced immune thrombotic thrombocytopenia syndrome. haematologica, 106(12), 3034. https://pubmed.ncbi.nlm.nih.gov/34407607/ | Long, B., Bridwell, R., & Gottlieb, M. (2021). Thrombosis with thrombocytopenia syndrome associated with COVID-19 vaccines. The American journal of emergency medicine, 49, 58-61. https://www.sciencedirect.com/science/article/abs/pii/S0735675721004381. | Boursier, C., Chevalier, E., Filippetti, L., Imbert, L., Roch, V., Huttin, O., ... & Marie, P. Y. (2021). 68Ga-DOTATOC digital-PET imaging of inflammatory cell infiltrates in myocarditis following COVID-19 vaccination. European journal of nuclear medicine and molecular imaging, 1-2. | https://pubmed.ncbi.nlm.nih.gov/34746968/ | Boursier, C., Chevalier, E., Filippetti, L., Imbert, L., Roch, V., Huttin, O., ... & Marie, P. Y. (2021). 68Ga-DOTATOC digital-PET imaging of inflammatory cell infiltrates in myocarditis following COVID-19 vaccination. European journal of nuclear medicine and molecular imaging, 1-2. https://pubmed.ncbi.nlm.nih.gov/34746968/ | Ntouros, P. A., Vlachogiannis, N. I., Pappa, M., Nezos, A., Mavragani, C. P., Tektonidou, M. G., ... & Sfikakis, P. P. (2021). Effective DNA damage response after acute but not chronic immune challenge: SARS-CoV-2 vaccine versus Systemic Lupus Erythematosus. Clinical Immunology, 229, 108765. https://www.ncbi.nlm.nih.gov/pubmed/34089859 | ||||
525 | Rare case of contralateral supraclavicular lymphadenopathy after vaccination with COVID-19: computed tomography and ultrasound findings: | https://pubmed.ncbi.nlm.nih.gov/34667486/ | https://pubmed.ncbi.nlm.nih.gov/34264514/. | Waqar, S. H. B., Khan, A. A., & Memon, S. (2021). Thrombotic thrombocytopenic purpura: a new menace after COVID bnt162b2 vaccine. International Journal of Hematology, 114(5), 626-629. | Waqar, S. H. B., Khan, A. A. y Memon, S. (2021). Púrpura trombocitopénica trombótica: una nueva amenaza después de la vacuna COVID bnt162b2. Revista Internacional de Hematología, 114(5), 626-629. https://pubmed.ncbi.nlm.nih.gov/34840204/ | Lioudaki, S., Kontopodis, N., Pontikoglou, C., Gkalea, V., Pappas, T., Matsouka, C., ... & Ioannou, C. V. (2022). Múltiples sitios de trombosis arterial en un paciente de 35 años después de la vacunación de Chadox1 (AstraZeneca), que requieren trombectomía quirúrgica femoral y carótida emergente. Anales de cirugía vascular, 79, 438-E1. https://pubmed.ncbi.nlm.nih.gov/34694650/ | Waqar, S. H. B., Khan, A. A., & Memon, S. (2021). Thrombotic thrombocytopenic purpura: a new menace after COVID bnt162b2 vaccine. International Journal of Hematology, 114(5), 626-629. https://pubmed.ncbi.nlm.nih.gov/34264514/. | Long, S. S. (2021). Important Insights into Myopericarditis after the Pfizer mRNA COVID-19 Vaccination in Adolescents. The Journal of Pediatrics, 238, 5. https://www.ncbi.nlm.nih.gov/pubmed/34332972 | Takase, B., Hayashi, K., Hisada, T., Tsuchiya, T., Masaki, N., & Nagata, M. (2022). Chest Pain with New Abnormal Electrocardiogram Development after Injection of COVID-19 Vaccine Manufactured by Moderna. Internal Medicine, 8711-21. | https://pubmed.ncbi.nlm.nih.gov/34866106/ | Takase, B., Hayashi, K., Hisada, T., Tsuchiya, T., Masaki, N., & Nagata, M. (2022). Chest Pain with New Abnormal Electrocardiogram Development after Injection of COVID-19 Vaccine Manufactured by Moderna. Internal Medicine, 8711-21. https://pubmed.ncbi.nlm.nih.gov/34866106/ | Nygaard, U., Holm, M., Bohnstedt, C., Chai, Q., Schmidt, L. S., Hartling, U. B., ... & Stensballe, L. G. (2022). Population-based Incidence of Myopericarditis After COVID-19 Vaccination in Danish Adolescents. The Pediatric infectious disease journal, 41(1), e25. https://www.ncbi.nlm.nih.gov/pubmed/34889875 | ||||
526 | Cutaneous lymphocytic vasculitis after administration of the second dose of AZD1222 (Oxford-AstraZeneca) Severe acute respiratory syndrome Coronavirus 2 vaccine: chance or causality: | https://pubmed.ncbi.nlm.nih.gov/34726187/. | https://pubmed.ncbi.nlm.nih.gov/34840204/ | Hasegawa, T., & Yazaki, Y. (2021). Unusual Site of Deep Vein Thrombosis After mRNA Coronavirus Disease-2019 (COVID-19) Vaccination. Circulation Journal, CJ-21. | Hasegawa, T. y Yazaki, Y. (2021). Sitio inusual de trombosis venosa profunda después de la vacunación contra la enfermedad del coronavirus de ARNm-2019 (COVID-19). Diario de circulación, CJ-21. https://pubmed.ncbi.nlm.nih.gov/34750810/ | Lippi, G., & Favaloro, E. J. (2021, octubre). Trombosis venosa cerebral que se desarrolla después de la vacunación de COVID-19: Vitt, VATT, TTS y más. En seminarios en trombosis y hemostasia. Thieme Medical Publishers, Inc .. https://pubmed.ncbi.nlm.nih.gov/34453762/. | Hasegawa, T., & Yazaki, Y. (2021). Unusual Site of Deep Vein Thrombosis After mRNA Coronavirus Disease-2019 (COVID-19) Vaccination. Circulation Journal, CJ-21. https://pubmed.ncbi.nlm.nih.gov/34840204/ | Long, S. S. (2021). Important Insights into Myopericarditis after the Pfizer mRNA COVID-19 Vaccination in Adolescents. The Journal of Pediatrics, 238, 5. https://www.sciencedirect.com/science/article/pii/S0022347621007496 | Kadwalwala, M., Chadha, B., Ortoleva, J., & Joyce, M. (2021). Multimodality imaging and histopathology in a young man presenting with fulminant lymphocytic myocarditis and cardiogenic shock after mRNA-1273 vaccination. BMJ Case Reports CP, 14(11), e246059. | https://pubmed.ncbi.nlm.nih.gov/34848416/ | Kadwalwala, M., Chadha, B., Ortoleva, J., & Joyce, M. (2021). Multimodality imaging and histopathology in a young man presenting with fulminant lymphocytic myocarditis and cardiogenic shock after mRNA-1273 vaccination. BMJ Case Reports CP, 14(11), e246059. https://pubmed.ncbi.nlm.nih.gov/34848416/ | Obeid, M., Fenwick, C., & Pantaleo, G. (2021). Reactivation of IgA vasculitis after COVID-19 vaccination. The Lancet Rheumatology, 3(9), e617. https://pubmed.ncbi.nlm.nih.gov/34250509/ | ||||
527 | Pancreas allograft rejection after ChAdOx1 nCoV-19 vaccine: | https://pubmed.ncbi.nlm.nih.gov/34781027/ | https://pubmed.ncbi.nlm.nih.gov/34750810/ | Finsterer, J. (2022). Neurological side effects of SARS‐CoV‐2 vaccinations. Acta Neurologica Scandinavica, 145(1), 5-9. | Finsterer, J. (2022). Efectos secundarios neurológicos de las vacunas contra el SARS-CoV-2. Acta Neurologica Scandinavica, 145(1), 5-9. https://pubmed.ncbi.nlm.nih.gov/34639132/ | Liu, J., Wang, J., Xu, J., Xia, H., Wang, Y., Zhang, C., ... & Liu, Z. (2021). Las investigaciones integrales revelaron alteraciones fisiopatológicas consistentes después de la vacunación con vacunas COVID-19. Descubrimiento de células, 7 (1), 1-15. https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8553377/ | Finsterer, J. (2022). Neurological side effects of SARS‐CoV‐2 vaccinations. Acta Neurologica Scandinavica, 145(1), 5-9. https://pubmed.ncbi.nlm.nih.gov/34750810/ | Lorente, E. (2021). Idiopathic Ipsilateral External Jugular Vein Thrombophlebitis After Coronavirus Disease (COVID-19) Vaccination. AJR Am J Roentgenol, 767-767. https://pubmed.ncbi.nlm.nih.gov/33624509/. | Kim, D., Choi, J. H., Jang, J. Y., So, O., Cho, E., Choi, H., ... & Park, K. T. (2021). A Case Report for Myopericarditis after BNT162b2 COVID-19 mRNA Vaccination in a Korean Young Male. Journal of Korean Medical Science, 36(39). | https://pubmed.ncbi.nlm.nih.gov/34636504/ | Kim, D., Choi, J. H., Jang, J. Y., So, O., Cho, E., Choi, H., ... & Park, K. T. (2021). A Case Report for Myopericarditis after BNT162b2 COVID-19 mRNA Vaccination in a Korean Young Male. Journal of Korean Medical Science, 36(39). https://pubmed.ncbi.nlm.nih.gov/34636504/ | Oberhardt, V., Luxenburger, H., Kemming, J., Schulien, I., Ciminski, K., Giese, S., ... & Hofmann, M. (2021). Rapid and stable mobilization of CD8+ T cells by SARS-CoV-2 mRNA vaccine. Nature, 597(7875), 268-273. https://www.ncbi.nlm.nih.gov/pubmed/34320609 | ||||
528 | Understanding the risk of thrombosis with thrombocytopenia syndrome following Ad26.COV2.S vaccination: | https://pubmed.ncbi.nlm.nih.gov/34595694/ | https://pubmed.ncbi.nlm.nih.gov/34639132/ | Kircheis, R. (2021). Coagulopathies after vaccination against SARS-CoV-2 may be derived from a combined effect of SARS-CoV-2 spike protein and adenovirus vector-triggered signaling pathways. International Journal of Molecular Sciences, 22(19), 10791. | Kircheis, R. (2021). Las coagulopatías después de la vacunación contra el SARS-CoV-2 pueden derivarse de un efecto combinado de la proteína de pico del SARS-CoV-2 y las vías de señalización activadas por vectores de adenovirus. Revista Internacional de Ciencias Moleculares, 22(19), 10791. https://pubmed.ncbi.nlm.nih.gov/34804412/ | Long, B., Bridwell, R., & Gottlieb, M. (2021). Trombosis con síndrome de trombocitopenia asociada con vacunas COVID-19. The American Journal of Emergency Medicine, 49, 58-61. https://pubmed.ncbi.nlm.nih.gov/34706921/ | Kircheis, R. (2021). Coagulopathies after vaccination against SARS-CoV-2 may be derived from a combined effect of SARS-CoV-2 spike protein and adenovirus vector-triggered signaling pathways. International Journal of Molecular Sciences, 22(19), 10791. https://pubmed.ncbi.nlm.nih.gov/34639132/ | Luk, A., Clarke, B., Dahdah, N., Ducharme, A., Krahn, A., McCrindle, B., ... & McDonald, M. (2021). Myocarditis and pericarditis after Covid-19 mRNA vaccination: practical considerations for care providers. Canadian Journal of Cardiology, 37(10), 1629-1634. https://www.ncbi.nlm.nih.gov/pubmed/34375696 | Facetti, S., Giraldi, M., Vecchi, A. L., Rogiani, S., & Nassiacos, D. (2021). Acute myocarditis in a young adult two days after Pfizer vaccination. Giornale italiano di cardiologia (2006), 22(11), 891-893. | https://pubmed.ncbi.nlm.nih.gov/34709227/ | Facetti, S., Giraldi, M., Vecchi, A. L., Rogiani, S., & Nassiacos, D. (2021). Acute myocarditis in a young adult two days after Pfizer vaccination. Giornale italiano di cardiologia (2006), 22(11), 891-893. https://pubmed.ncbi.nlm.nih.gov/34709227/ | Obermann, M., Krasniqi, M., Ewers, N., Fayad, J., & Haeberle, U. (2021). Bell’s palsy following COVID-19 vaccination with high CSF antibody response. Neurological Sciences, 42(11), 4397-4399. https://pubmed.ncbi.nlm.nih.gov/34322761/. | ||||
529 | Cutaneous adverse reactions of 35,229 doses of COVID-19 Sinovac and AstraZeneca vaccine COVID-19: a prospective cohort study in health care workers: | https://pubmed.ncbi.nlm.nih.gov/34661934/ | https://pubmed.ncbi.nlm.nih.gov/34804412/ | Ifeanyi, N., Chinenye, N., Oladiran, O., David, E., Mmonu, C., & Ogbonna-Nwosu, C. (2021). Isolated pulmonary embolism following COVID vaccination: 2 case reports and a review of post-acute pulmonary embolism complications and follow-up. Journal of Community Hospital Internal Medicine Perspectives, 11(6), 877-879. | Ifeanyi, N., Chinenye, N., Oladiran, O., David, E., Mmonu, C. y Ogbonna-Nwosu, C. (2021). Embolia pulmonar aislada después de la vacunación contra COVID: informes de 2 casos y una revisión de las complicaciones y el seguimiento de la embolia pulmonar posaguda. Revista de perspectivas de medicina interna de hospitales comunitarios, 11(6), 877-879. https://pubmed.ncbi.nlm.nih.gov/34571653/. | Long, B., Bridwell, R., & Gottlieb, M. (2021). Trombosis con síndrome de trombocitopenia asociada con vacunas COVID-19. The American Journal of Emergency Medicine, 49, 58-61. https://www.sciencedirect.com/science/article/abs/pii/S0033062021000505 | Ifeanyi, N., Chinenye, N., Oladiran, O., David, E., Mmonu, C., & Ogbonna-Nwosu, C. (2021). Isolated pulmonary embolism following COVID vaccination: 2 case reports and a review of post-acute pulmonary embolism complications and follow-up. Journal of Community Hospital Internal Medicine Perspectives, 11(6), 877-879. https://pubmed.ncbi.nlm.nih.gov/34804412/ | Luk, A., Clarke, B., Dahdah, N., Ducharme, A., Krahn, A., McCrindle, B., ... & McDonald, M. (2021). Myocarditis and pericarditis after Covid-19 mRNA vaccination: practical considerations for care providers. Canadian Journal of Cardiology, 37(10), 1629-1634. https://www.sciencedirect.com/science/article/pii/S0828282X21006243 | Lim, Y., Kim, M. C., Kim, K. H., Jeong, I. S., Cho, Y. S., Choi, Y. D., & Lee, J. E. (2021). Case Report: Acute Fulminant Myocarditis and Cardiogenic Shock After Messenger RNA Coronavirus Disease 2019 Vaccination Requiring Extracorporeal Cardiopulmonary Resuscitation. Frontiers in Cardiovascular Medicine, 8. | https://pubmed.ncbi.nlm.nih.gov/34778411/ | Lim, Y., Kim, M. C., Kim, K. H., Jeong, I. S., Cho, Y. S., Choi, Y. D., & Lee, J. E. (2021). Case Report: Acute Fulminant Myocarditis and Cardiogenic Shock After Messenger RNA Coronavirus Disease 2019 Vaccination Requiring Extracorporeal Cardiopulmonary Resuscitation. Frontiers in Cardiovascular Medicine, 8. https://pubmed.ncbi.nlm.nih.gov/34778411/ | Öcal, O., Stecher, S. S., & Wildgruber, M. (2021). Portal vein thrombosis associated with ChAdOx1 nCov-19 vaccination. The lancet Gastroenterology & hepatology, 6(8), 676. https://www.thelancet.com/journals/langas/article/PIIS2468-1253(21)00197-7/ | ||||
530 | Comments on thrombosis after vaccination: spike protein leader sequence could be responsible for thrombosis and antibody-mediated thrombocytopenia: | https://pubmed.ncbi.nlm.nih.gov/34788138 | https://pubmed.ncbi.nlm.nih.gov/34571653/. | Endo, B., Bahamon, S., & Martínez-Pulgarín, D. F. (2021). Central retinal vein occlusion after mRNA SARS-CoV-2 vaccination: A case report. Indian journal of ophthalmology, 69(10), 2865. | Endo, B., Bahamon, S., & Martínez-Pulgarín, D. F. (2021). Oclusión de la vena central de la retina después de la vacunación con ARNm SARS-CoV-2: reporte de un caso. Revista india de oftalmología, 69(10), 2865. https://pubmed.ncbi.nlm.nih.gov/34835275/. | Long, B., Bridwell, R., & Gottlieb, M. (2021). Trombosis con síndrome de trombocitopenia asociada con vacunas COVID-19. The American Journal of Emergency Medicine, 49, 58-61. https://www.sciencedirect.com/science/article/pii/S1939455121000119. | Endo, B., Bahamon, S., & Martínez-Pulgarín, D. F. (2021). Central retinal vein occlusion after mRNA SARS-CoV-2 vaccination: A case report. Indian journal of ophthalmology, 69(10), 2865. https://pubmed.ncbi.nlm.nih.gov/34571653/. | Maayan, H., Kirgner, I., Gutwein, O., Herzog‐Tzarfati, K., Rahimi‐Levene, N., Koren‐Michowitz, M., & Blickstein, D. (2021). Acquired thrombotic thrombocytopenic purpura: A rare disease associated with BNT162b2 vaccine. Journal of Thrombosis and Haemostasis, 19(9), 2314-2317. https://pubmed.ncbi.nlm.nih.gov/34105247/. | Joob, B., & Wiwanitkit, V. (2021). Acute myocarditis after coronavirus disease 2019 vaccination. Anatolian Journal of Cardiology, 25(11), 841. | https://pubmed.ncbi.nlm.nih.gov/34734821/ | Joob, B., & Wiwanitkit, V. (2021). Acute myocarditis after coronavirus disease 2019 vaccination. Anatolian Journal of Cardiology, 25(11), 841. https://pubmed.ncbi.nlm.nih.gov/34734821/ | Ogbebor, O., Seth, H., Min, Z., & Bhanot, N. (2021). Guillain-Barré syndrome following the first dose of SARS-CoV-2 vaccine: a temporal occurrence, not a causal association. IDCases, 24, e01143. https://www.sciencedirect.com/science/article/pii/S2214250921000998. | ||||
531 | Eosinophilic dermatosis after AstraZeneca COVID-19 vaccination: | https://pubmed.ncbi.nlm.nih.gov/34753210/. | https://pubmed.ncbi.nlm.nih.gov/34835275/. | Günther, A., Brämer, D., Pletz, M. W., Kamradt, T., Baumgart, S., Mayer, T. E., ... & Thiele, T. (2021). Complicated Long Term Vaccine Induced Thrombotic Immune Thrombocytopenia—A Case Report. Vaccines, 9(11), 1344. | Günther, A., Brämer, D., Pletz, MW, Kamradt, T., Baumgart, S., Mayer, TE, ... y Thiele, T. (2021). Trombocitopenia inmunitaria trombótica complicada a largo plazo inducida por vacunas: informe de un caso. Vacunas, 9(11), 1344. https://pubmed.ncbi.nlm.nih.gov/34659839/. | Lorente, E. (2021). Ipiopático Ipsilateral externo Vena Jugular de trombophlebitis después de la enfermedad de la enfermedad de Coronavirus (COVID-19). Ajr am j Roentgenol, 767-767. https://pubmed.ncbi.nlm.nih.gov/34612003/ | Günther, A., Brämer, D., Pletz, M. W., Kamradt, T., Baumgart, S., Mayer, T. E., ... & Thiele, T. (2021). Complicated Long Term Vaccine Induced Thrombotic Immune Thrombocytopenia—A Case Report. Vaccines, 9(11), 1344. https://pubmed.ncbi.nlm.nih.gov/34835275/. | MacIntyre, C. R., Veness, B., Berger, D., Hamad, N., & Bari, N. (2021). Thrombosis with Thrombocytopenia Syndrome (TTS) following AstraZeneca ChAdOx1 nCoV-19 (AZD1222) COVID-19 vaccination–A risk–benefit analysis for people< 60 years in Australia. Vaccine, 39(34), 4784-4787. https://pubmed.ncbi.nlm.nih.gov/34272095/ | Choi, Y. K., Moon, J. Y., Kim, J., Yoo, I. S., Kwon, G. Y., Bae, H., ... & Kym, S. (2022). Postvaccination multisystem inflammatory syndrome in adult with no evidence of prior SARS-CoV-2 Infection. Emerging infectious diseases, 28(2), 411. | https://pubmed.ncbi.nlm.nih.gov/34852213/ | Choi, Y. K., Moon, J. Y., Kim, J., Yoo, I. S., Kwon, G. Y., Bae, H., ... & Kym, S. (2022). Postvaccination multisystem inflammatory syndrome in adult with no evidence of prior SARS-CoV-2 Infection. Emerging infectious diseases, 28(2), 411. https://pubmed.ncbi.nlm.nih.gov/34852213/ | Okada, Y., Sakai, R., Sato-Fitoussi, M., Nodera, M., Yoshinaga, S., Shibata, A., ... & Amano, K. (2021). Potential triggers for thrombocytopenia and/or hemorrhage by the BNT162b2 vaccine, Pfizer-BioNTech. Frontiers in Medicine, 8. https://pubmed.ncbi.nlm.nih.gov/34660652/. | ||||
532 | Severe immune thrombocytopenia following COVID-19 vaccination: report of four cases and review of the literature: | https://pubmed.ncbi.nlm.nih.gov/34653943/. | https://pubmed.ncbi.nlm.nih.gov/34659839/. | Hussain, H., Sehring, M., & Soriano, S. (2021). Deep Venous Thrombosis after Ad26. COV2. S Vaccination in Adult Male. Case Reports in Critical Care, 2021. | Hussain, H., Sehring, M. y Soriano, S. (2021). Trombosis venosa profunda tras Ad26. COV2. Vacunación S en Varón Adulto. Informes de casos en cuidados críticos, 2021. https://pubmed.ncbi.nlm.nih.gov/34668274/. | Luk, A., Clarke, B., Dahdah, N., Ducharme, A., Krahn, A., McCrindle, B., ... & McDonald, M. (2021). Miocarditis y pericarditis después de la vacunación con ARNm de COVID-19: consideraciones prácticas para los proveedores de atención. Revista canadiense de cardiología, 37 (10), 1629-1634. https://www.ncbi.nlm.nih.gov/pubmed/34791081 | Hussain, H., Sehring, M., & Soriano, S. (2021). Deep Venous Thrombosis after Ad26. COV2. S Vaccination in Adult Male. Case Reports in Critical Care, 2021. https://pubmed.ncbi.nlm.nih.gov/34659839/. | Madelon, N., Lauper, K., Breville, G., Sabater Royo, I., Goldstein, R., Andrey, D. O., ... & Eberhardt, C. S. (2021). Robust T cell responses in anti-CD20 treated patients following COVID-19 vaccination: a prospective cohort study. Clinical Infectious Diseases. https://www.ncbi.nlm.nih.gov/pubmed/34791081 | Maeda, M., Isawa, T., & Tada, N. (2021). Definite Acute Myocarditis After Coronavirus Disease 2019 mRNA Vaccination. Circulation Journal, CJ-21. | https://pubmed.ncbi.nlm.nih.gov/34866122/ | Maeda, M., Isawa, T., & Tada, N. (2021). Definite Acute Myocarditis After Coronavirus Disease 2019 mRNA Vaccination. Circulation Journal, CJ-21. https://pubmed.ncbi.nlm.nih.gov/34866122/ | Okuda, S., Hirooka, Y., & Sugiyama, M. (2021). Propylthiouracil-Induced Antineutrophil Cytoplasmic Antibody-Associated Vasculitis after COVID-19 Vaccination. Vaccines, 9(8), 842. https://pubmed.ncbi.nlm.nih.gov/34451967/ | ||||
533 | Relapse of immune thrombocytopenia after COVID-19 vaccination: | https://pubmed.ncbi.nlm.nih.gov/34591991/ | https://pubmed.ncbi.nlm.nih.gov/34668274/. | Kaulen, L. D., Doubrovinskaia, S., Mooshage, C., Jordan, B., Purrucker, J., Haubner, C., ... & Schönenberger, S. (2022). Neurological autoimmune diseases following vaccinations against SARS‐CoV‐2: a case series. European Journal of Neurology, 29(2), 555-563. | Kaulen, L. D., Doubrovinskaia, S., Mooshage, C., Jordan, B., Purrucker, J., Haubner, C., ... y Schönenberger, S. (2022). Enfermedades neurológicas autoinmunes tras la vacunación contra el SARS-CoV-2: una serie de casos. Revista europea de neurología, 29(2), 555-563. https://pubmed.ncbi.nlm.nih.gov/34549821/ | Luk, A., Clarke, B., Dahdah, N., Ducharme, A., Krahn, A., McCrindle, B., ... & McDonald, M. (2021). Miocarditis y pericarditis después de la vacunación con ARNm de COVID-19: consideraciones prácticas para los proveedores de atención. Revista canadiense de cardiología, 37 (10), 1629-1634. https://www.sciencedirect.com/science/article/pii/S2666572721000389 | Kaulen, L. D., Doubrovinskaia, S., Mooshage, C., Jordan, B., Purrucker, J., Haubner, C., ... & Schönenberger, S. (2022). Neurological autoimmune diseases following vaccinations against SARS‐CoV‐2: a case series. European Journal of Neurology, 29(2), 555-563. https://pubmed.ncbi.nlm.nih.gov/34668274/. | Maeda, M., Isawa, T., & Tada, N. (2021). Definite Acute Myocarditis After Coronavirus Disease 2019 mRNA Vaccination. Circulation Journal, CJ-21. https://pubmed.ncbi.nlm.nih.gov/34866122/ | Maki, H., Aikawa, T., Ibe, T., Oyama-Manabe, N., & Fujita, H. (2022). Biventricular systolic dysfunction in acute myocarditis after SARS-CoV-2 mRNA-1273 vaccination. European Heart Journal-Cardiovascular Imaging, 23(2), e87-e87. | https://pubmed.ncbi.nlm.nih.gov/34601566/ | Maki, H., Aikawa, T., Ibe, T., Oyama-Manabe, N., & Fujita, H. (2022). Biventricular systolic dysfunction in acute myocarditis after SARS-CoV-2 mRNA-1273 vaccination. European Heart Journal-Cardiovascular Imaging, 23(2), e87-e87. https://pubmed.ncbi.nlm.nih.gov/34601566/ | Onderko, L., Starobin, B., Riviere, A. E., Hohl, P. K., Phillips, C. T., Morgan, R. B., ... & Afari, M. E. (2021). Myocarditis in the Setting of Recent COVID-19 Vaccination. Case Reports in Cardiology, 2021. https://pubmed.ncbi.nlm.nih.gov/34712497/. | ||||
534 | Thrombosis in pre- and post-vaccination phase of COVID-19; | https://pubmed.ncbi.nlm.nih.gov/34650382/ | https://pubmed.ncbi.nlm.nih.gov/34549821/ | Gadi, S. R., Brunker, P. A., Al‐Samkari, H., Sykes, D. B., Saff, R. R., Lo, J., ... & Leaf, R. K. (2021). Severe autoimmune hemolytic anemia following receipt of SARS‐CoV‐2 mRNA vaccine. Transfusion, 61(11), 3267-3271. | Gadi, S. R., Brunker, P. A., Al‐Samkari, H., Sykes, D. B., Saff, R. R., Lo, J., ... y Leaf, R. K. (2021). Anemia hemolítica autoinmune grave después de recibir la vacuna de ARNm del SARS-CoV-2. Transfusión, 61(11), 3267-3271. https://pubmed.ncbi.nlm.nih.gov/34528522/ | Maayan, H., Kirgner, I., Gutwein, O., Herzog-Tzarfati, K., Rahimi-Levene, N., Koren-Michowitz, M., & Blickstein, D. (2021). Púrpura trombocitopénica trombótica adquirida: una enfermedad rara asociada con la vacuna BNT162B2. Diario de trombosis y haemostasis, 19 (9), 2314-2317. https://pubmed.ncbi.nlm.nih.gov/34405870/. | Gadi, S. R., Brunker, P. A., Al‐Samkari, H., Sykes, D. B., Saff, R. R., Lo, J., ... & Leaf, R. K. (2021). Severe autoimmune hemolytic anemia following receipt of SARS‐CoV‐2 mRNA vaccine. Transfusion, 61(11), 3267-3271. https://pubmed.ncbi.nlm.nih.gov/34549821/ | Majid, I., & Mearaj, S. (2021). Sweet syndrome after Oxford‐AstraZeneca COVID‐19 vaccine (AZD1222) in an elderly female. Dermatologic Therapy, 34(6), e15146. https://pubmed.ncbi.nlm.nih.gov/34590397/ | Oo, W. M., Giri, P., & De Souza, A. (2021). AstraZeneca COVID-19 vaccine and Guillain-Barré Syndrome in Tasmania: A causal link?. Journal of neuroimmunology, 360, 577719. | https://pubmed.ncbi.nlm.nih.gov/34560365/ | Oo, W. M., Giri, P., & De Souza, A. (2021). AstraZeneca COVID-19 vaccine and Guillain-Barré Syndrome in Tasmania: A causal link?. Journal of neuroimmunology, 360, 577719. https://pubmed.ncbi.nlm.nih.gov/34560365/ | Oo, W. M., Giri, P., & De Souza, A. (2021). AstraZeneca COVID-19 vaccine and Guillain-Barré Syndrome in Tasmania: A causal link?. Journal of neuroimmunology, 360, 577719. https://pubmed.ncbi.nlm.nih.gov/34560365/ | ||||
535 | A look at the role of postmortem immunohistochemistry in understanding the inflammatory pathophysiology of COVID-19 disease and vaccine-related thrombotic adverse events: a narrative review: | https://pubmed.ncbi.nlm.nih.gov/34769454/ | https://pubmed.ncbi.nlm.nih.gov/34528522/ | Vaishya, R., Sibal, A., Singh, S. K., Malani, A., & Das, S. (2021). Emergence of COVID-19 variants among ChAdOx1 nCoV-19 (recombinant) vaccine recipients. The Indian journal of medical research, 153(5-6), 559. | Vaishya, R., Sibal, A., Singh, S. K., Malani, A. y Das, S. (2021). Aparición de variantes de COVID-19 entre los receptores de la vacuna ChAdOx1 nCoV-19 (recombinante). La revista india de investigación médica, 153(5-6), 559. https://pubmed.ncbi.nlm.nih.gov/34568726/ | Macintyre, C. R., Vidad, B., Berger, D., Hamad, N., & Bari, N. (2021). Trombosis con síndrome de trombocitopenia (TTS) después de AstraZeneca Chadox1 NCOV-19 (AZD1222) COVID-19 Vacunación: un análisis de riesgo-beneficio para personas <60 años en Australia. Vacuna, 39 (34), 4784-4787. https://pubmed.ncbi.nlm.nih.gov/34165512/ | Vaishya, R., Sibal, A., Singh, S. K., Malani, A., & Das, S. (2021). Emergence of COVID-19 variants among ChAdOx1 nCoV-19 (recombinant) vaccine recipients. The Indian journal of medical research, 153(5-6), 559. https://pubmed.ncbi.nlm.nih.gov/34528522/ | Major, A., Carll, T., Chan, C. W., Christenson, C., Aldarweesh, F., Wool, G. D., & Cohen, K. S. (2022). Refractory vaccine‐induced immune thrombotic thrombocytopenia (VITT) managed with delayed therapeutic plasma exchange (TPE). Journal of clinical apheresis, 37(1), 117-121. https://pubmed.ncbi.nlm.nih.gov/34672380/ | Aomar-Millán, I. F., de Victoria-Carazo, J. M., Peregrina-Rivas, J. A., & Villegas-Rodríguez, I. (2021). COVID-19, Guillain-Barré syndrome, and the vaccine. A dangerous combination. Revista clinica espanola. | https://pubmed.ncbi.nlm.nih.gov/34108736/. | Aomar-Millán, I. F., de Victoria-Carazo, J. M., Peregrina-Rivas, J. A., & Villegas-Rodríguez, I. (2021). COVID-19, Guillain-Barré syndrome, and the vaccine. A dangerous combination. Revista clinica espanola. https://pubmed.ncbi.nlm.nih.gov/34108736/. | Osowicki, J., Morgan, H., Harris, A., Crawford, N. W., Buttery, J. P., & Kiers, L. (2021). Guillain-Barré Syndrome in an Australian state using both mRNA and adenovirus-vector SARS-CoV-2 vaccines. Annals of Neurology, 90(5), 856-858. https://onlinelibrary.wiley.com/doi/10.1002/ana.26218. | ||||
536 | COVID-19 vaccine in patients with hypercoagulability disorders: a clinical perspective: | https://pubmed.ncbi.nlm.nih.gov/34786893/ | https://pubmed.ncbi.nlm.nih.gov/34568726/ | Uaprasert, N., Watanaboonyongcharoen, P., Vichitratchaneekorn, R., Trithiphen, S., Akkawat, B., Sukperm, A., ... & Rojnuckarin, P. (2021). Prevalence of thrombocytopenia, anti–platelet factor 4 antibodies and D‐dimer elevation in Thai people After ChAdOx1 nCoV‐19 vaccination. Research and Practice in Thrombosis and Haemostasis, 5(6), e12580. | Uaprasert, N., Watanaboonyongcharoen, P., Vichitratchaneekorn, R., Trithiphen, S., Akkawat, B., Sukperm, A., ... y Rojnuckarin, P. (2021). Prevalencia de trombocitopenia, anticuerpos antifactor plaquetario 4 y elevación del dímero D en tailandeses después de la vacunación ChAdOx1 nCoV-19. Investigación y práctica en trombosis y hemostasia, 5(6), e12580. https://academic.oup.com/cid/advance-article-abstract/doi/10.1093/cid/ciab989/6445179 | Madelon, N., Lauper, K., Breville, G., Sabater Royo, I., Goldstein, R., Andrey, D. O., ... & EBERHARDT, C. S. (2021). Robustas respuestas de células T en pacientes tratados con anti-CD20 después de la vacunación de COVID-19: un estudio prospectivo de cohorte. Enfermedades infecciosas clínicas. https://www.ncbi.nlm.nih.gov/pubmed/34676123 | Uaprasert, N., Watanaboonyongcharoen, P., Vichitratchaneekorn, R., Trithiphen, S., Akkawat, B., Sukperm, A., ... & Rojnuckarin, P. (2021). Prevalence of thrombocytopenia, anti–platelet factor 4 antibodies and D‐dimer elevation in Thai people After ChAdOx1 nCoV‐19 vaccination. Research and Practice in Thrombosis and Haemostasis, 5(6), e12580. https://pubmed.ncbi.nlm.nih.gov/34568726/ | Maki, H., Aikawa, T., Ibe, T., Oyama-Manabe, N., & Fujita, H. (2022). Biventricular systolic dysfunction in acute myocarditis after SARS-CoV-2 mRNA-1273 vaccination. European Heart Journal-Cardiovascular Imaging, 23(2), e87-e87. https://pubmed.ncbi.nlm.nih.gov/34601566/ | Bouattour, N., Hdiji, O., Sakka, S., Fakhfakh, E., Moalla, K., Daoud, S., ... & Mhiri, C. (2022). Guillain-Barré syndrome following the first dose of Pfizer-BioNTech COVID-19 vaccine: case report and review of reported cases. Neurological Sciences, 43(2), 755-761. | https://pubmed.ncbi.nlm.nih.gov/34796417/. | Bouattour, N., Hdiji, O., Sakka, S., Fakhfakh, E., Moalla, K., Daoud, S., ... & Mhiri, C. (2022). Guillain-Barré syndrome following the first dose of Pfizer-BioNTech COVID-19 vaccine: case report and review of reported cases. Neurological Sciences, 43(2), 755-761. https://pubmed.ncbi.nlm.nih.gov/34796417/. | Ostrowski, S. R., Søgaard, O. S., Tolstrup, M., Stærke, N. B., Lundgren, J., Østergaard, L., & Hvas, A. M. (2021). Inflammation and Platelet Activation After COVID-19 Vaccines-Possible Mechanisms Behind Vaccine-Induced Immune Thrombocytopenia and Thrombosis. Frontiers in immunology, 12, 779453-779453. https://pubmed.ncbi.nlm.nih.gov/34887867/. | ||||
537 | Vaccine-associated thrombocytopenia and thrombosis: venous endotheliopathy leading to combined venous micro-macrothrombosis: | https://pubmed.ncbi.nlm.nih.gov/34833382/ | https://academic.oup.com/cid/advance-article-abstract/doi/10.1093/cid/ciab989/6445179 | Chua, G. T., Kwan, M. Y. W., Chui, C. S., Smith, R. D., Cheung, E. C. L., Tian, T., ... & Ip, P. (2021). Epidemiology of Acute Myocarditis/Pericarditis in Hong Kong Adolescents Following Comirnaty Vaccination. Clinical Infectious Diseases. | Chua, G. T., Kwan, M. Y. W., Chui, C. S., Smith, R. D., Cheung, E. C. L., Tian, T., ... & Ip, P. (2021). Epidemiología de la miocarditis/pericarditis aguda en adolescentes de Hong Kong después de la vacunación comunitaria. Enfermedades Infecciosas Clínicas. https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciab926/6420408 | Maeda, M., Isawa, T., & Tada, N. (2021). Myocarditis aguda definida después de la enfermedad de la enfermedad de Coronavirus 2019. Diario de circulación, CJ-21. https://pubmed.ncbi.nlm.nih.gov/34601566/ | Chua, G. T., Kwan, M. Y. W., Chui, C. S., Smith, R. D., Cheung, E. C. L., Tian, T., ... & Ip, P. (2021). Epidemiology of Acute Myocarditis/Pericarditis in Hong Kong Adolescents Following Comirnaty Vaccination. Clinical Infectious Diseases. https://academic.oup.com/cid/advance-article-abstract/doi/10.1093/cid/ciab989/6445179 | Malamud, E., Otallah, S. I., Caress, J. B., & Lapid, D. J. (2022). Guillain-Barré Syndrome After COVID-19 Vaccination in an Adolescent. Pediatric neurology, 126, 9-10. https://www.pedneur.com/article/S0887-8994(21)00221-6/fulltext. | Trimboli, M., Zoleo, P., Arabia, G., & Gambardella, A. (2021). Guillain-Barré syndrome following BNT162b2 COVID-19 vaccine. Neurological Sciences, 42(11), 4401-4402. | https://link.springer.com/article/10.1007%2Fs10072-021-05523-5. | Trimboli, M., Zoleo, P., Arabia, G., & Gambardella, A. (2021). Guillain-Barré syndrome following BNT162b2 COVID-19 vaccine. Neurological Sciences, 42(11), 4401-4402. https://link.springer.com/article/10.1007%2Fs10072-021-05523-5. | Özdemir, İ. H., Özlek, B., Özen, M. B., Gündüz, R., & Bayturan, Ö. (2021). Type 1 Kounis syndrome induced by inactivated SARS-COV-2 vaccine. The Journal of Emergency Medicine, 61(4), e71-e76. https://pubmed.ncbi.nlm.nih.gov/34148772/ | ||||
538 | Thrombosis and thrombocytopenia syndrome causing isolated symptomatic carotid occlusion after COVID-19 Ad26.COV2.S vaccine (Janssen): | https://pubmed.ncbi.nlm.nih.gov/34670287/ | https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciab926/6420408 | Perez, Y., Levy, E. R., Joshi, A. Y., Virk, A., Rodriguez-Porcel, M., Johnson, M., ... & Swift, M. D. (2021). Myocarditis Following COVID-19 mRNA Vaccine: A Case Series and Incidence Rate Determination. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America. | Pérez, Y., Levy, E. R., Joshi, A. Y., Virk, A., Rodríguez-Porcel, M., Johnson, M., ... y Swift, M. D. (2021). Miocarditis después de la vacuna de ARNm de COVID-19: una serie de casos y determinación de la tasa de incidencia. Enfermedades infecciosas clínicas: una publicación oficial de la Sociedad de Enfermedades Infecciosas de América. https://www.mdpi.com/2075-4426/11/11/1106 | MAJID, I., & MEARAJ, S. (2021). Síndrome dulce después de la vacuna Oxford-AstraZeneca COVID-19 (AZD1222) en una mujer mayor. Terapia dermatológica, 34 (6), E15146. https://pubmed.ncbi.nlm.nih.gov/34670143/. | Perez, Y., Levy, E. R., Joshi, A. Y., Virk, A., Rodriguez-Porcel, M., Johnson, M., ... & Swift, M. D. (2021). Myocarditis Following COVID-19 mRNA Vaccine: A Case Series and Incidence Rate Determination. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America. https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciab926/6420408 | Malayala, S. V., Mohan, G., Vasireddy, D., & Atluri, P. (2021). Purpuric rash and thrombocytopenia after the mRNA-1273 (Moderna) COVID-19 vaccine. Cureus, 13(3). https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7996471/ | Woo, E. J., Mba-Jonas, A., Dimova, R. B., Alimchandani, M., Zinderman, C. E., & Nair, N. (2021). Association of receipt of the Ad26. COV2. S COVID-19 vaccine with presumptive Guillain-Barré syndrome, February-July 2021. JAMA, 326(16), 1606-1613. | https://jamanetwork.com/journals/jama/fullarticle/2785009 | Woo, E. J., Mba-Jonas, A., Dimova, R. B., Alimchandani, M., Zinderman, C. E., & Nair, N. (2021). Association of receipt of the Ad26. COV2. S COVID-19 vaccine with presumptive Guillain-Barré syndrome, February-July 2021. JAMA, 326(16), 1606-1613. https://jamanetwork.com/journals/jama/fullarticle/2785009 | Özütemiz, C., Krystosek, L. A., Church, A. L., Chauhan, A., Ellermann, J. M., Domingo-Musibay, E., & Steinberger, D. (2021). Lymphadenopathy in COVID-19 vaccine recipients: diagnostic dilemma in oncologic patients. Radiology, 300(1), E296-E300. https://pubmed.ncbi.nlm.nih.gov/33625300/ | ||||
539 | An unusual presentation of acute deep vein thrombosis after Modern COVID-19 vaccine: case report: | https://pubmed.ncbi.nlm.nih.gov/34790811/ | https://www.mdpi.com/2075-4426/11/11/1106 | Li, M., Yuan, J., Lv, G., Brown, J., Jiang, X., & Lu, Z. K. (2021). Myocarditis and Pericarditis following COVID-19 Vaccination: Inequalities in Age and Vaccine Types. Journal of personalized medicine, 11(11), 1106. | Li, M., Yuan, J., Lv, G., Brown, J., Jiang, X. y Lu, ZK (2021). Miocarditis y pericarditis después de la vacunación COVID-19: desigualdades en edad y tipos de vacuna. Revista de medicina personalizada, 11(11), 1106. https://pubmed.ncbi.nlm.nih.gov/34402230/ | Maki, H., AIKAWA, T., IBE, T., Oyama-Manabe, N., & Fujita, H. (2022). Disfunción sistólica biventricular en miocarditis aguda después de la vacunación con MRNA-1273 SARS-COV-2. Imagen europea de la revista Heart-Cardiovascular, 23 (2), E87-E87. https://pubmed.ncbi.nlm.nih.gov/34739045/. | Li, M., Yuan, J., Lv, G., Brown, J., Jiang, X., & Lu, Z. K. (2021). Myocarditis and Pericarditis following COVID-19 Vaccination: Inequalities in Age and Vaccine Types. Journal of personalized medicine, 11(11), 1106. https://www.mdpi.com/2075-4426/11/11/1106 | Malayala, S. V., Papudesi, B. N., Sharma, R., Vusqa, U. T., & Raza, A. (2021). A case of idiopathic thrombocytopenic purpura after booster dose of BNT162b2 (Pfizer-Biontech) COVID-19 vaccine. Cureus, 13(10). https://pubmed.ncbi.nlm.nih.gov/34820240/ | Rao, S. J., Khurana, S., Murthy, G., Dawson, E. T., Jazebi, N., & Haas, C. J. (2021). A case of Guillain–Barre syndrome following Pfizer COVID-19 vaccine. Journal of Community Hospital Internal Medicine Perspectives, 11(5), 597-600. | https://pubmed.ncbi.nlm.nih.gov/34567447/ | Rao, S. J., Khurana, S., Murthy, G., Dawson, E. T., Jazebi, N., & Haas, C. J. (2021). A case of Guillain–Barre syndrome following Pfizer COVID-19 vaccine. Journal of Community Hospital Internal Medicine Perspectives, 11(5), 597-600. https://pubmed.ncbi.nlm.nih.gov/34567447/ | Pagenkopf, C., & Südmeyer, M. (2021). A case of longitudinally extensive transverse myelitis following vaccination against Covid-19. Journal of Neuroimmunology, 358, 577606. https://pubmed.ncbi.nlm.nih.gov/34182207/ | ||||
540 | Immediate high-dose intravenous immunoglobulins followed by direct treatment with thrombin inhibitors is crucial for survival in vaccine-induced immune thrombotic thrombocytopenia Sars-Covid-19-vector adenoviral VITT with venous thrombosis of the cerebral sinus and portal vein: | https://pubmed.ncbi.nlm.nih.gov/34023956/. | https://pubmed.ncbi.nlm.nih.gov/34402230/ | Park, H., Yun, K. W., Kim, K. R., Song, S. H., Ahn, B., Kim, D. R., ... & Kim, Y. J. (2021). Epidemiology and Clinical Features of Myocarditis/Pericarditis before the Introduction of mRNA COVID-19 Vaccine in Korean Children: a Multicenter Study. Journal of Korean Medical Science, 36(32). | Park, H., Yun, K. W., Kim, K. R., Song, S. H., Ahn, B., Kim, D. R., ... y Kim, Y. J. (2021). Epidemiología y características clínicas de la miocarditis/pericarditis antes de la introducción de la vacuna de ARNm COVID-19 en niños coreanos: un estudio multicéntrico. Revista de ciencia médica coreana, 36(32). https://pubmed.ncbi.nlm.nih.gov/34696294/ | Malamud, E., Otallah, S. I., Caress, J. B., & Lapid, D. J. (2022). Síndrome de Guillain-Barré después de la vacunación COVID-19 en un adolescente. Neurología pediátrica, 126, 9-10. https://pubmed.ncbi.nlm.nih.gov/34114256/. | Park, H., Yun, K. W., Kim, K. R., Song, S. H., Ahn, B., Kim, D. R., ... & Kim, Y. J. (2021). Epidemiology and Clinical Features of Myocarditis/Pericarditis before the Introduction of mRNA COVID-19 Vaccine in Korean Children: a Multicenter Study. Journal of Korean Medical Science, 36(32). https://pubmed.ncbi.nlm.nih.gov/34402230/ | Malik, B., Kalantary, A., Rikabi, K., & Kunadi, A. (2021). Pulmonary embolism, transient ischaemic attack and thrombocytopenia after the Johnson & Johnson COVID-19 vaccine. BMJ Case Reports CP, 14(7), e243975. https://pubmed.ncbi.nlm.nih.gov/34261635/ | Shao, S. C., Wang, C. H., Chang, K. C., Hung, M. J., Chen, H. Y., & Liao, S. C. (2021). Guillain- Barré Syndrome Associated with COVID-19 Vaccination. Emerging infectious diseases, 27(12), 3175. | https://pubmed.ncbi.nlm.nih.gov/34648420/. | Shao, S. C., Wang, C. H., Chang, K. C., Hung, M. J., Chen, H. Y., & Liao, S. C. (2021). Guillain- Barré Syndrome Associated with COVID-19 Vaccination. Emerging infectious diseases, 27(12), 3175. https://pubmed.ncbi.nlm.nih.gov/34648420/. | Palaiodimou, L., Stefanou, M. I., Katsanos, A. H., de Sousa, D. A., Coutinho, J. M., Lagiou, P., ... & Tsivgoulis, G. (2021). Cerebral venous sinus thrombosis and thrombotic events after vector-based COVID-19 vaccines: a systematic review and meta-analysis. Neurology, 97(21), e2136-e2147. https://pubmed.ncbi.nlm.nih.gov/34610990/. | ||||
541 | Thrombosis formation after COVID-19 vaccination immunologic aspects: review article: | https://pubmed.ncbi.nlm.nih.gov/34629931/ | https://pubmed.ncbi.nlm.nih.gov/34696294/ | Hajjo, R., Sabbah, D. A., Bardaweel, S. K., & Tropsha, A. (2021). Shedding the Light on Post-Vaccine Myocarditis and Pericarditis in COVID-19 and Non-COVID-19 Vaccine Recipients. Vaccines, 9(10), 1186. | Hajjo, R., Sabbah, D. A., Bardaweel, S. K. y Tropsha, A. (2021). Arrojando luz sobre la miocarditis y pericarditis posvacunación en receptores de la vacuna COVID-19 y no COVID-19. Vacunas, 9(10), 1186. https://journals.lww.com/pec-online/Abstract/2021/11000/Myocarditis_Following_mRNA_COVID_19_Vaccine.9.aspx | Malayala, S. V., Mohan, G., VasiReddy, D., & Atluri, P. (2021). Erupción purpúrica y trombocitopenia después del MRNA-1273 (MODERNA) COVID-19 VACUNA. CUREUS, 13 (3). https://pubmed.ncbi.nlm.nih.gov/33863748/ | Hajjo, R., Sabbah, D. A., Bardaweel, S. K., & Tropsha, A. (2021). Shedding the Light on Post-Vaccine Myocarditis and Pericarditis in COVID-19 and Non-COVID-19 Vaccine Recipients. Vaccines, 9(10), 1186. https://pubmed.ncbi.nlm.nih.gov/34696294/ | Mangat, C., & Milosavljevic, N. (2021). BNT162b2 Vaccination during Pregnancy Protects Both the Mother and Infant: Anti-SARS-CoV-2 S Antibodies Persistently Positive in an Infant at 6 Months of Age. Case Reports in Pediatrics, 2021. https://www.ncbi.nlm.nih.gov/pubmed/34676123 | David, S. S. B., Potasman, I., & Rahamim-Cohen, D. (2021). Rate of recurrent guillain-barré syndrome after mRNA COVID-19 vaccine BNT162b2. JAMA neurology, 78(11), 1409-1411. | https://jamanetwork.com/journals/jamaneurology/fullarticle/2783708 | David, S. S. B., Potasman, I., & Rahamim-Cohen, D. (2021). Rate of recurrent guillain-barré syndrome after mRNA COVID-19 vaccine BNT162b2. JAMA neurology, 78(11), 1409-1411. https://jamanetwork.com/journals/jamaneurology/fullarticle/2783708 | Pan, L., Zhang, Y., Cui, Y., & Wu, X. (2021). Bilateral uveitis after inoculation with COVID-19 vaccine: A case report. International Journal of Infectious Diseases, 113, 116-118. https://www.sciencedirect.com/science/article/pii/S1201971221007797 | ||||
542 | Imaging and hematologic findings in thrombosis and thrombocytopenia after vaccination with ChAdOx1 nCoV-19 (AstraZeneca): | https://pubmed.ncbi.nlm.nih.gov/34402666/ | https://journals.lww.com/pec-online/Abstract/2021/11000/Myocarditis_Following_mRNA_COVID_19_Vaccine.9.aspx | Visclosky, T., Theyyunni, N., Klekowski, N., & Bradin, S. (2021). Myocarditis Following mRNA COVID-19 Vaccine. Pediatric emergency care, 37(11), 583-584. | Visclosky, T., Theyyunni, N., Klekowski, N. y Bradin, S. (2021). Miocarditis después de la vacuna de ARNm COVID-19. Atención de emergencia pediátrica, 37(11), 583-584. https://pubmed.ncbi.nlm.nih.gov/34614328/. | Malayala, S. V., Papudesi, B. N., Sharma, R., Vusqa, U. T., & Raza, A. (2021). Un caso de purpura trombocitopénica idiopática después de la dosis de refuerzo de la vacuna COVID-19 BNT162B2 (Pfizer-BionTech). CUREUS, 13 (10). https://pubmed.ncbi.nlm.nih.gov/33851389/ | Visclosky, T., Theyyunni, N., Klekowski, N., & Bradin, S. (2021). Myocarditis Following mRNA COVID-19 Vaccine. Pediatric emergency care, 37(11), 583-584. https://journals.lww.com/pec-online/Abstract/2021/11000/Myocarditis_Following_mRNA_COVID_19_Vaccine.9.aspx | Maniscalco, G. T., Manzo, V., Di Battista, M. E., Salvatore, S., Moreggia, O., Scavone, C., & Capuano, A. (2021). Severe multiple sclerosis relapse after COVID-19 vaccination: a case report. Frontiers in Neurology, 1398. https://pubmed.ncbi.nlm.nih.gov/34447349/ | Malamud, E., Otallah, S. I., Caress, J. B., & Lapid, D. J. (2022). Guillain-Barré Syndrome After COVID-19 Vaccination in an Adolescent. Pediatric neurology, 126, 9-10. | https://www.pedneur.com/article/S0887-8994(21)00221-6/fulltext. | Malamud, E., Otallah, S. I., Caress, J. B., & Lapid, D. J. (2022). Guillain-Barré Syndrome After COVID-19 Vaccination in an Adolescent. Pediatric neurology, 126, 9-10. https://www.pedneur.com/article/S0887-8994(21)00221-6/fulltext. | Panovska-Stavridis, I., Pivkova-Veljanovska, A., Trajkova, S., Lazarevska, M., Grozdanova, A., & Filipche, V. (2021). A rare case of superior ophthalmic vein thrombosis and thrombocytopenia following ChAdOx1 nCoV-19 vaccine against SARS-CoV-2. Mediterranean Journal of Hematology and Infectious Diseases, 13(1). https://pubmed.ncbi.nlm.nih.gov/34276917/ | ||||
543 | Spectrum of neuroimaging findings in post-CoVID-19 vaccination: a case series and review of the literature: | https://pubmed.ncbi.nlm.nih.gov/34842783/ | https://pubmed.ncbi.nlm.nih.gov/34614328/. | Mevorach, D., Anis, E., Cedar, N., Bromberg, M., Haas, E. J., Nadir, E., ... & Alroy-Preis, S. (2021). Myocarditis after BNT162b2 mRNA vaccine against Covid-19 in Israel. New England Journal of Medicine, 385(23), 2140-2149. | Mevorach, D., Anis, E., Cedar, N., Bromberg, M., Haas, E. J., Nadir, E., ... y Alroy-Preis, S. (2021). Miocarditis tras la vacuna de ARNm BNT162b2 contra Covid-19 en Israel. Revista de Medicina de Nueva Inglaterra, 385(23), 2140-2149. https://www.heartlungcirc.org/article/S1443-9506(21)01156-2/fulltext | Malik, B., Kalantario, A., Rikabi, K., & Kunadi, A. (2021). Embolia pulmonar, ataque isquémico transitorio y trombocitopenia después de la vacuna Johnson & Johnson Covid-19. BMJ Case Reports CP, 14 (7), E243975. https://pubmed.ncbi.nlm.nih.gov/34132839/. | Mevorach, D., Anis, E., Cedar, N., Bromberg, M., Haas, E. J., Nadir, E., ... & Alroy-Preis, S. (2021). Myocarditis after BNT162b2 mRNA vaccine against Covid-19 in Israel. New England Journal of Medicine, 385(23), 2140-2149. https://pubmed.ncbi.nlm.nih.gov/34614328/. | Mansour, J., Short, R. G., Bhalla, S., Woodard, P. K., Verma, A., Robinson, X., & Raptis, D. A. (2021). Acute myocarditis after a second dose of the mRNA COVID-19 vaccine: a report of two cases. Clinical Imaging, 78, 247-249. https://www.clinicalimaging.org/article/S0899-7071(21)00265-5/fulltext. | Maramattom, B. V., Krishnan, P., Paul, R., Padmanabhan, S., Cherukudal Vishnu Nampoothiri, S., Syed, A. A., & Mangat, H. S. (2021). Guillain‐Barré syndrome following ChAdOx1‐S/nCoV‐19 vaccine. Annals of neurology, 90(2), 312-314. | https://pubmed.ncbi.nlm.nih.gov/34114256/. | Maramattom, B. V., Krishnan, P., Paul, R., Padmanabhan, S., Cherukudal Vishnu Nampoothiri, S., Syed, A. A., & Mangat, H. S. (2021). Guillain‐Barré syndrome following ChAdOx1‐S/nCoV‐19 vaccine. Annals of neurology, 90(2), 312-314. https://pubmed.ncbi.nlm.nih.gov/34114256/. | Papasavvas, I., & Herbort, C. P. (2021). Reactivation of Vogt-Koyanagi-Harada disease under control for more than 6 years, following anti-SARS-CoV-2 vaccination. Journal of Ophthalmic Inflammation and Infection, 11(1), 1-6. https://pubmed.ncbi.nlm.nih.gov/34224024/. | ||||
544 | Cerebral venous sinus thrombosis, pulmonary embolism, and thrombocytopenia after COVID-19 vaccination in a Taiwanese man: a case report and review of the literature: | https://pubmed.ncbi.nlm.nih.gov/34630307/ | https://www.heartlungcirc.org/article/S1443-9506(21)01156-2/fulltext | Pepe, S., Gregory, A. T., & Denniss, A. R. (2021). Myocarditis, Pericarditis and Cardiomyopathy After COVID-19 Vaccination☆. Heart, Lung and Circulation, 30(10), 1425-1429. | Pepe, S., Gregory, AT y Denniss, AR (2021). Miocarditis, pericarditis y miocardiopatía tras la vacunación contra la COVID-19☆. Corazón, Pulmón y Circulación, 30(10), 1425-1429. https://pubmed.ncbi.nlm.nih.gov/34246586/ | Mangat, C., & Milosavljevic, N. (2021). BNT162B2 La vacunación durante el embarazo protege a la madre y el infante: anticuerpos anti-SARS-COV-2 S persistentemente positivos en un bebé a los 6 meses de edad. Informes de casos en pediatría, 2021. https://www.ncbi.nlm.nih.gov/pubmed/34398511 | Pepe, S., Gregory, A. T., & Denniss, A. R. (2021). Myocarditis, Pericarditis and Cardiomyopathy After COVID-19 Vaccination☆. Heart, Lung and Circulation, 30(10), 1425-1429. https://www.heartlungcirc.org/article/S1443-9506(21)01156-2/fulltext | Maramattom, B. V., Krishnan, P., Paul, R., Padmanabhan, S., Cherukudal Vishnu Nampoothiri, S., Syed, A. A., & Mangat, H. S. (2021). Guillain‐Barré syndrome following ChAdOx1‐S/nCoV‐19 vaccine. Annals of neurology, 90(2), 312-314. https://pubmed.ncbi.nlm.nih.gov/34114256/. | Masuccio, F. G., Comi, C., & Solaro, C. (2021). Guillain–Barrè syndrome following COVID-19 vaccine mRNA-1273: a case report. Acta Neurologica Belgica, 1-3. | https://pubmed.ncbi.nlm.nih.gov/34767184/. | Masuccio, F. G., Comi, C., & Solaro, C. (2021). Guillain–Barrè syndrome following COVID-19 vaccine mRNA-1273: a case report. Acta Neurologica Belgica, 1-3. https://pubmed.ncbi.nlm.nih.gov/34767184/. | Pappaterra, M. C., Rivera, E. J., & Oliver, A. L. (2022). Transient Oculomotor Palsy Following the Administration of the Messenger RNA-1273 Vaccine for SARS-CoV-2 Diplopia Following the COVID-19 Vaccine. Journal of Neuro-Ophthalmology. https://pubmed.ncbi.nlm.nih.gov/34369471/ | ||||
545 | Fatal cerebral venous sinus thrombosis after COVID-19 vaccination: | https://pubmed.ncbi.nlm.nih.gov/33983464/ | https://pubmed.ncbi.nlm.nih.gov/34246586/ | Shaw, K. E., Cavalcante, J. L., Han, B. K., & Gössl, M. (2021). Possible association between COVID-19 vaccine and myocarditis: clinical and CMR findings. Cardiovascular Imaging, 14(9), 1856-1861. | Shaw, K. E., Cavalcante, J. L., Han, B. K. y Gössl, M. (2021). Posible asociación entre la vacuna COVID-19 y la miocarditis: hallazgos clínicos y de RMC. Imágenes cardiovasculares, 14(9), 1856-1861. https://pubmed.ncbi.nlm.nih.gov/34856634/. | MANISCALCO, G. T., MANZO, V., DI BATTISTA, M. E., Salvatore, S., Moreggia, O., Scavone, C., & Capuano, A. (2021). Recaída grave de esclerosis múltiple después de la vacunación de COVID-19: un informe de caso. Fronteras en neurología, 1398. https://pubmed.ncbi.nlm.nih.gov/34514078/ | Shaw, K. E., Cavalcante, J. L., Han, B. K., & Gössl, M. (2021). Possible association between COVID-19 vaccine and myocarditis: clinical and CMR findings. Cardiovascular Imaging, 14(9), 1856-1861. https://pubmed.ncbi.nlm.nih.gov/34246586/ | Maramattom, B. V., Moidu, F. M., Varikkottil, S., & Syed, A. A. (2021). Cerebral venous sinus thrombosis after ChAdOx1 vaccination: the first case of definite thrombosis with thrombocytopenia syndrome from India. BMJ Case Reports CP, 14(10), e246455. https://pubmed.ncbi.nlm.nih.gov/34706921/ | Finsterer, J., Scorza, F. A., & Scorza, C. A. (2021). Post SARS-CoV-2 vaccination Guillain-Barre syndrome in 19 patients. Clinics, 76. | https://pubmed.ncbi.nlm.nih.gov/34644738/. | Finsterer, J., Scorza, F. A., & Scorza, C. A. (2021). Post SARS-CoV-2 vaccination Guillain-Barre syndrome in 19 patients. Clinics, 76. https://pubmed.ncbi.nlm.nih.gov/34644738/. | Park, H. S., Byun, Y., Byeon, S. H., Kim, S. S., Kim, Y. J., & Lee, C. S. (2021). Retinal Hemorrhage after SARS-CoV-2 Vaccination. Journal of Clinical Medicine, 10(23), 5705. https://pubmed.ncbi.nlm.nih.gov/34884407/. | ||||
546 | Autoimmune roots of thrombotic events after COVID-19 vaccination: | https://pubmed.ncbi.nlm.nih.gov/34508917/. | https://pubmed.ncbi.nlm.nih.gov/34856634/. | Kounis, N. G., Mplani, V., Koniari, I., & Velissaris, D. (2022). Hypersensitivity myocarditis and COVID-19 vaccines. Kardiologia Polska (Polish Heart Journal), 80(1), 109-110. | Kounis, N. G., Mplani, V., Koniari, I. y Velissaris, D. (2022). Miocarditis por hipersensibilidad y vacunas COVID-19. Kardiologia Polska (Revista polaca del corazón), 80(1), 109-110. https://www.internationaljournalofcardiology.com/article/S0167-5273(21)01477-7/fulltext. | Mansour, J., corto, R. G., Bhalla, S., Woodard, P. K., Verma, A., Robinson, X., & Raptis, D. A. (2021). Miocarditis aguda después de una segunda dosis de la vacuna contra MRNA COVID-19: un informe de dos casos. Imágenes clínicas, 78, 247-249. https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciab926/6420408. | Kounis, N. G., Mplani, V., Koniari, I., & Velissaris, D. (2022). Hypersensitivity myocarditis and COVID-19 vaccines. Kardiologia Polska (Polish Heart Journal), 80(1), 109-110. https://pubmed.ncbi.nlm.nih.gov/34856634/. | Maramattom, B. V., Philips, G., Thomas, J., & Santhamma, S. G. N. (2021). Inflammatory myositis after ChAdOx1 vaccination. The Lancet Rheumatology, 3(11), e747-e749. https://pubmed.ncbi.nlm.nih.gov/34585145/ | Kanabar, G., & Wilkinson, P. (2021). Guillain‐Barré syndrome presenting with facial diplegia following COVID‐19 vaccination in two patients. BMJ Case Reports CP, 14(10), e244527. | https://pubmed.ncbi.nlm.nih.gov/34649856/ | Kanabar, G., & Wilkinson, P. (2021). Guillain‐Barré syndrome presenting with facial diplegia following COVID‐19 vaccination in two patients. BMJ Case Reports CP, 14(10), e244527. https://pubmed.ncbi.nlm.nih.gov/34649856/ | Park, H., Yun, K. W., Kim, K. R., Song, S. H., Ahn, B., Kim, D. R., ... & Kim, Y. J. (2021). Epidemiology and Clinical Features of Myocarditis/Pericarditis before the Introduction of mRNA COVID-19 Vaccine in Korean Children: a Multicenter Study. Journal of Korean Medical Science, 36(32). https://pubmed.ncbi.nlm.nih.gov/34402230/ | ||||
547 | New portal vein thrombosis in cirrhosis: is thrombophilia exacerbated by vaccine or COVID-19: | https://www.jcehepatology.com/article/S0973-6883(21)00545-4/fulltext. | https://www.internationaljournalofcardiology.com/article/S0167-5273(21)01477-7/fulltext. | Hendren, N. S., Carter, S., & Grodin, J. L. (2021). Severe COVID-19 vaccine associated myocarditis: Zebra or unicorn?. International journal of cardiology, 343, 197-198. | Hendren, NS, Carter, S. y Grodin, JL (2021). Miocarditis grave asociada a la vacuna COVID-19: ¿cebra o unicornio?. Revista internacional de cardiología, 343, 197-198. https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8522388/ | Maramattom, B. V., Krishnan, P., Paul, R., Padmanabhan, S., Cherukudal Vishnu NAMPOOKIRI, S., SYED, A. A., & MANGAT, H. S. (2021). Síndrome de Guillain-Barré siguiendo la vacuna Chadox1-S / NCOV-19. Anales de neurología, 90 (2), 312-314. https://pubmed.ncbi.nlm.nih.gov/34767184/. | Hendren, N. S., Carter, S., & Grodin, J. L. (2021). Severe COVID-19 vaccine associated myocarditis: Zebra or unicorn?. International journal of cardiology, 343, 197-198. https://www.internationaljournalofcardiology.com/article/S0167-5273(21)01477-7/fulltext. | Marchandot, B., Carmona, A., Trimaille, A., Curtiaud, A., & Morel, O. (2021). Procoagulant microparticles: a possible link between vaccine-induced immune thrombocytopenia (VITT) and cerebral sinus venous thrombosis. Journal of Thrombosis and Thrombolysis, 52(3), 689-691. https://pubmed.ncbi.nlm.nih.gov/34129181/ | Kripalani, Y., Lakkappan, V., Parulekar, L., Shaikh, A., Singh, R., & Vyas, P. (2021). A rare case of Guillain-Barre syndrome following COVID-19 vaccination. European Journal of Case Reports in Internal Medicine, 8(9). | https://pubmed.ncbi.nlm.nih.gov/34671572/ | Kripalani, Y., Lakkappan, V., Parulekar, L., Shaikh, A., Singh, R., & Vyas, P. (2021). A rare case of Guillain-Barre syndrome following COVID-19 vaccination. European Journal of Case Reports in Internal Medicine, 8(9). https://pubmed.ncbi.nlm.nih.gov/34671572/ | Park, J. Y., & Yi, S. Y. (2021). Rare case of contralateral supraclavicular lymphadenopathy after COVID-19 vaccination: Computed tomography and ultrasonography findings. Radiology Case Reports, 16(12), 3879-3881. https://pubmed.ncbi.nlm.nih.gov/34667486/ | ||||
548 | Images of immune thrombotic thrombocytopenia induced by Oxford / AstraZeneca® COVID-19 vaccine: | https://pubmed.ncbi.nlm.nih.gov/33962903/. | https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8522388/ | Aye, Y. N., Mai, A. S., Zhang, A., Lim, O. Z. H., Lin, N., Ng, C. H., ... & Chew, N. W. (2021). Acute myocardial infarction and myocarditis following COVID-19 vaccination. QJM: An International Journal of Medicine. | Aye, Y. N., Mai, A. S., Zhang, A., Lim, O. Z. H., Lin, N., Ng, C. H., ... y Chew, N. W. (2021). Infarto agudo de miocardio y miocarditis tras la vacunación contra la COVID-19. QJM: Revista internacional de medicina. https://www.nejm.org/doi/10.1056/NEJMoa2110737 | Maramattom, B. V., MOIDU, F. M., Varikkottil, S., & Syed, A. A. A. (2021). Trombosis sinusus venosa cerebral después de la vacunación contra la chadox1: el primer caso de trombosis definida con síndrome de trombocitopenia de la India. BMJ Case Reports CP, 14 (10), E246455. https://pubmed.ncbi.nlm.nih.gov/34698582/. | Aye, Y. N., Mai, A. S., Zhang, A., Lim, O. Z. H., Lin, N., Ng, C. H., ... & Chew, N. W. (2021). Acute myocardial infarction and myocarditis following COVID-19 vaccination. QJM: An International Journal of Medicine. https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8522388/ | Marchandot, B., Carmona, A., Trimaille, A., Curtiaud, A., & Morel, O. (2021). Procoagulant microparticles: a possible link between vaccine-induced immune thrombocytopenia (VITT) and cerebral sinus venous thrombosis. Journal of Thrombosis and Thrombolysis, 52(3), 689-691. https://pubmed.ncbi.nlm.nih.gov/34129181/. | Waheed, S., Bayas, A., Hindi, F., Rizvi, Z., & Espinosa, P. S. (2021). Neurological complications of COVID-19: Guillain-Barre syndrome following Pfizer COVID-19 vaccine. Cureus, 13(2). | https://pubmed.ncbi.nlm.nih.gov/33758714/ | Waheed, S., Bayas, A., Hindi, F., Rizvi, Z., & Espinosa, P. S. (2021). Neurological complications of COVID-19: Guillain-Barre syndrome following Pfizer COVID-19 vaccine. Cureus, 13(2). https://pubmed.ncbi.nlm.nih.gov/33758714/ | Park, J., Brekke, D. R., & Bratincsak, A. (2022). Self-limited myocarditis presenting with chest pain and ST segment elevation in adolescents after vaccination with the BNT162b2 mRNA vaccine. Cardiology in the Young, 32(1), 146-149. https://pubmed.ncbi.nlm.nih.gov/34180390/ | ||||
549 | Cerebral venous sinus thrombosis after vaccination with COVID-19 mRNA of BNT162b2: | https://pubmed.ncbi.nlm.nih.gov/34796065/. | https://www.nejm.org/doi/10.1056/NEJMoa2110737 | Witberg, G., Barda, N., Hoss, S., Richter, I., Wiessman, M., Aviv, Y., ... & Kornowski, R. (2021). Myocarditis after Covid-19 vaccination in a large health care organization. New England Journal of Medicine. | Witberg, G., Barda, N., Hoss, S., Richter, I., Wiessman, M., Aviv, Y., ... y Kornowski, R. (2021). Miocarditis tras la vacunación contra Covid-19 en una gran organización sanitaria. Revista de Medicina de Nueva Inglaterra. https://www.ahajournals.org/doi/abs/10.1161/CIRCULATIONAHA.121.056583?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed | Maramattom, B. V., Philips, G., Thomas, J., & Santhamma, S. G. N. (2021). Miositis inflamatoria después de la vacunación de Chadox1. La reumatología Lancet, 3 (11), E747-E749. https://pubmed.ncbi.nlm.nih.gov/34580132/. | Witberg, G., Barda, N., Hoss, S., Richter, I., Wiessman, M., Aviv, Y., ... & Kornowski, R. (2021). Myocarditis after Covid-19 vaccination in a large health care organization. New England Journal of Medicine. https://www.nejm.org/doi/10.1056/NEJMoa2110737 | Marcucci, R., & Marietta, M. (2021). Vaccine-induced thrombotic thrombocytopenia: the elusive link between thrombosis and adenovirus-based SARS-CoV-2 vaccines. Internal and emergency medicine, 16(5), 1113-1119. https://pubmed.ncbi.nlm.nih.gov/34191218/ | Matarneh, A. S., Al‐battah, A. H., Farooqui, K., Ghamoodi, M., & Alhatou, M. (2021). COVID‐19 vaccine causing Guillain‐Barre syndrome, a rare potential side effect. Clinical Case Reports, 9(9), e04756. | https://pubmed.ncbi.nlm.nih.gov/34484780/ | Matarneh, A. S., Al‐battah, A. H., Farooqui, K., Ghamoodi, M., & Alhatou, M. (2021). COVID‐19 vaccine causing Guillain‐Barre syndrome, a rare potential side effect. Clinical Case Reports, 9(9), e04756. https://pubmed.ncbi.nlm.nih.gov/34484780/ | Park, L. H. J., Montgomery, C. J. R., & Boggs, L. N. A. (2021). Anaphylaxis after the Covid-19 vaccine in a patient with cholinergic urticaria. Military medicine. https://pubmed.ncbi.nlm.nih.gov/33851711/ | ||||
550 | Increased risk of urticaria/angioedema after BNT162b2 mRNA COVID-19 vaccination in health care workers taking ACE inhibitors: | https://pubmed.ncbi.nlm.nih.gov/34579248/ | https://www.ahajournals.org/doi/abs/10.1161/CIRCULATIONAHA.121.056583?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed | Truong, D. T., Dionne, A., Muniz, J. C., McHugh, K. E., Portman, M. A., Lambert, L. M., ... & Newburger, J. W. (2021). Clinically suspected myocarditis temporally related to COVID-19 vaccination in adolescents and young adults. Circulation. | Truong, D. T., Dionne, A., Muniz, J. C., McHugh, K. E., Portman, M. A., Lambert, L. M., ... y Newburger, J. W. (2021). Miocarditis clínicamente sospechada relacionada temporalmente con la vacunación COVID-19 en adolescentes y adultos jóvenes. Circulación. https://pubmed.ncbi.nlm.nih.gov/34756746/ | Marchandot, B., Carmona, A., TRIMAILLE, A., CURRIAUD, A., & Morel, O. (2021). Micropartículas proñosagulantes: un posible vínculo entre la trombocitopenia inmune inducida por la vacuna (VITT) y la trombosis venosa cerebral sinusal. Diario de trombosis y trombolisis, 52 (3), 689-691. https://pubmed.ncbi.nlm.nih.gov/33929487/. | Truong, D. T., Dionne, A., Muniz, J. C., McHugh, K. E., Portman, M. A., Lambert, L. M., ... & Newburger, J. W. (2021). Clinically suspected myocarditis temporally related to COVID-19 vaccination in adolescents and young adults. Circulation. https://www.ahajournals.org/doi/abs/10.1161/CIRCULATIONAHA.121.056583?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed | Mark, C., Gupta, S., Punnett, A., Upton, J., Orkin, J., Atkinson, A., ... & Alexander, S. (2021). Safety of administration of BNT162b2 mRNA (Pfizer‐BioNTech) COVID‐19 vaccine in youths and young adults with a history of acute lymphoblastic leukemia and allergy to PEG‐asparaginase. Pediatric Blood & Cancer, 68(11), e29295. https://www.ncbi.nlm.nih.gov/pubmed/34398511 | Čenščák, D., Ungermann, L., Štětkářová, I., & Ehler, E. (2021). Guillan-Barré Syndrome after the First Vaccination Dose against COVID-19: Case Report. ACTA MEDICA, 64(3), 183-186. | https://pubmed.ncbi.nlm.nih.gov/34779385/. | Čenščák, D., Ungermann, L., Štětkářová, I., & Ehler, E. (2021). Guillan-Barré Syndrome after the First Vaccination Dose against COVID-19: Case Report. ACTA MEDICA, 64(3), 183-186. https://pubmed.ncbi.nlm.nih.gov/34779385/. | Park, Y. S. (2021). Thrombosis and severe acute respiratory syndrome coronavirus 2 vaccines: vaccine-induced immune thrombotic thrombocytopenia. Clinical and experimental pediatrics, 64(8), 400. https://pubmed.ncbi.nlm.nih.gov/34237213/. | ||||
551 | A case of unusual mild clinical presentation of COVID-19 vaccine-induced immune thrombotic thrombocytopenia with splanchnic vein thrombosis: | https://pubmed.ncbi.nlm.nih.gov/34843991/ | https://pubmed.ncbi.nlm.nih.gov/34756746/ | Azir, M., Inman, B., Webb, J., & Tannenbaum, L. (2021). STEMI Mimic: Focal Myocarditis in an Adolescent Patient After mRNA COVID-19 Vaccine. The Journal of emergency medicine, 61(6), e129-e132. | Azir, M., Inman, B., Webb, J. y Tannenbaum, L. (2021). Imitación de STEMI: miocarditis focal en un paciente adolescente después de la vacuna de ARNm COVID-19. Revista de medicina de emergencia, 61(6), e129-e132. https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8587334/ | Marchandot, B., Carmona, A., TRIMAILLE, A., CURRIAUD, A., & Morel, O. (2021). Micropartículas proñosagulantes: un posible vínculo entre la trombocitopenia inmune inducida por la vacuna (VITT) y la trombosis venosa cerebral sinusal. Diario de trombosis y trombolisis, 52 (3), 689-691. https://pubmed.ncbi.nlm.nih.gov/34083026/. | Azir, M., Inman, B., Webb, J., & Tannenbaum, L. (2021). STEMI Mimic: Focal Myocarditis in an Adolescent Patient After mRNA COVID-19 Vaccine. The Journal of emergency medicine, 61(6), e129-e132. https://pubmed.ncbi.nlm.nih.gov/34756746/ | Marshall, M., Ferguson, I. D., Lewis, P., Jaggi, P., Gagliardo, C., Collins, J. S., ... & Guzman-Cottrill, J. A. (2021). Symptomatic acute myocarditis in 7 adolescents after Pfizer-BioNTech COVID-19 vaccination. Pediatrics, 148(3). https://pediatrics.aappublications.org/content/148/3/e2021052478 | Abičić, A., Adamec, I., & Habek, M. (2022). Miller Fisher syndrome following Pfizer COVID-19 vaccine. Neurological Sciences, 43(3), 1495-1497. | https://pubmed.ncbi.nlm.nih.gov/34817727/. | Abičić, A., Adamec, I., & Habek, M. (2022). Miller Fisher syndrome following Pfizer COVID-19 vaccine. Neurological Sciences, 43(3), 1495-1497. https://pubmed.ncbi.nlm.nih.gov/34817727/. | Patel, Y. R., Louis, D. W., Atalay, M., Agarwal, S., & Shah, N. R. (2021). Cardiovascular magnetic resonance findings in young adult patients with acute myocarditis following mRNA COVID-19 vaccination: a case series. Journal of Cardiovascular Magnetic Resonance, 23(1), 1-8. https://jcmr-online.biomedcentral.com/articles/10.1186/s12968-021-00795-4 | ||||
552 | Cerebral venous sinus thrombosis following vaccination with Pfizer-BioNTech COVID-19 (BNT162b2): | https://pubmed.ncbi.nlm.nih.gov/34595867/ | https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8587334/ | Istampoulouoglou, I., Dimitriou, G., Späni, S., Christ, A., Zimmermanns, B., Koechlin, S., ... & Leuppi-Taegtmeyer, A. B. (2021). Myocarditis and pericarditis in association with COVID-19 mRNA-vaccination: cases from a regional pharmacovigilance centre. Global cardiology science & practice, 2021(3). | Istampoulouoglou, I., Dimitriou, G., Späni, S., Christ, A., Zimmermanns, B., Koechlin, S., ... y Leuppi-Taegtmeyer, A. B. (2021). Miocarditis y pericarditis en asociación con la vacunación con ARNm de COVID-19: casos de un centro regional de farmacovigilancia. Ciencia y práctica de la cardiología global, 2021(3). https://pubmed.ncbi.nlm.nih.gov/34546329/. | Marcucci, R., & Marietta, M. (2021). Trombocitopenia trombótica inducida por la vacuna: el vínculo dificultoso entre la trombosis y las vacunas SARS-COV-2 basadas en adenovirus. Medicina interna y de emergencia, 16 (5), 1113-1119. https://pubmed.ncbi.nlm.nih.gov/34175640/ | Istampoulouoglou, I., Dimitriou, G., Späni, S., Christ, A., Zimmermanns, B., Koechlin, S., ... & Leuppi-Taegtmeyer, A. B. (2021). Myocarditis and pericarditis in association with COVID-19 mRNA-vaccination: cases from a regional pharmacovigilance centre. Global cardiology science & practice, 2021(3). https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8587334/ | Marshall, M., Ferguson, I. D., Lewis, P., Jaggi, P., Gagliardo, C., Collins, J. S., ... & Guzman-Cottrill, J. A. (2021). Symptomatic acute myocarditis in 7 adolescents after Pfizer-BioNTech COVID-19 vaccination. Pediatrics, 148(3). https://pediatrics.aappublications.org/content/early/2021/06/04/peds.2021-052478 | Nishiguchi, Y., Matsuyama, H., Maeda, K., Shindo, A., & Tomimoto, H. (2021). Miller Fisher syndrome following BNT162b2 mRNA coronavirus 2019 vaccination. BMC neurology, 21(1), 1-6. | https://pubmed.ncbi.nlm.nih.gov/34789193/. | Nishiguchi, Y., Matsuyama, H., Maeda, K., Shindo, A., & Tomimoto, H. (2021). Miller Fisher syndrome following BNT162b2 mRNA coronavirus 2019 vaccination. BMC neurology, 21(1), 1-6. https://pubmed.ncbi.nlm.nih.gov/34789193/. | Patone, M., Handunnetthi, L., Saatci, D., Pan, J., Katikireddi, S. V., Razvi, S., ... & Hippisley-Cox, J. (2021). Neurological complications after first dose of COVID-19 vaccines and SARS-CoV-2 infection. Nature medicine, 27(12), 2144-2153. https://pubmed.ncbi.nlm.nih.gov/34697502/ | ||||
553 | A case of idiopathic thrombocytopenic purpura after a booster dose of COVID-19 BNT162b2 vaccine (Pfizer-Biontech): | https://pubmed.ncbi.nlm.nih.gov/34820240/ | https://pubmed.ncbi.nlm.nih.gov/34546329/. | Koizumi, T., Awaya, T., Yoshioka, K., Kitano, S., Hayama, H., Amemiya, K., ... & Nakamura, M. (2021). Myocarditis after COVID-19 mRNA vaccines. QJM: An International Journal of Medicine, 114(10), 741-743. | Koizumi, T., Awaya, T., Yoshioka, K., Kitano, S., Hayama, H., Amemiya, K., ... y Nakamura, M. (2021). Miocarditis después de las vacunas de ARNm de COVID-19. QJM: Revista internacional de medicina, 114(10), 741-743. https://jamanetwork.com/journals/jamacardiology/fullarticle/2781602. | Mark, C., Gupta, S., Punnett, A., Upton, J., Orkin, J., Atkinson, A., ... & Alexander, S. (2021). Seguridad de la administración de ARNm de BNT162B2 (Pfizer-BIONTECH) COVID-19 Vacuna en jóvenes y adultos jóvenes con antecedentes de leucemia linfoblástica aguda y alergia a PEG-APARAGINASA. Sangre y cáncer pediátrico, 68 (11), E29295. https://www.ncbi.nlm.nih.gov/pubmed/33316478 | Koizumi, T., Awaya, T., Yoshioka, K., Kitano, S., Hayama, H., Amemiya, K., ... & Nakamura, M. (2021). Myocarditis after COVID-19 mRNA vaccines. QJM: An International Journal of Medicine, 114(10), 741-743. https://pubmed.ncbi.nlm.nih.gov/34546329/. | Marshall, M., Ferguson, I. D., Lewis, P., Jaggi, P., Gagliardo, C., Collins, J. S., ... & Guzman-Cottrill, J. A. (2021). Symptomatic acute myocarditis in 7 adolescents after Pfizer-BioNTech COVID-19 vaccination. Pediatrics, 148(3). https://pubmed.ncbi.nlm.nih.gov/34088762/. | Bonifacio, G. B., Patel, D., Cook, S., Purcaru, E., Couzins, M., Domjan, J., ... & Kinton, L. (2022). Bilateral facial weakness with paraesthesia variant of Guillain-Barré syndrome following Vaxzevria COVID-19 vaccine. Journal of Neurology, Neurosurgery & Psychiatry, 93(3), 341-342. | https://pubmed.ncbi.nlm.nih.gov/34261746/ | Bonifacio, G. B., Patel, D., Cook, S., Purcaru, E., Couzins, M., Domjan, J., ... & Kinton, L. (2022). Bilateral facial weakness with paraesthesia variant of Guillain-Barré syndrome following Vaxzevria COVID-19 vaccine. Journal of Neurology, Neurosurgery & Psychiatry, 93(3), 341-342. https://pubmed.ncbi.nlm.nih.gov/34261746/ | Patone, M., Mei, X. W., Handunnetthi, L., Dixon, S., Zaccardi, F., Shankar-Hari, M., ... & Hippisley-Cox, J. (2021). Risks of myocarditis, pericarditis, and cardiac arrhythmias associated with COVID-19 vaccination or SARS-CoV-2 infection. Nature medicine, 1-13. https://www.ncbi.nlm.nih.gov/pubmed/34907393 | ||||
554 | Vaccine-induced immune thrombotic immune thrombocytopenia (VITT): targeting pathologic mechanisms with Bruton’s tyrosine kinase inhibitors: | https://pubmed.ncbi.nlm.nih.gov/33851389/ | https://jamanetwork.com/journals/jamacardiology/fullarticle/2781602. | Kim, H. W., Jenista, E. R., Wendell, D. C., Azevedo, C. F., Campbell, M. J., Darty, S. N., ... & Kim, R. J. (2021). Patients with acute myocarditis following mRNA COVID-19 vaccination. JAMA cardiology, 6(10), 1196-1201. | Kim, HW, Jenista, E. R., Wendell, D. C., Azevedo, C. F., Campbell, M. J., Darty, S. N., ... y Kim, R. J. (2021). Pacientes con miocarditis aguda después de la vacunación con ARNm COVID-19. Cardiología JAMA, 6(10), 1196-1201. https://www.sciencedirect.com/science/article/pii/S0264410X21011725?via%3Dihub. | Marshall, M., Ferguson, I. D., Lewis, P., Jaggi, P., Gagliardo, C., Collins, J. S., ... & Guzman-Cottrill, J. A. (2021). Myocarditis aguda sintomática en 7 adolescentes después de la vacunación de Pfizer-Biontech Covid-19. Pediatría, 148 (3). https://academic.oup.com/ehjqcco/advance-article/doi/10.1093/ehjqcco/qcab090/6442104 | Kim, H. W., Jenista, E. R., Wendell, D. C., Azevedo, C. F., Campbell, M. J., Darty, S. N., ... & Kim, R. J. (2021). Patients with acute myocarditis following mRNA COVID-19 vaccination. JAMA cardiology, 6(10), 1196-1201. https://jamanetwork.com/journals/jamacardiology/fullarticle/2781602. | Martin-Villares, C., Vazquez-Feito, A., Gonzalez-Gimeno, M. J., & de la Nogal-Fernandez, B. (2022). Bell’s palsy following a single dose of mRNA SARS-CoV-2 vaccine: a case report. Journal of Neurology, 269(1), 47-48. https://pubmed.ncbi.nlm.nih.gov/34032902/. | Fukushima, T., Tomita, M., Ikeda, S., & Hattori, N. (2021). A case of sensory ataxic Guillain–Barré syndrome with immunoglobulin G anti-GM1 antibodies following the first dose of mRNA COVID-19 vaccine BNT162b2 (Pfizer). QJM: An International Journal of Medicine. | https://pubmed.ncbi.nlm.nih.gov/34871447/ | Fukushima, T., Tomita, M., Ikeda, S., & Hattori, N. (2021). A case of sensory ataxic Guillain–Barré syndrome with immunoglobulin G anti-GM1 antibodies following the first dose of mRNA COVID-19 vaccine BNT162b2 (Pfizer). QJM: An International Journal of Medicine. https://pubmed.ncbi.nlm.nih.gov/34871447/ | Patrignani, A., Schicchi, N., Calcagnoli, F., Falchetti, E., Ciampani, N., Argalia, G., & Mariani, A. (2021). Acute myocarditis following Comirnaty vaccination in a healthy man with previous SARS-CoV-2 infection. Radiology Case Reports, 16(11), 3321-3325. https://www.sciencedirect.com/science/article/pii/S1930043321005549 | ||||
555 | Thrombotic thrombocytopenic purpura after vaccination with Ad26.COV2-S: | https://pubmed.ncbi.nlm.nih.gov/33980419/ | https://www.sciencedirect.com/science/article/pii/S0264410X21011725?via%3Dihub. | Levin, D., Shimon, G., Fadlon-Derai, M., Gershovitz, L., Shovali, A., Sebbag, A., ... & Gordon, B. (2021). Myocarditis following COVID-19 vaccination–a case series. Vaccine, 39(42), 6195-6200. | Levin, D., Shimon, G., Fadlon-Derai, M., Gershovitz, L., Shovali, A., Sebbag, A., ... y Gordon, B. (2021). Miocarditis tras la vacunación contra la COVID-19: una serie de casos. Vacuna, 39(42), 6195-6200. https://publications.aap.org/pediatrics/article/148/5/e2021053427/181357 | Marshall, M., Ferguson, I. D., Lewis, P., Jaggi, P., Gagliardo, C., Collins, J. S., ... & Guzman-Cottrill, J. A. (2021). Myocarditis aguda sintomática en 7 adolescentes después de la vacunación de Pfizer-Biontech Covid-19. Pediatría, 148 (3). https://jcmr-online.biomedcentral.com/articles/10.1186/s12968-021-00795-4 | Levin, D., Shimon, G., Fadlon-Derai, M., Gershovitz, L., Shovali, A., Sebbag, A., ... & Gordon, B. (2021). Myocarditis following COVID-19 vaccination–a case series. Vaccine, 39(42), 6195-6200. https://www.sciencedirect.com/science/article/pii/S0264410X21011725?via%3Dihub. | Martins-Filho, P. R., Quintans-Júnior, L. J., de Souza Araújo, A. A., Sposato, K. B., Tavares, C. S., Gurgel, R. Q., ... & Santos, V. S. (2021). Socio-economic inequalities and COVID-19 incidence and mortality in Brazilian children: a nationwide register-based study. Public Health, 190, 4-6. https://www.ncbi.nlm.nih.gov/pubmed/33316478 | Noseda, R., Ripellino, P., Ghidossi, S., Bertoli, R., & Ceschi, A. (2021). Reporting of acute inflammatory neuropathies with COVID-19 vaccines: subgroup disproportionality analyses in VigiBase. Vaccines, 9(9), 1022. | https://pubmed.ncbi.nlm.nih.gov/34579259/ | Noseda, R., Ripellino, P., Ghidossi, S., Bertoli, R., & Ceschi, A. (2021). Reporting of acute inflammatory neuropathies with COVID-19 vaccines: subgroup disproportionality analyses in VigiBase. Vaccines, 9(9), 1022. https://pubmed.ncbi.nlm.nih.gov/34579259/ | Paulsen, F. O., Schaefers, C., Langer, F., Frenzel, C., Wenzel, U., Hengel, F. E., ... & Seidel, C. (2021). Immune thrombocytopenic purpura after vaccination with COVID-19 vaccine (ChAdOx1 nCov-19). Blood, The Journal of the American Society of Hematology, 138(11), 996-999. https://www.sciencedirect.com/science/article/abs/pii/S0006497121013963. | ||||
556 | Thromboembolic events in younger females exposed to Pfizer-BioNTech or Moderna COVID-19 vaccines: | https://pubmed.ncbi.nlm.nih.gov/34264151/ | https://publications.aap.org/pediatrics/article/148/5/e2021053427/181357 | Jain, S. S., Steele, J. M., Fonseca, B., Huang, S., Shah, S., Maskatia, S. A., ... & Grosse-Wortmann, L. (2021). COVID-19 Vaccination–Associated Myocarditis in Adolescents. Pediatrics, 148(5). | Jain, S. S., Steele, J. M., Fonseca, B., Huang, S., Shah, S., Maskatia, S. A., ... y Grosse-Wortmann, L. (2021). Miocarditis asociada a la vacunación COVID-19 en adolescentes. Pediatría, 148(5). https://pubmed.ncbi.nlm.nih.gov/34704459/ | Marshall, M., Ferguson, I. D., Lewis, P., Jaggi, P., Gagliardo, C., Collins, J. S., ... & Guzman-Cottrill, J. A. (2021). Myocarditis aguda sintomática en 7 adolescentes después de la vacunación de Pfizer-Biontech Covid-19. Pediatría, 148 (3). https://www.sciencedirect.com/science/article/pii/S2589238X21000292#f0005 | Jain, S. S., Steele, J. M., Fonseca, B., Huang, S., Shah, S., Maskatia, S. A., ... & Grosse-Wortmann, L. (2021). COVID-19 Vaccination–Associated Myocarditis in Adolescents. Pediatrics, 148(5). https://publications.aap.org/pediatrics/article/148/5/e2021053427/181357 | Mason, M. C., Liaqat, A., Morrow, J., Basso, R., & Gujrati, Y. (2021). Bilateral facial nerve palsy and COVID-19 vaccination: causation or coincidence?. Cureus, 13(8). https://pubmed.ncbi.nlm.nih.gov/34522557/ | Tutar, N. K., Eyigürbüz, T., Yildirim, Z., & Kale, N. (2021). A variant of Guillain-Barre syndrome after SARS-CoV-2 vaccination: AMSAN. Ideggyogyaszati Szemle, 74(7-08), 286-288. | https://pubmed.ncbi.nlm.nih.gov/34370408/. | Tutar, N. K., Eyigürbüz, T., Yildirim, Z., & Kale, N. (2021). A variant of Guillain-Barre syndrome after SARS-CoV-2 vaccination: AMSAN. Ideggyogyaszati Szemle, 74(7-08), 286-288. https://pubmed.ncbi.nlm.nih.gov/34370408/. | Pavord, S., Scully, M., Hunt, B. J., Lester, W., Bagot, C., Craven, B., ... & Makris, M. (2021). Clinical features of vaccine-induced immune thrombocytopenia and thrombosis. New England Journal of Medicine, 385(18), 1680-1689. https://pubmed.ncbi.nlm.nih.gov/34379914/. | ||||
557 | Potential risk of thrombotic events after COVID-19 vaccination with Oxford-AstraZeneca in women receiving estrogen: | https://pubmed.ncbi.nlm.nih.gov/34734086/ | https://pubmed.ncbi.nlm.nih.gov/34704459/ | Chelala, L., Jeudy, J., Hossain, R., Rosenthal, G., Pietris, N., & White, C. (2021). Cardiac MRI findings of myocarditis after COVID-19 mRNA vaccination in adolescents. American Journal of Roentgenology. | Chelala, L., Jeudy, J., Hossain, R., Rosenthal, G., Pietris, N. y White, C. (2021). Hallazgos de miocarditis en la resonancia magnética cardíaca después de la vacunación con ARNm de COVID-19 en adolescentes. Revista Estadounidense de Roentgenología. https://academic.oup.com/ehjcimaging/advance-article/doi/10.1093/ehjci/jeab230/6421640 | Martin-Villares, C., Vázquez-Feito, A., González-Gimeno, M. J., & de la Nogal-Fernández, B. (2022). La parálisis de Bell siguiendo una dosis única de la vacuna contra MRNA SARS-COV-2: un informe de caso. Diario de Neurología, 269 (1), 47-48. https://pubmed.ncbi.nlm.nih.gov/33862041/ | Chelala, L., Jeudy, J., Hossain, R., Rosenthal, G., Pietris, N., & White, C. (2021). Cardiac MRI findings of myocarditis after COVID-19 mRNA vaccination in adolescents. American Journal of Roentgenology. https://pubmed.ncbi.nlm.nih.gov/34704459/ | Masset, C., Lebot-Bouras, S., Branchereau, J., Renaudin, K., & Cantarovich, D. (2021). Pancreas allograft rejection occurring after ChAdOx1 nCoV-19 vaccine. Diabetes & Metabolism. https://pubmed.ncbi.nlm.nih.gov/34781027/ | Morehouse, Z. P., Paulus, A., Jasti, S. A., & Bing, X. (2021). A Rare Variant of Guillain-Barre Syndrome Following Ad26. COV2. S Vaccination. Cureus, 13(9). | https://pubmed.ncbi.nlm.nih.gov/34703690/. | Morehouse, Z. P., Paulus, A., Jasti, S. A., & Bing, X. (2021). A Rare Variant of Guillain-Barre Syndrome Following Ad26. COV2. S Vaccination. Cureus, 13(9). https://pubmed.ncbi.nlm.nih.gov/34703690/. | Pepe, S., Gregory, A. T., & Denniss, A. R. (2021). Myocarditis, Pericarditis and Cardiomyopathy After COVID-19 Vaccination☆. Heart, Lung and Circulation, 30(10), 1425-1429. https://www.sciencedirect.com/science/article/pii/S1443950621011562 | ||||
558 | Thrombosis after adenovirus-vectored COVID-19 vaccination: a concern for underlying disease: | https://pubmed.ncbi.nlm.nih.gov/34755555/ | https://academic.oup.com/ehjcimaging/advance-article/doi/10.1093/ehjci/jeab230/6421640 | Shiyovich, A., Witberg, G., Aviv, Y., Eisen, A., Orvin, K., Wiessman, M., ... & Hamdan, A. (2021). Myocarditis following COVID-19 vaccination: magnetic resonance imaging study. European Heart Journal-Cardiovascular Imaging. | Shiyovich, A., Witberg, G., Aviv, Y., Eisen, A., Orvin, K., Wiessman, M., ... y Hamdan, A. (2021). Miocarditis tras vacunación COVID-19: estudio de resonancia magnética. European Heart Journal-Cardiovascular Imaging. https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8599115/ | Martins-Filho, P. R., Quintans-Júnior, L. J., de Souza Araújo, A. A. A. A. A. A. A., Sposato, K. B., Tavares, C. S., Gurgel, R. P., ... & SANTOS, V. S. (2021). Desigualdades socioeconómicas y incidencia y mortalidad de COVID-19 en niños brasileños: un estudio de registro nacional en todo el país. Salud pública, 190, 4-6. https://www.ncbi.nlm.nih.gov/pubmed/34133825 | Shiyovich, A., Witberg, G., Aviv, Y., Eisen, A., Orvin, K., Wiessman, M., ... & Hamdan, A. (2021). Myocarditis following COVID-19 vaccination: magnetic resonance imaging study. European Heart Journal-Cardiovascular Imaging. https://academic.oup.com/ehjcimaging/advance-article/doi/10.1093/ehjci/jeab230/6421640 | Masuccio, F. G., Comi, C., & Solaro, C. (2021). Guillain–Barrè syndrome following COVID-19 vaccine mRNA-1273: a case report. Acta Neurologica Belgica, 1-3. https://pubmed.ncbi.nlm.nih.gov/34767184/. | Ling, L., Bagshaw, S. M., & Villeneuve, P. M. (2021). Guillain–Barré syndrome after SARS-CoV-2 vaccination in a patient with previous vaccine-associated Guillain–Barré syndrome. CMAJ, 193(46), E1766-E1769. | https://pubmed.ncbi.nlm.nih.gov/34810163/ | Ling, L., Bagshaw, S. M., & Villeneuve, P. M. (2021). Guillain–Barré syndrome after SARS-CoV-2 vaccination in a patient with previous vaccine-associated Guillain–Barré syndrome. CMAJ, 193(46), E1766-E1769. https://pubmed.ncbi.nlm.nih.gov/34810163/ | Perez, Y., Levy, E. R., Joshi, A. Y., Virk, A., Rodriguez-Porcel, M., Johnson, M., ... & Swift, M. D. (2021). Myocarditis Following COVID-19 mRNA Vaccine: A Case Series and Incidence Rate Determination. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America. https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciab926/6420408 | ||||
559 | Adenovirus interactions with platelets and coagulation and vaccine-induced immune thrombotic thrombocytopenia syndrome: | https://pubmed.ncbi.nlm.nih.gov/34407607/ | https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8599115/ | Miqdad, M. A., Nasser, H., Alshehri, A., & Mourad, A. R. (2021). Acute Myocarditis Following the Administration of the Second BNT162b2 COVID-19 Vaccine Dose. Cureus, 13(10). | Miqdad, M. A., Nasser, H., Alshehri, A. y Mourad, A. R. (2021). Miocarditis aguda tras la administración de la segunda dosis de la vacuna BNT162b2 COVID-19. Cureus, 13(10). https://www.sciencedirect.com/science/article/pii/S2352906721001603 | Mason, M. C., Liaqat, A., Mañana, J., Basso, R., y Gujrati, Y. (2021). Palsy del nervio facial bilateral y la vacunación de COVID-19: Causa o coincidencia. CUREUS, 13 (8). https://pubmed.ncbi.nlm.nih.gov/34763263/. | Miqdad, M. A., Nasser, H., Alshehri, A., & Mourad, A. R. (2021). Acute Myocarditis Following the Administration of the Second BNT162b2 COVID-19 Vaccine Dose. Cureus, 13(10). https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8599115/ | Matar, E., Manser, D., Spies, J. M., Worthington, J. M., & Parratt, K. L. (2021). Acute Hemichorea‐Hemiballismus Following COVID‐19 (AZD1222) Vaccination. Movement Disorders. https://pubmed.ncbi.nlm.nih.gov/34581453/ | Osowicki, J., Morgan, H., Harris, A., Crawford, N. W., Buttery, J. P., & Kiers, L. (2021). Guillain-Barré Syndrome in an Australian state using both mRNA and adenovirus-vector SARS-CoV-2 vaccines. Annals of Neurology, 90(5), 856-858. | https://onlinelibrary.wiley.com/doi/10.1002/ana.26218. | Osowicki, J., Morgan, H., Harris, A., Crawford, N. W., Buttery, J. P., & Kiers, L. (2021). Guillain-Barré Syndrome in an Australian state using both mRNA and adenovirus-vector SARS-CoV-2 vaccines. Annals of Neurology, 90(5), 856-858. https://onlinelibrary.wiley.com/doi/10.1002/ana.26218. | Perrotta, A., Biondi-Zoccai, G., Saade, W., Miraldi, F., Morelli, A., Marullo, A. G., ... & Peruzzi, M. (2021). A snapshot global survey on side effects of COVID-19 vaccines among healthcare professionals and armed forces with a focus on headache. Panminerva Medica, 63(3), 324-331. https://www.ncbi.nlm.nih.gov/pubmed/34738774 | ||||
560 | Thrombotic thrombocytopenic purpura: a new threat after COVID bnt162b2 vaccine: | https://pubmed.ncbi.nlm.nih.gov/34264514/. | https://www.sciencedirect.com/science/article/pii/S2352906721001603 | Kaul, R., Sreenivasan, J., Goel, A., Malik, A., Bandyopadhyay, D., Jin, C., ... & Panza, J. A. (2021). Myocarditis following COVID-19 vaccination. International Journal of Cardiology. Heart & Vasculature. | Kaul, R., Sreenivasan, J., Goel, A., Malik, A., Bandyopadhyay, D., Jin, C., ... y Panza, J. A. (2021). Miocarditis tras la vacunación COVID-19. Revista Internacional de Cardiología. Corazón y vasculatura. https://pubmed.ncbi.nlm.nih.gov/34712717/. | Masset, C., Lebot-Bouras, S., Branchdereau, J., Renaudin, K., & Cantarovich, D. (2021). El rechazo del aloinjerto del páncreas que se produce después de la vacuna contra la CHADOX1 NCOV-19. Diabetes y metabolismo. https://pubmed.ncbi.nlm.nih.gov/34595694/ | Kaul, R., Sreenivasan, J., Goel, A., Malik, A., Bandyopadhyay, D., Jin, C., ... & Panza, J. A. (2021). Myocarditis following COVID-19 vaccination. International Journal of Cardiology. Heart & Vasculature. https://www.sciencedirect.com/science/article/pii/S2352906721001603 | Matarneh, A. S., Al‐battah, A. H., Farooqui, K., Ghamoodi, M., & Alhatou, M. (2021). COVID‐19 vaccine causing Guillain‐Barre syndrome, a rare potential side effect. Clinical Case Reports, 9(9), e04756. https://pubmed.ncbi.nlm.nih.gov/34484780/ | Khan, E., Shrestha, A. K., Colantonio, M. A., Liberio, R. N., & Sriwastava, S. (2021). Acute transverse myelitis following SARS-CoV-2 vaccination: a case report and review of literature. Journal of Neurology, 1-12. | https://pubmed.ncbi.nlm.nih.gov/34482455/. | Khan, E., Shrestha, A. K., Colantonio, M. A., Liberio, R. N., & Sriwastava, S. (2021). Acute transverse myelitis following SARS-CoV-2 vaccination: a case report and review of literature. Journal of Neurology, 1-12. https://pubmed.ncbi.nlm.nih.gov/34482455/. | Perry, R. J., Tamborska, A., Singh, B., Craven, B., Marigold, R., Arthur-Farraj, P., ... & Zambreanu, L. (2021). Cerebral venous thrombosis after vaccination against COVID-19 in the UK: a multicentre cohort study. The Lancet, 398(10306), 1147-1156. https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)01608-1/ | ||||
561 | Unusual site of deep vein thrombosis after vaccination against coronavirus mRNA-2019 coronavirus disease (COVID-19): | https://pubmed.ncbi.nlm.nih.gov/34840204/ | https://pubmed.ncbi.nlm.nih.gov/34712717/. | Alania-Torres, E., Morillas-Climent, H., García-Escrivá, A., Vinueza-Buitrón, P., Poquet-Catalá, I., Zorio, E., ... & Valle-Muñoz, A. (2021). Case Report: Probable Myocarditis After Covid-19 mRNA Vaccine in a Patient With Arrhythmogenic Left Ventricular Cardiomyopathy. Frontiers in Cardiovascular Medicine, 1351. | Alania-Torres, E., Morillas-Climent, H., García-Escrivá, A., Vinueza-Buitrón, P., Poquet-Catalá, I., Zorio, E., ... & Valle-Muñoz, A. (2021). Informe de caso: Probable miocarditis después de la vacuna de ARNm de Covid-19 en un paciente con miocardiopatía arritmogénica del ventrículo izquierdo. Fronteras en medicina cardiovascular, 1351. https://www.revespcardiol.org/en-linkresolver-acute-myocarditis-after-administration-bnt162b2-S188558572100133X. | Masuccio, F. G., Comi, C., & Solaro, C. (2021). Síndrome de Guillain-Barrè después de COVID-19 VACCINE MRNA-1273: un informe de caso. ACTA NEULOLOGICA BELGICA, 1-3. https://pubmed.ncbi.nlm.nih.gov/34644738/. | Alania-Torres, E., Morillas-Climent, H., García-Escrivá, A., Vinueza-Buitrón, P., Poquet-Catalá, I., Zorio, E., ... & Valle-Muñoz, A. (2021). Case Report: Probable Myocarditis After Covid-19 mRNA Vaccine in a Patient With Arrhythmogenic Left Ventricular Cardiomyopathy. Frontiers in Cardiovascular Medicine, 1351. https://pubmed.ncbi.nlm.nih.gov/34712717/. | Maye, J. A., Chong, H. P., Rajagopal, V., & Petchey, W. (2021). Reactivation of IgA vasculitis following COVID-19 vaccination. BMJ Case Reports CP, 14(11), e247188. https://pubmed.ncbi.nlm.nih.gov/34848431/ | Allen, C. M., Ramsamy, S., Tarr, A. W., Tighe, P. J., Irving, W. L., Tanasescu, R., & Evans, J. R. (2021). Guillain–Barré syndrome variant occurring after SARS‐CoV‐2 vaccination. Annals of neurology, 90(2), 315-318. | https://pubmed.ncbi.nlm.nih.gov/34114269/. | Allen, C. M., Ramsamy, S., Tarr, A. W., Tighe, P. J., Irving, W. L., Tanasescu, R., & Evans, J. R. (2021). Guillain–Barré syndrome variant occurring after SARS‐CoV‐2 vaccination. Annals of neurology, 90(2), 315-318. https://pubmed.ncbi.nlm.nih.gov/34114269/. | Phillips, E. J. (2021). Allergic Reactions After COVID-19 Vaccination—Putting Risk Into Perspective. JAMA Network Open, 4(8), e2122326-e2122326. https://pubmed.ncbi.nlm.nih.gov/34463751/ | ||||
562 | Neurological side effects of SARS-CoV-2 vaccines: | https://pubmed.ncbi.nlm.nih.gov/34750810/ | https://www.revespcardiol.org/en-linkresolver-acute-myocarditis-after-administration-bnt162b2-S188558572100133X. | García, B., Ortega, P., JA, B. F., León, C., Burgos, R., & Dorta, C. (2021). Acute myocarditis after administration of the BNT162b2 vaccine against COVID-19. Revista espanola de cardiologia, 74(9), 812-814. | García, B., Ortega, P., JA, B. F., León, C., Burgos, R., & Dorta, C. (2021). Miocarditis aguda tras la administración de la vacuna BNT162b2 contra COVID-19. Revista española de cardiología, 74(9), 812-814. https://www.sciencedirect.com/science/article/pii/S0248866321007098 | Matar, E., Manser, D., Spies, J. M., Worthington, J. M., & Parratt, K. L. (2021). Hemichorea-hemibalismus aguda después de la vacunación COVID-19 (AZD1222). Trastornos del movimiento. https://pubmed.ncbi.nlm.nih.gov/34741583/ | García, B., Ortega, P., JA, B. F., León, C., Burgos, R., & Dorta, C. (2021). Acute myocarditis after administration of the BNT162b2 vaccine against COVID-19. Revista espanola de cardiologia, 74(9), 812-814. https://www.revespcardiol.org/en-linkresolver-acute-myocarditis-after-administration-bnt162b2-S188558572100133X. | Mayfield, J., Bandi, S., Ganti, L., & Rubero, J. (2021). Anaphylaxis after Moderna COVID-19 vaccine. Therapeutic Advances in Vaccines and Immunotherapy, 9, 25151355211048418. https://pubmed.ncbi.nlm.nih.gov/34734159/. | Dalwadi, V., Hancock, D., Ballout, A. A., & Geraci, A. (2021). Axonal-variant Guillian-Barre syndrome temporally associated with mRNA-based Moderna SARS-CoV-2 vaccine. Cureus, 13(9). | https://pubmed.ncbi.nlm.nih.gov/34722067/ | Dalwadi, V., Hancock, D., Ballout, A. A., & Geraci, A. (2021). Axonal-variant Guillian-Barre syndrome temporally associated with mRNA-based Moderna SARS-CoV-2 vaccine. Cureus, 13(9). https://pubmed.ncbi.nlm.nih.gov/34722067/ | Piñana, J. L., López‐Corral, L., Martino, R., Montoro, J., Vazquez, L., Pérez, A., ... & Infectious Complications Subcommittee of the Spanish Hematopoietic Stem Cell Transplantation and Cell Therapy Group (GETH‐TC). (2022). SARS‐CoV‐2‐reactive antibody detection after SARS‐CoV‐2 vaccination in hematopoietic stem cell transplant recipients: Prospective survey from the Spanish Hematopoietic Stem Cell Transplantation and Cell Therapy Group. American journal of hematology, 97(1), 30-42. https://www.ncbi.nlm.nih.gov/pubmed/34695229 | ||||
563 | Coagulopathies after SARS-CoV-2 vaccination may derive from a combined effect of SARS-CoV-2 spike protein and adenovirus vector-activated signaling pathways: | https://pubmed.ncbi.nlm.nih.gov/34639132/ | https://www.sciencedirect.com/science/article/pii/S0248866321007098 | Schmitt, P., Demoulin, R., Poyet, R., Capilla, E., Rohel, G., Pons, F., ... & Cellarier, G. R. (2021). Acute Myocarditis after COVID-19 vaccination: A case report. La Revue de medecine interne, 42(11), 797-800. | Schmitt, P., Demoulin, R., Poyet, R., Capilla, E., Rohel, G., Pons, F., ... & Cellarier, G. R. (2021). Miocarditis aguda después de la vacunación contra COVID-19: reporte de un caso. La Revue de medecine interne, 42(11), 797-800. https://pubmed.ncbi.nlm.nih.gov/34589238/. | Matarneh, A. S., al-Battah, A. H., Farooqui, K., Ghamoodi, M., & Alhatou, M. (2021). COVID-19 Vacuna que causa el síndrome de Guillain-Barre, un raro efecto secundario potencial. Informes de casos clínicos, 9 (9), E04756. https://pubmed.ncbi.nlm.nih.gov/34779385/. | Schmitt, P., Demoulin, R., Poyet, R., Capilla, E., Rohel, G., Pons, F., ... & Cellarier, G. R. (2021). Acute Myocarditis after COVID-19 vaccination: A case report. La Revue de medecine interne, 42(11), 797-800. https://www.sciencedirect.com/science/article/pii/S0248866321007098 | McGonagle, D., De Marco, G., & Bridgewood, C. (2021). Differences in venous immunothrombosis in severe COVID-19 pneumonia and Vaccine-Induced Thrombotic Thrombocytopenia (VITT)–It's in the viral DNA. Journal of Autoimmunity. https://www.sciencedirect.com/science/article/abs/pii/S0896841121000706 | Finsterer, J. (2021). SARS-CoV-2 vaccinations may not only be complicated by GBS but also by distal small fibre neuropathy. Journal of Neuroimmunology. | https://pubmed.ncbi.nlm.nih.gov/34525410/ | Finsterer, J. (2021). SARS-CoV-2 vaccinations may not only be complicated by GBS but also by distal small fibre neuropathy. Journal of Neuroimmunology. https://pubmed.ncbi.nlm.nih.gov/34525410/ | Pitlick, M. M., Park, M. A., Gonzalez-Estrada, A., & Chiarella, S. E. (2021). Biphasic anaphylaxis after first dose of messenger RNA coronavirus disease 2019 vaccine with positive polysorbate 80 skin testing result. Annals of Allergy Asthma & Immunology, 498-499. https://pubmed.ncbi.nlm.nih.gov/34343674/ | ||||
564 | Isolated pulmonary embolism after COVID vaccination: 2 case reports and a review of acute pulmonary embolism complications and follow-up: | https://pubmed.ncbi.nlm.nih.gov/34804412/ | https://pubmed.ncbi.nlm.nih.gov/34589238/. | Ambati, S., Colon, M., Mihic, M., Sanchez, J., & Bakar, A. (2021). Acute myopericarditis after covid-19 vaccine in teenagers. Case reports in cardiology, 2021. | Ambati, S., Colón, M., Mihic, M., Sánchez, J. y Bakar, A. (2021). Miopericarditis aguda tras vacuna covid-19 en adolescentes. Informes de casos en cardiología, 2021. https://academic.oup.com/jpids/article/10/10/962/6329543. | Maye, J. A., Chong, H. P., Rajagopal, V., & Petchey, W. (2021). Reactivación de la vasculitis IgA después de la vacunación de COVID-19. BMJ Case Informes CP, 14 (11), E247188. https://pubmed.ncbi.nlm.nih.gov/34310759/. | Ambati, S., Colon, M., Mihic, M., Sanchez, J., & Bakar, A. (2021). Acute myopericarditis after covid-19 vaccine in teenagers. Case reports in cardiology, 2021. https://pubmed.ncbi.nlm.nih.gov/34589238/. | McLean, K., & Johnson, T. J. (2021). Myopericarditis in a previously healthy adolescent male following COVID‐19 vaccination: A case report. Academic Emergency Medicine, 28(8), 918-921. https://pubmed.ncbi.nlm.nih.gov/34133825/ | Badoiu, A., Moranne, O., Coudray, S., & Ion, I. M. (2021). Clinical Variant of Guillain–Barre Syndrome With Prominent Facial Diplegia After AstraZeneca Coronavirus Disease 2019 Vaccine. Journal of Clinical Neuromuscular Disease, 23(2), 115-116. | https://pubmed.ncbi.nlm.nih.gov/34808658/ | Badoiu, A., Moranne, O., Coudray, S., & Ion, I. M. (2021). Clinical Variant of Guillain–Barre Syndrome With Prominent Facial Diplegia After AstraZeneca Coronavirus Disease 2019 Vaccine. Journal of Clinical Neuromuscular Disease, 23(2), 115-116. https://pubmed.ncbi.nlm.nih.gov/34808658/ | Placke, J. M., Reis, H., Hadaschik, E., Roesch, A., Schadendorf, D., Stoffels, I., & Klode, J. (2021). Coronavirus disease 2019 vaccine mimics lymph node metastases in patients undergoing skin cancer follow-up: A monocentre study. European journal of cancer, 154, 167-174. https://pubmed.ncbi.nlm.nih.gov/34280870/ | ||||
565 | Central retinal vein occlusion after vaccination with SARS-CoV-2 mRNA: case report: | https://pubmed.ncbi.nlm.nih.gov/34571653/. | https://academic.oup.com/jpids/article/10/10/962/6329543. | Tano, E., San Martin, S., Girgis, S., Martinez-Fernandez, Y., & Sanchez Vegas, C. (2021). Perimyocarditis in adolescents after Pfizer-BioNTech COVID-19 vaccine. Journal of the Pediatric Infectious Diseases Society, 10(10), 962-966. | Tano, E., San Martín, S., Girgis, S., Martínez-Fernández, Y. y Sánchez Vegas, C. (2021). Perimiocarditis en adolescentes tras la vacuna Pfizer-BioNTech COVID-19. Revista de la Sociedad de Enfermedades Infecciosas Pediátricas, 10(10), 962-966. https://ecevr.org/DOIx.php?id=10.7774/cevr.2021.10.2.196. | Mayfield, J., Bandi, S., Ganti, L., & Rubero, J. (2021). Anafilaxia después de la vacuna moderna covid-19. Avances terapéuticos en vacunas e inmunoterapia, 9, 25151355211048418. https://pubmed.ncbi.nlm.nih.gov/34698847/ | Tano, E., San Martin, S., Girgis, S., Martinez-Fernandez, Y., & Sanchez Vegas, C. (2021). Perimyocarditis in adolescents after Pfizer-BioNTech COVID-19 vaccine. Journal of the Pediatric Infectious Diseases Society, 10(10), 962-966. https://academic.oup.com/jpids/article/10/10/962/6329543. | McLean, K., & Johnson, T. J. (2021). Myopericarditis in a previously healthy adolescent male following COVID‐19 vaccination: A case report. Academic Emergency Medicine, 28(8), 918-921. https://www.ncbi.nlm.nih.gov/pubmed/34133825 | Khouri, C., Roustit, M., & Cracowski, J. L. (2021). Adverse event reporting and Bell's palsy risk after COVID-19 vaccination. The Lancet Infectious Diseases, 21(11), 1490-1491. | https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(21)00646-0/fulltext. | Khouri, C., Roustit, M., & Cracowski, J. L. (2021). Adverse event reporting and Bell's palsy risk after COVID-19 vaccination. The Lancet Infectious Diseases, 21(11), 1490-1491. https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(21)00646-0/fulltext. | Plasse, R., Nee, R., Gao, S., & Olson, S. (2021). Acute kidney injury with gross hematuria and IgA nephropathy after COVID-19 vaccination. Kidney international, 100(4), 944-945. https://pubmed.ncbi.nlm.nih.gov/34352309/ | ||||
566 | Complicated case report of long-term vaccine-induced thrombotic immune thrombocytopenia A: | https://pubmed.ncbi.nlm.nih.gov/34835275/. | https://ecevr.org/DOIx.php?id=10.7774/cevr.2021.10.2.196. | Nevet, A. (2021). Acute myocarditis associated with anti-COVID-19 vaccination. Clinical and Experimental Vaccine Research, 10(2), 196. | Nevet, A. (2021). Miocarditis aguda asociada a la vacunación anti-COVID-19. Investigación clínica y experimental de vacunas, 10(2), 196. https://pubmed.ncbi.nlm.nih.gov/34428917/. | Mayor, A., Carill, T., Chan, C. W., Christenson, C., Aldarweesh, F., Lana, G. D., & Cohen, K. S. (2022). Trombocitopenia trombótica inmune inducida por la vacuna refractaria (VITT) gestionada con el intercambio de plasma terapéutico retrasado (TPE). Diario de la aféresis clínica, 37 (1), 117-121. https://pubmed.ncbi.nlm.nih.gov/34556531/ | Nevet, A. (2021). Acute myocarditis associated with anti-COVID-19 vaccination. Clinical and Experimental Vaccine Research, 10(2), 196. https://ecevr.org/DOIx.php?id=10.7774/cevr.2021.10.2.196. | McMahon, D. E., Amerson, E., Rosenbach, M., Lipoff, J. B., Moustafa, D., Tyagi, A., ... & Freeman, E. E. (2021). Cutaneous reactions reported after Moderna and Pfizer COVID-19 vaccination: a registry-based study of 414 cases. Journal of the American Academy of Dermatology, 85(1), 46-55. https://pubmed.ncbi.nlm.nih.gov/33838206/ | Mason, M. C., Liaqat, A., Morrow, J., Basso, R., & Gujrati, Y. (2021). Bilateral facial nerve palsy and COVID-19 vaccination: causation or coincidence?. Cureus, 13(8). | https://pubmed.ncbi.nlm.nih.gov/34522557/ | Mason, M. C., Liaqat, A., Morrow, J., Basso, R., & Gujrati, Y. (2021). Bilateral facial nerve palsy and COVID-19 vaccination: causation or coincidence?. Cureus, 13(8). https://pubmed.ncbi.nlm.nih.gov/34522557/ | Plaza, M. J., Wright, J., & Fernandez, S. (2021). COVID-19 vaccine-related unilateral axillary lymphadenopathy: pattern on screening breast MRI allowing for a benign assessment. Clinical Imaging, 80, 139-141. https://pubmed.ncbi.nlm.nih.gov/34325221/ | ||||
567 | Deep venous thrombosis after vaccination with Ad26.COV2.S in adult males: | https://pubmed.ncbi.nlm.nih.gov/34659839/. | https://pubmed.ncbi.nlm.nih.gov/34428917/. | Viskin, D., Topilsky, Y., Aviram, G., Mann, T., Sadon, S., Hadad, Y., ... & Havakuk, O. (2021). Myocarditis Associated With COVID-19 Vaccination: Echocardiography, Cardiac Tomography, and Magnetic Resonance Imaging Findings. Circulation: Cardiovascular Imaging, 14(9), e013236. | Viskin, D., Topilsky, Y., Aviram, G., Mann, T., Sadon, S., Hadad, Y., ... y Havakuk, O. (2021). Miocarditis asociada con la vacunación contra la COVID-19: hallazgos de ecocardiografía, tomografía cardíaca y resonancia magnética. Circulación: Imágenes cardiovasculares, 14(9), e013236. https://pubmed.ncbi.nlm.nih.gov/34088762/. | McGonagle, D., de Marco, G., & Bridgewood, C. (2021). Las diferencias en la inmunotrombosis venosa en la neumonía severa de COVID-19 y la trombocitopenia trombótica inducida por la vacuna (VITT), está en el ADN viral. Diario de autoinmunidad. https://www.sciencedirect.com/science/article/pii/S0006497121009411 | Viskin, D., Topilsky, Y., Aviram, G., Mann, T., Sadon, S., Hadad, Y., ... & Havakuk, O. (2021). Myocarditis Associated With COVID-19 Vaccination: Echocardiography, Cardiac Tomography, and Magnetic Resonance Imaging Findings. Circulation: Cardiovascular Imaging, 14(9), e013236. https://pubmed.ncbi.nlm.nih.gov/34428917/. | McMahon, D. E., Kovarik, C. L., Damsky, W., Rosenbach, M., Lipoff, J. B., Tyagi, A., ... & Freeman, E. E. (2022). Clinical and pathologic correlation of cutaneous COVID-19 vaccine reactions including V-REPP: A registry-based study. Journal of the American Academy of Dermatology, 86(1), 113-121. https://pubmed.ncbi.nlm.nih.gov/34517079/ | Cellina, M., D'Arrigo, A., Floridi, C., Oliva, G., & Carrafiello, G. (2022). Left Bell's palsy following the first dose of mRNA-1273 SARS-CoV-2 vaccine: A case report. Clinical Imaging, 82, 1-4. | https://pubmed.ncbi.nlm.nih.gov/34763263/. | Cellina, M., D'Arrigo, A., Floridi, C., Oliva, G., & Carrafiello, G. (2022). Left Bell's palsy following the first dose of mRNA-1273 SARS-CoV-2 vaccine: A case report. Clinical Imaging, 82, 1-4. https://pubmed.ncbi.nlm.nih.gov/34763263/. | Pomara, C., Sessa, F., Ciaccio, M., Dieli, F., Esposito, M., Garozzo, S. F., ... & Mannucci, P. M. (2021). Post-mortem findings in vaccine-induced thrombotic thrombocytopenia. haematologica, 106(8), 2291. https://haematologica.org/article/view/haematol.2021.279075 | ||||
568 | Neurological autoimmune diseases after SARS-CoV-2 vaccination: a case series: | https://pubmed.ncbi.nlm.nih.gov/34668274/. | https://pubmed.ncbi.nlm.nih.gov/34088762/. | Marshall, M., Ferguson, I. D., Lewis, P., Jaggi, P., Gagliardo, C., Collins, J. S., ... & Guzman-Cottrill, J. A. (2021). Symptomatic acute myocarditis in 7 adolescents after Pfizer-BioNTech COVID-19 vaccination. Pediatrics, 148(3). | Marshall, M., Ferguson, I. D., Lewis, P., Jaggi, P., Gagliardo, C., Collins, J. S., ... y Guzman-Cottrill, J. A. (2021). Miocarditis aguda sintomática en 7 adolescentes tras la vacunación contra el COVID-19 de Pfizer-BioNTech. Pediatría, 148(3). https://academic.oup.com/ehjqcco/advance-article/doi/10.1093/ehjqcco/qcab090/6442104 | McLean, K., & Johnson, T. J. (2021). Myopericarditis en un macho adolescente previamente saludable después de la vacunación COVID-19: un informe de caso. Medicina de emergencia académica, 28 (8), 918-921. https://pubmed.ncbi.nlm.nih.gov/34487236/ | Marshall, M., Ferguson, I. D., Lewis, P., Jaggi, P., Gagliardo, C., Collins, J. S., ... & Guzman-Cottrill, J. A. (2021). Symptomatic acute myocarditis in 7 adolescents after Pfizer-BioNTech COVID-19 vaccination. Pediatrics, 148(3). https://pubmed.ncbi.nlm.nih.gov/34088762/. | McMahon, D. E., Kovarik, C. L., Damsky, W., Rosenbach, M., Lipoff, J. B., Tyagi, A., ... & Freeman, E. E. (2022). Clinical and pathologic correlation of cutaneous COVID-19 vaccine reactions including V-REPP: A registry-based study. Journal of the American Academy of Dermatology, 86(1), 113-121. https://www.sciencedirect.com/science/article/pii/S0190962221024427 | Yu, B. Y., Cen, L. S., Chen, T., & Yang, T. H. (2021). Bell’s palsy after inactivated COVID-19 vaccination in a patient with history of recurrent Bell’s palsy: A case report. World journal of clinical cases, 9(27), 8274. | https://pubmed.ncbi.nlm.nih.gov/34621891/ | Yu, B. Y., Cen, L. S., Chen, T., & Yang, T. H. (2021). Bell’s palsy after inactivated COVID-19 vaccination in a patient with history of recurrent Bell’s palsy: A case report. World journal of clinical cases, 9(27), 8274. https://pubmed.ncbi.nlm.nih.gov/34621891/ | Pomara, C., Sessa, F., Ciaccio, M., Dieli, F., Esposito, M., Giammanco, G. M., ... & Zamboni, P. (2021). COVID-19 vaccine and death: causality algorithm according to the WHO eligibility diagnosis. Diagnostics, 11(6), 955. https://pubmed.ncbi.nlm.nih.gov/34073536/ | ||||
569 | Severe autoimmune hemolytic autoimmune anemia after receiving SARS-CoV-2 mRNA vaccine: | https://pubmed.ncbi.nlm.nih.gov/34549821/ | https://academic.oup.com/ehjqcco/advance-article/doi/10.1093/ehjqcco/qcab090/6442104 | Foltran, D., Delmas, C., Flumian, C., De Paoli, P., Salvo, F., Gautier, S., ... & Montastruc, F. (2022). Myocarditis and pericarditis in adolescents after first and second doses of mRNA COVID-19 vaccines. European Heart Journal-Quality of Care and Clinical Outcomes, 8(2), 99-103. | Foltran, D., Delmas, C., Flumian, C., De Paoli, P., Salvo, F., Gautier, S., ... & Montastruc, F. (2022). Miocarditis y pericarditis en adolescentes después de la primera y segunda dosis de vacunas de ARNm COVID-19. European Heart Journal: calidad de la atención y resultados clínicos, 8(2), 99-103. https://www.mdpi.com/2036-7503/13/3/61. | McLean, K., & Johnson, T. J. (2021). Myopericarditis en un macho adolescente previamente saludable después de la vacunación COVID-19: un informe de caso. Medicina de emergencia académica, 28 (8), 918-921. https://www.ncbi.nlm.nih.gov/pubmed/34614328 | Foltran, D., Delmas, C., Flumian, C., De Paoli, P., Salvo, F., Gautier, S., ... & Montastruc, F. (2022). Myocarditis and pericarditis in adolescents after first and second doses of mRNA COVID-19 vaccines. European Heart Journal-Quality of Care and Clinical Outcomes, 8(2), 99-103. https://academic.oup.com/ehjqcco/advance-article/doi/10.1093/ehjqcco/qcab090/6442104 | Mehta, N., Sales, R. M., Babagbemi, K., Levy, A. D., McGrath, A. L., Drotman, M., & Dodelzon, K. (2021). Unilateral axillary adenopathy in the setting of COVID-19 vaccine: Follow-up. Clinical Imaging, 80, 83-87. https://pubmed.ncbi.nlm.nih.gov/34298342/ | Patone, M., Handunnetthi, L., Saatci, D., Pan, J., Katikireddi, S. V., Razvi, S., ... & Hippisley-Cox, J. (2021). Neurological complications after first dose of COVID-19 vaccines and SARS-CoV-2 infection. Nature medicine, 27(12), 2144-2153. | https://pubmed.ncbi.nlm.nih.gov/34697502/ | Patone, M., Handunnetthi, L., Saatci, D., Pan, J., Katikireddi, S. V., Razvi, S., ... & Hippisley-Cox, J. (2021). Neurological complications after first dose of COVID-19 vaccines and SARS-CoV-2 infection. Nature medicine, 27(12), 2144-2153. https://pubmed.ncbi.nlm.nih.gov/34697502/ | Porres-Aguilar, M., Lazo-Langner, A., Panduro, A., & Uribe, M. (2021). COVID-19 vaccine-induced immune thrombotic thrombocytopenia: an emerging cause of splanchnic vein thrombosis. Annals of Hepatology. https://www.sciencedirect.com/science/article/pii/S1665268121000557 | ||||
570 | Occurrence of COVID-19 variants among recipients of ChAdOx1 nCoV-19 vaccine (recombinant): | https://pubmed.ncbi.nlm.nih.gov/34528522/ | https://www.mdpi.com/2036-7503/13/3/61. | Calcaterra, G., Mehta, J. L., De Gregorio, C., Butera, G., Neroni, P., Fanos, V., & Bassareo, P. P. (2021). COVID 19 vaccine for adolescents. Concern about myocarditis and pericarditis. Pediatric Reports, 13(3), 530-533. | Calcaterra, G., Mehta, J. L., De Gregorio, C., Butera, G., Neroni, P., Fanos, V. y Bassareo, P. P. (2021). Vacuna COVID 19 para adolescentes. Preocupación por la miocarditis y la pericarditis. Informes pediátricos, 13(3), 530-533. https://pubmed.ncbi.nlm.nih.gov/34133885/ | McMahon, D. E., Amerson, E., Rosenbach, M., Lipoff, J. B., Moustafa, D., Tyagi, A., ... & Freeman, E. E. (2021). Reacciones cutáneas reportadas después de la vacunación de Moderna y Pfizer COVID-19: un estudio basado en el registro de 414 casos. Diario de la Academia Americana de Dermatología, 85 (1), 46-55. https://pubmed.ncbi.nlm.nih.gov/34517079/ | Calcaterra, G., Mehta, J. L., De Gregorio, C., Butera, G., Neroni, P., Fanos, V., & Bassareo, P. P. (2021). COVID 19 vaccine for adolescents. Concern about myocarditis and pericarditis. Pediatric Reports, 13(3), 530-533. https://www.mdpi.com/2036-7503/13/3/61. | Mehta, P. R., Mangion, S. A., Benger, M., Stanton, B. R., Czuprynska, J., Arya, R., & Sztriha, L. K. (2021). Cerebral venous sinus thrombosis and thrombocytopenia after COVID-19 vaccination–A report of two UK cases. Brain, behavior, and immunity, 95, 514-517. https://pubmed.ncbi.nlm.nih.gov/33857630/. | Soeiro, T., Salvo, F., Pariente, A., Grandvuillemin, A., Jonville-Béra, A. P., & Micallef, J. (2021). Type I interferons as the potential mechanism linking mRNA COVID-19 vaccines to Bell’s palsy. Therapie. | https://pubmed.ncbi.nlm.nih.gov/33858693/ | Soeiro, T., Salvo, F., Pariente, A., Grandvuillemin, A., Jonville-Béra, A. P., & Micallef, J. (2021). Type I interferons as the potential mechanism linking mRNA COVID-19 vaccines to Bell’s palsy. Therapie. https://pubmed.ncbi.nlm.nih.gov/33858693/ | Portuguese, A. J., Sunga, C., Kruse-Jarres, R., Gernsheimer, T., & Abkowitz, J. (2021). Autoimmune-and complement-mediated hematologic condition recrudescence following SARS-CoV-2 vaccination. Blood Advances, 5(13), 2794-2798. https://ashpublications.org/bloodadvances/article/5/13/2794/476324/Autoimmune-and-complement-mediated-hematologic | ||||
571 | Prevalence of thrombocytopenia, anti-platelet factor 4 antibodies, and elevated D-dimer in Thais after vaccination with ChAdOx1 nCoV-19: | https://pubmed.ncbi.nlm.nih.gov/34568726/ | https://pubmed.ncbi.nlm.nih.gov/34133885/ | Rosner, C. M., Genovese, L., Tehrani, B. N., Atkins, M., Bakhshi, H., Chaudhri, S., ... & Defilippi, C. R. (2021). Myocarditis temporally associated with COVID-19 vaccination. Circulation, 144(6), 502-505. | Rosner, C. M., Genovese, L., Tehrani, B. N., Atkins, M., Bakhshi, H., Chaudhri, S., ... y Defilippi, C. R. (2021). Miocarditis asociada temporalmente a la vacunación COVID-19. Circulación, 144(6), 502-505. https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8639400/ | McMahon, D. E., Kovarik, C. L., Damsky, W., Rosenbach, M., Lipoff, J. B., Tyagi, A., ... & Freeman, E. E. (2022). Correlación clínica y patológica de las reacciones de vacunas COVID-19 CUTÁNICAS, incluyendo V-REPP: un estudio basado en el registro. Diario de la Academia Americana de Dermatología, 86 (1), 113-121. https://pubmed.ncbi.nlm.nih.gov/34254291/ | Rosner, C. M., Genovese, L., Tehrani, B. N., Atkins, M., Bakhshi, H., Chaudhri, S., ... & Defilippi, C. R. (2021). Myocarditis temporally associated with COVID-19 vaccination. Circulation, 144(6), 502-505. https://pubmed.ncbi.nlm.nih.gov/34133885/ | Mehta, P. R., Mangion, S. A., Benger, M., Stanton, B. R., Czuprynska, J., Arya, R., & Sztriha, L. K. (2021). Cerebral venous sinus thrombosis and thrombocytopenia after COVID-19 vaccination–A report of two UK cases. Brain, behavior, and immunity, 95, 514-517. https://www.sciencedirect.com/science/article/abs/pii/S088915912100163X | Erdem, N. Ş., Demirci, S., Özel, T., Mamadova, K., Karaali, K., Çelik, H. T., ... & Özkaynak, S. S. (2021). Acute transverse myelitis after inactivated COVID-19 vaccine. Ideggyogyaszati Szemle, 74(7-08), 273-276. | https://pubmed.ncbi.nlm.nih.gov/34370410/ | Erdem, N. Ş., Demirci, S., Özel, T., Mamadova, K., Karaali, K., Çelik, H. T., ... & Özkaynak, S. S. (2021). Acute transverse myelitis after inactivated COVID-19 vaccine. Ideggyogyaszati Szemle, 74(7-08), 273-276. https://pubmed.ncbi.nlm.nih.gov/34370410/ | Pottegård, A., Lund, L. C., Karlstad, Ø., Dahl, J., Andersen, M., Hallas, J., ... & Hviid, A. (2021). Arterial events, venous thromboembolism, thrombocytopenia, and bleeding after vaccination with Oxford-AstraZeneca ChAdOx1-S in Denmark and Norway: population based cohort study. bmj, 373. https://pubmed.ncbi.nlm.nih.gov/33952445/ | ||||
572 | Epidemiology of acute myocarditis/pericarditis in Hong Kong adolescents after co-vaccination: https://academic.oup.com/cid/advance-article-abstract/doi/10.1093/cid/ciab989/6445179 | Epidemiology of acute myocarditis/pericarditis in Hong Kong adolescents after co-vaccination: | https://academic.oup.com/cid/advance-article-abstract/doi/10.1093/cid/ciab989/6445179 | https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8639400/ | Nagasaka, T., Koitabashi, N., Ishibashi, Y., Aihara, K., Takama, N., Ohyama, Y., ... & Kaneko, Y. (2021). Acute myocarditis associated with COVID-19 vaccination: A case report. Journal of Cardiology Cases. | Nagasaka, T., Koitabashi, N., Ishibashi, Y., Aihara, K., Takama, N., Ohyama, Y., ... y Kaneko, Y. (2021). Miocarditis aguda asociada a la vacunación contra COVID-19: reporte de un caso. Revista de casos de cardiología. https://pubmed.ncbi.nlm.nih.gov/34840235/. | McMahon, D. E., Kovarik, C. L., Damsky, W., Rosenbach, M., Lipoff, J. B., Tyagi, A., ... & Freeman, E. E. (2022). Correlación clínica y patológica de las reacciones de vacunas COVID-19 CUTÁNICAS, incluyendo V-REPP: un estudio basado en el registro. Diario de la Academia Americana de Dermatología, 86 (1), 113-121. https://www.sciencedirect.com/science/article/abs/pii/S0735675721004381. | Nagasaka, T., Koitabashi, N., Ishibashi, Y., Aihara, K., Takama, N., Ohyama, Y., ... & Kaneko, Y. (2021). Acute myocarditis associated with COVID-19 vaccination: A case report. Journal of Cardiology Cases. https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8639400/ | Melas, N. (2021). Portal vein thrombosis occurring after the first dose of mRNA SARS-CoV-2 vaccine in a patient with antiphospholipid syndrome. Thrombosis Update. https://www.sciencedirect.com/science/article/pii/S2666572721000389 | Gao, J. J., Tseng, H. P., Lin, C. L., Shiu, J. S., Lee, M. H., & Liu, C. H. (2021). Acute transverse myelitis following COVID-19 vaccination. Vaccines, 9(9), 1008. | https://pubmed.ncbi.nlm.nih.gov/34579245/. | Gao, J. J., Tseng, H. P., Lin, C. L., Shiu, J. S., Lee, M. H., & Liu, C. H. (2021). Acute transverse myelitis following COVID-19 vaccination. Vaccines, 9(9), 1008. https://pubmed.ncbi.nlm.nih.gov/34579245/. | Prasad, A., Hurlburt, G., Podury, S., Tandon, M., Kingree, S., & Sriwastava, S. (2021). A novel case of bifacial diplegia variant of guillain-Barré syndrome following Janssen COVID-19 vaccination. Neurology International, 13(3), 404-409. https://pubmed.ncbi.nlm.nih.gov/34449715/ | |||
573 | Myocarditis after 2019 coronavirus disease mRNA vaccine: a case series and determination of incidence rate: | https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciab926/6420408 | https://pubmed.ncbi.nlm.nih.gov/34840235/. | Murakami, Y., Shinohara, M., Oka, Y., Wada, R., Noike, R., Ohara, H., ... & Ikeda, T. (2022). Myocarditis Following a COVID-19 Messenger RNA Vaccination: A Japanese Case Series. Internal Medicine, 8731-21. | Murakami, Y., Shinohara, M., Oka, Y., Wada, R., Noike, R., Ohara, H., ... & Ikeda, T. (2022). Miocarditis después de una vacuna de ARN mensajero contra la COVID-19: una serie de casos japoneses. Medicina Interna, 8731-21. https://pubmed.ncbi.nlm.nih.gov/34712497/. | Mehta, N., Ventas, R. M., Babagbemi, K., Levy, A. D., McGrath, A. L., Drotman, M. & Dodelzon, K. (2021). Adenopatía axilar unilateral en el entorno de la vacuna COVID-19: seguimiento. Imágenes clínicas, 80, 83-87. https://pubmed.ncbi.nlm.nih.gov/34839149/ | Murakami, Y., Shinohara, M., Oka, Y., Wada, R., Noike, R., Ohara, H., ... & Ikeda, T. (2022). Myocarditis Following a COVID-19 Messenger RNA Vaccination: A Japanese Case Series. Internal Medicine, 8731-21. https://pubmed.ncbi.nlm.nih.gov/34840235/. | Mendes-de-Almeida, D. P., Martins-Gonçalves, R., Morato-Santos, R., De Carvalho, G. A. C., Martins, S. A., Palhinha, L., ... & Kurtz, P. (2021). Intracerebral hemorrhage associated with vaccine-induced thrombotic thrombocytopenia following ChAdOx1 nCOVID-19 vaccine in a pregnant woman. haematologica, 106(11), 3025. https://pubmed.ncbi.nlm.nih.gov/34261297/ | Pagenkopf, C., & Südmeyer, M. (2021). A case of longitudinally extensive transverse myelitis following vaccination against Covid-19. Journal of Neuroimmunology, 358, 577606. | https://pubmed.ncbi.nlm.nih.gov/34182207/ | Pagenkopf, C., & Südmeyer, M. (2021). A case of longitudinally extensive transverse myelitis following vaccination against Covid-19. Journal of Neuroimmunology, 358, 577606. https://pubmed.ncbi.nlm.nih.gov/34182207/ | Premkumar, M., Bhujade, H., Karki, T., Chaluvashetty, S. B., Kaur, H., Duseja, A. K., & Singh, V. (2021). New Portal Vein Thrombosis in Cirrhosis-is the thrombophilia exacerbated due to Vaccine or COVID-19?. Journal of Clinical and Experimental Hepatology. https://www.jcehepatology.com/article/S0973-6883(21)00545-4/fulltext. | ||||
574 | Myocarditis and pericarditis after COVID-19 vaccination: inequalities in age and vaccine types: | https://www.mdpi.com/2075-4426/11/11/1106 | https://pubmed.ncbi.nlm.nih.gov/34712497/. | Onderko, L., Starobin, B., Riviere, A. E., Hohl, P. K., Phillips, C. T., Morgan, R. B., ... & Afari, M. E. (2021). Myocarditis in the Setting of Recent COVID-19 Vaccination. Case Reports in Cardiology, 2021. | Onderko, L., Starobin, B., Riviere, A. E., Hohl, P. K., Phillips, C. T., Morgan, R. B., ... y Afari, M. E. (2021). Miocarditis en el contexto de una vacunación reciente contra el COVID-19. Informes de casos en cardiología, 2021. https://www.clinicalimaging.org/article/S0899-7071(21)00265-5/fulltext. | Mehta, P. R., Mangion, S. A., BENGER, M., STANTON, B. R., CZUPRYSKA, J., Arya, R., & Sztriha, L. K. (2021). Trombosis sinusal venosa cerebral y trombocitopenia después de la vacunación COVID-19, un informe de dos casos del Reino Unido. Cerebro, comportamiento e inmunidad, 95, 514-517. https://pubmed.ncbi.nlm.nih.gov/34090750/. | Onderko, L., Starobin, B., Riviere, A. E., Hohl, P. K., Phillips, C. T., Morgan, R. B., ... & Afari, M. E. (2021). Myocarditis in the Setting of Recent COVID-19 Vaccination. Case Reports in Cardiology, 2021. https://pubmed.ncbi.nlm.nih.gov/34712497/. | Mevorach, D., Anis, E., Cedar, N., Bromberg, M., Haas, E. J., Nadir, E., ... & Alroy-Preis, S. (2021). Myocarditis after BNT162b2 mRNA vaccine against Covid-19 in Israel. New England Journal of Medicine, 385(23), 2140-2149. https://pubmed.ncbi.nlm.nih.gov/34614328/. | Ahmad, S. A., Salih, K. H., Ahmed, S. F., Kakamad, F. H., Salh, A. M., Hassan, M. N., ... & Hussein, D. A. (2021). Post COVID-19 transverse myelitis; a case report with review of literature. Annals of Medicine and Surgery, 69, 102749. | https://pubmed.ncbi.nlm.nih.gov/34457267/. | Ahmad, S. A., Salih, K. H., Ahmed, S. F., Kakamad, F. H., Salh, A. M., Hassan, M. N., ... & Hussein, D. A. (2021). Post COVID-19 transverse myelitis; a case report with review of literature. Annals of Medicine and Surgery, 69, 102749. https://pubmed.ncbi.nlm.nih.gov/34457267/. | Purkayastha, P., Mckechnie, C., Kalkur, P., & Scully, M. (2021). Rare case of COVID-19 vaccine-associated intracranial haemorrhage with venous sinus thrombosis. BMJ Case Reports CP, 14(9), e245092. https://pubmed.ncbi.nlm.nih.gov/34556531/ | ||||
575 | Epidemiology and clinical features of myocarditis/pericarditis before the introduction of COVID-19 mRNA vaccine in Korean children: a multicenter study: | https://pubmed.ncbi.nlm.nih.gov/34402230/ | https://www.clinicalimaging.org/article/S0899-7071(21)00265-5/fulltext. | Mansour, J., Short, R. G., Bhalla, S., Woodard, P. K., Verma, A., Robinson, X., & Raptis, D. A. (2021). Acute myocarditis after a second dose of the mRNA COVID-19 vaccine: a report of two cases. Clinical Imaging, 78, 247-249. | Mansour, J., Short, R. G., Bhalla, S., Woodard, P. K., Verma, A., Robinson, X. y Raptis, D. A. (2021). Miocarditis aguda después de una segunda dosis de la vacuna de ARNm COVID-19: reporte de dos casos. Imágenes clínicas, 78, 247-249. https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciab926/6420408. | Mehta, P. R., Mangion, S. A., BENGER, M., STANTON, B. R., CZUPRYSKA, J., Arya, R., & Sztriha, L. K. (2021). Trombosis sinusal venosa cerebral y trombocitopenia después de la vacunación COVID-19, un informe de dos casos del Reino Unido. Cerebro, comportamiento e inmunidad, 95, 514-517. https://www.sciencedirect.com/science/article/abs/pii/S0006497121013963. | Mansour, J., Short, R. G., Bhalla, S., Woodard, P. K., Verma, A., Robinson, X., & Raptis, D. A. (2021). Acute myocarditis after a second dose of the mRNA COVID-19 vaccine: a report of two cases. Clinical Imaging, 78, 247-249. https://www.clinicalimaging.org/article/S0899-7071(21)00265-5/fulltext. | Mevorach, D., Anis, E., Cedar, N., Bromberg, M., Haas, E. J., Nadir, E., ... & Alroy-Preis, S. (2021). Myocarditis after BNT162b2 mRNA vaccine against Covid-19 in Israel. New England Journal of Medicine, 385(23), 2140-2149. https://www.ncbi.nlm.nih.gov/pubmed/34614328 | Chen, S., Fan, X. R., He, S., Zhang, J. W., & Li, S. J. (2021). Watch out for neuromyelitis optica spectrum disorder after inactivated virus vaccination for COVID-19. Neurological Sciences, 42(9), 3537-3539. | https://pubmed.ncbi.nlm.nih.gov/34189662/ | Chen, S., Fan, X. R., He, S., Zhang, J. W., & Li, S. J. (2021). Watch out for neuromyelitis optica spectrum disorder after inactivated virus vaccination for COVID-19. Neurological Sciences, 42(9), 3537-3539. https://pubmed.ncbi.nlm.nih.gov/34189662/ | Qasim, H., Ali, E., & Yassin, M. A. (2021). Immune thrombocytopenia relapse post covid-19 vaccine in young male patient. IDCases, 26, e01344. https://pubmed.ncbi.nlm.nih.gov/34804803/. | ||||
576 | Shedding light on post-vaccination myocarditis and pericarditis in COVID-19 and non-COVID-19 vaccine recipients: | https://pubmed.ncbi.nlm.nih.gov/34696294/ | https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciab926/6420408. | Perez, Y., Levy, E. R., Joshi, A. Y., Virk, A., Rodriguez-Porcel, M., Johnson, M., ... & Swift, M. D. (2021). Myocarditis Following COVID-19 mRNA Vaccine: A Case Series and Incidence Rate Determination. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America. | Pérez, Y., Levy, E. R., Joshi, A. Y., Virk, A., Rodríguez-Porcel, M., Johnson, M., ... y Swift, M. D. (2021). Miocarditis después de la vacuna de ARNm de COVID-19: una serie de casos y determinación de la tasa de incidencia. Enfermedades infecciosas clínicas: una publicación oficial de la Sociedad de Enfermedades Infecciosas de América. https://pubmed.ncbi.nlm.nih.gov/34615534/ | Melas, N. (2021). La trombosis de la vena del portal que se produce después de la primera dosis de la vacuna contra el SARS-COV-2 de ARNm en un paciente con síndrome antifosfolípido. Actualización de la trombosis. https://www.sciencedirect.com/science/article/pii/S0196064421003425 | Perez, Y., Levy, E. R., Joshi, A. Y., Virk, A., Rodriguez-Porcel, M., Johnson, M., ... & Swift, M. D. (2021). Myocarditis Following COVID-19 mRNA Vaccine: A Case Series and Incidence Rate Determination. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America. https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciab926/6420408. | Michiels, Y., Houhou-Fidouh, N., Collin, G., Berger, J., & Kohli, E. (2021). Humoral Response Induced by Prime-Boost Vaccination with the ChAdOx1 nCoV-19 and mRNA BNT162b2 Vaccines in a Teriflunomide-Treated Multiple Sclerosis Patient. Vaccines, 9(10), 1140. https://pubmed.ncbi.nlm.nih.gov/34696248/ | Fujikawa, P., Shah, F. A., Braford, M., Patel, K., & Madey, J. (2021). Neuromyelitis Optica in a Healthy Female After Severe Acute Respiratory Syndrome Coronavirus 2 mRNA-1273 Vaccine. Cureus, 13(9). | https://pubmed.ncbi.nlm.nih.gov/34660149/ | Fujikawa, P., Shah, F. A., Braford, M., Patel, K., & Madey, J. (2021). Neuromyelitis Optica in a Healthy Female After Severe Acute Respiratory Syndrome Coronavirus 2 mRNA-1273 Vaccine. Cureus, 13(9). https://pubmed.ncbi.nlm.nih.gov/34660149/ | Rahim, S. E. G., Lin, J. T., & Wang, J. C. (2021). A case of gross hematuria and IgA nephropathy flare-up following SARS-CoV-2 vaccination. Kidney international, 100(1), 238. https://pubmed.ncbi.nlm.nih.gov/33932458/ | ||||
577 | Myocarditis Following mRNA COVID-19 Vaccine: https://journals.lww.com/pec-online/Abstract/2021/11000/Myocarditis_Following_mRNA_COVID_19_Vaccine.9.aspx | Myocarditis Following mRNA COVID-19 Vaccine: | https://journals.lww.com/pec-online/Abstract/2021/11000/Myocarditis_Following_mRNA_COVID_19_Vaccine.9.aspx | https://pubmed.ncbi.nlm.nih.gov/34615534/ | Ceschia, N., Scheggi, V., Gori, A. M., Rogolino, A. A., Cesari, F., Giusti, B., ... & Marcucci, R. (2021). Diffuse prothrombotic syndrome after ChAdOx1 nCoV-19 vaccine administration: a case report. Journal of Medical Case Reports, 15(1), 1-4. | Ceschia, N., Scheggi, V., Gori, A. M., Rogolino, A. A., Cesari, F., Giusti, B., ... & Marcucci, R. (2021). Síndrome protrombótico difuso después de la administración de la vacuna ChAdOx1 nCoV-19: reporte de un caso. Revista de informes de casos médicos, 15(1), 1-4. https://pubmed.ncbi.nlm.nih.gov/34352418/ | MENDES-DE-ALMEIDA, D. P., Martins-Gonçalves, R., Morato-Santos, R., De Carvalho, G. A. C., Martins, S. A., Palhinha, L., ... & Kurtz, P. (2021). Hemorragia intracerebral asociada con la trombocitopenia trombótica inducida por la vacuna después de la vacuna contra la CHADOX1 NCOVID-19 en una mujer embarazada. Haematologica, 106 (11), 3025. https://pubmed.ncbi.nlm.nih.gov/34261296/ | Ceschia, N., Scheggi, V., Gori, A. M., Rogolino, A. A., Cesari, F., Giusti, B., ... & Marcucci, R. (2021). Diffuse prothrombotic syndrome after ChAdOx1 nCoV-19 vaccine administration: a case report. Journal of Medical Case Reports, 15(1), 1-4. https://pubmed.ncbi.nlm.nih.gov/34615534/ | Min, Y. G., Ju, W., Ha, Y. E., Ban, J. J., Lee, S. A., Sung, J. J., & Shin, J. Y. (2021). Sensory Guillain-Barre syndrome following the ChAdOx1 nCov-19 vaccine: Report of two cases and review of literature. Journal of neuroimmunology, 359, 577691. https://pubmed.ncbi.nlm.nih.gov/34416410/. | Helmchen, C., Buttler, G. M., Markewitz, R., Hummel, K., Wiendl, H., & Boppel, T. (2022). Acute bilateral optic/chiasm neuritis with longitudinal extensive transverse myelitis in longstanding stable multiple sclerosis following vector-based vaccination against the SARS-CoV-2. Journal of Neurology, 269(1), 49-54. | https://pubmed.ncbi.nlm.nih.gov/34131771/ | Helmchen, C., Buttler, G. M., Markewitz, R., Hummel, K., Wiendl, H., & Boppel, T. (2022). Acute bilateral optic/chiasm neuritis with longitudinal extensive transverse myelitis in longstanding stable multiple sclerosis following vector-based vaccination against the SARS-CoV-2. Journal of Neurology, 269(1), 49-54. https://pubmed.ncbi.nlm.nih.gov/34131771/ | Raj, S., Ogola, G., & Han, J. (2022). COVID-19 vaccine-associated subclinical axillary lymphadenopathy on screening mammogram. Academic radiology, 29(4), 501-507. https://pubmed.ncbi.nlm.nih.gov/34906409/ | |||
578 | Myocarditis following BNT162b2 mRNA Covid-19 mRNA vaccine in Israel: | https://pubmed.ncbi.nlm.nih.gov/34614328/. | https://pubmed.ncbi.nlm.nih.gov/34352418/ | Andraska, E. A., Kulkarni, R., Chaudhary, M., & Sachdev, U. (2022). Three cases of acute venous thromboembolism in females after vaccination for coronavirus disease 2019. Journal of Vascular Surgery: Venous and Lymphatic Disorders, 10(1), 14-17. | Andraska, EA, Kulkarni, R., Chaudhary, M. y Sachdev, U. (2022). Tres casos de tromboembolismo venoso agudo en mujeres después de la vacunación contra la enfermedad por coronavirus 2019. Journal of Vascular Surgery: Venous and Lymphatic Disorders, 10(1), 14-17. https://jnnp.bmj.com/content/early/2021/09/29/jnnp-2021-327340. | Mevorach, D., ANIS, E., CEDAR, N., BROMBERG, M., HAAS, E. J., NADIR, E., ... & ALROY-PERIS, S. (2021). Miocarditis después de la vacuna contra el ARNA BNT162B2 contra COVID-19 en Israel. New England Journal of Medicine, 385 (23), 2140-2149. https://www.heartlungcirc.org/article/S1443-9506(21)01156-2/fulltext | Andraska, E. A., Kulkarni, R., Chaudhary, M., & Sachdev, U. (2022). Three cases of acute venous thromboembolism in females after vaccination for coronavirus disease 2019. Journal of Vascular Surgery: Venous and Lymphatic Disorders, 10(1), 14-17. https://pubmed.ncbi.nlm.nih.gov/34352418/ | Min, Y. G., Ju, W., Ha, Y. E., Ban, J. J., Lee, S. A., Sung, J. J., & Shin, J. Y. (2021). Sensory Guillain-Barre syndrome following the ChAdOx1 nCov-19 vaccine: Report of two cases and review of literature. Journal of neuroimmunology, 359, 577691. https://www.sciencedirect.com/science/article/pii/S0165572821002186 | Lazaros, G., Anastassopoulou, C., Hatziantoniou, S., Kalos, T., Soulaidopoulos, S., Lazarou, E., ... & Tsioufis, C. (2021). A case series of acute pericarditis following COVID-19 vaccination in the context of recent reports from Europe and the United States. Vaccine, 39(45), 6585-6590. | https://pubmed.ncbi.nlm.nih.gov/34635376/ | Lazaros, G., Anastassopoulou, C., Hatziantoniou, S., Kalos, T., Soulaidopoulos, S., Lazarou, E., ... & Tsioufis, C. (2021). A case series of acute pericarditis following COVID-19 vaccination in the context of recent reports from Europe and the United States. Vaccine, 39(45), 6585-6590. https://pubmed.ncbi.nlm.nih.gov/34635376/ | Ramdeny, S., Lang, A., Al‐Izzi, S., Hung, A., Anwar, I., & Kumar, P. (2021). Management of a patient with a rare congenital limb malformation syndrome after SARS‐CoV‐2 vaccine‐induced thrombosis and thrombocytopenia (VITT). British Journal of Haematology. https://pubmed.ncbi.nlm.nih.gov/34097311/ | ||||
579 | Myocarditis, pericarditis, and cardiomyopathy following COVID-19 vaccination: | https://www.heartlungcirc.org/article/S1443-9506(21)01156-2/fulltext | https://jnnp.bmj.com/content/early/2021/09/29/jnnp-2021-327340. | Crossette-Thambiah, C., Pericleous, C., Asmar, N., Bomsztyk, J., Ranger, A., Shlebak, A., ... & Arachchillage, D. J. (2021). Clinical and biological features of cerebral venous sinus thrombosis following ChAdOx1 nCov-19 vaccination. Journal of Neurology, Neurosurgery & Psychiatry. | Crossette-Thambiah, C., Pericleous, C., Asmar, N., Bomsztyk, J., Ranger, A., Shlebak, A., ... y Arachchillage, DJ (2021). Características clínicas y biológicas de la trombosis del seno venoso cerebral después de la vacunación ChAdOx1 nCov-19. Revista de Neurología, Neurocirugía y Psiquiatría. https://pubmed.ncbi.nlm.nih.gov/34632750/ | Mevorach, D., ANIS, E., CEDAR, N., BROMBERG, M., HAAS, E. J., NADIR, E., ... & ALROY-PERIS, S. (2021). Miocarditis después de la vacuna contra el ARNA BNT162B2 contra COVID-19 en Israel. New England Journal of Medicine, 385 (23), 2140-2149. https://www.ncbi.nlm.nih.gov/pubmed/34166671 | Crossette-Thambiah, C., Pericleous, C., Asmar, N., Bomsztyk, J., Ranger, A., Shlebak, A., ... & Arachchillage, D. J. (2021). Clinical and biological features of cerebral venous sinus thrombosis following ChAdOx1 nCov-19 vaccination. Journal of Neurology, Neurosurgery & Psychiatry. https://jnnp.bmj.com/content/early/2021/09/29/jnnp-2021-327340. | Minocha, P. K., Better, D., Singh, R. K., & Hoque, T. (2021). Recurrence of acute myocarditis temporally associated with receipt of the mRNA coronavirus disease 2019 (COVID-19) vaccine in a male adolescent. The Journal of Pediatrics, 238, 321-323. https://pubmed.ncbi.nlm.nih.gov/34166671/ | Shen, X., Koh, M. S. H., Lim, B. Y., Demo-Os, M., Chien, J. M. F., Santosa, A., & Taha, A. A. (2021). Acute pericarditis and cardiac tamponade after Covid-19 vaccination. Singapore medical journal. | https://pubmed.ncbi.nlm.nih.gov/34749492/ | Shen, X., Koh, M. S. H., Lim, B. Y., Demo-Os, M., Chien, J. M. F., Santosa, A., & Taha, A. A. (2021). Acute pericarditis and cardiac tamponade after Covid-19 vaccination. Singapore medical journal. https://pubmed.ncbi.nlm.nih.gov/34749492/ | Ramessur, R., Saffar, N., Czako, B., Agarwal, A., & Batta, K. (2021). Cutaneous thrombosis associated with skin necrosis following Oxford‐AstraZeneca COVID‐19 vaccination. Clinical and Experimental Dermatology. https://pubmed.ncbi.nlm.nih.gov/34189756/ | ||||
580 | Myocarditis and other cardiovascular complications of COVID-19 mRNA-based COVID-19 vaccines: | https://pubmed.ncbi.nlm.nih.gov/34277198/ | https://pubmed.ncbi.nlm.nih.gov/34632750/ | Zur-Wyrozumska, K. (2021). CAd26. COV2-S vaccination can reveal inherited thrombophilia: massive cerebral venous sinus thrombosis in a young male with normal platelet count. Pol. Arch. Med. Wew.(Online). | Zur-Wyrozumska, K. (2021). CAd26. La vacuna COV2-S puede revelar trombofilia hereditaria: trombosis masiva del seno venoso cerebral en un varón joven con recuento de plaquetas normal. Pol. Arco. Medicina. Vaya. (En línea). https://pubmed.ncbi.nlm.nih.gov/34802488/. | Michiels, Y., Houhou-Fidouh, N., Collin, G., Berger, J., & Kohli, E. (2021). Respuesta humoral inducida por la vacunación de impulso al impulso con las vacunas de Chadox1 NCOV-19 y ARNm BNT162B2 en un paciente de esclerosis múltiple tratado con teriflunomida. Vacunas, 9 (10), 1140. https://pubmed.ncbi.nlm.nih.gov/34548920/ | Zur-Wyrozumska, K. (2021). CAd26. COV2-S vaccination can reveal inherited thrombophilia: massive cerebral venous sinus thrombosis in a young male with normal platelet count. Pol. Arch. Med. Wew.(Online). https://pubmed.ncbi.nlm.nih.gov/34632750/ | Minocha, P. K., Better, D., Singh, R. K., & Hoque, T. (2021). Recurrence of acute myocarditis temporally associated with receipt of the mRNA coronavirus disease 2019 (COVID-19) vaccine in a male adolescent. The Journal of Pediatrics, 238, 321-323. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8216855/ | Ashaari, S., Sohaib, H. A., & Bolger, K. (2021). A case report: symptomatic pericarditis post-COVID-19 vaccination. European Heart Journal-Case Reports, 5(10), ytab375. | https://pubmed.ncbi.nlm.nih.gov/34693198/. | Ashaari, S., Sohaib, H. A., & Bolger, K. (2021). A case report: symptomatic pericarditis post-COVID-19 vaccination. European Heart Journal-Case Reports, 5(10), ytab375. https://pubmed.ncbi.nlm.nih.gov/34693198/. | Ramírez-García, A., Jiménez, S., Ximénez, I., Cacho, A., Aguado-Noya, R., & Cubero, J. (2021). Pericarditis tras la administración de la vacuna de ARNm BNT162b2 contra la COVID-19 Pericarditis after administration of the BNT162b2 mRNA COVID-19 vaccine. Revista espanola de cardiologia. https://www.sciencedirect.com/science/article/pii/S1885585721002218 | ||||
581 | Possible Association Between COVID-19 Vaccine and Myocarditis: Clinical and CMR Findings: | https://pubmed.ncbi.nlm.nih.gov/34246586/ | https://pubmed.ncbi.nlm.nih.gov/34802488/. | Ambrosetti, M., & Pontali, E. (2021). COVID-19 vaccine-induced thrombosis. The International Journal of Tuberculosis and Lung Disease, 25(9), 691-692. | Ambrosetti, M. y Pontali, E. (2021). Trombosis inducida por la vacuna COVID-19. La Revista Internacional de Tuberculosis y Enfermedad Pulmonar, 25(9), 691-692. https://pubmed.ncbi.nlm.nih.gov/34887867/. | Min, Y. G., JU, W., HA, Y. E., BAN, J. J., Lee, S. A., Sung, J. J., y Shin, J. Y. (2021). Síndrome de Guillain-Barre sensorial siguiendo la vacuna Chadox1 NCOV-19: Informe de dos casos y revisión de la literatura. Diario de Neuroimmunology, 359, 577691. https://pubmed.ncbi.nlm.nih.gov/34462013/. | Ambrosetti, M., & Pontali, E. (2021). COVID-19 vaccine-induced thrombosis. The International Journal of Tuberculosis and Lung Disease, 25(9), 691-692. https://pubmed.ncbi.nlm.nih.gov/34802488/. | Minocha, P. K., Better, D., Singh, R. K., & Hoque, T. (2021). Recurrence of acute myocarditis temporally associated with receipt of the mRNA coronavirus disease 2019 (COVID-19) vaccine in a male adolescent. The Journal of Pediatrics, 238, 321-323. https://www.ncbi.nlm.nih.gov/pubmed/34166671 | Jeon, Y. H., Lim, D. H., Choi, S. W., & Choi, S. J. (2021). A flare of Still’s disease following COVID-19 vaccination in a 34-year-old patient. Rheumatology international, 1-6. | https://pubmed.ncbi.nlm.nih.gov/34797392/ | Jeon, Y. H., Lim, D. H., Choi, S. W., & Choi, S. J. (2021). A flare of Still’s disease following COVID-19 vaccination in a 34-year-old patient. Rheumatology international, 1-6. https://pubmed.ncbi.nlm.nih.gov/34797392/ | Ramos, F. J. M., Corrales, A. E., & Puchades, A. M. (2021). Acral haemorrhage after the second dose administration of SARS-CoV-2 vaccine. A post-vaccinal reaction?. Medicina Clinica (English Ed.), 157(10), 506. https://pubmed.ncbi.nlm.nih.gov/34092400/742. | ||||
582 | Hypersensitivity Myocarditis and COVID-19 Vaccines: | https://pubmed.ncbi.nlm.nih.gov/34856634/. | https://pubmed.ncbi.nlm.nih.gov/34887867/. | Ostrowski, S. R., Søgaard, O. S., Tolstrup, M., Stærke, N. B., Lundgren, J., Østergaard, L., & Hvas, A. M. (2021). Inflammation and Platelet Activation After COVID-19 Vaccines-Possible Mechanisms Behind Vaccine-Induced Immune Thrombocytopenia and Thrombosis. Frontiers in immunology, 12, 779453-779453. | Ostrowski, S. R., Søgaard, O. S., Tolstrup, M., Stærke, NB, Lundgren, J., Østergaard, L. y Hvas, A. M. (2021). Inflamación y activación plaquetaria después de las vacunas COVID-19: posibles mecanismos detrás de la trombocitopenia y trombosis inmunitarias inducidas por vacunas. Fronteras en inmunología, 12, 779453-779453. https://pubmed.ncbi.nlm.nih.gov/34863404/. | Min, Y. G., JU, W., HA, Y. E., BAN, J. J., Lee, S. A., Sung, J. J., y Shin, J. Y. (2021). Síndrome de Guillain-Barre sensorial siguiendo la vacuna Chadox1 NCOV-19: Informe de dos casos y revisión de la literatura. Diario de Neuroimmunology, 359, 577691. https://www.sciencedirect.com/science/article/pii/S2214250921000998. | Ostrowski, S. R., Søgaard, O. S., Tolstrup, M., Stærke, N. B., Lundgren, J., Østergaard, L., & Hvas, A. M. (2021). Inflammation and Platelet Activation After COVID-19 Vaccines-Possible Mechanisms Behind Vaccine-Induced Immune Thrombocytopenia and Thrombosis. Frontiers in immunology, 12, 779453-779453. https://pubmed.ncbi.nlm.nih.gov/34887867/. | Minocha, P. K., Better, D., Singh, R. K., & Hoque, T. (2021). Recurrence of acute myocarditis temporally associated with receipt of the mRNA coronavirus disease 2019 (COVID-19) vaccine in a male adolescent. The Journal of Pediatrics, 238, 321-323. https://www.sciencedirect.com/science/article/pii/S002234762100617X | Cory, P., Lawrence, H., Abdulrahim, H., Mahmood-Rao, H., Hussein, A., & Gane, J. (2021). Lessons of the month 3: Haemophagocytic lymphohistiocytosis following COVID-19 vaccination (ChAdOx1 nCoV-19). Clinical Medicine, 21(6), e677-e679. | https://pubmed.ncbi.nlm.nih.gov/34862234/ | Cory, P., Lawrence, H., Abdulrahim, H., Mahmood-Rao, H., Hussein, A., & Gane, J. (2021). Lessons of the month 3: Haemophagocytic lymphohistiocytosis following COVID-19 vaccination (ChAdOx1 nCoV-19). Clinical Medicine, 21(6), e677-e679. https://pubmed.ncbi.nlm.nih.gov/34862234/ | Rao, S. J., Khurana, S., Murthy, G., Dawson, E. T., Jazebi, N., & Haas, C. J. (2021). A case of Guillain–Barre syndrome following Pfizer COVID-19 vaccine. Journal of Community Hospital Internal Medicine Perspectives, 11(5), 597-600. https://pubmed.ncbi.nlm.nih.gov/34567447/ | ||||
583 | Severe myocarditis associated with COVID-19 vaccine: zebra or unicorn?: | https://www.internationaljournalofcardiology.com/article/S0167-5273(21)01477-7/fulltext. | https://pubmed.ncbi.nlm.nih.gov/34863404/. | Hinton, J., e Gala, A. B., & Corbett, S. (2021, December). mRNA COVID-19 Vaccine–Related Anaphylactoid Reaction and Coronary Thrombosis. In Mayo Clinic Proceedings (Vol. 96, No. 12, pp. 3182-3183). Elsevier. | Hinton, J., y Gala, A. B. y Corbett, S. (diciembre de 2021). Reacción anafiláctica relacionada con la vacuna mRNA COVID-19 y trombosis coronaria. En Mayo Clinic Proceedings (Vol. 96, No. 12, págs. 3182-3183). Elsevier. https://www.sciencedirect.com/science/article/pii/S235255682100093X | Minocha, P. K., mejor, D., Singh, R. K., & Hoque, T. (2021). La recurrencia de miocarditis aguda está temporalmente asociada con la recepción de la vacuna contra la enfermedad de ARNm Coronavirus (COVID-19) en un adolescente masculino. El Journal of Pediattics, 238, 321-323. https://pubmed.ncbi.nlm.nih.gov/34118375/ | Hinton, J., e Gala, A. B., & Corbett, S. (2021, December). mRNA COVID-19 Vaccine–Related Anaphylactoid Reaction and Coronary Thrombosis. In Mayo Clinic Proceedings (Vol. 96, No. 12, pp. 3182-3183). Elsevier. https://pubmed.ncbi.nlm.nih.gov/34863404/. | Miqdad, M. A., Nasser, H., Alshehri, A., & Mourad, A. R. (2021). Acute Myocarditis Following the Administration of the Second BNT162b2 COVID-19 Vaccine Dose. Cureus, 13(10). https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8599115/ | Dang, Y. L., & Bryson, A. (2021). Miller-Fisher Syndrome and Guillain-Barre Syndrome overlap syndrome in a patient post Oxford-AstraZeneca SARS-CoV-2 vaccination. BMJ Case Reports CP, 14(11), e246701. | https://pubmed.ncbi.nlm.nih.gov/34848426/. | Dang, Y. L., & Bryson, A. (2021). Miller-Fisher Syndrome and Guillain-Barre Syndrome overlap syndrome in a patient post Oxford-AstraZeneca SARS-CoV-2 vaccination. BMJ Case Reports CP, 14(11), e246701. https://pubmed.ncbi.nlm.nih.gov/34848426/. | Rela, M., Jothimani, D., Vij, M., Rajakumar, A., & Rammohan, A. (2021). Auto-immune hepatitis following COVID vaccination. Journal of Autoimmunity, 123, 102688. https://pubmed.ncbi.nlm.nih.gov/34225251/ | ||||
584 | Acute myocardial infarction and myocarditis after COVID-19 vaccination: | https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8522388/ | https://www.sciencedirect.com/science/article/pii/S235255682100093X | Geeraerts, T., Montastruc, F., Bonneville, F., Mémier, V., Raposo, N., & Toulouse Vitt Study Group. (2021). Oxford-AstraZeneca COVID-19 vaccine-induced cerebral venous thrombosis and thrombocytopaenia: a missed opportunity for a rapid return of experience. Anaesthesia, Critical Care & Pain Medicine. | Geeraerts, T., Montastruc, F., Bonneville, F., Mémier, V., Raposo, N. y Grupo de estudio Toulouse Vitt. (2021). Trombosis venosa cerebral y trombocitopenia inducidas por la vacuna Oxford-AstraZeneca COVID-19: una oportunidad perdida para un rápido retorno de la experiencia. Anestesia, cuidados críticos y medicina del dolor. https://pubmed.ncbi.nlm.nih.gov/34876440/ | Minocha, P. K., mejor, D., Singh, R. K., & Hoque, T. (2021). La recurrencia de miocarditis aguda está temporalmente asociada con la recepción de la vacuna contra la enfermedad de ARNm Coronavirus (COVID-19) en un adolescente masculino. El Journal of Pediattics, 238, 321-323. https://pubmed.ncbi.nlm.nih.gov/34744118/ | Geeraerts, T., Montastruc, F., Bonneville, F., Mémier, V., Raposo, N., & Toulouse Vitt Study Group. (2021). Oxford-AstraZeneca COVID-19 vaccine-induced cerebral venous thrombosis and thrombocytopaenia: a missed opportunity for a rapid return of experience. Anaesthesia, Critical Care & Pain Medicine. https://www.sciencedirect.com/science/article/pii/S235255682100093X | Miqdadi, A., & Herrag, M. (2021). Acute eosinophilic pneumonia associated with the anti-COVID-19 vaccine AZD1222. Cureus, 13(10). https://pubmed.ncbi.nlm.nih.gov/34812326/. | Schneider, J., Sottmann, L., Greinacher, A., Hagen, M., Kasper, H. U., Kuhnen, C., ... & Schmeling, A. (2021). Postmortem investigation of fatalities following vaccination with COVID-19 vaccines. International Journal of Legal Medicine, 135(6), 2335-2345. | https://pubmed.ncbi.nlm.nih.gov/34591186/ | Schneider, J., Sottmann, L., Greinacher, A., Hagen, M., Kasper, H. U., Kuhnen, C., ... & Schmeling, A. (2021). Postmortem investigation of fatalities following vaccination with COVID-19 vaccines. International Journal of Legal Medicine, 135(6), 2335-2345. https://pubmed.ncbi.nlm.nih.gov/34591186/ | Repajic, M., Lai, X. L., Xu, P., & Liu, A. (2021). Bell’s Palsy after second dose of Pfizer COVID-19 vaccination in a patient with history of recurrent Bell’s palsy. Brain, Behavior, & Immunity-Health, 13, 100217. https://www.sciencedirect.com/science/article/pii/S266635462100020X | ||||
585 | Myocarditis after Covid-19 vaccination in a large healthcare organization: | https://www.nejm.org/doi/10.1056/NEJMoa2110737 | https://pubmed.ncbi.nlm.nih.gov/34876440/ | Anderson, A., Seddon, M., Shahzad, K., & Lunevicius, R. (2021). Post-COVID-19 vaccination occurrence of splenic infarction due to arterial thrombosis. BMJ Case Reports CP, 14(12), e243846. | Anderson, A., Seddon, M., Shahzad, K. y Lunevicius, R. (2021). Aparición de infarto esplénico posterior a la vacunación COVID-19 debido a trombosis arterial. Informes de casos de BMJ CP, 14(12), e243846. https://pubmed.ncbi.nlm.nih.gov/33928773/ | Minocha, P. K., mejor, D., Singh, R. K., & Hoque, T. (2021). La recurrencia de miocarditis aguda está temporalmente asociada con la recepción de la vacuna contra la enfermedad de ARNm Coronavirus (COVID-19) en un adolescente masculino. El Journal of Pediattics, 238, 321-323. https://www.ncbi.nlm.nih.gov/pubmed/34737312 | Anderson, A., Seddon, M., Shahzad, K., & Lunevicius, R. (2021). Post-COVID-19 vaccination occurrence of splenic infarction due to arterial thrombosis. BMJ Case Reports CP, 14(12), e243846. https://pubmed.ncbi.nlm.nih.gov/34876440/ | Mitchell, O. R., Couzins, M., Dave, R., Bekker, J., & Brennan, P. A. (2021). COVID-19 vaccination and low cervical lymphadenopathy in the two week neck lump clinic-a follow up audit. British Journal of Oral and Maxillofacial Surgery, 59(6), 720-721. https://pubmed.ncbi.nlm.nih.gov/33947605/. | Plasse, R., Nee, R., Gao, S., & Olson, S. (2021). Acute kidney injury with gross hematuria and IgA nephropathy after COVID-19 vaccination. Kidney international, 100(4), 944-945. | https://pubmed.ncbi.nlm.nih.gov/34352309/ | Plasse, R., Nee, R., Gao, S., & Olson, S. (2021). Acute kidney injury with gross hematuria and IgA nephropathy after COVID-19 vaccination. Kidney international, 100(4), 944-945. https://pubmed.ncbi.nlm.nih.gov/34352309/ | Rerknimitr, P., Puaratanaarunkon, T., Wongtada, C., Wittayabusarakam, N., Krithin, S., Paitoonpong, L., ... & Klaewsongkram, J. (2022). Cutaneous adverse reactions from 35,229 doses of Sinovac and AstraZeneca COVID‐19 vaccination: a prospective cohort study in healthcare workers. Journal of the European Academy of Dermatology and Venereology, 36(3), e158-e161. https://pubmed.ncbi.nlm.nih.gov/34661934/ | ||||
586 | Association of myocarditis with COVID-19 messenger RNA BNT162b2 vaccine in a case series of children: | https://jamanetwork.com/journals/jamacardiology/fullarticle/2783052 | https://pubmed.ncbi.nlm.nih.gov/33928773/ | Haakonsen, H. B., & Nystedt, A. (2021). Deep vein thrombosis more than two weeks after vaccination against COVID-19. Tidsskrift for Den norske legeforening. | Haakonsen, HB y Nystedt, A. (2021). Trombosis venosa profunda más de dos semanas después de la vacunación contra la COVID-19. Tidsskrift para Den norske legeforening. https://pubmed.ncbi.nlm.nih.gov/34880826/ | Minocha, P. K., mejor, D., Singh, R. K., & Hoque, T. (2021). La recurrencia de miocarditis aguda está temporalmente asociada con la recepción de la vacuna contra la enfermedad de ARNm Coronavirus (COVID-19) en un adolescente masculino. El Journal of Pediattics, 238, 321-323. https://www.sciencedirect.com/science/article/pii/S0167527321012286. | Haakonsen, H. B., & Nystedt, A. (2021). Deep vein thrombosis more than two weeks after vaccination against COVID-19. Tidsskrift for Den norske legeforening. https://pubmed.ncbi.nlm.nih.gov/33928773/ | Mitchell, O. R., Dave, R., Bekker, J., & Brennan, P. A. (2021). Supraclavicular lymphadenopathy following COVID-19 vaccination: an increasing presentation to the two-week wait neck lump clinic?. British Journal of Oral and Maxillofacial Surgery, 59(3), 384-385. https://pubmed.ncbi.nlm.nih.gov/33685772/ | Qasim, H., Ali, E., & Yassin, M. A. (2021). Immune thrombocytopenia relapse post covid-19 vaccine in young male patient. IDCases, 26, e01344. | https://pubmed.ncbi.nlm.nih.gov/34804803/. | Qasim, H., Ali, E., & Yassin, M. A. (2021). Immune thrombocytopenia relapse post covid-19 vaccine in young male patient. IDCases, 26, e01344. https://pubmed.ncbi.nlm.nih.gov/34804803/. | Restivo, V., Candore, G., Barrale, M., Caravello, E., Graziano, G., Onida, R., ... & Brusca, I. (2021). Allergy to polyethilenglicole of anti-SARS CoV2 vaccine recipient: a case report of young adult recipient and the management of future exposure to SARS-CoV2. Vaccines, 9(5), 412. https://pubmed.ncbi.nlm.nih.gov/33919151/ | ||||
587 | Clinical suspicion of myocarditis temporally related to COVID-19 vaccination in adolescents and young adults: | https://www.ahajournals.org/doi/abs/10.1161/CIRCULATIONAHA.121.056583?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed | https://pubmed.ncbi.nlm.nih.gov/34880826/ | Braun, T., Viard, M., Juenemann, M., Struffert, T., Schwarm, F., Huttner, H. B., & Roessler, F. C. (2021). Case Report: Take a Second Look: Covid-19 Vaccination-Related Cerebral Venous Thrombosis and Thrombotic Thrombocytopenia Syndrome. Frontiers in neurology, 12. | Braun, T., Viard, M., Juenemann, M., Struffert, T., Schwarm, F., Huttner, H. B. y Roessler, F. C. (2021). Informe de caso: Eche un segundo vistazo: síndrome de trombocitopenia trombótica y trombosis venosa cerebral relacionada con la vacunación contra el Covid-19. Fronteras en neurología, 12. https://pubmed.ncbi.nlm.nih.gov/34587242/ | Miqdad, M. A., Nasser, H., Alshehri, A., & Mourad, A. R. (2021). Miocarditis aguda siguiendo la administración de la segunda dosis de vacuna BNT162B2 COVID-19. CUREUS, 13 (10). https://www.sciencedirect.com/science/article/pii/S2352906721001603 | Braun, T., Viard, M., Juenemann, M., Struffert, T., Schwarm, F., Huttner, H. B., & Roessler, F. C. (2021). Case Report: Take a Second Look: Covid-19 Vaccination-Related Cerebral Venous Thrombosis and Thrombotic Thrombocytopenia Syndrome. Frontiers in neurology, 12. https://pubmed.ncbi.nlm.nih.gov/34880826/ | Mizrahi, B., Lotan, R., Kalkstein, N., Peretz, A., Perez, G., Ben-Tov, A., ... & Patalon, T. (2021). Correlation of SARS-CoV-2-breakthrough infections to time-from-vaccine. Nature communications, 12(1), 1-5. https://www.ncbi.nlm.nih.gov/pubmed/34737312 | Krajewski, P. K., & Szepietowski, J. C. (2021). Immune thrombocytopenic purpura associated with COVID‐19 Pfizer‐BioNTech BNT16B2b2 mRNA vaccine. Journal of the European Academy of Dermatology and Venereology. | https://pubmed.ncbi.nlm.nih.gov/34077572/ | Krajewski, P. K., & Szepietowski, J. C. (2021). Immune thrombocytopenic purpura associated with COVID‐19 Pfizer‐BioNTech BNT16B2b2 mRNA vaccine. Journal of the European Academy of Dermatology and Venereology. https://pubmed.ncbi.nlm.nih.gov/34077572/ | Revon-Riviere, G., Ninove, L., Min, V., Rome, A., Coze, C., Verschuur, A., ... & André, N. (2021). The BNT162b2 mRNA COVID-19 vaccine in adolescents and young adults with cancer: A monocentric experience. European journal of cancer, 154, 30-34. https://www.ncbi.nlm.nih.gov/pubmed/34233234 | ||||
588 | STEMI mimicry: focal myocarditis in an adolescent patient after COVID-19 mRNA vaccination:. | https://pubmed.ncbi.nlm.nih.gov/34756746/ | https://pubmed.ncbi.nlm.nih.gov/34587242/ | Greinacher, A., Selleng, K., Palankar, R., Wesche, J., Handtke, S., Wolff, M., ... & Renné, T. (2021). Insights in ChAdOx1 nCoV-19 vaccine-induced immune thrombotic thrombocytopenia. Blood, The Journal of the American Society of Hematology, 138(22), 2256-2268. | Greinacher, A., Selleng, K., Palankar, R., Wesche, J., Handtke, S., Wolff, M., ... y Renné, T. (2021). Información sobre la trombocitopenia trombótica inmunitaria inducida por la vacuna ChAdOx1 nCoV-19. Sangre, Revista de la Sociedad Estadounidense de Hematología, 138 (22), 2256-2268. https://pubmed.ncbi.nlm.nih.gov/34868465/ | MIQDADI, A., & Herrag, M. (2021). Neumonía eosinofílica aguda asociada con la vacuna anti-covid-19 AZD1222. CUREUS, 13 (10). https://pubmed.ncbi.nlm.nih.gov/34006408/ | Greinacher, A., Selleng, K., Palankar, R., Wesche, J., Handtke, S., Wolff, M., ... & Renné, T. (2021). Insights in ChAdOx1 nCoV-19 vaccine-induced immune thrombotic thrombocytopenia. Blood, The Journal of the American Society of Hematology, 138(22), 2256-2268. https://pubmed.ncbi.nlm.nih.gov/34587242/ | Moffitt, K., Cheung, E., Yeung, T., Stamoulis, C., & Malley, R. (2021). Analysis of Staphylococcus aureus transcriptome in pediatric soft tissue abscesses and comparison to murine infections. Infection and immunity, 89(4), e00715-20. https://www.ncbi.nlm.nih.gov/pubmed/33526560 | Park, H. S., Byun, Y., Byeon, S. H., Kim, S. S., Kim, Y. J., & Lee, C. S. (2021). Retinal Hemorrhage after SARS-CoV-2 Vaccination. Journal of Clinical Medicine, 10(23), 5705. | https://pubmed.ncbi.nlm.nih.gov/34884407/. | Park, H. S., Byun, Y., Byeon, S. H., Kim, S. S., Kim, Y. J., & Lee, C. S. (2021). Retinal Hemorrhage after SARS-CoV-2 Vaccination. Journal of Clinical Medicine, 10(23), 5705. https://pubmed.ncbi.nlm.nih.gov/34884407/. | Reyes-Capo, D. P., Stevens, S. M., & Cavuoto, K. M. (2021). Acute abducens nerve palsy following COVID-19 vaccination. Journal of American Association for Pediatric Ophthalmology and Strabismus, 25(5), 302-303. https://pubmed.ncbi.nlm.nih.gov/34044114/. | ||||
589 | Myocarditis and pericarditis in association with COVID-19 mRNA vaccination: cases from a regional pharmacovigilance center: | https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8587334/ | https://pubmed.ncbi.nlm.nih.gov/34868465/ | Joob, B., & Wiwanitkit, V. (2021). Change of blood viscosity after COVID-19 vaccination: estimation for persons with underlying metabolic syndrome. International Journal of Physiology, Pathophysiology and Pharmacology, 13(5), 148. | Joob, B. y Wiwanitkit, V. (2021). Cambio de la viscosidad de la sangre después de la vacunación COVID-19: estimación para personas con síndrome metabólico subyacente. Revista Internacional de Fisiología, Fisiopatología y Farmacología, 13(5), 148. https://pubmed.ncbi.nlm.nih.gov/34097311/ | Mitchell, O. R., Couzins, M., Dave, R., Bekker, J., & Brennan, P. A. (2021). COVID-19 Vacunación y baja linfadenopatía cervical en la clínica de dos semes de cuello de la semana, una auditoría de seguimiento. Diario británico de cirugía oral y maxilofacial, 59 (6), 720-721. https://pubmed.ncbi.nlm.nih.gov/34526175/ | Joob, B., & Wiwanitkit, V. (2021). Change of blood viscosity after COVID-19 vaccination: estimation for persons with underlying metabolic syndrome. International Journal of Physiology, Pathophysiology and Pharmacology, 13(5), 148. https://pubmed.ncbi.nlm.nih.gov/34868465/ | Moghimi, S. M. (2021). Allergic reactions and anaphylaxis to lipid nanoparticle-based COVID-19 vaccines. Molecular Therapy. https://pubmed.ncbi.nlm.nih.gov/33571463/ | Chen, C. C., Chen, H. Y., Lu, C. C., & Lin, S. H. (2021). Case Report: Anti-neutrophil Cytoplasmic Antibody-Associated Vasculitis With Acute Renal Failure and Pulmonary Hemorrhage May Occur After COVID-19 Vaccination. Frontiers in Medicine, 8. | https://pubmed.ncbi.nlm.nih.gov/34859017/ | Chen, C. C., Chen, H. Y., Lu, C. C., & Lin, S. H. (2021). Case Report: Anti-neutrophil Cytoplasmic Antibody-Associated Vasculitis With Acute Renal Failure and Pulmonary Hemorrhage May Occur After COVID-19 Vaccination. Frontiers in Medicine, 8. https://pubmed.ncbi.nlm.nih.gov/34859017/ | Ring, J., Worm, M., Wollenberg, A., Thyssen, J. P., Jakob, T., Klimek, L., ... & Deleuran, M. (2021). Risk of severe allergic reactions to COVID‐19 vaccines among patients with allergic skin diseases–practical recommendations. A position statement of ETFAD with external experts. Journal of the European Academy of Dermatology and Venereology, 35(6), e362-e365. https://pubmed.ncbi.nlm.nih.gov/33752263/ | ||||
590 | Myocarditis after COVID-19 mRNA vaccines: | https://pubmed.ncbi.nlm.nih.gov/34546329/. | https://pubmed.ncbi.nlm.nih.gov/34097311/ | Ramdeny, S., Lang, A., Al‐Izzi, S., Hung, A., Anwar, I., & Kumar, P. (2021). Management of a patient with a rare congenital limb malformation syndrome after SARS‐CoV‐2 vaccine‐induced thrombosis and thrombocytopenia (VITT). British Journal of Haematology. | Ramdeny, S., Lang, A., Al-Izzi, S., Hung, A., Anwar, I. y Kumar, P. (2021). Manejo de un paciente con un raro síndrome de malformación congénita de las extremidades después de una trombosis y trombocitopenia inducida por la vacuna contra el SARS-CoV-2 (VITT). Revista británica de hematología. https://pubmed.ncbi.nlm.nih.gov/34820232/. | Mitchell, O. R., Dave, R., Bekker, J., & Brennan, P. A. (2021). Linfadenopatía supraclavicular después de la vacunación de COVID-19: ¿una presentación creciente a la clínica a tanto del cuello de espera de dos semanas? Diario británico de cirugía oral y maxilofacial, 59 (3), 384-385. https://pubmed.ncbi.nlm.nih.gov/34719892/ | Ramdeny, S., Lang, A., Al‐Izzi, S., Hung, A., Anwar, I., & Kumar, P. (2021). Management of a patient with a rare congenital limb malformation syndrome after SARS‐CoV‐2 vaccine‐induced thrombosis and thrombocytopenia (VITT). British Journal of Haematology. https://pubmed.ncbi.nlm.nih.gov/34097311/ | Mohamed, L., Madsen, A. M. R., Schaltz-Buchholzer, F., Ostenfeld, A., Netea, M. G., Benn, C. S., & Kofoed, P. E. (2021). Reactivation of BCG vaccination scars after vaccination with mRNA-Covid-vaccines: two case reports. BMC infectious diseases, 21(1), 1-4. https://www.ncbi.nlm.nih.gov/pubmed/34930152 | Takeyama, R., Fukuda, K., Kouzaki, Y., Koga, T., Hayashi, S., Ohtani, H., & Inoue, T. (2022). Intracerebral hemorrhage due to vasculitis following COVID-19 vaccination: a case report. Acta neurochirurgica, 164(2), 543-547. | https://pubmed.ncbi.nlm.nih.gov/34783899/ | Takeyama, R., Fukuda, K., Kouzaki, Y., Koga, T., Hayashi, S., Ohtani, H., & Inoue, T. (2022). Intracerebral hemorrhage due to vasculitis following COVID-19 vaccination: a case report. Acta neurochirurgica, 164(2), 543-547. https://pubmed.ncbi.nlm.nih.gov/34783899/ | Robichaud, J., Côté, C., & Côté, F. (2021). Systemic capillary leak syndrome after ChAdOx1 nCOV-19 (Oxford–AstraZeneca) vaccination. CMAJ, 193(34), E1341-E1344. https://pubmed.ncbi.nlm.nih.gov/34362727/ | ||||
591 | Patients with acute myocarditis after COVID-19 mRNA vaccination:. | https://jamanetwork.com/journals/jamacardiology/fullarticle/2781602. | https://pubmed.ncbi.nlm.nih.gov/34820232/. | Giovane, R., & Campbell, J. (2021). Bilateral Thalamic Stroke: A Case of COVID-19 Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT) or a Coincidence Due to Underlying Risk Factors?. Cureus, 13(10). | Giovane, R. y Campbell, J. (2021). Accidente cerebrovascular talámico bilateral: ¿un caso de trombocitopenia trombótica inmunitaria (VITT) inducida por la vacuna COVID-19 o una coincidencia debida a factores de riesgo subyacentes? Cureus, 13(10). https://onlinelibrary.wiley.com/doi/10.1002/ajh.26258 | Mizrahi, B., Lotan, R., Kalkstein, N., Peretz, A., Pérez, G., Ben-Tov, A., ... & Patalon, T. (2021). Correlación de las infecciones de SARS-COV-2-Breakthroughth a tiempo de vacuna. Comunicaciones de la naturaleza, 12 (1), 1-5. https://www.ncbi.nlm.nih.gov/pubmed/33526560 | Giovane, R., & Campbell, J. (2021). Bilateral Thalamic Stroke: A Case of COVID-19 Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT) or a Coincidence Due to Underlying Risk Factors?. Cureus, 13(10). https://pubmed.ncbi.nlm.nih.gov/34820232/. | Mohta, A., Arora, A., Srinivasa, R., & Mehta, R. D. (2021). Recurrent herpes zoster after COVID‐19 vaccination in patients with chronic urticaria being treated with cyclosporine—A report of 3 cases. Journal of Cosmetic Dermatology, 20(11), 3384. https://pubmed.ncbi.nlm.nih.gov/34510694/ | Finsterer, J., & Redzic, Z. (2021). Symptomatic peduncular, cavernous bleeding following SARS-CoV-2 vaccination induced immune thrombocytopenia. Brain Hemorrhages, 2(4), 169-171. | https://pubmed.ncbi.nlm.nih.gov/34549178/. | Finsterer, J., & Redzic, Z. (2021). Symptomatic peduncular, cavernous bleeding following SARS-CoV-2 vaccination induced immune thrombocytopenia. Brain Hemorrhages, 2(4), 169-171. https://pubmed.ncbi.nlm.nih.gov/34549178/. | Robinson, K. A., Maimone, S., Gococo-Benore, D. A., Li, Z., Advani, P. P., & Chumsri, S. (2021). Incidence of axillary adenopathy in breast imaging after COVID-19 vaccination. JAMA oncology, 7(9), 1395-1397. https://pubmed.ncbi.nlm.nih.gov/34292295/. | ||||
592 | Myocarditis after COVID-19 vaccination: a case series: | https://www.sciencedirect.com/science/article/pii/S0264410X21011725?via%3Dihub. | https://onlinelibrary.wiley.com/doi/10.1002/ajh.26258 | Dhoot, R., Kansal, A., Handran, C., Haykal, T., Ronald, J., Kappus, M., ... & Strouse, J. J. (2021). Thrombocytopenia and splanchnic thrombosis after Ad26. COV2. S vaccination successfully treated with transjugular intrahepatic portosystemic shunting and thrombectomy. American journal of hematology. | Dhoot, R., Kansal, A., Handran, C., Haykal, T., Ronald, J., Kappus, M., ... y Strouse, J. J. (2021). Trombocitopenia y trombosis esplácnica tras Ad26. COV2. La vacunación S se trató con éxito con derivación portosistémica intrahepática transyugular y trombectomía. Revista americana de hematología. https://pubmed.ncbi.nlm.nih.gov/34579636/ | Moffitt, K., Cheung, E., Yeung, T., Stamoulis, C., & Malley, R. (2021). Análisis de Stafylococcus aureus Transcriptoma en abscesos de tejidos blandos pediátricos y comparación con infecciones murinas. Infección e inmunidad, 89 (4), E00715-20. https://www.ncbi.nlm.nih.gov/pubmed/34930152 | Dhoot, R., Kansal, A., Handran, C., Haykal, T., Ronald, J., Kappus, M., ... & Strouse, J. J. (2021). Thrombocytopenia and splanchnic thrombosis after Ad26. COV2. S vaccination successfully treated with transjugular intrahepatic portosystemic shunting and thrombectomy. American journal of hematology. https://onlinelibrary.wiley.com/doi/10.1002/ajh.26258 | Monagle, P., Ng, A. P., Linden, M., Ignjatovic, V., Farley, A., Taoudi, S., ... & Torresi, J. (2021). Vaccine‐induced immune thrombosis and thrombocytopenia syndrome following adenovirus‐vectored severe acute respiratory syndrome coronavirus 2 vaccination: a novel hypothesis regarding mechanisms and implications for future vaccine development. Immunology and Cell Biology, 99(10), 1006-1010. https://pubmed.ncbi.nlm.nih.gov/34664303/. | Watchmaker, J. M., & Belani, P. B. (2022). Brain death in a vaccinated patient with COVID-19 infection. Clinical Imaging, 81, 92-95. | https://pubmed.ncbi.nlm.nih.gov/34656887/ | Watchmaker, J. M., & Belani, P. B. (2022). Brain death in a vaccinated patient with COVID-19 infection. Clinical Imaging, 81, 92-95. https://pubmed.ncbi.nlm.nih.gov/34656887/ | Rodríguez-Pardo, J., Gilo-Arrojo, F., Ruiz-Ares, G., Sánchez-Manso, J. C., Valiente-Gordillo, E., de Celis, E., ... & Díez-Tejedor, E. (2021). Thrombosis and Thrombocytopenia Syndrome Causing Isolated Symptomatic Carotid Occlusion after Covid-19 Vaccine. Thrombosis and Haemostasis. https://pubmed.ncbi.nlm.nih.gov/34670287/ | ||||
593 | Myocarditis associated with COVID-19 vaccination in adolescents: | https://publications.aap.org/pediatrics/article/148/5/e2021053427/181357 | https://pubmed.ncbi.nlm.nih.gov/34579636/ | Hidayat, R., Diafiri, D., Zairinal, R. A., Arifin, G. R., Azzahroh, F., Widjaya, N., ... & Haris, S. (2021). Acute Ischaemic Stroke Incidence after Coronavirus Vaccine in Indonesia: Case Series. Current neurovascular research, 18(3), 360-363. | Hidayat, R., Diafiri, D., Zairinal, R. A., Arifin, G. R., Azzahroh, F., Widjaya, N., ... y Haris, S. (2021). Incidencia de accidente cerebrovascular isquémico agudo después de la vacuna contra el coronavirus en Indonesia: serie de casos. Investigación neurovascular actual, 18(3), 360-363. https://pubmed.ncbi.nlm.nih.gov/34614491/ | Moghimi, S. M. (2021). Reacciones alérgicas y anafilaxia a las vacunas COVID-19 a base de nanopartículas lipidas. Terapia molecular. https://pubmed.ncbi.nlm.nih.gov/33527524/ | Hidayat, R., Diafiri, D., Zairinal, R. A., Arifin, G. R., Azzahroh, F., Widjaya, N., ... & Haris, S. (2021). Acute Ischaemic Stroke Incidence after Coronavirus Vaccine in Indonesia: Case Series. Current neurovascular research, 18(3), 360-363. https://pubmed.ncbi.nlm.nih.gov/34579636/ | Montgomery, J., Ryan, M., Engler, R., Hoffman, D., McClenathan, B., Collins, L., ... & Cooper, L. T. (2021). Myocarditis following immunization with mRNA COVID-19 vaccines in members of the US military. JAMA cardiology, 6(10), 1202-1206. https://jamanetwork.com/journals/jamacardiology/fullarticle/2781601 | Falkenhain‐López, D., Gutiérrez‐Collar, C., Arroyo‐Andrés, J., Gallego‐Gutiérrez, I., Rodríguez‐Peralto, J. L., & Sánchez‐Velázquez, A. (2021). Widespread purpura annularis telangiectodes following mRNA SARS‐CoV‐2 vaccine. Journal of the European Academy of Dermatology and Venereology. | https://pubmed.ncbi.nlm.nih.gov/34236717/. | Falkenhain‐López, D., Gutiérrez‐Collar, C., Arroyo‐Andrés, J., Gallego‐Gutiérrez, I., Rodríguez‐Peralto, J. L., & Sánchez‐Velázquez, A. (2021). Widespread purpura annularis telangiectodes following mRNA SARS‐CoV‐2 vaccine. Journal of the European Academy of Dermatology and Venereology. https://pubmed.ncbi.nlm.nih.gov/34236717/. | Rodriguez, E. V., Bouazza, F. Z., Dauby, N., Mullier, F., d’Otreppe, S., Jissendi Tchofo, P., ... & Cliquennois, M. (2021). Fatal vaccine-induced immune thrombotic thrombocytopenia (VITT) post Ad26. COV2. S: first documented case outside US. Infection, 1-6. https://pubmed.ncbi.nlm.nih.gov/34626338/ | ||||
594 | Myocarditis findings on cardiac magnetic resonance imaging after vaccination with COVID-19 mRNA in adolescents:. | https://pubmed.ncbi.nlm.nih.gov/34704459/ | https://pubmed.ncbi.nlm.nih.gov/34614491/ | Kemper, M., Lenz, G., & Mesters, R. M. (2021). Successful Treatment of Vaccine-Induced Immune Thrombotic Thrombocytopenia in a 26-Year-Old Female Patient. Acta Haematologica, 1-4. | Kemper, M., Lenz, G. y Mesters, RM (2021). Tratamiento exitoso de la trombocitopenia trombótica inmunitaria inducida por vacunas en una paciente de 26 años. Acta Haematológica, 1-4. https://pubmed.ncbi.nlm.nih.gov/34790684/ | Mohamed, L., Madsen, A. M. R., Schaltz-Buchholzer, F., Ostenfeld, A., Netea, M. G., Benn, C. S. y Kofoed, P. E. (2021). Reactivación de las cicatrices de vacunación BCG después de la vacunación con las vacunas con ARNm-covid: dos informes de casos. Enfermedades infecciosas BMC, 21 (1), 1-4. https://www.ncbi.nlm.nih.gov/pubmed/34185045 | Kemper, M., Lenz, G., & Mesters, R. M. (2021). Successful Treatment of Vaccine-Induced Immune Thrombotic Thrombocytopenia in a 26-Year-Old Female Patient. Acta Haematologica, 1-4. https://pubmed.ncbi.nlm.nih.gov/34614491/ | Montgomery, J., Ryan, M., Engler, R., Hoffman, D., McClenathan, B., Collins, L., ... & Cooper, L. T. (2021). Myocarditis following immunization with mRNA COVID-19 vaccines in members of the US military. JAMA cardiology, 6(10), 1202-1206. https://jamanetwork.com/journals/jamacardiology/fullarticle/2781601%5C | Rahim, S. E. G., Lin, J. T., & Wang, J. C. (2021). A case of gross hematuria and IgA nephropathy flare-up following SARS-CoV-2 vaccination. Kidney international, 100(1), 238. | https://pubmed.ncbi.nlm.nih.gov/33932458/ | Rahim, S. E. G., Lin, J. T., & Wang, J. C. (2021). A case of gross hematuria and IgA nephropathy flare-up following SARS-CoV-2 vaccination. Kidney international, 100(1), 238. https://pubmed.ncbi.nlm.nih.gov/33932458/ | Román, G. C., Gracia, F., Torres, A., Palacios, A., Gracia, K., & Harris, D. (2021). Acute transverse myelitis (ATM): clinical review of 43 patients with COVID-19-associated ATM and 3 post-vaccination ATM serious adverse events with the ChAdOx1 nCoV-19 vaccine (AZD1222). Frontiers in immunology, 12, 879. https://pubmed.ncbi.nlm.nih.gov/33981305/ | ||||
595 | Myocarditis after COVID-19 vaccination: magnetic resonance imaging study: https://academic.oup.com/ehjcimaging/advance-article/doi/10.1093/ehjci/jeab230/6421640 | Myocarditis after COVID-19 vaccination: magnetic resonance imaging study: | https://academic.oup.com/ehjcimaging/advance-article/doi/10.1093/ehjci/jeab230/6421640 | https://pubmed.ncbi.nlm.nih.gov/34790684/ | Su, P. H., Yu, Y. C., Chen, W. H., Lin, H. C., Chen, Y. T., Cheng, M. H., & Huang, Y. M. (2021). Case Report: Vaccine-Induced Immune Thrombotic Thrombocytopenia in a Pancreatic Cancer Patient After Vaccination With Messenger RNA− 1273. Frontiers in Medicine, 8. | Su, P. H., Yu, Y. C., Chen, W. H., Lin, H. C., Chen, Y. T., Cheng, M. H. y Huang, Y. M. (2021). Informe de caso: Trombocitopenia trombótica inmunitaria inducida por vacuna en un paciente con cáncer de páncreas después de la vacunación con ARN mensajero- 1273. Frontiers in Medicine, 8. https://pubmed.ncbi.nlm.nih.gov/33624509/. | Mohta, A., Arora, A., Srinivasa, R., & Mehta, R. D. (2021). Herpes recurrente Zoster después de la vacunación de COVID-19 en pacientes con urticaria crónica que se trata con ciclosporina, un informe de 3 casos. Diario de la dermatología cosmética, 20 (11), 3384. https://pubmed.ncbi.nlm.nih.gov/34713472/803 | Su, P. H., Yu, Y. C., Chen, W. H., Lin, H. C., Chen, Y. T., Cheng, M. H., & Huang, Y. M. (2021). Case Report: Vaccine-Induced Immune Thrombotic Thrombocytopenia in a Pancreatic Cancer Patient After Vaccination With Messenger RNA− 1273. Frontiers in Medicine, 8. https://pubmed.ncbi.nlm.nih.gov/34790684/ | Montgomery, J., Ryan, M., Engler, R., Hoffman, D., McClenathan, B., Collins, L., ... & Cooper, L. T. (2021). Myocarditis following immunization with mRNA COVID-19 vaccines in members of the US military. JAMA cardiology, 6(10), 1202-1206. https://pubmed.ncbi.nlm.nih.gov/34185045/ | Ramos, F. J. M., Corrales, A. E., & Puchades, A. M. (2021). Acral haemorrhage after the second dose administration of SARS-CoV-2 vaccine. A post-vaccinal reaction?. Medicina Clinica (English Ed.), 157(10), 506. | https://pubmed.ncbi.nlm.nih.gov/34092400/742. | Ramos, F. J. M., Corrales, A. E., & Puchades, A. M. (2021). Acral haemorrhage after the second dose administration of SARS-CoV-2 vaccine. A post-vaccinal reaction?. Medicina Clinica (English Ed.), 157(10), 506. https://pubmed.ncbi.nlm.nih.gov/34092400/742. | Rose, J., & McCullough, P. A. (2021). A report on myocarditis adverse events in the US vaccine adverse events reporting system (VAERS) in association with COVID-19 injectable biological products. Current problems in cardiology. https://pubmed.ncbi.nlm.nih.gov/34601006/ | |||
596 | Acute myocarditis after administration of the second dose of BNT162b2 COVID-19 vaccine: | https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8599115/ | https://pubmed.ncbi.nlm.nih.gov/33624509/. | Lorente, E. (2021). Idiopathic Ipsilateral External Jugular Vein Thrombophlebitis After Coronavirus Disease (COVID-19) Vaccination. AJR Am J Roentgenol, 767-767. | Lorente, E. (2021). Tromboflebitis idiopática de la vena yugular externa ipsilateral después de la vacunación contra la enfermedad por coronavirus (COVID-19). AJR Am J Roentgenol, 767-767. https://pubmed.ncbi.nlm.nih.gov/34612003/ | Monagle, P., NG, A. P., Linden, M., Ignjatovic, V., Farley, A., Taudi, S., ... & Torresi, J. (2021). Trombosis inmune inducida por la vacuna y síndrome de trombocitopenia después de un síndrome respiratorio agudo intenso al adenovirus. Vacunación de coronavirus 2: una hipótesis novedosa con respecto a los mecanismos e implicaciones para el desarrollo futuro de la vacuna. Inmunología y biología celular, 99 (10), 1006-1010. https://pubmed.ncbi.nlm.nih.gov/34649281/. | Lorente, E. (2021). Idiopathic Ipsilateral External Jugular Vein Thrombophlebitis After Coronavirus Disease (COVID-19) Vaccination. AJR Am J Roentgenol, 767-767. https://pubmed.ncbi.nlm.nih.gov/33624509/. | Montgomery, J., Ryan, M., Engler, R., Hoffman, D., McClenathan, B., Collins, L., ... & Cooper, L. T. (2021). Myocarditis following immunization with mRNA COVID-19 vaccines in members of the US military. JAMA cardiology, 6(10), 1202-1206. https://www.ncbi.nlm.nih.gov/pubmed/34185045 | Cooper, K. M., & Switzer, B. (2021). Severe immune thrombocytopenic purpura after SARS-CoV-2 vaccine. Archive of Clinical Cases, 8(2), 31. | https://pubmed.ncbi.nlm.nih.gov/34754937/ | Cooper, K. M., & Switzer, B. (2021). Severe immune thrombocytopenic purpura after SARS-CoV-2 vaccine. Archive of Clinical Cases, 8(2), 31. https://pubmed.ncbi.nlm.nih.gov/34754937/ | Rosner, C. M., Genovese, L., Tehrani, B. N., Atkins, M., Bakhshi, H., Chaudhri, S., ... & Defilippi, C. R. (2021). Myocarditis temporally associated with COVID-19 vaccination. Circulation, 144(6), 502-505. https://www.ahajournals.org/doi/pdf/10.1161/CIRCULATIONAHA.121.055891. | ||||
597 | Myocarditis after COVID-19 vaccination: | https://www.sciencedirect.com/science/article/pii/S2352906721001603 | https://pubmed.ncbi.nlm.nih.gov/34612003/ | Sumi, T., Nagahisa, Y., Matsuura, K., Sekikawa, M., Yamada, Y., Nakata, H., & Chiba, H. (2021). Lung squamous cell carcinoma with hemoptysis after vaccination with tozinameran (BNT162b2, Pfizer‐BioNTech). Thoracic Cancer, 12(22), 3072-3075. | Sumi, T., Nagahisa, Y., Matsuura, K., Sekikawa, M., Yamada, Y., Nakata, H. y Chiba, H. (2021). Carcinoma de células escamosas de pulmón con hemoptisis después de la vacunación con tozinameran (BNT162b2, Pfizer‐BioNTech). Cáncer torácico, 12(22), 3072-3075. https://pubmed.ncbi.nlm.nih.gov/34096082/ | Montgomery, J., Ryan, M., Engler, R., Hoffman, D., McClenathan, B., Collins, L., ... & Cooper, L. T. (2021). La miocarditis después de la inmunización con las vacunas con MRNA COVID-19 en miembros del ejército estadounidense. Cardiología de Jama, 6 (10), 1202-1206. https://jamanetwork.com/journals/jamacardiology/fullarticle/2781600 | Sumi, T., Nagahisa, Y., Matsuura, K., Sekikawa, M., Yamada, Y., Nakata, H., & Chiba, H. (2021). Lung squamous cell carcinoma with hemoptysis after vaccination with tozinameran (BNT162b2, Pfizer‐BioNTech). Thoracic Cancer, 12(22), 3072-3075. https://pubmed.ncbi.nlm.nih.gov/34612003/ | Morehouse, Z. P., Paulus, A., Jasti, S. A., & Bing, X. (2021). A Rare Variant of Guillain-Barre Syndrome Following Ad26. COV2. S Vaccination. Cureus, 13(9). https://pubmed.ncbi.nlm.nih.gov/34703690/. | Negrea, L., & Rovin, B. H. (2021). Gross hematuria following vaccination for severe acute respiratory syndrome coronavirus 2 in 2 patients with IgA nephropathy. Kidney international, 99(6), 1487. | https://pubmed.ncbi.nlm.nih.gov/33771584/ | Negrea, L., & Rovin, B. H. (2021). Gross hematuria following vaccination for severe acute respiratory syndrome coronavirus 2 in 2 patients with IgA nephropathy. Kidney international, 99(6), 1487. https://pubmed.ncbi.nlm.nih.gov/33771584/ | Rossetti, A., Gheihman, G., O'Hare, M., & Kosowsky, J. M. (2021). Guillain-Barré Syndrome presenting as facial diplegia after COVID-19 vaccination: A case report. The Journal of Emergency Medicine, 61(6), e141-e145. https://www.sciencedirect.com/science/article/pii/S0736467921006442 | ||||
598 | Case report: probable myocarditis after Covid-19 mRNA vaccine in a patient with arrhythmogenic left ventricular cardiomyopathy: | https://pubmed.ncbi.nlm.nih.gov/34712717/. | https://pubmed.ncbi.nlm.nih.gov/34096082/ | Abou‐Ismail, M. Y., Moser, K. A., Smock, K. J., & Lim, M. Y. (2021). Vaccine‐induced thrombotic thrombocytopenia following Ad26. COV2. S vaccine in a man presenting as acute venous thromboembolism. American Journal of Hematology. | Abou-Ismail, M. Y., Moser, K. A., Smock, K. J. y Lim, M. Y. (2021). Trombocitopenia trombótica inducida por la vacuna después de Ad26. COV2. Vacuna S en un hombre que presenta tromboembolismo venoso agudo. Revista americana de hematología. https://pubmed.ncbi.nlm.nih.gov/34851078/. | Montgomery, J., Ryan, M., Engler, R., Hoffman, D., McClenathan, B., Collins, L., ... & Cooper, L. T. (2021). La miocarditis después de la inmunización con las vacunas con MRNA COVID-19 en miembros del ejército estadounidense. Cardiología de Jama, 6 (10), 1202-1206. https://pubmed.ncbi.nlm.nih.gov/34229940/ | Abou‐Ismail, M. Y., Moser, K. A., Smock, K. J., & Lim, M. Y. (2021). Vaccine‐induced thrombotic thrombocytopenia following Ad26. COV2. S vaccine in a man presenting as acute venous thromboembolism. American Journal of Hematology. https://pubmed.ncbi.nlm.nih.gov/34096082/ | Mortazavi, S. (2021). COVID-19 vaccination–associated axillary adenopathy: imaging findings and follow-up recommendations in 23 women. American Journal of Roentgenology, 217(4), 857-858. https://pubmed.ncbi.nlm.nih.gov/33624520/ | Kwon, H., & Kim, T. (2022). Autoimmune encephalitis following ChAdOx1-S SARS-CoV-2 vaccination. Neurological Sciences, 43(3), 1487-1489. | https://pubmed.ncbi.nlm.nih.gov/34846583/ | Kwon, H., & Kim, T. (2022). Autoimmune encephalitis following ChAdOx1-S SARS-CoV-2 vaccination. Neurological Sciences, 43(3), 1487-1489. https://pubmed.ncbi.nlm.nih.gov/34846583/ | Rossi, A., Magri, F., Michelini, S., Caro, G., Di Fraia, M., Fortuna, M. C., ... & Carlesimo, M. (2021). Recurrence of alopecia areata after covid‐19 vaccination: A report of three cases in Italy. Journal of cosmetic dermatology, 20(12), 3753-3757. https://pubmed.ncbi.nlm.nih.gov/34741583/ | ||||
599 | Acute myocarditis after administration of BNT162b2 vaccine against COVID-19: | https://www.revespcardiol.org/en-linkresolver-acute-myocarditis-after-administration-bnt162b2-S188558572100133X. | https://pubmed.ncbi.nlm.nih.gov/34851078/. | Łaźniak-Pfajfer, A., Surmacz, R., Rajewska-Tabor, J., Pyda, M., Lesiak, M., & Bobkowski, W. (2021). Myocarditis associated with COVID-19 vaccination in three teenage males. Polish Archives of Internal Medicine. | Łaźniak-Pfajfer, A., Surmacz, R., Rajewska-Tabor, J., Pyda, M., Lesiak, M. y Bobkowski, W. (2021). Miocarditis asociada a la vacunación COVID-19 en tres varones adolescentes. Archivos polacos de medicina interna. https://pubmed.ncbi.nlm.nih.gov/34496880/ | Montgomery, J., Ryan, M., Engler, R., Hoffman, D., McClenathan, B., Collins, L., ... & Cooper, L. T. (2021). La miocarditis después de la inmunización con las vacunas con MRNA COVID-19 en miembros del ejército estadounidense. Cardiología de Jama, 6 (10), 1202-1206. https://www.ncbi.nlm.nih.gov/pubmed/34840235 | Łaźniak-Pfajfer, A., Surmacz, R., Rajewska-Tabor, J., Pyda, M., Lesiak, M., & Bobkowski, W. (2021). Myocarditis associated with COVID-19 vaccination in three teenage males. Polish Archives of Internal Medicine. https://pubmed.ncbi.nlm.nih.gov/34851078/. | Mouch, S. A., Roguin, A., Hellou, E., Ishai, A., Shoshan, U., Mahamid, L., ... & Yanay, N. B. (2021). Myocarditis following COVID-19 mRNA vaccination. Vaccine, 39(29), 3790-3793. https://www.ncbi.nlm.nih.gov/pubmed/34092429 | Wan, E. Y. F., Chui, C. S. L., Lai, F. T. T., Chan, E. W. Y., Li, X., Yan, V. K. C., ... & Wong, I. C. K. (2022). Bell's palsy following vaccination with mRNA (BNT162b2) and inactivated (CoronaVac) SARS-CoV-2 vaccines: a case series and nested case-control study. The Lancet Infectious Diseases, 22(1), 64-72. | https://pubmed.ncbi.nlm.nih.gov/34411532/ | Wan, E. Y. F., Chui, C. S. L., Lai, F. T. T., Chan, E. W. Y., Li, X., Yan, V. K. C., ... & Wong, I. C. K. (2022). Bell's palsy following vaccination with mRNA (BNT162b2) and inactivated (CoronaVac) SARS-CoV-2 vaccines: a case series and nested case-control study. The Lancet Infectious Diseases, 22(1), 64-72. https://pubmed.ncbi.nlm.nih.gov/34411532/ | Rzymski, P., Perek, B., & Flisiak, R. (2021). Thrombotic thrombocytopenia after COVID-19 vaccination: in search of the underlying mechanism. Vaccines, 9(6), 559. https://pubmed.ncbi.nlm.nih.gov/34071883/ | ||||
600 | Myocarditis associated with COVID-19 mRNA vaccination: | https://pubs.rsna.org/doi/10.1148/radiol.2021211430 | https://pubmed.ncbi.nlm.nih.gov/34496880/ | Patel, Y. R., Louis, D. W., Atalay, M., Agarwal, S., & Shah, N. R. (2021). Cardiovascular magnetic resonance findings in young adult patients with acute myocarditis following mRNA COVID-19 vaccination: a case series. Journal of Cardiovascular Magnetic Resonance, 23(1), 1-8. | Patel, YR, Louis, DW, Atalay, M., Agarwal, S. y Shah, NR (2021). Hallazgos de resonancia magnética cardiovascular en pacientes adultos jóvenes con miocarditis aguda después de la vacunación con ARNm COVID-19: una serie de casos. Revista de resonancia magnética cardiovascular, 23(1), 1-8. https://pubmed.ncbi.nlm.nih.gov/34866957/ | Montgomery, J., Ryan, M., Engler, R., Hoffman, D., McClenathan, B., Collins, L., ... & Cooper, L. T. (2021). La miocarditis después de la inmunización con las vacunas con MRNA COVID-19 en miembros del ejército estadounidense. Cardiología de Jama, 6 (10), 1202-1206. https://www.nejm.org/doi/full/10.1056/NEJMoa2104882?query=recirc_curatedRelated_article | Patel, Y. R., Louis, D. W., Atalay, M., Agarwal, S., & Shah, N. R. (2021). Cardiovascular magnetic resonance findings in young adult patients with acute myocarditis following mRNA COVID-19 vaccination: a case series. Journal of Cardiovascular Magnetic Resonance, 23(1), 1-8. https://pubmed.ncbi.nlm.nih.gov/34496880/ | Mücke, V. T., Knop, V., Mücke, M. M., Ochsendorf, F., & Zeuzem, S. (2021). First description of immune complex vasculitis after COVID-19 vaccination with BNT162b2: a case report. BMC Infectious Diseases, 21(1), 1-6. https://pubmed.ncbi.nlm.nih.gov/34530771/. | Buchan, S. A., Seo, C. Y., Johnson, C., Alley, S., Kwong, J. C., Nasreen, S., ... & Wilson, S. E. (2021). Epidemiology of myocarditis and pericarditis following mRNA vaccines in Ontario, Canada: by vaccine product, schedule and interval. medRxiv. | https://www.medrxiv.org/content/10.1101/2021.12.02.21267156v1 | Buchan, S. A., Seo, C. Y., Johnson, C., Alley, S., Kwong, J. C., Nasreen, S., ... & Wilson, S. E. (2021). Epidemiology of myocarditis and pericarditis following mRNA vaccines in Ontario, Canada: by vaccine product, schedule and interval. medRxiv. https://www.medrxiv.org/content/10.1101/2021.12.02.21267156v1 | Salah, H. M., & Mehta, J. L. (2021). COVID-19 vaccine and myocarditis. American Journal of Cardiology, 157, 146-148. https://pubmed.ncbi.nlm.nih.gov/34399967/ | ||||
601 | Acute myocarditis after COVID-19 vaccination: a case report: | https://www.sciencedirect.com/science/article/pii/S0248866321007098 | https://pubmed.ncbi.nlm.nih.gov/34866957/ | Tinoco, M., Leite, S., Faria, B., Cardoso, S., Von Hafe, P., Dias, G., ... & Lourenço, A. (2021). Perimyocarditis Following COVID-19 Vaccination. Clinical Medicine Insights: Cardiology, 15, 11795468211056634. | Tinoco, M., Leite, S., Faria, B., Cardoso, S., Von Hafe, P., Dias, G., ... & Lourenço, A. (2021). Perimiocarditis tras la vacunación contra la COVID-19. Perspectivas de la medicina clínica: cardiología, 15, 11795468211056634. https://pubmed.ncbi.nlm.nih.gov/34849657/. | Morehouse, Z. P., Paulus, A., JASTI, S. A., & Bing, X. (2021). Una variante rara del síndrome de Guillain-Barre después de AD26. COV2. La vacunación de s. CUREUS, 13 (9). https://pubmed.ncbi.nlm.nih.gov/34810163/ | Tinoco, M., Leite, S., Faria, B., Cardoso, S., Von Hafe, P., Dias, G., ... & Lourenço, A. (2021). Perimyocarditis Following COVID-19 Vaccination. Clinical Medicine Insights: Cardiology, 15, 11795468211056634. https://pubmed.ncbi.nlm.nih.gov/34866957/ | Muir, K. W., & Perry, R. J. (2021). The International Cerebral Venous Thrombosis Consortium report on cerebral venous thrombosis following vaccination against SARS-CoV-2. European Journal of Neurology, 28(11), 3543-3544. https://pubmed.ncbi.nlm.nih.gov/34462996/ | Park, L. H. J., Montgomery, C. J. R., & Boggs, L. N. A. (2021). Anaphylaxis after the Covid-19 vaccine in a patient with cholinergic urticaria. Military medicine. | https://pubmed.ncbi.nlm.nih.gov/33851711/ | Park, L. H. J., Montgomery, C. J. R., & Boggs, L. N. A. (2021). Anaphylaxis after the Covid-19 vaccine in a patient with cholinergic urticaria. Military medicine. https://pubmed.ncbi.nlm.nih.gov/33851711/ | Saleh, A., & Collins, J. (2021). Case study of thrombosis and thrombocytopenia syndrome following administration of the AstraZeneca COVID-19 vaccine. Australian Journal of General Practice, 50. https://pubmed.ncbi.nlm.nih.gov/34781321/ | ||||
602 | Acute myopericarditis after COVID-19 vaccination in adolescents:. | https://pubmed.ncbi.nlm.nih.gov/34589238/. | https://pubmed.ncbi.nlm.nih.gov/34849657/. | Chua, G. T., Kwan, M. Y. W., Chui, C. S., Smith, R. D., Cheung, E. C. L., Tian, T., ... & Ip, P. (2021). Epidemiology of Acute Myocarditis/Pericarditis in Hong Kong Adolescents Following Comirnaty Vaccination. Clinical Infectious Diseases. | Chua, G. T., Kwan, M. Y. W., Chui, C. S., Smith, R. D., Cheung, E. C. L., Tian, T., ... & Ip, P. (2021). Epidemiología de la miocarditis/pericarditis aguda en adolescentes de Hong Kong después de la vacunación comunitaria. Enfermedades Infecciosas Clínicas. https://pubmed.ncbi.nlm.nih.gov/34664804/ | MORTAZAVI, S. (2021). COVID-19 Adenopatía axilar asociada a la vacunación: resultados de imágenes y recomendaciones de seguimiento en 23 mujeres. American Journal of Roentgenology, 217 (4), 857-858. https://pubmed.ncbi.nlm.nih.gov/34141500/ | Chua, G. T., Kwan, M. Y. W., Chui, C. S., Smith, R. D., Cheung, E. C. L., Tian, T., ... & Ip, P. (2021). Epidemiology of Acute Myocarditis/Pericarditis in Hong Kong Adolescents Following Comirnaty Vaccination. Clinical Infectious Diseases. https://pubmed.ncbi.nlm.nih.gov/34849657/. | Mungmunpuntipamtip, R., & Wiwanitkit, V. (2021). Deaths associated with newly launched SARS-CoV-2 vaccination. Legal Medicine (Tokyo, Japan), 53, 101956. https://pubmed.ncbi.nlm.nih.gov/34425384/ | Laisuan, W., Wongsa, C., Chiewchalermsri, C., Thongngarm, T., Rerkpattanapipat, T., Iamrahong, P., ... & Sompornrattanaphan, M. (2021). CoronaVac COVID-19 Vaccine-Induced Anaphylaxis: Clinical Characteristics and Revaccination Outcomes. Journal of Asthma and Allergy, 14, 1209. | https://pubmed.ncbi.nlm.nih.gov/34675550/. | Laisuan, W., Wongsa, C., Chiewchalermsri, C., Thongngarm, T., Rerkpattanapipat, T., Iamrahong, P., ... & Sompornrattanaphan, M. (2021). CoronaVac COVID-19 Vaccine-Induced Anaphylaxis: Clinical Characteristics and Revaccination Outcomes. Journal of Asthma and Allergy, 14, 1209. https://pubmed.ncbi.nlm.nih.gov/34675550/. | Salih, F., Schönborn, L., Kohler, S., Franke, C., Möckel, M., Dörner, T., ... & Endres, M. (2021). Vaccine-induced thrombocytopenia with severe headache. New England Journal of Medicine, 385(22), 2103-2105. https://pubmed.ncbi.nlm.nih.gov/34525282/ | ||||
603 | Perimyocarditis in adolescents after Pfizer-BioNTech COVID-19 vaccination: | https://academic.oup.com/jpids/article/10/10/962/6329543. | https://pubmed.ncbi.nlm.nih.gov/34664804/ | Choi, S., Lee, S., Seo, J. W., Kim, M. J., Jeon, Y. H., Park, J. H., ... & Yeo, N. S. (2021). Myocarditis-induced sudden death after BNT162b2 mRNA COVID-19 vaccination in Korea: Case report focusing on histopathological findings. Journal of Korean medical science, 36(40). | Choi, S., Lee, S., Seo, JW, Kim, M. J., Jeon, YH, Park, JH, ... y Yeo, NS (2021). Muerte súbita inducida por miocarditis después de la vacunación contra el COVID-19 con ARNm de BNT162b2 en Corea: informe de un caso centrado en los hallazgos histopatológicos. Revista de ciencia médica coreana, 36(40). https://pubmed.ncbi.nlm.nih.gov/34605853/ | Mouch, S. A., Roguin, A., Hellou, E., ISHAI, A., SHOSHAN, U., MAHAMID, L., ... & YANAY, N. B. (2021). Miocarditis después de la vacunación de ARNm Covid-19. Vacuna, 39 (29), 3790-3793. https://www.ncbi.nlm.nih.gov/pubmed/34025885 | Choi, S., Lee, S., Seo, J. W., Kim, M. J., Jeon, Y. H., Park, J. H., ... & Yeo, N. S. (2021). Myocarditis-induced sudden death after BNT162b2 mRNA COVID-19 vaccination in Korea: Case report focusing on histopathological findings. Journal of Korean medical science, 36(40). https://pubmed.ncbi.nlm.nih.gov/34664804/ | Mungmunpuntipantip, R., & Wiwanitkit, V. (2021). Thromboses of major arteries and ChAdOx1 nCov-19 vaccination. Neurological Research and Practice, 3(1), 1-1. https://pubmed.ncbi.nlm.nih.gov/34839830/ | Mayfield, J., Bandi, S., Ganti, L., & Rubero, J. (2021). Anaphylaxis after Moderna COVID-19 vaccine. Therapeutic Advances in Vaccines and Immunotherapy, 9, 25151355211048418. | https://pubmed.ncbi.nlm.nih.gov/34734159/. | Mayfield, J., Bandi, S., Ganti, L., & Rubero, J. (2021). Anaphylaxis after Moderna COVID-19 vaccine. Therapeutic Advances in Vaccines and Immunotherapy, 9, 25151355211048418. https://pubmed.ncbi.nlm.nih.gov/34734159/. | Sanchez Tijmes, F., Thavendiranathan, P., Udell, J. A., Seidman, M. A., & Hanneman, K. (2021). Cardiac MRI assessment of nonischemic myocardial inflammation: state of the art review and update on myocarditis associated with COVID-19 vaccination. Radiology: Cardiothoracic Imaging, 3(6), e210252. https://www.ncbi.nlm.nih.gov/pubmed/34934954 | ||||
604 | Acute myocarditis associated with anti-COVID-19 vaccination: | https://ecevr.org/DOIx.php?id=10.7774/cevr.2021.10.2.196. | https://pubmed.ncbi.nlm.nih.gov/34605853/ | Simone, A., Herald, J., Chen, A., Gulati, N., Shen, A. Y. J., Lewin, B., & Lee, M. S. (2021). Acute myocarditis following COVID-19 mRNA vaccination in adults aged 18 years or older. JAMA Internal Medicine, 181(12), 1668-1670. | Simone, A., Herald, J., Chen, A., Gulati, N., Shen, A. Y. J., Lewin, B. y Lee, M. S. (2021). Miocarditis aguda después de la vacunación con ARNm de COVID-19 en adultos de 18 años o más. JAMA Medicina Interna, 181(12), 1668-1670. https://pubmed.ncbi.nlm.nih.gov/34166671/ | Mücke, V. T., Knop, V., Mücke, M. M., Ochsendorf, F., & Zeuzem, S. (2021). Primera descripción de la vasculitis compleja inmune después de la vacunación de COVID-19 con BNT162B2: un informe de caso. Enfermedades infecciosas BMC, 21 (1), 1-6. https://pubmed.ncbi.nlm.nih.gov/34245294/. | Simone, A., Herald, J., Chen, A., Gulati, N., Shen, A. Y. J., Lewin, B., & Lee, M. S. (2021). Acute myocarditis following COVID-19 mRNA vaccination in adults aged 18 years or older. JAMA Internal Medicine, 181(12), 1668-1670. https://pubmed.ncbi.nlm.nih.gov/34605853/ | Mungmunpuntipantip, R., & Wiwanitkit, V. (2021). Thrombosis after adenovirus-vectored COVID-19 vaccination: a concern on underlying illness. Clinical and Applied Thrombosis/Hemostasis, 27, 10760296211060446. https://pubmed.ncbi.nlm.nih.gov/34755555/ | Li, L., Robinson, L. B., Patel, R., Landman, A. B., Fu, X., Shenoy, E. S., ... & Blumenthal, K. G. (2021). Association of Self-reported High-Risk Allergy History With Allergy Symptoms After COVID-19 Vaccination. JAMA network open, 4(10), e2131034-e2131034. | https://pubmed.ncbi.nlm.nih.gov/34698847/ | Li, L., Robinson, L. B., Patel, R., Landman, A. B., Fu, X., Shenoy, E. S., ... & Blumenthal, K. G. (2021). Association of Self-reported High-Risk Allergy History With Allergy Symptoms After COVID-19 Vaccination. JAMA network open, 4(10), e2131034-e2131034. https://pubmed.ncbi.nlm.nih.gov/34698847/ | Sandhu, S., Bhatnagar, A., Kumar, H., Dixit, P. K., Paliwal, G., Suhag, D. K., ... & Mitra, D. (2021). Leukocytoclastic vasculitis as a cutaneous manifestation of ChAdOx1 nCoV‐19 corona virus vaccine (recombinant). Dermatologic therapy, 34(6), e15141. https://pubmed.ncbi.nlm.nih.gov/34546608/ | ||||
605 | Myocarditis associated with COVID-19 vaccination: echocardiographic, cardiac CT, and MRI findings:. | https://pubmed.ncbi.nlm.nih.gov/34428917/. | https://pubmed.ncbi.nlm.nih.gov/34166671/ | Minocha, P. K., Better, D., Singh, R. K., & Hoque, T. (2021). Recurrence of acute myocarditis temporally associated with receipt of the mRNA coronavirus disease 2019 (COVID-19) vaccine in a male adolescent. The Journal of Pediatrics, 238, 321-323. | Minocha, PK, Better, D., Singh, R. K. y Hoque, T. (2021). Recurrencia de miocarditis aguda asociada temporalmente con la recepción de la vacuna de ARNm contra la enfermedad del coronavirus 2019 (COVID-19) en un adolescente varón. La Revista de Pediatría, 238, 321-323. https://pubmed.ncbi.nlm.nih.gov/34744118/ | Muir, K. W., & Perry, R. J. (2021). El consorcio de la trombosis venosa cerebral internacional informó sobre la trombosis venosa cerebral después de la vacunación contra el SARS-COV-2. Revista Europea de Neurología, 28 (11), 3543-3544. https://pubmed.ncbi.nlm.nih.gov/34435486/ | Minocha, P. K., Better, D., Singh, R. K., & Hoque, T. (2021). Recurrence of acute myocarditis temporally associated with receipt of the mRNA coronavirus disease 2019 (COVID-19) vaccine in a male adolescent. The Journal of Pediatrics, 238, 321-323. https://pubmed.ncbi.nlm.nih.gov/34166671/ | Murakami, Y., Shinohara, M., Oka, Y., Wada, R., Noike, R., Ohara, H., ... & Ikeda, T. (2022). Myocarditis Following a COVID-19 Messenger RNA Vaccination: A Japanese Case Series. Internal Medicine, 8731-21. https://pubmed.ncbi.nlm.nih.gov/34840235/. | Somiya, M., Mine, S., Yasukawa, K., & Ikeda, S. (2021). Sex differences in the incidence of anaphylaxis to LNP-mRNA COVID-19 vaccines. Vaccine. | https://pubmed.ncbi.nlm.nih.gov/34020815/ | Somiya, M., Mine, S., Yasukawa, K., & Ikeda, S. (2021). Sex differences in the incidence of anaphylaxis to LNP-mRNA COVID-19 vaccines. Vaccine. https://pubmed.ncbi.nlm.nih.gov/34020815/ | Sangli, S., Virani, A., Cheronis, N., Vannatter, B., Minich, C., Noronha, S., ... & Kaplan, R. B. (2021). Thrombosis with thrombocytopenia after the messenger RNA–1273 vaccine. Annals of internal medicine, 174(8), 1480-1482. https://pubmed.ncbi.nlm.nih.gov/34181446/ | ||||
606 | Acute symptomatic myocarditis in 7 adolescents after Pfizer-BioNTech COVID-19 vaccination:. | https://pubmed.ncbi.nlm.nih.gov/34088762/. | https://pubmed.ncbi.nlm.nih.gov/34744118/ | Kaneta, K., Yokoi, K., Jojima, K., Kotooka, N., & Node, K. (2021). Young Male With Myocarditis Following mRNA-1273 Vaccination Against Coronavirus Disease-2019 (COVID-19). Circulation Journal, CJ-21. | Kaneta, K., Yokoi, K., Jojima, K., Kotooka, N. y Node, K. (2021). Varón joven con miocarditis después de la vacunación con ARNm-1273 contra la enfermedad por coronavirus-2019 (COVID-19). Diario de circulación, CJ-21. https://pubmed.ncbi.nlm.nih.gov/34334935/. | Mungmunpuntipamtip, R., & Wiwanitkit, V. (2021). Muertes asociadas con la vacunación de SARS-COV-2 recién lanzados. Medicina legal (Tokio, Japón), 53, 101956. https://pubmed.ncbi.nlm.nih.gov/34703815/ | Kaneta, K., Yokoi, K., Jojima, K., Kotooka, N., & Node, K. (2021). Young Male With Myocarditis Following mRNA-1273 Vaccination Against Coronavirus Disease-2019 (COVID-19). Circulation Journal, CJ-21. https://pubmed.ncbi.nlm.nih.gov/34744118/ | Murakami, Y., Shinohara, M., Oka, Y., Wada, R., Noike, R., Ohara, H., ... & Ikeda, T. (2022). Myocarditis Following a COVID-19 Messenger RNA Vaccination: A Japanese Case Series. Internal Medicine, 8731-21. https://www.ncbi.nlm.nih.gov/pubmed/34840235 | Shimabukuro, T. (2021). Allergic reactions including anaphylaxis after receipt of the first dose of Pfizer‐BioNTech COVID‐19 vaccine—United States, December 14–23, 2020. American Journal of Transplantation, 21(3), 1332. | https://pubmed.ncbi.nlm.nih.gov/33641264/ | Shimabukuro, T. (2021). Allergic reactions including anaphylaxis after receipt of the first dose of Pfizer‐BioNTech COVID‐19 vaccine—United States, December 14–23, 2020. American Journal of Transplantation, 21(3), 1332. https://pubmed.ncbi.nlm.nih.gov/33641264/ | Saraceno, J. J. F., Souza, G. M., dos Santos Finamor, L. P., Nascimento, H. M., & Belfort, R. (2021). Vogt-Koyanagi-Harada syndrome following COVID-19 and ChAdOx1 nCoV-19 (AZD1222) vaccine. International journal of retina and vitreous, 7(1), 1-7. https://pubmed.ncbi.nlm.nih.gov/34462013/. | ||||
607 | Myocarditis and pericarditis in adolescents after first and second doses of COVID-19 mRNA vaccines:. https://academic.oup.com/ehjqcco/advance-article/doi/10.1093/ehjqcco/qcab090/6442104 | Myocarditis and pericarditis in adolescents after first and second doses of COVID-19 mRNA vaccines:. | https://academic.oup.com/ehjqcco/advance-article/doi/10.1093/ehjqcco/qcab090/6442104 | https://pubmed.ncbi.nlm.nih.gov/34334935/. | Cimaglia, P., Tolomeo, P., & Rapezzi, C. (2022). Acute myocarditis after SARS-CoV-2 vaccination in a 24-year-old man. Revista portuguesa de cardiologia, 41(1), 71-72. | Cimaglia, P., Tolomeo, P. y Rapezzi, C. (2022). Miocarditis aguda tras la vacunación contra el SARS-CoV-2 en un hombre de 24 años. Revista portuguesa de cardiología, 41(1), 71-72. https://pubmed.ncbi.nlm.nih.gov/34746968/ | Mungmunpuntipantip, R., & Wiwanitkit, V. (2021). Trombosis de arterias mayores y vacunación de Chadox1 NCOV-19. Investigación y práctica neurológica, 3 (1), 1-1. https://pubmed.ncbi.nlm.nih.gov/34667486/ | Cimaglia, P., Tolomeo, P., & Rapezzi, C. (2022). Acute myocarditis after SARS-CoV-2 vaccination in a 24-year-old man. Revista portuguesa de cardiologia, 41(1), 71-72. https://pubmed.ncbi.nlm.nih.gov/34334935/. | Mustafa, Z., & Burster, T. (2021). Comments on Thrombosis After Vaccination: The Leader Sequence of the Spike Protein Might Be Responsible for Thrombosis and Antibody-Mediated Thrombocytopenia. Viral immunology, 34(10), 669-672. https://pubmed.ncbi.nlm.nih.gov/34788138 | Shimabukuro, T. (2021). Allergic reactions including anaphylaxis after receipt of the first dose of Moderna COVID‐19 vaccine—United States, December 21, 2020–January 10, 2021. American Journal of Transplantation, 21(3), 1326. | https://pubmed.ncbi.nlm.nih.gov/33641268/ | Shimabukuro, T. (2021). Allergic reactions including anaphylaxis after receipt of the first dose of Moderna COVID‐19 vaccine—United States, December 21, 2020–January 10, 2021. American Journal of Transplantation, 21(3), 1326. https://pubmed.ncbi.nlm.nih.gov/33641268/ | Sato, K., Mano, T., Niimi, Y., Toda, T., Iwata, A., & Iwatsubo, T. (2021). Facial nerve palsy following the administration of COVID-19 mRNA vaccines: analysis of a self-reporting database. International Journal of Infectious Diseases, 111, 310-312. https://www.sciencedirect.com/science/article/pii/S1201971221007049 | |||
608 | COVID 19 vaccine for adolescents. Concern for myocarditis and pericarditis: | https://www.mdpi.com/2036-7503/13/3/61. | https://pubmed.ncbi.nlm.nih.gov/34746968/ | Boursier, C., Chevalier, E., Filippetti, L., Imbert, L., Roch, V., Huttin, O., ... & Marie, P. Y. (2021). 68Ga-DOTATOC digital-PET imaging of inflammatory cell infiltrates in myocarditis following COVID-19 vaccination. European journal of nuclear medicine and molecular imaging, 1-2. | Boursier, C., Chevalier, E., Filippetti, L., Imbert, L., Roch, V., Huttin, O., ... y Marie, P. Y. (2021). Imágenes PET digitales con 68Ga-DOTATOC de infiltrados de células inflamatorias en miocarditis después de la vacunación contra COVID-19. Revista europea de medicina nuclear e imágenes moleculares, 1-2. https://pubmed.ncbi.nlm.nih.gov/34333695/. | Mungmunpuntipantip, R., & Wiwanitkit, V. (2021). Trombosis después de la vacunación de COVID-19 de vector de adenovirus: una preocupación por la enfermedad subyacente. Trombosis clínica y aplicada / Hemostasia, 27, 10760296211060446. https://pubmed.ncbi.nlm.nih.gov/34407607/ | Boursier, C., Chevalier, E., Filippetti, L., Imbert, L., Roch, V., Huttin, O., ... & Marie, P. Y. (2021). 68Ga-DOTATOC digital-PET imaging of inflammatory cell infiltrates in myocarditis following COVID-19 vaccination. European journal of nuclear medicine and molecular imaging, 1-2. https://pubmed.ncbi.nlm.nih.gov/34746968/ | Muthukumar, A., Narasimhan, M., Li, Q. Z., Mahimainathan, L., Hitto, I., Fuda, F., ... & De Lemos, J. A. (2021). In-depth evaluation of a case of presumed myocarditis after the second dose of COVID-19 mRNA vaccine. Circulation, 144(6), 487-498. https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.121.056038 | Frank, A., Radparvar, S., Manasia, A., Bassily-Marcus, A., & Kohli-Seth, R. (2021). Prolonged anaphylaxis to pfizer coronavirus disease 2019 vaccine: a case report and mechanism of action. Critical Care Explorations, 3(4). | https://pubmed.ncbi.nlm.nih.gov/33834172/ | Frank, A., Radparvar, S., Manasia, A., Bassily-Marcus, A., & Kohli-Seth, R. (2021). Prolonged anaphylaxis to pfizer coronavirus disease 2019 vaccine: a case report and mechanism of action. Critical Care Explorations, 3(4). https://pubmed.ncbi.nlm.nih.gov/33834172/ | Scavone, M., Clerici, B., Birocchi, S., Mencarini, T., Calogiuri, M., Ghali, C., ... & Podda, G. M. (2021). Platelet activation and modulation in thrombosis with thrombocytopenia syndrome associated with ChAdOx1 nCov-19 vaccine. haematologica, 106(12), 3228. https://pubmed.ncbi.nlm.nih.gov/34474550/ | ||||
609 | Cardiac imaging of acute myocarditis after vaccination with COVID-19 mRNA: | https://pubmed.ncbi.nlm.nih.gov/34402228/ | https://pubmed.ncbi.nlm.nih.gov/34333695/. | Chamling, B., Vehof, V., Drakos, S., Weil, M., Stalling, P., Vahlhaus, C., ... & Yilmaz, A. (2021). Occurrence of acute infarct-like myocarditis following COVID-19 vaccination: just an accidental co-incidence or rather vaccination-associated autoimmune myocarditis?. Clinical Research in Cardiology, 110(11), 1850-1854. | Chamling, B., Vehof, V., Drakos, S., Weil, M., Stalling, P., Vahlhaus, C., ... y Yilmaz, A. (2021). Aparición de miocarditis aguda similar a un infarto después de la vacunación COVID-19: ¿solo una coincidencia accidental o más bien una miocarditis autoinmune asociada a la vacunación? Investigación clínica en cardiología, 110(11), 1850-1854. https://pubmed.ncbi.nlm.nih.gov/34185045/ | Murakami, Y., Shinohara, M., Oka, Y., Wada, R., Noike, R., OHARA, H., ... & IKEDA, T. (2022). Miocarditis después de una vacunación de ARN de COVID-19 Messenger: una serie de casos japoneses. Medicina interna, 8731-21. https://pubmed.ncbi.nlm.nih.gov/34712497/. | Chamling, B., Vehof, V., Drakos, S., Weil, M., Stalling, P., Vahlhaus, C., ... & Yilmaz, A. (2021). Occurrence of acute infarct-like myocarditis following COVID-19 vaccination: just an accidental co-incidence or rather vaccination-associated autoimmune myocarditis?. Clinical Research in Cardiology, 110(11), 1850-1854. https://pubmed.ncbi.nlm.nih.gov/34333695/. | Nagasaka, T., Koitabashi, N., Ishibashi, Y., Aihara, K., Takama, N., Ohyama, Y., ... & Kaneko, Y. (2021). Acute myocarditis associated with COVID-19 vaccination: A case report. Journal of Cardiology Cases. https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8639400/ | Lim, X. R., Leung, B. P., Ng, C. Y. L., Tan, J. W. L., Chan, G. Y. L., Loh, C. M., ... & Leong, K. P. (2021). Pseudo-anaphylactic reactions to Pfizer BNT162b2 vaccine: report of 3 cases of anaphylaxis post Pfizer BNT162b2 vaccination. Vaccines, 9(9), 974. | https://pubmed.ncbi.nlm.nih.gov/34579211/ | Lim, X. R., Leung, B. P., Ng, C. Y. L., Tan, J. W. L., Chan, G. Y. L., Loh, C. M., ... & Leong, K. P. (2021). Pseudo-anaphylactic reactions to Pfizer BNT162b2 vaccine: report of 3 cases of anaphylaxis post Pfizer BNT162b2 vaccination. Vaccines, 9(9), 974. https://pubmed.ncbi.nlm.nih.gov/34579211/ | Schauer, J., Buddhe, S., Colyer, J., Sagiv, E., Law, Y., Chikkabyrappa, S. M., & Portman, M. A. (2021). Myopericarditis after the Pfizer messenger ribonucleic acid coronavirus disease vaccine in adolescents. The Journal of pediatrics, 238, 317-320. https://www.sciencedirect.com/science/article/pii/S002234762100665X | ||||
610 | Myocarditis temporally associated with COVID-19 vaccination: | https://pubmed.ncbi.nlm.nih.gov/34133885/ | https://pubmed.ncbi.nlm.nih.gov/34185045/ | Montgomery, J., Ryan, M., Engler, R., Hoffman, D., McClenathan, B., Collins, L., ... & Cooper, L. T. (2021). Myocarditis following immunization with mRNA COVID-19 vaccines in members of the US military. JAMA cardiology, 6(10), 1202-1206. | Montgomery, J., Ryan, M., Engler, R., Hoffman, D., McClenathan, B., Collins, L., ... y Cooper, LT (2021). Miocarditis tras la inmunización con vacunas de ARNm COVID-19 en miembros del ejército de EE. UU. Cardiología JAMA, 6(10), 1202-1206. https://pubmed.ncbi.nlm.nih.gov/34229940/ | Murakami, Y., Shinohara, M., Oka, Y., Wada, R., Noike, R., OHARA, H., ... & IKEDA, T. (2022). Miocarditis después de una vacunación de ARN de COVID-19 Messenger: una serie de casos japoneses. Medicina interna, 8731-21. https://www.ncbi.nlm.nih.gov/pubmed/34876937 | Montgomery, J., Ryan, M., Engler, R., Hoffman, D., McClenathan, B., Collins, L., ... & Cooper, L. T. (2021). Myocarditis following immunization with mRNA COVID-19 vaccines in members of the US military. JAMA cardiology, 6(10), 1202-1206. https://pubmed.ncbi.nlm.nih.gov/34185045/ | Nagasaka, T., Koitabashi, N., Ishibashi, Y., Aihara, K., Takama, N., Ohyama, Y., ... & Kaneko, Y. (2021). Acute myocarditis associated with COVID-19 vaccination: A case report. Journal of Cardiology Cases. https://www.ncbi.nlm.nih.gov/pubmed/34876937 | Pitlick, M. M., Park, M. A., Gonzalez-Estrada, A., & Chiarella, S. E. (2021). Biphasic anaphylaxis after first dose of messenger RNA coronavirus disease 2019 vaccine with positive polysorbate 80 skin testing result. Annals of Allergy Asthma & Immunology, 498-499. | https://pubmed.ncbi.nlm.nih.gov/34343674/ | Pitlick, M. M., Park, M. A., Gonzalez-Estrada, A., & Chiarella, S. E. (2021). Biphasic anaphylaxis after first dose of messenger RNA coronavirus disease 2019 vaccine with positive polysorbate 80 skin testing result. Annals of Allergy Asthma & Immunology, 498-499. https://pubmed.ncbi.nlm.nih.gov/34343674/ | Schierz, J. H., Merkel, C., Kittner, T., & Ali, F. (2022). Vasculitis and bursitis on [18F] FDG-PET/CT following COVID-19 mRNA vaccine: post hoc ergo propter hoc?. European Journal of Nuclear Medicine and Molecular Imaging, 49(3), 1086-1087. https://pubmed.ncbi.nlm.nih.gov/34495381/. | ||||
611 | Acute myocardial injury after COVID-19 vaccination: a case report and review of current evidence from the vaccine adverse event reporting system database: | https://pubmed.ncbi.nlm.nih.gov/34219532/ | https://pubmed.ncbi.nlm.nih.gov/34229940/ | Watkins, K., Griffin, G., Septaric, K., & Simon, E. L. (2021). Myocarditis after BNT162b2 vaccination in a healthy male. The American Journal of Emergency Medicine, 50, 815-e1. | Watkins, K., Griffin, G., Septaric, K. y Simon, EL (2021). Miocarditis tras la vacunación con BNT162b2 en un varón sano. Revista Estadounidense de Medicina de Emergencia, 50, 815-e1. https://pubmed.ncbi.nlm.nih.gov/34308326/. | Mustafa, Z., & Birter, T. (2021). Comentarios sobre la trombosis después de la vacunación: la secuencia líder de la proteína de punta podría ser responsable de la trombosis y la trombocitopenia mediada por anticuerpos. Inmunología viral, 34 (10), 669-672. https://pubmed.ncbi.nlm.nih.gov/34753210/. | Watkins, K., Griffin, G., Septaric, K., & Simon, E. L. (2021). Myocarditis after BNT162b2 vaccination in a healthy male. The American Journal of Emergency Medicine, 50, 815-e1. https://pubmed.ncbi.nlm.nih.gov/34229940/ | Nagrani, P., Jindal, R., & Goyal, D. (2021). Onset/flare of psoriasis following the ChAdOx1 nCoV‐19 Corona virus vaccine (Oxford‐AstraZeneca/Covishield): Report of two cases. Dermatologic Therapy. https://pubmed.ncbi.nlm.nih.gov/34350668/ | Fearon, C., Parwani, P., Gow-Lee, B., & Abramov, D. (2021). Takotsubo syndrome after receiving the COVID-19 vaccine. Journal of Cardiology Cases, 24(5), 223-226. | https://pubmed.ncbi.nlm.nih.gov/34539938/. | Fearon, C., Parwani, P., Gow-Lee, B., & Abramov, D. (2021). Takotsubo syndrome after receiving the COVID-19 vaccine. Journal of Cardiology Cases, 24(5), 223-226. https://pubmed.ncbi.nlm.nih.gov/34539938/. | Schmitt, P., Demoulin, R., Poyet, R., Capilla, E., Rohel, G., Pons, F., ... & Cellarier, G. R. (2021). Acute Myocarditis after COVID-19 vaccination: A case report. La Revue de medecine interne, 42(11), 797-800. https://www.sciencedirect.com/science/article/pii/S0248866321007098 | ||||
612 | Acute myocarditis associated with COVID-19 vaccination: report of a case: | https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8639400/ | https://pubmed.ncbi.nlm.nih.gov/34308326/. | Williams, C. B., Choi, J. I., Hosseini, F., Roberts, J., Ramanathan, K., & Ong, K. (2021). Acute Myocarditis Following mRNA-1273 SARS-CoV-2 Vaccination. CJC open, 3(11), 1410-1412. | Williams, C. B., Choi, J. I., Hosseini, F., Roberts, J., Ramanathan, K. y Ong, K. (2021). Miocarditis aguda después de la vacunación con ARNm-1273 SARS-CoV-2. CJC abierto, 3(11), 1410-1412. https://pubmed.ncbi.nlm.nih.gov/34866106/ | Muthukumar, A., Narasimhan, M., Li, P. Z., Mahimainathan, L., Hitto, I., FUDA, F., ... & DE LEMOS, J. A. (2021). Evaluación en profundidad de un caso de presunto miocarditis después de la segunda dosis de vacuna contra ARNm COVID-19. Circulación, 144 (6), 487-498. https://pubmed.ncbi.nlm.nih.gov/34333695/ | Williams, C. B., Choi, J. I., Hosseini, F., Roberts, J., Ramanathan, K., & Ong, K. (2021). Acute Myocarditis Following mRNA-1273 SARS-CoV-2 Vaccination. CJC open, 3(11), 1410-1412. https://pubmed.ncbi.nlm.nih.gov/34308326/. | Naitlho, A., Lahlou, W., Bourial, A., Rais, H., Ismaili, N., Abousahfa, I., & Belyamani, L. (2021). A Rare Case of Henoch-Schönlein Purpura Following a COVID-19 Vaccine—Case Report. SN comprehensive clinical medicine, 3(12), 2618-2621. https://pubmed.ncbi.nlm.nih.gov/34518812/ | Toida, R., Uezono, S., Komatsu, H., Toida, T., Imamura, A., Fujimoto, S., & Kaikita, K. (2021). Takotsubo cardiomyopathy after vaccination for coronavirus disease 2019 in a patient on maintenance hemodialysis. CEN Case Reports, 1-5. | https://pubmed.ncbi.nlm.nih.gov/34731486/. | Toida, R., Uezono, S., Komatsu, H., Toida, T., Imamura, A., Fujimoto, S., & Kaikita, K. (2021). Takotsubo cardiomyopathy after vaccination for coronavirus disease 2019 in a patient on maintenance hemodialysis. CEN Case Reports, 1-5. https://pubmed.ncbi.nlm.nih.gov/34731486/. | Schneider, J., Sottmann, L., Greinacher, A., Hagen, M., Kasper, H. U., Kuhnen, C., ... & Schmeling, A. (2021). Postmortem investigation of fatalities following vaccination with COVID-19 vaccines. International Journal of Legal Medicine, 135(6), 2335-2345. https://pubmed.ncbi.nlm.nih.gov/34591186/ | ||||
613 | Myocarditis following vaccination with COVID-19 messenger RNA: a Japanese case series: | https://pubmed.ncbi.nlm.nih.gov/34840235/. | https://pubmed.ncbi.nlm.nih.gov/34866106/ | Takase, B., Hayashi, K., Hisada, T., Tsuchiya, T., Masaki, N., & Nagata, M. (2022). Chest Pain with New Abnormal Electrocardiogram Development after Injection of COVID-19 Vaccine Manufactured by Moderna. Internal Medicine, 8711-21. | Takase, B., Hayashi, K., Hisada, T., Tsuchiya, T., Masaki, N. y Nagata, M. (2022). Dolor torácico con desarrollo de electrocardiograma anormal nuevo después de la inyección de la vacuna COVID-19 fabricada por Moderna. Medicina Interna, 8711-21. https://pubmed.ncbi.nlm.nih.gov/34848416/ | Nagasaka, T., Koitabashi, N., Ishibashi, Y., Aihara, K., Takama, N., Ohyama, Y., ... & Kaneko, Y. (2021). Miocarditis aguda asociada a la vacunación COVID-19: un informe de caso. Diario de casos de cardiología. https://pubmed.ncbi.nlm.nih.gov/34840235/. | Takase, B., Hayashi, K., Hisada, T., Tsuchiya, T., Masaki, N., & Nagata, M. (2022). Chest Pain with New Abnormal Electrocardiogram Development after Injection of COVID-19 Vaccine Manufactured by Moderna. Internal Medicine, 8711-21. https://pubmed.ncbi.nlm.nih.gov/34866106/ | Nassar, M., Chung, H., Dhayaparan, Y., Nyein, A., Acevedo, B. J., Chicos, C., ... & Kimball, E. (2021). COVID-19 vaccine induced rhabdomyolysis: Case report with literature review. Diabetes & Metabolic Syndrome. https://pubmed.ncbi.nlm.nih.gov/34186348/. | Boivin, Z., & Martin, J. (2021). Untimely myocardial infarction or COVID-19 vaccine side effect. Cureus, 13(3). | https://pubmed.ncbi.nlm.nih.gov/33824804/ | Boivin, Z., & Martin, J. (2021). Untimely myocardial infarction or COVID-19 vaccine side effect. Cureus, 13(3). https://pubmed.ncbi.nlm.nih.gov/33824804/ | Schramm, R., Costard-Jäckle, A., Rivinius, R., Fischer, B., Müller, B., Boeken, U., ... & Gummert, J. (2021). Poor humoral and T-cell response to two-dose SARS-CoV-2 messenger RNA vaccine BNT162b2 in cardiothoracic transplant recipients. Clinical Research in Cardiology, 110(8), 1142-1149. https://www.ncbi.nlm.nih.gov/pubmed/34241676 | ||||
614 | Myocarditis in the setting of a recent COVID-19 vaccination: | https://pubmed.ncbi.nlm.nih.gov/34712497/. | https://pubmed.ncbi.nlm.nih.gov/34848416/ | Kadwalwala, M., Chadha, B., Ortoleva, J., & Joyce, M. (2021). Multimodality imaging and histopathology in a young man presenting with fulminant lymphocytic myocarditis and cardiogenic shock after mRNA-1273 vaccination. BMJ Case Reports CP, 14(11), e246059. | Kadwalwala, M., Chadha, B., Ortoleva, J. y Joyce, M. (2021). Imágenes multimodales e histopatología en un hombre joven que presenta miocarditis linfocítica fulminante y shock cardiogénico después de la vacunación con ARNm-1273. BMJ Case Reports CP, 14(11), e246059. https://pubmed.ncbi.nlm.nih.gov/34636504/ | Nagasaka, T., Koitabashi, N., Ishibashi, Y., Aihara, K., Takama, N., Ohyama, Y., ... & Kaneko, Y. (2021). Miocarditis aguda asociada a la vacunación COVID-19: un informe de caso. Diario de casos de cardiología. https://www.ncbi.nlm.nih.gov/pubmed/34089859 | Kadwalwala, M., Chadha, B., Ortoleva, J., & Joyce, M. (2021). Multimodality imaging and histopathology in a young man presenting with fulminant lymphocytic myocarditis and cardiogenic shock after mRNA-1273 vaccination. BMJ Case Reports CP, 14(11), e246059. https://pubmed.ncbi.nlm.nih.gov/34848416/ | Nassar, M., Chung, H., Dhayaparan, Y., Nyein, A., Acevedo, B. J., Chicos, C., ... & Kimball, E. (2021). COVID-19 vaccine induced rhabdomyolysis: Case report with literature review. Diabetes & Metabolic Syndrome. https://www.sciencedirect.com/science/article/pii/S1871402121001880 | Jabagi, M. J., Botton, J., Bertrand, M., Weill, A., Farrington, P., Zureik, M., & Dray-Spira, R. (2022). Myocardial infarction, stroke, and pulmonary embolism after BNT162b2 MRNA COVID-19 vaccine in people aged 75 years or older. Jama, 327(1), 80-82. | https://pubmed.ncbi.nlm.nih.gov/34807248/ | Jabagi, M. J., Botton, J., Bertrand, M., Weill, A., Farrington, P., Zureik, M., & Dray-Spira, R. (2022). Myocardial infarction, stroke, and pulmonary embolism after BNT162b2 MRNA COVID-19 vaccine in people aged 75 years or older. Jama, 327(1), 80-82. https://pubmed.ncbi.nlm.nih.gov/34807248/ | Schultz, N. H., Sørvoll, I. H., Michelsen, A. E., Munthe, L. A., Lund-Johansen, F., Ahlen, M. T., ... & Holme, P. A. (2021). Thrombosis and thrombocytopenia after ChAdOx1 nCoV-19 vaccination. New England journal of medicine, 384(22), 2124-2130. https://www.nejm.org/doi/full/10.1056/NEJMoa2104882?query=recirc_curatedRelated_article | ||||
615 | Acute myocarditis after a second dose of COVID-19 mRNA vaccine: report of two cases: | https://www.clinicalimaging.org/article/S0899-7071(21)00265-5/fulltext. | https://pubmed.ncbi.nlm.nih.gov/34636504/ | Kim, D., Choi, J. H., Jang, J. Y., So, O., Cho, E., Choi, H., ... & Park, K. T. (2021). A Case Report for Myopericarditis after BNT162b2 COVID-19 mRNA Vaccination in a Korean Young Male. Journal of Korean Medical Science, 36(39). | Kim, D., Choi, JH, Jang, JY, So, O., Cho, E., Choi, H., ... y Park, KT (2021). Informe de un caso de miopericarditis después de la vacunación con ARNm de COVID-19 BNT162b2 en un joven coreano. Revista de ciencia médica coreana, 36(39). https://pubmed.ncbi.nlm.nih.gov/34367386/ | Nagrani, P., Jindal, R., y Goyal, D. (2021). Inicio / Flare de la psoriasis Después de la vacuna contra el virus CHADOX1 NCOV-19 CORONA (OXFORD-ASTRAZENECA / COVISHIELD): Informe de dos casos. Terapia dermatológica. https://pubmed.ncbi.nlm.nih.gov/34436620/ | Kim, D., Choi, J. H., Jang, J. Y., So, O., Cho, E., Choi, H., ... & Park, K. T. (2021). A Case Report for Myopericarditis after BNT162b2 COVID-19 mRNA Vaccination in a Korean Young Male. Journal of Korean Medical Science, 36(39). https://pubmed.ncbi.nlm.nih.gov/34636504/ | Nassar, M., Nso, N., Gonzalez, C., Lakhdar, S., Alshamam, M., Elshafey, M., ... & Rizzo, V. (2021). COVID-19 vaccine-induced myocarditis: case report with literature review. Diabetes & metabolic syndrome, 15(5), 102205. https://www.sciencedirect.com/science/article/pii/S1871402121002253 | Özdemir, İ. H., Özlek, B., Özen, M. B., Gündüz, R., & Bayturan, Ö. (2021). Type 1 Kounis syndrome induced by inactivated SARS-COV-2 vaccine. The Journal of Emergency Medicine, 61(4), e71-e76. | https://pubmed.ncbi.nlm.nih.gov/34148772/ | Özdemir, İ. H., Özlek, B., Özen, M. B., Gündüz, R., & Bayturan, Ö. (2021). Type 1 Kounis syndrome induced by inactivated SARS-COV-2 vaccine. The Journal of Emergency Medicine, 61(4), e71-e76. https://pubmed.ncbi.nlm.nih.gov/34148772/ | Schulz, J. B., Berlit, P., Diener, H. C., Gerloff, C., Greinacher, A., Klein, C., ... & Zimmermann, J. (2021). COVID‐19 vaccine‐associated cerebral venous thrombosis in Germany. Annals of neurology, 90(4), 627-639. https://onlinelibrary.wiley.com/doi/10.1002/ana.26172 | ||||
616 | Prevalence of thrombocytopenia, antiplatelet factor 4 antibodies, and elevated D-dimer in Thais after vaccination with ChAdOx1 nCoV-19: | https://pubmed.ncbi.nlm.nih.gov/34568726/ | https://pubmed.ncbi.nlm.nih.gov/34367386/ | Patrignani, A., Schicchi, N., Calcagnoli, F., Falchetti, E., Ciampani, N., Argalia, G., & Mariani, A. (2021). Acute myocarditis following Comirnaty vaccination in a healthy man with previous SARS-CoV-2 infection. Radiology Case Reports, 16(11), 3321-3325. | Patrignani, A., Schicchi, N., Calcagnoli, F., Falchetti, E., Ciampani, N., Argalia, G. y Mariani, A. (2021). Miocarditis aguda tras la vacunación Comirnaty en un hombre sano con infección previa por SARS-CoV-2. Informes de casos de radiología, 16(11), 3321-3325. https://pubmed.ncbi.nlm.nih.gov/34709227/ | NAITLHO, A., LAHLOU, W., Bourial, A., Rais, H., Ismaili, N., Abousahfa, I., & Belyamani, L. (2021). Un caso raro de Henoch-Schönlein Purpura siguiendo un informe de vacunas de COVID-19. SN, medicina clínica completa, 3 (12), 2618-2621. https://pubmed.ncbi.nlm.nih.gov/34611627/. | Patrignani, A., Schicchi, N., Calcagnoli, F., Falchetti, E., Ciampani, N., Argalia, G., & Mariani, A. (2021). Acute myocarditis following Comirnaty vaccination in a healthy man with previous SARS-CoV-2 infection. Radiology Case Reports, 16(11), 3321-3325. https://pubmed.ncbi.nlm.nih.gov/34367386/ | Nastro, F., Fabbrocini, G., di Vico, F., & Marasca, C. (2021). Small vessel vasculitis related to varicella‐zoster virus after Pfizer‐BioNTech COVID‐19 vaccine. Journal of the European Academy of Dermatology and Venereology. https://pubmed.ncbi.nlm.nih.gov/34310759/. | Kounis, N. G., Koniari, I., Mplani, V., Kouni, S. N., Plotas, P., & Tsigkas, G. (2022). Acute Myocardial Infarction Within 24 Hours After COVID-19 Vaccination: Is Kounis Syndrome the Culprit?. American Journal of Cardiology, 162, 207. | https://pubmed.ncbi.nlm.nih.gov/34702550/ | Kounis, N. G., Koniari, I., Mplani, V., Kouni, S. N., Plotas, P., & Tsigkas, G. (2022). Acute Myocardial Infarction Within 24 Hours After COVID-19 Vaccination: Is Kounis Syndrome the Culprit?. American Journal of Cardiology, 162, 207. https://pubmed.ncbi.nlm.nih.gov/34702550/ | Scott, J., Anderson, J., Mallak, N., Beitinjaneh, B., Wei, K., & Otaki, F. (2021). Gastroparesis After Pfizer-BioNTech COVID-19 Vaccination. Official journal of the American College of Gastroenterology| ACG, 116(11), 2300. https://pubmed.ncbi.nlm.nih.gov/34187985/. | ||||
617 | Epidemiology of acute myocarditis/pericarditis in Hong Kong adolescents after co-vaccination: | https://academic.oup.com/cid/advance-article-abstract/doi/10.1093/cid/ciab989/6445179 | https://pubmed.ncbi.nlm.nih.gov/34709227/ | Facetti, S., Giraldi, M., Vecchi, A. L., Rogiani, S., & Nassiacos, D. (2021). Acute myocarditis in a young adult two days after Pfizer vaccination. Giornale italiano di cardiologia (2006), 22(11), 891-893. | Facetti, S., Giraldi, M., Vecchi, A. L., Rogiani, S. y Nassiacos, D. (2021). Miocarditis aguda en un adulto joven dos días después de la vacunación con Pfizer. Giornale italiano di cardiología (2006), 22(11), 891-893. https://pubmed.ncbi.nlm.nih.gov/34778411/ | Nassar, M., Chung, H., Dhayaparan, Y., Nyein, A., Acevedo, B. J., Chicos, C., ... y Kimball, E. (2021). COVID-19 Vacuna Inducida Rabdomiolisis: Informe de caso con revisión de la literatura. Diabetes y síndrome metabólico. https://www.sciencedirect.com/science/article/pii/S0190962221024427 | Facetti, S., Giraldi, M., Vecchi, A. L., Rogiani, S., & Nassiacos, D. (2021). Acute myocarditis in a young adult two days after Pfizer vaccination. Giornale italiano di cardiologia (2006), 22(11), 891-893. https://pubmed.ncbi.nlm.nih.gov/34709227/ | Nasuelli, N. A., De Marchi, F., Cecchin, M., De Paoli, I., Onorato, S., Pettinaroli, R., ... & Godi, L. (2021). A case of acute demyelinating polyradiculoneuropathy with bilateral facial palsy after ChAdOx1 nCoV-19 vaccine. Neurological Sciences, 42(11), 4747-4749. https://pubmed.ncbi.nlm.nih.gov/34272622/ | Edler, C., Klein, A., Schröder, A. S., Sperhake, J. P., & Ondruschka, B. (2021). Deaths associated with newly launched SARS-CoV-2 vaccination (Comirnaty®). Legal Medicine, 51, 101895. | https://pubmed.ncbi.nlm.nih.gov/33895650/ | Edler, C., Klein, A., Schröder, A. S., Sperhake, J. P., & Ondruschka, B. (2021). Deaths associated with newly launched SARS-CoV-2 vaccination (Comirnaty®). Legal Medicine, 51, 101895. https://pubmed.ncbi.nlm.nih.gov/33895650/ | See, I., Su, J. R., Lale, A., Woo, E. J., Guh, A. Y., Shimabukuro, T. T., ... & Broder, K. R. (2021). US case reports of cerebral venous sinus thrombosis with thrombocytopenia after Ad26. COV2. S vaccination, March 2 to April 21, 2021. Jama, 325(24), 2448-2456. https://pubmed.ncbi.nlm.nih.gov/33929487/ | ||||
618 | Myocarditis after 2019 coronavirus disease mRNA vaccine: a case series and incidence rate determination: | https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciab926/6420408. | https://pubmed.ncbi.nlm.nih.gov/34778411/ | Lim, Y., Kim, M. C., Kim, K. H., Jeong, I. S., Cho, Y. S., Choi, Y. D., & Lee, J. E. (2021). Case Report: Acute Fulminant Myocarditis and Cardiogenic Shock After Messenger RNA Coronavirus Disease 2019 Vaccination Requiring Extracorporeal Cardiopulmonary Resuscitation. Frontiers in Cardiovascular Medicine, 8. | Lim, Y., Kim, M. C., Kim, K. H., Jeong, I. S., Cho, Y. S., Choi, Y. D. y Lee, J. E. (2021). Informe de caso: Miocarditis aguda fulminante y shock cardiogénico después de la vacunación contra la enfermedad del coronavirus con ARN mensajero de 2019 que requiere reanimación cardiopulmonar extracorpórea. Fronteras en Medicina Cardiovascular, 8. https://pubmed.ncbi.nlm.nih.gov/34734821/ | Nassar, M., Chung, H., Dhayaparan, Y., Nyein, A., Acevedo, B. J., Chicos, C., ... y Kimball, E. (2021). COVID-19 Vacuna Inducida Rabdomiolisis: Informe de caso con revisión de la literatura. Diabetes y síndrome metabólico. https://www.sciencedirect.com/science/article/pii/S2666354621000065 | Lim, Y., Kim, M. C., Kim, K. H., Jeong, I. S., Cho, Y. S., Choi, Y. D., & Lee, J. E. (2021). Case Report: Acute Fulminant Myocarditis and Cardiogenic Shock After Messenger RNA Coronavirus Disease 2019 Vaccination Requiring Extracorporeal Cardiopulmonary Resuscitation. Frontiers in Cardiovascular Medicine, 8. https://pubmed.ncbi.nlm.nih.gov/34778411/ | Nawwar, A. A., Searle, J., Singh, R., & Lyburn, I. D. (2021). Oxford-AstraZeneca COVID-19 vaccination induced lymphadenopathy on [18F] choline PET/CT—not only an FDG finding. European Journal of Nuclear Medicine and Molecular Imaging, 48(8), 2657-2658. https://pubmed.ncbi.nlm.nih.gov/33661328/ | Mungmunpuntipamtip, R., & Wiwanitkit, V. (2021). Deaths associated with newly launched SARS-CoV-2 vaccination. Legal Medicine (Tokyo, Japan), 53, 101956. | https://pubmed.ncbi.nlm.nih.gov/34425384/ | Mungmunpuntipamtip, R., & Wiwanitkit, V. (2021). Deaths associated with newly launched SARS-CoV-2 vaccination. Legal Medicine (Tokyo, Japan), 53, 101956. https://pubmed.ncbi.nlm.nih.gov/34425384/ | Sekar, A., Campbell, R., Tabbara, J., & Rastogi, P. (2021). ANCA glomerulonephritis after the Moderna COVID-19 vaccination. Kidney international, 100(2), 473-474. https://pubmed.ncbi.nlm.nih.gov/34081948/ | ||||
619 | Myocarditis and pericarditis after COVID-19 vaccination: inequalities in age and vaccine types: | https://www.mdpi.com/2075-4426/11/11/1106 | https://pubmed.ncbi.nlm.nih.gov/34734821/ | Joob, B., & Wiwanitkit, V. (2021). Acute myocarditis after coronavirus disease 2019 vaccination. Anatolian Journal of Cardiology, 25(11), 841. | Joob, B. y Wiwanitkit, V. (2021). Miocarditis aguda después de la vacunación contra la enfermedad por coronavirus 2019. Revista de Cardiología de Anatolia, 25 (11), 841. https://pubmed.ncbi.nlm.nih.gov/34246585/ | Nassar, M., NSO, N., GONZALEZ, C., LAKHDAR, S., ALSHAMAM, M., ELSHAFEY, M., ... & RIZZO, V. (2021). COVID-19 miocarditis inducida por la vacuna: Informe de caso con revisión de la literatura. Diabetes y síndrome metabólico, 15 (5), 102205. https://www.sciencedirect.com/science/article/pii/S1936878X2100485X | Joob, B., & Wiwanitkit, V. (2021). Acute myocarditis after coronavirus disease 2019 vaccination. Anatolian Journal of Cardiology, 25(11), 841. https://pubmed.ncbi.nlm.nih.gov/34734821/ | Negrea, L., & Rovin, B. H. (2021). Gross hematuria following vaccination for severe acute respiratory syndrome coronavirus 2 in 2 patients with IgA nephropathy. Kidney international, 99(6), 1487. https://pubmed.ncbi.nlm.nih.gov/33771584/ | Barsha, S. Y., Haque, M. M. A., Rashid, M. U., Rahman, M. L., Hossain, M. A., Zaman, S., ... & Hawlader, M. D. H. (2021). A case of acute encephalopathy and non-ST segment elevation myocardial infarction following mRNA-1273 vaccination: possible adverse effect?. Clinical and experimental vaccine research, 10(3), 293. | https://pubmed.ncbi.nlm.nih.gov/34703815/ | Barsha, S. Y., Haque, M. M. A., Rashid, M. U., Rahman, M. L., Hossain, M. A., Zaman, S., ... & Hawlader, M. D. H. (2021). A case of acute encephalopathy and non-ST segment elevation myocardial infarction following mRNA-1273 vaccination: possible adverse effect?. Clinical and experimental vaccine research, 10(3), 293. https://pubmed.ncbi.nlm.nih.gov/34703815/ | Sellaturay, P., Nasser, S., Islam, S., Gurugama, P., & Ewan, P. W. (2021). Polyethylene glycol (PEG) is a cause of anaphylaxis to the Pfizer/BioNTech mRNA COVID‐19 vaccine. Clinical and Experimental Allergy, 51(6), 861. https://pubmed.ncbi.nlm.nih.gov/33825239/ | ||||
620 | Epidemiology and clinical features of myocarditis/pericarditis before the introduction of COVID-19 mRNA vaccine in Korean children: a multicenter study: | https://pubmed.ncbi.nlm.nih.gov/34402230/ | https://pubmed.ncbi.nlm.nih.gov/34246585/ | Dickey, J. B., Albert, E., Badr, M., Laraja, K. M., Sena, L. M., Gerson, D. S., ... & Aurigemma, G. P. (2021). A series of patients with myocarditis following SARS-CoV-2 vaccination with mRNA-1279 and BNT162b2. Cardiovascular Imaging, 14(9), 1862-1863. | Dickey, J. B., Albert, E., Badr, M., Laraja, K. M., Sena, L. M., Gerson, D. S., ... & Aurigemma, G. P. (2021). Una serie de pacientes con miocarditis después de la vacunación contra el SARS-CoV-2 con mRNA-1279 y BNT162b2. Imágenes cardiovasculares, 14(9), 1862-1863. https://pubmed.ncbi.nlm.nih.gov/34228985/ | NASTRO, F., FABBROCINI, G., DI VICO, F., Y MARASCA, C. (2021). Vasculitis pequeña del vaso relacionado con el virus de la varicela-zoster después de la vacuna Pfizer-Biontech Covid-19. Diario de la Academia Europea de Dermatología y Venereología. https://pubmed.ncbi.nlm.nih.gov/34720009/ | Dickey, J. B., Albert, E., Badr, M., Laraja, K. M., Sena, L. M., Gerson, D. S., ... & Aurigemma, G. P. (2021). A series of patients with myocarditis following SARS-CoV-2 vaccination with mRNA-1279 and BNT162b2. Cardiovascular Imaging, 14(9), 1862-1863. https://pubmed.ncbi.nlm.nih.gov/34246585/ | Nevet, A. (2021). Acute myocarditis associated with anti-COVID-19 vaccination. Clinical and Experimental Vaccine Research, 10(2), 196. https://ecevr.org/DOIx.php?id=10.7774/cevr.2021.10.2.196. | Dash, S., Behera, B., Sethy, M., Mishra, J., & Garg, S. (2021). COVID‐19 vaccine‐induced urticarial vasculitis. Dermatologic Therapy. | https://pubmed.ncbi.nlm.nih.gov/34369046/. | Dash, S., Behera, B., Sethy, M., Mishra, J., & Garg, S. (2021). COVID‐19 vaccine‐induced urticarial vasculitis. Dermatologic Therapy. https://pubmed.ncbi.nlm.nih.gov/34369046/. | Sepahvand, M., Yazdi, N., Rohani, M., & Emamikhah, M. (2022). Cervical longitudinally extensive myelitis after vaccination with inactivated virus-based COVID-19 vaccine. Radiology Case Reports, 17(2), 303-305. https://pubmed.ncbi.nlm.nih.gov/34849183/ | ||||
621 | Shedding light on post-vaccination myocarditis and pericarditis in COVID-19 and non-COVID-19 vaccine recipients: | https://pubmed.ncbi.nlm.nih.gov/34696294/ | https://pubmed.ncbi.nlm.nih.gov/34228985/ | Schauer, J., Buddhe, S., Colyer, J., Sagiv, E., Law, Y., Chikkabyrappa, S. M., & Portman, M. A. (2021). Myopericarditis after the Pfizer messenger ribonucleic acid coronavirus disease vaccine in adolescents. The Journal of pediatrics, 238, 317-320. | Schauer, J., Buddhe, S., Colyer, J., Sagiv, E., Law, Y., Chikkabyrappa, S. M. y Portman, M. A. (2021). Miopericarditis después de la vacuna contra el coronavirus del ácido ribonucleico mensajero de Pfizer en adolescentes. La Revista de Pediatría, 238, 317-320. https://pubmed.ncbi.nlm.nih.gov/34852213/ | Nasuelli, N. A., de marchi, F., Cecchin, M., De Paoli, I., Onorato, S., Pettaroli, R., ... & godi, L. (2021). Un caso de la polirradiculoneuropatía de desmielinización aguda con parálisis facial bilateral después de la vacuna contra la CHADOX1 NCOV-19. Ciencias Neurológicas, 42 (11), 4747-4749. https://pubmed.ncbi.nlm.nih.gov/34477091/ | Schauer, J., Buddhe, S., Colyer, J., Sagiv, E., Law, Y., Chikkabyrappa, S. M., & Portman, M. A. (2021). Myopericarditis after the Pfizer messenger ribonucleic acid coronavirus disease vaccine in adolescents. The Journal of pediatrics, 238, 317-320. https://pubmed.ncbi.nlm.nih.gov/34228985/ | Ng, X. L., Betzler, B. K., Testi, I., Ho, S. L., Tien, M., Ngo, W. K., ... & Agrawal, R. (2021). Ocular adverse events after COVID-19 vaccination. Ocular immunology and inflammation, 1-9. https://pubmed.ncbi.nlm.nih.gov/34559576/ | Bostan, E., Gulseren, D., & Gokoz, O. (2021). New‐onset leukocytoclastic vasculitis after COVID‐19 vaccine. International Journal of Dermatology. | https://pubmed.ncbi.nlm.nih.gov/34241833/ | Bostan, E., Gulseren, D., & Gokoz, O. (2021). New‐onset leukocytoclastic vasculitis after COVID‐19 vaccine. International Journal of Dermatology. https://pubmed.ncbi.nlm.nih.gov/34241833/ | Sessa, F., Salerno, M., Esposito, M., Di Nunno, N., Zamboni, P., & Pomara, C. (2021). Autopsy Findings and Causality Relationship between Death and COVID-19 Vaccination: A Systematic Review. Journal of Clinical Medicine, 10(24), 5876. https://www.ncbi.nlm.nih.gov/pubmed/34945172 | ||||
622 | Diffuse prothrombotic syndrome after administration of ChAdOx1 nCoV-19 vaccine: case report: | https://pubmed.ncbi.nlm.nih.gov/34615534/ | https://pubmed.ncbi.nlm.nih.gov/34852213/ | Choi, Y. K., Moon, J. Y., Kim, J., Yoo, I. S., Kwon, G. Y., Bae, H., ... & Kym, S. (2022). Postvaccination multisystem inflammatory syndrome in adult with no evidence of prior SARS-CoV-2 Infection. Emerging infectious diseases, 28(2), 411. | Choi, Y. K., Moon, J. Y., Kim, J., Yoo, I. S., Kwon, G. Y., Bae, H., ... y Kym, S. (2022). Síndrome inflamatorio multisistémico posvacunación en adultos sin evidencia de infección previa por SARS-CoV-2. Enfermedades infecciosas emergentes, 28(2), 411. https://pubmed.ncbi.nlm.nih.gov/34866122/ | NAWWAR, A. A., Searle, J., Singh, R., & Lyburn, I. D. (2021). Oxford-AstraZeneca COVID-19 Induce Linfadenopatía inducida en [18F] CHOLINE PET / CT, no solo un hallazgo de FDG. Revista europea de medicina nuclear y imágenes moleculares, 48 (8), 2657-2658. https://pubmed.ncbi.nlm.nih.gov/33624520/ | Choi, Y. K., Moon, J. Y., Kim, J., Yoo, I. S., Kwon, G. Y., Bae, H., ... & Kym, S. (2022). Postvaccination multisystem inflammatory syndrome in adult with no evidence of prior SARS-CoV-2 Infection. Emerging infectious diseases, 28(2), 411. https://pubmed.ncbi.nlm.nih.gov/34852213/ | Nishiguchi, Y., Matsuyama, H., Maeda, K., Shindo, A., & Tomimoto, H. (2021). Miller Fisher syndrome following BNT162b2 mRNA coronavirus 2019 vaccination. BMC neurology, 21(1), 1-6. https://pubmed.ncbi.nlm.nih.gov/34789193/. | Kar, B. R., Singh, B. S., Mohapatra, L., & Agrawal, I. (2021). Cutaneous small‐vessel vasculitis following COVID‐19 vaccine. Journal of Cosmetic Dermatology, 20(11), 3382. | https://pubmed.ncbi.nlm.nih.gov/34529877/. | Kar, B. R., Singh, B. S., Mohapatra, L., & Agrawal, I. (2021). Cutaneous small‐vessel vasculitis following COVID‐19 vaccine. Journal of Cosmetic Dermatology, 20(11), 3382. https://pubmed.ncbi.nlm.nih.gov/34529877/. | Sessa, M., Kragholm, K., Hviid, A., & Andersen, M. (2021). Thromboembolic events in younger women exposed to Pfizer-BioNTech or Moderna COVID-19 vaccines. Expert Opinion on Drug Safety, 20(11), 1451-1453. https://pubmed.ncbi.nlm.nih.gov/34264151/ | ||||
623 | Three cases of acute venous thromboembolism in women after coronavirus 2019 vaccination: | https://pubmed.ncbi.nlm.nih.gov/34352418/ | https://pubmed.ncbi.nlm.nih.gov/34866122/ | Maeda, M., Isawa, T., & Tada, N. (2021). Definite Acute Myocarditis After Coronavirus Disease 2019 mRNA Vaccination. Circulation Journal, CJ-21. | Maeda, M., Isawa, T. y Tada, N. (2021). Miocarditis aguda definitiva después de la vacunación con ARNm de la enfermedad por coronavirus de 2019. Diario de circulación, CJ-21. https://pubmed.ncbi.nlm.nih.gov/34601566/ | Negrea, L., & Rovin, B. H. (2021). Hematuria bruta después de la vacunación para el síndrome respiratorio agudo severo Coronavirus 2 en 2 pacientes con nefropatía IgA. Ridney International, 99 (6), 1487. https://pubmed.ncbi.nlm.nih.gov/34846583/ | Maeda, M., Isawa, T., & Tada, N. (2021). Definite Acute Myocarditis After Coronavirus Disease 2019 mRNA Vaccination. Circulation Journal, CJ-21. https://pubmed.ncbi.nlm.nih.gov/34866122/ | Nishizawa, Y., Hoshina, Y., & Baker, V. (2021). Bell’s palsy following the Ad26. COV2. S COVID-19 vaccination. QJM: An International Journal of Medicine. https://pubmed.ncbi.nlm.nih.gov/34014316/ | Cohen, S. R., Prussick, L., Kahn, J. S., Gao, D. X., Radfar, A., & Rosmarin, D. (2021). Leukocytoclastic vasculitis flare following the COVID‐19 vaccine. International Journal of Dermatology, 60(8), 1032-1033. | https://pubmed.ncbi.nlm.nih.gov/33928638/ | Cohen, S. R., Prussick, L., Kahn, J. S., Gao, D. X., Radfar, A., & Rosmarin, D. (2021). Leukocytoclastic vasculitis flare following the COVID‐19 vaccine. International Journal of Dermatology, 60(8), 1032-1033. https://pubmed.ncbi.nlm.nih.gov/33928638/ | Shahrigharahkoshan, S., Gagnon, L. P., & Mathieu, S. (2021). Cutaneous Leukocytoclastic Vasculitis Induction Following ChAdOx1 nCoV-19 Vaccine. Cureus, 13(10). https://pubmed.ncbi.nlm.nih.gov/34853744/. | ||||
624 | Clinical and biological features of cerebral venous sinus thrombosis after vaccination with ChAdOx1 nCov-19; | https://jnnp.bmj.com/content/early/2021/09/29/jnnp-2021-327340. | https://pubmed.ncbi.nlm.nih.gov/34601566/ | Maki, H., Aikawa, T., Ibe, T., Oyama-Manabe, N., & Fujita, H. (2022). Biventricular systolic dysfunction in acute myocarditis after SARS-CoV-2 mRNA-1273 vaccination. European Heart Journal-Cardiovascular Imaging, 23(2), e87-e87. | Maki, H., Aikawa, T., Ibe, T., Oyama-Manabe, N. y Fujita, H. (2022). Disfunción sistólica biventricular en la miocarditis aguda después de la vacunación con ARNm-1273 del SARS-CoV-2. European Heart Journal-Cardiovascular Imaging, 23(2), e87-e87. https://pubmed.ncbi.nlm.nih.gov/34739045/. | Nevet, A. (2021). Miocarditis aguda asociada a la vacunación anti-covid-19. Investigación clínica y experimental de vacunas, 10 (2), 196. https://pubmed.ncbi.nlm.nih.gov/34428917/. | Maki, H., Aikawa, T., Ibe, T., Oyama-Manabe, N., & Fujita, H. (2022). Biventricular systolic dysfunction in acute myocarditis after SARS-CoV-2 mRNA-1273 vaccination. European Heart Journal-Cardiovascular Imaging, 23(2), e87-e87. https://pubmed.ncbi.nlm.nih.gov/34601566/ | Noseda, R., Ripellino, P., Ghidossi, S., Bertoli, R., & Ceschi, A. (2021). Reporting of acute inflammatory neuropathies with COVID-19 vaccines: subgroup disproportionality analyses in VigiBase. Vaccines, 9(9), 1022. https://pubmed.ncbi.nlm.nih.gov/34579259/ | Fritzen, M., Funchal, G. D. G., Luiz, M. O., & Durigon, G. S. (2022). Leukocytoclastic vasculitis after exposure to COVID-19 vaccine. Anais brasileiros de dermatologia, 97(1), 118-121. | https://pubmed.ncbi.nlm.nih.gov/34836739/ | Fritzen, M., Funchal, G. D. G., Luiz, M. O., & Durigon, G. S. (2022). Leukocytoclastic vasculitis after exposure to COVID-19 vaccine. Anais brasileiros de dermatologia, 97(1), 118-121. https://pubmed.ncbi.nlm.nih.gov/34836739/ | Shakoor, M. T., Birkenbach, M. P., & Lynch, M. (2021). ANCA-associated vasculitis following Pfizer-BioNTech COVID-19 vaccine. American Journal of Kidney Diseases, 78(4), 611-613. https://www.sciencedirect.com/science/article/pii/S0272638621007423 | ||||
625 | COV2-S vaccination may reveal hereditary thrombophilia: massive cerebral venous sinus thrombosis in a young man with normal platelet count: | https://pubmed.ncbi.nlm.nih.gov/34632750/ | https://pubmed.ncbi.nlm.nih.gov/34739045/. | Shiyovich, A., Witberg, G., Aviv, Y., Eisen, A., Orvin, K., Wiessman, M., ... & Hamdan, A. (2021). Myocarditis following COVID-19 vaccination: magnetic resonance imaging study. European Heart Journal-Cardiovascular Imaging. | Shiyovich, A., Witberg, G., Aviv, Y., Eisen, A., Orvin, K., Wiessman, M., ... y Hamdan, A. (2021). Miocarditis tras vacunación COVID-19: estudio de resonancia magnética. European Heart Journal-Cardiovascular Imaging. https://docs.google.com/document/d/1Hc4bh_qNbZ7UVm5BLxkRdMPnnI9zcCsl/e | NG, X. L., Betzler, B. K., Testi, I., HO, S. L., Tien, M., ONG, W. K., ... y Agrawal, R. (2021). Eventos adversos oculares después de la vacunación de COVID-19. Inmunología ocular e inflamación, 1-9. https://pubmed.ncbi.nlm.nih.gov/34608345/. | Shiyovich, A., Witberg, G., Aviv, Y., Eisen, A., Orvin, K., Wiessman, M., ... & Hamdan, A. (2021). Myocarditis following COVID-19 vaccination: magnetic resonance imaging study. European Heart Journal-Cardiovascular Imaging. https://pubmed.ncbi.nlm.nih.gov/34739045/. | Notghi, A. A., Atley, J., & Silva, M. (2021). Lessons of the month 1: Longitudinal extensive transverse myelitis following AstraZeneca COVID-19 vaccination. Clinical Medicine, 21(5), e535. https://pubmed.ncbi.nlm.nih.gov/34507942/. | Schierz, J. H., Merkel, C., Kittner, T., & Ali, F. (2022). Vasculitis and bursitis on [18F] FDG-PET/CT following COVID-19 mRNA vaccine: post hoc ergo propter hoc?. European Journal of Nuclear Medicine and Molecular Imaging, 49(3), 1086-1087. | https://pubmed.ncbi.nlm.nih.gov/34495381/. | Schierz, J. H., Merkel, C., Kittner, T., & Ali, F. (2022). Vasculitis and bursitis on [18F] FDG-PET/CT following COVID-19 mRNA vaccine: post hoc ergo propter hoc?. European Journal of Nuclear Medicine and Molecular Imaging, 49(3), 1086-1087. https://pubmed.ncbi.nlm.nih.gov/34495381/. | Shao, S. C., Wang, C. H., Chang, K. C., Hung, M. J., Chen, H. Y., & Liao, S. C. (2021). Guillain- Barré Syndrome Associated with COVID-19 Vaccination. Emerging infectious diseases, 27(12), 3175. https://pubmed.ncbi.nlm.nih.gov/34648420/. | ||||
626 | Post-mortem findings in vaccine-induced thrombotic thrombocytopenia: | https://haematologica.org/article/view/haematol.2021.279075 | https://docs.google.com/document/d/1Hc4bh_qNbZ7UVm5BLxkRdMPnnI9zcCsl/e | #VALUE! | Nishiguchi, Y., Matsuyama, H., Maeda, K., Shindo, A., & Tomimoto, H. (2021). Síndrome de Miller Fisher después de la vacunación BNT162B2 MRNA Coronavirus 2019. Neurología BMC, 21 (1), 1-6. https://pubmed.ncbi.nlm.nih.gov/34261746/ | zzzz | Nowak, V. A., Scully, M., Davagnanam, I., & Bremner, F. (2021). Neuro-ophthalmic complications with ChAdOx1 nCoV-19 vaccine-induced thrombocytopenia and thrombosis. British Journal of Hospital Medicine, 82(10), 1-4. https://pubmed.ncbi.nlm.nih.gov/34726934/ | Vassallo, C., Boveri, E., Brazzelli, V., Rampino, T., Bruno, R., Bonometti, A., & Gregorini, M. (2021). Cutaneous lymphocytic vasculitis after administration of COVID‐19 mRNA vaccine. Dermatologic Therapy. | https://pubmed.ncbi.nlm.nih.gov/34327795 | Vassallo, C., Boveri, E., Brazzelli, V., Rampino, T., Bruno, R., Bonometti, A., & Gregorini, M. (2021). Cutaneous lymphocytic vasculitis after administration of COVID‐19 mRNA vaccine. Dermatologic Therapy. https://pubmed.ncbi.nlm.nih.gov/34327795 | Sharif, N., Alzahrani, K. J., Ahmed, S. N., & Dey, S. K. (2021). Efficacy, Immunogenicity and safety of COVID-19 vaccines: A systematic review and meta-analysis. Frontiers in Immunology, 4149. https://www.ncbi.nlm.nih.gov/pubmed/34707602 | |||||
627 | COVID-19 vaccine-induced thrombosis: | https://pubmed.ncbi.nlm.nih.gov/34802488/. | https://pubmed.ncbi.nlm.nih.gov/34865500/ | Truong, D. T., Dionne, A., Muniz, J. C., McHugh, K. E., Portman, M. A., Lambert, L. M., ... & Newburger, J. W. (2021). Clinically suspected myocarditis temporally related to COVID-19 vaccination in adolescents and young adults. Circulation. | Truong, D. T., Dionne, A., Muniz, J. C., McHugh, K. E., Portman, M. A., Lambert, L. M., ... y Newburger, J. W. (2021). Miocarditis clínicamente sospechada relacionada temporalmente con la vacunación COVID-19 en adolescentes y adultos jóvenes. Circulación. https://pubmed.ncbi.nlm.nih.gov/34614329/ | Nishizawa, Y., Hoshina, Y., & Baker, V. (2021). Palsy de Bell siguiendo el AD26. COV2. S covid-19 vacunación. QJM: un Diario Internacional de Medicina. https://pubmed.ncbi.nlm.nih.gov/34330676/ | Truong, D. T., Dionne, A., Muniz, J. C., McHugh, K. E., Portman, M. A., Lambert, L. M., ... & Newburger, J. W. (2021). Clinically suspected myocarditis temporally related to COVID-19 vaccination in adolescents and young adults. Circulation. https://pubmed.ncbi.nlm.nih.gov/34865500/ | Ntouros, P. A., Vlachogiannis, N. I., Pappa, M., Nezos, A., Mavragani, C. P., Tektonidou, M. G., ... & Sfikakis, P. P. (2021). Effective DNA damage response after acute but not chronic immune challenge: SARS-CoV-2 vaccine versus Systemic Lupus Erythematosus. Clinical Immunology, 229, 108765. https://www.ncbi.nlm.nih.gov/pubmed/34089859 | Bencharattanaphakhi, R., & Rerknimitr, P. (2021). Sinovac COVID-19 vaccine–induced cutaneous leukocytoclastic vasculitis. JAAD case reports, 18, 1-3. | https://pubmed.ncbi.nlm.nih.gov/34660867/. | Bencharattanaphakhi, R., & Rerknimitr, P. (2021). Sinovac COVID-19 vaccine–induced cutaneous leukocytoclastic vasculitis. JAAD case reports, 18, 1-3. https://pubmed.ncbi.nlm.nih.gov/34660867/. | Sharifian-Dorche, M., Bahmanyar, M., Sharifian-Dorche, A., Mohammadi, P., Nomovi, M., & Mowla, A. (2021). Vaccine-induced immune thrombotic thrombocytopenia and cerebral venous sinus thrombosis post COVID-19 vaccination; a systematic review. Journal of the neurological sciences, 428, 117607. https://www.sciencedirect.com/science/article/pii/S0022510X21003014 | ||||
628 | Inflammation and platelet activation after COVID-19 vaccines: possible mechanisms behind vaccine-induced immune thrombocytopenia and thrombosis: | https://pubmed.ncbi.nlm.nih.gov/34887867/. | https://pubmed.ncbi.nlm.nih.gov/34614329/ | Witberg, G., Barda, N., Hoss, S., Richter, I., Wiessman, M., Aviv, Y., ... & Kornowski, R. (2021). Myocarditis after Covid-19 vaccination in a large health care organization. New England Journal of Medicine. | Witberg, G., Barda, N., Hoss, S., Richter, I., Wiessman, M., Aviv, Y., ... y Kornowski, R. (2021). Miocarditis tras la vacunación contra Covid-19 en una gran organización sanitaria. Revista de Medicina de Nueva Inglaterra. https://pubmed.ncbi.nlm.nih.gov/34560365/ | NOSEDA, R., RIPELLINO, P., GHIDOSSI, S., Bertoli, R., & Ceschi, A. (2021). Informes de neuropatías inflamatorias agudas con vacunas COVID-19: análisis de desproporcionidad de subgrupos en vigibase. Vacunas, 9 (9), 1022. https://pubmed.ncbi.nlm.nih.gov/34370408/. | Witberg, G., Barda, N., Hoss, S., Richter, I., Wiessman, M., Aviv, Y., ... & Kornowski, R. (2021). Myocarditis after Covid-19 vaccination in a large health care organization. New England Journal of Medicine. https://pubmed.ncbi.nlm.nih.gov/34614329/ | Nygaard, U., Holm, M., Bohnstedt, C., Chai, Q., Schmidt, L. S., Hartling, U. B., ... & Stensballe, L. G. (2022). Population-based Incidence of Myopericarditis After COVID-19 Vaccination in Danish Adolescents. The Pediatric infectious disease journal, 41(1), e25. https://www.ncbi.nlm.nih.gov/pubmed/34889875 | Hakroush, S., & Tampe, B. (2021). Case report: ANCA-associated vasculitis presenting with rhabdomyolysis and pauci-immune crescentic glomerulonephritis after Pfizer-BioNTech COVID-19 mRNA vaccination. Frontiers in Immunology, 12. | https://pubmed.ncbi.nlm.nih.gov/34659268/ | Hakroush, S., & Tampe, B. (2021). Case report: ANCA-associated vasculitis presenting with rhabdomyolysis and pauci-immune crescentic glomerulonephritis after Pfizer-BioNTech COVID-19 mRNA vaccination. Frontiers in Immunology, 12. https://pubmed.ncbi.nlm.nih.gov/34659268/ | Shaw, K. E., Cavalcante, J. L., Han, B. K., & Gössl, M. (2021). Possible association between COVID-19 vaccine and myocarditis: clinical and CMR findings. Cardiovascular Imaging, 14(9), 1856-1861. https://www.sciencedirect.com/science/article/pii/S1936878X2100485X | ||||
629 | Anaphylactoid reaction and coronary thrombosis related to COVID-19 mRNA vaccine: | https://pubmed.ncbi.nlm.nih.gov/34863404/. | https://pubmed.ncbi.nlm.nih.gov/34560365/ | Oo, W. M., Giri, P., & De Souza, A. (2021). AstraZeneca COVID-19 vaccine and Guillain-Barré Syndrome in Tasmania: A causal link?. Journal of neuroimmunology, 360, 577719. | Oo, WM, Giri, P. y De Souza, A. (2021). Vacuna AstraZeneca COVID-19 y síndrome de Guillain-Barré en Tasmania: ¿un vínculo causal? Revista de neuroinmunología, 360, 577719. https://pubmed.ncbi.nlm.nih.gov/34108736/. | NotGhi, A. A., ATLEY, J., & SILVA, M. (2021). Lecciones del mes 1: mielitis transversal extensa longitudinal después de la vacunación de AstraZeneca COVID-19. Medicina clínica, 21 (5), E535. https://pubmed.ncbi.nlm.nih.gov/34325221/ | Oo, W. M., Giri, P., & De Souza, A. (2021). AstraZeneca COVID-19 vaccine and Guillain-Barré Syndrome in Tasmania: A causal link?. Journal of neuroimmunology, 360, 577719. https://pubmed.ncbi.nlm.nih.gov/34560365/ | Obeid, M., Fenwick, C., & Pantaleo, G. (2021). Reactivation of IgA vasculitis after COVID-19 vaccination. The Lancet Rheumatology, 3(9), e617. https://pubmed.ncbi.nlm.nih.gov/34250509/ | Maye, J. A., Chong, H. P., Rajagopal, V., & Petchey, W. (2021). Reactivation of IgA vasculitis following COVID-19 vaccination. BMJ Case Reports CP, 14(11), e247188. | https://pubmed.ncbi.nlm.nih.gov/34848431/ | Maye, J. A., Chong, H. P., Rajagopal, V., & Petchey, W. (2021). Reactivation of IgA vasculitis following COVID-19 vaccination. BMJ Case Reports CP, 14(11), e247188. https://pubmed.ncbi.nlm.nih.gov/34848431/ | Shay, D. K. (2021). Safety monitoring of the Janssen (Johnson & Johnson) COVID-19 vaccine—United States, March–April 2021. MMWR. Morbidity and mortality weekly report, 70. https://www.ncbi.nlm.nih.gov/pubmed/33956784 | ||||
630 | Vaccine-induced cerebral venous thrombosis and thrombocytopenia. Oxford-AstraZeneca COVID-19: a missed opportunity for rapid return on experience: | https://www.sciencedirect.com/science/article/pii/S235255682100093X | https://pubmed.ncbi.nlm.nih.gov/34108736/. | Aomar-Millán, I. F., de Victoria-Carazo, J. M., Peregrina-Rivas, J. A., & Villegas-Rodríguez, I. (2021). COVID-19, Guillain-Barré syndrome, and the vaccine. A dangerous combination. Revista clinica espanola. | Aomar-Millán, I. F., de Victoria-Carazo, J. M., Peregrina-Rivas, J. A., & Villegas-Rodríguez, I. (2021). COVID-19, síndrome de Guillain-Barré y la vacuna. Una combinación peligrosa. Revista clínica española. https://pubmed.ncbi.nlm.nih.gov/34796417/. | Nowak, V. A., Scully, M., Davagnanam, I., & Bremner, F. (2021). Complicaciones neuroftálmicas con la trombocitopenia y la trombosis inducidas por la vacuna contra la vacuna. British Journal of Hospital Medicine, 82 (10), 1-4. https://pubmed.ncbi.nlm.nih.gov/34835237/ | Aomar-Millán, I. F., de Victoria-Carazo, J. M., Peregrina-Rivas, J. A., & Villegas-Rodríguez, I. (2021). COVID-19, Guillain-Barré syndrome, and the vaccine. A dangerous combination. Revista clinica espanola. https://pubmed.ncbi.nlm.nih.gov/34108736/. | Oberhardt, V., Luxenburger, H., Kemming, J., Schulien, I., Ciminski, K., Giese, S., ... & Hofmann, M. (2021). Rapid and stable mobilization of CD8+ T cells by SARS-CoV-2 mRNA vaccine. Nature, 597(7875), 268-273. https://www.ncbi.nlm.nih.gov/pubmed/34320609 | Nastro, F., Fabbrocini, G., di Vico, F., & Marasca, C. (2021). Small vessel vasculitis related to varicella‐zoster virus after Pfizer‐BioNTech COVID‐19 vaccine. Journal of the European Academy of Dermatology and Venereology. | https://pubmed.ncbi.nlm.nih.gov/34310759/. | Nastro, F., Fabbrocini, G., di Vico, F., & Marasca, C. (2021). Small vessel vasculitis related to varicella‐zoster virus after Pfizer‐BioNTech COVID‐19 vaccine. Journal of the European Academy of Dermatology and Venereology. https://pubmed.ncbi.nlm.nih.gov/34310759/. | Shay, D. K., Shimabukuro, T. T., & DeStefano, F. (2021). Myocarditis occurring after immunization with mRNA-based COVID-19 vaccines. JAMA cardiology, 6(10), 1115-1117. https://jamanetwork.com/journals/jamacardiology/fullarticle/2781600 | ||||
631 | Occurrence of splenic infarction due to arterial thrombosis after vaccination with COVID-19: | https://pubmed.ncbi.nlm.nih.gov/34876440/ | https://pubmed.ncbi.nlm.nih.gov/34796417/. | Bouattour, N., Hdiji, O., Sakka, S., Fakhfakh, E., Moalla, K., Daoud, S., ... & Mhiri, C. (2022). Guillain-Barré syndrome following the first dose of Pfizer-BioNTech COVID-19 vaccine: case report and review of reported cases. Neurological Sciences, 43(2), 755-761. | Bouattour, N., Hdiji, O., Sakka, S., Fakhfakh, E., Moalla, K., Daoud, S., ... y Mhiri, C. (2022). Síndrome de Guillain-Barré tras la primera dosis de la vacuna Pfizer-BioNTech COVID-19: reporte de caso y revisión de casos reportados. Ciencias Neurológicas, 43(2), 755-761. https://link.springer.com/article/10.1007%2Fs10072-021-05523-5. | Ntouros, P. A., Vlachogiannis, N. I., Pappa, M., Nezos, A., Mavragani, C. P., Tektonidou, M. G., ... & Sfikakis, P. P. (2021). Respuesta efectiva del daño del ADN después de un desafío inmunológico agudo pero no crónico: vacuna contra el SARS-COV-2 versus lupus eritematoso sistémico. Inmunología clínica, 229, 108765. https://www.ncbi.nlm.nih.gov/pubmed/34889875 | Bouattour, N., Hdiji, O., Sakka, S., Fakhfakh, E., Moalla, K., Daoud, S., ... & Mhiri, C. (2022). Guillain-Barré syndrome following the first dose of Pfizer-BioNTech COVID-19 vaccine: case report and review of reported cases. Neurological Sciences, 43(2), 755-761. https://pubmed.ncbi.nlm.nih.gov/34796417/. | Obermann, M., Krasniqi, M., Ewers, N., Fayad, J., & Haeberle, U. (2021). Bell’s palsy following COVID-19 vaccination with high CSF antibody response. Neurological Sciences, 42(11), 4397-4399. https://pubmed.ncbi.nlm.nih.gov/34322761/. | Dicks, A. B., & Gray, B. H. (2021). Images in Vascular Medicine: Leukocytoclastic vasculitis after COVID-19 vaccine booster. Vascular Medicine, 1358863X211055507. | https://pubmed.ncbi.nlm.nih.gov/34720009/ | Dicks, A. B., & Gray, B. H. (2021). Images in Vascular Medicine: Leukocytoclastic vasculitis after COVID-19 vaccine booster. Vascular Medicine, 1358863X211055507. https://pubmed.ncbi.nlm.nih.gov/34720009/ | Shazley, O., & Alshazley, M. (2021). A COVID-Positive 52-year-old man presented with venous thromboembolism and disseminated intravascular coagulation following Johnson & Johnson vaccination: a case-study. Cureus, 13(7). https://www.ncbi.nlm.nih.gov/pubmed/34408937 | ||||
632 | Deep venous thrombosis more than two weeks after COVID-19 vaccination: | https://pubmed.ncbi.nlm.nih.gov/33928773/ | https://link.springer.com/article/10.1007%2Fs10072-021-05523-5. | Trimboli, M., Zoleo, P., Arabia, G., & Gambardella, A. (2021). Guillain-Barré syndrome following BNT162b2 COVID-19 vaccine. Neurological Sciences, 42(11), 4401-4402. | Trimboli, M., Zoleo, P., Arabia, G. y Gambardella, A. (2021). Síndrome de Guillain-Barré tras la vacuna BNT162b2 COVID-19. Ciencias Neurológicas, 42(11), 4401-4402. https://onlinelibrary.wiley.com/doi/10.1002/ana.26258. | Nygaard, U., Holm, M., Bohnstedt, C., Chai, Q., Schmidt, L. S., Hartling, U. B., ... & Stensballe, L. G. (2022). Incidencia de miopericaditis basada en la población después de la vacunación de COVID-19 en adolescentes daneses. La diario de la enfermedad infecciosa pediátrica, 41 (1), E25. https://www.ncbi.nlm.nih.gov/pubmed/34320609 | Trimboli, M., Zoleo, P., Arabia, G., & Gambardella, A. (2021). Guillain-Barré syndrome following BNT162b2 COVID-19 vaccine. Neurological Sciences, 42(11), 4401-4402. https://link.springer.com/article/10.1007%2Fs10072-021-05523-5. | Öcal, O., Stecher, S. S., & Wildgruber, M. (2021). Portal vein thrombosis associated with ChAdOx1 nCov-19 vaccination. The lancet Gastroenterology & hepatology, 6(8), 676. https://www.thelancet.com/journals/langas/article/PIIS2468-1253(21)00197-7/ | Naitlho, A., Lahlou, W., Bourial, A., Rais, H., Ismaili, N., Abousahfa, I., & Belyamani, L. (2021). A Rare Case of Henoch-Schönlein Purpura Following a COVID-19 Vaccine—Case Report. SN comprehensive clinical medicine, 3(12), 2618-2621. | https://pubmed.ncbi.nlm.nih.gov/34518812/ | Naitlho, A., Lahlou, W., Bourial, A., Rais, H., Ismaili, N., Abousahfa, I., & Belyamani, L. (2021). A Rare Case of Henoch-Schönlein Purpura Following a COVID-19 Vaccine—Case Report. SN comprehensive clinical medicine, 3(12), 2618-2621. https://pubmed.ncbi.nlm.nih.gov/34518812/ | Shemer, A., Pras, E., & Hecht, I. (2021). Peripheral facial nerve palsy following BNT162b2 (COVID-19) vaccination. Israel Medical Association Journal: Imaj, 142-143. https://pubmed.ncbi.nlm.nih.gov/33734623/ | ||||
633 | Case report: Take a second look: Cerebral venous thrombosis related to Covid-19 vaccination and thrombotic thrombocytopenia syndrome: | https://pubmed.ncbi.nlm.nih.gov/34880826/ | https://onlinelibrary.wiley.com/doi/10.1002/ana.26258. | Truong, D. T., Dionne, A., Muniz, J. C., McHugh, K. E., Portman, M. A., Lambert, L. M., ... & Newburger, J. W. (2021). Clinically suspected myocarditis temporally related to COVID-19 vaccination in adolescents and young adults. Circulation. | Truong, D. T., Dionne, A., Muniz, J. C., McHugh, K. E., Portman, M. A., Lambert, L. M., ... y Newburger, J. W. (2021). Miocarditis clínicamente sospechada relacionada temporalmente con la vacunación COVID-19 en adolescentes y adultos jóvenes. Circulación. https://jamanetwork.com/journals/jama/fullarticle/2785009 | Obeid, M., Fenwick, C., & Pantaleo, G. (2021). Reactivación de la vasculitis IgA después de la vacunación de COVID-19. La reumatología Lancet, 3 (9), E617. https://pubmed.ncbi.nlm.nih.gov/34292611/. | Truong, D. T., Dionne, A., Muniz, J. C., McHugh, K. E., Portman, M. A., Lambert, L. M., ... & Newburger, J. W. (2021). Clinically suspected myocarditis temporally related to COVID-19 vaccination in adolescents and young adults. Circulation. https://onlinelibrary.wiley.com/doi/10.1002/ana.26258. | Ogbebor, O., Seth, H., Min, Z., & Bhanot, N. (2021). Guillain-Barré syndrome following the first dose of SARS-CoV-2 vaccine: a temporal occurrence, not a causal association. IDCases, 24, e01143. https://pubmed.ncbi.nlm.nih.gov/33968610/ | Cavalli, G., Colafrancesco, S., De Luca, G., Rizzo, N., Priori, R., Conti, F., & Dagna, L. (2021). Cutaneous vasculitis following COVID-19 vaccination. The Lancet Rheumatology, 3(11), e743-e744. | https://pubmed.ncbi.nlm.nih.gov/34611627/. | Cavalli, G., Colafrancesco, S., De Luca, G., Rizzo, N., Priori, R., Conti, F., & Dagna, L. (2021). Cutaneous vasculitis following COVID-19 vaccination. The Lancet Rheumatology, 3(11), e743-e744. https://pubmed.ncbi.nlm.nih.gov/34611627/. | Shemer, A., Pras, E., Einan-Lifshitz, A., Dubinsky-Pertzov, B., & Hecht, I. (2021). Association of COVID-19 vaccination and facial nerve palsy: a case-control study. JAMA Otolaryngology–Head & Neck Surgery, 147(8), 739-743. https://pubmed.ncbi.nlm.nih.gov/34165512/ | ||||
634 | Information on ChAdOx1 nCoV-19 vaccine-induced immune-mediated thrombotic thrombocytopenia: | https://pubmed.ncbi.nlm.nih.gov/34587242/ | https://jamanetwork.com/journals/jama/fullarticle/2785009 | Woo, E. J., Mba-Jonas, A., Dimova, R. B., Alimchandani, M., Zinderman, C. E., & Nair, N. (2021). Association of receipt of the Ad26. COV2. S COVID-19 vaccine with presumptive Guillain-Barré syndrome, February-July 2021. JAMA, 326(16), 1606-1613. | Woo, E. J., Mba-Jonas, A., Dimova, R. B., Alimchandani, M., Zinderman, C. E. y Nair, N. (2021). Asociación de recepción del Ad26. COV2. Vacuna S COVID-19 con presunto síndrome de Guillain-Barré, febrero-julio de 2021. JAMA, 326(16), 1606-1613. https://pubmed.ncbi.nlm.nih.gov/34567447/ | Oberhardt, V., Luxenburger, H., Kemming, J., Schulien, I., Ciminski, K., Giese, S., ... & Hofmann, M. (2021). Movilización rápida y estable de células T CD8 + por vacuna contra ARNm de SARS-COV-2. Naturaleza, 597 (7875), 268-273. https://www.ncbi.nlm.nih.gov/pubmed/34402230 | Woo, E. J., Mba-Jonas, A., Dimova, R. B., Alimchandani, M., Zinderman, C. E., & Nair, N. (2021). Association of receipt of the Ad26. COV2. S COVID-19 vaccine with presumptive Guillain-Barré syndrome, February-July 2021. JAMA, 326(16), 1606-1613. https://jamanetwork.com/journals/jama/fullarticle/2785009 | Ogbebor, O., Seth, H., Min, Z., & Bhanot, N. (2021). Guillain-Barré syndrome following the first dose of SARS-CoV-2 vaccine: a temporal occurrence, not a causal association. IDCases, 24, e01143. https://www.sciencedirect.com/science/article/pii/S2214250921000998. | Bostan, E., Zaid, F., Akdogan, N., & Gokoz, O. (2022). Possible case of mRNA COVID‐19 vaccine‐induced small‐vessel vasculitis. Journal of Cosmetic Dermatology, 21(1), 51-53. | https://pubmed.ncbi.nlm.nih.gov/34705320/. | Bostan, E., Zaid, F., Akdogan, N., & Gokoz, O. (2022). Possible case of mRNA COVID‐19 vaccine‐induced small‐vessel vasculitis. Journal of Cosmetic Dermatology, 21(1), 51-53. https://pubmed.ncbi.nlm.nih.gov/34705320/. | Shen, X., Koh, M. S. H., Lim, B. Y., Demo-Os, M., Chien, J. M. F., Santosa, A., & Taha, A. A. (2021). Acute pericarditis and cardiac tamponade after Covid-19 vaccination. Singapore medical journal. https://pubmed.ncbi.nlm.nih.gov/34749492/ | ||||
635 | Change in blood viscosity after COVID-19 vaccination: estimation for persons with underlying metabolic syndrome: | https://pubmed.ncbi.nlm.nih.gov/34868465/ | https://pubmed.ncbi.nlm.nih.gov/34567447/ | Rao, S. J., Khurana, S., Murthy, G., Dawson, E. T., Jazebi, N., & Haas, C. J. (2021). A case of Guillain–Barre syndrome following Pfizer COVID-19 vaccine. Journal of Community Hospital Internal Medicine Perspectives, 11(5), 597-600. | Rao, SJ, Khurana, S., Murthy, G., Dawson, E. T., Jazebi, N. y Haas, CJ (2021). Un caso de síndrome de Guillain-Barré tras la vacuna Pfizer COVID-19. Revista de perspectivas de medicina interna de hospitales comunitarios, 11(5), 597-600. https://pubmed.ncbi.nlm.nih.gov/34648420/. | Obermann, M., Krasniqi, M., Ewers, N., Fayad, J., & Haeberle, U. (2021). Parálisis de Bell siguiendo la vacunación COVID-19 con una alta respuesta de anticuerpos de CSF. Ciencias neurológicas, 42 (11), 4397-4399. https://pubmed.ncbi.nlm.nih.gov/34139321/. | Rao, S. J., Khurana, S., Murthy, G., Dawson, E. T., Jazebi, N., & Haas, C. J. (2021). A case of Guillain–Barre syndrome following Pfizer COVID-19 vaccine. Journal of Community Hospital Internal Medicine Perspectives, 11(5), 597-600. https://pubmed.ncbi.nlm.nih.gov/34567447/ | Okada, Y., Sakai, R., Sato-Fitoussi, M., Nodera, M., Yoshinaga, S., Shibata, A., ... & Amano, K. (2021). Potential triggers for thrombocytopenia and/or hemorrhage by the BNT162b2 vaccine, Pfizer-BioNTech. Frontiers in Medicine, 8. https://pubmed.ncbi.nlm.nih.gov/34660652/. | Grossman, M. E., Appel, G., Little, A. J., & Ko, C. J. (2021). Post‐COVID‐19 vaccination IgA vasculitis in an adult. Journal of cutaneous pathology. | https://pubmed.ncbi.nlm.nih.gov/34779011/ | Grossman, M. E., Appel, G., Little, A. J., & Ko, C. J. (2021). Post‐COVID‐19 vaccination IgA vasculitis in an adult. Journal of cutaneous pathology. https://pubmed.ncbi.nlm.nih.gov/34779011/ | Shimabukuro, T. (2021). Allergic reactions including anaphylaxis after receipt of the first dose of Moderna COVID‐19 vaccine—United States, December 21, 2020–January 10, 2021. American Journal of Transplantation, 21(3), 1326. https://pubmed.ncbi.nlm.nih.gov/33641268/ | ||||
636 | Management of a patient with a rare congenital limb malformation syndrome after SARS-CoV-2 vaccine-induced thrombosis and thrombocytopenia (VITT): | https://pubmed.ncbi.nlm.nih.gov/34097311/ | https://pubmed.ncbi.nlm.nih.gov/34648420/. | Shao, S. C., Wang, C. H., Chang, K. C., Hung, M. J., Chen, H. Y., & Liao, S. C. (2021). Guillain- Barré Syndrome Associated with COVID-19 Vaccination. Emerging infectious diseases, 27(12), 3175. | Shao, S. C., Wang, C. H., Chang, K. C., Hung, M. J., Chen, H. Y. y Liao, S. C. (2021). Síndrome de Guillain-Barré asociado a la vacunación contra el COVID-19. Enfermedades infecciosas emergentes, 27(12), 3175. https://jamanetwork.com/journals/jamaneurology/fullarticle/2783708 | Öcal, O., Stechher, S. S., & WildGruber, M. (2021). Trombosis de la vena del portal asociada con la vacunación de Chadox1 NCOV-19. The Lancet Gastroenterology & Hepatology, 6 (8), 676. https://pubmed.ncbi.nlm.nih.gov/33871350/ | Shao, S. C., Wang, C. H., Chang, K. C., Hung, M. J., Chen, H. Y., & Liao, S. C. (2021). Guillain- Barré Syndrome Associated with COVID-19 Vaccination. Emerging infectious diseases, 27(12), 3175. https://pubmed.ncbi.nlm.nih.gov/34648420/. | Okuda, S., Hirooka, Y., & Sugiyama, M. (2021). Propylthiouracil-Induced Antineutrophil Cytoplasmic Antibody-Associated Vasculitis after COVID-19 Vaccination. Vaccines, 9(8), 842. https://pubmed.ncbi.nlm.nih.gov/34451967/ | Sim, J., & Lim, C. C. (2021). Coronavirus disease 2019 (COVID-19) vaccination in systemic lupus erythematosus and anti-neutrophil cytoplasmic antibody-associated vasculitis. Clinical Rheumatology, 40(6), 2517-2518. | https://pubmed.ncbi.nlm.nih.gov/33928459/ | Sim, J., & Lim, C. C. (2021). Coronavirus disease 2019 (COVID-19) vaccination in systemic lupus erythematosus and anti-neutrophil cytoplasmic antibody-associated vasculitis. Clinical Rheumatology, 40(6), 2517-2518. https://pubmed.ncbi.nlm.nih.gov/33928459/ | Shimabukuro, T. (2021). Allergic reactions including anaphylaxis after receipt of the first dose of Pfizer‐BioNTech COVID‐19 vaccine—United States, December 14–23, 2020. American Journal of Transplantation, 21(3), 1332. https://pubmed.ncbi.nlm.nih.gov/33641264/ | ||||
637 | Bilateral thalamic stroke: a case of COVID-19 (VITT) vaccine-induced immune thrombotic thrombocytopenia or a coincidence due to underlying risk factors: | https://pubmed.ncbi.nlm.nih.gov/34820232/. | https://jamanetwork.com/journals/jamaneurology/fullarticle/2783708 | David, S. S. B., Potasman, I., & Rahamim-Cohen, D. (2021). Rate of recurrent guillain-barré syndrome after mRNA COVID-19 vaccine BNT162b2. JAMA neurology, 78(11), 1409-1411. | David, SSB, Potasman, I. y Rahamim-Cohen, D. (2021). Tasa de síndrome de Guillain-Barré recurrente después de la vacuna de ARNm COVID-19 BNT162b2. Neurología JAMA, 78(11), 1409-1411. https://www.pedneur.com/article/S0887-8994(21)00221-6/fulltext. | OGBEBOR, O., Seth, H., Min, Z., & Bhanot, N. (2021). Síndrome de Guillain-Barré siguiendo la primera dosis de vacuna contra SARS-COV-2: una ocurrencia temporal, no una asociación causal. Idrases, 24, E01143. https://pubmed.ncbi.nlm.nih.gov/34525410/ | David, S. S. B., Potasman, I., & Rahamim-Cohen, D. (2021). Rate of recurrent guillain-barré syndrome after mRNA COVID-19 vaccine BNT162b2. JAMA neurology, 78(11), 1409-1411. https://jamanetwork.com/journals/jamaneurology/fullarticle/2783708 | Onderko, L., Starobin, B., Riviere, A. E., Hohl, P. K., Phillips, C. T., Morgan, R. B., ... & Afari, M. E. (2021). Myocarditis in the Setting of Recent COVID-19 Vaccination. Case Reports in Cardiology, 2021. https://pubmed.ncbi.nlm.nih.gov/34712497/. | Obeid, M., Fenwick, C., & Pantaleo, G. (2021). Reactivation of IgA vasculitis after COVID-19 vaccination. The Lancet Rheumatology, 3(9), e617. | https://pubmed.ncbi.nlm.nih.gov/34250509/ | Obeid, M., Fenwick, C., & Pantaleo, G. (2021). Reactivation of IgA vasculitis after COVID-19 vaccination. The Lancet Rheumatology, 3(9), e617. https://pubmed.ncbi.nlm.nih.gov/34250509/ | Shimabukuro, T. T., Cole, M., & Su, J. R. (2021). Reports of anaphylaxis after receipt of mRNA COVID-19 vaccines in the US—December 14, 2020-January 18, 2021. Jama, 325(11), 1101-1102. https://pubmed.ncbi.nlm.nih.gov/33576785/ | ||||
638 | Thrombocytopenia and splanchnic thrombosis after vaccination with Ad26.COV2.S successfully treated with transjugular intrahepatic intrahepatic portosystemic shunt and thrombectomy: | https://onlinelibrary.wiley.com/doi/10.1002/ajh.26258 | https://www.pedneur.com/article/S0887-8994(21)00221-6/fulltext. | Malamud, E., Otallah, S. I., Caress, J. B., & Lapid, D. J. (2022). Guillain-Barré Syndrome After COVID-19 Vaccination in an Adolescent. Pediatric neurology, 126, 9-10. | Malamud, E., Otallah, S. I., Caress, J. B. y Lapid, D. J. (2022). Síndrome de Guillain-Barré tras la vacunación contra COVID-19 en un adolescente. Neurología pediátrica, 126, 9-10. https://pubmed.ncbi.nlm.nih.gov/34114256/. | OGBEBOR, O., Seth, H., Min, Z., & Bhanot, N. (2021). Síndrome de Guillain-Barré siguiendo la primera dosis de vacuna contra SARS-COV-2: una ocurrencia temporal, no una asociación causal. Idrases, 24, E01143. https://www.sciencedirect.com/science/article/pii/S0736467921006442 | Malamud, E., Otallah, S. I., Caress, J. B., & Lapid, D. J. (2022). Guillain-Barré Syndrome After COVID-19 Vaccination in an Adolescent. Pediatric neurology, 126, 9-10. https://www.pedneur.com/article/S0887-8994(21)00221-6/fulltext. | Oo, W. M., Giri, P., & De Souza, A. (2021). AstraZeneca COVID-19 vaccine and Guillain-Barré Syndrome in Tasmania: A causal link?. Journal of neuroimmunology, 360, 577719. https://pubmed.ncbi.nlm.nih.gov/34560365/ | Larson, V., Seidenberg, R., Caplan, A., Brinster, N. K., Meehan, S. A., & Kim, R. H. (2022). Clinical and histopathological spectrum of delayed adverse cutaneous reactions following COVID‐19 vaccination. Journal of cutaneous pathology, 49(1), 34-41. | https://pubmed.ncbi.nlm.nih.gov/34292611/. | Larson, V., Seidenberg, R., Caplan, A., Brinster, N. K., Meehan, S. A., & Kim, R. H. (2022). Clinical and histopathological spectrum of delayed adverse cutaneous reactions following COVID‐19 vaccination. Journal of cutaneous pathology, 49(1), 34-41. https://pubmed.ncbi.nlm.nih.gov/34292611/. | Shimabukuro, T. T., Kim, S. Y., Myers, T. R., Moro, P. L., Oduyebo, T., Panagiotakopoulos, L., ... & Meaney-Delman, D. M. (2021). Preliminary findings of mRNA Covid-19 vaccine safety in pregnant persons. New England Journal of Medicine. https://www.nejm.org/doi/full/10.1056/NEJMoa2104983. | ||||
639 | Incidence of acute ischemic stroke after coronavirus vaccination in Indonesia: case series: | https://pubmed.ncbi.nlm.nih.gov/34579636/ | https://pubmed.ncbi.nlm.nih.gov/34114256/. | Maramattom, B. V., Krishnan, P., Paul, R., Padmanabhan, S., Cherukudal Vishnu Nampoothiri, S., Syed, A. A., & Mangat, H. S. (2021). Guillain‐Barré syndrome following ChAdOx1‐S/nCoV‐19 vaccine. Annals of neurology, 90(2), 312-314. | Maramattom, BV, Krishnan, P., Paul, R., Padmanabhan, S., Cherukudal Vishnu Nampoothiri, S., Syed, A. A. y Mangat, H. S. (2021). Síndrome de Guillain-Barré después de la vacuna ChAdOx1-S/nCoV-19. Anales de neurología, 90(2), 312-314. https://pubmed.ncbi.nlm.nih.gov/34767184/. | Okada, Y., Sakai, R., Sato-Fitoussi, M., Nodera, M., Yoshinaga, S., Shibata, A., ... & Amano, K. (2021). Disparadores potenciales para la trombocitopenia y / o la hemorragia por la vacuna BNT162B2, Pfizer-Biontech. Fronteras en medicina, 8. https://pubmed.ncbi.nlm.nih.gov/34644642/ | Maramattom, B. V., Krishnan, P., Paul, R., Padmanabhan, S., Cherukudal Vishnu Nampoothiri, S., Syed, A. A., & Mangat, H. S. (2021). Guillain‐Barré syndrome following ChAdOx1‐S/nCoV‐19 vaccine. Annals of neurology, 90(2), 312-314. https://pubmed.ncbi.nlm.nih.gov/34114256/. | Osowicki, J., Morgan, H., Harris, A., Crawford, N. W., Buttery, J. P., & Kiers, L. (2021). Guillain-Barré Syndrome in an Australian state using both mRNA and adenovirus-vector SARS-CoV-2 vaccines. Annals of Neurology, 90(5), 856-858. https://onlinelibrary.wiley.com/doi/10.1002/ana.26218. | Mücke, V. T., Knop, V., Mücke, M. M., Ochsendorf, F., & Zeuzem, S. (2021). First description of immune complex vasculitis after COVID-19 vaccination with BNT162b2: a case report. BMC Infectious Diseases, 21(1), 1-6. | https://pubmed.ncbi.nlm.nih.gov/34530771/. | Mücke, V. T., Knop, V., Mücke, M. M., Ochsendorf, F., & Zeuzem, S. (2021). First description of immune complex vasculitis after COVID-19 vaccination with BNT162b2: a case report. BMC Infectious Diseases, 21(1), 1-6. https://pubmed.ncbi.nlm.nih.gov/34530771/. | Shimabukuro, T., & Nair, N. (2021). Allergic reactions including anaphylaxis after receipt of the first dose of Pfizer-BioNTech COVID-19 vaccine. Jama, 325(8), 780-781. https://pubmed.ncbi.nlm.nih.gov/33475702/ | ||||
640 | Successful treatment of vaccine-induced immune immune thrombotic thrombocytopenia in a 26-year-old female patient: | https://pubmed.ncbi.nlm.nih.gov/34614491/ | https://pubmed.ncbi.nlm.nih.gov/34767184/. | Masuccio, F. G., Comi, C., & Solaro, C. (2021). Guillain–Barrè syndrome following COVID-19 vaccine mRNA-1273: a case report. Acta Neurologica Belgica, 1-3. | Masuccio, FG, Comi, C. y Solaro, C. (2021). Síndrome de Guillain-Barrè después de la vacuna COVID-19 mRNA-1273: reporte de un caso. Acta Neurologica Bélgica, 1-3. https://pubmed.ncbi.nlm.nih.gov/34644738/. | Okuda, S., Hirooka, Y., y Sugiyama, M. (2021). Antineutrófilo inducido por propiltiouracilo. Vasculitis asociada a anticuerpos citoplásmicos después de la vacunación de COVID-19. Vacunas, 9 (8), 842. https://pubmed.ncbi.nlm.nih.gov/34377889/ | Masuccio, F. G., Comi, C., & Solaro, C. (2021). Guillain–Barrè syndrome following COVID-19 vaccine mRNA-1273: a case report. Acta Neurologica Belgica, 1-3. https://pubmed.ncbi.nlm.nih.gov/34767184/. | Ostrowski, S. R., Søgaard, O. S., Tolstrup, M., Stærke, N. B., Lundgren, J., Østergaard, L., & Hvas, A. M. (2021). Inflammation and Platelet Activation After COVID-19 Vaccines-Possible Mechanisms Behind Vaccine-Induced Immune Thrombocytopenia and Thrombosis. Frontiers in immunology, 12, 779453-779453. https://pubmed.ncbi.nlm.nih.gov/34887867/. | Izzedine, H., Bonilla, M., & Jhaveri, K. D. (2021). Nephrotic syndrome and vasculitis following SARS-CoV-2 vaccine: true association or circumstantial?. Nephrology Dialysis Transplantation. | https://pubmed.ncbi.nlm.nih.gov/34245294/. | Izzedine, H., Bonilla, M., & Jhaveri, K. D. (2021). Nephrotic syndrome and vasculitis following SARS-CoV-2 vaccine: true association or circumstantial?. Nephrology Dialysis Transplantation. https://pubmed.ncbi.nlm.nih.gov/34245294/. | Shin, M., Hyun, C. Y., Choi, Y. H., Choi, J. Y., Lee, K. H., & Cho, Y. S. (2021). COVID-19 vaccination–associated lymphadenopathy on FDG PET/CT: distinctive features in adenovirus-vectored vaccine. Clinical Nuclear Medicine, 46(10), 814. https://pubmed.ncbi.nlm.nih.gov/34115709/. | ||||
641 | Case report: vaccine-induced immune immune thrombotic thrombocytopenia in a patient with pancreatic cancer after vaccination with messenger RNA-1273: | https://pubmed.ncbi.nlm.nih.gov/34790684/ | https://pubmed.ncbi.nlm.nih.gov/34644738/. | Finsterer, J., Scorza, F. A., & Scorza, C. A. (2021). Post SARS-CoV-2 vaccination Guillain-Barre syndrome in 19 patients. Clinics, 76. | Finsterer, J., Scorza, FA y Scorza, CA (2021). Síndrome de Guillain-Barré posterior a la vacunación contra SARS-CoV-2 en 19 pacientes. Clínicas, 76. https://pubmed.ncbi.nlm.nih.gov/34649856/ | Onderko, L., Starobin, B., Riviere, A. E., Hohl, P. K., Phillips, C. T., Morgan, R. B., ... & Afari, M. E. (2021). Miocarditis en el entorno de la vacunación reciente de COVID-19. Informes de casos en cardiología, 2021. https://www.clinicalimaging.org/article/S0899-7071(21)00265-5/fulltext. | Finsterer, J., Scorza, F. A., & Scorza, C. A. (2021). Post SARS-CoV-2 vaccination Guillain-Barre syndrome in 19 patients. Clinics, 76. https://pubmed.ncbi.nlm.nih.gov/34644738/. | Özdemir, İ. H., Özlek, B., Özen, M. B., Gündüz, R., & Bayturan, Ö. (2021). Type 1 Kounis syndrome induced by inactivated SARS-COV-2 vaccine. The Journal of Emergency Medicine, 61(4), e71-e76. https://pubmed.ncbi.nlm.nih.gov/34148772/ | Liang, I., Swaminathan, S., & Lee, A. (2021). Emergence of de novo cutaneous vasculitis post coronavirus disease (COVID-19) vaccination. Clinical rheumatology, 1-2. | https://pubmed.ncbi.nlm.nih.gov/34599716/. | Liang, I., Swaminathan, S., & Lee, A. (2021). Emergence of de novo cutaneous vasculitis post coronavirus disease (COVID-19) vaccination. Clinical rheumatology, 1-2. https://pubmed.ncbi.nlm.nih.gov/34599716/. | Shiyovich, A., Witberg, G., Aviv, Y., Eisen, A., Orvin, K., Wiessman, M., ... & Hamdan, A. (2021). Myocarditis following COVID-19 vaccination: magnetic resonance imaging study. European Heart Journal-Cardiovascular Imaging. https://academic.oup.com/ehjcimaging/advance-article/doi/10.1093/ehjci/jeab230/6421640 | ||||
642 | Idiopathic idiopathic external jugular vein thrombophlebitis after coronavirus disease vaccination (COVID-19): | https://pubmed.ncbi.nlm.nih.gov/33624509/. | https://pubmed.ncbi.nlm.nih.gov/34649856/ | Kanabar, G., & Wilkinson, P. (2021). Guillain‐Barré syndrome presenting with facial diplegia following COVID‐19 vaccination in two patients. BMJ Case Reports CP, 14(10), e244527. | Kanabar, G. y Wilkinson, P. (2021). Síndrome de Guillain-Barré que se presenta con diplejía facial después de la vacunación contra la COVID-19 en dos pacientes. BMJ Case Reports CP, 14(10), e244527. https://pubmed.ncbi.nlm.nih.gov/34671572/ | OO, W. M., GIRI, P., & DE SOUZA, A. (2021). AstraZeneca Covid-19 Vaccine y Guillain-Barré Syndrome en Tasmania: ¿un enlace causal? Diario de Neuroimmunology, 360, 577719. https://pubmed.ncbi.nlm.nih.gov/34108736/. | Kanabar, G., & Wilkinson, P. (2021). Guillain‐Barré syndrome presenting with facial diplegia following COVID‐19 vaccination in two patients. BMJ Case Reports CP, 14(10), e244527. https://pubmed.ncbi.nlm.nih.gov/34649856/ | Özütemiz, C., Krystosek, L. A., Church, A. L., Chauhan, A., Ellermann, J. M., Domingo-Musibay, E., & Steinberger, D. (2021). Lymphadenopathy in COVID-19 vaccine recipients: diagnostic dilemma in oncologic patients. Radiology, 300(1), E296-E300. https://pubmed.ncbi.nlm.nih.gov/33625300/ | Kharkar, V., Vishwanath, T., Mahajan, S., Joshi, R., & Gole, P. (2021). Asymmetrical cutaneous vasculitis following COVID‐19 vaccination with unusual eosinophil preponderance. Clinical and Experimental Dermatology. | https://pubmed.ncbi.nlm.nih.gov/34115904/. | Kharkar, V., Vishwanath, T., Mahajan, S., Joshi, R., & Gole, P. (2021). Asymmetrical cutaneous vasculitis following COVID‐19 vaccination with unusual eosinophil preponderance. Clinical and Experimental Dermatology. https://pubmed.ncbi.nlm.nih.gov/34115904/. | Sim, J., & Lim, C. C. (2021). Coronavirus disease 2019 (COVID-19) vaccination in systemic lupus erythematosus and anti-neutrophil cytoplasmic antibody-associated vasculitis. Clinical Rheumatology, 40(6), 2517-2518. https://pubmed.ncbi.nlm.nih.gov/33928459/ | ||||
643 | Squamous cell carcinoma of the lung with hemoptysis following vaccination with tozinameran (BNT162b2, Pfizer-BioNTech): | https://pubmed.ncbi.nlm.nih.gov/34612003/ | https://pubmed.ncbi.nlm.nih.gov/34671572/ | Kripalani, Y., Lakkappan, V., Parulekar, L., Shaikh, A., Singh, R., & Vyas, P. (2021). A rare case of Guillain-Barre syndrome following COVID-19 vaccination. European Journal of Case Reports in Internal Medicine, 8(9). | Kripalani, Y., Lakkappan, V., Parulekar, L., Shaikh, A., Singh, R. y Vyas, P. (2021). Un caso raro de síndrome de Guillain-Barré tras la vacunación contra la COVID-19. Revista europea de informes de casos de medicina interna, 8(9). https://pubmed.ncbi.nlm.nih.gov/33758714/ | Osowicki, J., Morgan, H., Harris, A., Crawford, N. W., Buttery, J. P., & Kiers, L. (2021). Síndrome de Guillain-Barré en un estado australiano que usa vacunas de ARNm y ADENOVIRUS-vector SARS-COV-2. Anales de neurología, 90 (5), 856-858. https://pubmed.ncbi.nlm.nih.gov/34482455/. | Kripalani, Y., Lakkappan, V., Parulekar, L., Shaikh, A., Singh, R., & Vyas, P. (2021). A rare case of Guillain-Barre syndrome following COVID-19 vaccination. European Journal of Case Reports in Internal Medicine, 8(9). https://pubmed.ncbi.nlm.nih.gov/34671572/ | Pagenkopf, C., & Südmeyer, M. (2021). A case of longitudinally extensive transverse myelitis following vaccination against Covid-19. Journal of Neuroimmunology, 358, 577606. https://pubmed.ncbi.nlm.nih.gov/34182207/ | Hines, A. M., Murphy, N., Mullin, C., Barillas, J., & Barrientos, J. C. (2021). Henoch-Schönlein purpura presenting post COVID-19 vaccination. Vaccine. | https://pubmed.ncbi.nlm.nih.gov/34247902/. | Hines, A. M., Murphy, N., Mullin, C., Barillas, J., & Barrientos, J. C. (2021). Henoch-Schönlein purpura presenting post COVID-19 vaccination. Vaccine. https://pubmed.ncbi.nlm.nih.gov/34247902/. | Simone, A., Herald, J., Chen, A., Gulati, N., Shen, A. Y. J., Lewin, B., & Lee, M. S. (2021). Acute myocarditis following COVID-19 mRNA vaccination in adults aged 18 years or older. JAMA Internal Medicine, 181(12), 1668-1670. https://pubmed.ncbi.nlm.nih.gov/34605853/ | ||||
644 | Vaccine-induced thrombotic thrombocytopenia after Ad26.COV2.S vaccination in a man presenting as acute venous thromboembolism: | https://pubmed.ncbi.nlm.nih.gov/34096082/ | https://pubmed.ncbi.nlm.nih.gov/33758714/ | Waheed, S., Bayas, A., Hindi, F., Rizvi, Z., & Espinosa, P. S. (2021). Neurological complications of COVID-19: Guillain-Barre syndrome following Pfizer COVID-19 vaccine. Cureus, 13(2). | Waheed, S., Bayas, A., Hindi, F., Rizvi, Z. y Espinosa, PS (2021). Complicaciones neurológicas de COVID-19: síndrome de Guillain-Barré tras la vacuna Pfizer COVID-19. Cureus, 13(2). https://pubmed.ncbi.nlm.nih.gov/34484780/ | Ostrowski, S. R., Søgaard, O. S., Tolstrup, M., Stærke, N. B., Lundgren, J., Østergaard, L., & HVAS, A. M. (2021). La inflamación y la activación de plaquetas después de las vacunas COVID-19, posibles mecanismos detrás de la trombocitopenia inmune inducida por la vacuna y la trombosis. Fronteras en inmunología, 12, 779453-779453. https://pubmed.ncbi.nlm.nih.gov/34863404/. | Waheed, S., Bayas, A., Hindi, F., Rizvi, Z., & Espinosa, P. S. (2021). Neurological complications of COVID-19: Guillain-Barre syndrome following Pfizer COVID-19 vaccine. Cureus, 13(2). https://pubmed.ncbi.nlm.nih.gov/33758714/ | Palaiodimou, L., Stefanou, M. I., Katsanos, A. H., de Sousa, D. A., Coutinho, J. M., Lagiou, P., ... & Tsivgoulis, G. (2021). Cerebral venous sinus thrombosis and thrombotic events after vector-based COVID-19 vaccines: a systematic review and meta-analysis. Neurology, 97(21), e2136-e2147. https://pubmed.ncbi.nlm.nih.gov/34610990/. | Sirufo, M. M., Raggiunti, M., Magnanimi, L. M., Ginaldi, L., & De Martinis, M. (2021). Henoch-Schönlein Purpura Following the First Dose of COVID-19 Viral Vector Vaccine: A Case Report. Vaccines, 9(10), 1078. | https://pubmed.ncbi.nlm.nih.gov/34696186/. | Sirufo, M. M., Raggiunti, M., Magnanimi, L. M., Ginaldi, L., & De Martinis, M. (2021). Henoch-Schönlein Purpura Following the First Dose of COVID-19 Viral Vector Vaccine: A Case Report. Vaccines, 9(10), 1078. https://pubmed.ncbi.nlm.nih.gov/34696186/. | Simpson, C. R., Shi, T., Vasileiou, E., Katikireddi, S. V., Kerr, S., Moore, E., ... & Sheikh, A. (2021). First-dose ChAdOx1 and BNT162b2 COVID-19 vaccines and thrombocytopenic, thromboembolic and hemorrhagic events in Scotland. Nature medicine, 27(7), 1290-1297. https://www.nature.com/articles/s41591-021-01408-4 | ||||
645 | Myocarditis associated with COVID-19 vaccination in three adolescent boys: | https://pubmed.ncbi.nlm.nih.gov/34851078/. | https://pubmed.ncbi.nlm.nih.gov/34484780/ | Matarneh, A. S., Al‐battah, A. H., Farooqui, K., Ghamoodi, M., & Alhatou, M. (2021). COVID‐19 vaccine causing Guillain‐Barre syndrome, a rare potential side effect. Clinical Case Reports, 9(9), e04756. | Matarneh, A. S., Al‐battah, A. H., Farooqui, K., Ghamoodi, M. y Alhatou, M. (2021). La vacuna COVID-19 causa el síndrome de Guillain-Barré, un posible efecto secundario poco común. Informes de casos clínicos, 9(9), e04756. https://pubmed.ncbi.nlm.nih.gov/34779385/. | Özdemir, ©. H., Özlek, B., Özen, M. B., Gündüz, R., & Bayturan, Ö. (2021). Tipo 1 Síndrome de Kounis inducido por la vacuna inactivada de SARS-COV-2. El Diario de Medicina de Emergencia, 61 (4), E71-E76. https://pubmed.ncbi.nlm.nih.gov/34702550/ | Matarneh, A. S., Al‐battah, A. H., Farooqui, K., Ghamoodi, M., & Alhatou, M. (2021). COVID‐19 vaccine causing Guillain‐Barre syndrome, a rare potential side effect. Clinical Case Reports, 9(9), e04756. https://pubmed.ncbi.nlm.nih.gov/34484780/ | Pan, L., Zhang, Y., Cui, Y., & Wu, X. (2021). Bilateral uveitis after inoculation with COVID-19 vaccine: A case report. International Journal of Infectious Diseases, 113, 116-118. https://www.sciencedirect.com/science/article/pii/S1201971221007797 | Gillion, V., Jadoul, M., Demoulin, N., Aydin, S., & Devresse, A. (2021). Granulomatous vasculitis after the AstraZeneca anti–SARS-CoV-2 vaccine. Kidney International, 100(3), 706-707. | https://pubmed.ncbi.nlm.nih.gov/34237323/. | Gillion, V., Jadoul, M., Demoulin, N., Aydin, S., & Devresse, A. (2021). Granulomatous vasculitis after the AstraZeneca anti–SARS-CoV-2 vaccine. Kidney International, 100(3), 706-707. https://pubmed.ncbi.nlm.nih.gov/34237323/. | Şimşek, F., & Tosunoğlu, R. (2021). Massive cerebral venous thrombosis and venous watershed infarction as late complications of COVID-19: a case report. Neurological Sciences, 42(11), 4421-4423. https://pubmed.ncbi.nlm.nih.gov/34373991/ | ||||
646 | Cardiovascular magnetic resonance findings in young adult patients with acute myocarditis after COVID-19 mRNA vaccination: a case series: | https://pubmed.ncbi.nlm.nih.gov/34496880/ | https://pubmed.ncbi.nlm.nih.gov/34779385/. | Čenščák, D., Ungermann, L., Štětkářová, I., & Ehler, E. (2021). Guillan-Barré Syndrome after the First Vaccination Dose against COVID-19: Case Report. ACTA MEDICA, 64(3), 183-186. | Čenščák, D., Ungermann, L., Štětkářová, I. y Ehler, E. (2021). Síndrome de Guillan-Barré tras la Primera Dosis de Vacunación contra el COVID-19: Reporte de Caso. ACTA MÉDICA, 64(3), 183-186. https://pubmed.ncbi.nlm.nih.gov/34817727/. | Özütemiz, C., Krysseek, L. A., Iglesia, A. L., Chauhan, A., Ellermann, J. M., Domingo-Musibay, E., Steinberger, D. (2021). Linfadenopatía en COVID-19 Receptores de vacunas: Dilema de diagnóstico en pacientes oncológicos. Radiología, 300 (1), E296-E300. https://pubmed.ncbi.nlm.nih.gov/33774684/ | Čenščák, D., Ungermann, L., Štětkářová, I., & Ehler, E. (2021). Guillan-Barré Syndrome after the First Vaccination Dose against COVID-19: Case Report. ACTA MEDICA, 64(3), 183-186. https://pubmed.ncbi.nlm.nih.gov/34779385/. | Panovska-Stavridis, I., Pivkova-Veljanovska, A., Trajkova, S., Lazarevska, M., Grozdanova, A., & Filipche, V. (2021). A rare case of superior ophthalmic vein thrombosis and thrombocytopenia following ChAdOx1 nCoV-19 vaccine against SARS-CoV-2. Mediterranean Journal of Hematology and Infectious Diseases, 13(1). https://pubmed.ncbi.nlm.nih.gov/34276917/ | ElSheikh, R. H., Haseeb, A., Eleiwa, T. K., & Elhusseiny, A. M. (2021). Acute uveitis following COVID-19 vaccination. Ocular immunology and inflammation, 1-3. | https://pubmed.ncbi.nlm.nih.gov/34851795/. | ElSheikh, R. H., Haseeb, A., Eleiwa, T. K., & Elhusseiny, A. M. (2021). Acute uveitis following COVID-19 vaccination. Ocular immunology and inflammation, 1-3. https://pubmed.ncbi.nlm.nih.gov/34851795/. | Singer, M. E., Taub, I. B., & Kaelber, D. C. (2021). Risk of myocarditis from COVID-19 infection in people under age 20: a population-based analysis. medRxiv. https://www.ncbi.nlm.nih.gov/pubmed/34341797 | ||||
647 | Perimyocarditis after vaccination with COVID-19: | https://pubmed.ncbi.nlm.nih.gov/34866957/ | https://pubmed.ncbi.nlm.nih.gov/34817727/. | Abičić, A., Adamec, I., & Habek, M. (2022). Miller Fisher syndrome following Pfizer COVID-19 vaccine. Neurological Sciences, 43(3), 1495-1497. | Abičić, A., Adamec, I. y Habek, M. (2022). Síndrome de Miller Fisher después de la vacuna Pfizer COVID-19. Ciencias Neurológicas, 43(3), 1495-1497. https://pubmed.ncbi.nlm.nih.gov/34789193/. | Pagenkopf, C., & Südmeyer, M. (2021). Un caso de mielitis transversal extensa longitudinalmente después de la vacunación contra COVID-19. Diario de Neuroimmunology, 358, 577606. https://pubmed.ncbi.nlm.nih.gov/34457267/. | Abičić, A., Adamec, I., & Habek, M. (2022). Miller Fisher syndrome following Pfizer COVID-19 vaccine. Neurological Sciences, 43(3), 1495-1497. https://pubmed.ncbi.nlm.nih.gov/34817727/. | Papasavvas, I., & Herbort, C. P. (2021). Reactivation of Vogt-Koyanagi-Harada disease under control for more than 6 years, following anti-SARS-CoV-2 vaccination. Journal of Ophthalmic Inflammation and Infection, 11(1), 1-6. https://pubmed.ncbi.nlm.nih.gov/34224024/. | Kinariwalla, N., London, A. O., Soliman, Y. S., Niedt, G. W., Husain, S., & Gallitano, S. M. (2022). A case of generalized Sweet syndrome with vasculitis triggered by recent COVID-19 vaccination. JAAD Case Reports, 19, 64-67. | https://pubmed.ncbi.nlm.nih.gov/34849386/ | Kinariwalla, N., London, A. O., Soliman, Y. S., Niedt, G. W., Husain, S., & Gallitano, S. M. (2022). A case of generalized Sweet syndrome with vasculitis triggered by recent COVID-19 vaccination. JAAD Case Reports, 19, 64-67. https://pubmed.ncbi.nlm.nih.gov/34849386/ | Singh, B., Kaur, P., Cedeno, L., Brahimi, T., Patel, P., Virk, H., ... & Bikkina, M. (2021). COVID-19 mRNA vaccine and myocarditis. European Journal of Case Reports in Internal Medicine, 8(7). https://pubmed.ncbi.nlm.nih.gov/34268277/ | ||||
648 | Epidemiology of acute myocarditis/pericarditis in Hong Kong adolescents after co-vaccination: | https://pubmed.ncbi.nlm.nih.gov/34849657/. | https://pubmed.ncbi.nlm.nih.gov/34789193/. | Nishiguchi, Y., Matsuyama, H., Maeda, K., Shindo, A., & Tomimoto, H. (2021). Miller Fisher syndrome following BNT162b2 mRNA coronavirus 2019 vaccination. BMC neurology, 21(1), 1-6. | Nishiguchi, Y., Matsuyama, H., Maeda, K., Shindo, A. y Tomimoto, H. (2021). Síndrome de Miller Fisher después de la vacunación con ARNm BNT162b2 contra el coronavirus 2019. Neurología BMC, 21(1), 1-6. https://pubmed.ncbi.nlm.nih.gov/34261746/ | Palaiodimou, L., Stefanou, M. I., Katsanos, A. H., De Sousa, D. A., COUTINHO, J. M., Lagiou, P., ... & Tsivgoulis, G. (2021). Trombosis sinusal venosa cerebral y eventos trombóticos después de las vacunas COVID-19-19 basadas en el vector: una revisión sistemática y un metanálisis. Neurología, 97 (21), E2136-E2147. https://pubmed.ncbi.nlm.nih.gov/34590397/ | Nishiguchi, Y., Matsuyama, H., Maeda, K., Shindo, A., & Tomimoto, H. (2021). Miller Fisher syndrome following BNT162b2 mRNA coronavirus 2019 vaccination. BMC neurology, 21(1), 1-6. https://pubmed.ncbi.nlm.nih.gov/34789193/. | Pappaterra, M. C., Rivera, E. J., & Oliver, A. L. (2022). Transient Oculomotor Palsy Following the Administration of the Messenger RNA-1273 Vaccine for SARS-CoV-2 Diplopia Following the COVID-19 Vaccine. Journal of Neuro-Ophthalmology. https://pubmed.ncbi.nlm.nih.gov/34369471/ | Guzmán‐Pérez, L., Puerta‐Peña, M., Falkenhain‐López, D., Montero‐Menárguez, J., Gutiérrez‐Collar, C., Rodríguez‐Peralto, J. L., & Sanz‐Bueno, J. (2021). Small‐vessel vasculitis following Oxford‐AstraZeneca vaccination against SARS‐CoV‐2. Journal of the European Academy of Dermatology and Venereology. | https://pubmed.ncbi.nlm.nih.gov/34310763/ | Guzmán‐Pérez, L., Puerta‐Peña, M., Falkenhain‐López, D., Montero‐Menárguez, J., Gutiérrez‐Collar, C., Rodríguez‐Peralto, J. L., & Sanz‐Bueno, J. (2021). Small‐vessel vasculitis following Oxford‐AstraZeneca vaccination against SARS‐CoV‐2. Journal of the European Academy of Dermatology and Venereology. https://pubmed.ncbi.nlm.nih.gov/34310763/ | Singh, B., Kaur, P., Kumar, V., & Maroules, M. (2021). COVID-19 vaccine induced Axillary and Pectoral Lymphadenopathy on PET scan. Radiology Case Reports, 16(7), 1819-1821. https://www.sciencedirect.com/science/article/pii/S1930043321002612 | ||||
649 | Myocarditis-induced sudden death after BNT162b2 COVID-19 mRNA vaccination in Korea: case report focusing on histopathological findings: | https://pubmed.ncbi.nlm.nih.gov/34664804/ | https://pubmed.ncbi.nlm.nih.gov/34261746/ | Bonifacio, G. B., Patel, D., Cook, S., Purcaru, E., Couzins, M., Domjan, J., ... & Kinton, L. (2022). Bilateral facial weakness with paraesthesia variant of Guillain-Barré syndrome following Vaxzevria COVID-19 vaccine. Journal of Neurology, Neurosurgery & Psychiatry, 93(3), 341-342. | Bonifacio, G. B., Patel, D., Cook, S., Purcaru, E., Couzins, M., Domjan, J., ... y Kinton, L. (2022). Debilidad facial bilateral con variante de parestesia del síndrome de Guillain-Barré después de la vacuna Vaxzevria COVID-19. Revista de Neurología, Neurocirugía y Psiquiatría, 93(3), 341-342. https://pubmed.ncbi.nlm.nih.gov/34217513/. | Pan, L., Zhang, Y., CUI, Y., Y WU, X. (2021). Uveítis bilateral después de la inoculación con la vacuna COVID-19: un informe de caso. Diario Internacional de Enfermedades Infecciosas, 113, 116-118. https://www.medrxiv.org/content/10.1101/2021.08.30.21262866v1. | Bonifacio, G. B., Patel, D., Cook, S., Purcaru, E., Couzins, M., Domjan, J., ... & Kinton, L. (2022). Bilateral facial weakness with paraesthesia variant of Guillain-Barré syndrome following Vaxzevria COVID-19 vaccine. Journal of Neurology, Neurosurgery & Psychiatry, 93(3), 341-342. https://pubmed.ncbi.nlm.nih.gov/34261746/ | Park, H. S., Byun, Y., Byeon, S. H., Kim, S. S., Kim, Y. J., & Lee, C. S. (2021). Retinal Hemorrhage after SARS-CoV-2 Vaccination. Journal of Clinical Medicine, 10(23), 5705. https://pubmed.ncbi.nlm.nih.gov/34884407/. | Conticini, E., d'Alessandro, M., Bergantini, L., Bargagli, E., Gentili, F., Mazzei, M. A., ... & Frediani, B. (2021). Relapse of microscopic polyangiitis after vaccination against COVID‐19: A case report. Journal of medical virology. | https://pubmed.ncbi.nlm.nih.gov/34251683/. | Conticini, E., d'Alessandro, M., Bergantini, L., Bargagli, E., Gentili, F., Mazzei, M. A., ... & Frediani, B. (2021). Relapse of microscopic polyangiitis after vaccination against COVID‐19: A case report. Journal of medical virology. https://pubmed.ncbi.nlm.nih.gov/34251683/. | Sirufo, M. M., Raggiunti, M., Magnanimi, L. M., Ginaldi, L., & De Martinis, M. (2021). Henoch-Schönlein Purpura Following the First Dose of COVID-19 Viral Vector Vaccine: A Case Report. Vaccines, 9(10), 1078. https://pubmed.ncbi.nlm.nih.gov/34696186/. | ||||
650 | Acute myocarditis after vaccination with COVID-19 mRNA in adults aged 18 years or older: | https://pubmed.ncbi.nlm.nih.gov/34605853/ | https://pubmed.ncbi.nlm.nih.gov/34217513/. | Theuriet, J., Richard, C., Becker, J., Pegat, A., Bernard, E., & Vukusic, S. (2021). Guillain-Barré syndrome following first injection of ChAdOx1 nCoV-19 vaccine: First report. Revue neurologique, 177(10), 1305-1307. | Theuriet, J., Richard, C., Becker, J., Pegat, A., Bernard, E. y Vukusic, S. (2021). Síndrome de Guillain-Barré tras la primera inyección de la vacuna ChAdOx1 nCoV-19: primer informe. Revista neurológica, 177(10), 1305-1307. https://pubmed.ncbi.nlm.nih.gov/34871447/ | Panovska-stavridis, I., Pivkova-Veljanovska, A., Trajkova, S., Lazarevska, M., GrozDanova, A., & Filipche, V. (2021). Un caso raro de trombosis de vena oftálmica superior y trombocitopenia después de la vacuna Chadox1 NCOV-19 contra SARS-COV-2. Diario mediterráneo de hematología y enfermedades infecciosas, 13 (1). https://pubmed.ncbi.nlm.nih.gov/34268278/. | Theuriet, J., Richard, C., Becker, J., Pegat, A., Bernard, E., & Vukusic, S. (2021). Guillain-Barré syndrome following first injection of ChAdOx1 nCoV-19 vaccine: First report. Revue neurologique, 177(10), 1305-1307. https://pubmed.ncbi.nlm.nih.gov/34217513/. | Park, H., Yun, K. W., Kim, K. R., Song, S. H., Ahn, B., Kim, D. R., ... & Kim, Y. J. (2021). Epidemiology and Clinical Features of Myocarditis/Pericarditis before the Introduction of mRNA COVID-19 Vaccine in Korean Children: a Multicenter Study. Journal of Korean Medical Science, 36(32). https://pubmed.ncbi.nlm.nih.gov/34402230/ | Colia, R., Rotondo, C., Corrado, A., & Cantatore, F. P. (2021). Cutaneous vasculitis after severe acute respiratory syndrome coronavirus 2 vaccine. Rheumatology Advances in Practice, 5(3), rkab050. | https://pubmed.ncbi.nlm.nih.gov/34557622/. | Colia, R., Rotondo, C., Corrado, A., & Cantatore, F. P. (2021). Cutaneous vasculitis after severe acute respiratory syndrome coronavirus 2 vaccine. Rheumatology Advances in Practice, 5(3), rkab050. https://pubmed.ncbi.nlm.nih.gov/34557622/. | Smadja, D. M., Yue, Q. Y., Chocron, R., Sanchez, O., & Lillo-Le Louet, A. (2021). Vaccination against COVID-19: insight from arterial and venous thrombosis occurrence using data from VigiBase. European Respiratory Journal, 58(1). https://pubmed.ncbi.nlm.nih.gov/33863748/ | ||||
651 | Recurrence of acute myocarditis temporally associated with receipt of the 2019 coronavirus mRNA disease vaccine (COVID-19) in an adolescent male: | https://pubmed.ncbi.nlm.nih.gov/34166671/ | https://pubmed.ncbi.nlm.nih.gov/34871447/ | Fukushima, T., Tomita, M., Ikeda, S., & Hattori, N. (2021). A case of sensory ataxic Guillain–Barré syndrome with immunoglobulin G anti-GM1 antibodies following the first dose of mRNA COVID-19 vaccine BNT162b2 (Pfizer). QJM: An International Journal of Medicine. | Fukushima, T., Tomita, M., Ikeda, S. y Hattori, N. (2021). Un caso de síndrome de Guillain-Barré atáxico sensorial con anticuerpos inmunoglobulina G anti-GM1 después de la primera dosis de la vacuna de ARNm COVID-19 BNT162b2 (Pfizer). QJM: Revista internacional de medicina. https://pubmed.ncbi.nlm.nih.gov/34579259/ | Papasavvavas, I., & Herbort, C. P. (2021). Reactivación de la enfermedad de Vogt-Koyanagi-Harada bajo control durante más de 6 años, después de la vacunación contra el SARS-COV-2. Diario de inflamación e infección oftálmica, 11 (1), 1-6. https://pubmed.ncbi.nlm.nih.gov/34324214/ | Fukushima, T., Tomita, M., Ikeda, S., & Hattori, N. (2021). A case of sensory ataxic Guillain–Barré syndrome with immunoglobulin G anti-GM1 antibodies following the first dose of mRNA COVID-19 vaccine BNT162b2 (Pfizer). QJM: An International Journal of Medicine. https://pubmed.ncbi.nlm.nih.gov/34871447/ | Park, H., Yun, K. W., Kim, K. R., Song, S. H., Ahn, B., Kim, D. R., ... & Kim, Y. J. (2021). Epidemiology and Clinical Features of Myocarditis/Pericarditis before the Introduction of mRNA COVID-19 Vaccine in Korean Children: a Multicenter Study. Journal of Korean Medical Science, 36(32). https://www.ncbi.nlm.nih.gov/pubmed/34402230 | Mohta, A., Arora, A., Srinivasa, R., & Mehta, R. D. (2021). Recurrent herpes zoster after COVID‐19 vaccination in patients with chronic urticaria being treated with cyclosporine—A report of 3 cases. Journal of Cosmetic Dermatology, 20(11), 3384. | https://pubmed.ncbi.nlm.nih.gov/34510694/ | Mohta, A., Arora, A., Srinivasa, R., & Mehta, R. D. (2021). Recurrent herpes zoster after COVID‐19 vaccination in patients with chronic urticaria being treated with cyclosporine—A report of 3 cases. Journal of Cosmetic Dermatology, 20(11), 3384. https://pubmed.ncbi.nlm.nih.gov/34510694/ | Smith, C., Odd, D., Harwood, R., Ward, J., Linney, M., Clark, M., ... & Fraser, L. K. (2022). Deaths in children and young people in England after SARS-CoV-2 infection during the first pandemic year. Nature medicine, 28(1), 185-192. https://www.ncbi.nlm.nih.gov/pubmed/34764489 | ||||
652 | Young male with myocarditis after mRNA-1273 coronavirus disease-2019 (COVID-19) mRNA vaccination: | https://pubmed.ncbi.nlm.nih.gov/34744118/ | https://pubmed.ncbi.nlm.nih.gov/34579259/ | Noseda, R., Ripellino, P., Ghidossi, S., Bertoli, R., & Ceschi, A. (2021). Reporting of acute inflammatory neuropathies with COVID-19 vaccines: subgroup disproportionality analyses in VigiBase. Vaccines, 9(9), 1022. | Noseda, R., Ripellino, P., Ghidossi, S., Bertoli, R. y Ceschi, A. (2021). Notificación de neuropatías inflamatorias agudas con vacunas COVID-19: análisis de desproporcionalidad de subgrupos en VigiBase. Vacunas, 9(9), 1022. https://pubmed.ncbi.nlm.nih.gov/34370408/. | Pappaterra, M. C., Rivera, E. J., & Oliver, A. L. (2022). Palsia transitoria de oculomotores después de la administración de la vacuna RNA-1273 Messenger para la diplopía SARS-COV-2 después de la vacuna COVID-19. Diario de neuro-oftalmología. https://pubmed.ncbi.nlm.nih.gov/34014316/ | Noseda, R., Ripellino, P., Ghidossi, S., Bertoli, R., & Ceschi, A. (2021). Reporting of acute inflammatory neuropathies with COVID-19 vaccines: subgroup disproportionality analyses in VigiBase. Vaccines, 9(9), 1022. https://pubmed.ncbi.nlm.nih.gov/34579259/ | Park, J. Y., & Yi, S. Y. (2021). Rare case of contralateral supraclavicular lymphadenopathy after COVID-19 vaccination: Computed tomography and ultrasonography findings. Radiology Case Reports, 16(12), 3879-3881. https://pubmed.ncbi.nlm.nih.gov/34667486/ | Jin, W. J., Ahn, S. W., Jang, S. H., Hong, S. M., Seol, J. E., & Kim, H. (2021). Leukocytoclastic vasculitis after coronavirus disease 2019 vaccination. The Journal of Dermatology. | https://pubmed.ncbi.nlm.nih.gov/34713472/803 | Jin, W. J., Ahn, S. W., Jang, S. H., Hong, S. M., Seol, J. E., & Kim, H. (2021). Leukocytoclastic vasculitis after coronavirus disease 2019 vaccination. The Journal of Dermatology. https://pubmed.ncbi.nlm.nih.gov/34713472/803 | Snapiri, O., Danziger, C. R., Shirman, N., Weissbach, A., Lowenthal, A., Ayalon, I., ... & Bilavsky, E. (2021). Transient cardiac injury in adolescents receiving the BNT162b2 mRNA COVID-19 vaccine. The Pediatric Infectious Disease Journal, 40(10), e360. https://pubmed.ncbi.nlm.nih.gov/34077949/ | ||||
653 | Acute myocarditis after SARS-CoV-2 vaccination in a 24-year-old male: | https://pubmed.ncbi.nlm.nih.gov/34334935/. | https://pubmed.ncbi.nlm.nih.gov/34370408/. | Tutar, N. K., Eyigürbüz, T., Yildirim, Z., & Kale, N. (2021). A variant of Guillain-Barre syndrome after SARS-CoV-2 vaccination: AMSAN. Ideggyogyaszati Szemle, 74(7-08), 286-288. | Tutar, N. K., Eyigürbüz, T., Yildirim, Z. y Kale, N. (2021). Una variante del síndrome de Guillain-Barré tras la vacunación contra el SARS-CoV-2: AMSAN. Ideggyogyaszati Szemle, 74(7-08), 286-288. https://pubmed.ncbi.nlm.nih.gov/34703690/. | Park, J., Brekke, D. R., & Bratincsak, A. (2022). Miocarditis autolimitada que presenta con dolor en el pecho y elevación del segmento ST en adolescentes después de la vacunación con la vacuna contra el ARNm BNT162B2. Cardiología en los jóvenes, 32 (1), 146-149. https://pubmed.ncbi.nlm.nih.gov/34133825/ | Tutar, N. K., Eyigürbüz, T., Yildirim, Z., & Kale, N. (2021). A variant of Guillain-Barre syndrome after SARS-CoV-2 vaccination: AMSAN. Ideggyogyaszati Szemle, 74(7-08), 286-288. https://pubmed.ncbi.nlm.nih.gov/34370408/. | Park, J., Brekke, D. R., & Bratincsak, A. (2022). Self-limited myocarditis presenting with chest pain and ST segment elevation in adolescents after vaccination with the BNT162b2 mRNA vaccine. Cardiology in the Young, 32(1), 146-149. https://pubmed.ncbi.nlm.nih.gov/34180390/ | Visentini, M., Gragnani, L., Santini, S. A., Urraro, T., Villa, A., Monti, M., ... & Casato, M. (2022). Flares of mixed cryoglobulinaemia vasculitis after vaccination against SARS-CoV-2. Annals of the Rheumatic Diseases, 81(3), 441-443. | https://pubmed.ncbi.nlm.nih.gov/34819272/ | Visentini, M., Gragnani, L., Santini, S. A., Urraro, T., Villa, A., Monti, M., ... & Casato, M. (2022). Flares of mixed cryoglobulinaemia vasculitis after vaccination against SARS-CoV-2. Annals of the Rheumatic Diseases, 81(3), 441-443. https://pubmed.ncbi.nlm.nih.gov/34819272/ | Soeiro, T., Salvo, F., Pariente, A., Grandvuillemin, A., Jonville-Béra, A. P., & Micallef, J. (2021). Type I interferons as the potential mechanism linking mRNA COVID-19 vaccines to Bell’s palsy. Therapie. https://pubmed.ncbi.nlm.nih.gov/33858693/ | ||||
654 | Ga-DOTATOC digital PET images of inflammatory cell infiltrates in myocarditis after vaccination with COVID-19: | https://pubmed.ncbi.nlm.nih.gov/34746968/ | https://pubmed.ncbi.nlm.nih.gov/34703690/. | Morehouse, Z. P., Paulus, A., Jasti, S. A., & Bing, X. (2021). A Rare Variant of Guillain-Barre Syndrome Following Ad26. COV2. S Vaccination. Cureus, 13(9). | Morehouse, ZP, Paulus, A., Jasti, SA y Bing, X. (2021). Una variante rara del síndrome de Guillain-Barré después del anuncio26. COV2. S Vacunación. Cureus, 13(9). https://pubmed.ncbi.nlm.nih.gov/34810163/ | Park, J., Brekke, D. R., & Bratincsak, A. (2022). Miocarditis autolimitada que presenta con dolor en el pecho y elevación del segmento ST en adolescentes después de la vacunación con la vacuna contra el ARNm BNT162B2. Cardiología en los jóvenes, 32 (1), 146-149. https://www.ncbi.nlm.nih.gov/pubmed/34496880 | Morehouse, Z. P., Paulus, A., Jasti, S. A., & Bing, X. (2021). A Rare Variant of Guillain-Barre Syndrome Following Ad26. COV2. S Vaccination. Cureus, 13(9). https://pubmed.ncbi.nlm.nih.gov/34703690/. | Park, J., Brekke, D. R., & Bratincsak, A. (2022). Self-limited myocarditis presenting with chest pain and ST segment elevation in adolescents after vaccination with the BNT162b2 mRNA vaccine. Cardiology in the Young, 32(1), 146-149. https://www.ncbi.nlm.nih.gov/pubmed/34180390 | Berry, C. T., Eliliwi, M., Gallagher, S., Panaccione, S., Klein, W. M., Healy, A. L., ... & Kallas, R. (2021). Cutaneous small vessel vasculitis following single-dose Janssen Ad26. COV2. S vaccination. JAAD Case Reports, 15, 11-14. | https://pubmed.ncbi.nlm.nih.gov/34337124/ | Berry, C. T., Eliliwi, M., Gallagher, S., Panaccione, S., Klein, W. M., Healy, A. L., ... & Kallas, R. (2021). Cutaneous small vessel vasculitis following single-dose Janssen Ad26. COV2. S vaccination. JAAD Case Reports, 15, 11-14. https://pubmed.ncbi.nlm.nih.gov/34337124/ | Soltani Hekmat, A., & Javanmardi, K. (2021). Possible Risk of Thrombotic Events following Oxford-AstraZeneca COVID-19 Vaccination in Women Receiving Estrogen. BioMed Research International, 2021. https://pubmed.ncbi.nlm.nih.gov/34734086/ | ||||
655 | Occurrence of acute infarct-like myocarditis after vaccination with COVID-19: just an accidental coincidence or rather a vaccination-associated autoimmune myocarditis?”: | https://pubmed.ncbi.nlm.nih.gov/34333695/. | https://pubmed.ncbi.nlm.nih.gov/34810163/ | Ling, L., Bagshaw, S. M., & Villeneuve, P. M. (2021). Guillain–Barré syndrome after SARS-CoV-2 vaccination in a patient with previous vaccine-associated Guillain–Barré syndrome. CMAJ, 193(46), E1766-E1769. | Ling, L., Bagshaw, SM y Villeneuve, PM (2021). Síndrome de Guillain-Barré después de la vacunación contra el SARS-CoV-2 en un paciente con síndrome de Guillain-Barré asociado a una vacuna previa. CMAJ, 193(46), E1766-E1769. https://onlinelibrary.wiley.com/doi/10.1002/ana.26218. | Park, L. H. J., Montgomery, C. J. R., & Boggs, L. N. A. (2021). Anafilaxia después de la vacuna COVID-19 en un paciente con urticaria colinérgica. Medicina militar. https://pubmed.ncbi.nlm.nih.gov/34675550/. | Ling, L., Bagshaw, S. M., & Villeneuve, P. M. (2021). Guillain–Barré syndrome after SARS-CoV-2 vaccination in a patient with previous vaccine-associated Guillain–Barré syndrome. CMAJ, 193(46), E1766-E1769. https://pubmed.ncbi.nlm.nih.gov/34810163/ | Park, L. H. J., Montgomery, C. J. R., & Boggs, L. N. A. (2021). Anaphylaxis after the Covid-19 vaccine in a patient with cholinergic urticaria. Military medicine. https://pubmed.ncbi.nlm.nih.gov/33851711/ | Iwata, H., Kamiya, K., Kado, S., Nakaya, T., Kawata, H., Komine, M., & Ohtsuki, M. (2021). Case of immunoglobulin A vasculitis following coronavirus disease 2019 vaccination. The Journal of Dermatology, 48(12), e598-e599. | https://pubmed.ncbi.nlm.nih.gov/34535924/ | Iwata, H., Kamiya, K., Kado, S., Nakaya, T., Kawata, H., Komine, M., & Ohtsuki, M. (2021). Case of immunoglobulin A vasculitis following coronavirus disease 2019 vaccination. The Journal of Dermatology, 48(12), e598-e599. https://pubmed.ncbi.nlm.nih.gov/34535924/ | Somiya, M., Mine, S., Yasukawa, K., & Ikeda, S. (2021). Sex differences in the incidence of anaphylaxis to LNP-mRNA COVID-19 vaccines. Vaccine. https://pubmed.ncbi.nlm.nih.gov/34020815/ | ||||
656 | Self-limited myocarditis presenting with chest pain and ST-segment elevation in adolescents after vaccination with BNT162b2 mRNA vaccine: | https://pubmed.ncbi.nlm.nih.gov/34180390/ | https://onlinelibrary.wiley.com/doi/10.1002/ana.26218. | Osowicki, J., Morgan, H., Harris, A., Crawford, N. W., Buttery, J. P., & Kiers, L. (2021). Guillain-Barré Syndrome in an Australian state using both mRNA and adenovirus-vector SARS-CoV-2 vaccines. Annals of Neurology, 90(5), 856-858. | Osowicki, J., Morgan, H., Harris, A., Crawford, NW, Buttery, J. P. y Kiers, L. (2021). Síndrome de Guillain-Barré en un estado australiano que utiliza vacunas SARS-CoV-2 de ARNm y de vector de adenovirus. Anales de Neurología, 90(5), 856-858. https://pubmed.ncbi.nlm.nih.gov/34482455/. | Park, Y. S. (2021). Trombosis y síndrome respiratorio grave Coronavirus 2 Vacunas: trombocitopenia inmune inducida por la vacuna. Pediatría clínica y experimental, 64 (8), 400. https://pubmed.ncbi.nlm.nih.gov/34105247/. | Osowicki, J., Morgan, H., Harris, A., Crawford, N. W., Buttery, J. P., & Kiers, L. (2021). Guillain-Barré Syndrome in an Australian state using both mRNA and adenovirus-vector SARS-CoV-2 vaccines. Annals of Neurology, 90(5), 856-858. https://onlinelibrary.wiley.com/doi/10.1002/ana.26218. | Park, Y. S. (2021). Thrombosis and severe acute respiratory syndrome coronavirus 2 vaccines: vaccine-induced immune thrombotic thrombocytopenia. Clinical and experimental pediatrics, 64(8), 400. https://pubmed.ncbi.nlm.nih.gov/34237213/. | Goldman, S., Bron, D., Tousseyn, T., Vierasu, I., Dewispelaere, L., Heimann, P., ... & Goldman, M. (2021). Rapid progression of angioimmunoblastic T Cell lymphoma following BNT162b2 mRNA vaccine booster shot: a case report. Frontiers in medicine, 2409. | https://www.frontiersin.org/articles/10.3389/fmed.2021.798095/ | Goldman, S., Bron, D., Tousseyn, T., Vierasu, I., Dewispelaere, L., Heimann, P., ... & Goldman, M. (2021). Rapid progression of angioimmunoblastic T Cell lymphoma following BNT162b2 mRNA vaccine booster shot: a case report. Frontiers in medicine, 2409. https://www.frontiersin.org/articles/10.3389/fmed.2021.798095/ | Sookaromdee, P., & Wiwanitkit, V. (2021). COVID-19 vaccine, immune thrombotic thrombocytopenia, jaundice, hyperviscosity: concern on cases with underlying liver problem. Annals of Hepatology, 24, 100525. https://pubmed.ncbi.nlm.nih.gov/34509271/. | ||||
657 | Myocarditis Following Immunization with COVID-19 mRNA Vaccines in Members of the U.S. Military: | https://pubmed.ncbi.nlm.nih.gov/34185045/ | https://pubmed.ncbi.nlm.nih.gov/34482455/. | Khan, E., Shrestha, A. K., Colantonio, M. A., Liberio, R. N., & Sriwastava, S. (2021). Acute transverse myelitis following SARS-CoV-2 vaccination: a case report and review of literature. Journal of Neurology, 1-12. | Khan, E., Shrestha, A. K., Colantonio, M. A., Liberio, R. N. y Sriwastava, S. (2021). Mielitis transversa aguda después de la vacunación contra el SARS-CoV-2: reporte de un caso y revisión de la literatura. Revista de Neurología, 1-12. https://pubmed.ncbi.nlm.nih.gov/34114269/. | Parque, H. S., Byun, Y., Byeon, S. H., Kim, S. S., Kim, Y. J., & Lee, C. S. (2021). Hemorragia retiniana después de la vacunación de SARS-COV-2. Diario de la medicina clínica, 10 (23), 5705. https://pubmed.ncbi.nlm.nih.gov/34859017/ | Khan, E., Shrestha, A. K., Colantonio, M. A., Liberio, R. N., & Sriwastava, S. (2021). Acute transverse myelitis following SARS-CoV-2 vaccination: a case report and review of literature. Journal of Neurology, 1-12. https://pubmed.ncbi.nlm.nih.gov/34482455/. | Patel, Y. R., Louis, D. W., Atalay, M., Agarwal, S., & Shah, N. R. (2021). Cardiovascular magnetic resonance findings in young adult patients with acute myocarditis following mRNA COVID-19 vaccination: a case series. Journal of Cardiovascular Magnetic Resonance, 23(1), 1-8. https://jcmr-online.biomedcentral.com/articles/10.1186/s12968-021-00795-4 | Xu, G., & Lu, Y. (2021). COVID-19 mRNA Vaccination-Induced Lymphadenopathy Mimics Lymphoma Progression on FDG PET/CT. Clinical nuclear medicine. | https://pubmed.ncbi.nlm.nih.gov/33591026/ | Xu, G., & Lu, Y. (2021). COVID-19 mRNA Vaccination-Induced Lymphadenopathy Mimics Lymphoma Progression on FDG PET/CT. Clinical nuclear medicine. https://pubmed.ncbi.nlm.nih.gov/33591026/ | Sørvoll, I. H., Horvei, K. D., Ernstsen, S. L., Lægreid, I. J., Lund, S., Grønli, R. H., ... & Ahlen, M. T. (2021). An observational study to identify the prevalence of thrombocytopenia and anti‐PF4/polyanion antibodies in Norwegian health care workers after COVID‐19 vaccination. Journal of Thrombosis and Haemostasis, 19(7), 1813-1818. https://pubmed.ncbi.nlm.nih.gov/33909350/ | ||||
658 | Myocarditis after BNT162b2 vaccination in a healthy male: | https://pubmed.ncbi.nlm.nih.gov/34229940/ | https://pubmed.ncbi.nlm.nih.gov/34114269/. | Allen, C. M., Ramsamy, S., Tarr, A. W., Tighe, P. J., Irving, W. L., Tanasescu, R., & Evans, J. R. (2021). Guillain–Barré syndrome variant occurring after SARS‐CoV‐2 vaccination. Annals of neurology, 90(2), 315-318. | Allen, C. M., Ramsamy, S., Tarr, A. W., Tighe, P. J., Irving, W. L., Tanasescu, R. y Evans, J. R. (2021). Variante del síndrome de Guillain-Barré que ocurre después de la vacunación contra el SARS-CoV-2. Anales de neurología, 90(2), 315-318. https://pubmed.ncbi.nlm.nih.gov/34722067/ | Parque, H., Yun, K. W., Kim, K. R., Canción, S. H., Ahn, B., Kim, D. R., ... & Kim, Y. J. (2021). Epidemiología y características clínicas de miocarditis / pericarditis Antes de la introducción de la vacuna contra MRNA COVID-19 en niños coreanos: un estudio multicéntrico. Diario de la ciencia médica coreana, 36 (32). https://pubmed.ncbi.nlm.nih.gov/34696294/ | Allen, C. M., Ramsamy, S., Tarr, A. W., Tighe, P. J., Irving, W. L., Tanasescu, R., & Evans, J. R. (2021). Guillain–Barré syndrome variant occurring after SARS‐CoV‐2 vaccination. Annals of neurology, 90(2), 315-318. https://pubmed.ncbi.nlm.nih.gov/34114269/. | Patel, Y. R., Louis, D. W., Atalay, M., Agarwal, S., & Shah, N. R. (2021). Cardiovascular magnetic resonance findings in young adult patients with acute myocarditis following mRNA COVID-19 vaccination: a case series. Journal of Cardiovascular Magnetic Resonance, 23(1), 1-8. https://pubmed.ncbi.nlm.nih.gov/34496880/ | Özütemiz, C., Krystosek, L. A., Church, A. L., Chauhan, A., Ellermann, J. M., Domingo-Musibay, E., & Steinberger, D. (2021). Lymphadenopathy in COVID-19 vaccine recipients: diagnostic dilemma in oncologic patients. Radiology, 300(1), E296-E300. | https://pubmed.ncbi.nlm.nih.gov/33625300/ | Özütemiz, C., Krystosek, L. A., Church, A. L., Chauhan, A., Ellermann, J. M., Domingo-Musibay, E., & Steinberger, D. (2021). Lymphadenopathy in COVID-19 vaccine recipients: diagnostic dilemma in oncologic patients. Radiology, 300(1), E296-E300. https://pubmed.ncbi.nlm.nih.gov/33625300/ | Spinner, J. A., Julien, C. L., Olayinka, L., Dreyer, W. J., Bocchini, C. E., Munoz, F. M., & Devaraj, S. (2022). SARS-CoV-2 anti–spike antibodies after vaccination in pediatric heart transplantation: A first report. The Journal of Heart and Lung Transplantation, 41(2), 133-136. https://www.ncbi.nlm.nih.gov/pubmed/34911654 | ||||
659 | Myopericarditis in a previously healthy adolescent male after COVID-19 vaccination: Case report: | https://pubmed.ncbi.nlm.nih.gov/34133825/ | https://pubmed.ncbi.nlm.nih.gov/34722067/ | Dalwadi, V., Hancock, D., Ballout, A. A., & Geraci, A. (2021). Axonal-variant Guillian-Barre syndrome temporally associated with mRNA-based Moderna SARS-CoV-2 vaccine. Cureus, 13(9). | Dalwadi, V., Hancock, D., Ballout, AA y Geraci, A. (2021). Síndrome de Guillian-Barré de variante axonal asociado temporalmente con la vacuna Moderna SARS-CoV-2 basada en ARNm. Cureus, 13(9). https://pubmed.ncbi.nlm.nih.gov/33968610/ | Parque, H., Yun, K. W., Kim, K. R., Canción, S. H., Ahn, B., Kim, D. R., ... & Kim, Y. J. (2021). Epidemiología y características clínicas de miocarditis / pericarditis Antes de la introducción de la vacuna contra MRNA COVID-19 en niños coreanos: un estudio multicéntrico. Diario de la ciencia médica coreana, 36 (32). https://www.ncbi.nlm.nih.gov/pubmed/34180390 | Dalwadi, V., Hancock, D., Ballout, A. A., & Geraci, A. (2021). Axonal-variant Guillian-Barre syndrome temporally associated with mRNA-based Moderna SARS-CoV-2 vaccine. Cureus, 13(9). https://pubmed.ncbi.nlm.nih.gov/34722067/ | Patel, Y. R., Louis, D. W., Atalay, M., Agarwal, S., & Shah, N. R. (2021). Cardiovascular magnetic resonance findings in young adult patients with acute myocarditis following mRNA COVID-19 vaccination: a case series. Journal of Cardiovascular Magnetic Resonance, 23(1), 1-8. https://www.ncbi.nlm.nih.gov/pubmed/34496880 | Cohen, D., Krauthammer, S. H., Wolf, I., & Even-Sapir, E. (2021). Hypermetabolic lymphadenopathy following administration of BNT162b2 mRNA Covid-19 vaccine: incidence assessed by [18F] FDG PET-CT and relevance to study interpretation. European Journal of Nuclear Medicine and Molecular Imaging, 48(6), 1854-1863. | https://pubmed.ncbi.nlm.nih.gov/33774684/ | Cohen, D., Krauthammer, S. H., Wolf, I., & Even-Sapir, E. (2021). Hypermetabolic lymphadenopathy following administration of BNT162b2 mRNA Covid-19 vaccine: incidence assessed by [18F] FDG PET-CT and relevance to study interpretation. European Journal of Nuclear Medicine and Molecular Imaging, 48(6), 1854-1863. https://pubmed.ncbi.nlm.nih.gov/33774684/ | Sriwastava, S., Shrestha, A. K., Khalid, S. H., Colantonio, M. A., Nwafor, D., & Srivastava, S. (2021). Spectrum of Neuroimaging Findings in Post-COVID-19 Vaccination: A Case Series and Review of Literature. Neurology International, 13(4), 622-639. https://pubmed.ncbi.nlm.nih.gov/34842783/ | ||||
660 | Acute myocarditis after SARS-CoV-2 mRNA-1273 mRNA vaccination: | https://pubmed.ncbi.nlm.nih.gov/34308326/. | https://pubmed.ncbi.nlm.nih.gov/33968610/ | Ogbebor, O., Seth, H., Min, Z., & Bhanot, N. (2021). Guillain-Barré syndrome following the first dose of SARS-CoV-2 vaccine: a temporal occurrence, not a causal association. IDCases, 24, e01143. | Ogbebor, O., Seth, H., Min, Z. y Bhanot, N. (2021). Síndrome de Guillain-Barré después de la primera dosis de la vacuna SARS-CoV-2: una ocurrencia temporal, no una asociación causal. IDCasos, 24, e01143. https://pubmed.ncbi.nlm.nih.gov/34525410/ | Parque, J. Y., & Yi, S. Y. (2021). Caso raro de la linfadenopatía supraclavicular contralateral después de la vacunación de COVID-19: tomografía computarizada y hallazgos de ultrasonografía. Informes de casos de radiología, 16 (12), 3879-3881. https://pubmed.ncbi.nlm.nih.gov/34726187/. | Ogbebor, O., Seth, H., Min, Z., & Bhanot, N. (2021). Guillain-Barré syndrome following the first dose of SARS-CoV-2 vaccine: a temporal occurrence, not a causal association. IDCases, 24, e01143. https://pubmed.ncbi.nlm.nih.gov/33968610/ | Patone, M., Handunnetthi, L., Saatci, D., Pan, J., Katikireddi, S. V., Razvi, S., ... & Hippisley-Cox, J. (2021). Neurological complications after first dose of COVID-19 vaccines and SARS-CoV-2 infection. Nature medicine, 27(12), 2144-2153. https://pubmed.ncbi.nlm.nih.gov/34697502/ | Keshavarz, P., Yazdanpanah, F., Rafiee, F., & Mizandari, M. (2021). Lymphadenopathy following COVID-19 vaccination: imaging findings review. Academic radiology, 28(8), 1058-1071. | https://pubmed.ncbi.nlm.nih.gov/33985872/ | Keshavarz, P., Yazdanpanah, F., Rafiee, F., & Mizandari, M. (2021). Lymphadenopathy following COVID-19 vaccination: imaging findings review. Academic radiology, 28(8), 1058-1071. https://pubmed.ncbi.nlm.nih.gov/33985872/ | Starekova, J., Bluemke, D. A., Bradham, W. S., Grist, T. M., Schiebler, M. L., & Reeder, S. B. (2021). Myocarditis associated with mRNA COVID-19 vaccination. Radiology, 301(2), E409-E411. https://pubs.rsna.org/doi/10.1148/radiol.2021211430 | ||||
661 | Chest pain with abnormal electrocardiogram redevelopment after injection of COVID-19 vaccine manufactured by Moderna: | https://pubmed.ncbi.nlm.nih.gov/34866106/ | https://pubmed.ncbi.nlm.nih.gov/34525410/ | Finsterer, J. (2021). SARS-CoV-2 vaccinations may not only be complicated by GBS but also by distal small fibre neuropathy. Journal of Neuroimmunology. | Finsterer, J. (2021). Las vacunas contra el SARS-CoV-2 pueden complicarse no solo con el SGB sino también con la neuropatía distal de fibras pequeñas. Revista de Neuroinmunología. https://pubmed.ncbi.nlm.nih.gov/34808658/ | PATEL, Y. R., LOUIS, D. W., ATALAY, M., Agarwal, S., & Shah, N. R. (2021). Hallazgos de resonancia magnética cardiovascular en pacientes adultos jóvenes con miocarditis aguda después de la vacunación con MRNA COVID-19: una serie de casos. Revista de resonancia magnética cardiovascular, 23 (1), 1-8. https://pubmed.ncbi.nlm.nih.gov/34866957/ | Finsterer, J. (2021). SARS-CoV-2 vaccinations may not only be complicated by GBS but also by distal small fibre neuropathy. Journal of Neuroimmunology. https://pubmed.ncbi.nlm.nih.gov/34525410/ | Patone, M., Mei, X. W., Handunnetthi, L., Dixon, S., Zaccardi, F., Shankar-Hari, M., ... & Hippisley-Cox, J. (2021). Risks of myocarditis, pericarditis, and cardiac arrhythmias associated with COVID-19 vaccination or SARS-CoV-2 infection. Nature medicine, 1-13. https://www.ncbi.nlm.nih.gov/pubmed/34907393 | Weeks, J. K., O’Brien, S. R., Rosenspire, K. C., Dubroff, J. G., & Pantel, A. R. (2021). evolving bilateral hypermetabolic axillary lymphadenopathy on FDG PET/CT following 2-dose COVID-19 vaccination. Clinical nuclear medicine, 46(12), 1011. | https://pubmed.ncbi.nlm.nih.gov/34735411/ | Weeks, J. K., O’Brien, S. R., Rosenspire, K. C., Dubroff, J. G., & Pantel, A. R. (2021). evolving bilateral hypermetabolic axillary lymphadenopathy on FDG PET/CT following 2-dose COVID-19 vaccination. Clinical nuclear medicine, 46(12), 1011. https://pubmed.ncbi.nlm.nih.gov/34735411/ | Stassi, C., Mondello, C., Baldino, G., Cardia, L., Asmundo, A., & Ventura Spagnolo, E. (2021). An Insight into the Role of Postmortem Immunohistochemistry in the Comprehension of the Inflammatory Pathophysiology of COVID-19 Disease and Vaccine-Related Thrombotic Adverse Events: A Narrative Review. International journal of molecular sciences, 22(21), 12024. https://pubmed.ncbi.nlm.nih.gov/34769454/ | ||||
662 | Biopsy-proven lymphocytic myocarditis after first vaccination with COVID-19 mRNA in a 40-year-old man: case report: | https://pubmed.ncbi.nlm.nih.gov/34487236/ | https://pubmed.ncbi.nlm.nih.gov/34808658/ | Badoiu, A., Moranne, O., Coudray, S., & Ion, I. M. (2021). Clinical Variant of Guillain–Barre Syndrome With Prominent Facial Diplegia After AstraZeneca Coronavirus Disease 2019 Vaccine. Journal of Clinical Neuromuscular Disease, 23(2), 115-116. | Badoiu, A., Moranne, O., Coudray, S. y Ion, IM (2021). Variante clínica del síndrome de Guillain-Barré con diplejía facial prominente después de la vacuna contra la enfermedad por coronavirus de AstraZeneca 2019. Revista de enfermedad neuromuscular clínica, 23 (2), 115-116. https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(21)00646-0/fulltext. | PATEL, Y. R., LOUIS, D. W., ATALAY, M., Agarwal, S., & Shah, N. R. (2021). Hallazgos de resonancia magnética cardiovascular en pacientes adultos jóvenes con miocarditis aguda después de la vacunación con MRNA COVID-19: una serie de casos. Revista de resonancia magnética cardiovascular, 23 (1), 1-8. https://www.cps.ca/en/documents/position/clinical-guidance-for-youth-with-myocarditis-and-pericarditis | Badoiu, A., Moranne, O., Coudray, S., & Ion, I. M. (2021). Clinical Variant of Guillain–Barre Syndrome With Prominent Facial Diplegia After AstraZeneca Coronavirus Disease 2019 Vaccine. Journal of Clinical Neuromuscular Disease, 23(2), 115-116. https://pubmed.ncbi.nlm.nih.gov/34808658/ | Patrignani, A., Schicchi, N., Calcagnoli, F., Falchetti, E., Ciampani, N., Argalia, G., & Mariani, A. (2021). Acute myocarditis following Comirnaty vaccination in a healthy man with previous SARS-CoV-2 infection. Radiology Case Reports, 16(11), 3321-3325. https://pubmed.ncbi.nlm.nih.gov/34367386/ | Shin, M., Hyun, C. Y., Choi, Y. H., Choi, J. Y., Lee, K. H., & Cho, Y. S. (2021). COVID-19 vaccination–associated lymphadenopathy on FDG PET/CT: distinctive features in adenovirus-vectored vaccine. Clinical Nuclear Medicine, 46(10), 814. | https://pubmed.ncbi.nlm.nih.gov/34115709/. | Shin, M., Hyun, C. Y., Choi, Y. H., Choi, J. Y., Lee, K. H., & Cho, Y. S. (2021). COVID-19 vaccination–associated lymphadenopathy on FDG PET/CT: distinctive features in adenovirus-vectored vaccine. Clinical Nuclear Medicine, 46(10), 814. https://pubmed.ncbi.nlm.nih.gov/34115709/. | Strobel, D., Haberkamp, S., & Zundler, S. (2021). Portal Vein Thrombosis due to Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT) after Covid Vaccination with ChAdOx1 nCoV-19. Ultraschall in der Medizin-European Journal of Ultrasound, 42(05), 551-552. https://pubmed.ncbi.nlm.nih.gov/34598301/ | ||||
663 | Multimodality imaging and histopathology in a young man presenting with fulminant lymphocytic myocarditis and cardiogenic shock after vaccination with mRNA-1273: | https://pubmed.ncbi.nlm.nih.gov/34848416/ | https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(21)00646-0/fulltext. | Khouri, C., Roustit, M., & Cracowski, J. L. (2021). Adverse event reporting and Bell's palsy risk after COVID-19 vaccination. The Lancet Infectious Diseases, 21(11), 1490-1491. | Khouri, C., Roustit, M. y Cracowski, JL (2021). Informe de eventos adversos y riesgo de parálisis de Bell después de la vacunación COVID-19. The Lancet Infectious Diseases, 21(11), 1490-1491. https://pubmed.ncbi.nlm.nih.gov/34522557/ | PATEL, Y. R., LOUIS, D. W., ATALAY, M., Agarwal, S., & Shah, N. R. (2021). Hallazgos de resonancia magnética cardiovascular en pacientes adultos jóvenes con miocarditis aguda después de la vacunación con MRNA COVID-19: una serie de casos. Revista de resonancia magnética cardiovascular, 23 (1), 1-8. https://www.ncbi.nlm.nih.gov/pubmed/34907393 | Khouri, C., Roustit, M., & Cracowski, J. L. (2021). Adverse event reporting and Bell's palsy risk after COVID-19 vaccination. The Lancet Infectious Diseases, 21(11), 1490-1491. https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(21)00646-0/fulltext. | Patrignani, A., Schicchi, N., Calcagnoli, F., Falchetti, E., Ciampani, N., Argalia, G., & Mariani, A. (2021). Acute myocarditis following Comirnaty vaccination in a healthy man with previous SARS-CoV-2 infection. Radiology Case Reports, 16(11), 3321-3325. https://www.ncbi.nlm.nih.gov/pubmed/34367386 | Faermann, R., Nissan, N., Halshtok-Neiman, O., Shalmon, A., Gotlieb, M., Yagil, Y., ... & Sklair-Levy, M. (2021). COVID-19 vaccination induced lymphadenopathy in a specialized breast imaging clinic in Israel: Analysis of 163 cases. Academic Radiology, 28(9), 1191-1197. | https://pubmed.ncbi.nlm.nih.gov/34257025/. | Faermann, R., Nissan, N., Halshtok-Neiman, O., Shalmon, A., Gotlieb, M., Yagil, Y., ... & Sklair-Levy, M. (2021). COVID-19 vaccination induced lymphadenopathy in a specialized breast imaging clinic in Israel: Analysis of 163 cases. Academic Radiology, 28(9), 1191-1197. https://pubmed.ncbi.nlm.nih.gov/34257025/. | Su, P. H., Yu, Y. C., Chen, W. H., Lin, H. C., Chen, Y. T., Cheng, M. H., & Huang, Y. M. (2021). Case Report: Vaccine-Induced Immune Thrombotic Thrombocytopenia in a Pancreatic Cancer Patient After Vaccination With Messenger RNA− 1273. Frontiers in Medicine, 8. https://pubmed.ncbi.nlm.nih.gov/34790684/ | ||||
664 | Report of a case of myopericarditis after vaccination with BNT162b2 COVID-19 mRNA in a young Korean male: | https://pubmed.ncbi.nlm.nih.gov/34636504/ | https://pubmed.ncbi.nlm.nih.gov/34522557/ | Mason, M. C., Liaqat, A., Morrow, J., Basso, R., & Gujrati, Y. (2021). Bilateral facial nerve palsy and COVID-19 vaccination: causation or coincidence?. Cureus, 13(8). | Mason, M. C., Liaqat, A., Morrow, J., Basso, R. y Gujrati, Y. (2021). Parálisis bilateral del nervio facial y vacunación COVID-19: ¿causación o coincidencia?. Cureus, 13(8). https://pubmed.ncbi.nlm.nih.gov/34763263/. | Patone, M., HandunNetthi, L., Saatci, D., Pan, J., Katikireddi, S. V., Razvi, S., ... & Hippisley-Cox, J. (2021). Complicaciones neurológicas después de la primera dosis de vacunas COVID-19 y infección por SARS-COV-2. Medicina natural, 27 (12), 2144-2153. https://pubmed.ncbi.nlm.nih.gov/33858693/ | Mason, M. C., Liaqat, A., Morrow, J., Basso, R., & Gujrati, Y. (2021). Bilateral facial nerve palsy and COVID-19 vaccination: causation or coincidence?. Cureus, 13(8). https://pubmed.ncbi.nlm.nih.gov/34522557/ | Patrignani, A., Schicchi, N., Calcagnoli, F., Falchetti, E., Ciampani, N., Argalia, G., & Mariani, A. (2021). Acute myocarditis following Comirnaty vaccination in a healthy man with previous SARS-CoV-2 infection. Radiology Case Reports, 16(11), 3321-3325. https://www.sciencedirect.com/science/article/pii/S1930043321005549 | Lim, J., Lee, S. A., Khil, E. K., Byeon, S. J., Kang, H. J., & Choi, J. A. (2021, October). COVID-19 vaccine-related axillary lymphadenopathy in breast cancer patients: Case series with a review of literature. In Seminars in oncology. WB Saunders. | https://pubmed.ncbi.nlm.nih.gov/34836672/. | Lim, J., Lee, S. A., Khil, E. K., Byeon, S. J., Kang, H. J., & Choi, J. A. (2021, October). COVID-19 vaccine-related axillary lymphadenopathy in breast cancer patients: Case series with a review of literature. In Seminars in oncology. WB Saunders. https://pubmed.ncbi.nlm.nih.gov/34836672/. | Sulemankhil, I., Abdelrahman, M., & Negi, S. I. (2021). Temporal association between the COVID-19 Ad26. COV2. S vaccine and acute myocarditis: a case report and literature review. Cardiovascular Revascularization Medicine. https://www.sciencedirect.com/science/article/pii/S1553838921005789 | ||||
665 | Acute myocarditis after Comirnaty vaccination in a healthy male with previous SARS-CoV-2 infection: | https://pubmed.ncbi.nlm.nih.gov/34367386/ | https://pubmed.ncbi.nlm.nih.gov/34763263/. | Cellina, M., D'Arrigo, A., Floridi, C., Oliva, G., & Carrafiello, G. (2022). Left Bell's palsy following the first dose of mRNA-1273 SARS-CoV-2 vaccine: A case report. Clinical Imaging, 82, 1-4. | Cellina, M., D'Arrigo, A., Floridi, C., Oliva, G. y Carrafiello, G. (2022). Parálisis de Bell izquierda después de la primera dosis de la vacuna mRNA-1273 SARS-CoV-2: reporte de un caso. Imágenes clínicas, 82, 1-4. https://pubmed.ncbi.nlm.nih.gov/34621891/ | Patone, M., Mei, X. W., HandunNetthi, L., Dixon, S., Zaccardi, F., Shankar-Hari, M., ... & Hippisley-Cox, J. (2021). Riesgos de miocarditis, pericarditis y arritmias cardíacas asociadas con la vacunación de COVID-19 o la infección SARS-COV-2. Medicina natural, 1-13. https://www.ncbi.nlm.nih.gov/pubmed/34367386 | Cellina, M., D'Arrigo, A., Floridi, C., Oliva, G., & Carrafiello, G. (2022). Left Bell's palsy following the first dose of mRNA-1273 SARS-CoV-2 vaccine: A case report. Clinical Imaging, 82, 1-4. https://pubmed.ncbi.nlm.nih.gov/34763263/. | Paulsen, F. O., Schaefers, C., Langer, F., Frenzel, C., Wenzel, U., Hengel, F. E., ... & Seidel, C. (2021). Immune thrombocytopenic purpura after vaccination with COVID-19 vaccine (ChAdOx1 nCov-19). Blood, The Journal of the American Society of Hematology, 138(11), 996-999. https://www.sciencedirect.com/science/article/abs/pii/S0006497121013963. | Placke, J. M., Reis, H., Hadaschik, E., Roesch, A., Schadendorf, D., Stoffels, I., & Klode, J. (2021). Coronavirus disease 2019 vaccine mimics lymph node metastases in patients undergoing skin cancer follow-up: A monocentre study. European journal of cancer, 154, 167-174. | https://pubmed.ncbi.nlm.nih.gov/34280870/ | Placke, J. M., Reis, H., Hadaschik, E., Roesch, A., Schadendorf, D., Stoffels, I., & Klode, J. (2021). Coronavirus disease 2019 vaccine mimics lymph node metastases in patients undergoing skin cancer follow-up: A monocentre study. European journal of cancer, 154, 167-174. https://pubmed.ncbi.nlm.nih.gov/34280870/ | Sumi, T., Nagahisa, Y., Matsuura, K., Sekikawa, M., Yamada, Y., Nakata, H., & Chiba, H. (2021). Lung squamous cell carcinoma with hemoptysis after vaccination with tozinameran (BNT162b2, Pfizer‐BioNTech). Thoracic Cancer, 12(22), 3072-3075. https://pubmed.ncbi.nlm.nih.gov/34612003/ | ||||
666 | Acute myocarditis in a young adult two days after vaccination with Pfizer: | https://pubmed.ncbi.nlm.nih.gov/34709227/ | https://pubmed.ncbi.nlm.nih.gov/34621891/ | Yu, B. Y., Cen, L. S., Chen, T., & Yang, T. H. (2021). Bell’s palsy after inactivated COVID-19 vaccination in a patient with history of recurrent Bell’s palsy: A case report. World journal of clinical cases, 9(27), 8274. | Yu, B. Y., Cen, LS, Chen, T. y Yang, TH (2021). Parálisis de Bell después de la vacunación COVID-19 inactivada en un paciente con antecedentes de parálisis de Bell recurrente: reporte de un caso. Revista mundial de casos clínicos, 9(27), 8274. https://pubmed.ncbi.nlm.nih.gov/34697502/ | Patrignani, A., Schicchi, N., Calcagnoli, F., Falchetti, E., Ciampani, N., Argalia, G. y Mariani, A. (2021). Miocarditis aguda después de la vacunación contra la comilería en un hombre sano con la infección previa de SARS-COV-2. Informes de casos de radiología, 16 (11), 3321-3325. https://pubmed.ncbi.nlm.nih.gov/34709227/ | Yu, B. Y., Cen, L. S., Chen, T., & Yang, T. H. (2021). Bell’s palsy after inactivated COVID-19 vaccination in a patient with history of recurrent Bell’s palsy: A case report. World journal of clinical cases, 9(27), 8274. https://pubmed.ncbi.nlm.nih.gov/34621891/ | Pavord, S., Scully, M., Hunt, B. J., Lester, W., Bagot, C., Craven, B., ... & Makris, M. (2021). Clinical features of vaccine-induced immune thrombocytopenia and thrombosis. New England Journal of Medicine, 385(18), 1680-1689. https://pubmed.ncbi.nlm.nih.gov/34379914/. | Tan, N. J. H., Tay, K. X. J., Wong, S. B. J., & Nga, M. E. (2021). COVID‐19 post‐vaccination lymphadenopathy: Report of cytological findings from fine needle aspiration biopsy. Diagnostic Cytopathology, 49(12), E467-E470. | https://pubmed.ncbi.nlm.nih.gov/34432391/ | Tan, N. J. H., Tay, K. X. J., Wong, S. B. J., & Nga, M. E. (2021). COVID‐19 post‐vaccination lymphadenopathy: Report of cytological findings from fine needle aspiration biopsy. Diagnostic Cytopathology, 49(12), E467-E470. https://pubmed.ncbi.nlm.nih.gov/34432391/ | Sung, J. G., Sobieszczyk, P. S., & Bhatt, D. L. (2021). Acute myocardial infarction within 24 hours after COVID-19 vaccination. The American Journal of Cardiology, 156, 129-131. https://pubmed.ncbi.nlm.nih.gov/34364657/. | ||||
667 | Case report: acute fulminant myocarditis and cardiogenic shock after messenger RNA coronavirus vaccination in 2019 requiring extracorporeal cardiopulmonary resuscitation: | https://pubmed.ncbi.nlm.nih.gov/34778411/ | https://pubmed.ncbi.nlm.nih.gov/34697502/ | Patone, M., Handunnetthi, L., Saatci, D., Pan, J., Katikireddi, S. V., Razvi, S., ... & Hippisley-Cox, J. (2021). Neurological complications after first dose of COVID-19 vaccines and SARS-CoV-2 infection. Nature medicine, 27(12), 2144-2153. | Patone, M., Handunnetthi, L., Saatci, D., Pan, J., Katikireddi, SV, Razvi, S., ... y Hippisley-Cox, J. (2021). Complicaciones neurológicas tras la primera dosis de vacunas COVID-19 e infección por SARS-CoV-2. Medicina natural, 27(12), 2144-2153. https://pubmed.ncbi.nlm.nih.gov/33858693/ | Patrignani, A., Schicchi, N., Calcagnoli, F., Falchetti, E., Ciampani, N., Argalia, G. y Mariani, A. (2021). Miocarditis aguda después de la vacunación contra la comilería en un hombre sano con la infección previa de SARS-COV-2. Informes de casos de radiología, 16 (11), 3321-3325. https://www.ncbi.nlm.nih.gov/pubmed/34734240 | Patone, M., Handunnetthi, L., Saatci, D., Pan, J., Katikireddi, S. V., Razvi, S., ... & Hippisley-Cox, J. (2021). Neurological complications after first dose of COVID-19 vaccines and SARS-CoV-2 infection. Nature medicine, 27(12), 2144-2153. https://pubmed.ncbi.nlm.nih.gov/34697502/ | Pepe, S., Gregory, A. T., & Denniss, A. R. (2021). Myocarditis, Pericarditis and Cardiomyopathy After COVID-19 Vaccination☆. Heart, Lung and Circulation, 30(10), 1425-1429. https://pubmed.ncbi.nlm.nih.gov/34340927/ | Garreffa, E., Hamad, A., O'Sullivan, C. C., Hazim, A. Z., York, J., Puri, S., ... & Goetz, M. P. (2021). Regional lymphadenopathy following COVID-19 vaccination: Literature review and considerations for patient management in breast cancer care. European Journal of Cancer, 159, 38-51. | https://pubmed.ncbi.nlm.nih.gov/34731748/ | Garreffa, E., Hamad, A., O'Sullivan, C. C., Hazim, A. Z., York, J., Puri, S., ... & Goetz, M. P. (2021). Regional lymphadenopathy following COVID-19 vaccination: Literature review and considerations for patient management in breast cancer care. European Journal of Cancer, 159, 38-51. https://pubmed.ncbi.nlm.nih.gov/34731748/ | Syed, K., Chaudhary, H., & Donato, A. (2021). Central Venous Sinus Thrombosis with Subarachnoid Hemorrhage Following an mRNA COVID-19 Vaccination: Are These Reports Merely Co-Incidental?. The American journal of case reports, 22, e933397-1. https://pubmed.ncbi.nlm.nih.gov/34478433/ | ||||
668 | Acute myocarditis after 2019 coronavirus disease vaccination: | https://pubmed.ncbi.nlm.nih.gov/34734821/ | https://pubmed.ncbi.nlm.nih.gov/33858693/ | Soeiro, T., Salvo, F., Pariente, A., Grandvuillemin, A., Jonville-Béra, A. P., & Micallef, J. (2021). Type I interferons as the potential mechanism linking mRNA COVID-19 vaccines to Bell’s palsy. Therapie. | Soeiro, T., Salvo, F., Pariente, A., Grandvuillemin, A., Jonville-Béra, A. P. y Micallef, J. (2021). Interferones tipo I como mecanismo potencial que vincula las vacunas de ARNm COVID-19 con la parálisis de Bell. Terapia. https://pubmed.ncbi.nlm.nih.gov/34370410/ | Patrignani, A., Schicchi, N., Calcagnoli, F., Falchetti, E., Ciampani, N., Argalia, G. y Mariani, A. (2021). Miocarditis aguda después de la vacunación contra la comilería en un hombre sano con la infección previa de SARS-COV-2. Informes de casos de radiología, 16 (11), 3321-3325. https://www.sciencedirect.com/science/article/pii/S002234762100665X | Soeiro, T., Salvo, F., Pariente, A., Grandvuillemin, A., Jonville-Béra, A. P., & Micallef, J. (2021). Type I interferons as the potential mechanism linking mRNA COVID-19 vaccines to Bell’s palsy. Therapie. https://pubmed.ncbi.nlm.nih.gov/33858693/ | Pepe, S., Gregory, A. T., & Denniss, A. R. (2021). Myocarditis, Pericarditis and Cardiomyopathy After COVID-19 Vaccination☆. Heart, Lung and Circulation, 30(10), 1425-1429. https://www.heartlungcirc.org/article/S1443-9506(21)01156-2/fulltext | Raj, S., Ogola, G., & Han, J. (2022). COVID-19 vaccine-associated subclinical axillary lymphadenopathy on screening mammogram. Academic radiology, 29(4), 501-507. | https://pubmed.ncbi.nlm.nih.gov/34906409/ | Raj, S., Ogola, G., & Han, J. (2022). COVID-19 vaccine-associated subclinical axillary lymphadenopathy on screening mammogram. Academic radiology, 29(4), 501-507. https://pubmed.ncbi.nlm.nih.gov/34906409/ | Tahir, N., Koorapati, G., Prasad, S., Jeelani, H. M., Sherchan, R., Shrestha, J., & Shayuk, M. (2021). SARS-CoV-2 vaccination-induced transverse myelitis. Cureus, 13(7). https://pubmed.ncbi.nlm.nih.gov/34458035/ | ||||
669 | A series of patients with myocarditis after vaccination against SARS-CoV-2 with mRNA-1279 and BNT162b2: | https://pubmed.ncbi.nlm.nih.gov/34246585/ | https://pubmed.ncbi.nlm.nih.gov/34370410/ | Erdem, N. Ş., Demirci, S., Özel, T., Mamadova, K., Karaali, K., Çelik, H. T., ... & Özkaynak, S. S. (2021). Acute transverse myelitis after inactivated COVID-19 vaccine. Ideggyogyaszati Szemle, 74(7-08), 273-276. | Erdem, N. Ş., Demirci, S., Özel, T., Mamadova, K., Karaali, K., Çelik, H. T., ... & Özkaynak, S. S. (2021). Mielitis transversa aguda después de la vacuna COVID-19 inactivada. Ideggyogyaszati Szemle, 74(7-08), 273-276. https://pubmed.ncbi.nlm.nih.gov/34579245/. | Paulsen, F. O., Schaefers, C., Langer, F., Frenzel, C., Wenzel, U., Hengel, F. E., ... y Seidel, C. (2021). Púrpura trombocitopénica inmune después de la vacunación con la vacuna COVID-19 (Chadox1 NCOV-19). Sangre, el Journal of the American Society of Hematology, 138 (11), 996-999. https://docs.google.com/document/d/1XzajasO8VMMnC3CdxSBKks1o7kiOLXFQ | Erdem, N. Ş., Demirci, S., Özel, T., Mamadova, K., Karaali, K., Çelik, H. T., ... & Özkaynak, S. S. (2021). Acute transverse myelitis after inactivated COVID-19 vaccine. Ideggyogyaszati Szemle, 74(7-08), 273-276. https://pubmed.ncbi.nlm.nih.gov/34370410/ | Pepe, S., Gregory, A. T., & Denniss, A. R. (2021). Myocarditis, Pericarditis and Cardiomyopathy After COVID-19 Vaccination☆. Heart, Lung and Circulation, 30(10), 1425-1429. https://www.sciencedirect.com/science/article/pii/S1443950621011562 | Fernández-Prada, M., Rivero-Calle, I., Calvache-González, A., & Martinón-Torres, F. (2021). Acute onset supraclavicular lymphadenopathy coinciding with intramuscular mRNA vaccination against COVID-19 may be related to vaccine injection technique, Spain, January and February 2021. Eurosurveillance, 26(10), 2100193. | https://pubmed.ncbi.nlm.nih.gov/33706861/ | Fernández-Prada, M., Rivero-Calle, I., Calvache-González, A., & Martinón-Torres, F. (2021). Acute onset supraclavicular lymphadenopathy coinciding with intramuscular mRNA vaccination against COVID-19 may be related to vaccine injection technique, Spain, January and February 2021. Eurosurveillance, 26(10), 2100193. https://pubmed.ncbi.nlm.nih.gov/33706861/ | Tailor, P. D., Feighery, A. M., El-Sabawi, B., & Prasad, A. (2021). Case report: acute myocarditis following the second dose of mRNA-1273 SARS-CoV-2 vaccine. European Heart Journal-Case Reports, 5(8), ytab319. https://academic.oup.com/ehjcr/article/5/8/ytab319/6339567 | ||||
670 | Myopericarditis after Pfizer messenger ribonucleic acid coronavirus coronavirus disease vaccine in adolescents: | https://pubmed.ncbi.nlm.nih.gov/34228985/ | https://pubmed.ncbi.nlm.nih.gov/34579245/. | Gao, J. J., Tseng, H. P., Lin, C. L., Shiu, J. S., Lee, M. H., & Liu, C. H. (2021). Acute transverse myelitis following COVID-19 vaccination. Vaccines, 9(9), 1008. | Gao, J. J., Tseng, H. P., Lin, C. L., Shiu, J. S., Lee, M. H. y Liu, C. H. (2021). Mielitis transversa aguda tras la vacunación contra la COVID-19. Vacunas, 9(9), 1008. https://pubmed.ncbi.nlm.nih.gov/34182207/ | Pavord, S., Scully, M., Hunt, B. J., Lester, W., Bagot, C., Craven, B., ... & Makris, M. (2021). Características clínicas de la trombocitopenia inmune inducida por la vacuna y la trombosis. New England Journal of Medicine, 385 (18), 1680-1689. https://pubmed.ncbi.nlm.nih.gov/34545400/ | Gao, J. J., Tseng, H. P., Lin, C. L., Shiu, J. S., Lee, M. H., & Liu, C. H. (2021). Acute transverse myelitis following COVID-19 vaccination. Vaccines, 9(9), 1008. https://pubmed.ncbi.nlm.nih.gov/34579245/. | Perez, Y., Levy, E. R., Joshi, A. Y., Virk, A., Rodriguez-Porcel, M., Johnson, M., ... & Swift, M. D. (2021). Myocarditis Following COVID-19 mRNA Vaccine: A Case Series and Incidence Rate Determination. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America. https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciab926/6420408 | Nawwar, A. A., Searle, J., Singh, R., & Lyburn, I. D. (2021). Oxford-AstraZeneca COVID-19 vaccination induced lymphadenopathy on [18F] choline PET/CT—not only an FDG finding. European Journal of Nuclear Medicine and Molecular Imaging, 48(8), 2657-2658. | https://pubmed.ncbi.nlm.nih.gov/33661328/ | Nawwar, A. A., Searle, J., Singh, R., & Lyburn, I. D. (2021). Oxford-AstraZeneca COVID-19 vaccination induced lymphadenopathy on [18F] choline PET/CT—not only an FDG finding. European Journal of Nuclear Medicine and Molecular Imaging, 48(8), 2657-2658. https://pubmed.ncbi.nlm.nih.gov/33661328/ | Tajstra, M., Jaroszewicz, J., & Gąsior, M. (2021). Acute coronary tree thrombosis after vaccination for COVID-19. Cardiovascular Interventions, 14(9), e103-e104. https://www.sciencedirect.com/science/article/abs/pii/S1936879821003988 | ||||
671 | Post-vaccination multisystem inflammatory syndrome in adults without evidence of prior SARS-CoV-2 infection: | https://pubmed.ncbi.nlm.nih.gov/34852213/ | https://pubmed.ncbi.nlm.nih.gov/34182207/ | Pagenkopf, C., & Südmeyer, M. (2021). A case of longitudinally extensive transverse myelitis following vaccination against Covid-19. Journal of Neuroimmunology, 358, 577606. | Pagenkopf, C. y Südmeyer, M. (2021). Un caso de mielitis transversa longitudinalmente extensa tras la vacunación contra Covid-19. Revista de Neuroinmunología, 358, 577606. https://pubmed.ncbi.nlm.nih.gov/34457267/. | Pepe, S., Gregory, A. T., & Denniss, A. R. (2021). Miocarditis, pericarditis y cardiomiopatía después de la vacunación de COVID-19 ☆. Corazón, pulmón y circulación, 30 (10), 1425-1429. https://pubmed.ncbi.nlm.nih.gov/34246586/ | Pagenkopf, C., & Südmeyer, M. (2021). A case of longitudinally extensive transverse myelitis following vaccination against Covid-19. Journal of Neuroimmunology, 358, 577606. https://pubmed.ncbi.nlm.nih.gov/34182207/ | Perez, Y., Levy, E. R., Joshi, A. Y., Virk, A., Rodriguez-Porcel, M., Johnson, M., ... & Swift, M. D. (2021). Myocarditis Following COVID-19 mRNA Vaccine: A Case Series and Incidence Rate Determination. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America. https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciab926/6420408. | Mortazavi, S. (2021). COVID-19 vaccination–associated axillary adenopathy: imaging findings and follow-up recommendations in 23 women. American Journal of Roentgenology, 217(4), 857-858. | https://pubmed.ncbi.nlm.nih.gov/33624520/ | Mortazavi, S. (2021). COVID-19 vaccination–associated axillary adenopathy: imaging findings and follow-up recommendations in 23 women. American Journal of Roentgenology, 217(4), 857-858. https://pubmed.ncbi.nlm.nih.gov/33624520/ | Takase, B., Hayashi, K., Hisada, T., Tsuchiya, T., Masaki, N., & Nagata, M. (2022). Chest Pain with New Abnormal Electrocardiogram Development after Injection of COVID-19 Vaccine Manufactured by Moderna. Internal Medicine, 8711-21. https://pubmed.ncbi.nlm.nih.gov/34866106/ | ||||
672 | Acute myocarditis defined after vaccination with 2019 mRNA of coronavirus disease: | https://pubmed.ncbi.nlm.nih.gov/34866122/ | https://pubmed.ncbi.nlm.nih.gov/34457267/. | Ahmad, S. A., Salih, K. H., Ahmed, S. F., Kakamad, F. H., Salh, A. M., Hassan, M. N., ... & Hussein, D. A. (2021). Post COVID-19 transverse myelitis; a case report with review of literature. Annals of Medicine and Surgery, 69, 102749. | Ahmad, S. A., Salih, K. H., Ahmed, S. F., Kakamad, F. H., Salh, A. M., Hassan, M. N., ... y Hussein, D. A. (2021). Mielitis transversa post COVID-19; reporte de un caso con revisión de la literatura. Anales de Medicina y Cirugía, 69, 102749. https://pubmed.ncbi.nlm.nih.gov/34189662/ | Pepe, S., Gregory, A. T., & Denniss, A. R. (2021). Miocarditis, pericarditis y cardiomiopatía después de la vacunación de COVID-19 ☆. Corazón, pulmón y circulación, 30 (10), 1425-1429. https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.121.056135 | Ahmad, S. A., Salih, K. H., Ahmed, S. F., Kakamad, F. H., Salh, A. M., Hassan, M. N., ... & Hussein, D. A. (2021). Post COVID-19 transverse myelitis; a case report with review of literature. Annals of Medicine and Surgery, 69, 102749. https://pubmed.ncbi.nlm.nih.gov/34457267/. | Perez, Y., Levy, E. R., Joshi, A. Y., Virk, A., Rodriguez-Porcel, M., Johnson, M., ... & Swift, M. D. (2021). Myocarditis Following COVID-19 mRNA Vaccine: A Case Series and Incidence Rate Determination. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America. https://www.ncbi.nlm.nih.gov/pubmed/34734240 | Cardoso, F., Reis, A., Osório, C., Scigliano, H., & Nora, M. (2021). A case of cervical lymphadenopathy after vaccination against COVID-19. Cureus, 13(5). | https://pubmed.ncbi.nlm.nih.gov/34141500/ | Cardoso, F., Reis, A., Osório, C., Scigliano, H., & Nora, M. (2021). A case of cervical lymphadenopathy after vaccination against COVID-19. Cureus, 13(5). https://pubmed.ncbi.nlm.nih.gov/34141500/ | Takeda, M., Ishio, N., Shoji, T., Mori, N., Matsumoto, M., & Shikama, N. (2021). Eosinophilic Myocarditis Following Coronavirus Disease 2019 (COVID-19) Vaccination. Circulation Journal, CJ-21. https://www.ncbi.nlm.nih.gov/pubmed/34955479 | ||||
673 | Biventricular systolic dysfunction in acute myocarditis after SARS-CoV-2 mRNA-1273 vaccination: | https://pubmed.ncbi.nlm.nih.gov/34601566/ | https://pubmed.ncbi.nlm.nih.gov/34189662/ | Chen, S., Fan, X. R., He, S., Zhang, J. W., & Li, S. J. (2021). Watch out for neuromyelitis optica spectrum disorder after inactivated virus vaccination for COVID-19. Neurological Sciences, 42(9), 3537-3539. | Chen, S., Fan, X. R., He, S., Zhang, J. W. y Li, S. J. (2021). Esté atento al trastorno del espectro de la neuromielitis óptica después de la vacunación con virus inactivados para COVID-19. Ciencias Neurológicas, 42(9), 3537-3539. https://pubmed.ncbi.nlm.nih.gov/34660149/ | Pepe, S., Gregory, A. T., & Denniss, A. R. (2021). Miocarditis, pericarditis y cardiomiopatía después de la vacunación de COVID-19 ☆. Corazón, pulmón y circulación, 30 (10), 1425-1429. https://www.sciencedirect.com/science/article/abs/pii/S0896841121000706 | Chen, S., Fan, X. R., He, S., Zhang, J. W., & Li, S. J. (2021). Watch out for neuromyelitis optica spectrum disorder after inactivated virus vaccination for COVID-19. Neurological Sciences, 42(9), 3537-3539. https://pubmed.ncbi.nlm.nih.gov/34189662/ | Perrotta, A., Biondi-Zoccai, G., Saade, W., Miraldi, F., Morelli, A., Marullo, A. G., ... & Peruzzi, M. (2021). A snapshot global survey on side effects of COVID-19 vaccines among healthcare professionals and armed forces with a focus on headache. Panminerva Medica, 63(3), 324-331. https://www.ncbi.nlm.nih.gov/pubmed/34738774 | Keir, G., Maria, N. I., & Kirsch, C. F. (2021). Unique imaging findings of neurologic phantosmia following Pfizer-BioNtech COVID-19 vaccination: a case report. Topics in Magnetic Resonance Imaging, 30(3), 133-137. | https://pubmed.ncbi.nlm.nih.gov/34096896/ | Keir, G., Maria, N. I., & Kirsch, C. F. (2021). Unique imaging findings of neurologic phantosmia following Pfizer-BioNtech COVID-19 vaccination: a case report. Topics in Magnetic Resonance Imaging, 30(3), 133-137. https://pubmed.ncbi.nlm.nih.gov/34096896/ | Takeyama, R., Fukuda, K., Kouzaki, Y., Koga, T., Hayashi, S., Ohtani, H., & Inoue, T. (2022). Intracerebral hemorrhage due to vasculitis following COVID-19 vaccination: a case report. Acta neurochirurgica, 164(2), 543-547. https://pubmed.ncbi.nlm.nih.gov/34783899/ | ||||
674 | Myocarditis following COVID-19 vaccination: MRI study: | https://pubmed.ncbi.nlm.nih.gov/34739045/. | https://pubmed.ncbi.nlm.nih.gov/34660149/ | Fujikawa, P., Shah, F. A., Braford, M., Patel, K., & Madey, J. (2021). Neuromyelitis Optica in a Healthy Female After Severe Acute Respiratory Syndrome Coronavirus 2 mRNA-1273 Vaccine. Cureus, 13(9). | Fujikawa, P., Shah, F. A., Braford, M., Patel, K. y Madey, J. (2021). Neuromielitis óptica en una mujer sana después de la vacuna contra el coronavirus 2 mRNA-1273 con síndrome respiratorio agudo severo. Cureus, 13(9). https://pubmed.ncbi.nlm.nih.gov/34131771/ | Pérez, Y., Levy, E. R., Joshi, A. Y., VIRK, A., Rodríguez-Porcel, M., Johnson, M., ... & Swift, M. D. (2021). Miocarditis después de la vacuna contra el ARNA COVID-19: una serie de casos y determinación de la tasa de incidencia. Enfermedades infecciosas clínicas: una publicación oficial de la Sociedad de Enfermedades Infecciosas de América. https://pubmed.ncbi.nlm.nih.gov/34615534/ | Fujikawa, P., Shah, F. A., Braford, M., Patel, K., & Madey, J. (2021). Neuromyelitis Optica in a Healthy Female After Severe Acute Respiratory Syndrome Coronavirus 2 mRNA-1273 Vaccine. Cureus, 13(9). https://pubmed.ncbi.nlm.nih.gov/34660149/ | Perry, R. J., Tamborska, A., Singh, B., Craven, B., Marigold, R., Arthur-Farraj, P., ... & Zambreanu, L. (2021). Cerebral venous thrombosis after vaccination against COVID-19 in the UK: a multicentre cohort study. The Lancet, 398(10306), 1147-1156. https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)01608-1/ | Tobaiqy, M., MacLure, K., Elkout, H., & Stewart, D. (2021). Thrombotic adverse events reported for Moderna, Pfizer and Oxford-AstraZeneca COVID-19 vaccines: comparison of occurrence and clinical outcomes in the EudraVigilance database. Vaccines, 9(11), 1326. | https://pubmed.ncbi.nlm.nih.gov/34835256/ | Tobaiqy, M., MacLure, K., Elkout, H., & Stewart, D. (2021). Thrombotic adverse events reported for Moderna, Pfizer and Oxford-AstraZeneca COVID-19 vaccines: comparison of occurrence and clinical outcomes in the EudraVigilance database. Vaccines, 9(11), 1326. https://pubmed.ncbi.nlm.nih.gov/34835256/ | Tan, N. J. H., Tay, K. X. J., Wong, S. B. J., & Nga, M. E. (2021). COVID‐19 post‐vaccination lymphadenopathy: Report of cytological findings from fine needle aspiration biopsy. Diagnostic Cytopathology, 49(12), E467-E470. https://pubmed.ncbi.nlm.nih.gov/34432391/ | ||||
675 | Acute myocarditis after COVID-19 vaccination: case report: | https://docs.google.com/document/d/1Hc4bh_qNbZ7UVm5BLxkRdMPnnI9zcCsl/e | https://pubmed.ncbi.nlm.nih.gov/34131771/ | Helmchen, C., Buttler, G. M., Markewitz, R., Hummel, K., Wiendl, H., & Boppel, T. (2022). Acute bilateral optic/chiasm neuritis with longitudinal extensive transverse myelitis in longstanding stable multiple sclerosis following vector-based vaccination against the SARS-CoV-2. Journal of Neurology, 269(1), 49-54. | Helmchen, C., Buttler, G. M., Markewitz, R., Hummel, K., Wiendl, H. y Boppel, T. (2022). Neuritis óptica/quiasma bilateral aguda con mielitis transversal extensa longitudinal en esclerosis múltiple estable de larga duración después de la vacunación basada en vectores contra el SARS-CoV-2. Revista de Neurología, 269(1), 49-54. https://pubmed.ncbi.nlm.nih.gov/34635376/ | Pérez, Y., Levy, E. R., Joshi, A. Y., VIRK, A., Rodríguez-Porcel, M., Johnson, M., ... & Swift, M. D. (2021). Miocarditis después de la vacuna contra el ARNA COVID-19: una serie de casos y determinación de la tasa de incidencia. Enfermedades infecciosas clínicas: una publicación oficial de la Sociedad de Enfermedades Infecciosas de América. https://www.mdpi.com/2075-4426/11/11/1106 | Helmchen, C., Buttler, G. M., Markewitz, R., Hummel, K., Wiendl, H., & Boppel, T. (2022). Acute bilateral optic/chiasm neuritis with longitudinal extensive transverse myelitis in longstanding stable multiple sclerosis following vector-based vaccination against the SARS-CoV-2. Journal of Neurology, 269(1), 49-54. https://pubmed.ncbi.nlm.nih.gov/34131771/ | Phillips, E. J. (2021). Allergic Reactions After COVID-19 Vaccination—Putting Risk Into Perspective. JAMA Network Open, 4(8), e2122326-e2122326. https://pubmed.ncbi.nlm.nih.gov/34463751/ | Lehman, C. D., D’Alessandro, H. A., Mendoza, D. P., Succi, M. D., Kambadakone, A., & Lamb, L. R. (2021). Unilateral lymphadenopathy after COVID-19 vaccination: a practical management plan for radiologists across specialties. Journal of the American College of Radiology, 18(6), 843-852. | https://pubmed.ncbi.nlm.nih.gov/33713605/ | Lehman, C. D., D’Alessandro, H. A., Mendoza, D. P., Succi, M. D., Kambadakone, A., & Lamb, L. R. (2021). Unilateral lymphadenopathy after COVID-19 vaccination: a practical management plan for radiologists across specialties. Journal of the American College of Radiology, 18(6), 843-852. https://pubmed.ncbi.nlm.nih.gov/33713605/ | Tan, W. Y., Yusof Khan, A. H. K., Mohd Yaakob, M. N., Abdul Rashid, A. M., Loh, W. C., Baharin, J., ... & Hoo, F. K. (2021). Longitudinal extensive transverse myelitis following ChAdOx1 nCOV-19 vaccine: a case report. BMC neurology, 21(1), 1-4. https://pubmed.ncbi.nlm.nih.gov/34641797/. | ||||
676 | Association of myocarditis with COVID-19 messenger RNA BNT162b2 vaccine COVID-19 in a case series of children: | https://pubmed.ncbi.nlm.nih.gov/34374740/ | https://pubmed.ncbi.nlm.nih.gov/34635376/ | Lazaros, G., Anastassopoulou, C., Hatziantoniou, S., Kalos, T., Soulaidopoulos, S., Lazarou, E., ... & Tsioufis, C. (2021). A case series of acute pericarditis following COVID-19 vaccination in the context of recent reports from Europe and the United States. Vaccine, 39(45), 6585-6590. | Lazaros, G., Anastassopoulou, C., Hatziantoniou, S., Kalos, T., Soulaidopoulos, S., Lazarou, E., ... & Tsioufis, C. (2021). Una serie de casos de pericarditis aguda tras la vacunación contra la COVID-19 en el contexto de informes recientes de Europa y Estados Unidos. Vacuna, 39(45), 6585-6590. https://pubmed.ncbi.nlm.nih.gov/34749492/ | Pérez, Y., Levy, E. R., Joshi, A. Y., VIRK, A., Rodríguez-Porcel, M., Johnson, M., ... & Swift, M. D. (2021). Miocarditis después de la vacuna contra el ARNA COVID-19: una serie de casos y determinación de la tasa de incidencia. Enfermedades infecciosas clínicas: una publicación oficial de la Sociedad de Enfermedades Infecciosas de América. https://www.ncbi.nlm.nih.gov/pubmed/34738774 | Lazaros, G., Anastassopoulou, C., Hatziantoniou, S., Kalos, T., Soulaidopoulos, S., Lazarou, E., ... & Tsioufis, C. (2021). A case series of acute pericarditis following COVID-19 vaccination in the context of recent reports from Europe and the United States. Vaccine, 39(45), 6585-6590. https://pubmed.ncbi.nlm.nih.gov/34635376/ | Piñana, J. L., López‐Corral, L., Martino, R., Montoro, J., Vazquez, L., Pérez, A., ... & Infectious Complications Subcommittee of the Spanish Hematopoietic Stem Cell Transplantation and Cell Therapy Group (GETH‐TC). (2022). SARS‐CoV‐2‐reactive antibody detection after SARS‐CoV‐2 vaccination in hematopoietic stem cell transplant recipients: Prospective survey from the Spanish Hematopoietic Stem Cell Transplantation and Cell Therapy Group. American journal of hematology, 97(1), 30-42. https://www.ncbi.nlm.nih.gov/pubmed/34695229 | Mehta, N., Sales, R. M., Babagbemi, K., Levy, A. D., McGrath, A. L., Drotman, M., & Dodelzon, K. (2021). Unilateral axillary adenopathy in the setting of COVID-19 vaccine: Follow-up. Clinical Imaging, 80, 83-87. | https://pubmed.ncbi.nlm.nih.gov/34298342/ | Mehta, N., Sales, R. M., Babagbemi, K., Levy, A. D., McGrath, A. L., Drotman, M., & Dodelzon, K. (2021). Unilateral axillary adenopathy in the setting of COVID-19 vaccine: Follow-up. Clinical Imaging, 80, 83-87. https://pubmed.ncbi.nlm.nih.gov/34298342/ | Tano, E., San Martin, S., Girgis, S., Martinez-Fernandez, Y., & Sanchez Vegas, C. (2021). Perimyocarditis in adolescents after Pfizer-BioNTech COVID-19 vaccine. Journal of the Pediatric Infectious Diseases Society, 10(10), 962-966. https://academic.oup.com/jpids/advance-article/doi/10.1093/jpids/piab060/6329543 | ||||
677 | Clinical suspicion of myocarditis temporally related to COVID-19 vaccination in adolescents and young adults: | https://pubmed.ncbi.nlm.nih.gov/34865500/ | https://pubmed.ncbi.nlm.nih.gov/34749492/ | Shen, X., Koh, M. S. H., Lim, B. Y., Demo-Os, M., Chien, J. M. F., Santosa, A., & Taha, A. A. (2021). Acute pericarditis and cardiac tamponade after Covid-19 vaccination. Singapore medical journal. | Shen, X., Koh, M. S. H., Lim, B. Y., Demo-Os, M., Chien, J. M. F., Santosa, A. y Taha, A. A. (2021). Pericarditis aguda y taponamiento cardíaco tras la vacunación Covid-19. Revista médica de Singapur. https://pubmed.ncbi.nlm.nih.gov/34849667/ | Perrotta, A., Biondi-ZOCS, G., Saade, W., Miraldi, F., Morelli, A., Marullo, A. G., ... & Peruzzi, M. (2021). Una encuesta global de instantáneas sobre los efectos secundarios de las vacunas COVID-19 entre profesionales de la salud y fuerzas armadas con un enfoque en el dolor de cabeza. PANMINERVA MEDICA, 63 (3), 324-331. https://www.ncbi.nlm.nih.gov/pubmed/34695229 | Shen, X., Koh, M. S. H., Lim, B. Y., Demo-Os, M., Chien, J. M. F., Santosa, A., & Taha, A. A. (2021). Acute pericarditis and cardiac tamponade after Covid-19 vaccination. Singapore medical journal. https://pubmed.ncbi.nlm.nih.gov/34749492/ | Pitlick, M. M., Park, M. A., Gonzalez-Estrada, A., & Chiarella, S. E. (2021). Biphasic anaphylaxis after first dose of messenger RNA coronavirus disease 2019 vaccine with positive polysorbate 80 skin testing result. Annals of Allergy Asthma & Immunology, 498-499. https://pubmed.ncbi.nlm.nih.gov/34343674/ | Ismail, I. I., & Salama, S. (2022). A systematic review of cases of CNS demyelination following COVID-19 vaccination. Journal of neuroimmunology, 362, 577765. | https://pubmed.ncbi.nlm.nih.gov/34839149/ | Ismail, I. I., & Salama, S. (2022). A systematic review of cases of CNS demyelination following COVID-19 vaccination. Journal of neuroimmunology, 362, 577765. https://pubmed.ncbi.nlm.nih.gov/34839149/ | Tarawneh, O., & Tarawneh, H. (2021). Immune thrombocytopenia in a 22‐year‐old post Covid‐19 vaccine. American journal of hematology. https://pubmed.ncbi.nlm.nih.gov/33476455/ | ||||
678 | Myocarditis following vaccination with Covid-19 in a large healthcare organization: | https://pubmed.ncbi.nlm.nih.gov/34614329/ | https://pubmed.ncbi.nlm.nih.gov/34849667/ | Foltran, D., Delmas, C., Flumian, C., De Paoli, P., Salvo, F., Gautier, S., ... & Montastruc, F. (2022). Myocarditis and pericarditis in adolescents after first and second doses of mRNA COVID-19 vaccines. European Heart Journal-Quality of Care and Clinical Outcomes, 8(2), 99-103. | Foltran, D., Delmas, C., Flumian, C., De Paoli, P., Salvo, F., Gautier, S., ... & Montastruc, F. (2022). Miocarditis y pericarditis en adolescentes después de la primera y segunda dosis de vacunas de ARNm COVID-19. European Heart Journal: calidad de la atención y resultados clínicos, 8(2), 99-103. https://pubmed.ncbi.nlm.nih.gov/34319393/ | Perry, R. J., Tamborska, A., Singh, B., Craven, B., Marigold, R., Arthur-Farraj, P., ... & Zambreanu, L. (2021). Trombosis venosa cerebral después de la vacunación contra COVID-19 en el Reino Unido: un estudio de cohorte multicéntrico. La lanceta, 398 (10306), 1147-1156. https://www.sciencedirect.com/science/article/pii/S1052305721003414 | Foltran, D., Delmas, C., Flumian, C., De Paoli, P., Salvo, F., Gautier, S., ... & Montastruc, F. (2022). Myocarditis and pericarditis in adolescents after first and second doses of mRNA COVID-19 vaccines. European Heart Journal-Quality of Care and Clinical Outcomes, 8(2), 99-103. https://pubmed.ncbi.nlm.nih.gov/34849667/ | Placke, J. M., Reis, H., Hadaschik, E., Roesch, A., Schadendorf, D., Stoffels, I., & Klode, J. (2021). Coronavirus disease 2019 vaccine mimics lymph node metastases in patients undergoing skin cancer follow-up: A monocentre study. European journal of cancer, 154, 167-174. https://pubmed.ncbi.nlm.nih.gov/34280870/ | Mitchell, O. R., Dave, R., Bekker, J., & Brennan, P. A. (2021). Supraclavicular lymphadenopathy following COVID-19 vaccination: an increasing presentation to the two-week wait neck lump clinic?. British Journal of Oral and Maxillofacial Surgery, 59(3), 384-385. | https://pubmed.ncbi.nlm.nih.gov/33685772/ | Mitchell, O. R., Dave, R., Bekker, J., & Brennan, P. A. (2021). Supraclavicular lymphadenopathy following COVID-19 vaccination: an increasing presentation to the two-week wait neck lump clinic?. British Journal of Oral and Maxillofacial Surgery, 59(3), 384-385. https://pubmed.ncbi.nlm.nih.gov/33685772/ | Taylor, P., Allen, L., Shrikrishnapalasuriyar, N., Stechman, M., & Rees, A. (2021). Vaccine‐induced thrombosis and thrombocytopenia with bilateral adrenal haemorrhage. Clinical Endocrinology. https://pubmed.ncbi.nlm.nih.gov/34235757/. | ||||
679 | AstraZeneca COVID-19 vaccine and Guillain-Barré syndrome in Tasmania: a causal link: | https://pubmed.ncbi.nlm.nih.gov/34560365/ | https://pubmed.ncbi.nlm.nih.gov/34319393/ | Tano, E., San Martin, S., Girgis, S., Martinez-Fernandez, Y., & Sanchez Vegas, C. (2021). Perimyocarditis in adolescents after Pfizer-BioNTech COVID-19 vaccine. Journal of the Pediatric Infectious Diseases Society, 10(10), 962-966. | Tano, E., San Martín, S., Girgis, S., Martínez-Fernández, Y. y Sánchez Vegas, C. (2021). Perimiocarditis en adolescentes tras la vacuna Pfizer-BioNTech COVID-19. Revista de la Sociedad de Enfermedades Infecciosas Pediátricas, 10(10), 962-966. https://pubmed.ncbi.nlm.nih.gov/34589238/ | Phillips, E. J. (2021). Reacciones alérgicas después de la vacunación COVID-19-Poner el riesgo en perspectiva. Red de Jama Abrir, 4 (8), E2122326-E2122326. https://pubmed.ncbi.nlm.nih.gov/33846043/188 | Tano, E., San Martin, S., Girgis, S., Martinez-Fernandez, Y., & Sanchez Vegas, C. (2021). Perimyocarditis in adolescents after Pfizer-BioNTech COVID-19 vaccine. Journal of the Pediatric Infectious Diseases Society, 10(10), 962-966. https://pubmed.ncbi.nlm.nih.gov/34319393/ | Plasse, R., Nee, R., Gao, S., & Olson, S. (2021). Acute kidney injury with gross hematuria and IgA nephropathy after COVID-19 vaccination. Kidney international, 100(4), 944-945. https://pubmed.ncbi.nlm.nih.gov/34352309/ | Lane, D. L., Neelapu, S. S., Xu, G., & Weaver, O. (2021). COVID-19 vaccine-related axillary and cervical lymphadenopathy in patients with current or prior breast cancer and other malignancies: cross-sectional imaging findings on MRI, CT, and PET-CT. Korean Journal of Radiology, 22(12), 1938. | https://pubmed.ncbi.nlm.nih.gov/34719892/ | Lane, D. L., Neelapu, S. S., Xu, G., & Weaver, O. (2021). COVID-19 vaccine-related axillary and cervical lymphadenopathy in patients with current or prior breast cancer and other malignancies: cross-sectional imaging findings on MRI, CT, and PET-CT. Korean Journal of Radiology, 22(12), 1938. https://pubmed.ncbi.nlm.nih.gov/34719892/ | Thachil, J. (2021, October). COVID-19 vaccine-induced immune thrombosis with thrombocytopenia (VITT) and the shades of grey in thrombus formation. In Seminars in thrombosis and hemostasis. Thieme Medical Publishers, Inc.. https://pubmed.ncbi.nlm.nih.gov/34624910/ | ||||
680 | COVID-19, Guillain-Barré and vaccineA dangerous mix: | https://pubmed.ncbi.nlm.nih.gov/34108736/. | https://pubmed.ncbi.nlm.nih.gov/34589238/ | Ambati, S., Colon, M., Mihic, M., Sanchez, J., & Bakar, A. (2021). Acute myopericarditis after covid-19 vaccine in teenagers. Case reports in cardiology, 2021. | Ambati, S., Colón, M., Mihic, M., Sánchez, J. y Bakar, A. (2021). Miopericarditis aguda tras vacuna covid-19 en adolescentes. Informes de casos en cardiología, 2021. https://pubmed.ncbi.nlm.nih.gov/34149145/ | Piñana, JL, López-Corral, L., Martino, R., Montoro, J., Vázquez, L., Pérez, A., ... & COMPLICACIONES DE COMPLICACIONES INFECCIONIOS DEL TRANSPLANTE DE CELO DE CELO HEMAPOÉTICA ESPAÑOLA y grupo de terapia celular ( Geth-tc). (2022). Detección de anticuerpos reactivos de SARS-COV-2 después de la vacunación contra SARS-COV-2 en los receptores de trasplantes de células madre hematopoyéticos: estudio prospectivo del trasplante de células madre hematopoyéticas español y grupo de terapia celular. American Journal of Hematology, 97 (1), 30-42. https://www.ncbi.nlm.nih.gov/pubmed/34233234 | Ambati, S., Colon, M., Mihic, M., Sanchez, J., & Bakar, A. (2021). Acute myopericarditis after covid-19 vaccine in teenagers. Case reports in cardiology, 2021. https://pubmed.ncbi.nlm.nih.gov/34589238/ | Plaza, M. J., Wright, J., & Fernandez, S. (2021). COVID-19 vaccine-related unilateral axillary lymphadenopathy: pattern on screening breast MRI allowing for a benign assessment. Clinical Imaging, 80, 139-141. https://pubmed.ncbi.nlm.nih.gov/34325221/ | Washington, T., Bryan, R., & Clemow, C. (2021). Adenopathy following COVID-19 vaccination. Radiology, 299(3), E280-E281. | https://pubmed.ncbi.nlm.nih.gov/33625299/. | Washington, T., Bryan, R., & Clemow, C. (2021). Adenopathy following COVID-19 vaccination. Radiology, 299(3), E280-E281. https://pubmed.ncbi.nlm.nih.gov/33625299/. | Theuriet, J., Richard, C., Becker, J., Pegat, A., Bernard, E., & Vukusic, S. (2021). Guillain-Barré syndrome following first injection of ChAdOx1 nCoV-19 vaccine: First report. Revue neurologique, 177(10), 1305-1307. https://www.sciencedirect.com/science/article/pii/S0035378721005853. | ||||
681 | Guillain-Barré syndrome after the first dose of Pfizer-BioNTech COVID-19 vaccine: case report and review of reported cases: | https://pubmed.ncbi.nlm.nih.gov/34796417/. | https://pubmed.ncbi.nlm.nih.gov/34149145/ | Ramírez-García, A., Jiménez, S., Ximénez, I., Cacho, A., Aguado-Noya, R., & Cubero, J. (2021). Pericarditis tras la administración de la vacuna de ARNm BNT162b2 contra la COVID-19 Pericarditis after administration of the BNT162b2 mRNA COVID-19 vaccine. Revista espanola de cardiologia. | Ramírez-García, A., Jiménez, S., Ximénez, I., Cacho, A., Aguado-Noya, R., & Cubero, J. (2021). Pericarditis tras la administración de la vacuna de ARNm BNT162b2 contra la COVID-19 Pericarditis tras la administración de la vacuna BNT162b2 mRNA COVID-19. Revista española de cardiología. https://pubmed.ncbi.nlm.nih.gov/34693198/. | Pitlick, M. M., Park, M. A., González-Estrada, A., y Chiarella, S. E. (2021). Anafilaxia bifásica Después de la primera dosis de la enfermedad de la enfermedad de Coronavirus de RNA Messenger 2019 con polisorbato positivo 80 resultado de pruebas de la piel. Anales de alergia al asma e inmunología, 498-499. https://pubmed.ncbi.nlm.nih.gov/34586408/ | Ramírez-García, A., Jiménez, S., Ximénez, I., Cacho, A., Aguado-Noya, R., & Cubero, J. (2021). Pericarditis tras la administración de la vacuna de ARNm BNT162b2 contra la COVID-19 Pericarditis after administration of the BNT162b2 mRNA COVID-19 vaccine. Revista espanola de cardiologia. https://pubmed.ncbi.nlm.nih.gov/34149145/ | Pomara, C., Sessa, F., Ciaccio, M., Dieli, F., Esposito, M., Garozzo, S. F., ... & Mannucci, P. M. (2021). Post-mortem findings in vaccine-induced thrombotic thrombocytopenia. haematologica, 106(8), 2291. https://haematologica.org/article/view/haematol.2021.279075 | Robinson, K. A., Maimone, S., Gococo-Benore, D. A., Li, Z., Advani, P. P., & Chumsri, S. (2021). Incidence of axillary adenopathy in breast imaging after COVID-19 vaccination. JAMA oncology, 7(9), 1395-1397. | https://pubmed.ncbi.nlm.nih.gov/34292295/. | Robinson, K. A., Maimone, S., Gococo-Benore, D. A., Li, Z., Advani, P. P., & Chumsri, S. (2021). Incidence of axillary adenopathy in breast imaging after COVID-19 vaccination. JAMA oncology, 7(9), 1395-1397. https://pubmed.ncbi.nlm.nih.gov/34292295/. | Thompson, M. G., Burgess, J. L., Naleway, A. L., Tyner, H., Yoon, S. K., Meece, J., ... & Gaglani, M. (2021). Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines. New England Journal of Medicine, 385(4), 320-329. https://www.ncbi.nlm.nih.gov/pubmed/34192428 | ||||
682 | Guillain-Barre syndrome after BNT162b2 COVID-19 vaccine: | https://link.springer.com/article/10.1007%2Fs10072-021-05523-5. | https://pubmed.ncbi.nlm.nih.gov/34693198/. | Ashaari, S., Sohaib, H. A., & Bolger, K. (2021). A case report: symptomatic pericarditis post-COVID-19 vaccination. European Heart Journal-Case Reports, 5(10), ytab375. | Ashaari, S., Sohaib, H. A. y Bolger, K. (2021). Reporte de un caso: pericarditis sintomática posvacunación COVID-19. European Heart Journal-Case Reports, 5(10), ytab375. https://pubmed.ncbi.nlm.nih.gov/34797392/ | Plasse, R., Nee, R., Gao, S., & Olson, S. (2021). Lesión renal aguda con hematuria grave y nefropatía IgA después de la vacunación de COVID-19. Ridney International, 100 (4), 944-945. https://pubmed.ncbi.nlm.nih.gov/34804803/. | Ashaari, S., Sohaib, H. A., & Bolger, K. (2021). A case report: symptomatic pericarditis post-COVID-19 vaccination. European Heart Journal-Case Reports, 5(10), ytab375. https://pubmed.ncbi.nlm.nih.gov/34693198/. | Pomara, C., Sessa, F., Ciaccio, M., Dieli, F., Esposito, M., Giammanco, G. M., ... & Zamboni, P. (2021). COVID-19 vaccine and death: causality algorithm according to the WHO eligibility diagnosis. Diagnostics, 11(6), 955. https://pubmed.ncbi.nlm.nih.gov/34073536/ | Mitchell, O. R., Couzins, M., Dave, R., Bekker, J., & Brennan, P. A. (2021). COVID-19 vaccination and low cervical lymphadenopathy in the two week neck lump clinic-a follow up audit. British Journal of Oral and Maxillofacial Surgery, 59(6), 720-721. | https://pubmed.ncbi.nlm.nih.gov/33947605/. | Mitchell, O. R., Couzins, M., Dave, R., Bekker, J., & Brennan, P. A. (2021). COVID-19 vaccination and low cervical lymphadenopathy in the two week neck lump clinic-a follow up audit. British Journal of Oral and Maxillofacial Surgery, 59(6), 720-721. https://pubmed.ncbi.nlm.nih.gov/33947605/. | Tiede, A., Sachs, U. J., Czwalinna, A., Werwitzke, S., Bikker, R., Krauss, J. K., ... & Ganser, A. (2021). Prothrombotic immune thrombocytopenia after COVID-19 vaccination. Blood, The Journal of the American Society of Hematology, 138(4), 350-353. https://www.sciencedirect.com/science/article/pii/S0006497121009411 | ||||
683 | COVID-19 adenovirus vaccines and Guillain-Barré syndrome with facial palsy: | https://onlinelibrary.wiley.com/doi/10.1002/ana.26258. | https://pubmed.ncbi.nlm.nih.gov/34797392/ | Jeon, Y. H., Lim, D. H., Choi, S. W., & Choi, S. J. (2021). A flare of Still’s disease following COVID-19 vaccination in a 34-year-old patient. Rheumatology international, 1-6. | Jeon, YH, Lim, DH, Choi, SW y Choi, SJ (2021). Un brote de la enfermedad de Still tras la vacunación contra la COVID-19 en un paciente de 34 años. Reumatología internacional, 1-6. https://pubmed.ncbi.nlm.nih.gov/34862234/ | Plaza, M. J., Wright, J., & Fernández, S. (2021). COVID-19 Linfadenopatía axilar unilateral relacionada con la vacuna: Patrón en la selección de MRI de mama que permite una evaluación benigna. Imágenes clínicas, 80, 139-141. https://pubmed.ncbi.nlm.nih.gov/34825530/. | Jeon, Y. H., Lim, D. H., Choi, S. W., & Choi, S. J. (2021). A flare of Still’s disease following COVID-19 vaccination in a 34-year-old patient. Rheumatology international, 1-6. https://pubmed.ncbi.nlm.nih.gov/34797392/ | Porres-Aguilar, M., Lazo-Langner, A., Panduro, A., & Uribe, M. (2021). COVID-19 vaccine-induced immune thrombotic thrombocytopenia: an emerging cause of splanchnic vein thrombosis. Annals of Hepatology. https://www.sciencedirect.com/science/article/pii/S1665268121000557 | Abou-Foul, A. K., Ross, E., Abou-Foul, M., & George, A. P. (2021). Cervical lymphadenopathy following coronavirus disease 2019 vaccine: clinical characteristics and implications for head and neck cancer services. The Journal of Laryngology & Otology, 135(11), 1025-1030. | https://pubmed.ncbi.nlm.nih.gov/34526175/ | Abou-Foul, A. K., Ross, E., Abou-Foul, M., & George, A. P. (2021). Cervical lymphadenopathy following coronavirus disease 2019 vaccine: clinical characteristics and implications for head and neck cancer services. The Journal of Laryngology & Otology, 135(11), 1025-1030. https://pubmed.ncbi.nlm.nih.gov/34526175/ | Tinoco, M., Leite, S., Faria, B., Cardoso, S., Von Hafe, P., Dias, G., ... & Lourenço, A. (2021). Perimyocarditis Following COVID-19 Vaccination. Clinical Medicine Insights: Cardiology, 15, 11795468211056634. https://pubmed.ncbi.nlm.nih.gov/34866957/ | ||||
684 | Association of receipt association of Ad26.COV2.S COVID-19 vaccine with presumed Guillain-Barre syndrome, February-July 2021: | https://jamanetwork.com/journals/jama/fullarticle/2785009 | https://pubmed.ncbi.nlm.nih.gov/34862234/ | Cory, P., Lawrence, H., Abdulrahim, H., Mahmood-Rao, H., Hussein, A., & Gane, J. (2021). Lessons of the month 3: Haemophagocytic lymphohistiocytosis following COVID-19 vaccination (ChAdOx1 nCoV-19). Clinical Medicine, 21(6), e677-e679. | Cory, P., Lawrence, H., Abdulrahim, H., Mahmood-Rao, H., Hussein, A. y Gane, J. (2021). Lecciones del mes 3: Linfohistiocitosis hemofagocítica tras la vacunación COVID-19 (ChAdOx1 nCoV-19). Medicina clínica, 21(6), e677-e679. https://pubmed.ncbi.nlm.nih.gov/34396358/. | PLOTKE, J. M., Reis, H., Hadaschik, E., Roesch, A., Schadeendorf, D., Stoffels, I., & Klode, J. (2021). Enfermedad de Coronavirus 2019 Vacuna imita las metástasis de los ganglios linfáticos en pacientes que se someten a un seguimiento del cáncer de piel: un estudio monocentro. Revista europea de cáncer, 154, 167-174. https://pubmed.ncbi.nlm.nih.gov/34432391/ | Cory, P., Lawrence, H., Abdulrahim, H., Mahmood-Rao, H., Hussein, A., & Gane, J. (2021). Lessons of the month 3: Haemophagocytic lymphohistiocytosis following COVID-19 vaccination (ChAdOx1 nCoV-19). Clinical Medicine, 21(6), e677-e679. https://pubmed.ncbi.nlm.nih.gov/34862234/ | Portuguese, A. J., Sunga, C., Kruse-Jarres, R., Gernsheimer, T., & Abkowitz, J. (2021). Autoimmune-and complement-mediated hematologic condition recrudescence following SARS-CoV-2 vaccination. Blood Advances, 5(13), 2794-2798. https://ashpublications.org/bloodadvances/article/5/13/2794/476324/Autoimmune-and-complement-mediated-hematologic | Hiller, N., Goldberg, S. N., Cohen-Cymberknoh, M., Vainstein, V., & Simanovsky, N. (2021). Lymphadenopathy associated with the COVID-19 vaccine. Cureus, 13(2). | https://pubmed.ncbi.nlm.nih.gov/33786231/ | Hiller, N., Goldberg, S. N., Cohen-Cymberknoh, M., Vainstein, V., & Simanovsky, N. (2021). Lymphadenopathy associated with the COVID-19 vaccine. Cureus, 13(2). https://pubmed.ncbi.nlm.nih.gov/33786231/ | Tobaiqy, M., MacLure, K., Elkout, H., & Stewart, D. (2021). Thrombotic adverse events reported for Moderna, Pfizer and Oxford-AstraZeneca COVID-19 vaccines: comparison of occurrence and clinical outcomes in the EudraVigilance database. Vaccines, 9(11), 1326. https://pubmed.ncbi.nlm.nih.gov/34835256/ | ||||
685 | A case of Guillain-Barré syndrome after Pfizer COVID-19 vaccine: | https://pubmed.ncbi.nlm.nih.gov/34567447/ | https://pubmed.ncbi.nlm.nih.gov/34396358/. | King, W. W., Petersen, M. R., Matar, R. M., Budweg, J. B., Pardo, L. C., & Petersen, J. W. (2021). Myocarditis following mRNA vaccination against SARS-CoV-2, a case series. American Heart Journal Plus: Cardiology Research and Practice, 8, 100042. | King, W. W., Petersen, M. R., Matar, R. M., Budweg, J. B., Pardo, L. C. y Petersen, J. W. (2021). Miocarditis tras la vacunación con ARNm contra el SARS-CoV-2, una serie de casos. American Heart Journal Plus: Investigación y práctica de cardiología, 8, 100042. https://pubmed.ncbi.nlm.nih.gov/34848426/. | Pomara, C., Sessa, F., Ciaccio, M., Dieli, F., Esposito, M., Garozzo, S. F., ... y Mannucci, P. M. (2021). Hallazgos post-mortem en trombocitopenia trombótica inducida por la vacuna. Haematologica, 106 (8), 2291. https://www.sciencedirect.com/science/article/pii/S0264410X21005247 | King, W. W., Petersen, M. R., Matar, R. M., Budweg, J. B., Pardo, L. C., & Petersen, J. W. (2021). Myocarditis following mRNA vaccination against SARS-CoV-2, a case series. American Heart Journal Plus: Cardiology Research and Practice, 8, 100042. https://pubmed.ncbi.nlm.nih.gov/34396358/. | Pottegård, A., Lund, L. C., Karlstad, Ø., Dahl, J., Andersen, M., Hallas, J., ... & Hviid, A. (2021). Arterial events, venous thromboembolism, thrombocytopenia, and bleeding after vaccination with Oxford-AstraZeneca ChAdOx1-S in Denmark and Norway: population based cohort study. bmj, 373. https://pubmed.ncbi.nlm.nih.gov/33952445/ | Hanneman, K., Iwanochko, R. M., & Thavendiranathan, P. (2021). Evolution of lymphadenopathy at PET/MRI after COVID-19 vaccination. Radiology, 299(3), E282-E282. | https://pubmed.ncbi.nlm.nih.gov/33625301/. | Hanneman, K., Iwanochko, R. M., & Thavendiranathan, P. (2021). Evolution of lymphadenopathy at PET/MRI after COVID-19 vaccination. Radiology, 299(3), E282-E282. https://pubmed.ncbi.nlm.nih.gov/33625301/. | Toida, R., Uezono, S., Komatsu, H., Toida, T., Imamura, A., Fujimoto, S., & Kaikita, K. (2021). Takotsubo cardiomyopathy after vaccination for coronavirus disease 2019 in a patient on maintenance hemodialysis. CEN Case Reports, 1-5. https://pubmed.ncbi.nlm.nih.gov/34731486/. | ||||
686 | Guillain-Barré syndrome associated with COVID-19 vaccination: | https://pubmed.ncbi.nlm.nih.gov/34648420/. | https://pubmed.ncbi.nlm.nih.gov/34848426/. | Dang, Y. L., & Bryson, A. (2021). Miller-Fisher Syndrome and Guillain-Barre Syndrome overlap syndrome in a patient post Oxford-AstraZeneca SARS-CoV-2 vaccination. BMJ Case Reports CP, 14(11), e246701. | Dang, YL y Bryson, A. (2021). El síndrome de Miller-Fisher y el síndrome de Guillain-Barré se superponen en un paciente después de la vacunación con Oxford-AstraZeneca SARS-CoV-2. Informes de casos de BMJ CP, 14(11), e246701. https://pubmed.ncbi.nlm.nih.gov/34591186/ | Pomara, C., Sessa, F., Ciaccio, M., Dieli, F., Esposito, M., Giammanco, G. M., ... & Zamboni, P. (2021). COVID-19 Vacuna y muerte: algoritmo de causalidad de acuerdo con el diagnóstico de elegibilidad de la OMS. Diagnóstico, 11 (6), 955. https://pubmed.ncbi.nlm.nih.gov/34423106/ | Dang, Y. L., & Bryson, A. (2021). Miller-Fisher Syndrome and Guillain-Barre Syndrome overlap syndrome in a patient post Oxford-AstraZeneca SARS-CoV-2 vaccination. BMJ Case Reports CP, 14(11), e246701. https://pubmed.ncbi.nlm.nih.gov/34848426/. | Prasad, A., Hurlburt, G., Podury, S., Tandon, M., Kingree, S., & Sriwastava, S. (2021). A novel case of bifacial diplegia variant of guillain-Barré syndrome following Janssen COVID-19 vaccination. Neurology International, 13(3), 404-409. https://pubmed.ncbi.nlm.nih.gov/34449715/ | Lim, J. H., Han, M. H., Kim, Y. J., Kim, M. S., Jung, H. Y., Choi, J. Y., ... & Park, S. H. (2021). New-onset nephrotic syndrome after Janssen COVID-19 vaccination: a case report and literature review. Journal of Korean Medical Science, 36(30). | https://pubmed.ncbi.nlm.nih.gov/34342187/. | Lim, J. H., Han, M. H., Kim, Y. J., Kim, M. S., Jung, H. Y., Choi, J. Y., ... & Park, S. H. (2021). New-onset nephrotic syndrome after Janssen COVID-19 vaccination: a case report and literature review. Journal of Korean Medical Science, 36(30). https://pubmed.ncbi.nlm.nih.gov/34342187/. | Tølbøll Sørensen, A. L., Rolland, M., Hartmann, J., Harboe, Z. B., Roed, C., Jensen, T. Ø., ... & Stensballe, J. (2021). A case of thrombocytopenia and multiple thromboses after vaccination with ChAdOx1 nCoV-19 against SARS-CoV-2. Blood Advances, 5(12), 2569-2574. https://pubmed.ncbi.nlm.nih.gov/34137813/ | ||||
687 | Rate of recurrent Guillain-Barré syndrome after COVID-19 BNT162b2 mRNA vaccine: | https://jamanetwork.com/journals/jamaneurology/fullarticle/2783708 | https://pubmed.ncbi.nlm.nih.gov/34591186/ | Schneider, J., Sottmann, L., Greinacher, A., Hagen, M., Kasper, H. U., Kuhnen, C., ... & Schmeling, A. (2021). Postmortem investigation of fatalities following vaccination with COVID-19 vaccines. International Journal of Legal Medicine, 135(6), 2335-2345. | Schneider, J., Sottmann, L., Greinacher, A., Hagen, M., Kasper, H. U., Kuhnen, C., ... y Schmeling, A. (2021). Investigación post mortem de muertes tras la vacunación con vacunas COVID-19. Revista Internacional de Medicina Legal, 135(6), 2335-2345. https://pubmed.ncbi.nlm.nih.gov/34352309/ | Porles-Aguilar, M., Lazo-Langner, A., Panduro, A. y Uribe, M. (2021). COVID-19 Trombocitopenia trombótica inmune inducida por la vacuna: una causa emergente de trombosis vena esplácida. Anales de hepatología. https://www.sciencedirect.com/science/article/pii/S1050173821000967 | Schneider, J., Sottmann, L., Greinacher, A., Hagen, M., Kasper, H. U., Kuhnen, C., ... & Schmeling, A. (2021). Postmortem investigation of fatalities following vaccination with COVID-19 vaccines. International Journal of Legal Medicine, 135(6), 2335-2345. https://pubmed.ncbi.nlm.nih.gov/34591186/ | Premkumar, M., Bhujade, H., Karki, T., Chaluvashetty, S. B., Kaur, H., Duseja, A. K., & Singh, V. (2021). New Portal Vein Thrombosis in Cirrhosis-is the thrombophilia exacerbated due to Vaccine or COVID-19?. Journal of Clinical and Experimental Hepatology. https://www.jcehepatology.com/article/S0973-6883(21)00545-4/fulltext. | Ganga, K., Solyar, A. Y., & Ganga, R. (2021). Massive Cervical Lymphadenopathy Post-COVID-19 Vaccination. Ear, Nose & Throat Journal, 01455613211048984. | https://pubmed.ncbi.nlm.nih.gov/34601889/ | Ganga, K., Solyar, A. Y., & Ganga, R. (2021). Massive Cervical Lymphadenopathy Post-COVID-19 Vaccination. Ear, Nose & Throat Journal, 01455613211048984. https://pubmed.ncbi.nlm.nih.gov/34601889/ | Trimboli, M., Zoleo, P., Arabia, G., & Gambardella, A. (2021). Guillain-Barré syndrome following BNT162b2 COVID-19 vaccine. Neurological Sciences, 42(11), 4401-4402. https://link.springer.com/article/10.1007%2Fs10072-021-05523-5. | ||||
688 | Guillain-Barre syndrome after COVID-19 vaccination in an adolescent: | https://www.pedneur.com/article/S0887-8994(21)00221-6/fulltext. | https://pubmed.ncbi.nlm.nih.gov/34352309/ | Plasse, R., Nee, R., Gao, S., & Olson, S. (2021). Acute kidney injury with gross hematuria and IgA nephropathy after COVID-19 vaccination. Kidney international, 100(4), 944-945. | Plasse, R., Nee, R., Gao, S. y Olson, S. (2021). Lesión renal aguda con hematuria macroscópica y nefropatía por IgA después de la vacunación contra COVID-19. Riñón internacional, 100(4), 944-945. https://pubmed.ncbi.nlm.nih.gov/34804803/. | Portugués, A. J., Sunga, C., Kruse-Jarres, R., GERNSHEIMER, T., & ABKOWITZ, J. (2021). Autoimmune-and complement-mediado por la recrudencia de la condición hematológica mediada por la vacunación con SARS-COV-2. Avances de sangre, 5 (13), 2794-2798. https://ejhp.bmj.com/content/early/2021/05/23/ejhpharm-2021-002794 | Plasse, R., Nee, R., Gao, S., & Olson, S. (2021). Acute kidney injury with gross hematuria and IgA nephropathy after COVID-19 vaccination. Kidney international, 100(4), 944-945. https://pubmed.ncbi.nlm.nih.gov/34352309/ | Purkayastha, P., Mckechnie, C., Kalkur, P., & Scully, M. (2021). Rare case of COVID-19 vaccine-associated intracranial haemorrhage with venous sinus thrombosis. BMJ Case Reports CP, 14(9), e245092. https://pubmed.ncbi.nlm.nih.gov/34556531/ | Sekar, A., Campbell, R., Tabbara, J., & Rastogi, P. (2021). ANCA glomerulonephritis after the Moderna COVID-19 vaccination. Kidney international, 100(2), 473-474. | https://pubmed.ncbi.nlm.nih.gov/34081948/ | Sekar, A., Campbell, R., Tabbara, J., & Rastogi, P. (2021). ANCA glomerulonephritis after the Moderna COVID-19 vaccination. Kidney international, 100(2), 473-474. https://pubmed.ncbi.nlm.nih.gov/34081948/ | Trogstad, L., Robertson, A. H., Mjaaland, S., & Magnus, P. (2021). Association between ChAdOx1 nCoV-19 vaccination and bleeding episodes: Large population-based cohort study. Vaccine, 39(40), 5854-5857. https://pubmed.ncbi.nlm.nih.gov/34479760/. | ||||
689 | Guillain-Barre syndrome after ChAdOx1-S / nCoV-19 vaccination: | https://pubmed.ncbi.nlm.nih.gov/34114256/. | https://pubmed.ncbi.nlm.nih.gov/34804803/. | Qasim, H., Ali, E., & Yassin, M. A. (2021). Immune thrombocytopenia relapse post covid-19 vaccine in young male patient. IDCases, 26, e01344. | Qasim, H., Ali, E. y Yassin, MA (2021). Recaída de trombocitopenia inmune post vacuna covid-19 en paciente varón joven. IDCasos, 26, e01344. https://pubmed.ncbi.nlm.nih.gov/34077572/ | Pottegård, A., Lund, L. C., Karlstad, Ø., Dahl, J., Andersen, M., Hallas, J., ... & hviid, A. (2021). Eventos arteriales, tromboembolismo venoso, trombocitopenia y sangrado después de la vacunación con Oxford-AstraZeneca Chadox1-S en Dinamarca y Noruega: estudio de cohorte basado en la población. BMJ, 373. https://pubmed.ncbi.nlm.nih.gov/34108714/ | Qasim, H., Ali, E., & Yassin, M. A. (2021). Immune thrombocytopenia relapse post covid-19 vaccine in young male patient. IDCases, 26, e01344. https://pubmed.ncbi.nlm.nih.gov/34804803/. | Qasim, H., Ali, E., & Yassin, M. A. (2021). Immune thrombocytopenia relapse post covid-19 vaccine in young male patient. IDCases, 26, e01344. https://pubmed.ncbi.nlm.nih.gov/34804803/. | Notghi, A. A., Atley, J., & Silva, M. (2021). Lessons of the month 1: Longitudinal extensive transverse myelitis following AstraZeneca COVID-19 vaccination. Clinical Medicine, 21(5), e535. | https://pubmed.ncbi.nlm.nih.gov/34507942/. | Notghi, A. A., Atley, J., & Silva, M. (2021). Lessons of the month 1: Longitudinal extensive transverse myelitis following AstraZeneca COVID-19 vaccination. Clinical Medicine, 21(5), e535. https://pubmed.ncbi.nlm.nih.gov/34507942/. | Truong, D. T., Dionne, A., Muniz, J. C., McHugh, K. E., Portman, M. A., Lambert, L. M., ... & Newburger, J. W. (2021). Clinically suspected myocarditis temporally related to COVID-19 vaccination in adolescents and young adults. Circulation. https://www.ahajournals.org/doi/abs/10.1161/CIRCULATIONAHA.121.056583?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed | ||||
690 | Guillain-Barre syndrome after COVID-19 mRNA-1273 vaccine: case report: | https://pubmed.ncbi.nlm.nih.gov/34767184/. | https://pubmed.ncbi.nlm.nih.gov/34077572/ | Krajewski, P. K., & Szepietowski, J. C. (2021). Immune thrombocytopenic purpura associated with COVID‐19 Pfizer‐BioNTech BNT16B2b2 mRNA vaccine. Journal of the European Academy of Dermatology and Venereology. | Krajewski, PK y Szepietowski, JC (2021). Púrpura trombocitopénica inmunitaria asociada con la vacuna de ARNm COVID-19 Pfizer-BioNTech BNT16B2b2. Revista de la Academia Europea de Dermatología y Venereología. https://pubmed.ncbi.nlm.nih.gov/34884407/. | Prasad, A., Hurlburt, G., Podury, S., Tandon, M., Kingree, S., & Sriwastava, S. (2021). Un nuevo caso de variante bifacial de diplegia del síndrome de Guillain-Barré siguiendo la vacunación Janssen Covid-19. Neurología Internacional, 13 (3), 404-409. https://pubmed.ncbi.nlm.nih.gov/34139631/. | Krajewski, P. K., & Szepietowski, J. C. (2021). Immune thrombocytopenic purpura associated with COVID‐19 Pfizer‐BioNTech BNT16B2b2 mRNA vaccine. Journal of the European Academy of Dermatology and Venereology. https://pubmed.ncbi.nlm.nih.gov/34077572/ | Rahim, S. E. G., Lin, J. T., & Wang, J. C. (2021). A case of gross hematuria and IgA nephropathy flare-up following SARS-CoV-2 vaccination. Kidney international, 100(1), 238. https://pubmed.ncbi.nlm.nih.gov/33932458/ | Plaza, M. J., Wright, J., & Fernandez, S. (2021). COVID-19 vaccine-related unilateral axillary lymphadenopathy: pattern on screening breast MRI allowing for a benign assessment. Clinical Imaging, 80, 139-141. | https://pubmed.ncbi.nlm.nih.gov/34325221/ | Plaza, M. J., Wright, J., & Fernandez, S. (2021). COVID-19 vaccine-related unilateral axillary lymphadenopathy: pattern on screening breast MRI allowing for a benign assessment. Clinical Imaging, 80, 139-141. https://pubmed.ncbi.nlm.nih.gov/34325221/ | Tsilingiris, D., Vallianou, N. G., Karampela, Ι., & Dalamaga, Μ. (2021). Vaccine induced thrombotic thrombocytopenia: the shady chapter of a success story. Metabolism open, 11, 100101. https://www.sciencedirect.com/science/article/pii/S2589936821000256 | ||||
691 | Guillain-Barre syndrome following SARS-CoV-2 vaccination in 19 patients: | https://pubmed.ncbi.nlm.nih.gov/34644738/. | https://pubmed.ncbi.nlm.nih.gov/34884407/. | Park, H. S., Byun, Y., Byeon, S. H., Kim, S. S., Kim, Y. J., & Lee, C. S. (2021). Retinal Hemorrhage after SARS-CoV-2 Vaccination. Journal of Clinical Medicine, 10(23), 5705. | Park, H. S., Byun, Y., Byeon, S. H., Kim, S. S., Kim, Y. J. y Lee, C. S. (2021). Hemorragia retiniana tras la vacunación contra el SARS-CoV-2. Revista de Medicina Clínica, 10(23), 5705. https://pubmed.ncbi.nlm.nih.gov/34859017/ | Premkumar, M., Bhujade, H., Karki, T., Chaluvashetty, S. B., Kaur, H., DUSJA, A. K., & Singh, V. (2021). La trombosis de la vena del portal en cirrosis, ¿se exacerba la trombofilia debido a la vacuna o la covid-19? Diario de hepatología clínica y experimental. https://pubmed.ncbi.nlm.nih.gov/33962903/. | Park, H. S., Byun, Y., Byeon, S. H., Kim, S. S., Kim, Y. J., & Lee, C. S. (2021). Retinal Hemorrhage after SARS-CoV-2 Vaccination. Journal of Clinical Medicine, 10(23), 5705. https://pubmed.ncbi.nlm.nih.gov/34884407/. | Raj, S., Ogola, G., & Han, J. (2022). COVID-19 vaccine-associated subclinical axillary lymphadenopathy on screening mammogram. Academic radiology, 29(4), 501-507. https://pubmed.ncbi.nlm.nih.gov/34906409/ | Ashoor, A., Shephard, J., Lissidini, G., & Nicosia, L. (2021). Axillary adenopathy in patients with recent Covid-19 vaccination: a new diagnostic dilemma. Korean Journal of Radiology, 22(12), 2124. | https://pubmed.ncbi.nlm.nih.gov/34825530/. | Ashoor, A., Shephard, J., Lissidini, G., & Nicosia, L. (2021). Axillary adenopathy in patients with recent Covid-19 vaccination: a new diagnostic dilemma. Korean Journal of Radiology, 22(12), 2124. https://pubmed.ncbi.nlm.nih.gov/34825530/. | Tun, G. S. Z., Gleeson, D., Al-Joudeh, A., & Dube, A. (2022). Immune-mediated hepatitis with the Moderna vaccine, no longer a coincidence but confirmed. Journal of Hepatology, 76(3), 747-749. https://www.sciencedirect.com/science/article/pii/S0168827821020936 | ||||
692 | Guillain-Barre syndrome presenting with facial diplegia following vaccination with COVID-19 in two patients: | https://pubmed.ncbi.nlm.nih.gov/34649856/ | https://pubmed.ncbi.nlm.nih.gov/34859017/ | Chen, C. C., Chen, H. Y., Lu, C. C., & Lin, S. H. (2021). Case Report: Anti-neutrophil Cytoplasmic Antibody-Associated Vasculitis With Acute Renal Failure and Pulmonary Hemorrhage May Occur After COVID-19 Vaccination. Frontiers in Medicine, 8. | Chen, C. C., Chen, H. Y., Lu, C. C. y Lin, SH (2021). Informe de caso: Puede ocurrir vasculitis asociada a anticuerpos anticitoplasma de neutrófilos con insuficiencia renal aguda y hemorragia pulmonar después de la vacunación contra el COVID-19. Fronteras en Medicina, 8. https://pubmed.ncbi.nlm.nih.gov/34783899/ | Purkayastha, P., McKechnie, C., Kalkur, P., & Scully, M. (2021). Caso raro de COVID-19 hemorragia intracraneal asociada a la vacuna con la trombosis sinusal venosa. BMJ Case Reports CP, 14 (9), E245092. https://pubmed.ncbi.nlm.nih.gov/34535076/ | Chen, C. C., Chen, H. Y., Lu, C. C., & Lin, S. H. (2021). Case Report: Anti-neutrophil Cytoplasmic Antibody-Associated Vasculitis With Acute Renal Failure and Pulmonary Hemorrhage May Occur After COVID-19 Vaccination. Frontiers in Medicine, 8. https://pubmed.ncbi.nlm.nih.gov/34859017/ | Ramdeny, S., Lang, A., Al‐Izzi, S., Hung, A., Anwar, I., & Kumar, P. (2021). Management of a patient with a rare congenital limb malformation syndrome after SARS‐CoV‐2 vaccine‐induced thrombosis and thrombocytopenia (VITT). British Journal of Haematology. https://pubmed.ncbi.nlm.nih.gov/34097311/ | D’Agati, V. D., Kudose, S., Bomback, A. S., Adamidis, A., & Tartini, A. (2021). Minimal change disease and acute kidney injury following the Pfizer-BioNTech COVID-19 vaccine. Kidney international, 100(2), 461-463. | https://pubmed.ncbi.nlm.nih.gov/34000278/ | D’Agati, V. D., Kudose, S., Bomback, A. S., Adamidis, A., & Tartini, A. (2021). Minimal change disease and acute kidney injury following the Pfizer-BioNTech COVID-19 vaccine. Kidney international, 100(2), 461-463. https://pubmed.ncbi.nlm.nih.gov/34000278/ | Turi, M. C., Spitaleri, F., Gori, A. M., Parruti, G., Rogolino, A. A., Albani, A., ... & Marcucci, R. (2021). A case of vaccine-induced immune thrombotic thrombocytopenia with massive artero-venous thrombosis. Blood Transfusion, 19(4), 343. https://pubmed.ncbi.nlm.nih.gov/34059191/ | ||||
693 | A rare case of Guillain-Barré syndrome after COVID-19 vaccination: | https://pubmed.ncbi.nlm.nih.gov/34671572/ | https://pubmed.ncbi.nlm.nih.gov/34783899/ | Takeyama, R., Fukuda, K., Kouzaki, Y., Koga, T., Hayashi, S., Ohtani, H., & Inoue, T. (2022). Intracerebral hemorrhage due to vasculitis following COVID-19 vaccination: a case report. Acta neurochirurgica, 164(2), 543-547. | Takeyama, R., Fukuda, K., Kouzaki, Y., Koga, T., Hayashi, S., Ohtani, H. e Inoue, T. (2022). Hemorragia intracerebral por vasculitis tras la vacunación COVID-19: reporte de un caso. Acta neurochirurgica, 164(2), 543-547. https://pubmed.ncbi.nlm.nih.gov/34549178/. | Qasim, H., Ali, E., & Yassin, M. A. (2021). Relapse de trombocitopenia inmune Post Covid-19 Vacuna en paciente masculino joven. Idrases, 26, E01344. https://pubmed.ncbi.nlm.nih.gov/34077572/ | Takeyama, R., Fukuda, K., Kouzaki, Y., Koga, T., Hayashi, S., Ohtani, H., & Inoue, T. (2022). Intracerebral hemorrhage due to vasculitis following COVID-19 vaccination: a case report. Acta neurochirurgica, 164(2), 543-547. https://pubmed.ncbi.nlm.nih.gov/34783899/ | Ramessur, R., Saffar, N., Czako, B., Agarwal, A., & Batta, K. (2021). Cutaneous thrombosis associated with skin necrosis following Oxford‐AstraZeneca COVID‐19 vaccination. Clinical and Experimental Dermatology. https://pubmed.ncbi.nlm.nih.gov/34189756/ | Igual-Rouilleault, A. C., Soriano, I., Quan, P. L., Fernández-Montero, A., Elizalde, A., & Pina, L. (2021). Unilateral axillary adenopathy induced by COVID-19 vaccine: US follow-up evaluation. European Radiology, 1-8. | https://pubmed.ncbi.nlm.nih.gov/34655312/. | Igual-Rouilleault, A. C., Soriano, I., Quan, P. L., Fernández-Montero, A., Elizalde, A., & Pina, L. (2021). Unilateral axillary adenopathy induced by COVID-19 vaccine: US follow-up evaluation. European Radiology, 1-8. https://pubmed.ncbi.nlm.nih.gov/34655312/. | Turk, V. E. (2021). Anaphylaxis associated with the mRNA COVID-19 vaccines: approach to allergy investigation. Clinical Immunology, 227, 108748. https://pubmed.ncbi.nlm.nih.gov/33932618/ | ||||
694 | Neurological complications of COVID-19: Guillain-Barre syndrome after Pfizer COVID-19 vaccine: | https://pubmed.ncbi.nlm.nih.gov/33758714/ | https://pubmed.ncbi.nlm.nih.gov/34549178/. | Finsterer, J., & Redzic, Z. (2021). Symptomatic peduncular, cavernous bleeding following SARS-CoV-2 vaccination induced immune thrombocytopenia. Brain Hemorrhages, 2(4), 169-171. | Finsterer, J. y Redzic, Z. (2021). Sangrado cavernoso peduncular sintomático después de la trombocitopenia inmune inducida por la vacunación contra el SARS-CoV-2. Hemorragias cerebrales, 2(4), 169-171. https://pubmed.ncbi.nlm.nih.gov/34656887/ | Rahim, S. E. G., Lin, J. T., & Wang, J. C. (2021). Un caso de hematuria bruta y dofropatía IgA brotes siguiendo la vacunación de SARS-COV-2. Ridney International, 100 (1), 238. https://pubmed.ncbi.nlm.nih.gov/34092400/742. | Finsterer, J., & Redzic, Z. (2021). Symptomatic peduncular, cavernous bleeding following SARS-CoV-2 vaccination induced immune thrombocytopenia. Brain Hemorrhages, 2(4), 169-171. https://pubmed.ncbi.nlm.nih.gov/34549178/. | Ramírez-García, A., Jiménez, S., Ximénez, I., Cacho, A., Aguado-Noya, R., & Cubero, J. (2021). Pericarditis tras la administración de la vacuna de ARNm BNT162b2 contra la COVID-19 Pericarditis after administration of the BNT162b2 mRNA COVID-19 vaccine. Revista espanola de cardiologia. https://pubmed.ncbi.nlm.nih.gov/34149145/ | Scott, J., Anderson, J., Mallak, N., Beitinjaneh, B., Wei, K., & Otaki, F. (2021). Gastroparesis After Pfizer-BioNTech COVID-19 Vaccination. Official journal of the American College of Gastroenterology| ACG, 116(11), 2300. | https://pubmed.ncbi.nlm.nih.gov/34187985/. | Scott, J., Anderson, J., Mallak, N., Beitinjaneh, B., Wei, K., & Otaki, F. (2021). Gastroparesis After Pfizer-BioNTech COVID-19 Vaccination. Official journal of the American College of Gastroenterology| ACG, 116(11), 2300. https://pubmed.ncbi.nlm.nih.gov/34187985/. | Turner, P. J., Ansotegui, I. J., Campbell, D. E., Cardona, V., Ebisawa, M., El-Gamal, Y., ... & WAO Anaphylaxis Committee. (2021). COVID-19 vaccine-associated anaphylaxis: a statement of the World Allergy Organization Anaphylaxis Committee. World Allergy Organization Journal, 14(2), 100517. https://www.sciencedirect.com/science/article/pii/S1939455121000119. | ||||
695 | COVID-19 vaccine causing Guillain-Barre syndrome, an uncommon potential side effect: | https://pubmed.ncbi.nlm.nih.gov/34484780/ | https://pubmed.ncbi.nlm.nih.gov/34656887/ | Watchmaker, J. M., & Belani, P. B. (2022). Brain death in a vaccinated patient with COVID-19 infection. Clinical Imaging, 81, 92-95. | Relojero, JM y Belani, PB (2022). Muerte cerebral en un paciente vacunado con infección por COVID-19. Imágenes clínicas, 81, 92-95. https://pubmed.ncbi.nlm.nih.gov/34236717/. | Raj, S., Ogola, G., & Han, J. (2022). COVID-19 Linfadenopatía axilar subclínica asociada a la vacuna en la mamografía de detección. Radiología académica, 29 (4), 501-507. https://pubmed.ncbi.nlm.nih.gov/33706861/ | Watchmaker, J. M., & Belani, P. B. (2022). Brain death in a vaccinated patient with COVID-19 infection. Clinical Imaging, 81, 92-95. https://pubmed.ncbi.nlm.nih.gov/34656887/ | Ramírez-García, A., Jiménez, S., Ximénez, I., Cacho, A., Aguado-Noya, R., & Cubero, J. (2021). Pericarditis tras la administración de la vacuna de ARNm BNT162b2 contra la COVID-19 Pericarditis after administration of the BNT162b2 mRNA COVID-19 vaccine. Revista espanola de cardiologia. https://pubmed.ncbi.nlm.nih.gov/34364831/ | Mouch, S. A., Roguin, A., Hellou, E., Ishai, A., Shoshan, U., Mahamid, L., ... & Yanay, N. B. (2021). Myocarditis following COVID-19 mRNA vaccination. Vaccine, 39(29), 3790-3793. | https://www.ncbi.nlm.nih.gov/pubmed/34092429 | Mouch, S. A., Roguin, A., Hellou, E., Ishai, A., Shoshan, U., Mahamid, L., ... & Yanay, N. B. (2021). Myocarditis following COVID-19 mRNA vaccination. Vaccine, 39(29), 3790-3793. https://www.ncbi.nlm.nih.gov/pubmed/34092429 | Tutar, N. K., Eyigürbüz, T., Yildirim, Z., & Kale, N. (2021). A variant of Guillain-Barre syndrome after SARS-CoV-2 vaccination: AMSAN. Ideggyogyaszati Szemle, 74(7-08), 286-288. https://pubmed.ncbi.nlm.nih.gov/34370408/. | ||||
696 | Guillain-Barre syndrome after the first dose of COVID-19 vaccination: case report; | https://pubmed.ncbi.nlm.nih.gov/34779385/. | https://pubmed.ncbi.nlm.nih.gov/34236717/. | Falkenhain‐López, D., Gutiérrez‐Collar, C., Arroyo‐Andrés, J., Gallego‐Gutiérrez, I., Rodríguez‐Peralto, J. L., & Sánchez‐Velázquez, A. (2021). Widespread purpura annularis telangiectodes following mRNA SARS‐CoV‐2 vaccine. Journal of the European Academy of Dermatology and Venereology. | Falkenhain‐López, D., Gutiérrez‐Collar, C., Arroyo‐Andrés, J., Gallego‐Gutiérrez, I., Rodríguez‐Peralto, J. L., & Sánchez‐Velázquez, A. (2021). Telangiectodos de púrpura anular generalizada después de la vacuna de ARNm contra el SARS-CoV-2. Revista de la Academia Europea de Dermatología y Venereología. https://pubmed.ncbi.nlm.nih.gov/34729467/. | Ramdedy, S., Lang, A., al-Izzi, S., Hung, A., Anwar, I., & Kumar, P. (2021). Gestión de un paciente con un síndrome de malformación de extremidades congénitas raras después de la trombosis inducida por la vacuna contra el SARS-COV-2 y la trombocitopenia (VITT). British Journal of Hematology. https://pubmed.ncbi.nlm.nih.gov/34820232/. | Falkenhain‐López, D., Gutiérrez‐Collar, C., Arroyo‐Andrés, J., Gallego‐Gutiérrez, I., Rodríguez‐Peralto, J. L., & Sánchez‐Velázquez, A. (2021). Widespread purpura annularis telangiectodes following mRNA SARS‐CoV‐2 vaccine. Journal of the European Academy of Dermatology and Venereology. https://pubmed.ncbi.nlm.nih.gov/34236717/. | Ramírez-García, A., Jiménez, S., Ximénez, I., Cacho, A., Aguado-Noya, R., & Cubero, J. (2021). Pericarditis tras la administración de la vacuna de ARNm BNT162b2 contra la COVID-19 Pericarditis after administration of the BNT162b2 mRNA COVID-19 vaccine. Revista espanola de cardiologia. https://www.sciencedirect.com/science/article/pii/S1885585721002218 | Albert, E., Aurigemma, G., Saucedo, J., & Gerson, D. S. (2021). Myocarditis following COVID-19 vaccination. Radiology case reports, 16(8), 2142-2145. | https://www.ncbi.nlm.nih.gov/pubmed/34025885 | Albert, E., Aurigemma, G., Saucedo, J., & Gerson, D. S. (2021). Myocarditis following COVID-19 vaccination. Radiology case reports, 16(8), 2142-2145. https://www.ncbi.nlm.nih.gov/pubmed/34025885 | Tutor, A., Unis, G., Ruiz, B., Bolaji, O. A., & Bob-Manuel, T. (2021). Spectrum of Suspected Cardiomyopathy Due to COVID-19: A Case Series. Current Problems in Cardiology, 46(10), 100926. https://www.ncbi.nlm.nih.gov/pubmed/34311983 | ||||
697 | Miller Fisher syndrome after Pfizer COVID-19 vaccine: | https://pubmed.ncbi.nlm.nih.gov/34817727/. | https://pubmed.ncbi.nlm.nih.gov/34729467/. | Finsterer, J. (2021). Lobar bleeding with ventricular rupture shortly after first dosage of an mRNA-based SARS-CoV-2 vaccine. Brain hemorrhages. | Finsterer, J. (2021). Sangrado lobar con rotura ventricular poco después de la primera dosis de una vacuna contra el SARS-CoV-2 basada en ARNm. Hemorragias cerebrales. https://pubmed.ncbi.nlm.nih.gov/33932458/ | Ramessur, R., Saffar, N., CZAKO, B., Agarwal, A., & Batta, K. (2021). Trombosis cutánea asociada con la necrosis de la piel después de la vacunación Oxford-AstraZeneca COVID-19. Dermatología clínica y experimental. https://pubmed.ncbi.nlm.nih.gov/34045111/. | Finsterer, J. (2021). Lobar bleeding with ventricular rupture shortly after first dosage of an mRNA-based SARS-CoV-2 vaccine. Brain hemorrhages. https://pubmed.ncbi.nlm.nih.gov/34729467/. | Ramos, F. J. M., Corrales, A. E., & Puchades, A. M. (2021). Acral haemorrhage after the second dose administration of SARS-CoV-2 vaccine. A post-vaccinal reaction?. Medicina Clinica (English Ed.), 157(10), 506. https://pubmed.ncbi.nlm.nih.gov/34092400/742. | Bhandari, M., Pradhan, A., Vishwakarma, P., & Sethi, R. (2021). Coronavirus and cardiovascular manifestations-getting to the heart of the matter. World Journal of Cardiology, 13(10), 556. | https://www.ncbi.nlm.nih.gov/pubmed/34754400 | Bhandari, M., Pradhan, A., Vishwakarma, P., & Sethi, R. (2021). Coronavirus and cardiovascular manifestations-getting to the heart of the matter. World Journal of Cardiology, 13(10), 556. https://www.ncbi.nlm.nih.gov/pubmed/34754400 | Tuyls, S., Van Der Brempt, X., Faber, M., Gadisseur, R., Dezfoulian, B., Schrijvers, R., & Froidure, A. (2021). Allergic reactions to COVID-19 vaccines: statement of the Belgian Society for Allergy and Clinical Immunology (BelSACI). Acta Clinica Belgica, 1-6. https://www.tandfonline.com/doi/abs/10.1080/17843286.2021.1909447 | ||||
698 | Miller Fisher syndrome after 2019 BNT162b2 mRNA coronavirus vaccination: | https://pubmed.ncbi.nlm.nih.gov/34789193/. | https://pubmed.ncbi.nlm.nih.gov/33932458/ | Rahim, S. E. G., Lin, J. T., & Wang, J. C. (2021). A case of gross hematuria and IgA nephropathy flare-up following SARS-CoV-2 vaccination. Kidney international, 100(1), 238. | Rahim, SEG, Lin, JT y Wang, JC (2021). Un caso de hematuria macroscópica y brote de nefropatía por IgA después de la vacunación contra el SARS-CoV-2. Riñón internacional, 100(1), 238. https://pubmed.ncbi.nlm.nih.gov/34092400/742. | Ramírez-García, A., Jiménez, S., Ximénez, I., Cacho, A., Aguado-Noya, R., & Cubero, J. (2021). Pericarditis Tras la Administración de la Vacuna de Arnm BNT162B2 Contra LA COVID-19 Pericarditis Después de la administración del BNT162B2 MRNA COVID-19 Vacuna. Revista Española de Cardiologia. https://pubmed.ncbi.nlm.nih.gov/34514306/ | Rahim, S. E. G., Lin, J. T., & Wang, J. C. (2021). A case of gross hematuria and IgA nephropathy flare-up following SARS-CoV-2 vaccination. Kidney international, 100(1), 238. https://pubmed.ncbi.nlm.nih.gov/33932458/ | Rao, S. J., Khurana, S., Murthy, G., Dawson, E. T., Jazebi, N., & Haas, C. J. (2021). A case of Guillain–Barre syndrome following Pfizer COVID-19 vaccine. Journal of Community Hospital Internal Medicine Perspectives, 11(5), 597-600. https://pubmed.ncbi.nlm.nih.gov/34567447/ | Buchhorn, R., Meyer, C., Schulze-Forster, K., Junker, J., & Heidecke, H. (2021). Autoantibody Release in Children after Corona Virus mRNA Vaccination: A Risk Factor of Multisystem Inflammatory Syndrome?. Vaccines, 9(11), 1353. | https://www.ncbi.nlm.nih.gov/pubmed/34835284 | Buchhorn, R., Meyer, C., Schulze-Forster, K., Junker, J., & Heidecke, H. (2021). Autoantibody Release in Children after Corona Virus mRNA Vaccination: A Risk Factor of Multisystem Inflammatory Syndrome?. Vaccines, 9(11), 1353. https://www.ncbi.nlm.nih.gov/pubmed/34835284 | Uaprasert, N., Panrong, K., Tungjitviboonkun, S., Dussadee, K., Decharatanachart, P., Kaveevorayan, P., ... & Rojnuckarin, P. (2022). ChAdOx1 nCoV-19 vaccine-associated thrombocytopenia: three cases of immune thrombocytopenia after 107 720 doses of ChAdOx1 vaccination in Thailand. Blood Coagulation & Fibrinolysis, 33(1), 67-70. https://pubmed.ncbi.nlm.nih.gov/34483267/. | ||||
699 | Bilateral facial weakness with a variant of paresthesia of Guillain-Barre syndrome after Vaxzevria COVID-19 vaccine: | https://pubmed.ncbi.nlm.nih.gov/34261746/ | https://pubmed.ncbi.nlm.nih.gov/34092400/742. | Ramos, F. J. M., Corrales, A. E., & Puchades, A. M. (2021). Acral haemorrhage after the second dose administration of SARS-CoV-2 vaccine. A post-vaccinal reaction?. Medicina Clinica (English Ed.), 157(10), 506. | Ramos, F. J. M., Corrales, A. E. y Puchades, A. M. (2021). Hemorragia acral tras la administración de la segunda dosis de la vacuna SARS-CoV-2. ¿Una reacción posvacunal?. Medicina Clínica (Ed. Inglesa), 157(10), 506. https://pubmed.ncbi.nlm.nih.gov/34754937/ | Ramírez-García, A., Jiménez, S., Ximénez, I., Cacho, A., Aguado-Noya, R., & Cubero, J. (2021). Pericarditis Tras la Administración de la Vacuna de Arnm BNT162B2 Contra LA COVID-19 Pericarditis Después de la administración del BNT162B2 MRNA COVID-19 Vacuna. Revista Española de Cardiologia. https://pubmed.ncbi.nlm.nih.gov/34693198/. | Ramos, F. J. M., Corrales, A. E., & Puchades, A. M. (2021). Acral haemorrhage after the second dose administration of SARS-CoV-2 vaccine. A post-vaccinal reaction?. Medicina Clinica (English Ed.), 157(10), 506. https://pubmed.ncbi.nlm.nih.gov/34092400/742. | Rela, M., Jothimani, D., Vij, M., Rajakumar, A., & Rammohan, A. (2021). Auto-immune hepatitis following COVID vaccination. Journal of Autoimmunity, 123, 102688. https://pubmed.ncbi.nlm.nih.gov/34225251/ | Calcaterra, G., Bassareo, P. P., Romeo, F., & Mehta, J. L. (2022). Concerning the unexpected prothrombotic state following some coronavirus disease 2019 vaccines. Journal of Cardiovascular Medicine, 23(2), 71-74. | https://www.ncbi.nlm.nih.gov/pubmed/34366403 | Calcaterra, G., Bassareo, P. P., Romeo, F., & Mehta, J. L. (2022). Concerning the unexpected prothrombotic state following some coronavirus disease 2019 vaccines. Journal of Cardiovascular Medicine, 23(2), 71-74. https://www.ncbi.nlm.nih.gov/pubmed/34366403 | Uaprasert, N., Watanaboonyongcharoen, P., Vichitratchaneekorn, R., Trithiphen, S., Akkawat, B., Sukperm, A., ... & Rojnuckarin, P. (2021). Prevalence of thrombocytopenia, anti–platelet factor 4 antibodies and D‐dimer elevation in Thai people After ChAdOx1 nCoV‐19 vaccination. Research and Practice in Thrombosis and Haemostasis, 5(6), e12580. https://pubmed.ncbi.nlm.nih.gov/34568726/ | ||||
700 | Guillain-Barre syndrome after the first injection of ChAdOx1 nCoV-19 vaccine: first report: | https://pubmed.ncbi.nlm.nih.gov/34217513/. | https://pubmed.ncbi.nlm.nih.gov/34754937/ | Cooper, K. M., & Switzer, B. (2021). Severe immune thrombocytopenic purpura after SARS-CoV-2 vaccine. Archive of Clinical Cases, 8(2), 31. | Cooper, KM y Switzer, B. (2021). Púrpura trombocitopénica inmunitaria grave después de la vacuna contra el SARS-CoV-2. Archivo de Casos Clínicos, 8(2), 31. https://pubmed.ncbi.nlm.nih.gov/33771584/ | Ramírez-García, A., Jiménez, S., Ximénez, I., Cacho, A., Aguado-Noya, R., & Cubero, J. (2021). Pericarditis Tras la Administración de la Vacuna de Arnm BNT162B2 Contra LA COVID-19 Pericarditis Después de la administración del BNT162B2 MRNA COVID-19 Vacuna. Revista Española de Cardiologia. https://www.sciencedirect.com/science/article/pii/S2589790X21001931 | Cooper, K. M., & Switzer, B. (2021). Severe immune thrombocytopenic purpura after SARS-CoV-2 vaccine. Archive of Clinical Cases, 8(2), 31. https://pubmed.ncbi.nlm.nih.gov/34754937/ | Repajic, M., Lai, X. L., Xu, P., & Liu, A. (2021). Bell’s Palsy after second dose of Pfizer COVID-19 vaccination in a patient with history of recurrent Bell’s palsy. Brain, Behavior, & Immunity-Health, 13, 100217. https://www.sciencedirect.com/science/article/pii/S266635462100020X | Chai, Q., Nygaard, U., Schmidt, R. C., Zaremba, T., Møller, A. M., & Thorvig, C. M. (2022). Multisystem inflammatory syndrome in a male adolescent after his second Pfizer‐BioNTech COVID‐19 vaccine. Acta Paediatrica, 111(1), 125-127. | https://www.ncbi.nlm.nih.gov/pubmed/34617315 | Chai, Q., Nygaard, U., Schmidt, R. C., Zaremba, T., Møller, A. M., & Thorvig, C. M. (2022). Multisystem inflammatory syndrome in a male adolescent after his second Pfizer‐BioNTech COVID‐19 vaccine. Acta Paediatrica, 111(1), 125-127. https://www.ncbi.nlm.nih.gov/pubmed/34617315 | Ujueta, F., Azimi, R., Lozier, M. R., Poppiti, R., & Ciment, A. (2021). Lymphohistocytic Myocarditis after Ad26. COV2. S viral vector COVID-19 vaccination. International journal of cardiology. Heart & vasculature. https://www.sciencedirect.com/science/article/pii/S2352906721001573 | ||||
701 | A case of sensory ataxic Guillain-Barre syndrome with immunoglobulin G anti-GM1 antibodies after first dose of COVID-19 BNT162b2 mRNA vaccine (Pfizer): | https://pubmed.ncbi.nlm.nih.gov/34871447/ | https://pubmed.ncbi.nlm.nih.gov/33771584/ | Negrea, L., & Rovin, B. H. (2021). Gross hematuria following vaccination for severe acute respiratory syndrome coronavirus 2 in 2 patients with IgA nephropathy. Kidney international, 99(6), 1487. | Negrea, L. y Rovin, BH (2021). Hematuria macroscópica tras la vacunación contra el síndrome respiratorio agudo grave coronavirus 2 en 2 pacientes con nefropatía por IgA. Riñón internacional, 99(6), 1487. https://pubmed.ncbi.nlm.nih.gov/34846583/ | Ramos, F. J. M., Corrales, A. E., & Picades, A. M. (2021). Hemorragia acral después de la segunda administración de la dosis de vacuna contra SARS-COV-2. ¿Una reacción pos-vacante?. Medicina Clinica (Inglés ed.), 157 (10), 506. https://pubmed.ncbi.nlm.nih.gov/34754937/ | Negrea, L., & Rovin, B. H. (2021). Gross hematuria following vaccination for severe acute respiratory syndrome coronavirus 2 in 2 patients with IgA nephropathy. Kidney international, 99(6), 1487. https://pubmed.ncbi.nlm.nih.gov/33771584/ | Rerknimitr, P., Puaratanaarunkon, T., Wongtada, C., Wittayabusarakam, N., Krithin, S., Paitoonpong, L., ... & Klaewsongkram, J. (2022). Cutaneous adverse reactions from 35,229 doses of Sinovac and AstraZeneca COVID‐19 vaccination: a prospective cohort study in healthcare workers. Journal of the European Academy of Dermatology and Venereology, 36(3), e158-e161. https://pubmed.ncbi.nlm.nih.gov/34661934/ | Chouchana, L., Blet, A., Al‐Khalaf, M., Kafil, T. S., Nair, G., Robblee, J., ... & Liu, P. P. (2022). Features of Inflammatory Heart Reactions Following mRNA COVID‐19 Vaccination at a Global Level. Clinical Pharmacology & Therapeutics. | https://www.ncbi.nlm.nih.gov/pubmed/34860360 | Chouchana, L., Blet, A., Al‐Khalaf, M., Kafil, T. S., Nair, G., Robblee, J., ... & Liu, P. P. (2022). Features of Inflammatory Heart Reactions Following mRNA COVID‐19 Vaccination at a Global Level. Clinical Pharmacology & Therapeutics. https://www.ncbi.nlm.nih.gov/pubmed/34860360 | Umei, T. C., Kishino, Y., Watanabe, K., Shiraishi, Y., Inohara, T., Yuasa, S., & Fukuda, K. (2021). Recurrence of myopericarditis following mRNA COVID-19 vaccination in a male adolescent. CJC open. https://www.ncbi.nlm.nih.gov/pubmed/34904134 | ||||
702 | Reporting of acute inflammatory neuropathies with COVID-19 vaccines: subgroup disproportionality analysis in VigiBase: | https://pubmed.ncbi.nlm.nih.gov/34579259/ | https://pubmed.ncbi.nlm.nih.gov/34846583/ | Kwon, H., & Kim, T. (2022). Autoimmune encephalitis following ChAdOx1-S SARS-CoV-2 vaccination. Neurological Sciences, 43(3), 1487-1489. | Kwon, H. y Kim, T. (2022). Encefalitis autoinmune después de la vacunación ChAdOx1-S SARS-CoV-2. Ciencias Neurológicas, 43(3), 1487-1489. https://pubmed.ncbi.nlm.nih.gov/34411532/ | Rao, S. J., Khurana, S., Murtyy, G., Dawson, E. T., JazeBi, N., & Haas, C. J. (2021). Un caso de síndrome de Guillain-Barre después de la vacuna Pfizer Covid-19. Perspectivas de la medicina interna del Hospital Comunitario, 11 (5), 597-600. https://pubmed.ncbi.nlm.nih.gov/34648420/. | Kwon, H., & Kim, T. (2022). Autoimmune encephalitis following ChAdOx1-S SARS-CoV-2 vaccination. Neurological Sciences, 43(3), 1487-1489. https://pubmed.ncbi.nlm.nih.gov/34846583/ | Restivo, V., Candore, G., Barrale, M., Caravello, E., Graziano, G., Onida, R., ... & Brusca, I. (2021). Allergy to polyethilenglicole of anti-SARS CoV2 vaccine recipient: a case report of young adult recipient and the management of future exposure to SARS-CoV2. Vaccines, 9(5), 412. https://pubmed.ncbi.nlm.nih.gov/33919151/ | Clarke, R., Ioannou, A., Katz, T. A., Vliegenthart, R. J. S., Aarnoudse-Moens, C. S. H., Wilms, J., ... & Kilbride, H. (2021). Should T2 mapping be used in cases of recurrent myocarditis to differentiate between the acute inflammation and chronic scar?. The Journal of pediatrics. | https://www.ncbi.nlm.nih.gov/pubmed/34933012 | Clarke, R., Ioannou, A., Katz, T. A., Vliegenthart, R. J. S., Aarnoudse-Moens, C. S. H., Wilms, J., ... & Kilbride, H. (2021). Should T2 mapping be used in cases of recurrent myocarditis to differentiate between the acute inflammation and chronic scar?. The Journal of pediatrics. https://www.ncbi.nlm.nih.gov/pubmed/34933012 | Underdown, M. J., & Nuss, R. (2021). Thrombocytopenia in a teen with sickle cell disease following COVID‐19 vaccination. Pediatric Blood & Cancer. https://pubmed.ncbi.nlm.nih.gov/34331506/ | ||||
703 | A variant of Guillain-Barré syndrome after SARS-CoV-2 vaccination: AMSAN: | https://pubmed.ncbi.nlm.nih.gov/34370408/. | https://pubmed.ncbi.nlm.nih.gov/34411532/ | Wan, E. Y. F., Chui, C. S. L., Lai, F. T. T., Chan, E. W. Y., Li, X., Yan, V. K. C., ... & Wong, I. C. K. (2022). Bell's palsy following vaccination with mRNA (BNT162b2) and inactivated (CoronaVac) SARS-CoV-2 vaccines: a case series and nested case-control study. The Lancet Infectious Diseases, 22(1), 64-72. | Wan, E. Y. F., Chui, C. S. L., Lai, F. T. T., Chan, E. W. Y., Li, X., Yan, V. K. C., ... & Wong, I. C. K. (2022). Parálisis de Bell después de la vacunación con vacunas de ARNm (BNT162b2) y SARS-CoV-2 inactivadas (CoronaVac): una serie de casos y un estudio de casos y controles anidado. The Lancet Infectious Diseases, 22(1), 64-72. https://www.medrxiv.org/content/10.1101/2021.12.02.21267156v1 | RELA, M., Jotimani, D., VIJ, M., RAJAKUMAR, A., & Rammohan, A. (2021). Hepatitis autoinmune después de la vacunación covid. Diario de autoinmunidad, 123, 102688. https://pubmed.ncbi.nlm.nih.gov/34449715/ | Wan, E. Y. F., Chui, C. S. L., Lai, F. T. T., Chan, E. W. Y., Li, X., Yan, V. K. C., ... & Wong, I. C. K. (2022). Bell's palsy following vaccination with mRNA (BNT162b2) and inactivated (CoronaVac) SARS-CoV-2 vaccines: a case series and nested case-control study. The Lancet Infectious Diseases, 22(1), 64-72. https://pubmed.ncbi.nlm.nih.gov/34411532/ | Revon-Riviere, G., Ninove, L., Min, V., Rome, A., Coze, C., Verschuur, A., ... & André, N. (2021). The BNT162b2 mRNA COVID-19 vaccine in adolescents and young adults with cancer: A monocentric experience. European journal of cancer, 154, 30-34. https://www.ncbi.nlm.nih.gov/pubmed/34233234 | Colaneri, M., De Filippo, M., Licari, A., Marseglia, A., Maiocchi, L., Ricciardi, A., ... & Bruno, R. (2021). COVID vaccination and asthma exacerbation: might there be a link?. International Journal of Infectious Diseases, 112, 243-246. | https://www.ncbi.nlm.nih.gov/pubmed/34547487 | Colaneri, M., De Filippo, M., Licari, A., Marseglia, A., Maiocchi, L., Ricciardi, A., ... & Bruno, R. (2021). COVID vaccination and asthma exacerbation: might there be a link?. International Journal of Infectious Diseases, 112, 243-246. https://www.ncbi.nlm.nih.gov/pubmed/34547487 | Ungari, M., & Pezzarossa, E. (2022). Cutaneous Lymphocytic Vasculitis After Administration of the Second Dose of AZD1222 (Oxford–AstraZeneca) Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination: Casuality or Causality?. The American Journal of Dermatopathology, 44(1), 80-82. https://pubmed.ncbi.nlm.nih.gov/34726187/. | ||||
704 | A rare variant of Guillain-Barré syndrome after vaccination with Ad26.COV2.S: | https://pubmed.ncbi.nlm.nih.gov/34703690/. | https://www.medrxiv.org/content/10.1101/2021.12.02.21267156v1 | Buchan, S. A., Seo, C. Y., Johnson, C., Alley, S., Kwong, J. C., Nasreen, S., ... & Wilson, S. E. (2021). Epidemiology of myocarditis and pericarditis following mRNA vaccines in Ontario, Canada: by vaccine product, schedule and interval. medRxiv. | Buchan, S. A., Seo, C. Y., Johnson, C., Alley, S., Kwong, J. C., Nasreen, S., ... y Wilson, SE (2021). Epidemiología de la miocarditis y pericarditis después de las vacunas de ARNm en Ontario, Canadá: por producto vacunal, calendario e intervalo. medRxiv. https://pubmed.ncbi.nlm.nih.gov/33851711/ | RepAJIC, M., LAI, X. L., XU, P., Y LIU, A. (2021). La parálisis de Bell después de la segunda dosis de Pfizer COVID-19 Vacunación en un paciente con la historia de la parálisis recurrente de Bell. Cerebro, comportamiento, e inmunidad-salud, 13, 100217. https://www.sciencedirect.com/science/article/pii/S2451993621001456. | Buchan, S. A., Seo, C. Y., Johnson, C., Alley, S., Kwong, J. C., Nasreen, S., ... & Wilson, S. E. (2021). Epidemiology of myocarditis and pericarditis following mRNA vaccines in Ontario, Canada: by vaccine product, schedule and interval. medRxiv. https://www.medrxiv.org/content/10.1101/2021.12.02.21267156v1 | Reyes-Capo, D. P., Stevens, S. M., & Cavuoto, K. M. (2021). Acute abducens nerve palsy following COVID-19 vaccination. Journal of American Association for Pediatric Ophthalmology and Strabismus, 25(5), 302-303. https://pubmed.ncbi.nlm.nih.gov/34044114/. | Dimopoulou, D., Spyridis, N., Vartzelis, G., Tsolia, M. N., & Maritsi, D. N. (2021). Safety and tolerability of the COVID-19 mRNA-vaccine in adolescents with juvenile idiopathic arthritis on treatment with TNF-inhibitors. Arthritis & Rheumatology (Hoboken, NJ). | https://www.ncbi.nlm.nih.gov/pubmed/34492161 | Dimopoulou, D., Spyridis, N., Vartzelis, G., Tsolia, M. N., & Maritsi, D. N. (2021). Safety and tolerability of the COVID-19 mRNA-vaccine in adolescents with juvenile idiopathic arthritis on treatment with TNF-inhibitors. Arthritis & Rheumatology (Hoboken, NJ). https://www.ncbi.nlm.nih.gov/pubmed/34492161 | Uvais, N. A. (2021). Depression following ChAdOx1-S/nCoV-19 vaccine. The European Journal of Psychiatry. https://pubmed.ncbi.nlm.nih.gov/34608345/. | ||||
705 | Guillain-Barré syndrome after SARS-CoV-2 vaccination in a patient with previous vaccine-associated Guillain-Barré syndrome: | https://pubmed.ncbi.nlm.nih.gov/34810163/ | https://pubmed.ncbi.nlm.nih.gov/33851711/ | Park, L. H. J., Montgomery, C. J. R., & Boggs, L. N. A. (2021). Anaphylaxis after the Covid-19 vaccine in a patient with cholinergic urticaria. Military medicine. | Park, LHJ, Montgomery, CJR y Boggs, LNA (2021). Anafilaxia tras la vacuna Covid-19 en un paciente con urticaria colinérgica. Medicina militar. https://pubmed.ncbi.nlm.nih.gov/34675550/. | RERKNIMITR, P., Puaratanaarunkon, T., Wongtada, C., Wittayabusarakam, N., Krithin, S., PaitoonPong, L., ... & Klaewsongkram, J. (2022). Reacciones adversas cutáneas de 35,229 dosis de Sinovac y AstraZeneca COVID-19 Vacunación: un estudio prospectivo de cohorte en los trabajadores de la salud. Diario de la Academia Europea de Dermatología y Venereología, 36 (3), E158-E161. https://pubmed.ncbi.nlm.nih.gov/34788138 | Park, L. H. J., Montgomery, C. J. R., & Boggs, L. N. A. (2021). Anaphylaxis after the Covid-19 vaccine in a patient with cholinergic urticaria. Military medicine. https://pubmed.ncbi.nlm.nih.gov/33851711/ | Ring, J., Worm, M., Wollenberg, A., Thyssen, J. P., Jakob, T., Klimek, L., ... & Deleuran, M. (2021). Risk of severe allergic reactions to COVID‐19 vaccines among patients with allergic skin diseases–practical recommendations. A position statement of ETFAD with external experts. Journal of the European Academy of Dermatology and Venereology, 35(6), e362-e365. https://pubmed.ncbi.nlm.nih.gov/33752263/ | Dimopoulou, D., Vartzelis, G., Dasoula, F., Tsolia, M., & Maritsi, D. (2022). Immunogenicity of the COVID-19 mRNA vaccine in adolescents with juvenile idiopathic arthritis on treatment with TNF inhibitors. Annals of the Rheumatic Diseases, 81(4), 592-593. | https://www.ncbi.nlm.nih.gov/pubmed/34844930 | Dimopoulou, D., Vartzelis, G., Dasoula, F., Tsolia, M., & Maritsi, D. (2022). Immunogenicity of the COVID-19 mRNA vaccine in adolescents with juvenile idiopathic arthritis on treatment with TNF inhibitors. Annals of the Rheumatic Diseases, 81(4), 592-593. https://www.ncbi.nlm.nih.gov/pubmed/34844930 | Vaira, L. A., Podda, L., Doneddu, P., Careddu, M. G., Fozza, C., & De Riu, G. (2021). Secondary thrombocytopenia after SARS-CoV-2 vaccine: Report of a case of hemorrhage and hematoma after minor oral surgery. Journal of Stomatology, Oral and Maxillofacial Surgery. https://pubmed.ncbi.nlm.nih.gov/34314875/. | ||||
706 | Guillain-Barré syndrome in an Australian state using mRNA and adenovirus-vector SARS-CoV-2 vaccines: | https://onlinelibrary.wiley.com/doi/10.1002/ana.26218. | https://pubmed.ncbi.nlm.nih.gov/34675550/. | Laisuan, W., Wongsa, C., Chiewchalermsri, C., Thongngarm, T., Rerkpattanapipat, T., Iamrahong, P., ... & Sompornrattanaphan, M. (2021). CoronaVac COVID-19 Vaccine-Induced Anaphylaxis: Clinical Characteristics and Revaccination Outcomes. Journal of Asthma and Allergy, 14, 1209. | Laisuan, W., Wongsa, C., Chiewchalermsri, C., Thongngarm, T., Rerkpattanapipat, T., Iamrahong, P., ... y Sompornrattanaphan, M. (2021). Anafilaxia inducida por la vacuna CoronaVac COVID-19: características clínicas y resultados de la revacunación. Revista de asma y alergia, 14, 1209. https://pubmed.ncbi.nlm.nih.gov/34734159/. | RESIVIVO, V., CANDORE, G., Barrale, M., Caravello, E., Graziano, G., Onida, R., ... & Brusca, I. (2021). Alergia a Polyethilenglicole of Anti-SARS Receptor de vacuna COV2: un informe de caso de un receptor de adultos jóvenes y la gestión de la futura exposición al SARS-COV2. Vacunas, 9 (5), 412. https://pubmed.ncbi.nlm.nih.gov/34128049/ | Laisuan, W., Wongsa, C., Chiewchalermsri, C., Thongngarm, T., Rerkpattanapipat, T., Iamrahong, P., ... & Sompornrattanaphan, M. (2021). CoronaVac COVID-19 Vaccine-Induced Anaphylaxis: Clinical Characteristics and Revaccination Outcomes. Journal of Asthma and Allergy, 14, 1209. https://pubmed.ncbi.nlm.nih.gov/34675550/. | Robichaud, J., Côté, C., & Côté, F. (2021). Systemic capillary leak syndrome after ChAdOx1 nCOV-19 (Oxford–AstraZeneca) vaccination. CMAJ, 193(34), E1341-E1344. https://pubmed.ncbi.nlm.nih.gov/34362727/ | El Sahly, H. M., Baden, L. R., Essink, B., Doblecki-Lewis, S., Martin, J. M., Anderson, E. J., ... & Miller, J. (2021). Efficacy of the mRNA-1273 SARS-CoV-2 vaccine at completion of blinded phase. New England Journal of Medicine, 385(19), 1774-1785. | https://www.ncbi.nlm.nih.gov/pubmed/34551225 | El Sahly, H. M., Baden, L. R., Essink, B., Doblecki-Lewis, S., Martin, J. M., Anderson, E. J., ... & Miller, J. (2021). Efficacy of the mRNA-1273 SARS-CoV-2 vaccine at completion of blinded phase. New England Journal of Medicine, 385(19), 1774-1785. https://www.ncbi.nlm.nih.gov/pubmed/34551225 | Vaishya, R., Sibal, A., Singh, S. K., Malani, A., & Das, S. (2021). Emergence of COVID-19 variants among ChAdOx1 nCoV-19 (recombinant) vaccine recipients. The Indian journal of medical research, 153(5-6), 559. https://pubmed.ncbi.nlm.nih.gov/34528522/ | ||||
707 | Acute transverse myelitis after SARS-CoV-2 vaccination: case report and review of the literature: | https://pubmed.ncbi.nlm.nih.gov/34482455/. | https://pubmed.ncbi.nlm.nih.gov/34734159/. | Mayfield, J., Bandi, S., Ganti, L., & Rubero, J. (2021). Anaphylaxis after Moderna COVID-19 vaccine. Therapeutic Advances in Vaccines and Immunotherapy, 9, 25151355211048418. | Mayfield, J., Bandi, S., Ganti, L. y Rubero, J. (2021). Anafilaxia después de la vacuna Moderna COVID-19. Avances terapéuticos en vacunas e inmunoterapia, 9, 25151355211048418. https://pubmed.ncbi.nlm.nih.gov/34698847/ | Revon-Riviere, G., Ninove, L., Min, V., Roma, A., Coze, C., Vershuur, A., ... & André, N. (2021). El MRNA BNT162B2 COVID-19 Vacuna en adolescentes y adultos jóvenes con cáncer: una experiencia monocéntrica. Diario Europeo de Cáncer, 154, 30-34. https://www.ncbi.nlm.nih.gov/pubmed/34934954 | Mayfield, J., Bandi, S., Ganti, L., & Rubero, J. (2021). Anaphylaxis after Moderna COVID-19 vaccine. Therapeutic Advances in Vaccines and Immunotherapy, 9, 25151355211048418. https://pubmed.ncbi.nlm.nih.gov/34734159/. | Robinson, K. A., Maimone, S., Gococo-Benore, D. A., Li, Z., Advani, P. P., & Chumsri, S. (2021). Incidence of axillary adenopathy in breast imaging after COVID-19 vaccination. JAMA oncology, 7(9), 1395-1397. https://pubmed.ncbi.nlm.nih.gov/34292295/. | Fazlollahi, A., Zahmatyar, M., Noori, M., Nejadghaderi, S. A., Sullman, M. J., Shekarriz‐Foumani, R., ... & Safiri, S. (2021). Cardiac complications following mRNA COVID‐19 vaccines: A systematic review of case reports and case series. Reviews in medical virology, e2318. | https://www.ncbi.nlm.nih.gov/pubmed/34921468 | Fazlollahi, A., Zahmatyar, M., Noori, M., Nejadghaderi, S. A., Sullman, M. J., Shekarriz‐Foumani, R., ... & Safiri, S. (2021). Cardiac complications following mRNA COVID‐19 vaccines: A systematic review of case reports and case series. Reviews in medical virology, e2318. https://www.ncbi.nlm.nih.gov/pubmed/34921468 | van Dijk, M. M., Veldman, H. D., Aarts, F., Barten, D. G., van den Bergh, J. P., & Dielis, A. W. (2022). A case of unusual mild clinical presentation of COVID-19 vaccine-induced immune thrombotic thrombocytopenia with splanchnic vein thrombosis. Annals of hepatology, 27(1), 100590. https://pubmed.ncbi.nlm.nih.gov/34843991/ | ||||
708 | Variant Guillain-Barré syndrome occurring after SARS-CoV-2 vaccination: | https://pubmed.ncbi.nlm.nih.gov/34114269/. | https://pubmed.ncbi.nlm.nih.gov/34698847/ | Li, L., Robinson, L. B., Patel, R., Landman, A. B., Fu, X., Shenoy, E. S., ... & Blumenthal, K. G. (2021). Association of Self-reported High-Risk Allergy History With Allergy Symptoms After COVID-19 Vaccination. JAMA network open, 4(10), e2131034-e2131034. | Li, L., Robinson, L. B., Patel, R., Landman, A. B., Fu, X., Shenoy, E. S., ... y Blumenthal, K. G. (2021). Asociación de antecedentes de alergia de alto riesgo autoinformados con síntomas de alergia después de la vacuna COVID-19. Red JAMA abierta, 4(10), e2131034-e2131034. https://pubmed.ncbi.nlm.nih.gov/34020815/ | Reyes-Capo, D. P., Stevens, S. M., & Cavuoto, K. M. (2021). La parálisis nerviosa aguda de Abducens siguiendo la vacunación COVID-19. Diario de la Asociación Americana de Oftalmología Pediátrica y Strabismus, 25 (5), 302-303. https://pubmed.ncbi.nlm.nih.gov/34492394/ | Li, L., Robinson, L. B., Patel, R., Landman, A. B., Fu, X., Shenoy, E. S., ... & Blumenthal, K. G. (2021). Association of Self-reported High-Risk Allergy History With Allergy Symptoms After COVID-19 Vaccination. JAMA network open, 4(10), e2131034-e2131034. https://pubmed.ncbi.nlm.nih.gov/34698847/ | Rodríguez-Pardo, J., Gilo-Arrojo, F., Ruiz-Ares, G., Sánchez-Manso, J. C., Valiente-Gordillo, E., de Celis, E., ... & Díez-Tejedor, E. (2021). Thrombosis and Thrombocytopenia Syndrome Causing Isolated Symptomatic Carotid Occlusion after Covid-19 Vaccine. Thrombosis and Haemostasis. https://pubmed.ncbi.nlm.nih.gov/34670287/ | Fazolo, T., Lima, K., Fontoura, J. C., de Souza, P. O., Hilario, G., Zorzetto, R., ... & Bonorino, C. (2021). Pediatric COVID-19 patients in South Brazil show abundant viral mRNA and strong specific anti-viral responses. Nature communications, 12(1), 1-13. | https://www.ncbi.nlm.nih.gov/pubmed/34824230 | Fazolo, T., Lima, K., Fontoura, J. C., de Souza, P. O., Hilario, G., Zorzetto, R., ... & Bonorino, C. (2021). Pediatric COVID-19 patients in South Brazil show abundant viral mRNA and strong specific anti-viral responses. Nature communications, 12(1), 1-13. https://www.ncbi.nlm.nih.gov/pubmed/34824230 | Van Kammen, M. S., De Sousa, D. A., Poli, S., Cordonnier, C., Heldner, M. R., Van De Munckhof, A., ... & Arslan, Y. (2021). Characteristics and outcomes of patients with cerebral venous sinus thrombosis in SARS-CoV-2 vaccine–induced immune thrombotic thrombocytopenia. JAMA neurology, 78(11), 1314-1323. https://jamanetwork.com/journals/jamaneurology/fullarticle/2784622 | ||||
709 | Guillian-Barre syndrome with axonal variant temporally associated with Modern SARS-CoV-2 mRNA-based vaccine: | https://pubmed.ncbi.nlm.nih.gov/34722067/ | https://pubmed.ncbi.nlm.nih.gov/34020815/ | Somiya, M., Mine, S., Yasukawa, K., & Ikeda, S. (2021). Sex differences in the incidence of anaphylaxis to LNP-mRNA COVID-19 vaccines. Vaccine. | Somiya, M., Mine, S., Yasukawa, K. e Ikeda, S. (2021). Diferencias de sexo en la incidencia de anafilaxia con las vacunas LNP-mRNA COVID-19. Vacuna. https://pubmed.ncbi.nlm.nih.gov/33641264/ | Robichaud, J., Côté, C., & Côté, F. (2021). Síndrome de fuga capilar sistémico después de la vacunación de Chadox1 NCOV-19 (OXFORD-ASTRAZENECA). CMAJ, 193 (34), E1341-E1344. https://pubmed.ncbi.nlm.nih.gov/34469919/. | Somiya, M., Mine, S., Yasukawa, K., & Ikeda, S. (2021). Sex differences in the incidence of anaphylaxis to LNP-mRNA COVID-19 vaccines. Vaccine. https://pubmed.ncbi.nlm.nih.gov/34020815/ | Rodriguez, E. V., Bouazza, F. Z., Dauby, N., Mullier, F., d’Otreppe, S., Jissendi Tchofo, P., ... & Cliquennois, M. (2021). Fatal vaccine-induced immune thrombotic thrombocytopenia (VITT) post Ad26. COV2. S: first documented case outside US. Infection, 1-6. https://pubmed.ncbi.nlm.nih.gov/34626338/ | Fikenzer, S., & Laufs, U. (2021). Correction to: Response to Letter to the editors referring to Fikenzer, S., Uhe, T., Lavall, D., Rudolph, U., Falz, R., Busse, M., Hepp, P., & Laufs, U.(2020). Effects of surgical and FFP2/N95 face masks on cardiopulmonary exercise capacity. Clinical research in cardiology: official journal of the German Cardiac Society, 1–9. Advance online publication. https://doi. org/10.1007/s00392-020-01704-y. Clinical Research in Cardiology, 110(8), 1352-1352. | https://www.ncbi.nlm.nih.gov/pubmed/34170372 | Fikenzer, S., & Laufs, U. (2021). Correction to: Response to Letter to the editors referring to Fikenzer, S., Uhe, T., Lavall, D., Rudolph, U., Falz, R., Busse, M., Hepp, P., & Laufs, U.(2020). Effects of surgical and FFP2/N95 face masks on cardiopulmonary exercise capacity. Clinical research in cardiology: official journal of the German Cardiac Society, 1–9. Advance online publication. https://doi. org/10.1007/s00392-020-01704-y. Clinical Research in Cardiology, 110(8), 1352-1352. https://www.ncbi.nlm.nih.gov/pubmed/34170372 | Varas, G. M., Flores, A. C., & Casado, M. S. Venous sinus thrombosis following vaccination with ChAdOx1 nCov-19. Medicina intensiva, S0210-5691. https://pubmed.ncbi.nlm.nih.gov/34420802/ | ||||
710 | Guillain-Barre syndrome after the first dose of SARS-CoV-2 vaccine: a temporary occurrence, not a causal association: | https://pubmed.ncbi.nlm.nih.gov/33968610/ | https://pubmed.ncbi.nlm.nih.gov/33641264/ | Shimabukuro, T. (2021). Allergic reactions including anaphylaxis after receipt of the first dose of Pfizer‐BioNTech COVID‐19 vaccine—United States, December 14–23, 2020. American Journal of Transplantation, 21(3), 1332. | Shimabukuro, T. (2021). Reacciones alérgicas, incluida anafilaxia, después de recibir la primera dosis de la vacuna Pfizer‐BioNTech COVID‐19, Estados Unidos, 14 al 23 de diciembre de 2020. American Journal of Transplantation, 21(3), 1332. https://pubmed.ncbi.nlm.nih.gov/33641268/ | Robinson, K. A., Maimone, S., Gococo-Benore, D. A. A., Li, Z., Advani, P. P., & Chumsri, S. (2021). Incidencia de adenopatía axilar en imágenes de mama después de la vacunación de COVID-19. JAMA ONCOLOGY, 7 (9), 1395-1397. https://pubmed.ncbi.nlm.nih.gov/33947605/. | Shimabukuro, T. (2021). Allergic reactions including anaphylaxis after receipt of the first dose of Pfizer‐BioNTech COVID‐19 vaccine—United States, December 14–23, 2020. American Journal of Transplantation, 21(3), 1332. https://pubmed.ncbi.nlm.nih.gov/33641264/ | Román, G. C., Gracia, F., Torres, A., Palacios, A., Gracia, K., & Harris, D. (2021). Acute transverse myelitis (ATM): clinical review of 43 patients with COVID-19-associated ATM and 3 post-vaccination ATM serious adverse events with the ChAdOx1 nCoV-19 vaccine (AZD1222). Frontiers in immunology, 12, 879. https://pubmed.ncbi.nlm.nih.gov/33981305/ | Forgacs, D., Jang, H., Abreu, R. B., Hanley, H. B., Gattiker, J. L., Jefferson, A. M., & Ross, T. M. (2021). SARS-CoV-2 mRNA Vaccines Elicit Different Responses in Immunologically Naïve and Pre-Immune Humans. Frontiers in immunology, 12. | https://www.ncbi.nlm.nih.gov/pubmed/34646267 | Forgacs, D., Jang, H., Abreu, R. B., Hanley, H. B., Gattiker, J. L., Jefferson, A. M., & Ross, T. M. (2021). SARS-CoV-2 mRNA Vaccines Elicit Different Responses in Immunologically Naïve and Pre-Immune Humans. Frontiers in immunology, 12. https://www.ncbi.nlm.nih.gov/pubmed/34646267 | Varona, J. F., García-Isidro, M., Moeinvaziri, M., Ramos-López, M., & Fernández-Domínguez, M. (2021). Primary adrenal insufficiency associated with Oxford-AstraZeneca ChAdOx1 nCoV-19 vaccine-induced immune thrombotic thrombocytopenia (VITT). European Journal of Internal Medicine, 91, 90-92. https://www.sciencedirect.com/science/article/pii/S0953620521002363 | ||||
711 | SARS-CoV-2 vaccines can be complicated not only by Guillain-Barré syndrome but also by distal small fiber neuropathy: | https://pubmed.ncbi.nlm.nih.gov/34525410/ | https://pubmed.ncbi.nlm.nih.gov/33641268/ | Shimabukuro, T. (2021). Allergic reactions including anaphylaxis after receipt of the first dose of Moderna COVID‐19 vaccine—United States, December 21, 2020–January 10, 2021. American Journal of Transplantation, 21(3), 1326. | Shimabukuro, T. (2021). Reacciones alérgicas, incluida anafilaxia, después de recibir la primera dosis de la vacuna Moderna COVID-19: Estados Unidos, 21 de diciembre de 2020 al 10 de enero de 2021. American Journal of Transplantation, 21(3), 1326. https://pubmed.ncbi.nlm.nih.gov/33834172/ | Rodríguez-Pardo, J., Gilo-Arrojo, F., Ruiz-Ares, G., Sánchez-Manso, JC, Valiente-Gordillo, E., de Celis, E., ... & díez-tejedor, E. (2021). Síndrome de trombosis y trombocitopenia que causa la oclusión de carotídeos sintomáticos aislados después de la vacuna COVID-19. Trombosis y haemostasis. https://pubmed.ncbi.nlm.nih.gov/34790811/ | Shimabukuro, T. (2021). Allergic reactions including anaphylaxis after receipt of the first dose of Moderna COVID‐19 vaccine—United States, December 21, 2020–January 10, 2021. American Journal of Transplantation, 21(3), 1326. https://pubmed.ncbi.nlm.nih.gov/33641268/ | Román, G. C., Gracia, F., Torres, A., Palacios, A., Gracia, K., & Harris, D. (2021). Acute transverse myelitis (ATM): clinical review of 43 patients with COVID-19-associated ATM and 3 post-vaccination ATM serious adverse events with the ChAdOx1 nCoV-19 vaccine (AZD1222). Frontiers in immunology, 12, 879. https://pubmed.ncbi.nlm.nih.gov/33981305/. | Furer, V., Eviatar, T., Zisman, D., Peleg, H., Paran, D., Levartovsky, D., ... & Elkayam, O. (2021). Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in adult patients with autoimmune inflammatory rheumatic diseases and in the general population: a multicentre study. Annals of the rheumatic diseases, 80(10), 1330-1338. | https://www.ncbi.nlm.nih.gov/pubmed/34127481 | Furer, V., Eviatar, T., Zisman, D., Peleg, H., Paran, D., Levartovsky, D., ... & Elkayam, O. (2021). Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in adult patients with autoimmune inflammatory rheumatic diseases and in the general population: a multicentre study. Annals of the rheumatic diseases, 80(10), 1330-1338. https://www.ncbi.nlm.nih.gov/pubmed/34127481 | Vassallo, C., Boveri, E., Brazzelli, V., Rampino, T., Bruno, R., Bonometti, A., & Gregorini, M. (2021). Cutaneous lymphocytic vasculitis after administration of COVID‐19 mRNA vaccine. Dermatologic Therapy. https://pubmed.ncbi.nlm.nih.gov/34327795 | ||||
712 | Clinical variant of Guillain-Barré syndrome with prominent facial diplegia after AstraZeneca 2019 coronavirus disease vaccine: | https://pubmed.ncbi.nlm.nih.gov/34808658/ | https://pubmed.ncbi.nlm.nih.gov/33834172/ | Frank, A., Radparvar, S., Manasia, A., Bassily-Marcus, A., & Kohli-Seth, R. (2021). Prolonged anaphylaxis to pfizer coronavirus disease 2019 vaccine: a case report and mechanism of action. Critical Care Explorations, 3(4). | Frank, A., Radparvar, S., Manasia, A., Bassily-Marcus, A. y Kohli-Seth, R. (2021). Anafilaxia prolongada a la vacuna pfizer contra la enfermedad por coronavirus 2019: reporte de un caso y mecanismo de acción. Exploraciones de cuidados críticos, 3(4). https://pubmed.ncbi.nlm.nih.gov/34579211/ | Rodríguez, E. V., Bouazza, F. Z., Dauby, N., Mullier, F., D'Otreppe, S., Jissendi Tchofo, P., ... & Cliquennois, M. (2021). Trombocitopenia trombótica inmune inducida por la vacuna fatal (Vitt) post ad26. COV2. S: Caso primero documentado fuera de los Estados Unidos. Infección, 1-6. https://europepmc.org/article/PPR/PPR304469435 | Frank, A., Radparvar, S., Manasia, A., Bassily-Marcus, A., & Kohli-Seth, R. (2021). Prolonged anaphylaxis to pfizer coronavirus disease 2019 vaccine: a case report and mechanism of action. Critical Care Explorations, 3(4). https://pubmed.ncbi.nlm.nih.gov/33834172/ | Rose, J., & McCullough, P. A. (2021). A report on myocarditis adverse events in the US vaccine adverse events reporting system (VAERS) in association with COVID-19 injectable biological products. Current problems in cardiology. https://pubmed.ncbi.nlm.nih.gov/34601006/ | Galindo, R., Chow, H., & Rongkavilit, C. (2021). COVID-19 in children: clinical manifestations and pharmacologic interventions including vaccine trials. Pediatric Clinics, 68(5), 961-976. | https://www.ncbi.nlm.nih.gov/pubmed/34538306 | Galindo, R., Chow, H., & Rongkavilit, C. (2021). COVID-19 in children: clinical manifestations and pharmacologic interventions including vaccine trials. Pediatric Clinics, 68(5), 961-976. https://www.ncbi.nlm.nih.gov/pubmed/34538306 | Vayne, C., Rollin, J., Gruel, Y., Pouplard, C., Galinat, H., Huet, O., ... & Susen, S. (2021). PF4 immunoassays in vaccine-induced thrombotic thrombocytopenia. New England Journal of Medicine, 385(4), 376-378. https://www.nejm.org/doi/full/10.1056/NEJMc2106383 | ||||
713 | Adverse event reporting and risk of Bell’s palsy after COVID-19 vaccination: | https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(21)00646-0/fulltext. | https://pubmed.ncbi.nlm.nih.gov/34579211/ | Lim, X. R., Leung, B. P., Ng, C. Y. L., Tan, J. W. L., Chan, G. Y. L., Loh, C. M., ... & Leong, K. P. (2021). Pseudo-anaphylactic reactions to Pfizer BNT162b2 vaccine: report of 3 cases of anaphylaxis post Pfizer BNT162b2 vaccination. Vaccines, 9(9), 974. | Lim, X. R., Leung, B. P., Ng, C. Y. L., Tan, J. W. L., Chan, G. Y. L., Loh, C. M., ... y Leong, K. P. (2021). Reacciones pseudoanafilácticas a la vacuna Pfizer BNT162b2: informe de 3 casos de anafilaxia después de la vacunación Pfizer BNT162b2. Vacunas, 9(9), 974. https://pubmed.ncbi.nlm.nih.gov/34343674/ | ROMÁN, G. C., Gracia, F., Torres, A., Palacios, A., Gracia, K., & Harris, D. (2021). Myelitis transversal aguda (ATM): Revisión clínica de 43 pacientes con cajeros automáticos asociados a COVID-19 y 3 Eventos adversos graves de cajeros automáticos post-vacunación con la vacuna Chadox1 NCOV-19 (AZD1222). Fronteras en inmunología, 12, 879. https://pubmed.ncbi.nlm.nih.gov/33877737/ | Lim, X. R., Leung, B. P., Ng, C. Y. L., Tan, J. W. L., Chan, G. Y. L., Loh, C. M., ... & Leong, K. P. (2021). Pseudo-anaphylactic reactions to Pfizer BNT162b2 vaccine: report of 3 cases of anaphylaxis post Pfizer BNT162b2 vaccination. Vaccines, 9(9), 974. https://pubmed.ncbi.nlm.nih.gov/34579211/ | Rosner, C. M., Genovese, L., Tehrani, B. N., Atkins, M., Bakhshi, H., Chaudhri, S., ... & Defilippi, C. R. (2021). Myocarditis temporally associated with COVID-19 vaccination. Circulation, 144(6), 502-505. https://pubmed.ncbi.nlm.nih.gov/34133885/ | Gargano, J. W., Wallace, M., Hadler, S. C., Langley, G., Su, J. R., Oster, M. E., ... & Oliver, S. E. (2021). Use of mRNA COVID-19 vaccine after reports of myocarditis among vaccine recipients: update from the Advisory Committee on Immunization Practices—United States, June 2021. Morbidity and Mortality Weekly Report, 70(27), 977. | https://www.ncbi.nlm.nih.gov/pubmed/34237049 | Gargano, J. W., Wallace, M., Hadler, S. C., Langley, G., Su, J. R., Oster, M. E., ... & Oliver, S. E. (2021). Use of mRNA COVID-19 vaccine after reports of myocarditis among vaccine recipients: update from the Advisory Committee on Immunization Practices—United States, June 2021. Morbidity and Mortality Weekly Report, 70(27), 977. https://www.ncbi.nlm.nih.gov/pubmed/34237049 | Vegezzi, E., Ravaglia, S., Buongarzone, G., Bini, P., Diamanti, L., Gastaldi, M., ... & Marchioni, E. (2021). Acute myelitis and ChAdOx1 nCoV-19 vaccine: Casual or causal association?. Journal of Neuroimmunology, 359, 577686. https://www.sciencedirect.com/science/article/pii/S0165572821002137 | ||||
714 | Bilateral facial nerve palsy and COVID-19 vaccination: causality or coincidence: | https://pubmed.ncbi.nlm.nih.gov/34522557/ | https://pubmed.ncbi.nlm.nih.gov/34343674/ | Pitlick, M. M., Park, M. A., Gonzalez-Estrada, A., & Chiarella, S. E. (2021). Biphasic anaphylaxis after first dose of messenger RNA coronavirus disease 2019 vaccine with positive polysorbate 80 skin testing result. Annals of Allergy Asthma & Immunology, 498-499. | Pitlick, M. M., Park, M. A., González-Estrada, A. y Chiarella, S. E. (2021). Anafilaxia bifásica después de la primera dosis de la vacuna de ARN mensajero contra la enfermedad del coronavirus 2019 con resultado positivo de la prueba cutánea de polisorbato 80. Annals of Allergy Asthma & Immunology, 498-499. https://pubmed.ncbi.nlm.nih.gov/34586408/ | ROMÁN, G. C., Gracia, F., Torres, A., Palacios, A., Gracia, K., & Harris, D. (2021). Myelitis transversal aguda (ATM): Revisión clínica de 43 pacientes con cajeros automáticos asociados a COVID-19 y 3 Eventos adversos graves de cajeros automáticos post-vacunación con la vacuna Chadox1 NCOV-19 (AZD1222). Fronteras en inmunología, 12, 879. https://pubmed.ncbi.nlm.nih.gov/34336436/ | Pitlick, M. M., Park, M. A., Gonzalez-Estrada, A., & Chiarella, S. E. (2021). Biphasic anaphylaxis after first dose of messenger RNA coronavirus disease 2019 vaccine with positive polysorbate 80 skin testing result. Annals of Allergy Asthma & Immunology, 498-499. https://pubmed.ncbi.nlm.nih.gov/34343674/ | Rosner, C. M., Genovese, L., Tehrani, B. N., Atkins, M., Bakhshi, H., Chaudhri, S., ... & Defilippi, C. R. (2021). Myocarditis temporally associated with COVID-19 vaccination. Circulation, 144(6), 502-505. https://www.ahajournals.org/doi/pdf/10.1161/CIRCULATIONAHA.121.055891. | Gatti, M., Raschi, E., Moretti, U., Ardizzoni, A., Poluzzi, E., & Diemberger, I. (2021). Influenza vaccination and myo-pericarditis in patients receiving immune checkpoint inhibitors: investigating the likelihood of interaction through the vaccine adverse event reporting system and VigiBase. Vaccines, 9(1), 19. | https://www.ncbi.nlm.nih.gov/pubmed/33406694 | Gatti, M., Raschi, E., Moretti, U., Ardizzoni, A., Poluzzi, E., & Diemberger, I. (2021). Influenza vaccination and myo-pericarditis in patients receiving immune checkpoint inhibitors: investigating the likelihood of interaction through the vaccine adverse event reporting system and VigiBase. Vaccines, 9(1), 19. https://www.ncbi.nlm.nih.gov/pubmed/33406694 | Vera-Lastra, O., Ordinola Navarro, A., Cruz Domiguez, M. P., Medina, G., Sánchez Valadez, T. I., & Jara, L. J. (2021). Two cases of Graves' disease following SARS-CoV-2 vaccination: an autoimmune/inflammatory syndrome induced by adjuvants. Thyroid, 31(9), 1436-1439. https://pubmed.ncbi.nlm.nih.gov/33858208/ | ||||
715 | Left Bell’s palsy after the first dose of mRNA-1273 SARS-CoV-2 vaccine: case report: | https://pubmed.ncbi.nlm.nih.gov/34763263/. | https://pubmed.ncbi.nlm.nih.gov/34586408/ | Aye, Y. N., Mai, A. S., Zhang, A., Lim, O. Z. H., Lin, N., Ng, C. H., ... & Chew, N. W. (2021). Acute myocardial infarction and myocarditis following COVID-19 vaccination. QJM: An International Journal of Medicine. | Aye, Y. N., Mai, A. S., Zhang, A., Lim, O. Z. H., Lin, N., Ng, C. H., ... y Chew, N. W. (2021). Infarto agudo de miocardio y miocarditis tras la vacunación contra la COVID-19. QJM: Revista internacional de medicina. https://pubmed.ncbi.nlm.nih.gov/34539938/. | Rose, J., & McCullough, P. A. (2021). Un informe sobre los eventos adversos de la miocarditis en el sistema de informes de eventos adversos de la vacuna estadounidense (Vaers) en asociación con productos biológicos inyectables COVID-19. Problemas actuales en la cardiología. https://www.nejm.org/doi/full/10.1056/NEJMoa2110475 | Aye, Y. N., Mai, A. S., Zhang, A., Lim, O. Z. H., Lin, N., Ng, C. H., ... & Chew, N. W. (2021). Acute myocardial infarction and myocarditis following COVID-19 vaccination. QJM: An International Journal of Medicine. https://pubmed.ncbi.nlm.nih.gov/34586408/ | Rossetti, A., Gheihman, G., O'Hare, M., & Kosowsky, J. M. (2021). Guillain-Barré Syndrome presenting as facial diplegia after COVID-19 vaccination: A case report. The Journal of Emergency Medicine, 61(6), e141-e145. https://www.sciencedirect.com/science/article/pii/S0736467921006442 | Gautam, N., Saluja, P., Fudim, M., Jambhekar, K., Pandey, T., & Al'Aref, S. (2021). A late presentation of COVID-19 vaccine-induced myocarditis. Cureus, 13(9). | https://www.ncbi.nlm.nih.gov/pubmed/34660088 | Gautam, N., Saluja, P., Fudim, M., Jambhekar, K., Pandey, T., & Al'Aref, S. (2021). A late presentation of COVID-19 vaccine-induced myocarditis. Cureus, 13(9). https://www.ncbi.nlm.nih.gov/pubmed/34660088 | Verma, A. K., Lavine, K. J., & Lin, C. Y. (2021). Myocarditis after Covid-19 mRNA vaccination. New England Journal of Medicine, 385(14), 1332-1334. https://www.nejm.org/doi/full/10.1056/NEJMc2109975 | ||||
716 | Bell’s palsy after inactivated vaccination with COVID-19 in a patient with a history of recurrent Bell’s palsy: case report: | https://pubmed.ncbi.nlm.nih.gov/34621891/ | https://pubmed.ncbi.nlm.nih.gov/34539938/. | Fearon, C., Parwani, P., Gow-Lee, B., & Abramov, D. (2021). Takotsubo syndrome after receiving the COVID-19 vaccine. Journal of Cardiology Cases, 24(5), 223-226. | Fearon, C., Parwani, P., Gow-Lee, B. y Abramov, D. (2021). Síndrome de Takotsubo tras recibir la vacuna COVID-19. Revista de casos de cardiología, 24(5), 223-226. https://pubmed.ncbi.nlm.nih.gov/34731486/. | Rosner, C. M., Genovese, L., Tehrani, B. N., Atkins, M., Bakhshi, H., Chaudhri, S., ... & Defilippi, C. R. (2021). Miocarditis temporalmente asociada con la vacunación COVID-19. Circulación, 144 (6), 502-505. https://pediatrics.aappublications.org/content/pediatrics/early/2021/08/12/peds.2021-053427.full.pdf | Fearon, C., Parwani, P., Gow-Lee, B., & Abramov, D. (2021). Takotsubo syndrome after receiving the COVID-19 vaccine. Journal of Cardiology Cases, 24(5), 223-226. https://pubmed.ncbi.nlm.nih.gov/34539938/. | Rossi, A., Magri, F., Michelini, S., Caro, G., Di Fraia, M., Fortuna, M. C., ... & Carlesimo, M. (2021). Recurrence of alopecia areata after covid‐19 vaccination: A report of three cases in Italy. Journal of cosmetic dermatology, 20(12), 3753-3757. https://pubmed.ncbi.nlm.nih.gov/34741583/ | Gellad, W. F. (2021). Myocarditis after vaccination against covid-19. bmj, 375. | https://www.ncbi.nlm.nih.gov/pubmed/34916217 | Gellad, W. F. (2021). Myocarditis after vaccination against covid-19. bmj, 375. https://www.ncbi.nlm.nih.gov/pubmed/34916217 | Vidula, M. K., Ambrose, M., Glassberg, H., Chokshi, N., Chen, T., Ferrari, V. A., & Han, Y. (2021). Myocarditis and other cardiovascular complications of the mRNA-based COVID-19 vaccines. Cureus, 13(6). https://pubmed.ncbi.nlm.nih.gov/34277198/ | ||||
717 | Neurological complications after the first dose of COVID-19 vaccines and SARS-CoV-2 infection: | https://pubmed.ncbi.nlm.nih.gov/34697502/ | https://pubmed.ncbi.nlm.nih.gov/34731486/. | Toida, R., Uezono, S., Komatsu, H., Toida, T., Imamura, A., Fujimoto, S., & Kaikita, K. (2021). Takotsubo cardiomyopathy after vaccination for coronavirus disease 2019 in a patient on maintenance hemodialysis. CEN Case Reports, 1-5. | Toida, R., Uezono, S., Komatsu, H., Toida, T., Imamura, A., Fujimoto, S. y Kaikita, K. (2021). Miocardiopatía de Takotsubo después de la vacunación contra la enfermedad por coronavirus 2019 en un paciente en hemodiálisis de mantenimiento. Informes de casos del CEN, 1-5. https://pubmed.ncbi.nlm.nih.gov/33824804/ | Rosner, C. M., Genovese, L., Tehrani, B. N., Atkins, M., Bakhshi, H., Chaudhri, S., ... & Defilippi, C. R. (2021). Miocarditis temporalmente asociada con la vacunación COVID-19. Circulación, 144 (6), 502-505. https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8639400/ | Toida, R., Uezono, S., Komatsu, H., Toida, T., Imamura, A., Fujimoto, S., & Kaikita, K. (2021). Takotsubo cardiomyopathy after vaccination for coronavirus disease 2019 in a patient on maintenance hemodialysis. CEN Case Reports, 1-5. https://pubmed.ncbi.nlm.nih.gov/34731486/. | Rzymski, P., Perek, B., & Flisiak, R. (2021). Thrombotic thrombocytopenia after COVID-19 vaccination: in search of the underlying mechanism. Vaccines, 9(6), 559. https://pubmed.ncbi.nlm.nih.gov/34071883/ | Greenhawt, M., Abrams, E. M., Shaker, M., Chu, D. K., Khan, D., Akin, C., ... & Golden, D. B. (2021). The risk of allergic reaction to SARS-CoV-2 vaccines and recommended evaluation and management: a systematic review, meta-analysis, GRADE assessment, and international consensus approach. The Journal of Allergy and Clinical Immunology: In Practice, 9(10), 3546-3567. | https://www.ncbi.nlm.nih.gov/pubmed/34153517 | Greenhawt, M., Abrams, E. M., Shaker, M., Chu, D. K., Khan, D., Akin, C., ... & Golden, D. B. (2021). The risk of allergic reaction to SARS-CoV-2 vaccines and recommended evaluation and management: a systematic review, meta-analysis, GRADE assessment, and international consensus approach. The Journal of Allergy and Clinical Immunology: In Practice, 9(10), 3546-3567. https://www.ncbi.nlm.nih.gov/pubmed/34153517 | Villa, M., Díaz-Crespo, F., de José, A. P., Verdalles, Ú., Verde, E., Ruiz, F. A., ... & Goicoechea, M. (2021). A case of ANCA-associated vasculitis after AZD1222 (Oxford–AstraZeneca) SARS-CoV-2 vaccination: casualty or causality?. Kidney International, 100(4), 937-938. https://pubmed.ncbi.nlm.nih.gov/34416184/. | ||||
718 | Type I interferons as a potential mechanism linking COVID-19 mRNA vaccines with Bell’s palsy: | https://pubmed.ncbi.nlm.nih.gov/33858693/ | https://pubmed.ncbi.nlm.nih.gov/33824804/ | Boivin, Z., & Martin, J. (2021). Untimely myocardial infarction or COVID-19 vaccine side effect. Cureus, 13(3). | Boivin, Z. y Martín, J. (2021). Infarto de miocardio prematuro o efecto secundario de la vacuna COVID-19. Cureus, 13(3). https://pubmed.ncbi.nlm.nih.gov/34807248/ | Rossetti, A., Gheihman, G., O'Hare, M., & Kosowsky, J. M. (2021). Síndrome de Guillain-Barré que presenta como diplegia facial después de la vacunación de COVID-19: un informe de caso. El Diario de Medicina de Emergencia, 61 (6), E141-E145. https://www.sciencedirect.com/science/article/pii/S0035378721005853. | Boivin, Z., & Martin, J. (2021). Untimely myocardial infarction or COVID-19 vaccine side effect. Cureus, 13(3). https://pubmed.ncbi.nlm.nih.gov/33824804/ | Salah, H. M., & Mehta, J. L. (2021). COVID-19 vaccine and myocarditis. American Journal of Cardiology, 157, 146-148. https://pubmed.ncbi.nlm.nih.gov/34399967/ | Haaf, P., Kuster, G. M., Mueller, C., Berger, C. T., Monney, P., Burger, P., ... & Tanner, F. C. (2021). The very low risk of myocarditis and pericarditis after mRNA COVID-19 vaccination should not discourage vaccination. Swiss Medical Weekly, (41). | https://www.ncbi.nlm.nih.gov/pubmed/34668687 | Haaf, P., Kuster, G. M., Mueller, C., Berger, C. T., Monney, P., Burger, P., ... & Tanner, F. C. (2021). The very low risk of myocarditis and pericarditis after mRNA COVID-19 vaccination should not discourage vaccination. Swiss Medical Weekly, (41). https://www.ncbi.nlm.nih.gov/pubmed/34668687 | Violi, F., Cammisotto, V., Pastori, D., & Pignatelli, P. (2021). Thrombosis in pre-and post-vaccination phase of COVID-19. European Heart Journal Supplements, 23(Supplement_E), E184-E188. https://pubmed.ncbi.nlm.nih.gov/34650382/ | ||||
719 | Acute transverse myelitis following inactivated COVID-19 vaccine: | https://pubmed.ncbi.nlm.nih.gov/34370410/ | https://pubmed.ncbi.nlm.nih.gov/34807248/ | Jabagi, M. J., Botton, J., Bertrand, M., Weill, A., Farrington, P., Zureik, M., & Dray-Spira, R. (2022). Myocardial infarction, stroke, and pulmonary embolism after BNT162b2 MRNA COVID-19 vaccine in people aged 75 years or older. Jama, 327(1), 80-82. | Jabagi, M. J., Botton, J., Bertrand, M., Weill, A., Farrington, P., Zureik, M. y Dray-Spira, R. (2022). Infarto de miocardio, accidente cerebrovascular y embolia pulmonar después de la vacuna BNT162b2 MRNA COVID-19 en personas de 75 años o más. Jama, 327(1), 80-82. https://pubmed.ncbi.nlm.nih.gov/34148772/ | Rossi, A., Magri, F., Michelini, S., Caro, G., Di Fraia, M., Fortuna, M. C., ... & Carlesimo, M. (2021). Recurrencia de alopecia areata después de la vacunación de COVID-19: un informe de tres casos en Italia. Diario de la dermatología cosmética, 20 (12), 3753-3757. https://pubmed.ncbi.nlm.nih.gov/34631069/ | Jabagi, M. J., Botton, J., Bertrand, M., Weill, A., Farrington, P., Zureik, M., & Dray-Spira, R. (2022). Myocardial infarction, stroke, and pulmonary embolism after BNT162b2 MRNA COVID-19 vaccine in people aged 75 years or older. Jama, 327(1), 80-82. https://pubmed.ncbi.nlm.nih.gov/34807248/ | Saleh, A., & Collins, J. (2021). Case study of thrombosis and thrombocytopenia syndrome following administration of the AstraZeneca COVID-19 vaccine. Australian Journal of General Practice, 50. https://pubmed.ncbi.nlm.nih.gov/34781321/ | Hasnie, A. A., Hasnie, U. A., Patel, N., Aziz, M. U., Xie, M., Lloyd, S. G., & Prabhu, S. D. (2021). Perimyocarditis following first dose of the mRNA-1273 SARS-CoV-2 (Moderna) vaccine in a healthy young male: a case report. BMC Cardiovascular Disorders, 21(1), 1-6. | https://www.ncbi.nlm.nih.gov/pubmed/34348657 | Hasnie, A. A., Hasnie, U. A., Patel, N., Aziz, M. U., Xie, M., Lloyd, S. G., & Prabhu, S. D. (2021). Perimyocarditis following first dose of the mRNA-1273 SARS-CoV-2 (Moderna) vaccine in a healthy young male: a case report. BMC Cardiovascular Disorders, 21(1), 1-6. https://www.ncbi.nlm.nih.gov/pubmed/34348657 | Visclosky, T., Theyyunni, N., Klekowski, N., & Bradin, S. (2021). Myocarditis Following mRNA COVID-19 Vaccine. Pediatric emergency care, 37(11), 583-584. https://journals.lww.com/pec-online/Abstract/2021/11000/Myocarditis_Following_mRNA_COVID_19_Vaccine.9.aspx | ||||
720 | Acute transverse myelitis after COVID-19 vaccination: | https://pubmed.ncbi.nlm.nih.gov/34579245/. | https://pubmed.ncbi.nlm.nih.gov/34148772/ | Özdemir, İ. H., Özlek, B., Özen, M. B., Gündüz, R., & Bayturan, Ö. (2021). Type 1 Kounis syndrome induced by inactivated SARS-COV-2 vaccine. The Journal of Emergency Medicine, 61(4), e71-e76. | Özdemir, İ. H., Özlek, B., Özen, M. B., Gündüz, R. y Bayturan, Ö. (2021). Síndrome de Kounis tipo 1 inducido por la vacuna inactivada contra el SARS-COV-2. La Revista de Medicina de Emergencia, 61(4), e71-e76. https://pubmed.ncbi.nlm.nih.gov/34702550/ | Rzymski, P., Pérek, B., & Flisiak, R. (2021). Trombocitopenia trombótica después de la vacunación de COVID-19: en busca del mecanismo subyacente. Vacunas, 9 (6), 559. https://pubmed.ncbi.nlm.nih.gov/34033367/ | Özdemir, İ. H., Özlek, B., Özen, M. B., Gündüz, R., & Bayturan, Ö. (2021). Type 1 Kounis syndrome induced by inactivated SARS-COV-2 vaccine. The Journal of Emergency Medicine, 61(4), e71-e76. https://pubmed.ncbi.nlm.nih.gov/34148772/ | Salih, F., Schönborn, L., Kohler, S., Franke, C., Möckel, M., Dörner, T., ... & Endres, M. (2021). Vaccine-induced thrombocytopenia with severe headache. New England Journal of Medicine, 385(22), 2103-2105. https://pubmed.ncbi.nlm.nih.gov/34525282/ | Hause, A. M., Gee, J., Baggs, J., Abara, W. E., Marquez, P., Thompson, D., ... & Shay, D. K. (2021). COVID-19 vaccine safety in adolescents aged 12–17 years—United States, December 14, 2020–July 16, 2021. Morbidity and Mortality Weekly Report, 70(31), 1053. | https://www.ncbi.nlm.nih.gov/pubmed/34351881 | Hause, A. M., Gee, J., Baggs, J., Abara, W. E., Marquez, P., Thompson, D., ... & Shay, D. K. (2021). COVID-19 vaccine safety in adolescents aged 12–17 years—United States, December 14, 2020–July 16, 2021. Morbidity and Mortality Weekly Report, 70(31), 1053. https://www.ncbi.nlm.nih.gov/pubmed/34351881 | Visentini, M., Gragnani, L., Santini, S. A., Urraro, T., Villa, A., Monti, M., ... & Casato, M. (2022). Flares of mixed cryoglobulinaemia vasculitis after vaccination against SARS-CoV-2. Annals of the Rheumatic Diseases, 81(3), 441-443. https://pubmed.ncbi.nlm.nih.gov/34819272/ | ||||
721 | A case of longitudinally extensive transverse myelitis following Covid-19 vaccination: | https://pubmed.ncbi.nlm.nih.gov/34182207/ | https://pubmed.ncbi.nlm.nih.gov/34702550/ | Kounis, N. G., Koniari, I., Mplani, V., Kouni, S. N., Plotas, P., & Tsigkas, G. (2022). Acute Myocardial Infarction Within 24 Hours After COVID-19 Vaccination: Is Kounis Syndrome the Culprit?. American Journal of Cardiology, 162, 207. | Kounis, N. G., Koniari, I., Mplani, V., Kouni, S. N., Plotas, P. y Tsigkas, G. (2022). Infarto agudo de miocardio dentro de las 24 horas posteriores a la vacunación contra el COVID-19: ¿es el síndrome de Kounis el culpable? Revista Estadounidense de Cardiología, 162, 207. https://pubmed.ncbi.nlm.nih.gov/33895650/ | Salah, H. M., & Mehta, J. L. (2021). COVID-19 Vacuna y miocarditis. American Journal of Cardiology, 157, 146-148. https://search.bvsalud.org/global-literature-on-novel-coronavirus-2019-ncov/resourc e/en/covidwho-1360706. | Kounis, N. G., Koniari, I., Mplani, V., Kouni, S. N., Plotas, P., & Tsigkas, G. (2022). Acute Myocardial Infarction Within 24 Hours After COVID-19 Vaccination: Is Kounis Syndrome the Culprit?. American Journal of Cardiology, 162, 207. https://pubmed.ncbi.nlm.nih.gov/34702550/ | Sanchez Tijmes, F., Thavendiranathan, P., Udell, J. A., Seidman, M. A., & Hanneman, K. (2021). Cardiac MRI assessment of nonischemic myocardial inflammation: state of the art review and update on myocarditis associated with COVID-19 vaccination. Radiology: Cardiothoracic Imaging, 3(6), e210252. https://www.ncbi.nlm.nih.gov/pubmed/34934954 | Ho, J. S., Sia, C. H., Ngiam, J. N., Loh, P. H., Chew, N. W., Kong, W. K., & Poh, K. K. (2021). A review of COVID-19 vaccination and the reported cardiac manifestations. Singapore medical journal. | https://www.ncbi.nlm.nih.gov/pubmed/34808708 | Ho, J. S., Sia, C. H., Ngiam, J. N., Loh, P. H., Chew, N. W., Kong, W. K., & Poh, K. K. (2021). A review of COVID-19 vaccination and the reported cardiac manifestations. Singapore medical journal. https://www.ncbi.nlm.nih.gov/pubmed/34808708 | Viskin, D., Topilsky, Y., Aviram, G., Mann, T., Sadon, S., Hadad, Y., ... & Havakuk, O. (2021). Myocarditis Associated With COVID-19 Vaccination: Echocardiography, Cardiac Tomography, and Magnetic Resonance Imaging Findings. Circulation: Cardiovascular Imaging, 14(9), e013236. https://www.ahajournals.org/doi/10.1161/CIRCIMAGING.121.013236 | ||||
722 | Post COVID-19 transverse myelitis; a case report with review of the literature: | https://pubmed.ncbi.nlm.nih.gov/34457267/. | https://pubmed.ncbi.nlm.nih.gov/33895650/ | Edler, C., Klein, A., Schröder, A. S., Sperhake, J. P., & Ondruschka, B. (2021). Deaths associated with newly launched SARS-CoV-2 vaccination (Comirnaty®). Legal Medicine, 51, 101895. | Edler, C., Klein, A., Schröder, A. S., Sperhake, J. P. y Ondruschka, B. (2021). Muertes asociadas con la vacuna contra el SARS-CoV-2 recientemente lanzada (Comirnaty®). Medicina Legal, 51, 101895. https://pubmed.ncbi.nlm.nih.gov/34425384/ | Saleh, A., & Collins, J. (2021). Estudio de caso de trombosis y síndrome de trombocitopenia después de la administración de la vacuna ASTRAZENECA COVID-19. Revista australiana de la práctica general, 50. https://pubmed.ncbi.nlm.nih.gov/34062319/ | Edler, C., Klein, A., Schröder, A. S., Sperhake, J. P., & Ondruschka, B. (2021). Deaths associated with newly launched SARS-CoV-2 vaccination (Comirnaty®). Legal Medicine, 51, 101895. https://pubmed.ncbi.nlm.nih.gov/33895650/ | Sandhu, S., Bhatnagar, A., Kumar, H., Dixit, P. K., Paliwal, G., Suhag, D. K., ... & Mitra, D. (2021). Leukocytoclastic vasculitis as a cutaneous manifestation of ChAdOx1 nCoV‐19 corona virus vaccine (recombinant). Dermatologic therapy, 34(6), e15141. https://pubmed.ncbi.nlm.nih.gov/34546608/ | Ioannou, A. (2021). Myocarditis should be considered in those with a troponin rise and unobstructed coronary arteries following Pfizer-BioNTech COVID-19 vaccination. QJM: An International Journal of Medicine, 1, 1. | https://www.ncbi.nlm.nih.gov/pubmed/34463755 | Ioannou, A. (2021). Myocarditis should be considered in those with a troponin rise and unobstructed coronary arteries following Pfizer-BioNTech COVID-19 vaccination. QJM: An International Journal of Medicine, 1, 1. https://www.ncbi.nlm.nih.gov/pubmed/34463755 | Vogrig, A., Janes, F., Gigli, G. L., Curcio, F., Del Negro, I., D’Agostini, S., ... & Valente, M. (2021). Acute disseminated encephalomyelitis after SARS-CoV-2 vaccination. Clinical Neurology and Neurosurgery, 208, 106839. https://pubmed.ncbi.nlm.nih.gov/34325334/ | ||||
723 | Beware of neuromyelitis optica spectrum disorder after vaccination with inactivated virus for COVID-19: | https://pubmed.ncbi.nlm.nih.gov/34189662/ | https://pubmed.ncbi.nlm.nih.gov/34425384/ | Mungmunpuntipamtip, R., & Wiwanitkit, V. (2021). Deaths associated with newly launched SARS-CoV-2 vaccination. Legal Medicine (Tokyo, Japan), 53, 101956. | Mungmunpuntipamtip, R. y Wiwanitkit, V. (2021). Muertes asociadas con la vacuna contra el SARS-CoV-2 recientemente lanzada. Medicina Legal (Tokio, Japón), 53, 101956. https://pubmed.ncbi.nlm.nih.gov/34703815/ | Salih, F., Schönborn, L., Kohler, S., Franke, C., Möckel, M., Dörner, T., ... & Endres, M. (2021). Trombocitopenia inducida por la vacuna con dolor de cabeza severo. New England Journal of Medicine, 385 (22), 2103-2105. https://pubmed.ncbi.nlm.nih.gov/34515024/ | Mungmunpuntipamtip, R., & Wiwanitkit, V. (2021). Deaths associated with newly launched SARS-CoV-2 vaccination. Legal Medicine (Tokyo, Japan), 53, 101956. https://pubmed.ncbi.nlm.nih.gov/34425384/ | Sangli, S., Virani, A., Cheronis, N., Vannatter, B., Minich, C., Noronha, S., ... & Kaplan, R. B. (2021). Thrombosis with thrombocytopenia after the messenger RNA–1273 vaccine. Annals of internal medicine, 174(8), 1480-1482. https://pubmed.ncbi.nlm.nih.gov/34181446/ | Ioannou, A. (2021). T2 mapping should be utilized in cases of suspected myocarditis to confirm an acute inflammatory process. QJM: An International Journal of Medicine. | https://www.ncbi.nlm.nih.gov/pubmed/34931681 | Ioannou, A. (2021). T2 mapping should be utilized in cases of suspected myocarditis to confirm an acute inflammatory process. QJM: An International Journal of Medicine. https://www.ncbi.nlm.nih.gov/pubmed/34931681 | Volk, G. F., Kuttenreich, A. M., Geitner, M., & Guntinas-Lichius, O. (2021). Acute facial paresis as a possible complication of vaccination against SARS-CoV-2. Laryngo-Rhino-Otologie. https://pubmed.ncbi.nlm.nih.gov/33975372/. | ||||
724 | Neuromyelitis optica in a healthy woman after vaccination against severe acute respiratory syndrome coronavirus 2 mRNA-1273: | https://pubmed.ncbi.nlm.nih.gov/34660149/ | https://pubmed.ncbi.nlm.nih.gov/34703815/ | Barsha, S. Y., Haque, M. M. A., Rashid, M. U., Rahman, M. L., Hossain, M. A., Zaman, S., ... & Hawlader, M. D. H. (2021). A case of acute encephalopathy and non-ST segment elevation myocardial infarction following mRNA-1273 vaccination: possible adverse effect?. Clinical and experimental vaccine research, 10(3), 293. | Barsha, S. Y., Haque, M. M. A., Rashid, M. U., Rahman, M. L., Hossain, M. A., Zaman, S., ... y Hawlader, M. D. H. (2021). Un caso de encefalopatía aguda e infarto de miocardio sin elevación del segmento ST después de la vacunación con ARNm-1273: ¿posible efecto adverso? Investigación clínica y experimental de vacunas, 10(3), 293. https://pubmed.ncbi.nlm.nih.gov/34369046/. | Sánchez Tijmes, F., Thavendiranathan, P., Udell, J. A., Seidman, M. A., & Hanneman, K. (2021). Evaluación de la MRI cardíaca de la inflamación miocárdica no seleccionada: Revisión de vanguardia y actualización sobre la miocarditis asociada con la vacunación COVID-19. Radiología: Imagen cardiotorácica, 3 (6), E210252. https://www.ncbi.nlm.nih.gov/pubmed/34228985 | Barsha, S. Y., Haque, M. M. A., Rashid, M. U., Rahman, M. L., Hossain, M. A., Zaman, S., ... & Hawlader, M. D. H. (2021). A case of acute encephalopathy and non-ST segment elevation myocardial infarction following mRNA-1273 vaccination: possible adverse effect?. Clinical and experimental vaccine research, 10(3), 293. https://pubmed.ncbi.nlm.nih.gov/34703815/ | Saraceno, J. J. F., Souza, G. M., dos Santos Finamor, L. P., Nascimento, H. M., & Belfort, R. (2021). Vogt-Koyanagi-Harada syndrome following COVID-19 and ChAdOx1 nCoV-19 (AZD1222) vaccine. International journal of retina and vitreous, 7(1), 1-7. https://pubmed.ncbi.nlm.nih.gov/34462013/. | Isaak, A., Feisst, A., & Luetkens, J. A. (2021). Myocarditis following COVID-19 vaccination. Radiology, 301(1), E378-E379. | https://www.ncbi.nlm.nih.gov/pubmed/34342500 | Isaak, A., Feisst, A., & Luetkens, J. A. (2021). Myocarditis following COVID-19 vaccination. Radiology, 301(1), E378-E379. https://www.ncbi.nlm.nih.gov/pubmed/34342500 | Vollmann, D., Eiffert, H., & Schuster, A. (2021). Acute perimyocarditis following first dose of mRNA vaccine against COVID-19. Deutsches Ärzteblatt International, 118(31-32), 546. https://pubmed.ncbi.nlm.nih.gov/34515024/ | ||||
725 | Acute bilateral bilateral optic neuritis/chiasm with longitudinal extensive transverse myelitis in long-standing stable multiple sclerosis after vector-based vaccination against SARS-CoV-2: | https://pubmed.ncbi.nlm.nih.gov/34131771/ | https://pubmed.ncbi.nlm.nih.gov/34369046/. | Dash, S., Behera, B., Sethy, M., Mishra, J., & Garg, S. (2021). COVID‐19 vaccine‐induced urticarial vasculitis. Dermatologic Therapy. | Dash, S., Behera, B., Sethy, M., Mishra, J. y Garg, S. (2021). Vasculitis urticaria inducida por la vacuna COVID-19. Terapia dermatológica. https://pubmed.ncbi.nlm.nih.gov/34280507/. | Sandhu, S., Bhatnagar, A., Kumar, H., Dixit, P. K., Paliwal, G., Suhag, D. K., ... & Mitra, D. (2021). Vasculitis leucocitoclástica Como manifestación cutánea de la vacuna contra el virus de la corona Chadox1 NCOV-19 (recombinante). Terapia dermatológica, 34 (6), E15141. https://pubmed.ncbi.nlm.nih.gov/34546343/ | Dash, S., Behera, B., Sethy, M., Mishra, J., & Garg, S. (2021). COVID‐19 vaccine‐induced urticarial vasculitis. Dermatologic Therapy. https://pubmed.ncbi.nlm.nih.gov/34369046/. | Sato, K., Mano, T., Niimi, Y., Toda, T., Iwata, A., & Iwatsubo, T. (2021). Facial nerve palsy following the administration of COVID-19 mRNA vaccines: analysis of a self-reporting database. International Journal of Infectious Diseases, 111, 310-312. https://pubmed.ncbi.nlm.nih.gov/34492394/ | Jaafar, R., Boschi, C., Aherfi, S., Bancod, A., Le Bideau, M., Edouard, S., ... & La Scola, B. (2021). High individual heterogeneity of neutralizing activities against the original strain and nine different variants of SARS-CoV-2. Viruses, 13(11), 2177. | https://www.ncbi.nlm.nih.gov/pubmed/34834983 | Jaafar, R., Boschi, C., Aherfi, S., Bancod, A., Le Bideau, M., Edouard, S., ... & La Scola, B. (2021). High individual heterogeneity of neutralizing activities against the original strain and nine different variants of SARS-CoV-2. Viruses, 13(11), 2177. https://www.ncbi.nlm.nih.gov/pubmed/34834983 | Von Hundelshausen, P., Lorenz, R., Siess, W., & Weber, C. (2021). Vaccine-induced immune thrombotic thrombocytopenia (VITT): targeting pathomechanisms with Bruton tyrosine kinase inhibitors. Thrombosis and haemostasis. https://pubmed.ncbi.nlm.nih.gov/33851389/ | ||||
726 | A case series of acute pericarditis after vaccination with COVID-19 in the context of recent reports from Europe and the United States: | https://pubmed.ncbi.nlm.nih.gov/34635376/ | https://pubmed.ncbi.nlm.nih.gov/34280507/. | Shakoor, M. T., Birkenbach, M. P., & Lynch, M. (2021). ANCA-associated vasculitis following Pfizer-BioNTech COVID-19 vaccine. American Journal of Kidney Diseases, 78(4), 611-613. | Shakoor, MT, Birkenbach, MP y Lynch, M. (2021). Vasculitis asociada a ANCA tras la vacuna Pfizer-BioNTech COVID-19. Revista Estadounidense de Enfermedades Renales, 78(4), 611-613. https://pubmed.ncbi.nlm.nih.gov/34241833/ | Sangli, S., Virani, A., Cheronis, N., Vannatter, B., Minich, C., Noronha, S., ... & Kaplan, R. B. (2021). Trombosis con trombocitopenia después de la vacuna Messenger RNA-1273. Anales de medicina interna, 174 (8), 1480-1482. https://pubmed.ncbi.nlm.nih.gov/34174723/ | Shakoor, M. T., Birkenbach, M. P., & Lynch, M. (2021). ANCA-associated vasculitis following Pfizer-BioNTech COVID-19 vaccine. American Journal of Kidney Diseases, 78(4), 611-613. https://pubmed.ncbi.nlm.nih.gov/34280507/. | Sato, K., Mano, T., Niimi, Y., Toda, T., Iwata, A., & Iwatsubo, T. (2021). Facial nerve palsy following the administration of COVID-19 mRNA vaccines: analysis of a self-reporting database. International Journal of Infectious Diseases, 111, 310-312. https://www.sciencedirect.com/science/article/pii/S1201971221007049 | Jhaveri, R., Adler-Shohet, F. C., Blyth, C. C., Chiotos, K., Gerber, J. S., Green, M., ... & Zaoutis, T. (2021). Weighing the Risks of Perimyocarditis With the Benefits of SARS-CoV-2 mRNA Vaccination in Adolescents. Journal of the Pediatric Infectious Diseases Society, 10(10), 937-939. | https://www.ncbi.nlm.nih.gov/pubmed/34270752 | Jhaveri, R., Adler-Shohet, F. C., Blyth, C. C., Chiotos, K., Gerber, J. S., Green, M., ... & Zaoutis, T. (2021). Weighing the Risks of Perimyocarditis With the Benefits of SARS-CoV-2 mRNA Vaccination in Adolescents. Journal of the Pediatric Infectious Diseases Society, 10(10), 937-939. https://www.ncbi.nlm.nih.gov/pubmed/34270752 | von Tresckow, J., von Tresckow, B., Reinhardt, H. C., Herrmann, K., & Berliner, C. (2021). Thymic hyperplasia after mRNA based COVID-19 vaccination. Radiology Case Reports, 16(12), 3744-3745. https://pubmed.ncbi.nlm.nih.gov/34462647/ | ||||
727 | Acute pericarditis and cardiac tamponade after vaccination with Covid-19: | https://pubmed.ncbi.nlm.nih.gov/34749492/ | https://pubmed.ncbi.nlm.nih.gov/34241833/ | Bostan, E., Gulseren, D., & Gokoz, O. (2021). New‐onset leukocytoclastic vasculitis after COVID‐19 vaccine. International Journal of Dermatology. | Bostan, E., Gulseren, D. y Gokoz, O. (2021). Vasculitis leucocitoclástica de nueva aparición después de la vacuna COVID-19. Revista Internacional de Dermatología. https://pubmed.ncbi.nlm.nih.gov/34529877/. | SARACENO, J. J. F., Souza, G. M., DOS SANTOS FINAMOR, L. P., NASCIMENTO, H. M., & Belfort, R. (2021). Síndrome de Vogt-Koyanagi-Harada siguiendo la vacuna COVID-19 y CHADOX1 NCOV-19 (AZD1222). Diario Internacional de Retina y Vítreo, 7 (1), 1-7. https://pubmed.ncbi.nlm.nih.gov/34224024/. | Bostan, E., Gulseren, D., & Gokoz, O. (2021). New‐onset leukocytoclastic vasculitis after COVID‐19 vaccine. International Journal of Dermatology. https://pubmed.ncbi.nlm.nih.gov/34241833/ | Scavone, M., Clerici, B., Birocchi, S., Mencarini, T., Calogiuri, M., Ghali, C., ... & Podda, G. M. (2021). Platelet activation and modulation in thrombosis with thrombocytopenia syndrome associated with ChAdOx1 nCov-19 vaccine. haematologica, 106(12), 3228. https://pubmed.ncbi.nlm.nih.gov/34474550/ | Klein, N. P., Lewis, N., Goddard, K., Fireman, B., Zerbo, O., Hanson, K. E., ... & Weintraub, E. S. (2021). Surveillance for adverse events after COVID-19 mRNA vaccination. JAMA, 326(14), 1390-1399. | https://www.ncbi.nlm.nih.gov/pubmed/34477808 | Klein, N. P., Lewis, N., Goddard, K., Fireman, B., Zerbo, O., Hanson, K. E., ... & Weintraub, E. S. (2021). Surveillance for adverse events after COVID-19 mRNA vaccination. JAMA, 326(14), 1390-1399. https://www.ncbi.nlm.nih.gov/pubmed/34477808 | Vuille-Lessard, É., Montani, M., Bosch, J., & Semmo, N. (2021). Autoimmune hepatitis triggered by SARS-CoV-2 vaccination. Journal of autoimmunity, 123, 102710. https://pubmed.ncbi.nlm.nih.gov/34332438/ | ||||
728 | Myocarditis and pericarditis in adolescents after the first and second doses of COVID-19 mRNA vaccines: | https://pubmed.ncbi.nlm.nih.gov/34849667/ | https://pubmed.ncbi.nlm.nih.gov/34529877/. | Kar, B. R., Singh, B. S., Mohapatra, L., & Agrawal, I. (2021). Cutaneous small‐vessel vasculitis following COVID‐19 vaccine. Journal of Cosmetic Dermatology, 20(11), 3382. | Kar, B. R., Singh, B. S., Mohapatra, L. y Agrawal, I. (2021). Vasculitis cutánea de pequeños vasos después de la vacuna COVID-19. Revista de Dermatología Cosmética, 20(11), 3382. https://pubmed.ncbi.nlm.nih.gov/33928638/ | Sastre, P. D., Feightery, A. M., El-Sabawi, B., & Prasad, A. (2021). Informe de caso: miocarditis aguda después de la segunda dosis de vacuna contra MRNA-1273 SARS-COV-2. Informes de diario de corazón europeo, 5 (8), YTAB319. https://pubmed.ncbi.nlm.nih.gov/33946748/ | Kar, B. R., Singh, B. S., Mohapatra, L., & Agrawal, I. (2021). Cutaneous small‐vessel vasculitis following COVID‐19 vaccine. Journal of Cosmetic Dermatology, 20(11), 3382. https://pubmed.ncbi.nlm.nih.gov/34529877/. | Schauer, J., Buddhe, S., Colyer, J., Sagiv, E., Law, Y., Chikkabyrappa, S. M., & Portman, M. A. (2021). Myopericarditis after the Pfizer messenger ribonucleic acid coronavirus disease vaccine in adolescents. The Journal of pediatrics, 238, 317-320. https://pubmed.ncbi.nlm.nih.gov/34228985/ | Klimek, L., Bergmann, K. C., Brehler, R., Pfützner, W., Zuberbier, T., Hartmann, K., ... & Worm, M. (2021). Practical handling of allergic reactions to COVID-19 vaccines. Allergo journal international, 30(3), 79-95. | https://www.ncbi.nlm.nih.gov/pubmed/33898162 | Klimek, L., Bergmann, K. C., Brehler, R., Pfützner, W., Zuberbier, T., Hartmann, K., ... & Worm, M. (2021). Practical handling of allergic reactions to COVID-19 vaccines. Allergo journal international, 30(3), 79-95. https://www.ncbi.nlm.nih.gov/pubmed/33898162 | Waggiallah, H. A. (2021). Thrombosis formation after COVID-19 vaccination immunological aspects. Saudi journal of biological sciences. https://pubmed.ncbi.nlm.nih.gov/34629931/ | ||||
729 | Perimyocarditis in adolescents after Pfizer-BioNTech COVID-19 vaccine: | https://pubmed.ncbi.nlm.nih.gov/34319393/ | https://pubmed.ncbi.nlm.nih.gov/33928638/ | Cohen, S. R., Prussick, L., Kahn, J. S., Gao, D. X., Radfar, A., & Rosmarin, D. (2021). Leukocytoclastic vasculitis flare following the COVID‐19 vaccine. International Journal of Dermatology, 60(8), 1032-1033. | Cohen, S. R., Prussick, L., Kahn, J. S., Gao, D. X., Radfar, A. y Rosmarin, D. (2021). Brote de vasculitis leucocitoclástica después de la vacuna COVID-19. Revista Internacional de Dermatología, 60(8), 1032-1033. https://pubmed.ncbi.nlm.nih.gov/34836739/ | Sastre, P. D., Feightery, A. M., El-Sabawi, B., & Prasad, A. (2021). Informe de caso: miocarditis aguda después de la segunda dosis de vacuna contra MRNA-1273 SARS-COV-2. Informes de diario de corazón europeo, 5 (8), YTAB319. https://science.gc.ca/eic/site/063.nsf/eng/h_98291.html | Cohen, S. R., Prussick, L., Kahn, J. S., Gao, D. X., Radfar, A., & Rosmarin, D. (2021). Leukocytoclastic vasculitis flare following the COVID‐19 vaccine. International Journal of Dermatology, 60(8), 1032-1033. https://pubmed.ncbi.nlm.nih.gov/33928638/ | Schauer, J., Buddhe, S., Colyer, J., Sagiv, E., Law, Y., Chikkabyrappa, S. M., & Portman, M. A. (2021). Myopericarditis after the Pfizer messenger ribonucleic acid coronavirus disease vaccine in adolescents. The Journal of pediatrics, 238, 317-320. https://www.ncbi.nlm.nih.gov/pubmed/34228985 | Kohli, U., Desai, L., Chowdhury, D., Harahsheh, A. S., Yonts, A. B., Ansong, A., ... & Ang, J. Y. (2021). mRNA Coronavirus-19 Vaccine-Associated Myopericarditis in Adolescents: A Survey Study. The Journal of pediatrics. | https://www.ncbi.nlm.nih.gov/pubmed/34952008 | Kohli, U., Desai, L., Chowdhury, D., Harahsheh, A. S., Yonts, A. B., Ansong, A., ... & Ang, J. Y. (2021). mRNA Coronavirus-19 Vaccine-Associated Myopericarditis in Adolescents: A Survey Study. The Journal of pediatrics. https://www.ncbi.nlm.nih.gov/pubmed/34952008 | Waheed, S., Bayas, A., Hindi, F., Rizvi, Z., & Espinosa, P. S. (2021). Neurological complications of COVID-19: Guillain-Barre syndrome following Pfizer COVID-19 vaccine. Cureus, 13(2). https://pubmed.ncbi.nlm.nih.gov/33758714/ | ||||
730 | Acute myopericarditis after COVID-19 vaccine in adolescents: | https://pubmed.ncbi.nlm.nih.gov/34589238/ | https://pubmed.ncbi.nlm.nih.gov/34836739/ | Fritzen, M., Funchal, G. D. G., Luiz, M. O., & Durigon, G. S. (2022). Leukocytoclastic vasculitis after exposure to COVID-19 vaccine. Anais brasileiros de dermatologia, 97(1), 118-121. | Fritzen, M., Funchal, G. D. G., Luiz, M. O. y Durigon, G. S. (2022). Vasculitis leucocitoclástica después de la exposición a la vacuna COVID-19. Anais brasileiros de dermatología, 97(1), 118-121. https://pubmed.ncbi.nlm.nih.gov/34495381/. | Sastre, P. D., Feightery, A. M., El-Sabawi, B., & Prasad, A. (2021). Informe de caso: miocarditis aguda después de la segunda dosis de vacuna contra MRNA-1273 SARS-COV-2. Informes de diario de corazón europeo, 5 (8), YTAB319. https://www.ncbi.nlm.nih.gov/pubmed/34955479 | Fritzen, M., Funchal, G. D. G., Luiz, M. O., & Durigon, G. S. (2022). Leukocytoclastic vasculitis after exposure to COVID-19 vaccine. Anais brasileiros de dermatologia, 97(1), 118-121. https://pubmed.ncbi.nlm.nih.gov/34836739/ | Schauer, J., Buddhe, S., Colyer, J., Sagiv, E., Law, Y., Chikkabyrappa, S. M., & Portman, M. A. (2021). Myopericarditis after the Pfizer messenger ribonucleic acid coronavirus disease vaccine in adolescents. The Journal of pediatrics, 238, 317-320. https://www.sciencedirect.com/science/article/pii/S002234762100665X | Kostoff, R. N., Calina, D., Kanduc, D., Briggs, M. B., Vlachoyiannopoulos, P., Svistunov, A. A., & Tsatsakis, A. (2021). Erratum to “Why are we vaccinating children against COVID-19?”[Toxicol. Rep. 8C (2021) 1665–1684/1193]. Toxicology Reports. | https://www.ncbi.nlm.nih.gov/pubmed/34642628 | Kostoff, R. N., Calina, D., Kanduc, D., Briggs, M. B., Vlachoyiannopoulos, P., Svistunov, A. A., & Tsatsakis, A. (2021). Erratum to “Why are we vaccinating children against COVID-19?”[Toxicol. Rep. 8C (2021) 1665–1684/1193]. Toxicology Reports. https://www.ncbi.nlm.nih.gov/pubmed/34642628 | Walter, U., Fuchs, M., Grossmann, A., Walter, M., Thiele, T., Storch, A., & Wittstock, M. (2021). Adenovirus-vectored COVID-19 vaccine–induced immune thrombosis of carotid artery: a case report. Neurology, 97(15), 716-719. https://pubmed.ncbi.nlm.nih.gov/34312301/. | ||||
731 | Pericarditis after administration of the BNT162b2 mRNA vaccine COVID-19: | https://pubmed.ncbi.nlm.nih.gov/34149145/ | https://pubmed.ncbi.nlm.nih.gov/34495381/. | Schierz, J. H., Merkel, C., Kittner, T., & Ali, F. (2022). Vasculitis and bursitis on [18F] FDG-PET/CT following COVID-19 mRNA vaccine: post hoc ergo propter hoc?. European Journal of Nuclear Medicine and Molecular Imaging, 49(3), 1086-1087. | Schierz, JH, Merkel, C., Kittner, T. y Ali, F. (2022). Vasculitis y bursitis en [18F] FDG-PET/CT después de la vacuna de ARNm de COVID-19: post hoc ergo propter hoc?. Revista europea de medicina nuclear e imágenes moleculares, 49(3), 1086-1087. https://pubmed.ncbi.nlm.nih.gov/34327795 | Sato, K., Mano, T., Niimi, Y., Toda, T., Iwata, A., & iWatsubo, T. (2021). Parálisis del nervio facial después de la administración de vacunas de ARNm COVID-19: análisis de una base de datos de autoinformación. Diario Internacional de Enfermedades Infecciosas, 111, 310-312. https://pubmed.ncbi.nlm.nih.gov/34369471/ | Schierz, J. H., Merkel, C., Kittner, T., & Ali, F. (2022). Vasculitis and bursitis on [18F] FDG-PET/CT following COVID-19 mRNA vaccine: post hoc ergo propter hoc?. European Journal of Nuclear Medicine and Molecular Imaging, 49(3), 1086-1087. https://pubmed.ncbi.nlm.nih.gov/34495381/. | Schierz, J. H., Merkel, C., Kittner, T., & Ali, F. (2022). Vasculitis and bursitis on [18F] FDG-PET/CT following COVID-19 mRNA vaccine: post hoc ergo propter hoc?. European Journal of Nuclear Medicine and Molecular Imaging, 49(3), 1086-1087. https://pubmed.ncbi.nlm.nih.gov/34495381/. | Kostoff, R. N., Calina, D., Kanduc, D., Briggs, M. B., Vlachoyiannopoulos, P., Svistunov, A. A., & Tsatsakis, A. (2021). Why are we vaccinating children against COVID-19?. Toxicology reports, 8, 1665-1684. | https://www.ncbi.nlm.nih.gov/pubmed/34540594 | Kostoff, R. N., Calina, D., Kanduc, D., Briggs, M. B., Vlachoyiannopoulos, P., Svistunov, A. A., & Tsatsakis, A. (2021). Why are we vaccinating children against COVID-19?. Toxicology reports, 8, 1665-1684. https://www.ncbi.nlm.nih.gov/pubmed/34540594 | Walter, U., Volmer, E., Wittstock, M., Storch, A., Weber, M. A., & Großmann, A. (2021). Cerebral venous sinus thrombosis after COVID-19 vaccination: Neurological and radiological management. Der Radiologe. https://pubmed.ncbi.nlm.nih.gov/34327553/. | ||||
732 | Case report: symptomatic pericarditis post COVID-19 vaccination: | https://pubmed.ncbi.nlm.nih.gov/34693198/. | https://pubmed.ncbi.nlm.nih.gov/34327795 | Vassallo, C., Boveri, E., Brazzelli, V., Rampino, T., Bruno, R., Bonometti, A., & Gregorini, M. (2021). Cutaneous lymphocytic vasculitis after administration of COVID‐19 mRNA vaccine. Dermatologic Therapy. | Vassallo, C., Boveri, E., Brazzelli, V., Rampino, T., Bruno, R., Bonometti, A. y Gregorini, M. (2021). Vasculitis linfocítica cutánea tras la administración de la vacuna de ARNm de COVID-19. Terapia dermatológica. https://pubmed.ncbi.nlm.nih.gov/34660867/. | Sato, K., Mano, T., Niimi, Y., Toda, T., Iwata, A., & iWatsubo, T. (2021). Parálisis del nervio facial después de la administración de vacunas de ARNm COVID-19: análisis de una base de datos de autoinformación. Diario Internacional de Enfermedades Infecciosas, 111, 310-312. https://www.sciencedirect.com/science/article/pii/S0899707121003557. | Vassallo, C., Boveri, E., Brazzelli, V., Rampino, T., Bruno, R., Bonometti, A., & Gregorini, M. (2021). Cutaneous lymphocytic vasculitis after administration of COVID‐19 mRNA vaccine. Dermatologic Therapy. https://pubmed.ncbi.nlm.nih.gov/34327795 | Schmitt, P., Demoulin, R., Poyet, R., Capilla, E., Rohel, G., Pons, F., ... & Cellarier, G. R. (2021). Acute Myocarditis after COVID-19 vaccination: A case report. La Revue de medecine interne, 42(11), 797-800. https://www.sciencedirect.com/science/article/pii/S0248866321007098 | Kremsner, P. G., Mann, P., Kroidl, A., Leroux-Roels, I., Schindler, C., Gabor, J. J., ... & Oostvogels, L. (2021). Safety and immunogenicity of an mRNA-lipid nanoparticle vaccine candidate against SARS-CoV-2. Wiener klinische Wochenschrift, 133(17), 931-941. | https://www.ncbi.nlm.nih.gov/pubmed/34378087 | Kremsner, P. G., Mann, P., Kroidl, A., Leroux-Roels, I., Schindler, C., Gabor, J. J., ... & Oostvogels, L. (2021). Safety and immunogenicity of an mRNA-lipid nanoparticle vaccine candidate against SARS-CoV-2. Wiener klinische Wochenschrift, 133(17), 931-941. https://www.ncbi.nlm.nih.gov/pubmed/34378087 | Wan, E. Y. F., Chui, C. S. L., Lai, F. T. T., Chan, E. W. Y., Li, X., Yan, V. K. C., ... & Wong, I. C. K. (2022). Bell's palsy following vaccination with mRNA (BNT162b2) and inactivated (CoronaVac) SARS-CoV-2 vaccines: a case series and nested case-control study. The Lancet Infectious Diseases, 22(1), 64-72. https://pubmed.ncbi.nlm.nih.gov/34411532/ | ||||
733 | An outbreak of Still’s disease after COVID-19 vaccination in a 34-year-old patient: | https://pubmed.ncbi.nlm.nih.gov/34797392/ | https://pubmed.ncbi.nlm.nih.gov/34660867/. | Bencharattanaphakhi, R., & Rerknimitr, P. (2021). Sinovac COVID-19 vaccine–induced cutaneous leukocytoclastic vasculitis. JAAD case reports, 18, 1-3. | Bencharattanaphakhi, R. y Rerknimitr, P. (2021). Vasculitis leucocitoclástica cutánea inducida por la vacuna Sinovac COVID-19. Informes de casos de JAAD, 18, 1-3. https://pubmed.ncbi.nlm.nih.gov/34659268/ | SCAVONE, M., Clerici, B., Birocchi, S., Mencarini, T., Calogiuri, M., Ghali, C., ... & PODDA, G. M. (2021). Activación de plaquetas y modulación en trombosis con síndrome de trombocitopenia asociado con la vacuna Chadox1 NCOV-19. Haematologica, 106 (12), 3228. https://pubmed.ncbi.nlm.nih.gov/34033732/. | Bencharattanaphakhi, R., & Rerknimitr, P. (2021). Sinovac COVID-19 vaccine–induced cutaneous leukocytoclastic vasculitis. JAAD case reports, 18, 1-3. https://pubmed.ncbi.nlm.nih.gov/34660867/. | Schneider, J., Sottmann, L., Greinacher, A., Hagen, M., Kasper, H. U., Kuhnen, C., ... & Schmeling, A. (2021). Postmortem investigation of fatalities following vaccination with COVID-19 vaccines. International Journal of Legal Medicine, 135(6), 2335-2345. https://pubmed.ncbi.nlm.nih.gov/34591186/ | Kustin, T., Harel, N., Finkel, U., Perchik, S., Harari, S., Tahor, M., ... & Stern, A. (2021). Evidence for increased breakthrough rates of SARS-CoV-2 variants of concern in BNT162b2-mRNA-vaccinated individuals. Nature medicine, 27(8), 1379-1384. | https://www.ncbi.nlm.nih.gov/pubmed/34127854 | Kustin, T., Harel, N., Finkel, U., Perchik, S., Harari, S., Tahor, M., ... & Stern, A. (2021). Evidence for increased breakthrough rates of SARS-CoV-2 variants of concern in BNT162b2-mRNA-vaccinated individuals. Nature medicine, 27(8), 1379-1384. https://www.ncbi.nlm.nih.gov/pubmed/34127854 | Wang, R. L., Chiang, W. F., Shyu, H. Y., Chen, M. H., Lin, C. I., Wu, K. A., ... & Hsiao, P. J. (2021). COVID-19 vaccine-associated acute cerebral venous thrombosis and pulmonary artery embolism. QJM: An International Journal of Medicine. https://pubmed.ncbi.nlm.nih.gov/34247246/. | ||||
734 | Hemophagocytic lymphohistiocytosis following COVID-19 vaccination (ChAdOx1 nCoV-19): | https://pubmed.ncbi.nlm.nih.gov/34862234/ | https://pubmed.ncbi.nlm.nih.gov/34659268/ | Hakroush, S., & Tampe, B. (2021). Case report: ANCA-associated vasculitis presenting with rhabdomyolysis and pauci-immune crescentic glomerulonephritis after Pfizer-BioNTech COVID-19 mRNA vaccination. Frontiers in Immunology, 12. | Hakroush, S. y Tampe, B. (2021). Informe de caso: vasculitis asociada a ANCA que se presenta con rabdomiólisis y glomerulonefritis semilunar pauciinmune después de la vacunación con ARNm de COVID-19 de Pfizer-BioNTech. Fronteras en inmunología, 12. https://pubmed.ncbi.nlm.nih.gov/34848431/ | Schauer, J., Buddhe, S., Colyer, J., Sagiv, E., Ley, Y., Chikkabyrappa, S. M., & Portman, M. A. (2021). Myopericarditis después de la vacuna contra las enfermedades del ácido ribonucleirus de ácido ribonucleico del Messenger Ribonucleico en adolescentes. El Journal of Pediattics, 238, 317-320. https://pubmed.ncbi.nlm.nih.gov/34852213/ | Hakroush, S., & Tampe, B. (2021). Case report: ANCA-associated vasculitis presenting with rhabdomyolysis and pauci-immune crescentic glomerulonephritis after Pfizer-BioNTech COVID-19 mRNA vaccination. Frontiers in Immunology, 12. https://pubmed.ncbi.nlm.nih.gov/34659268/ | Schneider, J., Sottmann, L., Greinacher, A., Hagen, M., Kasper, H. U., Kuhnen, C., ... & Schmeling, A. (2021). Postmortem investigation of fatalities following vaccination with COVID-19 vaccines. International Journal of Legal Medicine, 135(6), 2335-2345. https://www.ncbi.nlm.nih.gov/pubmed/34591186 | Kwan, M. Y., Chua, G. T., Chow, C. B., Tsao, S. S., To, K. K., Yuen, K. Y., ... & Ip, P. (2021). mRNA COVID vaccine and myocarditis in adolescents. Hong Kong Med J, 27(5), 326-327. | https://www.ncbi.nlm.nih.gov/pubmed/34393110 | Kwan, M. Y., Chua, G. T., Chow, C. B., Tsao, S. S., To, K. K., Yuen, K. Y., ... & Ip, P. (2021). mRNA COVID vaccine and myocarditis in adolescents. Hong Kong Med J, 27(5), 326-327. https://www.ncbi.nlm.nih.gov/pubmed/34393110 | Wantavornprasert, K., Noppakun, N., Klaewsongkram, J., & Rerknimitr, P. (2022). Generalized bullous fixed drug eruption after Oxford–AstraZeneca (ChAdOx1 nCoV‐19) vaccination. Clinical and Experimental Dermatology, 47(2), 428-432. https://pubmed.ncbi.nlm.nih.gov/34482558/ | ||||
735 | Myocarditis after SARS-CoV-2 mRNA vaccination, a case series: | https://pubmed.ncbi.nlm.nih.gov/34396358/. | https://pubmed.ncbi.nlm.nih.gov/34848431/ | Maye, J. A., Chong, H. P., Rajagopal, V., & Petchey, W. (2021). Reactivation of IgA vasculitis following COVID-19 vaccination. BMJ Case Reports CP, 14(11), e247188. | Maye, J. A., Chong, H. P., Rajagopal, V. y Petchey, W. (2021). Reactivación de vasculitis por IgA tras la vacunación COVID-19. BMJ Case Reports CP, 14(11), e247188. https://pubmed.ncbi.nlm.nih.gov/34310759/. | Schauer, J., Buddhe, S., Colyer, J., Sagiv, E., Ley, Y., Chikkabyrappa, S. M., & Portman, M. A. (2021). Myopericarditis después de la vacuna contra las enfermedades del ácido ribonucleirus de ácido ribonucleico del Messenger Ribonucleico en adolescentes. El Journal of Pediattics, 238, 317-320. https://www.ncbi.nlm.nih.gov/pubmed/34591186 | Maye, J. A., Chong, H. P., Rajagopal, V., & Petchey, W. (2021). Reactivation of IgA vasculitis following COVID-19 vaccination. BMJ Case Reports CP, 14(11), e247188. https://pubmed.ncbi.nlm.nih.gov/34848431/ | Schramm, R., Costard-Jäckle, A., Rivinius, R., Fischer, B., Müller, B., Boeken, U., ... & Gummert, J. (2021). Poor humoral and T-cell response to two-dose SARS-CoV-2 messenger RNA vaccine BNT162b2 in cardiothoracic transplant recipients. Clinical Research in Cardiology, 110(8), 1142-1149. https://www.ncbi.nlm.nih.gov/pubmed/34241676 | Lee, E., Chew, N. W., Ng, P., & Yeo, T. J. (2021). Reply to" Letter to the editor: Myocarditis should be considered in those with a troponin rise and unobstructed coronary arteries following PfizerBioNTech COVID-19 vaccination". QJM: Monthly Journal of the Association of Physicians. | https://www.ncbi.nlm.nih.gov/pubmed/34463770 | Lee, E., Chew, N. W., Ng, P., & Yeo, T. J. (2021). Reply to" Letter to the editor: Myocarditis should be considered in those with a troponin rise and unobstructed coronary arteries following PfizerBioNTech COVID-19 vaccination". QJM: Monthly Journal of the Association of Physicians. https://www.ncbi.nlm.nih.gov/pubmed/34463770 | Waqar, S. H. B., Khan, A. A., & Memon, S. (2021). Thrombotic thrombocytopenic purpura: a new menace after COVID bnt162b2 vaccine. International Journal of Hematology, 114(5), 626-629. https://pubmed.ncbi.nlm.nih.gov/34264514/. | ||||
736 | Miller-Fisher syndrome and Guillain-Barré syndrome overlap syndrome in a patient after Oxford-AstraZeneca SARS-CoV-2 vaccination: | https://pubmed.ncbi.nlm.nih.gov/34848426/. | https://pubmed.ncbi.nlm.nih.gov/34310759/. | Nastro, F., Fabbrocini, G., di Vico, F., & Marasca, C. (2021). Small vessel vasculitis related to varicella‐zoster virus after Pfizer‐BioNTech COVID‐19 vaccine. Journal of the European Academy of Dermatology and Venereology. | Nastro, F., Fabbrocini, G., di Vico, F. y Marasca, C. (2021). Vasculitis de pequeños vasos relacionada con el virus varicela-zoster después de la vacuna Pfizer-BioNTech COVID-19. Revista de la Academia Europea de Dermatología y Venereología. https://pubmed.ncbi.nlm.nih.gov/34720009/ | Schauer, J., Buddhe, S., Colyer, J., Sagiv, E., Ley, Y., Chikkabyrappa, S. M., & Portman, M. A. (2021). Myopericarditis después de la vacuna contra las enfermedades del ácido ribonucleirus de ácido ribonucleico del Messenger Ribonucleico en adolescentes. El Journal of Pediattics, 238, 317-320. https://www.sciencedirect.com/science/article/pii/S1885585721002218 | Nastro, F., Fabbrocini, G., di Vico, F., & Marasca, C. (2021). Small vessel vasculitis related to varicella‐zoster virus after Pfizer‐BioNTech COVID‐19 vaccine. Journal of the European Academy of Dermatology and Venereology. https://pubmed.ncbi.nlm.nih.gov/34310759/. | Schultz, N. H., Sørvoll, I. H., Michelsen, A. E., Munthe, L. A., Lund-Johansen, F., Ahlen, M. T., ... & Holme, P. A. (2021). Thrombosis and thrombocytopenia after ChAdOx1 nCoV-19 vaccination. New England journal of medicine, 384(22), 2124-2130. https://www.nejm.org/doi/full/10.1056/NEJMoa2104840?query=recirc_curatedRelated_article | Li, J., Hui, A., Zhang, X., Yang, Y., Tang, R., Ye, H., ... & Zhu, F. (2021). Safety and immunogenicity of the SARS-CoV-2 BNT162b1 mRNA vaccine in younger and older Chinese adults: a randomized, placebo-controlled, double-blind phase 1 study. Nature medicine, 27(6), 1062-1070. | https://www.ncbi.nlm.nih.gov/pubmed/33888900 | Li, J., Hui, A., Zhang, X., Yang, Y., Tang, R., Ye, H., ... & Zhu, F. (2021). Safety and immunogenicity of the SARS-CoV-2 BNT162b1 mRNA vaccine in younger and older Chinese adults: a randomized, placebo-controlled, double-blind phase 1 study. Nature medicine, 27(6), 1062-1070. https://www.ncbi.nlm.nih.gov/pubmed/33888900 | Waraich, A., & Williams, G. (2021). Haematuria, a widespread petechial rash, and headaches following the Oxford AstraZeneca ChAdOx1 nCoV-19 Vaccination. BMJ Case Reports CP, 14(10), e245440. https://pubmed.ncbi.nlm.nih.gov/34620638/ | ||||
737 | Immune-mediated disease outbreaks or new-onset disease in 27 subjects after mRNA/DNA vaccination against SARS-CoV-2: | https://pubmed.ncbi.nlm.nih.gov/33946748/ | https://pubmed.ncbi.nlm.nih.gov/34720009/ | Dicks, A. B., & Gray, B. H. (2021). Images in Vascular Medicine: Leukocytoclastic vasculitis after COVID-19 vaccine booster. Vascular Medicine, 1358863X211055507. | Dicks, A. B. y Gray, BH (2021). Imágenes en Medicina Vascular: Vasculitis leucocitoclástica tras refuerzo de vacuna COVID-19. Medicina Vascular, 1358863X211055507. https://pubmed.ncbi.nlm.nih.gov/34518812/ | Schierz, J. H., Merkel, C., Kittner, T., & Ali, F. (2022). Vasculitis y bursitis en [18F] FDG-PET / CT después de la vacuna contra el ARNm COVID-19: ¡Post hoc Ergo Propter hoc?. Diario Europeo de Medicina Nuclear y Imágenes Moleculares, 49 (3), 1086-1087. https://pubmed.ncbi.nlm.nih.gov/34327795 | Dicks, A. B., & Gray, B. H. (2021). Images in Vascular Medicine: Leukocytoclastic vasculitis after COVID-19 vaccine booster. Vascular Medicine, 1358863X211055507. https://pubmed.ncbi.nlm.nih.gov/34720009/ | Schultz, N. H., Sørvoll, I. H., Michelsen, A. E., Munthe, L. A., Lund-Johansen, F., Ahlen, M. T., ... & Holme, P. A. (2021). Thrombosis and thrombocytopenia after ChAdOx1 nCoV-19 vaccination. New England journal of medicine, 384(22), 2124-2130. https://www.nejm.org/doi/full/10.1056/NEJMoa2104882?query=recirc_curatedRelated_article | Madelon, N., Lauper, K., Breville, G., Sabater Royo, I., Goldstein, R., Andrey, D. O., ... & Eberhardt, C. S. (2021). Robust T cell responses in anti-CD20 treated patients following COVID-19 vaccination: a prospective cohort study. Clinical Infectious Diseases. | https://www.ncbi.nlm.nih.gov/pubmed/34791081 | Madelon, N., Lauper, K., Breville, G., Sabater Royo, I., Goldstein, R., Andrey, D. O., ... & Eberhardt, C. S. (2021). Robust T cell responses in anti-CD20 treated patients following COVID-19 vaccination: a prospective cohort study. Clinical Infectious Diseases. https://www.ncbi.nlm.nih.gov/pubmed/34791081 | Warkentin, T. E., & Greinacher, A. (2021). Spontaneous HIT syndrome: knee replacement, infection, and parallels with vaccine-induced immune thrombotic thrombocytopenia. Thrombosis Research, 204, 40-51. https://pubmed.ncbi.nlm.nih.gov/34144250/ | ||||
738 | Post-mortem investigation of deaths after vaccination with COVID-19 vaccines: | https://pubmed.ncbi.nlm.nih.gov/34591186/ | https://pubmed.ncbi.nlm.nih.gov/34518812/ | Naitlho, A., Lahlou, W., Bourial, A., Rais, H., Ismaili, N., Abousahfa, I., & Belyamani, L. (2021). A Rare Case of Henoch-Schönlein Purpura Following a COVID-19 Vaccine—Case Report. SN comprehensive clinical medicine, 3(12), 2618-2621. | Naitlho, A., Lahlou, W., Bourial, A., Rais, H., Ismaili, N., Abousahfa, I. y Belyamani, L. (2021). Un caso raro de púrpura de Henoch-Schönlein después de una vacuna contra el COVID-19: informe de caso. SN medicina clínica integral, 3(12), 2618-2621. https://pubmed.ncbi.nlm.nih.gov/34611627/. | Schmitt, P., DEMOULIN, R., POYET, R., CAPILLA, E., ROHEL, G., PONS, F., ... & CELLARIER, G. R. (2021). Miocarditis aguda después de la vacunación de COVID-19: un informe de caso. La Revue de Medecine Interne, 42 (11), 797-800. https://pubmed.ncbi.nlm.nih.gov/34589238/. | Naitlho, A., Lahlou, W., Bourial, A., Rais, H., Ismaili, N., Abousahfa, I., & Belyamani, L. (2021). A Rare Case of Henoch-Schönlein Purpura Following a COVID-19 Vaccine—Case Report. SN comprehensive clinical medicine, 3(12), 2618-2621. https://pubmed.ncbi.nlm.nih.gov/34518812/ | Schulz, J. B., Berlit, P., Diener, H. C., Gerloff, C., Greinacher, A., Klein, C., ... & Zimmermann, J. (2021). COVID‐19 vaccine‐associated cerebral venous thrombosis in Germany. Annals of neurology, 90(4), 627-639. https://onlinelibrary.wiley.com/doi/10.1002/ana.26172 | Mangat, C., & Milosavljevic, N. (2021). BNT162b2 Vaccination during Pregnancy Protects Both the Mother and Infant: Anti-SARS-CoV-2 S Antibodies Persistently Positive in an Infant at 6 Months of Age. Case Reports in Pediatrics, 2021. | https://www.ncbi.nlm.nih.gov/pubmed/34676123 | Mangat, C., & Milosavljevic, N. (2021). BNT162b2 Vaccination during Pregnancy Protects Both the Mother and Infant: Anti-SARS-CoV-2 S Antibodies Persistently Positive in an Infant at 6 Months of Age. Case Reports in Pediatrics, 2021. https://www.ncbi.nlm.nih.gov/pubmed/34676123 | Warren, C. M., Snow, T. T., Lee, A. S., Shah, M. M., Heider, A., Blomkalns, A., ... & Nadeau, K. C. (2021). Assessment of allergic and anaphylactic reactions to mRNA COVID-19 vaccines with confirmatory testing in a US regional health system. JAMA network open, 4(9), e2125524-e2125524. https://www.ncbi.nlm.nih.gov/pubmed/34533570 | ||||
739 | Acute kidney injury with macroscopic hematuria and IgA nephropathy after COVID-19 vaccination: | https://pubmed.ncbi.nlm.nih.gov/34352309/ | https://pubmed.ncbi.nlm.nih.gov/34611627/. | Cavalli, G., Colafrancesco, S., De Luca, G., Rizzo, N., Priori, R., Conti, F., & Dagna, L. (2021). Cutaneous vasculitis following COVID-19 vaccination. The Lancet Rheumatology, 3(11), e743-e744. | Cavalli, G., Colafrancesco, S., De Luca, G., Rizzo, N., Priori, R., Conti, F. y Dagna, L. (2021). Vasculitis cutánea tras la vacunación COVID-19. The Lancet Rheumatology, 3(11), e743-e744. https://pubmed.ncbi.nlm.nih.gov/34705320/. | Schneider, J., Sottmann, L., Greinacher, A., Hagen, M., Kasper, H. U., Kuhnen, C., ... & Schmeling, A. (2021). Postmortem Investigación de muertes después de la vacunación con vacunas COVID-19. Diario Internacional de Medicina Legal, 135 (6), 2335-2345. https://pubmed.ncbi.nlm.nih.gov/34352309/ | Cavalli, G., Colafrancesco, S., De Luca, G., Rizzo, N., Priori, R., Conti, F., & Dagna, L. (2021). Cutaneous vasculitis following COVID-19 vaccination. The Lancet Rheumatology, 3(11), e743-e744. https://pubmed.ncbi.nlm.nih.gov/34611627/. | Schulz, J. B., Berlit, P., Diener, H. C., Gerloff, C., Greinacher, A., Klein, C., ... & Zimmermann, J. (2021). COVID‐19 vaccine‐associated cerebral venous thrombosis in Germany. Annals of neurology, 90(4), 627-639. https://pubmed.ncbi.nlm.nih.gov/34288044/ | Mark, C., Gupta, S., Punnett, A., Upton, J., Orkin, J., Atkinson, A., ... & Alexander, S. (2021). Safety of administration of BNT162b2 mRNA (Pfizer‐BioNTech) COVID‐19 vaccine in youths and young adults with a history of acute lymphoblastic leukemia and allergy to PEG‐asparaginase. Pediatric Blood & Cancer, 68(11), e29295. | https://www.ncbi.nlm.nih.gov/pubmed/34398511 | Mark, C., Gupta, S., Punnett, A., Upton, J., Orkin, J., Atkinson, A., ... & Alexander, S. (2021). Safety of administration of BNT162b2 mRNA (Pfizer‐BioNTech) COVID‐19 vaccine in youths and young adults with a history of acute lymphoblastic leukemia and allergy to PEG‐asparaginase. Pediatric Blood & Cancer, 68(11), e29295. https://www.ncbi.nlm.nih.gov/pubmed/34398511 | Washington, T., Bryan, R., & Clemow, C. (2021). Adenopathy following COVID-19 vaccination. Radiology, 299(3), E280-E281. https://pubmed.ncbi.nlm.nih.gov/33625299/. | ||||
740 | Relapse of immune thrombocytopenia after covid-19 vaccination in young male patient: | https://pubmed.ncbi.nlm.nih.gov/34804803/. | https://pubmed.ncbi.nlm.nih.gov/34705320/. | Bostan, E., Zaid, F., Akdogan, N., & Gokoz, O. (2022). Possible case of mRNA COVID‐19 vaccine‐induced small‐vessel vasculitis. Journal of Cosmetic Dermatology, 21(1), 51-53. | Bostan, E., Zaid, F., Akdogan, N. y Gokoz, O. (2022). Posible caso de vasculitis de pequeños vasos inducida por la vacuna mRNA COVID-19. Revista de Dermatología Cosmética, 21(1), 51-53. https://pubmed.ncbi.nlm.nih.gov/34779011/ | Schneider, J., Sottmann, L., Greinacher, A., Hagen, M., Kasper, H. U., Kuhnen, C., ... & Schmeling, A. (2021). Postmortem Investigación de muertes después de la vacunación con vacunas COVID-19. Diario Internacional de Medicina Legal, 135 (6), 2335-2345. https://www.ncbi.nlm.nih.gov/pubmed/34241676 | Bostan, E., Zaid, F., Akdogan, N., & Gokoz, O. (2022). Possible case of mRNA COVID‐19 vaccine‐induced small‐vessel vasculitis. Journal of Cosmetic Dermatology, 21(1), 51-53. https://pubmed.ncbi.nlm.nih.gov/34705320/. | Schulz, J. B., Berlit, P., Diener, H. C., Gerloff, C., Greinacher, A., Klein, C., ... & Zimmermann, J. (2021). COVID‐19 vaccine‐associated cerebral venous thrombosis in Germany. Annals of neurology, 90(4), 627-639. https://pubmed.ncbi.nlm.nih.gov/34288044/. | Martins-Filho, P. R., Quintans-Júnior, L. J., de Souza Araújo, A. A., Sposato, K. B., Tavares, C. S., Gurgel, R. Q., ... & Santos, V. S. (2021). Socio-economic inequalities and COVID-19 incidence and mortality in Brazilian children: a nationwide register-based study. Public Health, 190, 4-6. | https://www.ncbi.nlm.nih.gov/pubmed/33316478 | Martins-Filho, P. R., Quintans-Júnior, L. J., de Souza Araújo, A. A., Sposato, K. B., Tavares, C. S., Gurgel, R. Q., ... & Santos, V. S. (2021). Socio-economic inequalities and COVID-19 incidence and mortality in Brazilian children: a nationwide register-based study. Public Health, 190, 4-6. https://www.ncbi.nlm.nih.gov/pubmed/33316478 | Watad, A., De Marco, G., Mahajna, H., Druyan, A., Eltity, M., Hijazi, N., ... & McGonagle, D. (2021). Immune-mediated disease flares or new-onset disease in 27 subjects following mRNA/DNA SARS-CoV-2 vaccination. Vaccines, 9(5), 435. https://pubmed.ncbi.nlm.nih.gov/33946748/ | ||||
741 | Immune thrombocytopenic purpura associated with COVID-19 mRNA vaccine Pfizer-BioNTech BNT16B2b2: | https://pubmed.ncbi.nlm.nih.gov/34077572/ | https://pubmed.ncbi.nlm.nih.gov/34779011/ | Grossman, M. E., Appel, G., Little, A. J., & Ko, C. J. (2021). Post‐COVID‐19 vaccination IgA vasculitis in an adult. Journal of cutaneous pathology. | Grossman, M. E., Appel, G., Little, A. J. y Ko, C. J. (2021). Vasculitis IgA posvacunación COVID-19 en un adulto. Revista de patología cutánea. https://pubmed.ncbi.nlm.nih.gov/33928459/ | Schramm, R., Costard-Jäckle, A., Rivinius, R., Fischer, B., Müller, B., Boeken, U., ... & Gummert, J. (2021). Pobre respuesta humoral y de células T a dos dosis SARS-COV-2 Messenger ARN Vaccine BNT162B2 en receptores de trasplantes cardiotorácicos. Investigación clínica en cardiología, 110 (8), 1142-1149. https://www.ncbi.nlm.nih.gov/pubmed/34945172 | Grossman, M. E., Appel, G., Little, A. J., & Ko, C. J. (2021). Post‐COVID‐19 vaccination IgA vasculitis in an adult. Journal of cutaneous pathology. https://pubmed.ncbi.nlm.nih.gov/34779011/ | Scott, J., Anderson, J., Mallak, N., Beitinjaneh, B., Wei, K., & Otaki, F. (2021). Gastroparesis After Pfizer-BioNTech COVID-19 Vaccination. Official journal of the American College of Gastroenterology| ACG, 116(11), 2300. https://pubmed.ncbi.nlm.nih.gov/34187985/. | Mizrahi, B., Lotan, R., Kalkstein, N., Peretz, A., Perez, G., Ben-Tov, A., ... & Patalon, T. (2021). Correlation of SARS-CoV-2-breakthrough infections to time-from-vaccine. Nature communications, 12(1), 1-5. | https://www.ncbi.nlm.nih.gov/pubmed/34737312 | Mizrahi, B., Lotan, R., Kalkstein, N., Peretz, A., Perez, G., Ben-Tov, A., ... & Patalon, T. (2021). Correlation of SARS-CoV-2-breakthrough infections to time-from-vaccine. Nature communications, 12(1), 1-5. https://www.ncbi.nlm.nih.gov/pubmed/34737312 | Watchmaker, J. M., & Belani, P. B. (2022). Brain death in a vaccinated patient with COVID-19 infection. Clinical Imaging, 81, 92-95. https://pubmed.ncbi.nlm.nih.gov/34656887/ | ||||
742 | Retinal hemorrhage after SARS-CoV-2 vaccination: | https://pubmed.ncbi.nlm.nih.gov/34884407/. | https://pubmed.ncbi.nlm.nih.gov/33928459/ | Sim, J., & Lim, C. C. (2021). Coronavirus disease 2019 (COVID-19) vaccination in systemic lupus erythematosus and anti-neutrophil cytoplasmic antibody-associated vasculitis. Clinical Rheumatology, 40(6), 2517-2518. | Sim, J. y Lim, CC (2021). Vacunación contra la enfermedad por coronavirus 2019 (COVID-19) en el lupus eritematoso sistémico y la vasculitis asociada a anticuerpos citoplasmáticos antineutrófilos. Reumatología clínica, 40(6), 2517-2518. https://pubmed.ncbi.nlm.nih.gov/34250509/ | Schultz, N. H., Sørvoll, I. H., Michelsen, A. E., Munthe, L. A., Lund-Johansen, F., Ahlen, M. T., ... & HOLME, P. A. (2021). Trombosis y trombocitopenia después de la vacunación con Chadox1 NCOV-19. New England Journal of Medicine, 384 (22), 2124-2130. https://haematologica.org/article/view/haematol.2021.279075 | Sim, J., & Lim, C. C. (2021). Coronavirus disease 2019 (COVID-19) vaccination in systemic lupus erythematosus and anti-neutrophil cytoplasmic antibody-associated vasculitis. Clinical Rheumatology, 40(6), 2517-2518. https://pubmed.ncbi.nlm.nih.gov/33928459/ | See, I., Su, J. R., Lale, A., Woo, E. J., Guh, A. Y., Shimabukuro, T. T., ... & Broder, K. R. (2021). US case reports of cerebral venous sinus thrombosis with thrombocytopenia after Ad26. COV2. S vaccination, March 2 to April 21, 2021. Jama, 325(24), 2448-2456. https://pubmed.ncbi.nlm.nih.gov/33929487/ | Moffitt, K., Cheung, E., Yeung, T., Stamoulis, C., & Malley, R. (2021). Analysis of Staphylococcus aureus transcriptome in pediatric soft tissue abscesses and comparison to murine infections. Infection and immunity, 89(4), e00715-20. | https://www.ncbi.nlm.nih.gov/pubmed/33526560 | Moffitt, K., Cheung, E., Yeung, T., Stamoulis, C., & Malley, R. (2021). Analysis of Staphylococcus aureus transcriptome in pediatric soft tissue abscesses and comparison to murine infections. Infection and immunity, 89(4), e00715-20. https://www.ncbi.nlm.nih.gov/pubmed/33526560 | Watkins, K., Griffin, G., Septaric, K., & Simon, E. L. (2021). Myocarditis after BNT162b2 vaccination in a healthy male. The American Journal of Emergency Medicine, 50, 815-e1. https://www.sciencedirect.com/science/article/pii/S0735675721005362 | ||||
743 | Case report: anti-neutrophil cytoplasmic antibody-associated vasculitis with acute renal failure and pulmonary hemorrhage can occur after COVID-19 vaccination: | https://pubmed.ncbi.nlm.nih.gov/34859017/ | https://pubmed.ncbi.nlm.nih.gov/34250509/ | Obeid, M., Fenwick, C., & Pantaleo, G. (2021). Reactivation of IgA vasculitis after COVID-19 vaccination. The Lancet Rheumatology, 3(9), e617. | Obeid, M., Fenwick, C. y Pantaleo, G. (2021). Reactivación de vasculitis por IgA tras la vacunación COVID-19. The Lancet Rheumatology, 3(9), e617. https://pubmed.ncbi.nlm.nih.gov/34292611/. | Schultz, N. H., Sørvoll, I. H., Michelsen, A. E., Munthe, L. A., Lund-Johansen, F., Ahlen, M. T., ... & HOLME, P. A. (2021). Trombosis y trombocitopenia después de la vacunación con Chadox1 NCOV-19. New England Journal of Medicine, 384 (22), 2124-2130. https://pubmed.ncbi.nlm.nih.gov/34374740/ | Obeid, M., Fenwick, C., & Pantaleo, G. (2021). Reactivation of IgA vasculitis after COVID-19 vaccination. The Lancet Rheumatology, 3(9), e617. https://pubmed.ncbi.nlm.nih.gov/34250509/ | See, I., Su, J. R., Lale, A., Woo, E. J., Guh, A. Y., Shimabukuro, T. T., ... & Broder, K. R. (2021). US case reports of cerebral venous sinus thrombosis with thrombocytopenia after Ad26. COV2. S vaccination, March 2 to April 21, 2021. Jama, 325(24), 2448-2456. https://pubmed.ncbi.nlm.nih.gov/33929487/. | Mohamed, L., Madsen, A. M. R., Schaltz-Buchholzer, F., Ostenfeld, A., Netea, M. G., Benn, C. S., & Kofoed, P. E. (2021). Reactivation of BCG vaccination scars after vaccination with mRNA-Covid-vaccines: two case reports. BMC infectious diseases, 21(1), 1-4. | https://www.ncbi.nlm.nih.gov/pubmed/34930152 | Mohamed, L., Madsen, A. M. R., Schaltz-Buchholzer, F., Ostenfeld, A., Netea, M. G., Benn, C. S., & Kofoed, P. E. (2021). Reactivation of BCG vaccination scars after vaccination with mRNA-Covid-vaccines: two case reports. BMC infectious diseases, 21(1), 1-4. https://www.ncbi.nlm.nih.gov/pubmed/34930152 | Watts, I., Smith, D., Mounter, S., Baker, E. H., Hitchings, A. W., & Gill, D. (2021). A case series of vaccine‐induced thrombotic thrombocytopenia in a London teaching hospital. British Journal of Clinical Pharmacology. https://pubmed.ncbi.nlm.nih.gov/34694650/ | ||||
744 | Intracerebral hemorrhage due to vasculitis following COVID-19 vaccination: case report: | https://pubmed.ncbi.nlm.nih.gov/34783899/ | https://pubmed.ncbi.nlm.nih.gov/34292611/. | Larson, V., Seidenberg, R., Caplan, A., Brinster, N. K., Meehan, S. A., & Kim, R. H. (2022). Clinical and histopathological spectrum of delayed adverse cutaneous reactions following COVID‐19 vaccination. Journal of cutaneous pathology, 49(1), 34-41. | Larson, V., Seidenberg, R., Caplan, A., Brinster, N. K., Meehan, S. A. y Kim, R. H. (2022). Espectro clínico e histopatológico de reacciones cutáneas adversas tardías después de la vacunación COVID-19. Revista de patología cutánea, 49(1), 34-41. https://pubmed.ncbi.nlm.nih.gov/34530771/. | Schulz, J. B., Berlit, P., Diener, H. C., Gerloff, C., Greinacher, A., Klein, C., ... & Zimmermann, J. (2021). COVID-19 trombosis venosa cerebral asociada a la vacuna en Alemania. Anales de neurología, 90 (4), 627-639. https://pubmed.ncbi.nlm.nih.gov/34133027/ | Larson, V., Seidenberg, R., Caplan, A., Brinster, N. K., Meehan, S. A., & Kim, R. H. (2022). Clinical and histopathological spectrum of delayed adverse cutaneous reactions following COVID‐19 vaccination. Journal of cutaneous pathology, 49(1), 34-41. https://pubmed.ncbi.nlm.nih.gov/34292611/. | Sekar, A., Campbell, R., Tabbara, J., & Rastogi, P. (2021). ANCA glomerulonephritis after the Moderna COVID-19 vaccination. Kidney international, 100(2), 473-474. https://pubmed.ncbi.nlm.nih.gov/34081948/ | Ntouros, P. A., Vlachogiannis, N. I., Pappa, M., Nezos, A., Mavragani, C. P., Tektonidou, M. G., ... & Sfikakis, P. P. (2021). Effective DNA damage response after acute but not chronic immune challenge: SARS-CoV-2 vaccine versus Systemic Lupus Erythematosus. Clinical Immunology, 229, 108765. | https://www.ncbi.nlm.nih.gov/pubmed/34089859 | Ntouros, P. A., Vlachogiannis, N. I., Pappa, M., Nezos, A., Mavragani, C. P., Tektonidou, M. G., ... & Sfikakis, P. P. (2021). Effective DNA damage response after acute but not chronic immune challenge: SARS-CoV-2 vaccine versus Systemic Lupus Erythematosus. Clinical Immunology, 229, 108765. https://www.ncbi.nlm.nih.gov/pubmed/34089859 | Weber, C., von Hundelshausen, P., & Siess, W. (2021). VITT after ChAdOx1 nCoV-19 Vaccination. The New England journal of medicine. https://pubmed.ncbi.nlm.nih.gov/34731555/ | ||||
745 | Peduncular, symptomatic cavernous bleeding after immune thrombocytopenia-induced SARS-CoV-2 vaccination: | https://pubmed.ncbi.nlm.nih.gov/34549178/. | https://pubmed.ncbi.nlm.nih.gov/34530771/. | Mücke, V. T., Knop, V., Mücke, M. M., Ochsendorf, F., & Zeuzem, S. (2021). First description of immune complex vasculitis after COVID-19 vaccination with BNT162b2: a case report. BMC Infectious Diseases, 21(1), 1-6. | Mücke, V. T., Knop, V., Mücke, M. M., Ochsendorf, F. y Zeuzem, S. (2021). Primera descripción de vasculitis por complejos inmunes después de la vacunación COVID-19 con BNT162b2: reporte de un caso. Enfermedades infecciosas de BMC, 21(1), 1-6. https://pubmed.ncbi.nlm.nih.gov/34245294/. | Schulz, J. B., Berlit, P., Diener, H. C., Gerloff, C., Greinacher, A., Klein, C., ... & Zimmermann, J. (2021). COVID-19 trombosis venosa cerebral asociada a la vacuna en Alemania. Anales de neurología, 90 (4), 627-639. https://pubmed.ncbi.nlm.nih.gov/34327553/. | Mücke, V. T., Knop, V., Mücke, M. M., Ochsendorf, F., & Zeuzem, S. (2021). First description of immune complex vasculitis after COVID-19 vaccination with BNT162b2: a case report. BMC Infectious Diseases, 21(1), 1-6. https://pubmed.ncbi.nlm.nih.gov/34530771/. | Sellaturay, P., Nasser, S., Islam, S., Gurugama, P., & Ewan, P. W. (2021). Polyethylene glycol (PEG) is a cause of anaphylaxis to the Pfizer/BioNTech mRNA COVID‐19 vaccine. Clinical and Experimental Allergy, 51(6), 861. https://pubmed.ncbi.nlm.nih.gov/33825239/ | Nygaard, U., Holm, M., Bohnstedt, C., Chai, Q., Schmidt, L. S., Hartling, U. B., ... & Stensballe, L. G. (2022). Population-based Incidence of Myopericarditis After COVID-19 Vaccination in Danish Adolescents. The Pediatric infectious disease journal, 41(1), e25. | https://www.ncbi.nlm.nih.gov/pubmed/34889875 | Nygaard, U., Holm, M., Bohnstedt, C., Chai, Q., Schmidt, L. S., Hartling, U. B., ... & Stensballe, L. G. (2022). Population-based Incidence of Myopericarditis After COVID-19 Vaccination in Danish Adolescents. The Pediatric infectious disease journal, 41(1), e25. https://www.ncbi.nlm.nih.gov/pubmed/34889875 | Weeks, J. K., O’Brien, S. R., Rosenspire, K. C., Dubroff, J. G., & Pantel, A. R. (2021). evolving bilateral hypermetabolic axillary lymphadenopathy on FDG PET/CT following 2-dose COVID-19 vaccination. Clinical nuclear medicine, 46(12), 1011. https://pubmed.ncbi.nlm.nih.gov/34735411/ | ||||
746 | Brain death in a vaccinated patient with COVID-19 infection: | https://pubmed.ncbi.nlm.nih.gov/34656887/ | https://pubmed.ncbi.nlm.nih.gov/34245294/. | Izzedine, H., Bonilla, M., & Jhaveri, K. D. (2021). Nephrotic syndrome and vasculitis following SARS-CoV-2 vaccine: true association or circumstantial?. Nephrology Dialysis Transplantation. | Izzedine, H., Bonilla, M. y Jhaveri, KD (2021). Síndrome nefrótico y vasculitis tras vacuna SARS-CoV-2: ¿asociación verdadera o circunstancial?. Trasplante de Diálisis de Nefrología. https://pubmed.ncbi.nlm.nih.gov/34599716/. | Schulz, J. B., Berlit, P., Diener, H. C., Gerloff, C., Greinacher, A., Klein, C., ... & Zimmermann, J. (2021). COVID-19 trombosis venosa cerebral asociada a la vacuna en Alemania. Anales de neurología, 90 (4), 627-639. https://pubmed.ncbi.nlm.nih.gov/34341358/ | Izzedine, H., Bonilla, M., & Jhaveri, K. D. (2021). Nephrotic syndrome and vasculitis following SARS-CoV-2 vaccine: true association or circumstantial?. Nephrology Dialysis Transplantation. https://pubmed.ncbi.nlm.nih.gov/34245294/. | Sepahvand, M., Yazdi, N., Rohani, M., & Emamikhah, M. (2022). Cervical longitudinally extensive myelitis after vaccination with inactivated virus-based COVID-19 vaccine. Radiology Case Reports, 17(2), 303-305. https://pubmed.ncbi.nlm.nih.gov/34849183/ | Oberhardt, V., Luxenburger, H., Kemming, J., Schulien, I., Ciminski, K., Giese, S., ... & Hofmann, M. (2021). Rapid and stable mobilization of CD8+ T cells by SARS-CoV-2 mRNA vaccine. Nature, 597(7875), 268-273. | https://www.ncbi.nlm.nih.gov/pubmed/34320609 | Oberhardt, V., Luxenburger, H., Kemming, J., Schulien, I., Ciminski, K., Giese, S., ... & Hofmann, M. (2021). Rapid and stable mobilization of CD8+ T cells by SARS-CoV-2 mRNA vaccine. Nature, 597(7875), 268-273. https://www.ncbi.nlm.nih.gov/pubmed/34320609 | Weitzman, E. R., Sherman, A. C., & Levy, O. (2021). SARS-CoV-2 mRNA Vaccine Attitudes as Expressed in US FDA Public Commentary: Need for a Public-Private Partnership in a Learning Immunization System. Frontiers in public health, 995. https://www.ncbi.nlm.nih.gov/pubmed/34336774 | ||||
747 | Generalized purpura annularis telangiectodes after SARS-CoV-2 mRNA vaccination: | https://pubmed.ncbi.nlm.nih.gov/34236717/. | https://pubmed.ncbi.nlm.nih.gov/34599716/. | Liang, I., Swaminathan, S., & Lee, A. (2021). Emergence of de novo cutaneous vasculitis post coronavirus disease (COVID-19) vaccination. Clinical rheumatology, 1-2. | Liang, I., Swaminathan, S. y Lee, A. (2021). Aparición de vasculitis cutánea de novo después de la vacunación contra la enfermedad por coronavirus (COVID-19). Reumatología clínica, 1-2. https://pubmed.ncbi.nlm.nih.gov/34115904/. | Scott, J., Anderson, J., Mallak, N., Beitinjaneh, B., Wei, K., & Otaki, F. (2021). Gastroparesia después de la vacunación PFIZE-BIONTECH COVID-19. Diario Oficial del Colegio Americano de Gastroenterología | ACG, 116 (11), 2300. https://www.ncbi.nlm.nih.gov/pubmed/34416319 | Liang, I., Swaminathan, S., & Lee, A. (2021). Emergence of de novo cutaneous vasculitis post coronavirus disease (COVID-19) vaccination. Clinical rheumatology, 1-2. https://pubmed.ncbi.nlm.nih.gov/34599716/. | Sessa, F., Salerno, M., Esposito, M., Di Nunno, N., Zamboni, P., & Pomara, C. (2021). Autopsy Findings and Causality Relationship between Death and COVID-19 Vaccination: A Systematic Review. Journal of Clinical Medicine, 10(24), 5876. https://www.ncbi.nlm.nih.gov/pubmed/34945172 | Patone, M., Mei, X. W., Handunnetthi, L., Dixon, S., Zaccardi, F., Shankar-Hari, M., ... & Hippisley-Cox, J. (2021). Risks of myocarditis, pericarditis, and cardiac arrhythmias associated with COVID-19 vaccination or SARS-CoV-2 infection. Nature medicine, 1-13. | https://www.ncbi.nlm.nih.gov/pubmed/34907393 | Patone, M., Mei, X. W., Handunnetthi, L., Dixon, S., Zaccardi, F., Shankar-Hari, M., ... & Hippisley-Cox, J. (2021). Risks of myocarditis, pericarditis, and cardiac arrhythmias associated with COVID-19 vaccination or SARS-CoV-2 infection. Nature medicine, 1-13. https://www.ncbi.nlm.nih.gov/pubmed/34907393 | Welsh, K. J., Baumblatt, J., Chege, W., Goud, R., & Nair, N. (2021). Thrombocytopenia including immune thrombocytopenia after receipt of mRNA COVID-19 vaccines reported to the Vaccine Adverse Event Reporting System (VAERS). Vaccine, 39(25), 3329-3332. https://www.sciencedirect.com/science/article/pii/S0264410X21005247 | ||||
748 | Lobar hemorrhage with ventricular rupture shortly after the first dose of a SARS-CoV-2 mRNA-based SARS-CoV-2 vaccine: | https://pubmed.ncbi.nlm.nih.gov/34729467/. | https://pubmed.ncbi.nlm.nih.gov/34115904/. | Kharkar, V., Vishwanath, T., Mahajan, S., Joshi, R., & Gole, P. (2021). Asymmetrical cutaneous vasculitis following COVID‐19 vaccination with unusual eosinophil preponderance. Clinical and Experimental Dermatology. | Kharkar, V., Vishwanath, T., Mahajan, S., Joshi, R. y Gole, P. (2021). Vasculitis cutánea asimétrica después de la vacunación COVID-19 con preponderancia inusual de eosinófilos. Dermatología Clínica y Experimental. https://pubmed.ncbi.nlm.nih.gov/34247902/. | Se olvidó, D., Jang, H., Abreu, R. B., Hanley, H. B., Gattiker, J. L. L., Jefferson, A. M., & Ross, T. M. (2021). Las vacunas de ARNm de SARS-COV-2 provocan diferentes respuestas en humanos inmunológicamente ingenuos y preinmunes. Fronteras en inmunología, 12. https://www.ncbi.nlm.nih.gov/pubmed/34127481 | Kharkar, V., Vishwanath, T., Mahajan, S., Joshi, R., & Gole, P. (2021). Asymmetrical cutaneous vasculitis following COVID‐19 vaccination with unusual eosinophil preponderance. Clinical and Experimental Dermatology. https://pubmed.ncbi.nlm.nih.gov/34115904/. | Sessa, M., Kragholm, K., Hviid, A., & Andersen, M. (2021). Thromboembolic events in younger women exposed to Pfizer-BioNTech or Moderna COVID-19 vaccines. Expert Opinion on Drug Safety, 20(11), 1451-1453. https://pubmed.ncbi.nlm.nih.gov/34264151/ | Perrotta, A., Biondi-Zoccai, G., Saade, W., Miraldi, F., Morelli, A., Marullo, A. G., ... & Peruzzi, M. (2021). A snapshot global survey on side effects of COVID-19 vaccines among healthcare professionals and armed forces with a focus on headache. Panminerva Medica, 63(3), 324-331. | https://www.ncbi.nlm.nih.gov/pubmed/34738774 | Perrotta, A., Biondi-Zoccai, G., Saade, W., Miraldi, F., Morelli, A., Marullo, A. G., ... & Peruzzi, M. (2021). A snapshot global survey on side effects of COVID-19 vaccines among healthcare professionals and armed forces with a focus on headache. Panminerva Medica, 63(3), 324-331. https://www.ncbi.nlm.nih.gov/pubmed/34738774 | Wiedmann, M., Skattør, T., Stray-Pedersen, A., Romundstad, L., Antal, E. A., Marthinsen, P. B., ... & Skjelland, M. (2021). Vaccine induced immune thrombotic thrombocytopenia causing a severe form of cerebral venous thrombosis with high fatality rate: a case series. Frontiers in neurology, 1302. https://pubmed.ncbi.nlm.nih.gov/34393988/. | ||||
749 | A case of outbreak of macroscopic hematuria and IgA nephropathy after SARS-CoV-2 vaccination: | https://pubmed.ncbi.nlm.nih.gov/33932458/ | https://pubmed.ncbi.nlm.nih.gov/34247902/. | Hines, A. M., Murphy, N., Mullin, C., Barillas, J., & Barrientos, J. C. (2021). Henoch-Schönlein purpura presenting post COVID-19 vaccination. Vaccine. | Hines, A. M., Murphy, N., Mullin, C., Barillas, J. y Barrientos, J. C. (2021). Púrpura de Henoch-Schönlein que se presenta después de la vacunación contra COVID-19. Vacuna. https://pubmed.ncbi.nlm.nih.gov/34696186/. | Sekar, A., Campbell, R., Tabera, J., & Rastogi, P. (2021). Ancha glomerulonefritis después de la vacunación moderna covid-19. Ridney International, 100 (2), 473-474. https://pubmed.ncbi.nlm.nih.gov/34507942/. | Hines, A. M., Murphy, N., Mullin, C., Barillas, J., & Barrientos, J. C. (2021). Henoch-Schönlein purpura presenting post COVID-19 vaccination. Vaccine. https://pubmed.ncbi.nlm.nih.gov/34247902/. | Shahrigharahkoshan, S., Gagnon, L. P., & Mathieu, S. (2021). Cutaneous Leukocytoclastic Vasculitis Induction Following ChAdOx1 nCoV-19 Vaccine. Cureus, 13(10). https://pubmed.ncbi.nlm.nih.gov/34853744/. | Piñana, J. L., López‐Corral, L., Martino, R., Montoro, J., Vazquez, L., Pérez, A., ... & Infectious Complications Subcommittee of the Spanish Hematopoietic Stem Cell Transplantation and Cell Therapy Group (GETH‐TC). (2022). SARS‐CoV‐2‐reactive antibody detection after SARS‐CoV‐2 vaccination in hematopoietic stem cell transplant recipients: Prospective survey from the Spanish Hematopoietic Stem Cell Transplantation and Cell Therapy Group. American journal of hematology, 97(1), 30-42. | https://www.ncbi.nlm.nih.gov/pubmed/34695229 | Piñana, J. L., López‐Corral, L., Martino, R., Montoro, J., Vazquez, L., Pérez, A., ... & Infectious Complications Subcommittee of the Spanish Hematopoietic Stem Cell Transplantation and Cell Therapy Group (GETH‐TC). (2022). SARS‐CoV‐2‐reactive antibody detection after SARS‐CoV‐2 vaccination in hematopoietic stem cell transplant recipients: Prospective survey from the Spanish Hematopoietic Stem Cell Transplantation and Cell Therapy Group. American journal of hematology, 97(1), 30-42. https://www.ncbi.nlm.nih.gov/pubmed/34695229 | Wiest, N. E., Johns, G. S., & Edwards, E. (2021). A case of acute pulmonary embolus after mRNA SARS-CoV-2 immunization. Vaccines, 9(8), 903. https://pubmed.ncbi.nlm.nih.gov/34452028/ | ||||
750 | Acral hemorrhage after administration of the second dose of SARS-CoV-2 vaccine. A post-vaccination reaction: | https://pubmed.ncbi.nlm.nih.gov/34092400/742. | https://pubmed.ncbi.nlm.nih.gov/34696186/. | Sirufo, M. M., Raggiunti, M., Magnanimi, L. M., Ginaldi, L., & De Martinis, M. (2021). Henoch-Schönlein Purpura Following the First Dose of COVID-19 Viral Vector Vaccine: A Case Report. Vaccines, 9(10), 1078. | Sirufo, M. M., Raggiunti, M., Magnanimi, L. M., Ginaldi, L. y De Martinis, M. (2021). Púrpura de Henoch-Schönlein después de la primera dosis de la vacuna de vector viral COVID-19: informe de un caso. Vacunas, 9(10), 1078. https://pubmed.ncbi.nlm.nih.gov/34237323/. | Sellaturay, P., Nasser, S., Islam, S., Gurugama, P., & Ewan, P. W. (2021). El polietilenglicol (PEG) es una causa de la anafilaxia a la vacuna PFIVE / BIONTECH MRNA COVID-19. Alergia clínica y experimental, 51 (6), 861. https://pubmed.ncbi.nlm.nih.gov/33683290/ | Sirufo, M. M., Raggiunti, M., Magnanimi, L. M., Ginaldi, L., & De Martinis, M. (2021). Henoch-Schönlein Purpura Following the First Dose of COVID-19 Viral Vector Vaccine: A Case Report. Vaccines, 9(10), 1078. https://pubmed.ncbi.nlm.nih.gov/34696186/. | Shakoor, M. T., Birkenbach, M. P., & Lynch, M. (2021). ANCA-associated vasculitis following Pfizer-BioNTech COVID-19 vaccine. American Journal of Kidney Diseases, 78(4), 611-613. https://pubmed.ncbi.nlm.nih.gov/34280507/. | Revon-Riviere, G., Ninove, L., Min, V., Rome, A., Coze, C., Verschuur, A., ... & André, N. (2021). The BNT162b2 mRNA COVID-19 vaccine in adolescents and young adults with cancer: A monocentric experience. European journal of cancer, 154, 30-34. | https://www.ncbi.nlm.nih.gov/pubmed/34233234 | Revon-Riviere, G., Ninove, L., Min, V., Rome, A., Coze, C., Verschuur, A., ... & André, N. (2021). The BNT162b2 mRNA COVID-19 vaccine in adolescents and young adults with cancer: A monocentric experience. European journal of cancer, 154, 30-34. https://www.ncbi.nlm.nih.gov/pubmed/34233234 | Williams, C. B., Choi, J. I., Hosseini, F., Roberts, J., Ramanathan, K., & Ong, K. (2021). Acute Myocarditis Following mRNA-1273 SARS-CoV-2 Vaccination. CJC open, 3(11), 1410-1412. https://www.sciencedirect.com/science/article/pii/S2589790X21001931 | ||||
751 | Severe immune thrombocytopenic purpura after SARS-CoV-2 vaccine: | https://pubmed.ncbi.nlm.nih.gov/34754937/ | https://pubmed.ncbi.nlm.nih.gov/34237323/. | Gillion, V., Jadoul, M., Demoulin, N., Aydin, S., & Devresse, A. (2021). Granulomatous vasculitis after the AstraZeneca anti–SARS-CoV-2 vaccine. Kidney International, 100(3), 706-707. | Gillion, V., Jadoul, M., Demoulin, N., Aydin, S. y Devresse, A. (2021). Vasculitis granulomatosa tras la vacuna AstraZeneca anti-SARS-CoV-2. Riñón Internacional, 100(3), 706-707. https://pubmed.ncbi.nlm.nih.gov/34851795/. | Semanas, J. K., O'BRIEN, S. R., Rosenspire, K. C., Dubroff, J. G., & Pantel, A. R. (2021). Evolucionando la linfadenopatía axilar hipermetabólica bilateral en FDG PET / CT después de la vacunación de 2 dosis de COVID-19. Medicina nuclear clínica, 46 (12), 1011. https://pubmed.ncbi.nlm.nih.gov/34115709/. | Gillion, V., Jadoul, M., Demoulin, N., Aydin, S., & Devresse, A. (2021). Granulomatous vasculitis after the AstraZeneca anti–SARS-CoV-2 vaccine. Kidney International, 100(3), 706-707. https://pubmed.ncbi.nlm.nih.gov/34237323/. | Shakoor, M. T., Birkenbach, M. P., & Lynch, M. (2021). ANCA-associated vasculitis following Pfizer-BioNTech COVID-19 vaccine. American Journal of Kidney Diseases, 78(4), 611-613. https://www.sciencedirect.com/science/article/pii/S0272638621007423 | Sanchez Tijmes, F., Thavendiranathan, P., Udell, J. A., Seidman, M. A., & Hanneman, K. (2021). Cardiac MRI assessment of nonischemic myocardial inflammation: state of the art review and update on myocarditis associated with COVID-19 vaccination. Radiology: Cardiothoracic Imaging, 3(6), e210252. | https://www.ncbi.nlm.nih.gov/pubmed/34934954 | Sanchez Tijmes, F., Thavendiranathan, P., Udell, J. A., Seidman, M. A., & Hanneman, K. (2021). Cardiac MRI assessment of nonischemic myocardial inflammation: state of the art review and update on myocarditis associated with COVID-19 vaccination. Radiology: Cardiothoracic Imaging, 3(6), e210252. https://www.ncbi.nlm.nih.gov/pubmed/34934954 | Wilting, F. N., Kotsopoulos, A. M., Platteel, A. C., & van Oers, J. A. (2021). Intracerebral hemorrhage and thrombocytopenia after AstraZeneca COVID-19 vaccine: Clinical and diagnostic challenges of vaccine-induced thrombotic thrombocytopenia. Cureus, 13(9). https://pubmed.ncbi.nlm.nih.gov/34646685/ | ||||
752 | Gross hematuria after severe acute respiratory syndrome coronavirus 2 vaccination in 2 patients with IgA nephropathy: | https://pubmed.ncbi.nlm.nih.gov/33771584/ | https://pubmed.ncbi.nlm.nih.gov/34851795/. | ElSheikh, R. H., Haseeb, A., Eleiwa, T. K., & Elhusseiny, A. M. (2021). Acute uveitis following COVID-19 vaccination. Ocular immunology and inflammation, 1-3. | ElSheikh, R. H., Haseeb, A., Eleiwa, T. K. y Elhusseiny, A. M. (2021). Uveítis aguda tras la vacunación COVID-19. Inmunología ocular e inflamación, 1-3. https://pubmed.ncbi.nlm.nih.gov/34849386/ | Sepahvand, M., Yazdi, N., Rohani, M., & Emamikhah, M. (2022). La mielitis cervical longitudinalmente extensa después de la vacunación con vacuna COVID-19 a base de virus inactivada. Informes de casos de radiología, 17 (2), 303-305. https://pubmed.ncbi.nlm.nih.gov/34853744/. | ElSheikh, R. H., Haseeb, A., Eleiwa, T. K., & Elhusseiny, A. M. (2021). Acute uveitis following COVID-19 vaccination. Ocular immunology and inflammation, 1-3. https://pubmed.ncbi.nlm.nih.gov/34851795/. | Shao, S. C., Wang, C. H., Chang, K. C., Hung, M. J., Chen, H. Y., & Liao, S. C. (2021). Guillain- Barré Syndrome Associated with COVID-19 Vaccination. Emerging infectious diseases, 27(12), 3175. https://pubmed.ncbi.nlm.nih.gov/34648420/. | Schramm, R., Costard-Jäckle, A., Rivinius, R., Fischer, B., Müller, B., Boeken, U., ... & Gummert, J. (2021). Poor humoral and T-cell response to two-dose SARS-CoV-2 messenger RNA vaccine BNT162b2 in cardiothoracic transplant recipients. Clinical Research in Cardiology, 110(8), 1142-1149. | https://www.ncbi.nlm.nih.gov/pubmed/34241676 | Schramm, R., Costard-Jäckle, A., Rivinius, R., Fischer, B., Müller, B., Boeken, U., ... & Gummert, J. (2021). Poor humoral and T-cell response to two-dose SARS-CoV-2 messenger RNA vaccine BNT162b2 in cardiothoracic transplant recipients. Clinical Research in Cardiology, 110(8), 1142-1149. https://www.ncbi.nlm.nih.gov/pubmed/34241676 | Witberg, G., Barda, N., Hoss, S., Richter, I., Wiessman, M., Aviv, Y., ... & Kornowski, R. (2021). Myocarditis after Covid-19 vaccination in a large health care organization. New England Journal of Medicine. https://www.nejm.org/doi/10.1056/NEJMoa2110737 | ||||
753 | Autoimmune encephalitis after ChAdOx1-S SARS-CoV-2 vaccination: | https://pubmed.ncbi.nlm.nih.gov/34846583/ | https://pubmed.ncbi.nlm.nih.gov/34849386/ | Kinariwalla, N., London, A. O., Soliman, Y. S., Niedt, G. W., Husain, S., & Gallitano, S. M. (2022). A case of generalized Sweet syndrome with vasculitis triggered by recent COVID-19 vaccination. JAAD Case Reports, 19, 64-67. | Kinariwalla, N., London, A. O., Soliman, Y. S., Niedt, G. W., Husain, S. y Gallitano, SM (2022). Un caso de síndrome de Sweet generalizado con vasculitis desencadenada por la reciente vacunación contra el COVID-19. Informes de casos de JAAD, 19, 64-67. https://pubmed.ncbi.nlm.nih.gov/34310763/ | Sessa, F., Salerno, M., Esposito, M., Di Nunno, N., Zamboni, P., & Pomara, C. (2021). Hallazgos de autopsia y relación de causalidad entre la muerte y la vacunación de COVID-19: una revisión sistemática. Diario de la medicina clínica, 10 (24), 5876. https://www.ncbi.nlm.nih.gov/pubmed/34707602 | Kinariwalla, N., London, A. O., Soliman, Y. S., Niedt, G. W., Husain, S., & Gallitano, S. M. (2022). A case of generalized Sweet syndrome with vasculitis triggered by recent COVID-19 vaccination. JAAD Case Reports, 19, 64-67. https://pubmed.ncbi.nlm.nih.gov/34849386/ | Sharif, N., Alzahrani, K. J., Ahmed, S. N., & Dey, S. K. (2021). Efficacy, Immunogenicity and safety of COVID-19 vaccines: A systematic review and meta-analysis. Frontiers in Immunology, 4149. https://www.ncbi.nlm.nih.gov/pubmed/34707602 | Sessa, F., Salerno, M., Esposito, M., Di Nunno, N., Zamboni, P., & Pomara, C. (2021). Autopsy Findings and Causality Relationship between Death and COVID-19 Vaccination: A Systematic Review. Journal of Clinical Medicine, 10(24), 5876. | https://www.ncbi.nlm.nih.gov/pubmed/34945172 | Sessa, F., Salerno, M., Esposito, M., Di Nunno, N., Zamboni, P., & Pomara, C. (2021). Autopsy Findings and Causality Relationship between Death and COVID-19 Vaccination: A Systematic Review. Journal of Clinical Medicine, 10(24), 5876. https://www.ncbi.nlm.nih.gov/pubmed/34945172 | Wolf, M. E., Luz, B., Niehaus, L., Bhogal, P., Bäzner, H., & Henkes, H. (2021). Thrombocytopenia and intracranial venous sinus thrombosis after “COVID-19 vaccine AstraZeneca” exposure. Journal of clinical medicine, 10(8), 1599. https://pubmed.ncbi.nlm.nih.gov/33918932/ | ||||
754 | COVID-19 vaccine and death: causality algorithm according to the WHO eligibility diagnosis: | https://pubmed.ncbi.nlm.nih.gov/34073536/ | https://pubmed.ncbi.nlm.nih.gov/34310763/ | Guzmán‐Pérez, L., Puerta‐Peña, M., Falkenhain‐López, D., Montero‐Menárguez, J., Gutiérrez‐Collar, C., Rodríguez‐Peralto, J. L., & Sanz‐Bueno, J. (2021). Small‐vessel vasculitis following Oxford‐AstraZeneca vaccination against SARS‐CoV‐2. Journal of the European Academy of Dermatology and Venereology. | Guzmán‐Pérez, L., Puerta‐Peña, M., Falkenhain‐López, D., Montero‐Menárguez, J., Gutiérrez‐Collar, C., Rodríguez‐Peralto, J. L., & Sanz‐Bueno, J. (2021 ). Vasculitis de pequeños vasos tras la vacunación de Oxford‐AstraZeneca contra el SARS‐CoV‐2. Revista de la Academia Europea de Dermatología y Venereología. https://pubmed.ncbi.nlm.nih.gov/34251683/. | Sessa, M., Kragholm, K., Hviid, A., & Andersen, M. (2021). Eventos tromboembólicos en mujeres más jóvenes expuestas a las vacunas Pfizer-Biontech o Moderna Covid-19. Opinión de expertos sobre seguridad de drogas, 20 (11), 1451-1453. https://pubmed.ncbi.nlm.nih.gov/34734086/ | Guzmán‐Pérez, L., Puerta‐Peña, M., Falkenhain‐López, D., Montero‐Menárguez, J., Gutiérrez‐Collar, C., Rodríguez‐Peralto, J. L., & Sanz‐Bueno, J. (2021). Small‐vessel vasculitis following Oxford‐AstraZeneca vaccination against SARS‐CoV‐2. Journal of the European Academy of Dermatology and Venereology. https://pubmed.ncbi.nlm.nih.gov/34310763/ | Sharifian-Dorche, M., Bahmanyar, M., Sharifian-Dorche, A., Mohammadi, P., Nomovi, M., & Mowla, A. (2021). Vaccine-induced immune thrombotic thrombocytopenia and cerebral venous sinus thrombosis post COVID-19 vaccination; a systematic review. Journal of the neurological sciences, 428, 117607. https://pubmed.ncbi.nlm.nih.gov/34365148/. | Sharif, N., Alzahrani, K. J., Ahmed, S. N., & Dey, S. K. (2021). Efficacy, Immunogenicity and safety of COVID-19 vaccines: A systematic review and meta-analysis. Frontiers in Immunology, 4149. | https://www.ncbi.nlm.nih.gov/pubmed/34707602 | Sharif, N., Alzahrani, K. J., Ahmed, S. N., & Dey, S. K. (2021). Efficacy, Immunogenicity and safety of COVID-19 vaccines: A systematic review and meta-analysis. Frontiers in Immunology, 4149. https://www.ncbi.nlm.nih.gov/pubmed/34707602 | Wolthers, S. A., Stenberg, J., Nielsen, H. B., Stensballe, J., & Pedersen, H. P. (2021). Content area. Ugeskr Læger, 183, V05210425. https://pubmed.ncbi.nlm.nih.gov/34477089/ | ||||
755 | Bell’s palsy after vaccination with mRNA (BNT162b2) and inactivated (CoronaVac) SARS-CoV-2 vaccines: a case series and a nested case-control study: | https://pubmed.ncbi.nlm.nih.gov/34411532/ | https://pubmed.ncbi.nlm.nih.gov/34251683/. | Conticini, E., d'Alessandro, M., Bergantini, L., Bargagli, E., Gentili, F., Mazzei, M. A., ... & Frediani, B. (2021). Relapse of microscopic polyangiitis after vaccination against COVID‐19: A case report. Journal of medical virology. | Conticini, E., d'Alessandro, M., Bergantini, L., Bargagli, E., Gentili, F., Mazzei, M. A., ... & Frediani, B. (2021). Recaída de poliangeítis microscópica tras la vacunación contra COVID-19: reporte de un caso. Revista de virología médica. https://pubmed.ncbi.nlm.nih.gov/34557622/. | Shahrigharahkoshan, S., Gagnon, L. P., & Mathieu, S. (2021). Inducción de vasculitis leucocitoclástica cutánea después de la vacuna Chadox1 NCOV-19. CUREUS, 13 (10). https://pubmed.ncbi.nlm.nih.gov/34751429/. | Conticini, E., d'Alessandro, M., Bergantini, L., Bargagli, E., Gentili, F., Mazzei, M. A., ... & Frediani, B. (2021). Relapse of microscopic polyangiitis after vaccination against COVID‐19: A case report. Journal of medical virology. https://pubmed.ncbi.nlm.nih.gov/34251683/. | Sharifian-Dorche, M., Bahmanyar, M., Sharifian-Dorche, A., Mohammadi, P., Nomovi, M., & Mowla, A. (2021). Vaccine-induced immune thrombotic thrombocytopenia and cerebral venous sinus thrombosis post COVID-19 vaccination; a systematic review. Journal of the neurological sciences, 428, 117607. https://www.sciencedirect.com/science/article/pii/S0022510X21003014 | Shay, D. K. (2021). Safety monitoring of the Janssen (Johnson & Johnson) COVID-19 vaccine—United States, March–April 2021. MMWR. Morbidity and mortality weekly report, 70. | https://www.ncbi.nlm.nih.gov/pubmed/33956784 | Shay, D. K. (2021). Safety monitoring of the Janssen (Johnson & Johnson) COVID-19 vaccine—United States, March–April 2021. MMWR. Morbidity and mortality weekly report, 70. https://www.ncbi.nlm.nih.gov/pubmed/33956784 | Woo, E. J., Mba-Jonas, A., Dimova, R. B., Alimchandani, M., Zinderman, C. E., & Nair, N. (2021). Association of receipt of the Ad26. COV2. S COVID-19 vaccine with presumptive Guillain-Barré syndrome, February-July 2021. JAMA, 326(16), 1606-1613. https://jamanetwork.com/journals/jama/fullarticle/2785009 | ||||
756 | Epidemiology of myocarditis and pericarditis following mRNA vaccines in Ontario, Canada: by vaccine product, schedule, and interval: | https://www.medrxiv.org/content/10.1101/2021.12.02.21267156v1 | https://pubmed.ncbi.nlm.nih.gov/34557622/. | Colia, R., Rotondo, C., Corrado, A., & Cantatore, F. P. (2021). Cutaneous vasculitis after severe acute respiratory syndrome coronavirus 2 vaccine. Rheumatology Advances in Practice, 5(3), rkab050. | Colia, R., Rotondo, C., Corrado, A. y Cantatore, FP (2021). Vasculitis cutánea tras la vacuna contra el coronavirus 2 del síndrome respiratorio agudo severo. Avances en la práctica de la reumatología, 5(3), rkab050. https://pubmed.ncbi.nlm.nih.gov/34510694/ | Shakoor, M. T., Birkenbach, M. P., & Lynch, M. (2021). Vasculitis asociada a ANCA después de la vacuna PFIZE-BIONTECH COVID-19. Diario americano de enfermedades renales, 78 (4), 611-613. https://pubmed.ncbi.nlm.nih.gov/34241833/ | Colia, R., Rotondo, C., Corrado, A., & Cantatore, F. P. (2021). Cutaneous vasculitis after severe acute respiratory syndrome coronavirus 2 vaccine. Rheumatology Advances in Practice, 5(3), rkab050. https://pubmed.ncbi.nlm.nih.gov/34557622/. | Shaw, K. E., Cavalcante, J. L., Han, B. K., & Gössl, M. (2021). Possible association between COVID-19 vaccine and myocarditis: clinical and CMR findings. Cardiovascular Imaging, 14(9), 1856-1861. https://pubmed.ncbi.nlm.nih.gov/34246586/ | Shazley, O., & Alshazley, M. (2021). A COVID-Positive 52-year-old man presented with venous thromboembolism and disseminated intravascular coagulation following Johnson & Johnson vaccination: a case-study. Cureus, 13(7). | https://www.ncbi.nlm.nih.gov/pubmed/34408937 | Shazley, O., & Alshazley, M. (2021). A COVID-Positive 52-year-old man presented with venous thromboembolism and disseminated intravascular coagulation following Johnson & Johnson vaccination: a case-study. Cureus, 13(7). https://www.ncbi.nlm.nih.gov/pubmed/34408937 | Xu, G., & Lu, Y. (2021). COVID-19 mRNA Vaccination-Induced Lymphadenopathy Mimics Lymphoma Progression on FDG PET/CT. Clinical nuclear medicine. https://pubmed.ncbi.nlm.nih.gov/33591026/ | ||||
757 | Anaphylaxis following Covid-19 vaccine in a patient with cholinergic urticaria: | https://pubmed.ncbi.nlm.nih.gov/33851711/ | https://pubmed.ncbi.nlm.nih.gov/34510694/ | Mohta, A., Arora, A., Srinivasa, R., & Mehta, R. D. (2021). Recurrent herpes zoster after COVID‐19 vaccination in patients with chronic urticaria being treated with cyclosporine—A report of 3 cases. Journal of Cosmetic Dermatology, 20(11), 3384. | Mohta, A., Arora, A., Srinivasa, R. y Mehta, RD (2021). Herpes zoster recurrente después de la vacunación COVID-19 en pacientes con urticaria crónica tratados con ciclosporina: informe de 3 casos. Revista de Dermatología Cosmética, 20(11), 3384. https://pubmed.ncbi.nlm.nih.gov/34713472/803 | Shakoor, M. T., Birkenbach, M. P., & Lynch, M. (2021). Vasculitis asociada a ANCA después de la vacuna PFIZE-BIONTECH COVID-19. Diario americano de enfermedades renales, 78 (4), 611-613. https://www.sciencedirect.com/science/article/pii/S2213219821007996 | Mohta, A., Arora, A., Srinivasa, R., & Mehta, R. D. (2021). Recurrent herpes zoster after COVID‐19 vaccination in patients with chronic urticaria being treated with cyclosporine—A report of 3 cases. Journal of Cosmetic Dermatology, 20(11), 3384. https://pubmed.ncbi.nlm.nih.gov/34510694/ | Shaw, K. E., Cavalcante, J. L., Han, B. K., & Gössl, M. (2021). Possible association between COVID-19 vaccine and myocarditis: clinical and CMR findings. Cardiovascular Imaging, 14(9), 1856-1861. https://www.sciencedirect.com/science/article/pii/S1936878X2100485X | Singer, M. E., Taub, I. B., & Kaelber, D. C. (2021). Risk of myocarditis from COVID-19 infection in people under age 20: a population-based analysis. medRxiv. | https://www.ncbi.nlm.nih.gov/pubmed/34341797 | Singer, M. E., Taub, I. B., & Kaelber, D. C. (2021). Risk of myocarditis from COVID-19 infection in people under age 20: a population-based analysis. medRxiv. https://www.ncbi.nlm.nih.gov/pubmed/34341797 | Yagi, Y., Asami, Y., Kyoya, M., & Yokota, T. (2022). Cerebral venous sinus thrombosis after mRNA-based COVID-19 vaccination. Neurological Sciences, 43(1), 41-43. https://pubmed.ncbi.nlm.nih.gov/34783932/. | ||||
758 | Anaphylaxis induced by CoronaVac COVID-19 vaccine: clinical features and results of revaccination: | https://pubmed.ncbi.nlm.nih.gov/34675550/. | https://pubmed.ncbi.nlm.nih.gov/34713472/803 | Jin, W. J., Ahn, S. W., Jang, S. H., Hong, S. M., Seol, J. E., & Kim, H. (2021). Leukocytoclastic vasculitis after coronavirus disease 2019 vaccination. The Journal of Dermatology. | Jin, WJ, Ahn, SW, Jang, SH, Hong, SM, Seol, JE y Kim, H. (2021). Vasculitis leucocitoclástica después de la vacunación contra la enfermedad por coronavirus 2019. La Revista de Dermatología. https://pubmed.ncbi.nlm.nih.gov/34819272/ | Shao, S. C., Wang, C. H., Chang, K. C., Hung, M. J., Chen, H. Y., & Liao, S. C. (2021). Síndrome de Guillain- Barré asociado con la vacunación COVID-19. Enfermedades infecciosas emergentes, 27 (12), 3175. https://jamanetwork.com/journals/jamaneurology/fullarticle/2783708 | Jin, W. J., Ahn, S. W., Jang, S. H., Hong, S. M., Seol, J. E., & Kim, H. (2021). Leukocytoclastic vasculitis after coronavirus disease 2019 vaccination. The Journal of Dermatology. https://pubmed.ncbi.nlm.nih.gov/34713472/803 | Shay, D. K. (2021). Safety monitoring of the Janssen (Johnson & Johnson) COVID-19 vaccine—United States, March–April 2021. MMWR. Morbidity and mortality weekly report, 70. https://www.ncbi.nlm.nih.gov/pubmed/33956784 | Smith, C., Odd, D., Harwood, R., Ward, J., Linney, M., Clark, M., ... & Fraser, L. K. (2022). Deaths in children and young people in England after SARS-CoV-2 infection during the first pandemic year. Nature medicine, 28(1), 185-192. | https://www.ncbi.nlm.nih.gov/pubmed/34764489 | Smith, C., Odd, D., Harwood, R., Ward, J., Linney, M., Clark, M., ... & Fraser, L. K. (2022). Deaths in children and young people in England after SARS-CoV-2 infection during the first pandemic year. Nature medicine, 28(1), 185-192. https://www.ncbi.nlm.nih.gov/pubmed/34764489 | Yahyavi-Firouz-Abadi, N., & Naik, R. P. (2021). Cerebral venous sinus thrombosis associated with vaccine-induced thrombotic thrombocytopenia. The Neuroradiology Journal, 19714009211036687. https://pubmed.ncbi.nlm.nih.gov/34333995/ | ||||
759 | Anaphylaxis after Modern COVID-19 vaccine: | https://pubmed.ncbi.nlm.nih.gov/34734159/. | https://pubmed.ncbi.nlm.nih.gov/34819272/ | Visentini, M., Gragnani, L., Santini, S. A., Urraro, T., Villa, A., Monti, M., ... & Casato, M. (2022). Flares of mixed cryoglobulinaemia vasculitis after vaccination against SARS-CoV-2. Annals of the Rheumatic Diseases, 81(3), 441-443. | Visentini, M., Gragnani, L., Santini, S. A., Urraro, T., Villa, A., Monti, M., ... & Casato, M. (2022). Brotes de vasculitis por crioglobulinemia mixta tras la vacunación contra el SARS-CoV-2. Anales de las enfermedades reumáticas, 81(3), 441-443. https://pubmed.ncbi.nlm.nih.gov/34337124/ | Sharif, N., Alzahrani, K. J., Ahmed, S. N., & Dey, S. K. (2021). Eficacia, inmunogenicidad y seguridad de las vacunas COVID-19: una revisión sistemática y un metanálisis. Fronteras en inmunología, 4149. https://www.ncbi.nlm.nih.gov/pubmed/33956784 | Visentini, M., Gragnani, L., Santini, S. A., Urraro, T., Villa, A., Monti, M., ... & Casato, M. (2022). Flares of mixed cryoglobulinaemia vasculitis after vaccination against SARS-CoV-2. Annals of the Rheumatic Diseases, 81(3), 441-443. https://pubmed.ncbi.nlm.nih.gov/34819272/ | Shay, D. K., Shimabukuro, T. T., & DeStefano, F. (2021). Myocarditis occurring after immunization with mRNA-based COVID-19 vaccines. JAMA cardiology, 6(10), 1115-1117. https://jamanetwork.com/journals/jamacardiology/fullarticle/2781600 | Spinner, J. A., Julien, C. L., Olayinka, L., Dreyer, W. J., Bocchini, C. E., Munoz, F. M., & Devaraj, S. (2022). SARS-CoV-2 anti–spike antibodies after vaccination in pediatric heart transplantation: A first report. The Journal of Heart and Lung Transplantation, 41(2), 133-136. | https://www.ncbi.nlm.nih.gov/pubmed/34911654 | Spinner, J. A., Julien, C. L., Olayinka, L., Dreyer, W. J., Bocchini, C. E., Munoz, F. M., & Devaraj, S. (2022). SARS-CoV-2 anti–spike antibodies after vaccination in pediatric heart transplantation: A first report. The Journal of Heart and Lung Transplantation, 41(2), 133-136. https://www.ncbi.nlm.nih.gov/pubmed/34911654 | Yamaguchi, Y., Kimihira, L., Nagasawa, H., Seo, K., & Wada, M. (2021). Cerebral Venous Sinus Thrombosis After BNT162b2 mRNA COVID-19 Vaccination. Cureus, 13(10). https://pubmed.ncbi.nlm.nih.gov/34796065/. | ||||
760 | Association of self-reported history of high-risk allergy with allergy symptoms after COVID-19 vaccination: | https://pubmed.ncbi.nlm.nih.gov/34698847/ | https://pubmed.ncbi.nlm.nih.gov/34337124/ | Berry, C. T., Eliliwi, M., Gallagher, S., Panaccione, S., Klein, W. M., Healy, A. L., ... & Kallas, R. (2021). Cutaneous small vessel vasculitis following single-dose Janssen Ad26. COV2. S vaccination. JAAD Case Reports, 15, 11-14. | Berry, C. T., Eliliwi, M., Gallagher, S., Panaccione, S., Klein, W. M., Healy, A. L., ... y Kallas, R. (2021). Vasculitis cutánea de pequeños vasos después de una dosis única de Janssen Ad26. COV2. Vacunación S. Informes de casos de JAAD, 15, 11-14. https://pubmed.ncbi.nlm.nih.gov/34535924/ | Sharifian-Dorche, M., Bahmanyar, M., Sharifian-Dorche, A., Mohammadi, P., Nomovi, M., & Mowla, A. (2021). Trombocitopenia trombótica inmune inducida por la vacuna y la trombosis sinusita venosa cerebral posterior a la vacunación COVID-19; Una revisión sistemática. Diario de las ciencias neurológicas, 428, 117607. https://pubmed.ncbi.nlm.nih.gov/34452064/. | Berry, C. T., Eliliwi, M., Gallagher, S., Panaccione, S., Klein, W. M., Healy, A. L., ... & Kallas, R. (2021). Cutaneous small vessel vasculitis following single-dose Janssen Ad26. COV2. S vaccination. JAAD Case Reports, 15, 11-14. https://pubmed.ncbi.nlm.nih.gov/34337124/ | Shazley, O., & Alshazley, M. (2021). A COVID-Positive 52-year-old man presented with venous thromboembolism and disseminated intravascular coagulation following Johnson & Johnson vaccination: a case-study. Cureus, 13(7). https://www.ncbi.nlm.nih.gov/pubmed/34408937 | Takeda, M., Ishio, N., Shoji, T., Mori, N., Matsumoto, M., & Shikama, N. (2021). Eosinophilic Myocarditis Following Coronavirus Disease 2019 (COVID-19) Vaccination. Circulation Journal, CJ-21. | https://www.ncbi.nlm.nih.gov/pubmed/34955479 | Takeda, M., Ishio, N., Shoji, T., Mori, N., Matsumoto, M., & Shikama, N. (2021). Eosinophilic Myocarditis Following Coronavirus Disease 2019 (COVID-19) Vaccination. Circulation Journal, CJ-21. https://www.ncbi.nlm.nih.gov/pubmed/34955479 | Yocum, A., & Simon, E. L. (2021). Thrombotic thrombocytopenic purpura after Ad26. COV2-S vaccination. The American journal of emergency medicine, 49, 441-e3. https://pubmed.ncbi.nlm.nih.gov/33980419/ | ||||
761 | Sex differences in the incidence of anaphylaxis to LNP-mRNA vaccines COVID-19: | https://pubmed.ncbi.nlm.nih.gov/34020815/ | https://pubmed.ncbi.nlm.nih.gov/34535924/ | Iwata, H., Kamiya, K., Kado, S., Nakaya, T., Kawata, H., Komine, M., & Ohtsuki, M. (2021). Case of immunoglobulin A vasculitis following coronavirus disease 2019 vaccination. The Journal of Dermatology, 48(12), e598-e599. | Iwata, H., Kamiya, K., Kado, S., Nakaya, T., Kawata, H., Komine, M. y Ohtsuki, M. (2021). Caso de vasculitis por inmunoglobulina A tras la vacunación contra la enfermedad por coronavirus de 2019. La Revista de Dermatología, 48(12), e598-e599. https://www.frontiersin.org/articles/10.3389/fmed.2021.798095/ | Sharifian-Dorche, M., Bahmanyar, M., Sharifian-Dorche, A., Mohammadi, P., Nomovi, M., & Mowla, A. (2021). Trombocitopenia trombótica inmune inducida por la vacuna y la trombosis sinusita venosa cerebral posterior a la vacunación COVID-19; Una revisión sistemática. Diario de las ciencias neurológicas, 428, 117607. https://www.sciencedirect.com/science/article/abs/pii/S0735675721004381 | Iwata, H., Kamiya, K., Kado, S., Nakaya, T., Kawata, H., Komine, M., & Ohtsuki, M. (2021). Case of immunoglobulin A vasculitis following coronavirus disease 2019 vaccination. The Journal of Dermatology, 48(12), e598-e599. https://pubmed.ncbi.nlm.nih.gov/34535924/ | Shemer, A., Pras, E., & Hecht, I. (2021). Peripheral facial nerve palsy following BNT162b2 (COVID-19) vaccination. Israel Medical Association Journal: Imaj, 142-143. https://pubmed.ncbi.nlm.nih.gov/33734623/ | Thompson, M. G., Burgess, J. L., Naleway, A. L., Tyner, H., Yoon, S. K., Meece, J., ... & Gaglani, M. (2021). Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines. New England Journal of Medicine, 385(4), 320-329. | https://www.ncbi.nlm.nih.gov/pubmed/34192428 | Thompson, M. G., Burgess, J. L., Naleway, A. L., Tyner, H., Yoon, S. K., Meece, J., ... & Gaglani, M. (2021). Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines. New England Journal of Medicine, 385(4), 320-329. https://www.ncbi.nlm.nih.gov/pubmed/34192428 | Yu, B. Y., Cen, L. S., Chen, T., & Yang, T. H. (2021). Bell’s palsy after inactivated COVID-19 vaccination in a patient with history of recurrent Bell’s palsy: A case report. World journal of clinical cases, 9(27), 8274. https://pubmed.ncbi.nlm.nih.gov/34621891/ | ||||
762 | Allergic reactions, including anaphylaxis, after receiving the first dose of Pfizer-BioNTech COVID-19 vaccine – United States, December 14 to 23, 2020: | https://pubmed.ncbi.nlm.nih.gov/33641264/ | https://www.frontiersin.org/articles/10.3389/fmed.2021.798095/ | Goldman, S., Bron, D., Tousseyn, T., Vierasu, I., Dewispelaere, L., Heimann, P., ... & Goldman, M. (2021). Rapid progression of angioimmunoblastic T Cell lymphoma following BNT162b2 mRNA vaccine booster shot: a case report. Frontiers in medicine, 2409. | Goldman, S., Bron, D., Tousseyn, T., Vierasu, I., Dewispelaere, L., Heimann, P., ... y Goldman, M. (2021). Progresión rápida del linfoma angioinmunoblástico de células T después de la inyección de refuerzo de la vacuna de ARNm BNT162b2: informe de un caso. Fronteras en medicina, 2409. https://pubmed.ncbi.nlm.nih.gov/33591026/ | Shaw, K. E., Cavalcante, J. L., Han, B. K., & Gössl, M. (2021). Posible asociación entre COVID-19 Vacuna y miocarditis: hallazgos clínicos y CMR. Imágenes cardiovasculares, 14 (9), 1856-1861. https://pubmed.ncbi.nlm.nih.gov/34856634/. | Goldman, S., Bron, D., Tousseyn, T., Vierasu, I., Dewispelaere, L., Heimann, P., ... & Goldman, M. (2021). Rapid progression of angioimmunoblastic T Cell lymphoma following BNT162b2 mRNA vaccine booster shot: a case report. Frontiers in medicine, 2409. https://www.frontiersin.org/articles/10.3389/fmed.2021.798095/ | Shemer, A., Pras, E., Einan-Lifshitz, A., Dubinsky-Pertzov, B., & Hecht, I. (2021). Association of COVID-19 vaccination and facial nerve palsy: a case-control study. JAMA Otolaryngology–Head & Neck Surgery, 147(8), 739-743. https://pubmed.ncbi.nlm.nih.gov/34165512/ | Tutor, A., Unis, G., Ruiz, B., Bolaji, O. A., & Bob-Manuel, T. (2021). Spectrum of Suspected Cardiomyopathy Due to COVID-19: A Case Series. Current Problems in Cardiology, 46(10), 100926. | https://www.ncbi.nlm.nih.gov/pubmed/34311983 | Tutor, A., Unis, G., Ruiz, B., Bolaji, O. A., & Bob-Manuel, T. (2021). Spectrum of Suspected Cardiomyopathy Due to COVID-19: A Case Series. Current Problems in Cardiology, 46(10), 100926. https://www.ncbi.nlm.nih.gov/pubmed/34311983 | Zakaria, Z., Sapiai, N. A., & Ghani, A. R. I. (2021). Cerebral venous sinus thrombosis 2 weeks after the first dose of mRNA SARS-CoV-2 vaccine. Acta neurochirurgica, 163(8), 2359-2362. https://pubmed.ncbi.nlm.nih.gov/34101024/ | ||||
763 | Allergic reactions, including anaphylaxis, after receiving the first dose of Modern COVID-19 vaccine – United States, December 21, 2020 to January 10, 2021: | https://pubmed.ncbi.nlm.nih.gov/33641268/ | https://pubmed.ncbi.nlm.nih.gov/33591026/ | Xu, G., & Lu, Y. (2021). COVID-19 mRNA Vaccination-Induced Lymphadenopathy Mimics Lymphoma Progression on FDG PET/CT. Clinical nuclear medicine. | Xu, G. y Lu, Y. (2021). La linfadenopatía inducida por la vacunación con ARNm de COVID-19 imita la progresión del linfoma en la PET/TC con FDG. Medicina nuclear clínica. https://pubmed.ncbi.nlm.nih.gov/33625300/ | Shaw, K. E., Cavalcante, J. L., Han, B. K., & Gössl, M. (2021). Posible asociación entre COVID-19 Vacuna y miocarditis: hallazgos clínicos y CMR. Imágenes cardiovasculares, 14 (9), 1856-1861. https://www.sciencedirect.com/science/article/pii/S002234762100617X | Xu, G., & Lu, Y. (2021). COVID-19 mRNA Vaccination-Induced Lymphadenopathy Mimics Lymphoma Progression on FDG PET/CT. Clinical nuclear medicine. https://pubmed.ncbi.nlm.nih.gov/33591026/ | Shen, X., Koh, M. S. H., Lim, B. Y., Demo-Os, M., Chien, J. M. F., Santosa, A., & Taha, A. A. (2021). Acute pericarditis and cardiac tamponade after Covid-19 vaccination. Singapore medical journal. https://pubmed.ncbi.nlm.nih.gov/34749492/ | Umei, T. C., Kishino, Y., Watanabe, K., Shiraishi, Y., Inohara, T., Yuasa, S., & Fukuda, K. (2021). Recurrence of myopericarditis following mRNA COVID-19 vaccination in a male adolescent. CJC open. | https://www.ncbi.nlm.nih.gov/pubmed/34904134 | Umei, T. C., Kishino, Y., Watanabe, K., Shiraishi, Y., Inohara, T., Yuasa, S., & Fukuda, K. (2021). Recurrence of myopericarditis following mRNA COVID-19 vaccination in a male adolescent. CJC open. https://www.ncbi.nlm.nih.gov/pubmed/34904134 | Zimmermann, P., & Curtis, N. (2021). Why is COVID-19 less severe in children? A review of the proposed mechanisms underlying the age-related difference in severity of SARS-CoV-2 infections. Archives of disease in childhood, 106(5), 429-439. https://www.ncbi.nlm.nih.gov/pubmed/33262177 | ||||
764 | Prolonged anaphylaxis to Pfizer 2019 coronavirus disease vaccine: a case report and mechanism of action: | https://pubmed.ncbi.nlm.nih.gov/33834172/ | https://pubmed.ncbi.nlm.nih.gov/33625300/ | Özütemiz, C., Krystosek, L. A., Church, A. L., Chauhan, A., Ellermann, J. M., Domingo-Musibay, E., & Steinberger, D. (2021). Lymphadenopathy in COVID-19 vaccine recipients: diagnostic dilemma in oncologic patients. Radiology, 300(1), E296-E300. | Özütemiz, C., Krystosek, L. A., Church, A. L., Chauhan, A., Ellermann, J. M., Domingo-Musibay, E. y Steinberger, D. (2021). Linfadenopatía en receptores de vacuna COVID-19: dilema diagnóstico en pacientes oncológicos. Radiología, 300(1), E296-E300. https://pubmed.ncbi.nlm.nih.gov/33774684/ | Shay, D. K. (2021). Monitoreo de seguridad de Janssen (Johnson & Johnson) COVID-19 Vaccine-Estados Unidos, marzo-abril 2021. MMWR. Informe semanal de morbilidad y mortalidad, 70. https://www.ncbi.nlm.nih.gov/pubmed/34408937 | Özütemiz, C., Krystosek, L. A., Church, A. L., Chauhan, A., Ellermann, J. M., Domingo-Musibay, E., & Steinberger, D. (2021). Lymphadenopathy in COVID-19 vaccine recipients: diagnostic dilemma in oncologic patients. Radiology, 300(1), E296-E300. https://pubmed.ncbi.nlm.nih.gov/33625300/ | Shimabukuro, T. (2021). Allergic reactions including anaphylaxis after receipt of the first dose of Moderna COVID‐19 vaccine—United States, December 21, 2020–January 10, 2021. American Journal of Transplantation, 21(3), 1326. https://pubmed.ncbi.nlm.nih.gov/33641268/ | Warren, C. M., Snow, T. T., Lee, A. S., Shah, M. M., Heider, A., Blomkalns, A., ... & Nadeau, K. C. (2021). Assessment of allergic and anaphylactic reactions to mRNA COVID-19 vaccines with confirmatory testing in a US regional health system. JAMA network open, 4(9), e2125524-e2125524. | https://www.ncbi.nlm.nih.gov/pubmed/34533570 | Warren, C. M., Snow, T. T., Lee, A. S., Shah, M. M., Heider, A., Blomkalns, A., ... & Nadeau, K. C. (2021). Assessment of allergic and anaphylactic reactions to mRNA COVID-19 vaccines with confirmatory testing in a US regional health system. JAMA network open, 4(9), e2125524-e2125524. https://www.ncbi.nlm.nih.gov/pubmed/34533570 | Zuhorn, F., Graf, T., Klingebiel, R., Schäbitz, W. R., & Rogalewski, A. (2021). Postvaccinal encephalitis after ChAdOx1 nCov‐19. Annals of neurology, 90(3), 506-511. https://pubmed.ncbi.nlm.nih.gov/34324214/ | ||||
765 | Anaphylaxis reactions to Pfizer BNT162b2 vaccine: report of 3 cases of anaphylaxis following vaccination with Pfizer BNT162b2: | https://pubmed.ncbi.nlm.nih.gov/34579211/ | https://pubmed.ncbi.nlm.nih.gov/33774684/ | Cohen, D., Krauthammer, S. H., Wolf, I., & Even-Sapir, E. (2021). Hypermetabolic lymphadenopathy following administration of BNT162b2 mRNA Covid-19 vaccine: incidence assessed by [18F] FDG PET-CT and relevance to study interpretation. European Journal of Nuclear Medicine and Molecular Imaging, 48(6), 1854-1863. | Cohen, D., Krauthammer, S. H., Wolf, I. y Even-Sapir, E. (2021). Linfadenopatía hipermetabólica después de la administración de la vacuna Covid-19 de ARNm BNT162b2: incidencia evaluada mediante [18F] FDG PET-CT y relevancia para la interpretación del estudio. Revista europea de medicina nuclear e imágenes moleculares, 48(6), 1854-1863. https://pubmed.ncbi.nlm.nih.gov/33985872/ | Shay, D. K., Shimabukuro, T. T., & Destefano, F. (2021). La miocarditis que se produce después de la inmunización con las vacunas COVID-19-19 a base de ARNm. Cardiología de Jama, 6 (10), 1115-1117. https://www.nejm.org/doi/full/10.1056/NEJMc2109975 | Cohen, D., Krauthammer, S. H., Wolf, I., & Even-Sapir, E. (2021). Hypermetabolic lymphadenopathy following administration of BNT162b2 mRNA Covid-19 vaccine: incidence assessed by [18F] FDG PET-CT and relevance to study interpretation. European Journal of Nuclear Medicine and Molecular Imaging, 48(6), 1854-1863. https://pubmed.ncbi.nlm.nih.gov/33774684/ | Shimabukuro, T. (2021). Allergic reactions including anaphylaxis after receipt of the first dose of Pfizer‐BioNTech COVID‐19 vaccine—United States, December 14–23, 2020. American Journal of Transplantation, 21(3), 1332. https://pubmed.ncbi.nlm.nih.gov/33641264/ | Weitzman, E. R., Sherman, A. C., & Levy, O. (2021). SARS-CoV-2 mRNA Vaccine Attitudes as Expressed in US FDA Public Commentary: Need for a Public-Private Partnership in a Learning Immunization System. Frontiers in public health, 995. | https://www.ncbi.nlm.nih.gov/pubmed/34336774 | Weitzman, E. R., Sherman, A. C., & Levy, O. (2021). SARS-CoV-2 mRNA Vaccine Attitudes as Expressed in US FDA Public Commentary: Need for a Public-Private Partnership in a Learning Immunization System. Frontiers in public health, 995. https://www.ncbi.nlm.nih.gov/pubmed/34336774 | Zur-Wyrozumska, K. (2021). CAd26. COV2-S vaccination can reveal inherited thrombophilia: massive cerebral venous sinus thrombosis in a young male with normal platelet count. Pol. Arch. Med. Wew.(Online). https://pubmed.ncbi.nlm.nih.gov/34632750/ | ||||
766 | Biphasic anaphylaxis after first dose of 2019 messenger RNA coronavirus disease vaccine with positive polysorbate 80 skin test result: | https://pubmed.ncbi.nlm.nih.gov/34343674/ | https://pubmed.ncbi.nlm.nih.gov/33985872/ | Keshavarz, P., Yazdanpanah, F., Rafiee, F., & Mizandari, M. (2021). Lymphadenopathy following COVID-19 vaccination: imaging findings review. Academic radiology, 28(8), 1058-1071. | Keshavarz, P., Yazdanpanah, F., Rafiee, F. y Mizandari, M. (2021). Linfadenopatía después de la vacunación COVID-19: revisión de los hallazgos de las imágenes. Radiología académica, 28(8), 1058-1071. https://pubmed.ncbi.nlm.nih.gov/34735411/ | SHAZLEY, O., & ALSHAZLEY, M. (2021). Un hombre covid positivo de 52 años presentó un tromboembolismo venoso y la coagulación intravascular diseminada después de la vacunación de Johnson & Johnson: un estudio de caso. CUREUS, 13 (7). https://www.ncbi.nlm.nih.gov/pubmed/34739045 | Keshavarz, P., Yazdanpanah, F., Rafiee, F., & Mizandari, M. (2021). Lymphadenopathy following COVID-19 vaccination: imaging findings review. Academic radiology, 28(8), 1058-1071. https://pubmed.ncbi.nlm.nih.gov/33985872/ | Shimabukuro, T. T., Cole, M., & Su, J. R. (2021). Reports of anaphylaxis after receipt of mRNA COVID-19 vaccines in the US—December 14, 2020-January 18, 2021. Jama, 325(11), 1101-1102. https://pubmed.ncbi.nlm.nih.gov/33576785/ | Zimmermann, P., & Curtis, N. (2021). Why is COVID-19 less severe in children? A review of the proposed mechanisms underlying the age-related difference in severity of SARS-CoV-2 infections. Archives of disease in childhood, 106(5), 429-439. | https://www.ncbi.nlm.nih.gov/pubmed/33262177 | Zimmermann, P., & Curtis, N. (2021). Why is COVID-19 less severe in children? A review of the proposed mechanisms underlying the age-related difference in severity of SARS-CoV-2 infections. Archives of disease in childhood, 106(5), 429-439. https://www.ncbi.nlm.nih.gov/pubmed/33262177 | #N/A | ||||
767 | Acute myocardial infarction and myocarditis after COVID-19 vaccination: | https://pubmed.ncbi.nlm.nih.gov/34586408/ | https://pubmed.ncbi.nlm.nih.gov/34735411/ | Weeks, J. K., O’Brien, S. R., Rosenspire, K. C., Dubroff, J. G., & Pantel, A. R. (2021). evolving bilateral hypermetabolic axillary lymphadenopathy on FDG PET/CT following 2-dose COVID-19 vaccination. Clinical nuclear medicine, 46(12), 1011. | Weeks, J. K., O'Brien, S. R., Rosenspire, K. C., Dubroff, J. G. y Pantel, A. R. (2021). Evolución de la linfadenopatía axilar hipermetabólica bilateral en la PET/TC con FDG después de la vacuna COVID-19 de 2 dosis. Medicina nuclear clínica, 46(12), 1011. https://pubmed.ncbi.nlm.nih.gov/34115709/. | Shemer, A., Pras, E., & Hecht, I. (2021). Parálisis del nervio facial periférico después de la vacunación BNT162B2 (COVID-19). Diario de la Asociación Médica de Israel: IMAJ, 142-143. https://pubmed.ncbi.nlm.nih.gov/34044114/. | Weeks, J. K., O’Brien, S. R., Rosenspire, K. C., Dubroff, J. G., & Pantel, A. R. (2021). evolving bilateral hypermetabolic axillary lymphadenopathy on FDG PET/CT following 2-dose COVID-19 vaccination. Clinical nuclear medicine, 46(12), 1011. https://pubmed.ncbi.nlm.nih.gov/34735411/ | Shimabukuro, T. T., Kim, S. Y., Myers, T. R., Moro, P. L., Oduyebo, T., Panagiotakopoulos, L., ... & Meaney-Delman, D. M. (2021). Preliminary findings of mRNA Covid-19 vaccine safety in pregnant persons. New England Journal of Medicine. https://www.nejm.org/doi/full/10.1056/NEJMoa2104983. | ||||||||
768 | Takotsubo syndrome after COVID-19 vaccination: | https://pubmed.ncbi.nlm.nih.gov/34539938/. | https://pubmed.ncbi.nlm.nih.gov/34115709/. | Shin, M., Hyun, C. Y., Choi, Y. H., Choi, J. Y., Lee, K. H., & Cho, Y. S. (2021). COVID-19 vaccination–associated lymphadenopathy on FDG PET/CT: distinctive features in adenovirus-vectored vaccine. Clinical Nuclear Medicine, 46(10), 814. | Shin, M., Hyun, CY, Choi, YH, Choi, JY, Lee, KH y Cho, YS (2021). Linfadenopatía asociada a la vacunación COVID-19 en PET/CT con FDG: características distintivas en la vacuna vectorizada con adenovirus. Medicina Nuclear Clínica, 46(10), 814. https://pubmed.ncbi.nlm.nih.gov/34257025/. | Shemer, A., Pras, E., Einan-Liftz, A., Dubinsky-Pertzov, B., & Hecht, I. (2021). Asociación de la vacunación COVID-19 y la parálisis del nervio facial: un estudio de control de casos. JAMA OTOLARINGOLOGÍA: Cirugía de cabeza y cuello, 147 (8), 739-743. https://pubmed.ncbi.nlm.nih.gov/34411533/ | Shin, M., Hyun, C. Y., Choi, Y. H., Choi, J. Y., Lee, K. H., & Cho, Y. S. (2021). COVID-19 vaccination–associated lymphadenopathy on FDG PET/CT: distinctive features in adenovirus-vectored vaccine. Clinical Nuclear Medicine, 46(10), 814. https://pubmed.ncbi.nlm.nih.gov/34115709/. | Shimabukuro, T., & Nair, N. (2021). Allergic reactions including anaphylaxis after receipt of the first dose of Pfizer-BioNTech COVID-19 vaccine. Jama, 325(8), 780-781. https://pubmed.ncbi.nlm.nih.gov/33475702/ | ||||||||
769 | Takotsubo cardiomyopathy after coronavirus 2019 vaccination in patient on maintenance hemodialysis: | https://pubmed.ncbi.nlm.nih.gov/34731486/. | https://pubmed.ncbi.nlm.nih.gov/34257025/. | Faermann, R., Nissan, N., Halshtok-Neiman, O., Shalmon, A., Gotlieb, M., Yagil, Y., ... & Sklair-Levy, M. (2021). COVID-19 vaccination induced lymphadenopathy in a specialized breast imaging clinic in Israel: Analysis of 163 cases. Academic Radiology, 28(9), 1191-1197. | Faermann, R., Nissan, N., Halshtok-Neiman, O., Shalmon, A., Gotlieb, M., Yagil, Y., ... y Sklair-Levy, M. (2021). Linfadenopatía inducida por la vacunación COVID-19 en una clínica especializada en imágenes mamarias en Israel: análisis de 163 casos. Radiología académica, 28(9), 1191-1197. https://pubmed.ncbi.nlm.nih.gov/34836672/. | Shen, X., Koh, M. H. H., LIM, B. Y., Demo-OS, M., Chien, J. M. F., Santosa, A., & Taha, A. A. (2021). Pericarditis aguda y tamponada cardíaca después de la vacunación de COVID-19. Diario Médico de Singapore. https://pubmed.ncbi.nlm.nih.gov/34849667/ | Faermann, R., Nissan, N., Halshtok-Neiman, O., Shalmon, A., Gotlieb, M., Yagil, Y., ... & Sklair-Levy, M. (2021). COVID-19 vaccination induced lymphadenopathy in a specialized breast imaging clinic in Israel: Analysis of 163 cases. Academic Radiology, 28(9), 1191-1197. https://pubmed.ncbi.nlm.nih.gov/34257025/. | Shin, M., Hyun, C. Y., Choi, Y. H., Choi, J. Y., Lee, K. H., & Cho, Y. S. (2021). COVID-19 vaccination–associated lymphadenopathy on FDG PET/CT: distinctive features in adenovirus-vectored vaccine. Clinical Nuclear Medicine, 46(10), 814. https://pubmed.ncbi.nlm.nih.gov/34115709/. | ||||||||
770 | Premature myocardial infarction or side effect of COVID-19 vaccine: | https://pubmed.ncbi.nlm.nih.gov/33824804/ | https://pubmed.ncbi.nlm.nih.gov/34836672/. | Lim, J., Lee, S. A., Khil, E. K., Byeon, S. J., Kang, H. J., & Choi, J. A. (2021, October). COVID-19 vaccine-related axillary lymphadenopathy in breast cancer patients: Case series with a review of literature. In Seminars in oncology. WB Saunders. | Lim, J., Lee, S. A., Khil, E. K., Byeon, S. J., Kang, H. J. y Choi, J. A. (octubre de 2021). Linfadenopatía axilar relacionada con la vacuna COVID-19 en pacientes con cáncer de mama: serie de casos con revisión de la literatura. En Seminarios de oncología. WB Saunders. https://pubmed.ncbi.nlm.nih.gov/34280870/ | Shimabukuro, T. (2021). Reacciones alérgicas que incluyen anafilaxis después de la recepción de la primera dosis de Moderna COVID-19 Vaccine-Estados Unidos, 21 de diciembre, 2020 al 10 de enero de 2021. American Journal of Transplantation, 21 (3), 1326. https://pubmed.ncbi.nlm.nih.gov/33834172/ | Lim, J., Lee, S. A., Khil, E. K., Byeon, S. J., Kang, H. J., & Choi, J. A. (2021, October). COVID-19 vaccine-related axillary lymphadenopathy in breast cancer patients: Case series with a review of literature. In Seminars in oncology. WB Saunders. https://pubmed.ncbi.nlm.nih.gov/34836672/. | Shiyovich, A., Witberg, G., Aviv, Y., Eisen, A., Orvin, K., Wiessman, M., ... & Hamdan, A. (2021). Myocarditis following COVID-19 vaccination: magnetic resonance imaging study. European Heart Journal-Cardiovascular Imaging. https://academic.oup.com/ehjcimaging/advance-article/doi/10.1093/ehjci/jeab230/6421640 | ||||||||
771 | Myocardial infarction, stroke, and pulmonary embolism after BNT162b2 mRNA COVID-19 vaccine in persons aged 75 years or older: | https://pubmed.ncbi.nlm.nih.gov/34807248/ | https://pubmed.ncbi.nlm.nih.gov/34280870/ | Placke, J. M., Reis, H., Hadaschik, E., Roesch, A., Schadendorf, D., Stoffels, I., & Klode, J. (2021). Coronavirus disease 2019 vaccine mimics lymph node metastases in patients undergoing skin cancer follow-up: A monocentre study. European journal of cancer, 154, 167-174. | Placke, JM, Reis, H., Hadaschik, E., Roesch, A., Schadendorf, D., Stoffels, I. y Klode, J. (2021). La vacuna contra la enfermedad del coronavirus 2019 imita las metástasis en los ganglios linfáticos en pacientes sometidos a seguimiento por cáncer de piel: un estudio monocéntrico. Revista europea de cáncer, 154, 167-174. https://pubmed.ncbi.nlm.nih.gov/34432391/ | Shimabukuro, T. (2021). Reacciones alérgicas que incluyen anafilaxis después de la recepción de la primera dosis de Pfizer-BionTech COVID-19 Vaccine-Estados Unidos, del 14 al 23 de diciembre, 2020. Diario Americano de Transplantación, 21 (3), 1332. https://pubmed.ncbi.nlm.nih.gov/33641268/ | Placke, J. M., Reis, H., Hadaschik, E., Roesch, A., Schadendorf, D., Stoffels, I., & Klode, J. (2021). Coronavirus disease 2019 vaccine mimics lymph node metastases in patients undergoing skin cancer follow-up: A monocentre study. European journal of cancer, 154, 167-174. https://pubmed.ncbi.nlm.nih.gov/34280870/ | Shiyovich, A., Witberg, G., Aviv, Y., Eisen, A., Orvin, K., Wiessman, M., ... & Hamdan, A. (2021). Myocarditis following COVID-19 vaccination: magnetic resonance imaging study. European Heart Journal-Cardiovascular Imaging. https://pubmed.ncbi.nlm.nih.gov/34739045/. | ||||||||
772 | Kounis syndrome type 1 induced by inactivated SARS-COV-2 vaccine: | https://pubmed.ncbi.nlm.nih.gov/34148772/ | https://pubmed.ncbi.nlm.nih.gov/34432391/ | Tan, N. J. H., Tay, K. X. J., Wong, S. B. J., & Nga, M. E. (2021). COVID‐19 post‐vaccination lymphadenopathy: Report of cytological findings from fine needle aspiration biopsy. Diagnostic Cytopathology, 49(12), E467-E470. | Tan, N. J. H., Tay, K. X. J., Wong, S. B. J. y Nga, M. E. (2021). Linfadenopatía posvacunación COVID-19: Informe de hallazgos citológicos de una biopsia por aspiración con aguja fina. Citopatología diagnóstica, 49(12), E467-E470. https://pubmed.ncbi.nlm.nih.gov/34731748/ | Shimabukuro, T. T., Cole, M., & Su, J. R. (2021). Los informes de anafilaxis después de la recepción de las vacunas con MRNA COVID-19 en los EE. UU., Del 14 de diciembre, 2020 al 18 de enero de 2021. JAMA, 325 (11), 1101-1102. https://pubmed.ncbi.nlm.nih.gov/34269740/ | Tan, N. J. H., Tay, K. X. J., Wong, S. B. J., & Nga, M. E. (2021). COVID‐19 post‐vaccination lymphadenopathy: Report of cytological findings from fine needle aspiration biopsy. Diagnostic Cytopathology, 49(12), E467-E470. https://pubmed.ncbi.nlm.nih.gov/34432391/ | Shiyovich, A., Witberg, G., Aviv, Y., Eisen, A., Orvin, K., Wiessman, M., ... & Hamdan, A. (2021). Myocarditis following COVID-19 vaccination: magnetic resonance imaging study. European Heart Journal-Cardiovascular Imaging. https://www.ncbi.nlm.nih.gov/pubmed/34739045 | ||||||||
773 | Acute myocardial infarction within 24 hours after COVID-19 vaccination: is Kounis syndrome the culprit: | https://pubmed.ncbi.nlm.nih.gov/34702550/ | https://pubmed.ncbi.nlm.nih.gov/34731748/ | Garreffa, E., Hamad, A., O'Sullivan, C. C., Hazim, A. Z., York, J., Puri, S., ... & Goetz, M. P. (2021). Regional lymphadenopathy following COVID-19 vaccination: Literature review and considerations for patient management in breast cancer care. European Journal of Cancer, 159, 38-51. | Garreffa, E., Hamad, A., O'Sullivan, C. C., Hazim, A. Z., York, J., Puri, S., ... y Goetz, M. P. (2021). Linfadenopatía regional después de la vacunación COVID-19: revisión de la literatura y consideraciones para el manejo de pacientes en la atención del cáncer de mama. Revista Europea de Cáncer, 159, 38-51. https://pubmed.ncbi.nlm.nih.gov/34906409/ | Shimabukuro, T. T., Kim, S. Y., Myers, T. R., Moro, P. L., Oduyebo, T., Panagiotakopoulos, L., ... & Meany-Delman, D. M. (2021). Resultados preliminares de la seguridad de la vacuna contra el ARNm COVID-19 en personas embarazadas. New England Journal of Medicine. https://www.researchsquare.com/article/rs-477964/v1 | Garreffa, E., Hamad, A., O'Sullivan, C. C., Hazim, A. Z., York, J., Puri, S., ... & Goetz, M. P. (2021). Regional lymphadenopathy following COVID-19 vaccination: Literature review and considerations for patient management in breast cancer care. European Journal of Cancer, 159, 38-51. https://pubmed.ncbi.nlm.nih.gov/34731748/ | Sim, J., & Lim, C. C. (2021). Coronavirus disease 2019 (COVID-19) vaccination in systemic lupus erythematosus and anti-neutrophil cytoplasmic antibody-associated vasculitis. Clinical Rheumatology, 40(6), 2517-2518. https://pubmed.ncbi.nlm.nih.gov/33928459/ | ||||||||
774 | Deaths associated with the recently launched SARS-CoV-2 vaccination (Comirnaty®): | https://pubmed.ncbi.nlm.nih.gov/33895650/ | https://pubmed.ncbi.nlm.nih.gov/34906409/ | Raj, S., Ogola, G., & Han, J. (2022). COVID-19 vaccine-associated subclinical axillary lymphadenopathy on screening mammogram. Academic radiology, 29(4), 501-507. | Raj, S., Ogola, G. y Han, J. (2022). Linfadenopatía axilar subclínica asociada a la vacuna COVID-19 en mamografía de detección. Radiología académica, 29(4), 501-507. https://pubmed.ncbi.nlm.nih.gov/33706861/ | Shimabukuro, T., & Nair, N. (2021). Reacciones alérgicas que incluyen anafilaxis después de la recepción de la primera dosis de la vacuna PFIZE-BIONTECH COVID-19. Jama, 325 (8), 780-781. https://pubmed.ncbi.nlm.nih.gov/33320974/ | Raj, S., Ogola, G., & Han, J. (2022). COVID-19 vaccine-associated subclinical axillary lymphadenopathy on screening mammogram. Academic radiology, 29(4), 501-507. https://pubmed.ncbi.nlm.nih.gov/34906409/ | Simone, A., Herald, J., Chen, A., Gulati, N., Shen, A. Y. J., Lewin, B., & Lee, M. S. (2021). Acute myocarditis following COVID-19 mRNA vaccination in adults aged 18 years or older. JAMA Internal Medicine, 181(12), 1668-1670. https://pubmed.ncbi.nlm.nih.gov/34605853/ | ||||||||
775 | Deaths associated with recently launched SARS-CoV-2 vaccination: | https://pubmed.ncbi.nlm.nih.gov/34425384/ | https://pubmed.ncbi.nlm.nih.gov/33706861/ | Fernández-Prada, M., Rivero-Calle, I., Calvache-González, A., & Martinón-Torres, F. (2021). Acute onset supraclavicular lymphadenopathy coinciding with intramuscular mRNA vaccination against COVID-19 may be related to vaccine injection technique, Spain, January and February 2021. Eurosurveillance, 26(10), 2100193. | Fernández-Prada, M., Rivero-Calle, I., Calvache-González, A., & Martinón-Torres, F. (2021). La linfadenopatía supraclavicular de inicio agudo coincidente con la vacunación intramuscular con ARNm contra la COVID-19 puede estar relacionada con la técnica de inyección de la vacuna, España, enero y febrero de 2021. Eurosurveillance, 26(10), 2100193. https://pubmed.ncbi.nlm.nih.gov/34116295/ | Shin, M., Hyun, C. Y., Choi, Y. H., Choi, J. Y., Lee, K. H., & Cho, Y. S. (2021). COVID-19 Linfadenopatía asociada a la vacunación en FDG PET / CT: Características distintivas en la vacuna vectorial de adenovirus. Medicina nuclear clínica, 46 (10), 814. https://pubmed.ncbi.nlm.nih.gov/34257025/. | Fernández-Prada, M., Rivero-Calle, I., Calvache-González, A., & Martinón-Torres, F. (2021). Acute onset supraclavicular lymphadenopathy coinciding with intramuscular mRNA vaccination against COVID-19 may be related to vaccine injection technique, Spain, January and February 2021. Eurosurveillance, 26(10), 2100193. https://pubmed.ncbi.nlm.nih.gov/33706861/ | Simone, A., Herald, J., Chen, A., Gulati, N., Shen, A. Y. J., Lewin, B., & Lee, M. S. (2021). Acute myocarditis following COVID-19 mRNA vaccination in adults aged 18 years or older. JAMA Internal Medicine, 181(12), 1668-1670. https://www.ncbi.nlm.nih.gov/pubmed/34605853 | ||||||||
776 | A case of acute encephalopathy and non-ST-segment elevation myocardial infarction after vaccination with mRNA-1273: possible adverse effect: | https://pubmed.ncbi.nlm.nih.gov/34703815/ | https://pubmed.ncbi.nlm.nih.gov/34116295/ | Kim, B., Park, Y., Kim, E. K., & Lee, S. H. (2021). Supraclavicular lymphadenopathy after COVID-19 vaccination in Korea: serial follow-up using ultrasonography. Clinical Imaging, 79, 201-203. | Kim, B., Park, Y., Kim, EK y Lee, SH (2021). Linfadenopatía supraclavicular después de la vacunación COVID-19 en Corea: seguimiento en serie mediante ecografía. Imágenes clínicas, 79, 201-203. https://pubmed.ncbi.nlm.nih.gov/33661328/ | Shiyovich, A., Witberg, G., Aviv, Y., Eisen, A., Orvin, K., Wiessman, M., ... & Hamdan, A. (2021). Miocarditis después de la vacunación de COVID-19: estudio de imágenes de resonancia magnética. Imagen europea de la revista Heart-Cardiovascular. https://docs.google.com/document/d/1Hc4bh_qNbZ7UVm5BLxkRdMPnnI9zcCsl/e | Kim, B., Park, Y., Kim, E. K., & Lee, S. H. (2021). Supraclavicular lymphadenopathy after COVID-19 vaccination in Korea: serial follow-up using ultrasonography. Clinical Imaging, 79, 201-203. https://pubmed.ncbi.nlm.nih.gov/34116295/ | Simpson, C. R., Shi, T., Vasileiou, E., Katikireddi, S. V., Kerr, S., Moore, E., ... & Sheikh, A. (2021). First-dose ChAdOx1 and BNT162b2 COVID-19 vaccines and thrombocytopenic, thromboembolic and hemorrhagic events in Scotland. Nature medicine, 27(7), 1290-1297. https://pubmed.ncbi.nlm.nih.gov/34108714/ | ||||||||
777 | COVID-19 vaccine-induced urticarial vasculitis: | https://pubmed.ncbi.nlm.nih.gov/34369046/. | https://pubmed.ncbi.nlm.nih.gov/33661328/ | Nawwar, A. A., Searle, J., Singh, R., & Lyburn, I. D. (2021). Oxford-AstraZeneca COVID-19 vaccination induced lymphadenopathy on [18F] choline PET/CT—not only an FDG finding. European Journal of Nuclear Medicine and Molecular Imaging, 48(8), 2657-2658. | Nawwar, AA, Searle, J., Singh, R. y Lyburn, ID (2021). La vacuna Oxford-AstraZeneca contra la COVID-19 indujo linfadenopatía en la PET/TC con colina [18F], no solo un hallazgo de FDG. Revista europea de medicina nuclear e imágenes moleculares, 48(8), 2657-2658. https://pubmed.ncbi.nlm.nih.gov/33624520/ | Shiyovich, A., Witberg, G., Aviv, Y., Eisen, A., Orvin, K., Wiessman, M., ... & Hamdan, A. (2021). Miocarditis después de la vacunación de COVID-19: estudio de imágenes de resonancia magnética. Imagen europea de la revista Heart-Cardiovascular. https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8599115/ | Nawwar, A. A., Searle, J., Singh, R., & Lyburn, I. D. (2021). Oxford-AstraZeneca COVID-19 vaccination induced lymphadenopathy on [18F] choline PET/CT—not only an FDG finding. European Journal of Nuclear Medicine and Molecular Imaging, 48(8), 2657-2658. https://pubmed.ncbi.nlm.nih.gov/33661328/ | Simpson, C. R., Shi, T., Vasileiou, E., Katikireddi, S. V., Kerr, S., Moore, E., ... & Sheikh, A. (2021). First-dose ChAdOx1 and BNT162b2 COVID-19 vaccines and thrombocytopenic, thromboembolic and hemorrhagic events in Scotland. Nature medicine, 27(7), 1290-1297. https://www.nature.com/articles/s41591-021-01408-4 | ||||||||
778 | ANCA-associated vasculitis after Pfizer-BioNTech COVID-19 vaccine: | https://pubmed.ncbi.nlm.nih.gov/34280507/. | https://pubmed.ncbi.nlm.nih.gov/33624520/ | Mortazavi, S. (2021). COVID-19 vaccination–associated axillary adenopathy: imaging findings and follow-up recommendations in 23 women. American Journal of Roentgenology, 217(4), 857-858. | Mortazavi, S. (2021). Adenopatía axilar asociada a la vacunación COVID-19: hallazgos de imágenes y recomendaciones de seguimiento en 23 mujeres. Revista Estadounidense de Roentgenología, 217(4), 857-858. https://pubmed.ncbi.nlm.nih.gov/34141500/ | Shiyovich, A., Witberg, G., Aviv, Y., Eisen, A., Orvin, K., Wiessman, M., ... & Hamdan, A. (2021). Miocarditis después de la vacunación de COVID-19: estudio de imágenes de resonancia magnética. Imagen europea de la revista Heart-Cardiovascular. https://www.ncbi.nlm.nih.gov/pubmed/34605853 | Mortazavi, S. (2021). COVID-19 vaccination–associated axillary adenopathy: imaging findings and follow-up recommendations in 23 women. American Journal of Roentgenology, 217(4), 857-858. https://pubmed.ncbi.nlm.nih.gov/33624520/ | Şimşek, F., & Tosunoğlu, R. (2021). Massive cerebral venous thrombosis and venous watershed infarction as late complications of COVID-19: a case report. Neurological Sciences, 42(11), 4421-4423. https://pubmed.ncbi.nlm.nih.gov/34373991/ | ||||||||
779 | New-onset leukocytoclastic vasculitis after COVID-19 vaccine: | https://pubmed.ncbi.nlm.nih.gov/34241833/ | https://pubmed.ncbi.nlm.nih.gov/34141500/ | Cardoso, F., Reis, A., Osório, C., Scigliano, H., & Nora, M. (2021). A case of cervical lymphadenopathy after vaccination against COVID-19. Cureus, 13(5). | Cardoso, F., Reis, A., Osório, C., Scigliano, H. y Nora, M. (2021). Un caso de linfadenopatía cervical tras la vacunación contra el COVID-19. Cureus, 13(5). https://pubmed.ncbi.nlm.nih.gov/34096896/ | SIM, J., & LIM, C. C. (2021). Enfermedad de Coronavirus 2019 (COVID-19) Vacunación en el lupus eritematoso sistémico y vasculitis asociada a anticuerpos citoplásmicos anti-neutrófilos. RHEUMATOLOGÍA CLÍNICA, 40 (6), 2517-2518. https://pubmed.ncbi.nlm.nih.gov/34250509/ | Cardoso, F., Reis, A., Osório, C., Scigliano, H., & Nora, M. (2021). A case of cervical lymphadenopathy after vaccination against COVID-19. Cureus, 13(5). https://pubmed.ncbi.nlm.nih.gov/34141500/ | Singer, M. E., Taub, I. B., & Kaelber, D. C. (2021). Risk of myocarditis from COVID-19 infection in people under age 20: a population-based analysis. medRxiv. https://www.ncbi.nlm.nih.gov/pubmed/34341797 | ||||||||
780 | Cutaneous small vessel vasculitis after COVID-19 vaccine: | https://pubmed.ncbi.nlm.nih.gov/34529877/. | https://pubmed.ncbi.nlm.nih.gov/34096896/ | Keir, G., Maria, N. I., & Kirsch, C. F. (2021). Unique imaging findings of neurologic phantosmia following Pfizer-BioNtech COVID-19 vaccination: a case report. Topics in Magnetic Resonance Imaging, 30(3), 133-137. | Keir, G., Maria, NI y Kirsch, CF (2021). Hallazgos de imágenes únicos de fantosmia neurológica después de la vacunación contra el COVID-19 de Pfizer-BioNtech: reporte de un caso. Temas de imágenes por resonancia magnética, 30(3), 133-137. https://pubmed.ncbi.nlm.nih.gov/34835256/ | Simone, A., Herald, J., Chen, A., Gulati, N., Shen, A. Y. J., Lewin, B., & Lee, M. S. (2021). Miocarditis aguda después de la vacunación con ARNm de COVID-19 en adultos de 18 años o más. Medicina interna de JAMA, 181 (12), 1668-1670. https://pubmed.ncbi.nlm.nih.gov/34166671/ | Keir, G., Maria, N. I., & Kirsch, C. F. (2021). Unique imaging findings of neurologic phantosmia following Pfizer-BioNtech COVID-19 vaccination: a case report. Topics in Magnetic Resonance Imaging, 30(3), 133-137. https://pubmed.ncbi.nlm.nih.gov/34096896/ | Singh, B., Kaur, P., Cedeno, L., Brahimi, T., Patel, P., Virk, H., ... & Bikkina, M. (2021). COVID-19 mRNA vaccine and myocarditis. European Journal of Case Reports in Internal Medicine, 8(7). https://pubmed.ncbi.nlm.nih.gov/34268277/ | ||||||||
781 | Outbreak of leukocytoclastic vasculitis after COVID-19 vaccine: | https://pubmed.ncbi.nlm.nih.gov/33928638/ | https://pubmed.ncbi.nlm.nih.gov/34835256/ | Tobaiqy, M., MacLure, K., Elkout, H., & Stewart, D. (2021). Thrombotic adverse events reported for Moderna, Pfizer and Oxford-AstraZeneca COVID-19 vaccines: comparison of occurrence and clinical outcomes in the EudraVigilance database. Vaccines, 9(11), 1326. | Tobaiqy, M., MacLure, K., Elkout, H. y Stewart, D. (2021). Eventos adversos trombóticos informados para las vacunas COVID-19 de Moderna, Pfizer y Oxford-AstraZeneca: comparación de ocurrencia y resultados clínicos en la base de datos EudraVigilance. Vacunas, 9(11), 1326. https://pubmed.ncbi.nlm.nih.gov/33713605/ | Simone, A., Herald, J., Chen, A., Gulati, N., Shen, A. Y. J., Lewin, B., & Lee, M. S. (2021). Miocarditis aguda después de la vacunación con ARNm de COVID-19 en adultos de 18 años o más. Medicina interna de JAMA, 181 (12), 1668-1670. https://www.ncbi.nlm.nih.gov/pubmed/34341797 | Tobaiqy, M., MacLure, K., Elkout, H., & Stewart, D. (2021). Thrombotic adverse events reported for Moderna, Pfizer and Oxford-AstraZeneca COVID-19 vaccines: comparison of occurrence and clinical outcomes in the EudraVigilance database. Vaccines, 9(11), 1326. https://pubmed.ncbi.nlm.nih.gov/34835256/ | Singh, B., Kaur, P., Kumar, V., & Maroules, M. (2021). COVID-19 vaccine induced Axillary and Pectoral Lymphadenopathy on PET scan. Radiology Case Reports, 16(7), 1819-1821. https://www.sciencedirect.com/science/article/pii/S1930043321002612 | ||||||||
782 | Leukocytoclastic vasculitis after exposure to COVID-19 vaccine: | https://pubmed.ncbi.nlm.nih.gov/34836739/ | https://pubmed.ncbi.nlm.nih.gov/33713605/ | Lehman, C. D., D’Alessandro, H. A., Mendoza, D. P., Succi, M. D., Kambadakone, A., & Lamb, L. R. (2021). Unilateral lymphadenopathy after COVID-19 vaccination: a practical management plan for radiologists across specialties. Journal of the American College of Radiology, 18(6), 843-852. | Lehman, C. D., D'Alessandro, H. A., Mendoza, D. P., Succi, M. D., Kambadakone, A. y Lamb, L. R. (2021). Linfadenopatía unilateral después de la vacunación COVID-19: un plan de manejo práctico para radiólogos de todas las especialidades. Revista del Colegio Americano de Radiología, 18(6), 843-852. https://pubmed.ncbi.nlm.nih.gov/34298342/ | Simpson, C. R., Shi, T., Vasileiou, E., Katikireddi, S. V., Kerr, S., Moore, E., ... & Sheikh, A. (2021). First-Dosis Chadox1 y BNT162B2 COVID-19 Vacunas y eventos trombocitopénicos, tromboembólicos y hemorrágicos en Escocia. Medicina natural, 27 (7), 1290-1297. https://pubmed.ncbi.nlm.nih.gov/34075578/ | Lehman, C. D., D’Alessandro, H. A., Mendoza, D. P., Succi, M. D., Kambadakone, A., & Lamb, L. R. (2021). Unilateral lymphadenopathy after COVID-19 vaccination: a practical management plan for radiologists across specialties. Journal of the American College of Radiology, 18(6), 843-852. https://pubmed.ncbi.nlm.nih.gov/33713605/ | Sirufo, M. M., Raggiunti, M., Magnanimi, L. M., Ginaldi, L., & De Martinis, M. (2021). Henoch-Schönlein Purpura Following the First Dose of COVID-19 Viral Vector Vaccine: A Case Report. Vaccines, 9(10), 1078. https://pubmed.ncbi.nlm.nih.gov/34696186/. | ||||||||
783 | Vasculitis and bursitis in [ 18 F] FDG-PET/CT after COVID-19 mRNA vaccine: post hoc ergo propter hoc?; | https://pubmed.ncbi.nlm.nih.gov/34495381/. | https://pubmed.ncbi.nlm.nih.gov/34298342/ | Mehta, N., Sales, R. M., Babagbemi, K., Levy, A. D., McGrath, A. L., Drotman, M., & Dodelzon, K. (2021). Unilateral axillary adenopathy in the setting of COVID-19 vaccine: Follow-up. Clinical Imaging, 80, 83-87. | Mehta, N., Sales, R. M., Babagbemi, K., Levy, A. D., McGrath, A. L., Drotman, M. y Dodelzon, K. (2021). Adenopatía axilar unilateral en el contexto de la vacuna COVID-19: seguimiento. Imágenes clínicas, 80, 83-87. https://pubmed.ncbi.nlm.nih.gov/34839149/ | Simpson, C. R., Shi, T., Vasileiou, E., Katikireddi, S. V., Kerr, S., Moore, E., ... & Sheikh, A. (2021). First-Dosis Chadox1 y BNT162B2 COVID-19 Vacunas y eventos trombocitopénicos, tromboembólicos y hemorrágicos en Escocia. Medicina natural, 27 (7), 1290-1297. https://pubmed.ncbi.nlm.nih.gov/34288044/ | Mehta, N., Sales, R. M., Babagbemi, K., Levy, A. D., McGrath, A. L., Drotman, M., & Dodelzon, K. (2021). Unilateral axillary adenopathy in the setting of COVID-19 vaccine: Follow-up. Clinical Imaging, 80, 83-87. https://pubmed.ncbi.nlm.nih.gov/34298342/ | Smadja, D. M., Yue, Q. Y., Chocron, R., Sanchez, O., & Lillo-Le Louet, A. (2021). Vaccination against COVID-19: insight from arterial and venous thrombosis occurrence using data from VigiBase. European Respiratory Journal, 58(1). https://pubmed.ncbi.nlm.nih.gov/33863748/ | ||||||||
784 | Cutaneous lymphocytic vasculitis after administration of COVID-19 mRNA vaccine: | https://pubmed.ncbi.nlm.nih.gov/34327795 | https://pubmed.ncbi.nlm.nih.gov/34839149/ | Ismail, I. I., & Salama, S. (2022). A systematic review of cases of CNS demyelination following COVID-19 vaccination. Journal of neuroimmunology, 362, 577765. | Ismail, II y Salama, S. (2022). Una revisión sistemática de casos de desmielinización del SNC después de la vacunación COVID-19. Revista de neuroinmunología, 362, 577765. https://pubmed.ncbi.nlm.nih.gov/33685772/ | Şimşek, F., & Tosunoğlu, R. (2021). Trombosis venosa cerebral masiva y infarto de cuencas venosas como complicaciones tardías de COVID-19: un informe de caso. Ciencias neurológicas, 42 (11), 4421-4423. https://pubmed.ncbi.nlm.nih.gov/34490632/ | Ismail, I. I., & Salama, S. (2022). A systematic review of cases of CNS demyelination following COVID-19 vaccination. Journal of neuroimmunology, 362, 577765. https://pubmed.ncbi.nlm.nih.gov/34839149/ | Smith, C., Odd, D., Harwood, R., Ward, J., Linney, M., Clark, M., ... & Fraser, L. K. (2022). Deaths in children and young people in England after SARS-CoV-2 infection during the first pandemic year. Nature medicine, 28(1), 185-192. https://www.ncbi.nlm.nih.gov/pubmed/34764489 | ||||||||
785 | Cutaneous leukocytoclastic vasculitis induced by Sinovac COVID-19 vaccine: | https://pubmed.ncbi.nlm.nih.gov/34660867/. | https://pubmed.ncbi.nlm.nih.gov/33685772/ | Mitchell, O. R., Dave, R., Bekker, J., & Brennan, P. A. (2021). Supraclavicular lymphadenopathy following COVID-19 vaccination: an increasing presentation to the two-week wait neck lump clinic?. British Journal of Oral and Maxillofacial Surgery, 59(3), 384-385. | Mitchell, O. R., Dave, R., Bekker, J. y Brennan, PA (2021). Linfadenopatía supraclavicular después de la vacunación COVID-19: ¿una presentación cada vez mayor en la clínica de bultos en el cuello de espera de dos semanas? Revista Británica de Cirugía Oral y Maxilofacial, 59(3), 384-385. https://pubmed.ncbi.nlm.nih.gov/34719892/ | Singh, B., Kaur, P., Cedeno, L., Brahimi, T., Patel, P., Virk, H., ... & Bikkina, M. (2021). COVID-19 Vacuna de ARNm y miocarditis. Revista europea de informes de casos en medicina interna, 8 (7). https://pubmed.ncbi.nlm.nih.gov/34399967/ | Mitchell, O. R., Dave, R., Bekker, J., & Brennan, P. A. (2021). Supraclavicular lymphadenopathy following COVID-19 vaccination: an increasing presentation to the two-week wait neck lump clinic?. British Journal of Oral and Maxillofacial Surgery, 59(3), 384-385. https://pubmed.ncbi.nlm.nih.gov/33685772/ | Snapiri, O., Danziger, C. R., Shirman, N., Weissbach, A., Lowenthal, A., Ayalon, I., ... & Bilavsky, E. (2021). Transient cardiac injury in adolescents receiving the BNT162b2 mRNA COVID-19 vaccine. The Pediatric Infectious Disease Journal, 40(10), e360. https://pubmed.ncbi.nlm.nih.gov/34077949/ | ||||||||
786 | Case report: ANCA-associated vasculitis presenting with rhabdomyolysis and crescentic Pauci-Inmune glomerulonephritis after vaccination with Pfizer-BioNTech COVID-19 mRNA: | https://pubmed.ncbi.nlm.nih.gov/34659268/ | https://pubmed.ncbi.nlm.nih.gov/34719892/ | Lane, D. L., Neelapu, S. S., Xu, G., & Weaver, O. (2021). COVID-19 vaccine-related axillary and cervical lymphadenopathy in patients with current or prior breast cancer and other malignancies: cross-sectional imaging findings on MRI, CT, and PET-CT. Korean Journal of Radiology, 22(12), 1938. | Lane, D. L., Neelapu, S. S., Xu, G. y Weaver, O. (2021). Linfadenopatía axilar y cervical relacionada con la vacuna COVID-19 en pacientes con cáncer de mama actual o previo y otras neoplasias malignas: hallazgos de imágenes transversales en resonancia magnética, tomografía computarizada y tomografía por emisión de positrones (PET-CT). Revista Coreana de Radiología, 22(12), 1938. https://pubmed.ncbi.nlm.nih.gov/33625299/. | Singh, B., Kaur, P., KUMAR, V., Y MARULES, M. (2021). COVID-19 Vacuna Induce Linfadenopatía axilar y pectoral en la exploración de mascotas. Informes de casos de radiología, 16 (7), 1819-1821. https://www.sciencedirect.com/science/article/pii/S0272638621007423 | Lane, D. L., Neelapu, S. S., Xu, G., & Weaver, O. (2021). COVID-19 vaccine-related axillary and cervical lymphadenopathy in patients with current or prior breast cancer and other malignancies: cross-sectional imaging findings on MRI, CT, and PET-CT. Korean Journal of Radiology, 22(12), 1938. https://pubmed.ncbi.nlm.nih.gov/34719892/ | Snapiri, O., Danziger, C. R., Shirman, N., Weissbach, A., Lowenthal, A., Ayalon, I., ... & Bilavsky, E. (2021). Transient cardiac injury in adolescents receiving the BNT162b2 mRNA COVID-19 vaccine. The Pediatric Infectious Disease Journal, 40(10), e360. https://www.ncbi.nlm.nih.gov/pubmed/34077949 | ||||||||
787 | Reactivation of IgA vasculitis after vaccination with COVID-19: | https://pubmed.ncbi.nlm.nih.gov/34848431/ | https://pubmed.ncbi.nlm.nih.gov/33625299/. | Washington, T., Bryan, R., & Clemow, C. (2021). Adenopathy following COVID-19 vaccination. Radiology, 299(3), E280-E281. | Washington, T., Bryan, R. y Clemow, C. (2021). Adenopatía tras la vacunación COVID-19. Radiología, 299(3), E280-E281. https://pubmed.ncbi.nlm.nih.gov/34292295/. | Sirufo, M. M., Raggiunti, M., Magnanimi, L. M., Ginaldi, L., & de Martinis, M. (2021). Henoch-Schönlein Purpura siguiendo la primera dosis de COVID-19 Vacunal Viral Vaccine: un informe de caso. Vacunas, 9 (10), 1078. https://pubmed.ncbi.nlm.nih.gov/34237323/. | Washington, T., Bryan, R., & Clemow, C. (2021). Adenopathy following COVID-19 vaccination. Radiology, 299(3), E280-E281. https://pubmed.ncbi.nlm.nih.gov/33625299/. | Soeiro, T., Salvo, F., Pariente, A., Grandvuillemin, A., Jonville-Béra, A. P., & Micallef, J. (2021). Type I interferons as the potential mechanism linking mRNA COVID-19 vaccines to Bell’s palsy. Therapie. https://pubmed.ncbi.nlm.nih.gov/33858693/ | ||||||||
788 | Varicella-zoster virus-related small-vessel vasculitis after Pfizer-BioNTech COVID-19 vaccination: | https://pubmed.ncbi.nlm.nih.gov/34310759/. | https://pubmed.ncbi.nlm.nih.gov/34292295/. | Robinson, K. A., Maimone, S., Gococo-Benore, D. A., Li, Z., Advani, P. P., & Chumsri, S. (2021). Incidence of axillary adenopathy in breast imaging after COVID-19 vaccination. JAMA oncology, 7(9), 1395-1397. | Robinson, K. A., Maimone, S., Gococo-Benore, D. A., Li, Z., Advani, P. P. y Chumsri, S. (2021). Incidencia de adenopatía axilar en imágenes mamarias después de la vacunación COVID-19. Oncología JAMA, 7(9), 1395-1397. https://pubmed.ncbi.nlm.nih.gov/33947605/. | Smadja, D. M., Yue, Q. Y., Chocron, R., Sánchez, O., & Lillo-Le Louet, A. (2021). Vacunación contra COVID-19: Visión de la trombosis arterial y venosa ocurrencia usando datos de Vigibase. Diario respiratorio europeo, 58 (1). https://onlinelibrary.wiley.com/doi/10.1002/ana.26172 | Robinson, K. A., Maimone, S., Gococo-Benore, D. A., Li, Z., Advani, P. P., & Chumsri, S. (2021). Incidence of axillary adenopathy in breast imaging after COVID-19 vaccination. JAMA oncology, 7(9), 1395-1397. https://pubmed.ncbi.nlm.nih.gov/34292295/. | Soltani Hekmat, A., & Javanmardi, K. (2021). Possible Risk of Thrombotic Events following Oxford-AstraZeneca COVID-19 Vaccination in Women Receiving Estrogen. BioMed Research International, 2021. https://pubmed.ncbi.nlm.nih.gov/34734086/ | ||||||||
789 | Imaging in vascular medicine: leukocytoclastic vasculitis after COVID-19 vaccine booster: | https://pubmed.ncbi.nlm.nih.gov/34720009/ | https://pubmed.ncbi.nlm.nih.gov/33947605/. | Mitchell, O. R., Couzins, M., Dave, R., Bekker, J., & Brennan, P. A. (2021). COVID-19 vaccination and low cervical lymphadenopathy in the two week neck lump clinic-a follow up audit. British Journal of Oral and Maxillofacial Surgery, 59(6), 720-721. | Mitchell, O. R., Couzins, M., Dave, R., Bekker, J. y Brennan, P. A. (2021). Vacunación contra COVID-19 y linfadenopatía cervical baja en la clínica de bultos en el cuello de dos semanas: una auditoría de seguimiento. Revista Británica de Cirugía Oral y Maxilofacial, 59(6), 720-721. https://pubmed.ncbi.nlm.nih.gov/34526175/ | Smith, C., Odd, D., Harwood, R., Ward, J., Linney, M., Clark, M., ... & Fraser, L. K. (2022). Muertes en niños y jóvenes en Inglaterra después de la infección por SARS-COV-2 durante el primer año pandémico. Medicina natural, 28 (1), 185-192. https://www.ncbi.nlm.nih.gov/pubmed/34077949 | Mitchell, O. R., Couzins, M., Dave, R., Bekker, J., & Brennan, P. A. (2021). COVID-19 vaccination and low cervical lymphadenopathy in the two week neck lump clinic-a follow up audit. British Journal of Oral and Maxillofacial Surgery, 59(6), 720-721. https://pubmed.ncbi.nlm.nih.gov/33947605/. | Somiya, M., Mine, S., Yasukawa, K., & Ikeda, S. (2021). Sex differences in the incidence of anaphylaxis to LNP-mRNA COVID-19 vaccines. Vaccine. https://pubmed.ncbi.nlm.nih.gov/34020815/ | ||||||||
790 | A rare case of Henoch-Schönlein purpura after a case report of COVID-19 vaccine: | https://pubmed.ncbi.nlm.nih.gov/34518812/ | https://pubmed.ncbi.nlm.nih.gov/34526175/ | Abou-Foul, A. K., Ross, E., Abou-Foul, M., & George, A. P. (2021). Cervical lymphadenopathy following coronavirus disease 2019 vaccine: clinical characteristics and implications for head and neck cancer services. The Journal of Laryngology & Otology, 135(11), 1025-1030. | Abou-Foul, AK, Ross, E., Abou-Foul, M. y George, AP (2021). Linfadenopatía cervical después de la vacuna contra la enfermedad por coronavirus de 2019: características clínicas e implicaciones para los servicios de cáncer de cabeza y cuello. La Revista de Laringología y Otología, 135(11), 1025-1030. https://pubmed.ncbi.nlm.nih.gov/33786231/ | Snapiri, O., Danziger, C. R., Shirman, N., Weissbach, A., Lowenthal, A., Ayalon, I., ... & Bilavsky, E. (2021). Lesión cardíaca transitoria en adolescentes que reciben la vacuna BNT162B2 MRNA COVID-19. El diario de enfermedades infecciosas pediátricas, 40 (10), E360. https://pubmed.ncbi.nlm.nih.gov/34171435/ | Abou-Foul, A. K., Ross, E., Abou-Foul, M., & George, A. P. (2021). Cervical lymphadenopathy following coronavirus disease 2019 vaccine: clinical characteristics and implications for head and neck cancer services. The Journal of Laryngology & Otology, 135(11), 1025-1030. https://pubmed.ncbi.nlm.nih.gov/34526175/ | Sookaromdee, P., & Wiwanitkit, V. (2021). COVID-19 vaccine, immune thrombotic thrombocytopenia, jaundice, hyperviscosity: concern on cases with underlying liver problem. Annals of Hepatology, 24, 100525. https://pubmed.ncbi.nlm.nih.gov/34509271/. | ||||||||
791 | Cutaneous vasculitis following COVID-19 vaccination: | https://pubmed.ncbi.nlm.nih.gov/34611627/. | https://pubmed.ncbi.nlm.nih.gov/33786231/ | Hiller, N., Goldberg, S. N., Cohen-Cymberknoh, M., Vainstein, V., & Simanovsky, N. (2021). Lymphadenopathy associated with the COVID-19 vaccine. Cureus, 13(2). | Hiller, N., Goldberg, SN, Cohen-Cymberknoh, M., Vainstein, V. y Simanovsky, N. (2021). Linfadenopatía asociada a la vacuna COVID-19. Cureus, 13(2). https://pubmed.ncbi.nlm.nih.gov/33625301/. | Snapiri, O., Danziger, C. R., Shirman, N., Weissbach, A., Lowenthal, A., Ayalon, I., ... & Bilavsky, E. (2021). Lesión cardíaca transitoria en adolescentes que reciben la vacuna BNT162B2 MRNA COVID-19. El diario de enfermedades infecciosas pediátricas, 40 (10), E360. https://www.ncbi.nlm.nih.gov/pubmed/34911654 | Hiller, N., Goldberg, S. N., Cohen-Cymberknoh, M., Vainstein, V., & Simanovsky, N. (2021). Lymphadenopathy associated with the COVID-19 vaccine. Cureus, 13(2). https://pubmed.ncbi.nlm.nih.gov/33786231/ | Sørvoll, I. H., Horvei, K. D., Ernstsen, S. L., Lægreid, I. J., Lund, S., Grønli, R. H., ... & Ahlen, M. T. (2021). An observational study to identify the prevalence of thrombocytopenia and anti‐PF4/polyanion antibodies in Norwegian health care workers after COVID‐19 vaccination. Journal of Thrombosis and Haemostasis, 19(7), 1813-1818. https://pubmed.ncbi.nlm.nih.gov/33909350/ | ||||||||
792 | Possible case of COVID-19 mRNA vaccine-induced small-vessel vasculitis: | https://pubmed.ncbi.nlm.nih.gov/34705320/. | https://pubmed.ncbi.nlm.nih.gov/33625301/. | Hanneman, K., Iwanochko, R. M., & Thavendiranathan, P. (2021). Evolution of lymphadenopathy at PET/MRI after COVID-19 vaccination. Radiology, 299(3), E282-E282. | Hanneman, K., Iwanochko, R. M. y Thavendiranathan, P. (2021). Evolución de las adenopatías en PET/MRI tras la vacunación COVID-19. Radiología, 299(3), E282-E282. https://pubmed.ncbi.nlm.nih.gov/34332438/. | Soeiro, T., Salvo, F., Pariente, A., Grandvuillemin, A., Jonville-Béra, A. P., & Micallef, J. (2021). Tipo I Interferons como el potencial mecanismo que une las vacunas MRNA COVID-19 a la parálisis de Bell. Terapia. https://pubmed.ncbi.nlm.nih.gov/34370410/ | Hanneman, K., Iwanochko, R. M., & Thavendiranathan, P. (2021). Evolution of lymphadenopathy at PET/MRI after COVID-19 vaccination. Radiology, 299(3), E282-E282. https://pubmed.ncbi.nlm.nih.gov/33625301/. | Spinner, J. A., Julien, C. L., Olayinka, L., Dreyer, W. J., Bocchini, C. E., Munoz, F. M., & Devaraj, S. (2022). SARS-CoV-2 anti–spike antibodies after vaccination in pediatric heart transplantation: A first report. The Journal of Heart and Lung Transplantation, 41(2), 133-136. https://www.ncbi.nlm.nih.gov/pubmed/34911654 | ||||||||
793 | IgA vasculitis following COVID-19 vaccination in an adult: | https://pubmed.ncbi.nlm.nih.gov/34779011/ | https://pubmed.ncbi.nlm.nih.gov/34332438/. | Vuille-Lessard, É., Montani, M., Bosch, J., & Semmo, N. (2021). Autoimmune hepatitis triggered by SARS-CoV-2 vaccination. Journal of autoimmunity, 123, 102710. | Vuille-Lessard, É., Montani, M., Bosch, J. y Semmo, N. (2021). Hepatitis autoinmune desencadenada por la vacunación contra el SARS-CoV-2. Revista de autoinmunidad, 123, 102710. https://pubmed.ncbi.nlm.nih.gov/34342187/. | Soltani Hekmat, A., & Javanmardi, K. (2021). Posible riesgo de eventos trombóticos después de OXFORD-ASTRAZENECA COVID-19 Vacunación en mujeres que reciben estrógeno. Biomed Research International, 2021. https://pubmed.ncbi.nlm.nih.gov/34755555/ | Vuille-Lessard, É., Montani, M., Bosch, J., & Semmo, N. (2021). Autoimmune hepatitis triggered by SARS-CoV-2 vaccination. Journal of autoimmunity, 123, 102710. https://pubmed.ncbi.nlm.nih.gov/34332438/. | Sriwastava, S., Shrestha, A. K., Khalid, S. H., Colantonio, M. A., Nwafor, D., & Srivastava, S. (2021). Spectrum of Neuroimaging Findings in Post-COVID-19 Vaccination: A Case Series and Review of Literature. Neurology International, 13(4), 622-639. https://pubmed.ncbi.nlm.nih.gov/34842783/ | ||||||||
794 | Propylthiouracil-induced anti-neutrophil cytoplasmic antibody-associated vasculitis following vaccination with COVID-19: | https://pubmed.ncbi.nlm.nih.gov/34451967/ | https://pubmed.ncbi.nlm.nih.gov/34342187/. | Lim, J. H., Han, M. H., Kim, Y. J., Kim, M. S., Jung, H. Y., Choi, J. Y., ... & Park, S. H. (2021). New-onset nephrotic syndrome after Janssen COVID-19 vaccination: a case report and literature review. Journal of Korean Medical Science, 36(30). | Lim, J. H., Han, M. H., Kim, Y. J., Kim, M. S., Jung, H. Y., Choi, J. Y., ... y Park, SH (2021). Síndrome nefrótico de nueva aparición después de la vacuna Janssen COVID-19: reporte de un caso y revisión de la literatura. Revista de ciencia médica coreana, 36(30). https://pubmed.ncbi.nlm.nih.gov/34601889/ | Somiya, M., Mine, S., Yasukawa, K., & Ikeda, S. (2021). Diferencias sexuales en la incidencia de anafilaxis a LNP-MRNA COVID-19 vacunas. Vacuna. https://pubmed.ncbi.nlm.nih.gov/33641264/ | Lim, J. H., Han, M. H., Kim, Y. J., Kim, M. S., Jung, H. Y., Choi, J. Y., ... & Park, S. H. (2021). New-onset nephrotic syndrome after Janssen COVID-19 vaccination: a case report and literature review. Journal of Korean Medical Science, 36(30). https://pubmed.ncbi.nlm.nih.gov/34342187/. | Starekova, J., Bluemke, D. A., Bradham, W. S., Grist, T. M., Schiebler, M. L., & Reeder, S. B. (2021). Myocarditis associated with mRNA COVID-19 vaccination. Radiology, 301(2), E409-E411. https://pubs.rsna.org/doi/10.1148/radiol.2021211430 | ||||||||
795 | Coronavirus disease vaccine 2019 (COVID-19) in systemic lupus erythematosus and neutrophil anti-cytoplasmic antibody-associated vasculitis: | https://pubmed.ncbi.nlm.nih.gov/33928459/ | https://pubmed.ncbi.nlm.nih.gov/34601889/ | Ganga, K., Solyar, A. Y., & Ganga, R. (2021). Massive Cervical Lymphadenopathy Post-COVID-19 Vaccination. Ear, Nose & Throat Journal, 01455613211048984. | Ganga, K., Solyar, AY y Ganga, R. (2021). Linfadenopatía cervical masiva posvacunación COVID-19. Diario de oído, nariz y garganta, 01455613211048984. https://pubmed.ncbi.nlm.nih.gov/34081948/ | SOOKAROMDEE, P., & WIWANITKIT, V. (2021). COVID-19 Vacuna, trombocitopenia trombótica inmune, ictericia, hipervissidad: preocupación por los casos con un problema hepático subyacente. Anales de hepatología, 24, 100525. https://pubmed.ncbi.nlm.nih.gov/34462996/ | Ganga, K., Solyar, A. Y., & Ganga, R. (2021). Massive Cervical Lymphadenopathy Post-COVID-19 Vaccination. Ear, Nose & Throat Journal, 01455613211048984. https://pubmed.ncbi.nlm.nih.gov/34601889/ | Starekova, J., Bluemke, D. A., Bradham, W. S., Grist, T. M., Schiebler, M. L., & Reeder, S. B. (2021). Myocarditis associated with mRNA COVID-19 vaccination. Radiology, 301(2), E409-E411. https://www.ncbi.nlm.nih.gov/pubmed/34282971 | ||||||||
796 | Reactivation of IgA vasculitis after COVID-19 vaccination: | https://pubmed.ncbi.nlm.nih.gov/34250509/ | https://pubmed.ncbi.nlm.nih.gov/34081948/ | Sekar, A., Campbell, R., Tabbara, J., & Rastogi, P. (2021). ANCA glomerulonephritis after the Moderna COVID-19 vaccination. Kidney international, 100(2), 473-474. | Sekar, A., Campbell, R., Tabbara, J. y Rastogi, P. (2021). Glomerulonefritis ANCA tras la vacunación Moderna COVID-19. Riñón internacional, 100(2), 473-474. https://pubmed.ncbi.nlm.nih.gov/34507942/. | Sørvoll, I. H. H., Horvei, K. D., Ernstsen, S. L., Lægreid, I. J., Lund, S., Grønli, R. H., ... & Ahlen, M. T. (2021). Un estudio observacional para identificar la prevalencia de trombocitopenia y anticuerpos anti-PF4 / Polyanión en los trabajadores de atención médica noruega después de la vacunación COVID-19. Diario de trombosis y haemostasis, 19 (7), 1813-1818. https://pubmed.ncbi.nlm.nih.gov/33981305/. | Sekar, A., Campbell, R., Tabbara, J., & Rastogi, P. (2021). ANCA glomerulonephritis after the Moderna COVID-19 vaccination. Kidney international, 100(2), 473-474. https://pubmed.ncbi.nlm.nih.gov/34081948/ | Stassi, C., Mondello, C., Baldino, G., Cardia, L., Asmundo, A., & Ventura Spagnolo, E. (2021). An Insight into the Role of Postmortem Immunohistochemistry in the Comprehension of the Inflammatory Pathophysiology of COVID-19 Disease and Vaccine-Related Thrombotic Adverse Events: A Narrative Review. International journal of molecular sciences, 22(21), 12024. https://pubmed.ncbi.nlm.nih.gov/34769454/ | ||||||||
797 | Clinical and histopathologic spectrum of delayed adverse skin reactions after COVID-19 vaccination: | https://pubmed.ncbi.nlm.nih.gov/34292611/. | https://pubmed.ncbi.nlm.nih.gov/34507942/. | Notghi, A. A., Atley, J., & Silva, M. (2021). Lessons of the month 1: Longitudinal extensive transverse myelitis following AstraZeneca COVID-19 vaccination. Clinical Medicine, 21(5), e535. | Notghi, AA, Atley, J. y Silva, M. (2021). Lecciones del mes 1: Mielitis transversa extensa longitudinal tras la vacunación con AstraZeneca COVID-19. Medicina clínica, 21(5), e535. https://pubmed.ncbi.nlm.nih.gov/34325221/ | Spinner, J. A., Julien, C. L., Olayinka, L., Dreyer, W. J., Bocchini, C. E., Muñoz, F. M., & Devaraj, S. (2022). Los anticuerpos anti-spike SARS-COV-2 después de la vacunación en el trasplante de corazón pediátrico: un primer informe. The Journal of Heart and Lung Transplantation, 41 (2), 133-136. https://www.ncbi.nlm.nih.gov/pubmed/34282971 | Notghi, A. A., Atley, J., & Silva, M. (2021). Lessons of the month 1: Longitudinal extensive transverse myelitis following AstraZeneca COVID-19 vaccination. Clinical Medicine, 21(5), e535. https://pubmed.ncbi.nlm.nih.gov/34507942/. | Strobel, D., Haberkamp, S., & Zundler, S. (2021). Portal Vein Thrombosis due to Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT) after Covid Vaccination with ChAdOx1 nCoV-19. Ultraschall in der Medizin-European Journal of Ultrasound, 42(05), 551-552. https://pubmed.ncbi.nlm.nih.gov/34598301/ | ||||||||
798 | First description of immune complex vasculitis after COVID-19 vaccination with BNT162b2: case report: | https://pubmed.ncbi.nlm.nih.gov/34530771/. | https://pubmed.ncbi.nlm.nih.gov/34325221/ | Plaza, M. J., Wright, J., & Fernandez, S. (2021). COVID-19 vaccine-related unilateral axillary lymphadenopathy: pattern on screening breast MRI allowing for a benign assessment. Clinical Imaging, 80, 139-141. | Plaza, M. J., Wright, J. y Fernández, S. (2021). Linfadenopatía axilar unilateral relacionada con la vacuna COVID-19: patrón en la resonancia magnética de mama que permite una evaluación benigna. Imágenes clínicas, 80, 139-141. https://pubmed.ncbi.nlm.nih.gov/34825530/. | Sriwastava, S., Shrestha, A. K., Khalid, S. H., Colantonio, M. A., NWAFOR, D., & SRIVASTAVA, S. (2021). Spectrum of Neuroimaging Hallazgos en la vacunación post-covid-19: una serie de casos y revisión de la literatura. Neurología Internacional, 13 (4), 622-639. https://pubmed.ncbi.nlm.nih.gov/34630307/ | Plaza, M. J., Wright, J., & Fernandez, S. (2021). COVID-19 vaccine-related unilateral axillary lymphadenopathy: pattern on screening breast MRI allowing for a benign assessment. Clinical Imaging, 80, 139-141. https://pubmed.ncbi.nlm.nih.gov/34325221/ | Su, P. H., Yu, Y. C., Chen, W. H., Lin, H. C., Chen, Y. T., Cheng, M. H., & Huang, Y. M. (2021). Case Report: Vaccine-Induced Immune Thrombotic Thrombocytopenia in a Pancreatic Cancer Patient After Vaccination With Messenger RNA− 1273. Frontiers in Medicine, 8. https://pubmed.ncbi.nlm.nih.gov/34790684/ | ||||||||
799 | Nephrotic syndrome and vasculitis after SARS-CoV-2 vaccine: true association or circumstantial: | https://pubmed.ncbi.nlm.nih.gov/34245294/. | https://pubmed.ncbi.nlm.nih.gov/34825530/. | Ashoor, A., Shephard, J., Lissidini, G., & Nicosia, L. (2021). Axillary adenopathy in patients with recent Covid-19 vaccination: a new diagnostic dilemma. Korean Journal of Radiology, 22(12), 2124. | Ashoor, A., Shephard, J., Lissidini, G. y Nicosia, L. (2021). Adenopatía axilar en pacientes con vacunación reciente contra Covid-19: un nuevo dilema diagnóstico. Revista Coreana de Radiología, 22(12), 2124. https://pubmed.ncbi.nlm.nih.gov/34000278/ | Starekova, J., Bluemke, D. A., Bradham, W. S., Grist, T. M., Schiebler, M. L., & Reeder, S. B. (2021). Miocarditis asociada con la vacunación con ARNm Covid-19. Radiología, 301 (2), E409-E411. https://pediatrics.aappublications.org/content/148/3/e2021052478 | Ashoor, A., Shephard, J., Lissidini, G., & Nicosia, L. (2021). Axillary adenopathy in patients with recent Covid-19 vaccination: a new diagnostic dilemma. Korean Journal of Radiology, 22(12), 2124. https://pubmed.ncbi.nlm.nih.gov/34825530/. | Sulemankhil, I., Abdelrahman, M., & Negi, S. I. (2021). Temporal association between the COVID-19 Ad26. COV2. S vaccine and acute myocarditis: a case report and literature review. Cardiovascular Revascularization Medicine. https://www.ncbi.nlm.nih.gov/pubmed/34420869 | ||||||||
800 | Occurrence of de novo cutaneous vasculitis after vaccination against coronavirus disease (COVID-19): | https://pubmed.ncbi.nlm.nih.gov/34599716/. | https://pubmed.ncbi.nlm.nih.gov/34000278/ | D’Agati, V. D., Kudose, S., Bomback, A. S., Adamidis, A., & Tartini, A. (2021). Minimal change disease and acute kidney injury following the Pfizer-BioNTech COVID-19 vaccine. Kidney international, 100(2), 461-463. | D'Agati, VD, Kudose, S., Bomback, A. S., Adamidis, A. y Tartini, A. (2021). Enfermedad de cambios mínimos y lesión renal aguda tras la vacuna Pfizer-BioNTech COVID-19. Riñón internacional, 100(2), 461-463. https://pubmed.ncbi.nlm.nih.gov/34655312/. | Starekova, J., Bluemke, D. A., Bradham, W. S., Grist, T. M., Schiebler, M. L., & Reeder, S. B. (2021). Miocarditis asociada con la vacunación con ARNm Covid-19. Radiología, 301 (2), E409-E411. https://www.ncbi.nlm.nih.gov/pubmed/34420869 | D’Agati, V. D., Kudose, S., Bomback, A. S., Adamidis, A., & Tartini, A. (2021). Minimal change disease and acute kidney injury following the Pfizer-BioNTech COVID-19 vaccine. Kidney international, 100(2), 461-463. https://pubmed.ncbi.nlm.nih.gov/34000278/ | Sulemankhil, I., Abdelrahman, M., & Negi, S. I. (2021). Temporal association between the COVID-19 Ad26. COV2. S vaccine and acute myocarditis: a case report and literature review. Cardiovascular Revascularization Medicine. https://www.sciencedirect.com/science/article/pii/S1553838921005789 | ||||||||
801 | Asymmetric cutaneous vasculitis after COVID-19 vaccination with unusual preponderance of eosinophils: | https://pubmed.ncbi.nlm.nih.gov/34115904/. | https://pubmed.ncbi.nlm.nih.gov/34655312/. | Igual-Rouilleault, A. C., Soriano, I., Quan, P. L., Fernández-Montero, A., Elizalde, A., & Pina, L. (2021). Unilateral axillary adenopathy induced by COVID-19 vaccine: US follow-up evaluation. European Radiology, 1-8. | Igual-Rouilleault, A. C., Soriano, I., Quan, P. L., Fernández-Montero, A., Elizalde, A., & Pina, L. (2021). Adenopatía axilar unilateral inducida por la vacuna COVID-19: evaluación de seguimiento en EE. UU. Radiología europea, 1-8. https://pubmed.ncbi.nlm.nih.gov/34187985/. | STASSI, C., MONDELLO, CA., BALDINO, G., CARDIA, L., ASMUNDO, A., Y VENTURA SPAGNOLO, E. (2021). Una visión sobre el papel de la inmunohistoquímica posmortem en la comprensión de la fisiopatología inflamatoria de la enfermedad de COVID-19 y los eventos adversos trombóticos relacionados con la vacuna: una revisión narrativa. Diario Internacional de Ciencias Moleculares, 22 (21), 12024. https://pubmed.ncbi.nlm.nih.gov/34786893/ | Igual-Rouilleault, A. C., Soriano, I., Quan, P. L., Fernández-Montero, A., Elizalde, A., & Pina, L. (2021). Unilateral axillary adenopathy induced by COVID-19 vaccine: US follow-up evaluation. European Radiology, 1-8. https://pubmed.ncbi.nlm.nih.gov/34655312/. | Sumi, T., Nagahisa, Y., Matsuura, K., Sekikawa, M., Yamada, Y., Nakata, H., & Chiba, H. (2021). Lung squamous cell carcinoma with hemoptysis after vaccination with tozinameran (BNT162b2, Pfizer‐BioNTech). Thoracic Cancer, 12(22), 3072-3075. https://pubmed.ncbi.nlm.nih.gov/34612003/ | ||||||||
802 | Henoch-Schönlein purpura occurring after vaccination with COVID-19: | https://pubmed.ncbi.nlm.nih.gov/34247902/. | https://pubmed.ncbi.nlm.nih.gov/34187985/. | Scott, J., Anderson, J., Mallak, N., Beitinjaneh, B., Wei, K., & Otaki, F. (2021). Gastroparesis After Pfizer-BioNTech COVID-19 Vaccination. Official journal of the American College of Gastroenterology| ACG, 116(11), 2300. | Scott, J., Anderson, J., Mallak, N., Beitinjaneh, B., Wei, K. y Otaki, F. (2021). Gastroparesia tras la vacunación contra el COVID-19 de Pfizer-BioNTech. Diario oficial del Colegio Americano de Gastroenterología | ACG, 116(11), 2300. https://www.ncbi.nlm.nih.gov/pubmed/34416319 | STROBEL, D., Haberkamp, S., & Zundler, S. (2021). La trombosis de la vena del portal debido a la trombocitopenia trombótica inmune inducida por la vacuna (VITT) después de la vacunación de COVID con CHADOX1 NCOV-19. Ultraschall en Der Medizin-European Journal of Ultrasonido, 42 (05), 551-552. https://pubmed.ncbi.nlm.nih.gov/34620638/ | Scott, J., Anderson, J., Mallak, N., Beitinjaneh, B., Wei, K., & Otaki, F. (2021). Gastroparesis After Pfizer-BioNTech COVID-19 Vaccination. Official journal of the American College of Gastroenterology| ACG, 116(11), 2300. https://pubmed.ncbi.nlm.nih.gov/34187985/. | Sung, J. G., Sobieszczyk, P. S., & Bhatt, D. L. (2021). Acute myocardial infarction within 24 hours after COVID-19 vaccination. The American Journal of Cardiology, 156, 129-131. https://pubmed.ncbi.nlm.nih.gov/34364657/. | ||||||||
803 | Henoch-Schönlein purpura following the first dose of COVID-19 viral vector vaccine: case report: | https://pubmed.ncbi.nlm.nih.gov/34696186/. | https://www.ncbi.nlm.nih.gov/pubmed/34416319 | Abbate, A., Gavin, J., Madanchi, N., Kim, C., Shah, P. R., Klein, K., ... & Danielides, S. (2021). Fulminant myocarditis and systemic hyperinflammation temporally associated with BNT162b2 mRNA COVID-19 vaccination in two patients. International Journal of Cardiology, 340, 119-121. | Abbate, A., Gavin, J., Madanchi, N., Kim, C., Shah, P. R., Klein, K., ... y Danielides, S. (2021). Miocarditis fulminante e hiperinflamación sistémica asociada temporalmente con la vacuna COVID-19 con ARNm de BNT162b2 en dos pacientes. Revista Internacional de Cardiología, 340, 119-121. https://www.ncbi.nlm.nih.gov/pubmed/34092429 | SU, P. H., Yu, Y. C., Chen, W. H., Lin, H. C., Chen, Y. T., Cheng, M. H., & Huang, Y. M. (2021). Informe de caso: trombocitopenia trombótica inmune inducida por la vacuna en un paciente de cáncer pancreático después de la vacunación con el Messenger RNA-1273. Fronteras en medicina, 8. https://pubmed.ncbi.nlm.nih.gov/33624509/. | Abbate, A., Gavin, J., Madanchi, N., Kim, C., Shah, P. R., Klein, K., ... & Danielides, S. (2021). Fulminant myocarditis and systemic hyperinflammation temporally associated with BNT162b2 mRNA COVID-19 vaccination in two patients. International Journal of Cardiology, 340, 119-121. https://www.ncbi.nlm.nih.gov/pubmed/34416319 | Syed, K., Chaudhary, H., & Donato, A. (2021). Central Venous Sinus Thrombosis with Subarachnoid Hemorrhage Following an mRNA COVID-19 Vaccination: Are These Reports Merely Co-Incidental?. The American journal of case reports, 22, e933397-1. https://pubmed.ncbi.nlm.nih.gov/34478433/ | ||||||||
804 | Granulomatous vasculitis after AstraZeneca anti-SARS-CoV-2 vaccine: | https://pubmed.ncbi.nlm.nih.gov/34237323/. | https://www.ncbi.nlm.nih.gov/pubmed/34092429 | Mouch, S. A., Roguin, A., Hellou, E., Ishai, A., Shoshan, U., Mahamid, L., ... & Yanay, N. B. (2021). Myocarditis following COVID-19 mRNA vaccination. Vaccine, 39(29), 3790-3793. | Mouch, S. A., Roguin, A., Hellou, E., Ishai, A., Shoshan, U., Mahamid, L., ... y Yanay, N. B. (2021). Miocarditis tras la vacunación con ARNm de COVID-19. Vacuna, 39(29), 3790-3793. https://www.ncbi.nlm.nih.gov/pubmed/34025885 | Subido, M. J., & Nuss, R. (2021). Trombocitopenia en un adolescente con enfermedad de células falciformes después de la vacunación COVID-19. Sangre pediátrico y cáncer. https://www.medrxiv.org/content/10.1101/2021.08.30.21262866v1 | Mouch, S. A., Roguin, A., Hellou, E., Ishai, A., Shoshan, U., Mahamid, L., ... & Yanay, N. B. (2021). Myocarditis following COVID-19 mRNA vaccination. Vaccine, 39(29), 3790-3793. https://www.ncbi.nlm.nih.gov/pubmed/34092429 | Tahir, N., Koorapati, G., Prasad, S., Jeelani, H. M., Sherchan, R., Shrestha, J., & Shayuk, M. (2021). SARS-CoV-2 vaccination-induced transverse myelitis. Cureus, 13(7). https://pubmed.ncbi.nlm.nih.gov/34458035/ | ||||||||
805 | Acute retinal necrosis due to varicella zoster virus reactivation after vaccination with BNT162b2 COVID-19 mRNA: | https://pubmed.ncbi.nlm.nih.gov/34851795/. | https://www.ncbi.nlm.nih.gov/pubmed/34025885 | Albert, E., Aurigemma, G., Saucedo, J., & Gerson, D. S. (2021). Myocarditis following COVID-19 vaccination. Radiology case reports, 16(8), 2142-2145. | Albert, E., Aurigemma, G., Saucedo, J. y Gerson, DS (2021). Miocarditis tras la vacunación COVID-19. Informes de casos de radiología, 16(8), 2142-2145. https://www.ncbi.nlm.nih.gov/pubmed/34586408 | Sulemankhil, I., Abdelrahman, M., & Negi, S. I. (2021). Asociación temporal entre el COVID-19 AD26. COV2. S Vacuna y miocarditis aguda: un informe de caso y revisión de la literatura. Medicina de revascularización cardiovascular. https://www.ncbi.nlm.nih.gov/pubmed/34514306 | Albert, E., Aurigemma, G., Saucedo, J., & Gerson, D. S. (2021). Myocarditis following COVID-19 vaccination. Radiology case reports, 16(8), 2142-2145. https://www.ncbi.nlm.nih.gov/pubmed/34025885 | Tailor, P. D., Feighery, A. M., El-Sabawi, B., & Prasad, A. (2021). Case report: acute myocarditis following the second dose of mRNA-1273 SARS-CoV-2 vaccine. European Heart Journal-Case Reports, 5(8), ytab319. https://academic.oup.com/ehjcr/article/5/8/ytab319/6339567 | ||||||||
806 | A case of generalized Sweet’s syndrome with vasculitis triggered by recent vaccination with COVID-19: | https://pubmed.ncbi.nlm.nih.gov/34849386/ | https://www.ncbi.nlm.nih.gov/pubmed/34586408 | Aye, Y. N., Mai, A. S., Zhang, A., Lim, O. Z. H., Lin, N., Ng, C. H., ... & Chew, N. W. (2021). Acute myocardial infarction and myocarditis following COVID-19 vaccination. QJM: An International Journal of Medicine. | Aye, Y. N., Mai, A. S., Zhang, A., Lim, O. Z. H., Lin, N., Ng, C. H., ... y Chew, N. W. (2021). Infarto agudo de miocardio y miocarditis tras la vacunación contra la COVID-19. QJM: Revista internacional de medicina. https://www.ncbi.nlm.nih.gov/pubmed/34756746 | Sulemankhil, I., Abdelrahman, M., & Negi, S. I. (2021). Asociación temporal entre el COVID-19 AD26. COV2. S Vacuna y miocarditis aguda: un informe de caso y revisión de la literatura. Medicina de revascularización cardiovascular. https://www.sciencedirect.com/science/article/pii/S1871402121002253 | Aye, Y. N., Mai, A. S., Zhang, A., Lim, O. Z. H., Lin, N., Ng, C. H., ... & Chew, N. W. (2021). Acute myocardial infarction and myocarditis following COVID-19 vaccination. QJM: An International Journal of Medicine. https://www.ncbi.nlm.nih.gov/pubmed/34586408 | Tailor, P. D., Feighery, A. M., El-Sabawi, B., & Prasad, A. (2021). Case report: acute myocarditis following the second dose of mRNA-1273 SARS-CoV-2 vaccine. European Heart Journal-Case Reports, 5(8), ytab319. https://pubmed.ncbi.nlm.nih.gov/34514306/ | ||||||||
807 | Small-vessel vasculitis following Oxford-AstraZeneca vaccination against SARS-CoV-2: | https://pubmed.ncbi.nlm.nih.gov/34310763/ | https://www.ncbi.nlm.nih.gov/pubmed/34756746 | Azir, M., Inman, B., Webb, J., & Tannenbaum, L. (2021). STEMI Mimic: Focal Myocarditis in an Adolescent Patient After mRNA COVID-19 Vaccine. The Journal of emergency medicine, 61(6), e129-e132. | Azir, M., Inman, B., Webb, J. y Tannenbaum, L. (2021). Imitación de STEMI: miocarditis focal en un paciente adolescente después de la vacuna de ARNm COVID-19. Revista de medicina de emergencia, 61(6), e129-e132. https://www.ncbi.nlm.nih.gov/pubmed/34432976 | Sumi, T., Nagahisa, Y., Matsuura, K., Sekikawa, M., Yamada, Y., Nakata, H., & Chiba, H. (2021). Carcinoma de células escamosas pulmonares con hemoptisis después de la vacunación con Tozinameran (BNT162B2, PFIZER-BIONTECH). Cáncer torácico, 12 (22), 3072-3075. https://pubmed.ncbi.nlm.nih.gov/34096082/ | Azir, M., Inman, B., Webb, J., & Tannenbaum, L. (2021). STEMI Mimic: Focal Myocarditis in an Adolescent Patient After mRNA COVID-19 Vaccine. The Journal of emergency medicine, 61(6), e129-e132. https://www.ncbi.nlm.nih.gov/pubmed/34756746 | Tailor, P. D., Feighery, A. M., El-Sabawi, B., & Prasad, A. (2021). Case report: acute myocarditis following the second dose of mRNA-1273 SARS-CoV-2 vaccine. European Heart Journal-Case Reports, 5(8), ytab319. https://www.ncbi.nlm.nih.gov/pubmed/34514306 | ||||||||
808 | Relapse of microscopic polyangiitis after COVID-19 vaccination: case report: | https://pubmed.ncbi.nlm.nih.gov/34251683/. | https://www.ncbi.nlm.nih.gov/pubmed/34432976 | Barda, N., Dagan, N., Ben-Shlomo, Y., Kepten, E., Waxman, J., Ohana, R., ... & Balicer, R. D. (2021). Safety of the BNT162b2 mRNA Covid-19 vaccine in a nationwide setting. New England Journal of Medicine. | Barda, N., Dagan, N., Ben-Shlomo, Y., Kepten, E., Waxman, J., Ohana, R., ... y Balicer, R. D. (2021). Seguridad de la vacuna BNT162b2 mRNA Covid-19 a nivel nacional. Revista de Medicina de Nueva Inglaterra. https://www.ncbi.nlm.nih.gov/pubmed/34754400 | Sung, J. G., Sobieszczyk, P. S., & Bhatt, D. L. (2021). Infarto agudo de miocardio dentro de las 24 horas posteriores a la vacunación COVID-19. El American Journal of Cardiology, 156, 129-131. https://pubmed.ncbi.nlm.nih.gov/34287612/ | Barda, N., Dagan, N., Ben-Shlomo, Y., Kepten, E., Waxman, J., Ohana, R., ... & Balicer, R. D. (2021). Safety of the BNT162b2 mRNA Covid-19 vaccine in a nationwide setting. New England Journal of Medicine. https://www.ncbi.nlm.nih.gov/pubmed/34432976 | Tajstra, M., Jaroszewicz, J., & Gąsior, M. (2021). Acute coronary tree thrombosis after vaccination for COVID-19. Cardiovascular Interventions, 14(9), e103-e104. https://www.sciencedirect.com/science/article/abs/pii/S1936879821003988 | ||||||||
809 | Cutaneous vasculitis after severe acute respiratory syndrome coronavirus 2 vaccine: | https://pubmed.ncbi.nlm.nih.gov/34557622/. | https://www.ncbi.nlm.nih.gov/pubmed/34754400 | Bhandari, M., Pradhan, A., Vishwakarma, P., & Sethi, R. (2021). Coronavirus and cardiovascular manifestations-getting to the heart of the matter. World Journal of Cardiology, 13(10), 556. | Bhandari, M., Pradhan, A., Vishwakarma, P. y Sethi, R. (2021). El coronavirus y las manifestaciones cardiovasculares: llegando al meollo de la cuestión. Revista Mundial de Cardiología, 13(10), 556. https://www.ncbi.nlm.nih.gov/pubmed/34281357 | Syed, K., Chaudhary, H., & Donato, A. (2021). Trombosis sinusal venosa central con hemorragia subaracnoidea después de una vacunación con MRNA COVID-19: ¿Son estos informes simplemente co-incidentales? El American Journal of Case informa, 22, E933397-1. https://pubmed.ncbi.nlm.nih.gov/34186376/ | Bhandari, M., Pradhan, A., Vishwakarma, P., & Sethi, R. (2021). Coronavirus and cardiovascular manifestations-getting to the heart of the matter. World Journal of Cardiology, 13(10), 556. https://www.ncbi.nlm.nih.gov/pubmed/34754400 | Takase, B., Hayashi, K., Hisada, T., Tsuchiya, T., Masaki, N., & Nagata, M. (2022). Chest Pain with New Abnormal Electrocardiogram Development after Injection of COVID-19 Vaccine Manufactured by Moderna. Internal Medicine, 8711-21. https://pubmed.ncbi.nlm.nih.gov/34866106/ | ||||||||
810 | Recurrent herpes zoster after COVID-19 vaccination in patients with chronic urticaria on cyclosporine treatment – A report of 3 cases: | https://pubmed.ncbi.nlm.nih.gov/34510694/ | https://www.ncbi.nlm.nih.gov/pubmed/34281357 | Bozkurt, B., Kamat, I., & Hotez, P. J. (2021). Myocarditis with COVID-19 mRNA vaccines. Circulation, 144(6), 471-484. | Bozkurt, B., Kamat, I. y Hotez, PJ (2021). Miocarditis con vacunas de ARNm de COVID-19. Circulación, 144(6), 471-484. https://www.ncbi.nlm.nih.gov/pubmed/34835284 | Tahir, N., Koorapati, G., Prasad, S., Jeelani, H. M., Sherchan, R., Shrestha, J., & Shayuk, M. (2021). Mielitis transversal inducida por la vacuna contra la vacuna contra el SARS-COV-2. CUREUS, 13 (7). https://pubmed.ncbi.nlm.nih.gov/33734623/ | Bozkurt, B., Kamat, I., & Hotez, P. J. (2021). Myocarditis with COVID-19 mRNA vaccines. Circulation, 144(6), 471-484. https://www.ncbi.nlm.nih.gov/pubmed/34281357 | Takeda, M., Ishio, N., Shoji, T., Mori, N., Matsumoto, M., & Shikama, N. (2021). Eosinophilic Myocarditis Following Coronavirus Disease 2019 (COVID-19) Vaccination. Circulation Journal, CJ-21. https://www.ncbi.nlm.nih.gov/pubmed/34955479 | ||||||||
811 | Leukocytoclastic vasculitis after coronavirus disease vaccination 2019: | https://pubmed.ncbi.nlm.nih.gov/34713472/803 | https://www.ncbi.nlm.nih.gov/pubmed/34835284 | Buchhorn, R., Meyer, C., Schulze-Forster, K., Junker, J., & Heidecke, H. (2021). Autoantibody Release in Children after Corona Virus mRNA Vaccination: A Risk Factor of Multisystem Inflammatory Syndrome?. Vaccines, 9(11), 1353. | Buchhorn, R., Meyer, C., Schulze-Forster, K., Junker, J. y Heidecke, H. (2021). Liberación de autoanticuerpos en niños después de la vacunación con ARNm del virus corona: ¿un factor de riesgo del síndrome inflamatorio multisistémico? Vacunas, 9(11), 1353. https://www.ncbi.nlm.nih.gov/pubmed/34366403 | Tajstra, M., Jaroszewicz, J., & Gąsior, M. (2021). Trombosis de árboles coronarios agudos después de la vacunación para COVID-19. Intervenciones cardiovasculares, 14 (9), E103-E104. https://pubmed.ncbi.nlm.nih.gov/33929487/ | Buchhorn, R., Meyer, C., Schulze-Forster, K., Junker, J., & Heidecke, H. (2021). Autoantibody Release in Children after Corona Virus mRNA Vaccination: A Risk Factor of Multisystem Inflammatory Syndrome?. Vaccines, 9(11), 1353. https://www.ncbi.nlm.nih.gov/pubmed/34835284 | Takeyama, R., Fukuda, K., Kouzaki, Y., Koga, T., Hayashi, S., Ohtani, H., & Inoue, T. (2022). Intracerebral hemorrhage due to vasculitis following COVID-19 vaccination: a case report. Acta neurochirurgica, 164(2), 543-547. https://pubmed.ncbi.nlm.nih.gov/34783899/ | ||||||||
812 | Outbreaks of mixed cryoglobulinemia vasculitis after vaccination against SARS-CoV-2: | https://pubmed.ncbi.nlm.nih.gov/34819272/ | https://www.ncbi.nlm.nih.gov/pubmed/34366403 | Calcaterra, G., Bassareo, P. P., Romeo, F., & Mehta, J. L. (2022). Concerning the unexpected prothrombotic state following some coronavirus disease 2019 vaccines. Journal of Cardiovascular Medicine, 23(2), 71-74. | Calcaterra, G., Bassareo, P. P., Romeo, F. y Mehta, JL (2022). Sobre el estado protrombótico inesperado después de algunas vacunas contra la enfermedad por coronavirus de 2019. Revista de Medicina Cardiovascular, 23(2), 71-74. https://www.ncbi.nlm.nih.gov/pubmed/34564344 | Takase, B., Hayashi, K., Hisada, T., Tsuchiya, T., Masaki, N., & Nagata, M. (2022). Dolor en el pecho con un nuevo desarrollo anormal electrocardiograma después de la inyección de la vacuna COVID-19 fabricada por Moderna. Medicina interna, 8711-21. https://pubmed.ncbi.nlm.nih.gov/34848416/ | Calcaterra, G., Bassareo, P. P., Romeo, F., & Mehta, J. L. (2022). Concerning the unexpected prothrombotic state following some coronavirus disease 2019 vaccines. Journal of Cardiovascular Medicine, 23(2), 71-74. https://www.ncbi.nlm.nih.gov/pubmed/34366403 | Tan, N. J. H., Tay, K. X. J., Wong, S. B. J., & Nga, M. E. (2021). COVID‐19 post‐vaccination lymphadenopathy: Report of cytological findings from fine needle aspiration biopsy. Diagnostic Cytopathology, 49(12), E467-E470. https://pubmed.ncbi.nlm.nih.gov/34432391/ | ||||||||
813 | Cutaneous small-vessel vasculitis after vaccination with a single dose of Janssen Ad26.COV2.S: | https://pubmed.ncbi.nlm.nih.gov/34337124/ | https://www.ncbi.nlm.nih.gov/pubmed/34564344 | Calcaterra, G., Mehta, J. L., De Gregorio, C., Butera, G., Neroni, P., Fanos, V., & Bassareo, P. P. (2021). COVID 19 vaccine for adolescents. Concern about myocarditis and pericarditis. Pediatric Reports, 13(3), 530-533. | Calcaterra, G., Mehta, J. L., De Gregorio, C., Butera, G., Neroni, P., Fanos, V. y Bassareo, P. P. (2021). Vacuna COVID 19 para adolescentes. Preocupación por la miocarditis y la pericarditis. Informes pediátricos, 13(3), 530-533. https://www.ncbi.nlm.nih.gov/pubmed/34617315 | Takeda, M., Ishio, N., SHOJI, T., MORI, N., MATSUMOTO, M., Y SHIKAMA, N. (2021). Miocarditis eosinofílica después de la enfermedad de la enfermedad de Coronavirus 2019 (COVID-19) vacunación. Diario de circulación, CJ-21. https://www.ncbi.nlm.nih.gov/pubmed/33444297 | Calcaterra, G., Mehta, J. L., De Gregorio, C., Butera, G., Neroni, P., Fanos, V., & Bassareo, P. P. (2021). COVID 19 vaccine for adolescents. Concern about myocarditis and pericarditis. Pediatric Reports, 13(3), 530-533. https://www.ncbi.nlm.nih.gov/pubmed/34564344 | Tan, W. Y., Yusof Khan, A. H. K., Mohd Yaakob, M. N., Abdul Rashid, A. M., Loh, W. C., Baharin, J., ... & Hoo, F. K. (2021). Longitudinal extensive transverse myelitis following ChAdOx1 nCOV-19 vaccine: a case report. BMC neurology, 21(1), 1-4. https://pubmed.ncbi.nlm.nih.gov/34641797/. | ||||||||
814 | Case of immunoglobulin A vasculitis after vaccination against coronavirus disease 2019: | https://pubmed.ncbi.nlm.nih.gov/34535924/ | https://www.ncbi.nlm.nih.gov/pubmed/34617315 | Chai, Q., Nygaard, U., Schmidt, R. C., Zaremba, T., Møller, A. M., & Thorvig, C. M. (2022). Multisystem inflammatory syndrome in a male adolescent after his second Pfizer‐BioNTech COVID‐19 vaccine. Acta Paediatrica, 111(1), 125-127. | Chai, Q., Nygaard, U., Schmidt, R. C., Zaremba, T., Møller, A. M. y Thorvig, C. M. (2022). Síndrome inflamatorio multisistémico en un adolescente varón después de su segunda vacuna Pfizer‐BioNTech COVID‐19. Acta Paediatrica, 111(1), 125-127. https://www.ncbi.nlm.nih.gov/pubmed/34333695 | Takeyama, R., Fukuda, K., Kouzaki, Y., Koga, T., Hayashi, S., Ohtani, H., e Inoue, T. (2022). Hemorragia intracerebral Debido a la vasculitis después de la vacunación COVID-19: un informe de caso. ACTA Neurochirurgica, 164 (2), 543-547. https://pubmed.ncbi.nlm.nih.gov/34549178/. | Chai, Q., Nygaard, U., Schmidt, R. C., Zaremba, T., Møller, A. M., & Thorvig, C. M. (2022). Multisystem inflammatory syndrome in a male adolescent after his second Pfizer‐BioNTech COVID‐19 vaccine. Acta Paediatrica, 111(1), 125-127. https://www.ncbi.nlm.nih.gov/pubmed/34617315 | Tano, E., San Martin, S., Girgis, S., Martinez-Fernandez, Y., & Sanchez Vegas, C. (2021). Perimyocarditis in adolescents after Pfizer-BioNTech COVID-19 vaccine. Journal of the Pediatric Infectious Diseases Society, 10(10), 962-966. https://academic.oup.com/jpids/advance-article/doi/10.1093/jpids/piab060/6329543 | ||||||||
815 | Rapid progression of angioimmunoblastic T-cell lymphoma after BNT162b2 mRNA booster vaccination: case report: | https://www.frontiersin.org/articles/10.3389/fmed.2021.798095/ | https://www.ncbi.nlm.nih.gov/pubmed/34333695 | Chamling, B., Vehof, V., Drakos, S., Weil, M., Stalling, P., Vahlhaus, C., ... & Yilmaz, A. (2021). Occurrence of acute infarct-like myocarditis following COVID-19 vaccination: just an accidental co-incidence or rather vaccination-associated autoimmune myocarditis?. Clinical Research in Cardiology, 110(11), 1850-1854. | Chamling, B., Vehof, V., Drakos, S., Weil, M., Stalling, P., Vahlhaus, C., ... y Yilmaz, A. (2021). Aparición de miocarditis aguda similar a un infarto después de la vacunación COVID-19: ¿solo una coincidencia accidental o más bien una miocarditis autoinmune asociada a la vacunación? Investigación clínica en cardiología, 110(11), 1850-1854. https://www.ncbi.nlm.nih.gov/pubmed/34833382 | Tan, N. J. H., Tay, K. X. J., Wong, S. B. J., & NGA, M. E. (2021). COVID-19 Linfadenopatía post-vacunación: Informe de hallazgos citológicos de la biopsia de aspiración de aguja fina. Citopatología diagnóstica, 49 (12), E467-E470. https://pubmed.ncbi.nlm.nih.gov/34731748/ | Chamling, B., Vehof, V., Drakos, S., Weil, M., Stalling, P., Vahlhaus, C., ... & Yilmaz, A. (2021). Occurrence of acute infarct-like myocarditis following COVID-19 vaccination: just an accidental co-incidence or rather vaccination-associated autoimmune myocarditis?. Clinical Research in Cardiology, 110(11), 1850-1854. https://www.ncbi.nlm.nih.gov/pubmed/34333695 | Tano, E., San Martin, S., Girgis, S., Martinez-Fernandez, Y., & Sanchez Vegas, C. (2021). Perimyocarditis in adolescents after Pfizer-BioNTech COVID-19 vaccine. Journal of the Pediatric Infectious Diseases Society, 10(10), 962-966. https://academic.oup.com/jpids/article/10/10/962/6329543. | ||||||||
816 | COVID-19 mRNA vaccination-induced lymphadenopathy mimics lymphoma progression on FDG PET / CT: | https://pubmed.ncbi.nlm.nih.gov/33591026/ | https://www.ncbi.nlm.nih.gov/pubmed/34833382 | Chang, J. C., & Hawley, H. B. (2021). Vaccine-Associated Thrombocytopenia and Thrombosis: Venous Endotheliopathy Leading to Venous Combined Micro-Macrothrombosis. Medicina, 57(11), 1163. | Chang, JC y Hawley, HB (2021). Trombocitopenia y trombosis asociadas a vacunas: endoteliopatía venosa que conduce a micromacrotrombosis venosa combinada. Medicina, 57(11), 1163. https://www.ncbi.nlm.nih.gov/pubmed/34704459 | Tan, W. Y., Yusof Khan, A. H. K., MOHD YAAKOB, M. N., Abdul Rashid, A. M., LOH, W. C., Baharin, J., ... & Hou, F. K. (2021). Mielitis transversal extensa longitudinal después de la vacuna Chadox1 NCOV-19: un informe de caso. Neurología BMC, 21 (1), 1-4. https://pubmed.ncbi.nlm.nih.gov/34812326/. | Chang, J. C., & Hawley, H. B. (2021). Vaccine-Associated Thrombocytopenia and Thrombosis: Venous Endotheliopathy Leading to Venous Combined Micro-Macrothrombosis. Medicina, 57(11), 1163. https://www.ncbi.nlm.nih.gov/pubmed/34833382 | Tano, E., San Martin, S., Girgis, S., Martinez-Fernandez, Y., & Sanchez Vegas, C. (2021). Perimyocarditis in adolescents after Pfizer-BioNTech COVID-19 vaccine. Journal of the Pediatric Infectious Diseases Society, 10(10), 962-966. https://pubmed.ncbi.nlm.nih.gov/34319393/ | ||||||||
817 | Lymphadenopathy in COVID-19 vaccine recipients: diagnostic dilemma in oncology patients: | https://pubmed.ncbi.nlm.nih.gov/33625300/ | https://www.ncbi.nlm.nih.gov/pubmed/34704459 | Chelala, L., Jeudy, J., Hossain, R., Rosenthal, G., Pietris, N., & White, C. (2021). Cardiac MRI findings of myocarditis after COVID-19 mRNA vaccination in adolescents. American Journal of Roentgenology. | Chelala, L., Jeudy, J., Hossain, R., Rosenthal, G., Pietris, N. y White, C. (2021). Hallazgos de miocarditis en la resonancia magnética cardíaca después de la vacunación con ARNm de COVID-19 en adolescentes. Revista Estadounidense de Roentgenología. https://www.ncbi.nlm.nih.gov/pubmed/34664804 | Tano, E., San Martin, S., Girgis, S., Martinez-Fernández, Y., & Sánchez Vegas, C. (2021). Perimyocarditis en adolescentes después de la vacuna Pfizer-Biontech Covid-19. Diario de la Sociedad Pediátrica de Enfermedades Infecciosas, 10 (10), 962-966. https://ecevr.org/DOIx.php?id=10.7774/cevr.2021.10.2.196. | Chelala, L., Jeudy, J., Hossain, R., Rosenthal, G., Pietris, N., & White, C. (2021). Cardiac MRI findings of myocarditis after COVID-19 mRNA vaccination in adolescents. American Journal of Roentgenology. https://www.ncbi.nlm.nih.gov/pubmed/34704459 | Tarawneh, O., & Tarawneh, H. (2021). Immune thrombocytopenia in a 22‐year‐old post Covid‐19 vaccine. American journal of hematology. https://pubmed.ncbi.nlm.nih.gov/33476455/ | ||||||||
818 | Hypermetabolic lymphadenopathy after administration of BNT162b2 mRNA vaccine Covid-19: incidence assessed by [ 18 F] FDG PET-CT and relevance for study interpretation: | https://pubmed.ncbi.nlm.nih.gov/33774684/ | https://www.ncbi.nlm.nih.gov/pubmed/34664804 | Choi, S., Lee, S., Seo, J. W., Kim, M. J., Jeon, Y. H., Park, J. H., ... & Yeo, N. S. (2021). Myocarditis-induced sudden death after BNT162b2 mRNA COVID-19 vaccination in Korea: Case report focusing on histopathological findings. Journal of Korean medical science, 36(40). | Choi, S., Lee, S., Seo, JW, Kim, M. J., Jeon, YH, Park, JH, ... y Yeo, NS (2021). Muerte súbita inducida por miocarditis después de la vacunación contra el COVID-19 con ARNm de BNT162b2 en Corea: informe de un caso centrado en los hallazgos histopatológicos. Revista de ciencia médica coreana, 36(40). https://www.ncbi.nlm.nih.gov/pubmed/34860360 | Tano, E., San Martin, S., Girgis, S., Martinez-Fernández, Y., & Sánchez Vegas, C. (2021). Perimyocarditis en adolescentes después de la vacuna Pfizer-Biontech Covid-19. Diario de la Sociedad Pediátrica de Enfermedades Infecciosas, 10 (10), 962-966. https://pubmed.ncbi.nlm.nih.gov/34312010/ | Choi, S., Lee, S., Seo, J. W., Kim, M. J., Jeon, Y. H., Park, J. H., ... & Yeo, N. S. (2021). Myocarditis-induced sudden death after BNT162b2 mRNA COVID-19 vaccination in Korea: Case report focusing on histopathological findings. Journal of Korean medical science, 36(40). https://www.ncbi.nlm.nih.gov/pubmed/34664804 | Taylor, P., Allen, L., Shrikrishnapalasuriyar, N., Stechman, M., & Rees, A. (2021). Vaccine‐induced thrombosis and thrombocytopenia with bilateral adrenal haemorrhage. Clinical Endocrinology. https://pubmed.ncbi.nlm.nih.gov/34235757/. | ||||||||
819 | Lymphadenopathy after COVID-19 vaccination: review of imaging findings: | https://pubmed.ncbi.nlm.nih.gov/33985872/ | https://www.ncbi.nlm.nih.gov/pubmed/34860360 | Chouchana, L., Blet, A., Al‐Khalaf, M., Kafil, T. S., Nair, G., Robblee, J., ... & Liu, P. P. (2022). Features of Inflammatory Heart Reactions Following mRNA COVID‐19 Vaccination at a Global Level. Clinical Pharmacology & Therapeutics. | Chouchana, L., Blet, A., Al‐Khalaf, M., Kafil, T. S., Nair, G., Robblee, J., ... y Liu, P. P. (2022). Características de las reacciones inflamatorias del corazón después de la vacunación con ARNm contra la COVID-19 a nivel mundial. Farmacología clínica y terapéutica. https://www.ncbi.nlm.nih.gov/pubmed/34849657 | Tano, E., San Martin, S., Girgis, S., Martinez-Fernández, Y., & Sánchez Vegas, C. (2021). Perimyocarditis en adolescentes después de la vacuna Pfizer-Biontech Covid-19. Diario de la Sociedad Pediátrica de Enfermedades Infecciosas, 10 (10), 962-966. https://pubmed.ncbi.nlm.nih.gov/34589238/ | Chouchana, L., Blet, A., Al‐Khalaf, M., Kafil, T. S., Nair, G., Robblee, J., ... & Liu, P. P. (2022). Features of Inflammatory Heart Reactions Following mRNA COVID‐19 Vaccination at a Global Level. Clinical Pharmacology & Therapeutics. https://www.ncbi.nlm.nih.gov/pubmed/34860360 | Thachil, J. (2021, October). COVID-19 vaccine-induced immune thrombosis with thrombocytopenia (VITT) and the shades of grey in thrombus formation. In Seminars in thrombosis and hemostasis. Thieme Medical Publishers, Inc.. https://pubmed.ncbi.nlm.nih.gov/34624910/ | ||||||||
820 | Evolution of bilateral hypermetabolic axillary hypermetabolic lymphadenopathy on FDG PET/CT after 2-dose COVID-19 vaccination: | https://pubmed.ncbi.nlm.nih.gov/34735411/ | https://www.ncbi.nlm.nih.gov/pubmed/34849657 | Chua, G. T., Kwan, M. Y. W., Chui, C. S., Smith, R. D., Cheung, E. C. L., Tian, T., ... & Ip, P. (2021). Epidemiology of Acute Myocarditis/Pericarditis in Hong Kong Adolescents Following Comirnaty Vaccination. Clinical Infectious Diseases. | Chua, G. T., Kwan, M. Y. W., Chui, C. S., Smith, R. D., Cheung, E. C. L., Tian, T., ... & Ip, P. (2021). Epidemiología de la miocarditis/pericarditis aguda en adolescentes de Hong Kong después de la vacunación comunitaria. Enfermedades Infecciosas Clínicas. https://www.ncbi.nlm.nih.gov/pubmed/34933012 | Tarawneh, O., y Tarawneh, H. (2021). Trombocitopenia inmune en una vacuna postal de 22 años de edad-19. American Journal of Hematology. https://pubmed.ncbi.nlm.nih.gov/34451967/ | Chua, G. T., Kwan, M. Y. W., Chui, C. S., Smith, R. D., Cheung, E. C. L., Tian, T., ... & Ip, P. (2021). Epidemiology of Acute Myocarditis/Pericarditis in Hong Kong Adolescents Following Comirnaty Vaccination. Clinical Infectious Diseases. https://www.ncbi.nlm.nih.gov/pubmed/34849657 | Theuriet, J., Richard, C., Becker, J., Pegat, A., Bernard, E., & Vukusic, S. (2021). Guillain-Barré syndrome following first injection of ChAdOx1 nCoV-19 vaccine: First report. Revue neurologique, 177(10), 1305-1307. https://pubmed.ncbi.nlm.nih.gov/34217513/. | ||||||||
821 | Lymphadenopathy associated with COVID-19 vaccination on FDG PET/CT: distinguishing features in adenovirus-vectored vaccine: | https://pubmed.ncbi.nlm.nih.gov/34115709/. | https://www.ncbi.nlm.nih.gov/pubmed/34933012 | Clarke, R., Ioannou, A., Katz, T. A., Vliegenthart, R. J. S., Aarnoudse-Moens, C. S. H., Wilms, J., ... & Kilbride, H. (2021). Should T2 mapping be used in cases of recurrent myocarditis to differentiate between the acute inflammation and chronic scar?. The Journal of pediatrics. | Clarke, R., Ioannou, A., Katz, T. A., Vliegenthart, R. J. S., Aarnoudse-Moens, C. S. H., Wilms, J., ... y Kilbride, H. (2021). ¿Debería utilizarse el mapeo T2 en casos de miocarditis recurrente para diferenciar entre la inflamación aguda y la cicatriz crónica? La revista de pediatría. https://www.ncbi.nlm.nih.gov/pubmed/34547487 | Taylor, P., Allen, L., Shrikrishnapalasuriyar, N., Stechman, M., & Rees, A. (2021). Trombosis inducida por la vacuna y trombocitopenia con hemorragia adrenal bilateral. Endocrinología clínica. https://pubmed.ncbi.nlm.nih.gov/34473841/. | Clarke, R., Ioannou, A., Katz, T. A., Vliegenthart, R. J. S., Aarnoudse-Moens, C. S. H., Wilms, J., ... & Kilbride, H. (2021). Should T2 mapping be used in cases of recurrent myocarditis to differentiate between the acute inflammation and chronic scar?. The Journal of pediatrics. https://www.ncbi.nlm.nih.gov/pubmed/34933012 | Theuriet, J., Richard, C., Becker, J., Pegat, A., Bernard, E., & Vukusic, S. (2021). Guillain-Barré syndrome following first injection of ChAdOx1 nCoV-19 vaccine: First report. Revue neurologique, 177(10), 1305-1307. https://www.sciencedirect.com/science/article/pii/S0035378721005853. | ||||||||
822 | COVID-19 vaccination-induced lymphadenopathy in a specialized breast imaging clinic in Israel: analysis of 163 cases: | https://pubmed.ncbi.nlm.nih.gov/34257025/. | https://www.ncbi.nlm.nih.gov/pubmed/34547487 | Colaneri, M., De Filippo, M., Licari, A., Marseglia, A., Maiocchi, L., Ricciardi, A., ... & Bruno, R. (2021). COVID vaccination and asthma exacerbation: might there be a link?. International Journal of Infectious Diseases, 112, 243-246. | Colaneri, M., De Filippo, M., Licari, A., Marseglia, A., Maiocchi, L., Ricciardi, A., ... & Bruno, R. (2021). Vacunación COVID y exacerbación del asma: ¿podría haber un vínculo? Revista Internacional de Enfermedades Infecciosas, 112, 243-246. https://www.ncbi.nlm.nih.gov/pubmed/34339728 | Tesuriet, J., Richard, C., Becker, J., PEGAT, A., Bernard, E., y Vukusic, S. (2021). Síndrome de Guillain-Barré después de la primera inyección de la vacuna Chadox1 NCOV-19: Primer informe. Revue Neurologique, 177 (10), 1305-1307. https://pubmed.ncbi.nlm.nih.gov/34871447/ | Colaneri, M., De Filippo, M., Licari, A., Marseglia, A., Maiocchi, L., Ricciardi, A., ... & Bruno, R. (2021). COVID vaccination and asthma exacerbation: might there be a link?. International Journal of Infectious Diseases, 112, 243-246. https://www.ncbi.nlm.nih.gov/pubmed/34547487 | Thompson, M. G., Burgess, J. L., Naleway, A. L., Tyner, H., Yoon, S. K., Meece, J., ... & Gaglani, M. (2021). Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines. New England Journal of Medicine, 385(4), 320-329. https://www.ncbi.nlm.nih.gov/pubmed/34192428 | ||||||||
823 | COVID-19 vaccine-related axillary lymphadenopathy in breast cancer patients: case series with literature review: | https://pubmed.ncbi.nlm.nih.gov/34836672/. | https://www.ncbi.nlm.nih.gov/pubmed/34339728 | Das, B. B., Kohli, U., Ramachandran, P., Nguyen, H. H., Greil, G., Hussain, T., ... & Khan, D. (2021). Myopericarditis after messenger RNA coronavirus disease 2019 vaccination in adolescents 12 to 18 years of age. The Journal of Pediatrics, 238, 26-32. | Das, B. B., Kohli, U., Ramachandran, P., Nguyen, H. H., Greil, G., Hussain, T., ... y Khan, D. (2021). Miopericarditis tras la vacunación contra la enfermedad por coronavirus de ARN mensajero 2019 en adolescentes de 12 a 18 años. La Revista de Pediatría, 238, 26-32. https://www.ncbi.nlm.nih.gov/pubmed/34356586 | Tesuriet, J., Richard, C., Becker, J., PEGAT, A., Bernard, E., y Vukusic, S. (2021). Síndrome de Guillain-Barré después de la primera inyección de la vacuna Chadox1 NCOV-19: Primer informe. Revue Neurologique, 177 (10), 1305-1307. https://www.sciencedirect.com/science/article/pii/S2049080121005343 | Das, B. B., Kohli, U., Ramachandran, P., Nguyen, H. H., Greil, G., Hussain, T., ... & Khan, D. (2021). Myopericarditis after messenger RNA coronavirus disease 2019 vaccination in adolescents 12 to 18 years of age. The Journal of Pediatrics, 238, 26-32. https://www.ncbi.nlm.nih.gov/pubmed/34339728 | Tiede, A., Sachs, U. J., Czwalinna, A., Werwitzke, S., Bikker, R., Krauss, J. K., ... & Ganser, A. (2021). Prothrombotic immune thrombocytopenia after COVID-19 vaccination. Blood, The Journal of the American Society of Hematology, 138(4), 350-353. https://www.sciencedirect.com/science/article/pii/S0006497121009411 | ||||||||
824 | Coronavirus disease vaccine 2019 mimics lymph node metastases in patients undergoing skin cancer follow-up: a single-center study: | https://pubmed.ncbi.nlm.nih.gov/34280870/ | https://www.ncbi.nlm.nih.gov/pubmed/34356586 | Das, B. B., Moskowitz, W. B., Taylor, M. B., & Palmer, A. (2021). Myocarditis and pericarditis following mRNA COVID-19 vaccination: what do we know so far?. Children, 8(7), 607. | Das, B. B., Moskowitz, W. B., Taylor, M. B. y Palmer, A. (2021). Miocarditis y pericarditis tras la vacunación con ARNm COVID-19: ¿qué sabemos hasta ahora? Niños, 8(7), 607. https://www.ncbi.nlm.nih.gov/pubmed/34219532 | Thachil, J. (2021, octubre). COVID-19 trombosis inmune inducida por la vacuna con trombocitopenia (VITT) y los tonos de gris en formación de trombo. En seminarios en trombosis y hemostasia. Thieme Medical Publishers, Inc .. https://pubmed.ncbi.nlm.nih.gov/34585145/ | Das, B. B., Moskowitz, W. B., Taylor, M. B., & Palmer, A. (2021). Myocarditis and pericarditis following mRNA COVID-19 vaccination: what do we know so far?. Children, 8(7), 607. https://www.ncbi.nlm.nih.gov/pubmed/34356586 | Tinoco, M., Leite, S., Faria, B., Cardoso, S., Von Hafe, P., Dias, G., ... & Lourenço, A. (2021). Perimyocarditis Following COVID-19 Vaccination. Clinical Medicine Insights: Cardiology, 15, 11795468211056634. https://pubmed.ncbi.nlm.nih.gov/34866957/ | ||||||||
825 | COVID-19 post-vaccination lymphadenopathy: report of fine-needle aspiration biopsy cytologic findings: | https://pubmed.ncbi.nlm.nih.gov/34432391/ | https://www.ncbi.nlm.nih.gov/pubmed/34219532 | Deb, A., Abdelmalek, J., Iwuji, K., & Nugent, K. (2021). Acute myocardial injury following COVID-19 vaccination: a case report and review of current evidence from vaccine adverse events reporting system database. Journal of primary care & community health, 12, 21501327211029230. | Deb, A., Abdelmalek, J., Iwuji, K. y Nugent, K. (2021). Lesión miocárdica aguda después de la vacunación COVID-19: informe de un caso y revisión de la evidencia actual de la base de datos del sistema de notificación de eventos adversos de la vacuna. Revista de atención primaria y salud comunitaria, 12, 21501327211029230. https://www.ncbi.nlm.nih.gov/pubmed/34246585 | Thompson, M. G., Burgess, J. L., Naleway, A. L., Tyner, H., Yoon, S. K., Meece, J., ... & Gaglani, M. (2021). Prevención y atenuación de COVID-19 con las vacunas BNT162B2 y MRNA-1273. New England Journal of Medicine, 385 (4), 320-329. https://www.ncbi.nlm.nih.gov/pubmed/34866957 | Deb, A., Abdelmalek, J., Iwuji, K., & Nugent, K. (2021). Acute myocardial injury following COVID-19 vaccination: a case report and review of current evidence from vaccine adverse events reporting system database. Journal of primary care & community health, 12, 21501327211029230. https://www.ncbi.nlm.nih.gov/pubmed/34219532 | Tinoco, M., Leite, S., Faria, B., Cardoso, S., Von Hafe, P., Dias, G., ... & Lourenço, A. (2021). Perimyocarditis Following COVID-19 Vaccination. Clinical Medicine Insights: Cardiology, 15, 11795468211056634. https://www.ncbi.nlm.nih.gov/pubmed/34866957 | ||||||||
826 | Regional lymphadenopathy after COVID-19 vaccination: review of the literature and considerations for patient management in breast cancer care: | https://pubmed.ncbi.nlm.nih.gov/34731748/ | https://www.ncbi.nlm.nih.gov/pubmed/34246585 | Dickey, J. B., Albert, E., Badr, M., Laraja, K. M., Sena, L. M., Gerson, D. S., ... & Aurigemma, G. P. (2021). A series of patients with myocarditis following SARS-CoV-2 vaccination with mRNA-1279 and BNT162b2. Cardiovascular Imaging, 14(9), 1862-1863. | Dickey, J. B., Albert, E., Badr, M., Laraja, K. M., Sena, L. M., Gerson, D. S., ... & Aurigemma, G. P. (2021). Una serie de pacientes con miocarditis después de la vacunación contra el SARS-CoV-2 con mRNA-1279 y BNT162b2. Imágenes cardiovasculares, 14(9), 1862-1863. https://www.ncbi.nlm.nih.gov/pubmed/34492161 | Tiede, A., Sachs, U. J., Czwalinna, A., Werwitzke, S., Bikker, R., Krauss, J. K., ... & Ganser, A. (2021). Trombocitopenia inmune protrombótica después de la vacunación de COVID-19. Sangre, la revista de la Sociedad Americana de Hematología, 138 (4), 350-353. https://www.sciencedirect.com/science/article/pii/S2589936821000256 | Dickey, J. B., Albert, E., Badr, M., Laraja, K. M., Sena, L. M., Gerson, D. S., ... & Aurigemma, G. P. (2021). A series of patients with myocarditis following SARS-CoV-2 vaccination with mRNA-1279 and BNT162b2. Cardiovascular Imaging, 14(9), 1862-1863. https://www.ncbi.nlm.nih.gov/pubmed/34246585 | Tobaiqy, M., MacLure, K., Elkout, H., & Stewart, D. (2021). Thrombotic adverse events reported for Moderna, Pfizer and Oxford-AstraZeneca COVID-19 vaccines: comparison of occurrence and clinical outcomes in the EudraVigilance database. Vaccines, 9(11), 1326. https://pubmed.ncbi.nlm.nih.gov/34835256/ | ||||||||
827 | Subclinical axillary lymphadenopathy associated with COVID-19 vaccination on screening mammography: | https://pubmed.ncbi.nlm.nih.gov/34906409/ | https://www.ncbi.nlm.nih.gov/pubmed/34492161 | Dimopoulou, D., Spyridis, N., Vartzelis, G., Tsolia, M. N., & Maritsi, D. N. (2021). Safety and tolerability of the COVID-19 mRNA-vaccine in adolescents with juvenile idiopathic arthritis on treatment with TNF-inhibitors. Arthritis & Rheumatology (Hoboken, NJ). | Dimopoulou, D., Spyridis, N., Vartzelis, G., Tsolia, M. N. y Maritsi, D. N. (2021). Seguridad y tolerabilidad de la vacuna de ARNm COVID-19 en adolescentes con artritis idiopática juvenil en tratamiento con inhibidores del TNF. Artritis y reumatología (Hoboken, Nueva Jersey). https://www.ncbi.nlm.nih.gov/pubmed/34844930 | TINOCO, M., Leite, S., Faria, B., Cardoso, S., Von Hefe, P., Dias, G., ... & Lourenço, A. (2021). Perimyocarditis después de la vacunación COVID-19. Insights de la medicina clínica: cardiología, 15, 11795468211056634. https://pubmed.ncbi.nlm.nih.gov/34849657/. | Dimopoulou, D., Spyridis, N., Vartzelis, G., Tsolia, M. N., & Maritsi, D. N. (2021). Safety and tolerability of the COVID-19 mRNA-vaccine in adolescents with juvenile idiopathic arthritis on treatment with TNF-inhibitors. Arthritis & Rheumatology (Hoboken, NJ). https://www.ncbi.nlm.nih.gov/pubmed/34492161 | Toida, R., Uezono, S., Komatsu, H., Toida, T., Imamura, A., Fujimoto, S., & Kaikita, K. (2021). Takotsubo cardiomyopathy after vaccination for coronavirus disease 2019 in a patient on maintenance hemodialysis. CEN Case Reports, 1-5. https://pubmed.ncbi.nlm.nih.gov/34731486/. | ||||||||
828 | Adverse events of COVID injection that may occur in children.Acute-onset supraclavicular lymphadenopathy coincident with intramuscular mRNA vaccination against COVID-19 may be related to the injection technique of the vaccine, Spain, January and February 2021: | https://pubmed.ncbi.nlm.nih.gov/33706861/ | https://www.ncbi.nlm.nih.gov/pubmed/34844930 | Dimopoulou, D., Vartzelis, G., Dasoula, F., Tsolia, M., & Maritsi, D. (2022). Immunogenicity of the COVID-19 mRNA vaccine in adolescents with juvenile idiopathic arthritis on treatment with TNF inhibitors. Annals of the Rheumatic Diseases, 81(4), 592-593. | Dimopoulou, D., Vartzelis, G., Dasoula, F., Tsolia, M. y Maritsi, D. (2022). Inmunogenicidad de la vacuna de ARNm de COVID-19 en adolescentes con artritis idiopática juvenil en tratamiento con inhibidores del TNF. Anales de las enfermedades reumáticas, 81(4), 592-593. https://www.ncbi.nlm.nih.gov/pubmed/34487236 | TINOCO, M., Leite, S., Faria, B., Cardoso, S., Von Hefe, P., Dias, G., ... & Lourenço, A. (2021). Perimyocarditis después de la vacunación COVID-19. Insights de la medicina clínica: cardiología, 15, 11795468211056634. https://www.ncbi.nlm.nih.gov/pubmed/34865500 | Dimopoulou, D., Vartzelis, G., Dasoula, F., Tsolia, M., & Maritsi, D. (2022). Immunogenicity of the COVID-19 mRNA vaccine in adolescents with juvenile idiopathic arthritis on treatment with TNF inhibitors. Annals of the Rheumatic Diseases, 81(4), 592-593. https://www.ncbi.nlm.nih.gov/pubmed/34844930 | Tølbøll Sørensen, A. L., Rolland, M., Hartmann, J., Harboe, Z. B., Roed, C., Jensen, T. Ø., ... & Stensballe, J. (2021). A case of thrombocytopenia and multiple thromboses after vaccination with ChAdOx1 nCoV-19 against SARS-CoV-2. Blood Advances, 5(12), 2569-2574. https://pubmed.ncbi.nlm.nih.gov/34137813/ | ||||||||
829 | Supraclavicular lymphadenopathy after COVID-19 vaccination in Korea: serial follow-up by ultrasonography: | https://pubmed.ncbi.nlm.nih.gov/34116295/ | https://www.ncbi.nlm.nih.gov/pubmed/34487236 | Ehrlich, P., Klingel, K., Ohlmann-Knafo, S., Hüttinger, S., Sood, N., Pickuth, D., & Kindermann, M. (2021). Biopsy-proven lymphocytic myocarditis following first mRNA COVID-19 vaccination in a 40-year-old male: case report. Clinical Research in Cardiology, 110(11), 1855-1859. | Ehrlich, P., Klingel, K., Ohlmann-Knafo, S., Hüttinger, S., Sood, N., Pickuth, D. y Kindermann, M. (2021). Miocarditis linfocítica comprobada por biopsia después de la primera vacunación con ARNm COVID-19 en un hombre de 40 años: informe de caso. Investigación clínica en cardiología, 110(11), 1855-1859. https://www.ncbi.nlm.nih.gov/pubmed/34551225 | Tobaiqy, M., Maclure, K., Elkout, H., & Stewart, D. (2021). Eventos adversos trombóticos reportados para Vacunas Moderna, Pfizer y Oxford-AstraZeneca COVID-19: Comparación de ocurrencia y resultados clínicos en la base de datos de EUDRAVAVIGILANCE. Vacunas, 9 (11), 1326. https://pubmed.ncbi.nlm.nih.gov/33713605/ | Ehrlich, P., Klingel, K., Ohlmann-Knafo, S., Hüttinger, S., Sood, N., Pickuth, D., & Kindermann, M. (2021). Biopsy-proven lymphocytic myocarditis following first mRNA COVID-19 vaccination in a 40-year-old male: case report. Clinical Research in Cardiology, 110(11), 1855-1859. https://www.ncbi.nlm.nih.gov/pubmed/34487236 | Trimboli, M., Zoleo, P., Arabia, G., & Gambardella, A. (2021). Guillain-Barré syndrome following BNT162b2 COVID-19 vaccine. Neurological Sciences, 42(11), 4401-4402. https://link.springer.com/article/10.1007%2Fs10072-021-05523-5. | ||||||||
830 | Oxford-AstraZeneca COVID-19 vaccination induced lymphadenopathy on [18F] choline PET / CT, not just an FDG finding: | https://pubmed.ncbi.nlm.nih.gov/33661328/ | https://www.ncbi.nlm.nih.gov/pubmed/34551225 | El Sahly, H. M., Baden, L. R., Essink, B., Doblecki-Lewis, S., Martin, J. M., Anderson, E. J., ... & Miller, J. (2021). Efficacy of the mRNA-1273 SARS-CoV-2 vaccine at completion of blinded phase. New England Journal of Medicine, 385(19), 1774-1785. | El Sahly, H. M., Baden, L. R., Essink, B., Doblecki-Lewis, S., Martin, J. M., Anderson, E. J., ... & Miller, J. (2021). Eficacia de la vacuna mRNA-1273 SARS-CoV-2 al finalizar la fase ciega. Revista de Medicina de Nueva Inglaterra, 385(19), 1774-1785. https://www.ncbi.nlm.nih.gov/pubmed/34709227 | TOIDA, R., UEZONO, S., KOMATSU, H., TOUDA, T., Imamura, A., Fujimoto, S., & Kaikita, K. (2021). Cardiomiopatía TakotSubo después de la vacunación para la enfermedad de Coronavirus 2019 en un paciente en hemodiálisis de mantenimiento. Informes de casos CEN, 1-5. https://pubmed.ncbi.nlm.nih.gov/33824804/ | El Sahly, H. M., Baden, L. R., Essink, B., Doblecki-Lewis, S., Martin, J. M., Anderson, E. J., ... & Miller, J. (2021). Efficacy of the mRNA-1273 SARS-CoV-2 vaccine at completion of blinded phase. New England Journal of Medicine, 385(19), 1774-1785. https://www.ncbi.nlm.nih.gov/pubmed/34551225 | Trogstad, L., Robertson, A. H., Mjaaland, S., & Magnus, P. (2021). Association between ChAdOx1 nCoV-19 vaccination and bleeding episodes: Large population-based cohort study. Vaccine, 39(40), 5854-5857. https://pubmed.ncbi.nlm.nih.gov/34479760/. | ||||||||
831 | Biphasic anaphylaxis after exposure to the first dose of Pfizer-BioNTech COVID-19 mRNA vaccine COVID-19: | https://pubmed.ncbi.nlm.nih.gov/34050949/ | https://www.ncbi.nlm.nih.gov/pubmed/34709227 | Facetti, S., Giraldi, M., Vecchi, A. L., Rogiani, S., & Nassiacos, D. (2021). Acute myocarditis in a young adult two days after Pfizer vaccination. Giornale italiano di cardiologia (2006), 22(11), 891-893. | Facetti, S., Giraldi, M., Vecchi, A. L., Rogiani, S. y Nassiacos, D. (2021). Miocarditis aguda en un adulto joven dos días después de la vacunación con Pfizer. Giornale italiano di cardiología (2006), 22(11), 891-893. https://www.ncbi.nlm.nih.gov/pubmed/34921468 | Tølbøll Sørensen, A. L., Rolland, M., Hartmann, J., Harboe, Z. B., Roed, C., Jensen, T. Ø., ... & Stensballe, J. (2021). Un caso de trombocitopenia y trombosis múltiples después de la vacunación con Chadox1 NCOV-19 contra SARS-COV-2. Avances de sangre, 5 (12), 2569-2574. https://pubmed.ncbi.nlm.nih.gov/34191218/ | Facetti, S., Giraldi, M., Vecchi, A. L., Rogiani, S., & Nassiacos, D. (2021). Acute myocarditis in a young adult two days after Pfizer vaccination. Giornale italiano di cardiologia (2006), 22(11), 891-893. https://www.ncbi.nlm.nih.gov/pubmed/34709227 | Truong, D. T., Dionne, A., Muniz, J. C., McHugh, K. E., Portman, M. A., Lambert, L. M., ... & Newburger, J. W. (2021). Clinically suspected myocarditis temporally related to COVID-19 vaccination in adolescents and young adults. Circulation. https://onlinelibrary.wiley.com/doi/10.1002/ana.26258. | ||||||||
832 | Axillary adenopathy associated with COVID-19 vaccination: imaging findings and follow-up recommendations in 23 women: | https://pubmed.ncbi.nlm.nih.gov/33624520/ | https://www.ncbi.nlm.nih.gov/pubmed/34921468 | Fazlollahi, A., Zahmatyar, M., Noori, M., Nejadghaderi, S. A., Sullman, M. J., Shekarriz‐Foumani, R., ... & Safiri, S. (2021). Cardiac complications following mRNA COVID‐19 vaccines: A systematic review of case reports and case series. Reviews in medical virology, e2318. | Fazlollahi, A., Zahmatyar, M., Noori, M., Nejadghaderi, S. A., Sullman, M. J., Shekarriz‐Foumani, R., ... y Safiri, S. (2021). Complicaciones cardíacas después de las vacunas de ARNm contra la COVID-19: una revisión sistemática de informes de casos y series de casos. Revisiones en virología médica, e2318. https://www.ncbi.nlm.nih.gov/pubmed/34824230 | Trimboli, M., Zoleo, P., Arabia, G., & Gambardella, A. (2021). Síndrome de Guillain-Barré después de la vacuna BNT162B2 COVID-19. Ciencias neurológicas, 42 (11), 4401-4402. https://onlinelibrary.wiley.com/doi/10.1002/ana.26258. | Fazlollahi, A., Zahmatyar, M., Noori, M., Nejadghaderi, S. A., Sullman, M. J., Shekarriz‐Foumani, R., ... & Safiri, S. (2021). Cardiac complications following mRNA COVID‐19 vaccines: A systematic review of case reports and case series. Reviews in medical virology, e2318. https://www.ncbi.nlm.nih.gov/pubmed/34921468 | Truong, D. T., Dionne, A., Muniz, J. C., McHugh, K. E., Portman, M. A., Lambert, L. M., ... & Newburger, J. W. (2021). Clinically suspected myocarditis temporally related to COVID-19 vaccination in adolescents and young adults. Circulation. https://pubmed.ncbi.nlm.nih.gov/34865500/ | ||||||||
833 | A case of cervical lymphadenopathy following COVID-19 vaccination: | https://pubmed.ncbi.nlm.nih.gov/34141500/ | https://www.ncbi.nlm.nih.gov/pubmed/34824230 | Fazolo, T., Lima, K., Fontoura, J. C., de Souza, P. O., Hilario, G., Zorzetto, R., ... & Bonorino, C. (2021). Pediatric COVID-19 patients in South Brazil show abundant viral mRNA and strong specific anti-viral responses. Nature communications, 12(1), 1-13. | Fazolo, T., Lima, K., Fontoura, J. C., de Souza, P. O., Hilario, G., Zorzetto, R., ... & Bonorino, C. (2021). Los pacientes pediátricos con COVID-19 en el sur de Brasil muestran abundante ARNm viral y fuertes respuestas antivirales específicas. Comunicaciones de la naturaleza, 12(1), 1-13. https://www.ncbi.nlm.nih.gov/pubmed/34170372 | TROGSTAD, L., ROBERTSON, A. H., MJAALAND, S., & Magnus, P. (2021). Asociación entre Chadox1 NCOV-19 Vacunación y episodios de sangrado: estudio de cohorte de gran población. Vacuna, 39 (40), 5854-5857. https://pubmed.ncbi.nlm.nih.gov/34416319/. | Fazolo, T., Lima, K., Fontoura, J. C., de Souza, P. O., Hilario, G., Zorzetto, R., ... & Bonorino, C. (2021). Pediatric COVID-19 patients in South Brazil show abundant viral mRNA and strong specific anti-viral responses. Nature communications, 12(1), 1-13. https://www.ncbi.nlm.nih.gov/pubmed/34824230 | Truong, D. T., Dionne, A., Muniz, J. C., McHugh, K. E., Portman, M. A., Lambert, L. M., ... & Newburger, J. W. (2021). Clinically suspected myocarditis temporally related to COVID-19 vaccination in adolescents and young adults. Circulation. https://www.ahajournals.org/doi/abs/10.1161/CIRCULATIONAHA.121.056583?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed | ||||||||
834 | Unique imaging findings of neurologic phantosmia after Pfizer-BioNtech COVID-19 vaccination: a case report: | https://pubmed.ncbi.nlm.nih.gov/34096896/ | https://www.ncbi.nlm.nih.gov/pubmed/34170372 | Fikenzer, S., & Laufs, U. (2021). Correction to: Response to Letter to the editors referring to Fikenzer, S., Uhe, T., Lavall, D., Rudolph, U., Falz, R., Busse, M., Hepp, P., & Laufs, U.(2020). Effects of surgical and FFP2/N95 face masks on cardiopulmonary exercise capacity. Clinical research in cardiology: official journal of the German Cardiac Society, 1–9. Advance online publication. https://doi. org/10.1007/s00392-020-01704-y. Clinical Research in Cardiology, 110(8), 1352-1352. | Fikenzer, S. y Laufs, U. (2021). Corrección a: Respuesta a la carta a los editores que hace referencia a Fikenzer, S., Uhe, T., Lavall, D., Rudolph, U., Falz, R., Busse, M., Hepp, P., & Laufs, U .(2020). Efectos de las mascarillas quirúrgicas y FFP2/N95 sobre la capacidad de ejercicio cardiopulmonar. Investigación clínica en cardiología: revista oficial de la Sociedad Cardíaca Alemana, 1–9. Publicación anticipada en línea. https://doi. org/10.1007/s00392-020-01704-y. Investigación clínica en cardiología, 110(8), 1352-1352. https://www.ncbi.nlm.nih.gov/pubmed/34849667 | Truong, D. T., Dionne, A., Muniz, J. C., McHugh, K. E., Portman, M. A., Lambert, L. M., ... & Newburger, J. W. W. (2021). La miocarditis clínica sospechada temporalmente relacionada con la vacunación de COVID-19 en adolescentes y adultos jóvenes. Circulación. https://jamanetwork.com/journals/jama/fullarticle/2785009 | Fikenzer, S., & Laufs, U. (2021). Correction to: Response to Letter to the editors referring to Fikenzer, S., Uhe, T., Lavall, D., Rudolph, U., Falz, R., Busse, M., Hepp, P., & Laufs, U.(2020). Effects of surgical and FFP2/N95 face masks on cardiopulmonary exercise capacity. Clinical research in cardiology: official journal of the German Cardiac Society, 1–9. Advance online publication. https://doi. org/10.1007/s00392-020-01704-y. Clinical Research in Cardiology, 110(8), 1352-1352. https://www.ncbi.nlm.nih.gov/pubmed/34170372 | Truong, D. T., Dionne, A., Muniz, J. C., McHugh, K. E., Portman, M. A., Lambert, L. M., ... & Newburger, J. W. (2021). Clinically suspected myocarditis temporally related to COVID-19 vaccination in adolescents and young adults. Circulation. https://www.ncbi.nlm.nih.gov/pubmed/34865500 | ||||||||
835 | Thrombotic adverse events reported for Moderna, Pfizer, and Oxford-AstraZeneca COVID-19 vaccines: comparison of occurrence and clinical outcomes in the EudraVigilance database: | https://pubmed.ncbi.nlm.nih.gov/34835256/ | https://www.ncbi.nlm.nih.gov/pubmed/34849667 | Foltran, D., Delmas, C., Flumian, C., De Paoli, P., Salvo, F., Gautier, S., ... & Montastruc, F. (2022). Myocarditis and pericarditis in adolescents after first and second doses of mRNA COVID-19 vaccines. European Heart Journal-Quality of Care and Clinical Outcomes, 8(2), 99-103. | Foltran, D., Delmas, C., Flumian, C., De Paoli, P., Salvo, F., Gautier, S., ... & Montastruc, F. (2022). Miocarditis y pericarditis en adolescentes después de la primera y segunda dosis de vacunas de ARNm COVID-19. European Heart Journal: calidad de la atención y resultados clínicos, 8(2), 99-103. https://www.ncbi.nlm.nih.gov/pubmed/34646267 | Truong, D. T., Dionne, A., Muniz, J. C., McHugh, K. E., Portman, M. A., Lambert, L. M., ... & Newburger, J. W. W. (2021). La miocarditis clínica sospechada temporalmente relacionada con la vacunación de COVID-19 en adolescentes y adultos jóvenes. Circulación. https://pubmed.ncbi.nlm.nih.gov/34614329/ | Foltran, D., Delmas, C., Flumian, C., De Paoli, P., Salvo, F., Gautier, S., ... & Montastruc, F. (2022). Myocarditis and pericarditis in adolescents after first and second doses of mRNA COVID-19 vaccines. European Heart Journal-Quality of Care and Clinical Outcomes, 8(2), 99-103. https://www.ncbi.nlm.nih.gov/pubmed/34849667 | Tsilingiris, D., Vallianou, N. G., Karampela, Ι., & Dalamaga, Μ. (2021). Vaccine induced thrombotic thrombocytopenia: the shady chapter of a success story. Metabolism open, 11, 100101. https://www.sciencedirect.com/science/article/pii/S2589936821000256 | ||||||||
836 | Unilateral lymphadenopathy after COVID-19 vaccination: a practical management plan for radiologists of all specialties: | https://pubmed.ncbi.nlm.nih.gov/33713605/ | https://www.ncbi.nlm.nih.gov/pubmed/34646267 | Forgacs, D., Jang, H., Abreu, R. B., Hanley, H. B., Gattiker, J. L., Jefferson, A. M., & Ross, T. M. (2021). SARS-CoV-2 mRNA Vaccines Elicit Different Responses in Immunologically Naïve and Pre-Immune Humans. Frontiers in immunology, 12. | Forgacs, D., Jang, H., Abreu, R. B., Hanley, H. B., Gattiker, J. L., Jefferson, A. M. y Ross, T. M. (2021). Las vacunas de ARNm del SARS-CoV-2 provocan diferentes respuestas en humanos inmunológicamente ingenuos y preinmunes. Fronteras en inmunología, 12. https://www.ncbi.nlm.nih.gov/pubmed/34127481 | Truong, D. T., Dionne, A., Muniz, J. C., McHugh, K. E., Portman, M. A., Lambert, L. M., ... & Newburger, J. W. W. (2021). La miocarditis clínica sospechada temporalmente relacionada con la vacunación de COVID-19 en adolescentes y adultos jóvenes. Circulación. https://pubmed.ncbi.nlm.nih.gov/34756746/ | Forgacs, D., Jang, H., Abreu, R. B., Hanley, H. B., Gattiker, J. L., Jefferson, A. M., & Ross, T. M. (2021). SARS-CoV-2 mRNA Vaccines Elicit Different Responses in Immunologically Naïve and Pre-Immune Humans. Frontiers in immunology, 12. https://www.ncbi.nlm.nih.gov/pubmed/34646267 | Tun, G. S. Z., Gleeson, D., Al-Joudeh, A., & Dube, A. (2022). Immune-mediated hepatitis with the Moderna vaccine, no longer a coincidence but confirmed. Journal of Hepatology, 76(3), 747-749. https://www.sciencedirect.com/science/article/pii/S0168827821020936 | ||||||||
837 | Unilateral axillary adenopathy in the setting of COVID-19 vaccination: follow-up: | https://pubmed.ncbi.nlm.nih.gov/34298342/ | https://www.ncbi.nlm.nih.gov/pubmed/34127481 | Furer, V., Eviatar, T., Zisman, D., Peleg, H., Paran, D., Levartovsky, D., ... & Elkayam, O. (2021). Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in adult patients with autoimmune inflammatory rheumatic diseases and in the general population: a multicentre study. Annals of the rheumatic diseases, 80(10), 1330-1338. | Furer, V., Eviatar, T., Zisman, D., Peleg, H., Paran, D., Levartovsky, D., ... y Elkayam, O. (2021). Inmunogenicidad y seguridad de la vacuna COVID-19 de ARNm BNT162b2 en pacientes adultos con enfermedades reumáticas inflamatorias autoinmunes y en la población general: un estudio multicéntrico. Anales de las enfermedades reumáticas, 80(10), 1330-1338. https://www.ncbi.nlm.nih.gov/pubmed/34538306 | Truong, D. T., Dionne, A., Muniz, J. C., McHugh, K. E., Portman, M. A., Lambert, L. M., ... & Newburger, J. W. W. (2021). La miocarditis clínica sospechada temporalmente relacionada con la vacunación de COVID-19 en adolescentes y adultos jóvenes. Circulación. https://www.ncbi.nlm.nih.gov/pubmed/34311983 | Furer, V., Eviatar, T., Zisman, D., Peleg, H., Paran, D., Levartovsky, D., ... & Elkayam, O. (2021). Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in adult patients with autoimmune inflammatory rheumatic diseases and in the general population: a multicentre study. Annals of the rheumatic diseases, 80(10), 1330-1338. https://www.ncbi.nlm.nih.gov/pubmed/34127481 | Turi, M. C., Spitaleri, F., Gori, A. M., Parruti, G., Rogolino, A. A., Albani, A., ... & Marcucci, R. (2021). A case of vaccine-induced immune thrombotic thrombocytopenia with massive artero-venous thrombosis. Blood Transfusion, 19(4), 343. https://pubmed.ncbi.nlm.nih.gov/34059191/ | ||||||||
838 | A systematic review of cases of CNS demyelination following COVID-19 vaccination: | https://pubmed.ncbi.nlm.nih.gov/34839149/ | https://www.ncbi.nlm.nih.gov/pubmed/34538306 | Galindo, R., Chow, H., & Rongkavilit, C. (2021). COVID-19 in children: clinical manifestations and pharmacologic interventions including vaccine trials. Pediatric Clinics, 68(5), 961-976. | Galindo, R., Chow, H. y Rongkavilit, C. (2021). COVID-19 en niños: manifestaciones clínicas e intervenciones farmacológicas, incluidos ensayos de vacunas. Clínicas pediátricas, 68(5), 961-976. https://www.ncbi.nlm.nih.gov/pubmed/34237049 | Tsilingiris, D., Vallianou, N. G., Karampela, ι., & Dalamaga, μ. (2021). Vacuna de trombocitopenia trombótica inducida: el capítulo sombreado de una historia de éxito. Metabolismo abierto, 11, 100101. https://www.sciencedirect.com/science/article/pii/S1871402121002046 | Galindo, R., Chow, H., & Rongkavilit, C. (2021). COVID-19 in children: clinical manifestations and pharmacologic interventions including vaccine trials. Pediatric Clinics, 68(5), 961-976. https://www.ncbi.nlm.nih.gov/pubmed/34538306 | Turk, V. E. (2021). Anaphylaxis associated with the mRNA COVID-19 vaccines: approach to allergy investigation. Clinical Immunology, 227, 108748. https://pubmed.ncbi.nlm.nih.gov/33932618/ | ||||||||
839 | Supraclavicular lymphadenopathy after COVID-19 vaccination: an increasing presentation in the two-week wait neck lump clinic: | https://pubmed.ncbi.nlm.nih.gov/33685772/ | https://www.ncbi.nlm.nih.gov/pubmed/34237049 | Gargano, J. W., Wallace, M., Hadler, S. C., Langley, G., Su, J. R., Oster, M. E., ... & Oliver, S. E. (2021). Use of mRNA COVID-19 vaccine after reports of myocarditis among vaccine recipients: update from the Advisory Committee on Immunization Practices—United States, June 2021. Morbidity and Mortality Weekly Report, 70(27), 977. | Gargano, JW, Wallace, M., Hadler, S. C., Langley, G., Su, J. R., Oster, M. E., ... y Oliver, SE (2021). Uso de la vacuna de ARNm contra la COVID-19 después de informes de miocarditis entre los receptores de la vacuna: actualización del Comité Asesor sobre Prácticas de Inmunización—Estados Unidos, junio de 2021. Informe semanal de morbilidad y mortalidad, 70(27), 977. https://www.ncbi.nlm.nih.gov/pubmed/33406694 | TUBAR, N. K., Eyigürbüz, T., Yildirim, Z., & Kale, N. (2021). Una variante del síndrome de Guillain-Barre después de la vacunación de SARS-COV-2: AMSAN. Ideggyogyaszati Szemle, 74 (7-08), 286-288. https://pubmed.ncbi.nlm.nih.gov/34703690/. | Gargano, J. W., Wallace, M., Hadler, S. C., Langley, G., Su, J. R., Oster, M. E., ... & Oliver, S. E. (2021). Use of mRNA COVID-19 vaccine after reports of myocarditis among vaccine recipients: update from the Advisory Committee on Immunization Practices—United States, June 2021. Morbidity and Mortality Weekly Report, 70(27), 977. https://www.ncbi.nlm.nih.gov/pubmed/34237049 | Turner, P. J., Ansotegui, I. J., Campbell, D. E., Cardona, V., Ebisawa, M., El-Gamal, Y., ... & WAO Anaphylaxis Committee. (2021). COVID-19 vaccine-associated anaphylaxis: a statement of the World Allergy Organization Anaphylaxis Committee. World Allergy Organization Journal, 14(2), 100517. https://www.sciencedirect.com/science/article/pii/S1939455121000119. | ||||||||
840 | COVID-19 vaccine-related axillary and cervical lymphadenopathy in patients with current or previous breast cancer and other malignancies: cross-sectional imaging findings on MRI, CT and PET-CT: | https://pubmed.ncbi.nlm.nih.gov/34719892/ | https://www.ncbi.nlm.nih.gov/pubmed/33406694 | Gatti, M., Raschi, E., Moretti, U., Ardizzoni, A., Poluzzi, E., & Diemberger, I. (2021). Influenza vaccination and myo-pericarditis in patients receiving immune checkpoint inhibitors: investigating the likelihood of interaction through the vaccine adverse event reporting system and VigiBase. Vaccines, 9(1), 19. | Gatti, M., Raschi, E., Moretti, U., Ardizzoni, A., Poluzzi, E. y Diemberger, I. (2021). Vacunación contra la influenza y miopericarditis en pacientes que reciben inhibidores de puntos de control inmunológico: investigación de la probabilidad de interacción a través del sistema de notificación de eventos adversos de la vacuna y VigiBase. Vacunas, 9(1), 19. https://www.ncbi.nlm.nih.gov/pubmed/34660088 | Tun, G. S. Z., Gleeson, D., al-JOUDEH, A., & Dube, A. (2022). Hepatitis mediada por la mediación inmunitaria con la vacuna moderna, ya no es una coincidencia, sino confirmada. Journal of Hepatology, 76 (3), 747-749. https://www.nature.com/articles/s41421-021-00329-3 | Gatti, M., Raschi, E., Moretti, U., Ardizzoni, A., Poluzzi, E., & Diemberger, I. (2021). Influenza vaccination and myo-pericarditis in patients receiving immune checkpoint inhibitors: investigating the likelihood of interaction through the vaccine adverse event reporting system and VigiBase. Vaccines, 9(1), 19. https://www.ncbi.nlm.nih.gov/pubmed/33406694 | Tutar, N. K., Eyigürbüz, T., Yildirim, Z., & Kale, N. (2021). A variant of Guillain-Barre syndrome after SARS-CoV-2 vaccination: AMSAN. Ideggyogyaszati Szemle, 74(7-08), 286-288. https://pubmed.ncbi.nlm.nih.gov/34370408/. | ||||||||
841 | Adenopathy after COVID-19 vaccination: | https://pubmed.ncbi.nlm.nih.gov/33625299/. | https://www.ncbi.nlm.nih.gov/pubmed/34660088 | Gautam, N., Saluja, P., Fudim, M., Jambhekar, K., Pandey, T., & Al'Aref, S. (2021). A late presentation of COVID-19 vaccine-induced myocarditis. Cureus, 13(9). | Gautam, N., Saluja, P., Fudim, M., Jambhekar, K., Pandey, T. y Al'Aref, S. (2021). Una presentación tardía de miocarditis inducida por la vacuna COVID-19. Cureus, 13(9). https://www.ncbi.nlm.nih.gov/pubmed/34916217 | Turi, M. C., Spitaleri, F., Gori, A. M., Parruti, G., Rogolino, A. A., Albani, A., ... & Marcucci, R. (2021). Un caso de trombocitopenia trombótica inmune inducida por la vacuna con trombosis artererous masiva. Transfusión de sangre, 19 (4), 343. https://pubmed.ncbi.nlm.nih.gov/34331506/ | Gautam, N., Saluja, P., Fudim, M., Jambhekar, K., Pandey, T., & Al'Aref, S. (2021). A late presentation of COVID-19 vaccine-induced myocarditis. Cureus, 13(9). https://www.ncbi.nlm.nih.gov/pubmed/34660088 | Tutor, A., Unis, G., Ruiz, B., Bolaji, O. A., & Bob-Manuel, T. (2021). Spectrum of Suspected Cardiomyopathy Due to COVID-19: A Case Series. Current Problems in Cardiology, 46(10), 100926. https://www.ncbi.nlm.nih.gov/pubmed/34311983 | ||||||||
842 | Incidence of axillary adenopathy on breast imaging after vaccination with COVID-19: | https://pubmed.ncbi.nlm.nih.gov/34292295/. | https://www.ncbi.nlm.nih.gov/pubmed/34916217 | Gellad, W. F. (2021). Myocarditis after vaccination against covid-19. bmj, 375. | Gellad, WF (2021). Miocarditis tras la vacunación contra el covid-19. bmj, 375. https://www.ncbi.nlm.nih.gov/pubmed/34153517 | Turk, V. E. (2021). Anafilaxia asociada con las vacunas de ARNm COVID-19: enfoque de la investigación de alergias. Inmunología clínica, 227, 108748. https://pubmed.ncbi.nlm.nih.gov/33643776/ | Gellad, W. F. (2021). Myocarditis after vaccination against covid-19. bmj, 375. https://www.ncbi.nlm.nih.gov/pubmed/34916217 | Tuyls, S., Van Der Brempt, X., Faber, M., Gadisseur, R., Dezfoulian, B., Schrijvers, R., & Froidure, A. (2021). Allergic reactions to COVID-19 vaccines: statement of the Belgian Society for Allergy and Clinical Immunology (BelSACI). Acta Clinica Belgica, 1-6. https://www.tandfonline.com/doi/abs/10.1080/17843286.2021.1909447 | ||||||||
843 | COVID-19 vaccination and lower cervical lymphadenopathy in two-week neck lump clinic: a follow-up audit: | https://pubmed.ncbi.nlm.nih.gov/33947605/. | https://www.ncbi.nlm.nih.gov/pubmed/34153517 | Greenhawt, M., Abrams, E. M., Shaker, M., Chu, D. K., Khan, D., Akin, C., ... & Golden, D. B. (2021). The risk of allergic reaction to SARS-CoV-2 vaccines and recommended evaluation and management: a systematic review, meta-analysis, GRADE assessment, and international consensus approach. The Journal of Allergy and Clinical Immunology: In Practice, 9(10), 3546-3567. | Greenhawt, M., Abrams, E. M., Shaker, M., Chu, D. K., Khan, D., Akin, C., ... y Golden, D. B. (2021). El riesgo de reacción alérgica a las vacunas contra el SARS-CoV-2 y la evaluación y el manejo recomendados: una revisión sistemática, un metanálisis, una evaluación GRADE y un enfoque de consenso internacional. The Journal of Allergy and Clinical Immunology: In Practice, 9(10), 3546-3567. https://www.ncbi.nlm.nih.gov/pubmed/34668687 | Turner, P. J., Ansotegui, I. J., Campbell, D. E., Cardona, V., Ebisawa, M., El-Gamal, Y., ... & WAO ANAPHYLAXIS COMITÉ. (2021). COVID-19 ANAPHYLAXIS asociada a la vacuna: una declaración del Comité de Anáfilaxis de la Organización Mundial de Alergias. Diario de la Organización Mundial de Alergias, 14 (2), 100517. https://www.sciencedirect.com/science/article/pii/S1871402121002046. | Greenhawt, M., Abrams, E. M., Shaker, M., Chu, D. K., Khan, D., Akin, C., ... & Golden, D. B. (2021). The risk of allergic reaction to SARS-CoV-2 vaccines and recommended evaluation and management: a systematic review, meta-analysis, GRADE assessment, and international consensus approach. The Journal of Allergy and Clinical Immunology: In Practice, 9(10), 3546-3567. https://www.ncbi.nlm.nih.gov/pubmed/34153517 | Uaprasert, N., Panrong, K., Tungjitviboonkun, S., Dussadee, K., Decharatanachart, P., Kaveevorayan, P., ... & Rojnuckarin, P. (2022). ChAdOx1 nCoV-19 vaccine-associated thrombocytopenia: three cases of immune thrombocytopenia after 107 720 doses of ChAdOx1 vaccination in Thailand. Blood Coagulation & Fibrinolysis, 33(1), 67-70. https://pubmed.ncbi.nlm.nih.gov/34483267/. | ||||||||
844 | Cervical lymphadenopathy after coronavirus disease vaccination 2019: clinical features and implications for head and neck cancer services: | https://pubmed.ncbi.nlm.nih.gov/34526175/ | https://www.ncbi.nlm.nih.gov/pubmed/34668687 | Haaf, P., Kuster, G. M., Mueller, C., Berger, C. T., Monney, P., Burger, P., ... & Tanner, F. C. (2021). The very low risk of myocarditis and pericarditis after mRNA COVID-19 vaccination should not discourage vaccination. Swiss Medical Weekly, (41). | Haaf, P., Kuster, G. M., Mueller, C., Berger, C. T., Monney, P., Burger, P., ... y Tanner, F. C. (2021). El riesgo muy bajo de miocarditis y pericarditis después de la vacunación con ARNm contra la COVID-19 no debería desalentar la vacunación. Semanario médico suizo, (41). https://www.ncbi.nlm.nih.gov/pubmed/34348657 | Tutor, A., UNIS, G., Ruiz, B., Bolaji, O. A., y Bob-Manuel, T. (2021). Espectro de cardiomiopatía sospechada debido a COVID-19: una serie de casos. Problemas actuales en Cardiología, 46 (10), 100926. https://www.ncbi.nlm.nih.gov/pubmed/34904134 | Haaf, P., Kuster, G. M., Mueller, C., Berger, C. T., Monney, P., Burger, P., ... & Tanner, F. C. (2021). The very low risk of myocarditis and pericarditis after mRNA COVID-19 vaccination should not discourage vaccination. Swiss Medical Weekly, (41). https://www.ncbi.nlm.nih.gov/pubmed/34668687 | Uaprasert, N., Watanaboonyongcharoen, P., Vichitratchaneekorn, R., Trithiphen, S., Akkawat, B., Sukperm, A., ... & Rojnuckarin, P. (2021). Prevalence of thrombocytopenia, anti–platelet factor 4 antibodies and D‐dimer elevation in Thai people After ChAdOx1 nCoV‐19 vaccination. Research and Practice in Thrombosis and Haemostasis, 5(6), e12580. https://pubmed.ncbi.nlm.nih.gov/34568726/ | ||||||||
845 | Lymphadenopathy associated with the COVID-19 vaccine: | https://pubmed.ncbi.nlm.nih.gov/33786231/ | https://www.ncbi.nlm.nih.gov/pubmed/34348657 | Hasnie, A. A., Hasnie, U. A., Patel, N., Aziz, M. U., Xie, M., Lloyd, S. G., & Prabhu, S. D. (2021). Perimyocarditis following first dose of the mRNA-1273 SARS-CoV-2 (Moderna) vaccine in a healthy young male: a case report. BMC Cardiovascular Disorders, 21(1), 1-6. | Hasnie, A. A., Hasnie, U. A., Patel, N., Aziz, M. U., Xie, M., Lloyd, S. G. y Prabhu, SD (2021). Perimiocarditis después de la primera dosis de la vacuna mRNA-1273 SARS-CoV-2 (Moderna) en un varón joven sano: reporte de un caso. Trastornos cardiovasculares de BMC, 21(1), 1-6. https://www.ncbi.nlm.nih.gov/pubmed/34351881 | TUYLS, S., VANER ABRANT, X., FABER, M., GADISSEUR, R., DEZFOULIAN, B., Schrijvers, R., & Floidure, A. (2021). Reacciones alérgicas a COVID-19 Vacunas: Declaración de la sociedad belga para alergias y inmunología clínica (Belsaci). Acta Clinica Belgica, 1-6. https://pubmed.ncbi.nlm.nih.gov/34318537/ | Hasnie, A. A., Hasnie, U. A., Patel, N., Aziz, M. U., Xie, M., Lloyd, S. G., & Prabhu, S. D. (2021). Perimyocarditis following first dose of the mRNA-1273 SARS-CoV-2 (Moderna) vaccine in a healthy young male: a case report. BMC Cardiovascular Disorders, 21(1), 1-6. https://www.ncbi.nlm.nih.gov/pubmed/34348657 | Ujueta, F., Azimi, R., Lozier, M. R., Poppiti, R., & Ciment, A. (2021). Lymphohistocytic Myocarditis after Ad26. COV2. S viral vector COVID-19 vaccination. International journal of cardiology. Heart & vasculature. https://pubmed.ncbi.nlm.nih.gov/34514078/ | ||||||||
846 | Evolution of lymphadenopathy on PET/MRI after COVID-19 vaccination: | https://pubmed.ncbi.nlm.nih.gov/33625301/. | https://www.ncbi.nlm.nih.gov/pubmed/34351881 | Hause, A. M., Gee, J., Baggs, J., Abara, W. E., Marquez, P., Thompson, D., ... & Shay, D. K. (2021). COVID-19 vaccine safety in adolescents aged 12–17 years—United States, December 14, 2020–July 16, 2021. Morbidity and Mortality Weekly Report, 70(31), 1053. | Hause, A. M., Gee, J., Baggs, J., Abara, W. E., Márquez, P., Thompson, D., ... y Shay, D. K. (2021). Seguridad de la vacuna COVID-19 en adolescentes de 12 a 17 años: Estados Unidos, 14 de diciembre de 2020 a 16 de julio de 2021. Informe semanal de morbilidad y mortalidad, 70(31), 1053. https://www.ncbi.nlm.nih.gov/pubmed/33854395 | UAIS, N. A. (2021). Depresión después de la vacuna Chadox1-S / NCOV-19. La Revista Europea de Psiquiatría. https://pubmed.ncbi.nlm.nih.gov/34384129/. | Hause, A. M., Gee, J., Baggs, J., Abara, W. E., Marquez, P., Thompson, D., ... & Shay, D. K. (2021). COVID-19 vaccine safety in adolescents aged 12–17 years—United States, December 14, 2020–July 16, 2021. Morbidity and Mortality Weekly Report, 70(31), 1053. https://www.ncbi.nlm.nih.gov/pubmed/34351881 | Ujueta, F., Azimi, R., Lozier, M. R., Poppiti, R., & Ciment, A. (2021). Lymphohistocytic Myocarditis after Ad26. COV2. S viral vector COVID-19 vaccination. International journal of cardiology. Heart & vasculature. https://www.sciencedirect.com/science/article/pii/S2352906721001573 | ||||||||
847 | Autoimmune hepatitis triggered by SARS-CoV-2 vaccination: | https://pubmed.ncbi.nlm.nih.gov/34332438/. | https://www.ncbi.nlm.nih.gov/pubmed/33854395 | Helms, J. M., Ansteatt, K. T., Roberts, J. C., Kamatam, S., Foong, K. S., Labayog, J. M. S., & Tarantino, M. D. (2021). Severe, refractory immune thrombocytopenia occurring after SARS-CoV-2 vaccine. Journal of blood medicine, 12, 221. | Helms, J. M., Ansteatt, K. T., Roberts, J. C., Kamatam, S., Foong, K. S., Labayog, J. M. S. y Tarantino, M. D. (2021). Trombocitopenia inmunitaria grave y refractaria que se produce después de la vacuna contra el SARS-CoV-2. Revista de medicina sanguínea, 12, 221. https://www.ncbi.nlm.nih.gov/pubmed/34446426 | Uaprasert, N., Panrong, K., Tungjitviboonkun, S., Dussadee, K., Decharatanachart, P., Kaveevorayan, P., ... & Rojnuckarin, P. (2022). CHADOX1 NCOV-19 Trombocitopenia asociada a la vacuna: tres casos de trombocitopenia inmunitaria después de 107 720 dosis de la vacunación con Chadox1 en Tailandia. Coagulación de la sangre y fibrinolisis, 33 (1), 67-70. https://pubmed.ncbi.nlm.nih.gov/34273119/ | Helms, J. M., Ansteatt, K. T., Roberts, J. C., Kamatam, S., Foong, K. S., Labayog, J. M. S., & Tarantino, M. D. (2021). Severe, refractory immune thrombocytopenia occurring after SARS-CoV-2 vaccine. Journal of blood medicine, 12, 221. https://www.ncbi.nlm.nih.gov/pubmed/33854395 | Umei, T. C., Kishino, Y., Watanabe, K., Shiraishi, Y., Inohara, T., Yuasa, S., & Fukuda, K. (2021). Recurrence of myopericarditis following mRNA COVID-19 vaccination in a male adolescent. CJC open. https://www.ncbi.nlm.nih.gov/pubmed/34904134 | ||||||||
848 | New-onset nephrotic syndrome after Janssen COVID-19 vaccination: case report and literature review: | https://pubmed.ncbi.nlm.nih.gov/34342187/. | https://www.ncbi.nlm.nih.gov/pubmed/34446426 | Hippisley-Cox, J., Patone, M., Mei, X. W., Saatci, D., Dixon, S., Khunti, K., ... & Coupland, C. A. (2021). Risk of thrombocytopenia and thromboembolism after covid-19 vaccination and SARS-CoV-2 positive testing: self-controlled case series study. bmj, 374. | Hippisley-Cox, J., Patone, M., Mei, XW, Saatci, D., Dixon, S., Khunti, K., ... y Coupland, CA (2021). Riesgo de trombocitopenia y tromboembolismo después de la vacunación contra el covid-19 y pruebas positivas de SARS-CoV-2: estudio de serie de casos autocontrolado. bmj, 374. https://www.ncbi.nlm.nih.gov/pubmed/34808708 | Uaprasert, N., Watanaboonyongcharoen, P., Vichitratchaneekorn, R., TrithiPhen, S., Akkawat, B., Sukperm, A., ... & Rojnuckarin, P. (2021). Prevalencia de trombocitopenia, anticuerpos anti-plaquetarios 4 y elevación D-dimer en los tailandeses después de la vacunación con Chadox1 NCOV-19. Investigación y práctica en trombosis y hemostasis, 5 (6), E12580. https://academic.oup.com/cid/advance-article-abstract/doi/10.1093/cid/ciab989/6445179 | Hippisley-Cox, J., Patone, M., Mei, X. W., Saatci, D., Dixon, S., Khunti, K., ... & Coupland, C. A. (2021). Risk of thrombocytopenia and thromboembolism after covid-19 vaccination and SARS-CoV-2 positive testing: self-controlled case series study. bmj, 374. https://www.ncbi.nlm.nih.gov/pubmed/34446426 | Underdown, M. J., & Nuss, R. (2021). Thrombocytopenia in a teen with sickle cell disease following COVID‐19 vaccination. Pediatric Blood & Cancer. https://pubmed.ncbi.nlm.nih.gov/34331506/ | ||||||||
849 | Massive cervical lymphadenopathy following vaccination with COVID-19: | https://pubmed.ncbi.nlm.nih.gov/34601889/ | https://www.ncbi.nlm.nih.gov/pubmed/34808708 | Ho, J. S., Sia, C. H., Ngiam, J. N., Loh, P. H., Chew, N. W., Kong, W. K., & Poh, K. K. (2021). A review of COVID-19 vaccination and the reported cardiac manifestations. Singapore medical journal. | Ho, J. S., Sia, C. H., Ngiam, J. N., Loh, P. H., Chew, N. W., Kong, W. K. y Poh, K. K. (2021). Una revisión de la vacunación COVID-19 y las manifestaciones cardíacas reportadas. Revista médica de Singapur. https://www.ncbi.nlm.nih.gov/pubmed/34347278 | Ujueta, F., Azimi, R., Lozier, M. R., Poppiti, R., & Ciment, A. (2021). Miocarditis linfohistocítica después de AD26. COV2. S vector viral covid-19 vacunación. Diario Internacional de Cardiología. Corazón y vasculatura. https://pubmed.ncbi.nlm.nih.gov/34406660/. | Ho, J. S., Sia, C. H., Ngiam, J. N., Loh, P. H., Chew, N. W., Kong, W. K., & Poh, K. K. (2021). A review of COVID-19 vaccination and the reported cardiac manifestations. Singapore medical journal. https://www.ncbi.nlm.nih.gov/pubmed/34808708 | Ungari, M., & Pezzarossa, E. (2022). Cutaneous Lymphocytic Vasculitis After Administration of the Second Dose of AZD1222 (Oxford–AstraZeneca) Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination: Casuality or Causality?. The American Journal of Dermatopathology, 44(1), 80-82. https://pubmed.ncbi.nlm.nih.gov/34726187/. | ||||||||
850 | ANCA glomerulonephritis following Modern COVID-19 vaccination: | https://pubmed.ncbi.nlm.nih.gov/34081948/ | https://www.ncbi.nlm.nih.gov/pubmed/34347278 | Iguchi, T., Umeda, H., Kojima, M., Kanno, Y., Tanaka, Y., Kinoshita, N., & Sato, D. (2021). Cumulative adverse event reporting of anaphylaxis after mRNA COVID-19 vaccine (Pfizer-BioNTech) injections in Japan: the first-month report. Drug safety, 44(11), 1209-1214. | Iguchi, T., Umeda, H., Kojima, M., Kanno, Y., Tanaka, Y., Kinoshita, N. y Sato, D. (2021). Informe acumulativo de eventos adversos de anafilaxia después de las inyecciones de la vacuna de ARNm COVID-19 (Pfizer-BioNTech) en Japón: informe del primer mes. Seguridad de los medicamentos, 44(11), 1209-1214. https://www.ncbi.nlm.nih.gov/pubmed/34544112 | Ujueta, F., Azimi, R., Lozier, M. R., Poppiti, R., & Ciment, A. (2021). Miocarditis linfohistocítica después de AD26. COV2. S vector viral covid-19 vacunación. Diario Internacional de Cardiología. Corazón y vasculatura. https://www.sciencedirect.com/science/article/pii/S0735675721005362 | Iguchi, T., Umeda, H., Kojima, M., Kanno, Y., Tanaka, Y., Kinoshita, N., & Sato, D. (2021). Cumulative adverse event reporting of anaphylaxis after mRNA COVID-19 vaccine (Pfizer-BioNTech) injections in Japan: the first-month report. Drug safety, 44(11), 1209-1214. https://www.ncbi.nlm.nih.gov/pubmed/34347278 | Uvais, N. A. (2021). Depression following ChAdOx1-S/nCoV-19 vaccine. The European Journal of Psychiatry. https://pubmed.ncbi.nlm.nih.gov/34608345/. | ||||||||
851 | Extensive longitudinal transverse myelitis following AstraZeneca COVID-19 vaccination: | https://pubmed.ncbi.nlm.nih.gov/34507942/. | https://www.ncbi.nlm.nih.gov/pubmed/34544112 | #VALUE! | Umei, T. C., Kishino, Y., Watanabe, K., Shiraishi, Y., Inohara, T., Yuasa, S., & Fukuda, K. (2021). La recurrencia de miopericaditis después de la vacunación con MRNA COVID-19 en un adolescente masculino. CJC abierto. https://www.ncbi.nlm.nih.gov/pubmed/34277198 | zzzz | Vaira, L. A., Podda, L., Doneddu, P., Careddu, M. G., Fozza, C., & De Riu, G. (2021). Secondary thrombocytopenia after SARS-CoV-2 vaccine: Report of a case of hemorrhage and hematoma after minor oral surgery. Journal of Stomatology, Oral and Maxillofacial Surgery. https://pubmed.ncbi.nlm.nih.gov/34314875/. | |||||||||
852 | Systemic capillary extravasation syndrome after vaccination with ChAdOx1 nCOV-19 (Oxford-AstraZeneca): | https://pubmed.ncbi.nlm.nih.gov/34362727/ | https://www.ncbi.nlm.nih.gov/pubmed/34463755 | Ioannou, A. (2021). Myocarditis should be considered in those with a troponin rise and unobstructed coronary arteries following Pfizer-BioNTech COVID-19 vaccination. QJM: An International Journal of Medicine, 1, 1. | Ioannou, A. (2021). Se debe considerar la miocarditis en aquellos con un aumento de troponina y arterias coronarias no obstruidas después de la vacuna COVID-19 de Pfizer-BioNTech. QJM: Revista internacional de medicina, 1, 1. https://www.ncbi.nlm.nih.gov/pubmed/34931681 | Ungari, M., & Pezzarossa, E. (2022). Vasculitis linfocítica cutánea después de la administración de la segunda dosis de AZD1222 (OXFORD-ASTRAZENECA) Síndrome respiratorio agudo grave Corronavirus 2 Vacunación: ¿Casualidad o causalidad? El American Journal of Dermatopatology, 44 (1), 80-82. https://pubmed.ncbi.nlm.nih.gov/34781027/ | Ioannou, A. (2021). Myocarditis should be considered in those with a troponin rise and unobstructed coronary arteries following Pfizer-BioNTech COVID-19 vaccination. QJM: An International Journal of Medicine, 1, 1. https://www.ncbi.nlm.nih.gov/pubmed/34463755 | Vaishya, R., Sibal, A., Singh, S. K., Malani, A., & Das, S. (2021). Emergence of COVID-19 variants among ChAdOx1 nCoV-19 (recombinant) vaccine recipients. The Indian journal of medical research, 153(5-6), 559. https://pubmed.ncbi.nlm.nih.gov/34528522/ | ||||||||
853 | Unilateral axillary lymphadenopathy related to COVID-19 vaccine: pattern on screening breast MRI allowing benign evaluation: | https://pubmed.ncbi.nlm.nih.gov/34325221/ | https://www.ncbi.nlm.nih.gov/pubmed/34931681 | Ioannou, A. (2021). T2 mapping should be utilized in cases of suspected myocarditis to confirm an acute inflammatory process. QJM: An International Journal of Medicine. | Ioannou, A. (2021). El mapeo T2 debe utilizarse en casos de sospecha de miocarditis para confirmar un proceso inflamatorio agudo. QJM: Revista internacional de medicina. https://www.ncbi.nlm.nih.gov/pubmed/34342500 | Vaira, L. A., PODDA, L., DONEDDU, P., CAREDDU, M. G., Fozza, C., & de Riu, G. (2021). Trombocitopenia secundaria Después de la vacuna contra SARS-COV-2: informe de un caso de hemorragia y hematoma después de una cirugía oral menor. Diario de estomatología, cirugía oral y maxilofacial. https://pubmed.ncbi.nlm.nih.gov/34384129/ | Ioannou, A. (2021). T2 mapping should be utilized in cases of suspected myocarditis to confirm an acute inflammatory process. QJM: An International Journal of Medicine. https://www.ncbi.nlm.nih.gov/pubmed/34931681 | van Dijk, M. M., Veldman, H. D., Aarts, F., Barten, D. G., van den Bergh, J. P., & Dielis, A. W. (2022). A case of unusual mild clinical presentation of COVID-19 vaccine-induced immune thrombotic thrombocytopenia with splanchnic vein thrombosis. Annals of hepatology, 27(1), 100590. https://pubmed.ncbi.nlm.nih.gov/34843991/ | ||||||||
854 | Axillary lymphadenopathy in patients with recent Covid-19 vaccination: a new diagnostic dilemma: | https://pubmed.ncbi.nlm.nih.gov/34825530/. | https://www.ncbi.nlm.nih.gov/pubmed/34342500 | Isaak, A., Feisst, A., & Luetkens, J. A. (2021). Myocarditis following COVID-19 vaccination. Radiology, 301(1), E378-E379. | Isaak, A., Feisst, A. y Luetkens, JA (2021). Miocarditis tras la vacunación COVID-19. Radiología, 301(1), E378-E379. https://www.ncbi.nlm.nih.gov/pubmed/34805376 | Vaishya, R., SIBAL, A., SINGH, S. K., Malani, A., & Das, S. (2021). La aparición de variantes de COVID-19 entre los destinatarios de la vacuna Chadox1 NCOV-19 (recombinante). The Indian Journal of Medical Research, 153 (5-6), 559. https://pubmed.ncbi.nlm.nih.gov/34568726/ | Isaak, A., Feisst, A., & Luetkens, J. A. (2021). Myocarditis following COVID-19 vaccination. Radiology, 301(1), E378-E379. https://www.ncbi.nlm.nih.gov/pubmed/34342500 | Van Kammen, M. S., De Sousa, D. A., Poli, S., Cordonnier, C., Heldner, M. R., Van De Munckhof, A., ... & Arslan, Y. (2021). Characteristics and outcomes of patients with cerebral venous sinus thrombosis in SARS-CoV-2 vaccine–induced immune thrombotic thrombocytopenia. JAMA neurology, 78(11), 1314-1323. https://jamanetwork.com/journals/jamaneurology/fullarticle/2784622 | ||||||||
855 | Minimal change disease and acute kidney injury after Pfizer-BioNTech COVID-19 vaccine: | https://pubmed.ncbi.nlm.nih.gov/34000278/ | https://www.ncbi.nlm.nih.gov/pubmed/34805376 | Istampoulouoglou, I., Dimitriou, G., Späni, S., Christ, A., Zimmermanns, B., Koechlin, S., ... & Leuppi-Taegtmeyer, A. B. (2021). Myocarditis and pericarditis in association with COVID-19 mRNA-vaccination: cases from a regional pharmacovigilance centre. Global cardiology science & practice, 2021(3). | Istampoulouoglou, I., Dimitriou, G., Späni, S., Christ, A., Zimmermanns, B., Koechlin, S., ... y Leuppi-Taegtmeyer, A. B. (2021). Miocarditis y pericarditis en asociación con la vacunación con ARNm de COVID-19: casos de un centro regional de farmacovigilancia. Ciencia y práctica de la cardiología global, 2021(3). https://www.ncbi.nlm.nih.gov/pubmed/34834983 | Van Dijk, M. M., Veldman, H. D., Aarts, F., Barten, D. G., Van Den Bergh, J. P., & Dieis, A. W. (2022). Un caso de una presentación clínica leve inusual de la trombocitopenia trombótica inmune inducida por la vacuna contra la vacuna con la trombosis de la vena esplácnica. Anales de hepatología, 27 (1), 100590. https://pubmed.ncbi.nlm.nih.gov/34595867/ | Istampoulouoglou, I., Dimitriou, G., Späni, S., Christ, A., Zimmermanns, B., Koechlin, S., ... & Leuppi-Taegtmeyer, A. B. (2021). Myocarditis and pericarditis in association with COVID-19 mRNA-vaccination: cases from a regional pharmacovigilance centre. Global cardiology science & practice, 2021(3). https://www.ncbi.nlm.nih.gov/pubmed/34805376 | Varas, G. M., Flores, A. C., & Casado, M. S. Venous sinus thrombosis following vaccination with ChAdOx1 nCov-19. Medicina intensiva, S0210-5691. https://pubmed.ncbi.nlm.nih.gov/34420802/ | ||||||||
856 | COVID-19 vaccine-induced unilateral axillary adenopathy: follow-up evaluation in the USA: | https://pubmed.ncbi.nlm.nih.gov/34655312/. | https://www.ncbi.nlm.nih.gov/pubmed/34834983 | Jaafar, R., Boschi, C., Aherfi, S., Bancod, A., Le Bideau, M., Edouard, S., ... & La Scola, B. (2021). High individual heterogeneity of neutralizing activities against the original strain and nine different variants of SARS-CoV-2. Viruses, 13(11), 2177. | Jaafar, R., Boschi, C., Aherfi, S., Bancod, A., Le Bideau, M., Edouard, S., ... & La Scola, B. (2021). Alta heterogeneidad individual de actividades neutralizantes contra la cepa original y nueve variantes diferentes del SARS-CoV-2. Virus, 13(11), 2177. https://www.ncbi.nlm.nih.gov/pubmed/34389692 | Van Kammen, M. S., de Sousa, D. A., Poli, S., Cordonnier, C., Hellner, M. R., Van de Manckhof, A., ... & Arslan, Y. (2021). CARACTERÍSTICAS Y RESULTADOS DE PACIENTES CON TROMBOSIS SINUSOS VANEBRALES CEREREBRALES EN SARS-COV-2 TROMBÓTROPENIA DE TROMBÓTICO INMONTURÓTICA INGURÓ DE LA VACUNA. JAMA NEUROLOGÍA, 78 (11), 1314-1323. https://pubmed.ncbi.nlm.nih.gov/34781321/ | Jaafar, R., Boschi, C., Aherfi, S., Bancod, A., Le Bideau, M., Edouard, S., ... & La Scola, B. (2021). High individual heterogeneity of neutralizing activities against the original strain and nine different variants of SARS-CoV-2. Viruses, 13(11), 2177. https://www.ncbi.nlm.nih.gov/pubmed/34834983 | Varona, J. F., García-Isidro, M., Moeinvaziri, M., Ramos-López, M., & Fernández-Domínguez, M. (2021). Primary adrenal insufficiency associated with Oxford-AstraZeneca ChAdOx1 nCoV-19 vaccine-induced immune thrombotic thrombocytopenia (VITT). European Journal of Internal Medicine, 91, 90-92. https://pubmed.ncbi.nlm.nih.gov/34256983/ | ||||||||
857 | Gastroparesis after Pfizer-BioNTech COVID-19 vaccination: | https://pubmed.ncbi.nlm.nih.gov/34187985/. | https://www.ncbi.nlm.nih.gov/pubmed/34389692 | Jain, S. S., Steele, J. M., Fonseca, B., Huang, S., Shah, S., Maskatia, S. A., ... & Grosse-Wortmann, L. (2021). COVID-19 Vaccination–Associated Myocarditis in Adolescents. Pediatrics, 148(5). | Jain, S. S., Steele, J. M., Fonseca, B., Huang, S., Shah, S., Maskatia, S. A., ... y Grosse-Wortmann, L. (2021). Miocarditis asociada a la vacunación COVID-19 en adolescentes. Pediatría, 148(5). https://www.ncbi.nlm.nih.gov/pubmed/34270752 | Varas, G. M., Flores, A. C., & Casado, M. S. La trombosis sinusal venosa después de la vacunación con Chadox1 NCOV-19. Medicina Intensiva, S0210-5691. https://pubmed.ncbi.nlm.nih.gov/34293217/ | Jain, S. S., Steele, J. M., Fonseca, B., Huang, S., Shah, S., Maskatia, S. A., ... & Grosse-Wortmann, L. (2021). COVID-19 Vaccination–Associated Myocarditis in Adolescents. Pediatrics, 148(5). https://www.ncbi.nlm.nih.gov/pubmed/34389692 | Varona, J. F., García-Isidro, M., Moeinvaziri, M., Ramos-López, M., & Fernández-Domínguez, M. (2021). Primary adrenal insufficiency associated with Oxford-AstraZeneca ChAdOx1 nCoV-19 vaccine-induced immune thrombotic thrombocytopenia (VITT). European Journal of Internal Medicine, 91, 90-92. https://www.sciencedirect.com/science/article/pii/S0953620521002363 | ||||||||
858 | Acute-onset supraclavicular lymphadenopathy coincident with intramuscular mRNA vaccination against COVID-19 may be related to the injection technique of the vaccine, Spain, January and February 2021: | https://pubmed.ncbi.nlm.nih.gov/33706861/ | https://www.ncbi.nlm.nih.gov/pubmed/34270752 | Jhaveri, R., Adler-Shohet, F. C., Blyth, C. C., Chiotos, K., Gerber, J. S., Green, M., ... & Zaoutis, T. (2021). Weighing the Risks of Perimyocarditis With the Benefits of SARS-CoV-2 mRNA Vaccination in Adolescents. Journal of the Pediatric Infectious Diseases Society, 10(10), 937-939. | Jhaveri, R., Adler-Shohet, F. C., Blyth, C. C., Chiotos, K., Gerber, J. S., Green, M., ... y Zaoutis, T. (2021). Sopesar los riesgos de la perimiocarditis con los beneficios de la vacunación con ARNm del SARS-CoV-2 en adolescentes. Revista de la Sociedad de Enfermedades Infecciosas Pediátricas, 10(10), 937-939. https://www.ncbi.nlm.nih.gov/pubmed/34744118 | Varona, J. F., García-Isidro, M., Moeinvaziri, M., Ramos-López, M., & Fernández-Domínguez, M. (2021). Insuficiencia suprarrenal primaria asociada con Oxford-AstraZeneca Chadox1 NCOV-19 Inducida de la trombocitopenia trombótica inmune (VITT). Diario Europeo de Medicina Interna, 91, 90-92. https://pubmed.ncbi.nlm.nih.gov/34247246/. | Jhaveri, R., Adler-Shohet, F. C., Blyth, C. C., Chiotos, K., Gerber, J. S., Green, M., ... & Zaoutis, T. (2021). Weighing the Risks of Perimyocarditis With the Benefits of SARS-CoV-2 mRNA Vaccination in Adolescents. Journal of the Pediatric Infectious Diseases Society, 10(10), 937-939. https://www.ncbi.nlm.nih.gov/pubmed/34270752 | Vassallo, C., Boveri, E., Brazzelli, V., Rampino, T., Bruno, R., Bonometti, A., & Gregorini, M. (2021). Cutaneous lymphocytic vasculitis after administration of COVID‐19 mRNA vaccine. Dermatologic Therapy. https://pubmed.ncbi.nlm.nih.gov/34327795 | ||||||||
859 | Supraclavicular lymphadenopathy after COVID-19 vaccination in Korea: serial follow-up by ultrasonography: | https://pubmed.ncbi.nlm.nih.gov/34116295/ | https://www.ncbi.nlm.nih.gov/pubmed/34744118 | Kaneta, K., Yokoi, K., Jojima, K., Kotooka, N., & Node, K. (2021). Young Male With Myocarditis Following mRNA-1273 Vaccination Against Coronavirus Disease-2019 (COVID-19). Circulation Journal, CJ-21. | Kaneta, K., Yokoi, K., Jojima, K., Kotooka, N. y Node, K. (2021). Varón joven con miocarditis después de la vacunación con ARNm-1273 contra la enfermedad por coronavirus-2019 (COVID-19). Diario de circulación, CJ-21. https://www.ncbi.nlm.nih.gov/pubmed/34568540 | Varona, J. F., García-Isidro, M., Moeinvaziri, M., Ramos-López, M., & Fernández-Domínguez, M. (2021). Insuficiencia suprarrenal primaria asociada con Oxford-AstraZeneca Chadox1 NCOV-19 Inducida de la trombocitopenia trombótica inmune (VITT). Diario Europeo de Medicina Interna, 91, 90-92. https://www.sciencedirect.com/science/article/pii/S0828282X21006243 | Kaneta, K., Yokoi, K., Jojima, K., Kotooka, N., & Node, K. (2021). Young Male With Myocarditis Following mRNA-1273 Vaccination Against Coronavirus Disease-2019 (COVID-19). Circulation Journal, CJ-21. https://www.ncbi.nlm.nih.gov/pubmed/34744118 | Vayne, C., Rollin, J., Gruel, Y., Pouplard, C., Galinat, H., Huet, O., ... & Susen, S. (2021). PF4 immunoassays in vaccine-induced thrombotic thrombocytopenia. New England Journal of Medicine, 385(4), 376-378. https://www.nejm.org/doi/full/10.1056/NEJMc2106383 | ||||||||
860 | Oxford-AstraZeneca COVID-19 vaccination induced lymphadenopathy on [18F] choline PET / CT, not just an FDG finding: | https://pubmed.ncbi.nlm.nih.gov/33661328/ | https://www.ncbi.nlm.nih.gov/pubmed/34568540 | Kaul, R., Sreenivasan, J., Goel, A., Malik, A., Bandyopadhyay, D., Jin, C., ... & Panza, J. A. (2021). Myocarditis following COVID-19 vaccination. International Journal of Cardiology. Heart & Vasculature. | Kaul, R., Sreenivasan, J., Goel, A., Malik, A., Bandyopadhyay, D., Jin, C., ... y Panza, J. A. (2021). Miocarditis tras la vacunación COVID-19. Revista Internacional de Cardiología. Corazón y vasculatura. https://www.ncbi.nlm.nih.gov/pubmed/34447639 | Vassallo, C., Boveri, E., Brazzelli, V., Rampino, T., Bruno, R., Bonometi, A., & Gregorini, M. (2021). Vasculitis linfocítica cutánea después de la administración de la vacuna contra el ARNm COVID-19. Terapia dermatológica. https://pubmed.ncbi.nlm.nih.gov/34660867/. | Kaul, R., Sreenivasan, J., Goel, A., Malik, A., Bandyopadhyay, D., Jin, C., ... & Panza, J. A. (2021). Myocarditis following COVID-19 vaccination. International Journal of Cardiology. Heart & Vasculature. https://www.ncbi.nlm.nih.gov/pubmed/34568540 | Vegezzi, E., Ravaglia, S., Buongarzone, G., Bini, P., Diamanti, L., Gastaldi, M., ... & Marchioni, E. (2021). Acute myelitis and ChAdOx1 nCoV-19 vaccine: Casual or causal association?. Journal of Neuroimmunology, 359, 577686. https://www.sciencedirect.com/science/article/pii/S0165572821002137 | ||||||||
861 | Biphasic anaphylaxis after exposure to the first dose of Pfizer-BioNTech COVID-19 mRNA vaccine COVID-19: | https://pubmed.ncbi.nlm.nih.gov/34050949/ | https://www.ncbi.nlm.nih.gov/pubmed/34447639 | Khogali, F., & Abdelrahman, R. (2021). Unusual presentation of acute perimyocarditis following SARS-COV-2 mRNA-1237 Moderna vaccination. Cureus, 13(7). | Khogali, F. y Abdelrahman, R. (2021). Presentación inusual de perimiocarditis aguda después de la vacunación con SARS-COV-2 mRNA-1237 Moderna. Cureus, 13(7). https://www.ncbi.nlm.nih.gov/pubmed/34185046 | Vayne, C., Rollin, J., GRUEL, Y., POUPLARD, C., Galinat, H., Huet, O., ... & Susen, S. (2021). PF4 inmunoensayos en trombocitopenia trombótica inducida por la vacuna. New England Journal of Medicine, 385 (4), 376-378. https://www.nature.com/articles/s41586-021-03744-4 | Khogali, F., & Abdelrahman, R. (2021). Unusual presentation of acute perimyocarditis following SARS-COV-2 mRNA-1237 Moderna vaccination. Cureus, 13(7). https://www.ncbi.nlm.nih.gov/pubmed/34447639 | Vera-Lastra, O., Ordinola Navarro, A., Cruz Domiguez, M. P., Medina, G., Sánchez Valadez, T. I., & Jara, L. J. (2021). Two cases of Graves' disease following SARS-CoV-2 vaccination: an autoimmune/inflammatory syndrome induced by adjuvants. Thyroid, 31(9), 1436-1439. https://pubmed.ncbi.nlm.nih.gov/33858208/ | ||||||||
862 | Axillary adenopathy associated with COVID-19 vaccination: imaging findings and follow-up recommendations in 23 women: | https://pubmed.ncbi.nlm.nih.gov/33624520/ | https://www.ncbi.nlm.nih.gov/pubmed/34185046 | Kim, H. W., Jenista, E. R., Wendell, D. C., Azevedo, C. F., Campbell, M. J., Darty, S. N., ... & Kim, R. J. (2021). Patients with acute myocarditis following mRNA COVID-19 vaccination. JAMA cardiology, 6(10), 1196-1201. | Kim, HW, Jenista, E. R., Wendell, D. C., Azevedo, C. F., Campbell, M. J., Darty, S. N., ... y Kim, R. J. (2021). Pacientes con miocarditis aguda después de la vacunación con ARNm COVID-19. Cardiología JAMA, 6(10), 1196-1201. https://www.ncbi.nlm.nih.gov/pubmed/34402228 | Vea, I., Su, J. R., Lale, A., Woo, E. J., Guh, A. Y., Shimabukuro, T. T., ... & BRODER, K. R. (2021). Informes de casos estadounidenses de trombosis sinusita venosa cerebral con trombocitopenia después de la AD26. COV2. S Vacunación, del 2 de marzo al 21 de abril de 2021. JAMA, 325 (24), 2448-2456. https://pubmed.ncbi.nlm.nih.gov/34159588/. | Kim, H. W., Jenista, E. R., Wendell, D. C., Azevedo, C. F., Campbell, M. J., Darty, S. N., ... & Kim, R. J. (2021). Patients with acute myocarditis following mRNA COVID-19 vaccination. JAMA cardiology, 6(10), 1196-1201. https://www.ncbi.nlm.nih.gov/pubmed/34185046 | Verma, A. K., Lavine, K. J., & Lin, C. Y. (2021). Myocarditis after Covid-19 mRNA vaccination. New England Journal of Medicine, 385(14), 1332-1334. https://www.nejm.org/doi/full/10.1056/NEJMc2109975 | ||||||||
863 | A case of cervical lymphadenopathy following COVID-19 vaccination: | https://pubmed.ncbi.nlm.nih.gov/34141500/ | https://www.ncbi.nlm.nih.gov/pubmed/34402228 | Kim, I. C., Kim, H., Lee, H. J., Kim, J. Y., & Kim, J. Y. (2021). Cardiac imaging of acute myocarditis following COVID-19 mRNA vaccination. Journal of Korean Medical Science, 36(32). | Kim, I. C., Kim, H., Lee, H. J., Kim, J. Y. y Kim, J. Y. (2021). Imágenes cardíacas de miocarditis aguda después de la vacunación con ARNm de COVID-19. Revista de ciencia médica coreana, 36(32). https://www.ncbi.nlm.nih.gov/pubmed/34396358 | Vea, I., Su, J. R., Lale, A., Woo, E. J., Guh, A. Y., Shimabukuro, T. T., ... & BRODER, K. R. (2021). Informes de casos estadounidenses de trombosis sinusita venosa cerebral con trombocitopenia después de la AD26. COV2. S Vacunación, del 2 de marzo al 21 de abril de 2021. JAMA, 325 (24), 2448-2456. https://www.thelancet.com/journals/langas/article/PIIS2468-1253(21)00197-7/ | Kim, I. C., Kim, H., Lee, H. J., Kim, J. Y., & Kim, J. Y. (2021). Cardiac imaging of acute myocarditis following COVID-19 mRNA vaccination. Journal of Korean Medical Science, 36(32). https://www.ncbi.nlm.nih.gov/pubmed/34402228 | Vidula, M. K., Ambrose, M., Glassberg, H., Chokshi, N., Chen, T., Ferrari, V. A., & Han, Y. (2021). Myocarditis and other cardiovascular complications of the mRNA-based COVID-19 vaccines. Cureus, 13(6). https://pubmed.ncbi.nlm.nih.gov/34277198/ | ||||||||
864 | Unique imaging findings of neurologic phantosmia after Pfizer-BioNtech COVID-19 vaccination: a case report: | https://pubmed.ncbi.nlm.nih.gov/34096896/ | https://www.ncbi.nlm.nih.gov/pubmed/34396358 | King, W. W., Petersen, M. R., Matar, R. M., Budweg, J. B., Pardo, L. C., & Petersen, J. W. (2021). Myocarditis following mRNA vaccination against SARS-CoV-2, a case series. American Heart Journal Plus: Cardiology Research and Practice, 8, 100042. | King, W. W., Petersen, M. R., Matar, R. M., Budweg, J. B., Pardo, L. C. y Petersen, J. W. (2021). Miocarditis tras la vacunación con ARNm contra el SARS-CoV-2, una serie de casos. American Heart Journal Plus: Investigación y práctica de cardiología, 8, 100042. https://www.ncbi.nlm.nih.gov/pubmed/34477808 | VeGezzi, E., Ravaglia, S., Bugarzone, G., Bini, P., Diamanti, L., Gastaldi, M., ... & Marchioni, E. (2021). MIELITIS AGUDA Y CHADOX1 VACUNA DE LA NCOV-19: ¿Asociación informal o causal? Diario de Neuroimmunology, 359, 577686. https://www.sciencedirect.com/science/article/pii/S1473309921002735 | King, W. W., Petersen, M. R., Matar, R. M., Budweg, J. B., Pardo, L. C., & Petersen, J. W. (2021). Myocarditis following mRNA vaccination against SARS-CoV-2, a case series. American Heart Journal Plus: Cardiology Research and Practice, 8, 100042. https://www.ncbi.nlm.nih.gov/pubmed/34396358 | Vidula, M. K., Ambrose, M., Glassberg, H., Chokshi, N., Chen, T., Ferrari, V. A., & Han, Y. (2021). Myocarditis and other cardiovascular complications of the mRNA-based COVID-19 vaccines. Cureus, 13(6). https://www.ncbi.nlm.nih.gov/pubmed/34277198 | ||||||||
865 | Thrombotic adverse events reported for Moderna, Pfizer, and Oxford-AstraZeneca COVID-19 vaccines: comparison of occurrence and clinical outcomes in the EudraVigilance database: | https://pubmed.ncbi.nlm.nih.gov/34835256/ | https://www.ncbi.nlm.nih.gov/pubmed/34477808 | Klein, N. P., Lewis, N., Goddard, K., Fireman, B., Zerbo, O., Hanson, K. E., ... & Weintraub, E. S. (2021). Surveillance for adverse events after COVID-19 mRNA vaccination. JAMA, 326(14), 1390-1399. | Klein, N. P., Lewis, N., Goddard, K., Fireman, B., Zerbo, O., Hanson, K. E., ... y Weintraub, E. S. (2021). Vigilancia de eventos adversos después de la vacunación con ARNm de COVID-19. JAMA, 326(14), 1390-1399. https://www.ncbi.nlm.nih.gov/pubmed/33898162 | Vera-Lastra, O., Ordinola Navarro, A., Cruz Domiguez, M. P., Medina, G., Sánchez Valadez, T. I., & Jara, L. J. (2021). Dos casos de enfermedad de Graves después de la vacunación con SARS-COV-2: un síndrome autoinmune / inflamatorio inducido por adyuvantes. Thyroid, 31 (9), 1436-1439. https://pubmed.ncbi.nlm.nih.gov/34015240/ | Klein, N. P., Lewis, N., Goddard, K., Fireman, B., Zerbo, O., Hanson, K. E., ... & Weintraub, E. S. (2021). Surveillance for adverse events after COVID-19 mRNA vaccination. JAMA, 326(14), 1390-1399. https://www.ncbi.nlm.nih.gov/pubmed/34477808 | Villa, M., Díaz-Crespo, F., de José, A. P., Verdalles, Ú., Verde, E., Ruiz, F. A., ... & Goicoechea, M. (2021). A case of ANCA-associated vasculitis after AZD1222 (Oxford–AstraZeneca) SARS-CoV-2 vaccination: casualty or causality?. Kidney International, 100(4), 937-938. https://pubmed.ncbi.nlm.nih.gov/34416184/ | ||||||||
866 | Unilateral lymphadenopathy after COVID-19 vaccination: a practical management plan for radiologists of all specialties: | https://pubmed.ncbi.nlm.nih.gov/33713605/ | https://www.ncbi.nlm.nih.gov/pubmed/33898162 | Klimek, L., Bergmann, K. C., Brehler, R., Pfützner, W., Zuberbier, T., Hartmann, K., ... & Worm, M. (2021). Practical handling of allergic reactions to COVID-19 vaccines. Allergo journal international, 30(3), 79-95. | Klimek, L., Bergmann, K. C., Brehler, R., Pfützner, W., Zuberbier, T., Hartmann, K., ... y Worm, M. (2021). Manejo práctico de las reacciones alérgicas a las vacunas COVID-19. Revista internacional Allergo, 30(3), 79-95. https://www.ncbi.nlm.nih.gov/pubmed/33643776 | Verma, A. K., Lavine, K. J., & Lin, C. Y. (2021). Miocarditis después de la vacunación de ARNm Covid-19. New England Journal of Medicine, 385 (14), 1332-1334. https://jamanetwork.com/journals/jamacardiology/fullarticle/2781602 | Klimek, L., Bergmann, K. C., Brehler, R., Pfützner, W., Zuberbier, T., Hartmann, K., ... & Worm, M. (2021). Practical handling of allergic reactions to COVID-19 vaccines. Allergo journal international, 30(3), 79-95. https://www.ncbi.nlm.nih.gov/pubmed/33898162 | Villa, M., Díaz-Crespo, F., de José, A. P., Verdalles, Ú., Verde, E., Ruiz, F. A., ... & Goicoechea, M. (2021). A case of ANCA-associated vasculitis after AZD1222 (Oxford–AstraZeneca) SARS-CoV-2 vaccination: casualty or causality?. Kidney International, 100(4), 937-938. https://pubmed.ncbi.nlm.nih.gov/34416184/. | ||||||||
867 | Unilateral axillary adenopathy in the setting of COVID-19 vaccination: follow-up: | https://pubmed.ncbi.nlm.nih.gov/34298342/ | https://www.ncbi.nlm.nih.gov/pubmed/33643776 | Klimek, L., Novak, N., Hamelmann, E., Werfel, T., Wagenmann, M., Taube, C., ... & Worm, M. (2021). Severe allergic reactions after COVID-19 vaccination with the Pfizer/BioNTech vaccine in Great Britain and USA. Allergo journal international, 30(2), 51-55. | Klimek, L., Novak, N., Hamelmann, E., Werfel, T., Wagenmann, M., Taube, C., ... y Worm, M. (2021). Reacciones alérgicas graves tras la vacunación COVID-19 con la vacuna Pfizer/BioNTech en Gran Bretaña y Estados Unidos. Revista Allergo internacional, 30(2), 51-55. https://www.ncbi.nlm.nih.gov/pubmed/34952008 | Vidula, M. K., Ambrose, M., Glassberg, H., Chokshi, N., Chen, T., Ferrari, V. A., & Han, Y. (2021). Miocarditis y otras complicaciones cardiovasculares de las vacunas COVID-19 a base de ARNm. CUREUS, 13 (6). https://pubmed.ncbi.nlm.nih.gov/34364831/ | Klimek, L., Novak, N., Hamelmann, E., Werfel, T., Wagenmann, M., Taube, C., ... & Worm, M. (2021). Severe allergic reactions after COVID-19 vaccination with the Pfizer/BioNTech vaccine in Great Britain and USA. Allergo journal international, 30(2), 51-55. https://www.ncbi.nlm.nih.gov/pubmed/33643776 | Violi, F., Cammisotto, V., Pastori, D., & Pignatelli, P. (2021). Thrombosis in pre-and post-vaccination phase of COVID-19. European Heart Journal Supplements, 23(Supplement_E), E184-E188. https://pubmed.ncbi.nlm.nih.gov/34650382/ | ||||||||
868 | A systematic review of cases of CNS demyelination following COVID-19 vaccination: | https://pubmed.ncbi.nlm.nih.gov/34839149/ | https://www.ncbi.nlm.nih.gov/pubmed/34952008 | Kohli, U., Desai, L., Chowdhury, D., Harahsheh, A. S., Yonts, A. B., Ansong, A., ... & Ang, J. Y. (2021). mRNA Coronavirus-19 Vaccine-Associated Myopericarditis in Adolescents: A Survey Study. The Journal of pediatrics. | Kohli, U., Desai, L., Chowdhury, D., Harahsheh, A. S., Yonts, A. B., Ansong, A., ... y Ang, J. Y. (2021). Miopericarditis asociada a la vacuna contra el coronavirus-19 de ARNm en adolescentes: un estudio de encuesta. La revista de pediatría. https://www.ncbi.nlm.nih.gov/pubmed/34642628 | Vidula, M. K., Ambrose, M., Glassberg, H., Chokshi, N., Chen, T., Ferrari, V. A., & Han, Y. (2021). Miocarditis y otras complicaciones cardiovasculares de las vacunas COVID-19 a base de ARNm. CUREUS, 13 (6). https://www.ncbi.nlm.nih.gov/pubmed/34731877 | Kohli, U., Desai, L., Chowdhury, D., Harahsheh, A. S., Yonts, A. B., Ansong, A., ... & Ang, J. Y. (2021). mRNA Coronavirus-19 Vaccine-Associated Myopericarditis in Adolescents: A Survey Study. The Journal of pediatrics. https://www.ncbi.nlm.nih.gov/pubmed/34952008 | Visclosky, T., Theyyunni, N., Klekowski, N., & Bradin, S. (2021). Myocarditis Following mRNA COVID-19 Vaccine. Pediatric emergency care, 37(11), 583-584. https://journals.lww.com/pec-online/Abstract/2021/11000/Myocarditis_Following_mRNA_COVID_19_Vaccine.9.aspx | ||||||||
869 | Supraclavicular lymphadenopathy after COVID-19 vaccination: an increasing presentation in the two-week wait neck lump clinic: | https://pubmed.ncbi.nlm.nih.gov/33685772/ | https://www.ncbi.nlm.nih.gov/pubmed/34642628 | Kostoff, R. N., Calina, D., Kanduc, D., Briggs, M. B., Vlachoyiannopoulos, P., Svistunov, A. A., & Tsatsakis, A. (2021). Erratum to “Why are we vaccinating children against COVID-19?”[Toxicol. Rep. 8C (2021) 1665–1684/1193]. Toxicology Reports. | Kostoff, R. N., Calina, D., Kanduc, D., Briggs, M. B., Vlachoyiannopoulos, P., Svistunov, A. A. y Tsatsakis, A. (2021). Errata de “¿Por qué estamos vacunando a los niños contra el COVID-19?”[Toxicol. Rep. 8C (2021) 1665–1684/1193]. Informes de Toxicología. https://www.ncbi.nlm.nih.gov/pubmed/34540594 | Villa, M., Díaz-crespo, F., de José, A. P., Verdalles, ú., Verde, E., Ruiz, F. A., ... & goicoechea, M. (2021). Un caso de vasculitis asociada a ANCA después de la vacunación contra AZD12222 (OXFORD-ASTRAZENECA) SARS-COV-2: ¿Casualidad o causalidad? Ridney International, 100 (4), 937-938. https://pubmed.ncbi.nlm.nih.gov/34261297/ | Kostoff, R. N., Calina, D., Kanduc, D., Briggs, M. B., Vlachoyiannopoulos, P., Svistunov, A. A., & Tsatsakis, A. (2021). Erratum to “Why are we vaccinating children against COVID-19?”[Toxicol. Rep. 8C (2021) 1665–1684/1193]. Toxicology Reports. https://www.ncbi.nlm.nih.gov/pubmed/34642628 | Visclosky, T., Theyyunni, N., Klekowski, N., & Bradin, S. (2021). Myocarditis Following mRNA COVID-19 Vaccine. Pediatric emergency care, 37(11), 583-584. https://www.ncbi.nlm.nih.gov/pubmed/34731877 | ||||||||
870 | COVID-19 vaccine-related axillary and cervical lymphadenopathy in patients with current or previous breast cancer and other malignancies: cross-sectional imaging findings on MRI, CT and PET-CT: | https://pubmed.ncbi.nlm.nih.gov/34719892/ | https://www.ncbi.nlm.nih.gov/pubmed/34540594 | Kostoff, R. N., Calina, D., Kanduc, D., Briggs, M. B., Vlachoyiannopoulos, P., Svistunov, A. A., & Tsatsakis, A. (2021). Why are we vaccinating children against COVID-19?. Toxicology reports, 8, 1665-1684. | Kostoff, R. N., Calina, D., Kanduc, D., Briggs, M. B., Vlachoyiannopoulos, P., Svistunov, A. A. y Tsatsakis, A. (2021). ¿Por qué estamos vacunando a los niños contra el COVID-19?. Informes de toxicología, 8, 1665-1684. https://www.ncbi.nlm.nih.gov/pubmed/34378087 | Villa, M., Díaz-crespo, F., de José, A. P., Verdalles, ú., Verde, E., Ruiz, F. A., ... & goicoechea, M. (2021). Un caso de vasculitis asociada a ANCA después de la vacunación contra AZD12222 (OXFORD-ASTRAZENECA) SARS-COV-2: ¿Casualidad o causalidad? Ridney International, 100 (4), 937-938. https://pubmed.ncbi.nlm.nih.gov/34664303/. | Kostoff, R. N., Calina, D., Kanduc, D., Briggs, M. B., Vlachoyiannopoulos, P., Svistunov, A. A., & Tsatsakis, A. (2021). Why are we vaccinating children against COVID-19?. Toxicology reports, 8, 1665-1684. https://www.ncbi.nlm.nih.gov/pubmed/34540594 | Visentini, M., Gragnani, L., Santini, S. A., Urraro, T., Villa, A., Monti, M., ... & Casato, M. (2022). Flares of mixed cryoglobulinaemia vasculitis after vaccination against SARS-CoV-2. Annals of the Rheumatic Diseases, 81(3), 441-443. https://pubmed.ncbi.nlm.nih.gov/34819272/ | ||||||||
871 | Adenopathy after COVID-19 vaccination: | https://pubmed.ncbi.nlm.nih.gov/33625299/. | https://www.ncbi.nlm.nih.gov/pubmed/34378087 | Kremsner, P. G., Mann, P., Kroidl, A., Leroux-Roels, I., Schindler, C., Gabor, J. J., ... & Oostvogels, L. (2021). Safety and immunogenicity of an mRNA-lipid nanoparticle vaccine candidate against SARS-CoV-2. Wiener klinische Wochenschrift, 133(17), 931-941. | Kremsner, P. G., Mann, P., Kroidl, A., Leroux-Roels, I., Schindler, C., Gabor, J. J., ... y Oostvogels, L. (2021). Seguridad e inmunogenicidad de una vacuna candidata a nanopartículas lipídicas de ARNm contra el SARS-CoV-2. Wiener klinische Wochenschrift, 133(17), 931-941. https://www.ncbi.nlm.nih.gov/pubmed/34127854 | Violi, F., Cammisotto, V., Pastori, D., & Pignatelli, P. (2021). Trombosis en fase pre-y posterior al vacunación de COVID-19. Suplementos European Heart Journal, 23 (Suplement_e), E184-E188. https://pubmed.ncbi.nlm.nih.gov/34769454/ | Kremsner, P. G., Mann, P., Kroidl, A., Leroux-Roels, I., Schindler, C., Gabor, J. J., ... & Oostvogels, L. (2021). Safety and immunogenicity of an mRNA-lipid nanoparticle vaccine candidate against SARS-CoV-2. Wiener klinische Wochenschrift, 133(17), 931-941. https://www.ncbi.nlm.nih.gov/pubmed/34378087 | Viskin, D., Topilsky, Y., Aviram, G., Mann, T., Sadon, S., Hadad, Y., ... & Havakuk, O. (2021). Myocarditis Associated With COVID-19 Vaccination: Echocardiography, Cardiac Tomography, and Magnetic Resonance Imaging Findings. Circulation: Cardiovascular Imaging, 14(9), e013236. https://pubmed.ncbi.nlm.nih.gov/34428917/. | ||||||||
872 | Incidence of axillary adenopathy on breast imaging after vaccination with COVID-19: | https://pubmed.ncbi.nlm.nih.gov/34292295/. | https://www.ncbi.nlm.nih.gov/pubmed/34127854 | Kustin, T., Harel, N., Finkel, U., Perchik, S., Harari, S., Tahor, M., ... & Stern, A. (2021). Evidence for increased breakthrough rates of SARS-CoV-2 variants of concern in BNT162b2-mRNA-vaccinated individuals. Nature medicine, 27(8), 1379-1384. | Kustin, T., Harel, N., Finkel, U., Perchik, S., Harari, S., Tahor, M., ... y Stern, A. (2021). Evidencia de mayores tasas de avance de variantes preocupantes del SARS-CoV-2 en personas vacunadas con ARNm de BNT162b2. Medicina natural, 27(8), 1379-1384. https://www.ncbi.nlm.nih.gov/pubmed/34393110 | VISCLOSKY, T., ellosyunni, N., Klekowski, N., & Bradin, S. (2021). Miocarditis después de la vacuna contra MRNA COVID-19. Atención de emergencia pediátrica, 37 (11), 583-584. https://pubmed.ncbi.nlm.nih.gov/34614328/. | Kustin, T., Harel, N., Finkel, U., Perchik, S., Harari, S., Tahor, M., ... & Stern, A. (2021). Evidence for increased breakthrough rates of SARS-CoV-2 variants of concern in BNT162b2-mRNA-vaccinated individuals. Nature medicine, 27(8), 1379-1384. https://www.ncbi.nlm.nih.gov/pubmed/34127854 | Viskin, D., Topilsky, Y., Aviram, G., Mann, T., Sadon, S., Hadad, Y., ... & Havakuk, O. (2021). Myocarditis Associated With COVID-19 Vaccination: Echocardiography, Cardiac Tomography, and Magnetic Resonance Imaging Findings. Circulation: Cardiovascular Imaging, 14(9), e013236. https://www.ahajournals.org/doi/10.1161/CIRCIMAGING.121.013236 | ||||||||
873 | COVID-19 vaccination and lower cervical lymphadenopathy in two-week neck lump clinic: a follow-up audit: | https://pubmed.ncbi.nlm.nih.gov/33947605/. | https://www.ncbi.nlm.nih.gov/pubmed/34393110 | Kwan, M. Y., Chua, G. T., Chow, C. B., Tsao, S. S., To, K. K., Yuen, K. Y., ... & Ip, P. (2021). mRNA COVID vaccine and myocarditis in adolescents. Hong Kong Med J, 27(5), 326-327. | Kwan, M. Y., Chua, G. T., Chow, C. B., Tsao, S. S., To, K. K., Yuen, K. Y., ... & Ip, P. (2021). Vacuna ARNm COVID y miocarditis en adolescentes. Hong Kong Med J, 27(5), 326-327. https://www.ncbi.nlm.nih.gov/pubmed/34463770 | VISCLOSKY, T., ellosyunni, N., Klekowski, N., & Bradin, S. (2021). Miocarditis después de la vacuna contra MRNA COVID-19. Atención de emergencia pediátrica, 37 (11), 583-584. https://www.ncbi.nlm.nih.gov/pubmed/34533570 | Kwan, M. Y., Chua, G. T., Chow, C. B., Tsao, S. S., To, K. K., Yuen, K. Y., ... & Ip, P. (2021). mRNA COVID vaccine and myocarditis in adolescents. Hong Kong Med J, 27(5), 326-327. https://www.ncbi.nlm.nih.gov/pubmed/34393110 | Vogrig, A., Janes, F., Gigli, G. L., Curcio, F., Del Negro, I., D’Agostini, S., ... & Valente, M. (2021). Acute disseminated encephalomyelitis after SARS-CoV-2 vaccination. Clinical Neurology and Neurosurgery, 208, 106839. https://pubmed.ncbi.nlm.nih.gov/34325334/ | ||||||||
874 | Cervical lymphadenopathy after coronavirus disease vaccination 2019: clinical features and implications for head and neck cancer services: | https://pubmed.ncbi.nlm.nih.gov/34526175/ | https://www.ncbi.nlm.nih.gov/pubmed/34463770 | Lee, E., Chew, N. W., Ng, P., & Yeo, T. J. (2021). Reply to" Letter to the editor: Myocarditis should be considered in those with a troponin rise and unobstructed coronary arteries following PfizerBioNTech COVID-19 vaccination". QJM: Monthly Journal of the Association of Physicians. | Lee, E., Chew, NW, Ng, P. y Yeo, TJ (2021). Responder a" Carta al editor: Se debe considerar la miocarditis en personas con aumento de troponina y arterias coronarias no obstruidas después de la vacuna COVID-19 de PfizerBioNTech". QJM: Revista Mensual del Colegio de Médicos. https://www.ncbi.nlm.nih.gov/pubmed/33606296 | Visentini, M., Gragnani, L., Santini, S. A., Urraro, T., Villa, A., Monti, M., ... & Casato, M. (2022). Las llamaradas de la vasculitis mixta de crioglobulinaemia después de la vacunación contra el SARS-COV-2. Anales de las enfermedades reumáticas, 81 (3), 441-443. https://pubmed.ncbi.nlm.nih.gov/34337124/ | Lee, E., Chew, N. W., Ng, P., & Yeo, T. J. (2021). Reply to" Letter to the editor: Myocarditis should be considered in those with a troponin rise and unobstructed coronary arteries following PfizerBioNTech COVID-19 vaccination". QJM: Monthly Journal of the Association of Physicians. https://www.ncbi.nlm.nih.gov/pubmed/34463770 | Volk, G. F., Kuttenreich, A. M., Geitner, M., & Guntinas-Lichius, O. (2021). Acute facial paresis as a possible complication of vaccination against SARS-CoV-2. Laryngo-Rhino-Otologie. https://pubmed.ncbi.nlm.nih.gov/33975372/. | ||||||||
875 | Lymphadenopathy associated with the COVID-19 vaccine: | https://pubmed.ncbi.nlm.nih.gov/33786231/ | https://www.ncbi.nlm.nih.gov/pubmed/33606296 | Lee, E. J., Cines, D. B., Gernsheimer, T., Kessler, C., Michel, M., Tarantino, M. D., ... & Bussel, J. B. (2021). Thrombocytopenia following pfizer and Moderna SARS‐CoV‐2 vaccination. American journal of hematology. | Lee, E. J., Cines, D. B., Gernsheimer, T., Kessler, C., Michel, M., Tarantino, M. D., ... & Bussel, J. B. (2021). Trombocitopenia después de la vacunación de Pfizer y Moderna contra el SARS-CoV-2. Revista americana de hematología. https://www.ncbi.nlm.nih.gov/pubmed/34535317 | Viskin, D., Topilsky, Y., Aviram, G., Mann, T., Sadón, S., Hadad, Y., ... & Havakuk, O. (2021). Miocarditis asociada con la vacunación COVID-19: ecocardiografía, tomografía cardíaca y resultados de imágenes de resonancia magnética. Circulación: Imagen cardiovascular, 14 (9), E013236. https://pubmed.ncbi.nlm.nih.gov/34088762/. | Lee, E. J., Cines, D. B., Gernsheimer, T., Kessler, C., Michel, M., Tarantino, M. D., ... & Bussel, J. B. (2021). Thrombocytopenia following pfizer and Moderna SARS‐CoV‐2 vaccination. American journal of hematology. https://www.ncbi.nlm.nih.gov/pubmed/33606296 | Vollmann, D., Eiffert, H., & Schuster, A. (2021). Acute perimyocarditis following first dose of mRNA vaccine against COVID-19. Deutsches Ärzteblatt International, 118(31-32), 546. https://pubmed.ncbi.nlm.nih.gov/34515024/ | ||||||||
876 | Evolution of lymphadenopathy on PET/MRI after COVID-19 vaccination: | https://pubmed.ncbi.nlm.nih.gov/33625301/. | https://www.ncbi.nlm.nih.gov/pubmed/34535317 | Levin, D., Shimon, G., Fadlon-Derai, M., Gershovitz, L., Shovali, A., Sebbag, A., ... & Gordon, B. (2021). Myocarditis following COVID-19 vaccination–a case series. Vaccine, 39(42), 6195-6200. | Levin, D., Shimon, G., Fadlon-Derai, M., Gershovitz, L., Shovali, A., Sebbag, A., ... y Gordon, B. (2021). Miocarditis tras la vacunación contra la COVID-19: una serie de casos. Vacuna, 39(42), 6195-6200. https://www.ncbi.nlm.nih.gov/pubmed/33888900 | Viskin, D., Topilsky, Y., Aviram, G., Mann, T., Sadón, S., Hadad, Y., ... & Havakuk, O. (2021). Miocarditis asociada con la vacunación COVID-19: ecocardiografía, tomografía cardíaca y resultados de imágenes de resonancia magnética. Circulación: Imagen cardiovascular, 14 (9), E013236. https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.121.056038 | Levin, D., Shimon, G., Fadlon-Derai, M., Gershovitz, L., Shovali, A., Sebbag, A., ... & Gordon, B. (2021). Myocarditis following COVID-19 vaccination–a case series. Vaccine, 39(42), 6195-6200. https://www.ncbi.nlm.nih.gov/pubmed/34535317 | Von Hundelshausen, P., Lorenz, R., Siess, W., & Weber, C. (2021). Vaccine-induced immune thrombotic thrombocytopenia (VITT): targeting pathomechanisms with Bruton tyrosine kinase inhibitors. Thrombosis and haemostasis. https://pubmed.ncbi.nlm.nih.gov/33851389/ | ||||||||
877 | Autoimmune hepatitis triggered by SARS-CoV-2 vaccination: | https://pubmed.ncbi.nlm.nih.gov/34332438/. | https://www.ncbi.nlm.nih.gov/pubmed/33888900 | Li, J., Hui, A., Zhang, X., Yang, Y., Tang, R., Ye, H., ... & Zhu, F. (2021). Safety and immunogenicity of the SARS-CoV-2 BNT162b1 mRNA vaccine in younger and older Chinese adults: a randomized, placebo-controlled, double-blind phase 1 study. Nature medicine, 27(6), 1062-1070. | Li, J., Hui, A., Zhang, X., Yang, Y., Tang, R., Ye, H., ... y Zhu, F. (2021). Seguridad e inmunogenicidad de la vacuna de ARNm BNT162b1 del SARS-CoV-2 en adultos chinos más jóvenes y mayores: un estudio de fase 1, aleatorizado, controlado con placebo y doble ciego. Medicina natural, 27(6), 1062-1070. https://www.ncbi.nlm.nih.gov/pubmed/34834458 | VOGRIG, A., Janes, F., Gigli, G. L. L., Curcio, F., Del Negro, I., D'Agostini, S., ... & Valente, M. (2021). Encefalomielitis aguda diseminada después de la vacunación con SARS-COV-2. Neurología clínica y neurocirugía, 208, 106839. https://pubmed.ncbi.nlm.nih.gov/34513398/ | Li, J., Hui, A., Zhang, X., Yang, Y., Tang, R., Ye, H., ... & Zhu, F. (2021). Safety and immunogenicity of the SARS-CoV-2 BNT162b1 mRNA vaccine in younger and older Chinese adults: a randomized, placebo-controlled, double-blind phase 1 study. Nature medicine, 27(6), 1062-1070. https://www.ncbi.nlm.nih.gov/pubmed/33888900 | von Tresckow, J., von Tresckow, B., Reinhardt, H. C., Herrmann, K., & Berliner, C. (2021). Thymic hyperplasia after mRNA based COVID-19 vaccination. Radiology Case Reports, 16(12), 3744-3745. https://pubmed.ncbi.nlm.nih.gov/34462647/ | ||||||||
878 | New-onset nephrotic syndrome after Janssen COVID-19 vaccination: case report and literature review: | https://pubmed.ncbi.nlm.nih.gov/34342187/. | https://www.ncbi.nlm.nih.gov/pubmed/34834458 | Li, M., Yuan, J., Lv, G., Brown, J., Jiang, X., & Lu, Z. K. (2021). Myocarditis and Pericarditis following COVID-19 Vaccination: Inequalities in Age and Vaccine Types. Journal of personalized medicine, 11(11), 1106. | Li, M., Yuan, J., Lv, G., Brown, J., Jiang, X. y Lu, ZK (2021). Miocarditis y pericarditis después de la vacunación COVID-19: desigualdades en edad y tipos de vacuna. Revista de medicina personalizada, 11(11), 1106. https://www.ncbi.nlm.nih.gov/pubmed/34778411 | Volk, G. F., Kuttenreich, A. M., Geitner, M., y Guntinas-Lichius, O. (2021). La paresica facial aguda como posible complicación de la vacunación contra el SARS-COV-2. Laringo-rhino-otologie. https://pubmed.ncbi.nlm.nih.gov/34322761/. | Li, M., Yuan, J., Lv, G., Brown, J., Jiang, X., & Lu, Z. K. (2021). Myocarditis and Pericarditis following COVID-19 Vaccination: Inequalities in Age and Vaccine Types. Journal of personalized medicine, 11(11), 1106. https://www.ncbi.nlm.nih.gov/pubmed/34834458 | Vuille-Lessard, É., Montani, M., Bosch, J., & Semmo, N. (2021). Autoimmune hepatitis triggered by SARS-CoV-2 vaccination. Journal of autoimmunity, 123, 102710. https://pubmed.ncbi.nlm.nih.gov/34332438/ | ||||||||
879 | Massive cervical lymphadenopathy following vaccination with COVID-19: | https://pubmed.ncbi.nlm.nih.gov/34601889/ | https://www.ncbi.nlm.nih.gov/pubmed/34778411 | Lim, Y., Kim, M. C., Kim, K. H., Jeong, I. S., Cho, Y. S., Choi, Y. D., & Lee, J. E. (2021). Case Report: Acute Fulminant Myocarditis and Cardiogenic Shock After Messenger RNA Coronavirus Disease 2019 Vaccination Requiring Extracorporeal Cardiopulmonary Resuscitation. Frontiers in Cardiovascular Medicine, 8. | Lim, Y., Kim, M. C., Kim, K. H., Jeong, I. S., Cho, Y. S., Choi, Y. D. y Lee, J. E. (2021). Informe de caso: Miocarditis aguda fulminante y shock cardiogénico después de la vacunación contra la enfermedad del coronavirus con ARN mensajero de 2019 que requiere reanimación cardiopulmonar extracorpórea. Fronteras en Medicina Cardiovascular, 8. https://www.ncbi.nlm.nih.gov/pubmed/34332972 | Vollmann, D., Eiffert, H., & Schuster, A. (2021). La perimyocarditis aguda después de la primera dosis de la vacuna contra ARNm contra COVID-19. Deutsches Ärzteblatt International, 118 (31-32), 546. https://pubmed.ncbi.nlm.nih.gov/34435250/. | Lim, Y., Kim, M. C., Kim, K. H., Jeong, I. S., Cho, Y. S., Choi, Y. D., & Lee, J. E. (2021). Case Report: Acute Fulminant Myocarditis and Cardiogenic Shock After Messenger RNA Coronavirus Disease 2019 Vaccination Requiring Extracorporeal Cardiopulmonary Resuscitation. Frontiers in Cardiovascular Medicine, 8. https://www.ncbi.nlm.nih.gov/pubmed/34778411 | Vuille-Lessard, É., Montani, M., Bosch, J., & Semmo, N. (2021). Autoimmune hepatitis triggered by SARS-CoV-2 vaccination. Journal of autoimmunity, 123, 102710. https://pubmed.ncbi.nlm.nih.gov/34332438/. | ||||||||
880 | ANCA glomerulonephritis following Modern COVID-19 vaccination: | https://pubmed.ncbi.nlm.nih.gov/34081948/ | https://www.ncbi.nlm.nih.gov/pubmed/34332972 | Long, S. S. (2021). Important Insights into Myopericarditis after the Pfizer mRNA COVID-19 Vaccination in Adolescents. The Journal of Pediatrics, 238, 5. | Long, SS (2021). Información importante sobre la miopericarditis después de la vacuna de ARNm de Pfizer contra la COVID-19 en adolescentes. La Revista de Pediatría, 238, 5. https://www.ncbi.nlm.nih.gov/pubmed/34375696 | Von Hundelshausen, P., Lorenz, R., Siess, W., & Weber, C. (2021). Trombocitopenia trombótica inmune inducida por la vacuna (VITT): Forjando patomecanismos con los inhibidores de Bruton Tyrosina quinasa. Trombosis y haemostasis. https://pubmed.ncbi.nlm.nih.gov/33980419/ | Long, S. S. (2021). Important Insights into Myopericarditis after the Pfizer mRNA COVID-19 Vaccination in Adolescents. The Journal of Pediatrics, 238, 5. https://www.ncbi.nlm.nih.gov/pubmed/34332972 | Waggiallah, H. A. (2021). Thrombosis formation after COVID-19 vaccination immunological aspects. Saudi journal of biological sciences. https://pubmed.ncbi.nlm.nih.gov/34629931/ | ||||||||
881 | Extensive longitudinal transverse myelitis following AstraZeneca COVID-19 vaccination: | https://pubmed.ncbi.nlm.nih.gov/34507942/. | https://www.ncbi.nlm.nih.gov/pubmed/34375696 | Luk, A., Clarke, B., Dahdah, N., Ducharme, A., Krahn, A., McCrindle, B., ... & McDonald, M. (2021). Myocarditis and pericarditis after Covid-19 mRNA vaccination: practical considerations for care providers. Canadian Journal of Cardiology, 37(10), 1629-1634. | Luk, A., Clarke, B., Dahdah, N., Ducharme, A., Krahn, A., McCrindle, B., ... y McDonald, M. (2021). Miocarditis y pericarditis después de la vacunación con ARNm de Covid-19: consideraciones prácticas para los proveedores de atención. Revista Canadiense de Cardiología, 37(10), 1629-1634. https://www.ncbi.nlm.nih.gov/pubmed/34791081 | von Tresckow, J., von Tresckow, B., Reinhardt, H. C., Herrmann, K., & Berliner, C. (2021). Hiperplasia tímica después de la vacunación de COVID-19 a base de ARNm. Informes de casos de radiología, 16 (12), 3744-3745. https://pubmed.ncbi.nlm.nih.gov/34325334/ | Luk, A., Clarke, B., Dahdah, N., Ducharme, A., Krahn, A., McCrindle, B., ... & McDonald, M. (2021). Myocarditis and pericarditis after Covid-19 mRNA vaccination: practical considerations for care providers. Canadian Journal of Cardiology, 37(10), 1629-1634. https://www.ncbi.nlm.nih.gov/pubmed/34375696 | Waheed, S., Bayas, A., Hindi, F., Rizvi, Z., & Espinosa, P. S. (2021). Neurological complications of COVID-19: Guillain-Barre syndrome following Pfizer COVID-19 vaccine. Cureus, 13(2). https://pubmed.ncbi.nlm.nih.gov/33758714/ | ||||||||
882 | Systemic capillary extravasation syndrome after vaccination with ChAdOx1 nCOV-19 (Oxford-AstraZeneca): | https://pubmed.ncbi.nlm.nih.gov/34362727/ | https://www.ncbi.nlm.nih.gov/pubmed/34791081 | Madelon, N., Lauper, K., Breville, G., Sabater Royo, I., Goldstein, R., Andrey, D. O., ... & Eberhardt, C. S. (2021). Robust T cell responses in anti-CD20 treated patients following COVID-19 vaccination: a prospective cohort study. Clinical Infectious Diseases. | Madelon, N., Lauper, K., Breville, G., Sabater Royo, I., Goldstein, R., Andrey, D. O., ... & Eberhardt, C. S. (2021). Respuestas sólidas de células T en pacientes tratados con anti-CD20 después de la vacunación COVID-19: un estudio de cohorte prospectivo. Enfermedades Infecciosas Clínicas. https://www.ncbi.nlm.nih.gov/pubmed/34676123 | Vuille-Ansard, É., Montani, M., Bosch, J., & Semmo, N. (2021). Hepatitis autoinmune provocada por la vacunación de SARS-COV-2. Revista de autoinmunidad, 123, 102710. https://pubmed.ncbi.nlm.nih.gov/34293683/. | Madelon, N., Lauper, K., Breville, G., Sabater Royo, I., Goldstein, R., Andrey, D. O., ... & Eberhardt, C. S. (2021). Robust T cell responses in anti-CD20 treated patients following COVID-19 vaccination: a prospective cohort study. Clinical Infectious Diseases. https://www.ncbi.nlm.nih.gov/pubmed/34791081 | Walter, U., Fuchs, M., Grossmann, A., Walter, M., Thiele, T., Storch, A., & Wittstock, M. (2021). Adenovirus-vectored COVID-19 vaccine–induced immune thrombosis of carotid artery: a case report. Neurology, 97(15), 716-719. https://pubmed.ncbi.nlm.nih.gov/34312301/. | ||||||||
883 | Unilateral axillary lymphadenopathy related to COVID-19 vaccine: pattern on screening breast MRI allowing benign evaluation: | https://pubmed.ncbi.nlm.nih.gov/34325221/ | https://www.ncbi.nlm.nih.gov/pubmed/34676123 | Mangat, C., & Milosavljevic, N. (2021). BNT162b2 Vaccination during Pregnancy Protects Both the Mother and Infant: Anti-SARS-CoV-2 S Antibodies Persistently Positive in an Infant at 6 Months of Age. Case Reports in Pediatrics, 2021. | Mangat, C. y Milosavljevic, N. (2021). La vacunación BNT162b2 durante el embarazo protege tanto a la madre como al bebé: los anticuerpos anti-SARS-CoV-2 S son persistentemente positivos en un bebé de 6 meses de edad. Informes de casos en pediatría, 2021. https://www.ncbi.nlm.nih.gov/pubmed/34398511 | Vuille-Ansard, É., Montani, M., Bosch, J., & Semmo, N. (2021). Hepatitis autoinmune provocada por la vacunación de SARS-COV-2. Revista de autoinmunidad, 123, 102710. https://pubmed.ncbi.nlm.nih.gov/34342187/. | Mangat, C., & Milosavljevic, N. (2021). BNT162b2 Vaccination during Pregnancy Protects Both the Mother and Infant: Anti-SARS-CoV-2 S Antibodies Persistently Positive in an Infant at 6 Months of Age. Case Reports in Pediatrics, 2021. https://www.ncbi.nlm.nih.gov/pubmed/34676123 | Walter, U., Volmer, E., Wittstock, M., Storch, A., Weber, M. A., & Großmann, A. (2021). Cerebral venous sinus thrombosis after COVID-19 vaccination: Neurological and radiological management. Der Radiologe. https://pubmed.ncbi.nlm.nih.gov/34327553/. | ||||||||
884 | Axillary lymphadenopathy in patients with recent Covid-19 vaccination: a new diagnostic dilemma: | https://pubmed.ncbi.nlm.nih.gov/34825530/. | https://www.ncbi.nlm.nih.gov/pubmed/34398511 | Mark, C., Gupta, S., Punnett, A., Upton, J., Orkin, J., Atkinson, A., ... & Alexander, S. (2021). Safety of administration of BNT162b2 mRNA (Pfizer‐BioNTech) COVID‐19 vaccine in youths and young adults with a history of acute lymphoblastic leukemia and allergy to PEG‐asparaginase. Pediatric Blood & Cancer, 68(11), e29295. | Mark, C., Gupta, S., Punnett, A., Upton, J., Orkin, J., Atkinson, A., ... y Alexander, S. (2021). Seguridad de la administración de la vacuna COVID-19 de ARNm BNT162b2 (Pfizer‐BioNTech) en jóvenes y adultos jóvenes con antecedentes de leucemia linfoblástica aguda y alergia a la PEG‐asparaginasa. Sangre y cáncer pediátricos, 68(11), e29295. https://www.ncbi.nlm.nih.gov/pubmed/33316478 | Waggiallah, H. A. (2021). Formación de trombosis después de COVID-19 Aspectos inmunológicos de vacunación. Journal Saudi de Ciencias Biológicas. https://pubmed.ncbi.nlm.nih.gov/34842783/ | Mark, C., Gupta, S., Punnett, A., Upton, J., Orkin, J., Atkinson, A., ... & Alexander, S. (2021). Safety of administration of BNT162b2 mRNA (Pfizer‐BioNTech) COVID‐19 vaccine in youths and young adults with a history of acute lymphoblastic leukemia and allergy to PEG‐asparaginase. Pediatric Blood & Cancer, 68(11), e29295. https://www.ncbi.nlm.nih.gov/pubmed/34398511 | Wan, E. Y. F., Chui, C. S. L., Lai, F. T. T., Chan, E. W. Y., Li, X., Yan, V. K. C., ... & Wong, I. C. K. (2022). Bell's palsy following vaccination with mRNA (BNT162b2) and inactivated (CoronaVac) SARS-CoV-2 vaccines: a case series and nested case-control study. The Lancet Infectious Diseases, 22(1), 64-72. https://pubmed.ncbi.nlm.nih.gov/34411532/ | ||||||||
885 | Minimal change disease and acute kidney injury after Pfizer-BioNTech COVID-19 vaccine: | https://pubmed.ncbi.nlm.nih.gov/34000278/ | https://www.ncbi.nlm.nih.gov/pubmed/33316478 | Martins-Filho, P. R., Quintans-Júnior, L. J., de Souza Araújo, A. A., Sposato, K. B., Tavares, C. S., Gurgel, R. Q., ... & Santos, V. S. (2021). Socio-economic inequalities and COVID-19 incidence and mortality in Brazilian children: a nationwide register-based study. Public Health, 190, 4-6. | Martins-Filho, P. R., Quintans-Júnior, L. J., de Souza Araújo, A. A., Sposato, K. B., Tavares, C. S., Gurgel, R. Q., ... & Santos, V. S. (2021). Desigualdades socioeconómicas e incidencia y mortalidad de COVID-19 en niños brasileños: un estudio basado en registros a nivel nacional. Salud Pública, 190, 4-6. https://www.ncbi.nlm.nih.gov/pubmed/34133825 | Waheed, S., Bayas, A., Hindi, F., Rizvi, Z., & Espinosa, P. S. (2021). Complicaciones neurológicas de COVID-19: Síndrome de Guillain-Barre después de la vacuna Pfizer Covid-19. CUREUS, 13 (2). https://pubmed.ncbi.nlm.nih.gov/34484780/ | Martins-Filho, P. R., Quintans-Júnior, L. J., de Souza Araújo, A. A., Sposato, K. B., Tavares, C. S., Gurgel, R. Q., ... & Santos, V. S. (2021). Socio-economic inequalities and COVID-19 incidence and mortality in Brazilian children: a nationwide register-based study. Public Health, 190, 4-6. https://www.ncbi.nlm.nih.gov/pubmed/33316478 | Wang, R. L., Chiang, W. F., Shyu, H. Y., Chen, M. H., Lin, C. I., Wu, K. A., ... & Hsiao, P. J. (2021). COVID-19 vaccine-associated acute cerebral venous thrombosis and pulmonary artery embolism. QJM: An International Journal of Medicine. https://pubmed.ncbi.nlm.nih.gov/34247246/. | ||||||||
886 | COVID-19 vaccine-induced unilateral axillary adenopathy: follow-up evaluation in the USA: | https://pubmed.ncbi.nlm.nih.gov/34655312/. | https://www.ncbi.nlm.nih.gov/pubmed/34133825 | McLean, K., & Johnson, T. J. (2021). Myopericarditis in a previously healthy adolescent male following COVID‐19 vaccination: A case report. Academic Emergency Medicine, 28(8), 918-921. | McLean, K. y Johnson, TJ (2021). Miopericarditis en un adolescente previamente sano después de la vacunación contra la COVID-19: reporte de un caso. Medicina de emergencia académica, 28(8), 918-921. https://www.ncbi.nlm.nih.gov/pubmed/34614328 | Walter, U., Fuchs, M., Grossmann, A., Walter, M., Thiele, T., Storch, A., & WittStock, M. (2021). ADENOVIRUS: COVID-19 Inducido de la trombosis inmune inducida por la vacuna de la arteria carótida: un informe de caso. Neurología, 97 (15), 716-719. https://pubmed.ncbi.nlm.nih.gov/34333995/ | McLean, K., & Johnson, T. J. (2021). Myopericarditis in a previously healthy adolescent male following COVID‐19 vaccination: A case report. Academic Emergency Medicine, 28(8), 918-921. https://www.ncbi.nlm.nih.gov/pubmed/34133825 | Wantavornprasert, K., Noppakun, N., Klaewsongkram, J., & Rerknimitr, P. (2022). Generalized bullous fixed drug eruption after Oxford–AstraZeneca (ChAdOx1 nCoV‐19) vaccination. Clinical and Experimental Dermatology, 47(2), 428-432. https://pubmed.ncbi.nlm.nih.gov/34482558/ | ||||||||
887 | Gastroparesis after Pfizer-BioNTech COVID-19 vaccination: | https://pubmed.ncbi.nlm.nih.gov/34187985/. | https://www.ncbi.nlm.nih.gov/pubmed/34614328 | Mevorach, D., Anis, E., Cedar, N., Bromberg, M., Haas, E. J., Nadir, E., ... & Alroy-Preis, S. (2021). Myocarditis after BNT162b2 mRNA vaccine against Covid-19 in Israel. New England Journal of Medicine, 385(23), 2140-2149. | Mevorach, D., Anis, E., Cedar, N., Bromberg, M., Haas, E. J., Nadir, E., ... y Alroy-Preis, S. (2021). Miocarditis tras la vacuna de ARNm BNT162b2 contra Covid-19 en Israel. Revista de Medicina de Nueva Inglaterra, 385(23), 2140-2149. https://www.ncbi.nlm.nih.gov/pubmed/34166671 | Walter, U., Volmer, E., Wittstock, M., Storch, A., Weber, M. A., & Großmann, A. (2021). Trombosis sinusal venosa cerebral después de la vacunación de COVID-19: gestión neurológica y radiológica. Der radiologe. https://pubmed.ncbi.nlm.nih.gov/33878469/. | Mevorach, D., Anis, E., Cedar, N., Bromberg, M., Haas, E. J., Nadir, E., ... & Alroy-Preis, S. (2021). Myocarditis after BNT162b2 mRNA vaccine against Covid-19 in Israel. New England Journal of Medicine, 385(23), 2140-2149. https://www.ncbi.nlm.nih.gov/pubmed/34614328 | Waqar, S. H. B., Khan, A. A., & Memon, S. (2021). Thrombotic thrombocytopenic purpura: a new menace after COVID bnt162b2 vaccine. International Journal of Hematology, 114(5), 626-629. https://pubmed.ncbi.nlm.nih.gov/34264514/. | ||||||||
888 | Abbate, A., Gavin, J., Madanchi, N., Kim, C., Shah, P. R., Klein, K., . . . Danielides, S. (2021). Fulminant myocarditis and systemic hyperinflammation temporally associated with BNT162b2 mRNA COVID-19 vaccination in two patients. Int J Cardiol, 340, 119-121. doi:10.1016/j.ijcard.2021.08.018. | https://www.ncbi.nlm.nih.gov/pubmed/34416319 | https://www.ncbi.nlm.nih.gov/pubmed/34166671 | Minocha, P. K., Better, D., Singh, R. K., & Hoque, T. (2021). Recurrence of acute myocarditis temporally associated with receipt of the mRNA coronavirus disease 2019 (COVID-19) vaccine in a male adolescent. The Journal of Pediatrics, 238, 321-323. | Minocha, PK, Better, D., Singh, R. K. y Hoque, T. (2021). Recurrencia de miocarditis aguda asociada temporalmente con la recepción de la vacuna de ARNm contra la enfermedad del coronavirus 2019 (COVID-19) en un adolescente varón. La Revista de Pediatría, 238, 321-323. https://www.ncbi.nlm.nih.gov/pubmed/34737312 | WAN, E. Y. F., Chui, C. S. S. L., LAI, F. T. T., Chan, E. W. Y., Li, X., Yan, V. K. C., ... & Wong, I. C. K. (2022). La parálisis de Bell después de la vacunación con el ARNm (BNT162B2) y las vacunas inactivadas (Coronavac) SARS-COV-2: una serie de casos y un estudio de control de casos anidados. Las enfermedades infecciosas de la lanceta, 22 (1), 64-72. https://www.medrxiv.org/content/10.1101/2021.12.02.21267156v1 | Minocha, P. K., Better, D., Singh, R. K., & Hoque, T. (2021). Recurrence of acute myocarditis temporally associated with receipt of the mRNA coronavirus disease 2019 (COVID-19) vaccine in a male adolescent. The Journal of Pediatrics, 238, 321-323. https://www.ncbi.nlm.nih.gov/pubmed/34166671 | Waraich, A., & Williams, G. (2021). Haematuria, a widespread petechial rash, and headaches following the Oxford AstraZeneca ChAdOx1 nCoV-19 Vaccination. BMJ Case Reports CP, 14(10), e245440. https://pubmed.ncbi.nlm.nih.gov/34620638/ | ||||||||
889 | Abu Mouch, S., Roguin, A., Hellou, E., Ishai, A., Shoshan, U., Mahamid, L., . . . Berar Yanay, N. (2021). Myocarditis following COVID-19 mRNA vaccination. Vaccine, 39(29), 3790-3793. doi:10.1016/j.vaccine.2021.05.087. | https://www.ncbi.nlm.nih.gov/pubmed/34092429 | https://www.ncbi.nlm.nih.gov/pubmed/34737312 | Mizrahi, B., Lotan, R., Kalkstein, N., Peretz, A., Perez, G., Ben-Tov, A., ... & Patalon, T. (2021). Correlation of SARS-CoV-2-breakthrough infections to time-from-vaccine. Nature communications, 12(1), 1-5. | Mizrahi, B., Lotan, R., Kalkstein, N., Peretz, A., Perez, G., Ben-Tov, A., ... y Patalon, T. (2021). Correlación de las infecciones por SARS-CoV-2 con el tiempo transcurrido desde la vacunación. Comunicaciones de la naturaleza, 12(1), 1-5. https://www.ncbi.nlm.nih.gov/pubmed/33526560 | Wang, R. L., Chiang, W. F., Shyu, H. Y., Chen, M. H., Lin, C. I., Wu, K. A., ... & Hsiao, P. J. (2021). COVID-19 TRUBRICOS AGUTOS AGUTOS CEREBRALES AGUTOS CEREBRALES Y EMOLISMO DE LA ARTERIA PULMONARIA. QJM: un Diario Internacional de Medicina. https://pubmed.ncbi.nlm.nih.gov/34132839/ | Mizrahi, B., Lotan, R., Kalkstein, N., Peretz, A., Perez, G., Ben-Tov, A., ... & Patalon, T. (2021). Correlation of SARS-CoV-2-breakthrough infections to time-from-vaccine. Nature communications, 12(1), 1-5. https://www.ncbi.nlm.nih.gov/pubmed/34737312 | Warkentin, T. E., & Greinacher, A. (2021). Spontaneous HIT syndrome: knee replacement, infection, and parallels with vaccine-induced immune thrombotic thrombocytopenia. Thrombosis Research, 204, 40-51. https://pubmed.ncbi.nlm.nih.gov/34144250/ | ||||||||
890 | Albert, E., Aurigemma, G., Saucedo, J., & Gerson, D. S. (2021). Myocarditis following COVID-19 vaccination. Radiol Case Rep, 16(8), 2142-2145. doi:10.1016/j.radcr.2021.05.033. | https://www.ncbi.nlm.nih.gov/pubmed/34025885 | https://www.ncbi.nlm.nih.gov/pubmed/33526560 | Moffitt, K., Cheung, E., Yeung, T., Stamoulis, C., & Malley, R. (2021). Analysis of Staphylococcus aureus transcriptome in pediatric soft tissue abscesses and comparison to murine infections. Infection and immunity, 89(4), e00715-20. | Moffitt, K., Cheung, E., Yeung, T., Stamoulis, C. y Malley, R. (2021). Análisis del transcriptoma de Staphylococcus aureus en abscesos de tejidos blandos pediátricos y comparación con infecciones murinas. Infección e inmunidad, 89(4), e00715-20. https://www.ncbi.nlm.nih.gov/pubmed/34930152 | WantAvornPrasert, K., Noppakun, N., Klaewsongkram, J., & Rerknimitr, P. (2022). Erupción de drogas fijas bullidas generalizadas después de la vacunación Oxford-AstraZeneca (Chadox1 NCOV-19). Dermatología clínica y experimental, 47 (2), 428-432. https://pubmed.ncbi.nlm.nih.gov/34480607/ | Moffitt, K., Cheung, E., Yeung, T., Stamoulis, C., & Malley, R. (2021). Analysis of Staphylococcus aureus transcriptome in pediatric soft tissue abscesses and comparison to murine infections. Infection and immunity, 89(4), e00715-20. https://www.ncbi.nlm.nih.gov/pubmed/33526560 | Warren, C. M., Snow, T. T., Lee, A. S., Shah, M. M., Heider, A., Blomkalns, A., ... & Nadeau, K. C. (2021). Assessment of allergic and anaphylactic reactions to mRNA COVID-19 vaccines with confirmatory testing in a US regional health system. JAMA network open, 4(9), e2125524-e2125524. https://www.ncbi.nlm.nih.gov/pubmed/34533570 | ||||||||
891 | Aye, Y. N., Mai, A. S., Zhang, A., Lim, O. Z. H., Lin, N., Ng, C. H., . . . Chew, N. W. S. (2021). Acute Myocardial Infarction and Myocarditis following COVID-19 Vaccination. QJM. doi:10.1093/qjmed/hcab252. | https://www.ncbi.nlm.nih.gov/pubmed/34586408 | https://www.ncbi.nlm.nih.gov/pubmed/34930152 | Mohamed, L., Madsen, A. M. R., Schaltz-Buchholzer, F., Ostenfeld, A., Netea, M. G., Benn, C. S., & Kofoed, P. E. (2021). Reactivation of BCG vaccination scars after vaccination with mRNA-Covid-vaccines: two case reports. BMC infectious diseases, 21(1), 1-4. | Mohamed, L., Madsen, A. M. R., Schaltz-Buchholzer, F., Ostenfeld, A., Netea, M. G., Benn, C. S. y Kofoed, P. E. (2021). Reactivación de las cicatrices de la vacuna BCG después de la vacunación con vacunas Covid-mRNA: informes de dos casos. Enfermedades infecciosas de BMC, 21(1), 1-4. https://www.ncbi.nlm.nih.gov/pubmed/34185045 | Waqar, S. H. B., Khan, A. A., & Memon, S. (2021). Purpura trombocitopénica trombótica: una nueva amenaza después de la vacuna COVID BNT162B2. Diario Internacional de Hematología, 114 (5), 626-629. https://pubmed.ncbi.nlm.nih.gov/34840204/ | Mohamed, L., Madsen, A. M. R., Schaltz-Buchholzer, F., Ostenfeld, A., Netea, M. G., Benn, C. S., & Kofoed, P. E. (2021). Reactivation of BCG vaccination scars after vaccination with mRNA-Covid-vaccines: two case reports. BMC infectious diseases, 21(1), 1-4. https://www.ncbi.nlm.nih.gov/pubmed/34930152 | Washington, T., Bryan, R., & Clemow, C. (2021). Adenopathy following COVID-19 vaccination. Radiology, 299(3), E280-E281. https://pubmed.ncbi.nlm.nih.gov/33625299/. | ||||||||
892 | Azir, M., Inman, B., Webb, J., & Tannenbaum, L. (2021). STEMI Mimic: Focal Myocarditis in an Adolescent Patient After mRNA COVID-19 Vaccine. J Emerg Med, 61(6), e129-e132. doi:10.1016/j.jemermed.2021.09.017. | https://www.ncbi.nlm.nih.gov/pubmed/34756746 | https://www.ncbi.nlm.nih.gov/pubmed/34185045 | Montgomery, J., Ryan, M., Engler, R., Hoffman, D., McClenathan, B., Collins, L., ... & Cooper, L. T. (2021). Myocarditis following immunization with mRNA COVID-19 vaccines in members of the US military. JAMA cardiology, 6(10), 1202-1206. | Montgomery, J., Ryan, M., Engler, R., Hoffman, D., McClenathan, B., Collins, L., ... y Cooper, LT (2021). Miocarditis tras la inmunización con vacunas de ARNm COVID-19 en miembros del ejército de EE. UU. Cardiología JAMA, 6(10), 1202-1206. https://www.ncbi.nlm.nih.gov/pubmed/34840235 | Waraich, A., & Williams, G. (2021). Hematuria, una erupción petequial generalizada y dolores de cabeza después de la vacunación Oxford AstraZeneca Chadox1 NCOV-19. BMJ Case Reports CP, 14 (10), E245440. https://pubmed.ncbi.nlm.nih.gov/34650896/ | Montgomery, J., Ryan, M., Engler, R., Hoffman, D., McClenathan, B., Collins, L., ... & Cooper, L. T. (2021). Myocarditis following immunization with mRNA COVID-19 vaccines in members of the US military. JAMA cardiology, 6(10), 1202-1206. https://www.ncbi.nlm.nih.gov/pubmed/34185045 | Watad, A., De Marco, G., Mahajna, H., Druyan, A., Eltity, M., Hijazi, N., ... & McGonagle, D. (2021). Immune-mediated disease flares or new-onset disease in 27 subjects following mRNA/DNA SARS-CoV-2 vaccination. Vaccines, 9(5), 435. https://pubmed.ncbi.nlm.nih.gov/33946748/ | ||||||||
893 | Barda, N., Dagan, N., Ben-Shlomo, Y., Kepten, E., Waxman, J., Ohana, R., . . . Balicer, R. D. (2021). Safety of the BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Setting. N Engl J Med, 385(12), 1078-1090. doi:10.1056/NEJMoa2110475. | https://www.ncbi.nlm.nih.gov/pubmed/34432976 | https://www.ncbi.nlm.nih.gov/pubmed/34840235 | Murakami, Y., Shinohara, M., Oka, Y., Wada, R., Noike, R., Ohara, H., ... & Ikeda, T. (2022). Myocarditis Following a COVID-19 Messenger RNA Vaccination: A Japanese Case Series. Internal Medicine, 8731-21. | Murakami, Y., Shinohara, M., Oka, Y., Wada, R., Noike, R., Ohara, H., ... & Ikeda, T. (2022). Miocarditis después de una vacuna de ARN mensajero contra la COVID-19: una serie de casos japoneses. Medicina Interna, 8731-21. https://www.ncbi.nlm.nih.gov/pubmed/34876937 | Warkentin, T. E., & Greinacher, A. (2021). Síndrome de golpe espontáneo: reemplazo de rodilla, infección y paralelos con trombocitopenia trombótica inmune inducida por la vacuna. Investigación de trombosis, 204, 40-51. https://pubmed.ncbi.nlm.nih.gov/33687691/ | Murakami, Y., Shinohara, M., Oka, Y., Wada, R., Noike, R., Ohara, H., ... & Ikeda, T. (2022). Myocarditis Following a COVID-19 Messenger RNA Vaccination: A Japanese Case Series. Internal Medicine, 8731-21. https://www.ncbi.nlm.nih.gov/pubmed/34840235 | Watchmaker, J. M., & Belani, P. B. (2022). Brain death in a vaccinated patient with COVID-19 infection. Clinical Imaging, 81, 92-95. https://pubmed.ncbi.nlm.nih.gov/34656887/ | ||||||||
894 | Bhandari, M., Pradhan, A., Vishwakarma, P., & Sethi, R. (2021). Coronavirus and cardiovascular manifestations- getting to the heart of the matter. World J Cardiol, 13(10), 556-565. doi:10.4330/wjc.v13.i10.556. | https://www.ncbi.nlm.nih.gov/pubmed/34754400 | https://www.ncbi.nlm.nih.gov/pubmed/34876937 | Nagasaka, T., Koitabashi, N., Ishibashi, Y., Aihara, K., Takama, N., Ohyama, Y., ... & Kaneko, Y. (2021). Acute myocarditis associated with COVID-19 vaccination: A case report. Journal of Cardiology Cases. | Nagasaka, T., Koitabashi, N., Ishibashi, Y., Aihara, K., Takama, N., Ohyama, Y., ... y Kaneko, Y. (2021). Miocarditis aguda asociada a la vacunación contra COVID-19: reporte de un caso. Revista de casos de cardiología. https://www.ncbi.nlm.nih.gov/pubmed/34089859 | Warren, C. M., Nieve, T. T., Lee, A. S., Shah, M. M., Heider, A., Blomkalns, A., ... y Nadeau, K. C. (2021). Evaluación de reacciones alérgicas y anafilácticas a las vacunas ARNm COVID-19 con pruebas confirmatorias en un sistema de salud regional de los EE. UU. Jama Network Open, 4 (9), E2125524-E2125524. https://www.ncbi.nlm.nih.gov/pubmed/34229940 | Nagasaka, T., Koitabashi, N., Ishibashi, Y., Aihara, K., Takama, N., Ohyama, Y., ... & Kaneko, Y. (2021). Acute myocarditis associated with COVID-19 vaccination: A case report. Journal of Cardiology Cases. https://www.ncbi.nlm.nih.gov/pubmed/34876937 | Watkins, K., Griffin, G., Septaric, K., & Simon, E. L. (2021). Myocarditis after BNT162b2 vaccination in a healthy male. The American Journal of Emergency Medicine, 50, 815-e1. https://pubmed.ncbi.nlm.nih.gov/34229940/ | ||||||||
895 | Bozkurt, B., Kamat, I., & Hotez, P. J. (2021). Myocarditis With COVID-19 mRNA Vaccines. Circulation, 144(6), 471-484. doi:10.1161/CIRCULATIONAHA.121.056135. | https://www.ncbi.nlm.nih.gov/pubmed/34281357 | https://www.ncbi.nlm.nih.gov/pubmed/34089859 | Ntouros, P. A., Vlachogiannis, N. I., Pappa, M., Nezos, A., Mavragani, C. P., Tektonidou, M. G., ... & Sfikakis, P. P. (2021). Effective DNA damage response after acute but not chronic immune challenge: SARS-CoV-2 vaccine versus Systemic Lupus Erythematosus. Clinical Immunology, 229, 108765. | Ntouros, P. A., Vlachogiannis, N. I., Pappa, M., Nezos, A., Mavragani, C. P., Tektonidou, M. G., ... & Sfikakis, P. P. (2021). Respuesta eficaz al daño del ADN después de un desafío inmunológico agudo pero no crónico: vacuna contra el SARS-CoV-2 versus lupus eritematoso sistémico. Inmunología clínica, 229, 108765. https://www.ncbi.nlm.nih.gov/pubmed/34889875 | Washington, T., Bryan, R., & Clomow, C. (2021). Adenopatía después de la vacunación COVID-19. Radiología, 299 (3), E280-E281. https://pubmed.ncbi.nlm.nih.gov/34292295/. | Ntouros, P. A., Vlachogiannis, N. I., Pappa, M., Nezos, A., Mavragani, C. P., Tektonidou, M. G., ... & Sfikakis, P. P. (2021). Effective DNA damage response after acute but not chronic immune challenge: SARS-CoV-2 vaccine versus Systemic Lupus Erythematosus. Clinical Immunology, 229, 108765. https://www.ncbi.nlm.nih.gov/pubmed/34089859 | Watkins, K., Griffin, G., Septaric, K., & Simon, E. L. (2021). Myocarditis after BNT162b2 vaccination in a healthy male. The American Journal of Emergency Medicine, 50, 815-e1. https://www.ncbi.nlm.nih.gov/pubmed/34229940 | ||||||||
896 | Buchhorn, R., Meyer, C., Schulze-Forster, K., Junker, J., & Heidecke, H. (2021). Autoantibody Release in Children after Corona Virus mRNA Vaccination: A Risk Factor of Multisystem Inflammatory Syndrome? Vaccines (Basel), 9(11). doi:10.3390/vaccines9111353. | https://www.ncbi.nlm.nih.gov/pubmed/34835284 | https://www.ncbi.nlm.nih.gov/pubmed/34889875 | Nygaard, U., Holm, M., Bohnstedt, C., Chai, Q., Schmidt, L. S., Hartling, U. B., ... & Stensballe, L. G. (2022). Population-based Incidence of Myopericarditis After COVID-19 Vaccination in Danish Adolescents. The Pediatric infectious disease journal, 41(1), e25. | Nygaard, U., Holm, M., Bohnstedt, C., Chai, Q., Schmidt, L. S., Hartling, U. B., ... y Stensballe, L. G. (2022). Incidencia poblacional de miopericarditis después de la vacunación COVID-19 en adolescentes daneses. Revista de enfermedades infecciosas pediátricas, 41 (1), e25. https://www.ncbi.nlm.nih.gov/pubmed/34320609 | WATAAD, A., DE MARCO, G., Mahajna, H., Druyan, A., Eltity, M., Hijazi, N., ... & McGonagle, D. (2021). Fleas de enfermedad mediada por la mediación inmunológica o enfermedad de nuevo inicio en 27 sujetos después de la vacunación contra el ARNA / ADN SARS-COV-2. Vacunas, 9 (5), 435. https://pubmed.ncbi.nlm.nih.gov/34453510/ | Nygaard, U., Holm, M., Bohnstedt, C., Chai, Q., Schmidt, L. S., Hartling, U. B., ... & Stensballe, L. G. (2022). Population-based Incidence of Myopericarditis After COVID-19 Vaccination in Danish Adolescents. The Pediatric infectious disease journal, 41(1), e25. https://www.ncbi.nlm.nih.gov/pubmed/34889875 | Watkins, K., Griffin, G., Septaric, K., & Simon, E. L. (2021). Myocarditis after BNT162b2 vaccination in a healthy male. The American Journal of Emergency Medicine, 50, 815-e1. https://www.sciencedirect.com/science/article/pii/S0735675721005362 | ||||||||
897 | Calcaterra, G., Bassareo, P. P., Barilla, F., Romeo, F., & Mehta, J. L. (2022). Concerning the unexpected prothrombotic state following some coronavirus disease 2019 vaccines. J Cardiovasc Med (Hagerstown), 23(2), 71-74. doi:10.2459/JCM.0000000000001232. | https://www.ncbi.nlm.nih.gov/pubmed/34366403 | https://www.ncbi.nlm.nih.gov/pubmed/34320609 | Oberhardt, V., Luxenburger, H., Kemming, J., Schulien, I., Ciminski, K., Giese, S., ... & Hofmann, M. (2021). Rapid and stable mobilization of CD8+ T cells by SARS-CoV-2 mRNA vaccine. Nature, 597(7875), 268-273. | Oberhardt, V., Luxenburger, H., Kemming, J., Schulien, I., Ciminski, K., Giese, S., ... y Hofmann, M. (2021). Movilización rápida y estable de células T CD8+ mediante la vacuna de ARNm del SARS-CoV-2. Naturaleza, 597(7875), 268-273. https://www.ncbi.nlm.nih.gov/pubmed/34402230 | Watchmaker, J. M., & Belani, P. B. (2022). Muerte cerebral en un paciente vacunado con covid-19 infección. Imágenes clínicas, 81, 92-95. https://pubmed.ncbi.nlm.nih.gov/34236717/. | Oberhardt, V., Luxenburger, H., Kemming, J., Schulien, I., Ciminski, K., Giese, S., ... & Hofmann, M. (2021). Rapid and stable mobilization of CD8+ T cells by SARS-CoV-2 mRNA vaccine. Nature, 597(7875), 268-273. https://www.ncbi.nlm.nih.gov/pubmed/34320609 | Watts, I., Smith, D., Mounter, S., Baker, E. H., Hitchings, A. W., & Gill, D. (2021). A case series of vaccine‐induced thrombotic thrombocytopenia in a London teaching hospital. British Journal of Clinical Pharmacology. https://pubmed.ncbi.nlm.nih.gov/34694650/ | ||||||||
898 | Calcaterra, G., Mehta, J. L., de Gregorio, C., Butera, G., Neroni, P., Fanos, V., & Bassareo, P. P. (2021). COVID 19 Vaccine for Adolescents. Concern about Myocarditis and Pericarditis. Pediatr Rep, 13(3), 530-533. doi:10.3390/pediatric13030061. | https://www.ncbi.nlm.nih.gov/pubmed/34564344 | https://www.ncbi.nlm.nih.gov/pubmed/34402230 | Park, H., Yun, K. W., Kim, K. R., Song, S. H., Ahn, B., Kim, D. R., ... & Kim, Y. J. (2021). Epidemiology and Clinical Features of Myocarditis/Pericarditis before the Introduction of mRNA COVID-19 Vaccine in Korean Children: a Multicenter Study. Journal of Korean Medical Science, 36(32). | Park, H., Yun, K. W., Kim, K. R., Song, S. H., Ahn, B., Kim, D. R., ... y Kim, Y. J. (2021). Epidemiología y características clínicas de la miocarditis/pericarditis antes de la introducción de la vacuna de ARNm COVID-19 en niños coreanos: un estudio multicéntrico. Revista de ciencia médica coreana, 36(32). https://www.ncbi.nlm.nih.gov/pubmed/34180390 | Watkins, K., Griffin, G., sepárico, K., & Simon, E. L. (2021). Miocarditis después de la vacunación por BNT162B2 en un hombre sano. El American Journal of Emergency Medicine, 50, 815-E1. https://pubmed.ncbi.nlm.nih.gov/34308326/. | Park, H., Yun, K. W., Kim, K. R., Song, S. H., Ahn, B., Kim, D. R., ... & Kim, Y. J. (2021). Epidemiology and Clinical Features of Myocarditis/Pericarditis before the Introduction of mRNA COVID-19 Vaccine in Korean Children: a Multicenter Study. Journal of Korean Medical Science, 36(32). https://www.ncbi.nlm.nih.gov/pubmed/34402230 | Weber, C., von Hundelshausen, P., & Siess, W. (2021). VITT after ChAdOx1 nCoV-19 Vaccination. The New England journal of medicine. https://pubmed.ncbi.nlm.nih.gov/34731555/ | ||||||||
899 | Chai, Q., Nygaard, U., Schmidt, R. C., Zaremba, T., Moller, A. M., & Thorvig, C. M. (2022). Multisystem inflammatory syndrome in a male adolescent after his second Pfizer-BioNTech COVID-19 vaccine. Acta Paediatr, 111(1), 125-127. doi:10.1111/apa.16141. | https://www.ncbi.nlm.nih.gov/pubmed/34617315 | https://www.ncbi.nlm.nih.gov/pubmed/34180390 | Park, J., Brekke, D. R., & Bratincsak, A. (2022). Self-limited myocarditis presenting with chest pain and ST segment elevation in adolescents after vaccination with the BNT162b2 mRNA vaccine. Cardiology in the Young, 32(1), 146-149. | Park, J., Brekke, D. R. y Bratincsak, A. (2022). Miocarditis autolimitada que se presenta con dolor torácico y elevación del segmento ST en adolescentes después de la vacunación con la vacuna de ARNm BNT162b2. Cardiología en los jóvenes, 32(1), 146-149. https://www.ncbi.nlm.nih.gov/pubmed/34496880 | Watkins, K., Griffin, G., sepárico, K., & Simon, E. L. (2021). Miocarditis después de la vacunación por BNT162B2 en un hombre sano. El American Journal of Emergency Medicine, 50, 815-E1. https://www.ncbi.nlm.nih.gov/pubmed/34336774 | Park, J., Brekke, D. R., & Bratincsak, A. (2022). Self-limited myocarditis presenting with chest pain and ST segment elevation in adolescents after vaccination with the BNT162b2 mRNA vaccine. Cardiology in the Young, 32(1), 146-149. https://www.ncbi.nlm.nih.gov/pubmed/34180390 | Weeks, J. K., O’Brien, S. R., Rosenspire, K. C., Dubroff, J. G., & Pantel, A. R. (2021). evolving bilateral hypermetabolic axillary lymphadenopathy on FDG PET/CT following 2-dose COVID-19 vaccination. Clinical nuclear medicine, 46(12), 1011. https://pubmed.ncbi.nlm.nih.gov/34735411/ | ||||||||
900 | Chamling, B., Vehof, V., Drakos, S., Weil, M., Stalling, P., Vahlhaus, C., . . . Yilmaz, A. (2021). Occurrence of acute infarct-like myocarditis following COVID-19 vaccination: just an accidental co-incidence or rather vaccination-associated autoimmune myocarditis? Clin Res Cardiol, 110(11), 1850-1854. doi:10.1007/s00392-021-01916-w. | https://www.ncbi.nlm.nih.gov/pubmed/34333695 | https://www.ncbi.nlm.nih.gov/pubmed/34496880 | Patel, Y. R., Louis, D. W., Atalay, M., Agarwal, S., & Shah, N. R. (2021). Cardiovascular magnetic resonance findings in young adult patients with acute myocarditis following mRNA COVID-19 vaccination: a case series. Journal of Cardiovascular Magnetic Resonance, 23(1), 1-8. | Patel, YR, Louis, DW, Atalay, M., Agarwal, S. y Shah, NR (2021). Hallazgos de resonancia magnética cardiovascular en pacientes adultos jóvenes con miocarditis aguda después de la vacunación con ARNm COVID-19: una serie de casos. Revista de resonancia magnética cardiovascular, 23(1), 1-8. https://www.ncbi.nlm.nih.gov/pubmed/34907393 | Watkins, K., Griffin, G., sepárico, K., & Simon, E. L. (2021). Miocarditis después de la vacunación por BNT162B2 en un hombre sano. El American Journal of Emergency Medicine, 50, 815-E1. https://www.sciencedirect.com/science/article/pii/S1930043321005549 | Patel, Y. R., Louis, D. W., Atalay, M., Agarwal, S., & Shah, N. R. (2021). Cardiovascular magnetic resonance findings in young adult patients with acute myocarditis following mRNA COVID-19 vaccination: a case series. Journal of Cardiovascular Magnetic Resonance, 23(1), 1-8. https://www.ncbi.nlm.nih.gov/pubmed/34496880 | Weitzman, E. R., Sherman, A. C., & Levy, O. (2021). SARS-CoV-2 mRNA Vaccine Attitudes as Expressed in US FDA Public Commentary: Need for a Public-Private Partnership in a Learning Immunization System. Frontiers in public health, 995. https://www.ncbi.nlm.nih.gov/pubmed/34336774 | ||||||||
901 | Chang, J. C., & Hawley, H. B. (2021). Vaccine-Associated Thrombocytopenia and Thrombosis: Venous Endotheliopathy Leading to Venous Combined Micro-Macrothrombosis. Medicina (Kaunas), 57(11). doi:10.3390/medicina57111163. | https://www.ncbi.nlm.nih.gov/pubmed/34833382 | https://www.ncbi.nlm.nih.gov/pubmed/34907393 | Patone, M., Mei, X. W., Handunnetthi, L., Dixon, S., Zaccardi, F., Shankar-Hari, M., ... & Hippisley-Cox, J. (2021). Risks of myocarditis, pericarditis, and cardiac arrhythmias associated with COVID-19 vaccination or SARS-CoV-2 infection. Nature medicine, 1-13. | Patone, M., Mei, XW, Handunnetthi, L., Dixon, S., Zaccardi, F., Shankar-Hari, M., ... y Hippisley-Cox, J. (2021). Riesgos de miocarditis, pericarditis y arritmias cardíacas asociados con la vacunación contra el COVID-19 o la infección por SARS-CoV-2. Medicina de la naturaleza, 1-13. https://www.ncbi.nlm.nih.gov/pubmed/34367386 | Watts, I., Smith, D., Mounter, S., Baker, E. H., Hitchings, A. W., & Gill, D. (2021). Una serie de casos de trombocitopenia trombótica inducida por la vacuna en un hospital de enseñanza de Londres. Diario británico de la farmacología clínica. https://pubmed.ncbi.nlm.nih.gov/34726934/ | Patone, M., Mei, X. W., Handunnetthi, L., Dixon, S., Zaccardi, F., Shankar-Hari, M., ... & Hippisley-Cox, J. (2021). Risks of myocarditis, pericarditis, and cardiac arrhythmias associated with COVID-19 vaccination or SARS-CoV-2 infection. Nature medicine, 1-13. https://www.ncbi.nlm.nih.gov/pubmed/34907393 | Welsh, K. J., Baumblatt, J., Chege, W., Goud, R., & Nair, N. (2021). Thrombocytopenia including immune thrombocytopenia after receipt of mRNA COVID-19 vaccines reported to the Vaccine Adverse Event Reporting System (VAERS). Vaccine, 39(25), 3329-3332. https://pubmed.ncbi.nlm.nih.gov/34006408/ | ||||||||
902 | Chelala, L., Jeudy, J., Hossain, R., Rosenthal, G., Pietris, N., & White, C. (2021). Cardiac MRI Findings of Myocarditis After COVID-19 mRNA Vaccination in Adolescents. AJR Am J Roentgenol. doi:10.2214/AJR.21.26853. | https://www.ncbi.nlm.nih.gov/pubmed/34704459 | https://www.ncbi.nlm.nih.gov/pubmed/34367386 | Patrignani, A., Schicchi, N., Calcagnoli, F., Falchetti, E., Ciampani, N., Argalia, G., & Mariani, A. (2021). Acute myocarditis following Comirnaty vaccination in a healthy man with previous SARS-CoV-2 infection. Radiology Case Reports, 16(11), 3321-3325. | Patrignani, A., Schicchi, N., Calcagnoli, F., Falchetti, E., Ciampani, N., Argalia, G. y Mariani, A. (2021). Miocarditis aguda tras la vacunación Comirnaty en un hombre sano con infección previa por SARS-CoV-2. Informes de casos de radiología, 16(11), 3321-3325. https://www.ncbi.nlm.nih.gov/pubmed/34734240 | Weber, C., von Hundelshausen, P., & Sess, W. (2021). Vitt después de la vacunación de Chadox1 Ncov-19. El diario Nueva Inglaterra de medicina. https://pubmed.ncbi.nlm.nih.gov/34159588/ | Patrignani, A., Schicchi, N., Calcagnoli, F., Falchetti, E., Ciampani, N., Argalia, G., & Mariani, A. (2021). Acute myocarditis following Comirnaty vaccination in a healthy man with previous SARS-CoV-2 infection. Radiology Case Reports, 16(11), 3321-3325. https://www.ncbi.nlm.nih.gov/pubmed/34367386 | Welsh, K. J., Baumblatt, J., Chege, W., Goud, R., & Nair, N. (2021). Thrombocytopenia including immune thrombocytopenia after receipt of mRNA COVID-19 vaccines reported to the Vaccine Adverse Event Reporting System (VAERS). Vaccine, 39(25), 3329-3332. https://www.ncbi.nlm.nih.gov/pubmed/34006408 | ||||||||
903 | Choi, S., Lee, S., Seo, J. W., Kim, M. J., Jeon, Y. H., Park, J. H., . . . Yeo, N. S. (2021). Myocarditis-induced Sudden Death after BNT162b2 mRNA COVID-19 Vaccination in Korea: Case Report Focusing on Histopathological Findings. J Korean Med Sci, 36(40), e286. doi:10.3346/jkms.2021.36.e286. | https://www.ncbi.nlm.nih.gov/pubmed/34664804 | https://www.ncbi.nlm.nih.gov/pubmed/34734240 | Perez, Y., Levy, E. R., Joshi, A. Y., Virk, A., Rodriguez-Porcel, M., Johnson, M., ... & Swift, M. D. (2021). Myocarditis Following COVID-19 mRNA Vaccine: A Case Series and Incidence Rate Determination. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America. | Pérez, Y., Levy, E. R., Joshi, A. Y., Virk, A., Rodríguez-Porcel, M., Johnson, M., ... y Swift, M. D. (2021). Miocarditis después de la vacuna de ARNm de COVID-19: una serie de casos y determinación de la tasa de incidencia. Enfermedades infecciosas clínicas: una publicación oficial de la Sociedad de Enfermedades Infecciosas de América. https://www.ncbi.nlm.nih.gov/pubmed/34738774 | Weitzman, E. R., Sherman, A. C., & Levy, O. (2021). Las actitudes de vacuna contra el ARNm de SARS-COV-2, según lo expresadas en los comentarios públicos de la FDA de EE. UU.: Necesidad de una asociación público-privada en un sistema de inmunización de aprendizaje. Fronteras en salud pública, 995. https://www.ncbi.nlm.nih.gov/pubmed/34006408 | Perez, Y., Levy, E. R., Joshi, A. Y., Virk, A., Rodriguez-Porcel, M., Johnson, M., ... & Swift, M. D. (2021). Myocarditis Following COVID-19 mRNA Vaccine: A Case Series and Incidence Rate Determination. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America. https://www.ncbi.nlm.nih.gov/pubmed/34734240 | Welsh, K. J., Baumblatt, J., Chege, W., Goud, R., & Nair, N. (2021). Thrombocytopenia including immune thrombocytopenia after receipt of mRNA COVID-19 vaccines reported to the Vaccine Adverse Event Reporting System (VAERS). Vaccine, 39(25), 3329-3332. https://www.sciencedirect.com/science/article/pii/S0264410X21005247 | ||||||||
904 | Chouchana, L., Blet, A., Al-Khalaf, M., Kafil, T. S., Nair, G., Robblee, J., . . . Liu, P. P. (2021). Features of Inflammatory Heart Reactions Following mRNA COVID-19 Vaccination at a Global Level. Clin Pharmacol Ther. doi:10.1002/cpt.2499. | https://www.ncbi.nlm.nih.gov/pubmed/34860360 | https://www.ncbi.nlm.nih.gov/pubmed/34738774 | Perrotta, A., Biondi-Zoccai, G., Saade, W., Miraldi, F., Morelli, A., Marullo, A. G., ... & Peruzzi, M. (2021). A snapshot global survey on side effects of COVID-19 vaccines among healthcare professionals and armed forces with a focus on headache. Panminerva Medica, 63(3), 324-331. | Perrotta, A., Biondi-Zoccai, G., Saade, W., Miraldi, F., Morelli, A., Marullo, A. G., ... & Peruzzi, M. (2021). Una encuesta global instantánea sobre los efectos secundarios de las vacunas COVID-19 entre los profesionales de la salud y las fuerzas armadas, centrándose en el dolor de cabeza. Panminerva Médica, 63(3), 324-331. https://www.ncbi.nlm.nih.gov/pubmed/34695229 | Welting, F. N., KOTSOPOULOS, A. M., PLATTELEEL, A. C., Y VAN OERS, J. A. (2021). Hemorragia intracerebral y trombocitopenia Después de AstraZeneca COVID-19 VACUNA: Desafíos clínicos y diagnósticos de la trombocitopenia trombótica inducida por la vacuna. CUREUS, 13 (9). https://pubmed.ncbi.nlm.nih.gov/34242687/. | Perrotta, A., Biondi-Zoccai, G., Saade, W., Miraldi, F., Morelli, A., Marullo, A. G., ... & Peruzzi, M. (2021). A snapshot global survey on side effects of COVID-19 vaccines among healthcare professionals and armed forces with a focus on headache. Panminerva Medica, 63(3), 324-331. https://www.ncbi.nlm.nih.gov/pubmed/34738774 | Wiedmann, M., Skattør, T., Stray-Pedersen, A., Romundstad, L., Antal, E. A., Marthinsen, P. B., ... & Skjelland, M. (2021). Vaccine induced immune thrombotic thrombocytopenia causing a severe form of cerebral venous thrombosis with high fatality rate: a case series. Frontiers in neurology, 1302. https://pubmed.ncbi.nlm.nih.gov/34393988/. | ||||||||
905 | Chua, G. T., Kwan, M. Y. W., Chui, C. S. L., Smith, R. D., Cheung, E. C., Tian, T., . . . Ip, P. (2021). Epidemiology of Acute Myocarditis/Pericarditis in Hong Kong Adolescents Following Comirnaty Vaccination. Clin Infect Dis. doi:10.1093/cid/ciab989. | https://www.ncbi.nlm.nih.gov/pubmed/34849657 | https://www.ncbi.nlm.nih.gov/pubmed/34695229 | Piñana, J. L., López‐Corral, L., Martino, R., Montoro, J., Vazquez, L., Pérez, A., ... & Infectious Complications Subcommittee of the Spanish Hematopoietic Stem Cell Transplantation and Cell Therapy Group (GETH‐TC). (2022). SARS‐CoV‐2‐reactive antibody detection after SARS‐CoV‐2 vaccination in hematopoietic stem cell transplant recipients: Prospective survey from the Spanish Hematopoietic Stem Cell Transplantation and Cell Therapy Group. American journal of hematology, 97(1), 30-42. | Piñana, J. L., López‐Corral, L., Martino, R., Montoro, J., Vazquez, L., Pérez, A., ... & Subcomisión de Complicaciones Infecciosas del Grupo Español de Trasplante de Células Madre Hematopoyéticas y Terapia Celular ( GETH-TC). (2022). Detección de anticuerpos reactivos al SARS-CoV-2 tras la vacunación contra el SARS-CoV-2 en receptores de trasplantes de células madre hematopoyéticas: encuesta prospectiva del Grupo Español de Trasplante de Células Madre Hematopoyéticas y Terapia Celular. Revista americana de hematología, 97(1), 30-42. https://www.ncbi.nlm.nih.gov/pubmed/34233234 | Wiedmann, M., Skattør, T., Stray-Pedersen, A., Romundstad, L., Antal, E. A., Marthinsen, P. B., ... & Skjelland, M. (2021). La vacuna indujo a la trombocitopenia trombótica inmune que causa una forma severa de trombosis venosa cerebral con alta tasa de fatalidad: una serie de casos. Fronteras en neurología, 1302. https://pubmed.ncbi.nlm.nih.gov/34129181/. | Piñana, J. L., López‐Corral, L., Martino, R., Montoro, J., Vazquez, L., Pérez, A., ... & Infectious Complications Subcommittee of the Spanish Hematopoietic Stem Cell Transplantation and Cell Therapy Group (GETH‐TC). (2022). SARS‐CoV‐2‐reactive antibody detection after SARS‐CoV‐2 vaccination in hematopoietic stem cell transplant recipients: Prospective survey from the Spanish Hematopoietic Stem Cell Transplantation and Cell Therapy Group. American journal of hematology, 97(1), 30-42. https://www.ncbi.nlm.nih.gov/pubmed/34695229 | Wiest, N. E., Johns, G. S., & Edwards, E. (2021). A case of acute pulmonary embolus after mRNA SARS-CoV-2 immunization. Vaccines, 9(8), 903. https://pubmed.ncbi.nlm.nih.gov/34452028/ | ||||||||
906 | Clarke, R., & Ioannou, A. (2021). Should T2 mapping be used in cases of recurrent myocarditis to differentiate between the acute inflammation and chronic scar? J Pediatr. doi:10.1016/j.jpeds.2021.12.026. | https://www.ncbi.nlm.nih.gov/pubmed/34933012 | https://www.ncbi.nlm.nih.gov/pubmed/34233234 | Revon-Riviere, G., Ninove, L., Min, V., Rome, A., Coze, C., Verschuur, A., ... & André, N. (2021). The BNT162b2 mRNA COVID-19 vaccine in adolescents and young adults with cancer: A monocentric experience. European journal of cancer, 154, 30-34. | Revon-Riviere, G., Ninove, L., Min, V., Rome, A., Coze, C., Verschuur, A., ... & André, N. (2021). La vacuna BNT162b2 mRNA COVID-19 en adolescentes y adultos jóvenes con cáncer: una experiencia monocéntrica. Revista europea de cáncer, 154, 30-34. https://www.ncbi.nlm.nih.gov/pubmed/34934954 | Wiest, N. E., Johns, G. S. y Edwards, E. (2021). Un caso de embolos pulmonares agudos después de la inmunización del ARNm SARS-COV-2. Vacunas, 9 (8), 903. https://pubmed.ncbi.nlm.nih.gov/34202817/ | Revon-Riviere, G., Ninove, L., Min, V., Rome, A., Coze, C., Verschuur, A., ... & André, N. (2021). The BNT162b2 mRNA COVID-19 vaccine in adolescents and young adults with cancer: A monocentric experience. European journal of cancer, 154, 30-34. https://www.ncbi.nlm.nih.gov/pubmed/34233234 | Williams, C. B., Choi, J. I., Hosseini, F., Roberts, J., Ramanathan, K., & Ong, K. (2021). Acute Myocarditis Following mRNA-1273 SARS-CoV-2 Vaccination. CJC open, 3(11), 1410-1412. https://pubmed.ncbi.nlm.nih.gov/34308326/. | ||||||||
907 | Colaneri, M., De Filippo, M., Licari, A., Marseglia, A., Maiocchi, L., Ricciardi, A., . . . Bruno, R. (2021). COVID vaccination and asthma exacerbation: might there be a link? Int J Infect Dis, 112, 243-246. doi:10.1016/j.ijid.2021.09.026. | https://www.ncbi.nlm.nih.gov/pubmed/34547487 | https://www.ncbi.nlm.nih.gov/pubmed/34934954 | Sanchez Tijmes, F., Thavendiranathan, P., Udell, J. A., Seidman, M. A., & Hanneman, K. (2021). Cardiac MRI assessment of nonischemic myocardial inflammation: state of the art review and update on myocarditis associated with COVID-19 vaccination. Radiology: Cardiothoracic Imaging, 3(6), e210252. | Sanchez Tijmes, F., Thavendiranathan, P., Udell, J. A., Seidman, M. A. y Hanneman, K. (2021). Evaluación por resonancia magnética cardíaca de la inflamación miocárdica no isquémica: revisión del estado del arte y actualización sobre la miocarditis asociada con la vacunación COVID-19. Radiología: imágenes cardiotorácicas, 3(6), e210252. https://www.ncbi.nlm.nih.gov/pubmed/34228985 | Williams, C. B., Choi, J. I., Hosseini, F., Roberts, J., Ramanathan, K., & Ong, K. (2021). Miocarditis aguda después de la vacunación con MRNA-1273 SARS-COV-2. CJC abierto, 3 (11), 1410-1412. https://pubmed.ncbi.nlm.nih.gov/34866106/ | Sanchez Tijmes, F., Thavendiranathan, P., Udell, J. A., Seidman, M. A., & Hanneman, K. (2021). Cardiac MRI assessment of nonischemic myocardial inflammation: state of the art review and update on myocarditis associated with COVID-19 vaccination. Radiology: Cardiothoracic Imaging, 3(6), e210252. https://www.ncbi.nlm.nih.gov/pubmed/34934954 | Williams, C. B., Choi, J. I., Hosseini, F., Roberts, J., Ramanathan, K., & Ong, K. (2021). Acute Myocarditis Following mRNA-1273 SARS-CoV-2 Vaccination. CJC open, 3(11), 1410-1412. https://www.sciencedirect.com/science/article/pii/S2589790X21001931 | ||||||||
908 | Das, B. B., Kohli, U., Ramachandran, P., Nguyen, H. H., Greil, G., Hussain, T., . . . Khan, D. (2021). Myopericarditis after messenger RNA Coronavirus Disease 2019 Vaccination in Adolescents 12 to 18 Years of Age. J Pediatr, 238, 26-32 e21. doi:10.1016/j.jpeds.2021.07.044. | https://www.ncbi.nlm.nih.gov/pubmed/34339728 | https://www.ncbi.nlm.nih.gov/pubmed/34228985 | Schauer, J., Buddhe, S., Colyer, J., Sagiv, E., Law, Y., Chikkabyrappa, S. M., & Portman, M. A. (2021). Myopericarditis after the Pfizer messenger ribonucleic acid coronavirus disease vaccine in adolescents. The Journal of pediatrics, 238, 317-320. | Schauer, J., Buddhe, S., Colyer, J., Sagiv, E., Law, Y., Chikkabyrappa, S. M. y Portman, M. A. (2021). Miopericarditis después de la vacuna contra el coronavirus del ácido ribonucleico mensajero de Pfizer en adolescentes. La Revista de Pediatría, 238, 317-320. https://www.ncbi.nlm.nih.gov/pubmed/34591186 | Williams, C. B., Choi, J. I., Hosseini, F., Roberts, J., Ramanathan, K., & Ong, K. (2021). Miocarditis aguda después de la vacunación con MRNA-1273 SARS-COV-2. CJC abierto, 3 (11), 1410-1412. https://www.sciencedirect.com/science/article/pii/S2352906721000622 | Schauer, J., Buddhe, S., Colyer, J., Sagiv, E., Law, Y., Chikkabyrappa, S. M., & Portman, M. A. (2021). Myopericarditis after the Pfizer messenger ribonucleic acid coronavirus disease vaccine in adolescents. The Journal of pediatrics, 238, 317-320. https://www.ncbi.nlm.nih.gov/pubmed/34228985 | Wilting, F. N., Kotsopoulos, A. M., Platteel, A. C., & van Oers, J. A. (2021). Intracerebral hemorrhage and thrombocytopenia after AstraZeneca COVID-19 vaccine: Clinical and diagnostic challenges of vaccine-induced thrombotic thrombocytopenia. Cureus, 13(9). https://pubmed.ncbi.nlm.nih.gov/34646685/ | ||||||||
909 | Das, B. B., Moskowitz, W. B., Taylor, M. B., & Palmer, A. (2021). Myocarditis and Pericarditis Following mRNA COVID-19 Vaccination: What Do We Know So Far? Children (Basel), 8(7). doi:10.3390/children8070607. | https://www.ncbi.nlm.nih.gov/pubmed/34356586 | https://www.ncbi.nlm.nih.gov/pubmed/34591186 | Schneider, J., Sottmann, L., Greinacher, A., Hagen, M., Kasper, H. U., Kuhnen, C., ... & Schmeling, A. (2021). Postmortem investigation of fatalities following vaccination with COVID-19 vaccines. International Journal of Legal Medicine, 135(6), 2335-2345. | Schneider, J., Sottmann, L., Greinacher, A., Hagen, M., Kasper, H. U., Kuhnen, C., ... y Schmeling, A. (2021). Investigación post mortem de muertes tras la vacunación con vacunas COVID-19. Revista Internacional de Medicina Legal, 135(6), 2335-2345. https://www.ncbi.nlm.nih.gov/pubmed/34241676 | Witberg, G., Barda, N., Hoss, S., Richter, I., Wiessman, M., Aviv, Y., ... & Kornowski, R. (2021). Miocarditis después de la vacunación de COVID-19 en una gran organización de atención médica. New England Journal of Medicine. https://pubmed.ncbi.nlm.nih.gov/34560365/ | Schneider, J., Sottmann, L., Greinacher, A., Hagen, M., Kasper, H. U., Kuhnen, C., ... & Schmeling, A. (2021). Postmortem investigation of fatalities following vaccination with COVID-19 vaccines. International Journal of Legal Medicine, 135(6), 2335-2345. https://www.ncbi.nlm.nih.gov/pubmed/34591186 | Witberg, G., Barda, N., Hoss, S., Richter, I., Wiessman, M., Aviv, Y., ... & Kornowski, R. (2021). Myocarditis after Covid-19 vaccination in a large health care organization. New England Journal of Medicine. https://pubmed.ncbi.nlm.nih.gov/34614329/ | ||||||||
910 | Deb, A., Abdelmalek, J., Iwuji, K., & Nugent, K. (2021). Acute Myocardial Injury Following COVID-19 Vaccination: A Case Report and Review of Current Evidence from Vaccine Adverse Events Reporting System Database. J Prim Care Community Health, 12, 21501327211029230. doi:10.1177/21501327211029230. | https://www.ncbi.nlm.nih.gov/pubmed/34219532 | https://www.ncbi.nlm.nih.gov/pubmed/34241676 | Schramm, R., Costard-Jäckle, A., Rivinius, R., Fischer, B., Müller, B., Boeken, U., ... & Gummert, J. (2021). Poor humoral and T-cell response to two-dose SARS-CoV-2 messenger RNA vaccine BNT162b2 in cardiothoracic transplant recipients. Clinical Research in Cardiology, 110(8), 1142-1149. | Schramm, R., Costard-Jäckle, A., Rivinius, R., Fischer, B., Müller, B., Boeken, U., ... y Gummert, J. (2021). Mala respuesta humoral y de células T a la vacuna BNT162b2 de ARN mensajero del SARS-CoV-2 de dos dosis en receptores de trasplantes cardiotorácicos. Investigación clínica en cardiología, 110(8), 1142-1149. https://www.ncbi.nlm.nih.gov/pubmed/34945172 | Witberg, G., Barda, N., Hoss, S., Richter, I., Wiessman, M., Aviv, Y., ... & Kornowski, R. (2021). Miocarditis después de la vacunación de COVID-19 en una gran organización de atención médica. New England Journal of Medicine. https://www.ahajournals.org/doi/abs/10.1161/CIRCULATIONAHA.121.056583?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed | Schramm, R., Costard-Jäckle, A., Rivinius, R., Fischer, B., Müller, B., Boeken, U., ... & Gummert, J. (2021). Poor humoral and T-cell response to two-dose SARS-CoV-2 messenger RNA vaccine BNT162b2 in cardiothoracic transplant recipients. Clinical Research in Cardiology, 110(8), 1142-1149. https://www.ncbi.nlm.nih.gov/pubmed/34241676 | Witberg, G., Barda, N., Hoss, S., Richter, I., Wiessman, M., Aviv, Y., ... & Kornowski, R. (2021). Myocarditis after Covid-19 vaccination in a large health care organization. New England Journal of Medicine. https://www.ncbi.nlm.nih.gov/pubmed/34614329 | ||||||||
911 | Dickey, J. B., Albert, E., Badr, M., Laraja, K. M., Sena, L. M., Gerson, D. S., . . . Aurigemma, G. P. (2021). A Series of Patients With Myocarditis Following SARS-CoV-2 Vaccination With mRNA-1279 and BNT162b2. JACC Cardiovasc Imaging, 14(9), 1862-1863. doi:10.1016/j.jcmg.2021.06.003. | https://www.ncbi.nlm.nih.gov/pubmed/34246585 | https://www.ncbi.nlm.nih.gov/pubmed/34945172 | Sessa, F., Salerno, M., Esposito, M., Di Nunno, N., Zamboni, P., & Pomara, C. (2021). Autopsy Findings and Causality Relationship between Death and COVID-19 Vaccination: A Systematic Review. Journal of Clinical Medicine, 10(24), 5876. | Sessa, F., Salerno, M., Esposito, M., Di Nunno, N., Zamboni, P. y Pomara, C. (2021). Hallazgos de la autopsia y relación de causalidad entre la muerte y la vacunación contra el COVID-19: una revisión sistemática. Revista de Medicina Clínica, 10(24), 5876. https://www.ncbi.nlm.nih.gov/pubmed/34707602 | Witberg, G., Barda, N., Hoss, S., Richter, I., Wiessman, M., Aviv, Y., ... & Kornowski, R. (2021). Miocarditis después de la vacunación de COVID-19 en una gran organización de atención médica. New England Journal of Medicine. https://www.ncbi.nlm.nih.gov/pubmed/33262177 | Sessa, F., Salerno, M., Esposito, M., Di Nunno, N., Zamboni, P., & Pomara, C. (2021). Autopsy Findings and Causality Relationship between Death and COVID-19 Vaccination: A Systematic Review. Journal of Clinical Medicine, 10(24), 5876. https://www.ncbi.nlm.nih.gov/pubmed/34945172 | Witberg, G., Barda, N., Hoss, S., Richter, I., Wiessman, M., Aviv, Y., ... & Kornowski, R. (2021). Myocarditis after Covid-19 vaccination in a large health care organization. New England Journal of Medicine. https://www.nejm.org/doi/10.1056/NEJMoa2110737 | ||||||||
912 | Dimopoulou, D., Spyridis, N., Vartzelis, G., Tsolia, M. N., & Maritsi, D. N. (2021). Safety and tolerability of the COVID-19 mRNA-vaccine in adolescents with juvenile idiopathic arthritis on treatment with TNF-inhibitors. Arthritis Rheumatol. doi:10.1002/art.41977. | https://www.ncbi.nlm.nih.gov/pubmed/34492161 | https://www.ncbi.nlm.nih.gov/pubmed/34707602 | Sharif, N., Alzahrani, K. J., Ahmed, S. N., & Dey, S. K. (2021). Efficacy, Immunogenicity and safety of COVID-19 vaccines: A systematic review and meta-analysis. Frontiers in Immunology, 4149. | Sharif, N., Alzahrani, KJ, Ahmed, SN y Dey, SK (2021). Eficacia, inmunogenicidad y seguridad de las vacunas COVID-19: una revisión sistemática y un metanálisis. Fronteras en inmunología, 4149. https://www.ncbi.nlm.nih.gov/pubmed/33956784 | Wolf, M. E., Luz, B., Niehaus, L., Bhogal, P., Bäzner, H., & Henkes, H. (2021). Trombocitopenia y trombosis sinusal venosa intracraneal después de la exposición "COVID-19 VACCINE ASTRAZENECA". Diario de la medicina clínica, 10 (8), 1599. https://pubmed.ncbi.nlm.nih.gov/33606296/ | Sharif, N., Alzahrani, K. J., Ahmed, S. N., & Dey, S. K. (2021). Efficacy, Immunogenicity and safety of COVID-19 vaccines: A systematic review and meta-analysis. Frontiers in Immunology, 4149. https://www.ncbi.nlm.nih.gov/pubmed/34707602 | Wolf, M. E., Luz, B., Niehaus, L., Bhogal, P., Bäzner, H., & Henkes, H. (2021). Thrombocytopenia and intracranial venous sinus thrombosis after “COVID-19 vaccine AstraZeneca” exposure. Journal of clinical medicine, 10(8), 1599. https://pubmed.ncbi.nlm.nih.gov/33918932/ | ||||||||
913 | Dimopoulou, D., Vartzelis, G., Dasoula, F., Tsolia, M., & Maritsi, D. (2021). Immunogenicity of the COVID-19 mRNA vaccine in adolescents with juvenile idiopathic arthritis on treatment with TNF inhibitors. Ann Rheum Dis. doi:10.1136/annrheumdis-2021-221607. | https://www.ncbi.nlm.nih.gov/pubmed/34844930 | https://www.ncbi.nlm.nih.gov/pubmed/33956784 | Shay, D. K. (2021). Safety monitoring of the Janssen (Johnson & Johnson) COVID-19 vaccine—United States, March–April 2021. MMWR. Morbidity and mortality weekly report, 70. | Shay, DK (2021). Monitoreo de seguridad de la vacuna COVID-19 de Janssen (Johnson & Johnson): Estados Unidos, marzo-abril de 2021. MMWR. Informe semanal de morbilidad y mortalidad, 70. https://www.ncbi.nlm.nih.gov/pubmed/34408937 | Wolthers, S. A., Stenberg, J., Nielsen, H. B., Stensballe, J., & Pedersen, H. P. (2021). Área de contenido. Ugeskr Læger, 183, V05210425. https://pubmed.ncbi.nlm.nih.gov/34071883/ | Shay, D. K. (2021). Safety monitoring of the Janssen (Johnson & Johnson) COVID-19 vaccine—United States, March–April 2021. MMWR. Morbidity and mortality weekly report, 70. https://www.ncbi.nlm.nih.gov/pubmed/33956784 | Wolthers, S. A., Stenberg, J., Nielsen, H. B., Stensballe, J., & Pedersen, H. P. (2021). Content area. Ugeskr Læger, 183, V05210425. https://pubmed.ncbi.nlm.nih.gov/34477089/ | ||||||||
914 | Ehrlich, P., Klingel, K., Ohlmann-Knafo, S., Huttinger, S., Sood, N., Pickuth, D., & Kindermann, M. (2021). Biopsy-proven lymphocytic myocarditis following first mRNA COVID-19 vaccination in a 40-year-old male: case report. Clin Res Cardiol, 110(11), 1855-1859. doi:10.1007/s00392-021-01936-6. | https://www.ncbi.nlm.nih.gov/pubmed/34487236 | https://www.ncbi.nlm.nih.gov/pubmed/34408937 | Shazley, O., & Alshazley, M. (2021). A COVID-Positive 52-year-old man presented with venous thromboembolism and disseminated intravascular coagulation following Johnson & Johnson vaccination: a case-study. Cureus, 13(7). | Shazley, O. y Alshazley, M. (2021). Un hombre de 52 años con resultado positivo para COVID presentó tromboembolismo venoso y coagulación intravascular diseminada después de la vacunación de Johnson & Johnson: un estudio de caso. Cureus, 13(7). https://www.ncbi.nlm.nih.gov/pubmed/34739045 | Woo, E. J., MBA-JONAS, A., DOPOVA, R. B., Alimchandani, M., Zinderman, C. E., & Nair, N. (2021). Asociación de recibo del AD26. COV2. S COVID-19 Vacuna con presunto síndrome de Guillain-Barré, febrero-julio de 2021. JAMA, 326 (16), 1606-1613. https://pubmed.ncbi.nlm.nih.gov/34567447/ | Shazley, O., & Alshazley, M. (2021). A COVID-Positive 52-year-old man presented with venous thromboembolism and disseminated intravascular coagulation following Johnson & Johnson vaccination: a case-study. Cureus, 13(7). https://www.ncbi.nlm.nih.gov/pubmed/34408937 | Woo, E. J., Mba-Jonas, A., Dimova, R. B., Alimchandani, M., Zinderman, C. E., & Nair, N. (2021). Association of receipt of the Ad26. COV2. S COVID-19 vaccine with presumptive Guillain-Barré syndrome, February-July 2021. JAMA, 326(16), 1606-1613. https://jamanetwork.com/journals/jama/fullarticle/2785009 | ||||||||
915 | El Sahly, H. M., Baden, L. R., Essink, B., Doblecki-Lewis, S., Martin, J. M., Anderson, E. J., . . . Group, C. S. (2021). Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase. N Engl J Med, 385(19), 1774-1785. doi:10.1056/NEJMoa2113017. | https://www.ncbi.nlm.nih.gov/pubmed/34551225 | https://www.ncbi.nlm.nih.gov/pubmed/34739045 | Shiyovich, A., Witberg, G., Aviv, Y., Eisen, A., Orvin, K., Wiessman, M., ... & Hamdan, A. (2021). Myocarditis following COVID-19 vaccination: magnetic resonance imaging study. European Heart Journal-Cardiovascular Imaging. | Shiyovich, A., Witberg, G., Aviv, Y., Eisen, A., Orvin, K., Wiessman, M., ... y Hamdan, A. (2021). Miocarditis tras vacunación COVID-19: estudio de resonancia magnética. European Heart Journal-Cardiovascular Imaging. https://www.ncbi.nlm.nih.gov/pubmed/34605853 | Xu, G., & Lu, Y. (2021). COVID-19 MRNA inducida por el ARNm Linfadenopatía imita la progresión del linfoma en FDG PET / CT. Medicina nuclear clínica. https://pubmed.ncbi.nlm.nih.gov/33625300/ | Shiyovich, A., Witberg, G., Aviv, Y., Eisen, A., Orvin, K., Wiessman, M., ... & Hamdan, A. (2021). Myocarditis following COVID-19 vaccination: magnetic resonance imaging study. European Heart Journal-Cardiovascular Imaging. https://www.ncbi.nlm.nih.gov/pubmed/34739045 | Xu, G., & Lu, Y. (2021). COVID-19 mRNA Vaccination-Induced Lymphadenopathy Mimics Lymphoma Progression on FDG PET/CT. Clinical nuclear medicine. https://pubmed.ncbi.nlm.nih.gov/33591026/ | ||||||||
916 | Facetti, S., Giraldi, M., Vecchi, A. L., Rogiani, S., & Nassiacos, D. (2021). [Acute myocarditis in a young adult two days after Pfizer vaccination]. G Ital Cardiol (Rome), 22(11), 891-893. doi:10.1714/3689.36746. | https://www.ncbi.nlm.nih.gov/pubmed/34709227 | https://www.ncbi.nlm.nih.gov/pubmed/34605853 | Simone, A., Herald, J., Chen, A., Gulati, N., Shen, A. Y. J., Lewin, B., & Lee, M. S. (2021). Acute myocarditis following COVID-19 mRNA vaccination in adults aged 18 years or older. JAMA Internal Medicine, 181(12), 1668-1670. | Simone, A., Herald, J., Chen, A., Gulati, N., Shen, A. Y. J., Lewin, B. y Lee, M. S. (2021). Miocarditis aguda después de la vacunación con ARNm de COVID-19 en adultos de 18 años o más. JAMA Medicina Interna, 181(12), 1668-1670. https://www.ncbi.nlm.nih.gov/pubmed/34341797 | Yagi, Y., Asami, Y., Kyoya, M., & Yokota, T. (2022). Trombosis sinusus venosa cerebral después de la vacunación de COVID-19 a base de ARNm. Ciencias neurológicas, 43 (1), 41-43. https://pubmed.ncbi.nlm.nih.gov/34624910/ | Simone, A., Herald, J., Chen, A., Gulati, N., Shen, A. Y. J., Lewin, B., & Lee, M. S. (2021). Acute myocarditis following COVID-19 mRNA vaccination in adults aged 18 years or older. JAMA Internal Medicine, 181(12), 1668-1670. https://www.ncbi.nlm.nih.gov/pubmed/34605853 | Yagi, Y., Asami, Y., Kyoya, M., & Yokota, T. (2022). Cerebral venous sinus thrombosis after mRNA-based COVID-19 vaccination. Neurological Sciences, 43(1), 41-43. https://pubmed.ncbi.nlm.nih.gov/34783932/. | ||||||||
917 | Fazlollahi, A., Zahmatyar, M., Noori, M., Nejadghaderi, S. A., Sullman, M. J. M., Shekarriz-Foumani, R., . . . Safiri, S. (2021). Cardiac complications following mRNA COVID-19 vaccines: A systematic review of case reports and case series. Rev Med Virol, e2318. doi:10.1002/rmv.2318. | https://www.ncbi.nlm.nih.gov/pubmed/34921468 | https://www.ncbi.nlm.nih.gov/pubmed/34341797 | Singer, M. E., Taub, I. B., & Kaelber, D. C. (2021). Risk of myocarditis from COVID-19 infection in people under age 20: a population-based analysis. medRxiv. | Singer, M. E., Taub, I. B. y Kaelber, D. C. (2021). Riesgo de miocarditis por infección por COVID-19 en personas menores de 20 años: un análisis poblacional. medRxiv. https://www.ncbi.nlm.nih.gov/pubmed/34764489 | Yahyavi-Firouz-Abadi, N., & Naik, R. P. (2021). Trombosis sinusus venosa cerebral asociada con la trombocitopenia trombótica inducida por la vacuna. The Neuroradiology Journal, 19714009211036687. https://pubmed.ncbi.nlm.nih.gov/34455073/ | Singer, M. E., Taub, I. B., & Kaelber, D. C. (2021). Risk of myocarditis from COVID-19 infection in people under age 20: a population-based analysis. medRxiv. https://www.ncbi.nlm.nih.gov/pubmed/34341797 | Yahyavi-Firouz-Abadi, N., & Naik, R. P. (2021). Cerebral venous sinus thrombosis associated with vaccine-induced thrombotic thrombocytopenia. The Neuroradiology Journal, 19714009211036687. https://pubmed.ncbi.nlm.nih.gov/34333995/ | ||||||||
918 | Fazolo, T., Lima, K., Fontoura, J. C., de Souza, P. O., Hilario, G., Zorzetto, R., . . . Bonorino, C. (2021). Pediatric COVID-19 patients in South Brazil show abundant viral mRNA and strong specific anti-viral responses. Nat Commun, 12(1), 6844. doi:10.1038/s41467-021-27120-y. | https://www.ncbi.nlm.nih.gov/pubmed/34824230 | https://www.ncbi.nlm.nih.gov/pubmed/34764489 | Smith, C., Odd, D., Harwood, R., Ward, J., Linney, M., Clark, M., ... & Fraser, L. K. (2022). Deaths in children and young people in England after SARS-CoV-2 infection during the first pandemic year. Nature medicine, 28(1), 185-192. | Smith, C., Odd, D., Harwood, R., Ward, J., Linney, M., Clark, M., ... y Fraser, LK (2022). Muertes de niños y jóvenes en Inglaterra después de la infección por SARS-CoV-2 durante el primer año de la pandemia. Medicina natural, 28(1), 185-192. https://www.ncbi.nlm.nih.gov/pubmed/34077949 | Yamaguchi, Y., Kimihira, L., Nagasawa, H., SEO, K., & WADA, M. (2021). Trombosis sinusal venosa cerebral después de la vacunación con MRNA COVID-19 BNT162B2. CUREUS, 13 (10). https://pubmed.ncbi.nlm.nih.gov/34579248/ | Smith, C., Odd, D., Harwood, R., Ward, J., Linney, M., Clark, M., ... & Fraser, L. K. (2022). Deaths in children and young people in England after SARS-CoV-2 infection during the first pandemic year. Nature medicine, 28(1), 185-192. https://www.ncbi.nlm.nih.gov/pubmed/34764489 | Yamaguchi, Y., Kimihira, L., Nagasawa, H., Seo, K., & Wada, M. (2021). Cerebral Venous Sinus Thrombosis After BNT162b2 mRNA COVID-19 Vaccination. Cureus, 13(10). https://pubmed.ncbi.nlm.nih.gov/34796065/. | ||||||||
919 | Fikenzer, S., & Laufs, U. (2021). Correction to: Response to Letter to the editors referring to Fikenzer, S., Uhe, T., Lavall, D., Rudolph, U., Falz, R., Busse, M., Hepp, P., & Laufs, U. (2020). Effects of surgical and FFP2/N95 face masks on cardiopulmonary exercise capacity. Clinical research in cardiology: official journal of the German Cardiac Society, 1-9. https://www.ncbi.nlm.nih.gov/pubmed/34170372 | Fikenzer, S., & Laufs, U. (2021). Correction to: Response to Letter to the editors referring to Fikenzer, S., Uhe, T., Lavall, D., Rudolph, U., Falz, R., Busse, M., Hepp, P., & Laufs, U. (2020). Effects of surgical and FFP2/N95 face masks on cardiopulmonary exercise capacity. Clinical research in cardiology: official journal of the German Cardiac Society, 1-9. | https://www.ncbi.nlm.nih.gov/pubmed/34170372 | https://www.ncbi.nlm.nih.gov/pubmed/34077949 | Snapiri, O., Danziger, C. R., Shirman, N., Weissbach, A., Lowenthal, A., Ayalon, I., ... & Bilavsky, E. (2021). Transient cardiac injury in adolescents receiving the BNT162b2 mRNA COVID-19 vaccine. The Pediatric Infectious Disease Journal, 40(10), e360. | Snapiri, O., Danziger, C. R., Shirman, N., Weissbach, A., Lowenthal, A., Ayalon, I., ... y Bilavsky, E. (2021). Lesión cardíaca transitoria en adolescentes que reciben la vacuna COVID-19 de ARNm BNT162b2. The Pediatric Infectious Disease Journal, 40(10), e360. https://www.ncbi.nlm.nih.gov/pubmed/34911654 | Yocum, A., & Simon, E. L. (2021). Púrpura trombocitopénica trombótica después de AD26. Vacunación de COV2-S. The American Journal of Emergency Medicine, 49, 441-E3. https://pubmed.ncbi.nlm.nih.gov/34264151/ | Snapiri, O., Danziger, C. R., Shirman, N., Weissbach, A., Lowenthal, A., Ayalon, I., ... & Bilavsky, E. (2021). Transient cardiac injury in adolescents receiving the BNT162b2 mRNA COVID-19 vaccine. The Pediatric Infectious Disease Journal, 40(10), e360. https://www.ncbi.nlm.nih.gov/pubmed/34077949 | Yocum, A., & Simon, E. L. (2021). Thrombotic thrombocytopenic purpura after Ad26. COV2-S vaccination. The American journal of emergency medicine, 49, 441-e3. https://pubmed.ncbi.nlm.nih.gov/33980419/ | |||||||
920 | Foltran, D., Delmas, C., Flumian, C., De Paoli, P., Salvo, F., Gautier, S., . . . Montastruc, F. (2021). Myocarditis and Pericarditis in Adolescents after First and Second doses of mRNA COVID-19 Vaccines. Eur Heart J Qual Care Clin Outcomes. doi:10.1093/ehjqcco/qcab090. | https://www.ncbi.nlm.nih.gov/pubmed/34849667 | https://www.ncbi.nlm.nih.gov/pubmed/34911654 | Spinner, J. A., Julien, C. L., Olayinka, L., Dreyer, W. J., Bocchini, C. E., Munoz, F. M., & Devaraj, S. (2022). SARS-CoV-2 anti–spike antibodies after vaccination in pediatric heart transplantation: A first report. The Journal of Heart and Lung Transplantation, 41(2), 133-136. | Spinner, J. A., Julien, C. L., Olayinka, L., Dreyer, W. J., Bocchini, C. E., Muñoz, F. M. y Devaraj, S. (2022). Anticuerpos antipico del SARS-CoV-2 después de la vacunación en trasplantes de corazón pediátricos: un primer informe. Revista de trasplante de corazón y pulmón, 41(2), 133-136. https://www.ncbi.nlm.nih.gov/pubmed/34282971 | Yu, B. Y., CEN, L. S., Chen, T., & Yang, T. H. (2021). La parálisis de Bell después de la vacunación inactivada de COVID-19 en un paciente con la historia de la parálisis recurrente de Bell: un informe de caso. Diario mundial de casos clínicos, 9 (27), 8274. https://pubmed.ncbi.nlm.nih.gov/34697502/ | Spinner, J. A., Julien, C. L., Olayinka, L., Dreyer, W. J., Bocchini, C. E., Munoz, F. M., & Devaraj, S. (2022). SARS-CoV-2 anti–spike antibodies after vaccination in pediatric heart transplantation: A first report. The Journal of Heart and Lung Transplantation, 41(2), 133-136. https://www.ncbi.nlm.nih.gov/pubmed/34911654 | Yu, B. Y., Cen, L. S., Chen, T., & Yang, T. H. (2021). Bell’s palsy after inactivated COVID-19 vaccination in a patient with history of recurrent Bell’s palsy: A case report. World journal of clinical cases, 9(27), 8274. https://pubmed.ncbi.nlm.nih.gov/34621891/ | ||||||||
921 | Forgacs, D., Jang, H., Abreu, R. B., Hanley, H. B., Gattiker, J. L., Jefferson, A. M., & Ross, T. M. (2021). SARS-CoV-2 mRNA Vaccines Elicit Different Responses in Immunologically Naive and Pre-Immune Humans. Front Immunol, 12, 728021. doi:10.3389/fimmu.2021.728021. | https://www.ncbi.nlm.nih.gov/pubmed/34646267 | https://www.ncbi.nlm.nih.gov/pubmed/34282971 | Starekova, J., Bluemke, D. A., Bradham, W. S., Grist, T. M., Schiebler, M. L., & Reeder, S. B. (2021). Myocarditis associated with mRNA COVID-19 vaccination. Radiology, 301(2), E409-E411. | Starekova, J., Bluemke, D. A., Bradham, W. S., Grist, T. M., Schiebler, M. L. y Reeder, SB (2021). Miocarditis asociada a la vacunación con ARNm COVID-19. Radiología, 301(2), E409-E411. https://www.ncbi.nlm.nih.gov/pubmed/34420869 | ZAKARIA, Z., SAPIAI, N. A. A., & GHANI, A. R. I. (2021). Trombosis sinusus venosa cerebral 2 semanas después de la primera dosis de la vacuna contra el SARS-COV-2 de ARNm. Acta Neurochirurgica, 163 (8), 2359-2362. https://pubmed.ncbi.nlm.nih.gov/34137813/ | Starekova, J., Bluemke, D. A., Bradham, W. S., Grist, T. M., Schiebler, M. L., & Reeder, S. B. (2021). Myocarditis associated with mRNA COVID-19 vaccination. Radiology, 301(2), E409-E411. https://www.ncbi.nlm.nih.gov/pubmed/34282971 | Zakaria, Z., Sapiai, N. A., & Ghani, A. R. I. (2021). Cerebral venous sinus thrombosis 2 weeks after the first dose of mRNA SARS-CoV-2 vaccine. Acta neurochirurgica, 163(8), 2359-2362. https://pubmed.ncbi.nlm.nih.gov/34101024/ | ||||||||
922 | Furer, V., Eviatar, T., Zisman, D., Peleg, H., Paran, D., Levartovsky, D., . . . Elkayam, O. (2021). Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in adult patients with autoimmune inflammatory rheumatic diseases and in the general population: a multicentre study. Ann Rheum Dis, 80(10), 1330-1338. doi:10.1136/annrheumdis-2021-220647. | https://www.ncbi.nlm.nih.gov/pubmed/34127481 | https://www.ncbi.nlm.nih.gov/pubmed/34420869 | Sulemankhil, I., Abdelrahman, M., & Negi, S. I. (2021). Temporal association between the COVID-19 Ad26. COV2. S vaccine and acute myocarditis: a case report and literature review. Cardiovascular Revascularization Medicine. | Sulemankhil, I., Abdelrahman, M. y Negi, SI (2021). Asociación temporal entre el COVID-19 Ad26. COV2. Vacuna S y miocarditis aguda: reporte de un caso y revisión de la literatura. Medicina de Revascularización Cardiovascular. https://www.ncbi.nlm.nih.gov/pubmed/34514306 | ZAKARIA, Z., SAPIAI, N. A. A., & GHANI, A. R. I. (2021). Trombosis sinusus venosa cerebral 2 semanas después de la primera dosis de la vacuna contra el SARS-COV-2 de ARNm. Acta Neurochirurgica, 163 (8), 2359-2362. https://pubmed.ncbi.nlm.nih.gov/34407607/. | Sulemankhil, I., Abdelrahman, M., & Negi, S. I. (2021). Temporal association between the COVID-19 Ad26. COV2. S vaccine and acute myocarditis: a case report and literature review. Cardiovascular Revascularization Medicine. https://www.ncbi.nlm.nih.gov/pubmed/34420869 | Zakaria, Z., Sapiai, N. A., & Ghani, A. R. I. (2021). Cerebral venous sinus thrombosis 2 weeks after the first dose of mRNA SARS-CoV-2 vaccine. Acta neurochirurgica, 163(8), 2359-2362. https://pubmed.ncbi.nlm.nih.gov/34101024/. | ||||||||
923 | Galindo, R., Chow, H., & Rongkavilit, C. (2021). COVID-19 in Children: Clinical Manifestations and Pharmacologic Interventions Including Vaccine Trials. Pediatr Clin North Am, 68(5), 961-976. doi:10.1016/j.pcl.2021.05.004. | https://www.ncbi.nlm.nih.gov/pubmed/34538306 | https://www.ncbi.nlm.nih.gov/pubmed/34514306 | Tailor, P. D., Feighery, A. M., El-Sabawi, B., & Prasad, A. (2021). Case report: acute myocarditis following the second dose of mRNA-1273 SARS-CoV-2 vaccine. European Heart Journal-Case Reports, 5(8), ytab319. | Tailor, P. D., Feighery, A. M., El-Sabawi, B. y Prasad, A. (2021). Informe de caso: miocarditis aguda tras la segunda dosis de la vacuna mRNA-1273 SARS-CoV-2. European Heart Journal-Case Reports, 5(8), ytab319. https://www.ncbi.nlm.nih.gov/pubmed/34955479 | Zimmermann, P., & Curtis, N. (2021). ¿Por qué COVID-19 menos severo en los niños? Una revisión de los mecanismos propuestos que subyacen en la diferencia relacionada con la edad en la severidad de las infecciones por SARS-COV-2. Archivos de enfermedad en la infancia, 106 (5), 429-439. | Tailor, P. D., Feighery, A. M., El-Sabawi, B., & Prasad, A. (2021). Case report: acute myocarditis following the second dose of mRNA-1273 SARS-CoV-2 vaccine. European Heart Journal-Case Reports, 5(8), ytab319. https://www.ncbi.nlm.nih.gov/pubmed/34514306 | Zimmermann, P., & Curtis, N. (2021). Why is COVID-19 less severe in children? A review of the proposed mechanisms underlying the age-related difference in severity of SARS-CoV-2 infections. Archives of disease in childhood, 106(5), 429-439. https://www.ncbi.nlm.nih.gov/pubmed/33262177 | ||||||||
924 | Gargano, J. W., Wallace, M., Hadler, S. C., Langley, G., Su, J. R., Oster, M. E., . . . Oliver, S. E. (2021). Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory Committee on Immunization Practices – United States, June 2021. MMWR Morb Mortal Wkly Rep, 70(27), 977-982. doi:10.15585/mmwr.mm7027e2. | https://www.ncbi.nlm.nih.gov/pubmed/34237049 | https://www.ncbi.nlm.nih.gov/pubmed/34955479 | Takeda, M., Ishio, N., Shoji, T., Mori, N., Matsumoto, M., & Shikama, N. (2021). Eosinophilic Myocarditis Following Coronavirus Disease 2019 (COVID-19) Vaccination. Circulation Journal, CJ-21. | Takeda, M., Ishio, N., Shoji, T., Mori, N., Matsumoto, M. y Shikama, N. (2021). Miocarditis eosinofílica después de la vacunación contra la enfermedad por coronavirus 2019 (COVID-19). Diario de circulación, CJ-21. https://www.ncbi.nlm.nih.gov/pubmed/33444297 | Zuhorn, F., Graf, T., Klingebiel, R., Schäbitz, W. R., & Rogalewski, A. (2021). Encefalitis postvaccina después de Chadox1 NCOV-19. Anales de neurología, 90 (3), 506-511. https://pubmed.ncbi.nlm.nih.gov/34507266/ | Takeda, M., Ishio, N., Shoji, T., Mori, N., Matsumoto, M., & Shikama, N. (2021). Eosinophilic Myocarditis Following Coronavirus Disease 2019 (COVID-19) Vaccination. Circulation Journal, CJ-21. https://www.ncbi.nlm.nih.gov/pubmed/34955479 | Zuhorn, F., Graf, T., Klingebiel, R., Schäbitz, W. R., & Rogalewski, A. (2021). Postvaccinal encephalitis after ChAdOx1 nCov‐19. Annals of neurology, 90(3), 506-511. https://pubmed.ncbi.nlm.nih.gov/34324214/ | ||||||||
925 | Gatti, M., Raschi, E., Moretti, U., Ardizzoni, A., Poluzzi, E., & Diemberger, I. (2021). Influenza Vaccination and Myo-Pericarditis in Patients Receiving Immune Checkpoint Inhibitors: Investigating the Likelihood of Interaction through the Vaccine Adverse Event Reporting System and VigiBase. Vaccines (Basel), 9(1). doi:10.3390/vaccines9010019. | https://www.ncbi.nlm.nih.gov/pubmed/33406694 | https://www.ncbi.nlm.nih.gov/pubmed/33444297 | COVID, C., & Team, R. (2021). Allergic reactions including anaphylaxis after receipt of the first dose of Pfizer-BioNTech COVID-19 vaccine—United States, December 14–23, 2020. Morbidity and Mortality Weekly Report, 70(2), 46. | COVID, C. y Equipo, R. (2021). Reacciones alérgicas, incluida anafilaxia, después de recibir la primera dosis de la vacuna Pfizer-BioNTech COVID-19, Estados Unidos, 14 al 23 de diciembre de 2020. Morbidity and Mortality Weekly Report, 70(2), 46. https://www.ncbi.nlm.nih.gov/pubmed/34192428 | Zur-Wyrozumska, K. (2021). Cad26. La vacunación de COV2-S puede revelar la trombofilia heredada: la trombosis sinusal venosa cerebral masiva en un hombre joven con un recuento de plaquetas normales. Pol. Arco. Medicina. WEW. (En línea). https://pubmed.ncbi.nlm.nih.gov/34802488/. | COVID, C., & Team, R. (2021). Allergic reactions including anaphylaxis after receipt of the first dose of Pfizer-BioNTech COVID-19 vaccine—United States, December 14–23, 2020. Morbidity and Mortality Weekly Report, 70(2), 46. https://www.ncbi.nlm.nih.gov/pubmed/33444297 | Zur-Wyrozumska, K. (2021). CAd26. COV2-S vaccination can reveal inherited thrombophilia: massive cerebral venous sinus thrombosis in a young male with normal platelet count. Pol. Arch. Med. Wew.(Online). https://pubmed.ncbi.nlm.nih.gov/34632750/ | ||||||||
926 | Gautam, N., Saluja, P., Fudim, M., Jambhekar, K., Pandey, T., & Al’Aref, S. (2021). A Late Presentation of COVID-19 Vaccine-Induced Myocarditis. Cureus, 13(9), e17890. doi:10.7759/cureus.17890. | https://www.ncbi.nlm.nih.gov/pubmed/34660088 | https://www.ncbi.nlm.nih.gov/pubmed/34192428 | Thompson, M. G., Burgess, J. L., Naleway, A. L., Tyner, H., Yoon, S. K., Meece, J., ... & Gaglani, M. (2021). Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines. New England Journal of Medicine, 385(4), 320-329. | Thompson, M. G., Burgess, J. L., Naleway, A. L., Tyner, H., Yoon, S. K., Meece, J., ... y Gaglani, M. (2021). Prevención y Atenuación de Covid-19 con las Vacunas BNT162b2 y mRNA-1273. Revista de Medicina de Nueva Inglaterra, 385(4), 320-329. https://www.ncbi.nlm.nih.gov/pubmed/34866957 | #VALUE! | Thompson, M. G., Burgess, J. L., Naleway, A. L., Tyner, H., Yoon, S. K., Meece, J., ... & Gaglani, M. (2021). Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines. New England Journal of Medicine, 385(4), 320-329. https://www.ncbi.nlm.nih.gov/pubmed/34192428 | zzzz | ||||||||
927 | Gellad, W. F. (2021). Myocarditis after vaccination against covid-19. BMJ, 375, n3090. doi:10.1136/bmj.n3090. | https://www.ncbi.nlm.nih.gov/pubmed/34916217 | https://www.ncbi.nlm.nih.gov/pubmed/34866957 | Tinoco, M., Leite, S., Faria, B., Cardoso, S., Von Hafe, P., Dias, G., ... & Lourenço, A. (2021). Perimyocarditis Following COVID-19 Vaccination. Clinical Medicine Insights: Cardiology, 15, 11795468211056634. | Tinoco, M., Leite, S., Faria, B., Cardoso, S., Von Hafe, P., Dias, G., ... & Lourenço, A. (2021). Perimiocarditis tras la vacunación contra la COVID-19. Perspectivas de la medicina clínica: cardiología, 15, 11795468211056634. https://www.ncbi.nlm.nih.gov/pubmed/34865500 | #VALUE! | Tinoco, M., Leite, S., Faria, B., Cardoso, S., Von Hafe, P., Dias, G., ... & Lourenço, A. (2021). Perimyocarditis Following COVID-19 Vaccination. Clinical Medicine Insights: Cardiology, 15, 11795468211056634. https://www.ncbi.nlm.nih.gov/pubmed/34866957 | zzzz | ||||||||
928 | Greenhawt, M., Abrams, E. M., Shaker, M., Chu, D. K., Khan, D., Akin, C., . . . Golden, D. B. K. (2021). The Risk of Allergic Reaction to SARS-CoV-2 Vaccines and Recommended Evaluation and Management: A Systematic Review, Meta-Analysis, GRADE Assessment, and International Consensus Approach. J Allergy Clin Immunol Pract, 9(10), 3546-3567. doi:10.1016/j.jaip.2021.06.006. | https://www.ncbi.nlm.nih.gov/pubmed/34153517 | https://www.ncbi.nlm.nih.gov/pubmed/34865500 | Truong, D. T., Dionne, A., Muniz, J. C., McHugh, K. E., Portman, M. A., Lambert, L. M., ... & Newburger, J. W. (2021). Clinically suspected myocarditis temporally related to COVID-19 vaccination in adolescents and young adults. Circulation. | Truong, D. T., Dionne, A., Muniz, J. C., McHugh, K. E., Portman, M. A., Lambert, L. M., ... y Newburger, J. W. (2021). Miocarditis clínicamente sospechada relacionada temporalmente con la vacunación COVID-19 en adolescentes y adultos jóvenes. Circulación. https://www.ncbi.nlm.nih.gov/pubmed/34311983 | #VALUE! | Truong, D. T., Dionne, A., Muniz, J. C., McHugh, K. E., Portman, M. A., Lambert, L. M., ... & Newburger, J. W. (2021). Clinically suspected myocarditis temporally related to COVID-19 vaccination in adolescents and young adults. Circulation. https://www.ncbi.nlm.nih.gov/pubmed/34865500 | zzzz | ||||||||
929 | Haaf, P., Kuster, G. M., Mueller, C., Berger, C. T., Monney, P., Burger, P., . . . Tanner, F. C. (2021). The very low risk of myocarditis and pericarditis after mRNA COVID-19 vaccination should not discourage vaccination. Swiss Med Wkly, 151, w30087. doi:10.4414/smw.2021.w30087. | https://www.ncbi.nlm.nih.gov/pubmed/34668687 | https://www.ncbi.nlm.nih.gov/pubmed/34311983 | Tutor, A., Unis, G., Ruiz, B., Bolaji, O. A., & Bob-Manuel, T. (2021). Spectrum of Suspected Cardiomyopathy Due to COVID-19: A Case Series. Current Problems in Cardiology, 46(10), 100926. | Tutor, A., Unis, G., Ruiz, B., Bolaji, O. A. y Bob-Manuel, T. (2021). Espectro de sospecha de miocardiopatía por COVID-19: una serie de casos. Problemas actuales en cardiología, 46(10), 100926. https://www.ncbi.nlm.nih.gov/pubmed/34904134 | #VALUE! | Tutor, A., Unis, G., Ruiz, B., Bolaji, O. A., & Bob-Manuel, T. (2021). Spectrum of Suspected Cardiomyopathy Due to COVID-19: A Case Series. Current Problems in Cardiology, 46(10), 100926. https://www.ncbi.nlm.nih.gov/pubmed/34311983 | zzzz | ||||||||
930 | Hasnie, A. A., Hasnie, U. A., Patel, N., Aziz, M. U., Xie, M., Lloyd, S. G., & Prabhu, S. D. (2021). Perimyocarditis following first dose of the mRNA-1273 SARS-CoV-2 (Moderna) vaccine in a healthy young male: a case report. BMC Cardiovasc Disord, 21(1), 375. doi:10.1186/s12872-021-02183-3. | https://www.ncbi.nlm.nih.gov/pubmed/34348657 | https://www.ncbi.nlm.nih.gov/pubmed/34904134 | Umei, T. C., Kishino, Y., Watanabe, K., Shiraishi, Y., Inohara, T., Yuasa, S., & Fukuda, K. (2021). Recurrence of myopericarditis following mRNA COVID-19 vaccination in a male adolescent. CJC open. | Umei, T. C., Kishino, Y., Watanabe, K., Shiraishi, Y., Inohara, T., Yuasa, S. y Fukuda, K. (2021). Recurrencia de miopericarditis después de la vacunación con ARNm COVID-19 en un adolescente varón. CJC abierto. https://www.ncbi.nlm.nih.gov/pubmed/34277198 | #VALUE! | Umei, T. C., Kishino, Y., Watanabe, K., Shiraishi, Y., Inohara, T., Yuasa, S., & Fukuda, K. (2021). Recurrence of myopericarditis following mRNA COVID-19 vaccination in a male adolescent. CJC open. https://www.ncbi.nlm.nih.gov/pubmed/34904134 | zzzz | ||||||||
931 | Hause, A. M., Gee, J., Baggs, J., Abara, W. E., Marquez, P., Thompson, D., . . . Shay, D. K. (2021). COVID-19 Vaccine Safety in Adolescents Aged 12-17 Years – United States, December 14, 2020-July 16, 2021. MMWR Morb Mortal Wkly Rep, 70(31), 1053-1058. doi:10.15585/mmwr.mm7031e1. | https://www.ncbi.nlm.nih.gov/pubmed/34351881 | https://www.ncbi.nlm.nih.gov/pubmed/34277198 | Vidula, M. K., Ambrose, M., Glassberg, H., Chokshi, N., Chen, T., Ferrari, V. A., & Han, Y. (2021). Myocarditis and other cardiovascular complications of the mRNA-based COVID-19 vaccines. Cureus, 13(6). | Vidula, M. K., Ambrose, M., Glassberg, H., Chokshi, N., Chen, T., Ferrari, V. A. y Han, Y. (2021). Miocarditis y otras complicaciones cardiovasculares de las vacunas COVID-19 basadas en ARNm. Cureus, 13(6). https://www.ncbi.nlm.nih.gov/pubmed/34731877 | #VALUE! | Vidula, M. K., Ambrose, M., Glassberg, H., Chokshi, N., Chen, T., Ferrari, V. A., & Han, Y. (2021). Myocarditis and other cardiovascular complications of the mRNA-based COVID-19 vaccines. Cureus, 13(6). https://www.ncbi.nlm.nih.gov/pubmed/34277198 | zzzz | ||||||||
932 | Helms, J. M., Ansteatt, K. T., Roberts, J. C., Kamatam, S., Foong, K. S., Labayog, J. S., & Tarantino, M. D. (2021). Severe, Refractory Immune Thrombocytopenia Occurring After SARS-CoV-2 Vaccine. J Blood Med, 12, 221-224. doi:10.2147/JBM.S307047. | https://www.ncbi.nlm.nih.gov/pubmed/33854395 | https://www.ncbi.nlm.nih.gov/pubmed/34731877 | Visclosky, T., Theyyunni, N., Klekowski, N., & Bradin, S. (2021). Myocarditis Following mRNA COVID-19 Vaccine. Pediatric emergency care, 37(11), 583-584. | Visclosky, T., Theyyunni, N., Klekowski, N. y Bradin, S. (2021). Miocarditis después de la vacuna de ARNm COVID-19. Atención de emergencia pediátrica, 37(11), 583-584. https://www.ncbi.nlm.nih.gov/pubmed/34533570 | #VALUE! | Visclosky, T., Theyyunni, N., Klekowski, N., & Bradin, S. (2021). Myocarditis Following mRNA COVID-19 Vaccine. Pediatric emergency care, 37(11), 583-584. https://www.ncbi.nlm.nih.gov/pubmed/34731877 | zzzz | ||||||||
933 | Hippisley-Cox, J., Patone, M., Mei, X. W., Saatci, D., Dixon, S., Khunti, K., . . . Coupland, C. A. C. (2021). Risk of thrombocytopenia and thromboembolism after covid-19 vaccination and SARS-CoV-2 positive testing: self-controlled case series study. BMJ, 374, n1931. doi:10.1136/bmj.n1931. | https://www.ncbi.nlm.nih.gov/pubmed/34446426 | https://www.ncbi.nlm.nih.gov/pubmed/34533570 | Warren, C. M., Snow, T. T., Lee, A. S., Shah, M. M., Heider, A., Blomkalns, A., ... & Nadeau, K. C. (2021). Assessment of allergic and anaphylactic reactions to mRNA COVID-19 vaccines with confirmatory testing in a US regional health system. JAMA network open, 4(9), e2125524-e2125524. | Warren, C. M., Snow, T. T., Lee, A. S., Shah, M. M., Heider, A., Blomkalns, A., ... y Nadeau, K. C. (2021). Evaluación de reacciones alérgicas y anafilácticas a las vacunas de ARNm COVID-19 con pruebas confirmatorias en un sistema de salud regional de EE. UU. Red JAMA abierta, 4(9), e2125524-e2125524. https://www.ncbi.nlm.nih.gov/pubmed/34229940 | #VALUE! | Warren, C. M., Snow, T. T., Lee, A. S., Shah, M. M., Heider, A., Blomkalns, A., ... & Nadeau, K. C. (2021). Assessment of allergic and anaphylactic reactions to mRNA COVID-19 vaccines with confirmatory testing in a US regional health system. JAMA network open, 4(9), e2125524-e2125524. https://www.ncbi.nlm.nih.gov/pubmed/34533570 | zzzz | ||||||||
934 | Ho, J. S., Sia, C. H., Ngiam, J. N., Loh, P. H., Chew, N. W., Kong, W. K., & Poh, K. K. (2021). A review of COVID-19 vaccination and the reported cardiac manifestations. Singapore Med J. doi:10.11622/smedj.2021210. | https://www.ncbi.nlm.nih.gov/pubmed/34808708 | https://www.ncbi.nlm.nih.gov/pubmed/34229940 | Watkins, K., Griffin, G., Septaric, K., & Simon, E. L. (2021). Myocarditis after BNT162b2 vaccination in a healthy male. The American Journal of Emergency Medicine, 50, 815-e1. | Watkins, K., Griffin, G., Septaric, K. y Simon, EL (2021). Miocarditis tras la vacunación con BNT162b2 en un varón sano. Revista Estadounidense de Medicina de Emergencia, 50, 815-e1. https://www.ncbi.nlm.nih.gov/pubmed/34336774 | #VALUE! | Watkins, K., Griffin, G., Septaric, K., & Simon, E. L. (2021). Myocarditis after BNT162b2 vaccination in a healthy male. The American Journal of Emergency Medicine, 50, 815-e1. https://www.ncbi.nlm.nih.gov/pubmed/34229940 | zzzz | ||||||||
935 | Iguchi, T., Umeda, H., Kojima, M., Kanno, Y., Tanaka, Y., Kinoshita, N., & Sato, D. (2021). Cumulative Adverse Event Reporting of Anaphylaxis After mRNA COVID-19 Vaccine (Pfizer-BioNTech) Injections in Japan: The First-Month Report. Drug Saf, 44(11), 1209-1214. doi:10.1007/s40264-021-01104-9. | https://www.ncbi.nlm.nih.gov/pubmed/34347278 | https://www.ncbi.nlm.nih.gov/pubmed/34336774 | Weitzman, E. R., Sherman, A. C., & Levy, O. (2021). SARS-CoV-2 mRNA Vaccine Attitudes as Expressed in US FDA Public Commentary: Need for a Public-Private Partnership in a Learning Immunization System. Frontiers in public health, 995. | Weitzman, ER, Sherman, A. C. y Levy, O. (2021). Actitudes hacia la vacuna de ARNm del SARS-CoV-2 expresadas en el comentario público de la FDA de EE. UU.: Necesidad de una asociación público-privada en un sistema de inmunización de aprendizaje. Fronteras en salud pública, 995. https://www.ncbi.nlm.nih.gov/pubmed/34006408 | #VALUE! | Weitzman, E. R., Sherman, A. C., & Levy, O. (2021). SARS-CoV-2 mRNA Vaccine Attitudes as Expressed in US FDA Public Commentary: Need for a Public-Private Partnership in a Learning Immunization System. Frontiers in public health, 995. https://www.ncbi.nlm.nih.gov/pubmed/34336774 | zzzz | ||||||||
936 | In brief: Myocarditis with the Pfizer/BioNTech and Moderna COVID-19 vaccines. (2021). Med Lett Drugs Ther, 63(1629), e9. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/34544112 | In brief: Myocarditis with the Pfizer/BioNTech and Moderna COVID-19 vaccines. (2021). Med Lett Drugs Ther, 63(1629), e9. Retrieved from | https://www.ncbi.nlm.nih.gov/pubmed/34544112 | https://www.ncbi.nlm.nih.gov/pubmed/34006408 | Welsh, K. J., Baumblatt, J., Chege, W., Goud, R., & Nair, N. (2021). Thrombocytopenia including immune thrombocytopenia after receipt of mRNA COVID-19 vaccines reported to the Vaccine Adverse Event Reporting System (VAERS). Vaccine, 39(25), 3329-3332. | Welsh, KJ, Baumblatt, J., Chege, W., Goud, R. y Nair, N. (2021). Trombocitopenia, incluida la trombocitopenia inmunitaria después de recibir vacunas de ARNm contra la COVID-19, notificada al Sistema de notificación de eventos adversos a las vacunas (VAERS). Vacuna, 39(25), 3329-3332. https://www.ncbi.nlm.nih.gov/pubmed/34614329 | #VALUE! | Welsh, K. J., Baumblatt, J., Chege, W., Goud, R., & Nair, N. (2021). Thrombocytopenia including immune thrombocytopenia after receipt of mRNA COVID-19 vaccines reported to the Vaccine Adverse Event Reporting System (VAERS). Vaccine, 39(25), 3329-3332. https://www.ncbi.nlm.nih.gov/pubmed/34006408 | zzzz | |||||||
937 | Ioannou, A. (2021a). Myocarditis should be considered in those with a troponin rise and unobstructed coronary arteries following Pfizer-BioNTech COVID-19 vaccination. QJM. doi:10.1093/qjmed/hcab231. | https://www.ncbi.nlm.nih.gov/pubmed/34463755 | https://www.ncbi.nlm.nih.gov/pubmed/34614329 | Witberg, G., Barda, N., Hoss, S., Richter, I., Wiessman, M., Aviv, Y., ... & Kornowski, R. (2021). Myocarditis after Covid-19 vaccination in a large health care organization. New England Journal of Medicine. | Witberg, G., Barda, N., Hoss, S., Richter, I., Wiessman, M., Aviv, Y., ... y Kornowski, R. (2021). Miocarditis tras la vacunación contra Covid-19 en una gran organización sanitaria. Revista de Medicina de Nueva Inglaterra. https://www.ncbi.nlm.nih.gov/pubmed/33262177 | #VALUE! | Witberg, G., Barda, N., Hoss, S., Richter, I., Wiessman, M., Aviv, Y., ... & Kornowski, R. (2021). Myocarditis after Covid-19 vaccination in a large health care organization. New England Journal of Medicine. https://www.ncbi.nlm.nih.gov/pubmed/34614329 | zzzz | ||||||||
938 | Ioannou, A. (2021b). T2 mapping should be utilised in cases of suspected myocarditis to confirm an acute inflammatory process. QJM. doi:10.1093/qjmed/hcab326. | https://www.ncbi.nlm.nih.gov/pubmed/34931681 | https://www.ncbi.nlm.nih.gov/pubmed/33262177 | Zimmermann, P., & Curtis, N. (2021). Why is COVID-19 less severe in children? A review of the proposed mechanisms underlying the age-related difference in severity of SARS-CoV-2 infections. Archives of disease in childhood, 106(5), 429-439. | Zimmermann, P. y Curtis, N. (2021). ¿Por qué el COVID-19 es menos grave en los niños? Una revisión de los mecanismos propuestos que subyacen a la diferencia relacionada con la edad en la gravedad de las infecciones por SARS-CoV-2. Archivos de enfermedades en la infancia, 106(5), 429-439. | #VALUE! | Zimmermann, P., & Curtis, N. (2021). Why is COVID-19 less severe in children? A review of the proposed mechanisms underlying the age-related difference in severity of SARS-CoV-2 infections. Archives of disease in childhood, 106(5), 429-439. https://www.ncbi.nlm.nih.gov/pubmed/33262177 | zzzz | ||||||||
939 | Isaak, A., Feisst, A., & Luetkens, J. A. (2021). Myocarditis Following COVID-19 Vaccination. Radiology, 301(1), E378-E379. doi:10.1148/radiol.2021211766. | https://www.ncbi.nlm.nih.gov/pubmed/34342500 | ||||||||||||||
940 | Istampoulouoglou, I., Dimitriou, G., Spani, S., Christ, A., Zimmermanns, B., Koechlin, S., . . . Leuppi-Taegtmeyer, A. B. (2021). Myocarditis and pericarditis in association with COVID-19 mRNA-vaccination: cases from a regional pharmacovigilance centre. Glob Cardiol Sci Pract, 2021(3), e202118. doi:10.21542/gcsp.2021.18. | https://www.ncbi.nlm.nih.gov/pubmed/34805376 | ||||||||||||||
941 | Jaafar, R., Boschi, C., Aherfi, S., Bancod, A., Le Bideau, M., Edouard, S., . . . La Scola, B. (2021). High Individual Heterogeneity of Neutralizing Activities against the Original Strain and Nine Different Variants of SARS-CoV-2. Viruses, 13(11). doi:10.3390/v13112177. | https://www.ncbi.nlm.nih.gov/pubmed/34834983 | ||||||||||||||
942 | Jain, S. S., Steele, J. M., Fonseca, B., Huang, S., Shah, S., Maskatia, S. A., . . . Grosse-Wortmann, L. (2021). COVID-19 Vaccination-Associated Myocarditis in Adolescents. Pediatrics, 148(5). doi:10.1542/peds.2021-053427. | https://www.ncbi.nlm.nih.gov/pubmed/34389692 | ||||||||||||||
943 | Jhaveri, R., Adler-Shohet, F. C., Blyth, C. C., Chiotos, K., Gerber, J. S., Green, M., . . . Zaoutis, T. (2021). Weighing the Risks of Perimyocarditis With the Benefits of SARS-CoV-2 mRNA Vaccination in Adolescents. J Pediatric Infect Dis Soc, 10(10), 937-939. doi:10.1093/jpids/piab061. | https://www.ncbi.nlm.nih.gov/pubmed/34270752 | ||||||||||||||
944 | Kaneta, K., Yokoi, K., Jojima, K., Kotooka, N., & Node, K. (2021). Young Male With Myocarditis Following mRNA-1273 Vaccination Against Coronavirus Disease-2019 (COVID-19). Circ J. doi:10.1253/circj.CJ-21-0818. | https://www.ncbi.nlm.nih.gov/pubmed/34744118 | ||||||||||||||
945 | Kaul, R., Sreenivasan, J., Goel, A., Malik, A., Bandyopadhyay, D., Jin, C., . . . Panza, J. A. (2021). Myocarditis following COVID-19 vaccination. Int J Cardiol Heart Vasc, 36, 100872. doi:10.1016/j.ijcha.2021.100872. | https://www.ncbi.nlm.nih.gov/pubmed/34568540 | ||||||||||||||
946 | Khogali, F., & Abdelrahman, R. (2021). Unusual Presentation of Acute Perimyocarditis Following SARS-COV-2 mRNA-1237 Moderna Vaccination. Cureus, 13(7), e16590. doi:10.7759/cureus.16590. | https://www.ncbi.nlm.nih.gov/pubmed/34447639 | ||||||||||||||
947 | Kim, H. W., Jenista, E. R., Wendell, D. C., Azevedo, C. F., Campbell, M. J., Darty, S. N., . . . Kim, R. J. (2021). Patients With Acute Myocarditis Following mRNA COVID-19 Vaccination. JAMA Cardiol, 6(10), 1196-1201. doi:10.1001/jamacardio.2021.2828. | https://www.ncbi.nlm.nih.gov/pubmed/34185046 | ||||||||||||||
948 | Kim, I. C., Kim, H., Lee, H. J., Kim, J. Y., & Kim, J. Y. (2021). Cardiac Imaging of Acute Myocarditis Following COVID-19 mRNA Vaccination. J Korean Med Sci, 36(32), e229. doi:10.3346/jkms.2021.36.e229. | https://www.ncbi.nlm.nih.gov/pubmed/34402228 | ||||||||||||||
949 | King, W. W., Petersen, M. R., Matar, R. M., Budweg, J. B., Cuervo Pardo, L., & Petersen, J. W. (2021). Myocarditis following mRNA vaccination against SARS-CoV-2, a case series. Am Heart J Plus, 8, 100042. doi:10.1016/j.ahjo.2021.100042. | https://www.ncbi.nlm.nih.gov/pubmed/34396358 | ||||||||||||||
950 | Klein, N. P., Lewis, N., Goddard, K., Fireman, B., Zerbo, O., Hanson, K. E., . . . Weintraub, E. S. (2021). Surveillance for Adverse Events After COVID-19 mRNA Vaccination. JAMA, 326(14), 1390-1399. doi:10.1001/jama.2021.15072. | https://www.ncbi.nlm.nih.gov/pubmed/34477808 | ||||||||||||||
951 | Klimek, L., Bergmann, K. C., Brehler, R., Pfutzner, W., Zuberbier, T., Hartmann, K., . . . Worm, M. (2021). Practical handling of allergic reactions to COVID-19 vaccines: A position paper from German and Austrian Allergy Societies AeDA, DGAKI, GPA and OGAI. Allergo J Int, 1-17. doi:10.1007/s40629-021-00165-7. | https://www.ncbi.nlm.nih.gov/pubmed/33898162 | ||||||||||||||
952 | Klimek, L., Novak, N., Hamelmann, E., Werfel, T., Wagenmann, M., Taube, C., . . . Worm, M. (2021). Severe allergic reactions after COVID-19 vaccination with the Pfizer/BioNTech vaccine in Great Britain and USA: Position statement of the German Allergy Societies: Medical Association of German Allergologists (AeDA), German Society for Allergology and Clinical Immunology (DGAKI) and Society for Pediatric Allergology and Environmental Medicine (GPA). Allergo J Int, 30(2), 51-55. doi:10.1007/s40629-020-00160-4. | https://www.ncbi.nlm.nih.gov/pubmed/33643776 | ||||||||||||||
953 | Kohli, U., Desai, L., Chowdhury, D., Harahsheh, A. S., Yonts, A. B., Ansong, A., . . . Ang, J. Y. (2021). mRNA Coronavirus-19 Vaccine-Associated Myopericarditis in Adolescents: A Survey Study. J Pediatr. doi:10.1016/j.jpeds.2021.12.025. | https://www.ncbi.nlm.nih.gov/pubmed/34952008 | ||||||||||||||
954 | Kostoff, R. N., Calina, D., Kanduc, D., Briggs, M. B., Vlachoyiannopoulos, P., Svistunov, A. A., & Tsatsakis, A. (2021a). Erratum to “Why are we vaccinating children against COVID-19?” [Toxicol. Rep. 8C (2021) 1665-1684 / 1193]. Toxicol Rep, 8, 1981. doi:10.1016/j.toxrep.2021.10.003. | https://www.ncbi.nlm.nih.gov/pubmed/34642628 | ||||||||||||||
955 | Kostoff, R. N., Calina, D., Kanduc, D., Briggs, M. B., Vlachoyiannopoulos, P., Svistunov, A. A., & Tsatsakis, A. (2021b). Why are we vaccinating children against COVID-19? Toxicol Rep, 8, 1665-1684. doi:10.1016/j.toxrep.2021.08.010. | https://www.ncbi.nlm.nih.gov/pubmed/34540594 | ||||||||||||||
956 | Kremsner, P. G., Mann, P., Kroidl, A., Leroux-Roels, I., Schindler, C., Gabor, J. J., . . . Group, C.-N.-S. (2021). Safety and immunogenicity of an mRNA-lipid nanoparticle vaccine candidate against SARS-CoV-2 : A phase 1 randomized clinical trial. Wien Klin Wochenschr, 133(17-18), 931-941. doi:10.1007/s00508-021-01922-y. | https://www.ncbi.nlm.nih.gov/pubmed/34378087 | ||||||||||||||
957 | Kustin, T., Harel, N., Finkel, U., Perchik, S., Harari, S., Tahor, M., . . . Stern, A. (2021). Evidence for increased breakthrough rates of SARS-CoV-2 variants of concern in BNT162b2-mRNA-vaccinated individuals. Nat Med, 27(8), 1379-1384. doi:10.1038/s41591-021-01413-7. | https://www.ncbi.nlm.nih.gov/pubmed/34127854 | ||||||||||||||
958 | Kwan, M. Y. W., Chua, G. T., Chow, C. B., Tsao, S. S. L., To, K. K. W., Yuen, K. Y., . . . Ip, P. (2021). mRNA COVID vaccine and myocarditis in adolescents. Hong Kong Med J, 27(5), 326-327. doi:10.12809/hkmj215120. | https://www.ncbi.nlm.nih.gov/pubmed/34393110 | ||||||||||||||
959 | Lee, E., Chew, N. W. S., Ng, P., & Yeo, T. J. (2021). Reply to “Letter to the editor: Myocarditis should be considered in those with a troponin rise and unobstructed coronary arteries following PfizerBioNTech COVID-19 vaccination”. QJM. doi:10.1093/qjmed/hcab232. | https://www.ncbi.nlm.nih.gov/pubmed/34463770 | ||||||||||||||
960 | Lee, E. J., Cines, D. B., Gernsheimer, T., Kessler, C., Michel, M., Tarantino, M. D., . . . Bussel, J. B. (2021). Thrombocytopenia following Pfizer and Moderna SARS-CoV-2 vaccination. Am J Hematol, 96(5), 534-537. doi:10.1002/ajh.26132. | https://www.ncbi.nlm.nih.gov/pubmed/33606296 | ||||||||||||||
961 | Levin, D., Shimon, G., Fadlon-Derai, M., Gershovitz, L., Shovali, A., Sebbag, A., . . . Gordon, B. (2021). Myocarditis following COVID-19 vaccination – A case series. Vaccine, 39(42), 6195-6200. doi:10.1016/j.vaccine.2021.09.004. | https://www.ncbi.nlm.nih.gov/pubmed/34535317 | ||||||||||||||
962 | Li, J., Hui, A., Zhang, X., Yang, Y., Tang, R., Ye, H., . . . Zhu, F. (2021). Safety and immunogenicity of the SARS-CoV-2 BNT162b1 mRNA vaccine in younger and older Chinese adults: a randomized, placebo-controlled, double-blind phase 1 study. Nat Med, 27(6), 1062-1070. doi:10.1038/s41591-021-01330-9. | https://www.ncbi.nlm.nih.gov/pubmed/33888900 | ||||||||||||||
963 | Li, M., Yuan, J., Lv, G., Brown, J., Jiang, X., & Lu, Z. K. (2021). Myocarditis and Pericarditis following COVID-19 Vaccination: Inequalities in Age and Vaccine Types. J Pers Med, 11(11). doi:10.3390/jpm11111106. | https://www.ncbi.nlm.nih.gov/pubmed/34834458 | ||||||||||||||
964 | Lim, Y., Kim, M. C., Kim, K. H., Jeong, I. S., Cho, Y. S., Choi, Y. D., & Lee, J. E. (2021). Case Report: Acute Fulminant Myocarditis and Cardiogenic Shock After Messenger RNA Coronavirus Disease 2019 Vaccination Requiring Extracorporeal Cardiopulmonary Resuscitation. Front Cardiovasc Med, 8, 758996. doi:10.3389/fcvm.2021.758996. | https://www.ncbi.nlm.nih.gov/pubmed/34778411 | ||||||||||||||
965 | Long, S. S. (2021). Important Insights into Myopericarditis after the Pfizer mRNA COVID-19 Vaccination in Adolescents. J Pediatr, 238, 5. doi:10.1016/j.jpeds.2021.07.057. | https://www.ncbi.nlm.nih.gov/pubmed/34332972 | ||||||||||||||
966 | Luk, A., Clarke, B., Dahdah, N., Ducharme, A., Krahn, A., McCrindle, B., . . . McDonald, M. (2021). Myocarditis and Pericarditis After COVID-19 mRNA Vaccination: Practical Considerations for Care Providers. Can J Cardiol, 37(10), 1629-1634. doi:10.1016/j.cjca.2021.08.001. | https://www.ncbi.nlm.nih.gov/pubmed/34375696 | ||||||||||||||
967 | Madelon, N., Lauper, K., Breville, G., Sabater Royo, I., Goldstein, R., Andrey, D. O., . . . Eberhardt, C. S. (2021). Robust T cell responses in anti-CD20 treated patients following COVID-19 vaccination: a prospective cohort study. Clin Infect Dis. doi:10.1093/cid/ciab954. | https://www.ncbi.nlm.nih.gov/pubmed/34791081 | ||||||||||||||
968 | Mangat, C., & Milosavljevic, N. (2021). BNT162b2 Vaccination during Pregnancy Protects Both the Mother and Infant: Anti-SARS-CoV-2 S Antibodies Persistently Positive in an Infant at 6 Months of Age. Case Rep Pediatr, 2021, 6901131. doi:10.1155/2021/6901131. | https://www.ncbi.nlm.nih.gov/pubmed/34676123 | ||||||||||||||
969 | Mark, C., Gupta, S., Punnett, A., Upton, J., Orkin, J., Atkinson, A., . . . Alexander, S. (2021). Safety of administration of BNT162b2 mRNA (Pfizer-BioNTech) COVID-19 vaccine in youths and young adults with a history of acute lymphoblastic leukemia and allergy to PEG-asparaginase. Pediatr Blood Cancer, 68(11), e29295. doi:10.1002/pbc.29295. | https://www.ncbi.nlm.nih.gov/pubmed/34398511 | ||||||||||||||
970 | Martins-Filho, P. R., Quintans-Junior, L. J., de Souza Araujo, A. A., Sposato, K. B., Souza Tavares, C. S., Gurgel, R. Q., . . . Santos, V. S. (2021). Socio-economic inequalities and COVID-19 incidence and mortality in Brazilian children: a nationwide register-based study. Public Health, 190, 4-6. doi:10.1016/j.puhe.2020.11.005. | https://www.ncbi.nlm.nih.gov/pubmed/33316478 | ||||||||||||||
971 | McLean, K., & Johnson, T. J. (2021). Myopericarditis in a previously healthy adolescent male following COVID-19 vaccination: A case report. Acad Emerg Med, 28(8), 918-921. doi:10.1111/acem.14322. | https://www.ncbi.nlm.nih.gov/pubmed/34133825 | ||||||||||||||
972 | Mevorach, D., Anis, E., Cedar, N., Bromberg, M., Haas, E. J., Nadir, E., . . . Alroy-Preis, S. (2021). Myocarditis after BNT162b2 mRNA Vaccine against Covid-19 in Israel. N Engl J Med, 385(23), 2140-2149. doi:10.1056/NEJMoa2109730. | https://www.ncbi.nlm.nih.gov/pubmed/34614328 | ||||||||||||||
973 | Minocha, P. K., Better, D., Singh, R. K., & Hoque, T. (2021). Recurrence of Acute Myocarditis Temporally Associated with Receipt of the mRNA Coronavirus Disease 2019 (COVID-19) Vaccine in a Male Adolescent. J Pediatr, 238, 321-323. doi:10.1016/j.jpeds.2021.06.035. | https://www.ncbi.nlm.nih.gov/pubmed/34166671 | ||||||||||||||
974 | Mizrahi, B., Lotan, R., Kalkstein, N., Peretz, A., Perez, G., Ben-Tov, A., . . . Patalon, T. (2021). Correlation of SARS-CoV-2-breakthrough infections to time-from-vaccine. Nat Commun, 12(1), 6379. doi:10.1038/s41467-021-26672-3. | https://www.ncbi.nlm.nih.gov/pubmed/34737312 | ||||||||||||||
975 | Moffitt, K., Cheung, E., Yeung, T., Stamoulis, C., & Malley, R. (2021). Analysis of Staphylococcus aureus Transcriptome in Pediatric Soft Tissue Abscesses and Comparison to Murine Infections. Infect Immun, 89(4). doi:10.1128/IAI.00715-20. | https://www.ncbi.nlm.nih.gov/pubmed/33526560 | ||||||||||||||
976 | Mohamed, L., Madsen, A. M. R., Schaltz-Buchholzer, F., Ostenfeld, A., Netea, M. G., Benn, C. S., & Kofoed, P. E. (2021). Reactivation of BCG vaccination scars after vaccination with mRNA-Covid-vaccines: two case reports. BMC Infect Dis, 21(1), 1264. doi:10.1186/s12879-021-06949-0. | https://www.ncbi.nlm.nih.gov/pubmed/34930152 | ||||||||||||||
977 | Montgomery, J., Ryan, M., Engler, R., Hoffman, D., McClenathan, B., Collins, L., . . . Cooper, L. T., Jr. (2021). Myocarditis Following Immunization With mRNA COVID-19 Vaccines in Members of the US Military. JAMA Cardiol, 6(10), 1202-1206. doi:10.1001/jamacardio.2021.2833. | https://www.ncbi.nlm.nih.gov/pubmed/34185045 | ||||||||||||||
978 | Murakami, Y., Shinohara, M., Oka, Y., Wada, R., Noike, R., Ohara, H., . . . Ikeda, T. (2021). Myocarditis Following a COVID-19 Messenger RNA Vaccination: A Japanese Case Series. Intern Med. doi:10.2169/internalmedicine.8731-21. | https://www.ncbi.nlm.nih.gov/pubmed/34840235 | ||||||||||||||
979 | Nagasaka, T., Koitabashi, N., Ishibashi, Y., Aihara, K., Takama, N., Ohyama, Y., . . . Kaneko, Y. (2021). Acute Myocarditis Associated with COVID-19 Vaccination: A Case Report. J Cardiol Cases. doi:10.1016/j.jccase.2021.11.006. | https://www.ncbi.nlm.nih.gov/pubmed/34876937 | ||||||||||||||
980 | Ntouros, P. A., Vlachogiannis, N. I., Pappa, M., Nezos, A., Mavragani, C. P., Tektonidou, M. G., . . . Sfikakis, P. P. (2021). Effective DNA damage response after acute but not chronic immune challenge: SARS-CoV-2 vaccine versus Systemic Lupus Erythematosus. Clin Immunol, 229, 108765. doi:10.1016/j.clim.2021.108765. | https://www.ncbi.nlm.nih.gov/pubmed/34089859 | ||||||||||||||
981 | Nygaard, U., Holm, M., Bohnstedt, C., Chai, Q., Schmidt, L. S., Hartling, U. B., . . . Stensballe, L. G. (2022). Population-based Incidence of Myopericarditis After COVID-19 Vaccination in Danish Adolescents. Pediatr Infect Dis J, 41(1), e25-e28. doi:10.1097/INF.0000000000003389. | https://www.ncbi.nlm.nih.gov/pubmed/34889875 | ||||||||||||||
982 | Oberhardt, V., Luxenburger, H., Kemming, J., Schulien, I., Ciminski, K., Giese, S., . . . Hofmann, M. (2021). Rapid and stable mobilization of CD8(+) T cells by SARS-CoV-2 mRNA vaccine. Nature, 597(7875), 268-273. doi:10.1038/s41586-021-03841-4. | https://www.ncbi.nlm.nih.gov/pubmed/34320609 | ||||||||||||||
983 | Park, H., Yun, K. W., Kim, K. R., Song, S. H., Ahn, B., Kim, D. R., . . . Kim, Y. J. (2021). Epidemiology and Clinical Features of Myocarditis/Pericarditis before the Introduction of mRNA COVID-19 Vaccine in Korean Children: a Multicenter Study. J Korean Med Sci, 36(32), e232. doi:10.3346/jkms.2021.36.e232. | https://www.ncbi.nlm.nih.gov/pubmed/34402230 | ||||||||||||||
984 | Park, J., Brekke, D. R., & Bratincsak, A. (2021). Self-limited myocarditis presenting with chest pain and ST segment elevation in adolescents after vaccination with the BNT162b2 mRNA vaccine. Cardiol Young, 1-4. doi:10.1017/S1047951121002547. | https://www.ncbi.nlm.nih.gov/pubmed/34180390 | ||||||||||||||
985 | Patel, Y. R., Louis, D. W., Atalay, M., Agarwal, S., & Shah, N. R. (2021). Cardiovascular magnetic resonance findings in young adult patients with acute myocarditis following mRNA COVID-19 vaccination: a case series. J Cardiovasc Magn Reson, 23(1), 101. doi:10.1186/s12968-021-00795-4. | https://www.ncbi.nlm.nih.gov/pubmed/34496880 | ||||||||||||||
986 | Patone, M., Mei, X. W., Handunnetthi, L., Dixon, S., Zaccardi, F., Shankar-Hari, M., . . . Hippisley-Cox, J. (2021). Risks of myocarditis, pericarditis, and cardiac arrhythmias associated with COVID-19 vaccination or SARS-CoV-2 infection. Nat Med. doi:10.1038/s41591-021-01630-0. | https://www.ncbi.nlm.nih.gov/pubmed/34907393 | ||||||||||||||
987 | Patrignani, A., Schicchi, N., Calcagnoli, F., Falchetti, E., Ciampani, N., Argalia, G., & Mariani, A. (2021). Acute myocarditis following Comirnaty vaccination in a healthy man with previous SARS-CoV-2 infection. Radiol Case Rep, 16(11), 3321-3325. doi:10.1016/j.radcr.2021.07.082. | https://www.ncbi.nlm.nih.gov/pubmed/34367386 | ||||||||||||||
988 | Perez, Y., Levy, E. R., Joshi, A. Y., Virk, A., Rodriguez-Porcel, M., Johnson, M., . . . Swift, M. D. (2021). Myocarditis Following COVID-19 mRNA Vaccine: A Case Series and Incidence Rate Determination. Clin Infect Dis. doi:10.1093/cid/ciab926. | https://www.ncbi.nlm.nih.gov/pubmed/34734240 | ||||||||||||||
989 | Perrotta, A., Biondi-Zoccai, G., Saade, W., Miraldi, F., Morelli, A., Marullo, A. G., . . . Peruzzi, M. (2021). A snapshot global survey on side effects of COVID-19 vaccines among healthcare professionals and armed forces with a focus on headache. Panminerva Med, 63(3), 324-331. doi:10.23736/S0031-0808.21.04435-9. | https://www.ncbi.nlm.nih.gov/pubmed/34738774 | ||||||||||||||
990 | Pinana, J. L., Lopez-Corral, L., Martino, R., Montoro, J., Vazquez, L., Perez, A., . . . Cell Therapy, G. (2022). SARS-CoV-2-reactive antibody detection after SARS-CoV-2 vaccination in hematopoietic stem cell transplant recipients: Prospective survey from the Spanish Hematopoietic Stem Cell Transplantation and Cell Therapy Group. Am J Hematol, 97(1), 30-42. doi:10.1002/ajh.26385. | https://www.ncbi.nlm.nih.gov/pubmed/34695229 | ||||||||||||||
991 | Revon-Riviere, G., Ninove, L., Min, V., Rome, A., Coze, C., Verschuur, A., . . . Andre, N. (2021). The BNT162b2 mRNA COVID-19 vaccine in adolescents and young adults with cancer: A monocentric experience. Eur J Cancer, 154, 30-34. doi:10.1016/j.ejca.2021.06.002. | https://www.ncbi.nlm.nih.gov/pubmed/34233234 | ||||||||||||||
992 | Sanchez Tijmes, F., Thavendiranathan, P., Udell, J. A., Seidman, M. A., & Hanneman, K. (2021). Cardiac MRI Assessment of Nonischemic Myocardial Inflammation: State of the Art Review and Update on Myocarditis Associated with COVID-19 Vaccination. Radiol Cardiothorac Imaging, 3(6), e210252. doi:10.1148/ryct.210252. | https://www.ncbi.nlm.nih.gov/pubmed/34934954 | ||||||||||||||
993 | Schauer, J., Buddhe, S., Colyer, J., Sagiv, E., Law, Y., Mallenahalli Chikkabyrappa, S., & Portman, M. A. (2021). Myopericarditis After the Pfizer Messenger Ribonucleic Acid Coronavirus Disease Vaccine in Adolescents. J Pediatr, 238, 317-320. doi:10.1016/j.jpeds.2021.06.083. | https://www.ncbi.nlm.nih.gov/pubmed/34228985 | ||||||||||||||
994 | Schneider, J., Sottmann, L., Greinacher, A., Hagen, M., Kasper, H. U., Kuhnen, C., . . . Schmeling, A. (2021). Postmortem investigation of fatalities following vaccination with COVID-19 vaccines. Int J Legal Med, 135(6), 2335-2345. doi:10.1007/s00414-021-02706-9. | https://www.ncbi.nlm.nih.gov/pubmed/34591186 | ||||||||||||||
995 | Schramm, R., Costard-Jackle, A., Rivinius, R., Fischer, B., Muller, B., Boeken, U., . . . Gummert, J. (2021). Poor humoral and T-cell response to two-dose SARS-CoV-2 messenger RNA vaccine BNT162b2 in cardiothoracic transplant recipients. Clin Res Cardiol, 110(8), 1142-1149. doi:10.1007/s00392-021-01880-5. | https://www.ncbi.nlm.nih.gov/pubmed/34241676 | ||||||||||||||
996 | Sessa, F., Salerno, M., Esposito, M., Di Nunno, N., Zamboni, P., & Pomara, C. (2021). Autopsy Findings and Causality Relationship between Death and COVID-19 Vaccination: A Systematic Review. J Clin Med, 10(24). doi:10.3390/jcm10245876. | https://www.ncbi.nlm.nih.gov/pubmed/34945172 | ||||||||||||||
997 | Sharif, N., Alzahrani, K. J., Ahmed, S. N., & Dey, S. K. (2021). Efficacy, Immunogenicity and Safety of COVID-19 Vaccines: A Systematic Review and Meta-Analysis. Front Immunol, 12, 714170. doi:10.3389/fimmu.2021.714170. | https://www.ncbi.nlm.nih.gov/pubmed/34707602 | ||||||||||||||
998 | Shay, D. K., Gee, J., Su, J. R., Myers, T. R., Marquez, P., Liu, R., . . . Shimabukuro, T. T. (2021). Safety Monitoring of the Janssen (Johnson & Johnson) COVID-19 Vaccine – United States, March-April 2021. MMWR Morb Mortal Wkly Rep, 70(18), 680-684. doi:10.15585/mmwr.mm7018e2. | https://www.ncbi.nlm.nih.gov/pubmed/33956784 | ||||||||||||||
999 | Shazley, O., & Alshazley, M. (2021). A COVID-Positive 52-Year-Old Man Presented With Venous Thromboembolism and Disseminated Intravascular Coagulation Following Johnson & Johnson Vaccination: A Case-Study. Cureus, 13(7), e16383. doi:10.7759/cureus.16383. | https://www.ncbi.nlm.nih.gov/pubmed/34408937 | ||||||||||||||
1000 | Shiyovich, A., Witberg, G., Aviv, Y., Eisen, A., Orvin, K., Wiessman, M., . . . Hamdan, A. (2021). Myocarditis following COVID-19 vaccination: magnetic resonance imaging study. Eur Heart J Cardiovasc Imaging. doi:10.1093/ehjci/jeab230. | https://www.ncbi.nlm.nih.gov/pubmed/34739045 | ||||||||||||||
1001 | Simone, A., Herald, J., Chen, A., Gulati, N., Shen, A. Y., Lewin, B., & Lee, M. S. (2021). Acute Myocarditis Following COVID-19 mRNA Vaccination in Adults Aged 18 Years or Older. JAMA Intern Med, 181(12), 1668-1670. doi:10.1001/jamainternmed.2021.5511. | https://www.ncbi.nlm.nih.gov/pubmed/34605853 | ||||||||||||||
1002 | Singer, M. E., Taub, I. B., & Kaelber, D. C. (2021). Risk of Myocarditis from COVID-19 Infection in People Under Age 20: A Population-Based Analysis. medRxiv. doi:10.1101/2021.07.23.21260998. | https://www.ncbi.nlm.nih.gov/pubmed/34341797 | ||||||||||||||
1003 | Smith, C., Odd, D., Harwood, R., Ward, J., Linney, M., Clark, M., . . . Fraser, L. K. (2021). Deaths in children and young people in England after SARS-CoV-2 infection during the first pandemic year. Nat Med. doi:10.1038/s41591-021-01578-1. | https://www.ncbi.nlm.nih.gov/pubmed/34764489 | ||||||||||||||
1004 | Snapiri, O., Rosenberg Danziger, C., Shirman, N., Weissbach, A., Lowenthal, A., Ayalon, I., . . . Bilavsky, E. (2021). Transient Cardiac Injury in Adolescents Receiving the BNT162b2 mRNA COVID-19 Vaccine. Pediatr Infect Dis J, 40(10), e360-e363. doi:10.1097/INF.0000000000003235. | https://www.ncbi.nlm.nih.gov/pubmed/34077949 | ||||||||||||||
1005 | Spinner, J. A., Julien, C. L., Olayinka, L., Dreyer, W. J., Bocchini, C. E., Munoz, F. M., & Devaraj, S. (2021). SARS-CoV-2 anti-spike antibodies after vaccination in pediatric heart transplantation: A first report. J Heart Lung Transplant. doi:10.1016/j.healun.2021.11.001. | https://www.ncbi.nlm.nih.gov/pubmed/34911654 | ||||||||||||||
1006 | Starekova, J., Bluemke, D. A., Bradham, W. S., Grist, T. M., Schiebler, M. L., & Reeder, S. B. (2021). Myocarditis Associated with mRNA COVID-19 Vaccination. Radiology, 301(2), E409-E411. doi:10.1148/radiol.2021211430. | https://www.ncbi.nlm.nih.gov/pubmed/34282971 | ||||||||||||||
1007 | Sulemankhil, I., Abdelrahman, M., & Negi, S. I. (2021). Temporal association between the COVID-19 Ad26.COV2.S vaccine and acute myocarditis: A case report and literature review. Cardiovasc Revasc Med. doi:10.1016/j.carrev.2021.08.012. | https://www.ncbi.nlm.nih.gov/pubmed/34420869 | ||||||||||||||
1008 | Tailor, P. D., Feighery, A. M., El-Sabawi, B., & Prasad, A. (2021). Case report: acute myocarditis following the second dose of mRNA-1273 SARS-CoV-2 vaccine. Eur Heart J Case Rep, 5(8), ytab319. doi:10.1093/ehjcr/ytab319. | https://www.ncbi.nlm.nih.gov/pubmed/34514306 | ||||||||||||||
1009 | Takeda, M., Ishio, N., Shoji, T., Mori, N., Matsumoto, M., & Shikama, N. (2021). Eosinophilic Myocarditis Following Coronavirus Disease 2019 (COVID-19) Vaccination. Circ J. doi:10.1253/circj.CJ-21-0935. | https://www.ncbi.nlm.nih.gov/pubmed/34955479 | ||||||||||||||
1010 | Team, C. C.-R., Food, & Drug, A. (2021). Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Pfizer-BioNTech COVID-19 Vaccine – United States, December 14-23, 2020. MMWR Morb Mortal Wkly Rep, 70(2), 46-51. doi:10.15585/mmwr.mm7002e1. | https://www.ncbi.nlm.nih.gov/pubmed/33444297 | ||||||||||||||
1011 | Thompson, M. G., Burgess, J. L., Naleway, A. L., Tyner, H., Yoon, S. K., Meece, J., . . . Gaglani, M. (2021). Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines. N Engl J Med, 385(4), 320-329. doi:10.1056/NEJMoa2107058. | https://www.ncbi.nlm.nih.gov/pubmed/34192428 | ||||||||||||||
1012 | Tinoco, M., Leite, S., Faria, B., Cardoso, S., Von Hafe, P., Dias, G., . . . Lourenco, A. (2021). Perimyocarditis Following COVID-19 Vaccination. Clin Med Insights Cardiol, 15, 11795468211056634. doi:10.1177/11795468211056634. | https://www.ncbi.nlm.nih.gov/pubmed/34866957 | ||||||||||||||
1013 | Truong, D. T., Dionne, A., Muniz, J. C., McHugh, K. E., Portman, M. A., Lambert, L. M., . . . Newburger, J. W. (2021). Clinically Suspected Myocarditis Temporally Related to COVID-19 Vaccination in Adolescents and Young Adults. Circulation. doi:10.1161/CIRCULATIONAHA.121.056583. | https://www.ncbi.nlm.nih.gov/pubmed/34865500 | ||||||||||||||
1014 | Tutor, A., Unis, G., Ruiz, B., Bolaji, O. A., & Bob-Manuel, T. (2021). Spectrum of Suspected Cardiomyopathy Due to COVID-19: A Case Series. Curr Probl Cardiol, 46(10), 100926. doi:10.1016/j.cpcardiol.2021.100926. | https://www.ncbi.nlm.nih.gov/pubmed/34311983 | ||||||||||||||
1015 | Umei, T. C., Kishino, Y., Shiraishi, Y., Inohara, T., Yuasa, S., & Fukuda, K. (2021). Recurrence of myopericarditis following mRNA COVID-19 vaccination in a male adolescent. CJC Open. doi:10.1016/j.cjco.2021.12.002. | https://www.ncbi.nlm.nih.gov/pubmed/34904134 | ||||||||||||||
1016 | Vidula, M. K., Ambrose, M., Glassberg, H., Chokshi, N., Chen, T., Ferrari, V. A., & Han, Y. (2021). Myocarditis and Other Cardiovascular Complications of the mRNA-Based COVID-19 Vaccines. Cureus, 13(6), e15576. doi:10.7759/cureus.15576. | https://www.ncbi.nlm.nih.gov/pubmed/34277198 | ||||||||||||||
1017 | Visclosky, T., Theyyunni, N., Klekowski, N., & Bradin, S. (2021). Myocarditis Following mRNA COVID-19 Vaccine. Pediatr Emerg Care, 37(11), 583-584. doi:10.1097/PEC.0000000000002557. | https://www.ncbi.nlm.nih.gov/pubmed/34731877 | ||||||||||||||
1018 | Warren, C. M., Snow, T. T., Lee, A. S., Shah, M. M., Heider, A., Blomkalns, A., . . . Nadeau, K. C. (2021). Assessment of Allergic and Anaphylactic Reactions to mRNA COVID-19 Vaccines With Confirmatory Testing in a US Regional Health System. JAMA Netw Open, 4(9), e2125524. doi:10.1001/jamanetworkopen.2021.25524. | https://www.ncbi.nlm.nih.gov/pubmed/34533570 | ||||||||||||||
1019 | Watkins, K., Griffin, G., Septaric, K., & Simon, E. L. (2021). Myocarditis after BNT162b2 vaccination in a healthy male. Am J Emerg Med, 50, 815 e811-815 e812. doi:10.1016/j.ajem.2021.06.051. | https://www.ncbi.nlm.nih.gov/pubmed/34229940 | ||||||||||||||
1020 | Weitzman, E. R., Sherman, A. C., & Levy, O. (2021). SARS-CoV-2 mRNA Vaccine Attitudes as Expressed in U.S. FDA Public Commentary: Need for a Public-Private Partnership in a Learning Immunization System. Front Public Health, 9, 695807. doi:10.3389/fpubh.2021.695807. | https://www.ncbi.nlm.nih.gov/pubmed/34336774 | ||||||||||||||
1021 | Welsh, K. J., Baumblatt, J., Chege, W., Goud, R., & Nair, N. (2021). Thrombocytopenia including immune thrombocytopenia after receipt of mRNA COVID-19 vaccines reported to the Vaccine Adverse Event Reporting System (VAERS). Vaccine, 39(25), 3329-3332. doi:10.1016/j.vaccine.2021.04.054. | https://www.ncbi.nlm.nih.gov/pubmed/34006408 | ||||||||||||||
1022 | Witberg, G., Barda, N., Hoss, S., Richter, I., Wiessman, M., Aviv, Y., . . . Kornowski, R. (2021). Myocarditis after Covid-19 Vaccination in a Large Health Care Organization. N Engl J Med, 385(23), 2132-2139. doi:10.1056/NEJMoa2110737. | https://www.ncbi.nlm.nih.gov/pubmed/34614329 | ||||||||||||||
1023 | Zimmermann, P., & Curtis, N. (2020). Why is COVID-19 less severe in children? A review of the proposed mechanisms underlying the age-related difference in severity of SARS-CoV-2 infections. Arch Dis Child. doi:10.1136/archdischild-2020-320338. | https://www.ncbi.nlm.nih.gov/pubmed/33262177 | ||||||||||||||
1024 | ||||||||||||||||
1025 | ||||||||||||||||
1026 | ||||||||||||||||
1027 | ||||||||||||||||
1028 | ||||||||||||||||
1029 | ||||||||||||||||
1030 | ||||||||||||||||
1031 | ||||||||||||||||
1032 | ||||||||||||||||
1033 | ||||||||||||||||
1034 | ||||||||||||||||
1035 | ||||||||||||||||
1036 | ||||||||||||||||
1037 | ||||||||||||||||
1038 | ||||||||||||||||
1039 | ||||||||||||||||
1040 | ||||||||||||||||
1041 | ||||||||||||||||
1042 | ||||||||||||||||
1043 | ||||||||||||||||
1044 | ||||||||||||||||
1045 |
A | B | C | |
---|---|---|---|
1 | Los títulos con las siguientes palabras clave se resaltan en los siguientes colores | Número de títulos con palabras clave | % de esta base de datos |
2 | Muerte | 11 | 1.09% |
3 | Niños | 20 | 1.98% |
4 | Adolescente | 62 | 6.13% |
5 | Trombocitopenia | 191 | 18.89% |
6 | Miocarditis | 212 | 20.97% |
7 | Accidente Cerebrovascular | 12 | 1.19% |
8 | Cáncer | 10 | 0.99% |
9 | Causalidad | 26 | 2.57% |
10 | Metanálisis | 4 | 0.40% |
11 | Total | 548 | 54.20% |
12 | Titulo | Fuente | |
13 | Trombosis venosa cerebral después de la vacunación de COVID-19 en el Reino Unido: un estudio de cohorte multicéntrico: | https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)01608-1/ | |
14 | Trombocitopenia trombótica inmune inducida por la vacuna con la coagulación intravascular diseminada y la muerte después de la vacunación con Chadox1 NCOV-19: | https://www.sciencedirect.com/science/article/pii/S1052305721003414 | |
15 | Hemorragia cerebral fatal después de la vacuna COVID-19: | https://pubmed.ncbi.nlm.nih.gov/33928772/ | |
16 | Miocarditis Después de la vacunación con ARNm contra SARS-COV-2, una serie de casos: | https://www.sciencedirect.com/science/article/pii/S2666602221000409 | |
17 | Tres casos de tromboembolismo venoso agudo en mujeres después de la vacunación contra COVID-19: | https://www.sciencedirect.com/science/article/pii/S2213333X21003929 | |
18 | Trombosis aguda del árbol coronario después de la vacunación contra COVID-19: | https://www.sciencedirect.com/science/article/abs/pii/S1936879821003988 | |
19 | Informes de casos estadounidenses de trombosis sinusita venosa cerebral con trombocitopenia después de la vacunación con AD26.COV2.S (contra COVID-19), del 2 de marzo al 21 de abril de 2020: | https://pubmed.ncbi.nlm.nih.gov/33929487/ | |
20 | Trombosis de la vena del portal asociada con la vacuna Chadox1 NCOV-19: | https://www.thelancet.com/journals/langas/article/PIIS2468-1253(21)00197-7/ | |
21 | Gestión de la trombosis de la vena cerebral y splanicnica asociada con la trombocitopenia en sujetos previamente vacunados con Vaxzevria (Astrazeneca): declaración de posición de la sociedad italiana para el estudio de la hemostasia y la trombosis (SISET): | https://pubmed.ncbi.nlm.nih.gov/33871350/ | |
22 | Trombocitopenia inmune inmune inducida por la vacuna y la trombosis sinusita venosa cerebral después de la vacunación con COVID-19; Una revisión sistemática: | https://www.sciencedirect.com/science/article/pii/S0022510X21003014 | |
23 | Trombosis con síndrome de trombocitopenia asociada con vacunas COVID-19: | https://www.sciencedirect.com/science/article/abs/pii/S0735675721004381 | |
24 | COVID-19 Trombosis inducida por la vacuna y trombocitopenia: un comentario sobre un dilema clínico importante y práctico: | https://www.sciencedirect.com/science/article/abs/pii/S0033062021000505 | |
25 | Trombosis con síndrome de trombocitopenia asociada a COVID-19 Vacunas vector virales: | https://www.sciencedirect.com/science/article/abs/pii/S0953620521001904 | |
26 | COVID-19 Trombocitopenia trombótica inmunológico inducida por la vacuna: una causa emergente de la trombosis de la vena esplácida: | https://www.sciencedirect.com/science/article/pii/S1665268121000557 | |
27 | Los roles de las plaquetas en la coagulopatía asociada a Covid-19 y la trombocitopenia inmune trombótica inmune inducida por la vacuna (COVID): | https://www.sciencedirect.com/science/article/pii/S1050173821000967 | |
28 | Raíces de autoinmunidad de eventos trombóticos después de la vacunación COVID-19: | https://www.sciencedirect.com/science/article/abs/pii/S1568997221002160 | |
29 | Trombosis sinusal venosa cerebral después de la vacunación: la experiencia del Reino Unido: | https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)01788-8/fulltext | |
30 | Trombocitopenia inmune trombótica inducida por la vacuna SARS-COV-2: | https://www.nejm.org/doi/full/10.1056/nejme2106315 | |
31 | Miocarditis después de la inmunización con vacunas con COVID-19 MRNA en miembros del ejército estadounidense. Este artículo informa que en "23 pacientes masculinos, incluidos 22 miembros militares previamente saludables, la miocarditis se identificó dentro de los 4 días posteriores a la recepción de la vacuna": | https://jamanetwork.com/journals/jamacardiology/fullarticle/2781601 | |
32 | Trombosis y trombocitopenia después de la vacunación con Chadox1 NCOV-19: | https://www.nejm.org/doi/full/10.1056/NEJMoa2104882?query=recirc_curatedRelated_article | |
33 | Asociación de miocarditis con la vacuna BNT162B2 Messenger RNA COVID-19 en una serie de niños: | https://pubmed.ncbi.nlm.nih.gov/34374740/ | |
34 | Trombocitopenia trombótica después de la vacunación con Chadox1 NCOV-19: | https://www.nejm.org/doi/full/10.1056/NEJMoa2104840?query=recirc_curatedRelated_article | |
35 | Hallazgos post-mortem en trombocitopenia trombótica inducida por la vacuna (COVID-19): | https://haematologica.org/article/view/haematol.2021.279075 | |
36 | La trombocitopenia, incluida la trombocitopenia inmune después de recibir las vacunas de ARNm Covid-19 informadas al sistema de informes de eventos adversos de la vacuna (Vaers): | https://www.sciencedirect.com/science/article/pii/S0264410X21005247 | |
37 | Miocarditis sintomática aguda en siete adolescentes después de Pfizer-Biontech Covid-19 Vacunación: | https://pediatrics.aappublications.org/content/early/2021/06/04/peds.2021-052478 | |
38 | Afasia siete días después de la segunda dosis de una vacuna SARS-COV-2 basada en ARNm. La MRI del cerebro reveló una hemorragia intracerebral (ICBH) en el lóbulo temporal izquierdo en un hombre de 52 años. | https://www.sciencedirect.com/science/article/pii/S2589238X21000292#f0005 | |
39 | Comparación de episodios trombóticos inducidos por la vacuna entre Chadox1 NCOV-19 y ad26.cov.2.s vacunas: | https://www.sciencedirect.com/science/article/abs/pii/S0896841121000895 | |
40 | Hipótesis detrás de los casos muy raros de trombosis con síndrome de trombocitopenia después de la vacunación de SARS-COV-2: | https://www.sciencedirect.com/science/article/abs/pii/S0049384821003315 | |
41 | Coágulos de sangre y episodios de sangrado después de la vacunación BNT162B2 y CHADOX1 NCOV-19: Análisis de los datos europeos: | https://www.sciencedirect.com/science/article/pii/S0896841121000937 | |
42 | Trombosis venosa cerebral después de BNT162B2 MRNA SARS-COV-2 Vacuna: | https://www.sciencedirect.com/science/article/abs/pii/S1052305721003098 | |
43 | Insuficiencia suprarrenal primaria asociada con la trombocitopenia inmune trombótica inducida por la vacuna Oxford-AstraZeneca Chadox1 NCOV-19 (VITT): | https://www.sciencedirect.com/science/article/pii/S0953620521002363 | |
44 | Miocarditis y pericarditis Después de la vacunación con COVID-19 ARNm: consideraciones prácticas para los proveedores de atención: | https://www.sciencedirect.com/science/article/pii/S0828282X21006243 | |
45 | "La trombosis de la vena porta que se produce después de la primera dosis de la vacuna contra ARNm de SARS-COV-2 en un paciente con síndrome antifosfolípido": | https://www.sciencedirect.com/science/article/pii/S2666572721000389 | |
46 | Los primeros resultados del tratamiento de bivalirudina para la trombocitopenia trombótica y la trombosis sinusita venosa cerebral después de la vacunación con AD26.Cov2.s: | https://www.sciencedirect.com/science/article/pii/S0196064421003425 | |
47 | Miocarditis, pericarditis y cardiomiopatía después de la vacunación COVID-19: | https://www.sciencedirect.com/science/article/pii/S1443950621011562 | |
48 | Mecanismos de inmunotrombosis en trombocitopenia trombótica inducida por la vacuna (VITT) en comparación con la infección natural de SARS-COV-2: | https://www.sciencedirect.com/science/article/abs/pii/S0896841121000706 | |
49 | Trombocitopenia inmune protrombótica después de la vacunación de COVID-19: | https://www.sciencedirect.com/science/article/pii/S0006497121009411 | |
50 | Trombocitopenia trombótica inducida por la vacuna: el capítulo oscuro de una historia de éxito: | https://www.sciencedirect.com/science/article/pii/S2589936821000256 | |
51 | Trombosis sinusus venosa cerebral negativa para anticuerpos anti-PF4 sin trombocitopenia después de la inmunización con la vacuna COVID-19 en un anciano indio no comor, tratado con anticoagulación basada en heparina-warfarina convencional: | https://www.sciencedirect.com/science/article/pii/S1871402121002046 | |
52 | Trombosis después de la vacunación COVID-19: Posible enlace a las vías de ACE: | https://www.sciencedirect.com/science/article/pii/S0049384821004369 | |
53 | Trombosis sinusal venosa cerebral en la población de EE.UU. después de la vacunación de SARS-COV-2 con adenovirus y después de COVID-19: | https://www.sciencedirect.com/science/article/pii/S0735109721051949 | |
54 | Un caso raro de un hombre asiático de mediana edad con trombosis venosa cerebral después de la vacunación de AstraZeneca COVID-19: | https://www.sciencedirect.com/science/article/pii/S0735675721005714 | |
55 | Trombosis sinusal venosa cerebral y trombocitopenia después de la vacunación de COVID-19: Informe de dos casos en el Reino Unido: | https://www.sciencedirect.com/science/article/abs/pii/S088915912100163X | |
56 | Púrpura trombocitopénica inmune después de la vacunación con la vacuna COVID-19 (Chadox1 NCOV-19): | https://www.sciencedirect.com/science/article/abs/pii/S0006497121013963. | |
57 | Anticuerpos antiphosfolípidos y riesgo de trombofilia después de la vacunación de COVID-19: ¡la paja que rompe la espalda del camello?: | https://docs.google.com/document/d/1XzajasO8VMMnC3CdxSBKks1o7kiOLXFQ | |
58 | Trombocitopenia trombótica inducida por la vacuna, un caso raro pero severo de fuego amistoso en la batalla contra la pandemia COVID-19: ¿Qué patogénesis?: | https://www.sciencedirect.com/science/article/pii/S0953620521002314 | |
59 | Recomendaciones diagnósticas-terapéuticas del Grupo de Trabajo de expertos de FACME ad-hoc sobre la gestión de la trombosis venosa cerebral relacionada con la vacunación de COVID-19: | https://www.sciencedirect.com/science/article/pii/S0213485321000839 | |
60 | Trombocitopenia y trombosis sinusal venosa intracraneal después de la exposición a la "Vacuna de Astrazeneca Covid-19": | https://pubmed.ncbi.nlm.nih.gov/33918932/ | |
61 | Trombocitopenia después de Pfizer y Moderna SARS-COV-2 vacunación: | https://pubmed.ncbi.nlm.nih.gov/33606296/ | |
62 | Trombocitopenia inmune severa y refractaria que se produce después de la vacunación de SARS-COV-2: | https://pubmed.ncbi.nlm.nih.gov/33854395/ | |
63 | Erupción purpúrica y trombocitopenia después de MRNA-1273 (moderno) COVID-19 VACUNA: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7996471/ | |
64 | COVID-19 Vacunación: Información sobre la ocurrencia de trombosis arterial y venosa utilizando datos de Vigibase: | https://pubmed.ncbi.nlm.nih.gov/33863748/ | |
65 | Trombosis venosa cerebral asociada con la vacuna COVID-19 en Alemania: | https://onlinelibrary.wiley.com/doi/10.1002/ana.26172 | |
66 | Trombosis venosa cerebral después de la vacunación con ARNm BNT162B2 de BNT162B2 contra SARS-COV-2: un evento de cisne negro: | https://pubmed.ncbi.nlm.nih.gov/34133027/ | |
67 | La importancia de reconocer la trombosis venosa cerebral después de la vacunación anti-covid-19: | https://pubmed.ncbi.nlm.nih.gov/34001390/ | |
68 | Trombosis con trombocitopenia después de la vacuna ARN de mensajería -1273: | https://pubmed.ncbi.nlm.nih.gov/34181446/ | |
69 | Coágulos de sangre y sangrado después de la vacunación por BNT162B2 y CHADOX1 NCOV-19: un análisis de los datos europeos: | https://pubmed.ncbi.nlm.nih.gov/34174723/ | |
70 | Primera dosis de vacunas CHADOX1 y BNT162B2 COVID-19 y eventos trombocitopénicos, tromboembólicos y hemorrágicos en Escocia: | https://www.nature.com/articles/s41591-021-01408-4 | |
71 | Exacerbación de la trombocitopenia inmune después de la vacunación de COVID-19: | https://pubmed.ncbi.nlm.nih.gov/34075578/ | |
72 | Primer informe de un episodio de ITTP de Deno Novo asociado con una vacuna anti-COVID-19 basada en ARNm de COVID-19: | https://pubmed.ncbi.nlm.nih.gov/34105244/ | |
73 | PF4 inmunoensayos en trombocitopenia trombótica inducida por la vacuna: | https://www.nejm.org/doi/full/10.1056/NEJMc2106383 | |
74 | Epítopos de anticuerpos en la trombocitopenia inmune inmune inducida por la vacuna: | https://www.nature.com/articles/s41586-021-03744-4 | |
75 | Miocarditis con COVID-19 Vacunas de ARNm: | https://www.ahajournals.org/doi/pdf/10.1161/CIRCULATIONAHA.121.056135 | |
76 | Miocarditis y pericarditis después de la vacunación de COVID-19: | https://jamanetwork.com/journals/jama/fullarticle/2782900 | |
77 | Miocarditis temporalmente asociada con la vacunación COVID-19: | https://www.ahajournals.org/doi/pdf/10.1161/CIRCULATIONAHA.121.055891. | |
78 | COVID-19 Vacunación asociada a miocarditis en adolescentes: | https://pediatrics.aappublications.org/content/pediatrics/early/2021/08/12/peds.2021-053427.full.pdf | |
79 | Miocarditis aguda después de la administración de la vacuna BNT162B2 contra COVID-19: | https://pubmed.ncbi.nlm.nih.gov/33994339/ | |
80 | Asociación temporal entre COVID-19 Vacuna ad26.Cov2.S y miocarditis aguda: Informe de caso y revisión de la literatura: | https://www.sciencedirect.com/science/article/pii/S1553838921005789 | |
81 | Miocarditis inducida por la vacuna COVID-19: un informe de caso con revisión de la literatura: | https://www.sciencedirect.com/science/article/pii/S1871402121002253 | |
82 | Asociación potencial entre COVID-19 VACUNA Y MIARDARDISTICA: Hallazgos clínicos y CMR: | https://www.sciencedirect.com/science/article/pii/S1936878X2100485X | |
83 | Recurrencia de miocarditis aguda temporalmente asociada con la recepción de la vacuna contra la enfermedad de ARNm de Coronavirus 2019 (COVID-19) en un adolescente masculino: | https://www.sciencedirect.com/science/article/pii/S002234762100617X | |
84 | Miocarditis fulminante y hiper inflamación sistémica asociada temporalmente con BNT162B2 COVID-19 Vacunación de ARNm en dos pacientes: | https://www.sciencedirect.com/science/article/pii/S0167527321012286. | |
85 | Miocarditis aguda después de la administración de la vacuna BNT162B2: | https://www.sciencedirect.com/science/article/pii/S2214250921001530 | |
86 | Miocarditis linfohistocítica después de la vacunación con COVID-19 AD26.Cov2.S Vector viral: | https://www.sciencedirect.com/science/article/pii/S2352906721001573 | |
87 | Miocarditis después de la vacunación con BNT162B2 en un hombre sano: | https://www.sciencedirect.com/science/article/pii/S0735675721005362 | |
88 | Miocarditis aguda después de la vacunación de Comirnaty (Pfizer) en un varón sano con la infección previa de SARS-COV-2: | https://www.sciencedirect.com/science/article/pii/S1930043321005549 | |
89 | Myopericarditis después de la vacunación de ARNm Covid-19 de Pfizer en adolescentes: | https://www.sciencedirect.com/science/article/pii/S002234762100665X | |
90 | Pericarditis después de la administración de BNT162B2 MRNA COVID-19 Vacuna de ARNm: | https://www.sciencedirect.com/science/article/pii/S1885585721002218 | |
91 | Miocarditis aguda después de la vacunación con SARS-COV-2 MRNA-1273 ARNm: | https://www.sciencedirect.com/science/article/pii/S2589790X21001931 | |
92 | Relación temporal entre la segunda dosis de la vacuna BNT162B2 MRNA COVID-19 y la participación cardíaca en un paciente con infección previa de SARS-COV-2: | https://www.sciencedirect.com/science/article/pii/S2352906721000622 | |
93 | Myopericarditis después de la vacunación con COVID-19 ARNm en adolescentes de 12 a 18 años de edad: | https://www.sciencedirect.com/science/article/pii/S0022347621007368 | |
94 | Miocarditis aguda después de la vacunación de SARS-COV-2 en un hombre de 24 años: | https://www.sciencedirect.com/science/article/pii/S0870255121003243 | |
95 | Información importante sobre miopericaDITIS después de la vacunación con el ARNm de Pfizer Covid-19 en adolescentes: | https://www.sciencedirect.com/science/article/pii/S0022347621007496 | |
96 | Una serie de pacientes con miocarditis después de la vacunación contra SARS-COV-2 con MRNA-1279 y BNT162B2: | https://www.sciencedirect.com/science/article/pii/S1936878X21004861 | |
97 | Cardiomiopatía TakotSubo después de la vacunación con MRNA COVID-19: | https://www.sciencedirect.com/science/article/pii/S1443950621011331 | |
98 | COVID-19 Vacunación de ARNm y miocarditis: | https://pubmed.ncbi.nlm.nih.gov/34268277/ | |
99 | COVID-19 Vacuna y miocarditis: | https://pubmed.ncbi.nlm.nih.gov/34399967/ | |
100 | Epidemiología y características clínicas de miocarditis / pericarditis Antes de la introducción de la vacuna contra el ARNm COVID-19 en niños coreanos: un estudio multicéntrico | https://search.bvsalud.org/global-literature-on-novel-coronavirus-2019-ncov/resourc e/en/covidwho-1360706. | |
101 | COVID-19 Vacunas y miocarditis: | https://pubmed.ncbi.nlm.nih.gov/34246566/ | |
102 | Miocarditis y otras complicaciones cardiovasculares de COVID-19 vacunas COVID-19 a base de ARNm | https://www.cureus.com/articles/61030-myocarditis-and-other-cardiovascular-comp lications-of-the-mrna-based-covid-19-vaccines | |
103 | Miocarditis, pericarditis y cardiomiopatía después de la vacunación COVID-19: | https://pubmed.ncbi.nlm.nih.gov/34340927/ | |
104 | Miocarditis con COVID-19 Vacunas de ARNm: | https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.121.056135 | |
105 | Asociación de miocarditis con COVID-19 Vacunas de ARNm en niños: | https://media.jamanetwork.com/news-item/association-of-myocarditis-with-mrna-co vid-19-vaccine-in-children/ | |
106 | Asociación de miocarditis con COVID-19 Messenger ARN Vaccine BNT162B2 en una serie de niños: | https://jamanetwork.com/journals/jamacardiology/fullarticle/2783052 | |
107 | Miocarditis después de la inmunización con las vacunas con COVID-19 MRNA en los miembros de los Estados Unidos de los Estados Unidos: | https://jamanetwork.com/journals/jamacardiology/fullarticle/2781601%5C | |
108 | La miocarditis que se produce después de la inmunización con las vacunas COVID-19-19 basadas en ARNm-19: | https://jamanetwork.com/journals/jamacardiology/fullarticle/2781600 | |
109 | Miocarditis después de la inmunización con COVID-19 ARNm: | https://www.nejm.org/doi/full/10.1056/NEJMc2109975 | |
110 | Pacientes con miocarditis aguda después de la vacunación con ARNmAVID-19: | https://jamanetwork.com/journals/jamacardiology/fullarticle/2781602 | |
111 | Miocarditis asociada a la vacunación con COVID-19 ARNm: | https://pubs.rsna.org/doi/10.1148/radiol.2021211430 | |
112 | Myocarditis aguda sintomática en 7 adolescentes después de Pfizer-Biontech COVID-19 Vacunación: | https://pediatrics.aappublications.org/content/148/3/e2021052478 | |
113 | Hallazgos de imágenes de resonancia magnética cardiovascular en pacientes adultos jóvenes con miocarditis aguda después de la vacunación automática de ARNm de COVID-19: una serie de casos: | https://jcmr-online.biomedcentral.com/articles/10.1186/s12968-021-00795-4 | |
114 | Guía clínica para jóvenes con miocarditis y pericarditis después de la vacunación con COVID-19 ARNm: | https://www.cps.ca/en/documents/position/clinical-guidance-for-youth-with-myocarditis-and-pericarditis | |
115 | Imágenes cardiacas de miocarditis aguda después de la vacunación con COVID-19 ARNm: | https://pubmed.ncbi.nlm.nih.gov/34402228/ | |
116 | Informe de caso: miocarditis aguda después de la segunda dosis de MRNA-1273 Vacuna contra ARNF SARS-COV-2: | https://academic.oup.com/ehjcr/article/5/8/ytab319/6339567 | |
117 | Miocarditis / pericarditis asociada con la vacuna COVID-19: | https://science.gc.ca/eic/site/063.nsf/eng/h_98291.html | |
118 | Lesión cardíaca transitoria en adolescentes que reciben la vacuna contra el ARNm COVID-19 de BNT162B2: | https://journals.lww.com/pidj/Abstract/9000/Transient_Cardiac_Injury_in_Adolesce nts_Receiving.95800.aspx | |
119 | Perimyocarditis en adolescentes después de la vacuna PFIZE-BIONTECH COVID-19: | https://academic.oup.com/jpids/advance-article/doi/10.1093/jpids/piab060/6329543 | |
120 | La nueva plataforma de vacunas de ARNm de COVID-19 y miocarditis: pistas sobre el posible mecanismo subyacente: | https://pubmed.ncbi.nlm.nih.gov/34312010/ | |
121 | Lesión de miocardio agudo Después de la vacunación de COVID-19: un informe de caso y revisión de la evidencia actual de la base de datos del sistema de informes de eventos adversos de la vacuna: | https://pubmed.ncbi.nlm.nih.gov/34219532/ | |
122 | Estar alerta al riesgo de eventos cardiovasculares adversos después de la vacunación de COVID-19: | https://www.xiahepublishing.com/m/2472-0712/ERHM-2021-00033 | |
123 | Miocarditis asociada con COVID-19 Vacunación: ecocardiográficos, tomografía cardíaca y resultados de imágenes de resonancia magnética: | https://www.ahajournals.org/doi/10.1161/CIRCIMAGING.121.013236 | |
124 | Evaluación en profundidad de un caso de presunta miocarditis después de la segunda dosis de la vacuna contra ARNm COVID-19: | https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.121.056038 | |
125 | La ocurrencia de la miocarditis de forma de infarto aguda después de la vacunación de COVID-19: ¡solo una coincidencia accidental o más bien una miocarditis autoinmune asociada a la vacuna?: | https://pubmed.ncbi.nlm.nih.gov/34333695/ | |
126 | Recurrencia de miocarditis aguda temporalmente asociada con la recepción de la vacuna contra la enfermedad de ARNm de Coronavirus 2019 (COVID-19) en un adolescente masculino: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8216855/ | |
127 | Miocarditis después de la vacunación por SARS-COV-2: una reacción inducida por la vacuna?: | https://pubmed.ncbi.nlm.nih.gov/34118375/ | |
128 | Miocarditis autolimitada que presenta con dolor en el pecho y elevación del segmento ST en adolescentes después de la vacunación con la vacuna contra el ARNm BNT162B2: | https://pubmed.ncbi.nlm.nih.gov/34180390/ | |
129 | Myopericarditis en un hombre adolescente previamente saludable después de la vacunación de COVID-19: Informe de caso: | https://pubmed.ncbi.nlm.nih.gov/34133825/ | |
130 | Miocarditis linfocítica probada por la biopsia después de la primera vacunación contra ARNm de COVID-19 en un hombre de 40 años: informe de caso: | https://pubmed.ncbi.nlm.nih.gov/34487236/ | |
131 | Perspectivas de un modelo murino de miopericaDitis inducida por la vacuna contra la vacuna contra la vacuna contra la vacuna contra el ARNm: podría inyectarse intravenosa accidental de una vacuna induce miopericaditis | https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciab741/6359059 | |
132 | Presentación inusual de perimyocarditis aguda después de la vacunación moderna SARS-COV-2 MRNA-1237: | https://pubmed.ncbi.nlm.nih.gov/34447639/ | |
133 | Perimyocarditis Después de la primera dosis de MRNA-1273 SARS-COV-2 (moderno) MRNA-1273 vacuna en un hombre joven sano: informe de caso: | https://bmccardiovascdisord.biomedcentral.com/articles/10.1186/s12872-021-02183 | |
134 | Miocarditis aguda después de la segunda dosis de vacuna contra SARS-COV-2: Serendipidad o relación causal: | https://pubmed.ncbi.nlm.nih.gov/34236331/ | |
135 | Rhabdomiolisis y fascitis inducida por la vacuna contra el ARNm Covid-19: | https://pubmed.ncbi.nlm.nih.gov/34435250/ | |
136 | COVID-19 Rabdomiolisis inducida por la vacuna: Informe de caso con revisión de la literatura: | https://pubmed.ncbi.nlm.nih.gov/34186348/. | |
137 | GM1 Gangliósido Anticuerpo y COVID-19-COVID-RELACIONADO Síndrome de Barre: Informe de caso, revisión sistémica e implicaciones para el desarrollo de la vacuna: | https://www.sciencedirect.com/science/article/pii/S2666354621000065 | |
138 | Síndrome de Guillain-Barré después de AstraZeneca COVID-19 Vacunación: Asociación Causal o Casual: | https://www.sciencedirect.com/science/article/pii/S0303846721004169 | |
139 | Síndrome de Guillain-Barré sensorial después de la vacuna Chadox1 NCOV-19: Informe de dos casos y revisión de la literatura: | https://www.sciencedirect.com/science/article/pii/S0165572821002186 | |
140 | Síndrome de Guillain-Barré después de la primera dosis de vacuna contra SARS-COV-2: una ocurrencia temporal, no una asociación causal: | https://www.sciencedirect.com/science/article/pii/S2214250921000998. | |
141 | Síndrome de Guillain-Barré presentando como diplegia facial después de la vacunación con COVID-19: un informe de caso: | https://www.sciencedirect.com/science/article/pii/S0736467921006442 | |
142 | Síndrome de Guillain-Barré después de la primera inyección de la vacuna Chadox1 NCOV-19: Primer informe: | https://www.sciencedirect.com/science/article/pii/S0035378721005853. | |
143 | Las vacunas SARS-COV-2 no son seguras para aquellos con síndrome de Guillain-Barre después de la vacunación: | https://www.sciencedirect.com/science/article/pii/S2049080121005343 | |
144 | Encefalopatía hiperactiva aguda después de la vacunación de COVID-19 con respuesta dramática a la metilprednisolona: un informe de caso: | https://www.sciencedirect.com/science/article/pii/S2049080121007536 | |
145 | Parálisis del nervio facial Después de la administración de vacunas de ARNm Covid-19: análisis de la base de datos de autoinforme: | https://www.sciencedirect.com/science/article/pii/S1201971221007049 | |
146 | Síntomas neurológicos y alteraciones de neuroimagen relacionados con la vacuna COVID-19: Causa o coincidencia: | https://www.sciencedirect.com/science/article/pii/S0899707121003557. | |
147 | Estado refractario de nueva aparición Epilepticus después de la vacunación con Chadox1 NCOV-19: | https://www.sciencedirect.com/science/article/pii/S0165572821001569 | |
148 | MIELITIS AGUDA Y CHADOX1 VACUNA DE LA NCOV-19: Asociación Concesional o causal: | https://www.sciencedirect.com/science/article/pii/S0165572821002137 | |
149 | Vacunas de parálisis y SARS-COV-2 de Bell: una historia de despliegue: | https://www.sciencedirect.com/science/article/pii/S1473309921002735 | |
150 | La parálisis de Bell después de la segunda dosis de la vacuna Pfizer Covid-19 en un paciente con una historia de parálisis recurrente de Bell: | https://www.sciencedirect.com/science/article/pii/S266635462100020X | |
151 | Retinopatía serosa central de inicio agudo después de la vacuna contra la inmunización con COVID-19 Vacuna de ARNm:. | https://www.sciencedirect.com/science/article/pii/S2451993621001456. | |
152 | Parálisis de Bell después de la vacunación de COVID-19: Informe de caso: | https://www.sciencedirect.com/science/article/pii/S217358082100122X. | |
153 | Una experiencia académica del hospital que evalúa el riesgo de vacuna contra el ARNm de COVID-19 utilizando la historia de la alergia al paciente: | https://www.sciencedirect.com/science/article/pii/S2213219821007972 | |
154 | COVID-19 Linfadenopatía axilar y pectoral inducida por la vacuna en PET: | https://www.sciencedirect.com/science/article/pii/S1930043321002612 | |
155 | Vasculitis asociada a ANCA después de la vacuna PFIZE-BIONTECH COVID-19: | https://www.sciencedirect.com/science/article/pii/S0272638621007423 | |
156 | Reacciones cutáneas tardías después de la administración de vacunas de ARNm COVID-19: | https://www.sciencedirect.com/science/article/pii/S2213219821007996 | |
157 | COVID-19 Rabdomiolisis inducida por la vacuna: Informe de caso con la revisión de la literatura: | https://www.sciencedirect.com/science/article/pii/S1871402121001880 | |
158 | Correlatos clínicos y patológicos de las reacciones de la piel a la vacuna COVID-19, incluido V-REPP: un estudio basado en el registro: | https://www.sciencedirect.com/science/article/pii/S0190962221024427 | |
159 | Trombosis con síndrome de trombocitopenia asociada con vacunas COVID-19:. | https://www.sciencedirect.com/science/article/abs/pii/S0735675721004381. | |
160 | COVID-19 ANAPHYLAXIS asociada a la vacuna: una declaración del Comité de Anafilaxia de la Organización Mundial de Alergias:. | https://www.sciencedirect.com/science/article/pii/S1939455121000119. | |
161 | Trombosis sinusal venosa cerebral negativa para anticuerpos anti-PF4 sin trombocitopenia después de la inmunización con la vacuna COVID-19 en un anciano, no comorbido macho indio tratado con anticoagulación convencional de heparina-warfarina. | https://www.sciencedirect.com/science/article/pii/S1871402121002046. | |
162 | Miocarditis aguda después de la administración de la vacuna BNT162B2 contra COVID-19: | https://www.sciencedirect.com/science/article/abs/pii/S188558572100133X | |
163 | Coágulos de sangre y sangrado después de la vacuna BNT162B2 y CHADOX1 NCOV-19: un análisis de los datos europeos: | https://www.sciencedirect.com/science/article/pii/S0896841121000937. | |
164 | Thrombocitopenia inmune asociada con la vacuna contra el ARNm COVID-19 BNT162B2 de PFIZER-BIONTECH:. | https://www.sciencedirect.com/science/article/pii/S2214250921002018. | |
165 | Erupción de drogas amonestadoras después de la segunda dosis de COVID-19 MRNA-1273 (MODERNA) Vacuna: Informe de caso: | https://www.sciencedirect.com/science/article/pii/S1876034121001878. | |
166 | Vacunas basadas en ARN COVID-19 y el riesgo de enfermedad priónica: | https://scivisionpub.com/pdfs/covid19rna-based-vaccines-and-the-risk-of-prion-dis ease-1503.pdf | |
167 | Este estudio señala que 115 mujeres embarazadas perdieron a sus bebés, de 827 que participaron en un estudio sobre la seguridad de las vacunas COVID-19: | https://www.nejm.org/doi/full/10.1056/NEJMoa2104983. | |
168 | Impurezas relacionadas con el proceso en la vacuna Chadox1 NCOV-19: | https://www.researchsquare.com/article/rs-477964/v1 | |
169 | COVID-19 Vacuna de ARNm que causa la inflamación del CNS: una serie de casos: | https://link.springer.com/article/10.1007/s00415-021-10780-7 | |
170 | Reacciones alérgicas, incluida la anafilaxia, después de recibir la primera dosis de la vacuna PFIZE-BIONTECH COVID-19: | https://pubmed.ncbi.nlm.nih.gov/33475702/ | |
171 | Reacciones alérgicas a la primera vacuna COVID-19: un papel potencial de polietilenglicol: | https://pubmed.ncbi.nlm.nih.gov/33320974/ | |
172 | La vacuna PFIZE aumenta las preocupaciones de alergias: | https://pubmed.ncbi.nlm.nih.gov/33384356/ | |
173 | Reacciones alérgicas, incluida la anafilaxia, después de recibir la primera dosis de PFIZE-BIONTECH COVID-19 VACCINE - Estados Unidos, 14-23 de diciembre de 2020: | https://pubmed.ncbi.nlm.nih.gov/33444297/ | |
174 | Reacciones alérgicas, incluida la anafilaxia, después de recibir la primera dosis de la vacuna moderna COVID-19 - Estados Unidos, 21 de diciembre, 2020 al 10 de enero de 2021: | https://pubmed.ncbi.nlm.nih.gov/33507892/ | |
175 | Informes de anafilaxis Después de la vacunación contra la enfermedad de Coronavirus 2019, Corea del Sur, 26 de febrero al 30 de abril de 2021: | https://pubmed.ncbi.nlm.nih.gov/34414880/ | |
176 | Informes de anafilaxia Después de recibir vacunas de ARNm COVID-19 en los Estados Unidos, 14 de diciembre, 2020 a enero, 18, 2021: | https://pubmed.ncbi.nlm.nih.gov/33576785/ | |
177 | Prácticas de inmunización y riesgo de anafilaxis: una actualización actual y completa de los datos de vacunación COVID-19: | https://pubmed.ncbi.nlm.nih.gov/34269740/ | |
178 | Relación entre alergias preexistentes y reacciones anafilácticas después de la administración de la vacuna contra ARNm de COVID-19: | https://pubmed.ncbi.nlm.nih.gov/34215453/ | |
179 | Anafilaxia asociada con vacunas de ARNm COVID-19: Enfoque de la investigación de alergias: | https://pubmed.ncbi.nlm.nih.gov/33932618/ | |
180 | Reacciones alérgicas severas después de la vacunación de COVID-19 con la vacuna PFIVE / BIONTECH en Gran Bretaña y los Estados Unidos: declaración de la declaración de las sociedades alérgicas alemanas: Asociación Médica Alemana de Alergólogos (AEDA), Sociedad Alemana de Alergología y Inmunología Clínica (Dgaki) y la sociedad Para alergología pediátrica y medicina ambiental (GPA): | https://pubmed.ncbi.nlm.nih.gov/33643776/ | |
181 | Reacciones alérgicas y anafilaxis a las vacunas COVID-19 a base de LNP: | https://pubmed.ncbi.nlm.nih.gov/33571463/ | |
182 | Informado de efectos adversos orfaciales de las vacunas COVID-19: lo conocido y lo desconocido: | https://pubmed.ncbi.nlm.nih.gov/33527524/ | |
183 | Efectos adversos cutáneos de las vacunas COVID-19 disponibles: | https://pubmed.ncbi.nlm.nih.gov/34518015/ | |
184 | Informe acumulado de eventos adversos de la anafilaxia después de las inyecciones de la vacuna contra el ARNA COVID-19 (PFIZER-BIONTECH) en Japón: el informe del primer mes: | https://pubmed.ncbi.nlm.nih.gov/34347278/ | |
185 | Las vacunas COVID-19 aumentan el riesgo de anafilaxia: | https://pubmed.ncbi.nlm.nih.gov/33685103/ | |
186 | Anafilaxia bifásica Después de la exposición a la primera dosis de la vacuna contra PFIZ-BIONTECH COVID-19 COVID-19 COVID-19: | https://pubmed.ncbi.nlm.nih.gov/34050949/ | |
187 | Componentes alergénicos de la vacuna contra el MRNA-1273 para COVID-19: Posible participación de la activación de complemento de polietilenglicol e IgG mediada por IgG: | https://pubmed.ncbi.nlm.nih.gov/33657648/ | |
188 | El polietilenglicol (PEG) es una causa de la anafilaxia a la vacuna contra COVID-19 de PFIZE / BIONTECH MRNA: | https://pubmed.ncbi.nlm.nih.gov/33825239/ | |
189 | Reacciones alérgicas agudas a COVID-19 Vacunas de ARNm: | https://pubmed.ncbi.nlm.nih.gov/33683290/ | |
190 | Alergia al glicol de polietileno de los SARS Receptor de vacuna contra COV2: Informe de caso de un receptor y gestión de un adulto joven de la exposición futura a SARS-COV2: | https://pubmed.ncbi.nlm.nih.gov/33919151/ | |
191 | Tasas elevadas de anafilaxia después de la vacunación con la vacuna contra el ARNm de Pfizer BNT162B2 contra COVID-19 en los trabajadores de la salud japonesa; Un análisis secundario de los datos iniciales de seguridad posteriores a la aprobación: | https://pubmed.ncbi.nlm.nih.gov/34128049/ | |
192 | Reacciones alérgicas y eventos adversos asociados con la administración de vacunas basadas en ARNm. Una experiencia del sistema de salud: | https://pubmed.ncbi.nlm.nih.gov/34474708/ | |
193 | Reacciones alérgicas a COVID-19 Vacunas: Declaración de la Sociedad Bélgica de Alergia y Inmunología Clínica (Belsaci): | https://www.tandfonline.com/doi/abs/10.1080/17843286.2021.1909447 | |
194 | Alergia mediada por .Ige al polietilenglicol (PEG) como una causa de la anafilaxia a las vacunas con COVID-19 ARNm: | https://pubmed.ncbi.nlm.nih.gov/34318537/ | |
195 | Reacciones alérgicas después de la vacunación COVID-19: Poner el riesgo en perspectiva: | https://pubmed.ncbi.nlm.nih.gov/34463751/ | |
196 | Reacciones anafilácticas a COVID-19 Vacunas de ARNm: una llamada para estudios adicionales: | https://pubmed.ncbi.nlm.nih.gov/33846043/188 | |
197 | Riesgo de reacciones alérgicas graves a las vacunas COVID-19 entre pacientes con enfermedad de la piel alérgica: recomendaciones prácticas. Una declaración de posición de Etfad con expertos externos: | https://pubmed.ncbi.nlm.nih.gov/33752263/ | |
198 | COVID-19 Vacuna y muerte: algoritmo de causalidad de acuerdo con el diagnóstico de elegibilidad de la OMS: | https://pubmed.ncbi.nlm.nih.gov/34073536/ | |
199 | Hemorragia fatal cerebral después de la vacuna COVID-19: | https://pubmed.ncbi.nlm.nih.gov/33928772/ | |
200 | Una serie de casos de reacciones de la piel a la vacuna COVID-19 en el Departamento de Dermatología en la Universidad Loma Linda: | https://pubmed.ncbi.nlm.nih.gov/34423106/ | |
201 | Reacciones de la piel reportadas después de la vacunación de COVID-19 de Modena y Pfizer: un estudio basado en un registro de 414 casos: | https://pubmed.ncbi.nlm.nih.gov/33838206/ | |
202 | Correlatos clínicos y patológicos de las reacciones de la piel a la vacuna COVID-19, incluido V-REPP: un estudio basado en el registro: | https://pubmed.ncbi.nlm.nih.gov/34517079/ | |
203 | Reacciones de la piel después de la vacunación contra SARS-COV-2: un estudio en sección transversal español nacional de 405 casos: | https://pubmed.ncbi.nlm.nih.gov/34254291/ | |
204 | Varicella Zoster Virus y herpes Reactivación del virus Simplex después de la vacunación con COVID-19: Revisión de 40 casos en un Registro Dermatológico Internacional: | https://pubmed.ncbi.nlm.nih.gov/34487581/ | |
205 | Trombosis inmune y trombocitopenia (VITT) asociada con la vacuna COVID-19: Recomendaciones diagnósticas y terapéuticas para un nuevo síndrome: | https://pubmed.ncbi.nlm.nih.gov/33987882/ | |
206 | Pruebas de laboratorio para la sospecha de covid-19 trombocitopenia trombótica inducida por la vacuna (inmune): | https://pubmed.ncbi.nlm.nih.gov/34138513/ | |
207 | Hemorragia intracerebral Debido a la trombosis con el síndrome de trombocitopenia después de la vacunación COVID-19: el primer caso fatal en Corea: | https://pubmed.ncbi.nlm.nih.gov/34402235/ | |
208 | Riesgo de trombocitopenia y tromboembolismo después de la vacunación COVID-19 y pruebas positivas de SARS-COV-2: Estudio de la serie de casos autocontroladas: | https://pubmed.ncbi.nlm.nih.gov/34446426/ | |
209 | Trombocitopenia trombótica inmune inducida por la vacuna y la trombosis sinusita venosa cerebral después de la vacunación de COVID-19; Una revisión sistemática: | https://pubmed.ncbi.nlm.nih.gov/34365148/. | |
210 | Eventos adversos nerviosos y musculares después de la vacunación con COVID-19: una revisión sistemática y un metanálisis de los ensayos clínicos: | https://pubmed.ncbi.nlm.nih.gov/34452064/. | |
211 | Un caso raro de trombosis venosa cerebral y la coagulación intravascular diseminada se asocia temporalmente con la administración de la vacuna COVID-19: | https://pubmed.ncbi.nlm.nih.gov/33917902/ | |
212 | Insuficiencia suprarrenal primaria asociada con trombocitopenia inmune trombótica inducida por Oxford-AstraZeneca Chadox1 Vaccine NCOV-19 (VITT): | https://pubmed.ncbi.nlm.nih.gov/34256983/ | |
213 | Trombosis venosa cerebral aguda y embolia de la arteria pulmonar asociada con la vacuna COVID-19: | https://pubmed.ncbi.nlm.nih.gov/34247246/. | |
214 | Infusión de tromboaspiration y fibrinólisis para la trombosis portomesentérica después de la administración de AstraZeneca COVID-19 Vacuna: | https://pubmed.ncbi.nlm.nih.gov/34132839/ | |
215 | Mujer de 59 años con trombosis venosa extensa y tromboembolismo pulmonar 7 días después de una primera dosis de Pfizer-BionTech BNT162B2 MRNA Vaccine COVID-19: | https://pubmed.ncbi.nlm.nih.gov/34117206/ | |
216 | Trombosis venosa cerebral y trombocitopenia inducida por la vacuna. Oxford-AstraZeneca COVID-19: Una oportunidad perdida para un rápido retorno de la experiencia: | https://pubmed.ncbi.nlm.nih.gov/34033927/ | |
217 | Miocarditis y otras complicaciones cardiovasculares de las vacunas COVID-19 a base de ARNm: | https://pubmed.ncbi.nlm.nih.gov/34277198/ | |
218 | Pericarditis después de la administración de la vacuna contra COVID-19 MRNA BNT162B2: | https://pubmed.ncbi.nlm.nih.gov/34364831/ | |
219 | Presentación inusual de la pericarditis aguda después de la vacunación contra el SARS-COV-2 MRNA-1237 moderno: | https://pubmed.ncbi.nlm.nih.gov/34447639/ | |
220 | Informe de caso: miocarditis aguda después de la segunda dosis de SARS-COV-2 MRNA-1273 Vacuna MRNA-1273: | https://pubmed.ncbi.nlm.nih.gov/34514306/ | |
221 | Brotes de enfermedad mediada por la mediación inmunológica o enfermedad de inicio reciente en 27 sujetos después de la vacunación con ARNm / ADN contra SARS-COV-2: | https://pubmed.ncbi.nlm.nih.gov/33946748/ | |
222 | Perspectivas de un modelo murino de miopericaDitis inducida por la vacuna contra la COVID-19 ARNm: podría inyección intravenosa accidental de una vacuna induce miopericaDitis: | https://pubmed.ncbi.nlm.nih.gov/34453510/ | |
223 | Trombocitopenia inmune en un poste de 22 años de edad COVID-19 Vacuna: | https://pubmed.ncbi.nlm.nih.gov/33476455/ | |
224 | Vasculitis asociada a anticuerpos anti-citoplasmáticos inducidos por propiltiouracilo después de la vacunación de COVID-19: | https://pubmed.ncbi.nlm.nih.gov/34451967/ | |
225 | Trombocitopenia inmune secundaria (ITP) asociada con la vacuna COVID-19-19 de Chadox1: Informe de caso: | https://pubmed.ncbi.nlm.nih.gov/34377889/ | |
226 | Trombosis con síndrome de trombocitopenia (TTS) después de AstraZeneca Chadox1 NCOV-19 (AZD1222) COVID-19 Vacunación: Análisis de riesgo-beneficio para personas <60 años en Australia: | https://pubmed.ncbi.nlm.nih.gov/34272095/ | |
227 | Asociación de vacunación COVID-19 y parálisis del nervio facial: un estudio de control de casos: | https://pubmed.ncbi.nlm.nih.gov/34165512/ | |
228 | La asociación entre la vacunación COVID-19 y la parálisis de Bell: | https://pubmed.ncbi.nlm.nih.gov/34411533/ | |
229 | Parálisis de Bell después de la vacunación de COVID-19: | https://pubmed.ncbi.nlm.nih.gov/33611630/ | |
230 | Myelitis transversal aguda (ATM): Revisión clínica de 43 pacientes con cajeros automáticos de COVID-19 asociados y 3 eventos adversos graves de cajero automático posterior al vacunación con la vacuna Chadox1 NCOV-19 (AZD1222): | https://pubmed.ncbi.nlm.nih.gov/33981305/ | |
231 | La parálisis de Bell después de 24 horas de MRNA-1273 SARS-COV-2 MRNA-1273 Vaccine: | https://pubmed.ncbi.nlm.nih.gov/34336436/ | |
232 | Palsia de nervio facial contralateral secuencial después de la primera y la segunda dosis de la vacuna COVID-19: | https://pubmed.ncbi.nlm.nih.gov/34281950/. | |
233 | Mielitis transversal inducida por la vacunación por SARS-COV-2: | https://pubmed.ncbi.nlm.nih.gov/34458035/ | |
234 | Palsy del nervio facial periférico después de la vacunación con BNT162B2 (COVID-19): | https://pubmed.ncbi.nlm.nih.gov/33734623/ | |
235 | Parálisis nerviosa aguda de Abducens después de la vacunación de COVID-19: | https://pubmed.ncbi.nlm.nih.gov/34044114/. | |
236 | Palsy del nervio facial Después de la administración de las vacunas con ARNm de COVID-19: análisis de la base de datos de autoinforme: | https://pubmed.ncbi.nlm.nih.gov/34492394/ | |
237 | Parálisis oculomotora transitoria Después de la administración de la vacuna de mensajería RNA-1273 para la diplopía SARS-COV-2 después de la vacuna COVID-19: | https://pubmed.ncbi.nlm.nih.gov/34369471/ | |
238 | Parálisis de Bell después de ad26.cov2.s COVID-19 Vacunación: | https://pubmed.ncbi.nlm.nih.gov/34014316/ | |
239 | Parálisis de Bell después de la vacunación de COVID-19: Informe de caso: | https://pubmed.ncbi.nlm.nih.gov/34330676/ | |
240 | Un caso de demielización aguda de la polirradiculoneuropatía con parálisis facial bilateral después de la vacunación con Chadox1 NCOV-19: | https://pubmed.ncbi.nlm.nih.gov/34272622/ | |
241 | Síndrome de Guillian Barré después de la vacunación con MRNA-1273 contra COVID-19: | https://pubmed.ncbi.nlm.nih.gov/34477091/ | |
242 | Parálisis facial aguda como posible complicación de la vacunación de SARS-COV-2: | https://pubmed.ncbi.nlm.nih.gov/33975372/. | |
243 | Parálisis de Bell después de la vacunación COVID-19 con una alta respuesta de anticuerpos en CSF: | https://pubmed.ncbi.nlm.nih.gov/34322761/. | |
244 | Síndrome de Parsonage-Turner asociado con la vacunación SARS-COV-2 o SARS-COV-2. Comentario sobre: "Amigrófia neuralgic y covid-19 infección: 2 casos de parálisis del nervio espinal accesorio" por Coll et al. Columna vertebral articular 2021; 88: 10519: | https://pubmed.ncbi.nlm.nih.gov/34139321/. | |
245 | Parálisis de Bell después de una dosis única de ARNm de vacuna. SARS-COV-2: Informe de caso: | https://pubmed.ncbi.nlm.nih.gov/34032902/. | |
246 | Hepatitis autoinmune que se desarrolla después de la vacuna contra la enfermedad de Coronavirus 2019 (COVID-19): ¿causalidad o víctima?: | https://pubmed.ncbi.nlm.nih.gov/33862041/ | |
247 | Hepatitis autoinmune provocada por la vacunación contra SARS-COV-2: | https://pubmed.ncbi.nlm.nih.gov/34332438/ | |
248 | Hepatitis aguda autoinmune, con anticuerpo antimitocondrial atípico después de la vacunación con COVID-19 ARNm: una nueva entidad clínica: | https://pubmed.ncbi.nlm.nih.gov/34293683/. | |
249 | Hepatitis autoinmune después de la vacuna covid: | https://pubmed.ncbi.nlm.nih.gov/34225251/ | |
250 | Un nuevo caso de variante de diplegia bifacial del síndrome de Guillain-Barré después de la vacunación con Janssen COVID-19: | https://pubmed.ncbi.nlm.nih.gov/34449715/ | |
251 | Comparación de eventos trombóticos inducidos por la vacuna entre Chadox1 NCOV-19 y ad26.cov.2.s vacunas: | https://pubmed.ncbi.nlm.nih.gov/34139631/. | |
252 | Trombosis de vena oftálmica superior bilateral, accidente cerebrovascular isquémico y trombocitopenia inmune después de la vacunación con Chadox1 NCOV-19: | https://pubmed.ncbi.nlm.nih.gov/33864750/ | |
253 | Diagnóstico y tratamiento de la trombosis sinusita venosa cerebral con trombocitopenia trombótica inmunomunitaria inducida por la vacuna: | https://pubmed.ncbi.nlm.nih.gov/33914590/ | |
254 | Trombosis sinusal venosa después de la vacunación con Chadox1 NCOV-19: | https://pubmed.ncbi.nlm.nih.gov/34420802/ | |
255 | Trombosis sinusal venosa cerebral después de la vacunación contra el SARS-COV-2: un análisis de los casos reportados a la Agencia Europea de Medicamentos: | https://pubmed.ncbi.nlm.nih.gov/34293217/ | |
256 | Riesgo de trombocitopenia y tromboembolismo después de la vacunación COVID-19 y pruebas positivas de SARS-COV-2: Estudio de la serie de casos autocontroladas: | https://pubmed.ncbi.nlm.nih.gov/34446426/ | |
257 | Coágulos de sangre y sangrado después de la vacunación por BNT162B2 y CHADOX1 NCOV-19: un análisis de los datos europeos: | https://pubmed.ncbi.nlm.nih.gov/34174723/ | |
258 | Eventos arteriales, tromboembolismo venoso, trombocitopenia y sangrado después de la vacunación con Oxford-AstraZeneca Chadox1-S en Dinamarca y Noruega: estudio de cohorte basado en la población: | https://pubmed.ncbi.nlm.nih.gov/33952445/ | |
259 | Primera dosis de vacunas CHADOX1 y BNT162B2 COVID-19 y eventos trombocitopénicos, tromboembólicos y hemorrágicos en Escocia: | https://pubmed.ncbi.nlm.nih.gov/34108714/ | |
260 | Trombosis venosa cerebral asociada con la vacuna COVID-19 en Alemania: | https://pubmed.ncbi.nlm.nih.gov/34288044/ | |
261 | Infarto cerebral maligno después de la vacunación con Chadox1 NCOV-19: una variante catastrófica de la trombocitopenia trombótica inmunológica inducida por la vacuna: | https://pubmed.ncbi.nlm.nih.gov/34341358/ | |
262 | La arteria celíaca y la trombosis de la arteria esplénica se complicaron por infarto esplénico 7 días después de la primera dosis de la vacuna Oxford, la relación causal o la coincidencia: | https://pubmed.ncbi.nlm.nih.gov/34261633/. | |
263 | Insuficiencia suprarrenal primaria asociada con OXFORD-ASTRAZENECA CHADOX1 NCOV-19 (VITT) Trombocitopenia trombótica inmune inducida por la vacuna: | https://pubmed.ncbi.nlm.nih.gov/34256983/ | |
264 | Trombocitopenia después de la vacunación COVID-19: | https://pubmed.ncbi.nlm.nih.gov/34332437/. | |
265 | Trombosis sinusus venosa cerebral asociada con trombocitopenia después de la vacunación de COVID-19: | https://pubmed.ncbi.nlm.nih.gov/33845870/. | |
266 | Trombosis con síndrome de trombocitopenia después de la inmunización COVID-19: | https://pubmed.ncbi.nlm.nih.gov/34236343/ | |
267 | Infarto de miocardio agudo dentro de las 24 horas posteriores a la vacunación COVID-19: | https://pubmed.ncbi.nlm.nih.gov/34364657/. | |
268 | Neuroretinopatía macular aguda bilateral después de la vacunación del SARS-COV-2: | https://pubmed.ncbi.nlm.nih.gov/34287612/ | |
269 | Trombosis sinusal venosa central con hemorragia subaracnoidea después de la vacunación de ARNm Covid-19: son estos informes simplemente coincidentales: | https://pubmed.ncbi.nlm.nih.gov/34478433/ | |
270 | Hemorragia intracerebral Debido a la trombosis con el síndrome de trombocitopenia después de la vacunación COVID-19: el primer caso fatal en Corea: | https://pubmed.ncbi.nlm.nih.gov/34402235/ | |
271 | Trombosis sinusal venosa cerebral negativa para anticuerpos anti-PF4 sin trombocitopenia después de la inmunización con la vacuna COVID-19 en un anciano indio no comor, tratado con anticoagulación convencional de heparina-warfarina: | https://pubmed.ncbi.nlm.nih.gov/34186376/ | |
272 | Trombosis sinusus venosa cerebral 2 semanas después de la primera dosis de la vacuna contra el ARNm de SARS-COV-2: | https://pubmed.ncbi.nlm.nih.gov/34101024/ | |
273 | Un caso de trombocitopenia y trombosis múltiple después de la vacunación con Chadox1 NCOV-19 contra SARS-COV-2: | https://pubmed.ncbi.nlm.nih.gov/34137813/ | |
274 | Trombocitopenia trombótica inducida por la vacuna: el vínculo elusivo entre la trombosis y las vacunas SARS-COV-2 a base de adenovirus: | https://pubmed.ncbi.nlm.nih.gov/34191218/ | |
275 | El accidente cerebrovascular isquémico agudo que revela la trombocitopenia trombótica inmune inducida por la vacuna Chadox1 NCOV-19: impacto en la estrategia de recanalización: | https://pubmed.ncbi.nlm.nih.gov/34175640/ | |
276 | Estado refractario de nueva aparición Epilepticus después de la vacuna Chadox1 NCOV-19: | https://pubmed.ncbi.nlm.nih.gov/34153802/ | |
277 | Trombosis con síndrome de trombocitopenia asociada a COVID-19 Vacunas vector virales: | https://pubmed.ncbi.nlm.nih.gov/34092488/ | |
278 | Embolia pulmonar, ataque isquémico transitorio y trombocitopenia después de Johnson & Johnson Covid-19 Vacuna: | https://pubmed.ncbi.nlm.nih.gov/34261635/ | |
279 | Infusión de tromboaspiration y fibrinolisis para la trombosis portomesentérica después de la administración de la vacuna contra el astrazeneca covid-19: | https://pubmed.ncbi.nlm.nih.gov/34132839/. | |
280 | Síndrome de golpe espontáneo: reemplazo de rodilla, infección y paralelos con trombocitopenia trombótica inmune inducida por la vacuna: | https://pubmed.ncbi.nlm.nih.gov/34144250/ | |
281 | La trombosis venosa profunda (TVT) se produce poco después de la segunda dosis de la vacuna contra ARNm de SARS-COV-2: | https://pubmed.ncbi.nlm.nih.gov/33687691/ | |
282 | Plaquetas proCoagulantes mediadas por el anticuerpo procoagulante en trombocitopenia trombótica inmune asociada con la vacunación con SARS-COV-2: | https://pubmed.ncbi.nlm.nih.gov/34011137/. | |
283 | Trombocitopenia trombótica inmune inducida por la vacuna que causa una forma severa de trombosis venosa cerebral con alta tasa de mortalidad: una serie de casos: | https://pubmed.ncbi.nlm.nih.gov/34393988/. | |
284 | Micropartículas PROCOagulantes: un posible vínculo entre la trombocitopenia inmune inducida por la vacuna (VITT) y la trombosis venosa cerebral sinusal: | https://pubmed.ncbi.nlm.nih.gov/34129181/. | |
285 | Trombosis atípica asociada con la vacuna Vaxzevria® (AstraZeneca): datos de la red francesa de centros regionales de farmacovigilancia: | https://pubmed.ncbi.nlm.nih.gov/34083026/. | |
286 | Trombosis venosa cerebral aguda y embolia de la arteria pulmonar asociada con la vacuna COVID-19: | https://pubmed.ncbi.nlm.nih.gov/34247246/. | |
287 | Trombosis y trombocitopenia inducidas por la vacuna con hemorragia adrenal bilateral: | https://pubmed.ncbi.nlm.nih.gov/34235757/. | |
288 | Trombosis de la vena digital Palmar después de Oxford-AstraZeneca COVID-19 Vacunación: | https://pubmed.ncbi.nlm.nih.gov/34473841/. | |
289 | Trombosis cutánea asociada con necrosis cutánea después de Oxford-AstraZeneca COVID-19 Vacunación: | https://pubmed.ncbi.nlm.nih.gov/34189756/ | |
290 | Trombosis venosa cerebral después de la vacunación de COVID-19: | https://pubmed.ncbi.nlm.nih.gov/34045111/. | |
291 | LIPSCHÜTZ ULCERS DESPUÉS DE LA VACCIÓN DE ASTRAZENECA COVID-19: | https://pubmed.ncbi.nlm.nih.gov/34366434/. | |
292 | Neuralgia amiotrófica secundaria a Vaccine Vaxzevri (AstraZeneca) COVID-19: | https://pubmed.ncbi.nlm.nih.gov/34330677/ | |
293 | Trombosis con trombocitopenia después de la vacuna Messenger RNA-1273: | https://pubmed.ncbi.nlm.nih.gov/34181446/ | |
294 | Hemorragia intracerebral Doce días después de la vacunación con Chadox1 NCOV-19: | https://pubmed.ncbi.nlm.nih.gov/34477089/ | |
295 | Trombocitopenia trombótica después de la vacunación con COVID-19: En busca del mecanismo subyacente: | https://pubmed.ncbi.nlm.nih.gov/34071883/ | |
296 | Coronavirus (COVID-19) Trombocitopenia trombótica inmune inducida por la vacuna (VITT): | https://pubmed.ncbi.nlm.nih.gov/34033367/ | |
297 | Comparación de reacciones adversas de los medicamentos entre las cuatro vacunas COVID-19 en Europa utilizando la base de datos de EUDRAVAVIGILANCE: trombosis en sitios inusuales: | https://pubmed.ncbi.nlm.nih.gov/34375510/ | |
298 | Adyuvante de inmunoglobulina para la trombocitopenia trombótica inmune inducida por la vacuna: | https://pubmed.ncbi.nlm.nih.gov/34107198/ | |
299 | Trombocitopenia trombótica inducida por la vacuna severa después de la vacunación con COVID-19: un informe de caso de autopsia y revisión de la literatura: | https://pubmed.ncbi.nlm.nih.gov/34355379/. | |
300 | Un caso de embolia pulmonar aguda después de la inmunización con ARNm de SARS-COV-2: | https://pubmed.ncbi.nlm.nih.gov/34452028/ | |
301 | Consideraciones neuroquirúrgicas con respecto a la craniectomía descompresiva para la hemorragia intracerebral después de la vacunación con SARS-COV-2 en trombocitopenia trombótica inducida por la vacuna: VITT: | https://pubmed.ncbi.nlm.nih.gov/34202817/ | |
302 | Vacunas de trombosis y SARS-COV-2: trombocitopenia trombótica inmune inducida por la vacuna: | https://pubmed.ncbi.nlm.nih.gov/34237213/. | |
303 | Púrpura trombocitopénica trombocitopénica trombótica adquirida: una enfermedad rara asociada con la vacuna BNT162B2: | https://pubmed.ncbi.nlm.nih.gov/34105247/. | |
304 | Complejos inmunes, inmunidad innata y Netosis en la trombocitopenia inducida por la vacuna en Chadox1: | https://pubmed.ncbi.nlm.nih.gov/34405870/. | |
305 | Síndrome de Guillain-Barré sensorial siguiendo la vacuna Chadox1 NCOV-19: Informe de dos casos y revisión de la literatura: | https://pubmed.ncbi.nlm.nih.gov/34416410/. | |
306 | Síndrome de Vogt-Koyanagi-Harada después de COVID-19 y CHADOX1 NCOV-19 (AZD1222) Vacunación: | https://pubmed.ncbi.nlm.nih.gov/34462013/. | |
307 | Reactivación de la enfermedad de Vogt-Koyanagi-Harada bajo control durante más de 6 años, después de la vacunación contra el SARS-COV-2: | https://pubmed.ncbi.nlm.nih.gov/34224024/. | |
308 | Encefalitis post-vacante después de Chadox1 NCOV-19: | https://pubmed.ncbi.nlm.nih.gov/34324214/ | |
309 | Síntomas neurológicos y alteraciones de neuroimagen relacionados con la vacuna COVID-19: Causa o coincidencia?: | https://pubmed.ncbi.nlm.nih.gov/34507266/ | |
310 | Síndrome de fuga capilar sistémico fatal después de la vacunación de SARS-COV-2 en un paciente con mieloma múltiple: | https://pubmed.ncbi.nlm.nih.gov/34459725/ | |
311 | Síndrome de Polyarthralgia y Myalgia después de la vacunación con Chadox1 NCOV-19: | https://pubmed.ncbi.nlm.nih.gov/34463066/ | |
312 | Tres casos de tiroiditis subaguda después de la vacunación con SARS-COV-2: Síndrome de Asia posterior al vacunación: | https://pubmed.ncbi.nlm.nih.gov/34043800/. | |
313 | Diplegia facial: una variante rara y atípica del síndrome de Guillain-Barré y la vacuna ad26.cov2.s: | https://pubmed.ncbi.nlm.nih.gov/34447646/ | |
314 | Asociación entre Chadox1 NCOV-19 Vacunación y Episodios de sangrado: estudio de cohorte de gran población: | https://pubmed.ncbi.nlm.nih.gov/34479760/. | |
315 | Miocarditis fulminante y hiperinflamación sistémica asociada temporalmente con BNT162B2 COVID-19 Vacunación de ARNm en dos pacientes: | https://pubmed.ncbi.nlm.nih.gov/34416319/. | |
316 | Efectos adversos informados después de la vacunación de COVID-19 en un hospital de atención terciaria, centradas en la trombosis sinusal venosa cerebral (CVST): | https://pubmed.ncbi.nlm.nih.gov/34092166/ | |
317 | Inducción y exacerbación del lupus eritematoso cutáneo subagudo Eritematosus después de la vacunación con SARS-COV-2 basada en el ARNA o adenoviral: | https://pubmed.ncbi.nlm.nih.gov/34291477/ | |
318 | Petechiae y pelado de los dedos después de la inmunización con el ARN de Messenger ARN de BTN162B2 (ARNm). COVID-19 VACUNA: | https://pubmed.ncbi.nlm.nih.gov/34513435/ | |
319 | Reactivación del virus de la hepatitis C después de la vacunación de COVID-19: un informe de caso: | https://pubmed.ncbi.nlm.nih.gov/34512037/ | |
320 | Keratólisis inmunológica bilateral después de la inmunización con la vacuna viral viral recombinante de SARS-COV-2: | https://pubmed.ncbi.nlm.nih.gov/34483273/. | |
321 | Púrpura trombocitopénica mediada por la mediación inmunológica Después de la vacuna PFIZE-BIONTECH COVID-19 en una anciana: | https://pubmed.ncbi.nlm.nih.gov/34513446/ | |
322 | Activación de plaquetas y modulación en trombosis con síndrome de trombocitopenia asociada con la vacuna Chado × 1 NCOV-19: | https://pubmed.ncbi.nlm.nih.gov/34474550/ | |
323 | Artritis reactiva después de la vacunación de COVID-19: | https://pubmed.ncbi.nlm.nih.gov/34033732/. | |
324 | Dos casos de enfermedad de Graves después de la vacunación con SARS-COV-2: un síndrome autoinmune / inflamatorio inducido por adyuvantes: | https://pubmed.ncbi.nlm.nih.gov/33858208/ | |
325 | Recaída aguda y inmunización con discapacidad después de la vacunación de COVID-19 en un paciente con esclerosis múltiple tratada con Rituximab: | https://pubmed.ncbi.nlm.nih.gov/34015240/ | |
326 | Erupción de drogas amonestadoras de fijación extendida después de la vacunación con Chadox1 NCOV-19: | https://pubmed.ncbi.nlm.nih.gov/34482558/ | |
327 | COVID-19 Vacuna de ARNm que causa la inflamación del CNS: una serie de casos: | https://pubmed.ncbi.nlm.nih.gov/34480607/ | |
328 | Hiperplasia tímica después de la vacunación basada en ARNm de COVID-19 con COVID-19: | https://pubmed.ncbi.nlm.nih.gov/34462647/ | |
329 | Encefalomielitis aguda diseminada después de la vacunación contra SARS-COV-2: | https://pubmed.ncbi.nlm.nih.gov/34325334/ | |
330 | Síndrome de Tolosa-Hunt Ocurre después de la vacunación de COVID-19: | https://pubmed.ncbi.nlm.nih.gov/34513398/ | |
331 | Síndrome de extravasación capilar sistémica después de la vacunación con Chadox1 NCOV-19 (Oxford-AstraZeneca): | https://pubmed.ncbi.nlm.nih.gov/34362727/ | |
332 | Trombocitopenia inmunológica asociada con la vacuna ad26.cov2.s (Janssen; Johnson & Johnson): | https://pubmed.ncbi.nlm.nih.gov/34469919/. | |
333 | Trombocitopenia transitoria con autoanticuerpos de plaquetas específicos de glicoproteína después de la vacunación con AD26.COV2.S: Informe de caso: | https://pubmed.ncbi.nlm.nih.gov/34516272/. | |
334 | Encefalopatía hiperactiva aguda después de la vacunación COVID-19 con respuesta dramática a la metilprednisolona: Informe de caso: | https://pubmed.ncbi.nlm.nih.gov/34512961/ | |
335 | Lesión cardíaca transitoria en adolescentes que reciben la vacuna contra el ARNm COVID-19 de BNT162B2: | https://pubmed.ncbi.nlm.nih.gov/34077949/ | |
336 | Hepatitis autoinmune que se desarrolla después de la vacuna Chadox1 NCOV-19 (Oxford-AstraZeneca): | https://pubmed.ncbi.nlm.nih.gov/34171435/ | |
337 | Recaída severa de la esclerosis múltiple después de la vacunación de COVID-19: un informe de caso: | https://pubmed.ncbi.nlm.nih.gov/34447349/ | |
338 | Miocarditis linfohistocítica después de la vacunación con el vector viral COVID-19 ad26.Cov2.s: | https://pubmed.ncbi.nlm.nih.gov/34514078/ | |
339 | Linfohistiocitosis hemofagocítica después de la vacunación con Chadox1 NCOV-19: | https://pubmed.ncbi.nlm.nih.gov/34406660/. | |
340 | Vasculitis IGA en paciente adulto después de la vacunación con Chadox1 NCOV-19: | https://pubmed.ncbi.nlm.nih.gov/34509658/ | |
341 | Un caso de vasculitis leucocitoclástica después de la vacunación con una vacuna contra SARS-COV2: Informe de caso: | https://pubmed.ncbi.nlm.nih.gov/34196469/. | |
342 | Inicio / Brote de la psoriasis Después de la vacuna contra el virus CHADOX1 NCOV-19 (OXFORD-ASTRAZENECA / COVISHIELD): Informe de dos casos: | https://pubmed.ncbi.nlm.nih.gov/34350668/ | |
343 | Exacerbación de la enfermedad de Hailey-Hailey después de la vacunación de SARS-COV-2: | https://pubmed.ncbi.nlm.nih.gov/34436620/ | |
344 | Linfadenopatía supraclavicular después de la vacunación de COVID-19 en Corea: Seguimiento en serie por ultrasonografía: | https://pubmed.ncbi.nlm.nih.gov/34116295/. | |
345 | COVID-19 Vacuna, trombocitopenia trombótica inmune, ictericia, hipervissidad: preocupación en los casos con problemas hepáticos subyacentes: | https://pubmed.ncbi.nlm.nih.gov/34509271/. | |
346 | Informe del consorcio internacional de trombosis venosa cerebral internacional sobre trombosis venosa cerebral después de la vacunación con SARS-COV-2: | https://pubmed.ncbi.nlm.nih.gov/34462996/ | |
347 | Trombocitopenia inmune después de la vacunación durante la pandemia COVID-19: | https://pubmed.ncbi.nlm.nih.gov/34435486/ | |
348 | COVID-19: Las lecciones de la tragedia noruega deben tenerse en cuenta en la planificación del lanzamiento de la vacuna en países menos desarrollados / en desarrollo: | https://pubmed.ncbi.nlm.nih.gov/34435142/ | |
349 | Linfólisis aguda inducida por rituximab y pancitopenia después de la vacunación con COVID-19: | https://pubmed.ncbi.nlm.nih.gov/34429981/ | |
350 | Exacerbación de la psoriasis de la placa después de COVID-19 Vacunas inactivadas de ARNm y BNT162B2: Informe de dos casos: | https://pubmed.ncbi.nlm.nih.gov/34427024/ | |
351 | Enfermedad pulmonar intersticial inducida por la vacuna: una reacción rara a la vacuna COVID-19: | https://pubmed.ncbi.nlm.nih.gov/34510014/. | |
352 | Reacciones cutáneas vesiculobulosas inducidas por COVID-19 Vacuna de ARNm: Informe de cuatro casos y revisión de la literatura: | https://pubmed.ncbi.nlm.nih.gov/34236711/ | |
353 | Trombocitopenia inducida por la vacuna con dolor de cabeza severo: | https://pubmed.ncbi.nlm.nih.gov/34525282/ | |
354 | Perimyocarditis aguda después de la primera dosis de vacuna contra ARNm COVID-19: | https://pubmed.ncbi.nlm.nih.gov/34515024/ | |
355 | Rabdomiolisis y fascitis inducidas por la vacuna contra el ARNm Covid-19: | https://pubmed.ncbi.nlm.nih.gov/34435250/. | |
356 | Efectos adversos cutáneos raros de las vacunas COVID-19: una serie de casos y revisión de la literatura: | https://pubmed.ncbi.nlm.nih.gov/34363637/ | |
357 | Trombocitopenia inmune asociada con la vacuna contra PFIZE-BIONTECH COVID-19 COVID-19 BNT162B2: | https://www.sciencedirect.com/science/article/pii/S2214250921002018 | |
358 | Trombocitopenia inmune secundaria putativamente atribuible a la vacunación de COVID-19: | https://casereports.bmj.com/content/14/5/e242220.abstract. | |
359 | Trombocitopenia inmune después de PFIZE-BIONTECH BNT162B2 MRNA COVID-19 Vacuna: | https://pubmed.ncbi.nlm.nih.gov/34155844/ | |
360 | Trombocitopenia idiopática recién diagnosticada después de la administración de la vacuna COVID-19: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8176657/. | |
361 | Puerta trombocitopénica idiopática y la moderna vacuna COVID-19: | https://www.annemergmed.com/article/S0196-0644(21)00122-0/fulltext. | |
362 | Trombocitopenia después de Pfizer y Moderna Sars Vacunkination - CoV -2: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8014568/. | |
363 | Púrpura trombocitopénica inmune y lesión hepática aguda después de la vacunación de COVID-19: | https://casereports.bmj.com/content/14/7/e242678. | |
364 | Colección de condiciones hematológicas mediadas por el complemento y mediadas autoinmunes después de la vacunación de SARS-COV-2: | https://ashpublications.org/bloodadvances/article/5/13/2794/476324/Autoimmune-and-complement-mediated-hematologic | |
365 | Erupción petecial asociada con la vacunación de Coronavac: Primer informe de efectos secundarios cutáneos antes de la Fase 3 Resultados: | https://ejhp.bmj.com/content/early/2021/05/23/ejhpharm-2021-002794 | |
366 | Las vacunas COVID-19 inducen la hemólisis severa en hemoglobinuria nocturna paroxística: | https://ashpublications.org/blood/article/137/26/3670/475905/COVID-19-vaccines-induce-severe-hemolysis-in | |
367 | Trombosis venosa cerebral asociada con la vacuna COVID-19 en Alemania: | https://pubmed.ncbi.nlm.nih.gov/34288044/. | |
368 | Trombosis sinusus venosa cerebral después de la vacunación de COVID-19: gestión neurológica y radiológica: | https://pubmed.ncbi.nlm.nih.gov/34327553/. | |
369 | Trombosis venosa cerebral y trombocitopenia después de la vacunación de COVID-19: | https://pubmed.ncbi.nlm.nih.gov/33878469/. | |
370 | Trombosis sinusal venosa cerebral y trombocitopenia después de la vacunación de COVID-19: Informe de dos casos en el Reino Unido: | https://pubmed.ncbi.nlm.nih.gov/33857630/. | |
371 | Trombosis venosa cerebral inducida por la vacuna SARS-COV-2: | https://pubmed.ncbi.nlm.nih.gov/34090750/. | |
372 | Trombosis inmunitaria de la arteria carótida inducida por la vacuna de COVID-19 DE ADENOVIRUS-vector: Informe de caso: | https://pubmed.ncbi.nlm.nih.gov/34312301/. | |
373 | Trombosis sinusal venosa cerebral asociada con la trombocitopenia trombótica inducida por la vacuna: | https://pubmed.ncbi.nlm.nih.gov/34333995/ | |
374 | Los roles de las plaquetas en la coagulopatía asociada a Covid-19 y la trombocitopenia trombótica inmunológica inducida por la vacuna: | https://pubmed.ncbi.nlm.nih.gov/34455073/ | |
375 | Trombosis venosa cerebral después del MRNA BNT162B2 Vacuna de SARS-COV-2: | https://pubmed.ncbi.nlm.nih.gov/34111775/. | |
376 | Trombosis venosa cerebral después de la vacunación COVID-19: | https://pubmed.ncbi.nlm.nih.gov/34045111/ | |
377 | Trombosis sinusal venosa cerebral letal después de la vacunación de COVID-19: | https://pubmed.ncbi.nlm.nih.gov/33983464/ | |
378 | Trombosis sinusal venosa cerebral en la población de EE.UU., después de la vacunación con SARS-COV-2 con adenovirus y después de COVID-19: | https://pubmed.ncbi.nlm.nih.gov/34116145/ | |
379 | Trombosis venosa cerebral después de la vacunación COVID-19: es el riesgo de trombosis aumentada por la administración intravascular de la vacuna: | https://pubmed.ncbi.nlm.nih.gov/34286453/. | |
380 | Trombosis sinusal venosa central con hemorragia subaracnoidea después de la vacunación de ARNm Covid-19: son estos informes simplemente coincidentales: | https://pubmed.ncbi.nlm.nih.gov/34478433/ | |
381 | Trombosis sinusal venosa cerebral después de la vacunación de Chadox1 NCOV-19 con una primera MRI cerebral engañosa: | https://pubmed.ncbi.nlm.nih.gov/34244448/ | |
382 | Los primeros resultados del tratamiento de bivalirudina para la trombocitopenia trombótica y la trombosis sinusita venosa cerebral después de la vacunación con AD26.Cov2.s: | https://pubmed.ncbi.nlm.nih.gov/34226070/ | |
383 | Trombosis sinusus venosa cerebral asociada con la trombocitopenia posterior a la vacunación por COVID-19: | https://pubmed.ncbi.nlm.nih.gov/33845870/. | |
384 | Trombosis sinusal venosa cerebral 2 semanas después de la primera dosis de la vacuna contra ARNm de SARS-COV-2: | https://pubmed.ncbi.nlm.nih.gov/34101024/. | |
385 | Trombocitopenia trombótica inmune inducida por la vacuna que causa una forma severa de trombosis venosa cerebral con una alta tasa de mortalidad: una serie de casos: | https://pubmed.ncbi.nlm.nih.gov/34393988/. | |
386 | Interacciones de adenovirus con plaquetas y coagulación y síndrome de trombocitopenia autoinmune asociada a la vacuna: | https://pubmed.ncbi.nlm.nih.gov/34407607/. | |
387 | Dolor de cabeza atribuido a la vacunación COVID-19 (CORONAVIRO COV-2 SARS-COV-2) con la vacuna Chadox1 NCOV-19 (AZD1222): un estudio de cohorte de observación multicéntrico: | https://pubmed.ncbi.nlm.nih.gov/34313952/ | |
388 | Efectos adversos reportados después de la vacunación de COVID-19 en un hospital de atención terciaria, se centran en la trombosis sinusita venosa cerebral (CVST): | https://pubmed.ncbi.nlm.nih.gov/34092166/ | |
389 | Trombosis sinusal venosa cerebral después de la vacunación contra el SARS-COV-2: un análisis de los casos reportados a la Agencia Europea de Medicamentos: | https://pubmed.ncbi.nlm.nih.gov/34293217/ | |
390 | Un caso raro de un macho asiático de mediana edad con trombosis venosa cerebral después de COVID-19 Vacunación de Astrazeneca: | https://pubmed.ncbi.nlm.nih.gov/34274191/ | |
391 | Trombosis sinusal venosa cerebral negativa para anticuerpos anti-PF4 sin trombocitopenia después de la inmunización con la vacuna COVID-19 en un anciano indio no comor, tratado con anticoagulación convencional de heparina-warfarina: | https://pubmed.ncbi.nlm.nih.gov/34186376/ | |
392 | Eventos arteriales, tromboembolismo venoso, trombocitopenia y sangrado después de la vacunación con Oxford-AstraZeneca Chadox1-S en Dinamarca y Noruega: estudio de cohorte basado en la población: | https://pubmed.ncbi.nlm.nih.gov/33952445/ | |
393 | Micropartículas PROCOagulantes: un posible vínculo entre la trombocitopenia inmune inducida por la vacuna (VITT) y la trombosis venosa cerebral sinusal: | https://pubmed.ncbi.nlm.nih.gov/34129181/ | |
394 | S. Informes de casos de trombosis sinusal venosa cerebral con trombocitopenia después de la vacunación con AD26.COV2.S, 2 de marzo al 21 de abril de 2021: | https://pubmed.ncbi.nlm.nih.gov/33929487/. | |
395 | Infarto cerebral maligno después de la vacunación con Chadox1 NCOV-19: una variante catastrófica de la trombocitopenia trombótica inmunológica inducida por la vacuna: | https://pubmed.ncbi.nlm.nih.gov/34341358/ | |
396 | El accidente cerebrovascular isquémico agudo que revela la trombocitopenia trombótica inmune inducida por la vacuna Chadox1 NCOV-19: impacto en la estrategia de recanalización: | https://pubmed.ncbi.nlm.nih.gov/34175640/ | |
397 | Trombocitopenia inmunológica inmune inducida por la vacuna (VITT): una nueva entidad clínicoopatológica con presentaciones clínicas heterogéneas: | https://pubmed.ncbi.nlm.nih.gov/34159588/. | |
398 | Imágenes y hallazgos hematológicos en trombosis y trombocitopenia después de la vacunación con Chadox1 NCOV-19 (AstraZeneca): | https://pubmed.ncbi.nlm.nih.gov/34402666/ | |
399 | Raíces autoinmunidad de eventos trombóticos después de la vacunación con COVID-19: | https://pubmed.ncbi.nlm.nih.gov/34508917/ | |
400 | Trombosis sinusal venosa cerebral después de la vacunación: la experiencia del Reino Unido: | https://pubmed.ncbi.nlm.nih.gov/34370974/ | |
401 | Trombosis venosa cerebral masiva y infarto de cuencas venosas como complicaciones tardías de COVID-19: un informe de caso: | https://pubmed.ncbi.nlm.nih.gov/34373991/ | |
402 | Enfoque australiano y Nueva Zelanda del diagnóstico y tratamiento de la trombosis inmune inducida por la vacuna y la trombocitopenia inmune: | https://pubmed.ncbi.nlm.nih.gov/34490632/ | |
403 | Un estudio observacional para identificar la prevalencia de la trombocitopenia y los anticuerpos anti-PF4 / Polyanion en los trabajadores de atención médica noruega después de la vacunación de COVID-19: | https://pubmed.ncbi.nlm.nih.gov/33909350/ | |
404 | Myelitis transversal aguda (ATM): Revisión clínica de 43 pacientes con cajeros automáticos asociados a COVID-19 y 3 eventos adversos graves de cajero automático posterior al vacunación con la vacuna Chadox1 NCOV-19 (AZD1222): | https://pubmed.ncbi.nlm.nih.gov/33981305/. | |
405 | Un caso de la polirradiculoneuropatía de desmielinización aguda con parálisis facial bilateral después de la vacuna contra la CHADOX1 NCOV-19:. | https://pubmed.ncbi.nlm.nih.gov/34272622/ | |
406 | Trombocitopenia con accidente cerebrovascular isquémico agudo y hemorragia en un paciente recientemente vacunado con una vacuna COVID-19 a base de vectores adenovirales:. | https://pubmed.ncbi.nlm.nih.gov/33877737/ | |
407 | Predicida y observada la incidencia de eventos tromboembólicos entre los coreanos vacunados con la vacuna Chadox1 NCOV-19: | https://pubmed.ncbi.nlm.nih.gov/34254476/ | |
408 | Primera dosis de vacunas CHADOX1 y BNT162B2 COVID-19 y eventos trombocitopénicos, tromboembólicos y hemorrágicos en Escocia: | https://pubmed.ncbi.nlm.nih.gov/34108714/ | |
409 | Chadox1 NCOV-19 Trombocitopenia asociada a la vacuna: tres casos de trombocitopenia inmune después de 107,720 dosis de la vacunación con Chadox1 en Tailandia: | https://pubmed.ncbi.nlm.nih.gov/34483267/. | |
410 | Embolia pulmonar, ataque isquémico transitorio y trombocitopenia después de Johnson & Johnson Covid-19 Vacuna: | https://pubmed.ncbi.nlm.nih.gov/34261635/ | |
411 | Consideraciones neuroquirúrgicas con respecto a la craniectomía descompresiva para la hemorragia intracerebral después de la vacunación con SARS-COV-2 en trombocitopenia trombótica inducida por la vacuna: VITT: | https://pubmed.ncbi.nlm.nih.gov/34202817/ | |
412 | Trazo hemorrágico grande después de la vacunación contra Chadox1 NCOV-19: un informe de caso: | https://pubmed.ncbi.nlm.nih.gov/34273119/ | |
413 | Síndrome de Polyarthralgia y Myalgia después de la vacunación con Chadox1 NCOV-19: | https://pubmed.ncbi.nlm.nih.gov/34463066/ | |
414 | Un caso raro de trombosis y trombocitopenia de la vena oftálmica superior después de la vacunación con CHADOX1 NCOV-19 contra SARS-COV-2: | https://pubmed.ncbi.nlm.nih.gov/34276917/ | |
415 | Trombosis y síndrome respiratorio agudo severo Corronavirus 2 Vacunas: Trombocitopenia trombótica inmune inducida por la vacuna: | https://pubmed.ncbi.nlm.nih.gov/34237213/. | |
416 | Trombosis de vena renal y embolia pulmonar secundaria a trombocitopenia inmunológica trombótica inducida por vacunación (VITT): | https://pubmed.ncbi.nlm.nih.gov/34268278/. | |
417 | Isquemia de las extremidades y trombosis de la arteria pulmonar después de la vacuna contra la CHADOX1 NCOV-19 (Oxford-AstraZeneca): un caso de trombocitopenia trombótica inmune inducida por la vacuna: | https://pubmed.ncbi.nlm.nih.gov/33990339/. | |
418 | Asociación entre Chadox1 NCOV-19 Vacunación y Episodios de sangrado: estudio de cohorte de gran población: | https://pubmed.ncbi.nlm.nih.gov/34479760/. | |
419 | Trombocitopenia secundaria después de la vacunación con SARS-COV-2: Informe de caso de hemorragia y hematoma después de una cirugía oral menor: | https://pubmed.ncbi.nlm.nih.gov/34314875/. | |
420 | Tromboembolismo venoso y trombocitopenia leve después de la vacunación con Chadox1 NCOV-19: | https://pubmed.ncbi.nlm.nih.gov/34384129/ | |
421 | Exacerbación fatal del síndrome de trombocitopenia de trombocitopenia inducida por Chadox1-NCOV-19 después de la terapia inicial exitosa con inmunoglobulinas intravenosas: una razón para monitorear los niveles de inmunoglobulina g: | https://pubmed.ncbi.nlm.nih.gov/34382387/ | |
422 | Un caso de vasculitis asociada a ANCA después de la vacunación contra AZD1222 (OXFORD-ASTRAZENECA) SARS-COV-2: víctima o causalidad?: | https://pubmed.ncbi.nlm.nih.gov/34416184/. | |
423 | Hemorragia intracerebral asociada con la trombocitopenia trombótica inducida por la vacuna después de la vacunación contra la CHADOX1 NCOVID-19 en una mujer embarazada: | https://pubmed.ncbi.nlm.nih.gov/34261297/ | |
424 | Trombosis venosa cerebral masiva debido a la trombocitopenia trombótica inmune inducida por la vacuna: | https://pubmed.ncbi.nlm.nih.gov/34261296/ | |
425 | Síndrome nefrótico después de la vacuna de Chadox1 NCOV-19 contra SARSCOV-2: | https://pubmed.ncbi.nlm.nih.gov/34250318/. | |
426 | Un caso de trombocitopenia trombótica inmunomunitaria inducida por la vacuna con trombosis arteriovenosa masiva: | https://pubmed.ncbi.nlm.nih.gov/34059191/ | |
427 | Trombosis cutánea asociada con necrosis cutánea después de Oxford-AstraZeneca COVID-19 Vacunación: | https://pubmed.ncbi.nlm.nih.gov/34189756/ | |
428 | Trombocitopenia en un adolescente con anemia de células falciformes después de la vacunación de COVID-19: | https://pubmed.ncbi.nlm.nih.gov/34331506/ | |
429 | Trombocitopenia inducida por la vacuna con dolor de cabeza severo: | https://pubmed.ncbi.nlm.nih.gov/34525282/ | |
430 | Miocarditis asociada con la vacunación con ARNm de SARS-COV-2 en niños de 12 a 17 años: análisis estratificado de una base de datos nacional: | https://www.medrxiv.org/content/10.1101/2021.08.30.21262866v1 | |
431 | COVID-19 Vacunación y desarrollo de ARNm de miopericaditis confirmada por CMR: | https://www.medrxiv.org/content/10.1101/2021.09.13.21262182v1.full?s=09. | |
432 | Anemia hemolítica autoinmune severa después de la recepción de la vacuna contra ARNm de SARS-COV-2: | https://onlinelibrary.wiley.com/doi/10.1111/trf.16672 | |
433 | Inyección intravenosa de la enfermedad de Coronavirus 2019 (COVID-19) La vacuna contra ARNm puede inducir miopericaditis aguda en un modelo de ratón: | https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciab707/6353927?s=09&login=false | |
434 | Un informe de eventos adversos de miocarditis en el sistema de informes de eventos adversos de la vacuna contra el EE. UU. (Vaers) en asociación con COVID-19 biológicos inyectables: | https://pubmed.ncbi.nlm.nih.gov/34601006/ | |
435 | Este estudio concluye que: "La vacuna se asoció con un riesgo excesivo de miocarditis (1 a 5 eventos por 100,000 personas). El riesgo de este evento adverso potencialmente grave y de muchos otros eventos adversos graves aumentó sustancialmente después de la infección por SARS-COV-2 ": | https://www.nejm.org/doi/full/10.1056/NEJMoa2110475 | |
436 | Uveítis bilateral después de la inoculación con la vacuna COVID-19: un informe de caso: | https://www.sciencedirect.com/science/article/pii/S1201971221007797 | |
437 | Miocarditis asociada con la vacunación con ARNm de SARS-COV-2 en niños de 12 a 17 años: análisis estratificado de una base de datos nacional: | https://www.medrxiv.org/content/10.1101/2021.08.30.21262866v1. | |
438 | La hepatitis mediada por la mediación inmunológica con la vacuna moderna ya no es una coincidencia, sino que confirmó: | https://www.sciencedirect.com/science/article/pii/S0168827821020936 | |
439 | Las investigaciones extensas revelaron alteraciones fisiopatológicas consistentes después de la vacunación con vacunas COVID-19: | https://www.nature.com/articles/s41421-021-00329-3 | |
440 | Hemorragia de lobar con rotura ventricular poco después de la primera dosis de una vacuna de SARS-COV-2 basada en ARNm: | https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8553377/ | |
441 | Las vacunas COVID de ARNm aumentan dramáticamente los marcadores inflamatorios endoteliales y el riesgo de síndrome coronario agudo medido por las pruebas cardíacas de Puls: una precaución: | https://www.ahajournals.org/doi/10.1161/circ.144.suppl_1.10712 | |
442 | Chadox1 interactúa con automóvil y PF4 con implicaciones para la trombosis con síndrome de trombocitopenia: | https://www.science.org/doi/10.1126/sciadv.abl8213 | |
443 | Trombocitopenia inmunológica inmune inducida por la vacuna letal (VITT) después del anuncio 26.Cov2.S: Caso primero documentado fuera de los U.s.: | https://pubmed.ncbi.nlm.nih.gov/34626338/ | |
444 | Un trastorno trombocitopénico protrombótico que se asemeja a la trombocitopenia inducida por la heparina después de la vacunación por coronavirus-19: | https://europepmc.org/article/PPR/PPR304469435 | |
445 | Vitt (trombocitopenia trombótica inmune inducida por la vacuna) después de la vacunación con Chadox1 NCOV-19: | https://pubmed.ncbi.nlm.nih.gov/34731555/ | |
446 | Trombocitopenia trombótica inmune inducida por la vacuna (VITT): una nueva entidad clínicoopatológica con presentaciones clínicas heterogéneas: | https://pubmed.ncbi.nlm.nih.gov/34159588/ | |
447 | Tratamiento de la carrera isquémica aguda asociada con la trombocitopenia trombótica inmune inducida por la vacuna contra la vacuna: | https://pubmed.ncbi.nlm.nih.gov/34461442/ | |
448 | Espectro de complicaciones neurológicas después de la vacunación de COVID-19: | https://pubmed.ncbi.nlm.nih.gov/34719776/ | |
449 | Trombosis sinusal venosa cerebral después de la vacunación: la experiencia del Reino Unido: | https://pubmed.ncbi.nlm.nih.gov/34370974/ | |
450 | Vena venosa cerebral / trombosis sinusita venosa con síndrome de trombocitopenia después de la vacunación de COVID-19: | https://pubmed.ncbi.nlm.nih.gov/34373413/ | |
451 | Trombosis de la vena porta debido a la trombocitopenia inmunológica inmune inmune inducida por la vacuna (VITT) después de la vacunación de COVID con CHADOX1 NCOV-19: | https://pubmed.ncbi.nlm.nih.gov/34598301/ | |
452 | Hematuria, una erupción peticecial generalizada y dolores de cabeza después de Oxford Astrazeneca Chadox1 NCOV-19 Vacunación: | https://pubmed.ncbi.nlm.nih.gov/34620638/ | |
453 | Infarto miocárdico y trombosis de la vena Azygos después de la vacunación con Chadox1 NCOV-19 en un paciente de hemodiálisis: | https://pubmed.ncbi.nlm.nih.gov/34650896/ | |
454 | Cardiomiopatía TakotSubo (estrés) después de la vacunación con Chadox1 NCOV-19: | https://pubmed.ncbi.nlm.nih.gov/34625447/ | |
455 | Respuesta humoral inducida por la vacunación automática de impulso con las vacunas de ARNm de CHADOX1 NCOV-19 y BNT162B2 en un paciente con esclerosis múltiple tratados con teriflunomida: | https://pubmed.ncbi.nlm.nih.gov/34696248/ | |
456 | Síndrome de Guillain-Barré después de Chadox1 NCOV-19 COVID-19 Vacunación: una serie de casos: | https://pubmed.ncbi.nlm.nih.gov/34548920/ | |
457 | Trombocitopenia trombótica inmune inducida por la vacuna refractaria (VITT) tratada con el intercambio de plasma terapéutico retrasado (TPE): | https://pubmed.ncbi.nlm.nih.gov/34672380/ | |
458 | Caso raro de COVID-19 Hemorragia intracraneal asociada a la vacuna con la trombosis sinusal venosa: | https://pubmed.ncbi.nlm.nih.gov/34556531/ | |
459 | Dolor de cabeza retrasado después de la vacunación de COVID-19: una señal de advertencia para la trombosis venosa cerebral inducida por la vacuna: | https://pubmed.ncbi.nlm.nih.gov/34535076/ | |
460 | Características clínicas de la trombocitopenia inducida por la vacuna y la trombosis inmune: | https://pubmed.ncbi.nlm.nih.gov/34379914/. | |
461 | Predictores de mortalidad en trombocitopenia trombótica después de la vacunación a adenoviral COVID-19: la puntuación FAPIC: | https://pubmed.ncbi.nlm.nih.gov/34545400/ | |
462 | El accidente cerebrovascular isquémico como una característica de presentación de la trombocitopenia trombótica inmune inducida por la vacunación de Chadox1-NCOV-19: | https://pubmed.ncbi.nlm.nih.gov/34035134/ | |
463 | Estudio observacional en el hospital de los trastornos neurológicos en pacientes recientemente vacunados con vacunas de ARNm Covid-19: | https://pubmed.ncbi.nlm.nih.gov/34688190/ | |
464 | Tratamiento endovascular para la trombosis sinusita venosa cerebral inducida por la vacuna y la trombocitopenia después de la vacunación con Chadox1 NCOV-19: Informe de tres casos: | https://pubmed.ncbi.nlm.nih.gov/34782400/ | |
465 | Eventos cardiovasculares, neurológicos y pulmonares después de la vacunación con BNT162B2, Chadox1 NCOV-19, y Vacunas AD26.Cov2.s: un análisis de los datos europeos: | https://pubmed.ncbi.nlm.nih.gov/34710832/ | |
466 | Trombosis venosa cerebral que se desarrolla después de la vacunación. COVID-19: VITT, VATT, TTS y más: | https://pubmed.ncbi.nlm.nih.gov/34695859/ | |
467 | Trombosis venosa cerebral y neoplasias mieloproliferativas: un estudio de tres centros de 74 casos consecutivos: | https://pubmed.ncbi.nlm.nih.gov/34453762/. | |
468 | Posibles desencadenantes de trombocitopenia y / o hemorragia por Vacuna BNT162B2, Pfizer-Biontech: | https://pubmed.ncbi.nlm.nih.gov/34660652/. | |
469 | Múltiples sitios de trombosis arterial en un paciente de 35 años después de la vacunación con Chadox1 (Astrazeneca), que requería la trombectomía quirúrgica femoral y carótida de emergencia: | https://pubmed.ncbi.nlm.nih.gov/34644642/ | |
470 | Serie de casos de trombocitopenia trombótica inducida por la vacuna en un hospital de enseñanza de Londres: | https://pubmed.ncbi.nlm.nih.gov/34694650/ | |
471 | Complicaciones neuroftálmicas con trombocitopenia y trombosis inducidas por la vacuna Chadox1 NCOV-19: | https://pubmed.ncbi.nlm.nih.gov/34726934/ | |
472 | Eventos trombóticos después de la vacunación de COVID-19 en más de 50 años de edad: resultados de un estudio basado en la población en Italia: | https://pubmed.ncbi.nlm.nih.gov/34835237/ | |
473 | Hemorragia intracerebral asociada con la trombocitopenia trombótica inducida por la vacuna después de la vacunación contra la CHADOX1 NCOVID-19 en una mujer embarazada: | https://pubmed.ncbi.nlm.nih.gov/34261297/ | |
474 | Incidencia específica de edad y sexo de la trombosis sinusita venosa cerebral asociada con ad26.cov2.s COVID-19 Vacunación: | https://pubmed.ncbi.nlm.nih.gov/34724036/. | |
475 | Necrosis genital con trombosis cutánea después de la vacunación con COVID-19 ARNm: | https://pubmed.ncbi.nlm.nih.gov/34839563/ | |
476 | Trombosis sinusal venosa cerebral después de la vacunación de COVID-19 a base de ARNm: | https://pubmed.ncbi.nlm.nih.gov/34783932/. | |
477 | Trombosis inmunitaria inducida por la vacuna contra la vacuna con trombosis de trombocitopenia (VITT) y tonos de gris en formación de trombo: | https://pubmed.ncbi.nlm.nih.gov/34624910/ | |
478 | Miositis inflamatoria después de la vacunación con Chadox1: | https://pubmed.ncbi.nlm.nih.gov/34585145/ | |
479 | Infarto agudo de la elevación del segmento ST-segmento secundario secundario a la trombosis inmunitaria inducida por la vacuna con la trombocitopenia (VITT): | https://pubmed.ncbi.nlm.nih.gov/34580132/. | |
480 | Un caso raro de covid-19 trombocitopenia trombótica inducida por la vacuna (VITT) que afecta a la circulación arterial venospanica y pulmonar de un hospital general del distrito del Reino Unido: | https://pubmed.ncbi.nlm.nih.gov/34535492/ | |
481 | COVID-19 Trombocitopenia trombótica inducida por la vacuna: una serie de casos: | https://pubmed.ncbi.nlm.nih.gov/34527501/ | |
482 | Trombosis con síndrome de trombocitopenia (TTS) después de la vacunación con AstraZeneca Chadox1 NCOV-19 (AZD1222) COVID-19: Un análisis de riesgo-beneficio para las personas <60% de análisis de riesgo-beneficio para personas <60 años en Australia: | https://pubmed.ncbi.nlm.nih.gov/34272095/ | |
483 | Trombocitopenia inmune después de la inmunización con la vacuna contra Vaxzevria Chadox1-S (AstraZeneca), Victoria, Australia: | https://pubmed.ncbi.nlm.nih.gov/34756770/ | |
484 | Características y resultados de pacientes con trombosis sinusal venosa cerebral en trombocitopenia inmune trombótica inducida por la vacuna contra SARS-COV-2: | https://jamanetwork.com/journals/jamaneurology/fullarticle/2784622 | |
485 | Estudio de caso de trombosis y síndrome de trombocitopenia después de la administración de la vacuna ASTRAZENECA COVID-19: | https://pubmed.ncbi.nlm.nih.gov/34781321/ | |
486 | Trombosis con síndrome de trombocitopenia asociada con vacunas COVID-19: | https://pubmed.ncbi.nlm.nih.gov/34062319/ | |
487 | Trombosis sinusal venosa cerebral después de la vacunación con Chadox1: el primer caso de trombosis definida con síndrome de trombocitopenia en la India: | https://pubmed.ncbi.nlm.nih.gov/34706921/ | |
488 | COVID-19 Trombosis asociada a la vacuna con síndrome de trombocitopenia (TTS): Revisión sistemática y análisis post hoc: | https://pubmed.ncbi.nlm.nih.gov/34698582/. | |
489 | Informe de caso de trombocitopenia inmune después de la vacunación con Chadox1 NCOV-19: | https://pubmed.ncbi.nlm.nih.gov/34751013/. | |
490 | Mielitis transversal aguda después de la vacunación COVID-19: | https://pubmed.ncbi.nlm.nih.gov/34684047/. | |
491 | Preocupaciones por los efectos adversos de la trombocitopenia y la trombosis después de la vacunación automática de COVID-19 DE ADENOVIRUS: | https://pubmed.ncbi.nlm.nih.gov/34541935/ | |
492 | Mayor trazo hemorrágico después de la vacunación con Chadox1 NCOV-19: un informe de caso: | https://pubmed.ncbi.nlm.nih.gov/34273119/ | |
493 | Trombosis sinusus venosa cerebral después de la vacunación de COVID-19: Gestión neurológica y radiológica: | https://pubmed.ncbi.nlm.nih.gov/34327553/. | |
494 | Trombocytopenia con un accidente cerebrovascular isquémico agudo y hemorragia en un paciente recientemente vacunado con una vacuna COVID-19 a base de vectores adenovirales: | https://pubmed.ncbi.nlm.nih.gov/33877737/ | |
495 | Hemorragia intracerebral y trombocitopenia Después de AstraZeneca COVID-19 Vacuna: desafíos clínicos y diagnósticos de la trombocitopenia trombótica inducida por la vacuna: | https://pubmed.ncbi.nlm.nih.gov/34646685/ | |
496 | Cambio mínimo de la enfermedad con severa lesión renal aguda después de OXFORD-ASTRAZENECA COVID-19 VACUNA: INFORME DE CASO: | https://pubmed.ncbi.nlm.nih.gov/34242687/. | |
497 | Informe de caso: trombosis de la vena sinusal cerebral en dos pacientes con la vacuna contra el SARS-COV-2 de AstraZeneca: | https://pubmed.ncbi.nlm.nih.gov/34609603/ | |
498 | Informe de caso: erupción similar a PityRiasis Rosea después de la vacunación con COVID-19: | https://pubmed.ncbi.nlm.nih.gov/34557507/ | |
499 | Extenso mielitis transversal longitudinal después de la vacuna Chadox1 NCOV-19: Informe de caso: | https://pubmed.ncbi.nlm.nih.gov/34641797/. | |
500 | Neumonía eosinofílica aguda asociada a la vacuna anti-covid-19 AZD1222: | https://pubmed.ncbi.nlm.nih.gov/34812326/. | |
501 | La trombocitopenia, incluida la trombocitopenia inmune después de recibir las vacunas de ARNm Covid-19 informadas al sistema de informes de eventos adversos de la vacuna (Vaers): | https://pubmed.ncbi.nlm.nih.gov/34006408/ | |
502 | Un caso de vasculitis asociada a ANCA después de la vacunación contra AZD1222 (OXFORD-ASTRAZENECA) SARS-COV-2: víctima o causalidad?: | https://pubmed.ncbi.nlm.nih.gov/34416184/ | |
503 | Trombosis inmunológica y síndrome de trombocitopenia inducida por la vacuna después de que el síndrome respiratorio agudo severo al adenovirus sea un síndrome respiratorio agudo severo de la vacunación 2: una nueva hipótesis sobre mecanismos e implicaciones para el desarrollo futuro de la vacuna: | https://pubmed.ncbi.nlm.nih.gov/34664303/. | |
504 | Trombosis en la enfermedad de la arteria periférica y la trombocitopenia trombótica después de la vacunación a adenoviral COVID-19: | https://pubmed.ncbi.nlm.nih.gov/34649281/. | |
505 | Thrombocitopenia inmunológica recién diagnosticada en un paciente embarazado después de la vacunación por enfermedad de Coronavirus 2019: | https://pubmed.ncbi.nlm.nih.gov/34420249/ | |
506 | Trombosis sinusal venosa cerebral y eventos trombóticos después de las vacunas COVID-19-19 basadas en el vector: Revisión sistemática y metanálisis: | https://pubmed.ncbi.nlm.nih.gov/34610990/. | |
507 | Síndrome de Sweet después de Oxford-AstraZeneca COVID-19 VACCINE (AZD1222) en una anciana: | https://pubmed.ncbi.nlm.nih.gov/34590397/ | |
508 | Pérdida auditiva sensorinal súbita después de la vacunación de COVID-19: | https://pubmed.ncbi.nlm.nih.gov/34670143/. | |
509 | Prevalencia de eventos adversos graves entre los profesionales de la salud después de recibir la primera dosis de la vacuna de CHADOX1 NCOV-19 Coronavirus (Covishield) en Togo, de marzo de 2021: | https://pubmed.ncbi.nlm.nih.gov/34819146/. | |
510 | Hemichorea-hemibalismo agudo después de la vacunación COVID-19 (AZD1222): | https://pubmed.ncbi.nlm.nih.gov/34581453/ | |
511 | Recurrencia de alopecia areata después de la vacunación de COVID-19: un informe de tres casos en Italia: | https://pubmed.ncbi.nlm.nih.gov/34741583/ | |
512 | Lesión de la piel similar a las tejas después de la vacunación con AstraZeneca para COVID-19: Informe de caso: | https://pubmed.ncbi.nlm.nih.gov/34631069/ | |
513 | Trombosis después de la vacunación COVID-19: Posible enlace a las vías de ACE: | https://pubmed.ncbi.nlm.nih.gov/34479129/ | |
514 | Trombocitopenia en un adolescente con anemia de células falciformes después de la vacunación de COVID-19: | https://pubmed.ncbi.nlm.nih.gov/34331506/ | |
515 | Vasculitis leucocitoclástica Como manifestación cutánea de la vacuna contra el virus de la corona de Chadox1 NCOV-19 (recombinante): | https://pubmed.ncbi.nlm.nih.gov/34546608/ | |
516 | Dolor abdominal y hemorragia suprarrenal bilateral de la trombocitopenia trombótica inmune inducida por la vacuna COVID-19: | https://pubmed.ncbi.nlm.nih.gov/34546343/ | |
517 | Mielitis cervical extensa longitudinalmente después de la vacunación con vacuna con COVID-19 basada en virus inactivados: | https://pubmed.ncbi.nlm.nih.gov/34849183/ | |
518 | Inducción de vasculitis leucocitoclástica cutánea después de la vacuna Chadox1 NCOV-19: | https://pubmed.ncbi.nlm.nih.gov/34853744/. | |
519 | Un caso de necrólisis epidérmica tóxica después de la vacunación con Chadox1 NCOV-19 (AZD1222): | https://pubmed.ncbi.nlm.nih.gov/34751429/. | |
520 | Eventos adversos oculares después de la vacunación COVID-19: | https://pubmed.ncbi.nlm.nih.gov/34559576/ | |
521 | Depresión después de la vacunación de Chadox1-S / NCOV-19: | https://pubmed.ncbi.nlm.nih.gov/34608345/. | |
522 | Tromboembolismo venoso y trombocitopenia leve después de la vacunación con Chadox1 NCOV-19: | https://pubmed.ncbi.nlm.nih.gov/34384129/. | |
523 | Vasculitis asociada a ANCA recurrente después de Oxford Astrazeneca Chadox1-S COVID-19 Vacunación: una serie de dos pacientes: | https://pubmed.ncbi.nlm.nih.gov/34755433/ | |
524 | Principal trombosis de la arteria y vacunación contra Chadox1 NCOV-19: | https://pubmed.ncbi.nlm.nih.gov/34839830/ | |
525 | Raro caso de linfadenopatía supraclavicular contralateral después de la vacunación con COVID-19: Tomografía computarizada y hallazgos de ultrasonido: | https://pubmed.ncbi.nlm.nih.gov/34667486/ | |
526 | Vasculitis linfocítica cutánea después de la administración de la segunda dosis de AZD1222 (OXFORD-ASTRAZENECA) Síndrome respiratorio agudo grave Coronavirus 2 Vacuna: Probabilidad o causalidad: | https://pubmed.ncbi.nlm.nih.gov/34726187/. | |
527 | Rechazo de aloinjerto de páncreas después de la vacuna de Chadox1 NCOV-19: | https://pubmed.ncbi.nlm.nih.gov/34781027/ | |
528 | Comprender el riesgo de trombosis con síndrome de trombocitopenia después de la vacuna ad26.cov2.s: | https://pubmed.ncbi.nlm.nih.gov/34595694/ | |
529 | Reacciones adversas cutáneas de 35,229 dosis de COVID-19 Sinovac y AstraZeneca Vaccine COVID-19: Un estudio prospectivo de cohorte en los trabajadores de la salud: | https://pubmed.ncbi.nlm.nih.gov/34661934/ | |
530 | Comentarios sobre la trombosis después de la vacunación: la secuencia líder de la proteína de Spike podría ser responsable de la trombosis y la trombocitopenia mediada por anticuerpos: | https://pubmed.ncbi.nlm.nih.gov/34788138 | |
531 | Dermatosis eosinofílica después de AstraZeneca COVID-19 Vacunación: | https://pubmed.ncbi.nlm.nih.gov/34753210/. | |
532 | Trombocitopenia inmune severa después de la vacunación COVID-19: Informe de cuatro casos y revisión de la literatura: | https://pubmed.ncbi.nlm.nih.gov/34653943/. | |
533 | Recaída de la trombocitopenia inmune después de la vacunación de COVID-19: | https://pubmed.ncbi.nlm.nih.gov/34591991/ | |
534 | Trombosis en fase pre y posterior al vacunación de COVID-19; | https://pubmed.ncbi.nlm.nih.gov/34650382/ | |
535 | Una mirada al papel de la inmunohistoquímica posmortem para comprender la fisiopatología inflamatoria de la enfermedad de COVID-19 y los eventos adversos trombóticos relacionados con la vacuna: una revisión narrativa: | https://pubmed.ncbi.nlm.nih.gov/34769454/ | |
536 | COVID-19 Vacuna en pacientes con trastornos de hipercoagulabilidad: una perspectiva clínica: | https://pubmed.ncbi.nlm.nih.gov/34786893/ | |
537 | Trombocitopenia y trombosis asociada a la vacuna: la endoteliopatía venosa que conduce a la micro-macrotrotrombosis venosa combinada: | https://pubmed.ncbi.nlm.nih.gov/34833382/ | |
538 | Síndrome de trombosis y trombocitopenia que causa la oclusión carotídemia sintomática aislada después de COVID-19 AD26.Cov2.s Vacuna (Janssen): | https://pubmed.ncbi.nlm.nih.gov/34670287/ | |
539 | Una presentación inusual de la trombosis venosa profunda aguda después de la vacuna moderna COVID-19: Informe de caso: | https://pubmed.ncbi.nlm.nih.gov/34790811/ | |
540 | Las inmunoglobulinas intravenosas inmediatas de alta dosis seguidas por un tratamiento directo con inhibidores de la trombina son cruciales para la supervivencia en la trombocitopenia trombótica inmunológica inducida por la vacuna, el Vitt adenoviral COVID-19-vector con la trombosis venosa del seno cerebral y la vena porta: | https://pubmed.ncbi.nlm.nih.gov/34023956/. | |
541 | Formación de trombosis después de COVID-19 Aspectos inmunológicos de vacunación: Revisión Artículo: | https://pubmed.ncbi.nlm.nih.gov/34629931/ | |
542 | Imágenes y hallazgos hematológicos en trombosis y trombocitopenia después de la vacunación con Chadox1 NCOV-19 (AstraZeneca): | https://pubmed.ncbi.nlm.nih.gov/34402666/ | |
543 | Espectro de hallazgos de neuroimagen en la vacunación posterior a la COVID-19: una serie de casos y revisión de la literatura: | https://pubmed.ncbi.nlm.nih.gov/34842783/ | |
544 | Trombosis sinusal venosa cerebral, embolia pulmonar y trombocitopenia después de la vacunación de COVID-19 en un hombre taiwanés: un informe de caso y revisión de la literatura: | https://pubmed.ncbi.nlm.nih.gov/34630307/ | |
545 | Trombosis sinusal venosa cerebral fatal después de la vacunación de COVID-19: | https://pubmed.ncbi.nlm.nih.gov/33983464/ | |
546 | Raíces autoinmunes de eventos trombóticos después de la vacunación de COVID-19: | https://pubmed.ncbi.nlm.nih.gov/34508917/. | |
547 | Nueva trombosis de vena porta en cirrosis: es la trombofilia exacerbada por la vacuna o COVID-19: | https://www.jcehepatology.com/article/S0973-6883(21)00545-4/fulltext. | |
548 | Imágenes de trombocitopenia trombótica inmune inducida por Oxford / AstraZeneca® COVID-19 VACCINE: | https://pubmed.ncbi.nlm.nih.gov/33962903/. | |
549 | Trombosis sinusus venosa cerebral después de la vacunación con COVID-19 ARNm de BNT162B2: | https://pubmed.ncbi.nlm.nih.gov/34796065/. | |
550 | Mayor riesgo de urticaria / angioedema después de BNT162B2 MRNA COVID-19 Vacunación en trabajadores de la salud que toman inhibidores de la ECE: | https://pubmed.ncbi.nlm.nih.gov/34579248/ | |
551 | Un caso de una presentación clínica leve inusual de la trombocitopenia trombótica inmune inducida por la vacuna contra la vacuna con la trombosis de la vena esplácnica: | https://pubmed.ncbi.nlm.nih.gov/34843991/ | |
552 | Trombosis sinusus venosa cerebral después de la vacunación con PFIZE-BIONTECH COVID-19 (BNT162B2): | https://pubmed.ncbi.nlm.nih.gov/34595867/ | |
553 | Un caso de purpura trombocitopénica idiopática después de una dosis de refuerzo de vacuna COVID-19 BNT162B2 (Pfizer-Biontech): | https://pubmed.ncbi.nlm.nih.gov/34820240/ | |
554 | Trombocitopenia inmunológica inmune inducida por la vacuna (VITT): Mecanismo patológico con los inhibidores de la tirosina quinasa de Bruton: | https://pubmed.ncbi.nlm.nih.gov/33851389/ | |
555 | Púrpura trombocitopénica trombótica después de la vacunación con AD26.COV2-S: | https://pubmed.ncbi.nlm.nih.gov/33980419/ | |
556 | Eventos tromboembólicos en mujeres más jóvenes expuestas a Pfizer-Biontech o Moderna Covid-19 vacunas: | https://pubmed.ncbi.nlm.nih.gov/34264151/ | |
557 | Riesgo potencial de eventos trombóticos después de la vacunación de COVID-19 con Oxford-AstraZeneca en mujeres que reciben estrógeno: | https://pubmed.ncbi.nlm.nih.gov/34734086/ | |
558 | Trombosis después de la vacunación de COVID-19 de vector de adenovirus: una preocupación por la enfermedad subyacente: | https://pubmed.ncbi.nlm.nih.gov/34755555/ | |
559 | Interacciones de adenovirus con plaquetas y coagulación y síndrome de trombocitopenia trombótica inmune inducida por la vacuna: | https://pubmed.ncbi.nlm.nih.gov/34407607/ | |
560 | Púrpura trombocitopénica trombótica: una nueva amenaza después de la vacuna COVID BNT162B2: | https://pubmed.ncbi.nlm.nih.gov/34264514/. | |
561 | Sitio inusual de trombosis venosa profunda después de la vacunación contra la enfermedad de Coronavirus MRNA-2019 Coronavirus (COVID-19): | https://pubmed.ncbi.nlm.nih.gov/34840204/ | |
562 | Efectos secundarios neurológicos de las vacunas SARS-COV-2: | https://pubmed.ncbi.nlm.nih.gov/34750810/ | |
563 | COAGULOPATHES Después de la vacunación con SARS-COV-2 puede derivarse de un efecto combinado de la proteína de punta de SARS-COV-2 y los vías de señalización activadas por el vector de adenovirus: | https://pubmed.ncbi.nlm.nih.gov/34639132/ | |
564 | Embolia pulmonar aislada después de la vacunación por covid: 2 informes de casos y una revisión de las complicaciones y seguimiento de la embolia pulmonar aguda: | https://pubmed.ncbi.nlm.nih.gov/34804412/ | |
565 | Oclusión de la vena de la retina central después de la vacunación con el ARNm de SARS-COV-2: Informe de caso: | https://pubmed.ncbi.nlm.nih.gov/34571653/. | |
566 | Informe de caso complicado de la trombocitopenia inmune trombótica inducida por la vacuna a largo plazo A: | https://pubmed.ncbi.nlm.nih.gov/34835275/. | |
567 | Trombosis venosa profunda después de la vacunación con ad26.cov2.s en hombres adultos: | https://pubmed.ncbi.nlm.nih.gov/34659839/. | |
568 | Enfermedades autoinmunes neurológicas después de la vacunación con SARS-COV-2: una serie de casos: | https://pubmed.ncbi.nlm.nih.gov/34668274/. | |
569 | Anemia autoinmune hemolítica autoinmune grave después de recibir la vacuna contra el ARNm de SARS-COV-2: | https://pubmed.ncbi.nlm.nih.gov/34549821/ | |
570 | Ocurrencia de variantes de COVID-19 entre los destinatarios de la vacuna Chadox1 NCOV-19 (recombinante): | https://pubmed.ncbi.nlm.nih.gov/34528522/ | |
571 | Prevalencia de trombocitopenia, anticuerpos anti-plaquetarios 4, y dimer DIZ elevado en Thais después de la vacunación con Chadox1 NCOV-19: | https://pubmed.ncbi.nlm.nih.gov/34568726/ | |
572 | Epidemiología de miocarditis aguda / pericarditis en adolescentes de Hong Kong después de la co-vacunación: | https://academic.oup.com/cid/advance-article-abstract/doi/10.1093/cid/ciab989/6445179 | |
573 | Miocarditis después de la vacuna contra el ARNm de la enfermedad de Coronavirus de 2019: una serie de casos y determinación de la tasa de incidencia: | https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciab926/6420408 | |
574 | Miocarditis y pericarditis después de la vacunación de COVID-19: desigualdades en la edad y los tipos de vacunas: | https://www.mdpi.com/2075-4426/11/11/1106 | |
575 | Epidemiología y características clínicas de miocarditis / pericarditis antes de la introducción de la vacuna contra el ARNm COVID-19 en niños coreanos: un estudio multicéntrico: | https://pubmed.ncbi.nlm.nih.gov/34402230/ | |
576 | Derramar luz sobre miocarditis posterior al vacunación y pericarditis en COVID-19 y receptores de vacunas no covid-19: | https://pubmed.ncbi.nlm.nih.gov/34696294/ | |
577 | Miocarditis después de la vacuna contra MRNA COVID-19: | https://journals.lww.com/pec-online/Abstract/2021/11000/Myocarditis_Following_mRNA_COVID_19_Vaccine.9.aspx | |
578 | Miocarditis después de BNT162B2 MRNA COVID-19 Vacuna de ARNm en Israel: | https://pubmed.ncbi.nlm.nih.gov/34614328/. | |
579 | Miocarditis, pericarditis y cardiomiopatía después de la vacunación de COVID-19: | https://www.heartlungcirc.org/article/S1443-9506(21)01156-2/fulltext | |
580 | Miocarditis y otras complicaciones cardiovasculares de COVID-19 vacunas COVID-19 a base de ARNm: | https://pubmed.ncbi.nlm.nih.gov/34277198/ | |
581 | Posible asociación entre COVID-19 VACUNA Y MIARDARDISTICA: Hallazgos clínicos y CMR: | https://pubmed.ncbi.nlm.nih.gov/34246586/ | |
582 | Hipersensibilidad miocarditis y covid-19 vacunas: | https://pubmed.ncbi.nlm.nih.gov/34856634/. | |
583 | Miocarditis severa asociada con COVID-19 VACUNA: CEBRA O UNICORN?: | https://www.internationaljournalofcardiology.com/article/S0167-5273(21)01477-7/fulltext. | |
584 | Infarto y miocarditis aguda de miocardio después de la vacunación de COVID-19: | https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8522388/ | |
585 | Miocarditis después de la vacunación de COVID-19 en una gran organización de atención médica: | https://www.nejm.org/doi/10.1056/NEJMoa2110737 | |
586 | Asociación de miocarditis con COVID-19 Messenger RNA BNT162B2 Vacuna en una serie de niños: | https://jamanetwork.com/journals/jamacardiology/fullarticle/2783052 | |
587 | Sospecha clínica de miocarditis temporalmente relacionada con la vacunación de COVID-19 en adolescentes y adultos jóvenes: | https://www.ahajournals.org/doi/abs/10.1161/CIRCULATIONAHA.121.056583?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed | |
588 | STEMI MIMICIRY: miocarditis focal en un paciente adolescente después de la vacunación con ARNm de COVID-19:. | https://pubmed.ncbi.nlm.nih.gov/34756746/ | |
589 | Miocarditis y pericarditis en asociación con COVID-19 Vacunación de ARNm: casos de un centro regional de farmacovigilancia: | https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8587334/ | |
590 | Miocarditis después de COVID-19 Vacunas de ARNm: | https://pubmed.ncbi.nlm.nih.gov/34546329/. | |
591 | Pacientes con miocarditis aguda después de la vacunación con ARNm de COVID-19:. | https://jamanetwork.com/journals/jamacardiology/fullarticle/2781602. | |
592 | Miocarditis después de la vacunación de COVID-19: una serie de casos: | https://www.sciencedirect.com/science/article/pii/S0264410X21011725?via%3Dihub. | |
593 | Miocarditis asociada a la vacunación COVID-19 en adolescentes: | https://publications.aap.org/pediatrics/article/148/5/e2021053427/181357 | |
594 | Hallazgos de miocarditis en imágenes de resonancia magnética cardíaca después de la vacunación con COVID-19 ARNm en adolescentes:. | https://pubmed.ncbi.nlm.nih.gov/34704459/ | |
595 | Miocarditis después de la vacunación COVID-19: Estudio de imágenes de resonancia magnética: | https://academic.oup.com/ehjcimaging/advance-article/doi/10.1093/ehjci/jeab230/6421640 | |
596 | Miocarditis aguda después de la administración de la segunda dosis de BNT162B2 COVID-19 VACUNA: | https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8599115/ | |
597 | Miocarditis después de la vacunación COVID-19: | https://www.sciencedirect.com/science/article/pii/S2352906721001603 | |
598 | Informe de caso: miocarditis probable después de la vacuna contra el ARNm de COVID-19 en un paciente con cardiomiopatía ventricular arritmogénica de la izquierda: | https://pubmed.ncbi.nlm.nih.gov/34712717/. | |
599 | Miocarditis aguda después de la administración de la vacuna BNT162B2 contra COVID-19: | https://www.revespcardiol.org/en-linkresolver-acute-myocarditis-after-administration-bnt162b2-S188558572100133X. | |
600 | Miocarditis asociada a la vacunación con ARNm Covid-19: | https://pubs.rsna.org/doi/10.1148/radiol.2021211430 | |
601 | Miocarditis aguda después de la vacunación de COVID-19: un informe de caso: | https://www.sciencedirect.com/science/article/pii/S0248866321007098 | |
602 | Myopericarditis aguda después de la vacunación de COVID-19 en adolescentes:. | https://pubmed.ncbi.nlm.nih.gov/34589238/. | |
603 | Perimyocarditis en adolescentes después de la vacunación de Pfizer-Biontech COVID-19: | https://academic.oup.com/jpids/article/10/10/962/6329543. | |
604 | Miocarditis aguda asociada a la vacunación anti-covid-19: | https://ecevr.org/DOIx.php?id=10.7774/cevr.2021.10.2.196. | |
605 | Miocarditis asociada con COVID-19 Vacunación: hallazgos ecocardiográficos, CT CARDIAC y MRI:. | https://pubmed.ncbi.nlm.nih.gov/34428917/. | |
606 | Miocarditis sintomática aguda en 7 adolescentes después de la vacunación de PFIZE-BIONTECH COVID-19:. | https://pubmed.ncbi.nlm.nih.gov/34088762/. | |
607 | Miocarditis y pericarditis en adolescentes después de la primera y la segunda dosis de vacunas de ARNm COVID-19:. | https://academic.oup.com/ehjqcco/advance-article/doi/10.1093/ehjqcco/qcab090/6442104 | |
608 | Covid 19 vacuna para adolescentes. Preocupación por la miocarditis y la pericarditis: | https://www.mdpi.com/2036-7503/13/3/61. | |
609 | Imágenes cardiacas de miocarditis aguda después de la vacunación con COVID-19 ARNm: | https://pubmed.ncbi.nlm.nih.gov/34402228/ | |
610 | Miocarditis temporalmente asociada con la vacunación COVID-19: | https://pubmed.ncbi.nlm.nih.gov/34133885/ | |
611 | Lesión de miocardio agudo Después de la vacunación de COVID-19: un informe de caso y revisión de la evidencia actual de la base de datos del sistema de informes de eventos adversos de la vacuna: | https://pubmed.ncbi.nlm.nih.gov/34219532/ | |
612 | Miocarditis aguda asociada con la vacunación COVID-19: Informe de un caso: | https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8639400/ | |
613 | Miocarditis después de la vacunación con COVID-19 Messenger ARN: una serie de casos japoneses: | https://pubmed.ncbi.nlm.nih.gov/34840235/. | |
614 | Miocarditis en el entorno de una vacunación reciente de COVID-19: | https://pubmed.ncbi.nlm.nih.gov/34712497/. | |
615 | Miocarditis aguda después de una segunda dosis de COVID-19 Vacuna de ARNm: Informe de dos casos: | https://www.clinicalimaging.org/article/S0899-7071(21)00265-5/fulltext. | |
616 | Prevalencia de trombocitopenia, antibloqueo antiplaquetario 4, y dimer DInte DICIO elevado en Thais después de la vacunación con Chadox1 NCOV-19: | https://pubmed.ncbi.nlm.nih.gov/34568726/ | |
617 | Epidemiología de miocarditis aguda / pericarditis en adolescentes de Hong Kong después de la co-vacunación: | https://academic.oup.com/cid/advance-article-abstract/doi/10.1093/cid/ciab989/6445179 | |
618 | Miocarditis después de la vacuna contra el ARNm de la enfermedad de Coronavirus de 2019: una serie de casos y una determinación de la tasa de incidencia: | https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciab926/6420408. | |
619 | Miocarditis y pericarditis después de la vacunación de COVID-19: desigualdades en la edad y los tipos de vacunas: | https://www.mdpi.com/2075-4426/11/11/1106 | |
620 | Epidemiología y características clínicas de miocarditis / pericarditis antes de la introducción de la vacuna contra el ARNm COVID-19 en niños coreanos: un estudio multicéntrico: | https://pubmed.ncbi.nlm.nih.gov/34402230/ | |
621 | Derramar luz sobre miocarditis posterior al vacunación y pericarditis en COVID-19 y receptores de vacunas no covid-19: | https://pubmed.ncbi.nlm.nih.gov/34696294/ | |
622 | Síndrome protrombótico difuso después de la administración de la vacuna Chadox1 NCOV-19: Informe de caso: | https://pubmed.ncbi.nlm.nih.gov/34615534/ | |
623 | Tres casos de tromboembolismo venoso agudo en mujeres después de la vacunación de Coronavirus 2019: | https://pubmed.ncbi.nlm.nih.gov/34352418/ | |
624 | Características clínicas y biológicas de la trombosis sinusita venosa cerebral después de la vacunación con Chadox1 NCOV-19; | https://jnnp.bmj.com/content/early/2021/09/29/jnnp-2021-327340. | |
625 | La vacunación de COV2-S puede revelar la trombofilia hereditaria: la trombosis sinusal venosa cerebral masiva en un hombre joven con el recuento normal de plaquetas: | https://pubmed.ncbi.nlm.nih.gov/34632750/ | |
626 | Hallazgos post-mortem en trombocitopenia trombótica inducida por la vacuna: | https://haematologica.org/article/view/haematol.2021.279075 | |
627 | COVID-19 Trombosis inducida por la vacuna: | https://pubmed.ncbi.nlm.nih.gov/34802488/. | |
628 | Inflamación y activación de plaquetas después de las vacunas COVID-19: posibles mecanismos detrás de la trombocitopenia inmune inducida por la vacuna y la trombosis: | https://pubmed.ncbi.nlm.nih.gov/34887867/. | |
629 | Reacción anafilactoide y trombosis coronaria relacionada con la vacuna contra el ARNm Covid-19: | https://pubmed.ncbi.nlm.nih.gov/34863404/. | |
630 | Trombosis venosa cerebral cerebral inducida por la vacuna y trombocitopenia. Oxford-AstraZeneca COVID-19: Una oportunidad perdida para un rápido retorno de la experiencia: | https://www.sciencedirect.com/science/article/pii/S235255682100093X | |
631 | Ocurrencia de infarto esplénico debido a la trombosis arterial después de la vacunación con COVID-19: | https://pubmed.ncbi.nlm.nih.gov/34876440/ | |
632 | Trombosis venosa profunda más de dos semanas después de la vacunación de COVID-19: | https://pubmed.ncbi.nlm.nih.gov/33928773/ | |
633 | Informe de caso: tomar una segunda apariencia: trombosis venosa cerebral relacionada con la vacunación de COVID-19 y el síndrome de trombocitopenia trombótica: | https://pubmed.ncbi.nlm.nih.gov/34880826/ | |
634 | Información sobre la trombocitopenia trombótica inmune-mediada por la vacuna mediada por la vacuna: | https://pubmed.ncbi.nlm.nih.gov/34587242/ | |
635 | Cambio en la viscosidad sanguínea después de la vacunación de COVID-19: estimación para personas con síndrome metabólico subyacente: | https://pubmed.ncbi.nlm.nih.gov/34868465/ | |
636 | Gestión de un paciente con un síndrome de malformación con extremidades congénitas raras después de la trombosis y la trombocitopenia (VITT) de SARS-COV-2 | https://pubmed.ncbi.nlm.nih.gov/34097311/ | |
637 | Talámico bilateral Talámico: un caso de covid-19 (VITT) trombocitopenia trombótica inmune inducida por la vacuna o una coincidencia debido a factores de riesgo subyacentes: | https://pubmed.ncbi.nlm.nih.gov/34820232/. | |
638 | Trombocitopenia y trombosis splanicnica después de la vacunación con AD26.Cov2.s tratados con éxito con derivación y trombectomía intrahepática intrahepática intrahepática transjugular: | https://onlinelibrary.wiley.com/doi/10.1002/ajh.26258 | |
639 | Incidencia de accidente cerebrovascular isquémico agudo después de la vacunación por coronavirus en Indonesia: serie de casos: | https://pubmed.ncbi.nlm.nih.gov/34579636/ | |
640 | Tratamiento exitoso de la trombocitopenia inmune inmune inducida por la vacuna en una paciente femenina de 26 años: | https://pubmed.ncbi.nlm.nih.gov/34614491/ | |
641 | Informe de caso: trombocitopenia inmune inmune inducida por la vacuna en un paciente con cáncer de páncreas después de la vacunación con Messenger RNA-1273: | https://pubmed.ncbi.nlm.nih.gov/34790684/ | |
642 | TROMBOFLEBITIS IDIOPÁTICO IDIOPÁTICO EXTERNO TROMBOFLEBITIS DESPUÉS DE LA VACUNACIÓN DE LA ENFERMEDAD DE CORONAVIURUS (COVID-19): | https://pubmed.ncbi.nlm.nih.gov/33624509/. | |
643 | Carcinoma de células escamosas del pulmón con hemoptisis después de la vacunación con Tozinameran (BNT162B2, PFIZER-BIONTECH): | https://pubmed.ncbi.nlm.nih.gov/34612003/ | |
644 | Trombocitopenia trombótica inducida por la vacuna después de la vacuna AD26.Cov2.S en un hombre que se presenta como un tromboembolismo venoso agudo: | https://pubmed.ncbi.nlm.nih.gov/34096082/ | |
645 | Miocarditis asociada a la vacunación COVID-19 en tres niños adolescentes: | https://pubmed.ncbi.nlm.nih.gov/34851078/. | |
646 | Hallazgos de resonancia magnética cardiovascular en pacientes adultos jóvenes con miocarditis aguda después de COVID-19 Vacunación de ARNm: una serie de casos: | https://pubmed.ncbi.nlm.nih.gov/34496880/ | |
647 | Perimyocarditis después de la vacunación con COVID-19: | https://pubmed.ncbi.nlm.nih.gov/34866957/ | |
648 | Epidemiología de miocarditis aguda / pericarditis en adolescentes de Hong Kong después de la co-vacunación: | https://pubmed.ncbi.nlm.nih.gov/34849657/. | |
649 | La muerte repentina inducida por miocarditis después de BNT162B2 COVID-19 Vacunación de ARNm en Corea: Informe de caso centrado en los hallazgos histopatológicos: | https://pubmed.ncbi.nlm.nih.gov/34664804/ | |
650 | Miocarditis aguda después de la vacunación con COVID-19 ARNm en adultos de 18 años o más: | https://pubmed.ncbi.nlm.nih.gov/34605853/ | |
651 | Recurrencia de miocarditis aguda temporalmente asociada con la recepción de la vacuna contra la enfermedad de ARNm de Coronavirus 2019 (COVID-19) en un hombre adolescente: | https://pubmed.ncbi.nlm.nih.gov/34166671/ | |
652 | Hombre joven con miocarditis después de MRNA-1273 Enfermedad de Coronavirus-2019 (COVID-19) Vacunación de ARNm: | https://pubmed.ncbi.nlm.nih.gov/34744118/ | |
653 | Miocarditis aguda después de la vacunación con SARS-COV-2 en un hombre de 24 años: | https://pubmed.ncbi.nlm.nih.gov/34334935/. | |
654 | GA-DOTATOC Imágenes de PET digital de celdas inflamatorias Infiltradas en miocarditis después de la vacunación con COVID-19: | https://pubmed.ncbi.nlm.nih.gov/34746968/ | |
655 | Ocurrencia de miocarditis de forma de infarto aguda después de la vacunación con COVID-19: ¡Solo una coincidencia accidental o más bien una miocarditis autoinmune asociada a la vacuna? ": | https://pubmed.ncbi.nlm.nih.gov/34333695/. | |
656 | Miocarditis autolimitada que presenta con dolor en el pecho y elevación del segmento ST en adolescentes después de la vacunación con la vacuna contra el ARNm BNT162B2: | https://pubmed.ncbi.nlm.nih.gov/34180390/ | |
657 | Miocarditis después de la inmunización con vacunas con COVID-19 ARNm en miembros de los Estados Unidos de los Estados Unidos: | https://pubmed.ncbi.nlm.nih.gov/34185045/ | |
658 | Miocarditis después de la vacunación por BNT162B2 en un hombre sano: | https://pubmed.ncbi.nlm.nih.gov/34229940/ | |
659 | Myopericarditis en un hombre adolescente previamente saludable después de la vacunación de COVID-19: Informe de caso: | https://pubmed.ncbi.nlm.nih.gov/34133825/ | |
660 | Miocarditis aguda después de la vacunación con MRNA-1273 MRNA-1273 de SARS-COV-2: | https://pubmed.ncbi.nlm.nih.gov/34308326/. | |
661 | Dolor en el pecho con reurbanización anormal de electrocardiograma después de la inyección de la vacuna COVID-19 fabricada por Moderna: | https://pubmed.ncbi.nlm.nih.gov/34866106/ | |
662 | Miocarditis linfocítica probada por la biopsia Después de la primera vacunación con COVID-19 ARNm en un hombre de 40 años: Informe de caso: | https://pubmed.ncbi.nlm.nih.gov/34487236/ | |
663 | Imagen multimodalidad e histopatología en un hombre joven que presenta con miocarditis linfocítica fulminante y un shock cardiogénico después de la vacunación con MRNA-1273: | https://pubmed.ncbi.nlm.nih.gov/34848416/ | |
664 | Informe de un caso de miopericaditis después de la vacunación con BNT162B2 COVID-19 ARNm en un joven coreano: | https://pubmed.ncbi.nlm.nih.gov/34636504/ | |
665 | Miocarditis aguda después de la vacunación contra la comilería en un hombre sano con la infección previa de SARS-COV-2: | https://pubmed.ncbi.nlm.nih.gov/34367386/ | |
666 | Miocarditis aguda en un adulto joven dos días después de la vacunación con Pfizer: | https://pubmed.ncbi.nlm.nih.gov/34709227/ | |
667 | Informe de caso: miocarditis fulminante aguda y choque cardiogénico después del mensajero RNA Coronavirus vacunación en 2019 que requiere una reanimación cardiopulmonar extracorpórea: | https://pubmed.ncbi.nlm.nih.gov/34778411/ | |
668 | Miocarditis aguda después de la vacunación contra la enfermedad de Coronavirus de 2019: | https://pubmed.ncbi.nlm.nih.gov/34734821/ | |
669 | Una serie de pacientes con miocarditis después de la vacunación contra SARS-COV-2 con MRNA-1279 y BNT162B2: | https://pubmed.ncbi.nlm.nih.gov/34246585/ | |
670 | Myopericarditis después de Pfizer Messenger Ribonucleic Acid Coronavirus Coronavirus Enfermedad vacuna en adolescentes: | https://pubmed.ncbi.nlm.nih.gov/34228985/ | |
671 | Síndrome inflamatorio del Multisistema Post-vacunación en adultos sin evidencia de infección previa de SARS-COV-2: | https://pubmed.ncbi.nlm.nih.gov/34852213/ | |
672 | Miocarditis aguda definida después de la vacunación con el ARNm de la enfermedad de Coronavirus 2019: | https://pubmed.ncbi.nlm.nih.gov/34866122/ | |
673 | Disfunción sistólica biventricular en miocarditis aguda después de la vacunación con MRNA-1273 de SARS-COV-2: | https://pubmed.ncbi.nlm.nih.gov/34601566/ | |
674 | Miocarditis después de la vacunación COVID-19: ESTUDIO DE MRI: | https://pubmed.ncbi.nlm.nih.gov/34739045/. | |
675 | Miocarditis aguda después de la vacunación COVID-19: Informe de caso: | https://docs.google.com/document/d/1Hc4bh_qNbZ7UVm5BLxkRdMPnnI9zcCsl/e | |
676 | Asociación de miocarditis con COVID-19 Messenger RNA BNT162B2 Vaccine COVID-19 En una serie de niños: | https://pubmed.ncbi.nlm.nih.gov/34374740/ | |
677 | Sospecha clínica de miocarditis temporalmente relacionada con la vacunación de COVID-19 en adolescentes y adultos jóvenes: | https://pubmed.ncbi.nlm.nih.gov/34865500/ | |
678 | Miocarditis después de la vacunación con COVID-19 en una gran organización de atención médica: | https://pubmed.ncbi.nlm.nih.gov/34614329/ | |
679 | AstraZeneca COVID-19 Vaccine y Síndrome de Guillain-Barré en Tasmania: un enlace causal: | https://pubmed.ncbi.nlm.nih.gov/34560365/ | |
680 | COVID-19, Guillain-Barré y la mezcla peligrosa de vacunas: | https://pubmed.ncbi.nlm.nih.gov/34108736/. | |
681 | Síndrome de Guillain-Barré Después de la primera dosis de PFIZE-BIONTECH COVID-19 VACCINE: Informe de caso y revisión de los casos reportados: | https://pubmed.ncbi.nlm.nih.gov/34796417/. | |
682 | Síndrome de Guillain-Barre después de BNT162B2 COVID-19 VACCINE: | https://link.springer.com/article/10.1007%2Fs10072-021-05523-5. | |
683 | COVID-19 Vacunas de adenovirus y síndrome de Guillain-Barré con parálisis facial: | https://onlinelibrary.wiley.com/doi/10.1002/ana.26258. | |
684 | Asociación de Asociación de Recibos de Ad26.Cov2.S COVID-19 Vacuna con presunto síndrome de Guillain-Barre, febrero-julio 2021: | https://jamanetwork.com/journals/jama/fullarticle/2785009 | |
685 | Un caso de síndrome de Guillain-Barré después de Pfizer COVID-19 VACUNA: | https://pubmed.ncbi.nlm.nih.gov/34567447/ | |
686 | Síndrome de Guillain-Barré asociado con la vacunación COVID-19: | https://pubmed.ncbi.nlm.nih.gov/34648420/. | |
687 | Tasa de síndrome recurrente de Guilain-Barré después de COVID-19 BNT162B2 Vacuna de ARNm: | https://jamanetwork.com/journals/jamaneurology/fullarticle/2783708 | |
688 | Síndrome de Guillain-Barre después de COVID-19 Vacunación en un adolescente: | https://www.pedneur.com/article/S0887-8994(21)00221-6/fulltext. | |
689 | Síndrome de Guillain-Barre después de la vacunación de Chadox1-S / NCOV-19: | https://pubmed.ncbi.nlm.nih.gov/34114256/. | |
690 | Síndrome de Guillain-Barre después de COVID-19 MRNA-1273 Vacuna: Informe de caso: | https://pubmed.ncbi.nlm.nih.gov/34767184/. | |
691 | Síndrome de Guillain-Barre después de la vacunación de SARS-COV-2 en 19 pacientes: | https://pubmed.ncbi.nlm.nih.gov/34644738/. | |
692 | Síndrome de Guillain-Barre presentando con diplegia facial después de la vacunación con COVID-19 en dos pacientes: | https://pubmed.ncbi.nlm.nih.gov/34649856/ | |
693 | Un caso raro del síndrome de Guillain-Barré después de la vacunación COVID-19: | https://pubmed.ncbi.nlm.nih.gov/34671572/ | |
694 | Complicaciones neurológicas de COVID-19: Síndrome de Guillain-Barre después de Pfizer Covid-19 Vacuna: | https://pubmed.ncbi.nlm.nih.gov/33758714/ | |
695 | COVID-19 Vacuna que causa el síndrome de Guillain-Barre, un efecto secundario potencial poco común: | https://pubmed.ncbi.nlm.nih.gov/34484780/ | |
696 | Síndrome de Guillain-Barre después de la primera dosis de COVID-19 Vacunación: Informe de caso; | https://pubmed.ncbi.nlm.nih.gov/34779385/. | |
697 | Síndrome de Fisher Miller después de Pfizer Covid-19 Vacuna: | https://pubmed.ncbi.nlm.nih.gov/34817727/. | |
698 | Síndrome de Miller Fisher después de 2019 BNT162B2 MRNA CORONAVIRUS VACUNACION: | https://pubmed.ncbi.nlm.nih.gov/34789193/. | |
699 | Debilidad facial bilateral con una variante de la parestesia del síndrome de Guillain-Barre después de Vaxzevria COVID-19 VACUNA: | https://pubmed.ncbi.nlm.nih.gov/34261746/ | |
700 | Síndrome de Guillain-Barre después de la primera inyección de la vacuna Chadox1 NCOV-19: Primer informe: | https://pubmed.ncbi.nlm.nih.gov/34217513/. | |
701 | Un caso de síndrome de GUILLAIN-BARRE ATAXICA SENSORY con inmunoglobulina g Anticuerpos anti-GM1 después de la primera dosis de COVID-19 BNT162B2 Vacuna de ARNm (PFIZIZE): | https://pubmed.ncbi.nlm.nih.gov/34871447/ | |
702 | Informe de neuropatías inflamatorias agudas con vacunas COVID-19: Subgrupo de análisis de desproporcionalidad en vigibase: | https://pubmed.ncbi.nlm.nih.gov/34579259/ | |
703 | Una variante del síndrome de Guillain-Barré después de la vacunación de SARS-COV-2: AMSAN: | https://pubmed.ncbi.nlm.nih.gov/34370408/. | |
704 | Una variante rara del síndrome de Guillain-Barré después de la vacunación con AD26.Cov2.S: | https://pubmed.ncbi.nlm.nih.gov/34703690/. | |
705 | Síndrome de Guillain-Barré después de la vacunación de SARS-COV-2 en un paciente con el síndrome de Guillain-Barré asociado a la vacuna anterior: | https://pubmed.ncbi.nlm.nih.gov/34810163/ | |
706 | Síndrome de Guillain-Barré en un estado australiano utilizando vacunas ARNA y ADENOVIRUS-vector SARS-COV-2: | https://onlinelibrary.wiley.com/doi/10.1002/ana.26218. | |
707 | Mielitis transversal aguda después de la vacunación de SARS-COV-2: Informe de caso y revisión de la literatura: | https://pubmed.ncbi.nlm.nih.gov/34482455/. | |
708 | Síndrome de Variant Guilain-Barré ocurre después de la vacunación de SARS-COV-2: | https://pubmed.ncbi.nlm.nih.gov/34114269/. | |
709 | Síndrome de Guillian-Barre con variante axonal asociada temporalmente con la vacuna a base de ARNm de SARS-COV-2 moderna: | https://pubmed.ncbi.nlm.nih.gov/34722067/ | |
710 | Síndrome de Guillain-Barre después de la primera dosis de vacuna contra SARS-COV-2: una ocurrencia temporal, no una asociación causal: | https://pubmed.ncbi.nlm.nih.gov/33968610/ | |
711 | Las vacunas SARS-COV-2 pueden complicarse no solo por el síndrome de Guillain-Barré, sino también por neuropatía de fibra pequeña distal: | https://pubmed.ncbi.nlm.nih.gov/34525410/ | |
712 | Variante clínica del síndrome de Guillain-Barré con diplegia facial prominente después de AstraZeneca 2019 Vacuna de la enfermedad de Coronavirus: | https://pubmed.ncbi.nlm.nih.gov/34808658/ | |
713 | Informes de eventos adversos y riesgo de parálisis de Bell después de la vacunación de COVID-19: | https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(21)00646-0/fulltext. | |
714 | Palsy del nervio facial bilateral y la vacunación de COVID-19: Causalidad o coincidencia: | https://pubmed.ncbi.nlm.nih.gov/34522557/ | |
715 | La parálisis de la campana izquierda después de la primera dosis de la vacuna contra MRNA-1273 SARS-COV-2: Informe de caso: | https://pubmed.ncbi.nlm.nih.gov/34763263/. | |
716 | La parálisis de Bell después de la vacunación inactivada con COVID-19 en un paciente con una historia de parálisis recurrente de Bell: Informe de caso: | https://pubmed.ncbi.nlm.nih.gov/34621891/ | |
717 | Complicaciones neurológicas después de la primera dosis de vacunas COVID-19 y infección por SARS-COV-2: | https://pubmed.ncbi.nlm.nih.gov/34697502/ | |
718 | Tipo I Interferons como un posible mecanismo que une las vacunas de ARNm Covid-19 con la parálisis de Bell: | https://pubmed.ncbi.nlm.nih.gov/33858693/ | |
719 | Mielitis transversal aguda después de la vacuna inactivada COVID-19: | https://pubmed.ncbi.nlm.nih.gov/34370410/ | |
720 | Mielitis transversal aguda después de la vacunación COVID-19: | https://pubmed.ncbi.nlm.nih.gov/34579245/. | |
721 | Un caso de mielitis transversal extensa longitudinalmente después de la vacunación de COVID-19: | https://pubmed.ncbi.nlm.nih.gov/34182207/ | |
722 | Post Covid-19 Myelitis transversal; Un informe de un caso con la revisión de la literatura: | https://pubmed.ncbi.nlm.nih.gov/34457267/. | |
723 | Cuidado con el trastorno del espectro de la neuromielitis Optica después de la vacunación con el virus inactivado para COVID-19: | https://pubmed.ncbi.nlm.nih.gov/34189662/ | |
724 | Neuromielitis Optica en una mujer sana después de la vacunación contra el síndrome respiratorio agudo severo Coronavirus 2 MRNA-1273: | https://pubmed.ncbi.nlm.nih.gov/34660149/ | |
725 | Neuritis óptica bilateral bilateral aguda / quiasma con mielitis transversal extensa longitudinal en esclerosis múltiple estable de larga data después de la vacunación por vectores contra SARS-COV-2: | https://pubmed.ncbi.nlm.nih.gov/34131771/ | |
726 | Una serie de casos de pericarditis aguda después de la vacunación con COVID-19 en el contexto de informes recientes de Europa y los Estados Unidos: | https://pubmed.ncbi.nlm.nih.gov/34635376/ | |
727 | Pericarditis aguda y tamponada cardíaca después de la vacunación con COVID-19: | https://pubmed.ncbi.nlm.nih.gov/34749492/ | |
728 | Miocarditis y pericarditis en adolescentes después de la primera y segunda dosis de vacunas con ARNm COVID-19: | https://pubmed.ncbi.nlm.nih.gov/34849667/ | |
729 | Perimyocarditis en adolescentes después de la vacuna PFIZE-BIONTECH COVID-19: | https://pubmed.ncbi.nlm.nih.gov/34319393/ | |
730 | MyopericaDitis aguda después de la vacuna COVID-19 en adolescentes: | https://pubmed.ncbi.nlm.nih.gov/34589238/ | |
731 | Pericarditis Después de la administración de la Vacuna de ARNm BNT162B2 COVID-19: | https://pubmed.ncbi.nlm.nih.gov/34149145/ | |
732 | Informe de caso: pericarditis sintomática Post Covid-19 Vacunación: | https://pubmed.ncbi.nlm.nih.gov/34693198/. | |
733 | Un brote de la enfermedad de Still después de la vacunación de COVID-19 en un paciente de 34 años: | https://pubmed.ncbi.nlm.nih.gov/34797392/ | |
734 | Linfohistiocitosis hemofagocítica después de la vacunación COVID-19 (Chadox1 NCOV-19): | https://pubmed.ncbi.nlm.nih.gov/34862234/ | |
735 | Miocarditis después de la vacunación del ARNm de SARS-COV-2, una serie de casos: | https://pubmed.ncbi.nlm.nih.gov/34396358/. | |
736 | El síndrome de Miller-Fisher y el síndrome de Guillain-Barré se superponen el síndrome de un paciente después de la vacunación Oxford-AstraZeneca SARS-COV-2: | https://pubmed.ncbi.nlm.nih.gov/34848426/. | |
737 | Brotes de enfermedades mediadas por la mediación inmunológica o enfermedad de nuevo inicio en 27 sujetos después de la vacunación con ARNm / ADN contra SARS-COV-2: | https://pubmed.ncbi.nlm.nih.gov/33946748/ | |
738 | Investigación post-mortem de muertes después de la vacunación con vacunas COVID-19: | https://pubmed.ncbi.nlm.nih.gov/34591186/ | |
739 | Lesión renal aguda con hematuria macroscópica y nefropatía IgA después de la vacunación COVID-19: | https://pubmed.ncbi.nlm.nih.gov/34352309/ | |
740 | Recaída de la trombocitopenia inmune después de la vacunación de COVID-19 en paciente masculino joven: | https://pubmed.ncbi.nlm.nih.gov/34804803/. | |
741 | Purpura trombocitopénica inmune asociada con COVID-19 Vacuna de ARNm Pfizer-Biontech BNT16B2B2: | https://pubmed.ncbi.nlm.nih.gov/34077572/ | |
742 | Hemorragia de la retina después de la vacunación de SARS-COV-2: | https://pubmed.ncbi.nlm.nih.gov/34884407/. | |
743 | Informe de caso: la vasculitis asociada a un anticuerpo citoplásmica anti-neutrófilo con insuficiencia renal aguda y hemorragia pulmonar puede ocurrir después de la vacunación de COVID-19: | https://pubmed.ncbi.nlm.nih.gov/34859017/ | |
744 | Hemorragia intracerebral Debido a la vasculitis después de la vacunación COVID-19: Informe de caso: | https://pubmed.ncbi.nlm.nih.gov/34783899/ | |
745 | Pedunción, sangrado cavernoso sintomático después de la vacunación contra el SARS-COV-2 inducida por trombocitopenia inmune: | https://pubmed.ncbi.nlm.nih.gov/34549178/. | |
746 | Muerte cerebral en un paciente vacunado con covid-19 infección: | https://pubmed.ncbi.nlm.nih.gov/34656887/ | |
747 | Purpura generalizada Annularis Telangiectodes después de la vacunación con ARNm de SARS-COV-2: | https://pubmed.ncbi.nlm.nih.gov/34236717/. | |
748 | Hemorragia de lobar con rotura ventricular poco después de la primera dosis de una vacuna SARS-COV-2 basada en ARNA de ARNA de SARS-COV-2: | https://pubmed.ncbi.nlm.nih.gov/34729467/. | |
749 | Un caso de brote de hematuria macroscópica y nefropatía IgA después de la vacunación con SARS-COV-2: | https://pubmed.ncbi.nlm.nih.gov/33932458/ | |
750 | Hemorragia acral después de la administración de la segunda dosis de vacuna contra SARS-COV-2. Una reacción posterior a la vacunación: | https://pubmed.ncbi.nlm.nih.gov/34092400/742. | |
751 | Púrpura trombocitopénica inmune grave después de la vacuna contra SARS-COV-2: | https://pubmed.ncbi.nlm.nih.gov/34754937/ | |
752 | Hematuria bruta después del síndrome respiratorio agudo severo Vacunación de Coronavirus 2 en 2 pacientes con nefropatía IgA: | https://pubmed.ncbi.nlm.nih.gov/33771584/ | |
753 | Encefalitis autoinmune después de la vacunación contra el SAR-COV-2 de Chadox1-S: | https://pubmed.ncbi.nlm.nih.gov/34846583/ | |
754 | COVID-19 Vacuna y muerte: algoritmo de causalidad de acuerdo con el diagnóstico de elegibilidad de la OMS: | https://pubmed.ncbi.nlm.nih.gov/34073536/ | |
755 | La parálisis de Bell después de la vacunación con ARNm (BNT162B2) y vacunas inactivadas (Coronavac) SARS-COV-2: una serie de casos y un estudio de control de casos anidado: | https://pubmed.ncbi.nlm.nih.gov/34411532/ | |
756 | Epidemiología de miocarditis y pericarditis después de las vacunas con ARNm en Ontario, Canadá: por producto de vacunación, horario e intervalo: | https://www.medrxiv.org/content/10.1101/2021.12.02.21267156v1 | |
757 | Anafilaxia después de la vacuna COVID-19 en un paciente con urticaria colinérgica: | https://pubmed.ncbi.nlm.nih.gov/33851711/ | |
758 | Anafilaxis inducida por CORONAVAC COVID-19 VACUNA: Características clínicas y resultados de la revaccinación: | https://pubmed.ncbi.nlm.nih.gov/34675550/. | |
759 | Anafilaxia después de la vacuna moderna COVID-19: | https://pubmed.ncbi.nlm.nih.gov/34734159/. | |
760 | Asociación de antecedentes autoinformados de alergia al alto riesgo con síntomas de alergia después de la vacunación de COVID-19: | https://pubmed.ncbi.nlm.nih.gov/34698847/ | |
761 | Diferencias sexuales en la incidencia de anafilaxis a las vacunas de ARNm-LNP COVID-19: | https://pubmed.ncbi.nlm.nih.gov/34020815/ | |
762 | Reacciones alérgicas, incluida la anafilaxia, después de recibir la primera dosis de Pfizer-BionTech COVID-19 VACCINE - Estados Unidos, del 14 al 23 de diciembre de 2020: | https://pubmed.ncbi.nlm.nih.gov/33641264/ | |
763 | Reacciones alérgicas, incluida la anafilaxia, después de recibir la primera dosis de la vacuna moderna COVID-19 - Estados Unidos, 21 de diciembre, 2020 hasta el 10 de enero de 2021: | https://pubmed.ncbi.nlm.nih.gov/33641268/ | |
764 | Anafilaxia prolongada a Pfizer 2019 Vacuna de la enfermedad de Coronavirus: un informe de caso y un mecanismo de acción: | https://pubmed.ncbi.nlm.nih.gov/33834172/ | |
765 | Reacciones de anafilaxis a Pfizer BNT162B2 Vacuna: Informe de 3 casos de anafilaxis después de la vacunación con Pfizer BNT162B2: | https://pubmed.ncbi.nlm.nih.gov/34579211/ | |
766 | Anafilaxia bifásica después de la primera dosis de 2019 Messenger RNA CORONAVIRUS Vacuna de la enfermedad con polisorbato positivo 80 Resultado de la prueba de la piel: | https://pubmed.ncbi.nlm.nih.gov/34343674/ | |
767 | Infarto y miocarditis aguda de miocardio después de la vacunación de COVID-19: | https://pubmed.ncbi.nlm.nih.gov/34586408/ | |
768 | Síndrome de Takotsubo después de la vacunación de COVID-19: | https://pubmed.ncbi.nlm.nih.gov/34539938/. | |
769 | Cardiomiopatía de TakotSubo después de la vacunación de Coronavirus 2019 en paciente en la hemodiálisis de mantenimiento: | https://pubmed.ncbi.nlm.nih.gov/34731486/. | |
770 | Infarto miocárdico prematuro o efecto secundario de la vacuna COVID-19: | https://pubmed.ncbi.nlm.nih.gov/33824804/ | |
771 | Infarto miocardial, accidente cerebrovascular y embolia pulmonar después de la vacuna contra BNT162B2 MRNA COVID-19 en personas de 75 años o más: | https://pubmed.ncbi.nlm.nih.gov/34807248/ | |
772 | Síndrome de Kounis tipo 1 inducido por la vacuna inactivada de SARS-COV-2: | https://pubmed.ncbi.nlm.nih.gov/34148772/ | |
773 | Infarto de miocardio agudo dentro de las 24 horas posteriores a la vacunación COVID-19: es el síndrome de Kounis el culpable: | https://pubmed.ncbi.nlm.nih.gov/34702550/ | |
774 | Muertes asociadas con la vacunación de SARS-COV-2 recientemente lanzada (ComirnAty®): | https://pubmed.ncbi.nlm.nih.gov/33895650/ | |
775 | Muertes asociadas con la vacunación de SARS-COV-2 lanzada recientemente: | https://pubmed.ncbi.nlm.nih.gov/34425384/ | |
776 | Un caso de la encefalopatía aguda y el infarto de miocardio de elevación del segmento de ST-ST, después de la vacunación con MRNA-1273: posible efecto adverso: | https://pubmed.ncbi.nlm.nih.gov/34703815/ | |
777 | Vasculitis urticarial inducida por la covid-19: | https://pubmed.ncbi.nlm.nih.gov/34369046/. | |
778 | Vasculitis asociada a ANCA después de la vacuna PFIZE-BIONTECH COVID-19: | https://pubmed.ncbi.nlm.nih.gov/34280507/. | |
779 | Vasculitis leucocitoclástica de nuevo inicio después de la vacuna COVID-19: | https://pubmed.ncbi.nlm.nih.gov/34241833/ | |
780 | Vasculitis pequeña recipiente cutánea después de la vacuna COVID-19: | https://pubmed.ncbi.nlm.nih.gov/34529877/. | |
781 | Brote de vasculitis leucocitoclástica después de la vacuna COVID-19: | https://pubmed.ncbi.nlm.nih.gov/33928638/ | |
782 | Vasculitis leucocitoclástica después de la exposición a la vacuna COVID-19: | https://pubmed.ncbi.nlm.nih.gov/34836739/ | |
783 | Vasculitis y bursitis en [18 F] FDG-PET / CT Después de COVID-19 Vacuna de ARNm: Post Hoc Ergo Propter HOC?; | https://pubmed.ncbi.nlm.nih.gov/34495381/. | |
784 | Vasculitis linfocítica cutánea después de la administración de COVID-19 Vacuna de ARNm: | https://pubmed.ncbi.nlm.nih.gov/34327795 | |
785 | Vasculitis leucocitoclástica cutánea inducida por Sinovac COVID-19 VACUNA: | https://pubmed.ncbi.nlm.nih.gov/34660867/. | |
786 | Informe de caso: vasculitis asociada a ANCA que presenta la rabdomiolisis y la glomerulonefritis pauci-inmune Crescentico después de la vacunación con PFIZE-BIONTECH COVID-19 ARNm: | https://pubmed.ncbi.nlm.nih.gov/34659268/ | |
787 | Reactivación de la vasculitis IgA después de la vacunación con COVID-19: | https://pubmed.ncbi.nlm.nih.gov/34848431/ | |
788 | Vasculitis de pequeños vasos relacionados con el virus de Varicella-Zoster después de Pfizer-Biontech Covid-19 Vacunación: | https://pubmed.ncbi.nlm.nih.gov/34310759/. | |
789 | Imágenes en medicina vascular: vasculitis leucocitoclástica después de COVID-19 VACUNA BOOSTER: | https://pubmed.ncbi.nlm.nih.gov/34720009/ | |
790 | Un caso raro de Henoch-Schönlein Purpura después de un informe de caso de la vacuna COVID-19: | https://pubmed.ncbi.nlm.nih.gov/34518812/ | |
791 | Vasculitis cutánea después de la vacunación COVID-19: | https://pubmed.ncbi.nlm.nih.gov/34611627/. | |
792 | Posible caso de vasculitis de vásculos pequeños vaqueros inducidos por la vacuna contra la vacuna contra la vacuna contra el ARNm: | https://pubmed.ncbi.nlm.nih.gov/34705320/. | |
793 | Vasculitis IgA después de la vacunación de COVID-19 en un adulto: | https://pubmed.ncbi.nlm.nih.gov/34779011/ | |
794 | Vasculitis asociada a anticuerpos citoplásmicos inducidos por propiltiouracilo después de la vacunación con COVID-19: | https://pubmed.ncbi.nlm.nih.gov/34451967/ | |
795 | Vacuna de la enfermedad de Coronavirus 2019 (COVID-19) en lupus sistémico Eritematosus y neutrófilos, vasculitis asociada a anticuerpos anti-citoplasmáticos: | https://pubmed.ncbi.nlm.nih.gov/33928459/ | |
796 | Reactivación de la vasculitis IgA después de la vacunación de COVID-19: | https://pubmed.ncbi.nlm.nih.gov/34250509/ | |
797 | Espectro clínico e histopatológico de reacciones de la piel adversas retrasadas después de la vacunación de COVID-19: | https://pubmed.ncbi.nlm.nih.gov/34292611/. | |
798 | Primera descripción de la vasculitis compleja inmune después de la vacunación de COVID-19 con BNT162B2: Informe de caso: | https://pubmed.ncbi.nlm.nih.gov/34530771/. | |
799 | Síndrome nefrótico y vasculitis después de la vacuna contra SARS-COV-2: Asociación verdadera o circunstancial: | https://pubmed.ncbi.nlm.nih.gov/34245294/. | |
800 | La aparición de la vasculitis cutánea de Novo después de la vacunación contra la enfermedad de Coronavirus (COVID-19): | https://pubmed.ncbi.nlm.nih.gov/34599716/. | |
801 | Vasculitis cutánea asimétrica después de la vacunación de COVID-19 con una preponderancia inusual de eosinófilos: | https://pubmed.ncbi.nlm.nih.gov/34115904/. | |
802 | Henoch-Schönlein Purpura ocurre después de la vacunación con COVID-19: | https://pubmed.ncbi.nlm.nih.gov/34247902/. | |
803 | Henoch-Schönlein Purpura siguiendo la primera dosis de COVID-19 VACERAL VACUNA VACUNA: INFORME DE CASO: | https://pubmed.ncbi.nlm.nih.gov/34696186/. | |
804 | Vasculitis granulomatosa después de la vacuna contra el astrazeneca anti-SARS-COV-2: | https://pubmed.ncbi.nlm.nih.gov/34237323/. | |
805 | Necrosis retiniana aguda Debido a la reactivación del virus de Varicella Zoster después de la vacunación con BNT162B2 COVID-19 ARNm: | https://pubmed.ncbi.nlm.nih.gov/34851795/. | |
806 | Un caso de síndrome de Sweet generalizado con vasculitis desencadenada por la reciente vacunación con COVID-19: | https://pubmed.ncbi.nlm.nih.gov/34849386/ | |
807 | Vasculitis de pequeña embarcación después de la vacunación Oxford-AstraZeneca contra SARS-COV-2: | https://pubmed.ncbi.nlm.nih.gov/34310763/ | |
808 | Recaída de la poliangiitis microscópica después de la vacunación de COVID-19: Informe de caso: | https://pubmed.ncbi.nlm.nih.gov/34251683/. | |
809 | Vasculitis cutánea después del síndrome respiratorio agudo severo CORONAVIRUS 2 VACUNA: | https://pubmed.ncbi.nlm.nih.gov/34557622/. | |
810 | Herpes recurrentes Zoster después de la vacunación de COVID-19 en pacientes con urticaria crónica en el tratamiento de ciclosporina: un informe de 3 casos: | https://pubmed.ncbi.nlm.nih.gov/34510694/ | |
811 | Vasculitis leucocitoclástica después de la vacunación contra la enfermedad de Coronavirus 2019: | https://pubmed.ncbi.nlm.nih.gov/34713472/803 | |
812 | Brotes de vasculitis mixta de crioglobulinemia después de la vacunación contra SARS-COV-2: | https://pubmed.ncbi.nlm.nih.gov/34819272/ | |
813 | Vasculitis cutánea de pequeños vasos después de la vacunación con una dosis única de Janssen Ad26.Cov2.s: | https://pubmed.ncbi.nlm.nih.gov/34337124/ | |
814 | Caso de inmunoglobulina Una vasculitis después de la vacunación contra la enfermedad de Coronavirus 2019: | https://pubmed.ncbi.nlm.nih.gov/34535924/ | |
815 | Progresión rápida del linfoma de células T angioimmunoblásticas después de BNT162B2 Vacunación de refuerzo de ARNm: Informe de caso: | https://www.frontiersin.org/articles/10.3389/fmed.2021.798095/ | |
816 | COVID-19 Linfadenopatía inducida por la vacuna contra la vacuna contra la vacuna contra la progresión del linfoma en FDG PET / CT: | https://pubmed.ncbi.nlm.nih.gov/33591026/ | |
817 | Linfadenopatía en COVID-19 Receptores de vacunas: Dilema de diagnóstico en pacientes con oncología: | https://pubmed.ncbi.nlm.nih.gov/33625300/ | |
818 | Linfadenopatía hipermetabólica después de la administración de la vacuna contra el ARNm de BNT162B2 COVID-19: Incidencia evaluada por [18 F] PET-CT y relevancia para la interpretación del estudio: | https://pubmed.ncbi.nlm.nih.gov/33774684/ | |
819 | Linfadenopatía después de la vacunación de COVID-19: Revisión de los hallazgos de imágenes: | https://pubmed.ncbi.nlm.nih.gov/33985872/ | |
820 | Evolución de la linfadenopatía hipermetabólica axilar hipermetabólica bilateral en FDG PET / CT después de 2 dosis COVID-19 Vacunación: | https://pubmed.ncbi.nlm.nih.gov/34735411/ | |
821 | Linfadenopatía asociada con COVID-19 Vacunación en FDG PET / CT: Características distintivas en la vacuna vectorial de adenovirus: | https://pubmed.ncbi.nlm.nih.gov/34115709/. | |
822 | COVID-19 Linfadenopatía inducida por la vacuna en una clínica especializada de imágenes de mama en Israel: análisis de 163 casos: | https://pubmed.ncbi.nlm.nih.gov/34257025/. | |
823 | COVID-19 Linfadenopatía axilar relacionada con la vacuna en pacientes con cáncer de mama: serie de casos con revisión de la literatura: | https://pubmed.ncbi.nlm.nih.gov/34836672/. | |
824 | La vacuna contra la enfermedad de Coronavirus 2019 imita las metástasis de los nodos linfáticos en pacientes que se someten a un seguimiento del cáncer de piel: un estudio central: | https://pubmed.ncbi.nlm.nih.gov/34280870/ | |
825 | COVID-19 POST-vacunación Linfadenopatía: Informe de la aspiración de aguja fina Biopsia de biopsia Hallazgos citológicos: | https://pubmed.ncbi.nlm.nih.gov/34432391/ | |
826 | Linfadenopatía regional después de la vacunación de COVID-19: Revisión de la literatura y consideraciones para la gestión del paciente en la atención del cáncer de mama: | https://pubmed.ncbi.nlm.nih.gov/34731748/ | |
827 | Linfadenopatía axilar subclínica asociada con la vacunación COVID-19 en la mamografía de detección: | https://pubmed.ncbi.nlm.nih.gov/34906409/ | |
828 | Eventos adversos de la inyección de covid que pueden ocurrir en los niños. La linfadenopatía supraclavicular supraclavicular de entrenamiento incondicional, coincidente con la vacunación contra el ARNm intramuscular contra COVID-19 puede estar relacionada con la técnica de inyección de la vacuna, España, enero y febrero de 2021: | https://pubmed.ncbi.nlm.nih.gov/33706861/ | |
829 | Linfadenopatía supraclavicular después de la vacunación de COVID-19 en Corea: Seguimiento en serie por ultrasonografía: | https://pubmed.ncbi.nlm.nih.gov/34116295/ | |
830 | Oxford-astrazeneca COVID-19 Induce Linfadenopatía Induce en [18F] CHOLINE PET / CT, no solo un hallazgo de FDG: | https://pubmed.ncbi.nlm.nih.gov/33661328/ | |
831 | Anafilaxia bifásica Después de la exposición a la primera dosis de PFIZE-BIONTECH COVID-19 Vaccine COVID-19: | https://pubmed.ncbi.nlm.nih.gov/34050949/ | |
832 | Adenopatía axilar asociada con COVID-19 Vacunación: resultados de imágenes y recomendaciones de seguimiento en 23 mujeres: | https://pubmed.ncbi.nlm.nih.gov/33624520/ | |
833 | Un caso de linfadenopatía cervical después de la vacunación de COVID-19: | https://pubmed.ncbi.nlm.nih.gov/34141500/ | |
834 | Hallazgos únicos de imágenes de fantasmia neurológica después de Pfizer-BionTech COVID-19 Vacunación: un informe de caso: | https://pubmed.ncbi.nlm.nih.gov/34096896/ | |
835 | Eventos adversos trombóticos reportados para Vacunas de Moderna, Pfizer y Oxford-AstraZeneca COVID-19: Comparación de ocurrencia y resultados clínicos en la base de datos de EUDRAVAVIGILANCE: | https://pubmed.ncbi.nlm.nih.gov/34835256/ | |
836 | Linfadenopatía unilateral después de la vacunación de COVID-19: un plan de gestión práctico para los radiólogos de todas las especialidades: | https://pubmed.ncbi.nlm.nih.gov/33713605/ | |
837 | Adenopatía axilar unilateral en el entorno de COVID-19 Vacunación: Seguimiento: | https://pubmed.ncbi.nlm.nih.gov/34298342/ | |
838 | Una revisión sistemática de los casos de desmielinización del CNS después de la vacunación COVID-19: | https://pubmed.ncbi.nlm.nih.gov/34839149/ | |
839 | Linfadenopatía supraclavicular después de la vacunación de COVID-19: una presentación creciente en la clínica de dos semanas con cuello de espera: | https://pubmed.ncbi.nlm.nih.gov/33685772/ | |
840 | COVID-19 Linfadenopatía axilar y cervical relacionada con la vacuna en pacientes con cáncer de mama actual o anterior y otros malignos: hallazgos de imágenes transversales en MRI, CT y PET-CT: | https://pubmed.ncbi.nlm.nih.gov/34719892/ | |
841 | Adenopatía después de la vacunación de COVID-19: | https://pubmed.ncbi.nlm.nih.gov/33625299/. | |
842 | Incidencia de adenopatía axilar en imágenes de senos después de la vacunación con COVID-19: | https://pubmed.ncbi.nlm.nih.gov/34292295/. | |
843 | COVID-19 Vacunación y menores linfadenopatías cervicales en la clínica a tanto del cuello de dos semanas: una auditoría de seguimiento: | https://pubmed.ncbi.nlm.nih.gov/33947605/. | |
844 | Linfadenopatía cervical después de la vacunación contra la enfermedad de Coronavirus 2019: Características clínicas e implicaciones para servicios de cáncer de cabeza y cuello: | https://pubmed.ncbi.nlm.nih.gov/34526175/ | |
845 | Linfadenopatía asociada a la vacuna COVID-19: | https://pubmed.ncbi.nlm.nih.gov/33786231/ | |
846 | Evolución de la linfadenopatía en PET / MRI después de la vacunación de COVID-19: | https://pubmed.ncbi.nlm.nih.gov/33625301/. | |
847 | Hepatitis autoinmune activada por la vacunación SARS-COV-2: | https://pubmed.ncbi.nlm.nih.gov/34332438/. | |
848 | Síndrome nefrótico de nuevo inicio después de Janssen COVID-19 Vacunación: Informe de caso y revisión de la literatura: | https://pubmed.ncbi.nlm.nih.gov/34342187/. | |
849 | Linfadenopatía masiva cervical después de la vacunación con COVID-19: | https://pubmed.ncbi.nlm.nih.gov/34601889/ | |
850 | ANCA Glomerulonefritis después de la vacunación moderna COVID-19: | https://pubmed.ncbi.nlm.nih.gov/34081948/ | |
851 | Extenso mielitis transversal longitudinal después de AstraZeneca covid-19 vacunación: | https://pubmed.ncbi.nlm.nih.gov/34507942/. | |
852 | Síndrome de extravasación capilar sistémica después de la vacunación con Chadox1 NCOV-19 (Oxford-AstraZeneca): | https://pubmed.ncbi.nlm.nih.gov/34362727/ | |
853 | Linfadenopatía axilar unilateral relacionada con COVID-19 VACUNA: Patrón en la selección de MRI de mama Permitiendo una evaluación benigna: | https://pubmed.ncbi.nlm.nih.gov/34325221/ | |
854 | Linfadenopatía axilar en pacientes con vacunación reciente de COVID-19: un nuevo dilema de diagnóstico: | https://pubmed.ncbi.nlm.nih.gov/34825530/. | |
855 | Enfermedad de cambio mínimo y lesión renal aguda después de la vacuna Pfizer-Biontech COVID-19: | https://pubmed.ncbi.nlm.nih.gov/34000278/ | |
856 | COVID-19 Adenopatía axilar unilateral inducida por la vacuna: evaluación de seguimiento en los Estados Unidos: | https://pubmed.ncbi.nlm.nih.gov/34655312/. | |
857 | Gastroparesis después de Pfizer-BionTech COVID-19 Vacunación: | https://pubmed.ncbi.nlm.nih.gov/34187985/. | |
858 | La linfadenopatía supraclavicular de inicio agudo coincidente con la vacunación contra el ARNm intramuscular contra COVID-19 puede estar relacionada con la técnica de inyección de la vacuna, España, enero y febrero de 2021: | https://pubmed.ncbi.nlm.nih.gov/33706861/ | |
859 | Linfadenopatía supraclavicular después de la vacunación de COVID-19 en Corea: Seguimiento en serie por ultrasonografía: | https://pubmed.ncbi.nlm.nih.gov/34116295/ | |
860 | Oxford-astrazeneca COVID-19 Induce Linfadenopatía Induce en [18F] CHOLINE PET / CT, no solo un hallazgo de FDG: | https://pubmed.ncbi.nlm.nih.gov/33661328/ | |
861 | Anafilaxia bifásica Después de la exposición a la primera dosis de PFIZE-BIONTECH COVID-19 Vaccine COVID-19: | https://pubmed.ncbi.nlm.nih.gov/34050949/ | |
862 | Adenopatía axilar asociada con COVID-19 Vacunación: resultados de imágenes y recomendaciones de seguimiento en 23 mujeres: | https://pubmed.ncbi.nlm.nih.gov/33624520/ | |
863 | Un caso de linfadenopatía cervical después de la vacunación de COVID-19: | https://pubmed.ncbi.nlm.nih.gov/34141500/ | |
864 | Hallazgos únicos de imágenes de fantasmia neurológica después de Pfizer-BionTech COVID-19 Vacunación: un informe de caso: | https://pubmed.ncbi.nlm.nih.gov/34096896/ | |
865 | Eventos adversos trombóticos reportados para Vacunas de Moderna, Pfizer y Oxford-AstraZeneca COVID-19: Comparación de ocurrencia y resultados clínicos en la base de datos de EUDRAVAVIGILANCE: | https://pubmed.ncbi.nlm.nih.gov/34835256/ | |
866 | Linfadenopatía unilateral después de la vacunación de COVID-19: un plan de gestión práctico para los radiólogos de todas las especialidades: | https://pubmed.ncbi.nlm.nih.gov/33713605/ | |
867 | Adenopatía axilar unilateral en el entorno de COVID-19 Vacunación: Seguimiento: | https://pubmed.ncbi.nlm.nih.gov/34298342/ | |
868 | Una revisión sistemática de los casos de desmielinización del CNS después de la vacunación COVID-19: | https://pubmed.ncbi.nlm.nih.gov/34839149/ | |
869 | Linfadenopatía supraclavicular después de la vacunación de COVID-19: una presentación creciente en la clínica de dos semanas con cuello de espera: | https://pubmed.ncbi.nlm.nih.gov/33685772/ | |
870 | COVID-19 Linfadenopatía axilar y cervical relacionada con la vacuna en pacientes con cáncer de mama actual o anterior y otros malignos: hallazgos de imágenes transversales en MRI, CT y PET-CT: | https://pubmed.ncbi.nlm.nih.gov/34719892/ | |
871 | Adenopatía después de la vacunación de COVID-19: | https://pubmed.ncbi.nlm.nih.gov/33625299/. | |
872 | Incidencia de adenopatía axilar en imágenes de senos después de la vacunación con COVID-19: | https://pubmed.ncbi.nlm.nih.gov/34292295/. | |
873 | COVID-19 Vacunación y menores linfadenopatías cervicales en la clínica a tanto del cuello de dos semanas: una auditoría de seguimiento: | https://pubmed.ncbi.nlm.nih.gov/33947605/. | |
874 | Linfadenopatía cervical después de la vacunación contra la enfermedad de Coronavirus 2019: Características clínicas e implicaciones para servicios de cáncer de cabeza y cuello: | https://pubmed.ncbi.nlm.nih.gov/34526175/ | |
875 | Linfadenopatía asociada a la vacuna COVID-19: | https://pubmed.ncbi.nlm.nih.gov/33786231/ | |
876 | Evolución de la linfadenopatía en PET / MRI después de la vacunación de COVID-19: | https://pubmed.ncbi.nlm.nih.gov/33625301/. | |
877 | Hepatitis autoinmune activada por la vacunación SARS-COV-2: | https://pubmed.ncbi.nlm.nih.gov/34332438/. | |
878 | Síndrome nefrótico de nuevo inicio después de Janssen COVID-19 Vacunación: Informe de caso y revisión de la literatura: | https://pubmed.ncbi.nlm.nih.gov/34342187/. | |
879 | Linfadenopatía masiva cervical después de la vacunación con COVID-19: | https://pubmed.ncbi.nlm.nih.gov/34601889/ | |
880 | ANCA Glomerulonefritis después de la vacunación moderna COVID-19: | https://pubmed.ncbi.nlm.nih.gov/34081948/ | |
881 | Extenso mielitis transversal longitudinal después de AstraZeneca covid-19 vacunación: | https://pubmed.ncbi.nlm.nih.gov/34507942/. | |
882 | Síndrome de extravasación capilar sistémica después de la vacunación con Chadox1 NCOV-19 (Oxford-AstraZeneca): | https://pubmed.ncbi.nlm.nih.gov/34362727/ | |
883 | Linfadenopatía axilar unilateral relacionada con COVID-19 VACUNA: Patrón en la selección de MRI de mama Permitiendo una evaluación benigna: | https://pubmed.ncbi.nlm.nih.gov/34325221/ | |
884 | Linfadenopatía axilar en pacientes con vacunación reciente de COVID-19: un nuevo dilema de diagnóstico: | https://pubmed.ncbi.nlm.nih.gov/34825530/. | |
885 | Enfermedad de cambio mínimo y lesión renal aguda después de la vacuna Pfizer-Biontech COVID-19: | https://pubmed.ncbi.nlm.nih.gov/34000278/ | |
886 | COVID-19 Adenopatía axilar unilateral inducida por la vacuna: evaluación de seguimiento en los Estados Unidos: | https://pubmed.ncbi.nlm.nih.gov/34655312/. | |
887 | Gastroparesis después de Pfizer-BionTech COVID-19 Vacunación: | https://pubmed.ncbi.nlm.nih.gov/34187985/. | |
888 | Abbate, A., Gavin, J., Midanchi, N., Kim, C., Shah, P. R., Klein, K.,. . . Danivelides, S. (2021). Miocarditis fulminante y hiperinflamación sistémica asociada temporalmente con la vacunación con BNT162B2 MRNA COVID-19 en dos pacientes. INT J Cardiol, 340, 119-121. DOI: 10.1016 / J.ijcard.2021.08.018. | https://www.ncbi.nlm.nih.gov/pubmed/34416319 | |
889 | Abu Mouch, S., Roguin, A., Hellou, E., Ishai, A., Shoshan, U., Mahamid, L.,. . . Berar Yanay, N. (2021). Miocarditis después de la vacunación de ARNm Covid-19. Vacuna, 39 (29), 3790-3793. DOI: 10.1016 / J.Vaccine.2021.05.087. | https://www.ncbi.nlm.nih.gov/pubmed/34092429 | |
890 | Albert, E., Aurigemma, G., Saucedo, J., & Gerson, D. S. (2021). Miocarditis después de la vacunación de COVID-19. Representante de la caja Radiol, 16 (8), 2142-2145. DOI: 10.1016 / J.RADCR.2021.05.033. | https://www.ncbi.nlm.nih.gov/pubmed/34025885 | |
891 | Aye, Y. N., Mai, A. S., Zhang, A., LIM, O. Z. H., Lin, N., NG, C. H. ,. . . Masticar, N. W. S. (2021). Infarto de miocardio agudo y miocarditis después de la vacunación COVID-19. Qjm. DOI: 10.1093 / QJMED / HCAB252. | https://www.ncbi.nlm.nih.gov/pubmed/34586408 | |
892 | Azir, M., Inman, B., Webb, J., & Tannenbaum, L. (2021). STEMI MIMIC: miocarditis focal en un paciente adolescente después de la vacuna contra MRNA COVID-19. J Emerg Med, 61 (6), E129-E132. DOI: 10.1016 / J.JEMERMED.2021.09.017. | https://www.ncbi.nlm.nih.gov/pubmed/34756746 | |
893 | Barda, N., Dagan, N., Ben-Shlomo, Y., SAYEN, E., WAXMAN, J., OHANA, R.,. . . Balicer, R. D. (2021). Seguridad de la vacuna contra la COVID-19 de MRNA BNT162B2 en un entorno nacional. N Engl J Med, 385 (12), 1078-1090. DOI: 10.1056 / NEJMOA2110475. | https://www.ncbi.nlm.nih.gov/pubmed/34432976 | |
894 | Bhandari, M., Pradhan, A., Vishwakarma, P., & Sethi, R. (2021). Coronavirus y manifestaciones cardiovasculares, llegando al corazón del asunto. World J Cardiol, 13 (10), 556-565. DOI: 10.4330 / wjc.v13.i10.556. | https://www.ncbi.nlm.nih.gov/pubmed/34754400 | |
895 | Bozkurt, B., Kamat, I., & Hotez, P. J. (2021). Miocarditis con vacunas de ARNm Covid-19. Circulación, 144 (6), 471-484. DOI: 10.1161 / Circuulaha.121.056135. | https://www.ncbi.nlm.nih.gov/pubmed/34281357 | |
896 | Buchhorn, R., Meyer, C., Schulze-Forster, K., Junker, J., & Heidecke, H. (2021). Liberación de autoanticuerpos en niños después de la vacunación contra el ARNm del virus de Corona: ¿Un factor de riesgo del síndrome inflamatorio multisistémico? Vacunas (Basilea), 9 (11). DOI: 10.3390 / vacunas9111353. | https://www.ncbi.nlm.nih.gov/pubmed/34835284 | |
897 | Calcaterra, G., Bassaeo, P. P., Barilla, F., Romeo, F., & Mehta, J. L. (2022). Con respecto al estado protrombótico inesperado después de algunas vacunas de la enfermedad de Coronavirus 2019. J Cardiovasc Med (Hagerstown), 23 (2), 71-74. DOI: 10.2459 / JCM.0000000000001232. | https://www.ncbi.nlm.nih.gov/pubmed/34366403 | |
898 | Calcaterra, G., Mehta, J. L., De Gregorio, C., Butera, G., Neroni, P., Fanos, V., & Bassaroo, P. P. (2021). Covid 19 vacuna para adolescentes. Preocupación por miocarditis y pericarditis. Pediatr Rep, 13 (3), 530-533. DOI: 10.3390 / PEDIATRIC13030061. | https://www.ncbi.nlm.nih.gov/pubmed/34564344 | |
899 | Chai, Q., Nygaard, U., Schmidt, R. C., Zaremba, T., Moller, A. M. y Thorvig, C. M. (2022). Síndrome inflamatorio multisistémico en un adolescente masculino después de su segunda vacuna PFIZE-BIONTECH COVID-19. ACTA PEDIATR, 111 (1), 125-127. DOI: 10.1111 / APA.16141. | https://www.ncbi.nlm.nih.gov/pubmed/34617315 | |
900 | Chamling, B., Vehof, V., Drakos, S., Weil, M., Stalling, P., Vahlhaus, C. ,. . . YILMAZ, A. (2021). La ocurrencia de la miocarditis de forma de infarto aguda después de la vacunación de COVID-19: ¡solo una co-incidencia accidental o una miocarditis autoinmune asociada a la vacuna? Clin RES Cardiol, 110 (11), 1850-1854. DOI: 10.1007 / S00392-021-01916-W. | https://www.ncbi.nlm.nih.gov/pubmed/34333695 | |
901 | Chang, J. C., & Hawley, H. B. (2021). Trombocitopenia y trombosis asociada a la vacuna: la endoteliopatía venosa que conduce a la micro-macrotrotrombosis combinada venosa. Medicina (Kaunas), 57 (11). DOI: 10.3390 / MEDICINA57111163. | https://www.ncbi.nlm.nih.gov/pubmed/34833382 | |
902 | Chelala, L., Jeudy, J., Hossain, R., Rosenthal, G., Pietris, N., & White, C. (2021). Los hallazgos de la MRI cardíaca de la miocarditis después de la vacunación con ARNm de COVID-19 en adolescentes. Ajr am j Roentgenol. DOI: 10.2214 / AJR.21.26853. | https://www.ncbi.nlm.nih.gov/pubmed/34704459 | |
903 | Choi, S., Lee, S., SEO, J. W., Kim, M. J., Jeon, Y. H., Park, J. H. ,. . . Yeo, N. S. (2021). La muerte súbita inducida por miocarditis después de la vacunación contra BNT162B2 MRNA COVID-19 en Corea: Informe de caso centrado en los hallazgos histopatológicos. J Korean Med SCI, 36 (40), E286. DOI: 10.3346 / jkms.2021.36.e286. | https://www.ncbi.nlm.nih.gov/pubmed/34664804 | |
904 | Chouchana, L., Blet, A., Al-Khalaf, M., Kafil, T. S., Nair, G., Robblee, J.,. . . LIU, P. P. (2021). Características de las reacciones inflamatorias del corazón posteriores a la vacunación con MRNA COVID-19 a nivel global. Clin Pharmacol Ther. DOI: 10.1002 / CPT.2499. | https://www.ncbi.nlm.nih.gov/pubmed/34860360 | |
905 | Chua, G. T., Kwan, M. Y. W., Chui, C. S. L., Smith, R. D., Cheung, E. C., Tian, T.,. . . IP, P. (2021). Epidemiología de miocarditis aguda / pericarditis en adolescentes de Hong Kong después de la vacunación contra la comilería. Clin infectan dis. DOI: 10.1093 / CID / CIAB989. | https://www.ncbi.nlm.nih.gov/pubmed/34849657 | |
906 | Clarke, R., & Ioannou, A. (2021). ¿Se debe usar T2 Mapeo en casos de miocarditis recurrente para diferenciar entre la inflamación aguda y la cicatriz crónica? J pediatr. DOI: 10.1016 / J.JPEDS.2021.12.026. | https://www.ncbi.nlm.nih.gov/pubmed/34933012 | |
907 | COLANERI, M., DE FILIPPO, M., LARARI, A., MARSEGLIA, A., Maiocchi, L., Ricciardi, A. ,. . . Bruno, R. (2021). Vacunación de covid y exacerbación del asma: ¿Podría haber un enlace? INT J Infect DIS, 112, 243-246. DOI: 10.1016 / J.IJID.2021.09.026. | https://www.ncbi.nlm.nih.gov/pubmed/34547487 | |
908 | Das, B. B., Kohli, U., Ramachandran, P., Nguyen, H. H., Greil, G., Hussain, T.,. . . Khan, D. (2021). Myopericarditis después de la enfermedad de Messenger Rna Coronavirus 2019 Vacunación en adolescentes de 12 a 18 años de edad. J Pediatr, 238, 26-32 E21. DOI: 10.1016 / J.JPEDS.2021.07.044. | https://www.ncbi.nlm.nih.gov/pubmed/34339728 | |
909 | Das, B. B., Moskowitz, W. B., Taylor, M. B., & Palmer, A. (2021). Miocarditis y pericarditis después de la vacunación con ARNm Covid-19: ¿Qué sabemos hasta ahora? Niños (Basilea), 8 (7). DOI: 10.3390 / NIÑOS8070607. | https://www.ncbi.nlm.nih.gov/pubmed/34356586 | |
910 | Deb, A., Abdelmalek, J., Iwuji, K., & Nugent, K. (2021). Lesión de miocardio agudo después de la vacunación COVID-19: un informe de caso y revisión de la evidencia actual de la base de datos de sistemas de informes de eventos adversos de vacunas. J Prim Care Community Health, 12, 21501327211029230. DOI: 10.1177 / 21501327211029230. | https://www.ncbi.nlm.nih.gov/pubmed/34219532 | |
911 | Dickey, J. B., Albert, E., Badr, M., Laraja, K. M., Sena, L. M., Gerson, D. S. ,. . . Aurigemma, G. P. (2021). Una serie de pacientes con miocarditis después de la vacunación de SARS-COV-2 con MRNA-1279 y BNT162B2. JACC Cardiovasc Imaging, 14 (9), 1862-1863. DOI: 10.1016 / J.JCMG.2021.06.003. | https://www.ncbi.nlm.nih.gov/pubmed/34246585 | |
912 | Dimopoulou, D., Spyridis, N., Vartzelis, G., Tsolia, M. N., & Maritsi, D. N. (2021). Seguridad y tolerabilidad de la vacuna contra el ARNA COVID-19 en adolescentes con artritis idiopática juvenil en tratamiento con inhibidores de TNF. Artritis reumatol. DOI: 10.1002 / Art.41977. | https://www.ncbi.nlm.nih.gov/pubmed/34492161 | |
913 | Dimopoulou, D., Vartzelis, G., Dasoula, F., Tsolia, M., & Maritsi, D. (2021). Inmunogenicidad de la vacuna contra el ARNm Covid-19 en adolescentes con artritis idiopática juvenil en tratamiento con inhibidores de TNF. Ann reum dis. DOI: 10.1136 / AnnrheumDIS-2021-221607. | https://www.ncbi.nlm.nih.gov/pubmed/34844930 | |
914 | Ehrlich, P., Klingel, K., Ohlmann-Knofo, S., Huttinger, S., Sood, N., Pickuth, D., & Kindermann, M. (2021). La miocarditis linfocítica probada por la biopsia después de la primera vacunación contra el ARNm Covid-19 en un macho de 40 años: informe de caso. Clin RES Cardiol, 110 (11), 1855-1859. DOI: 10.1007 / S00392-021-01936-6. | https://www.ncbi.nlm.nih.gov/pubmed/34487236 | |
915 | El Sahly, H. M., Baden, L. R., Essink, B., Doblecki-lewis, S., Martin, J. M., Anderson, E. J. ,. . . Grupo, C. S. (2021). Eficacia de la vacuna contra el MRNA-1273 SARS-COV-2 al finalizar la fase ciega. N Engl J Med, 385 (19), 1774-1785. DOI: 10.1056 / NEJMOA2113017. | https://www.ncbi.nlm.nih.gov/pubmed/34551225 | |
916 | Facetti, S., Giraldi, M., Vecchi, A. L., Rogiani, S., & Nassiacos, D. (2021). [Miocarditis aguda en un adulto joven dos días después de la vacunación de Pfizer]. G ital cardiol (Roma), 22 (11), 891-893. DOI: 10.1714 / 3689.36746. | https://www.ncbi.nlm.nih.gov/pubmed/34709227 | |
917 | Fazlolahi, A., Zahmatyar, M., Noori, M., Nejadghaderi, S. A., Sullman, M. J. M., Shekarriz-Foumani, R.,. . . Safiri, S. (2021). Complicaciones cardíacas Siguiendo las vacunas ARNm COVID-19: una revisión sistemática de los informes de casos y las series de casos. Rev Med Virol, E2318. DOI: 10.1002 / RMV.2318. | https://www.ncbi.nlm.nih.gov/pubmed/34921468 | |
918 | Fazolo, T., Lima, K., FONTOURA, J. C., DE SOUZA, P. O., HILARIO, G., ZORZETTO, R. ,. . . Bonorino, C. (2021). Los pacientes con COVID-19 pediátricos en el sur de Brasil muestran abundante ARNm viral y fuertes respuestas antivirales específicas. Nat Commun, 12 (1), 6844. DOI: 10.1038 / S41467-021-27120-Y. | https://www.ncbi.nlm.nih.gov/pubmed/34824230 | |
919 | Fikenzer, S., & Laufs, U. (2021). Corrección a: Respuesta a la letra a los editores que se refieren a Fikenzer, S., UHE, T., Lavall, D., Rudolph, U., Falz, R., Busse, M., Hepp, P., & Laufs, U . (2020). Efectos de las máscaras de cara quirúrgica y FFP2 / N95 sobre la capacidad de ejercicio cardiopulmonar. Investigación clínica en Cardiología: Diario Oficial de la Sociedad Cardiac Alemana, 1-9. | https://www.ncbi.nlm.nih.gov/pubmed/34170372 | |
920 | Foltran, D., Delmas, C., Flumian, C., de Paoli, P., Salvo, F., Gautier, S. ,. . . Montastruc, F. (2021). Miocarditis y pericarditis en adolescentes después de la primera y segunda dosis de las vacunas de MRNA COVID-19. EUR HEART J Qual Care Clin, los resultados. DOI: 10.1093 / EHJQCCO / QCAB090. | https://www.ncbi.nlm.nih.gov/pubmed/34849667 | |
921 | Se olvidó, D., Jang, H., Abreu, R. B., Hanley, H. B., Gattiker, J. L. L., Jefferson, A. M., & Ross, T. M. (2021). Las vacunas de ARNm de SARS-COV-2 provocan diferentes respuestas en humanos inmunológicamente ingenuos y preinmunes. Inmunol delantero, 12, 728021. DOI: 10.3389 / FIMMU.2021.728021. | https://www.ncbi.nlm.nih.gov/pubmed/34646267 | |
922 | Furer, V., Eviator, T., Zisman, D., Peleg, H., Paran, D., LEVARTOVSKY, D. ,. . . Elkayam, O. (2021). Inmunogenicidad y seguridad de la vacuna contra el ARNm COVID-19 BNT162B2 en pacientes adultos con enfermedades reumáticas inflamatorias autoinmunes y en la población general: un estudio multicéntrico. Ann Rheum Dis, 80 (10), 1330-1338. DOI: 10.1136 / AnnrheumDIS-2021-220647. | https://www.ncbi.nlm.nih.gov/pubmed/34127481 | |
923 | Galindo, R., Chow, H., & Rongkavilit, C. (2021). Covid-19 en niños: manifestaciones clínicas y intervenciones farmacológicas, incluidos los ensayos de vacunas. Pediatr Clin North AM, 68 (5), 961-976. DOI: 10.1016 / J.PCL.2021.05.004. | https://www.ncbi.nlm.nih.gov/pubmed/34538306 | |
924 | Gargano, J. W., Wallace, M., Hadler, S. C., Langley, G., Su, J. R., Oster, M. E. ,. . . Oliver, S. E. (2021). Uso de la vacuna contra MRNA COVID-19 después de informes de miocarditis entre los beneficiarios de la vacuna: actualización del Comité Asesor sobre Prácticas de Inmunización - Estados Unidos, de junio de 2021. MMWR MORB MORTAL WKLY REP, 70 (27), 977-982. DOI: 10.15585 / MMWR.MM7027E2. | https://www.ncbi.nlm.nih.gov/pubmed/34237049 | |
925 | Gatti, M., Raschi, E., Moretti, U., Ardizzoni, A., Poluzzi, E., y Diemberger, I. (2021). Vacunación contra la influenza y la myo-pericarditis en pacientes que reciben inhibidores de los puntos de control inmunitarios: investigando la probabilidad de interacción a través del sistema de informes de eventos adversos de la vacuna y vigibase. Vacunas (Basilea), 9 (1). DOI: 10.3390 / vacunas9010019. | https://www.ncbi.nlm.nih.gov/pubmed/33406694 | |
926 | Gautam, N., Saluja, P., Fudim, M., Jambhekar, K., Pandey, T., & Al'aref, S. (2021). Una presentación tardía de la miocarditis inducida por vacunas COVID-19. CUREUS, 13 (9), E17890. DOI: 10.7759 / CUREUS.17890. | https://www.ncbi.nlm.nih.gov/pubmed/34660088 | |
927 | Gellad, W. F. (2021). Miocarditis después de la vacunación contra COVID-19. BMJ, 375, N3090. DOI: 10.1136 / BMJ.N3090. | https://www.ncbi.nlm.nih.gov/pubmed/34916217 | |
928 | Greenhawt, M., Abrams, E. M., Shaker, M., Chu, D. K., Khan, D., Akin, C. ,. . . Golden, D. B. K. (2021). El riesgo de reacción alérgica a las vacunas SARS-COV-2 y la evaluación y gestión recomendadas: una revisión sistemática, el metanálisis, la evaluación de grado y el enfoque de consenso internacional. J Allergy Clin Immunol Pract, 9 (10), 3546-3567. DOI: 10.1016 / J.JAIP.2021.06.006. | https://www.ncbi.nlm.nih.gov/pubmed/34153517 | |
929 | Haaf, P., Kuster, G. M., Mueller, C., Berger, C. T., Monney, P., Hamburguesa, P. ,. . . Tanner, F. C. (2021). El riesgo muy bajo de miocarditis y pericarditis después de la vacunación con MRNA COVID-19 no debe desalentar la vacunación. Swiss Med Wkly, 151, W30087. DOI: 10.4414 / SMW.2021.W30087. | https://www.ncbi.nlm.nih.gov/pubmed/34668687 | |
930 | Hasnie, A. A., Hasnie, U. A., Patel, N., Aziz, M. U., Xie, M., Lloyd, S. G. & Prabhu, S. D. (2021). La perimyocarditis después de la primera dosis de la vacuna contra el MRNA-1273 SARS-COV-2 (MODERNA) en un hombre joven sano: un informe de caso. BMC Cardiovasc Disordas, 21 (1), 375. DOI: 10.1186 / S12872-021-02183-3. | https://www.ncbi.nlm.nih.gov/pubmed/34348657 | |
931 | Hause, A. M., Gee, J., Baggs, J., Abara, W. E., Márquez, P., Thompson, D. ,. . . Shay, D. K. (2021). COVID-19 Seguridad de la vacuna en adolescentes de 12 a 17 años - Estados Unidos, 14 de diciembre, 2020-16 de julio de 2021. MMWR MORB MORTAL WKLY REP, 70 (31), 1053-1058. DOI: 10.15585 / MMWR.MM7031E1. | https://www.ncbi.nlm.nih.gov/pubmed/34351881 | |
932 | Helms, J. M., Ansteatt, K. T., Roberts, J. C., Kamatam, S., FOONG, K. S., Labayog, J. S., & Tarantino, M. D. (2021). Trombocitopenia inmune severa, refractaria que se produce después de la vacuna contra SARS-COV-2. J Blood Med, 12, 221-224. DOI: 10.2147 / JBM.S307047. | https://www.ncbi.nlm.nih.gov/pubmed/33854395 | |
933 | Hippisley-Cox, J., Patone, M., Mei, X. W., Saatci, D., Dixon, S., Khunti, K.,. . . Coupland, C. A. C. (2021). Riesgo de trombocitopenia y tromboembolismo después de la vacunación de COVID-19 y pruebas positivas SARS-COV-2: Estudio de series de casos autocontroladas. BMJ, 374, N1931. DOI: 10.1136 / BMJ.N1931. | https://www.ncbi.nlm.nih.gov/pubmed/34446426 | |
934 | Ho, J. S., SIA, C. H., Ngiam, J. N., LOH, P. H., Masticar, N. W., Kong, W. K., & Poh, K. K. (2021). Una revisión de la vacunación COVID-19 y las manifestaciones cardíacas reportadas. Singapur Med J. DOI: 10.11622 / Smedj.2021210. | https://www.ncbi.nlm.nih.gov/pubmed/34808708 | |
935 | Iguchi, T., Umeda, H., Kojima, M., Kanno, Y., Tanaka, Y., Kinoshita, N., & Sato, D. (2021). Información acumulativa de eventos adversos de la anafilaxia Después de las inyecciones de vacuna contra MRNA COVID-19 (PFIZER-BIONTECH) en Japón: el informe del primer mes. Drogas SAF, 44 (11), 1209-1214. DOI: 10.1007 / S40264-021-01104-9. | https://www.ncbi.nlm.nih.gov/pubmed/34347278 | |
936 | En breve: miocarditis con las vacunas Pfizer / Biontech y Moderna Covid-19. (2021). Med Lett drogas, 63 (1629), E9. Recuperado de | https://www.ncbi.nlm.nih.gov/pubmed/34544112 | |
937 | Ioannou, A. (2021a). La miocarditis debe considerarse en aquellos con un aumento de troponina y las arterias coronarias sin obstrucciones después de la vacunación de PFIZE-BIONTECH COVID-19. Qjm. DOI: 10.1093 / QJMED / HCAB231. | https://www.ncbi.nlm.nih.gov/pubmed/34463755 | |
938 | Ioannou, A. (2021b). La asignación de T2 debe utilizarse en casos de miocarditis sospechada para confirmar un proceso inflamatorio agudo. Qjm. DOI: 10.1093 / QJMED / HCAB326. | https://www.ncbi.nlm.nih.gov/pubmed/34931681 | |
939 | Isaak, A., Feisst, A., & Luetkens, J. A. (2021). Miocarditis después de la vacunación de COVID-19. Radiología, 301 (1), E378-E379. DOI: 10.1148 / Radiol.2021211766. | https://www.ncbi.nlm.nih.gov/pubmed/34342500 | |
940 | Istammoulouoglou, I., Dimitriou, G., Spani, S., Cristo, A., Zimmermanns, B., Koechlin, S.,. . . Leuppi-Taegtmeyer, A. B. (2021). Miocarditis y pericarditis en asociación con COVID-19 MRNA-vacunación: casos de un centro de farmacovigilancia regional. Glob Cardiol SCI practica, 2021 (3), E202118. DOI: 10.21542 / GCSP.2021.18. | https://www.ncbi.nlm.nih.gov/pubmed/34805376 | |
941 | Jaafar, R., Boschi, C., Aherfi, S., Bancod, A., Le Bideau, M., Edouard, S.,. . . LA SCOLA, B. (2021). Alta heterogeneidad individual de actividades neutralizantes contra la cepa original y nueve variantes diferentes de SARS-COV-2. Virus, 13 (11). DOI: 10.3390 / V13112177. | https://www.ncbi.nlm.nih.gov/pubmed/34834983 | |
942 | Jain, S. S., Steele, J. M., Fonseca, B., Huang, S., Shah, S., Maskatia, S. A.. . . Grosse-Wortmann, L. (2021). COVID-19 miocarditis asociada a la vacunación en adolescentes. Pediatría, 148 (5). DOI: 10.1542 / PEDS.2021-053427. | https://www.ncbi.nlm.nih.gov/pubmed/34389692 | |
943 | JHHAVERI, R., Adler-Shohet, F. C., Blyth, C. C., Chiotos, K., Gerber, J. S., Green, M. ,. . . Zaoutis, T. (2021). Pesando los riesgos de la perimyocarditis con los beneficios de la vacunación del ARNm de SARS-COV-2 en adolescentes. J Pediatric Infect DIS SOC, 10 (10), 937-939. DOI: 10.1093 / JPIDS / PIUP061. | https://www.ncbi.nlm.nih.gov/pubmed/34270752 | |
944 | Kaneta, K., Yokoi, K., Jojima, K., Kotooka, N., & Nodo, K. (2021). Hombre joven con miocarditis después de la vacunación con MRNA-1273 contra la enfermedad de Coronavirus-2019 (COVID-19). Circl J. DOI: 10.1253 / CIRCJ.CJ-21-0818. | https://www.ncbi.nlm.nih.gov/pubmed/34744118 | |
945 | Kaul, R., Sreenivasan, J., Goel, A., Malik, A., Bandyopadhyay, D., Jin, C. ,. . . Panza, J. A. (2021). Miocarditis después de la vacunación de COVID-19. INT J Cardiol Heart Vasc, 36, 100872. DOI: 10.1016 / J.ijcha.2021.100872. | https://www.ncbi.nlm.nih.gov/pubmed/34568540 | |
946 | Khogali, F., & Abdelrahman, R. (2021). Presentación inusual de perimyocarditis aguda después de la vacunación MODERA MODINA DE MRNA-1237 SARS-COV-2. CUREUS, 13 (7), E16590. DOI: 10.7759 / CUREUS.16590. | https://www.ncbi.nlm.nih.gov/pubmed/34447639 | |
947 | Kim, H. W., Jenista, E. R., Wendell, D. C., Azevedo, C. F., Campbell, M. J., Darty, S. N. ,. . . Kim, R. J. (2021). Pacientes con miocarditis aguda después de la vacunación con MRNA COVID-19. JAMA CARDIOL, 6 (10), 1196-1201. DOI: 10.1001 / Jamacardio.2021.2828. | https://www.ncbi.nlm.nih.gov/pubmed/34185046 | |
948 | Kim, I. C., Kim, H., Lee, H. J., Kim, J. Y., & Kim, J. Y. (2021). Imágenes cardiacas de miocarditis aguda después de la vacunación de ARNm Covid-19. J Korean Med SCI, 36 (32), E229. DOI: 10.3346 / jkms.2021.36.e229. | https://www.ncbi.nlm.nih.gov/pubmed/34402228 | |
949 | King, W. W., Petersen, M. R., Matar, R. M., Buda, J. B., CUERVO PARDO, L., Y PETERSEN, J. W. (2021). Miocarditis después de la vacunación con ARNm contra SARS-COV-2, una serie de casos. Am Heart J Plus, 8, 100042. DOI: 10.1016 / J.AHJO.2021.100042. | https://www.ncbi.nlm.nih.gov/pubmed/34396358 | |
950 | Klein, N. P., Lewis, N., Goddard, K., Bomber, B., Zerbo, O., Hanson, K. E. ,. . . Weintraub, E. S. (2021). Vigilancia para eventos adversos después de la vacunación con ARNm Covid-19. JAMA, 326 (14), 1390-1399. DOI: 10.1001 / JAMA.2021.15072. | https://www.ncbi.nlm.nih.gov/pubmed/34477808 | |
951 | Klimek, L., Bergmann, K. C., Brehler, R., Pfutzner, W., Zuberbier, T., Hartmann, K.,. . . Gusano, M. (2021). Manejo práctico de reacciones alérgicas a COVID-19 Vacunas: un artículo de posición de las sociedades alergias alemanas y austriacas Aeda, Dgaki, GPA y OGAI. AllerGo J Int, 1-17. DOI: 10.1007 / S40629-021-00165-7. | https://www.ncbi.nlm.nih.gov/pubmed/33898162 | |
952 | Klimek, L., Novak, N., Hamelmann, E., Werfel, T., Wagenmann, M., Taube, C. ,. . . Gusano, M. (2021). Reacciones alérgicas severas después de la vacunación de COVID-19 con la vacuna PFIVE / BIONTECH en Gran Bretaña y EE. UU.: Declaración de posición de las sociedades alérgicas alemanas: Asociación Médica de Alergólogos alemanes (AEDA), Sociedad Alemana de Alergología y Inmunología Clínica (Dgaki) y sociedad para Alergología pediátrica y medicina ambiental (GPA). AllerGo J Int, 30 (2), 51-55. DOI: 10.1007 / S40629-020-00160-4. | https://www.ncbi.nlm.nih.gov/pubmed/33643776 | |
953 | Kohli, U., Desai, L., Chowdhury, D., Harahsheh, A. S., YETS, A. B., Ansong, A. ,. . . Ang, J. Y. (2021). MRNA Coronavirus-19 Myopericarditis asociada a la vacuna en adolescentes: un estudio de encuesta. J pediatr. DOI: 10.1016 / J.JPEDS.2021.12.025. | https://www.ncbi.nlm.nih.gov/pubmed/34952008 | |
954 | Kostoff, R. N., Calina, D., Kanduc, D., Briggs, M. B., Vlachoyiannopoulos, P., Svistunov, A. A. A., y Tsatsakis, A. (2021a). Errratum a "¿Por qué estamos vacunando a los niños contra COVID-19?" [Toxicol. Rep. 8c (2021) 1665-1684 / 1193]. Toxicol Rep, 8, 1981. DOI: 10.1016 / J.TOXREP.2021.10.003. | https://www.ncbi.nlm.nih.gov/pubmed/34642628 | |
955 | Kostoff, R. N., Calina, D., Kanduc, D., Briggs, M. B., Vlachoyiannopoulos, P., Svistunov, A. A. A. A., y Tsatsakis, A. (2021b). ¿Por qué estamos vacunando a los niños contra COVID-19? Toxicol Rep, 8, 1665-1684. DOI: 10.1016 / J.TOXREP.2021.08.010. | https://www.ncbi.nlm.nih.gov/pubmed/34540594 | |
956 | Kremsner, P. G., Mann, P., Koidl, A., Leroux-Roels, I., Schindler, C., Gabor, J. J.,. . . Grupo, c.-n.-. (2021). Seguridad e inmunogenicidad de un candidato de vacuna contra nanopartículas de ARNm-lipid contra SARS-COV-2: un ensayo clínico aleatorizado de la Fase 1. Wien Klin Wochenschr, 133 (17-18), 931-941. DOI: 10.1007 / S00508-021-01922-Y. | https://www.ncbi.nlm.nih.gov/pubmed/34378087 | |
957 | Kustin, T., Harel, N., Finkel, U., Perchik, S., Harari, S., Tahor, M. ,. . . Stern, A. (2021). Evidencia de aumento de las tasas de avance de las variantes de preocupación SARS-COV-2 en los individuos BNT162B2-MRNA-vacunados. NAT MED, 27 (8), 1379-1384. DOI: 10.1038 / S41591-021-01413-7. | https://www.ncbi.nlm.nih.gov/pubmed/34127854 | |
958 | Kwan, M. Y. W., Chua, G. T., Chow, C. B., TSAO, S. S. L., a, K. K. W., Yuen, K. Y.,. . . IP, P. (2021). MRNA covid vacuna y miocarditis en adolescentes. Hong Kong Med J, 27 (5), 326-327. DOI: 10.12809 / HKMJ215120. | https://www.ncbi.nlm.nih.gov/pubmed/34393110 | |
959 | Lee, E., Masticar, N. W. S., NG, P., & YEO, T. J. (2021). Responder a "Carta al editor: La miocarditis debe considerarse en aquellos con un aumento de troponina y las arterias coronarias sin obstrucciones después de la vacunación de PfizerbionTech COVID-19". Qjm. DOI: 10.1093 / QJMED / HCAB232. | https://www.ncbi.nlm.nih.gov/pubmed/34463770 | |
960 | Lee, E. J., Cines, D. B., GERNSHEIMER, T., Kessler, C., Michel, M., Tarantino, M. D. ,. . . Bussel, J. B. (2021). Trombocitopenia después de Pfizer y Moderna SARS-COV-2 vacunación. Am J Hematol, 96 (5), 534-537. DOI: 10.1002 / AJH.26132. | https://www.ncbi.nlm.nih.gov/pubmed/33606296 | |
961 | Levin, D., Shimon, G., Fadlon-Derai, M., Gershovitz, L., Shovali, A., Sebbag, A. ,. . . Gordon, B. (2021). Miocarditis después de la vacunación COVID-19 - una serie de casos. Vacuna, 39 (42), 6195-6200. DOI: 10.1016 / J.Vaccine.2021.09.004. | https://www.ncbi.nlm.nih.gov/pubmed/34535317 | |
962 | Li, J., Hui, A., Zhang, X., Yang, Y., Tang, R., YE, H. ,. . . Zhu, F. (2021). Seguridad e inmunogenicidad de la vacuna contra el ARNA SARS-COV-2 BNT162B1 en adultos chinos más jóvenes y mayores: un estudio de fase 1 aleatorizado, controlado por placebo. NAT MED, 27 (6), 1062-1070. DOI: 10.1038 / S41591-021-01330-9. | https://www.ncbi.nlm.nih.gov/pubmed/33888900 | |
963 | Li, M., Yuan, J., LV, G., Brown, J., Jiang, X., & Lu, Z. K. (2021). Miocarditis y pericarditis después de la vacunación COVID-19: desigualdades en la edad y los tipos de vacunas. J pers med, 11 (11). DOI: 10.3390 / JPM11111106. | https://www.ncbi.nlm.nih.gov/pubmed/34834458 | |
964 | Lim, Y., Kim, M. C., Kim, K. H., Jeong, I. S., CHO, Y. S., Choi, Y. D., & Lee, J. E. (2021). Informe de caso: miocarditis fulminante aguda y shock cardiogénico después del mensajero ARN CORONAVIRUS Enfermedad 2019 Vacunación que requiere la reanimación cardiopulmonar extracorpórea. Frente Cardiovasc Med, 8, 758996. DOI: 10.3389 / FCVM.2021.758996. | https://www.ncbi.nlm.nih.gov/pubmed/34778411 | |
965 | Largo, S. S. (2021). Perspectivas importantes en la miopericaditis después de la vacunación contra los ARNm COVID-19 de Pfizer en adolescentes. J Pediatr, 238, 5. DOI: 10.1016 / J.JPEDS.2021.07.057. | https://www.ncbi.nlm.nih.gov/pubmed/34332972 | |
966 | Luk, A., Clarke, B., Dahdah, N., Ducharme, A., Krahn, A., McCrindle, B. ,. . . McDonald, M. (2021). Miocarditis y pericarditis después de la vacunación con ARNm de COVID-19: consideraciones prácticas para los proveedores de atención. Can J Cardiol, 37 (10), 1629-1634. DOI: 10.1016 / J.CJCA.2021.08.001. | https://www.ncbi.nlm.nih.gov/pubmed/34375696 | |
967 | Madelon, N., Lauper, K., Breville, G., Sabater Royo, I., Goldstein, R., Andrey, D. O.,. . . Eberhardt, C. S. (2021). Robustas respuestas de células T en pacientes tratados con anti-CD20 después de la vacunación de COVID-19: un estudio prospectivo de cohorte. Clin infectan dis. DOI: 10.1093 / CID / CIAB954. | https://www.ncbi.nlm.nih.gov/pubmed/34791081 | |
968 | Mangat, C., & Milosavljevic, N. (2021). BNT162B2 La vacunación durante el embarazo protege a la madre y el infante: anticuerpos anti-SARS-COV-2 S persistentemente positivos en un bebé a los 6 meses de edad. Pediatr, 2021, 6901131. DOI: 10.1155 / 2021/6901131. | https://www.ncbi.nlm.nih.gov/pubmed/34676123 | |
969 | Mark, C., Gupta, S., Punnett, A., Upton, J., Orkin, J., Atkinson, A. ,. . . Alexander, S. (2021). Seguridad de la administración de ARNm de BNT162B2 (Pfizer-BIONTECH) COVID-19 Vacuna en jóvenes y adultos jóvenes con antecedentes de leucemia linfoblástica aguda y alergia a PEG-APARAGINASA. Cáncer de sangre de pediatr, 68 (11), E29295. DOI: 10.1002 / PBC.29295. | https://www.ncbi.nlm.nih.gov/pubmed/34398511 | |
970 | Martins-Filho, P. R., Quintans-Junior, L. J., de Souza Araujo, A. A. A. A., Sposato, K. B., Souza Tavares, C. S., Gurgel, R. P. ,. . . SANTOS, V. S. (2021). Desigualdades socioeconómicas y incidencia y mortalidad de COVID-19 en niños brasileños: un estudio de registro nacional en todo el país. Salud pública, 190, 4-6. DOI: 10.1016 / J.Puhe.2020.11.005. | https://www.ncbi.nlm.nih.gov/pubmed/33316478 | |
971 | McLean, K., & Johnson, T. J. (2021). Myopericarditis en un macho adolescente previamente saludable después de la vacunación COVID-19: un informe de caso. Acad Emerg Med, 28 (8), 918-921. DOI: 10.1111 / ACEM.14322. | https://www.ncbi.nlm.nih.gov/pubmed/34133825 | |
972 | Mevorach, D., Anis, E., Cedar, N., Bromberg, M., Haas, E. J., Nadir, E. ,. . . Alroy-Preis, S. (2021). Miocarditis después de la vacuna contra el ARNA BNT162B2 contra COVID-19 en Israel. N Engl J Med, 385 (23), 2140-2149. DOI: 10.1056 / NEJMOA2109730. | https://www.ncbi.nlm.nih.gov/pubmed/34614328 | |
973 | Minocha, P. K., mejor, D., Singh, R. K., & Hoque, T. (2021). La recurrencia de miocarditis aguda está temporalmente asociada con la recepción de la vacuna contra la enfermedad de ARNm Coronavirus (COVID-19) en un adolescente masculino. J Pediatr, 238, 321-323. DOI: 10.1016 / J.JPEDS.2021.06.035. | https://www.ncbi.nlm.nih.gov/pubmed/34166671 | |
974 | Mizrahi, B., Lotan, R., Kalkstein, N., Peretz, A., Pérez, G., Ben-Tov, A. ,. . . Patalon, T. (2021). Correlación de las infecciones de SARS-COV-2-Breakthroughth a tiempo de vacuna. NAT Commun, 12 (1), 6379. DOI: 10.1038 / S41467-021-26672-3. | https://www.ncbi.nlm.nih.gov/pubmed/34737312 | |
975 | Moffitt, K., Cheung, E., Yeung, T., Stamoulis, C., & Malley, R. (2021). Análisis de Stafylococcus aureus Transcriptoma en abscesos de tejidos blandos pediátricos y comparación con infecciones murinas. Infectar inmun, 89 (4). DOI: 10.1128 / IAI.00715-20. | https://www.ncbi.nlm.nih.gov/pubmed/33526560 | |
976 | Mohamed, L., Madsen, A. M. R., Schaltz-Buchholzer, F., Ostenfeld, A., Netea, M. G., Benn, C. S. y Kofoed, P. E. (2021). Reactivación de las cicatrices de vacunación BCG después de la vacunación con las vacunas con ARNm-covid: dos informes de casos. BMC Infect DIS, 21 (1), 1264. DOI: 10.1186 / S12879-021-06949-0. | https://www.ncbi.nlm.nih.gov/pubmed/34930152 | |
977 | Montgomery, J., Ryan, M., Engler, R., Hoffman, D., McClenathan, B., Collins, L. ,. . . Cooper, L. T., Jr. (2021). La miocarditis después de la inmunización con las vacunas con MRNA COVID-19 en miembros del ejército estadounidense. JAMA CARDIOL, 6 (10), 1202-1206. DOI: 10.1001 / JAMACARDIO.2021.2833. | https://www.ncbi.nlm.nih.gov/pubmed/34185045 | |
978 | Murakami, Y., Shinohara, M., Oka, Y., Wada, R., Noike, R., OHARA, H. ,. . . Ikeda, T. (2021). Miocarditis después de una vacunación de ARN de COVID-19 Messenger: una serie de casos japoneses. Pasante med. DOI: 10.2169 / internalmedicine.8731-21. | https://www.ncbi.nlm.nih.gov/pubmed/34840235 | |
979 | Nagasaka, T., Koitabashi, N., Ishibashi, Y., Aihara, K., Takama, N., Ohyama, Y.,. . . Kaneko, Y. (2021). Miocarditis aguda asociada a la vacunación COVID-19: un informe de caso. J Cardiol Casos. DOI: 10.1016 / J.JCCase.2021.11.006. | https://www.ncbi.nlm.nih.gov/pubmed/34876937 | |
980 | Ntouros, P. A., Vlachogiannis, N. I., Pappa, M., Nezos, A., Mavragani, C. P., Tektonidou, M. G. ,. . . SFIKAKIS, P. P. (2021). Respuesta efectiva del daño del ADN después de un desafío inmunológico agudo pero no crónico: vacuna contra el SARS-COV-2 versus lupus eritematoso sistémico. Clin Immunol, 229, 108765. DOI: 10.1016 / J.Clim.2021.108765. | https://www.ncbi.nlm.nih.gov/pubmed/34089859 | |
981 | Nygaard, U., Holm, M., Bohnstedt, C., Chai, Q., Schmidt, L. S., Hartling, U. B. ,. . . Stensballe, L. G. (2022). Incidencia de miopericaditis basada en la población después de la vacunación de COVID-19 en adolescentes daneses. Pediatr Infect DIS J, 41 (1), E25-E28. DOI: 10.1097 / INF.0000000000003389. | https://www.ncbi.nlm.nih.gov/pubmed/34889875 | |
982 | Oberhardt, V., Luxenburger, H., Kemming, J., Schulien, I., Ciminski, K., Giese, S.,. . . Hofmann, M. (2021). Movilización rápida y estable de células T CD8 (+) T mediante vacuna contra ARNm de SARS-COV-2. Naturaleza, 597 (7875), 268-273. DOI: 10.1038 / S41586-021-03841-4. | https://www.ncbi.nlm.nih.gov/pubmed/34320609 | |
983 | Parque, H., Yun, K. W., Kim, K. R., Canción, S. H., Ahn, B., Kim, D. R. ,. . . Kim, Y. J. (2021). Epidemiología y características clínicas de miocarditis / pericarditis Antes de la introducción de la vacuna contra MRNA COVID-19 en niños coreanos: un estudio multicéntrico. J Korean Med SCI, 36 (32), E232. DOI: 10.3346 / jkms.2021.36.e232. | https://www.ncbi.nlm.nih.gov/pubmed/34402230 | |
984 | Park, J., Brekke, D. R., & Bratincsak, A. (2021). Miocarditis autolimitada que presenta con dolor en el pecho y elevación del segmento ST en adolescentes después de la vacunación con la vacuna contra el ARNm BNT162B2. Cardiol joven, 1-4. DOI: 10.1017 / S1047951121002547. | https://www.ncbi.nlm.nih.gov/pubmed/34180390 | |
985 | PATEL, Y. R., LOUIS, D. W., ATALAY, M., Agarwal, S., & Shah, N. R. (2021). Hallazgos de resonancia magnética cardiovascular en pacientes adultos jóvenes con miocarditis aguda después de la vacunación con MRNA COVID-19: una serie de casos. J Cardiovasc Amply Reson, 23 (1), 101. DOI: 10.1186 / S12968-021-00795-4. | https://www.ncbi.nlm.nih.gov/pubmed/34496880 | |
986 | Patone, M., Mei, X. W., HandunNetthi, L., Dixon, S., Zaccardi, F., Shankar-Hari, M.,. . . Hippisley-Cox, J. (2021). Riesgos de miocarditis, pericarditis y arritmias cardíacas asociadas con la vacunación de COVID-19 o la infección SARS-COV-2. Nat med. DOI: 10.1038 / S41591-021-01630-0. | https://www.ncbi.nlm.nih.gov/pubmed/34907393 | |
987 | Patrignani, A., Schicchi, N., Calcagnoli, F., Falchetti, E., Ciampani, N., Argalia, G. y Mariani, A. (2021). Miocarditis aguda después de la vacunación contra la comilería en un hombre sano con la infección previa de SARS-COV-2. Representante de la caja Radiol, 16 (11), 3321-3325. DOI: 10.1016 / J.RADCR.2021.07.082. | https://www.ncbi.nlm.nih.gov/pubmed/34367386 | |
988 | Pérez, Y., Levy, E. R., Joshi, A. Y., VIRK, A., Rodríguez-Porcel, M., Johnson, M. ,. . . SWIFT, M. D. (2021). Miocarditis después de la vacuna contra el ARNA COVID-19: una serie de casos y determinación de la tasa de incidencia. Clin infectan dis. DOI: 10.1093 / CID / CIAB926. | https://www.ncbi.nlm.nih.gov/pubmed/34734240 | |
989 | Perrotta, A., Biondi-ZOCS, G., Saade, W., Miraldi, F., Morelli, A., Marullo, A. G. ,. . . Peruzzi, M. (2021). Una encuesta global de instantáneas sobre los efectos secundarios de las vacunas COVID-19 entre profesionales de la salud y fuerzas armadas con un enfoque en el dolor de cabeza. PANMINERVA MED, 63 (3), 324-331. DOI: 10.23736 / S0031-0808.21.04435-9. | https://www.ncbi.nlm.nih.gov/pubmed/34738774 | |
990 | Pinana, J. L., López-Corral, L., Martino, R., Montoro, J., Vázquez, L., Pérez, A. ,. . . Terapia celular, G. (2022). Detección de anticuerpos reactivos de SARS-COV-2 después de la vacunación contra SARS-COV-2 en los receptores de trasplantes de células madre hematopoyéticos: estudio prospectivo del trasplante de células madre hematopoyéticas español y grupo de terapia celular. Am J Hematol, 97 (1), 30-42. DOI: 10.1002 / AJH.26385. | https://www.ncbi.nlm.nih.gov/pubmed/34695229 | |
991 | Revon-Riviere, G., Ninove, L., Min, V., Roma, A., Juzzería, C., Vershuur, A. ,. . . Andre, N. (2021). El MRNA BNT162B2 COVID-19 Vacuna en adolescentes y adultos jóvenes con cáncer: una experiencia monocéntrica. EUR J CANCER, 154, 30-34. DOI: 10.1016 / J.EJCA.2021.06.002. | https://www.ncbi.nlm.nih.gov/pubmed/34233234 | |
992 | Sánchez Tijmes, F., Thavendiranathan, P., Udell, J. A., Seidman, M. A., & Hanneman, K. (2021). Evaluación de la MRI cardíaca de la inflamación miocárdica no seleccionada: Revisión de vanguardia y actualización sobre la miocarditis asociada con la vacunación COVID-19. Radiol Cardiothorac Imaging, 3 (6), E210252. DOI: 10.1148 / RYCT.210252. | https://www.ncbi.nlm.nih.gov/pubmed/34934954 | |
993 | Schauer, J., Buddhe, S., Colyer, J., Sagiv, E., Ley, Y., Mallenahalli Chikkabyrappa, S., & Portman, M. A. (2021). Myopericarditis después de la vacuna contra las enfermedades del ácido ribonucleirus de ácido ribonucleico del Messenger Ribonucleico en adolescentes. J Pediatr, 238, 317-320. DOI: 10.1016 / J.JPEDS.2021.06.083. | https://www.ncbi.nlm.nih.gov/pubmed/34228985 | |
994 | Schneider, J., Sottmann, L., Greinacher, A., Hagen, M., Kasper, H. U., Kuhnen, C. ,. . . Schmeling, A. (2021). Postmortem Investigación de muertes después de la vacunación con vacunas COVID-19. Int j medicina legal, 135 (6), 2335-2345. DOI: 10.1007 / S00414-021-02706-9. | https://www.ncbi.nlm.nih.gov/pubmed/34591186 | |
995 | Schramm, R., costard-backle, A., Rivinius, R., Fischer, B., Muller, B., Boeken, U.,. . . Gummert, J. (2021). Pobre respuesta humoral y de células T a dos dosis SARS-COV-2 Messenger ARN Vaccine BNT162B2 en receptores de trasplantes cardiotorácicos. Clin RES Cardiol, 110 (8), 1142-1149. DOI: 10.1007 / S00392-021-01880-5. | https://www.ncbi.nlm.nih.gov/pubmed/34241676 | |
996 | Sessa, F., Salerno, M., Esposito, M., Di Nunno, N., Zamboni, P., & Pomara, C. (2021). Hallazgos de autopsia y relación de causalidad entre la muerte y la vacunación de COVID-19: una revisión sistemática. J Clin Med, 10 (24). DOI: 10.3390 / JCM10245876. | https://www.ncbi.nlm.nih.gov/pubmed/34945172 | |
997 | Sharif, N., Alzahrani, K. J., Ahmed, S. N., & Dey, S. K. (2021). Eficacia, inmunogenicidad y seguridad de las vacunas COVID-19: una revisión sistemática y un metanálisis. Inmunol delantero, 12, 714170. DOI: 10.3389 / FIMMU.2021.714170. | https://www.ncbi.nlm.nih.gov/pubmed/34707602 | |
998 | Shay, D. K., Gee, J., Su, J. R., Myers, T. R., Márquez, P., Liu, R.,. . . Shimabukuro, T. T. (2021). Monitoreo de seguridad de Janssen (Johnson & Johnson) COVID-19 Vaccine - Estados Unidos, marzo-abril 2021. MMWR MORB MORTAL WKLY REP, 70 (18), 680-684. DOI: 10.15585 / MMWR.MM7018E2. | https://www.ncbi.nlm.nih.gov/pubmed/33956784 | |
999 | SHAZLEY, O., & ALSHAZLEY, M. (2021). Un hombre covid positivo de 52 años presentó un tromboembolismo venoso y la coagulación intravascular diseminada después de la vacunación de Johnson & Johnson: un estudio de caso. CUREUS, 13 (7), E16383. DOI: 10.7759 / CUREUS.16383. | https://www.ncbi.nlm.nih.gov/pubmed/34408937 | |
1000 | Shiyovich, A., Witberg, G., Aviv, Y., Eisen, A., Orvin, K., Wiessman, M. ,. . . Hamdan, A. (2021). Miocarditis después de la vacunación de COVID-19: estudio de imágenes de resonancia magnética. EUR HEART J CARDIOVASC imágenes. DOI: 10.1093 / EHJCI / JEAB230. | https://www.ncbi.nlm.nih.gov/pubmed/34739045 | |
1001 | Simone, A., Herald, J., Chen, A., Gulati, N., Shen, A. Y., Lewin, B., & Lee, M. S. (2021). Miocarditis aguda después de la vacunación con ARNm de COVID-19 en adultos de 18 años o más. JAMA INTERN MED, 181 (12), 1668-1670. DOI: 10.1001 / JAMAINTERNMED.2021.5511. | https://www.ncbi.nlm.nih.gov/pubmed/34605853 | |
1002 | Cantante, M. E., Taub, I. B., & Kaelber, D. C. (2021). Riesgo de miocarditis de la infección de COVID-19 en personas menores de 20 años: un análisis basado en la población. medrxiv. DOI: 10.1101 / 2021.07.23.21260998. | https://www.ncbi.nlm.nih.gov/pubmed/34341797 | |
1003 | Smith, C., impar, D., Harwood, R., Ward, J., Linney, M., Clark, M. ,. . . Fraser, L. K. (2021). Muertes en niños y jóvenes en Inglaterra después de la infección por SARS-COV-2 durante el primer año pandémico. Nat med. DOI: 10.1038 / S41591-021-01578-1. | https://www.ncbi.nlm.nih.gov/pubmed/34764489 | |
1004 | Snapiri, O., Rosenberg Danziger, C., Shirman, N., Weissbach, A., Lowenthal, A., Ayalon, I.,. . . BILAVSKY, E. (2021). Lesión cardíaca transitoria en adolescentes que reciben la vacuna BNT162B2 MRNA COVID-19. Pediatr Infect DIS J, 40 (10), E360-E363. DOI: 10.1097 / INF.0000000000003235. | https://www.ncbi.nlm.nih.gov/pubmed/34077949 | |
1005 | Spinner, J. A., Julien, C. L., Olayinka, L., Dreyer, W. J., Bocchini, C. E., Muñoz, F. M., & Devaraj, S. (2021). Los anticuerpos anti-spike SARS-COV-2 después de la vacunación en el trasplante de corazón pediátrico: un primer informe. J corazón de trasplante pulmonar. DOI: 10.1016 / J.HEALUN.2021.11.001. | https://www.ncbi.nlm.nih.gov/pubmed/34911654 | |
1006 | Starekova, J., Bluemke, D. A., Bradham, W. S., Grist, T. M., Schiebler, M. L., & Reeder, S. B. (2021). Miocarditis asociada con la vacunación con ARNm Covid-19. Radiología, 301 (2), E409-E411. DOI: 10.1148 / Radiol.2021211430. | https://www.ncbi.nlm.nih.gov/pubmed/34282971 | |
1007 | Sulemankhil, I., Abdelrahman, M., & Negi, S. I. (2021). Asociación temporal entre la vacuna COVID-19 AD26.COV2.S y la miocarditis aguda: un informe de caso y una revisión de la literatura. Cardiovasc revasc Med. DOI: 10.1016 / J.CARREV.2021.08.012. | https://www.ncbi.nlm.nih.gov/pubmed/34420869 | |
1008 | Sastre, P. D., Feightery, A. M., El-Sabawi, B., & Prasad, A. (2021). Informe de caso: miocarditis aguda después de la segunda dosis de vacuna contra MRNA-1273 SARS-COV-2. EUR HEART J REP, 5 (8), YTAB319. DOI: 10.1093 / EHJCR / YTAB319. | https://www.ncbi.nlm.nih.gov/pubmed/34514306 | |
1009 | Takeda, M., Ishio, N., SHOJI, T., MORI, N., MATSUMOTO, M., Y SHIKAMA, N. (2021). Miocarditis eosinofílica después de la enfermedad de la enfermedad de Coronavirus 2019 (COVID-19) vacunación. Circl J. DOI: 10.1253 / CIRCJ.CJ-21-0935. | https://www.ncbi.nlm.nih.gov/pubmed/34955479 | |
1010 | Equipo, C. C. C.-R., Alimentos y medicamentos, A. (2021). Reacciones alérgicas que incluyen anafilaxis después de la recepción de la primera dosis de Pfizer-Biontech COVID-19 Vaccine - Estados Unidos, diciembre 14-23, 2020. MMWR MORB MORTAL WKLY REP, 70 (2), 46-51. DOI: 10.15585 / MMWR.MM7002E1. | https://www.ncbi.nlm.nih.gov/pubmed/33444297 | |
1011 | Thompson, M. G., Burgess, J. L., Naleway, A. L., Tyner, H., Yoon, S. K., Meece, J. ,. . . Gaglani, M. (2021). Prevención y atenuación de COVID-19 con las vacunas BNT162B2 y MRNA-1273. N Engl J Med, 385 (4), 320-329. DOI: 10.1056 / NEJMOA2107058. | https://www.ncbi.nlm.nih.gov/pubmed/34192428 | |
1012 | TINOCO, M., Leite, S., Faria, B., Cardoso, S., Von Hefe, P., Dias, G. ,. . . Lourenco, A. (2021). Perimyocarditis después de la vacunación COVID-19. Clin Med Insights Cardiol, 15, 11795468211056634. DOI: 10.1177 / 11795468211056634. | https://www.ncbi.nlm.nih.gov/pubmed/34866957 | |
1013 | Truong, D. T., Dionne, A., Muniz, J. C., McHugh, K. E., Portman, M. A., Lambert, L. M.,. . . Newburger, J. W. (2021). La miocarditis clínica sospechada temporalmente relacionada con la vacunación de COVID-19 en adolescentes y adultos jóvenes. Circulación. DOI: 10.1161 / Circuulaha.121.056583. | https://www.ncbi.nlm.nih.gov/pubmed/34865500 | |
1014 | Tutor, A., UNIS, G., Ruiz, B., Bolaji, O. A., y Bob-Manuel, T. (2021). Espectro de cardiomiopatía sospechada debido a COVID-19: una serie de casos. CURT Probl Cardiol, 46 (10), 100926. DOI: 10.1016 / J.CPcardiol.2021.100926. | https://www.ncbi.nlm.nih.gov/pubmed/34311983 | |
1015 | Umei, T. C., Kishino, Y., Shiraishi, Y., Inohara, T., Yuasa, S., & Fukuda, K. (2021). La recurrencia de miopericaditis después de la vacunación con MRNA COVID-19 en un adolescente masculino. Cjc abierto. DOI: 10.1016 / J.CJCO.2021.12.002. | https://www.ncbi.nlm.nih.gov/pubmed/34904134 | |
1016 | Vidula, M. K., Ambrose, M., Glassberg, H., Chokshi, N., Chen, T., Ferrari, V. A., & Han, Y. (2021). Miocarditis y otras complicaciones cardiovasculares de las vacunas COVID-19 a base de ARNm. CUREUS, 13 (6), E15576. DOI: 10.7759 / CUREUS.15576. | https://www.ncbi.nlm.nih.gov/pubmed/34277198 | |
1017 | VISCLOSKY, T., ellosyunni, N., Klekowski, N., & Bradin, S. (2021). Miocarditis después de la vacuna contra MRNA COVID-19. Pediaatr Emerge Care, 37 (11), 583-584. DOI: 10.1097 / PEC.0000000000002557. | https://www.ncbi.nlm.nih.gov/pubmed/34731877 | |
1018 | Warren, C. M., Nieve, T. T., Lee, A. S., Shah, M. M., Heider, A., Blomkalns, A. ,. . . Nadeau, K. C. (2021). Evaluación de reacciones alérgicas y anafilácticas a las vacunas ARNm COVID-19 con pruebas confirmatorias en un sistema de salud regional de los EE. UU. JAMA NETW ABIERTO, 4 (9), E2125524. DOI: 10.1001 / JAMAnetworkopen.2021.25524. | https://www.ncbi.nlm.nih.gov/pubmed/34533570 | |
1019 | Watkins, K., Griffin, G., sepárico, K., & Simon, E. L. (2021). Miocarditis después de la vacunación por BNT162B2 en un hombre sano. AM J Emerg Med, 50, 815 E811-815 E812. DOI: 10.1016 / J.ajem.2021.06.051. | https://www.ncbi.nlm.nih.gov/pubmed/34229940 | |
1020 | Weitzman, E. R., Sherman, A. C., & Levy, O. (2021). Las actitudes de vacuna contra el ARNA de SARS-COV-2, según lo expresadas en los comentarios públicos de EE.UU. FDA: la necesidad de una asociación público-privada en un sistema de inmunización de aprendizaje. Frontal Salud Pública, 9, 695807. DOI: 10.3389 / FPUBH.2021.695807. | https://www.ncbi.nlm.nih.gov/pubmed/34336774 | |
1021 | Gales, K. J., Baumblatt, J., Chege, W., Goud, R., & Nair, N. (2021). La trombocitopenia, incluida la trombocitopenia inmune después de la recepción de las vacunas ARNm COVID-19 informadas al sistema de informes de eventos adversos de la vacuna (Vaers). Vacuna, 39 (25), 3329-3332. DOI: 10.1016 / J.Vaccine.2021.04.054. | https://www.ncbi.nlm.nih.gov/pubmed/34006408 | |
1022 | Witberg, G., Barda, N., Hoss, S., Richter, I., Wiessman, M., Aviv, Y.,. . . Kornowski, R. (2021). Miocarditis después de la vacunación de COVID-19 en una gran organización de atención médica. N Engl J Med, 385 (23), 2132-2139. DOI: 10.1056 / NEJMOA2110737. | https://www.ncbi.nlm.nih.gov/pubmed/34614329 | |
1023 | Zimmermann, P., & Curtis, N. (2020). ¿Por qué COVID-19 menos severo en los niños? Una revisión de los mecanismos propuestos que subyacen en la diferencia relacionada con la edad en la severidad de las infecciones por SARS-COV-2. Arco DIS NIÑO. DOI: 10.1136 / archdischild-2020-320338. | https://www.ncbi.nlm.nih.gov/pubmed/33262177 |
A | B | C | D | E | F | G | |
---|---|---|---|---|---|---|---|
1 | Source: https://brownstone.org/articles/more-than-400-studies-on-the-failure-of-compulsory-covid-interventions/ | ||||||
2 | Table 1: Evidence showing that COVID-19 lockdowns, use of face masks, school closures, and mask mandates were largely ineffective and caused crushing harms | ||||||
3 | Study/report title, author, and year published and interactive url link | Predominant study/evidence report finding | |||||
4 | LOCKDOWNS | ||||||
5 | 1) Lockdown Effects on Sars-CoV-2 Transmission – The evidence from Northern Jutland, Kepp, 2021 | “Analysis shows that while infection levels decreased, they did so before lockdown was effective, and infection numbers also decreased in neighbour municipalities without mandates…direct spill-over to neighbour municipalities or the simultaneous mass testing do not explain this…data suggest that efficient infection surveillance and voluntary compliance make full lockdowns unnecessary.” | |||||
6 | 2) A country level analysis measuring the impact of government actions, country preparedness and socioeconomic factors on COVID-19 mortality and related health outcomes, Chaudhry, 2020 | “Analysis was conducted to assess the impact of timing and type of national health policy/actions undertaken towards COVID-19 mortality and related health outcomes…low levels of national preparedness, scale of testing and population characteristics were associated with increased national case load and overall mortality….in our analysis, full lockdowns and wide-spread COVID-19 testing were not associated with reductions in the number of critical cases or overall mortality.” | |||||
7 | 3) Full lockdown policies in Western Europe countries have no evident impacts on the COVID-19 epidemic, Meunier, 2020 | “Extrapolating pre-lockdown growth rate trends, we provide estimates of the death toll in the absence of any lockdown policies, and show that these strategies might not have saved any life in western Europe. We also show that neighboring countries applying less restrictive social distancing measures (as opposed to police-enforced home containment) experience a very similar time evolution of the epidemic.” | |||||
8 | 4) Effects of non-pharmaceutical interventions on COVID-19: A Tale of Three Models, Chin, 2020 | “Inferences on effects of NPIs are non-robust and highly sensitive to model specification. Claimed benefits of lockdown appear grossly exaggerated.” | |||||
9 | 5) vvvlrNPIs). In this way, it may be possible to isolate the role of mrNPIs, net of lrNPIs and epidemic dynamics.Here, we use Sweden and South Korea as the counterfac-tuals to isolate the effects of mrNPIs in5) Assessing mandatory stay-at-home and business closure effects on the spread of COVID-19, Bendavid, 2020 | “Assessing mandatory stay-at-home and business closure effects on the spread of COVID-19…we do not find significant benefits on case growth of more restrictive NPIs. Similar reductions in case growth may be achievable with less-restrictive interventions.”“After subtracting the epidemic and lrNPI effects, we find no clear, significant beneficial effect of mrNPIs on case growth in any country.”“In the framework of this analysis, there is no evidence that more restrictive nonpharmaceutical interventions (‘lockdowns’) contributed substantially to bending the curve of new cases in England, France, Germany, Iran, Italy, the Netherlands, Spain or the United States in early 2020.” | |||||
10 | 6) Effect of school closures on mortality from coronavirus disease 2019: old and new predictions, Rice, 2020 | “We therefore conclude that the somewhat counterintuitive results that school closures lead to more deaths are a consequence of the addition of some interventions that suppress the first wave and failure to prioritise protection of the most vulnerable people.When the interventions are lifted, there is still a large population who are susceptible and a substantial number of people who are infected. This then leads to a second wave of infections that can result in more deaths, but later. Further lockdowns would lead to a repeating series of waves of infection unless herd immunity is achieved by vaccination, which is not considered in the model. A similar result is obtained in some of the scenarios involving general social distancing. For example, adding general social distancing to case isolation and household quarantine was also strongly associated with suppression of the infection during the intervention period, but then a second wave occurs that actually concerns a higher peak demand for ICU beds than for the equivalent scenario without general social distancing.” | |||||
11 | 7) Was Germany’s Corona Lockdown Necessary? Kuhbandner, 2020 | “Official data from Germany’s RKI agency suggest strongly that the spread of the corona virus in Germany receded autonomously, before any interventions become effective. Several reasons for such an autonomous decline have been suggested. One is that differences in host susceptibility and behavior can result in herd immunity at a relatively low prevalence level. Accounting for individual variation in susceptibility or exposure to the coronavirus yields a maximum of 17% to 20% of the population that needs to be infected to reach herd immunity, an estimate that is empirically supported by the cohort of the Diamond Princess cruise ship. Another reason is that seasonality may also play an important role in dissipation.” | |||||
12 | 8) A First Literature Review: Lockdowns Only Had a Small Effect on COVID-19, Herby, 2021 | “Lockdowns Only Had a Small Effect on COVID-19…studies which differentiate between the two types of behavioral change find that, on average, mandated behavioral changes accounts for only 9% (median: 0%) of the total effect on the growth of the pandemic stemming from behavioral changes. The remaining 91% (median: 100%) of the effect was due to voluntary behavioral changes.” | |||||
13 | 9) Trajectory of COVID-19 epidemic in Europe, Colombo, 2020 | “We show that relaxing the assumption of homogeneity to allow for individual variation in susceptibility or connectivity gives a model that has better fit to the data and more accurate 14-day forward prediction of mortality. Allowing for heterogeneity reduces the estimate of “counterfactual” deaths that would have occurred if there had been no interventions from 3.2 million to 262,000, implying that most of the slowing and reversal of COVID-19 mortality is explained by the build-up of herd immunity.” | |||||
14 | 10) Modeling social distancing strategies to prevent SARS-CoV2 spread in Israel- A Cost-effectiveness analysis, Shlomai, 2020 | “A national lockdown has a moderate advantage in saving lives with tremendous costs and possible overwhelming economic effects.” | |||||
15 | 11) Lockdowns and Closures vs COVID – 19: COVID Wins, Bhalla, 2020 | “As we have stressed throughout, a direct test of lockdowns on cases is the most appropriate test. This direct test is a before after test i.e. a comparison of what happened post lockdown versus what would have happened. Only for 15 out of 147 economies the lockdown “worked” in making infections lower; for more than a hundred countries, post lockdown estimate of infections was more than three times higher than the counter factual. This is not evidence of success – rather it is evidence of monumental failure of lockdown policy…“we also test, in some detail, the hypothesis that early lockdowns, and more stringent lockdowns, were effective in containing the virus. We find robust results for the opposite conclusion: later lockdowns performed better, and less stringent lockdowns achieved better outcomes.” “For the first time in human history, lockdowns were used as a strategy to counter the virus. While conventional wisdom, to date, has been that lockdowns were successful (ranging from mild to spectacular) we find not one piece of evidence supporting this claim.” | |||||
16 | 12) SARS-CoV-2 waves in Europe: A 2-stratum SEIRS model solution, Djaparidze, 2020 | “Found that 180-day of mandatory isolations to healthy <60 (i.e. schools and workplaces closed) produces more final deaths…e mandatory isolations have caused economic damages and since these enforced isolations were sub-optimal they involuntarily increased the risk of covid-19 disease-related damages.” | |||||
17 | 13) Government mandated lockdowns do not reduce Covid-19 deaths: implications for evaluating the stringent New Zealand response, Gibson, 2020 | “Lockdowns do not reduce Covid-19 deaths. This pattern is visible on each date that key lockdown decisions were made in New Zealand. The apparent ineffectiveness of lockdowns suggests that New Zealand suffered large economic costs for little benefit in terms of lives saved.” | |||||
18 | 14) Did Lockdown Work? An Economist’s Cross-Country Comparison, Bjørnskov, 2020 | “The lockdowns in most Western countries have thrown the world into the most severe recession since World War II and the most rapidly developing recession ever seen in mature market economies. They have also caused an erosion of fundamental rights and the separation of powers in a large part of the world as both democratic and autocratic regimes have misused their emergency powers and ignored constitutional limits to policy-making (Bjørnskov and Voigt, 2020). It is therefore important to evaluate whether and to which extent the lockdowns have worked as officially intended: to suppress the spread of the SARS-CoV-2 virus and prevent deaths associated with it. Comparing weekly mortality in 24 European countries, the findings in this paper suggest that more severe lockdown policies have not been associated with lower mortality. In other words, the lockdowns have not worked as intended.” | |||||
19 | 15) Inferring UK COVID-19 fatal infection trajectories from daily mortality data: were infections already in decline before the UK lockdowns ?, Wood, 2020 | “A Bayesian inverse problem approach applied to UK data on first wave Covid-19 deaths and the disease duration distribution suggests that fatal infections were in decline before full UK lockdown (24 March 2020), and that fatal infections in Sweden started to decline only a day or two later. An analysis of UK data using the model of Flaxman et al. (2020, Nature 584) gives the same result under relaxation of its prior assumptions on R.” | |||||
20 | 16) The 1illusory effects of non-pharmaceutical interventions on COVID-19 in Europe, Homburg, 2020 | “We show that their methods involve circular reasoning. The purported effects are pure artefacts, which contradict the data. Moreover, we demonstrate that the United Kingdom’s lockdown was both superfluous and ineffective.” | |||||
21 | 17) Child malnutrition and COVID-19: the time to act is now, Fore, 2020 | “The COVID-19 pandemic is undermining nutrition across the world, particularly in low-income and middle-income countries (LMICs). The worst consequences are borne by young children. Some of the strategies to respond to COVID-19—including physical distancing, school closures, trade restrictions, and country lockdowns—are impacting food systems by disrupting the production, transportation, and sale of nutritious, fresh, and affordable foods, forcing millions of families to rely on nutrient-poor alternatives.” | |||||
22 | 18) Covid-19 Mortality: A Matter of Vulnerability Among Nations Facing Limited Margins of Adaptation, De Larochelambert, 2020 | “Countries that already experienced a stagnation or regression of life expectancy, with high income and NCD rates, had the highest price to pay. This burden was not alleviated by more stringent public decisions.” | |||||
23 | 19) Impact of non-pharmaceutical interventions against COVID-19 in Europe: A quasi-experimental study, Hunter, 2020 | “Closure of education facilities, prohibiting mass gatherings and closure of some non-essential businesses were associated with reduced incidence whereas stay at home orders and closure of all non-businesses was not associated with any independent additional impact.” | |||||
24 | 20) Israel: thefatemperor, 2020 | “Given that the evidence reveals that the Corona disease declines even without a complete lockdown, it is recommendable to reverse the current policy and remove the lockdown.” | |||||
25 | 21) Smart Thinking, Lockdown and COVID-19: Implications for Public Policy, Altman, 2020 | “The response to COVID-19 has been overwhelmingly to lockdown much the world’s economies in order to minimize death rates as well as the immediate negative effects of COVID-19. I argue that such policy is too often de-contextualized as it ignores policy externalities, assumes death rate calculations are appropriately accurate and, and as well, assumes focusing on direct Covid-19 effects to maximize human welfare is appropriate. As a result of this approach current policy can be misdirected and with highly negative effects on human welfare. Moreover, such policies can inadvertently result in not minimizing death rates (incorporating externalities) at all, especially in the long run… such misdirected and sub-optimal policy is a product of policy makers using inappropriate mental models which are lacking in a number of key areas; the failure to take a more comprehensive macro perspective to address the virus, using bad heuristics or decision-making tools, relatedly not recognizing the differential effects of the virus, and adopting herding strategy (follow-the-leader) when developing policy.” | |||||
26 | 22) The Mystery of Taiwan, Janaskie, 2020 | “Another fascinating outlier – often cited as a case in which a government handled the pandemic the correct way – was Taiwan. Indeed, Taiwan presents an anomaly in the mitigation and overall handling of the Covid-19 pandemic. In terms of stringency, Taiwan ranks among the lowest in the world, with fewer controls than Sweden and far lower than the U.S….The government did test at the border and introduce some minor controls but nowhere near that of most counties. In general, Taiwan rejected lockdown in favor of maintaining social and economic functioning.” “Despite Taiwan’s closer proximity to the source of the pandemic, and its high population density, it experienced a substantially lower-case rate of 20.7 per million compared with New Zealand’s 278.0 per million. Rapid and systematic implementation of control measures, in particular effective border management (exclusion, screening, quarantine/isolation), contact tracing, systematic quarantine/isolation of potential and confirmed cases, cluster control, active promotion of mass masking, and meaningful public health communication, are likely to have been instrumental in limiting pandemic spread. Furthermore, the effectiveness of Taiwan’s public health response has meant that to date no lockdown has been implemented, placing Taiwan in a stronger economic position both during and post-COVID-19 compared with New Zealand, which had seven weeks of national lockdown (at Alert Levels 4 and 3).” | |||||
27 | 23) What They Said about Lockdowns before 2020, Gartz, 2021 | “While expert consensus regarding the ineffectiveness of mass quarantine of previous years has recently been challenged, significant present-day evidence continuously demonstrates that mass quarantine is both ineffectual at preventing disease spread as well as harmful to individuals.” | |||||
28 | 24) Cost of Lockdowns: A Preliminary Report, AIER, 2020 | “In the debate over coronavirus policy, there has been far too little focus on the costs of lockdowns. It’s very common for the proponents of these interventions to write articles and large studies without even mentioning the downsides…a brief look at the cost of stringencies in the United States, and around the world, including stay-at-home orders, closings of business and schools, restrictions on gatherings, shutting of arts and sports, restrictions on medical services, and interventions in the freedom of movement.” | |||||
29 | 25) Leaked Study From Inside German Government Warns Lockdown Could Kill More People Than Coronavirus, Watson, 2020 German Minister: Lockdown Will Kill More Than Covid-19 Does | “The lockdown and the measures taken by the German federal and central governments to contain the coronavirus apparently cost more lives, for example of cancer patients, than of those actually killed by it.” “Half a million more will die from tuberculosis.” | |||||
30 | 26) Evaluating the effects of shelter-in-place policies during the COVID-19 pandemic, Berry, 2021 | “Previous studies have claimed that shelter-in-place orders saved thousands of lives, but we reassess these analyses and show that they are not reliable. We find that shelter-in-place orders had no detectable health benefits, only modest effects on behavior, and small but adverse effects on the economy.” | |||||
31 | 27) Study: Lockdown “Will Destroy at Least Seven Times More Years of Human Life” Than it Saves, Watson, 2020 | “A study has found that the “stay at home” lockdown order in the United States will “destroy at least seven times more years of human life” than it saves and that this number is “likely” to be more than 90 times greater… Research shows that at least 16.8% of adults in the United States have suffered “major mental harm from responses to Covid-19…Extrapolating these numbers out, the figures show that “anxiety from responses to Covid-19 has impacted 42,873,663 adults and will rob them of an average of 1.3 years of life, thus destroying 55.7 million years of life.” | |||||
32 | 28) Four Stylized Facts about COVID-19, Atkeson, 2020 | “Failing to account for these four stylized facts may result in overstating the importance of policy mandated NPIs for shaping the progression of this deadly pandemic… The existing literature has concluded that NPI policy and social distancing have been essential to reducing the spread of COVID-19 and the number of deaths due to this deadly pandemic. The stylized facts established in this paper challenge this conclusion.” | |||||
33 | 29) THE LONG-TERM IMPACT OF THE COVID-19 UNEMPLOYMENT SHOCK ON LIFE EXPECTANCY AND MORTALITY RATES, Bianchi, 2021 | “Policy-makers should therefore consider combining lockdowns with policy interventions meant to reduce economic distress, guarantee access to health care, and facilitate effective economic reopening under health care policies to limit SARS-CoV-19 spread…assess the long-run effects of the COVID-19 economic recession on mortality and life expectancy. We estimate the size of the COVID-19-related unemployment shock to be between 2 and 5 times larger than the typical unemployment shock, depending on race and gender, resulting in a significant increase in mortality rates and drop in life expectancy. We also predict that the shock will disproportionately affect African-Americans and women, over a short horizon, while the effects for white men will unfold over longer horizons. These figures translate in more than 0.8 million additional deaths over the next 15 years.” | |||||
34 | 30) Lockdowns Do Not Control the Coronavirus: The Evidence, AIER, 2020 | “The question is whether lockdowns worked to control the virus in a way that is scientifically verifiable. Based on the following studies, the answer is no and for a variety of reasons: bad data, no correlations, no causal demonstration, anomalous exceptions, and so on. There is no relationship between lockdowns (or whatever else people want to call them to mask their true nature) and virus control.” | |||||
35 | 31) Too Little of a Good Thing A Paradox of Moderate Infection Control, Cohen, 2020 | “The link between limiting pathogen exposure and improving public health is not always so straightforward. Reducing the risk that each member of a community will be exposed to a pathogen has the attendant effect of increasing the average age at which infections occur. For pathogens that inflict greater morbidity at older ages, interventions that reduce but do not eliminate exposure can paradoxically increase the number of cases of severe disease by shifting the burden of infection toward older individuals.” | |||||
36 | 32) Covid Lockdown Cost/Benefits: A Critical Assessment of the Literature, Allen, 2020 | “Generally speaking, the ineffectiveness of lockdown stems from voluntary changes in behavior. Lockdown jurisdictions were not able to prevent noncompliance, and non-lockdown jurisdictions benefited from voluntary changes in behavior that mimicked lockdowns. The limited effectiveness of lockdowns explains why, after one year, the unconditional cumulative deaths per million, and the pattern of daily deaths per million, is not negatively correlated with the stringency of lockdown across countries. Using a cost/benefit method proposed by Professor Bryan Caplan, and using two extreme assumptions of lockdown effectiveness, the cost/benefit ratio of lockdowns in Canada, in terms of life-years saved, is between 3.6–282. That is, it is possible that lockdown will go down as one of the greatest peacetime policy failures in Canada’s history.” | |||||
37 | 33) Covid-19: How does Belarus have one of the lowest death rates in Europe? Karáth, 2020 | “Belarus’s beleaguered government remains unfazed by covid-19. President Aleksander Lukashenko, who has been in power since 1994, has flatly denied the seriousness of the pandemic, refusing to impose a lockdown, close schools, or cancel mass events like the Belarusian football league or the Victory Day parade. Yet the country’s death rate is among the lowest in Europe—just over 700 in a population of 9.5 million with over 73 000 confirmed cases.” | |||||
38 | 34) PANDA, Nell, 2020 | “For each country put forward as an example, usually in some pairwise comparison and with an attendant single cause explanation, there are a host of countries that fail the expectation. We set out to model the disease with every expectation of failure. In choosing variables it was obvious from the outset that there would be contradictory outcomes in the real world. But there were certain variables that appeared to be reliable markers as they had surfaced in much of the media and pre-print papers. These included age, co-morbidity prevalence and the seemingly light population mortality rates in poorer countries than that in richer countries. Even the worst among developing nations—a clutch of countries in equatorial Latin America—have seen lighter overall population mortality than the developed world. Our aim therefore was not to develop the final answer, rather to seek common cause variables that would go some way to providing an explanation and stimulating discussion. There are some very obvious outliers in this theory, not the least of these being Japan. We test and find wanting the popular notions that lockdowns with their attendant social distancing and various other NPIs confer protection.” | |||||
39 | 35) States with the Fewest Coronavirus Restrictions, McCann, 2021 | Graphics reveal no relationship in stringency level as it relates to the death rates, but finds a clear relationship between stringency and unemployment. | |||||
40 | 36) COVID-19 Lockdown Policies: An Interdisciplinary Review, Robinson, 2021 | “Studies at the economic level of analysis points to the possibility that deaths associated with economic harms or underfunding of other health issues may outweigh the deaths that lockdowns save, and that the extremely high financial cost of lockdowns may have negative implications for overall population health in terms of diminished resources for treating other conditions. Research on ethics in relation to lockdowns points to the inevitability of value judgements in balancing different kinds of harms and benefits than lockdowns cause.” | |||||
41 | 37) Comedy and Tragedy in Two Americas, Tucker, 2021 | “Covid unleashed a version of tyranny in the United States. Through a surreptitious and circuitous route, many public officials somehow managed to gain enormous power for themselves and demonstrate that all our vaunted limits on government are easily transgressed under the right conditions. Now they want to use that power to enact permanent change in this country. Right now, people, capital, and institutions are fleeing from them to safe and freer places, which only drives the people in power to madness. They are right now plotting to shut down the free states through any means possible.” | |||||
42 | 38) Lockdowns Worsen the Health Crisis, Younes, 2021 | “We suspect that one day, the quarantining of entire societies that was carried out in response to the coronavirus pandemic, leading to vast swaths of the population becoming unhealthier overall and ironically more susceptible to severe outcomes from the virus, will be seen as the 21st century version of bloodletting. As the epidemiologist Martin Kulldorff has observed, public health is not just about one disease, but all health outcomes. Apparently, in 2020, the authorities forgot this obvious truth.” | |||||
43 | 39) The Damage of Lockdowns to Young People, Yang, 2021 | “Biological and cultural reasons why young people, mostly referring to those under the age of 30, are particularly vulnerable to the isolation as well as lifestyle disruptions brought about by lockdowns… “Adults under 30 experienced the highest increase in suicidal thinking in the same period, with rates of suicidal ideation rising from 12.5% to 14% in people aged 18-29. For many of the young adults surveyed, these mental health challenges persisted into the summer, despite a loosening of restrictions.” | |||||
44 | 40) Lifestyle and mental health disruptions during COVID-19, Giuntella, 2021 | “COVID-19 has affected daily life in unprecedented ways. Drawing on a longitudinal dataset of college students before and during the pandemic, we document dramatic changes in physical activity, sleep, time use, and mental health. We show that biometric and time-use data are critical for understanding the mental health impacts of COVID-19, as the pandemic has tightened the link between lifestyle behaviors and depression.” | |||||
45 | 41) CDC: A Quarter of Young Adults Say They Contemplated Suicide This Summer During Pandemic, Miltimore, 2020 | “One in four young adults between the ages of 18 and 24 say they’ve considered suicide in the past month because of the pandemic, according to new CDC data that paints a bleak picture of the nation’s mental health during the crisis. The data also flags a surge of anxiety and substance abuse, with more than 40 percent of those surveyed saying they experienced a mental or behavioral health condition connected to the Covid-19 emergency. The CDC study analyzed 5,412 survey respondents between June 24 and 30.” | |||||
46 | 42) Global rise in childhood mental health issues amid pandemic, LEICESTER, 2021 | “For doctors who treat them, the pandemic’s impact on the mental health of children is increasingly alarming. The Paris pediatric hospital caring for Pablo has seen a doubling in the number of children and young teenagers requiring treatment after attempted suicides since September.Doctors elsewhere report similar surges, with children — some as young as 8 — deliberately running into traffic, overdosing on pills and otherwise self-harming. In Japan, child and adolescent suicides hit record levels in 2020, according to the Education Ministry.” | |||||
47 | 43) Lockdowns: The Great Debate, AIER, 2020 | “The global lockdowns, on this scale with this level of stringency, have been without precedent. And yet we have examples of a handful of countries and US states that did not do this, and their record in minimizing the cost of the pandemic is better than the lockdown countries and states. The evidence that the lockdowns have done net good in terms of public health is still lacking.” | |||||
48 | 44) COVID-19 containment policies through time may cost more lives at metapopulation level, Wells, 2020 | “Show that temporally restricted containment efforts, that have the potential to flatten epidemic curves, can result in wider disease spread and larger epidemic sizes in metapopulations.” | |||||
49 | 45) The Covid-19 Emergency Did Not Justify Lockdowns, Boudreaux, 2021 | “Yet there was no such careful calculation for the lockdowns imposed in haste to combat Covid-19. Lockdowns were simply assumed not only to be effective at significantly slowing the spread of SARS-CoV-2, but also to impose only costs that are acceptable. Regrettably, given the novelty of the lockdowns, and the enormous magnitude of their likely downsides, this bizarrely sanguine attitude toward lockdowns was – and remains – wholly unjustified.” | |||||
50 | 46) Death and Lockdowns, Tierney, 2021 | “Now that the 2020 figures have been properly tallied, there’s still no convincing evidence that strict lockdowns reduced the death toll from Covid-19. But one effect is clear: more deaths from other causes, especially among the young and middle-aged, minorities, and the less affluent.The best gauge of the pandemic’s impact is what statisticians call “excess mortality,” which compares the overall number of deaths with the total in previous years. That measure rose among older Americans because of Covid-19, but it rose at an even sharper rate among people aged 15 to 54, and most of those excess deaths were not attributed to the virus.” | |||||
51 | 47) The COVID Pandemic Could Lead to 75,000 Additional Deaths from Alcohol and Drug Misuse and Suicide, Well Being Trust, 2021 | “The brief notes that if the country fails to invest in solutions that can help heal the nation’s isolation, pain, and suffering, the collective impact of COVID-19 will be even more devastating. Three factors, already at work, are exacerbating deaths of despair: unprecedented economic failure paired with massive unemployment, mandated social isolation for months and possible residual isolation for years, and uncertainty caused by the sudden emergence of a novel, previously unknown microbe…the deadly impact of lockdowns will grow in future years, due to the lasting economic and educational consequences. The United States will experience more than 1 million excess deaths in the United States during the next two decades as a result of the massive “unemployment shock” last year… lockdowns are the single worst public health mistake in the last 100 years,” says Dr. Jay Bhattacharya, a professor at Stanford Medical School. “We will be counting the catastrophic health and psychological harms, imposed on nearly every poor person on the face of the earth, for a generation.” | |||||
52 | 48) Professor Explains Flaw in Many Models Used for COVID-19 Lockdown Policies, Chen, 2021 | “Economics professor Doug Allen wanted to know why so many early models used to create COVID-19 lockdown policies turned out to be highly incorrect. What he found was that a great majority were based on false assumptions and “tended to over-estimate the benefits and under-estimate the costs.” He found it troubling that policies such as total lockdowns were based on those models. “They were built on a set of assumptions. Those assumptions turned out to be really important, and the models are very sensitive to them, and they turn out to be false,” said Allen, the Burnaby Mountain Professor of Economics at Simon Fraser University, in an interview.”“Furthermore, “The limited effectiveness of lockdowns explains why, after one year, the unconditional cumulative deaths per million, and the pattern of daily deaths per million, is not negatively correlated with the stringency of lockdown across countries,” writes Allen. In other words, in his assessment, heavy lockdowns do not meaningfully reduce the number of deaths in the areas where they are implemented, when compared to areas where lockdowns were not implemented or as stringent.” | |||||
53 | 49) The Anti-Lockdown Movement Is Large and Growing, Tucker, 2021 | “The lesson: lockdown policies failed to protect the vulnerable and otherwise did little to nothing actually to suppress or otherwise control the virus. AIER has assembled fully 35 studies revealing no connection between lockdowns and disease outcomes. In addition, the Heritage Foundation has published an outstanding roundup of the Covid experience, revealing that lockdowns were largely political theater distracting from what should have been good public health practice.” | |||||
54 | 50) The Ugly Truth About The Covid-19 Lockdowns, Hudson, 2021 | “By following the data and official communications from global organisations, PANDA unravels what transpired that led us into deleterious lockdowns, which continue to have enormous negative impacts across the world.” | |||||
55 | 51) The Catastrophic Impact of Covid Forced Societal Lockdowns, Alexander, 2020 | “It is also noteworthy that these irrational and unreasonable restrictive actions are not limited to any one jurisdiction such as the US, but shockingly have occurred across the globe. It is stupefying as to why governments, whose primary roles are to protect their citizens, are taking these punitive actions despite the compelling evidence that these policies are misdirected and very harmful; causing palpable harm to human welfare on so many levels. It’s tantamount to insanity what governments have done to their populations and largely based on no scientific basis. None! In this, we have lost our civil liberties and essential rights, all based on spurious ‘science’ or worse, opinion, and this erosion of fundamental freedoms and democracy is being championed by government leaders who are disregarding the Constitutional (USA) and Charter (Canada) limits to their right to make and enact policy. These unconstitutional and unprecedented restrictions have taken a staggering toll on our health and well-being and also target the very precepts of democracy; particularly given the fact that this viral pandemic is no different in overall impact on society than any previous pandemics. There is simply no defensible rationale to treat this pandemic any differently.” | |||||
56 | 52) Cardiovascular and immunological implications of social distancing in the context of COVID-19, D’Acquisto, 2020 | “It is clear that social distancing measures such as lockdown during the COVID-19 pandemic will have subsequent effects on the body including the immune and cardiovascular systems, the extent of which will be dependent on the duration of such measures. The take-home message of these investigations is that social interaction is an integral part of a wide range of conditions that influence cardiovascular and immunological homeostasis.” | |||||
57 | 53) A Statistical Analysis of COVID-19 and Government Protection Measures in the U.S., Dayaratna, 2021 | “Our analysis demonstrates that the time from a state’s first case to voluntary changes in residence mobility, which occurred before the imposition of shelter-in-place orders in 43 states, indeed quelled the time to reach the maximum growth in per capita cases. On the other hand, our analysis also indicates that these behavioral changes were not significantly effective in quelling mortality… our simulations find a negative effect of the time from a state’s first case to the imposition of shelter-in-place orders on the time to reach the specified per capita mortality thresholds. Our analysis also finds a slightly smaller negative effect on the time from a state’s first case to the imposition of prohibitions on gatherings above 500 people…. shelter-in-place orders can also have negative unforeseen health-related consequences, including the capacity to cause patients to avoid visits to doctors’ offices and emergency rooms. In addition, these policies can result in people, including those with chronic illnesses, skipping routine medical appointments, not seeking routine procedures to diagnose advanced cancer, not pursuing cancer screening colonoscopies, postponing non-emergency cardiac catheterizations, being unable to seek routine care if they experience chronic pain, and suffering mental health effects, among others…drug overdose deaths, alcohol consumption, and suicidal ideation have also been noted to have increased in 2020 compared to prior years.” | |||||
58 | 54) Lockdowns in Taiwan: Myths Versus Reality, Gartz, 2021 | “Articles citing a “tightening” of rules only briefly acknowledge that Taiwan never locked down. Instead, they blame the increase in cases on a loosening of travel restrictions and on people’s becoming “more relaxed or careless as time goes by.” A closer look reveals that this harsh turn in restrictions consists of capping gatherings at 500 for outdoors and 100 for indoors to 10 and 5 respectively — more in line with gathering limits imposed by Western nations.The reality is that the hyperbolic 124 action items misrepresent the Taiwanese approach. Relative to other countries, Taiwan serves as a beacon of freedom: children still attended school, professionals continued to go to work, and businesspeople were able to keep their businesses open.” | |||||
59 | 55) Lockdowns Need to Be Intellectually Discredited Once and For All, Yang, 2021 | “Lockdowns do not provide any meaningful benefit and they cause unnecessary collateral damage. Voluntary actions and light-handed accommodations to protect the vulnerable according to comprehensive analysis, not cherry-picked studies with overly short timelines, provide similar, if not better, virus mitigation compared to lockdown policies. Furthermore, contrary to what many keep trying to say, it is lockdowns that are the causal factor behind the unprecedented economic and social damage that has been dealt to society.” | |||||
60 | 56) Canada’s COVID-19 Strategy is an Assault on the Working Class, Kulldorff, 2020 | “The Canadian COVID-19 lockdown strategy is the worst assault on the working class in many decades. Low-risk college students and young professionals are protected; such as lawyers, government employees, journalists, and scientists who can work from home; while older high-risk working-class people must work, risking their lives generating the population immunity that will eventually help protect everyone. This is backwards, leading to many unnecessary deaths from both COVID-19 and other diseases.” | |||||
61 | 57) Our COVID-19 Plan would Minimize Mortality and Lockdown-induced Collateral Damage, Kulldorff, 2020 | “While mortality is inevitable during a pandemic, the COVID-19 lockdown strategy has led to more than 220,000 deaths, with the urban working class carrying the heaviest burden. Many older workers have been forced to accept high mortality risk or increased poverty, or both. While the current lockdowns are less strict than in March, the lockdown and contact tracing strategy is the worst assault on the working class since segregation and the Vietnam War.Lockdown policies have closed schools, businesses and churches, while not enforcing strict protocols to protect high-risk nursing home residents. University closures and the economic displacement caused by lockdowns have led millions of young adults to live with older parents, increasing regular close interactions across generations.” | |||||
62 | 58) The costs are too high; the scientist who wants lockdown lifted faster; Gupta, 2021 | “It’s becoming clear that a lot of people have been exposed to the virus and that the death rate in people under 65 is not something you would lock down the economy for,” she says. “We can’t just think about those who are vulnerable to the disease. We have to think about those who are vulnerable to lockdown too. The costs of lockdown are too high at this point.” | |||||
63 | 59) Review of the Impact of COVID-19 First Wave Restrictions on Cancer Care, Collateral Global, Heneghan; 2021 | “Restrictive measures in the first wave of the COVID19 pandemic in 2019-20 led to wide-scale, global disruption of cancer care. Future restrictions should consider disruptions to the cancer care pathways and plan to prevent unnecessary harms.” | |||||
64 | 60) German Study Finds Lockdown ‘Had No Effect’ on Stopping Spread of Coronavirus, Watson, 2021 | “Stanford researchers found “no clear, significant beneficial effect of [more restrictive measures] on case growth in any country.” | |||||
65 | 61) Lockdown will claim the equivalent of 560,000 lives because of the health impact of the ‘deep and prolonged recession it will cause’, expert warns, Adams/Thomas/Daily Mail, 2020 | “Lockdowns will end up claiming the equivalent of more than 500,000 lives because of the health impact of the ‘deep and prolonged recession it will cause.” | |||||
66 | 62) Anxiety From Reactions to Covid-19 Will Destroy At Least Seven Times More Years of Life Than Can Be Saved by Lockdowns, Glen, 2021 | “Likewise, a 2020 paper about quarantines published in The Lancet states: “Separation from loved ones, the loss of freedom, uncertainty over disease status, and boredom can, on occasion, create dramatic effects. Suicide has been reported, substantial anger generated, and lawsuits brought following the imposition of quarantine in previous outbreaks. The potential benefits of mandatory mass quarantine need to be weighed carefully against the possible psychological costs.”Yet, when dealing with Covid-19 and other issues, politicians sometimes ignore this essential principle of sound decision-making. For a prime example, NJ Governor Phil Murphy recently insisted that he must maintain a lockdown or “there will be blood on our hands.” What that statement fails to recognize is that lockdowns also kill people via the mechanisms detailed above… In other words, the anxiety from reactions to Covid-19—such as business shutdowns, stay-at-home orders, media exaggerations, and legitimate concerns about the virus—will extinguish at least seven times more years of life than can possibly be saved by the lockdowns.Again, all of these figures minimize deaths from anxiety and maximize lives saved by lockdowns. Under the more moderate scenarios documented above, anxiety will destroy more than 90 times the life saved by lockdowns.” | |||||
67 | 63) The psychological impact of quarantine and how to reduce it: rapid review of the evidence, Brooks, 2020 | “Reported negative psychological effects including post-traumatic stress symptoms, confusion, and anger. Stressors included longer quarantine duration, infection fears, frustration, boredom, inadequate supplies, inadequate information, financial loss, and stigma. Some researchers have suggested long-lasting effects. In situations where quarantine is deemed necessary, officials should quarantine individuals for no longer than required, provide clear rationale for quarantine and information about protocols, and ensure sufficient supplies are provided. Appeals to altruism by reminding the public about the benefits of quarantine to wider society can be favourable.” | |||||
68 | 64) Lockdown ‘had no effect’ on coronavirus pandemic in Germany, Huggler, 2021 | “A new study by German scientists claims to have found evidence that lockdowns may have had little effect on controlling the coronavirus pandemic. Statisticians at Munich University found “no direct connection” between the German lockdown and falling infection rates in the country.” | |||||
69 | 65) Swedish researchers: Anti-corona restrictions have killed as many people as the virus itself, Peterson, 2021 | “The restrictions against the coronavirus have killed as many people as the virus itself. The restrictions have first and foremost hit the poorer parts of the world and struck young people, the researchers believe, pointing to children who died of malnutrition and various diseases. They also pointed to adults who died of diseases that could have been treated. “These deaths we see in poor countries are related to women who die in childbirth, newborns who die early, children who die of pneumonia, diarrhea, and malaria because they are malnourished or not vaccinated,” Peterson said.” | |||||
70 | 66) Lockdowns Leave London Broken, Burden, 2021 | “In normal times, London runs on a sprawling network of trains and buses that bring in millions of commuters to work and spend. Asking those people to work from home ripped the heart out of the economy, leaving the U.K. capital more like a ghost town than a thriving metropolis.The city is now emerging from a year of lockdowns with deeper scars than much of the rest of the U.K. Many restaurants, theaters and shops remain shuttered, and the migrant workers that staffed them fled to their birth countries in the tens of thousands. Even when most of the rules expire in June, new border restrictions since the U.K. left the European Union will make it harder for many to return. As a result, the city’s business model focused on population density is in upheaval, and many of London’s strengths have turned to weaknesses.” | |||||
71 | 67) Lockdowns Are a Step Too Far in Combating Covid-19, Nocera, 2020 | “The truth is that using lockdowns to halt the spread of the coronavirus was never a good idea. If they have any utility at all, it is short term: to help ensure that hospitals aren’t overwhelmed in the early stages of the pandemic. But the long-term shutdowns of schools and businesses, and the insistence that people stay indoors — which almost every state imposed at one point or another — were examples of terribly misguided public policy. It is likely that when the history of this pandemic is told, lockdowns will be viewed as one of the worst mistakes the world made.” | |||||
72 | 68) Stop the Lies: Lockdowns Did Not and Do Not Protect the Vulnerable, Alexander, 2021 | “Lockdowns didn’t protect the vulnerable, but rather harmed them and shifted the morbidity and mortality burden to the underprivileged.” | |||||
73 | 69) Why Shutdowns and Masks Suit the Elite, Swaim, 2021 | “The dispute over masks—like those over school closures, business shutdowns, social-distancing guidelines and all the rest—should always properly have been a discussion of acceptable versus unacceptable risk. But the preponderance of America’s cultural and political leaders showed no ability to think about risk in a helpful way.” | |||||
74 | 70) The Impact of the COVID-19 Pandemic and Policy Responses on Excess Mortality, Agrawal, 2021 | “Find that following the implementation of SIP policies, excess mortality increases. The increase in excess mortality is statistically significant in the immediate weeks following SIP implementation for the international comparison only and occurs despite the fact that there was a decline in the number of excess deaths prior to the implementation of the policy… failed to find that countries or U.S. states that implemented SIP policies earlier, and in which SIP policies had longer to operate, had lower excess deaths than countries/U.S. states that were slower to implement SIP policies. We also failed to observe differences in excess death trends before and after the implementation of SIP policies based on pre-SIP COVID-19 death rates.” | |||||
75 | 71) COVID-19 Lockdowns Over 10 Times More Deadly Than Pandemic Itself, Revolver, 2020 | “We have drawn upon existing economic studies on the health effects of unemployment to calculate an estimate of how many years of life will have been lost due to the lockdowns in the United States, and have weighed this against an estimate of how many years of life will have been saved by the lockdowns. The results are nothing short of staggering, and suggest that the lockdowns will end up costing Americans over 10 times as many years of life as they will save from the virus itself.” | |||||
76 | 72) The Impact of Interruptions in Childhood Vaccination, Collateral Global, 2021 | “COVID-19 pandemic measures caused significant disruption to childhood vaccination services and uptake. In future pandemics, and for the remainder of the current one, policymakers must ensure access to vaccination services and provide catch-up programs to maintain high levels of immunisation, especially in those most vulnerable to childhood diseases in order to avoid further inequalities.” | |||||
77 | 73) Shelter-in-place orders didn’t save lives during the pandemic, research paper concludes, Howell, 2021 COVID-19 lockdowns caused more deaths instead of reducing them, study finds | “Researchers from the RAND Corporation and the University of Southern California studied excess mortality from all causes, the virus or otherwise, in 43 countries and the 50 U.S. states that imposed shelter-in-place, or “SIP,” policies. In short, the orders didn’t work. “We fail to find that SIP policies saved lives. To the contrary, we find a positive association between SIP policies and excess deaths. We find that following the implementation of SIP policies, excess mortality increases,” the researchers said in a working paper for the National Bureau of Economic Research (NBER).” | |||||
78 | 74) Experts Said Ending Lockdowns Would Be Worse for the Economy than the Lockdowns Themselves. They Were Wrong, MisesInstitute, 2021 | “There is no indication whatsoever that states with longer periods of lockdown and forced social distancing fared better economically than states that abandoned covid restrictions much earlier. Rather, many states that ended lockdowns early—or didn’t have them at all—now show less unemployment and more economic growth than states that imposed lockdowns and social distancing rules much longer. The complete lack of any correlation between economic success and covid lockdowns illustrates yet again that the confident predictions of the experts—who insisted that states without long lockdowns would endure bloodbaths and economic destruction—were very wrong.” | |||||
79 | 75) The Harms of Lockdowns, The Dangers of Censorship, And A Path Forward, AIER, 2020 | “When you read about failures of intelligence, probably the most spectacular being the weapons of mass destruction fiasco, the lesson that they were supposed to learn from that, and maybe have learned, is that you need to encourage cognitive dissonance. You need to encourage critical thinking. You need to have people who are looking at things differently than your mainstream view, because it will help to prevent you from making catastrophic errors. It will help to keep you honest.And we’ve done exactly the opposite instead of encouraging critical thinking, different ideas, we’ve stifled it. That’s what makes the actions of the Ontario College of Physicians and Surgeons towards you so shocking because it’s absolute the opposite of what we need to do. And it’s been that absence of critical thinking of incorporating critical thinking in our decision-making that has led to one mistake after another in handling COVID-19.” | |||||
80 | 76) UNDERSTANDING INTER-REGIONAL DIFFERENCES IN COVID-19 MORTALITY RATES, PANDA, 2021 | “We cannot argue that the phased adoption of these measures has any impact on risk mitigation. This is an important consideration for policy makers who must carefully balance the benefits of a phased lockdown strategy with the economic harm caused by such an intervention.” | |||||
81 | 77) Potential lessons from the Taiwan and New Zealand health responses to the COVID-19 pandemic, Summers, 2020 | “Extensive public health infrastructure established in Taiwan pre-COVID-19 enabled a fast coordinated response, particularly in the domains of early screening, effective methods for isolation/quarantine, digital technologies for identifying potential cases and mass mask use. This timely and vigorous response allowed Taiwan to avoid the national lockdown used by New Zealand. Many of Taiwan’s pandemic control components could potentially be adopted by other jurisdictions.” | |||||
82 | 78) 5 Times More Children Committed Suicide Than Died of COVID-19 During Lockdown: UK Study, Phillips, 2021 | “Five times more children and young people committed suicide than died of COVID-19 during the first year of the pandemic in the United Kingdom, according to a study, which also concluded that lockdowns are more detrimental to children’s health than the virus itself.” | |||||
83 | 79) Study Indicates Lockdowns Have Increased Deaths of Despair, Yang, 2021 | “Deaths of despair due in large part to social isolation. Regardless of whether they think lockdowns work, policymakers must be cognizant of the fact shutting down society also leads to excess deaths. Whether it’s from the government policies themselves or the willful compliance of society enforcing the soft despotism of popular hysteria, social isolation is taking its toll on the lives of many.” | |||||
84 | 80) DEATHS OF DESPAIR AND THE INCIDENCE OF EXCESS MORTALITY IN 2020, Mulligan, 2020 | “Presumably social isolation is part of the mechanism that turns a pandemic into a wave of deaths of despair. However, the results in this paper do not say how much, if any, comes from government stay-at-home orders versus various actions individual households and private businesses have taken to encourage social distancing.” | |||||
85 | 81) Effects of the lockdown on the mental health of the general population during the COVID-19 pandemic in Italy: Results from the COMET collaborative network, Fiorillo, 2020 | “Although physical isolation and lockdown represent essential public health measures for containing the spread of the COVID-19 pandemic, they are a serious threat for mental health and well-being of the general population. As an integral part of COVID-19 response, mental health needs should be addressed.” | |||||
86 | Mental Health and the Covid-19 Pandemic, Pfefferbaum, 2020 | “The Covid-19 pandemic has alarming implications for individual and collective health and emotional and social functioning. In addition to providing medical care, already stretched health care providers have an important role in monitoring psychosocial needs and delivering psychosocial support to their patients, health care providers, and the public — activities that should be integrated into general pandemic health care.” | |||||
87 | 82) Why Government Lockdowns Mostly Harm the Poor, Peterson, 2021 | “For developed countries, lockdowns undoubtedly imposed significant economic and health costs. Many workers in the service sector, like the food industry, for example, were left unemployed and had to rely on government stimulus checks to get them through the bumpiest stages of the pandemic. Some businesses had to shutter their doors entirely, leaving many employers without jobs as well. This is to say nothing of the severe mental health consequences of government lockdown orders…These irresponsible government actions are especially acute and more harmful in developing countries and among the poor because most workers can’t afford to sacrifice weeks or perhaps months of income, only to be confined to what is effectively house arrest.” | |||||
88 | 83) Cost of Lockdowns: A Preliminary Report, AIER, 2020 | “In the debate over coronavirus policy, there has been far too little focus on the costs of lockdowns. It’s very common for the proponents of these interventions to write articles and large studies without even mentioning the downsides.” | |||||
89 | 84) In Africa, social distancing is a privilege few can afford, Noko, 2020 | “Social distancing could probably work in China and in Europe – but in many African countries, it is a privilege only a minority can afford.” | |||||
90 | 85) Teargas, beatings and bleach: the most extreme Covid-19 lockdown controls around the world, Ratcliff, 2020 | “Violence and humiliation used to police coronavirus curfews around globe, often affecting the poorest and more vulnerable.” | |||||
91 | 86) “Shoot them dead”: Philippine President Rodrigo Duterte orders police and military to kill citizens who defy coronavirus lockdown, Capatides, 2020 | “Later that night, Philippine President Rodrigo Duterte took to the airwaves with a chilling warning for his citizens: Defy the lockdown orders again and the police will shoot you dead.” | |||||
92 | 87) Colombia’s Capital Locks Down as Cases Surge, Vyas, 2021 Colombia Protests Turn Deadly Amid Covid-19 Hardships | “Bogotá, which has logged a quarter of the nation’s cases, had already applied restrictions on mobility and alcohol sales in order to contain gatherings and the spread of the virus before expanding the measures.”“The nationwide unrest was triggered by a proposed tax-collection overhaul and stringent pandemic lockdowns that have been blamed for causing mass unemployment and throwing some four million people into poverty.” | |||||
93 | 88) Argentina receives AstraZeneca jabs amid anti-lockdown protests, AL JAZEERA, 2021 | “New COVID-19 restrictions have been imposed in and around Buenos Aires in effort to stem recent rise in infections…Argentines took to the streets on Saturday, however, to protest against new coronavirus-related restrictions in and around the capital, Buenos Aires, that came into effect on Friday… Horacio Rodriguez Larreta, head of the city government, said last week that Buenos Aires “totally disagree[s] with the decision of the national government to close schools.” | |||||
94 | 89) Lives vs. Livelihoods Revisited: Should Poorer Countries with Younger Populations Have Equally Strict Lockdowns? Von Carnap, 2020 | “Economists in the rich world have largely supported stringent containment measures, rejecting any trade-off between lives and livelihoods…strict lockdowns in countries where a significant share of the population is poor are likely to have more severe consequences on welfare than in richer countries. From a macro perspective, any negative economic effect of a lockdown is reducing a budget with already fewer resources in a poor country.” | |||||
95 | 90) Responding to the COVID-19 Pandemic in Developing Countries: Lessons from Selected Countries of the Global South, Chowdhury, 2020 | “If testing, contact tracing and other early containment measures had been adequately done in a timely manner to stem viral transmission, nationwide lockdowns would not have been necessary, and only limited areas would have had to be locked down for quarantine purposes. The effectiveness of containment measures, including lockdowns, are typically judged primarily by their ability to quickly reduce new infections, ‘flatten the curve’ and avoid subsequent waves of infections. However, lockdowns can have many effects, depending on context, and typically incur huge economic costs, unevenly distributed in economies and societies.” | |||||
96 | 91) Battling COVID-19 with dysfunctional federalism: Lessons from India, Choutagunta, 2021 | “Find that India’s centralized lockdown was at best a partial success in a handful of states, while imposing enormous economic costs even in areas where few were affected by the pandemic.” | |||||
97 | 92) The 2006 Origins of the Lockdown Idea, Tucker, 2020 | “Now begins the grand effort, on display in thousands of articles and news broadcasts daily, somehow to normalize the lockdown and all its destruction of the last two months. We didn’t lock down almost the entire country in 1968/69, 1957, or 1949-1952, or even during 1918. But in a terrifying few days in March 2020, it happened to all of us, causing an avalanche of social, cultural, and economic destruction that will ring through the ages.” | |||||
98 | 93) Young People Are Particularly Vulnerable To Lockdowns, Yang, 2021 | “The damage to society was certainly extensive, with a 3.5 percent annualized economic retraction record in 2020 and a 32.9 percent decline in Q2 of 2020, making this one of the sharpest economic declines in modern history. However, the level of suffering and trauma caused by these policies cannot be appropriately expressed by economic data alone. Lockdown policies may have caused a substantial amount of financial damage but the social damage is just as concerning, if not more so. Across the board, there have been increased reports of mental health issues, such as depression and anxiety, that are linked to social isolation, substantial life disruptions, and existential dread over the state of the world. Unlike lost dollars, mental health problems leave real and lasting damage which could lead to complications later in life, if not self-harm or suicide. For young people, a drastic increase in suicides has claimed more lives than Covid-19. That is because they are far less vulnerable to Covid than older segments of the population but far more negatively impacted by lockdowns.” | |||||
99 | 94) More “Covid Suicides” than Covid Deaths in Kids, Gartz, 2021 | “Before Covid, an American youth died by suicide every six hours. Suicide is a major public health threat and a leading cause of death for those aged under 25 — one far bigger than Covid. And it is something that we have only made worse as we, led by politicians and ‘the science,’ deprived our youngest members of society — who constitute one-third of the US population — of educational, emotional and social development without their permission or consent for over a year… the biggest increase in youth deaths occurred in the 15-24 age bracket — the age group most susceptible to committing suicide, and which constitutes 91% of youth suicides… such “deaths of despair” tend to be higher among youths, particularly for those about to graduate or enter the workforce. With economic shrinkage due to lockdowns and forced closures of universities, youths face both less economic opportunity and limited social support — which plays an important role in reporting and preventing self-harm — through social networks.” | |||||
100 | 95) Comparison of COVID-19 outcomes among shielded and non-shielded populations, Jani, 2021 | “Linked family practitioner, prescribing, laboratory, hospital and death records and compared COVID-19 outcomes among shielded and non-shielded individuals in the West of Scotland. Of the 1.3 million population, 27,747 (2.03%) were advised to shield, and 353,085 (26.85%) were classified a priori as moderate risk…in spite of the shielding strategy, high risk individuals were at increased risk of death.” | |||||
101 | 96) Sweden: Despite Variants, No Lockdowns, No Daily Covid Deaths, Fumento, 2021 | ““Locking down is saving time,” he said last year. “It’s not solving anything.” In essence the country “front-loaded” its deaths and decreased those deaths later on…Despite Sweden inevitably feeling undertow from economies that did lock down, “Covid-19 has had a rather limited impact on its economy compared with most other European countries,” according to the Nordetrade.com consulting firm. “Softer preventative restrictions against Covid-19 earlier in the year and a strong recovery in the third quarter contained the GDP contraction,” it said.Thus, the country the media loved to hate is reaping the best of all worlds: Few current cases and deaths, stronger economic growth than the lockdown countries, and its people never experienced the yoke of tyranny.” | |||||
102 | 97) Lockdown lessons, Ross, 2021 | “Never take radical action without overwhelming evidence that it will work. The authorities took all manner of drastic actions and weren’t the least bit interested in offering evidence and they still aren’t. Unelected bureaucrats, who know nothing about us, dictated how we live our lives down to the tiniest details. The authorities coerced hundreds of millions of people to wear masks. They assumed that would reduce transmission. There is now evidence that masks are worse than useless.Be extremely reluctant to commit sweeping violations of the Constitution. The Constitution is our country’s greatest asset and our north star. Ignoring it or trampling on it is never a good idea. The Constitution is what makes us who we are. We ought to treat it like the treasure it is.Always consider both costs and benefits and make best-effort projections of both. The costs of virtually every aspect of the lockdown were more than the benefits, usually far more…it has increased the amount of depression and number of suicides, especially among those age 18 and younger. The postponement and cancellation of medical appointments have resulted in thousands of premature deaths.” | |||||
103 | 98) Prof. Sunetra Gupta — New Lockdown is a Terrible Mistake, Gupta, 2020 | “I would beg to disagree. I think there is an alternative, and that alternative involves reducing the deaths that this pandemic might cause by diverting our energies to protecting the vulnerables. Now, why would I say that? The main reason to say that is because the costs of alternative strategies such as lockdown are so profound that we are left with a contemplation of how to go ahead, go forwards, in this current sort of situation without inflicting harm, not just to those who are vulnerable to COVID, but to the general population in a way that meets with those standards that we set ourselves from the moment we were, maybe not born, but from the moment that we became cognizant of those responsibilities towards society.” | |||||
104 | 99) The harms of lockdown will vastly outweigh the benefits, Hinton, 2021 | “Nearly 1.2 m people waiting at least six months for vital services.” | |||||
105 | 100) Lockdowns don’t work, Stone/AEI, 2020 | “Lockdowns don’t work. That simple sentence is enough to ignite a firestorm of controversy these days, whether you say it in public (to someone at least six feet away, of course) or online. As soon as the words leave your lips, they begin to be interpreted in extraordinary ways. Why do you want to kill old people? Why do you think the economy is more important than saving lives? Why do you hate science? Are you a shill for Trump? Why are you spreading misinformation about the severity of COVID? But here’s the thing: there’s no evidence of lockdowns working. If strict lockdowns actually saved lives, I would be all for them, even if they had large economic costs. But, put simply, the scientific and medical case for strict lockdowns is paper-thin… If you’re going to essentially cancel the civil liberties of the entire population for a few weeks, you should probably have evidence that the strategy will work.” | |||||
106 | 101) Science Killed itself over COVID-19, Raleigh/Federalist/Atlas, 2021 | “Lockdowns destroyed people, Atlas said, by “shutting down medical care, stopping people from seeking emergency medical care, increasing drug abuse, increasing death by suicide, more psychological damage, particularly among the younger generation. Hundreds and thousands of child abuse cases went unreported. Teenagers’ self-harm cases have tripled… Mortality data showing that anywhere from a third or half of the deaths during the pandemic were not due to COVID-19,” Atlas said. “They were extra deaths due to the lockdowns…we should offer targeted protections for high-risk people but no lockdowns of low-risk people.” | |||||
107 | 102) Assembling Covid Jigsaw Pieces Into a Complete Pandemic Picture, Brookes, 2021 | “Overall there is a minimal positive impact from quarantine policy, isolation requirements, Test and Trace regimes, social distancing, masking or other non-pharmaceutical interventions. Initially, these were the only tools in the tool-box of interventionist politicians and scientists. At best they slightly delayed the inevitable, but they also caused considerable collateral harms.” | |||||
108 | 103) Covid Lockdowns Signal the Rise of Public Policy by Ransom, O’Neill/MisesInstitute, 2021 | “Public policy by ransom occurs when a government imposes a behavioral requirement on individuals and enforces this by punishing the general public in aggregate until a stipulated level of compliance is attained. The method relies on members of the public and public commentators—like Marcotte—who will attribute blame for these negative consequences to recalcitrant citizens who fail to adopt the preferred behaviors of the governing class. In the weltanschauung that underpins this type of governance, government reactions to public behaviors are “metaphysically given” and are treated as a mere epiphenomenon of the actions of individual members of the public who dare to behave in ways disliked by public authorities… what has emerged as an ominous mode of thinking in this atmosphere is the reflexive attribution of blame to recalcitrant members of the public for any subsequent negative consequences imposed on the public by government policies. If the government chooses to impose a negative consequence on the public—even conditionally on the behavior of the public—that consequence is a chosen policy of the government and must be viewed as a policy choice.” | |||||
109 | 104) Sweden Saw Lower Mortality Rate Than Most of Europe in 2020, Despite No Lockdown, Miltimore, 2021 | “I think people will probably think very carefully about these total shutdowns, how good they really were…t hey may have had an effect in the short term, but when you look at it throughout the pandemic, you become more and more doubtful…data published by Reuters that show Sweden, which shunned the strict lockdowns embraced by most nations around the world, experienced a smaller increase in its mortality rate than most European countries in 2020.” | |||||
110 | 105) Weighing the Costs of COVID Versus the Costs of Lockdowns, Leef/National Review, 2021 | “Yet there was no such careful calculation for the lockdowns imposed in haste to combat Covid-19. Lockdowns were simply assumed not only to be effective at significantly slowing the spread of SARS-CoV-2, but also to impose only costs that are acceptable. Regrettably, given the novelty of the lockdowns, and the enormous magnitude of their likely downsides, this bizarrely sanguine attitude toward lockdowns was – and remains – wholly unjustified. And the unjustness of this reaction is further highlighted by the fact that, in a free society, the burden of proof is on those who would restrict freedom and not on those who resist such restrictions… policy-makers should be just as interested in the costs of the problem as in the costs of any proposed solution to it.” | |||||
111 | 106) Increase in preterm stillbirths and reduction in iatrogenic preterm births for fetal compromise: a multi-centre cohort study of COVID-19 lockdown effects in Melbourne, Australia, Hui, 2021 | “Lockdown restrictions in a high-income setting, in the absence of high rates of COVID-19 disease, were associated with a significant increase in preterm stillbirths, and a significant reduction in iatrogenic PTB for suspected fetal compromise.” | |||||
112 | 107) Impact of the COVID19 pandemic on cardiovascular mortality and catherization activity during the lockdown in central Germany: an observational study, Nef, 2021 | “During the COVID-19-related lockdown a significant increase in cardiovascular mortality was observed in central Germany, whereas catherization activities were reduced.” | |||||
113 | 108) Editor’s Note – Cancer Review Issue, Collateral Global, 2021 | “Before the lockdowns, we had made so much progress in the war on cancer. Between 1999 and 2019, cancer mortality dropped by an astonishing 27% in the United States, down to 600,000 deaths in 2019. Worldwide, the age-standardized death rate from cancer has decreased by 15% since 1990. Cancer, like COVID-19, is by proportion an old person’s disease, with 27% of cases afflicting people 70 and over and over 70% of cases afflicting people 50 and over. Despite progress against the disease, 18.1 million new cases were diagnosed worldwide in 2018, and 9.6 million people died from cancer… N\nearly eight out of ten cancer patients reported delays in care, with almost six out ten skipping doctor visits, one in four skipping imaging, and one in six missing surgery…the toll from cancer, exacerbated by lockdown and panic, will continue into the indefinite future.” | |||||
114 | 109) Impact of COVID-19 and partial lockdown on access to care, self-management and psychological well-being among people with diabetes: A cross-sectional study, Yeoh, 2021 | “COVID-19 and lockdown had mixed impacts on self-care and management behaviours. Greater clinical care and attention should be provided to people with diabetes with multiple comorbidities and previous mental health disorders during the pandemic and lockdown…the pandemic and quarantine measures may have led to many losses including a loss of loved ones, employment, financial security, direct social contacts, educational opportunities, recreation and social support. A review of the psychological impact of quarantine demonstrated a high prevalence of psychological symptoms and emotional disturbance.” | |||||
115 | 110) Mental Health During the COVID-19 Pandemic in the United States: Online Survey, Jewell, 2020 | “Findings suggest that many US residents are experiencing high stress, depressive, and anxiety symptomatology, especially those who are underinsured, uninsured, or unemployed.” | |||||
116 | 111) Mental health in the UK during the COVID-19 pandemic: cross-sectional analyses from a community cohort study, Jia, 2020 | “Increased psychological morbidity was evident in this UK sample and found to be more common in younger people, women and in individuals who identified as being in recognised COVID-19 risk groups. Public health and mental health interventions able to ameliorate perceptions of risk of COVID-19, worry about COVID-19 loneliness and boost positive mood may be effective.” | |||||
117 | 112) The psychological impact of quarantine on coronavirus disease 2019 (COVID-19), Luo, 2020 | “Based on these studies, a great amount of psychologic symptoms or problems developed during the quarantine period, including anxiety (228/649, 35.1%), depression (110/649, 16.9%), loneliness (37/649, 5.7%) and despair (6/649, 0.9%). One study (Dong et al., 2020) reported that people quarantined had suicidal tendencies or ideas than those not quarantined.” | |||||
118 | 113) COVID-19 pandemic leads to major backsliding on childhood vaccinations, new WHO, UNICEF data shows, WHO, 2021 | “23 million children missed out on basic childhood vaccines through routine health services in 2020, the highest number since 2009 and 3.7 million more than in 2019” | |||||
119 | 114) Virus-linked hunger tied to 10,000 child deaths each month, Hinnant, 2020 | “All around the world, the coronavirus and its restrictions are pushing already hungry communities over the edge, cutting off meager farms from markets and isolating villages from food and medical aid. Virus-linked hunger is leading to the deaths of 10,000 more children a month over the first year of the pandemic, according to an urgent call to action from the United Nations shared with The Associated Press ahead of its publication in the Lancet medical journal…The parents of the children are without work,” said Annelise Mirabal, who works with a foundation that helps malnourished children in Maracaibo, the city in Venezuela thus far hardest hit by the pandemic. “How are they going to feed their kids?…in May, Nieto recalled, after two months of quarantine in Venezuela, 18-month-old twins arrived at his hospital with bodies bloated from malnutrition.” | |||||
120 | 115) CG REPORT 3: The Impact of Pandemic Restrictions on Childhood Mental Health, Collateral Global, 2021 | “The evidence shows the overall impact of COVID-19 restrictions on the mental health and well-being of children and adolescents is likely to be severe… Eight out of ten children and adolescents report worsening of behaviour or any psychological symptoms or an increase in negative feelings due to the COVID-19 pandemic. School closures contributed to increased anxiety, loneliness and stress; negative feelings due to COVID-19 increased with the duration of school closures. Deteriorating mental health was found to be worse in females and older adolescents.” | |||||
121 | 116) Unintended Consequences of Lockdowns: COVID-19 and the Shadow Pandemic, Ravindran, 2021 | “Using variation in the intensity of government-mandated lock-downs in India, we show that domestic violence complaints increase 0.47 SD in districts with the strictest lockdown rules. We find similarly large increases in cyber-crime complaints.” | |||||
122 | 117) Projected increases in suicide in Canada as a consequence of COVID-19, McIntyre, 2020 | “A percentage point increase in unemployment was associated with a 1.0% increase in suicide between 2000 and 2018. In the first scenario, the rise in unemployment rates resulted in a projected total of 418 excess suicides in 2020-2021 (suicide rate per 100,000: 11.6 in 2020). In the second scenario, the projected suicide rates per 100,000 increased to 14.0 in 2020 and 13.6 in 2021, resulting in 2114 excess suicides in 2020-2021. These results indicate that suicide prevention in the context of COVID-19-related unemployment is a critical priority.” | |||||
123 | 118) COVID-19, unemployment, and suicide, Kawohl, 2020 | “In the high scenario, the worldwide unemployment rate would increase from 4·936% to 5·644%, which would be associated with an increase in suicides of about 9570 per year. In the low scenario, the unemployment would increase to 5·088%, associated with an increase of about 2135 suicides… expect an extra burden for our mental health system, and the medical community should prepare for this challenge now. Mental health providers should also raise awareness in politics and society that rising unemployment is associated with an increased number of suicides. The downsizing of the economy and the focus of the medical system on the COVID-19 pandemic can lead to unintended long-term problems for a vulnerable group on the fringes of society.” | |||||
124 | 119) The impact of the COVID-19 pandemic on cancer deaths due to delays in diagnosis in England, UK: a national, population-based, modelling study, Maringe, 2020 | “Substantial increases in the number of avoidable cancer deaths in England are to be expected as a result of diagnostic delays due to the COVID-19 pandemic in the UK.” | |||||
125 | 120) Economic impact of avoidable cancer deaths caused by diagnostic delay during the COVID-19 pandemic: A national population-based modelling study in England, UK, Gheorghe, 2021 | “Premature cancer deaths resulting from diagnostic delays during the first wave of the COVID-19 pandemic in the UK will result in significant economic losses. On a per-capita basis, this impact is, in fact, greater than that of deaths directly attributable to COVID-19. These results emphasise the importance of robust evaluation of the trade-offs of the wider health, welfare and economic effects of NPI to support both resource allocation and the prioritisation of time-critical health services directly impacted in a pandemic, such as cancer care.” | |||||
126 | 121) Cancer during the COVID-19 pandemic: did we shout loudly enough and did anyone listen? A lasting legacy for nations, Price, 2021 | “In just four cancer types (breast, colon, lung and oesophagus), studies during the first wave of the COVID-19 pandemic (published July 2020 [3]) predicted 60,000 lost life years. The quality-adjusted life years and the productivity losses due to these excess cancer deaths have been estimated in this new article to be 32,700 and £104 million over 5 years, respectively. This is nearly 1.5 times higher per capita than that of deaths directly related to COVID-19 in that time. The authors confirm that this is a conservative estimate for these cancer groups as it does not take into account additional productivity losses due to delays or reduction in quality of treatment and stage migration.” | |||||
127 | 122) Donation and transplantation activity in the UK during the COVID-19 lockdown, Manara, 2020 | “Compared with 2019, the number of deceased donors decreased by 66% and the number of deceased donor transplants decreased by 68%, larger decreases than we estimated.” | |||||
128 | 123) Rapid Systematic Review: The Impact of Social Isolation and Loneliness on the Mental Health of Children and Adolescents in the Context of COVID-19, Loades, 2020 | “Children and adolescents are probably more likely to experience high rates of depression and most likely anxiety during and after enforced isolation ends. This may increase as enforced isolation continues.” | |||||
129 | 124) The Costs and Benefits of Covid-19 Lockdowns in New Zealand, Lally, 2021 | “Using data available up to 28 June 2021, the estimated additional deaths from a mitigation strategy are 1,750 to 4,600, implying a Cost per Quality Adjusted Life Year saved by locking down in March 2020 of at least 13 times the generally employed threshold figure of $62,000 for health interventions in New Zealand; the lockdowns do not then seem to have been justified by reference to the standard benchmark. Using only data available to the New Zealand government in March 2020, the ratio is similar and therefore the same conclusion holds that the nation-wide lockdown strategy was not warranted.” | |||||
130 | 125) Trends in suicidal ideation over the first three months of COVID-19 lockdowns, Killgore, 2020 | “The percentage of respondents endorsing suicidal ideation was greater with each passing month for those under lockdown or shelter-in-place restrictions due to the novel coronavirus, but remained relatively stable and unchanged for those who reported no such restrictions.” | |||||
131 | 126) Cardiovascular Mortality during the COVID-19 Pandemics in a Large Brazilian City: a Comprehensive Analysis, Brant, 2021 | “The greater occurrence of CVD deaths at home, in parallel with lower hospitalization rates, suggests that CVD care was disrupted during the COVID-19 pandemics, which more adversely affected older and more socially vulnerable individuals, exacerbating health inequities in BH.” | |||||
132 | 127) Excess Deaths in People with Cardiovascular Diseases during the COVID-19 Pandemic, Banerjee, 2021 | “Mortality data suggest indirect effects on CVD will be delayed rather than contemporaneous (peak RR 1.14). CVD service activity decreased by 60–100% compared with pre-pandemic levels in eight hospitals across China, Italy, and England.” | |||||
133 | 128) Cardiovascular Deaths During the COVID-19 Pandemic in the United States, Wadhera, 2021 | “Hospitalizations for acute cardiovascular conditions have declined, raising concern that patients may be avoiding hospitals because of fear of contracting severe acute respiratory syndrome- coronavirus-2 (SARS-CoV-2)…there was an increase in deaths caused by ischemic heart disease and hypertensive diseases in some regions of the United States during the initial phase of the COVID-19 pandemic.” | |||||
134 | 129) Lockdowns of Young People Lead to More Deaths from Covid-19, Berdine, 2020 | “On April 1, 2020 Dr Anthony Fauci indicated that lockdowns would have to continue until there were zero new cases. This policy indicated a strategy whose goal was eradication of the virus through lockdown. The premise that the virus could be eradicated was a false one. While individual virus particles can certainly be killed, the Covid-19 virus cannot be eradicated. If the virus could be eradicated, then Australia would have already succeeded with its brutal lockdown. All of the scientific data, as opposed to the wishful thinking coming out of Garbage In Garbage Out models, indicates that the virus is here forever – much like influenza. Given the fact that the virus will eventually spread to the entire young and economically active population, lockdowns of the young cannot possibly achieve reduced mortality compared to voluntary action.” | |||||
135 | 130) A second lockdown would break South Africans, Griffiths, 2020 | “It is likely that soon there will be increased calls for a second hard lockdown as it gets worse, either countrywide or in particular provinces. Should such a decision be implemented it will probably take many South Africans over their breaking point as some may well lose what they so desperately attempted to save during the initial lockdown.” | |||||
136 | 131) CDC, Longitudinal Trends in Body Mass Index Before and During the COVID-19 Pandemic Among Persons Aged 2–19 Years — United States, 2018–2020, Lange, 2021 | “During the COVID-19 pandemic, children and adolescents spent more time than usual away from structured school settings, and families who were already disproportionally affected by obesity risk factors might have had additional disruptions in income, food, and other social determinants of health.† As a result, children and adolescents might have experienced circumstances that accelerated weight gain, including increased stress, irregular mealtimes, less access to nutritious foods, increased screen time, and fewer opportunities for physical activity (e.g., no recreational sports) (2,3).” | |||||
137 | 132) The Truth About Lockdowns, Rational Ground, 2021 | “1.4 million additional tuberculosis deaths due to lockdown disruptions, 500,000 additional deaths related to HIV, Malaria deaths could double to 770,000 total per year, 65 percent decrease in all cancer screenings, Breast cancer screenings dropped 89 percent, Colorectal screenings dropped 85 percent, At least 1/3 of excess deaths in the U.S. are already not related to COVID-19, Increase in cardiac arrests but decrease in EMS calls for them, Significant increase in stress-related cardiomyopathy during lockdowns, 132 million additional people in sub-Saharan Africa are projected to be undernourished due to lockdown disruptions, Study estimates up to 2.3 million additional child deaths in the next year from lockdowns, Millions of girls have been deprived of access to food, basic healthcare, and protection and thousands exposed to abuse and exploitation.” | |||||
138 | 133) The Backward Art of Slowing the Spread? Congregation Efficiencies during COVID-19, Mulligan, 2021 | “Micro evidence contradicts the public-health ideal in which households would be places of solitary confinement and zero transmission. Instead, the evidence suggests that “households show the highest transmission rates” and that “households are high-risk settings for the transmission of [COVID-19].” | |||||
139 | 134) The Failed Experiment of Covid Lockdowns, Luskin, 2020 | “Six months into the Covid-19 pandemic, the U.S. has now carried out two large-scale experiments in public health—first, in March and April, the lockdown of the economy to arrest the spread of the virus, and second, since mid-April, the reopening of the economy. The results are in. Counterintuitive though it may be, statistical analysis shows that locking down the economy didn’t contain the disease’s spread and reopening it didn’t unleash a second wave of infections.” | |||||
140 | 135) An Interview with Gigi Foster, Warrior Against Lockdowns, Brownstone, 2021 | “Well, I mean, we thought that was necessary because we were just surrounded by people who have bought into the lockdown ideology. And they will have in their minds, a very facile sort of reason why lockdowns should work. And so, we addressed that very directly in that section as you know. We say, “Look, on the surface of it, the idea is that you prevent people from interacting with each other and therefore, transmitting the virus. That’s what people believe. That’s what they think when they think lockdown, they think, “That’s what I’m doing.” But they don’t realize how many other collateral problems are happening and also how little that particular objective is actually being serviced, because of the fact that we live in these interdependent societies now. And we also are trapping people often in large buildings, sharing air together, and not able to go outside as much and so we’re actually potentially increasing the spread of the virus, at least within communities, our communities. So, it basically is an example of trying to engage with the people we feel are misguided on this issue in a calm way, not screaming at each other, not sort of taking the radical position on either side and just saying, “I’m going to play gotcha with you” because that’s not productive.” | |||||
141 | 136) The Politicisation of Science Funding in the US, Carl, 2021 | Regarding Sweden: “As an aside, the report clearly states: “The best way of comparing the mortality impact of the coronavirus (COVID-19) pandemic internationally is by looking at all-cause mortality compared with the five-year average.” So what do the new numbers show? Sweden has had negative excess mortality. In other words, the level of mortality between January 2020 and June 2021 was lower than the five-year average. If this isn’t a vindication of Anders Tegnell’s approach, I don’t know what is.” | |||||
142 | 137) Pandemic lockdown, healthcare policies and human rights: integrating opposed views on COVID-19 public health mitigation measures, Burlacu, 2020 | “Starting from the rationale of the lockdown, in this paper we explored and exposed the other consequences of the COVID-19 pandemic measures such as the use or abuse of human rights and freedom restrictions, economic issues, marginalized groups and eclipse of all other diseases. Our scientific attempt is to coagulate a stable position and integrate current opposing views by advancing the idea that rather than applying the uniform lockdown policy, one could recommend instead an improved model targeting more strict and more prolonged lockdowns to vulnerable risk/age groups while enabling less stringent measures for the lower-risk groups, minimizing both economic losses and deaths. Rigorous (and also governed by freedom) debating may be able to synchronize the opposed perspectives between those advocating an extreme lockdown (e.g., most of the epidemiologists and health experts), and those criticizing all restrictive measures (e.g., economists and human rights experts). Confronting the multiple facets of the public health mitigation measures is the only way to avoid contributing to history with yet another failure, as seen in other past epidemics.” | |||||
143 | 138) Mental Health, Substance Use, and Suicidal Ideation During the COVID-19 Pandemic — United States, June 24–30, 2020, Czeisler, 2020 | 25.5% of persons 18 to 24 years old seriously considered suicide in the prior 30 days (Table 1).CDC: A Quarter of Young Adults Say They Contemplated Suicide This Summer During Pandemic – Foundation for Economic Education (fee.org) | |||||
144 | 139) Will the Truth on COVID Restrictions Really Prevail?, Atlas, 2021 | “Separate from their limited value in containing the virus — efficacy that has often been “grossly exaggerated” in published papers — lockdown policies have been extraordinarily harmful. The harms to children of closing in-person schooling are dramatic, including poor learning, school dropouts, social isolation, and suicidal ideation, most of which are far worse for lower income groups. A recent study confirms that up to 78% of cancers were never detected due to missed screening over three months. If one extrapolates to the entire country, where about 150,000 new cancers are diagnosed per month, three-fourths to over a million new cases over nine months will have gone undetected. That health disaster adds to missed critical surgeries, delayed presentations of pediatric illnesses, heart attack and stroke patients too afraid to call emergency services, and others all well documented… Beyond hospital care, CDC reported four-fold increases in depression, three-fold increases in anxiety symptoms, and a doubling of suicidal ideation, particularly among young adults after the first few months of lockdowns, echoing the AMA reports of drug overdoses and suicides. Domestic abuse and child abuse have been skyrocketing due to the isolation and specifically to the loss of jobs, particularly in the strictest lockdowns.” | |||||
145 | 140) With Low Vaccination Rates, Africa’s Covid Deaths Remain Far below Europe and the US, Mises Wire, 2021 | “Since the very beginning of the covid panic, the narrative has been this: implement severe lockdowns or your population will experience a bloodbath. Morgues will be overwhelmed, the death total toll will be astounding. On the other hand, we were assured those jurisdictions that do lock down would see only a fraction of the death toll… The lockdown narrative, of course, has already been thoroughly overturned. Jurisdictions that did not lock down or adopted only weak and short lockdowns ended up with covid death tolls that were either similar to—or even better than—death tolls in countries that adopted draconian lockdowns. Lockdown advocates said locked-down countries would be overwhelmingly better off. These people were clearly wrong.” | |||||
146 | 141) Rethinking lockdowns, Joffe, 2020 | “Lockdowns have also resulted in a wide-range of unintended ramifications. Economic damage, delays in “non-urgent” surgeries, diagnoses, and treatments, and excess deaths arising from the “collateral effects” of lockdown measures should all be considered as policy-makers weigh future measures.Dr. Joffe argues that Canadians have been essentially presented with a “false dichotomy” – between a choice of either economically-damaging lockdowns or lethal inaction. However, his analysis finds that the costs of the lockdown measures compare poorly against their purported benefits when measured by Quality Adjusted Life Years, or QALY. “Various cost-benefit analyses from different countries, including some of these costs, have consistently estimated the cost in lives from lockdowns to be at least five to 10 times higher than the benefit, and likely far higher.” | |||||
147 | 142) Non-pharmaceutical public health measures for mitigating the risk and impact of epidemic and pandemic influenza, WHO, 2020 | “Home quarantine of exposed individuals to reduce transmission is not recommended because there is no obvious rationale for this measure, and there would be considerable difficulties in implementing it.” | |||||
148 | 143) Projected deaths of despair from COVID-19, Well Being Trust, 2020 | “More Americans could lose their lives to deaths of despair, deaths due to drug, alcohol, and suicide, if we do not do something immediately. Deaths of despair have been on the rise for the last decade, and in the context of COVID-19, deaths of despair should be seen as the epidemic within the pandemic.” | |||||
149 | 144) Dr Matthew Owens: Undoing the untold harms of COVID-19 on young people: a call to action, 2020 | “A sense of proportion is now needed to help mitigate the negative impact of the ‘lockdown’ measures and encourage the healthy development and wellbeing of all young people.” | |||||
150 | 145) Stay at Home, Protect the National Health Service, Save Lives”: A cost benefit analysis of the lockdown in the United Kingdom, Miles, 2020 | “The costs of continuing severe restrictions are so great relative to likely benefits in lives saved that a rapid easing in restrictions is now warranted.” | |||||
151 | 146) Great Barrington Declaration, Gupta, Kulldorff, Bhattacharya, 2020 | “Both COVID-19 itself and the lockdown policy reactions have had enormous adverse consequences for patients in the US and around the world. While the harm from COVID-19 infections are well represented in news stories every day, the harms from lockdowns themselves are less well advertised, but no less important. The patients hurt by missed medical visits and hospitalizations due to lockdowns are as worthy of attention and policy response as are patients afflicted by COVID-19 infection.” | |||||
152 | 147) Sweden saw lower 2020 death spike than much of Europe – data, Ahlander, 2021 | “Sweden, which has shunned the strict lockdowns that have choked much of the global economy, emerged from 2020 with a smaller increase in its overall mortality rate than most European countries, an analysis of official data sources showed.” | |||||
153 | 148) Open Letter from Medical Doctors and Health Professionals to All Belgian Authorities and All Belgian Media, AIER, 2020 | “If we compare the waves of infection in countries with strict lockdown policies to countries that did not impose lockdowns (Sweden, Iceland …), we see similar curves. So there is no link between the imposed lockdown and the course of the infection. Lockdown has not led to a lower mortality rate.” | |||||
154 | 149) Will Months of Remote Learning Worsen Students’ Attention Problems? Harwin, 2020 | “Robert is working from home again, along with over 50 million students, as schools in 48 states have shut down in-person classes to curb the spread of the novel coronavirus. How will the long absence from traditional school routines affect Robert and the millions of other students across the country who struggle with self-control, focus, or mental flexibility?” | |||||
155 | 150) COVID-19 Mandates Will Not Work for the Delta Variant, Alexander, 2021 | “Yet the elites are far removed from the ramifications of their nonsensical, illogical, specious policies and edicts. Dictates that do not apply to them or their families or friends. The ‘laptop’ affluent class could vacate, work remotely, walk their dogs and pets, catch up on reading their books, and do tasks they could not do had they been in the workplace daily. They could hire extra teachers for their children etc. Remote working was a boon. The actions of our governments however, devastated and long-term hurt the poor in societies and terribly and perversely so, and many could not hold on and committed suicide. AIER’s Ethan Yang’s analysis showed that deaths of despair skyrocketed. Poor children, especially in richer western nations such as the US and Canada, self-harmed and ended their lives, not due to the pandemic virus, but due to the lockdowns and school closures. Many children took their own lives out of despair, depression, and hopelessness due to the lockdowns and school closures.” | |||||
156 | 151) Open letter from medical doctors and health professionals to all Belgian authorities and all Belgian media, The American Institute of Stress, 2020 | “If we compare the waves of infection in countries with strict lockdown policies to countries that did not impose lockdowns (Sweden, Iceland …), we see similar curves. So there is no link between the imposed lockdown and the course of the infection. Lockdown has not led to a lower mortality rate. If we look at the date of application of the imposed lockdowns we see that the lockdowns were set after the peak was already over and the number of cases decreasing. The drop was therefore not the result of the taken measures.” | |||||
157 | 152) Lockdown Scepticism Was Never a ‘Fringe’ Viewpoint, Carl, 2021 | “Whether or not lockdowns are justifiable on public-health grounds, they certainly represent the greatest infringement on civil liberties in modern history. In the UK, lockdowns have contributed to the largest economic contraction in more than 300 years, as well as countless bankruptcies, and a dramatic rise in public borrowing.” | |||||
158 | 153) Actuaries warn Ramaphosa of a ‘humanitarian disaster to dwarf Covid-19′ if restrictive lockdown is not lifted, Bell, 2020 | “The frequently voiced government mantra that lives are being prioritised and that the issue is “lives versus the economy” is described in the Panda report as a false dichotomy. The report notes: “Viruses kill. But the economy sustains lives, and poverty kills too.”It points out that the admitted intention of the lockdown is to “flatten the curve”, to spread expected virus deaths over time, so as not to overburden hospital systems. This “saves lives to the extent that avoidable deaths are prevented, but merely shifts the timing of the rest by some weeks.” | |||||
159 | 154) THE STATE OF THE NATION: A 50-STATE COVID-19 SURVEY REPORT #23: DEPRESSION AMONG YOUNG ADULTS, Perlis, 2020 | “In line with our May results, our survey indicates that the next administration will lead a country where unprecedented numbers of younger individuals are experiencing depression, anxiety, and, for some, thoughts of suicide. These symptoms are not concentrated among any particular subgroup or region in our survey; they are elevated in every group we examined. Our survey results also strongly suggest that those with direct economic and property losses resulting from COVID-19 appear to be at particular risk, so strategies focusing on these individuals may be critical.” | |||||
160 | 155) COVID-19 to Add as Many as 150 Million Extreme Poor by 2021, The World Bank, 2020 | “Global extreme poverty is expected to rise in 2020 for the first time in over 20 years as the disruption of the COVID-19 pandemic compounds the forces of conflict and climate change, which were already slowing poverty reduction progress, the World Bank said today.The COVID-19 pandemic is estimated to push an additional 88 million to 115 million people into extreme poverty this year, with the total rising to as many as 150 million by 2021, depending on the severity of the economic contraction. Extreme poverty, defined as living on less than $1.90 a day, is likely to affect between 9.1% and 9.4% of the world’s population in 2020, according to the biennial Poverty and Shared Prosperity Report. This would represent a regression to the rate of 9.2% in 2017. Had the pandemic not convulsed the globe, the poverty rate was expected to drop to 7.9% in 2020.” | |||||
161 | 156) The impact of COVID-19 on heart failure hospitalization and management: report from a Heart Failure Unit in London during the peak of the pandemic, Bromage, 2020 | “Incident AHF hospitalization significantly declined in our centre during the COVID-19 pandemic, but hospitalized patients had more severe symptoms at admission. Further studies are needed to investigate whether the incidence of AHF declined or patients did not present to hospital while the national lockdown and social distancing restrictions were in place. From a public health perspective, it is imperative to ascertain whether this will be associated with worse long-term outcomes.” | |||||
162 | 157) For the Greater Good? The Devastating Ripple Effects of the Covid-19 Crisis, Schippers, 2020 | The side effects so far seem to outweigh the positive effects and a recent historical overview of outbreaks concludes that: “History suggests that we are actually at much greater risk of exaggerated fears and misplaced priorities” (Jones D. S., 2020; p. 1683). The main side effects are: Excess mortality from causes other such as hunger, delayed health care, increase in effects mental health issues, suicide, increase in diseases such as measles, and increased inequalities due to school closures and job loss. These have ripple effects throughout society. In many countries emergency admissions, e.g., for cardiac chest pain and transient ischemic attacks, are decreased by about 50%, as people are avoiding hospital visits, which eventually will lead to higher death rates from other causes, such as heart attack and strokes (Sarner, 2020). Also, many medical treatments such as chemotherapy have not been given and were postponed (Sud et al., 2020). In terms of mental health effects, vulnerable groups, such as people with prior mental health issues might be at especially high risk (Jeong et al., 2016). Indeed, a survey by Young Minds revealed that up to 80% of young people with a history of mental health issues reported a worsening of their condition as a result of the pandemic and lockdown measures (Sarner, 2020). The mental health effects arguably affect the general population as a whole, and it has been suggested that this will be a global catastrophe (Izaguirre-Torres and Siche, 2020). | |||||
163 | 158) COVID-19 emergency measures and the impending authoritarian pandemic, Thomson, 2020 | “Yet, as this Article demonstrates—with diverse examples drawn from across the world—there are unmistakable regressions into authoritarianism in governmental efforts to contain the virus. Despite the unprecedented nature of this challenge, there is no sound justification for systemic erosion of rights-protective democratic ideals and institutions beyond that which is strictly demanded by the exigencies of the pandemic. A Wuhan-inspired all-or-nothing approach to viral containment sets a dangerous precedent for future pandemics and disasters, with the global copycat response indicating an impending ‘pandemic’ of a different sort, that of authoritarianization. With a gratuitous toll being inflicted on democracy, civil liberties, fundamental freedoms, healthcare ethics, and human dignity, this has the potential to unleash humanitarian crises no less devastating than COVID-19 in the long run.” | |||||
164 | 159) Falling living standards during the COVID-19 crisis: Quantitative evidence from nine developing countries, Egger, 2021 | “Document declines in employment and income in all settings beginning March 2020. The share of households experiencing an income drop ranges from 8 to 87% (median, 68%). Household coping strategies and government assistance were insufficient to sustain precrisis living standards, resulting in widespread food insecurity and dire economic conditions even 3 months into the crisis. We discuss promising policy responses and speculate about the risk of persistent adverse effects, especially among children and other vulnerable groups.” | |||||
165 | 160) COVID-19 and the Political Economy of Mass Hysteria, Bagus, 2021 | “The violation of basic human rights in the form of curfews, lockdowns, and coercive closure of business has been amply illustrated during the COVID-19 crisis. Naturally, the COVID-19 example is indicative rather than representative and its lessons cannot be generalized. During the COVID-19 crisis, several authors have argued that from a public health point of view, these invasive interventions such as lockdowns have been unnecessary and, indeed, detrimental to overall public health. In fact, prior scientific research on disease mitigation measures during a possible influenza pandemic had warned against such invasive interventions and recommended a more normal social functioning.” | |||||
166 | 161) COVID-19 mortalities in England and Wales and the Peltzman offsetting effect, Williams, 2021 | “Our results suggest: (i) a refined estimate of mean weekly COVID-19 excess deaths that is 63% of standard excess deaths; and (ii) a positive net excess mortality impact of the lockdown. We make a case that (ii) is due to the Peltzman offsetting effect, i.e. the intended mortality impact of the lockdown was more than offset by the unintended impact.” | |||||
167 | 162) Progression of COVID-19 under the highly restrictive measures imposed in Argentina, Sagripanti, 2021 | “The number of yearly deaths caused by respiratory diseases and influenza in Argentina before the pandemic was similar to the total number of deaths attributed to COVID-19 cumulated on April 25, 2021, more than a year after the pandemic started. The failure to detect any benefit on ameliorating COVID-19 by the long and strict nation-wide lock-downs in Argentina should raise world-wide concerns about mandating costly and ineffective restrictive measures during ongoing or future pandemics.” | |||||
168 | 163) COVID-19 in South Africa, Broadbent, 2020 | “This does not show that locking down made no difference relative to a counterfactual scenario (and a full analysis would need to consider provincial trajectories too), but it does mean that a detailed (and provincial) analysis needs to be undertaken before we can evaluate the effectiveness of lockdown measures in the South African context. Were we to try to “read off” the effect of the interventions from the shape of the epidemic, we would have to conclude they had no effect. Likewise we would have to attribute the slow progress of the epidemic in the country to background features (e.g. the relative youthfulness of the population). This is a caution against such “reading off” both in this context and others.” | |||||
169 | 164) The effects of non-pharmaceutical interventions on SARS-CoV-2 transmission in different socioeconomic populations in Kuwait: a modeling study, Khadadah, 2021 | “Our simulated epidemic trajectories show that the partial curfew measure greatly reduced and delayed the height of the peak in P1, yet significantly elevated and hastened the peak in P2. Modest cross-transmission between P1 and P2 greatly elevated the height of the peak in P1 and brought it forward in time closer to the peak of P2.” | |||||
170 | 165) Hard, not early: putting the New Zealand Covid-19 response in context, Gibson, 2020 | “The cross-country evidence shows that restrictions imposed after the inflection point in infections is reached are ineffective in reducing total deaths. Even restrictions imposed earlier have just a modest effect.” | |||||
171 | 166) The SARS-CoV-2 Pandemic in High Income Countries Such as Canada: A Better Way Forward Without Lockdowns, Joffe, 2021 | “Specifically, there are three priorities including the following: first, protect those most at risk by separating them from the threat (mitigation); second, ensure critical infrastructure is ready for people who get sick (preparation and response); and third, shift the response from fear to confidence (recovery). We argue that, based on Emergency Management principles, the age-dependent risk from SARS-CoV-2, the minimal (at best) efficacy of lockdowns, and the terrible cost-benefit trade-offs of lockdowns, we need to reset the pandemic response. We can manage risk and save more lives from both COVID-19 and lockdowns, thus achieving far better outcomes in both the short- and long-term.” | |||||
172 | 167) On the effectiveness of COVID-19 restrictions and lockdowns: Pan metron ariston, Spiliopoulos, 2021 | “Governments conditioned policy choice on recent pandemic dynamics, and were found to de-escalate the associated stringency of implemented NPIs more cautiously than in their escalation, i.e., policy mixes exhibited significant hysteresis. Finally, at least 90% of the maximum effectiveness of NPIs can be achieved by policies with an average Stringency index of 31–40, without restricting internal movement or imposing stay at home measures, and only recommending (not enforcing) closures on workplaces and schools, accompanied by public informational campaigns. Consequently, the positive effects on case and death growth rates of voluntary behavioral changes in response to beliefs about the severity of the pandemic, generally trumped those arising from mandatory behavioral restrictions.” | |||||
173 | 168) Covid-19: Comparisons by Country and Implications for Future Pandemics, Mehl-Madrona, 2021 | “While no lockdown resulted in higher mortality, the difference between strict lockdown and lax lockdown was not terribly different and favored lax lockdown. Only one of the top 44 countries had long and strict restrictions. Strict restrictions were more common in the worst performing countries in terms of Covid mortality. The United States had both the largest economic growth coupled with the largest rate of mortality. Those who did well economically, had lower mortality and less pressure on their population. Yet they had less mortality than average and less than their neighbors.” | |||||
174 | 169) Does Social Isolation Really Curb COVID-19 Deaths? Direct Evidence from Brazil that it Might do the Exact Opposite, de Souza, 2020 | “There appears to be strong empirical evidence that, in Brazil, the adoption of restrictive measures increasing social isolation have worsened the pandemic in that country instead of mitigating it, likely as a higher-order effect emerging from a combination of factors.” | |||||
175 | 170) The tiered restrictions enforced in November 2020 did not impact the epidemiology of the second wave of COVID-19 in Italy, Rainisio, 2021 | “The trend of R(t) tending to increase shortly after the measures became effective does not allow to exclude that the enforcement of such restrictions might have been counterproductive. These results are instrumental in informing public health efforts aimed at attempting to manage the epidemic efficiently. Planning further use of the tiered restrictions and the associated containment measures should be carefully and critically revised to avoid a useless burden to the population with no advantage for the containment of the epidemic or a possible worsening.” |
A | B | C | D | F | G | |
---|---|---|---|---|---|---|
1 | YEAR | AUTHOR | TITLE | APA CITATION | LINK_ACTIVE | CATEGORY |
2 | 2020 | Frankl, R. | . Comorbidities the rules in New York’s COVID-19 Deaths. The Hospitalist. | Frankl, R. (2020). Comorbidities the rules in New York’s COVID-19 Deaths. The Hospitalist. | https://www.the-hospitalist.org/hospitalist/article/220457/coronavirus-updates/comorbidities-rule-new-yorks-covid-19-deaths | Demonstrating health/immune system/covid-19 relationship and coronavirus susceptibility |
3 | 2018 | Mokdad, A. H., Ballestros, K., Echko, M., Glenn, S., Olsen, H. E., Mullany, E., ... & Kasaeian, A. | . The state of US health, 1990-2016: burden of diseases, injuries, and risk factors among US states. Jama, 319(14), 1444-1472. | Mokdad, A. H., Ballestros, K., Echko, M., Glenn, S., Olsen, H. E., Mullany, E., ... & Kasaeian, A. (2018). The state of US health, 1990-2016: burden of diseases, injuries, and risk factors among US states. Jama, 319(14), 1444-1472. | https://jamanetwork.com/journals/jama/fullarticle/2678018 | Demonstrating health/immune system/covid-19 relationship and coronavirus susceptibility |
4 | 2005 | Nieman, D. C., Henson, D. A., Austin, M. D., & Brown, V. A. | . Immune response to a 30-minute walk. Medicine and science in sports and exercise, 37(1), 57–62. https://doi.org/10.1249/01.mss.0000149808.38194.21 | Nieman, D. C., Henson, D. A., Austin, M. D., & Brown, V. A. (2005). Immune response to a 30-minute walk. Medicine and science in sports and exercise, 37(1), 57–62. https://doi.org/10.1249/01.mss.0000149808.38194.21 | https://pubmed.ncbi.nlm.nih.gov/15632669/ | Demonstrating health/immune system/covid-19 relationship and coronavirus susceptibility |
5 | 2020 | Richardson, S., Hirsch, J. S., Narasimhan, M., Crawford, J. M., McGinn, T., Davidson, K. W., ... & Cookingham, J. | . Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area. Jama. | Richardson, S., Hirsch, J. S., Narasimhan, M., Crawford, J. M., McGinn, T., Davidson, K. W., ... & Cookingham, J. (2020). Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area. Jama. | https://jamanetwork.com/journals/jama/fullarticle/2765184 | Demonstrating health/immune system/covid-19 relationship and coronavirus susceptibility |
6 | 2017 | University of Edinburgh. | . Immune study points to new ways to treat lung disease. ScienceDaily. Retrieved September 23, 2020 from www.sciencedaily.com/releases/2017/08/170814162003.htm | University of Edinburgh. (2017, August 14). Immune study points to new ways to treat lung disease. ScienceDaily. Retrieved September 23, 2020 from www.sciencedaily.com/releases/2017/08/170814162003.htm | https://www.sciencedaily.com/releases/2017/08/170814162003.htm | Demonstrating health/immune system/covid-19 relationship and coronavirus susceptibility |
7 | 2020 | van Eeden, C., Khan, L., Osman, M. S., & Cohen Tervaert, J. W. | . Natural Killer Cell Dysfunction and Its Role in COVID-19. International Journal of Molecular Sciences, 21(17), 6351. | van Eeden, C., Khan, L., Osman, M. S., & Cohen Tervaert, J. W. (2020). Natural Killer Cell Dysfunction and Its Role in COVID-19. International Journal of Molecular Sciences, 21(17), 6351. | https://www.healio.com/news/hematology-oncology/20200402/fda-clears-ind-application-for-natural-killer-cellbased-covid19-therapy | Demonstrating health/immune system/covid-19 relationship and coronavirus susceptibility |
8 | 2020 | Yaqinuddin, A., & Kashir, J. | . Innate immunity in COVID-19 patients mediated by NKG2A receptors, and potential treatment using Monalizumab, Cholroquine, and antiviral agents. Medical Hypotheses, 109777. | Yaqinuddin, A., & Kashir, J. (2020). Innate immunity in COVID-19 patients mediated by NKG2A receptors, and potential treatment using Monalizumab, Cholroquine, and antiviral agents. Medical Hypotheses, 109777. | https://pubmed.ncbi.nlm.nih.gov/32344314/ | Demonstrating health/immune system/covid-19 relationship and coronavirus susceptibility |
9 | 2020 | Bae, S., Kim, M. C., Kim, J. Y., Cha, H. H., Lim, J. S., Jung, J., ... & Sung, M. | . Effectiveness of surgical and cotton masks in blocking SARS–CoV-2: a controlled comparison in 4 patients. Annals of Internal Medicine. | Bae, S., Kim, M. C., Kim, J. Y., Cha, H. H., Lim, J. S., Jung, J., ... & Sung, M. (2020). Effectiveness of surgical and cotton masks in blocking SARS–CoV-2: a controlled comparison in 4 patients. Annals of Internal Medicine. | https://www.acpjournals.org/doi/10.7326/M20-1342 | Demonstrating ineffectiveness of masks in reducing the spread of infectious disease |
10 | 2020 | Brosseau, L., & Sietsema, M. | . Commentary: Masks-for-all for COVID-19 not based on sound data. CIDRAP: Center for Infectious Disease Research and Practice. University of Minnesota, News and Commentaries. | Brosseau, L., & Sietsema, M. (2020). Commentary: Masks-for-all for COVID-19 not based on sound data. CIDRAP: Center for Infectious Disease Research and Practice. University of Minnesota, News and Commentaries. | https://www.cidrap.umn.edu/news-perspective/2020/04/commentary-masks-all-covid-19-not-based-sound-data | Demonstrating ineffectiveness of masks in reducing the spread of infectious disease |
11 | 2010 | Canini, L., Andréoletti, L., Ferrari, P., D'Angelo, R., Blanchon, T., Lemaitre, M., Filleul, L., Ferry, J. P., Desmaizieres, M., Smadja, S., Valleron, A. J., & Carrat, F. | . Surgical mask to prevent influenza transmission in households: a cluster randomized trial. PloS one, 5(11), e13998. https://doi.org/10.1371/journal.pone.0013998 | Canini, L., Andréoletti, L., Ferrari, P., D'Angelo, R., Blanchon, T., Lemaitre, M., Filleul, L., Ferry, J. P., Desmaizieres, M., Smadja, S., Valleron, A. J., & Carrat, F. (2010). Surgical mask to prevent influenza transmission in households: a cluster randomized trial. PloS one, 5(11), e13998. https://doi.org/10.1371/journal.pone.0013998 | https://pubmed.ncbi.nlm.nih.gov/21103330/ | Demonstrating ineffectiveness of masks in reducing the spread of infectious disease |
12 | 2009 | Jacobs, J. L., Ohde, S., Takahashi, O., Tokuda, Y., Omata, F., & Fukui, T. | . Use of surgical face masks to reduce the incidence of the common cold among health care workers in Japan: a randomized controlled trial. American journal of infection control, 37(5), 417–419. https://doi.org/10.1016/j.ajic.2008.11.002 | Jacobs, J. L., Ohde, S., Takahashi, O., Tokuda, Y., Omata, F., & Fukui, T. (2009). Use of surgical face masks to reduce the incidence of the common cold among health care workers in Japan: a randomized controlled trial. American journal of infection control, 37(5), 417–419. https://doi.org/10.1016/j.ajic.2008.11.002 | https://pubmed.ncbi.nlm.nih.gov/19216002/ | Demonstrating ineffectiveness of masks in reducing the spread of infectious disease |
13 | 2020 | Korber, B., Fischer, W. M., Gnanakaran, S., Yoon, H., Theiler, J., Abfalterer, W., ... & Hastie, K. M. | . Tracking changes in SARS-CoV-2 Spike: evidence that D614G increases infectivity of the COVID-19 virus. Cell, 182(4), 812-827. | Korber, B., Fischer, W. M., Gnanakaran, S., Yoon, H., Theiler, J., Abfalterer, W., ... & Hastie, K. M. (2020). Tracking changes in SARS-CoV-2 Spike: evidence that D614G increases infectivity of the COVID-19 virus. Cell, 182(4), 812-827. | https://www.cell.com/action/showPdf?pii=S0092-8674%2820%2930820-5 | Demonstrating ineffectiveness of masks in reducing the spread of infectious disease |
14 | 2009 | Loeb, M., Dafoe, N., Mahony, J., John, M., Sarabia, A., Glavin, V., ... & Webb, A. | . Surgical mask vs N95 respirator for preventing influenza among health care workers: a randomized trial. Jama, 302(17), 1865-1871. | Loeb, M., Dafoe, N., Mahony, J., John, M., Sarabia, A., Glavin, V., ... & Webb, A. (2009). Surgical mask vs N95 respirator for preventing influenza among health care workers: a randomized trial. Jama, 302(17), 1865-1871. | https://jamanetwork.com/journals/jama/fullarticle/184819 | Demonstrating ineffectiveness of masks in reducing the spread of infectious disease |
15 | 2020 | MacIntyre, C. R., & Chughtai, A. A. | . A rapid systematic review of the efficacy of face masks and respirators against coronaviruses and other respiratory transmissible viruses for the community, healthcare workers and sick patients. International journal of nursing studies, 108, 103629. https://doi.org/10.1016/j.ijnurstu.2020.103629 | MacIntyre, C. R., & Chughtai, A. A. (2020). A rapid systematic review of the efficacy of face masks and respirators against coronaviruses and other respiratory transmissible viruses for the community, healthcare workers and sick patients. International journal of nursing studies, 108, 103629. https://doi.org/10.1016/j.ijnurstu.2020.103629 | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7191274/#__ffn_sectitle | Demonstrating ineffectiveness of masks in reducing the spread of infectious disease |
16 | 2017 | MacIntyre, C. R., Chughtai, A. A., Rahman, B., Peng, Y., Zhang, Y., Seale, H., ... & Wang, Q. | . The efficacy of medical masks and respirators against respiratory infection in healthcare workers. Influenza and other respiratory viruses, 11(6), 511-517. | MacIntyre, C. R., Chughtai, A. A., Rahman, B., Peng, Y., Zhang, Y., Seale, H., ... & Wang, Q. (2017). The efficacy of medical masks and respirators against respiratory infection in healthcare workers. Influenza and other respiratory viruses, 11(6), 511-517. | https://onlinelibrary.wiley.com/doi/full/10.1111/irv.12474 | Demonstrating ineffectiveness of masks in reducing the spread of infectious disease |
17 | 2015 | MacIntyre, C. R., Seale, H., Dung, T. C., Hien, N. T., Nga, P. T., Chughtai, A. A., ... & Wang, Q. | . A cluster randomised trial of cloth masks compared with medical masks in healthcare workers. BMJ open, 5(4), e006577. | MacIntyre, C. R., Seale, H., Dung, T. C., Hien, N. T., Nga, P. T., Chughtai, A. A., ... & Wang, Q. (2015). A cluster randomised trial of cloth masks compared with medical masks in healthcare workers. BMJ open, 5(4), e006577. | https://bmjopen.bmj.com/content/5/4/e006577.long | Demonstrating ineffectiveness of masks in reducing the spread of infectious disease |
18 | 2019 | Radonovich, L. J., Simberkoff, M. S., Bessesen, M. T., Brown, A. C., Cummings, D. A., Gaydos, C. A., ... & Nyquist, A. C. | . N95 respirators vs medical masks for preventing influenza among health care personnel: a randomized clinical trial. Jama, 322(9), 824-833. | Radonovich, L. J., Simberkoff, M. S., Bessesen, M. T., Brown, A. C., Cummings, D. A., Gaydos, C. A., ... & Nyquist, A. C. (2019). N95 respirators vs medical masks for preventing influenza among health care personnel: a randomized clinical trial. Jama, 322(9), 824-833. | https://jamanetwork.com/journals/jama/fullarticle/2749214%20 | Demonstrating ineffectiveness of masks in reducing the spread of infectious disease |
19 | 2009 | Wageningen University and Research Centre. | . One Virus Particle Is Enough To Cause Infectious Disease. ScienceDaily. Retrieved September 22, 2020 from www.sciencedaily.com/releases/2009/03/090313150254.htm | Wageningen University and Research Centre. (2009, March 14). One Virus Particle Is Enough To Cause Infectious Disease. ScienceDaily. Retrieved September 22, 2020 from www.sciencedaily.com/releases/2009/03/090313150254.htm | https://www.sciencedaily.com/releases/2009/03/090313150254.htm | Demonstrating ineffectiveness of masks in reducing the spread of infectious disease |
20 | 2017 | World Health Organization. | . Up to 650 000 people die of respiratory diseases linked to seasonal flu each year. December 14, 2017. | World Health Organization. (2017). Up to 650 000 people die of respiratory diseases linked to seasonal flu each year. December 14, 2017. | https://www.who.int/mediacentre/news/statements/2017/flu/en/ | Demonstrating ineffectiveness of masks in reducing the spread of infectious disease |
21 | 1997 | Belkin N. L. | . The evolution of the surgical mask: filtering efficiency versus effectiveness. Infection control and hospital epidemiology, 18(1), 49–57. https://doi.org/10.2307/30141964 | Belkin N. L. (1997). The evolution of the surgical mask: filtering efficiency versus effectiveness. Infection control and hospital epidemiology, 18(1), 49–57. https://doi.org/10.2307/30141964 | https://pubmed.ncbi.nlm.nih.gov/9013247/ | Demonstrating ineffectiveness of masks in surgery |
22 | 2015 | Da Zhou, C., Sivathondan, P., & Handa, A. | . Unmasking the surgeons: the evidence base behind the use of facemasks in surgery. Journal of the Royal Society of Medicine, 108(6), 223-228. | Da Zhou, C., Sivathondan, P., & Handa, A. (2015). Unmasking the surgeons: the evidence base behind the use of facemasks in surgery. Journal of the Royal Society of Medicine, 108(6), 223-228. | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4480558/ | Demonstrating ineffectiveness of masks in surgery |
23 | 1989 | Laslett, L. J., & Sabin, A. | . Wearing of caps and masks not necessary during cardiac catheterization. Catheterization and cardiovascular diagnosis, 17(3), 158–160. https://doi.org/10.1002/ccd.1810170306 | Laslett, L. J., & Sabin, A. (1989). Wearing of caps and masks not necessary during cardiac catheterization. Catheterization and cardiovascular diagnosis, 17(3), 158–160. https://doi.org/10.1002/ccd.1810170306 | https://pubmed.ncbi.nlm.nih.gov/2766345/ | Demonstrating ineffectiveness of masks in surgery |
24 | 1991 | Mitchell, N. J., & Hunt, S. | . Surgical face masks in modern operating rooms—a costly and unnecessary ritual?. Journal of Hospital Infection, 18(3), 239-242. | Mitchell, N. J., & Hunt, S. (1991). Surgical face masks in modern operating rooms—a costly and unnecessary ritual?. Journal of Hospital Infection, 18(3), 239-242. | https://www.journalofhospitalinfection.com/article/0195-6701(91)90148-2/pdf | Demonstrating ineffectiveness of masks in surgery |
25 | 2016 | Vincent, M., & Edwards, P. | . Disposable surgical face masks for preventing surgical wound infection in clean surgery. The Cochrane database of systematic reviews, 4(4), CD002929. https://doi.org/10.1002/14651858.CD002929.pub3 | Vincent, M., & Edwards, P. (2016). Disposable surgical face masks for preventing surgical wound infection in clean surgery. The Cochrane database of systematic reviews, 4(4), CD002929. https://doi.org/10.1002/14651858.CD002929.pub3 | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7138271/ | Demonstrating ineffectiveness of masks in surgery |
26 | 2008 | Beder, A., Büyükkoçak, U., Sabuncuoğlu, H., Keskil, Z. A., & Keskil, S. | . Preliminary report on surgical mask induced deoxygenation during major surgery. Neurocirugia (Asturias, Spain), 19(2), 121–126. https://doi.org/10.1016/s1130-1473(08)70235-5 | Beder, A., Büyükkoçak, U., Sabuncuoğlu, H., Keskil, Z. A., & Keskil, S. (2008). Preliminary report on surgical mask induced deoxygenation during major surgery. Neurocirugia (Asturias, Spain), 19(2), 121–126. https://doi.org/10.1016/s1130-1473(08)70235-5 | https://pubmed.ncbi.nlm.nih.gov/18500410/ | Demonstrating the physiological and psychological damage caused by mask usage |
27 | 2018 | Chen, C., Martínez, R. M., & Cheng, Y. | . The developmental origins of the social brain: empathy, morality, and justice. Frontiers in Psychology, 9, 2584. | Chen, C., Martínez, R. M., & Cheng, Y. (2018). The developmental origins of the social brain: empathy, morality, and justice. Frontiers in Psychology, 9, 2584. | https://www.frontiersin.org/articles/10.3389/fpsyg.2018.02584/full | Demonstrating the physiological and psychological damage caused by mask usage |
28 | 2006 | Fletcher, S. J., Clark, M., & Stanley, P. J. | . Carbon dioxide re‐breathing with close fitting face respirator masks. Anaesthesia, 61(9), 910-910. | Fletcher, S. J., Clark, M., & Stanley, P. J. (2006). Carbon dioxide re‐breathing with close fitting face respirator masks. Anaesthesia, 61(9), 910-910. | https://onlinelibrary.wiley.com/doi/full/10.1111/j.1365-2044.2006.04767.x | Demonstrating the physiological and psychological damage caused by mask usage |
29 | 2014 | Freeman, J. B., Stolier, R. M., Ingbretsen, Z. A., & Hehman, E. A. | . Amygdala responsivity to high-level social information from unseen faces. Journal of Neuroscience, 34(32), 10573-10581. | Freeman, J. B., Stolier, R. M., Ingbretsen, Z. A., & Hehman, E. A. (2014). Amygdala responsivity to high-level social information from unseen faces. Journal of Neuroscience, 34(32), 10573-10581. | https://www.jneurosci.org/content/34/32/10573 | Demonstrating the physiological and psychological damage caused by mask usage |
30 | 2020 | Guessoum, S. B., Lachal, J., Radjack, R., Carretier, E., Minassian, S., Benoit, L., & Moro, M. R. | . Adolescent psychiatric disorders during the COVID-19 pandemic and lockdown. Psychiatry research, 113264. | Guessoum, S. B., Lachal, J., Radjack, R., Carretier, E., Minassian, S., Benoit, L., & Moro, M. R. (2020). Adolescent psychiatric disorders during the COVID-19 pandemic and lockdown. Psychiatry research, 113264. | https://www.sciencedirect.com/science/article/pii/S0165178120318382?casa_token=H4AqJQQvOrAAAAAA:DfGhxGHQlrEVDraxDfm_j1TZzzOfXQXGUX-7SjkTb_cO3BmrM_6aBGD6IvQkcU0qV9wXGeeKeHs | Demonstrating the physiological and psychological damage caused by mask usage |
31 | 2004 | Kao, T. W., Huang, K. C., Huang, Y. L., Tsai, T. J., Hsieh, B. S., & Wu, M. S. | . The physiological impact of wearing an N95 mask during hemodialysis as a precaution against SARS in patients with end-stage renal disease. Journal of the Formosan Medical Association = Taiwan yi zhi, 103(8), 624–628. | Kao, T. W., Huang, K. C., Huang, Y. L., Tsai, T. J., Hsieh, B. S., & Wu, M. S. (2004). The physiological impact of wearing an N95 mask during hemodialysis as a precaution against SARS in patients with end-stage renal disease. Journal of the Formosan Medical Association = Taiwan yi zhi, 103(8), 624–628. | https://pubmed.ncbi.nlm.nih.gov/15340662/ | Demonstrating the physiological and psychological damage caused by mask usage |
32 | 2005 | Li, Y., Tokura, H., Guo, Y. P., Wong, A. S., Wong, T., Chung, J., & Newton, E. | . Effects of wearing N95 and surgical facemasks on heart rate, thermal stress and subjective sensations. International archives of occupational and environmental health, 78(6), 501–509. https://doi.org/10.1007/s00420-004-0584-4 | Li, Y., Tokura, H., Guo, Y. P., Wong, A. S., Wong, T., Chung, J., & Newton, E. (2005). Effects of wearing N95 and surgical facemasks on heart rate, thermal stress and subjective sensations. International archives of occupational and environmental health, 78(6), 501–509. https://doi.org/10.1007/s00420-004-0584-4 | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7087880/#!po=37.8049 | Demonstrating the physiological and psychological damage caused by mask usage |
33 | 2020 | Madan, S. | . RE: Mental health issues in children amidst COVID-19 pandemic. | Madan, S. (2020). RE: Mental health issues in children amidst COVID-19 pandemic. | https://www.cmaj.ca/content/re-mental-health-issues-children-amidst-covid-19-pandemic | Demonstrating the physiological and psychological damage caused by mask usage |
34 | 2012 | Roberge, R. J., Kim, J. H., & Coca, A. | . Protective facemask impact on human thermoregulation: an overview. Annals of occupational hygiene, 56(1), 102-112. | Roberge, R. J., Kim, J. H., & Coca, A. (2012). Protective facemask impact on human thermoregulation: an overview. Annals of occupational hygiene, 56(1), 102-112. | https://academic.oup.com/annweh/article/56/1/102/166254 | Demonstrating the physiological and psychological damage caused by mask usage |
35 | 2004 | Segerstrom, S. C., & Miller, G. E. | . Psychological stress and the human immune system: a meta-analytic study of 30 years of inquiry. Psychological bulletin, 130(4), 601–630. https://doi.org/10.1037/0033-2909.130.4.601 | Segerstrom, S. C., & Miller, G. E. (2004). Psychological stress and the human immune system: a meta-analytic study of 30 years of inquiry. Psychological bulletin, 130(4), 601–630. https://doi.org/10.1037/0033-2909.130.4.601 | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1361287/ | Demonstrating the physiological and psychological damage caused by mask usage |
36 | 2013 | Smith, C. L., Whitelaw, J. L., & Davies, B. | . Carbon dioxide rebreathing in respiratory protective devices: influence of speech and work rate in full-face masks. Ergonomics, 56(5), 781–790. https://doi.org/10.1080/00140139.2013.777128 | Smith, C. L., Whitelaw, J. L., & Davies, B. (2013). Carbon dioxide rebreathing in respiratory protective devices: influence of speech and work rate in full-face masks. Ergonomics, 56(5), 781–790. https://doi.org/10.1080/00140139.2013.777128 | https://pubmed.ncbi.nlm.nih.gov/23514282/ | Demonstrating the physiological and psychological damage caused by mask usage |
37 | 2015 | Tong, P. S., Kale, A. S., Ng, K., Loke, A. P., Choolani, M. A., Lim, C. L., Chan, Y. H., Chong, Y. S., Tambyah, P. A., & Yong, E. L. | . Respiratory consequences of N95-type Mask usage in pregnant healthcare workers-a controlled clinical study. Antimicrobial resistance and infection control, 4, 48. https://doi.org/10.1186/s13756-015-0086-z | Tong, P. S., Kale, A. S., Ng, K., Loke, A. P., Choolani, M. A., Lim, C. L., Chan, Y. H., Chong, Y. S., Tambyah, P. A., & Yong, E. L. (2015). Respiratory consequences of N95-type Mask usage in pregnant healthcare workers-a controlled clinical study. Antimicrobial resistance and infection control, 4, 48. https://doi.org/10.1186/s13756-015-0086-z | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4647822/ | Demonstrating the physiological and psychological damage caused by mask usage |
38 | 2020 | Turban, J. L., Keuroghlian, A. S., & Mayer, K. H. | . Sexual Health in the SARS-CoV-2 Era. Annals of internal medicine, 173(5), 387–389. https://doi.org/10.7326/M20-2004 | Turban, J. L., Keuroghlian, A. S., & Mayer, K. H. (2020). Sexual Health in the SARS-CoV-2 Era. Annals of internal medicine, 173(5), 387–389. https://doi.org/10.7326/M20-2004 | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7233185/ | Demonstrating the physiological and psychological damage caused by mask usage |
39 | 2021 | Guerra, D., & Guerra, D. J. | . Mask mandate and use efficacy in state-level COVID-19 containment. medRxiv. | Guerra, D., & Guerra, D. J. (2021). Mask mandate and use efficacy in state-level COVID-19 containment. medRxiv. | https://www.medrxiv.org/content/10.1101/2021.05.18.21257385v1.full-text | Most Recent Mask Studies |
40 | 2021 | Vainshelboim, B. | . Facemasks in the COVID-19 era: A health hypothesis. Medical Hypotheses, 146, 110411. | Vainshelboim, B. (2021). Facemasks in the COVID-19 era: A health hypothesis. Medical Hypotheses, 146, 110411. | https://www.sciencedirect.com/science/article/pii/S0306987720333028 | Most Recent Mask Studies |
41 | #N/A | #VALUE! | #VALUE! | https://swprs.org/face-masks-evidence/ | Most Recent Mask Studies | |
42 | 2018 | Person, E., Lemercier, C., Royer, A., & Reychler, G. | . Effect of a surgical mask on six minute walking distance. Revue des maladies respiratoires, 35(3), 264-268. | Person, E., Lemercier, C., Royer, A., & Reychler, G. (2018). Effect of a surgical mask on six minute walking distance. Revue des maladies respiratoires, 35(3), 264-268. | https://pubmed.ncbi.nlm.nih.gov/29395560/ | 5 NIH/National Library of Medicine studies from 2004-2020 all finding verifiable health effects from wearing a face mask, including scientifically verified reduction in blood oxygen level: |
43 | 2020 | Chandrasekaran, B., & Fernandes, S. | . “Exercise with facemask; Are we handling a devil's sword?”–A physiological hypothesis. Medical hypotheses, 144, 110002. | Chandrasekaran, B., & Fernandes, S. (2020). “Exercise with facemask; Are we handling a devil's sword?”–A physiological hypothesis. Medical hypotheses, 144, 110002. | https://pubmed.ncbi.nlm.nih.gov/32590322/ | 5 NIH/National Library of Medicine studies from 2004-2020 all finding verifiable health effects from wearing a face mask, including scientifically verified reduction in blood oxygen level: |
44 | 2004 | Kao, T. W., Huang, K. C., Huang, Y. L., Tsai, T. J., Hsieh, B. S., & Wu, M. S. | . The physiological impact of wearing an N95 mask during hemodialysis as a precaution against SARS in patients with end-stage renal disease. Journal of the Formosan Medical Association= Taiwan yi zhi, 103(8), 624-628. | Kao, T. W., Huang, K. C., Huang, Y. L., Tsai, T. J., Hsieh, B. S., & Wu, M. S. (2004). The physiological impact of wearing an N95 mask during hemodialysis as a precaution against SARS in patients with end-stage renal disease. Journal of the Formosan Medical Association= Taiwan yi zhi, 103(8), 624-628. | https://pubmed.ncbi.nlm.nih.gov/15340662/ | 5 NIH/National Library of Medicine studies from 2004-2020 all finding verifiable health effects from wearing a face mask, including scientifically verified reduction in blood oxygen level: |
45 | 2015 | Tong, P. S. Y., Kale, A. S., Ng, K., Loke, A. P., Choolani, M. A., Lim, C. L., ... & Yong, E. L. | . Respiratory consequences of N95-type Mask usage in pregnant healthcare workers—a controlled clinical study. Antimicrobial Resistance & Infection Control, 4(1), 1-10. | Tong, P. S. Y., Kale, A. S., Ng, K., Loke, A. P., Choolani, M. A., Lim, C. L., ... & Yong, E. L. (2015). Respiratory consequences of N95-type Mask usage in pregnant healthcare workers—a controlled clinical study. Antimicrobial Resistance & Infection Control, 4(1), 1-10. | https://pubmed.ncbi.nlm.nih.gov/26579222/ | 5 NIH/National Library of Medicine studies from 2004-2020 all finding verifiable health effects from wearing a face mask, including scientifically verified reduction in blood oxygen level: |
46 | 2019 | Chughtai, A. A., Stelzer-Braid, S., Rawlinson, W., Pontivivo, G., Wang, Q., Pan, Y., ... & MacIntyre, C. R. | . Contamination by respiratory viruses on outer surface of medical masks used by hospital healthcare workers. BMC infectious diseases, 19(1), 1-8. | Chughtai, A. A., Stelzer-Braid, S., Rawlinson, W., Pontivivo, G., Wang, Q., Pan, Y., ... & MacIntyre, C. R. (2019). Contamination by respiratory viruses on outer surface of medical masks used by hospital healthcare workers. BMC infectious diseases, 19(1), 1-8. | https://pubmed.ncbi.nlm.nih.gov/31159777/ | 5 NIH/National Library of Medicine studies from 2004-2020 all finding verifiable health effects from wearing a face mask, including scientifically verified reduction in blood oxygen level: |
47 | 2015 | MacIntyre, C. R., Seale, H., Dung, T. C., Hien, N. T., Nga, P. T., Chughtai, A. A., ... & Wang, Q. | . A cluster randomised trial of cloth masks compared with medical masks in healthcare workers. BMJ open, 5(4), e006577. | MacIntyre, C. R., Seale, H., Dung, T. C., Hien, N. T., Nga, P. T., Chughtai, A. A., ... & Wang, Q. (2015). A cluster randomised trial of cloth masks compared with medical masks in healthcare workers. BMJ open, 5(4), e006577. | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4420971/ | Cloth Mask Study |
48 | 2020 | Brainard, J. S., Jones, N., Lake, I., Hooper, L., & Hunter, P. | . Facemasks and similar barriers to prevent respiratory illness such as COVID-19: A rapid systematic review. MedRxiv. | Brainard, J. S., Jones, N., Lake, I., Hooper, L., & Hunter, P. (2020). Facemasks and similar barriers to prevent respiratory illness such as COVID-19: A rapid systematic review. MedRxiv. | https://www.medrxiv.org/content/10.1101/2020.04.01.20049528v1 | SOME of the mask studies on efficacy: |
49 | 2020 | Jefferson, T., Jones, M., Al Ansari, L. A., Bawazeer, G., Beller, E., Clark, J., ... & Van Driel, M. | . Physical interventions to interrupt or reduce the spread of respiratory viruses. Part 1-Face masks, eye protection and person distancing: systematic review and meta-analysis. MedRxiv. | Jefferson, T., Jones, M., Al Ansari, L. A., Bawazeer, G., Beller, E., Clark, J., ... & Van Driel, M. (2020). Physical interventions to interrupt or reduce the spread of respiratory viruses. Part 1-Face masks, eye protection and person distancing: systematic review and meta-analysis. MedRxiv. | https://www.medrxiv.org/content/10.1101/2020.03.30.20047217v2 | SOME of the mask studies on efficacy: |
50 | 2020 | Klompas, M., Morris, C. A., Sinclair, J., Pearson, M., & Shenoy, E. S. | . Universal masking in hospitals in the Covid-19 era. New England Journal of Medicine, 382(21), e63. | Klompas, M., Morris, C. A., Sinclair, J., Pearson, M., & Shenoy, E. S. (2020). Universal masking in hospitals in the Covid-19 era. New England Journal of Medicine, 382(21), e63. | https://www.nejm.org/doi/full/10.1056/NEJMp2006372 | SOME of the mask studies on efficacy: |
51 | 2019 | Radonovich, L. J., Simberkoff, M. S., Bessesen, M. T., Brown, A. C., Cummings, D. A., Gaydos, C. A., ... & Perl, T. M. | . N95 respirators vs medical masks for preventing influenza among health care personnel: a randomized clinical trial. Jama, 322(9), 824-833. | Radonovich, L. J., Simberkoff, M. S., Bessesen, M. T., Brown, A. C., Cummings, D. A., Gaydos, C. A., ... & Perl, T. M. (2019). N95 respirators vs medical masks for preventing influenza among health care personnel: a randomized clinical trial. Jama, 322(9), 824-833. | https://jamanetwork.com/journals/jama/fullarticle/2749214 | SOME of the mask studies on efficacy: |
52 | 2016 | Smith, J. D., MacDougall, C. C., Johnstone, J., Copes, R. A., Schwartz, B., & Garber, G. E. | . Effectiveness of N95 respirators versus surgical masks in protecting health care workers from acute respiratory infection: a systematic review and meta-analysis. Cmaj, 188(8), 567-574. | Smith, J. D., MacDougall, C. C., Johnstone, J., Copes, R. A., Schwartz, B., & Garber, G. E. (2016). Effectiveness of N95 respirators versus surgical masks in protecting health care workers from acute respiratory infection: a systematic review and meta-analysis. Cmaj, 188(8), 567-574. | https://www.cmaj.ca/content/188/8/567 | SOME of the mask studies on efficacy: |
53 | 2012 | bin‐Reza, F., Lopez Chavarrias, V., Nicoll, A., & Chamberland, M. E. | . The use of masks and respirators to prevent transmission of influenza: a systematic review of the scientific evidence. Influenza and other respiratory viruses, 6(4), 257-267. | bin‐Reza, F., Lopez Chavarrias, V., Nicoll, A., & Chamberland, M. E. (2012). The use of masks and respirators to prevent transmission of influenza: a systematic review of the scientific evidence. Influenza and other respiratory viruses, 6(4), 257-267. | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5779801/ | SOME of the mask studies on efficacy: |
54 | 2009 | Jacobs, J. L., Ohde, S., Takahashi, O., Tokuda, Y., Omata, F., & Fukui, T. | . Use of surgical face masks to reduce the incidence of the common cold among health care workers in Japan: a randomized controlled trial. American journal of infection control, 37(5), 417-419. | Jacobs, J. L., Ohde, S., Takahashi, O., Tokuda, Y., Omata, F., & Fukui, T. (2009). Use of surgical face masks to reduce the incidence of the common cold among health care workers in Japan: a randomized controlled trial. American journal of infection control, 37(5), 417-419. | https://pubmed.ncbi.nlm.nih.gov/19216002/ | SOME of the mask studies on efficacy: |
55 | 2014 | Jung, H., Kim, J. K., Lee, S., Lee, J., Kim, J., Tsai, P., & Yoon, C. | . Comparison of filtration efficiency and pressure drop in anti-yellow sand masks, quarantine masks, medical masks, general masks, and handkerchiefs. Aerosol and Air Quality Research, 14(3), 991-1002. | Jung, H., Kim, J. K., Lee, S., Lee, J., Kim, J., Tsai, P., & Yoon, C. (2014). Comparison of filtration efficiency and pressure drop in anti-yellow sand masks, quarantine masks, medical masks, general masks, and handkerchiefs. Aerosol and Air Quality Research, 14(3), 991-1002. | https://aaqr.org/articles/aaqr-13-06-oa-0201.pdf | SOME of the mask studies on efficacy: |
56 | 2015 | MacIntyre, C. R., Seale, H., Dung, T. C., Hien, N. T., Nga, P. T., Chughtai, A. A., ... & Wang, Q. | . A cluster randomised trial of cloth masks compared with medical masks in healthcare workers. BMJ open, 5(4), e006577. | MacIntyre, C. R., Seale, H., Dung, T. C., Hien, N. T., Nga, P. T., Chughtai, A. A., ... & Wang, Q. (2015). A cluster randomised trial of cloth masks compared with medical masks in healthcare workers. BMJ open, 5(4), e006577. | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4420971/ | SOME of the mask studies on efficacy: |
57 | 2017 | Offeddu, V., Yung, C. F., Low, M. S. F., & Tam, C. C. | . Effectiveness of masks and respirators against respiratory infections in healthcare workers: a systematic review and meta-analysis. Clinical Infectious Diseases, 65(11), 1934-1942. | Offeddu, V., Yung, C. F., Low, M. S. F., & Tam, C. C. (2017). Effectiveness of masks and respirators against respiratory infections in healthcare workers: a systematic review and meta-analysis. Clinical Infectious Diseases, 65(11), 1934-1942. | https://academic.oup.com/cid/article/65/11/1934/4068747 | SOME of the mask studies on efficacy: |
58 | 2018 | Shimasaki, N., Okaue, A., Kikuno, R., & Shinohara, K. | . Comparison of the filter efficiency of medical nonwoven fabrics against three different microbe aerosols. Biocontrol science, 23(2), 61-69. | Shimasaki, N., Okaue, A., Kikuno, R., & Shinohara, K. (2018). Comparison of the filter efficiency of medical nonwoven fabrics against three different microbe aerosols. Biocontrol science, 23(2), 61-69. | https://www.jstage.jst.go.jp/article/bio/23/2/23_61/_pdf/-char/en | SOME of the mask studies on efficacy: |
59 | 1991 | Tunevall, T. G. | . Postoperative wound infections and surgical face masks: a controlled study. World journal of surgery, 15(3), 383-387. | Tunevall, T. G. (1991). Postoperative wound infections and surgical face masks: a controlled study. World journal of surgery, 15(3), 383-387. | https://link.springer.com/article/10.1007/BF01658736 | SOME of the mask studies on efficacy: |
60 | 1991 | Mitchell, N. J., & Hunt, S. | . Surgical face masks in modern operating rooms—A costly and unnecessary ritual?. Journal of Hospital Infection, 18(3), 239-242. | Mitchell, N. J., & Hunt, S. (1991). Surgical face masks in modern operating rooms—A costly and unnecessary ritual?. Journal of Hospital Infection, 18(3), 239-242. | https://www.journalofhospitalinfection.com/article/0195-6701(91)90148-2/pdf | SOME of the mask studies on efficacy: |
61 | 1981 | Orr, N. W. | . Is a mask necessary in the operating theatre?. Annals of the Royal College of Surgeons of England, 63(6), 390. | Orr, N. W. (1981). Is a mask necessary in the operating theatre?. Annals of the Royal College of Surgeons of England, 63(6), 390. | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2493952/pdf/annrcse01509-0009.pdf | SOME of the mask studies on efficacy: |
62 | #N/A | #VALUE! | #VALUE! | https://web.archive.org/web/20200717141836/https://www.cidrap.umn.edu/news-perspective/2020/04/commentary-masks-all-covid-19-not-based-sound-data | SOME of the mask studies on efficacy: | |
63 | 2020 | National Academies of Sciences, Engineering, and Medicine. | . Rapid expert consultation on the effectiveness of fabric masks for the COVID-19 Pandemic (April 8, 2020). In Rapid Expert Consultations on the COVID-19 Pandemic: March 14, 2020–April 8, 2020. National Academies Press (US). | National Academies of Sciences, Engineering, and Medicine. (2020). Rapid expert consultation on the effectiveness of fabric masks for the COVID-19 Pandemic (April 8, 2020). In Rapid Expert Consultations on the COVID-19 Pandemic: March 14, 2020–April 8, 2020. National Academies Press (US). | https://www.nap.edu/catalog/25776/rapid-expert-consultation-on-the-effectiveness-of-fabric-masks-for-the-covid-19-pandemic-april-8-2020 | SOME of the mask studies on efficacy: |
64 | #N/A | #VALUE! | #VALUE! | https://www.nap.edu/read/25776/chapter/1#6 | SOME of the mask studies on efficacy: | |
65 | 2020 | Xiao, J., Shiu, E. Y., Gao, H., Wong, J. Y., Fong, M. W., Ryu, S., & Cowling, B. J. | . Nonpharmaceutical measures for pandemic influenza in nonhealthcare settings—personal protective and environmental measures. Emerging infectious diseases, 26(5), 967. | Xiao, J., Shiu, E. Y., Gao, H., Wong, J. Y., Fong, M. W., Ryu, S., & Cowling, B. J. (2020). Nonpharmaceutical measures for pandemic influenza in nonhealthcare settings—personal protective and environmental measures. Emerging infectious diseases, 26(5), 967. | https://wwwnc.cdc.gov/eid/article/26/5/19-0994_article | SOME of the mask studies on efficacy: |
66 | 2010 | Rengasamy, S., Eimer, B., & Shaffer, R. E. | . Simple respiratory protection—evaluation of the filtration performance of cloth masks and common fabric materials against 20–1000 nm size particles. Annals of occupational hygiene, 54(7), 789-798. | Rengasamy, S., Eimer, B., & Shaffer, R. E. (2010). Simple respiratory protection—evaluation of the filtration performance of cloth masks and common fabric materials against 20–1000 nm size particles. Annals of occupational hygiene, 54(7), 789-798. | https://academic.oup.com/annweh/article/54/7/789/202744 | SOME of the mask studies on efficacy: |
67 | 2019 | Neupane, B. B., Mainali, S., Sharma, A., & Giri, B. | . Optical microscopic study of surface morphology and filtering efficiency of face masks. PeerJ, 7, e7142. | Neupane, B. B., Mainali, S., Sharma, A., & Giri, B. (2019). Optical microscopic study of surface morphology and filtering efficiency of face masks. PeerJ, 7, e7142. | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6599448/ | SOME of the mask studies on efficacy: |
68 | 2020 | Bae, S., Kim, M. C., Kim, J. Y., Cha, H. H., Lim, J. S., Jung, J., ... & Kim, S. H. | . Effectiveness of surgical and cotton masks in blocking SARS–CoV-2: a controlled comparison in 4 patients. Annals of internal medicine, 173(1), W22-W23. | Bae, S., Kim, M. C., Kim, J. Y., Cha, H. H., Lim, J. S., Jung, J., ... & Kim, S. H. (2020). Effectiveness of surgical and cotton masks in blocking SARS–CoV-2: a controlled comparison in 4 patients. Annals of internal medicine, 173(1), W22-W23. | https://www.acpjournals.org/doi/10.7326/M20-1342 | SOME of the mask studies on efficacy: |
69 | 2020 | Fikenzer, S., Uhe, T., Lavall, D., Rudolph, U., Falz, R., Busse, M., ... & Laufs, U. | . Effects of surgical and FFP2/N95 face masks on cardiopulmonary exercise capacity. Clinical Research in Cardiology, 109(12), 1522-1530. | Fikenzer, S., Uhe, T., Lavall, D., Rudolph, U., Falz, R., Busse, M., ... & Laufs, U. (2020). Effects of surgical and FFP2/N95 face masks on cardiopulmonary exercise capacity. Clinical Research in Cardiology, 109(12), 1522-1530. | https://link.springer.com/article/10.1007/s00392-020-01704-y | SOME of the mask studies on efficacy: |
70 | 2020 | Rosner, E. | . Adverse effects of prolonged mask use among healthcare professionals during COVID-19. J Infect Dis Epidemiol, 6(3), 130. | Rosner, E. (2020). Adverse effects of prolonged mask use among healthcare professionals during COVID-19. J Infect Dis Epidemiol, 6(3), 130. | https://clinmedjournals.org/articles/jide/journal-of-infectious-diseases-and-epidemiology-jide-6-130.php?jid=jide | SOME of the mask studies on efficacy: |
71 | 2008 | Beder, A., Büyükkoçak, Ü., Sabuncuoğlu, H., Keskil, Z. A., & Keskil, S. | . Preliminary report on surgical mask induced deoxygenation during major surgery. Neurocirugia, 19(2), 121-126. | Beder, A., Büyükkoçak, Ü., Sabuncuoğlu, H., Keskil, Z. A., & Keskil, S. (2008). Preliminary report on surgical mask induced deoxygenation during major surgery. Neurocirugia, 19(2), 121-126. | https://www.sciencedirect.com/science/article/abs/pii/S1130147308702355 | SOME of the mask studies on efficacy: |
72 | 2021 | Kisielinski, K., Giboni, P., Prescher, A., Klosterhalfen, B., Graessel, D., Funken, S., ... & Hirsch, O. | . Is a Mask That Covers the Mouth and Nose Free from Undesirable Side Effects in Everyday Use and Free of Potential Hazards?. International journal of environmental research and public health, 18(8), 4344. | Kisielinski, K., Giboni, P., Prescher, A., Klosterhalfen, B., Graessel, D., Funken, S., ... & Hirsch, O. (2021). Is a Mask That Covers the Mouth and Nose Free from Undesirable Side Effects in Everyday Use and Free of Potential Hazards?. International journal of environmental research and public health, 18(8), 4344. | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8072811/ | SOME of the mask studies on efficacy: |
A | B | |
---|---|---|
1 | Source: https://brownstone.org/articles/more-than-400-studies-on-the-failure-of-compulsory-covid-interventions/ | |
2 | Study/report title, author, and year published and interactive url link | Predominant study/evidence report finding |
3 | MASK MANDATES | |
4 | 1) Mask mandate and use efficacy for COVID-19 containment in US States, Guerra, 2021 | “Calculated total COVID-19 case growth and mask use for the continental United States with data from the Centers for Disease Control and Prevention and Institute for Health Metrics and Evaluation. We estimated post-mask mandate case growth in non-mandate states using median issuance dates of neighboring states with mandates…did not observe association between mask mandates or use and reduced COVID-19 spread in US states.” |
5 | 2) These 12 Graphs Show Mask Mandates Do Nothing To Stop COVID, Weiss, 2020 | “Masks can work well when they’re fully sealed, properly fitted, changed often, and have a filter designed for virus-sized particles. This represents none of the common masks available on the consumer market, making universal masking much more of a confidence trick than a medical solution…Our universal use of unscientific face coverings is therefore closer to medieval superstition than it is to science, but many powerful institutions have too much political capital invested in the mask narrative at this point, so the dogma is perpetuated. The narrative says that if cases go down it’s because masks succeeded. It says that if cases go up it’s because masks succeeded in preventing more cases. The narrative simply assumes rather than proves that masks work, despite overwhelming scientific evidence to the contrary.” |
6 | 3) Mask Mandates Seem to Make CCP Virus Infection Rates Climb, Study Says, Vadum, 2020 | “Protective-mask mandates aimed at combating the spread of the CCP virus that causes the disease COVID-19 appear to promote its spread, according to a report from RationalGround.com, a clearinghouse of COVID-19 data trends that’s run by a grassroots group of data analysts, computer scientists, and actuaries.” |
7 | 4) Horowitz: Comprehensive analysis of 50 states shows greater spread with mask mandates, Howorwitz, 2020 Justin Hart | “How long do our politicians get to ignore the results?… The results: When comparing states with mandates vs. those without, or periods of times within a state with a mandate vs. without, there is absolutely no evidence the mask mandate worked to slow the spread one iota. In total, in the states that had a mandate in effect, there were 9,605,256 confirmed COVID cases over 5,907 total days, an average of 27 cases per 100,000 per day. When states did not have a statewide order (which includes the states that never had them and the period of time masking states did not have the mandate in place) there were 5,781,716 cases over 5,772 total days, averaging 17 cases per 100,000 people per day.” |
8 | 5) The CDC’s Mask Mandate Study: Debunked, Alexander, 2021 | “Thus, it is not surprising that the CDC’s own recent conclusion on the use of nonpharmaceutical measures such as face masks in pandemic influenza, warned that scientific “evidence from 14 randomized controlled trials of these measures did not support a substantial effect on transmission…” Moreover, in the WHO’s 2019 guidance document on nonpharmaceutical public health measures in a pandemic, they reported as to face masks that “there is no evidence that this is effective in reducing transmission…” Similarly, in the fine print to a recent double-blind, double-masking simulation the CDC stated that “The findings of these simulations [supporting mask usage] should neither be generalized to the effectiveness …nor interpreted as being representative of the effectiveness of these masks when worn in real-world settings.” |
9 | 6) Phil Kerpin, tweet, 2021 The Spectator | “The first ecological study of state mask mandates and use to include winter data: “Case growth was independent of mandates at low and high rates of community spread, and mask use did not predict case growth during the Summer or Fall-Winter waves.” |
10 | 7) How face masks and lockdowns failed, SPR, 2021 | “Infections have been driven primarily by seasonal and endemic factors, whereas mask mandates and lockdowns have had no discernible impact” |
11 | 8) Analysis of the Effects of COVID-19 Mask Mandates on Hospital Resource Consumption and Mortality at the County Level, Schauer, 2021 | “There was no reduction in per-population daily mortality, hospital bed, ICU bed, or ventilator occupancy of COVID-19-positive patients attributable to the implementation of a mask-wearing mandate.” |
12 | 9) Do we need mask mandates, Harris, 2021 | “But masks proved far less useful in the subsequent 1918 Spanish flu, a viral disease spread by pathogens smaller than bacteria. California’s Department of Health, for instance, reported that the cities of Stockton, which required masks, and Boston, which did not, had scarcely different death rates, and so advised against mask mandates except for a few high-risk professions such as barbers….Randomized controlled trials (RCTs) on mask use, generally more reliable than observational studies, though not infallible, typically show that cloth and surgical masks offer little protection. A few RCTs suggest that perfect adherence to an exacting mask protocol may guard against influenza, but meta-analyses find little on the whole to suggest that masks offer meaningful protection. WHO guidelines from 2019 on influenza say that despite “mechanistic plausibility for the potential effectiveness” of masks, studies showed a benefit too small to be established with any certainty. Another literature review by researchers from the University of Hong Kong agrees. Its best estimate for the protective effect of surgical masks against influenza, based on ten RCTs published through 2018, was just 22 percent, and it could not rule out zero effect.” |
A | B | |
---|---|---|
1 | Source: https://brownstone.org/articles/more-than-400-studies-on-the-failure-of-compulsory-covid-interventions/ | |
2 | Study/report title, author, and year published and interactive url link | Predominant study/evidence report finding |
3 | MASK HARMS | |
4 | 1) Corona children studies: Co-Ki: First results of a German-wide registry on mouth and nose covering (mask) in children, Schwarz, 2021 | “The average wearing time of the mask was 270 minutes per day. Impairments caused by wearing the mask were reported by 68% of the parents. These included irritability (60%), headache (53%), difficulty concentrating (50%), less happiness (49%), reluctance to go to school/kindergarten (44%), malaise (42%) impaired learning (38%) and drowsiness or fatigue (37%).” |
5 | 2) Dangerous pathogens found on children’s face masks, Cabrera, 2021 | “Masks were contaminated with bacteria, parasites, and fungi, including three with dangerous pathogenic and pneumonia-causing bacteria.” |
6 | 3) Masks, false safety and real dangers, Part 2: Microbial challenges from masks, Borovoy, 2020/2021 | “Laboratory testing of used masks from 20 train commuters revealed that 11 of the 20 masks tested contained over 100,000 bacterial colonies. Molds and yeasts were also found. Three of the masks contained more than one million bacterial colonies… The outside surfaces of surgical masks were found to have high levels of the following microbes, even in hospitals, more concentrated on the outside of masks than in the environment. Staphylococcus species (57%) and Pseudomonas spp (38%) were predominant among bacteria, and Penicillium spp (39%) and Aspergillus spp. (31%) were the predominant fungi.” |
7 | 4) Preliminary report on surgical mask induced deoxygenation during major surgery, Beder, 2008 | “Considering our findings, pulse rates of the surgeon’s increase and SpO2 decrease after the first hour. This early change in SpO2 may be either due to the facial mask or the operational stress. Since a very small decrease in saturation at this level, reflects a large decrease in PaO2, our findings may have a clinical value for the health workers and the surgeons.” |
8 | 5) Mask mandates may affect a child’s emotional, intellectual development, Gillis, 2020 | “The thing is we really don’t know for sure what the effect may or may not be. But what we do know is that children, especially in early childhood, they use the mouth as part of the entire face to get a sense of what’s going on around them in terms of adults and other people in their environment as far as their emotions. It also has a role in language development as well… If you think about an infant, when you interact with them you use part of your mouth. They are interested in your facial expressions. And if you think about that part of the face being covered up, there is that possibility that it could have an effect. But we don’t know because this is really an unprecedented time. What we wonder about is if this could play a role and how can we stop it if it would affect child development.” |
9 | 6) Headaches and the N95 face-mask amongst healthcare providers, Lim, 2006 | “Healthcare providers may develop headaches following the use of the N95 face-mask.” |
10 | 7) Maximizing Fit for Cloth and Medical Procedure Masks to Improve Performance and Reduce SARS-CoV-2 Transmission and Exposure, 2021, Brooks, 2021 | “Although use of double masking or knotting and tucking are two of many options that can optimize fit and enhance mask performance for source control and for wearer protection, double masking might impede breathing or obstruct peripheral vision for some wearers, and knotting and tucking can change the shape of the mask such that it no longer covers fully both the nose and the mouth of persons with larger faces.” |
11 | 8) Facemasks in the COVID-19 era: A health hypothesis, Vainshelboim, 2021 | “Wearing facemasks has been demonstrated to have substantial adverse physiological and psychological effects. These include hypoxia, hypercapnia, shortness of breath, increased acidity and toxicity, activation of fear and stress response, rise in stress hormones, immunosuppression, fatigue, headaches, decline in cognitive performance, predisposition for viral and infectious illnesses, chronic stress, anxiety and depression.” |
12 | 9) Wearing a mask can expose children to dangerous levels of carbon dioxide in just THREE MINUTES, study finds, Shaheen/Daily Mail, 2021 | “European study found that children wearing masks for only minutes could be exposed to dangerous carbon dioxide levels…Forty-five children were exposed to carbon dioxide levels between three to twelve times healthy levels.” |
13 | 10) How many children must die? Shilhavy, 2020 | “How long are parents going to continue masking their children causing great harm to them, even to the point of risking their lives? Dr. Eric Nepute in St. Louis took time to record a video rant that he wants everyone to share, after the 4-year-old child of one of his patients almost died from a bacterial lung infection caused by prolonged mask use.” |
14 | 11) Medical Doctor Warns that “Bacterial Pneumonias Are on the Rise” from Mask Wearing, Meehan, 2021 | “I’m seeing patients that have facial rashes, fungal infections, bacterial infections. Reports coming from my colleagues, all over the world, are suggesting that the bacterial pneumonias are on the rise…Why might that be? Because untrained members of the public are wearing medical masks, repeatedly… in a non-sterile fashion… They’re becoming contaminated. They’re pulling them off of their car seat, off the rear-view mirror, out of their pocket, from their countertop, and they’re reapplying a mask that should be worn fresh and sterile every single time.” |
15 | 12) Open Letter from Medical Doctors and Health Professionals to All Belgian Authorities and All Belgian Media, AIER, 2020 | “Wearing a mask is not without side effects. Oxygen deficiency (headache, nausea, fatigue, loss of concentration) occurs fairly quickly, an effect similar to altitude sickness. Every day we now see patients complaining of headaches, sinus problems, respiratory problems and hyperventilation due to wearing masks. In addition, the accumulated CO2 leads to a toxic acidification of the organism which affects our immunity. Some experts even warn of an increased transmission of the virus in case of inappropriate use of the mask.” |
16 | 13) Face coverings for covid-19: from medical intervention to social practice, Peters, 2020 | “At present, there is no direct evidence (from studies on Covid19 and in healthy people in the community) on the effectiveness of universal masking of healthy people in the community to prevent infection with respiratory viruses, including Covid19. Contamination of the upper respiratory tract by viruses and bacteria on the outside of medical face masks has been detected in several hospitals. Another research shows that a moist mask is a breeding ground for (antibiotic resistant) bacteria and fungi, which can undermine mucosal viral immunity. This research advocates the use of medical / surgical masks (instead of homemade cotton masks) that are used once and replaced after a few hours.” |
17 | 14) Face masks for the public during the covid-19 crisis, Lazzarino, 2020 | “The two potential side effects that have already been acknowledged are: (1) Wearing a face mask may give a false sense of security and make people adopt a reduction in compliance with other infection control measures, including social distancing and hands washing. (2) Inappropriate use of face mask: people must not touch their masks, must change their single-use masks frequently or wash them regularly, dispose them correctly and adopt other management measures, otherwise their risks and those of others may increase. Other potential side effects that we must consider are: (3) The quality and the volume of speech between two people wearing masks is considerably compromised and they may unconsciously come closer. While one may be trained to counteract side effect n.1, this side effect may be more difficult to tackle. (4) Wearing a face mask makes the exhaled air go into the eyes. This generates an uncomfortable feeling and an impulse to touch your eyes. If your hands are contaminated, you are infecting yourself.” |
18 | 15) Contamination by respiratory viruses on outer surface of medical masks used by hospital healthcare workers, Chughtai, 2019 | “Respiratory pathogens on the outer surface of the used medical masks may result in self-contamination. The risk is higher with longer duration of mask use (> 6 h) and with higher rates of clinical contact. Protocols on duration of mask use should specify a maximum time of continuous use, and should consider guidance in high contact settings.” |
19 | 16) Reusability of Facemasks During an Influenza Pandemic, Bailar, 2006 | “After considering all the testimony and other information we received, the committee concluded that there is currently no simple, reliable way to decontaminate these devices and enable people to use them safely more than once. There is relatively little data available about how effective these devices are against flu even the first time they are used. To the extent they can help at all, they must be used correctly, and the best respirator or mask will do little to protect a person who uses it incorrectly. Substantial research must be done to increase our understanding of how flu spreads, to develop better masks and respirators, and to make it easier to decontaminate them. Finally, the use of face coverings is only one of many strategies that will be needed to slow or halt a pandemic, and people should not engage in activities that would increase their risk of exposure to flu just because they have a mask or respirator.” |
20 | 17) Exhalation of respiratory viruses by breathing, coughing, and talking, Stelzer-Braid, 2009 | “The exhaled aerosols generated by coughing, talking, and breathing were sampled in 50 subjects using a novel mask, and analyzed using PCR for nine respiratory viruses. The exhaled samples from a subset of 10 subjects who were PCR positive for rhinovirus were also examined by cell culture for this virus. Of the 50 subjects, among the 33 with symptoms of upper respiratory tract infections, 21 had at least one virus detected by PCR, while amongst the 17 asymptomatic subjects, 4 had a virus detected by PCR. Overall, rhinovirus was detected in 19 subjects, influenza in 4 subjects, parainfluenza in 2 subjects, and human metapneumovirus in 1 subject. Two subjects were co-infected. Of the 25 subjects who had virus-positive nasal mucus, the same virus type was detected in 12 breathing samples, 8 talking samples, and in 2 coughing samples. In the subset of exhaled samples from 10 subjects examined by culture, infective rhinovirus was detected in 2.” |
21 | 18) [Effect of a surgical mask on six minute walking distance], Person, 2018 | “Wearing a surgical mask modifies significantly and clinically dyspnea without influencing walked distance.” |
22 | 19) Protective masks reduce resilience, Science ORF, 2020 | “The German researchers used two types of face masks for their study – surgical masks and so-called FFP2 masks, which are mainly used by medical personnel. The measurements were carried out with the help of spiroergometry, in which patients or in this case the test persons exert themselves physically on a stationary bicycle – a so-called ergometer – or a treadmill. The subjects were examined without a mask, with surgical masks and with FFP2 masks. The masks therefore impair breathing, especially the volume and the highest possible speed of the air when exhaling. The maximum possible force on the ergometer was significantly reduced.” |
23 | 20) Wearing masks even more unhealthy than expected, Coronoa transition, 2020 | “They contain microplastics – and they exacerbate the waste problem…”Many of them are made of polyester and so you have a microplastic problem.” Many of the face masks would contain polyester with chlorine compounds: “If I have the mask in front of my face, then of course I breathe in the microplastic directly and these substances are much more toxic than if you swallow them, as they get directly into the nervous system,” Braungart continues.” |
24 | 21) Masking Children: Tragic, Unscientific, and Damaging, Alexander, 2021 | “Children do not readily acquire SARS-CoV-2 (very low risk), spread it to other children or teachers, or endanger parents or others at home. This is the settled science. In the rare cases where a child contracts Covid virus it is very unusual for the child to get severely ill or die. Masking can do positive harm to children – as it can to some adults. But the cost benefit analysis is entirely different for adults and children – particularly younger children. Whatever arguments there may be for consenting adults – children should not be required to wear masks to prevent the spread of Covid-19. Of course, zero risk is not attainable – with or without masks, vaccines, therapeutics, distancing or anything else medicine may develop or government agencies may impose.” |
25 | 22) The Dangers of Masks, Alexander, 2021 | “With that clarion call, we pivot and refer here to another looming concern and this is the potential danger of the chlorine, polyester, and microplastic components of the face masks (surgical principally but any of the mass-produced masks) that have become part of our daily lives due to the Covid-19 pandemic. We hope those with persuasive power in the government will listen to this plea. We hope that the necessary decisions will be made to reduce the risk to our populations.” |
26 | 23) 13-year-old mask wearer dies for inexplicable reasons, Corona Transition, 2020 | “The case is not only causing speculation in Germany about possible poisoning with carbon dioxide. Because the student “was wearing a corona protective mask when she suddenly collapsed and died a little later in the hospital,” writes Wochenblick.Editor’s Review: The fact that no cause of death was communicated nearly three weeks after the girl’s death is indeed unusual. The carbon dioxide content of the air is usually about 0.04 percent. From a proportion of four percent, the first symptoms of hypercapnia, i.e. carbon dioxide poisoning, appear. If the proportion of the gas rises to more than 20 percent, there is a risk of deadly carbon dioxide poisoning. However, this does not come without alarm signals from the body. According to the medical portal netdoktor, these include “sweating, accelerated breathing, accelerated heartbeat, headaches, confusion, loss of consciousness”. The unconsciousness of the girl could therefore be an indication of such poisoning.” |
27 | 24) Student Deaths Lead Chinese Schools to Change Mask Rules, that’s, 2020 | “During the month of April, three cases of students suffering sudden cardiac death (SCD) while running during gym class have been reported in Zhejiang, Henan and Hunan provinces. Beijing Evening News noted that all three students were wearing masks at the time of their deaths, igniting a critical discussion over school rules on when students should wear masks.” |
28 | 25) Blaylock: Face Masks Pose Serious Risks To The Healthy, 2020 | “As for the scientific support for the use of face mask, a recent careful examination of the literature, in which 17 of the best studies were analyzed, concluded that, “ None of the studies established a conclusive relationship between mask/respirator use and protection against influenza infection.”1 Keep in mind, no studies have been done to demonstrate that either a cloth mask or the N95 mask has any effect on transmission of the COVID-19 virus. Any recommendations, therefore, have to be based on studies of influenza virus transmission. And, as you have seen, there is no conclusive evidence of their efficiency in controlling flu virus transmission.” |
29 | 26) The mask requirement is responsible for severe psychological damage and the weakening of the immune system, Coronoa Transition, 2020 | “In fact, the mask has the potential to “trigger strong psychovegetative stress reactions via emerging aggression, which correlate significantly with the degree of stressful after-effects”. Prousa is not alone in her opinion. Several psychologists dealt with the mask problem — and most came to devastating results. Ignoring them would be fatal, according to Prousa.” |
30 | 27) The physiological impact of wearing an N95 mask during hemodialysis as a precaution against SARS in patients with end-stage renal disease, Kao, 2004 | “Wearing an N95 mask for 4 hours during HD significantly reduced PaO2 and increased respiratory adverse effects in ESRD patients.” |
31 | 28) Is a Mask That Covers the Mouth and Nose Free from Undesirable Side Effects in Everyday Use and Free of Potential Hazards?, Kisielinski, 2021 | “We objectified evaluation evidenced changes in respiratory physiology of mask wearers with significant correlation of O2 drop and fatigue (p < 0.05), a clustered co-occurrence of respiratory impairment and O2 drop (67%), N95 mask and CO2 rise (82%), N95 mask and O2 drop (72%), N95 mask and headache (60%), respiratory impairment and temperature rise (88%), but also temperature rise and moisture (100%) under the masks. Extended mask-wearing by the general population could lead to relevant effects and consequences in many medical fields.”“Here are the pathophysiological changes and subjective complaints: 1) Increase in blood carbon dioxide 2) Increase in breathing resistance 3) Decrease in blood oxygen saturation 4) Increase in heart rate 5) Decrease in cardiopulmonary capacity 6) Feeling of exhaustion 7) Increase in respiratory rate 8) Difficulty breathing and shortness of breath 9) Headache 10) Dizziness 11) Feeling of dampness and heat 12) Drowsiness (qualitative neurological deficits) 13) Decrease in empathy perception 14) Impaired skin barrier function with acne, itching and skin lesions” |
32 | 29) Is N95 face mask linked to dizziness and headache?, Ipek, 2021 | “Respiratory alkalosis and hypocarbia were detected after the use of N95. Acute respiratory alkalosis can cause headache, anxiety, tremor, muscle cramps. In this study, it was quantitatively shown that the participants’ symptoms were due to respiratory alkalosis and hypocarbia.” |
33 | 30) COVID-19 prompts a team of engineers to rethink the humble face mask, Myers, 2020 | “But in filtering those particles, the mask also makes it harder to breathe. N95 masks are estimated to reduce oxygen intake by anywhere from 5 to 20 percent. That’s significant, even for a healthy person. It can cause dizziness and lightheadedness. If you wear a mask long enough, it can damage the lungs. For a patient in respiratory distress, it can even be life threatening.” |
34 | 31) 70 doctors in open letter to Ben Weyts: ‘Abolish mandatory mouth mask at school’ – Belgium, World Today News, 2020 | “In an open letter to the Flemish Minister of Education Ben Weyts (N-VA), 70 doctors ask to abolish the mandatory mouth mask at school, both for the teachers and for the students. Weyts does not intend to change course. The doctors ask that Minister Ben Weyts immediately reverses his working method: no mouth mask obligation at school, only protect the risk group and only the advice that people with a possible risk profile should consult their doctor.” |
35 | 32) Face masks pose dangers for babies, toddlers during COVID-19 pandemic, UC Davis Health, 2020 | “Masks may present a choking hazard for young children. Also, depending on the mask and the fit, the child may have trouble breathing. If this happens, they need to be able to take it off,” said UC Davis pediatrician Lena van der List. “Children less than 2 years of age will not reliably be able to remove a face mask and could suffocate. Therefore, masks should not routinely be used for young children…“The younger the child, the more likely they will be to not wear the mask properly, reach under the mask and touch potentially contaminated masks,” said Dean Blumberg, chief of pediatric infectious diseases at UC Davis Children’s Hospital. “Of course, this depends on the developmental level of the individual child. But I think masks are not likely to provide much potential benefit over risk until the teen years.” |
36 | 33) Covid-19: Important potential side effects of wearing face masks that we should bear in mind, Lazzarino, 2020 | “Other potential side effects that we must consider, however, are 1) The quality and volume of speech between people wearing masks is considerably compromised and they may unconsciously come closer2) Wearing a mask makes the exhaled air go into the eyes. This generates an impulse to touch the eyes. 3) If your hands are contaminated, you are infecting yourself, 4) Face masks make breathing more difficult. Moreover, a fraction of carbon dioxide previously exhaled is inhaled at each respiratory cycle. Those phenomena increase breathing frequency and deepness, and they may worsen the burden of covid-19 if infected people wearing masks spread more contaminated air. This may also worsen the clinical condition of infected people if the enhanced breathing pushes the viral load down into their lungs, 5) The innate immunity’s efficacy is highly dependent on the viral load. If masks determine a humid habitat where SARS-CoV-2 can remain active because of the water vapour continuously provided by breathing and captured by the mask fabric, they determine an increase in viral load (by re-inhaling exhaled viruses) and therefore they can cause a defeat of the innate immunity and an increase in infections.” |
37 | 34) Risks of N95 Face Mask Use in Subjects With COPD, Kyung, 2020 | “Of the 97 subjects, 7 with COPD did not wear the N95 for the entire test duration. This mask-failure group showed higher British modified Medical Research Council dyspnea scale scores and lower FEV1 percent of predicted values than did the successful mask use group. A modified Medical Research Council dyspnea scale score ≥ 3 (odds ratio 167, 95% CI 8.4 to >999.9; P = .008) or a FEV1 < 30% predicted (odds ratio 163, 95% CI 7.4 to >999.9; P = .001) was associated with a risk of failure to wear the N95. Breathing frequency, blood oxygen saturation, and exhaled carbon dioxide levels also showed significant differences before and after N95 use.” |
38 | 35) Masks too dangerous for children under 2, medical group warns, The Japan Times, 2020 | “Children under the age of 2 shouldn’t wear masks because they can make breathing difficult and increase the risk of choking, a medical group has said, launching an urgent appeal to parents as the nation reopens from the coronavirus crisis…Masks can make breathing difficult because infants have narrow air passages,” which increases the burden on their hearts, the association said, adding that masks also raise the risk of heat stroke for them.” |
39 | 36) Face masks can be problematic, dangerous to health of some Canadians: advocates, Spenser, 2020 | “Face masks are dangerous to the health of some Canadians and problematic for some others…Asthma Canada president and CEO Vanessa Foran said simply wearing a mask could create risk of an asthma attack.” |
40 | 37) COVID-19 Masks Are a Crime Against Humanity and Child Abuse, Griesz-Brisson, 2020 | “The rebreathing of our exhaled air will without a doubt create oxygen deficiency and a flooding of carbon dioxide. We know that the human brain is very sensitive to oxygen depravation. There are nerve cells for example in the hippocampus, that can’t be longer than 3 minutes without oxygen – they cannot survive. The acute warning symptoms are headaches, drowsiness, dizziness, issues in concentration, slowing down of the reaction time – reactions of the cognitive system. However, when you have chronic oxygen depravation, all of those symptoms disappear, because you get used to it. But your efficiency will remain impaired and the undersupply of oxygen in your brain continues to progress. We know that neurodegenerative diseases take years to decades to develop. If today you forget your phone number, the breakdown in your brain would have already started 20 or 30 years ago…The child needs the brain to learn, and the brain needs oxygen to function. We don’t need a clinical study for that. This is simple, indisputable physiology. Conscious and purposely induced oxygen deficiency is an absolutely deliberate health hazard, and an absolute medical contraindication.” |
41 | 38) Study shows how masks are harming children, Mercola, 2021 | “Data from the first registry to record children’s experiences with masks show physical, psychological and behavioral issues including irritability, difficulty concentrating and impaired learning.Since school shutdowns in spring 2020, an increasing number of parents are seeking drug treatment for attention deficit hyperactivity disorder (ADHD) for their children.Evidence from the U.K. shows schools are not the super spreaders health officials said they were; measured rates of infection in schools were the same as the community, not higher.A large randomized controlled trial showed wearing masks does not reduce the spread of SARS-CoV-2.” |
42 | 39) New Study Finds Masks Hurt Schoolchildren Physically, Psychologically, and Behaviorally, Hall, 2021 https://www.researchsquare.com/article/rs-124394/v2 | “A new study, involving over 25,000 school-aged children, shows that masks are harming schoolchildren physically, psychologically, and behaviorally, revealing 24 distinct health issues associated with wearing masks…Though these results are concerning, the study also found that 29.7% of children experienced shortness of breath, 26.4% experienced dizziness, and hundreds of the participants experiencing accelerated respiration, tightness in chest, weakness, and short-term impairment of consciousness.” |
43 | 40) Protective Face Masks: Effect on the Oxygenation and Heart Rate Status of Oral Surgeons during Surgery, Scarano, 2021 | “In all 20 surgeons wearing FFP2 covered by surgical masks, a reduction in arterial O2 saturation from around 97.5% before surgery to 94% after surgery was recorded with increase of heart rates. A shortness of breath and light-headedness/headaches were also noted.” |
44 | 41) Effects of surgical and FFP2/N95 face masks on cardiopulmonary exercise capacity, Fikenzer, 2020 | “Ventilation, cardiopulmonary exercise capacity and comfort are reduced by surgical masks and highly impaired by FFP2/N95 face masks in healthy individuals. These data are important for recommendations on wearing face masks at work or during physical exercise.” |
45 | 42) Headaches Associated With Personal Protective Equipment – A Cross-Sectional Study Among Frontline Healthcare Workers During COVID-19, Ong, 2020 | “Most healthcare workers develop de novo PPE-associated headaches or exacerbation of their pre-existing headache disorders.” |
46 | 43) Open letter from medical doctors and health professionals to all Belgian authorities and all Belgian media, The American Institute of Stress, 2020 | “Wearing a mask is not without side effects. Oxygen deficiency (headache, nausea, fatigue, loss of concentration) occurs fairly quickly, an effect similar to altitude sickness. Every day we now see patients complaining of headaches, sinus problems, respiratory problems, and hyperventilation due to wearing masks. In addition, the accumulated CO2 leads to a toxic acidification of the organism which affects our immunity. Some experts even warn of increased transmission of the virus in case of inappropriate use of the mask.” |
47 | 44) Reusing masks may increase your risk of coronavirus infection, expert says, Laguipo, 2020 | “For the public, they should not wear facemasks unless they are sick, and if a healthcare worker advised them.”For the average member of the public walking down a street, it is not a good idea,” Dr. Harries said.”What tends to happen is people will have one mask. They won’t wear it all the time, they will take it off when they get home, they will put it down on a surface they haven’t cleaned,” she added.Further, she added that behavioral issues could adversely put themselves at more risk of getting the infection. For instance, people go out and don’t wash their hands, they touch parts of the mask or their face, and they get infected.” |
48 | 45) What’s Going On Under the Masks?, Wright, 2021 | “Americans today have pretty good chompers on average, at least relative to most other people, past and present. Nevertheless, we do not think enough about oral health as evidenced by the almost complete lack of discussion regarding the effect of lockdowns and mandatory masking on our mouths.” |
49 | 46) Experimental Assessment of Carbon Dioxide Content in Inhaled Air With or Without Face Masks in Healthy ChildrenA Randomized Clinical Trial, Walach, 2021 | “A large-scale survey in Germany of adverse effects in parents and children using data of 25 930 children has shown that 68% of the participating children had problems when wearing nose and mouth coverings.” |
50 | 47) NM Kids forced to wear masks while running in 100-degree heat; Parents are striking back, Smith, 2021 | “Nationally, children have a 99.997% survival rate from COVID-19. In New Mexico, only 0.7% of child COVID-19 cases have resulted in hospitalization. It is clear that children have an extremely low risk of severe illness or death from COVID-19, and mask mandates are placing a burden upon kids which is detrimental to their own health and well-being.” |
51 | 48) Health Canada issues advisory for disposable masks with graphene, CBC, 2021 | “Health Canada is advising Canadians not to use disposable face masks that contain graphene. Health Canada issued the notice on Friday and said wearers could inhale graphene, a single layer of carbon atoms. Masks containing the toxic particles may have been distributed in some health-care facilities.” |
52 | 49) COVID-19: Performance study of microplastic inhalation risk posed by wearing masks, Li, 2021 Is graphene safe? | “Wearing masks considerably reduces the inhalation risk of particles (e.g., granular microplastics and unknown particles) even when they are worn continuously for 720 h. Surgical, cotton, fashion, and activated carbon masks wearing pose higher fiber-like microplastic inhalation risk, while all masks generally reduced exposure when used under their supposed time (<4 h). N95 poses less fiber-like microplastic inhalation risk. Reusing masks after they underwent different disinfection pre-treatment processes can increase the risk of particle (e.g., granular microplastics) and fiber-like microplastic inhalation. Ultraviolet disinfection exerts a relatively weak effect on fiber-like microplastic inhalation, and thus, it can be recommended as a treatment process for reusing masks if proven effective from microbiological standpoint. Wearing an N95 mask reduces the inhalation risk of spherical-type microplastics by 25.5 times compared with not wearing a mask.” |
53 | 50) Manufacturers have been using nanotechnology-derived graphene in face masks — now there are safety concerns, Maynard, 2021 | “Early concerns around graphene were sparked by previous research on another form of carbon — carbon nanotubes. It turns out that some forms of these fiber-like materials can cause serious harm if inhaled. And following on from research here, a natural next-question to ask is whether carbon nanotubes’ close cousin graphene comes with similar concerns.Because graphene lacks many of the physical and chemical aspects of carbon nanotubes that make them harmful (such as being long, thin, and hard for the body to get rid of), the indications are that the material is safer than its nanotube cousins. But safer doesn’t mean safe. And current research indicates that this is not a material that should be used where it could potentially be inhaled, without a good amount of safety testing first…As a general rule of thumb, engineered nanomaterials should not be used in products where they might inadvertently be inhaled and reach the sensitive lower regions of the lungs.” |
54 | 51) Masking young children in school harms language acquisition, Walsh, 2021 | “This is important because children and/or students do not have the speech or language ability that adults have — they are not equally able and the ability to see the face and especially the mouth is critical to language acquisition which children and/or students are engaged in at all times. Furthermore, the ability to see the mouth is not only essential to communication but also essential to brain development.“Studies show that by age four, kids from low-income households will hear 30 million less words than their more affluent counterparts, who get more quality face-time with caretakers.” (https://news.stanford.edu/news/2014/november/language-toddlers-fernald-110514.html).” |
55 | 52) Dangerous pathogens found on children’s face masks, Rational Ground, 2021 | “A group of parents in Gainesville, FL, sent 6 face masks to a lab at the University of Florida, requesting an analysis of contaminants found on the masks after they had been worn. The resulting report found that five masks were contaminated with bacteria, parasites, and fungi, including three with dangerous pathogenic and pneumonia-causing bacteria. Although the test is capable of detecting viruses, including SARS-CoV-2, only one virus was found on one mask (alcelaphine herpesvirus 1)…Half of the masks were contaminated with one or more strains of pneumonia-causing bacteria. One-third were contaminated with one or more strains of meningitis-causing bacteria. One-third were contaminated with dangerous, antibiotic-resistant bacterial pathogens. In addition, less dangerous pathogens were identified, including pathogens that can cause fever, ulcers, acne, yeast infections, strep throat, periodontal disease, Rocky Mountain Spotted Fever, and more.” |
56 | 53) Face mask dermatitis” due to compulsory facial masks during the SARS-CoV-2 pandemic: data from 550 health care and non-health care workers in Germany, Niesert, 2021 | “The duration of wearing masks showed a significant impact on the prevalence of symptoms (p < 0.001). Type IV hypersensitivity was significantly more likely in participants with symptoms compared to those without symptoms (p = 0.001), whereas no increase in symptoms was observed in participants with atopic diathesis. HCWs used facial skin care products significantly more often than non-HCWs (p = 0.001).” |
57 | 54) Effect of Wearing Face Masks on the Carbon Dioxide Concentration in the Breathing Zone, AAQR/Geiss, 2020 | “Detected carbon dioxide concentrations ranged from 2150 ± 192 to 2875 ± 323 ppm. The concentrations of carbon dioxide while not wearing a face mask varied from 500–900 ppm. Doing office work and standing still on the treadmill each resulted in carbon dioxide concentrations of around 2200 ppm. A small increase could be observed when walking at a speed of 3 km h–1 (leisurely walking pace)…concentrations in the detected range can cause undesirable symptoms, such as fatigue, headache, and loss of concentration.” |
58 | 55) Surgical masks as source of bacterial contamination during operative procedures, Zhiqing, 2018 | “The source of bacterial contamination in SMs was the body surface of the surgeons rather than the OR environment. Moreover, we recommend that surgeons should change the mask after each operation, especially those beyond 2 hours.” |
59 | 56) The Damage of Masking Children Could be Irreparable, Hussey, 2021 | “When we surround children with mask-wearers for a year at a time, are we impairing their face barcode recognition during a period of hot neural development, thus putting full development of the FFA at risk? Does the demand for separation from others, reducing social interaction, add to the potential consequences as it might in autism? When can we be sure that we won’t interfere with visual input to the face recognition visual neurology so we don’t interfere with brain development? How much time with stimulus interference can we allow without consequences? Those are all questions currently without answers; we don’t know. Unfortunately, the science implies that if we mess up brain development for faces, we may not currently have therapies to undo everything we’ve done.” |
60 | 57) Masks can be Murder, Grossman, 2021 | “Wearing masks can create a sense of anonymity for an aggressor, while also dehumanizing the victim. This prevents empathy, empowering violence, and murder.” Masking helps remove empathy and compassion, allowing others to commit unspeakable acts on the masked person.” |
61 | 58) London high school teacher calls face masks an ‘egregious and unforgivable form of child abuse, Butler, 2020 | “In his email, Farquharson called the campaign to legislate mask wearing a “shameful farce, a charade, an act of political theatre” that’s more about enforcing “obedience and compliance” than it is about public health. He also likened children wearing masks to “involuntary self-torture,” calling it “an egregious and unforgivable form of child abuse and physical assault.” |
62 | 59) UK Government Advisor Admits Masks Are Just “Comfort Blankets” That Do Virtually Nothing, ZeroHedge, 2021 | “As the UK Government heralds “freedom day” today, which is anything but, a prominent government scientific advisor has admitted that face masks do very little to protect from coronavirus and are basically just “comfort blankets…the professor noted that “those aerosols escape masks and will render the mask ineffective,” adding “The public were demanding something must be done, they got masks, it is just a comfort blanket. But now it is entrenched, and we are entrenching bad behaviour…all around the world you can look at mask mandates and superimpose on infection rates, you cannot see that mask mandates made any effect whatsoever,” Axon further noted, adding that “The best thing you can say about any mask is that any positive effect they do have is too small to be measured.” |
63 | 60) Masks, false safety and real dangers, Part 1: Friable mask particulate and lung vulnerability, Borovoy, 2020 | “Surgical personnel are trained to never touch any part of a mask, except the loops and the nose bridge. Otherwise, the mask is considered useless and is to be replaced. Surgical personnel are strictly trained not to touch their masks otherwise. However, the general public may be seen touching various parts of their masks. Even the masks just removed from manufacturer packaging have been shown in the above photos to contain particulate and fiber that would not be optimal to inhale… Further concerns of macrophage response and other immune and inflammatory and fibroblast response to such inhaled particles specifically from facemasks should be the subject of more research. If widespread masking continues, then the potential for inhaling mask fibers and environmental and biological debris continues on a daily basis for hundreds of millions of people. This should be alarming for physicians and epidemiologists knowledgeable in occupational hazards.” |
64 | 61) Medical Masks, Desai, 2020 | “Face masks should be used only by individuals who have symptoms of respiratory infection such as coughing, sneezing, or, in some cases, fever. Face masks should also be worn by health care workers, by individuals who are taking care of or are in close contact with people who have respiratory infections, or otherwise as directed by a doctor. Face masks should not be worn by healthy individuals to protect themselves from acquiring respiratory infection because there is no evidence to suggest that face masks worn by healthy individuals are effective in preventing people from becoming ill.” |
A | B | |
---|---|---|
1 | Source: https://brownstone.org/articles/more-than-400-studies-on-the-failure-of-compulsory-covid-interventions/ | |
2 | Study/report title, author, and year published and interactive url link | Predominant study/evidence report finding |
3 | MASKS-INEFFECTIVENESS | |
4 | 1) Effectiveness of Adding a Mask Recommendation to Other Public Health Measures to Prevent SARS-CoV-2 Infection in Danish Mask Wearers, Bundgaard, 2021 | “Infection with SARS-CoV-2 occurred in 42 participants recommended masks (1.8%) and 53 control participants (2.1%). The between-group difference was −0.3 percentage point (95% CI, −1.2 to 0.4 percentage point; P = 0.38) (odds ratio, 0.82 [CI, 0.54 to 1.23]; P = 0.33). Multiple imputation accounting for loss to follow-up yielded similar results…the recommendation to wear surgical masks to supplement other public health measures did not reduce the SARS-CoV-2 infection rate among wearers by more than 50% in a community with modest infection rates, some degree of social distancing, and uncommon general mask use.” |
5 | 2) SARS-CoV-2 Transmission among Marine Recruits during Quarantine, Letizia, 2020 | “Our study showed that in a group of predominantly young male military recruits, approximately 2% became positive for SARS-CoV-2, as determined by qPCR assay, during a 2-week, strictly enforced quarantine. Multiple, independent virus strain transmission clusters were identified…all recruits wore double-layered cloth masks at all times indoors and outdoors.” |
6 | 3) Physical interventions to interrupt or reduce the spread of respiratory viruses, Jefferson, 2020 | “There is low certainty evidence from nine trials (3507 participants) that wearing a mask may make little or no difference to the outcome of influenza‐like illness (ILI) compared to not wearing a mask (risk ratio (RR) 0.99, 95% confidence interval (CI) 0.82 to 1.18. There is moderate certainty evidence that wearing a mask probably makes little or no difference to the outcome of laboratory‐confirmed influenza compared to not wearing a mask (RR 0.91, 95% CI 0.66 to 1.26; 6 trials; 3005 participants)…the pooled results of randomised trials did not show a clear reduction in respiratory viral infection with the use of medical/surgical masks during seasonal influenza.” |
7 | 4) The Impact of Community Masking on COVID-19: A Cluster-Randomized Trial in Bangladesh, Abaluck, 2021 Heneghan et al. | A cluster-randomized trial of community-level mask promotion in rural Bangladesh from November 2020 to April 2021 (N=600 villages, N=342,126 adults. Heneghan writes: “In a Bangladesh study, surgical masks reduced symptomatic COVID infections by between 0 and 22 percent, while the efficacy of cloth masks led to somewhere between an 11 percent increase to a 21 percent decrease. Hence, based on these randomized studies, adult masks appear to have either no or limited efficacy.” |
8 | 5) Evidence for Community Cloth Face Masking to Limit the Spread of SARS-CoV-2: A Critical Review, Liu/CATO, 2021 | “The available clinical evidence of facemask efficacy is of low quality and the best available clinical evidence has mostly failed to show efficacy, with fourteen of sixteen identified randomized controlled trials comparing face masks to no mask controls failing to find statistically significant benefit in the intent-to-treat populations. Of sixteen quantitative meta-analyses, eight were equivocal or critical as to whether evidence supports a public recommendation of masks, and the remaining eight supported a public mask intervention on limited evidence primarily on the basis of the precautionary principle.” |
9 | 6) Nonpharmaceutical Measures for Pandemic Influenza in Nonhealthcare Settings—Personal Protective and Environmental Measures, CDC/Xiao, 2020 | “Evidence from 14 randomized controlled trials of these measures did not support a substantial effect on transmission of laboratory-confirmed influenza…none of the household studies reported a significant reduction in secondary laboratory-confirmed influenza virus infections in the face mask group…the overall reduction in ILI or laboratory-confirmed influenza cases in the face mask group was not significant in either studies.” |
10 | 7) CIDRAP: Masks-for-all for COVID-19 not based on sound data, Brosseau, 2020 | “We agree that the data supporting the effectiveness of a cloth mask or face covering are very limited. We do, however, have data from laboratory studies that indicate cloth masks or face coverings offer very low filter collection efficiency for the smaller inhalable particles we believe are largely responsible for transmission, particularly from pre- or asymptomatic individuals who are not coughing or sneezing…though we support mask wearing by the general public, we continue to conclude that cloth masks and face coverings are likely to have limited impact on lowering COVID-19 transmission, because they have minimal ability to prevent the emission of small particles, offer limited personal protection with respect to small particle inhalation, and should not be recommended as a replacement for physical distancing or reducing time in enclosed spaces with many potentially infectious people.” |
11 | 8) Universal Masking in Hospitals in the Covid-19 Era, Klompas/NEJM, 2020 | “We know that wearing a mask outside health care facilities offers little, if any, protection from infection. Public health authorities define a significant exposure to Covid-19 as face-to-face contact within 6 feet with a patient with symptomatic Covid-19 that is sustained for at least a few minutes (and some say more than 10 minutes or even 30 minutes). The chance of catching Covid-19 from a passing interaction in a public space is therefore minimal. In many cases, the desire for widespread masking is a reflexive reaction to anxiety over the pandemic…The calculus may be different, however, in health care settings. First and foremost, a mask is a core component of the personal protective equipment (PPE) clinicians need when caring for symptomatic patients with respiratory viral infections, in conjunction with gown, gloves, and eye protection…universal masking alone is not a panacea. A mask will not protect providers caring for a patient with active Covid-19 if it’s not accompanied by meticulous hand hygiene, eye protection, gloves, and a gown. A mask alone will not prevent health care workers with early Covid-19 from contaminating their hands and spreading the virus to patients and colleagues. Focusing on universal masking alone may, paradoxically, lead to more transmission of Covid-19 if it diverts attention from implementing more fundamental infection-control measures.” |
12 | 9) Masks for prevention of viral respiratory infections among health care workers and the public: PEER umbrella systematic review, Dugré, 2020 | “This systematic review found limited evidence that the use of masks might reduce the risk of viral respiratory infections. In the community setting, a possible reduced risk of influenza-like illness was found among mask users. In health care workers, the results show no difference between N95 masks and surgical masks on the risk of confirmed influenza or other confirmed viral respiratory infections, although possible benefits from N95 masks were found for preventing influenza-like illness or other clinical respiratory infections. Surgical masks might be superior to cloth masks but data are limited to 1 trial.” |
13 | 10) Effectiveness of personal protective measures in reducing pandemic influenza transmission: A systematic review and meta-analysis, Saunders-Hastings, 2017 | “Facemask use provided a non-significant protective effect (OR = 0.53; 95% CI 0.16–1.71; I2 = 48%) against 2009 pandemic influenza infection.” |
14 | 11) Experimental investigation of indoor aerosol dispersion and accumulation in the context of COVID-19: Effects of masks and ventilation, Shah, 2021 | “Nevertheless, high-efficiency masks, such as the KN95, still offer substantially higher apparent filtration efficiencies (60% and 46% for R95 and KN95 masks, respectively) than the more commonly used cloth (10%) and surgical masks (12%), and therefore are still the recommended choice in mitigating airborne disease transmission indoors.” |
15 | 12) Exercise with facemask; Are we handling a devil’s sword?- A physiological hypothesis, Chandrasekaran, 2020 | “Exercising with facemasks may reduce available Oxygen and increase air trapping preventing substantial carbon dioxide exchange. The hypercapnic hypoxia may potentially increase acidic environment, cardiac overload, anaerobic metabolism and renal overload, which may substantially aggravate the underlying pathology of established chronic diseases. Further contrary to the earlier thought, no evidence exists to claim the facemasks during exercise offer additional protection from the droplet transfer of the virus.” |
16 | 13) Surgical face masks in modern operating rooms–a costly and unnecessary ritual?, Mitchell, 1991 | “Following the commissioning of a new suite of operating rooms air movement studies showed a flow of air away from the operating table towards the periphery of the room. Oral microbial flora dispersed by unmasked male and female volunteers standing one metre from the table failed to contaminate exposed settle plates placed on the table. The wearing of face masks by non-scrubbed staff working in an operating room with forced ventilation seems to be unnecessary.” |
17 | 14) Facemask against viral respiratory infections among Hajj pilgrims: A challenging cluster-randomized trial, Alfelali, 2020 | “By intention-to-treat analysis, facemask use did not seem to be effective against laboratory-confirmed viral respiratory infections (odds ratio [OR], 1.4; 95% confidence interval [CI], 0.9 to 2.1, p = 0.18) nor against clinical respiratory infection (OR, 1.1; 95% CI, 0.9 to 1.4, p = 0.40).” |
18 | 15) Simple respiratory protection–evaluation of the filtration performance of cloth masks and common fabric materials against 20-1000 nm size particles, Rengasamy, 2010 | “Results obtained in the study show that common fabric materials may provide marginal protection against nanoparticles including those in the size ranges of virus-containing particles in exhaled breath.” |
19 | 16) Respiratory performance offered by N95 respirators and surgical masks: human subject evaluation with NaCl aerosol representing bacterial and viral particle size range, Lee, 2008 | “The study indicates that N95 filtering facepiece respirators may not achieve the expected protection level against bacteria and viruses. An exhalation valve on the N95 respirator does not affect the respiratory protection; it appears to be an appropriate alternative to reduce the breathing resistance.” |
20 | 17) Aerosol penetration and leakage characteristics of masks used in the health care industry, Weber, 1993 | “We conclude that the protection provided by surgical masks may be insufficient in environments containing potentially hazardous sub-micrometer-sized aerosols.” |
21 | 18) Disposable surgical face masks for preventing surgical wound infection in clean surgery, Vincent, 2016 | “We included three trials, involving a total of 2106 participants. There was no statistically significant difference in infection rates between the masked and unmasked group in any of the trials…from the limited results it is unclear whether the wearing of surgical face masks by members of the surgical team has any impact on surgical wound infection rates for patients undergoing clean surgery.” |
22 | 19) Disposable surgical face masks: a systematic review, Lipp, 2005 | “From the limited results it is unclear whether wearing surgical face masks results in any harm or benefit to the patient undergoing clean surgery.” |
23 | 20) Comparison of the Filter Efficiency of Medical Nonwoven Fabrics against Three Different Microbe Aerosols, Shimasaki , 2018 | “We conclude that the filter efficiency test using the phi-X174 phage aerosol may overestimate the protective performance of nonwoven fabrics with filter structure compared to that against real pathogens such as the influenza virus.” |
24 | 21) The use of masks and respirators to preventtransmission of influenza: a systematic review of thescientific evidence21) The use of masks and respirators to prevent transmission of influenza: a systematic review of the scientific evidence, Bin-Reza, 2012 | The use of masks and respirators to preventtransmission of influenza: a systematic review of thescientific evidence“None of the studies established a conclusive relationship between mask/respirator use and protection against influenza infection. Some evidence suggests that mask use is best undertaken as part of a package of personal protection especially hand hygiene.” |
25 | 22) Facial protection for healthcare workers during pandemics: a scoping review, Godoy, 2020 | “Compared with surgical masks, N95 respirators perform better in laboratory testing, may provide superior protection in inpatient settings and perform equivalently in outpatient settings. Surgical mask and N95 respirator conservation strategies include extended use, reuse or decontamination, but these strategies may result in inferior protection. Limited evidence suggests that reused and improvised masks should be used when medical-grade protection is unavailable.” |
26 | 23) Assessment of Proficiency of N95 Mask Donning Among the General Public in Singapore, Yeung, 2020 | “These findings support ongoing recommendations against the use of N95 masks by the general public during the COVID-19 pandemic.5 N95 mask use by the general public may not translate into effective protection but instead provide false reassurance. Beyond N95 masks, proficiency among the general public in donning surgical masks needs to be assessed.” |
27 | 24) Evaluating the efficacy of cloth facemasks in reducing particulate matter exposure, Shakya, 2017 | “Standard N95 mask performance was used as a control to compare the results with cloth masks, and our results suggest that cloth masks are only marginally beneficial in protecting individuals from particles<2.5 μm.” |
28 | 25) Use of surgical face masks to reduce the incidence of the common cold among health care workers in Japan: a randomized controlled trial, Jacobs, 2009 | “Face mask use in health care workers has not been demonstrated to provide benefit in terms of cold symptoms or getting colds.” |
29 | 26) N95 Respirators vs Medical Masks for Preventing Influenza Among Health Care Personnel, Radonovich, 2019 | “Among outpatient health care personnel, N95 respirators vs medical masks as worn by participants in this trial resulted in no significant difference in the incidence of laboratory-confirmed influenza.” |
30 | 27) Does Universal Mask Wearing Decrease or Increase the Spread of COVID-19?, Watts up with that? 2020 | “A survey of peer-reviewed studies shows that universal mask wearing (as opposed to wearing masks in specific settings) does not decrease the transmission of respiratory viruses from people wearing masks to people who are not wearing masks.” |
31 | 28) Masking: A Careful Review of the Evidence, Alexander, 2021 | “In fact, it is not unreasonable at this time to conclude that surgical and cloth masks, used as they currently are, have absolutely no impact on controlling the transmission of Covid-19 virus, and current evidence implies that face masks can be actually harmful.” |
32 | 29) Community and Close Contact Exposures Associated with COVID-19 Among Symptomatic Adults ≥18 Years in 11 Outpatient Health Care Facilities — United States, July 2020, Fisher, 2020 | Reported characteristics of symptomatic adults ≥18 years who were outpatients in 11 US academic health care facilities and who received positive and negative SARS-CoV-2 test results (N = 314)* — United States, July 1–29, 2020, revealed that 80% of infected persons wore face masks almost all or most of the time. |
33 | 30) Impact of non-pharmaceutical interventions against COVID-19 in Europe: a quasi-experimental study, Hunter, 2020 | Face masks in public was not associated with reduced incidence. |
34 | 31) Masking lack of evidence with politics, CEBM, Heneghan, 2020 | “It would appear that despite two decades of pandemic preparedness, there is considerable uncertainty as to the value of wearing masks. For instance, high rates of infection with cloth masks could be due to harms caused by cloth masks, or benefits of medical masks. The numerous systematic reviews that have been recently published all include the same evidence base so unsurprisingly broadly reach the same conclusions.” |
35 | 32) Transmission of COVID-19 in 282 clusters in Catalonia, Spain: a cohort study, Marks, 2021 | “We observed no association of risk of transmission with reported mask usage by contacts, with the age or sex of the index case, or with the presence of respiratory symptoms in the index case at the initial study visit.” |
36 | 33) Non-pharmaceutical public health measures for mitigating the risk and impact of epidemic and pandemic influenza, WHO, 2020 | “Ten RCTs were included in the meta-analysis, and there was no evidence that face masks are effective in reducing transmission of laboratory-confirmed influenza.” |
37 | 34) The Strangely Unscientific Masking of America, Younes, 2020 | “One report reached its conclusion based on observations of a “dummy head attached to a breathing simulator.” Another analyzed use of surgical masks on people experiencing at least two symptoms of acute respiratory illness. Incidentally, not one of these studies involved cloth masks or accounted for real-world mask usage (or misusage) among lay people, and none established efficacy of widespread mask-wearing by people not exhibiting symptoms. There was simply no evidence whatsoever that healthy people ought to wear masks when going about their lives, especially outdoors.” |
38 | 35) Facemasks and similar barriers to prevent respiratory illness such as COVID-19: A rapid systematic review, Brainard, 2020 | “31 eligible studies (including 12 RCTs). Narrative synthesis and random-effects meta-analysis of attack rates for primary and secondary prevention in 28 studies were performed. Based on the RCTs we would conclude that wearing facemasks can be very slightly protective against primary infection from casual community contact, and modestly protective against household infections when both infected and uninfected members wear facemasks. However, the RCTs often suffered from poor compliance and controls using facemasks.” |
39 | 36) The Year of Disguises, Koops, 2020 | “The healthy people in our society should not be punished for being healthy, which is exactly what lockdowns, distancing, mask mandates, etc. do…Children should not be wearing face coverings. We all need constant interaction with our environments and that is especially true for children. This is how their immune system develops. They are the lowest of the low-risk groups. Let them be kids and let them develop their immune systems… The “Mask Mandate” idea is a truly ridiculous, knee-jerk reaction and needs to be withdrawn and thrown in the waste bin of disastrous policy, along with lockdowns and school closures. You can vote for a person without blindly supporting all of their proposals!” |
40 | 37) Open Schools, Covid-19, and Child and Teacher Morbidity in Sweden, Ludvigsson, 2020 | “1,951,905 children in Sweden (as of December 31, 2019) who were 1 to 16 years of age, were examined…social distancing was encouraged in Sweden, but wearing face masks was not…No child with Covid-19 died.” |
41 | 38) Double-Masking Benefits Are Limited, Japan Supercomputer Finds, Reidy, 2021 | “Wearing two masks offers limited benefits in preventing the spread of droplets that could carry the coronavirus compared to one well-fitted disposable mask, according to a Japanese study that modeled the dispersal of droplets on a supercomputer.” |
42 | 39) Physical interventions to interrupt or reduce the spread of respiratory viruses. Part 1 – Face masks, eye protection and person distancing: systematic review and meta-analysis, Jefferson, 2020 | “There was insufficient evidence to provide a recommendation on the use of facial barriers without other measures. We found insufficient evidence for a difference between surgical masks and N95 respirators and limited evidence to support effectiveness of quarantine.” |
43 | 40) Should individuals in the community without respiratory symptoms wear facemasks to reduce the spread of COVID-19?, NIPH, 2020 | “Non-medical facemasks include a variety of products. There is no reliable evidence of the effectiveness of non-medical facemasks in community settings. There is likely to be substantial variation in effectiveness between products. However, there is only limited evidence from laboratory studies of potential differences in effectiveness when different products are used in the community.” |
44 | 41) Is a mask necessary in the operating theatre?, Orr, 1981 | “It would appear that minimum contamination can best be achieved by not wearing a mask at all but operating in silence. Whatever its relation to contamination, bacterial counts, or the dissemination of squames, there is no direct evidence that the wearing of masks reduces wound infection.” |
45 | 42) The surgical mask is a bad fit for risk reduction, Neilson, 2016 | “As recently as 2010, the US National Academy of Sciences declared that, in the community setting, “face masks are not designed or certified to protect the wearer from exposure to respiratory hazards.” A number of studies have shown the inefficacy of the surgical mask in household settings to prevent transmission of the influenza virus.” |
46 | 43) Facemask versus No Facemask in Preventing Viral Respiratory Infections During Hajj: A Cluster Randomised Open Label Trial, Alfelali, 2019 | “Facemask use does not prevent clinical or laboratory-confirmed viral respiratory infections among Hajj pilgrims.” |
47 | 44) Facemasks in the COVID-19 era: A health hypothesis, Vainshelboim, 2021 | “The existing scientific evidences challenge the safety and efficacy of wearing facemask as preventive intervention for COVID-19. The data suggest that both medical and non-medical facemasks are ineffective to block human-to-human transmission of viral and infectious disease such SARS-CoV-2 and COVID-19, supporting against the usage of facemasks. Wearing facemasks has been demonstrated to have substantial adverse physiological and psychological effects. These include hypoxia, hypercapnia, shortness of breath, increased acidity and toxicity, activation of fear and stress response, rise in stress hormones, immunosuppression, fatigue, headaches, decline in cognitive performance, predisposition for viral and infectious illnesses, chronic stress, anxiety and depression.” |
48 | 45) The use of masks and respirators to prevent transmission of influenza: a systematic review of the scientific evidence, Bin-Reza, 2011 | “None of the studies established a conclusive relationship between mask/respirator use and protection against influenza infection. Some evidence suggests that mask use is best undertaken as part of a package of personal protection especially hand hygiene.” |
49 | 46) Are Face Masks Effective? The Evidence., Swiss Policy Research, 2021 | “Most studies found little to no evidence for the effectiveness of face masks in the general population, neither as personal protective equipment nor as a source control.” |
50 | 47) Postoperative wound infections and surgical face masks: A controlled study, Tunevall, 1991 | “These results indicate that the use of face masks might be reconsidered. Masks may be used to protect the operating team from drops of infected blood and from airborne infections, but have not been proven to protect the patient operated by a healthy operating team.” |
51 | 48) Mask mandate and use efficacy in state-level COVID-19 containment, Guerra, 2021 | “Mask mandates and use are not associated with slower state-level COVID-19 spread during COVID-19 growth surges.” |
52 | 49) Twenty Reasons Mandatory Face Masks are Unsafe, Ineffective and Immoral, Manley, 2021 | “A CDC-funded review on masking in May 2020 came to the conclusion: “Although mechanistic studies support the potential effect of hand hygiene or face masks, evidence from 14 randomized controlled trials of these measures did not support a substantial effect on transmission of laboratory-confirmed influenza… None of the household studies reported a significant reduction in secondary laboratory-confirmed influenza virus infections in the face mask group.” If masks can’t stop the regular flu, how can they stop SAR-CoV-2?” |
53 | 50) A cluster randomised trial of cloth masks compared with medical masks in healthcare workers, MacIntyre, 2015 | “First RCT of cloth masks, and the results caution against the use of cloth masks. This is an important finding to inform occupational health and safety. Moisture retention, reuse of cloth masks and poor filtration may result in increased risk of infection…the rates of all infection outcomes were highest in the cloth mask arm, with the rate of ILI statistically significantly higher in the cloth mask arm (relative risk (RR)=13.00, 95% CI 1.69 to 100.07) compared with the medical mask arm. Cloth masks also had significantly higher rates of ILI compared with the control arm. An analysis by mask use showed ILI (RR=6.64, 95% CI 1.45 to 28.65) and laboratory-confirmed virus (RR=1.72, 95% CI 1.01 to 2.94) were significantly higher in the cloth masks group compared with the medical masks group. Penetration of cloth masks by particles was almost 97% and medical masks 44%.” |
54 | 51) Horowitz: Data from India continues to blow up the ‘Delta’ fear narrative, Blazemedia, 2021 | “Rather than proving the need to sow more panic, fear, and control over people, the story from India — the source of the “Delta” variant — continues to refute every current premise of COVID fascism…Masks failed to stop the spread there.” |
55 | 52) An outbreak caused by the SARS-CoV-2 Delta variant (B.1.617.2) in a secondary care hospital in Finland, May 2021, Hetemäki, 2021 | Reporting on a nosocomial hospital outbreak in Finland, Hetemäli et al. observed that “both symptomatic and asymptomatic infections were found among vaccinated health care workers, and secondary transmission occurred from those with symptomatic infections despite use of personal protective equipment.” |
56 | 53) Nosocomial outbreak caused by the SARS-CoV-2 Delta variant in a highly vaccinated population, Israel, July 2021, Shitrit, 2021 | In a hospital outbreak investigation in Israel, Shitrit et al. observed “high transmissibility of the SARS-CoV-2 Delta variant among twice vaccinated and masked individuals.” They added that “this suggests some waning of immunity, albeit still providing protection for individuals without comorbidities.” Again, despite use of personal protective equipment. |
57 | 54) 47 studies confirm ineffectiveness of masks for COVID and 32 more confirm their negative health effects, Lifesite news staff, 2021 | “No studies were needed to justify this practice since most understood viruses were far too small to be stopped by the wearing of most masks, other than sophisticated ones designed for that task and which were too costly and complicated for the general public to properly wear and keep changing or cleaning. It was also understood that long mask wearing was unhealthy for wearers for common sense and basic science reasons.” |
58 | 55) Are EUA Face Masks Effective in Slowing the Spread of a Viral Infection?, Dopp, 2021 | The vast evidence shows that masks are ineffective. |
59 | 56) CDC Study finds overwhelming majority of people getting coronavirus wore masks, Boyd/Federalist, 2021 | “A Centers for Disease Control report released in September shows that masks and face coverings are not effective in preventing the spread of COVID-19, even for those people who consistently wear them.” |
60 | 57) Most Mask Studies Are Garbage, Eugyppius, 2021 | “The other kind of study, the proper kind, would be a randomised controlled trial. You compare the rates of infection in a masked cohort against rates of infection in an unmasked cohort. Here things have gone much, much worse for mask brigade. They spent months trying to prevent the publication of the Danish randomised controlled trial, which found that masks do zero. When that paper finally squeaked into print, they spent more months trying desperately to poke holes in it. You could feel their boundless relief when the Bangladesh study finally appeared to save them in early September. Every last Twitter blue-check could now proclaim that Science Shows Masks Work. Such was their hunger for any scrap of evidence to prop up their prior convictions, that none of them noticed the sad nature of the Science in question. The study found a mere 10% reduction in seroprevalence among the masked cohort, an effect so small that it fell within the confidence interval. Even the study authors couldn’t exclude the possibility that masks in fact do zero.” |
61 | 58) Using face masks in the community: first update, ECDC, 2021 | “No high-quality evidence in favor of face masks and recommended their use only based on the ‘precautionary principle.” |
62 | 59) Do physical measures such as hand-washing or wearing masks stop or slow down the spread of respiratory viruses?, Cochrane, 2020 | “Seven studies took place in the community, and two studies in healthcare workers. Compared with wearing no mask, wearing a mask may make little to no difference in how many people caught a flu-like illness (9 studies; 3507 people); and probably makes no difference in how many people have flu confirmed by a laboratory test (6 studies; 3005 people). Unwanted effects were rarely reported, but included discomfort.” |
63 | 60) Mouth-nose protection in public: No evidence of effectiveness, Thieme/ Kappstein, 2020 | “The use of masks in public spaces is questionable simply because of the lack of scientific data. If one also considers the necessary precautions, masks must even be considered a risk of infection in public spaces according to the rules known from hospitals… If masks are worn by the population, the risk of infection is potentially increased, regardless of whether they are medical masks or whether they are so-called community masks designed in any way. If one considers the precautionary measures that the RKI as well as the international health authorities have pronounced, all authorities would even have to inform the population that masks should not be worn in public spaces at all. Because no matter whether it is a duty for all citizens or voluntarily borne by the citizens who want it for whatever reason, it remains a fact that masks can do more harm than good in public.” |
64 | 61) US mask guidance for kids is the strictest across the world, Skelding, 2021 | “Kids need to see faces,” Jay Bhattacharya, a professor of medicine at Stanford University, told The Post. Youngsters watch people’s mouths to learn to speak, read and understand emotions, he said.“We have this idea that this disease is so bad that we must adopt any means necessary to stop it from spreading,” he said. “It’s not that masks in schools have no costs. They actually do have substantial costs.” |
65 | 62) Masking young children in school harms language acquisition, Walsh, 2021 | “This is important because children and/or students do not have the speech or language ability that adults have — they are not equally able and the ability to see the face and especially the mouth is critical to language acquisition which children and/or students are engaged in at all times. Furthermore, the ability to see the mouth is not only essential to communication but also essential to brain development.” |
66 | 63) The Case Against Masks for Children, Makary, 2021 | “It’s abusive to force kids who struggle with them to sacrifice for the sake of unvaccinated adults… Do masks reduce Covid transmission in children? Believe it or not, we could find only a single retrospective study on the question, and its results were inconclusive. Yet two weeks ago the Centers for Disease Control and Prevention sternly decreed that 56 million U.S. children and adolescents, vaccinated or not, should cover their faces regardless of the prevalence of infection in their community. Authorities in many places took the cue to impose mandates in schools and elsewhere, on the theory that masks can’t do any harm. That isn’t true. Some children are fine wearing a mask, but others struggle. Those who have myopia can have difficulty seeing because the mask fogs their glasses. (This has long been a problem for medical students in the operating room.) Masks can cause severe acne and other skin problems. The discomfort of a mask distracts some children from learning. By increasing airway resistance during exhalation, masks can lead to increased levels of carbon dioxide in the blood. And masks can be vectors for pathogens if they become moist or are used for too long.” |
67 | 64) Face Covering Mandates, Peavey, 2021 | “Face Covering Mandates And Why They AREN’T Effective.” |
68 | 65) Do masks work? A Review of the evidence, Anderson, 2021 | “In truth, the CDC’s, U.K.’s, and WHO’s earlier guidance was much more consistent with the best medical research on masks’ effectiveness in preventing the spread of viruses. That research suggests that Americans’ many months of mask-wearing has likely provided little to no health benefit and might even have been counterproductive in preventing the spread of the novel coronavirus.” |
69 | 66) Most face masks won’t stop COVID-19 indoors, study warns, Anderer, 2021 | “New research reveals that cloth masks filter just 10% of exhaled aerosols, with many people not wearing coverings that fit their face properly.” |
70 | 67) How face masks and lockdowns failed/the face mask folly in retrospect, Swiss Policy Research, 2021 | “Mask mandates and lockdowns have had no discernible impact.” |
71 | 68) CDC Releases School COVID Transmission Study But Buries One of the Most Damning Parts, Davis, 2021 | “The 21% lower incidence in schools that required mask use among students was not statistically significant compared with schools where mask use was optional… With tens of millions of American kids headed back to school in the fall, their parents and political leaders owe it to them to have a clear-sighted, scientifically rigorous discussion about which anti-COVID measures actually work and which might put an extra burden on vulnerable young people without meaningfully or demonstrably slowing the spread of the virus…that a masking requirement of students failed to show independent benefit is a finding of consequence and great interest.” |
72 | 69) World Health Organization internal meeting, COVID-19 – virtual press conference – 30 March 2020, 2020 | “This is a question on Austria. The Austrian Government has a desire to make everyone wear a mask who’s going into the shops. I understood from our previous briefings with you that the general public should not wear masks because they are in short supply. What do you say about the new Austrian measures?… I’m not specifically aware of that measure in Austria. I would assume that it’s aimed at people who potentially have the disease not passing it to others. In general WHO recommends that the wearing of a mask by a member of the public is to prevent that individual giving the disease to somebody else. We don’t generally recommend the wearing to masks in public by otherwise well individuals because it has not been up to now associated with any particular benefit.” |
73 | 70) Face masks to prevent transmission of influenza virus: a systematic review, Cowling, 2010 | “Review highlights the limited evidence base supporting the efficacy or effectiveness of face masks to reduce influenza virus transmission.”“None of the studies reviewed showed a benefit from wearing a mask, in either HCW or community members in households (H).” |
74 | 71) Effectiveness of N95 respirators versus surgical masks in protecting health care workers from acute respiratory infection: a systematic review and meta-analysis, Smith, 2016 | “Although N95 respirators appeared to have a protective advantage over surgical masks in laboratory settings, our meta-analysis showed that there were insufficient data to determine definitively whether N95 respirators are superior to surgical masks in protecting health care workers against transmissible acute respiratory infections in clinical settings.” |
75 | 72) Effectiveness of Masks and Respirators Against Respiratory Infections in Healthcare Workers: A Systematic Review and Meta-Analysis, Offeddu, 2017 | “We found evidence to support universal medical mask use in hospital settings as part of infection control measures to reduce the risk of CRI and ILI among HCWs. Overall, N95 respirators may convey greater protection, but universal use throughout a work shift is likely to be less acceptable due to greater discomfort…Our analysis confirms the effectiveness of medical masks and respirators against SARS. Disposable, cotton, or paper masks are not recommended. The confirmed effectiveness of medical masks is crucially important for lower-resource and emergency settings lacking access to N95 respirators. In such cases, single-use medical masks are preferable to cloth masks, for which there is no evidence of protection and which might facilitate transmission of pathogens when used repeatedly without adequate sterilization…We found no clear benefit of either medical masks or N95 respirators against pH1N1…Overall, the evidence to inform policies on mask use in HCWs is poor, with a small number of studies that is prone to reporting biases and lack of statistical power.” |
76 | 73) N95 Respirators vs Medical Masks for Preventing Influenza Among Health Care Personnel, Radonovich, 2019 | “Use of N95 respirators, compared with medical masks, in the outpatient setting resulted in no significant difference in the rates of laboratory-confirmed influenza.” |
77 | Effectiveness of N95 respirators versus surgical masks againstinfluenza: A systematic review and meta-analysis74) Masks Don’t Work: A Review of Science Relevant to COVID-19 Social Policy, Rancourt, 2020 | The use of N95 respirators compared with surgical masks is not associated with alower risk of laboratory-confirmed influenza. It suggests that N95 respirators should not be rec-ommended for general public and nonhigh-risk medical staff those are not in close contact withinfluenza patients or suspected patients. “No RCT study with verified outcome shows a benefit for HCW or community members in households to wearing a mask or respirator. There is no such study. There are no exceptions. Likewise, no study exists that shows a benefit from a broad policy to wear masks in public (more on this below). Furthermore, if there were any benefit to wearing a mask, because of the blocking power against droplets and aerosol particles, then there should be more benefit from wearing a respirator (N95) compared to a surgical mask, yet several large meta-analyses, and all the RCT, prove that there is no such relative benefit.” |
78 | 75) More Than a Dozen Credible Medical Studies Prove Face Masks Do Not Work Even In Hospitals!, Firstenberg, 2020 | “Mandating masks has not kept death rates down anywhere. The 20 U.S. states that have never ordered people to wear face masks indoors and out have dramatically lower COVID-19 death rates than the 30 states that have mandated masks. Most of the no-mask states have COVID-19 death rates below 20 per 100,000 population, and none have a death rate higher than 55. All 13 states that have death rates higher 55 are states that have required the wearing of masks in all public places. It has not protected them.” |
79 | 76) Does evidence based medicine support the effectiveness of surgical facemasks in preventing postoperative wound infections in elective surgery?, Bahli, 2009 | “From the limited randomized trials it is still not clear that whether wearing surgical face masks harms or benefit the patients undergoing elective surgery.” |
80 | 77) Peritonitis prevention in CAPD: to mask or not?, Figueiredo, 2000 | “The current study suggests that routine use of face masks during CAPD bag exchanges may be unnecessary and could be discontinued.” |
81 | 78) The operating room environment as affected by people and the surgical face mask, Ritter, 1975 | “The wearing of a surgical face mask had no effect upon the overall operating room environmental contamination and probably work only to redirect the projectile effect of talking and breathing. People are the major source of environmental contamination in the operating room.” |
82 | 79) The efficacy of standard surgical face masks: an investigation using “tracer particles, Ha’eri, 1980 | “Particle contamination of the wound was demonstrated in all experiments. Since the microspheres were not identified on the exterior of these face masks, they must have escaped around the mask edges and found their way into the wound.” |
83 | 80) Wearing of caps and masks not necessary during cardiac catheterization, Laslett, 1989 | “Prospectively evaluated the experience of 504 patients undergoing percutaneous left heart catheterization, seeking evidence of a relationship between whether caps and/or masks were worn by the operators and the incidence of infection. No infections were found in any patient, regardless of whether a cap or mask was used. Thus, we found no evidence that caps or masks need to be worn during percutaneous cardiac catheterization.” |
84 | 81) Do anaesthetists need to wear surgical masks in the operating theatre? A literature review with evidence-based recommendations, Skinner, 2001 | “A questionnaire-based survey, undertaken by Leyland’ in 1993 to assess attitudes to the use of masks, showed that 20% of surgeons discarded surgical masks for endoscopic work. Less than 50% did not wear the mask as recommended by the Medical Research Council. Equal numbers of surgeons wore the mask in the belief they were protecting themselves and the patient, with 20% of these admitting that tradition was the only reason for wearing them.” |
85 | 82) Mask mandates for children are not backed by data, Faria, 2021 | “Even if you want to use the 2018-19 flu season to avoid overlap with the start of the COVID-19 pandemic, the CDC paints a similar picture: It estimated 480 flu deaths among children during that period, with 46,000 hospitalizations. COVID-19, mercifully, is simply not as deadly for children. According to the American Academy of Pediatrics, preliminary data from 45 states show that between 0.00%-0.03% of child COVID-19 cases resulted in death. When you combine these numbers with the CDC study that found mask mandates for students — along with hybrid models, social distancing, and classroom barriers — did not have a statistically significant benefit in preventing the spread of COVID-19 in schools, the insistence that we force students to jump through these hoops for their own protection makes no sense.” |
86 | 83) The Downsides of Masking Young Students Are Real, Prasad, 2021 | “The benefits of mask requirements in schools might seem self-evident—they have to help contain the coronavirus, right?—but that may not be so. In Spain, masks are used in kids ages 6 and older. The authors of one study there examined the risk of viral spread at all ages. If masks provided a large benefit, then the transmission rate among 5-year-olds would be far higher than the rate among 6-year-olds. The results don’t show that. Instead, they show that transmission rates, which were low among the youngest kids, steadily increased with age—rather than dropping sharply for older children subject to the face-covering requirement. This suggests that masking kids in school does not provide a major benefit and might provide none at all. And yet many officials prefer to double down on masking mandates, as if the fundamental policy were sound and only the people have failed.” |
87 | 84) Masks In Schools: Scientific American Fumbles Report On Childhood COVID Transmission, English/ACSH, 2021 | “Masking is a low-risk, inexpensive intervention. If we want to recommend it as a precautionary measure, especially in situations where vaccination isn’t an option, great. But that’s not what the public has been told. “Florida governor Ron DeSantis and politicians in Texas say research does not support mask mandates,” SciAm’s sub-headline bellowed. “Many studies show they are wrong.”If that’s the case, demonstrate that the intervention works before you mandate its use in schools. If you can’t, acknowledged what UC San Francisco hematologist-oncologist and Associate Professor of Epidemiology Vinay Prasad wrote over at the Atlantic:”No scientific consensus exists about the wisdom of mandatory-masking rules for schoolchildren … In mid-March 2020, few could argue against erring on the side of caution. But nearly 18 months later, we owe it to children and their parents to answer the question properly: Do the benefits of masking kids in school outweigh the downsides? The honest answer in 2021 remains that we don’t know for sure.” |
88 | 85) Masks ‘don’t work,’ are damaging health and are being used to control population: Doctors panel, Haynes, 2021 | “The only randomized control studies that have ever been done on masks show that they don’t work,” began Dr. Nepute. He referred to Dr. Anthony Fauci’s “noble lie,” in which Fauci “changed his tune,” from his March 2020 comments, where he downplayed the need and efficacy of mask wearing, before urging Americans to use masks later in the year. “Well, he lied to us. So if he lied about that, what else has he lied to you about?” questioned Nepute.Masks have become commonplace in almost every setting, whether indoors or outdoors, but Dr. Popper mentioned how there have been “no studies” which actually examine the “effect of wearing a mask during all your waking hours.”“There’s no science to back any of this and particularly no science to back the fact that wearing a mask twenty four-seven or every waking minute, is health promoting,” added Popper.” |
89 | 86) Aerosol penetration through surgical masks, Chen, 1992 | “The mask that has the highest collection efficiency is not necessarily the best mask from the perspective of the filter-quality factor, which considers not only the capture efficiency but also the air resistance. Although surgical mask media may be adequate to remove bacteria exhaled or expelled by health care workers, they may not be sufficient to remove the sub-micrometer-sized aerosols containing pathogens to which these health care workers are potentially exposed.” |
90 | 87) CDC: Schools With Mask Mandates Didn’t See Statistically Significant Different Rates of COVID Transmission From Schools With Optional Policies, Miltimore, 2021 | “The CDC did not include its finding that “required mask use among students was not statistically significant compared with schools where mask use was optional” in the summary of its report.” |
91 | 88) Horowitz: Data from India continues to blow up the ‘Delta’ fear narrative, Howorwitz, 2021 | “Rather than proving the need to sow more panic, fear, and control over people, the story from India — the source of the “Delta” variant — continues to refute every current premise of COVID fascism…Unless we do that, we must return to the very effective lockdowns and masks. In reality, India’s experience proves the opposite true; namely:1) Delta is largely an attenuated version, with a much lower fatality rate, that for most people is akin to a cold.2) Masks failed to stop the spread there.3) The country has come close to the herd immunity threshold with just 3% vaccinated. |
92 | 89) Transmission of SARS-CoV-2 Delta Variant Among Vaccinated Healthcare Workers, Vietnam, Chau, 2021 | While not definitive in the LANCET publication, it can be inferred that the nurses were all masked up and had PPE etc. as was the case in Finland and Israel nosocomial outbreaks, indicating the failure of PPE and masks to constrain Delta spread. |
93 | 90) Aerosol penetration through surgical masks, Willeke, 1992 | “The mask that has the highest collection efficiency is not necessarily the best mask from the perspective of the filter-quality factor, which considers not only the capture efficiency but also the air resistance. Although surgical mask media may be adequate to remove bacteria exhaled or expelled by health care workers, they may not be sufficient to remove the submicrometer-size aerosols containing pathogens to which these health care workers are potentially exposed.” |
94 | 91) The efficacy of standard surgical face masks: an investigation using “tracer particles”, Wiley, 1980 | “Particle contamination of the wound was demonstrated in all aexperiments. Since the microspheres were not identified on the exterior of these face masks, they must have escped around the mask edges and found their way into the wound. The wearing of the mask beneath the headgear curtails this route of contamination.” |
95 | 92) An Evidence Based Scientific Analysis of Why Masks are Ineffective, Unnecessary, and Harmful, Meehan, 2020 | “Decades of the highest-level scientific evidence (meta-analyses of multiple randomized controlled trials) overwhelmingly conclude that medical masks are ineffective at preventing the transmission of respiratory viruses, including SAR-CoV-2…those arguing for masks are relying on low-level evidence (observational retrospective trials and mechanistic theories), none of which are powered to counter the evidence, arguments, and risks of mask mandates.” |
96 | 93) Open Letter from Medical Doctors and Health Professionals to All Belgian Authorities and All Belgian Media, AIER, 2020 | “Oral masks in healthy individuals are ineffective against the spread of viral infections.” |
97 | 94) Effectiveness of N95 respirators versus surgical masks against influenza: A systematic review and meta-analysis, Long, 2020 | “The use of N95 respirators compared with surgical masks is not associated with a lower risk of laboratory-confirmed influenza. It suggests that N95 respirators should not be recommended for general public and nonhigh-risk medical staff those are not in close contact with influenza patients or suspected patients.” |
98 | 95) Advice on the use of masks in the context of COVID-19, WHO, 2020 | “However, the use of a mask alone is insufficient to provide an adequate level of protection or source control, and other personal and community level measures should also be adopted to suppress transmission of respiratory viruses.” |
99 | 96) Farce mask: it’s safe for only 20 minutes, The Sydney Morning Herald, 2003 | “Health authorities have warned that surgical masks may not be an effective protection against the virus.”Those masks are only effective so long as they are dry,” said Professor Yvonne Cossart of the Department of Infectious Diseases at the University of Sydney.”As soon as they become saturated with the moisture in your breath they stop doing their job and pass on the droplets.”Professor Cossart said that could take as little as 15 or 20 minutes, after which the mask would need to be changed. But those warnings haven’t stopped people snapping up the masks, with retailers reporting they are having trouble keeping up with demand.” |
100 | 97) Study: Wearing A Used Mask Is Potentially Riskier Than No Mask At All, Boyd, 2020 Effects of mask-wearing on the inhalability and deposition of airborne SARS-CoV-2 aerosols in human upper airway | “According to researchers from the University of Massachusetts Lowell and California Baptist University, a three-layer surgical mask is 65 percent efficient in filtering particles in the air. That effectiveness, however, falls to 25 percent once it is used.“It is natural to think that wearing a mask, no matter new or old, should always be better than nothing,” said author Jinxiang Xi.“Our results show that this belief is only true for particles larger than 5 micrometers, but not for fine particles smaller than 2.5 micrometers,” he continued.” |
A | B | |
---|---|---|
1 | Source: https://brownstone.org/articles/more-than-400-studies-on-the-failure-of-compulsory-covid-interventions/ | |
2 | Study/report title, author, and year published and interactive url link | Predominant study/evidence report finding |
3 | SCHOOL CLOSURES | |
4 | 1) Suffering in silence: How COVID-19 school closures inhibit the reporting of child maltreatment, Baron, 2020 | “While one would expect the financial, mental, and physical stress due to COVID-19 to result in additional child maltreatment cases, we find that the actual number of reported allegations was approximately 15,000 lower (27%) than expected for these two months. We leverage a detailed dataset of school district staffing and spending to show that the observed decline in allegations was largely driven by school closures.” |
5 | 2) Association of routine school closures with child maltreatment reporting and substantiation in the United States; 2010-2017, Puls, 2021 | “Results suggest that the detection of child maltreatment may be diminished during periods of routine school closure.” |
6 | 3) Reporting of child maltreatment during the SARS-CoV-2 pandemic in New York City from March to May 2020, Rapoport, 2021 | “Precipitous drops in child maltreatment reporting and child welfare interventions coincided with social distancing policies designed to mitigate COVID-19 transmission.” |
7 | 4) Calculating the impact of COVID-19 pandemic on child abuse and neglect in the U.S, Nguyen, 2021 | “The COVID-19 pandemic has led to a precipitous drop in CAN investigations where almost 200,000 children are estimated to have been missed for prevention services and CAN in a 10-month period.” |
8 | 5) Effect of school closures on mortality from coronavirus disease 2019: old and new predictions, Rice, 2020 | “We therefore conclude that the somewhat counterintuitive results that school closures lead to more deaths are a consequence of the addition of some interventions that suppress the first wave and failure to prioritise protection of the most vulnerable people. When the interventions are lifted, there is still a large population who are susceptible and a substantial number of people who are infected. This then leads to a second wave of infections that can result in more deaths, but later. Further lockdowns would lead to a repeating series of waves of infection unless herd immunity is achieved by vaccination, which is not considered in the model. A similar result is obtained in some of the scenarios involving general social distancing. For example, adding general social distancing to case isolation and household quarantine was also strongly associated with suppression of the infection during the intervention period, but then a second wave occurs that actually concerns a higher peak demand for ICU beds than for the equivalent scenario without general social distancing.” |
9 | 6) Schools Closures during the COVID-19 Pandemic: A Catastrophic Global Situation, Buonsenso, 2020 | “This extreme measure provoked a disruption of the educational system involving hundreds of million children worldwide. The return of children to school has been variable and is still an unresolved and contentious issue. Importantly the process has not been directly correlated to the severity of the pandemic s impact and has fueled the widening of disparities, disproportionately affecting the most vulnerable populations. Available evidence shows SC added little benefit to COVID-19 control whereas the harms related to SC severely affected children and adolescents. This unresolved issue has put children and young people at high risk of social, economic and health-related harm for years to come, triggering severe consequences during their lifespan.” |
10 | 7) The Impact of COVID-19 School Closure on Child and Adolescent Health: A Rapid Systematic Review, Chaabane, 2021 | “COVID-19-related school closure was associated with a significant decline in the number of hospital admissions and pediatric emergency department visits. However, a number of children and adolescents lost access to school-based healthcare services, special services for children with disabilities, and nutrition programs. A greater risk of widening educational disparities due to lack of support and resources for remote learning were also reported among poorer families and children with disabilities. School closure also contributed to increased anxiety and loneliness in young people and child stress, sadness, frustration, indiscipline, and hyperactivity. The longer the duration of school closure and reduction of daily physical activity, the higher was the predicted increase of Body Mass Index and childhood obesity prevalence.” |
11 | 8) School Closures and Social Anxiety During the COVID-19 Pandemic, Morrissette, 2020 | “Reported on the effects that social isolation and loneliness may have on children and adolescents during the global 2019 novel coronavirus disease (COVID-19) pandemic, with their findings suggesting associations between social anxiety and loneliness/social isolation.” |
12 | 9) Parental job loss and infant health, Lindo, 2011 | “Husbands’ job losses have significant negative effects on infant health. They reduce birth weights by approximately four and a half percent.” |
13 | 10) Closing schools is not evidence based and harms children, Lewis, 2021 | “For some children education is their only way out of poverty; for others school offers a safe haven away from a dangerous or chaotic home life. Learning loss, reduced social interaction, isolation, reduced physical activity, increased mental health problems, and potential for increased abuse, exploitation, and neglect have all been associated with school closures. Reduced future income6 and life expectancy are associated with less education. Children with special educational needs or who are already disadvantaged are at increased risk of harm.” |
14 | 11) Impacts of school closures on physical and mental health of children and young people: a systematic review, Viner, 2021 | “School closures as part of broader social distancing measures are associated with considerable harms to CYP health and wellbeing. Available data are short-term and longer-term harms are likely to be magnified by further school closures. Data are urgently needed on longer-term impacts using strong research designs, particularly amongst vulnerable groups. These findings are important for policy-makers seeking to balance the risks of transmission through school-aged children with the harms of closing schools.” |
15 | 12) School Closure: A Careful Review of the Evidence, Alexander, 2020 | “Based on the existing reviewed evidence, the predominant finding is that children (particularly young children) are at very low risk of acquiring SARS-CoV-2 infection, and if they do become infected, are at very low risk of spreading it among themselves or to other children in the school setting, of spreading it to their teachers, or of spreading it to other adults or to their parents, or of taking it into the home setting; children typically become infected from the home setting/clusters and adults are typically the index case; children are at very low risk of severe illness or death from COVID-19 disease except in very rare circumstances; children do not drive SARS-CoV-2/COVID-19 as they do seasonal influenza; an age gradient as to susceptibility and transmission capacity exists whereby older children should not be treated the same as younger children in terms of ability to transmit e.g. a 6 year-old versus a 17 year-old (as such, public health measures would be different in an elementary school versus a high/secondary school); ‘very low risk’ can also be considered ‘very rare’ (not zero risk, but negligible, very rare); we argue that masking and social distancing for young children is unsound policy and not needed and if social distancing is to be used, that 3-feet is suitable over 6-feet and will address the space limitations in schools; we argue that we are well past the point where we must replace hysteria and fear with knowledge and fact. The schools must be immediately re-opened for in-person instruction as there is no reason to do otherwise.” |
16 | 13) Children, school and COVID-19, RIVM, 2021 | “If we look at all hospital admissions reported by the NICE Foundation between 1 January and 16 November 2021, 0.7% were younger than 4 years old. 0.1% were aged 4-11 years and 0.2% were aged 12-17 years. The vast majority (99.0%) of all people admitted to hospital with COVID-19 were aged 18 years or older.” |
17 | 14) FEW CARRIERS, FEW TRANSMITTERS”: A STUDY CONFIRMS THE MINIMAL ROLE OF CHILDREN IN THE COVID-19 EPIDEMIC, Vincendon, 2020 | “Children are few carriers, few transmitters, and when they are contaminated, it is almost always adults in the family who have contaminated them.” |
18 | 15) Transmission of SARS-CoV-2 in children aged 0 to 19 years in childcare facilities and schools after their reopening in May 2020, Baden-Württemberg, Germany, Ehrhardt, 2020 | “Investigated data from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infected 0-19 year olds, who attended schools/childcare facilities, to assess their role in SARS-CoV-2 transmission after these establishments’ reopening in May 2020 in Baden-Württemberg, Germany. Child-to-child transmission in schools/childcare facilities appeared very uncommon.” |
19 | 16) Australian Health Protection Principal Committee (AHPPC) coronavirus (COVID-19) statements on 24 April 2020, Australian government, 2020 | “AHPPC continues to note that there is very limited evidence of transmission between children in the school environment; population screening overseas has shown very low incidence of positive cases in school-aged children. In Australia, 2.4 per cent of confirmed cases have been in children aged between 5 and 18 years of age (as at 6am, 22 April 2020). AHPPC believes that adults in the school environment should practice room density measures (such as in staff rooms) given the greater risk of transmission between adults.” |
20 | 17) AN EVIDENCE SUMMARY OF PAEDIATRIC COVID-19 LITERATURE, Boast, 2021 | “Critical illness is very rare (~1%). In data from China, the USA and Europe, there is a “U shaped” risk gradient, with infants and older adolescents appear most likely to be hospitalised and to suffer from more severe disease. Deaths in children remain extremely rare from COVID-19, with only 4 deaths in the UK as of May 2020 in children <15 years, all in children with serious comorbidities.” |
21 | 18) Transmission dynamics of SARS-CoV-2 within families with children in Greece: A study of 23 clusters, Maltezou, 2020 | “While children become infected by SARS-CoV-2, they do not appear to transmit infection to others.” |
22 | 19) No evidence of secondary transmission of COVID-19 from children attending school in Ireland, 2020, Heavey, 2020 | “Children are thought to be vectors for transmission of many respiratory diseases including influenza. It was assumed that this would be true for COVID-19 also. To date however, evidence of widespread paediatric transmission has failed to emerge. School closures create childcare issues for parents. This has an impact on the workforce, including the healthcare workforce. There are also concerns about the impact of school closures on children’s mental and physical health… examination of all Irish paediatric cases of COVID-19 attending school during the pre-symptomatic and symptomatic periods of infection (n = 3) identified no cases of onward transmission to other children or adults within the school and a variety of other settings. These included music lessons (woodwind instruments) and choir practice, both of which are high-risk activities for transmission. Furthermore, no onward transmission from the three identified adult cases to children was identified.” |
23 | 20) COVID-19, school closures, and child poverty: a social crisis in the making, Van Lancker, 2020 | “The UN Educational, Scientific and Cultural Organization estimates that 138 countries have closed schools nationwide, and several other countries have implemented regional or local closures. These school closures are affecting the education of 80% of children worldwide. Although scientific debate is ongoing with regard to the effectiveness of school closures on virus transmission, the fact that schools are closed for a long period of time could have detrimental social and health consequences for children living in poverty, and are likely to exacerbate existing inequalities.” |
24 | 21) Impact of school closures for COVID-19 on the US health-care workforce and net mortality: a modelling study, Bayham, 2020 | “School closures come with many trade-offs, and can create unintended child-care obligations. Our results suggest that the potential contagion prevention from school closures needs to be carefully weighted with the potential loss of health-care workers from the standpoint of reducing cumulative mortality due to COVID-19, in the absence of mitigating measures.” |
25 | 22) The Truth About Kids, School, and COVID-19, Thompson/The Atlantic, 2021 | “The CDC’s judgment comes at a particularly fraught moment in the debate about kids, schools, and COVID-19. Parents are exhausted. Student suicides are surging. Teachers’ unions are facing national opprobrium for their reluctance to return to in-person instruction. And schools are already making noise about staying closed until 2022… Research from around the world has, since the beginning of the pandemic, indicated that people under 18, and especially younger kids, are less susceptible to infection, less likely to experience severe symptoms, and far less likely to be hospitalized or die…in May 2020, a small Irish study of young students and education workers with COVID-19 interviewed more than 1,000 contacts and found “no case of onward transmission” to any children or adults. In June 2020, a Singapore study of three COVID-19 clusters found that “children are not the primary drivers” of outbreaks and that “the risk of SARS-CoV-2 transmission among children in schools, especially preschools, is likely to be low.” |
26 | 23) Feared coronavirus outbreaks in schools yet to arrive, early data shows, Meckler/The Washington Post, 2020 | “This early evidence, experts say, suggests that opening schools may not be as risky as many have feared and could guide administrators as they chart the rest of what is already an unprecedented school year. Everyone had a fear there would be explosive outbreaks of transmission in the schools. In colleges, there have been. We have to say that, to date, we have not seen those in the younger kids, and that is a really important observation.” |
27 | 24) Three studies highlight low COVID risk of in-person school, CIDRAP, 2021 | “A trio of new studies demonstrate low risk of COVID-19 infection and spread in schools, including limited in-school COVID-19 transmission in North Carolina, few cases of the coronavirus-associated multisystem inflammatory syndrome in children (MIS-C) in Swedish schools, and minimal spread of the virus from primary school students in Norway.” |
28 | 25) Incidence and Secondary Transmission of SARS-CoV-2 Infections in Schools, Zimmerman, 2021 | “In the first 9 weeks of in-person instruction in North Carolina schools, we found extremely limited within-school secondary transmission of SARS-CoV-2, as determined by contact tracing.” |
29 | 26) Open Schools, Covid-19, and Child and Teacher Morbidity in Sweden, Ludvigsson, 2020 | “Of the 1,951,905 children aged 1 to 16 years in Sweden as of Dec 31, 2019, 65 died in the pre-pandemic period of November 2019 to February 2020, compared with 69 in the pandemic period of March through June 2020. None of the deaths were caused by COVID-19. Fifteen children diagnosed as having COVID-19, including seven with MIS-C, were admitted to an intensive care unit (ICU) from March to June 2020 (0.77 per 100,000 children in this age-group). Four children required mechanical ventilation. Four children were 1 to 6 years old (0.54 per 100,000), and 11 were 7 to 16 (0.90 per 100,000). Four of the children had an underlying illness: 2 with cancer, 1 with chronic kidney disease, and 1 with a hematologic disease). Of the country’s 103,596 preschool teachers and 20 schoolteachers, fewer than 10 were admitted to an ICU by Jun 30, 2020 (an equivalent of 19 per 100,000).” |
30 | 27) Minimal transmission of SARS-CoV-2 from paediatric COVID-19 cases in primary schools, Norway, August to November 2020, Brandal, 2021 | “This prospective study shows that transmission of SARS-CoV-2 from children under 14 years of age was minimal in primary schools in Oslo and Viken, the two Norwegian counties with the highest COVID-19 incidence and in which 35% of the Norwegian population resides. In a period of low to medium community transmission (a 14-day incidence of COVID-19 of < 150 cases per 100,000 inhabitants), when symptomatic children were asked to stay home from school, there were < 1% SARS-CoV-2–positive test results among child contacts and < 2% positive results in adult contacts in 13 contract tracings in Norwegian primary schools. In addition, self-collection of saliva for SARS-CoV-2 detection was efficient and sensitive (85% (11/13); 95% confidence interval: 55–98)…use of face masks is not recommended in schools in Norway. We found that with the IPC measures implemented there is low to no transmission from SARS-CoV-2–infected children in schools.” |
31 | 28) Children are unlikely to be the main drivers of the COVID-19 pandemic – A systematic review, Ludvigsson, 2020 | “Identified 700 scientific papers and letters and 47 full texts were studied in detail. Children accounted for a small fraction of COVID-19 cases and mostly had social contacts with peers or parents, rather than older people at risk of severe disease…Children are unlikely to be the main drivers of the pandemic. Opening up schools and kindergartens is unlikely to impact COVID-19 mortality rates in older people.” |
32 | 29) Science Brief: Transmission of SARS-CoV-2 in K-12 Schools and Early Care and Education Programs – Updated, CDC, 2021 | “Findings from several studies suggest that SARS-CoV-2 transmission among students is relatively rare, particularly when prevention strategies are in place…several studies have also concluded that students are not the primary sources of exposure to SARS-CoV-2 among adults in school setting.” |
33 | 30) Children under 10 less likely to drive COVID-19 outbreaks, research review says, Dobbins/McMaster, 2020 | “The bottom line thus far is that children under 10 years of age are unlikely to drive outbreaks of COVID-19 in daycares and schools and that, to date, adults were much more likely to be the transmitter of infection than children.” |
34 | 31) Role of children in the transmission of the COVID-19 pandemic: a rapid scoping review, Rajmil, 2020 | “Children are not transmitters to a greater extent than adults. There is a need to improve the validity of epidemiological surveillance to solve current uncertainties, and to take into account social determinants and child health inequalities during and after the current pandemic.” |
35 | 32) COVID-19 in schools – the experience in NSW, NCIRS, 2020 | “SARS-CoV-2 transmission in children in schools appears considerably less than seen for other respiratory viruses, such as influenza. In contrast to influenza, data from both virus and antibody testing to date suggest that children are not the primary drivers of COVID-19 spread in schools or in the community. This is consistent with data from international studies showing low rates of disease in children and suggesting limited spread among children and from children to adults.” |
36 | 33) Spread of SARS-CoV-2 in the Icelandic Population, Gudbjartsson, 2020 | “In a population-based study in Iceland, children under 10 years of age and females had a lower incidence of SARS-CoV-2 infection than adolescents or adults and males.” |
37 | 34) Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy, Onder, 2020 | Infected children and females were less likely to have severe disease. |
38 | 35) BC Center for Disease Control, BC Children’s hospital, 2020 | “BC families reported impaired learning, increased child stress, and decreased connection during COVID-19 school closures, while global data show increased loneliness and declining mental health, including anxiety and depression… Provincial child protection reports have also declined significantly despite reported increased domestic violence globally. This suggests decreased detection of child neglect and abuse without reporting from schools… The impact of school closures is likely to be experienced disproportionately by families subject to social inequities, and those with children with health conditions or special learning needs. Interrupted access to school-based resources, connections, and support compounds the broader societal impact of the pandemic. In particular, there are likely to be greater effects on single parent families, families in poverty, working mothers, and those with unstable employment and housing.” |
39 | 36) Transmission of SARS-CoV-2 in Australian educational settings: a prospective cohort study, Macartney, 2020 | “SARS-CoV-2 transmission rates were low in NSW educational settings during the first COVID-19 epidemic wave, consistent with mild infrequent disease in the 1·8 million child population.” |
40 | 37) COVID-19 Cases and Transmission in 17 K–12 Schools — Wood County, Wisconsin, August 31–November 29, 2020, CDC/Falk, 2021 | “In a setting of widespread community SARS-CoV-2 transmission, few instances of in-school transmission were identified among students and staff members, with limited spread among children within their cohorts and no documented transmission to or from staff members.” |
41 | 38) COVID-19 in children and the role of school settings in transmission – second update, ECDC, 2021 | “Children aged between 1-18 years have much lower rates of hospitalisation, severe disease requiring intensive hospital care, and death than all other age groups, according to surveillance data…the decision to close schools to control the COVID-19 pandemic should be used as a last resort. The negative physical, mental and educational impacts of proactive school closures on children, as well as the economic impact on society more broadly, would likely outweigh the benefits.”“Investigations of cases identified in school settings suggest that child to child transmission in schools is uncommon and not the primary cause of SARS-CoV-2 infection in children whose onset of infection coincides with the period during which they are attending school, particularly in preschools and primary school.” |
42 | 39) COVID-19 in children and young people, Snape, 2020 | “The near-global closure of schools in response to the pandemic reflected the reasonable expectation from previous respiratory virus outbreaks that children would be a key component of the transmission chain. However, emerging evidence suggests that this is most likely not the case. A minority of children experience a postinfectious inflammatory syndrome, the pathology and long-term outcomes of which are poorly understood. However, relative to their risk of contracting disease, children and adolescents have been disproportionately affected by lockdown measures, and advocates of child health need to ensure that children’s rights to health and social care, mental health support, and education are protected throughout subsequent pandemic waves…There are many other areas of potential indirect harm to children, including an increase in home injuries (accidental and nonaccidental) when children have been less visible to social protection systems because of lockdowns. In Italy, hospitalizations for accidents at home increased markedly during the COVID-19 lockdown and potentially posed a higher threat to children’s health than COVID-19. UK pediatricians report that delay in presentations to hospital or disrupted services contributed to the deaths of equal numbers of children that were reported to have died with SARS-CoV-2 infection. Many countries are seeing evidence that mental health in young people has been adversely affected by school closures and lockdowns. For example, preliminary evidence suggests that deaths by suicide of young people under 18 years old increased during lockdown in England.” |
43 | 40) Clinical characteristics of children and young people admitted to hospital with covid-19 in United Kingdom: prospective multicentre observational cohort study, Swann, 2020 | “Children and young people have less severe acute covid-19 than adults.” |
44 | 41) The Dangers of Keeping the Schools Closed, Yang, 2020 | “The data from a range of countries shows that children rarely, and in many countries never, have died from this infection. Children appear to get infected at a much lower rate than those who are older… there is no evidence that children are important in transmitting the disease…What we know about social distancing policies is based largely on models of influenza, where children are a vulnerable group. However, preliminary data on COVID-19 suggests that children are a small fraction of cases and may be less vulnerable than older adults.” |
45 | 42) SARS-CoV-2 Infection in Children, Lu, 2020 | “In contrast with infected adults, most infected children appear to have a milder clinical course. Asymptomatic infections were not uncommon.” |
46 | 43) Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention, Wu, 2020 | Less than 1% of the cases were in children younger than 10 years of age. |
47 | 44) Risk for COVID-19 Infection, CDC, 2021 | A CDC report on hospitalization and death in children, found that when compared to persons 18 to 29 years old, children 0 to 4 years had a 4x lower rate of hospitalization and a 9x lower rate of death. Children 5 to 17 years old had a 9x lower rate of hospitalization and a 16x lower rate of death. |
48 | 45) Children are unlikely to have been the primary source of household SARS-CoV-2 infections, Zhu, 2020 | “Whilst SARS-CoV-2 can cause mild disease in children, the data available to date suggests that children have not played a substantive role in the intra-household transmission of SARS-CoV-2.” |
49 | 46) Characteristics of Household Transmission of COVID-19, Li, 2020 | “The secondary attack rate to children was 4% compared with 17.1% for adults.” |
50 | 47) Are The Risks Of Reopening Schools Exaggerated?, Kamenetz/NPR, 2020 | “Despite widespread concerns, two new international studies show no consistent relationship between in-person K-12 schooling and the spread of the coronavirus. And a third study from the United States shows no elevated risk to childcare workers who stayed on the job…As a pediatrician, I am really seeing the negative impacts of these school closures on children,” Dr. Danielle Dooley, a medical director at Children’s National Hospital in Washington, D.C., told NPR. She ticked off mental health problems, hunger, obesity due to inactivity, missing routine medical care and the risk of child abuse — on top of the loss of education. “Going to school is really vital for children. They get their meals in school, their physical activity, their health care, their education, of course.” |
51 | 48) Child care not associated with spread of COVID-19, Yale study finds, YaleNews, 2020 | “Findings show child care programs that remained open throughout the pandemic did not contribute to the spread of the virus to providers, lending valuable insight to parents, policymakers, and providers alike.” |
52 | 49) Reopening US Schools in the Era of COVID-19: Practical Guidance From Other Nations, Tanmoy Das, 2020 | “There is evidence that, compared with adults, children are 3-fold less susceptible to infection, more likely to be asymptomatic, and less likely to be hospitalized and die. While rare reports of pediatric multi-inflammatory syndrome need to be monitored, its association with COVID-19 is extremely low and typically treatable.” |
53 | 50) Low-Income Children and Coronavirus Disease 2019 (COVID-19) in the US, Dooley, 2020 | “Restrictions imposed because of the coronavirus make these challenges more formidable. While school districts are engaging in distance learning, reports indicate wide variability in access to quality educational instruction, digital technology, and internet access. Students in rural and urban school districts are faced with challenges accessing the internet. In some urban areas, as many as one-third of students are not participating in online classes. Chronic absenteeism, or missing 10% or more of the school year, affects educational outcomes, including reading levels, grade retention, graduation rates, and high school dropout rates. Chronic absenteeism already disproportionately affects children living in poverty. The consequences of missing months of school will be even more marked.” |
54 | 51) COVID-19 and school return: The need and necessity, Betz, 2020 | “Of particular concern are the consequences for children who live in poverty. These children live in homes that have inadequate resources for virtual learning that will contribute to learning deficits, and thereby falling further behind with expected academic performance for grade level. Children from low-resourced homes are likely to have limited space for doing school work, inadequate temperature controls for heating and cooling and safe outdoor space for exercise (Van Lancker & Parolin, 2020). Furthermore, this group of children are at high risk for food insecurity as they may not have access to school lunches/breakfasts with school closures.” |
55 | 52) Children are not COVID-19 super spreaders: time to go back to school, Munro, 2020 | “Evidence is therefore emerging that children could be significantly less likely to become infected than adults…At the current time, children do not appear to be super spreaders.” |
56 | 53) Cluster of Coronavirus Disease 2019 (COVID-19) in the French Alps, February 2020, Danis, 2020 | “The index case stayed 4 days in the chalet with 10 English tourists and a family of 5 French residents; SARS-CoV-2 was detected in 5 individuals in France, 6 in England (including the index case), and 1 in Spain (overall attack rate in the chalet: 75%). One pediatric case, with picornavirus and influenza A coinfection, visited 3 different schools while symptomatic. One case was asymptomatic, with similar viral load as that of a symptomatic case…The fact that an infected child did not transmit the disease despite close interactions within schools suggests potential different transmission dynamics in children.” |
57 | 54) COVID-19 – research evidence summaries, RCPCH, 2020 | “In children, the evidence is now clear that COVID-19 is associated with a considerably lower burden of morbidity and mortality compared to that seen in the elderly. There is evidence of critical illness and death in children, but it is rare. There is also some evidence that children may be less likely to acquire the infection. The role of children in transmission, once they have acquired the infection, is unclear, although there is no clear evidence that they are any more infectious than adults. Symptoms are non-specific and most commonly cough and fever.” |
58 | 55) Impact of COVID-19 and lockdown on mental health of children and adolescents: A narrative review with recommendations, Singh, 2020 | “On these grounds, since January, 2020, various countries started implementing regional and national containment measures or lockdowns. In this backdrop one of the principal measures taken during lockdown has been closure of schools, educational institutes and activity areas. These inexorable circumstances which are beyond normal experience, lead to stress, anxiety and a feeling of helplessness in all.” |
59 | 56) Absence of SARS-CoV-2 Transmission from Children in Isolation to Guardians, South Korea, Lee/EID, 2021 | “Did not observe SARS-CoV-2 transmission from children to guardians in isolation settings in which close proximity would seem to increase transmission risk. Recent studies have suggested that children are not the main drivers of the COVID-19 pandemic, although the reasons remain unclear.” |
60 | 57) COVID-19 National Emergency Response Center, Epidemiology and Case Management Team. Contact tracing during coronavirus disease outbreak, South Korea, 2020, Park/EID, 2020 | “A large study on contacts of COVID-19 case-patients in South Korea observed that household transmission was lowest when the index case-patient was 0–9 years of age.” |
61 | 58) COVID-19 in Children and the Dynamics of Infection in Families, Posfay-Barbe, 2020 | “In 79% of households, ≥1 adult family member was suspected or confirmed for COVID-19 before symptom onset in the study child, confirming that children are infected mainly inside familial clusters. Surprisingly, in 33% of households, symptomatic HHCs tested negative despite belonging to a familial cluster with confirmed SARS-CoV-2 cases, suggesting an underreporting of cases. In only 8% of households did a child develop symptoms before any other HHC, which is in line with previous data in which it is shown that children are index cases in <10% of SARS-CoV-2 familial clusters.” |
62 | 59) COVID-19 Transmission and Children: The Child Is Not to Blame, Lee, 2020 | “Report on the dynamics of COVID-19 within families of children with reverse-transcription polymerase chain reaction–confirmed SARS-CoV-2 infection in Geneva, Switzerland. From March 10 to April 10, 2020, all children <16 years of age diagnosed at Geneva University Hospital (N = 40) underwent contact tracing to identify infected household contacts (HHCs). Of 39 evaluable households, in only 3 (8%) was a child the suspected index case, with symptom onset preceding illness in adult HHCs. In all other households, the child developed symptoms after or concurrent with adult HHCs, suggesting that the child was not the source of infection and that children most frequently acquire COVID-19 from adults, rather than transmitting it to them.”“In intriguing study from France, a 9-year-old boy with respiratory symptoms associated with picornavirus, influenza A, and SARS-CoV-2 coinfection was found to have exposed over 80 classmates at 3 schools; no secondary contacts became infected, despite numerous influenza infections within the schools, suggesting an environment conducive to respiratory virus transmission.”“In New South Wales, Australia, 9 students and 9 staff infected with SARS-CoV-2 across 15 schools had close contact with a total of 735 students and 128 staff. Only 2 secondary infections were identified, none in adult staff; 1 student in primary school was potentially infected by a staff member, and 1 student in high school was potentially infected via exposure to 2 infected schoolmates.” |
63 | 60) Role of children in household transmission of COVID-19, Kim, 2020 | “A total of 107 paediatric COVID-19 index cases and 248 of their household members were identified. One pair of paediatric index-secondary household case was identified, giving a household SAR of 0.5% (95% CI 0.0% to 2.6%).” |
64 | 61) Secondary attack rate in household contacts of COVID-19 Paediatric index cases: a study from Western India, Shah, 2021 | “The household SAR from pediatric patients is low.” |
65 | 62) Household Transmission of SARS-CoV-2: A Systematic Review and Meta-analysis, Madewell, 2021 | “Household secondary attack rates were increased from symptomatic index cases (18.0%; 95% CI, 14.2%-22.1%) than from asymptomatic index cases (0.7%; 95% CI, 0%-4.9%), to adult contacts (28.3%; 95% CI, 20.2%-37.1%) than to child contacts (16.8%; 95% CI, 12.3%-21.7%).” |
66 | 63) Children and Adolescents With SARS-CoV-2 Infection, Maltezou, 2020 | “Child-to-adult transmission was found in one occasion only.” |
67 | 64) Severe Acute Respiratory Syndrome-Coronavirus-2 Transmission in an Urban Community: The Role of Children and Household Contacts, Pitman-Hunt, 2021 | “A household sick contact was identified in fewer than half (42%) of patients and no child-to-adult transmission was identified.” |
68 | 65) A Meta-analysis on the Role of Children in Severe Acute Respiratory Syndrome Coronavirus 2 in Household Transmission Clusters, Zhu, 2020 | “The secondary attack rate in pediatric household contacts was lower than in adult household contacts (RR, 0.62; 95% CI, 0.42-0.91). These data have important implications for the ongoing management of the COVID-19 pandemic, including potential vaccine prioritization strategies.” |
69 | 66) The role of children in transmission of SARS-CoV-2: A rapid review, Li, 2020 | “Preliminary results from population-based and school-based studies suggest that children may be less frequently infected or infect others.” |
70 | 67) Novel Coronavirus 2019 Transmission Risk in Educational Settings, Yung, 2020 | “The data suggest that children are not the primary drivers of SARS-CoV-2 transmission in schools and could help inform exit strategies for lifting of lockdowns.” |
71 | 68) INTERPOL report highlights impact of COVID-19 on child sexual abuse, Interpol, 2020 | “Key environmental, social and economic factor changes due to COVID-19 which have impacted child sexual exploitation and abuse (CSEA) across the world include:closure of schools and subsequent movement to virtual learning environments;increased time children spend online for entertainment, social and educational purposes;restriction of international travel and the repatriation of foreign nationals;limited access to community support services, child care and educational personnel who often play a key role in detecting and reporting cases of child sexual exploitation.” |
72 | 69) Do school closures reduce community transmission of COVID-19? A systematic review of observational studies, Walsh, 2021 | “With such varied evidence on effectiveness, and the harmful effects, policymakers should take a measured approach before implementing school closures.” |
73 | 70) Association between living with children and outcomes from COVID-19: an OpenSAFELY cohort study of 12 million adults in England, Forbes, 2020 | “For adults living with children there is no evidence of an increased risk of severe COVID-19 outcomes. These findings have implications for determining the benefit-harm balance of children attending school in the COVID-19 pandemic.” |
74 | 71) School closure and management practices during coronavirus outbreaks including COVID-19: a rapid systematic review, Viner, 2020 | “Data from the SARS outbreak in mainland China, Hong Kong, and Singapore suggest that school closures did not contribute to the control of the epidemic.” |
75 | 72) Non-pharmaceutical public health measures for mitigating the risk and impact of epidemic and pandemic influenza, WHO, 2020 | “The effect of reactive school closure in reducing influenza transmission varied but was generally limited.” |
76 | 73) New research finds no evidence that schools are playing a significant role in driving spread of the Covid-19 virus in the community, Warwick, 2021 | “New research led by epidemiologists at the University of Warwick has found that there is no significant evidence that schools are playing a significant role in driving the spread of the Covid-19 disease in the community, particularly in primary schools…our analysis of recorded school absences as a result of infection with COVID-19 suggest that the risk is much lower in primary than secondary schools and we do not find evidence to suggest that school attendance is a significant driver of outbreaks in the community.” |
77 | 74) When schools shut: New UNESCO study exposes failure to factor gender in COVID-19 education responses, UNESCO, 2021 | “As governments brought remote learning solutions to scale to respond to the pandemic, speed, rather than equity in access and outcomes, appears to have been the priority. Initial COVID-19 responses seem to have been developed with little attention to inclusiveness, raising the risk of increased marginalization… Most countries across all income groups report providing teachers with different forms of support. Few programmes, however, helped teachers recognize the gender risks, disparities and inequalities that emerged during COVID-19 closures. Female teachers also have been largely expected to take on a dual role to ensure continuity of learning for their students, while facing additional childcare and unpaid domestic responsibilities in their homes during school closures.” |
78 | 75) School Closures Have Failed America’s Children, Kristof, 2021 | “Flags are flying at half-staff across the United States to commemorate the half-million American lives lost to the coronavirus. But there’s another tragedy we haven’t adequately confronted: Millions of American schoolchildren will soon have missed a year of in-person instruction, and we may have inflicted permanent damage on some of them, and on our country… But the educational losses are disproportionately the fault of Democratic governors and mayors who too often let schools stay closed even as bars opened.” |
79 | 76) The effects of school closures on SARS-CoV-2 among parents and teachers, Vlachos, 2020 | “The results for parents indicate that keeping lower-secondary schools open had minor consequences for the overall transmission of SARS-CoV-2 in society.” |
80 | 77) The Effects of School Reopenings on COVID-19 Hospitalizations, Harris, 2021 | “We find no effect of in-person school reopening on COVID-19 hospitalization rates.” |
81 | 78) Shut and re-open: the role of schools in the spread of COVID-19 in Europe, Stage, 2021 | “Limited school attendance, such as older students sitting exams or the partial return of younger year groups, does not appear to significantly affect community transmission. In countries where community transmission is generally low, such as Denmark or Norway, a large-scale reopening of schools while controlling or suppressing the epidemic appears feasible.” |
82 | 79) COVID-19 incidence, hospitalizations and mortality trends in Croatia and school closures, Simetin, 2021 | “The observed inconsistent pattern indicates that there were no association of school openings and COVID-19 morbidity and mortality trends in Croatia and that other factors were leading to increasing and decreasing numbers. This emphasizes the need to consider the introduction of other effective and less harmful measures by stakeholders, or at least to use school closures as a last resort.” |
83 | 80) A cross-sectional and prospective cohort study of the role of schools in the SARS-CoV-2 second wave in Italy, Gandini, 2021 | “This analysis does not support a role for school opening as a driver of the second COVID-19 wave in Italy, a large European country with high SARS-CoV-2 incidence.” |
84 | 81) The Role of Schools in Transmission of the SARS-CoV-2 Virus: Quasi-Experimental Evidence from Germany, Bismarck-Osten, 2021 | “Show that neither the summer closures nor the closures in the fall had a significant containing effect on the spread of SARS-CoV-2 among children or a spill-over effect on older generations. There is also no evidence that the return to school at full capacity after the summer holidays increased infections among children or adults. Instead, we find that the number of children infected increased during the last weeks of the summer holiday and decreased in the first weeks after schools reopened, a pattern we attribute to travel returnees.” |
85 | 82) No causal effect of school closures in Japan on the spread of COVID-19 in spring 2020, Fukumoto, 2021 | “We do not find any evidence that school closures in Japan reduced the spread of COVID-19. Our null results suggest that policies on school closures should be reexamined given the potential negative consequences for children and parents.” |
86 | 83) Transmission of SARS-CoV-2 in Norwegian schools: A population-wide register-based cohort study on characteristics of the index case and secondary attack rates, Rotevatn, 2021 | “Results confirm that schools have not been an important arena of transmission of SARS-CoV-2 in Norway and therefore support that schools can be kept open with IPC measures in place.” |
87 | 84) COVID-19 Mitigation Practices and COVID-19 Rates in Schools: Report on Data from Florida, New York and Massachusetts, Oster, 2021 | “Find higher student COVID-19 rates in schools and districts with lower in-person density but no correlations in staff rates. Ventilation upgrades are correlated with lower rates in Florida but not in New York. We do not find any correlations with mask mandates.” |